PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, SM; Sun, Y; Fan, R; Xu, QZ; Liu, XD; Zhang, XM; Wang, Y; Zhou, PK				Zhang, Shi-Meng; Sun, Yi; Fan, Rong; Xu, Qin-Zhi; Liu, Xiao-Dan; Zhang, Xiangming; Wang, Ya; Zhou, Ping-Kun			HIV-1 Tat regulates cyclin B1 by promoting both expression and degradation	FASEB JOURNAL			English	Article						apoptosis; ubiquitination	HUMAN-IMMUNODEFICIENCY-VIRUS; KINASE ACTIVATION; INDUCED APOPTOSIS; INFECTED PATIENTS; PROSTATE-CANCER; T-CELLS; PROTEIN; GENE; TYPE-1; LYMPHOCYTES	Cyclin B1, an important cell cycle regulator, was up-regulated in lymphocytes of human immunodeficiency virus (HIV)-infected patients. However, the mechanism of cyclin B1 up-regulation and the effects of the up-regulation on the host cells remain unclear. Here, we show that HIV-encoded Tat protein regulates cyclin B1 levels in two different ways: first, Tat stimulates the transcription of cyclin B1, which increases cyclin B1 levels and promotes the cells apoptosis; and second, Tat stimulates polyubiquitination-mediated degradation of cyclin B1 through binding to the N-terminal of cyclin B1 (aa 61-129) that is just downstream of the D box, which prevents excessive levels of cyclin B1 in the cells. These results suggest that Tat-regulating cyclin B1 affects the status of HIV: Tat stimulates cyclin B1 expression to slow down the host cell cycle progress and to promote the host cell apoptosis, which might facilitate HIV release; Tat stimulates cyclin B1 degradation to prevent overaccumulation of cyclin B1, which might facilitate HIV replication. Taken together, our results reveal for the first time how HIV-Tat regulates cyclin B1 and keeps its balance in the cells.-Zhang, S.-M., Sun, Y., Fan, R., Xu, Q.-Z., Liu, X.-D., Zhang, X., Wang, Y., Zhou, P.-K. HIV-1 Tat regulates cyclin B1 by promoting both expression and degradation. FASEB J. 24, 495-503 (2010). www.fasebj.org	[Zhang, Shi-Meng; Sun, Yi; Fan, Rong; Xu, Qin-Zhi; Liu, Xiao-Dan; Zhou, Ping-Kun] Beijing Inst Radiat Med, Dept Radiat Toxicol & Oncol, Beijing, Peoples R China; [Zhang, Shi-Meng; Zhang, Xiangming; Wang, Ya] Emory Univ, Sch Med, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA USA	Academy of Military Medical Sciences - China; Emory University	Wang, Y (corresponding author), 1365 Clifton Rd,C5090, Atlanta, GA 30322 USA.	yawang@radonc.emory.org; zhoupk@nic.bmi.ac.cn	Zhou, Ping-Kun/GSJ-3972-2022; Zhou, Ping-Kun/AAF-3536-2019	Zhou, Ping-Kun/0000-0001-7666-1209; 	National BioResource Project (NBRP), Ministry of Science and Technology (MOST), 973 Program [2007CB914603]; China National Natural Science Foundation (CNNSF) [30500267, 30400120]; Outstanding Youth Science Foundation, Natural Science Foundation of China (NFSC) [30825011]; International Atomic Energy Agency Coordinated Research [E3.30.22, 12510/R4]; United States (National Institutes of Health) [G-M080771]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	National BioResource Project (NBRP), Ministry of Science and Technology (MOST), 973 Program(National Basic Research Program of ChinaMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); China National Natural Science Foundation (CNNSF)(National Natural Science Foundation of China (NSFC)); Outstanding Youth Science Foundation, Natural Science Foundation of China (NFSC)(National Natural Science Foundation of China (NSFC)); International Atomic Energy Agency Coordinated Research; United States (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank Dr. Lung-Ji Chang (University of Florida, Gainesville, FL, USA), Junjie Qian (Beijing Insitute of Radiation Medicine, Beijing, China), Hui Zhang (Thomas Jefferson University, Philadelphia, PA, USA) and Karen S. Katula (University of North Carolina, Chapel Hill, NC, USA) for providing reagents. This work was supported by grants from China [National BioResource Project (NBRP), Ministry of Science and Technology (MOST), 973 Program 2007CB914603; China National Natural Science Foundation (CNNSF), grants 30500267 and 30400120; Outstanding Youth Science Foundation, Natural Science Foundation of China (NFSC), grant 30825011; International Atomic Energy Agency Coordinated Research Project E3.30.22, grant 12510/R4) and from the United States (National Institutes of Health, grant G-M080771).	Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; Apcher GS, 2003, FEBS LETT, V553, P200, DOI 10.1016/S0014-5793(03)01025-1; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Bartz SR, 1999, J VIROL, V73, P1956, DOI 10.1128/JVI.73.3.1956-1963.1999; Borgne A, 2006, ONCOGENE, V25, P7361, DOI 10.1038/sj.onc.1209718; Cannavo G, 2001, BLOOD, V97, P1756, DOI 10.1182/blood.V97.6.1756; Cheng N, 2002, MOL CANCER RES, V1, P2; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Col E, 2005, EMBO J, V24, P2634, DOI 10.1038/sj.emboj.7600734; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; Ehret A, 2001, EUR J IMMUNOL, V31, P1790, DOI 10.1002/1521-4141(200106)31:6<1790::AID-IMMU1790>3.0.CO;2-G; Epie N, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-6; Galati D, 2003, J INFECT DIS, V188, P1483, DOI 10.1086/379249; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Gomez LA, 2007, MOL CANCER THER, V6, P1534, DOI 10.1158/1535-7163.MCT-06-0727; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; Huang XH, 2002, J MOL BIOL, V323, P771, DOI 10.1016/S0022-2836(02)00998-1; KASHANCHI F, 1994, NATURE, V367, P295, DOI 10.1038/367295a0; Katula KS, 1997, CELL GROWTH DIFFER, V8, P811; Kawamoto H, 1997, AM J PATHOL, V150, P15; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; LI CJ, 1995, P NATL ACAD SCI USA, V92, P5461, DOI 10.1073/pnas.92.12.5461; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Loregian A, 2003, FEBS LETT, V543, P61, DOI 10.1016/S0014-5793(03)00399-5; Macho A, 1999, ONCOGENE, V18, P7543, DOI 10.1038/sj.onc.1203095; Mahieux R, 2001, J VIROL, V75, P1736, DOI 10.1128/JVI.75.4.1736-1743.2001; Mashal RD, 1996, CANCER RES, V56, P4159; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Paiardini M, 2004, AIDS, V18, P393, DOI 10.1097/00002030-200402200-00004; Piedimonte G, 1999, AIDS, V13, P1159, DOI 10.1097/00002030-199907090-00003; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Porter LA, 2003, BLOOD, V101, P1928, DOI 10.1182/blood-2002-04-1103; Porter LA, 2000, BLOOD, V95, P2645; SASTRY KJ, 1990, J BIOL CHEM, V265, P20091; Sastry KJ, 1996, ONCOGENE, V13, P487; Seeger M, 1997, J BIOL CHEM, V272, P8145, DOI 10.1074/jbc.272.13.8145; Sun Y, 2006, INT J RADIAT ONCOL, V65, P842, DOI 10.1016/j.ijrobp.2006.02.040; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Zhang MJ, 2001, J BIOMED SCI, V8, P290, DOI 10.1159/000054045	42	12	12	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					495	503		10.1096/fj.09-143925	http://dx.doi.org/10.1096/fj.09-143925			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19825974	Green Published			2022-12-25	WOS:000274045000017
J	Lombardi, A; Bursomanno, S; Lopardo, T; Traini, R; Colombatti, M; Ippoliti, R; Flavell, DJ; Flavell, SU; Ceriotti, A; Fabbrini, MS				Lombardi, Alessio; Bursomanno, Sara; Lopardo, Teresa; Traini, Roberta; Colombatti, Marco; Ippoliti, Rodolfo; Flavell, David J.; Flavell, Sopsamorn U.; Ceriotti, Aldo; Fabbrini, Maria Serena			Pichia pastoris as a host for secretion of toxic saporin chimeras	FASEB JOURNAL			English	Article						plant ribosome-inactivating proteins; eukaryotic expression; codon usage; tumor-targeted therapy; human urokinase receptor	RIBOSOME-INACTIVATING PROTEINS; T-CELL IMMUNOTOXIN; ACUTE LYMPHOBLASTIC-LEUKEMIA; AMINO-TERMINAL FRAGMENT; SAPONARIA-OFFICINALIS; EXPRESSION; ANTIBODY; INTERNALIZATION; RICIN; GENE	Most of the targeting moieties, such as antibody fragments or growth factor domains, used to construct targeted toxins for anticancer therapy derive from secretory proteins. These normally fold in the oxidative environment of the endoplasmic reticulum, and hence their folding in bacterial cells can be quite inefficient. For instance, only low amounts of properly folded antimetastatic chimera constituted by the amino-terminal fragment of human urokinase (ATF) fused to the plant ribosome-inactivating protein saporin could be recovered. ATF-saporin was instead secreted efficiently when expressed in eukaryotic cells protected from autointoxication with neutralizing anti-saporin antibodies. Pichia pastoris is a microbial eukaryotic host where these domains can fold into a transport-competent conformation and reach the extracellular medium. We show here that despite some host toxicity codon-usage optimization greatly increased the expression levels of active saporin but not those of an active-site mutant SAP-KQ in GS115 (his4) strain. The lack of any toxicity associated with expression of the latter confirmed that toxicity is due to saporin catalytic activity. Nevertheless, GS115 (his4) cells in flask culture secreted 3.5 mg/L of a histidine-tagged ATF-saporin chimera showing an IC50 of 6 x 10(-11) M against U937 cells, thus demonstrating the suitability of this expression platform for secretion of toxic saporin-based chimeras.-Lombardi, A., Bursomanno, S., Lopardo, T., Traini, R., Colombatti, M., Ippoliti, R., Flavell, D. J., Flavell, S. U., Ceriotti, A., Fabbrini, M. S. Pichia pastoris as a host for secretion of toxic saporin chimeras. FASEB J. 24, 253-265 (2010). www.fasebj.org	[Lombardi, Alessio; Bursomanno, Sara; Lopardo, Teresa; Traini, Roberta; Ceriotti, Aldo; Fabbrini, Maria Serena] CNR, IBBA, I-20133 Milan, Italy; [Colombatti, Marco] Univ Verona, Policlin GB Rossi, I-37100 Verona, Italy; [Ippoliti, Rodolfo] Univ Aquila, I-67100 Laquila, Italy; [Flavell, David J.; Flavell, Sopsamorn U.] Leukaemia Busters Clin Trials Support Unit, Southampton, Hants, England; [Flavell, David J.; Flavell, Sopsamorn U.] Southampton Gen Hosp, Simon Flavell Leukaemia Res Lab, Southampton SO9 4XY, Hants, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Biotecnologia Agraria (IBBA-CNR); University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of L'Aquila; University of Southampton	Fabbrini, MS (corresponding author), CNR, IBBA, Via Bassini 15, I-20133 Milan, Italy.	fabbrini@ibba.cnr.it	Ceriotti, Aldo/A-1448-2016; Flavell, David/AAQ-1916-2020; IPPOLITI, RODOLFO/C-3677-2011	Ceriotti, Aldo/0000-0002-8230-8863; IPPOLITI, RODOLFO/0000-0003-0652-3470	Leukaemia Busters; Ingenio (Regione Lombardia); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Leukaemia Busters; Ingenio (Regione Lombardia)(Regione Lombardia); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Leukaemia Busters (www. leukaemiabusters.org.uk) as part of the Recombinant Immunotoxin Study Group coordinated by D.J.F. S. B. had a fellowship supported by Ingenio (Regione Lombardia). We thank Alessandro Pini (University of Siena, Siena, Italy) for providing pHEN1-containing scFv alpha PA63, and Pietro Della Cristina (University of Verona, Verona, Italy) and Richard Marshall (University of Warwick, Coventry, UK) for fruitful discussions. Financial contributions by AIRC Regionale Veneto and by Fondazione Cariverona (bando 2007) are gratefully acknowledged.	AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; BENATTI L, 1989, EUR J BIOCHEM, V183, P465, DOI 10.1111/j.1432-1033.1989.tb14951.x; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; CREGG JM, 1989, MOL CELL BIOL, V9, P1316, DOI 10.1128/MCB.9.3.1316; Day PJ, 1998, EUR J BIOCHEM, V258, P540, DOI 10.1046/j.1432-1327.1998.2580540.x; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Emberson LM, 2005, J IMMUNOL METHODS, V305, P135, DOI 10.1016/j.jim.2005.04.005; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Fabbrini MS, 1997, FASEB J, V11, P1169, DOI 10.1096/fasebj.11.13.9367352; Fabbrini MS, 1997, BIOCHEM J, V322, P719, DOI 10.1042/bj3220719; Fabbrini MS, 2000, FASEB J, V14, P391, DOI 10.1096/fasebj.14.2.391; Flavell DJ, 2001, BRIT J CANCER, V84, P571, DOI 10.1054/bjoc.2000.1633; Flavell DJ, 1998, CANCER RES, V58, P5787; Frankel AE, 2000, CLIN CANCER RES, V6, P326; Ghosh P, 2006, BIOCHEM J, V400, P99, DOI 10.1042/BJ20060895; Gurkan C, 2005, MICROB CELL FACT, V4, P1, DOI 10.1186/1475-2859-4-33; Haraguchi Y, 2008, PLANT CELL PHYSIOL, V49, P314, DOI 10.1093/pcp/pcn005; Hartley MR, 2004, BBA-PROTEINS PROTEOM, V1701, P1, DOI 10.1016/j.bbapap.2004.06.004; Hohenblum H, 2004, BIOTECHNOL BIOENG, V85, P367, DOI 10.1002/bit.10904; Hong E, 1996, J CELL BIOL, V135, P623, DOI 10.1083/jcb.135.3.623; Ippoliti R, 2000, FASEB J, V14, P1335, DOI 10.1096/fj.14.10.1335; Liu YY, 2003, PROTEIN EXPRES PURIF, V30, P262, DOI 10.1016/S1046-5928(03)00129-3; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Peumans WJ, 2001, FASEB J, V15, P1493, DOI 10.1096/fj.00-0751rev; Piazza T, 2005, J CELL SCI, V118, P1515, DOI 10.1242/jcs.02280; Rajamohan F, 2000, PROTEIN EXPRES PURIF, V18, P193, DOI 10.1006/prep.1999.1181; Ramage JG, 2003, LEUKEMIA RES, V27, P79, DOI 10.1016/S0145-2126(02)00077-2; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; Santanche S, 1997, BIOCHEM BIOPH RES CO, V234, P129, DOI 10.1006/bbrc.1997.6597; Savino C, 2000, FEBS LETT, V470, P239, DOI 10.1016/S0014-5793(00)01325-9; Silacci M, 2005, PROTEOMICS, V5, P2340, DOI 10.1002/pmic.200401273; SREEKRISHNA K, 1993, INDUSTRIAL MICROORGANISMS: BASIC AND APPLIED MOLECULAR GENETICS, P119; Tolner B, 2006, NAT PROTOC, V1, P1213, DOI 10.1038/nprot.2006.127; Wang P, 2000, PROTEIN EXPRES PURIF, V20, P179, DOI 10.1006/prep.2000.1310; Woo JH, 2004, APPL ENVIRON MICROB, V70, P3370, DOI 10.1128/AEM.70.6.3370-3376.2004; Woo JH, 2002, PROTEIN EXPRES PURIF, V25, P270, DOI 10.1016/S1046-5928(02)00009-8; Woo JH, 2008, PROTEIN EXPRES PURIF, V58, P1, DOI 10.1016/j.pep.2007.11.006; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Yadava A, 2003, INFECT IMMUN, V71, P4961, DOI 10.1128/IAI.71.9.4961-4969.2003; Zarovni N, 2007, CANCER GENE THER, V14, P165, DOI 10.1038/sj.cgt.7700998; Zhao GX, 2006, PROTEIN EXPRES PURIF, V49, P71, DOI 10.1016/j.pep.2006.05.005	44	31	34	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					253	265		10.1096/fj.08-118042	http://dx.doi.org/10.1096/fj.08-118042			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19786581				2022-12-25	WOS:000273233600026
J	Tedesco, M; La Sala, G; Barbagallo, F; De Felici, M; Farini, D				Tedesco, Marianna; La Sala, Gina; Barbagallo, Federica; De Felici, Massimo; Farini, Donatella			STRA8 Shuttles between Nucleus and Cytoplasm and Displays Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID GENE-8 STRA8; RETINOIC ACID; GERM-CELLS; EXPORT SIGNALS; NUCLEOCYTOPLASMIC TRANSPORT; SUBCELLULAR-DISTRIBUTION; EMBRYONAL CARCINOMA; MEIOTIC INITIATION; STEM-CELLS; MOUSE	Stra8 (stimulated by retinoic acid 8) encodes a protein crucial for mammalian germ cells entering into premeiotic stages. Here, to elucidate the still unknown STRA8 molecular functions, we studied the cellular localization of the protein in several cell types, including premeiotic mouse germ cells and stem cell lines. We reported distinct STRA8 localization in germ and stem cell types and a heterogeneous protein distribution in the cytoplasm and nucleus of such cells suggesting that the protein can shuttle between these two compartments. Moreover, we identified specific protein motifs determining its nuclear import/export. Furthermore, we demonstrated that in transfected cell lines the nuclear import of STRA8 is an active process depending on an N-terminal basic nuclear localization signal. Moreover, its nuclear export is mainly mediated by the Exportin1 (XPO1) recognition of a nuclear export signal. Significantly, we also demonstrated that STRA8 associates with DNA and possesses transcriptional activity. These observations strongly suggest that STRA8 can exert important functions in the nucleus rather than in the cytoplasm as believed previously, likely depending on the cell type and regulated by its nuclear-cytoplasmic shuttling.	[Tedesco, Marianna; La Sala, Gina; Barbagallo, Federica; De Felici, Massimo; Farini, Donatella] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, I-00173 Rome, Italy	University of Rome Tor Vergata	Farini, D (corresponding author), Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Via Montpellier 1, I-00173 Rome, Italy.	donatella.farini@uniroma2.it	Barbagallo, Federica/AAD-4903-2022; De Felici, Massimo/J-4845-2018; Barbagallo, Federica/K-1185-2018; LA SALA, GINA/AAF-5414-2021	Barbagallo, Federica/0000-0002-2972-370X; Barbagallo, Federica/0000-0002-2972-370X; LA SALA, GINA/0000-0002-1907-5948; FARINI, DONATELLA/0000-0002-1991-3956; De Felici, Massimo/0000-0001-8479-8264	Italian Ministry of Work and Welfare [1650];  [YFP-XPO1]	Italian Ministry of Work and Welfare; 	This work was supported by Italian Ministry of Work and Welfare Grant 1650.; We are grateful to Dr. Rodriguez for the generous gift of YFP-XPO1; to Prof. C. Sette and Dr. A. Di Florio for fruitful discussions; to Dr. S. Di Siena and Dr. F. Barrios for the spermatogonial cell preparation; to Mr. G. Bonelli for the images preparation; and to Dr. I. Moscatelli for critical reading of the paper.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Black BE, 2001, CURR BIOL, V11, P1749, DOI 10.1016/S0960-9822(01)00537-1; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Di Agostino S, 2004, MOL BIOL CELL, V15, P1224, DOI 10.1091/mbc.E03-09-0638; FISCHER U, 1994, EMBO J, V13, P4105, DOI 10.1002/j.1460-2075.1994.tb06728.x; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; HILSCHER B, 1974, CELL TISSUE RES, V154, P443, DOI 10.1007/BF00219667; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Hogarth CA, 2007, DEV DYNAM, V236, P2311, DOI 10.1002/dvdy.21238; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Norton JD, 2000, J CELL SCI, V113, P3897; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Pellegrini M, 2003, J CELL SCI, V116, P3363, DOI 10.1242/jcs.00650; PESCE M, 1995, DEV BIOL, V170, P722, DOI 10.1006/dbio.1995.1250; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; ROSSI P, 1993, DEV BIOL, V155, P68, DOI 10.1006/dbio.1993.1007; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; SPEED RM, 1982, CHROMOSOMA, V85, P427, DOI 10.1007/BF00330366; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yamaguchi YL, 2006, DEV BIOL, V297, P350, DOI 10.1016/j.ydbio.2006.04.465; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	44	65	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35781	35793		10.1074/jbc.M109.056481	http://dx.doi.org/10.1074/jbc.M109.056481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19805549	hybrid, Green Published			2022-12-25	WOS:000272645600055
J	Vince, JE; Pantaki, D; Feltham, R; Mace, PD; Cordier, SM; Schmukle, AC; Davidson, AJ; Callus, BA; Wong, WWL; Gentle, IE; Carter, H; Lee, EF; Walczak, H; Day, CL; Vaux, DL; Silke, J				Vince, James E.; Pantaki, Delara; Feltham, Rebecca; Mace, Peter D.; Cordier, Stephanie M.; Schmukle, Anna C.; Davidson, Angelina J.; Callus, Bernard A.; Wong, Wendy Wei-Lynn; Gentle, Ian E.; Carter, Holly; Lee, Erinna F.; Walczak, Henning; Day, Catherine L.; Vaux, David L.; Silke, John			TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-kappa B and to Prevent TNF-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED FACTOR-2; ALPHA-DEPENDENT APOPTOSIS; SIGNALING COMPLEX; MULTIPLE-MYELOMA; STRUCTURAL BASIS; UBIQUITINATION; PROTEIN; CIAP1; DEGRADATION; SURVIVAL	Tumor necrosis factor (TNF) receptor-associated factor-2 (TRAF2) binds to cIAP1 and cIAP2 (cIAP1/2) and recruits them to the cytoplasmic domain of several members of the TNF receptor (TNFR) superfamily, including the TNF-TNFR1 ligand-receptor complex. Here, we define a cIAP1/2-interacting motif (CIM) within the TRAF-N domain of TRAF2, and we use TRAF2 CIM mutants to determine the role of TRAF2 and cIAP1/2 individually, and the TRAF2-cIAP1/2 interaction, in TNFR1-dependent signaling. We show that both the TRAF2 RING domain and the TRAF2 CIM are required to regulate NF-kappa B-inducing kinase stability and suppress constitutive noncanonical NF-kappa B activation. Conversely, following TNFR1 stimulation, cells bearing a CIM-mutated TRAF2 showed reduced canonical NF-kappa B activation and TNF-induced RIPK1 ubiquitylation. Remarkably, the RING domain of TRAF2 was dispensable for these functions. However, like the TRAF2 CIM, the RING domain of TRAF2 was required for protection against TNF-induced apoptosis. These results show that TRAF2 has anti-apoptotic signaling roles in addition to promoting NF-kappa B signaling and that efficient activation of NF-kappa B by TNFR1 requires the recruitment of cIAP1/2 by TRAF2.	[Vince, James E.; Pantaki, Delara; Feltham, Rebecca; Davidson, Angelina J.; Callus, Bernard A.; Wong, Wendy Wei-Lynn; Gentle, Ian E.; Carter, Holly; Vaux, David L.; Silke, John] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Mace, Peter D.; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Cordier, Stephanie M.; Schmukle, Anna C.; Walczak, Henning] Univ London Imperial Coll Sci Technol & Med, Div Med, Tumour Immunol Unit, Dept Immunol,Hammersmith Hosp, London W12 0NN, England; [Lee, Erinna F.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	La Trobe University; University of Otago; Imperial College London; Walter & Eliza Hall Institute	Silke, J (corresponding author), La Trobe Univ, Dept Biochem, Kingsbury Dr, Melbourne, Vic 3086, Australia.	j.silke@latrobe.edu.au	Lee, Erinna/N-1523-2015; Walczak, Henning/AAV-2214-2020; Wong, W. Wei-Lynn/A-6851-2015; Gentle, Ian/X-2888-2019; Vaux, David L/C-7249-2013; Silke, John/B-7622-2008	Lee, Erinna/0000-0003-1255-9808; Walczak, Henning/0000-0002-6312-4591; Wong, W. Wei-Lynn/0000-0003-3155-1211; Gentle, Ian/0000-0002-6707-7809; Vaux, David L/0000-0003-2703-1651; Silke, John/0000-0002-7611-5774; Mace, Peter/0000-0003-2175-9537; Day, Catherine/0000-0003-1571-4367; Anderton, Holly/0000-0003-3913-9686; Feltham, Rebecca/0000-0001-8376-6869	Human Frontiers science program; University of Otago; The Cancer Council Victoria; Leukemia and Lymphoma Society; National Health and Medical Research Council [461221, 433013, 541901, 541902]	Human Frontiers science program(Human Frontier Science Program); University of Otago; The Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Supported by a Human Frontiers science program fellowship.; Recipient of a health sciences career development award (University of Otago).; Supported by The Cancer Council Victoria.; Australian Fellow, funded by the Leukemia and Lymphoma Society and National Health and Medical Research Council Grant 461221.; Supported by National Health and Medical Research Council Grants 433013, 541901, and 541902.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Arch RH, 2000, BIOCHEM BIOPH RES CO, V272, P936, DOI 10.1006/bbrc.2000.2873; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Callus BA, 2008, CELL DEATH DIFFER, V15, P213, DOI 10.1038/sj.cdd.4402245; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Dupoux A, 2009, BLOOD, V113, P175, DOI 10.1182/blood-2008-02-137919; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Imoto I, 2002, CANCER RES, V62, P4860; Imoto I, 2001, CANCER RES, V61, P6629; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; LI L, 2008, BIOCHIM BIOPHYS ACTA, V8, P8; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; SILKE J, 2009, CELL DEATH IN PRESS; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Tanimoto T, 2005, CANCER LETT, V224, P141, DOI 10.1016/j.canlet.2004.11.049; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao YG, 2007, J BIOL CHEM, V282, P7777, DOI 10.1074/jbc.M609146200	59	173	184	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35906	35915		10.1074/jbc.M109.072256	http://dx.doi.org/10.1074/jbc.M109.072256			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19815541	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000272645600066
J	Liu, G; Bollig-Fischer, A; Kreike, B; van de Vijver, MJ; Abrams, J; Ethier, SP; Yang, ZQ				Liu, G.; Bollig-Fischer, A.; Kreike, B.; van de Vijver, M. J.; Abrams, J.; Ethier, S. P.; Yang, Z-Q			Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer	ONCOGENE			English	Article						GASC1; gene amplification; histone demethylase	MAMMARY EPITHELIAL-CELLS; ERBB-2 OVEREXPRESSION; STEM/PROGENITOR CELLS; LYSINE METHYLATION; GLAND DEVELOPMENT; SELF-RENEWAL; STEM-CELLS; EXPRESSION; JMJD2C; 9P23-24	Earlier, mapping of the 9p23-24 amplicon in esophageal cancer cell lines led us to the positional cloning of gene amplified in squamous cell carcinoma 1 (GASC1), which encodes a nuclear protein with a Jumonji C domain that catalyzes lysine (K) demethylation of histones. However, the transforming roles of GASC1 in breast cancer remain to be determined. In this study, we identified GASC1 as one of the amplified genes for the 9p23-24 region in breast cancer, particularly in basal-like subtypes. The levels of GASC1 transcript expression were significantly higher in aggressive, basal- like breast cancers compared with nonbasal-like breast cancers. Our in vitro assays demonstrated that GASC1 induces transformed phenotypes, including growth factor-independent proliferation, anchorage-independent growth, altered morphogenesis in Matrigel, and mammosphere forming ability, when overexpressed in immortalized, non-transformed mammary epithelial MCF10A cells. Additionally, GASC1 demethylase activity regulates the expression of genes critical for stem cell self-renewal, including NOTCH1, and may be linked to the stem cell phenotypes in breast cancer. Thus, GASC1 is a driving oncogene in the 9p23-24 amplicon in human breast cancer and targeted inhibition of GASC1 histone demethylase in cancer could provide potential new avenues for therapeutic development. Oncogene (2009) 28, 4491-4500; doi:10.1038/onc.2009.297; published online 28 September 2009	[Liu, G.; Bollig-Fischer, A.; Ethier, S. P.; Yang, Z-Q] Wayne State Univ, Breast Canc Program, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA; [Kreike, B.] Netherlands Canc Inst, Div Radiat Oncol & Expt Therapy, Amsterdam, Netherlands; [van de Vijver, M. J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Abrams, J.] Wayne State Univ, Dept Internal Med, Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Barbara Ann Karmanos Cancer Institute; Wayne State University	Yang, ZQ (corresponding author), Wayne State Univ, Breast Canc Program, Dept Pathol, Karmanos Canc Inst, 4100 John R HWCRC 815, Detroit, MI 48201 USA.	yangz@karmanos.org	LIU, GANG/AAR-4584-2021	LIU, GANG/0000-0001-6620-176X; Bollig-Fischer, Aliccia/0000-0003-4832-9457; Kreike, Bas/0000-0003-0030-8200; van de Vijver, Marc/0000-0002-0385-4787	NCI NIH HHS [R01 CA100724, R01 CA100724-06] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100724] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Geli J, 2005, INT J ONCOL, V26, P1385; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Ignatoski KMW, 2003, MOL CANCER RES, V1, P551; Ignatoski KMW, 1999, ENDOCRINOLOGY, V140, P3615, DOI 10.1210/en.140.8.3615; Ignatoski KMW, 2000, BRIT J CANCER, V82, P666, DOI 10.1054/bjoc.1999.0979; Italiano A, 2006, CANCER GENET CYTOGEN, V167, P122, DOI 10.1016/j.cancergencyto.2006.01.004; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Katoh Y, 2007, INT J MOL MED, V20, P269; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Knuutila S, 1998, AM J PATHOL, V152, P1107; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lal G, 2006, CANCER, V107, P2752, DOI 10.1002/cncr.22325; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Moffa AB, 2004, MOL CANCER RES, V2, P643; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pierga JY, 2007, BRIT J CANCER, V96, P341, DOI 10.1038/sj.bjc.6603483; Poetsch M, 2002, ONCOGENE, V21, P3038, DOI 10.1038/sj.onc.1205457; Politi K, 2004, SEMIN CANCER BIOL, V14, P341, DOI 10.1016/j.semcancer.2004.04.013; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Savelyeva L, 2001, CANCER RES, V61, P5179; Savelyeva L, 1999, GENE CHROMOSOME CANC, V24, P87, DOI 10.1002/(SICI)1098-2264(199901)24:1<87::AID-GCC13>3.0.CO;2-5; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Vinatzer U, 2008, CLIN CANCER RES, V14, P6426, DOI 10.1158/1078-0432.CCR-08-0702; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yang ZQ, 2001, JPN J CANCER RES, V92, P423, DOI 10.1111/j.1349-7006.2001.tb01112.x; Yang ZQ, 2000, CANCER RES, V60, P4735	47	156	161	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 17	2009	28	50					4491	4500		10.1038/onc.2009.297	http://dx.doi.org/10.1038/onc.2009.297			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DU	19784073	Green Accepted, Bronze			2022-12-25	WOS:000272876500008
J	Gupta, M; Sajid, A; Arora, G; Tandon, V; Singh, Y				Gupta, Meetu; Sajid, Andaleeb; Arora, Gunjan; Tandon, Vibha; Singh, Yogendra			Forkhead-associated Domain-containing Protein Rv0019c and Polyketide-associated Protein PapA5, from Substrates of Serine/Threonine Protein Kinase PknB to Interacting Proteins of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FHA DOMAIN; BINDING DOMAIN; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; ABC TRANSPORTER; PHOSPHORYLATION; ACTIVATION; SECRETION; EMBR; ACETYLTRANSFERASE	Mycobacterium tuberculosis profoundly exploits protein phosphorylation events carried out by serine/threonine protein kinases (STPKs) for its survival and pathogenicity. Forkhead-associated domains (FHA), the phosphorylation-responsive modules, have emerged as prominent players in STPK mediated signaling. In this study, we demonstrate the association of the previously uncharacterized FHA domain-containing protein Rv0019c with cognate STPK PknB. The consequent phosphorylation of Rv0019c is shown to be dependent on the conserved residues in the Rv0019c FHA domain and activation loop of PknB. Furthermore, by creating deletion mutants we identify Thr(36) as the primary phosphorylation site in Rv0019c. During purification of Rv0019c from Escherichia coli, the E. coli protein chloramphenicol acetyltransferase (CAT) specifically and reproducibly copurifies with Rv0019c in a FHA domain-dependent manner. On the basis of structural similarity of E. coli CAT with M. tuberculosis PapA5, a protein involved in phthiocerol dimycocerosate biosynthesis, PapA5 is identified as an interaction partner of Rv0019c. The interaction studies on PapA5, purified as an unphosphorylated protein from E. coli, with Rv0019c deletion mutants reveal that the residues N-terminal to the functional FHA domain of Rv0019c are critical for formation of the Rv0019c-PapA5 complex and thus constitute a previously unidentified phosphoindependent binding motif. Finally, PapA5 is shown to be phosphorylated on threonine residue(s) by PknB, whereas serine/threonine phosphatase Mstp completely reverses the phosphorylation. Thus, our data provides initial clues for a possible regulation of PapA5 and hence the phthiocerol dimycocerosate biosynthesis by PknB, either by direct phosphorylation of PapA5 or indirectly through Rv0019c.	[Sajid, Andaleeb; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India; [Gupta, Meetu; Tandon, Vibha] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Tandon, Vibha] Univ Delhi, Dept Chem, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; University of Delhi	Singh, Y (corresponding author), Mall Rd, Delhi 110007, India.	ysingh@igib.res.in	Sajid, Andaleeb/AAI-2960-2020; Arora, Gunjan/AAL-3448-2020	Sajid, Andaleeb/0000-0001-6248-4985; Arora, Gunjan/0000-0003-0575-6205	Council of Scientific and Industrial Research [NWP-0038]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research Grant NWP-0038.	Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; England P, 2009, FEBS LETT, V583, P301, DOI 10.1016/j.febslet.2008.12.036; Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Hammet A, 2000, FEBS LETT, V471, P141, DOI 10.1016/S0014-5793(00)01392-2; Hammet A, 2003, IUBMB LIFE, V55, P23, DOI 10.1080/1521654031000070636; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Jelsbak L, 2005, P NATL ACAD SCI USA, V102, P3010, DOI 10.1073/pnas.0409371102; Johnson DL, 2008, J BACTERIOL, V190, P2972, DOI 10.1128/JB.01997-07; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; Kennelly PJ, 1996, J BACTERIOL, V178, P4759, DOI 10.1128/jb.178.16.4759-4764.1996; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; LESLIE AGW, 1988, P NATL ACAD SCI USA, V85, P4133, DOI 10.1073/pnas.85.12.4133; Li HY, 2004, J MOL BIOL, V335, P371, DOI 10.1016/j.jmb.2003.10.032; Li J, 2000, J CELL SCI, V113, P4143; Li J, 1999, P NATL ACAD SCI USA, V96, P7821, DOI 10.1073/pnas.96.14.7821; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Liao H, 1999, J MOL BIOL, V294, P1041, DOI 10.1006/jmbi.1999.3313; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2008, BIOCHEM J, V410, P309, DOI 10.1042/BJ20071384; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Onwueme KC, 2004, P NATL ACAD SCI USA, V101, P4608, DOI 10.1073/pnas.0306928101; Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; WANG JYJ, 1978, J BIOL CHEM, V253, P7605; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	49	45	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34723	34734		10.1074/jbc.M109.058834	http://dx.doi.org/10.1074/jbc.M109.058834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826007	hybrid, Green Published			2022-12-25	WOS:000272439600028
J	Gross, SA; Guzman, GA; Wissenbach, U; Philipp, SE; Zhu, MX; Bruns, D; Cavalie, A				Gross, Stefan Alfred; Guzman, Gustavo Adolfo; Wissenbach, Ulrich; Philipp, Stephan Ernst; Zhu, Michael Xi; Bruns, Dieter; Cavalie, Adolfo			TRPC5 Is a Ca2+-activated Channel Functionally Coupled to Ca2+-selective Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION CHANNELS; CA2+ MICRODOMAINS; CELL; ENTRY; STIM1; ORAI1; MODULATION; ACTIVATION; EXOCYTOSIS; INHIBITION	TRPC5 forms non-selective cation channels. Here we studied the role of internal Ca2+ in the activation of murine TRPC5 heterologously expressed in human embryonic kidney cells. Cell dialysis with various Ca2+ concentrations (Ca-i(2+)) revealed a dose-dependent activation of TRPC5 channels by internal Ca2+ with EC50 of 635.1 and 358.2 nM at negative and positive membrane potentials, respectively. Stepwise increases of Ca-i(2+) induced by photolysis of caged Ca2+ showed that the Ca2+ activation of TRPC5 channels follows a rapid exponential time course with a time constant of 8.6 +/- 0.2 ms at Ca-i(2+) below 10 mu M, suggesting that the action of internal Ca2+ is a primary mechanism in the activation of TRPC5 channels. A second slow activation phase with a time to peak of 1.4 +/- 0.1 s was also observed at Ca-i(2+) above 10 mu M. In support of a Ca2+-activation mechanism, the thapsigargin-induced release of Ca2+ from internal stores activated TRPC5 channels transiently, and the subsequent Ca2+ entry produced a sustained TRPC5 activation, which in turn supported a long-lasting membrane depolarization. By co-expressing STIM1 plus ORAI1 or the alpha C-1 and beta(2) subunits of L-type Ca2+ channels, we found that Ca2+ entry through either calcium-release-activated-calcium or voltage-dependent Ca2+ channels is sufficient for TRPC5 channel activation. The Ca2+ entry activated TRPC5 channels under buffering of internal Ca2+ with EGTA but not with BAPTA. Our data support the hypothesis that TRPC5 forms Ca2+-activated cation channels that are functionally coupled to Ca2+-selective ion channels through local Ca2+ increases beneath the plasma membrane.	[Cavalie, Adolfo] Univ Saarland, Inst Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany; [Guzman, Gustavo Adolfo; Bruns, Dieter] Univ Saarland, Inst Physiol, D-66421 Homburg, Germany; [Zhu, Michael Xi] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Zhu, Michael Xi] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA	Saarland University; Saarland University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Cavalie, A (corresponding author), Univ Saarland, Inst Expt & Klin Pharmakol & Toxikol, Campus Homburg,Bldg 46, D-66421 Homburg, Germany.	ptacav@uks.eu	Philipp, Stephan/AAR-7519-2020	Philipp, Stephan/0000-0003-1959-9167	Deutsche Forschungsgemeinschaft; National Institutes of Health; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042183, P30NS045758, R21NS056942] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Deutsche Forschungsgemeinschaft to D.B. and A.C.). This work was also supported, in whole or in part, by the National Institutes of Health and by the American Heart Association (to M.X.Z.).	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Aneiros E, 2005, J IMMUNOL, V174, P119, DOI 10.4049/jimmunol.174.1.119; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Beech D. J., 2007, V179, P109; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Chaudhuri P, 2008, MOL BIOL CELL, V19, P3203, DOI 10.1091/mbc.E07-08-0765; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; Dattilo M, 2008, MOL PHARMACOL, V73, P42, DOI 10.1124/mol.107.040899; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kinoshita-Kawada M, 2005, PFLUG ARCH EUR J PHY, V450, P345, DOI 10.1007/s00424-005-1419-1; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Obukhov AG, 2008, J CELL PHYSIOL, V216, P162, DOI 10.1002/jcp.21388; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Semtner M, 2007, J BIOL CHEM, V282, P33868, DOI 10.1074/jbc.M702577200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Trebak M., 2007, V179, P593; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391; Zhu MH, 2005, AM J PHYSIOL-CELL PH, V289, pC591, DOI 10.1152/ajpcell.00440.2004; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	47	78	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34423	34432		10.1074/jbc.M109.018192	http://dx.doi.org/10.1074/jbc.M109.018192			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815560	Green Published, hybrid			2022-12-25	WOS:000272165200072
J	Yea, K; Kim, J; Yoon, JH; Kwon, T; Kim, JH; Lee, BD; Lee, HJ; Lee, SJ; Kim, JI; Lee, TG; Baek, MC; Park, HS; Park, KS; Ohba, M; Suh, PG; Ryu, SH				Yea, Kyungmoo; Kim, Jaeyoon; Yoon, Jong Hyuk; Kwon, Taewan; Kim, Jong Hyun; Lee, Byoung Dae; Lee, Hae-Jeong; Lee, Seung Jae; Kim, Jong-In; Lee, Taehoon G.; Baek, Moon-Chang; Park, Ho Seon; Park, Kyong Soo; Ohba, Motoi; Suh, Pann-Ghill; Ryu, Sung Ho			Lysophosphatidylcholine Activates Adipocyte Glucose Uptake and Lowers Blood Glucose Levels in Murine Models of Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; INSULIN; TRANSPORT; EXERCISE; ACID; IDENTIFICATION; KERATINOCYTES; INCREASES	Glucose homeostasis is maintained by the orchestration of peripheral glucose utilization and hepatic glucose production, mainly by insulin. In this study, we found by utilizing a combined parallel chromatography mass profiling approach that lysophosphatidylcholine (LPC) regulates glucose levels. LPC was found to stimulate glucose uptake in 3T3-L1 adipocytes dose- and time-dependently, and this activity was found to be sensitive to variations in acyl chain lengths and to polar head group types in LPC. Treatment with LPC resulted in a significant increase in the level of GLUT4 at the plasma membranes of 3T3-L1 adipocytes. Moreover, LPC did not affect IRS-1 and AKT2 phosphorylations, and LPC-induced glucose uptake was not influenced by pretreatment with the PI 3-kinase inhibitor LY294002. However, glucose uptake stimulation by LPC was abrogated both by rottlerin (a protein kinase C delta inhibitor) and by the adenoviral expression of dominant negative protein kinase C delta. In line with its determined cellular functions, LPC was found to lower blood glucose levels in normal mice. Furthermore, LPC improved blood glucose levels in mouse models of type 1 and 2 diabetes. These results suggest that an understanding of the mode of action of LPC may provide a new perspective of glucose homeostasis.	[Yea, Kyungmoo; Kim, Jaeyoon; Yoon, Jong Hyuk; Kwon, Taewan; Kim, Jong Hyun; Lee, Byoung Dae; Suh, Pann-Ghill; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; [Lee, Hae-Jeong; Lee, Seung Jae; Kim, Jong-In] Pohang Univ Sci & Technol, Peptide Lib Support Facil, Postech Biotech Ctr, Pohang 790784, South Korea; [Lee, Taehoon G.] Sigmol Incorp, Pohang 790834, South Korea; [Baek, Moon-Chang] Kyungpook Natl Univ, Dept Mol Med, Sch Med, Taegu 700721, South Korea; [Park, Ho Seon; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; [Ohba, Motoi] Showa Univ, Inst Mol Oncol, Tokyo 1428555, Japan	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Kyungpook National University; Seoul National University (SNU); Showa University	Ryu, SH (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea.	sungho@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010; Park, Kyong Soo/C-2265-2008	Park, Kyong Soo/0000-0003-3597-342X; Ryu, Sung Ho/0000-0003-0913-3048; Park, Ho Seon/0000-0003-1200-4626	Korean Ministry of Education and Science [FPR08B1-160]; Korean Ministry of Science and Technology/Korean Science and Engineering Foundation	Korean Ministry of Education and Science(Ministry of Education (MOE), Republic of Korea); Korean Ministry of Science and Technology/Korean Science and Engineering Foundation(Korea Science and Engineering FoundationMinistry of Science & Technology (MOST), Republic of Korea)	This work was supported by Grant FPR08B1-160 from the 21C Frontier Functional Proteomics project of the Korean Ministry of Education and Science and by a grant from the Korean Ministry of Science and Technology/Korean Science and Engineering Foundation to the Korean National Core Research Center for Systems Bio-Dynamics.	An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Baek MC, 2006, PROTEOMICS, V6, P1741, DOI 10.1002/pmic.200500511; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Braiman L, 1999, MOL ENDOCRINOL, V13, P2002, DOI 10.1210/me.13.12.2002; Chaudhuri P, 2005, CIRC RES, V97, P674, DOI 10.1161/01.RES.0000184667.82354.b1; Chiasson JL, 2004, DIABETES, V53, pS34, DOI 10.2337/diabetes.53.suppl_3.S34; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Elmendorf JS, 2002, J MEMBRANE BIOL, V190, P167, DOI 10.1007/s00232-002-1035-3; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Hespel P, 1996, DIABETES, V45, pS99, DOI 10.2337/diab.45.1.S99; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Ishibashi KI, 2000, ENDOCRINOLOGY, V141, P4623, DOI 10.1210/en.141.12.4623; Kemppainen J, 2002, J PHYSIOL-LONDON, V542, P403, DOI 10.1113/jphysiol.2002.018135; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; Li LW, 1999, MOL CELL BIOL, V19, P8547; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Perrini S, 2004, DIABETES, V53, P41, DOI 10.2337/diabetes.53.1.41; Richter EA, 2001, J PHYSIOL-LONDON, V535, P313, DOI 10.1111/j.1469-7793.2001.t01-2-00313.x; Ryder JW, 2001, ACTA PHYSIOL SCAND, V171, P249, DOI 10.1046/j.1365-201x.2001.00827.x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Tanishita T, 1997, J BIOCHEM, V122, P90; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; VANDENBERGHE N, 1994, MOL CELL BIOL, V14, P2372, DOI 10.1128/MCB.14.4.2372; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Xing FY, 2009, J CELL MOL MED, V13, P1136, DOI 10.1111/j.1582-4934.2008.00394.x; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3; Yea K, 2008, J MOL MED-JMM, V86, P211, DOI 10.1007/s00109-007-0269-z	35	97	102	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33833	33840		10.1074/jbc.M109.024869	http://dx.doi.org/10.1074/jbc.M109.024869			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815546	Green Published, hybrid			2022-12-25	WOS:000272165200015
J	Kanekiyo, T; Bu, GJ				Kanekiyo, Takahisa; Bu, Guojun			Receptor-associated Protein Interacts with Amyloid-beta Peptide and Promotes Its Cellular Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; HEPARAN-SULFATE; LDL-RECEPTOR; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; ALPHA-2-MACROGLOBULIN RECEPTOR; LIPOPROTEIN RECEPTORS; MOLECULAR CHAPERONE; TRANSGENIC MICE; TERMINAL DOMAIN	Brain amyloid-beta (A beta) peptide accumulation and aggregation are critical events in the pathogenesis of Alzheimer disease. Increasing evidence has demonstrated that LRP1 is involved in Alzheimer disease pathogenesis. The physiological ligands of LRP1, including apoE, play significant roles in the cellular clearance of A beta. The receptor-associated protein (RAP) is a specialized chaperone for members of the low density lipoprotein receptor family. RAP shares structural and receptor-binding properties with apoE. Here, we show that RAP binds to both A beta 40 and A beta 42 in a concentration-dependent manner and forms complexes with them. Fluorescence-activated cell sorter analysis showed that RAP significantly enhances the cellular internalization of A beta in different cell types, including brain vascular smooth muscle, neuroblastoma, glioblastoma, and Chinese hamster ovary cells. This effect of RAP was confirmed by fluorescence microscopy and enzyme-linked immunosorbent assay. RAP binds to both LRP1 and heparin; however, the ability of RAP to enhance A beta cellular uptake was blocked by heparin and heparinase treatment but not by LRP1 deficiency. Furthermore, the effects of RAP were significantly decreased in heparan sulfate proteoglycan-deficient Chinese hamster ovary cells. Our findings reveal that RAP is a novel A beta-binding protein that promotes cellular internalization of A beta.	[Kanekiyo, Takahisa; Bu, Guojun] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Bu, Guojun] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Bu, Guojun] Xiamen Univ, Inst Biomed Res, Xiamen 361005, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Xiamen University	Bu, GJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, Campus Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.	bu@wustl.edu			National Institutes of Health [AG027924, AG031784]; Alzheimer's Association; Uehara Memorial Foundation; American Health Assistance Foundation; American Heart Association; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG027924, R01AG031784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Uehara Memorial Foundation(Uehara Memorial Foundation); American Health Assistance Foundation(BrightFocus Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG027924 and AG031784 (to G.B.). This work was also supported by a Zenith Fellows award from the Alzheimer's Association (to G. B.) and by fellowships from the Uehara Memorial Foundation, the American Health Assistance Foundation, and the American Heart Association (to T.K.).	ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Bu GJ, 1997, J CELL SCI, V110, P65; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; BU GJ, 1994, J BIOL CHEM, V269, P29874; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; Carey DJ, 1997, BIOCHEM J, V327, P1; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; IADONATO SP, 1993, BIOCHEM J, V296, P867, DOI 10.1042/bj2960867; Ida N, 1996, FEBS LETT, V394, P174, DOI 10.1016/0014-5793(96)00948-9; Jaeger S, 2008, CURR ALZHEIMER RES, V5, P15; Kanekiyo T, 2009, FUTUR NEUROL, V4, P55, DOI 10.2217/14796708.4.1.55; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Lee D, 2007, PROTEIN SCI, V16, P1628, DOI 10.1110/ps.072865407; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; LEVINE H, 1995, NEUROBIOL AGING, V16, P755, DOI 10.1016/0197-4580(95)00052-G; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Libeu CP, 2001, J BIOL CHEM, V276, P39138, DOI 10.1074/jbc.M104746200; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Melman L, 2001, J BIOL CHEM, V276, P29338, DOI 10.1074/jbc.M103717200; Nielsen PR, 1997, P NATL ACAD SCI USA, V94, P7521, DOI 10.1073/pnas.94.14.7521; O'Callaghan P, 2008, BRAIN PATHOL, V18, P548, DOI 10.1111/j.1750-3639.2008.00152.x; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Pandey P, 2008, GENES BRAIN BEHAV, V7, P943, DOI 10.1111/j.1601-183X.2008.00436.x; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Reblin T, 1997, J LIPID RES, V38, P2103; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Skidmore MA, 2008, CONNECT TISSUE RES, V49, P140, DOI 10.1080/03008200802148595; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Urmoneit B, 1997, LAB INVEST, V77, P157; Van Uden E, 2002, J NEUROSCI, V22, P9298; WARSHAWSKY I, 1993, J BIOL CHEM, V268, P22046; WARSHAWSKY I, 1993, J CLIN INVEST, V92, P937, DOI 10.1172/JCI116669; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; WILLNOW TE, 1994, METHOD CELL BIOL, V43, P305; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Wu YB, 2004, J BIOMOL NMR, V29, P271, DOI 10.1023/B:JNMR.0000032507.96325.6d; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Xu GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003159; Yamauchi Y, 2008, BIOCHEMISTRY-US, V47, P6702, DOI 10.1021/bi8003999; Zerbinatti CV, 2004, P NATL ACAD SCI USA, V101, P1075, DOI 10.1073/pnas.0305803101; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	64	38	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33352	33359		10.1074/jbc.M109.015032	http://dx.doi.org/10.1074/jbc.M109.015032			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19826010	hybrid, Green Published			2022-12-25	WOS:000272028500040
J	Kunzelmann, S; Webb, MR				Kunzelmann, Simone; Webb, Martin R.			A Biosensor for Fluorescent Determination of ADP with High Time Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRANDED-DNA TRANSLOCATION; PROKARYOTIC ACTIN HOMOLOG; PHOSPHATE-BINDING PROTEIN; IRON-SULFUR CLUSTERS; DYNAMIC INSTABILITY; PCRA HELICASE; REAL-TIME; SEGREGATION; KINASE; MECHANISM	Nearly every cellular process requires the presence of ATP. This is reflected in the vast number of enzymes like kinases or ATP hydrolases, both of which cleave the terminal phosphate from ATP, thereby releasing ADP. Despite the fact that ATP hydrolysis is one of the most fundamental reactions in biological systems, there are only a few methods available for direct measurements of enzymatic-driven ATP conversion. Here we describe the development of a reagentless biosensor for ADP, the common product of all ATPases and kinases, which allows the real-time detection of ADP, produced enzymatically. The biosensor is derived from a bacterial actin homologue, ParM, as protein framework. A single fluorophore (a diethylaminocoumarin), attached to ParM at the edge of the nucleotide binding site, couples ADP binding to a > 3.5-fold increase in fluorescence intensity. The labeled ParM variant has high affinity for ADP (0.46 mu M) and a fast signal response, controlled by the rate of ADP binding to the sensor (0.65 mu M(-1)s(-1)). Amino acids in the active site were mutated to reduce ATP affinity and achieve a > 400-fold discrimination against triphosphate binding. A further mutation ensured that the final sensor did not form filaments and, as a consequence, has extremely low ATPase activity. The broad applicability of N-[2-(1-maleimidyl)ethyl]-7-diethylaminocoumarin-3-carboxamide (MDCC)-ParM as a sensitive probe for ADP is demonstrated in real-time kinetic assays on two different ATPases and a protein kinase.	[Kunzelmann, Simone; Webb, Martin R.] MRC Natl Inst Med Res, London NW7 1AA, England	MRC National Institute for Medical Research	Webb, MR (corresponding author), MRC Natl Inst Med Res, Ridgeway,Mill Hill, London NW7 1AA, England.	mwebb@nimr.mrc.ac.uk		Webb, Martin/0000-0002-0134-9621	Medical Research Council Technology; Medical Research Council, United Kingdom; MRC [MC_U117512742] Funding Source: UKRI; Medical Research Council [MC_U117512742] Funding Source: researchfish	Medical Research Council Technology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Technology and by Medical Research Council, United Kingdom. A patent application has been made by the Medical Research Council on part of this work.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Brune M, 2001, BIOCHEMISTRY-US, V40, P5087, DOI 10.1021/bi002484h; Charter NW, 2006, J BIOMOL SCREEN, V11, P390, DOI 10.1177/1087057106286829; Dattelbaum JD, 2001, ANAL BIOCHEM, V291, P89, DOI 10.1006/abio.2001.4998; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Eccleston JF, 2006, J BIOL CHEM, V281, P8371, DOI 10.1074/jbc.M513455200; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; GILARDI G, 1994, ANAL CHEM, V66, P3840, DOI 10.1021/ac00093a047; Hong L, 2009, ANAL BIOCHEM, V391, P31, DOI 10.1016/j.ab.2009.04.033; IORDANESCU S, 1989, J BACTERIOL, V171, P4501, DOI 10.1128/JB.171.8.4501-4503.1989; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kleman-Leyer KM, 2009, ASSAY DRUG DEV TECHN, V7, P56, DOI 10.1089/adt.2008.175; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Lowery RG, 2006, EXPERT OPIN THER TAR, V10, P179, DOI 10.1517/14728222.10.1.179; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Okoh MP, 2006, BIOCHEMISTRY-US, V45, P14764, DOI 10.1021/bi060960j; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petrovic A, 2008, PROTEIN SCI, V17, P1264, DOI 10.1110/ps.034652.108; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Roeben A, 2006, J MOL BIOL, V358, P145, DOI 10.1016/j.jmb.2006.01.096; Salins LLE, 2001, ANAL BIOCHEM, V294, P19, DOI 10.1006/abio.2001.5131; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Srinivasan J, 2004, CHEM BIOL, V11, P499, DOI 10.1016/j.chembiol.2004.03.014; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; West TG, 2009, BIOPHYS J, V96, P3281, DOI 10.1016/j.bpj.2009.01.016	36	38	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33130	33138		10.1074/jbc.M109.047118	http://dx.doi.org/10.1074/jbc.M109.047118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801632	Green Published, hybrid			2022-12-25	WOS:000272028500017
J	Chua, YL; Ito, Y; Pole, JCM; Newman, S; Chin, SF; Stein, RC; Ellis, IO; Caldas, C; O'hare, MJ; Murrell, A; Edwards, PAW				Chua, Y. L.; Ito, Y.; Pole, J. C. M.; Newman, S.; Chin, S-F; Stein, R. C.; Ellis, I. O.; Caldas, C.; O'hare, M. J.; Murrell, A.; Edwards, P. A. W.			The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene	ONCOGENE			English	Article						breast cancer; NRG1; heregulins; DNA methylation; tumour suppressor gene; chromosome rearrangement	DIFFERENTIATION FACTOR NDF; MALIGNANT HUMAN BREAST; MOUSE MAMMARY-GLAND; CELL-LINES; GAMMA-HEREGULIN; GROWTH-FACTOR; CHROMOSOME-TRANSLOCATION; EPITHELIAL-CELLS; DNA METHYLATION; WERNER-SYNDROME	Neuregulin-1 (NRG1) is both a candidate oncogene and a candidate tumour suppressor gene. It not only encodes the heregulins and other mitogenic ligands for the ERBB family, but also causes apoptosis in NRG1-expressing cells. We found that most breast cancer cell lines had reduced or undetectable expression of NRG1. This included cell lines that had translocation breaks in the gene. Similarly, expression in cancers was generally comparable to or less than that in various normal breast samples. Many non-expressing cell lines had extensive methylation of the CpG island at the principal transcription start site at exon 2 of NRG1. Expression was reactivated by demethylation. Many tumours also showed methylation, whereas normal mammary epithelial fragments had none. Lower NRG1 expression correlated with higher methylation. Small interfering RNA (siRNA)-mediated depletion of NRG1 increased net proliferation in a normal breast cell line and a breast cancer cell line that expressed NRG1. The short arm of chromosome 8 is frequently lost in epithelial cancers, and NRG1 is the most centromeric gene that is always affected. NRG1 may therefore be the major tumour suppressor gene postulated to be on 8p: it is in the correct location, is antiproliferative and is silenced in many breast cancers. Oncogene (2009) 28, 4041-4052; doi:10.1038/onc.2009.259; published online 5 October 2009	[Edwards, P. A. W.] Univ Cambridge, Dept Pathol, Hutchison Med Res Council, Res Ctr, Cambridge CB2 0XZ, England; [Ito, Y.; Chin, S-F; Caldas, C.; Murrell, A.] Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0XZ, England; [Stein, R. C.; O'hare, M. J.] UCL, Ludwig Inst Canc Res, Breast Canc Lab, Univ Coll & Middlesex Sch Med, London, England; [Ellis, I. O.] Univ Nottingham Mol Med Sci, Dept Histopathol, City Hosp Nottingham, Nottingham, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Ludwig Institute for Cancer Research; University of London; University College London; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Edwards, PAW (corresponding author), Univ Cambridge, Dept Pathol, Hutchison Med Res Council, Res Ctr, Cambridge CB2 0XZ, England.	pawe1@cam.ac.uk	Caldas, Carlos/A-7543-2008; Stein, Robert C/N-6679-2015; Newman, Scott/B-4843-2012; Caldas, Carlos/U-7250-2019; Edwards, Paul A/M-8291-2014	Stein, Robert C/0000-0003-2969-0415; Caldas, Carlos/0000-0003-3547-1489; Edwards, Paul A/0000-0002-4789-3374; Ellis, Ian/0000-0001-5292-8474; chin, suet-feung/0000-0001-5697-1082	Breast Cancer Campaign; Cancer Research UK; Hutchison-Whampoa Ltd.; Ludwig Institute for Cancer Research	Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Hutchison-Whampoa Ltd.; Ludwig Institute for Cancer Research	We thank Huai-En Huang for some exploratory expression analysis. This study was funded principally by the Breast Cancer Campaign and also by Cancer Research UK, Hutchison-Whampoa Ltd. (who endowed the buildings in which the work was done) and the Ludwig Institute for Cancer Research.	Adelaide J, 2003, GENE CHROMOSOME CANC, V37, P333, DOI 10.1002/gcc.10218; Agrelo R, 2006, P NATL ACAD SCI USA, V103, P8822, DOI 10.1073/pnas.0600645103; Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Amin DN, 2005, EXP CELL RES, V309, P12, DOI 10.1016/j.yexcr.2005.04.034; Birnbaum D, 2003, LANCET ONCOL, V4, P639, DOI 10.1016/S1470-2045(03)01225-7; BRADBURY JM, 1993, ONCOGENE, V8, P1551; BRIAND P, 1987, IN VITRO CELL DEV B, V23, P181, DOI 10.1007/BF02623578; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Ching TT, 2005, NAT GENET, V37, P645, DOI 10.1038/ng1563; Clarke C, 2005, J MAMMARY GLAND BIOL, V10, P273, DOI 10.1007/s10911-005-9587-3; Cooke SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-288; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; Deadwyler GD, 2000, GLIA, V32, P304, DOI 10.1002/1098-1136(200012)32:3<304::AID-GLIA90>3.3.CO;2-Q; EDWARDS PAW, 1986, J CELL SCI, V80, P91; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Garcia MJ, 2005, ONCOGENE, V24, P5235, DOI 10.1038/sj.onc.1208741; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Grimm S, 1997, J EXP MED, V185, P1137, DOI 10.1084/jem.185.6.1137; Grimm S, 1998, J EXP MED, V188, P1535, DOI 10.1084/jem.188.8.1535; Hayes NVL, 2008, J MAMMARY GLAND BIOL, V13, P205, DOI 10.1007/s10911-008-9078-4; Huang HE, 2004, CANCER RES, V64, P6840, DOI 10.1158/0008-5472.CAN-04-1762; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; Kalirai H, 2006, J PATHOL, V208, P7, DOI 10.1002/path.1881; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; Liu XF, 1999, ONCOGENE, V18, P7110, DOI 10.1038/sj.onc.1203136; Muraoka-Cook RS, 2008, J MAMMARY GLAND BIOL, V13, P235, DOI 10.1007/s10911-008-9080-x; Muraoka-Cook RS, 2006, MOL CELL BIOL, V26, P6412, DOI 10.1128/MCB.01950-05; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pole JCM, 2006, ONCOGENE, V25, P5693, DOI 10.1038/sj.onc.1209570; Prentice LM, 2005, ONCOGENE, V24, P7281, DOI 10.1038/sj.onc.1208892; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Schaefer G, 1997, ONCOGENE, V15, P1385, DOI 10.1038/sj.onc.1201317; STAMPS AC, 1994, INT J CANCER, V57, P865, DOI 10.1002/ijc.2910570616; Steinthorsdottir V, 2004, GENE, V342, P97, DOI 10.1016/j.gene.2004.07.029; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wang XZ, 1999, ONCOGENE, V18, P5718, DOI 10.1038/sj.onc.1202950; Weinstein EJ, 2000, CANCER RES, V60, P3856; Weinstein EJ, 1998, ONCOGENE, V17, P2107, DOI 10.1038/sj.onc.1202428; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215	47	56	61	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2009	28	46					4041	4052		10.1038/onc.2009.259	http://dx.doi.org/10.1038/onc.2009.259			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AE	19802002	Green Submitted, Green Accepted			2022-12-25	WOS:000272560500001
J	Autiero, I; Costantini, S; Colonna, G				Autiero, Ida; Costantini, Susan; Colonna, Giovanni			Human Sirt-1: Molecular Modeling and Structure-Function Relationships of an Unordered Protein	PLOS ONE			English	Article								Background: Sirt-1 is a NAD+-dependent nuclear deacetylase of 747 residues that in mammals is involved in various important metabolic pathways, such as glucose metabolism and insulin secretion, and often works on many different metabolic substrates as a multifunctional protein. Sirt-1 down-regulates p53 activity, rising lifespan, and cell survival; it also deacetylases peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its coactivator 1 alpha (PGC-1 alpha), promoting lipid mobilization, positively regulating insulin secretion, and increasing mitochondrial dimension and number. Therefore, it has been implicated in diseases such as diabetes and the metabolic syndrome and, also, in the mechanisms of longevity induced by calorie restriction. Its whole structure is not yet experimentally determined and the structural features of its allosteric site are unknown, and no information is known about the structural changes determined by the binding of its allosteric effectors. Methodology: In this study, we modelled the whole three-dimensional structure of Sirt-1 and that of its endogenous activator, the nuclear protein AROS. Moreover, we modelled the Sirt-1/AROS complex in order to study the structural basis of its activation and regulation. Conclusions: Amazingly, the structural data show that Sirt-1 is an unordered protein with a globular core and two large unordered structural regions at both termini, which play an important role in the protein-protein interaction. Moreover, we have found on Sirt-1 a conserved pharmacophore pocket of which we have discussed the implication.	[Autiero, Ida; Costantini, Susan; Colonna, Giovanni] Univ Naples 2, CRISCEB Interdepartmental Res Ctr Computat & Biot, Naples, Italy; [Costantini, Susan] CROM Oncol Res Ctr Mercogliano Fiorentino Lo Vuol, Mercogliano, Italy; [Costantini, Susan; Colonna, Giovanni] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Autiero, I (corresponding author), Univ Naples 2, CRISCEB Interdepartmental Res Ctr Computat & Biot, Naples, Italy.	susan.costantini@unina2.it	Costantini, Susan/J-9914-2018; Colonna, Giovanni/AAY-3568-2021; Autiero, Ida/HCI-1827-2022; Autiero, Ida/P-7002-2018	Autiero, Ida/0000-0001-8886-8063; Autiero, Ida/0000-0001-8886-8063; Colonna, Giovanni/0000-0002-0473-1455; Costantini, Susan/0000-0002-7538-4657	CRISCEB, Second University of Naples, Naples, Italy	CRISCEB, Second University of Naples, Naples, Italy	The funding is from the Institute in which this project was carried out. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IA is supported by Doctorate in Computational Biology, CRISCEB, Second University of Naples, Naples, Italy.	Chang JH, 2002, J BIOL CHEM, V277, P34489, DOI 10.1074/jbc.M205460200; COFF JA, 2000, FUNCTION GENOMICS, V302, P511; Dalton JAR, 2007, BIOINFORMATICS, V23, P1901, DOI 10.1093/bioinformatics/btm262; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Ghosh HS, 2007, BIOCHEM J, V408, P105, DOI 10.1042/BJ20070817; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Zhao KH, 2004, J MOL BIOL, V337, P731, DOI 10.1016/j.jmb.2004.01.060	18	52	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7350	10.1371/journal.pone.0007350	http://dx.doi.org/10.1371/journal.pone.0007350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YN	19806227	gold, Green Published, Green Submitted			2022-12-25	WOS:000207567000002
J	McWalter, TA; Welte, A				McWalter, Thomas A.; Welte, Alex			A Comparison of Biomarker Based Incidence Estimators	PLOS ONE			English	Article							RECENT INFECTION; HIV	Background: Cross-sectional surveys utilizing biomarkers that test for recent infection provide a convenient and cost effective way to estimate HIV incidence. In particular, the BED assay has been developed for this purpose. Controversy surrounding the way in which false positive results from the biomarker should be handled has lead to a number of different estimators that account for imperfect specificity. We compare the estimators proposed by McDougal et al., Hargrove et al. and McWalter & Welte. Methodology/Principal Findings: The three estimators are analyzed and compared. An identity showing a relationship between the calibration parameters in the McDougal methodology is shown. When the three estimators are tested under a steady state epidemic, which includes individuals who fail to progress on the biomarker, only the McWalter/Welte method recovers an unbiased result. Conclusions/Significance: Our analysis shows that the McDougal estimator can be reduced to a formula that only requires calibration of a mean window period and a long-term specificity. This allows simpler calibration techniques to be used and shows that all three estimators can be expressed using the same set of parameters. The McWalter/Welte method is applicable under the least restrictive assumptions and is the least prone to bias of the methods reviewed.			McWalter, TA (corresponding author), Univ Witwatersrand, Sch Computat & Appl Math, Johannesburg, South Africa.	mcwalter@cam.wits.ac.za		McWalter, Thomas/0000-0002-2163-4112				BARNIGHAUSEN T, 2009, INT J EPIDEMIO UNPUB; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; KASSANJEE R, 2009, 5 IAS C HIV PATH TRE; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; MCWALTER TA, 2009, J MATH BIOL IN PRESS; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; VanDenBos A, 2007, PARAMETER ESTIMATION FOR SCIENTISTS AND ENGINEERS, P1, DOI 10.1002/9780470173862; WANG R, 2009, USE ADJUSTED CROSS S; Welte A, 2008, S AFR J SCI, V104, P199	14	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7368	10.1371/journal.pone.0007368	http://dx.doi.org/10.1371/journal.pone.0007368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809505	Green Published, gold			2022-12-25	WOS:000270594000018
J	Raoust, E; Balloy, V; Garcia-Verdugo, I; Touqui, L; Ramphal, R; Chignard, M				Raoust, Eloise; Balloy, Viviane; Garcia-Verdugo, Ignacio; Touqui, Lhousseine; Ramphal, Reuben; Chignard, Michel			Pseudomonas aeruginosa LPS or Flagellin Are Sufficient to Activate TLR-Dependent Signaling in Murine Alveolar Macrophages and Airway Epithelial Cells	PLOS ONE			English	Article								Background: The human lung is exposed to a large number of airborne pathogens as a result of the daily inhalation of 10,000 liters of air. Innate immunity is thus essential to defend the lungs against these pathogens. This defense is mediated in part through the recognition of specific microbial ligands by Toll-like receptors (TLR) of which there are at least 10 in humans. Pseudomonas aeruginosa is the main pathogen that infects the lungs of cystic fibrosis patients. Based on whole animal experiments, using TLR knockout mice, the control of this bacterium is believed to occur by the recognition of LPS and flagellin by TLRs 2,4 and 5, respectively. Methodology/Principal Findings: In the present study, we investigated in vitro the role of these same TLR and ligands, in alveolar macrophage (AM) and epithelial cell (EC) activation. Cellular responses to P. aeruginosa was evaluated by measuring KC, TNF-alpha, IL-6 and G-CSF secretion, four different markers of the innate immune response. AM and EC from WT and TLR2, 4, 5 and MyD88 knockout mice for were stimulated with the wild-type P. aeruginosa or with a mutant devoid of flagellin production. Conclusions/Significance: The results clearly demonstrate that only two ligand/receptor pairs are necessary for the induction of KC, TNF-alpha, and IL-6 synthesis by P. aeruginosa-activated cells, i.e. TLR2,4/LPS and TLR5/flagellin. Either ligand/ receptor pair is sufficient to sense the bacterium and to trigger cell activation, and when both are missing lung EC and AM are unable to produce such a response as were cells from MyD88(-/-) mice.			Raoust, E (corresponding author), Inst Pasteur, Unite Def Innee & Inflammat, Paris, France.	chignard@pasteur.fr	Balloy, Viviane/B-8551-2014; Garcia-Verdugo, Ignacio/J-3584-2017; Chignard, Michel/B-4351-2008	Balloy, Viviane/0000-0001-9093-9676; Garcia-Verdugo, Ignacio/0000-0003-4535-8316; Chignard, Michel/0000-0003-3810-6575	NIAID NIH HHS [AI 45014, R01 AI045014] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045014] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balloy V, 2005, INFECT IMMUN, V73, P5420, DOI 10.1128/IAI.73.9.5420-5425.2005; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Bortnick AE, 2003, AM J PHYSIOL-LUNG C, V285, pL869, DOI 10.1152/ajplung.00077.2003; Carnpodonico VL, 2008, TRENDS MOL MED, V14, P120, DOI 10.1016/j.molmed.2008.01.002; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; de Diego J L, 2007, Ernst Schering Found Symp Proc, P83; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Dunstan SJ, 2005, J INFECT DIS, V191, P1068, DOI 10.1086/428593; Elizur A, 2007, AM J PHYSIOL-LUNG C, V293, pL383, DOI 10.1152/ajplung.00024.2007; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; FEGAN M, 1990, J CLIN MICROBIOL, V28, P1143, DOI 10.1128/JCM.28.6.1143-1146.1990; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Goldberg JB, 2000, TRENDS MICROBIOL, V8, P514, DOI 10.1016/S0966-842X(00)01872-2; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Hajjar AM, 2005, AM J RESP CELL MOL, V33, P470, DOI 10.1165/rcmb.2005-0199OC; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hawn TR, 2007, J IMMUNOL, V179, P6981, DOI 10.4049/jimmunol.179.10.6981; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hernandez JM, 2003, CLIN CANCER RES, V9, P1906; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hybiske K, 2004, CELL MICROBIOL, V6, P49, DOI 10.1046/j.1462-5822.2003.00342.x; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Liu L, 1996, AM J PHYSIOL-LUNG C, V270, pL668, DOI 10.1152/ajplung.1996.270.4.L668; Lopez-Boado YS, 2005, INFECT IMMUN, V73, P7525, DOI 10.1128/IAI.73.11.7525-7534.2005; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Moravec R., 1994, PROMEGA NOTES, V45, P11; Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d; OREFFO VIC, 1990, ENVIRON HEALTH PERSP, V85, P51, DOI 10.2307/3430665; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; Prince A, 2006, AM J RESP CELL MOL, V34, P548, DOI 10.1165/rcmb.2006-0022SF; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Reiniger N, 2007, INFECT IMMUN, V75, P1598, DOI 10.1128/IAI.01980-06; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rivas-Santiago B, 2007, REV INVEST CLIN, V59, P481; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sadikot RT, 2006, J IMMUNOL, V176, P4923, DOI 10.4049/jimmunol.176.8.4923; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; SIMPSON DA, 1992, INFECT IMMUN, V60, P3771, DOI 10.1128/IAI.60.9.3771-3779.1992; Skerrett SJ, 2007, AM J PHYSIOL-LUNG C, V292, pL312, DOI 10.1152/ajplung.00250.2006; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; WALKER SR, 1989, EXP LUNG RES, V15, P553, DOI 10.3109/01902148909069618; Warshamana GS, 2001, EXP MOL PATHOL, V71, P13, DOI 10.1006/exmp.2001.2376; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	70	118	122	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7259	10.1371/journal.pone.0007259	http://dx.doi.org/10.1371/journal.pone.0007259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806220	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593800005
J	Khasnatinov, MA; Ustanikova, K; Frolova, TV; Pogodina, VV; Bochkova, NG; Levina, LS; Slovak, M; Kazimirova, M; Labuda, M; Klempa, B; Eleckova, E; Gould, EA; Gritsun, TS				Khasnatinov, Maxim A.; Ustanikova, Katarina; Frolova, Tatiana V.; Pogodina, Vanda V.; Bochkova, Nadezshda G.; Levina, Ludmila S.; Slovak, Mirko; Kazimirova, Maria; Labuda, Milan; Klempa, Boris; Eleckova, Elena; Gould, Ernest A.; Gritsun, Tamara S.			Non-Hemagglutinating Flaviviruses: Molecular Mechanisms for the Emergence of New Strains via Adaptation to European Ticks	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; ACID; TRANSMISSION; NUCLEOTIDE; EVOLUTION; SEQUENCE	Tick-borne encephalitis virus (TBEV) causes human epidemics across Eurasia. Clinical manifestations range from inapparent infections and fevers to fatal encephalitis but the factors that determine disease severity are currently undefined. TBEV is characteristically a hemagglutinating (HA) virus; the ability to agglutinate erythrocytes tentatively reflects virion receptor/fusion activity. However, for the past few years many atypical HA-deficient strains have been isolated from patients and also from the natural European host tick, Ixodes persulcatus. By analysing the sequences of HA-deficient strains we have identified 3 unique amino acid substitutions (D67G, E122G or D277A) in the envelope protein, each of which increases the net charge and hydrophobicity of the virion surface. Therefore, we genetically engineered virus mutants each containing one of these 3 substitutions; they all exhibited HA-deficiency. Unexpectedly, each genetically modified non-HA virus demonstrated increased TBEV reproduction in feeding Ixodes ricinus, not the recognised tick host for these strains. Moreover, virus transmission efficiency between infected and uninfected ticks co-feeding on mice was also intensified by each substitution. Retrospectively, the mutation D67G was identified in viruses isolated from patients with encephalitis. We propose that the emergence of atypical Siberian HA-deficient TBEV strains in Europe is linked to their molecular adaptation to local ticks. This process appears to be driven by the selection of single mutations that change the virion surface thus enhancing receptor/fusion function essential for TBEV entry into the unfamiliar tick species. As the consequence of this adaptive mutagenesis, some of these mutations also appear to enhance the ability of TBEV to cross the human blood-brain barrier, a likely explanation for fatal encephalitis. Future research will reveal if these emerging Siberian TBEV strains continue to disperse westwards across Europe by adaptation to the indigenous tick species and if they are associated with severe forms of TBE.			Khasnatinov, MA (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	t.s.gritsun@reading.ac.uk	Bochkova, Nadezhda/E-2592-2014; Khasnatinov, Maxim/F-2153-2011; Kazimirova, Maria/U-8222-2017; Klempa, Boris/N-3096-2019; Pogodina, Vanda/D-9553-2014; Khasnatinov, Maxim/S-7266-2016; Klempa, Boris/J-8876-2012	Kazimirova, Maria/0000-0001-6904-8342; Klempa, Boris/0000-0002-6931-1224; Khasnatinov, Maxim/0000-0002-8441-3640; Klempa, Boris/0000-0002-6931-1224	Biotechnology and Biological Sciences Research Council [BBS/B/00697] Funding Source: researchfish; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ADELSHIN PV, 2006, EPIDEMIOLOGY VACCINO, V2, P27; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; DALRYMPLE JM, 1976, VIROLOGY, V69, P93, DOI 10.1016/0042-6822(76)90197-5; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; GOLOVLJOVA I, 2008, INT J MED MICROBIOL; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; GOULD EA, 1985, J GEN VIROL, V66, P1369, DOI 10.1099/0022-1317-66-7-1369; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003; Gritsun TS, 1998, J VIROL METHODS, V76, P109, DOI 10.1016/S0166-0934(98)00130-X; Gritsun TS, 1995, VIROLOGY, V214, P611, DOI 10.1006/viro.1995.0072; Gritsun TS, 2001, J GEN VIROL, V82, P1667, DOI 10.1099/0022-1317-82-7-1667; GRITSUN TS, 1993, VIRUS RES, V27, P201, DOI 10.1016/0168-1702(93)90082-X; GRITSUN TS, 1995, VIRUS RES, V35, P307, DOI 10.1016/0168-1702(94)00090-Y; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hayasaka D, 2001, J GEN VIROL, V82, P1319, DOI 10.1099/0022-1317-82-6-1319; Heinz FX, 2004, ARCH VIROL, P133; HEINZ FX, 2000, VIRUS TAXONOMY, P859; HERRLER G, 1985, VIROLOGY, V141, P144, DOI 10.1016/0042-6822(85)90190-4; Jaaskelainen AE, 2006, EMERG INFECT DIS, V12, P1568, DOI 10.3201/eid1210.060320; Jones LD, 1997, MED VET ENTOMOL, V11, P172, DOI 10.1111/j.1365-2915.1997.tb00309.x; KARAN LS, 2006, B SIBERIAN MED, V15, P24; LABUDA M, 1994, VIRUS RES, V31, P305, DOI 10.1016/0168-1702(94)90024-8; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Labuda M, 1996, VIROLOGY, V219, P357, DOI 10.1006/viro.1996.0261; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; Leveque N, 2007, VIRUS RES, V130, P1, DOI 10.1016/j.virusres.2007.05.006; Lundkvist A, 2001, J MED VIROL, V65, P730, DOI 10.1002/jmv.2097; Perez K, 2006, J VIROL METHODS, V135, P254, DOI 10.1016/j.jviromet.2006.03.020; Pogodina V V, 2004, Vopr Virusol, V49, P24; Pogodina V. V., 2004, Voprosy Virusologii, V49, P20; Pogodina V. V., 2005, Voprosy Virusologii, V50, P7; Anonymous, 2007, Voprosy Virusologii, V52, P17; POGODINA VV, 1981, VOP VIRUSOL+, P741; POGODINA VV, 1992, VOP VIRUSOL+, V37, P103; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Romanova LI, 2007, VIROLOGY, V362, P75, DOI 10.1016/j.virol.2006.12.013; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Suss J, 2008, Euro Surveill, V13; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VLASAK R, 1988, P NATL ACAD SCI USA, V85, P4526, DOI 10.1073/pnas.85.12.4526; Votyakov V.I., 2002, TICK BORNE ENCEPHALI; Wengler G, 1999, VIROLOGY, V257, P472, DOI 10.1006/viro.1999.9661; ZANOTTO PMD, 1995, VIROLOGY, V210, P152, DOI 10.1006/viro.1995.1326	47	27	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7295	10.1371/journal.pone.0007295	http://dx.doi.org/10.1371/journal.pone.0007295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802385	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000270593600006
J	Liu, HW; Luo, YC; Ho, CL; Yang, JY; Lin, CH				Liu, Hong-Wen; Luo, Yun-Cin; Ho, Chia-Lin; Yang, Jung-Yen; Lin, Chi-Hung			Locomotion Guidance by Extracellular Matrix Is Adaptive and Can be Restored by a Transient Change in Ca2+ Level	PLOS ONE			English	Article								Navigation of cell locomotion by gradients of soluble factors can be desensitized if the concentration of the chemoattractant stays unchanged. It remains obscure if the guidance by immobilized extracellular matrix (ECM) as the substrate is also adaptive and if so, how can the desensitized ECM guidance be resensitized. When first interacting with a substrate containing micron-scale fibronectin (FBN) trails, highly motile fish keratocytes selectively adhere and migrate along the FBN paths. However, such guided motion become adaptive after about 10 min and the cells start to migrate out of the ECM trails. We found that a burst increase of intracellular calcium created by an uncaging technique immediately halts the undirected migration by disrupting the ECM-cytoskeleton coupling, as evidenced by the appearance of retrograde F-actin flow. When the motility later resumes, the activated integrin receptors render the cell selectively binding to the FBN path and reinitiates signaling events, including tyrosine phosphorylation of paxillin, that couple retrograde F-actin flow to the substrate. Thus, the calcium-resensitized cell can undergo a period of ECM-navigated movement, which later becomes desensitized. Our results also suggest that endogenous calcium transients as occur during spontaneous calcium oscillations may exert a cycling resensitization-desensitization control over cell's sensing of substrate guiding cues.			Liu, HW (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	linch@ym.edu.tw						Anderson KI, 2000, CURR BIOL, V10, P253, DOI 10.1016/S0960-9822(00)00357-2; Bolsover S, 2001, BIOCHEM J, V356, P345, DOI 10.1042/0264-6021:3560345; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9; DAVIS GE, 1993, J IMMUNOL, V151, P7138; Doyle AD, 2005, J CELL SCI, V118, P369, DOI 10.1242/jcs.01590; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Galbraith CG, 1999, J CELL BIOL, V147, P1313, DOI 10.1083/jcb.147.6.1313; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hsieh CF, 2006, J BIOL CHEM, V281, P25466, DOI 10.1074/jbc.M601793200; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; MAHER PA, 1985, P NATL ACAD SCI USA, V82, P6576, DOI 10.1073/pnas.82.19.6576; Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Shitashiro M, 2003, J BIOTECHNOL, V101, P11, DOI 10.1016/S0168-1656(02)00285-7; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; Vogt AK, 2004, J NEUROSCI METH, V134, P191, DOI 10.1016/j.jneumeth.2003.11.004; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7330	10.1371/journal.pone.0007330	http://dx.doi.org/10.1371/journal.pone.0007330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802394	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593600009
J	Perrard, MH; Chassaing, E; Montillet, G; Sabido, O; Durand, P				Perrard, Marie-Helene; Chassaing, Emeric; Montillet, Guillaume; Sabido, Odile; Durand, Philippe			Cytostatic Factor Proteins Are Present in Male Meiotic Cells and beta-Nerve Growth Factor Increases Mos Levels in Rat Late Spermatocytes	PLOS ONE			English	Article								Background: In co-cultures of pachytene spermatocytes with Sertoli cells, beta-NGF regulates the second meiotic division by blocking secondary spermatocytes in metaphase (metaphase II), and thereby lowers round spermatid formation. In vertebrates, mature oocytes are arrested at metaphase II until fertilization, because of the presence of cytostatic factor (CSF) in their cytoplasm. By analogy, we hypothesized the presence of CSF in male germ cells. Methodology/Principal Findings: We show here, that Mos, Emi2, cyclin E and Cdk2, the four proteins of CSF, and their respective mRNAs, are present in male rat meiotic cells; this was assessed by using Western blotting, immunocytochemistry and reverse transcriptase PCR. We measured the relative cellular levels of Mos, Emi2, Cyclin E and Cdk2 in the meiotic cells by flow cytometry and found that the four proteins increased throughout the first meiotic prophase, reaching their highest levels in middle to late pachytene spermatocytes, then decreased following the meiotic divisions. In co-cultures of pachytene spermatocytes with Sertoli cells, beta-NGF increased the number of metaphases II, while enhancing Mos and Emi2 levels in middle to late pachytene spermatocytes, pachytene spermatocytes in division and secondary spermatocytes. Conclusion/Significance: Our results suggest that CSF is not restricted to the oocyte. In addition, they reinforce the view that NGF, by enhancing Mos in late spermatocytes, is one of the intra-testicular factors which adjusts the number of round spermatids that can be supported by Sertoli cells.	[Perrard, Marie-Helene; Chassaing, Emeric; Montillet, Guillaume; Durand, Philippe] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, INRA,UMR 1288,CNRS,UMR 5242, F-69365 Lyon, France; [Sabido, Odile] Univ St Etienne, Fac Med, Ctr Commun Cytometrie Flux, St Etienne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet	Perrard, MH (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, INRA,UMR 1288,CNRS,UMR 5242, F-69365 Lyon, France.	marie-helene.durand@ens-lyon.fr	Perrard, Marie-Hélène/R-7864-2017; Perrard, marie-Hélène/L-2132-2014					Ashley T, 2001, J CELL SCI, V114, P685; Damestoy A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-22; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ferrara D, 2004, BIOL REPROD, V70, P1782, DOI 10.1095/biolreprod.103.026666; Fouchecourt S, 2006, J ENDOCRINOL, V190, P59, DOI 10.1677/joe.1.06699; Furuno N, 1997, EMBO J, V16, P3860, DOI 10.1093/emboj/16.13.3860; GABRIELLI BG, 1993, SCIENCE, V259, P1766, DOI 10.1126/science.8456304; Godet M, 2000, EUR J CELL BIOL, V79, P816, DOI 10.1078/0171-9335-00107; Godet M, 2008, DEV BIOL, V315, P173, DOI 10.1016/j.ydbio.2007.12.019; GOLDMAN DS, 1987, P NATL ACAD SCI USA, V84, P4509, DOI 10.1073/pnas.84.13.4509; HAKOVIRTA H, 1993, ENDOCRINOLOGY, V133, P1664, DOI 10.1210/en.133.4.1664; HERZOG NK, 1988, ONCOGENE, V3, P225; Hikim APS, 1999, REV REPROD, V4, P38; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; KIERSZENBAUM AL, 1994, ENDOCR REV, V15, P116, DOI 10.1210/er.15.1.116; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Madgwick S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-4; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Musa FRM, 1998, J ANDROL, V19, P657; MUTTER GL, 1987, P NATL ACAD SCI USA, V84, P5301, DOI 10.1073/pnas.84.15.5301; Nagao Y, 2002, CELL BIOL INT, V26, P193, DOI 10.1006/cbir.2001.0834; NAGAO Y, 1995, BBA-GEN SUBJECTS, V1245, P130, DOI 10.1016/0304-4165(94)00185-Z; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ohe M, 2007, DEV BIOL, V303, P157, DOI 10.1016/j.ydbio.2006.10.044; ONODA M, 1991, MOL CELL ENDOCRINOL, V77, P207, DOI 10.1016/0303-7207(91)90076-5; PARVINEN M, 1982, ENDOCR REV, V3, P404, DOI 10.1210/edrv-3-4-404; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; PAULES RS, 1989, P NATL ACAD SCI USA, V86, P5395, DOI 10.1073/pnas.86.14.5395; Perrard MH, 2007, J CELL PHYSIOL, V210, P51, DOI 10.1002/jcp.20805; Perrard MH, 2009, MICROSC RES TECHNIQ, V72, P596, DOI 10.1002/jemt.20706; Perrard MH, 2003, MOL REPROD DEV, V65, P86, DOI 10.1002/mrd.10259; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; Ravnik SE, 1999, DEV BIOL, V207, P408, DOI 10.1006/dbio.1998.9156; Roederer M, 2008, CYTOM PART A, V73A, P384, DOI 10.1002/cyto.a.20549; ROSENBERG MP, 1995, CELL GROWTH DIFFER, V6, P325; RUSSELL LD, 1984, J REPROD FERTIL, V70, P635, DOI 10.1530/jrf.0.0700635; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; Secker GA, 2008, EXP CELL RES, V314, P131, DOI 10.1016/j.yexcr.2007.09.001; Shiratsuchi A, 1999, J BIOL CHEM, V274, P5901, DOI 10.1074/jbc.274.9.5901; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Spruck C, 2006, CANCER RES, V66, P7355, DOI 10.1158/0008-5472.CAN-05-3240; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; VANDERHOORN FA, 1991, ONCOGENE, V6, P929; Vigier M, 2004, J MOL ENDOCRINOL, V33, P729, DOI 10.1677/jme.1.01493; Weiss M, 1997, BIOL REPROD, V57, P68, DOI 10.1095/biolreprod57.1.68; Wu B, 1997, BIOL REPROD, V56, P260, DOI 10.1095/biolreprod56.1.260; ZHENGWEI Y, 1990, BIOL REPROD, V43, P629, DOI 10.1095/biolreprod43.4.629	49	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7237	10.1371/journal.pone.0007237	http://dx.doi.org/10.1371/journal.pone.0007237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802389	Green Submitted, Green Published, gold			2022-12-25	WOS:000270593600002
J	Englitz, B; Tolnai, S; Typlt, M; Jost, J; Rubsamen, R				Englitz, Bernhard; Tolnai, Sandra; Typlt, Marei; Jost, Juergen; Ruebsamen, Rudolf			Reliability of Synaptic Transmission at the Synapses of Held In Vivo under Acoustic Stimulation	PLOS ONE			English	Article								Background: The giant synapses of Held play an important role in high-fidelity auditory processing and provide a model system for synaptic transmission at central synapses. Whether transmission of action potentials can fail at these synapses has been investigated in recent studies. At the endbulbs of Held in the anteroventral cochlear nucleus (AVCN) a consistent picture emerged, whereas at the calyx of Held in the medial nucleus of the trapezoid body (MNTB) results on the reliability of transmission remain inconsistent. In vivo this discrepancy could be due to the difficulty in identifying failures of transmission. Methods/Findings: We introduce a novel method for detecting unreliable transmission in vivo. Based on the temporal relationship between a cells' waveform and other potentials in the recordings, a statistical test is developed that provides a balanced decision between the presence and the absence of failures. Its performance is quantified using simulated voltage recordings and found to exhibit a high level of accuracy. The method was applied to extracellular recordings from the synapses of Held in vivo. At the calyces of Held failures of transmission were found only rarely. By contrast, at the endbulbs of Held in the AVCN failures were found under spontaneous, excited, and suppressed conditions. In accordance with previous studies, failures occurred most abundantly in the suppressed condition, suggesting a role for inhibition. Conclusions/Significance: Under the investigated activity conditions/anesthesia, transmission seems to remain largely unimpeded in the MNTB, whereas in the AVCN the occurrence of failures is related to inhibition and could be the basis/result of computational mechanisms for temporal processing. More generally, our approach provides a formal tool for studying the reliability of transmission with high statistical accuracy under typical in vivo recording conditions.			Englitz, B (corresponding author), Max Planck Inst Math Sci, Leipzig, Germany.	rueb@uni-leipzig.de	Englitz, Bernhard/K-7636-2018	Englitz, Bernhard/0000-0001-9106-0356; Typlt, Marei/0000-0002-1627-7560; Jost, Juergen/0000-0001-5258-6590				Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Awatramani GB, 2004, J NEUROSCI, V24, P2643, DOI 10.1523/JNEUROSCI.5144-03.2004; BANKS MI, 1992, J NEUROSCI, V12, P2819; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; CANT NB, 1979, NEUROSCIENCE, V4, P1925, DOI 10.1016/0306-4522(79)90066-6; CASPARY DM, 1994, J NEUROPHYSIOL, V72, P2124, DOI 10.1152/jn.1994.72.5.2124; Chuhma N, 1998, J NEUROSCI, V18, P512; EBERT U, 1995, EXP BRAIN RES, V104, P310; ENGLITZ B, 2009, THESIS U LEIPZIG; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Futai K, 2001, J NEUROSCI, V21, P3342, DOI 10.1523/JNEUROSCI.21-10-03342.2001; GUINAN JJ, 1972, INT J NEUROSCI, V4, P101, DOI 10.3109/00207457209147165; GUINAN JJ, 1990, HEARING RES, V49, P321, DOI 10.1016/0378-5955(90)90111-2; Haustein MD, 2008, J NEUROSCI METH, V174, P227, DOI 10.1016/j.jneumeth.2008.07.015; Held H., 1893, ARCH ANAT PHYSIOL, V17, P201; Hermann J, 2007, J NEUROPHYSIOL, V98, P807, DOI 10.1152/jn.00355.2007; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1037, DOI 10.1152/jn.1994.71.3.1037; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1022, DOI 10.1152/jn.1994.71.3.1022; Juiz JM, 1996, J COMP NEUROL, V373, P11, DOI 10.1002/(SICI)1096-9861(19960909)373:1<11::AID-CNE2>3.0.CO;2-G; KOLSTON J, 1992, ANAT EMBRYOL, V186, P443; Kopp-Scheinpflug C, 2008, NEUROSCIENCE, V154, P160, DOI 10.1016/j.neuroscience.2008.01.088; Kopp-Scheinpflug C, 2003, JARO-J ASSOC RES OTO, V4, P1, DOI 10.1007/s10162-002-2010-5; Kopp-Scheinpflug C, 2002, J NEUROSCI, V22, P11004; KUWABARA N, 1991, J COMP NEUROL, V314, P684, DOI 10.1002/cne.903140405; KUWABARA N, 1991, J COMP NEUROL, V314, P707, DOI 10.1002/cne.903140406; Mahendrasingam S, 2004, EUR J NEUROSCI, V19, P993, DOI 10.1111/j.1460-9568.2004.03193.x; Mc Laughlin M, 2008, J NEUROSCI, V28, P10206, DOI 10.1523/JNEUROSCI.2735-08.2008; MOORE JK, 1987, J COMP NEUROL, V260, P157, DOI 10.1002/cne.902600202; MOREST D K, 1968, Zeitschrift fuer Anatomie und Entwicklungsgeschichte, V127, P201, DOI 10.1007/BF00526129; Paolini AG, 2001, HEARING RES, V159, P101, DOI 10.1016/S0378-5955(01)00327-6; PFEIFFER RR, 1966, SCIENCE, V154, P667, DOI 10.1126/science.154.3749.667; ROTHMAN JS, 1993, J NEUROPHYSIOL, V70, P2562, DOI 10.1152/jn.1993.70.6.2562; Rothman JS, 1996, AUDIT NEUROSCI, V2, P47; RYUGO DK, 1982, J COMP NEUROL, V210, P239, DOI 10.1002/cne.902100304; SAINTMARIE RL, 1991, HEARING RES, V51, P11, DOI 10.1016/0378-5955(91)90003-R; Satzler K, 2002, J NEUROSCI, V22, P10567; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; SENTO S, 1989, J COMP NEUROL, V280, P553, DOI 10.1002/cne.902800406; SIVARAMAKRISHNAN S, 1995, J NEUROSCI, V15, P6576; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tollin DJ, 2005, J NEUROSCI, V25, P10648, DOI 10.1523/JNEUROSCI.1609-05.2005; Tolnai S, 2008, EUR J NEUROSCI, V27, P3191, DOI 10.1111/j.1460-9568.2008.06292.x; Tsuchitani C, 1997, HEARING RES, V105, P211, DOI 10.1016/S0378-5955(96)00212-2; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Wang Y, 2006, JARO-J ASSOC RES OTO, V7, P412, DOI 10.1007/s10162-006-0052-9; WICKESBERG RE, 1990, J NEUROSCI, V10, P1762; WU SH, 1992, J NEUROSCI, V12, P3084, DOI 10.1523/JNEUROSCI.12-08-03084.1992; WU SH, 1986, J NEUROSCI, V6, P2691; Zhang XD, 2001, J ACOUST SOC AM, V109, P648, DOI 10.1121/1.1336503	54	48	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7014	10.1371/journal.pone.0007014	http://dx.doi.org/10.1371/journal.pone.0007014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798414	gold, Green Published, Green Submitted			2022-12-25	WOS:000270593300001
J	Schweitzer, AD; Howell, RC; Jiang, ZW; Bryan, RA; Gerfen, G; Chen, CC; Mah, D; Cahill, S; Casadevall, A; Dadachova, E				Schweitzer, Andrew D.; Howell, Robertha C.; Jiang, Zewei; Bryan, Ruth A.; Gerfen, Gary; Chen, Chin-Cheng; Mah, Dennis; Cahill, Sean; Casadevall, Arturo; Dadachova, Ekaterina			Physico-Chemical Evaluation of Rationally Designed Melanins as Novel Nature-Inspired Radioprotectors	PLOS ONE			English	Article								Background: Melanin, a high-molecular weight pigment that is ubiquitous in nature, protects melanized microorganisms against high doses of ionizing radiation. However, the physics of melanin interaction with ionizing radiation is unknown. Methodology/Principal Findings: We rationally designed melanins from either 5-S-cysteinyl-DOPA, L-cysteine/L-DOPA, or L-DOPA with diverse structures as shown by elemental analysis and HPLC. Sulfur-containing melanins had higher predicted attenuation coefficients than non-sulfur-containing melanins. All synthetic melanins displayed strong electron paramagnetic resonance (2.14. 10(18), 7.09. 10(18), and 9.05. 10(17) spins/g, respectively), with sulfur-containing melanins demonstrating more complex spectra and higher numbers of stable free radicals. There was no change in the quality or quantity of the stable free radicals after high-dose (30,000 cGy), high-energy (Cs-137, 661.6 keV) irradiation, indicating a high degree of radical stability as well as a robust resistance to the ionizing effects of gamma irradiation. The rationally designed melanins protected mammalian cells against ionizing radiation of different energies. Conclusions/Significance: We propose that due to melanin's numerous aromatic oligomers containing multiple pi-electron system, a generated Compton recoil electron gradually loses energy while passing through the pigment, until its energy is sufficiently low that it can be trapped by stable free radicals present in the pigment. Controlled dissipation of high-energy recoil electrons by melanin prevents secondary ionizations and the generation of damaging free radical species.			Schweitzer, AD (corresponding author), Albert Einstein Coll Med, Dept Nucl Med, New York, NY USA.	edadacho@aecom.yu.edu	Dadachova, Ekaterina/I-7838-2013; Schweitzer, Andrew/M-3702-2013	Schweitzer, Andrew/0000-0001-9538-8076	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI060507, R56 AI060507, R01 AI052733, AI52733, AI60507] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060507, R01AI060507, R01AI052733] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bomford CK., 2002, WALTER MILLERS TXB R; Dadachova E, 2008, PIGM CELL MELANOMA R, V21, P192, DOI 10.1111/j.1755-148X.2007.00430.x; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; GALLAS JM, 1992, Patent No. 5112883; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; Hirayama H, 1985, SLAC265; International Commission on Radiation Units and Measurements, 1984, 37 ICRU; Ito S, 1998, PIGM CELL RES, V11, P120, DOI 10.1111/j.1600-0749.1998.tb00721.x; ITO S, 1985, ANAL BIOCHEM, V144, P527, DOI 10.1016/0003-2697(85)90150-2; Kawrakow I, 2006, PIRS701 NAT RES COUN; Kaxiras E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218102; Khan FM, 2014, PHYS RAD THERAPY, V5th; Klevenhagen SC, 1996, PHYS MED BIOL, V41, P2605, DOI 10.1088/0031-9155/41/12/002; La Russa DJ, 2007, MED PHYS, V34, P4690, DOI 10.1118/1.2799580; MA CM, 1995, PHYS MED BIOL, V40, P63, DOI 10.1088/0031-9155/40/1/006; Ma CM, 2001, MED PHYS, V28, P868, DOI 10.1118/1.1374247; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; MIRCHINK TG, 1972, MIKROBIOLOGIYA, V41, P83; Mironenko NV, 2000, ECOTOX ENVIRON SAFE, V45, P177, DOI 10.1006/eesa.1999.1848; Mosse I, 2000, RADIAT ENVIRON BIOPH, V39, P47, DOI 10.1007/PL00007685; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; SEALY RC, 1982, SCIENCE, V217, P545, DOI 10.1126/science.6283638; SEALY RC, 1982, P NATL ACAD SCI-BIOL, V79, P2885, DOI 10.1073/pnas.79.9.2885; SINILOVA N G, 1969, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, V46, P94; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r	30	57	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7229	10.1371/journal.pone.0007229	http://dx.doi.org/10.1371/journal.pone.0007229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789711	Green Submitted, gold, Green Published			2022-12-25	WOS:000270354100003
J	Gilbert, MM; Beam, CK; Robinson, BS; Moberg, KH				Gilbert, M. Melissa; Beam, Carolyn K.; Robinson, Brian S.; Moberg, Kenneth H.			Genetic Interactions between the Drosophila Tumor Suppressor Gene ept and the stat92E Transcription Factor	PLOS ONE			English	Article								Background: Tumor Susceptibility Gene-101 (TSG101) promotes the endocytic degradation of transmembrane proteins and is implicated as a mutational target in cancer, yet the effect of TSG101 loss on cell proliferation in vertebrates is uncertain. By contrast, Drosophila epithelial tissues lacking the TSG101 ortholog erupted (ept) develop as enlarged undifferentiated tumors, indicating that the gene can have anti-growth properties in a simple metazoan. A full understanding of pathways deregulated by loss of Drosophila ept will aid in understanding potential links between mammalian TSG101 and growth control. Principal Findings: We have taken a genetic approach to the identification of pathways required for excess growth of Drosophila eye-antennal imaginal discs lacking ept. We find that this phenotype is very sensitive to the genetic dose of stat92E, the transcriptional effector of the Jak-Stat signaling pathway, and that this pathway undergoes strong activation in ept mutant cells. Genetic evidence indicates that stat92E contributes to cell cycle deregulation and excess cell size phenotypes that are observed among ept mutant cells. In addition, autonomous Stat92E hyper-activation is associated with altered tissue architecture in ept tumors and an effect on expression of the apical polarity determinant crumbs. Conclusions: These findings identify ept as a cell-autonomous inhibitor of the Jak-Stat pathway and suggest that excess Jak-Stat signaling makes a significant contribution to proliferative and tissue architectural phenotypes that occur in ept mutant tissues.			Gilbert, MM (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	kmoberg@cellbio.emory.edu	Moberg, Ken/J-4849-2017	Moberg, Ken/0000-0002-9820-5543; Gilbert-Ross, Melissa/0000-0002-1960-8302	NATIONAL CANCER INSTITUTE [R01CA123368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169, T32GM008490, F32GM077898] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA123368-01, R01 CA123368-03, R01 CA123368-04, R01 CA123368, R01 CA123368-05, R01 CA123368-02] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169, F32-GM077898, T32 GM008490, F32 GM077898] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bach EA, 2003, GENETICS, V165, P1149; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Devergne O, 2007, J CELL SCI, V120, P3457, DOI 10.1242/jcs.005926; Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116; Gilbert MM, 2005, MECH DEVELOP, V122, P939, DOI 10.1016/j.mod.2005.03.004; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hombria JCG, 2002, CURR BIOL, V12, pR569, DOI 10.1016/S0960-9822(02)01057-6; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KIM BY, 2007, BIOCH BIOPHYS RES CO; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Lee MP, 1997, CANCER RES, V57, P3131; Li JH, 2003, MECH DEVELOP, V120, P1455, DOI 10.1016/j.mod.2003.09.004; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li LM, 1997, CELL, V88, P143, DOI 10.1016/S0092-8674(00)81866-8; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lovegrove B, 2006, CURR BIOL, V16, P2206, DOI 10.1016/j.cub.2006.09.029; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Luo H, 2002, MOL GENET GENOMICS, V267, P57, DOI 10.1007/s00438-001-0632-7; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Mortimer NT, 2007, DEV BIOL, V312, P560, DOI 10.1016/j.ydbio.2007.10.002; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Oh KB, 2007, ONCOGENE, V26, P5950, DOI 10.1038/sj.onc.1210401; Pignoni F, 1997, DEVELOPMENT, V124, P271; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; RAIBORG C, 2007, EXP CELL RES; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Steiner P, 1997, NAT GENET, V16, P332, DOI 10.1038/ng0897-332; Stuffers S., 2008, EXP CELL RES; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wagner KU, 2003, MOL CELL BIOL, V23, P150, DOI 10.1128/MCB.23.1.150-162.2003; Wagner KU, 1998, ONCOGENE, V17, P2761, DOI 10.1038/sj.onc.1202529; Wang Q, 1998, ONCOGENE, V16, P677, DOI 10.1038/sj.onc.1201563; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Young TW, 2007, MOL CELL PROTEOMICS, V6, P294, DOI 10.1074/mcp.M600305-MCP200; Young TW, 2007, CLIN CANCER RES, V13, P3848, DOI 10.1158/1078-0432.CCR-07-0337; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482	58	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7083	10.1371/journal.pone.0007083	http://dx.doi.org/10.1371/journal.pone.0007083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787055	gold, Green Submitted, Green Published			2022-12-25	WOS:000270290100002
J	Dolovcak, S; Waldrop, SL; Fitz, JG; Kilic, G				Dolovcak, Svjetlana; Waldrop, Shar L.; Fitz, J. Gregory; Kilic, Gordan			5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB) Stimulates Cellular ATP Release through Exocytosis of ATP-enriched Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA RELEASE; VOLUME REGULATION; MEMBRANE; CHANNELS; CONDUCTANCE; PANNEXIN-1; PATHWAY; CELLS; LINE; CONTRIBUTES	Cells release ATP in response to physiologic stimuli. Extracellular ATP regulates a broad range of important cellular functions by activation of the purinergic receptors in the plasma membrane. The purpose of these studies was to assess the role of vesicular exocytosis in cellular ATP release. FM1-43 fluorescence was used to measure exocytosis and bioluminescence to measure ATP release in HTC rat hepatoma and Mz-Cha-1 human cholangiocarcinoma cells. Exposure to a Cl- channel inhibitor 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) (50-300 mu M) stimulated a 5-100-fold increase in extracellular ATP levels within minutes of the exposure. This rapid response was not a result of changes in cell viability or Cl- channel activity. NPPB also potently stimulated ATP release in HEK293 cells and HEK293 cells expressing a rat P2X7 receptor indicating that P2X7 receptors are not involved in stimulation of ATP release by NPPB. In all cells studied, NPPB rapidly stimulated vesicular exocytosis that persisted many minutes after the exposure. The kinetics of NPPB-evoked exocytosis and ATP release were similar. Furthermore, the magnitudes of NPPB-evoked exocytosis and ATP release were correlated (correlation coefficient 0.77), indicating that NPPB may stimulate exocytosis of a pool of ATP-enriched vesicles. These findings provide further support for the concept that vesicular exocytosis plays an important role in cellular ATP release and suggest that NPPB can be used as a biochemical tool to specifically stimulate ATP release through exocytic mechanisms.	[Dolovcak, Svjetlana; Waldrop, Shar L.; Fitz, J. Gregory; Kilic, Gordan] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kilic, G (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	gordan.kilic@utsouthwestern.edu		Dolovcak, Svjetlana/0000-0002-5227-7525	National Institutes of Health [DK43278, DK46082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046082, R37DK046082, R01DK043278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43278 and DK46082.	Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bell PD, 2003, P NATL ACAD SCI USA, V100, P4322, DOI 10.1073/pnas.0736323100; Bodily K, 1997, HEPATOLOGY, V25, P403; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Boudreault F, 2004, J PHYSIOL-LONDON, V561, P499, DOI 10.1113/jphysiol.2004.072306; BREUER W, 1989, BIOCHEM BIOPH RES CO, V163, P398, DOI 10.1016/0006-291X(89)92149-9; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Doctor RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1042, DOI 10.1152/ajpcell.00367.2001; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Feranchak AP, 1999, J BIOL CHEM, V274, P30979, DOI 10.1074/jbc.274.43.30979; Feranchak AP, 2000, J HEPATOL, V33, P174, DOI 10.1016/S0168-8278(00)80357-8; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; Hazama A, 1999, J GEN PHYSIOL, V114, P525, DOI 10.1085/jgp.114.4.525; He ML, 2003, AM J PHYSIOL-CELL PH, V285, pC467, DOI 10.1152/ajpcell.00042.2003; Hisadome K, 2002, J GEN PHYSIOL, V119, P511, DOI 10.1085/jgp.20028540; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kilic G, 2002, BIOPHYS J, V83, P849, DOI 10.1016/S0006-3495(02)75213-2; Kilic G, 2001, J BIOL CHEM, V276, P26762, DOI 10.1074/jbc.M100992200; Kochukov MY, 2004, AM J PHYSIOL-CELL PH, V287, pC992, DOI 10.1152/ajpcell.00538.2003; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Qu Y, 2009, PURINERG SIGNAL, V5, P163, DOI 10.1007/s11302-009-9132-8; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Roman RM, 1997, J BIOL CHEM, V272, P21970, DOI 10.1074/jbc.272.35.21970; Roman RM, 1999, AM J PHYSIOL-GASTR L, V276, pG1391, DOI 10.1152/ajpgi.1999.276.6.G1391; Roman RM, 1996, AM J PHYSIOL-GASTR L, V271, pG239, DOI 10.1152/ajpgi.1996.271.2.G239; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Sauer H, 2000, AM J PHYSIOL-CELL PH, V279, pC295, DOI 10.1152/ajpcell.2000.279.2.C295; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Suadicani SO, 2009, ASN NEURO, V1, DOI 10.1042/AN20090001; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059	50	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33894	33903		10.1074/jbc.M109.046193	http://dx.doi.org/10.1074/jbc.M109.046193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808682	hybrid, Green Published			2022-12-25	WOS:000272165200022
J	Wang, F; Mei, ZQ; Qi, YT; Yan, CY; Xiang, SH; Zhou, ZY; Hu, Q; Wang, JW; Shi, YG				Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Xiang, Siheng; Zhou, Zhiyuan; Hu, Qi; Wang, Jiawei; Shi, Yigong			Crystal Structure of the MecA Degradation Tag	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; COMPETENCE; CLPC; PROTEOLYSIS; SOFTWARE	MecA is an adaptor protein that regulates the assembly and activity of the ATP-dependent ClpCP protease in Bacillus subtilis. MecA contains two domains. Although the amino-terminal domain of MecA recruits substrate proteins such as ComK and ComS, the carboxyl-terminal domain (residues 121-218) has dual roles in the regulation and function of ClpCP protease. MecA-(121-218) facilitates the assembly of ClpCP oligomer, which is required for the protease activity of ClpCP. This domain was identified to be a non-recycling degradation tag that targets heterologous fusion proteins to the ClpCP protease for degradation. To elucidate the mechanism of MecA, we determined the crystal structure of MecA-(121-218) at 2.2 angstrom resolution, which reveals a previously uncharacterized alpha/beta fold. Structure-guided mutagenesis allows identification of surface residues that are essential for the function of MecA. We also solved the structure of a carboxyl-terminal domain of YpbH, a paralogue of MecA in B. subtilis, at 2.4 angstrom resolution. Despite low sequence identity, the two structures share essentially the same fold. The presence of MecA homologues in other bacterial species suggests conservation of a large family of unique degradation tags.	[Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wang, Feng; Mei, Ziqing; Qi, Yutao; Xiang, Siheng; Zhou, Zhiyuan; Shi, Yigong] Tsinghua Univ, Prot Sci Lab, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China; [Yan, Chuangye; Hu, Qi; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Wang, JW (corresponding author), Tsinghua Univ, Sch Med, Rm C327,Med Sci Bldg, Beijing 100084, Peoples R China.	jwwang@tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Wang, Feng/AAC-6221-2022; Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021; Xiang, Siheng/A-5063-2010	Wang, Feng/0000-0002-9403-4337; Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X; Xiang, Siheng/0000-0003-4475-5707	Ministry of Science and Technology [2009CB918801]; Tsinghua University 985 Phase II; National Natural Science Foundation of China [30888001]; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University 985 Phase II; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	This work was supported by grants from the Ministry of Science and Technology (Grant 2009CB918801), Tsinghua University 985 Phase II funds, Project 30888001 supported by the National Natural Science Foundation of China, and Beijing Municipal Commissions of Education and Science and Technology.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mei ZQ, 2009, J BIOL CHEM, V284, P34366, DOI 10.1074/jbc.M109.053017; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Persuh M, 2002, J BACTERIOL, V184, P2310, DOI 10.1128/JB.184.8.2310-2313.2002; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Razeto A, 2007, STRUCTURE, V15, P683, DOI 10.1016/j.str.2007.04.009; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; VIJAYKUMAR S, 1985, P NATL ACAD SCI USA, V82, P3582, DOI 10.1073/pnas.82.11.3582; Yan N, 2004, NAT STRUCT MOL BIOL, V11, P420, DOI 10.1038/nsmb764; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	23	10	11	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34376	34381		10.1074/jbc.M109.053033	http://dx.doi.org/10.1074/jbc.M109.053033			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801546	Green Published, hybrid			2022-12-25	WOS:000272165200067
J	Gao, XL; Patel, TB				Gao, Xianlong; Patel, Tarun B.			Regulation of Protein Kinase A Activity by p90 Ribosomal S6 Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCRINE OVERACTIVITY; SPOTTY PIGMENTATION; CARNEY COMPLEX; CELL-SURVIVAL; ACTIVATION; SIGNAL; PHOSPHORYLATION; RSK; BAD; DOMAIN	Previously, we reported that the catalytic subunit of cAMP-dependent protein kinase (PKAc) binds to the active p90 ribosomal S6 kinase 1 (RSK1) (Chaturvedi, D., Poppleton, H. M., Stringfield, T., Barbier, A., and Patel, T. B. (2006) Mol. Cell. Biol. 26, 4586-4600). Herein, by overexpressing hemagglutinin-tagged RSK1 fragments in HeLa cells we have identified the region of RSK1 that is responsible for the interaction with PKAc. PKAc bound to the last 13 amino acids of RSK1, which overlaps the Erk1/2 docking site. This interaction between PKAc and RSK1 required the phosphorylation of Ser-732 in the C terminus of RSK1. Depending upon its phosphorylation status, RSK1 switched interactions between Erk1/2 and PKAc. In addition, a peptide corresponding to the last 13 amino acids of RSK1 with substitution of Ser-732 with Glu (peptide E), but not Ala (peptide A), decreased interactions between endogenous active RSK1 and PKAc. RSK1 attenuated the ability of cAMP to activate PKA in vitro and this modulation was abrogated by peptide E, but not by peptide A. Similarly, in intact cells, cAMP-mediated phosphorylation of Bcl-xL/Bcl-2-associated death promoter on Ser-115, the PKA site, was reduced when RSK1 was activated by epidermal growth factor, and this effect was blocked by peptide E, but not by peptide A. These findings demonstrate that interactions between endogenous RSK1 and PKAc in intact cells regulate the ability of cAMP to activate PKA and identify a novel mechanism by which PKA activity is regulated by the Erk1/2 pathway.	[Gao, Xianlong; Patel, Tarun B.] Loyola Univ, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA	Loyola University Chicago	Patel, TB (corresponding author), Loyola Univ, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA.	tpatel7@lumc.edu			National Institutes of Health [GM079226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM079226.	Boikos SA, 2007, CURR OPIN ONCOL, V19, P24, DOI 10.1097/CCO.0b013e32801195eb; CARNEY JA, 1995, SEMIN DERMATOL, V14, P90, DOI 10.1016/S1085-5629(05)80003-3; CARNEY JA, 1986, MAYO CLIN PROC, V61, P165, DOI 10.1016/S0025-6196(12)61843-6; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Chaturvedi D, 2009, J BIOL CHEM, V284, P23670, DOI 10.1074/jbc.M109.032813; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; HIRATA Y, 1993, J BIOL CHEM, V268, P24808; Jacquot S, 1998, AM J HUM GENET, V63, P1631, DOI 10.1086/302153; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kohler K, 2004, J CELL BIOL, V165, P175, DOI 10.1083/jcb.200312118; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Myers AP, 2004, MOL CELL BIOL, V24, P4255, DOI 10.1128/MCB.24.10.4255-4266.2004; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Robinson-White AJ, 2006, CANCER RES, V66, P10603, DOI 10.1158/0008-5472.CAN-06-2200; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Silverman E, 2004, MOL CELL BIOL, V24, P10573, DOI 10.1128/MCB.24.24.10573-10583.2004; Skalhegg Bjorn S., 1997, Frontiers in Bioscience (online), V2, pD331; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Wingate AD, 2006, BIOCHEM J, V393, P715, DOI 10.1042/BJ20050967; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yusta B, 2002, J BIOL CHEM, V277, P24896, DOI 10.1074/jbc.M201358200; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	32	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33070	33078		10.1074/jbc.M109.058453	http://dx.doi.org/10.1074/jbc.M109.058453			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808666	Green Published, hybrid			2022-12-25	WOS:000272028500010
J	Jackson, EK; Ren, J; Mi, ZC				Jackson, Edwin K.; Ren, Jin; Mi, Zaichuan			Extracellular 2 ',3 '-cAMP Is a Source of Adenosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; SPONTANEOUSLY HYPERTENSIVE-RATS; MUSCLE-CELL GROWTH; MAJOR RNASE TYPES; CYCLIC-AMP; CATALYTIC-PROPERTIES; ECTO-NUCLEOTIDASES; RENAL PHYSIOLOGY; BRAIN-TISSUE; PATHWAY	We discovered that renal injury releases 2',3'-cAMP (positional isomer of 3',5'-cAMP) into the interstitium. This finding motivated a novel hypothesis: renal injury leads to activation of an extracellular 2',3'-cAMP-adenosine pathway (i.e. metabolism of extracellular 2',3'-cAMP to 3'-AMP and 2'-AMP, which are metabolized to adenosine, a retaliatory metabolite). In isolated rat kidneys, arterial infusions of 2',3'-cAMP (30 mu mol/liter) increased the mean venous secretion of 3'-AMP (3,400-fold), 2'-AMP (26,000-fold), adenosine (53-fold), and inosine (adenosine metabolite, 30-fold). Renal injury with metabolic inhibitors increased the mean secretion of 2',3'-cAMP (29-fold), 3'-AMP (16-fold), 2'-AMP (10-fold), adenosine (4.2-fold), and inosine (6.1-fold) while slightly increasing 5'-AMP (2.4-fold). Arterial infusions of 2'-AMP and 3'-AMP increased secretion of adenosine and inosine similar to that achieved by 5'-AMP. Renal artery infusions of 2',3'-cAMP in vivo increased urinary excretion of 2'-AMP, 3'-AMP and adenosine, and infusions of 2'-AMP and 3'-AMP increased urinary excretion of adenosine as efficiently as 5'-AMP. The implications are that 1) in intact organs, 2'-AMP and 3'-AMP are converted to adenosine as efficiently as 5'-AMP (previously considered the most important adenosine precursor) and 2) because 2',3'-cAMP opens mitochondrial permeability transition pores, a pro-apoptotic/pronecrotic process, conversion of 2',3'-cAMP to adenosine by the extracellular 2',3'-cAMP-adenosine pathway would protect tissues by reducing a pro-death factor (2',3'-cAMP) while increasing a retaliatory metabolite (adenosine).	[Jackson, Edwin K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15219 USA; [Jackson, Edwin K.; Ren, Jin; Mi, Zaichuan] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15219 USA; [Jackson, Edwin K.; Ren, Jin; Mi, Zaichuan] Univ Pittsburgh, Sch Med, Ctr Clin Pharmacol, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jackson, EK (corresponding author), 100 Technol Dr,Ste 450, Pittsburgh, PA 15219 USA.	edj@pitt.edu		Jackson, Edwin/0000-0002-8101-6009	National Institutes of Health [DK068575, DK077777, HL069846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068575, R01DK077777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK068575, DK077777, and HL069846.	Akahane M, 2001, J RECONSTR MICROSURG, V17, P203, DOI 10.1055/s-2001-14352; Akahane M, 2001, J ORTHOP RES, V19, P559, DOI 10.1016/S0736-0266(00)00062-0; Alberts B, 1989, MOL BIOL CELL, P481; Almeida A, 2004, ANAL BIOCHEM, V328, P101, DOI 10.1016/j.ab.2004.02.004; Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Catts VS, 2005, MOL BRAIN RES, V138, P164, DOI 10.1016/j.molbrainres.2005.04.017; Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019; Chiavegatti T, 2008, BRIT J PHARMACOL, V153, P1331, DOI 10.1038/sj.bjp.0707648; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Dubey RK, 2000, HYPERTENSION, V35, P262, DOI 10.1161/01.HYP.35.1.262; Dubey RK, 2001, HYPERTENSION, V37, P1095, DOI 10.1161/01.HYP.37.4.1095; Dubey RK, 1998, HYPERTENSION, V31, P296, DOI 10.1161/01.HYP.31.1.296; Dubey RK, 1996, HYPERTENSION, V28, P765, DOI 10.1161/01.HYP.28.5.765; Dubey RK, 2000, HYPERTENSION, V36, P337, DOI 10.1161/01.HYP.36.3.337; DUBEY RK, 1997, HYPERTENSION, V30, P506; Gao LP, 2003, J PHARMACOL EXP THER, V305, P581, DOI 10.1124/jpet.102.047647; Giron MC, 2008, GASTROENTEROLOGY, V134, P1116, DOI 10.1053/j.gastro.2008.01.030; Hong KW, 1999, AM J PHYSIOL-HEART C, V276, pH376, DOI 10.1152/ajpheart.1999.276.2.H376; Jackson EK, 2008, J PHARMACOL EXP THER, V325, P210, DOI 10.1124/jpet.107.134445; Jackson EK, 2007, J PHARMACOL EXP THER, V321, P810, DOI 10.1124/jpet.106.119057; Jackson EK, 2007, J PHARMACOL EXP THER, V321, P799, DOI 10.1124/jpet.106.119164; Jackson EK, 2009, HYPERTENSION, V54, P270, DOI 10.1161/HYPERTENSIONAHA.109.130542; Jackson EK, 2006, J PHARMACOL EXP THER, V317, P1219, DOI 10.1124/jpet.106.101360; Jackson EK, 2007, J PHARMACOL EXP THER, V320, P117, DOI 10.1124/jpet.106.112748; JACKSON EK, 1991, ANNU REV PHARMACOL, V31, P1; Jackson EK, 2001, AM J PHYSIOL-RENAL, V281, pF597, DOI 10.1152/ajprenal.2001.281.4.F597; Jackson EK, 1997, J PHARMACOL EXP THER, V283, P177; Jackson EK, 2000, J PHARMACOL EXP THER, V295, P23; Jackson EK, 2003, J PHARMACOL EXP THER, V307, P888, DOI 10.1124/jpet.103.057166; Jackson EK, 2004, ANNU REV PHYSIOL, V66, P571, DOI 10.1146/annurev.physiol.66.032102.111604; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kruh GD, 2001, J BIOENERG BIOMEMBR, V33, P493, DOI 10.1023/A:1012827221844; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; MI Z, 1994, LIFE SCI, V54, P277; Mi ZC, 1998, J PHARMACOL EXP THER, V287, P926; MI ZC, 1995, J PHARMACOL EXP THER, V273, P728; Muller G, 2008, BIOCHEMISTRY-US, V47, P1259, DOI 10.1021/bi701413t; Ren J, 2008, J PHARMACOL EXP THER, V325, P920, DOI 10.1124/jpet.108.137752; Ren J, 2009, J PHARMACOL EXP THER, V328, P855, DOI 10.1124/jpet.108.146712; Sorrentino S, 1998, CELL MOL LIFE SCI, V54, P785, DOI 10.1007/s000180050207; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; THOMPSON JE, 1994, BIOCHEMISTRY-US, V33, P7408, DOI 10.1021/bi00189a047; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zimmermann H, 1999, PROG BRAIN RES, V120, P371; Zimmermann Herbert, 2006, Novartis Found Symp, V276, P113	48	75	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33097	33106		10.1074/jbc.M109.053876	http://dx.doi.org/10.1074/jbc.M109.053876			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801686	Green Published, hybrid			2022-12-25	WOS:000272028500013
J	Shi, I; Hallwyl, SCL; Seong, C; Mortensen, U; Rothstein, R; Sung, P				Shi, Idina; Hallwyl, Swee C. L.; Seong, Changhyun; Mortensen, Uffe; Rothstein, Rodney; Sung, Patrick			Role of the Rad52 Amino-terminal DNA Binding Activity in DNA Strand Capture in Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATOR FUNCTION; REPAIR; BREAK; PROTEIN; GENES; IDENTIFICATION	Saccharomyces cerevisiae Rad52 protein promotes homologous recombination by nucleating the Rad51 recombinase onto replication protein A-coated single-stranded DNA strands and also by directly annealing such strands. We show that the purified rad52-R70A mutant protein, with a compromised amino-terminal DNA binding domain, is capable of Rad51 delivery to DNA but is deficient in DNA annealing. Results from chromatin immunoprecipitation experiments find that rad52-R70A associates with DNA double-strand breaks and promotes recruitment of Rad51 as efficiently as wild-type Rad52. Analysis of gene conversion intermediates reveals that rad52-R70A cells can mediate DNA strand invasion but are unable to complete the recombination event. These results provide evidence that DNA binding by the evolutionarily conserved amino terminus of Rad52 is needed for the capture of the second DNA end during homologous recombination.	[Shi, Idina; Seong, Changhyun; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hallwyl, Swee C. L.; Mortensen, Uffe] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Rothstein, Rodney] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Seong, Changhyun] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Yale University; Technical University of Denmark; Columbia University; Harvard University; Harvard Medical School	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St,SHM-C130, New Haven, CT 06520 USA.	Patrick.Sung@yale.edu	Classen, Scott/AAY-8176-2020; Mortensen, Uffe/AAQ-1150-2021	Rothstein, Rodney/0000-0002-4107-9654	National Institutes of Health [PO1CA92584, ES07061, ES10252, and GM50237]; Danish Research Council for Technology and Production Sciences; Technical University of Denmark; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050237, R37GM050237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Council for Technology and Production Sciences; Technical University of Denmark; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1CA92584, ES07061, ES10252, and GM50237. This work was also supported by the Danish Research Council for Technology and Production Sciences (to U. M.) and the Technical University of Denmark (to S. C. L. H.).	BENDIXEN C, 1994, GENOMICS, V23, P300, DOI 10.1006/geno.1994.1503; BEZZUBOVA OY, 1993, NUCLEIC ACIDS RES, V21, P5945, DOI 10.1093/nar/21.25.5945; Cortes-Ledesma F, 2004, GENETICS, V168, P553, DOI 10.1534/genetics.104.030551; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Mortensen UH, 2002, GENETICS, V161, P549; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MURIS DFR, 1994, MUTAT RES-DNA REPAIR, V315, P295, DOI 10.1016/0921-8777(94)90040-X; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; OGAWA T, 1995, ADV BIOPHYS, V31, P93, DOI 10.1016/0065-227X(95)99385-3; OSTERMANN K, 1993, NUCLEIC ACIDS RES, V21, P5940, DOI 10.1093/nar/21.25.5940; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Raynard S, 2008, GENE DEV, V22, P2903, DOI 10.1101/gad.1742408; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Seong C, 2009, J BIOL CHEM, V284, P24363, DOI 10.1074/jbc.M109.032953; SHERMAN F, 1991, GETTING STARTED YEAS, P1; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugawara N, 2006, METHOD ENZYMOL, V408, P416, DOI 10.1016/S0076-6879(06)08026-8; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Van Komen S, 2006, METHOD ENZYMOL, V408, P445, DOI 10.1016/S0076-6879(06)08028-1; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	34	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33275	33284		10.1074/jbc.M109.057752	http://dx.doi.org/10.1074/jbc.M109.057752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19812039	Green Published, hybrid			2022-12-25	WOS:000272028500032
J	Hayakawa, T; Arisue, N; Udono, T; Hirai, H; Sattabongkot, J; Toyama, T; Tsuboi, T; Horii, T; Tanabe, K				Hayakawa, Toshiyuki; Arisue, Nobuko; Udono, Toshifumi; Hirai, Hirohisa; Sattabongkot, Jetsumon; Toyama, Tomoko; Tsuboi, Takafumi; Horii, Toshihiro; Tanabe, Kazuyuki			Identification of Plasmodium malariae, a Human Malaria Parasite, in Imported Chimpanzees	PLOS ONE			English	Article								It is widely believed that human malaria parasites infect only man as a natural host. However, earlier morphological observations suggest that great apes are likely to be natural reservoirs as well. To identify malaria parasites in great apes, we screened 60 chimpanzees imported into Japan. Using the sequences of small subunit rRNA and the mitochondrial genome, we identified infection of Plasmodium malariae, a human malaria parasite, in two chimpanzees that were imported about thirty years ago. The chimpanzees have been asymptomatic to the present. In Japan, indigenous malaria disappeared more than fifty years ago; and thus, it is most likely inferred that the chimpanzees were infected in Africa, and P. malariae isolates were brought into Japan from Africa with their hosts, suggesting persistence of parasites at low level for thirty years. Such a long term latent infection is a unique feature of P. malariae infection in humans. To our knowledge, this is the first to report P. malariae infection in chimpanzees and a human malaria parasite from nonhuman primates imported to a nonendemic country.			Hayakawa, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Malariol, Osaka, Japan.	hayakawa@biken.osaka-u.ac.jp; kztanabe@biken.osaka-u.ac.jp	Prachumsri, Jetsumon/AAZ-7732-2021; Tsuboi, Takafumi/AAK-6145-2021	Sattabongkot, Jetsumon/0000-0002-3938-4588; Horii, Toshihiro/0000-0002-3000-2045; Tsuboi, Takafumi/0000-0002-7415-1325				[Anonymous], 2003, PRIMATE MALARIAS; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; Duval L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005520; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; Jotty A, 2005, SCIENCE, V309, P1457, DOI 10.1126/science.1111873; Kano S, 2004, ACTA TROP, V89, P271, DOI 10.1016/j.actatropica.2003.10.003; Kantele A, 2008, EMERG INFECT DIS, V14, P1434, DOI 10.3201/eid1409.080170; Levine ND, 1988, PROTOZOAN PHYLUM API, V2; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Nishimoto Y, 2008, MOL PHYLOGENET EVOL, V47, P45, DOI 10.1016/j.ympev.2008.01.031; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Reichenow E., 1920, CENTRALBL F BAKT I A, V85, P207; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Vinetz JM, 1998, NEW ENGL J MED, V338, P367, DOI 10.1056/NEJM199802053380605; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006	19	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7412	10.1371/journal.pone.0007412	http://dx.doi.org/10.1371/journal.pone.0007412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823579	gold, Green Published, Green Submitted			2022-12-25	WOS:000270728500012
J	Koshiol, J; Rotunno, M; Consonni, D; Pesatori, AC; De Matteis, S; Goldstein, AM; Chaturvedi, AK; Wacholder, S; Landi, MT; Lubin, JH; Caporaso, NE				Koshiol, Jill; Rotunno, Melissa; Consonni, Dario; Pesatori, Angela Cecilia; De Matteis, Sara; Goldstein, Alisa M.; Chaturvedi, Anil K.; Wacholder, Sholom; Landi, Maria Teresa; Lubin, Jay H.; Caporaso, Neil E.			Chronic Obstructive Pulmonary Disease and Altered Risk of Lung Cancer in a Population-Based Case-Control Study	PLOS ONE			English	Article							CIGARETTE-SMOKING; FAMILY-HISTORY; SUSCEPTIBILITY LOCUS; CHRONIC-BRONCHITIS; NEVER SMOKERS; WOMEN; INFLAMMATION; ASTHMA; EXACERBATIONS; EPIDEMIOLOGY	Background: Chronic obstructive pulmonary disease ( COPD) has been consistently associated with increased risk of lung cancer. However, previous studies have had limited ability to determine whether the association is due to smoking. Methodology/Principal Findings: The Environment And Genetics in Lung cancer Etiology ( EAGLE) population-based case-control study recruited 2100 cases and 2120 controls, of whom 1934 cases and 2108 controls reported about diagnosis of chronic bronchitis, emphysema, COPD (chronic bronchitis and/or emphysema), or asthma more than 1 year before enrollment. We estimated odds ratios (OR) and 95% confidence intervals (CI) using logistic regression. After adjustment for smoking, other previous lung diseases, and study design variables, lung cancer risk was elevated among individuals with a history of chronic bronchitis (OR = 2.0, 95% CI = 1.5-2.5), emphysema (OR = 1.9, 95% CI = 1.4-2.8), or COPD (OR = 2.5, 95% CI = 2.0-3.1). Among current smokers, association between chronic bronchitis and lung cancer was strongest among lighter smokers. Asthma was associated with a decreased risk of lung cancer in males (OR = 0.48, 95% CI = 0.30-0.78). Conclusions/Significance: These results suggest that the associations of personal history of chronic bronchitis, emphysema, and COPD with increased risk of lung cancer are not entirely due to smoking. Inflammatory processes may both contribute to COPD and be important for lung carcinogenesis.			Koshiol, J (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	koshiolj@mail.nih.gov	De Matteis, Sara/AFW-0443-2022; Consonni, Dario/AAM-2947-2020; koshiol, Jill/L-8686-2014; pesatori, angela/K-5742-2016	De Matteis, Sara/0000-0001-8256-2661; Consonni, Dario/0000-0002-8935-3843; koshiol, Jill/0000-0002-3832-6204; pesatori, angela/0000-0002-0261-3252	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Barr RG, 2002, AM J EPIDEMIOL, V155, P965, DOI 10.1093/aje/155.10.965; Boutin-Forzano S, 2007, INT J TUBERC LUNG D, V11, P695; Brenner AV, 2001, INT J EPIDEMIOL, V30, P118, DOI 10.1093/ije/30.1.118; Brownson RC, 2000, CANCER CAUSE CONTROL, V11, P853, DOI 10.1023/A:1008999202040; Castaing M, 2005, AM J EPIDEMIOL, V162, P542, DOI 10.1093/aje/kwi241; COHEN BH, 1977, LANCET, V2, P523; Dubey S, 2008, AM J RESP CRIT CARE, V177, P941, DOI 10.1164/rccm.200801-107UP; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; Gao Y, 2009, INT J CANCER, V125, P146, DOI 10.1002/ijc.24283; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Global Initiative for Chronic Obstructive Lung Disease, 2008, GLOB STRAT DIAGN MAN; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Holtzman Michael J, 2005, Proc Am Thorac Soc, V2, P132, DOI 10.1513/pats.200502-015AW; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Landi MT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-203; Littman AJ, 2005, CANCER EPIDEM BIOMAR, V14, P773, DOI 10.1158/1055-9965.EPI-04-0599; Lubin JH, 2008, AM J EPIDEMIOL, V167, P970, DOI 10.1093/aje/kwm392; Lubin JH, 2007, INT J EPIDEMIOL, V36, P236, DOI 10.1093/ije/dym043; Lubin JH, 2006, CANCER EPIDEM BIOMAR, V15, P517, DOI 10.1158/1055-9965.EPI-05-0863; Lugogo NL, 2006, CLIN CHEST MED, V27, P1, DOI 10.1016/j.ccm.2005.10.006; Mallia P, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-116; Mattison Sue, 2006, Intensive Crit Care Nurs, V22, P329, DOI 10.1016/j.iccn.2006.03.003; McCallister JW, 2008, J ASTHMA, V45, P853, DOI 10.1080/02770900802444187; OSANN KE, 1991, CANCER RES, V51, P4893; Papi A, 2007, CURR OPIN PHARMACOL, V7, P259, DOI 10.1016/j.coph.2006.11.015; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pelkonen M, 2008, CURR OPIN PULM MED, V14, P105, DOI 10.1097/MCP.0b013e3282f379e9; Petty Thomas L, 2006, Int J Chron Obstruct Pulmon Dis, V1, P3, DOI 10.2147/copd.2006.1.1.3; SAMET JM, 1986, AM REV RESPIR DIS, V134, P466; Santillan AA, 2003, CANCER CAUSE CONTROL, V14, P327, DOI 10.1023/A:1023982402137; Schabath MB, 2006, AM J EPIDEMIOL, V163, DOI 10.1093/aje/kwj065; Schabath MB, 2005, AM J EPIDEMIOL, V161, P412, DOI 10.1093/aje/kwi063; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thun MJ, 2006, JNCI-J NATL CANCER I, V98, P691, DOI 10.1093/jnci/djj187; Turner MC, 2005, AM J EPIDEMIOL, V162, P212, DOI 10.1093/aje/kwi193; Turner MC, 2007, AM J RESP CRIT CARE, V176, P285, DOI 10.1164/rccm.200612-1792OC; VENA JE, 1985, AM J EPIDEMIOL, V122, P66, DOI 10.1093/oxfordjournals.aje.a114087; Viegi G, 1994, Monaldi Arch Chest Dis, V49, P191; Wang SY, 1996, LUNG CANCER-J IASLC, V14, pS99, DOI 10.1016/S0169-5002(96)90215-9; WU AH, 1995, AM J EPIDEMIOL, V141, P1023, DOI 10.1093/oxfordjournals.aje.a117366; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang P, 2008, ARCH INTERN MED, V168, P1097, DOI 10.1001/archinte.168.10.1097	48	107	112	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7380	10.1371/journal.pone.0007380	http://dx.doi.org/10.1371/journal.pone.0007380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812684	Green Submitted, Green Published, gold			2022-12-25	WOS:000270594200006
J	Sene, A; Tadayoni, R; Pannicke, T; Wurm, A; El Mathari, B; Benard, R; Roux, MJ; Yaffe, D; Mornet, D; Reichenbach, A; Sahel, JA; Rendon, A				Sene, Abdoulaye; Tadayoni, Ramin; Pannicke, Thomas; Wurm, Antje; El Mathari, Brahim; Benard, Romain; Roux, Michel Joseph; Yaffe, David; Mornet, Dominique; Reichenbach, Andreas; Sahel, Jose-Alain; Rendon, Alvaro			Functional Implication of Dp71 in Osmoregulation and Vascular Permeability of the Retina	PLOS ONE			English	Article								Functional alterations of Muller cells, the principal glia of the retina, are an early hallmark of most retina diseases and contribute to their further progression. The molecular mechanisms of these reactive Muller cell alterations, resulting in disturbed retinal homeostasis, remain largely unknown. Here we show that experimental detachment of mouse retina induces mislocation of the inwardly rectifying potassium channels (Kir4.1) and a downregulation of the water channel protein (AQP4) in Muller cells. These alterations are associated with a strong decrease of Dp71, a cytoskeleton protein responsible for the localization and the clustering of Kir4.1 and AQP4. Partial (in detached retinas) or total depletion of Dp71 in Muller cells (in Dp71-null mice) impairs the capability of volume regulation of Muller cells under osmotic stress. The abnormal swelling of Muller cells In Dp71-null mice involves the action of inflammatory mediators. Moreover, we investigated whether the alterations in Muller cells of Dp71-null mice may interfere with their regulatory effect on the blood-retina barrier. In the absence of Dp71, the retinal vascular permeability was increased as compared to the controls. Our results reveal that Dp71 is crucially implicated in the maintenance of potassium homeostasis, in transmembraneous water transport, and in the Muller cell-mediated regulation of retinal vascular permeability. Furthermore, our data provide novel insights into the mechanisms of retinal homeostasis provided by Muller cells under normal and pathological conditions.			Sene, A (corresponding author), INSERM, UMR S 968, Inst Vis, Paris, France.	alvaro.rendon@inserm.fr	Rendon, Alvaro/A-1127-2012; Grosche, Antje/N-1978-2014; Sahel, Jose-Alain/F-3172-2017; Reichenbach, Andreas/B-2510-2017; Roux, Michel J/A-3213-2009; Pannicke, Thomas/A-5078-2017; Sene, Abdoulaye/D-3342-2015	Grosche, Antje/0000-0003-0338-7530; Sahel, Jose-Alain/0000-0002-4831-1153; Roux, Michel J/0000-0002-5812-5215; Pannicke, Thomas/0000-0001-7435-9540; Sene, Abdoulaye/0000-0001-9194-7264				Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Barnett NL, 2000, GLIA, V30, P64, DOI 10.1002/(SICI)1098-1136(200003)30:1<64::AID-GLIA7>3.0.CO;2-I; Barnett NL, 2001, NEUROCHEM INT, V39, P291, DOI 10.1016/S0197-0186(01)00033-X; Bordais A, 2005, NEUROMUSCULAR DISORD, V15, P476, DOI 10.1016/j.nmd.2005.03.011; BRESNICK GH, 1983, OPHTHALMOLOGY, V90, P1301; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Bringmann A, 2000, GLIA, V29, P35, DOI 10.1002/(SICI)1098-1136(20000101)29:1<35::AID-GLIA4>3.0.CO;2-A; Bringmann A, 2004, OPHTHALMIC RES, V36, P241, DOI 10.1159/000081203; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Connors NC, 2002, J NEUROSCI, V22, P4321, DOI 10.1523/JNEUROSCI.22-11-04321.2002; CUNHAVAZ JG, 1984, SURV OPHTHALMOL, V28, P485, DOI 10.1016/0039-6257(84)90230-3; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; Distler C, 1996, VISION RES, V36, P2381, DOI 10.1016/0042-6989(96)00005-3; EHINGER B, 1977, EXP EYE RES, V25, P221, DOI 10.1016/0014-4835(77)90089-6; Eichler W, 2000, NEUROREPORT, V11, P3533, DOI 10.1097/00001756-200011090-00026; Faude F, 2001, INVEST OPHTH VIS SCI, V42, P1328; Fletcher Erica L, 2005, Clin Exp Optom, V88, P132; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Francke M, 2001, INVEST OPHTH VIS SCI, V42, P1072; Iandiev I, 2006, INVEST OPHTH VIS SCI, V47, P2161, DOI 10.1167/iovs.05-0595; Ishikawa A, 1996, CURR EYE RES, V15, P63, DOI 10.3109/02713689609017612; Ishikawa A, 1996, CURR EYE RES, V15, P958, DOI 10.3109/02713689609017641; Kaur C, 2006, INVEST OPHTH VIS SCI, V47, P1126, DOI 10.1167/iovs.05-0518; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; LEWIS GP, 1995, INVEST OPHTH VIS SCI, V36, P2404; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Pannicke T, 2005, GLIA, V50, P1, DOI 10.1002/glia.20151; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; REHAK M, 2008, INVEST OPHTHALMOL VI; Rivier F, 1999, HISTOCHEM J, V31, P425, DOI 10.1023/A:1003805905456; Rozen S, 2000, Methods Mol Biol, V132, P365; Sarig R, 1999, HUM MOL GENET, V8, P1, DOI 10.1093/hmg/8.1.1; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; Tretiach M, 2005, NEUROSCI LETT, V378, P160, DOI 10.1016/j.neulet.2004.12.026; Uckermann O, 2004, GLIA, V45, P59, DOI 10.1002/glia.10305; Wurm A, 2006, AM J PATHOL, V169, P1990, DOI 10.2353/ajpath.2006.060628; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Yang L, 2004, INVEST OPHTH VIS SCI, V45, P648, DOI 10.1167/iovs.03-0827	44	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7329	10.1371/journal.pone.0007329	http://dx.doi.org/10.1371/journal.pone.0007329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809515	gold, Green Submitted, Green Published			2022-12-25	WOS:000270594000008
J	Caldwell, KA; Tucci, ML; Armagost, J; Hodges, TW; Chen, J; Memon, SB; Blalock, JE; DeLeon, SM; Findlay, RH; Ruan, QM; Webber, PJ; Standaert, DG; Olson, JB; Caldwell, GA				Caldwell, Kim A.; Tucci, Michelle L.; Armagost, Jafa; Hodges, Tyler W.; Chen, Jue; Memon, Shermeen B.; Blalock, Jeana E.; DeLeon, Susan M.; Findlay, Robert H.; Ruan, Qingmin; Webber, Philip J.; Standaert, David G.; Olson, Julie B.; Caldwell, Guy A.			Investigating Bacterial Sources of Toxicity as an Environmental Contributor to Dopaminergic Neurodegeneration	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; 16S RIBOSOMAL-RNA; CAENORHABDITIS-ELEGANS; PARKINSONS-DISEASE; NOCARDIA-ASTEROIDES; ENDOTOXIN EXPOSURE; C-ELEGANS; NEURONS; CULTURE; STRESS	Parkinson disease (PD) involves progressive neurodegeneration, including loss of dopamine (DA) neurons from the substantia nigra. Select genes associated with rare familial forms of PD function in cellular pathways, such as the ubiquitin-proteasome system (UPS), involved in protein degradation. The misfolding and accumulation of proteins, such as alpha-synuclein, into inclusions termed Lewy Bodies represents a clinical hallmark of PD. Given the predominance of sporadic PD among patient populations, environmental toxins may induce the disease, although their nature is largely unknown. Thus, an unmet challenge surrounds the discovery of causal or contributory neurotoxic factors that could account for the prevalence of sporadic PD. Bacteria within the order Actinomycetales are renowned for their robust production of secondary metabolites and might represent unidentified sources of environmental exposures. Among these, the aerobic genera, Streptomyces, produce natural proteasome inhibitors that block protein degradation and may potentially damage DA neurons. Here we demonstrate that a metabolite produced by a common soil bacterium, S. venezuelae, caused DA neurodegeneration in the nematode, Caenorhabditis elegans, which increased as animals aged. This metabolite, which disrupts UPS function, caused gradual degeneration of all neuronal classes examined, however DA neurons were particularly vulnerable to exposure. The presence of DA exacerbated toxicity because neurodegeneration was attenuated in mutant nematodes depleted for tyrosine hydroxylase (TH), the rate-limiting enzyme in DA production. Strikingly, this factor caused dose-dependent death of human SH-SY5Y neuroblastoma cells, a dopaminergic line. Efforts to purify the toxic activity revealed that it is a highly stable, lipophilic, and chemically unique small molecule. Evidence of a robust neurotoxic factor that selectively impacts neuronal survival in a progressive yet moderate manner is consistent with the etiology of age-associated neurodegenerative diseases. Collectively, these data suggest the potential for exposures to the metabolites of specific common soil bacteria to possibly represent a contributory environmental component to PD.			Caldwell, KA (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA.	kcaldwel@bama.ua.edu; gcaldwel@bama.ua.edu	Findlay, Robert H/G-4223-2011	Thompson, Michelle/0000-0001-8134-9017; Standaert, David/0000-0003-2921-8348; DeLeon, Susan/0000-0002-9716-9026; Caldwell, Kim/0000-0003-1580-6122	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014426] Funding Source: NIH RePORTER; NIEHS NIH HHS [R21ES01442, R21 ES014426] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barry DP, 2006, APOPTOSIS, V11, P1695, DOI 10.1007/s10495-006-9236-3; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BRENNER S, 1974, GENETICS, V77, P71; Bush KT, 1997, J BIOL CHEM, V272, P9086; CALDWELL GA, 2006, INTEGRATED GENOMICS, P17; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Chapman G, 2003, EXP NEUROL, V184, P715, DOI 10.1016/S0014-4886(03)00337-6; Cook C, 2009, BBA-MOL BASIS DIS, V1792, P664, DOI 10.1016/j.bbadis.2009.01.012; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; DEIMAIN AL, 2000, ADV BIOCHEM ENG BIOT, P1; Diaz-Corrales FJ, 2004, BRAZ J MED BIOL RES, V37, P539, DOI 10.1590/S0100-879X2004000400011; Firestone JA, 2005, ARCH NEUROL-CHICAGO, V62, P91, DOI 10.1001/archneur.62.1.91; Gailliot FP, 1998, METH BIOTEC, V4, P53; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jones D, 1996, TOXICOLOGY, V109, P119, DOI 10.1016/0300-483X(96)03316-1; KOHBATA S, 1991, INFECT IMMUN, V59, P181, DOI 10.1128/IAI.59.1.181-191.1991; Kordower JH, 2006, ANN NEUROL, V60, P264, DOI 10.1002/ana.20935; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Li XP, 2008, J NEUROPATH EXP NEUR, V67, P933, DOI 10.1097/NEN.0b013e318186de64; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Ling ZD, 2004, NEUROSCIENCE, V124, P619, DOI 10.1016/j.neuroscience.2003.12.017; Ling ZD, 2002, MOVEMENT DISORD, V17, P116, DOI 10.1002/mds.10078; Loeffler DA, 2004, MICROB PATHOGENESIS, V37, P73, DOI 10.1016/j.micpath.2004.05.001; MADURO M, 1995, GENETICS, V141, P977; Manning-Bog AB, 2006, ANN NEUROL, V60, P256, DOI 10.1002/ana.20938; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; OGATA SA, 1992, INFECT IMMUN, V60, P1800, DOI 10.1128/IAI.60.5.1800-1805.1992; OGATA SA, 1992, INFECT IMMUN, V60, P3262, DOI 10.1128/IAI.60.8.3262-3267.1992; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Park YC, 2006, J NAT PROD, V69, P580, DOI 10.1021/np058113p; Praitis V, 2001, GENETICS, V157, P1217; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schapira AHV, 2006, ANN NEUROL, V60, P253, DOI 10.1002/ana.20934; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; STRINGHAM EG, 1994, ENVIRON TOXICOL CHEM, V13, P1211, DOI 10.1897/1552-8618(1994)13[1211:THLSOT]2.0.CO;2; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Sun F, 2006, NEUROTOXICOLOGY, V27, P807, DOI 10.1016/j.neuro.2006.06.006; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tam S, 2002, EXP NEUROL, V177, P453, DOI 10.1006/exnr.2002.8012; TANNER CM, 1992, OCCUP MED, V7, P503; Tanner CM, 2003, ADV NEUROL, V91, P133; Zeng BY, 2006, ANN NEUROL, V60, P248, DOI 10.1002/ana.20932; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	56	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7227	10.1371/journal.pone.0007227	http://dx.doi.org/10.1371/journal.pone.0007227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806188	gold, Green Submitted, Green Published			2022-12-25	WOS:000270593800004
J	Glover, WA; Yang, YQ; Zhang, Y				Glover, William A.; Yang, Yanqin; Zhang, Ying			Insights into the Molecular Basis of L-Form Formation and Survival in Escherichia coli	PLOS ONE			English	Article								L-forms have been shown to occur among many species of bacteria and are suspected to be involved in persistent infections. Since their discovery in 1935, numerous studies characterizing L-form morphology, growth, and pathogenic potential have been conducted. However, the molecular mechanisms underlying the formation and survival of L-forms remain unknown. Using unstable L-form colonies of Escherichia coli as a model, we performed genome-wide transcriptome analysis and screened a deletion mutant library to study the molecular mechanisms involved in formation and survival of L-forms. Microarray analysis of L-form versus classical colonies revealed many up-regulated genes of unknown function as well as multiple over-expressed stress pathways shared in common with persister cells and biofilms. Mutant screens identified three groups of mutants which displayed varying degrees of defects in L-form colony formation. Group 1 mutants, which showed the strongest defect in L-form colony formation, belonged to pathways involved in cell envelope stress, DNA repair, iron homeostasis, outer membrane biogenesis, and drug efflux/ABC transporters. Four (Group 1) mutants, rcsB, a positive response regulator of colanic acid capsule synthesis, ruvA, a recombinational junction binding protein, fur, a ferric uptake regulator and smpA a small membrane lipoprotein were selected for complementation. Complementation of the mutants using a high-copy overexpression vector failed, while utilization of a low-copy inducible vector successfully restored L-form formation. This work represents the first systematic genetic evaluation of genes and pathways involved in the formation and survival of unstable L-form bacteria. Our findings provide new insights into the molecular mechanisms underlying L-form formation and survival and have implications for understanding the emergence of antibiotic resistance, bacterial persistence and latent infections and designing novel drugs and vaccines.			Glover, WA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	yzhang@jhsph.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044063, T32AI007417] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI044063, T32 AI007417, R01 AI44063] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAN EJ, 2009, ADV APPL MICROBIOL, P1; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulanger A, 2005, J BACTERIOL, V187, P3282, DOI 10.1128/JB.187.9.3282-3286.2005; Carballes F, 1999, MOL MICROBIOL, V34, P442, DOI 10.1046/j.1365-2958.1999.01605.x; CLASENER H, 1972, ANNU REV MICROBIOL, V26, P55, DOI 10.1146/annurev.mi.26.100172.000415; Dell'Era S, 2009, MOL MICROBIOL, V73, P306, DOI 10.1111/j.1365-2958.2009.06774.x; DIENES L, 1951, BACTERIOL REV, V15, P245, DOI 10.1128/MMBR.15.4.245-288.1951; DIENES L, 1947, J BACTERIOL, V54, P231, DOI 10.1128/JB.54.2.231-237.1947; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Francez-Charlot A, 2005, J BACTERIOL, V187, P3873, DOI 10.1128/JB.187.11.3873-3877.2005; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Fuller E, 2005, ANTIMICROB AGENTS CH, V49, P5075, DOI 10.1128/AAC.49.12.5075-5080.2005; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grove JI, 2008, DNA REPAIR, V7, P1517, DOI 10.1016/j.dnarep.2008.05.010; GUTMAN LT, 1965, J CLIN INVEST, V44, P1945, DOI 10.1172/JCI105300; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HUBER TW, 1977, J CLIN MICROBIOL, V6, P166; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Klieneberger E, 1935, J PATHOL BACTERIOL, V40, P93, DOI 10.1002/path.1700400108; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kvist M, 2008, APPL ENVIRON MICROB, V74, P7376, DOI 10.1128/AEM.01310-08; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Leaver M, 2009, NATURE, V457, P849, DOI 10.1038/nature07742; LEDERBERG J, 1958, J BACTERIOL, V75, P143, DOI 10.1128/JB.75.2.143-160.1958; LEDERBERG J, 1956, P NATL ACAD SCI USA, V42, P574, DOI 10.1073/pnas.42.9.574; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Mattman L., 2001, CELL WALL DEFICIENT; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; OWENS WE, 1987, J CLIN MICROBIOL, V25, P1956, DOI 10.1128/JCM.25.10.1956-1961.1987; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schmidtke LM, 1999, VET MICROBIOL, V69, P287, DOI 10.1016/S0378-1135(99)00120-0; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Shingaki R, 2003, MICROBIOL-SGM, V149, P2501, DOI 10.1099/mic.0.26259-0; Siddiqui RA, 2006, FEMS MICROBIOL LETT, V258, P305, DOI 10.1111/j.1574-6968.2006.00237.x; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06	43	49	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7316	10.1371/journal.pone.0007316	http://dx.doi.org/10.1371/journal.pone.0007316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806199	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593800019
J	Krishna, ADS; Mandraju, RK; Kishore, G; Kondapi, AK				Krishna, Athuluri Divakar Sai; Mandraju, Raj Kumar; Kishore, Golla; Kondapi, Anand Kumar			An Efficient Targeted Drug Delivery through Apotransferrin Loaded Nanoparticles	PLOS ONE			English	Article								Background: Cancerous state is a highly stimulated environment of metabolically active cells. The cells under these conditions over express selective receptors for assimilation of factors essential for growth and transformation. Such receptors would serve as potential targets for the specific ligand mediated transport of pharmaceutically active molecules. The present study demonstrates the specificity and efficacy of protein nanoparticle of apotransferrin for targeted delivery of doxorubicin. Methodology/Principal Findings: Apotransferrin nanoparticles were developed by sol-oil chemistry. A comparative analysis of efficiency of drug delivery in conjugated and non-conjugated forms of doxorubicin to apotransferrin nanoparticle is presented. The spherical shaped apotransferrin nanoparticles (nano) have diameters of 25-50 eta m, which increase to 60-80 eta m upon direct loading of drug (direct-nano), and showed further increase in dimension (75-95 eta m) in conjugated nanoparticles (conj-nano). The competitive experiments with the transferrin receptor specific antibody showed the entry of both conj-nano and direct-nano into the cells through transferrin receptor mediated endocytosis. Results of various studies conducted clearly establish the superiority of the direct-nano over conj-nano viz. ( a) localization studies showed complete release of drug very early, even as early as 30 min after treatment, with the drug localizing in the target organelle ( nucleus) (b) pharmacokinetic studies showed enhanced drug concentrations, in circulation with sustainable half-life ( c) the studies also demonstrated efficient drug delivery, and an enhanced inhibition of proliferation in cancer cells. Tissue distribution analysis showed intravenous administration of direct nano lead to higher drug localization in liver, and blood as compared to relatively lesser localization in heart, kidney and spleen. Experiments using rat cancer model confirmed the efficacy of the formulation in regression of hepatocellular carcinoma with negligible toxicity to kidney and liver. Conclusions: The present study thus demonstrates that the direct-nano is highly efficacious in delivery of drug in a target specific manner with lower toxicity to heart, liver and kidney.			Krishna, ADS (corresponding author), Univ Hyderabad, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	akondapi@yahoo.com		A. DIVAKAR, SAI KRISHNA/0000-0003-0232-4052				Ali SA, 1999, J BIOL CHEM, V274, P24066, DOI 10.1074/jbc.274.34.24066; Anhorn MG, 2008, BIOCONJUGATE CHEM, V19, P2321, DOI 10.1021/bc8002452; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Baalousha M, 2005, MICROSC RES TECHNIQ, V66, P299, DOI 10.1002/jemt.20173; BABSON AL, 1973, CLIN CHEM, V19, P766; Berthelot MPE., 1859, REPORT CHIM APPL, V384, P2884; Beyer U, 1998, J MED CHEM, V41, P2701, DOI 10.1021/jm9704661; Bills CE, 1926, J BIOL CHEM, V67, P279; Bowers GN, 1972, CLIN CHEM, V18, P97; BOWERS LD, 1980, CLIN CHEM, V26, P555; BRASLAWSKY GR, 1991, CANCER IMMUNOL IMMUN, V33, P367, DOI 10.1007/BF01741596; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Chen BA, 2008, INT J NANOMED, V3, P277; COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034; ENNS CA, 1982, P NATL ACAD SCI-BIOL, V79, P3241, DOI 10.1073/pnas.79.10.3241; Erickson B, 2008, LANGMUIR, V24, P11003, DOI 10.1021/la801497d; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Gaur U, 2000, INT J PHARM, V202, P1, DOI 10.1016/S0378-5173(99)00447-0; Grayson SM, 2008, J DRUG TARGET, V16, P329, DOI [10.1080/10611860801969616, 10.1080/10611860801969616 ]; Hait W. N., 2009, CANCER RES, V69, P1267; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; Hamad I, 2008, EXPERT OPIN DRUG DEL, V5, P205, DOI 10.1517/17425247.5.2.205; Holmstrom P, 2006, LIVER INT, V26, P976, DOI 10.1111/j.1478-3231.2006.01316.x; Hsieh MF, 2008, J NANOSCI NANOTECHNO, V8, P2362, DOI 10.1166/jnn.2008.322; Iankov ID, 2007, MOL THER, V15, P114, DOI 10.1038/sj.mt.6300020; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Kircheis R, 2001, GENE THER, V8, P28, DOI 10.1038/sj.gt.3301351; KONDAPI AK, 2007, Patent No. 14433; Kondapi AK, 2006, ARCH BIOCHEM BIOPHYS, V450, P123, DOI 10.1016/j.abb.2006.04.003; Kono K, 2008, BIOMATERIALS, V29, P1664, DOI 10.1016/j.biomaterials.2007.12.017; Li HY, 2002, TRENDS PHARMACOL SCI, V23, P206, DOI 10.1016/S0165-6147(02)01989-2; Lochmann D, 2005, EUR J PHARM BIOPHARM, V59, P419, DOI 10.1016/j.ejpb.2004.04.001; Lopez-Tarruella S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2226; Mier W, 2005, BIOCONJUGATE CHEM, V16, P237, DOI 10.1021/bc034216c; Minguez B, 2009, CURR OPIN GASTROEN, V25, P186, DOI 10.1097/MOG.0b013e32832962a1; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Munnier E, 2008, INT J PHARMACEUT, V363, P170, DOI 10.1016/j.ijpharm.2008.07.006; PANDE G, 1986, CANCER RES, V46, P1673; Papagiannaros A, 2005, INT J PHARMACEUT, V302, P29, DOI 10.1016/j.ijpharm.2005.05.039; PLOSKER GL, 1993, DRUGS, V45, P788, DOI 10.2165/00003495-199345050-00011; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Reddy Lakkireddy Harivardhan, 2005, Acta Pharmaceutica (Zagreb), V55, P81; Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7; Singh M, 1999, CURR PHARM DESIGN, V5, P443; STEIN BS, 1984, J BIOL CHEM, V259, P4762; STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A; THORSTENSEN K, 1993, SCAND J CLIN LAB INV, V53, P113, DOI 10.3109/00365519309090703; Tian Z, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044116; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSENG HH, 2009, J CANC RES CLIN 0423; Udhrain A, 2007, INT J NANOMED, V2, P345; VINCENT A, 2009, ACS NANO; Wei JS, 2005, FRONT BIOSCI-LANDMRK, V10, P3058; Wong HL, 2006, J CONTROL RELEASE, V116, P275, DOI 10.1016/j.jconrel.2006.09.007; Xu JP, 2005, J CONTROL RELEASE, V107, P502, DOI 10.1016/j.jconrel.2005.06.013; Xu PS, 2009, MOL PHARMACEUT, V6, P190, DOI 10.1021/mp800137z; Yadav AK, 2008, J DRUG TARGET, V16, P464, DOI [10.1080/10611860802095494, 10.1080/10611860802095494 ]; Yadav AK, 2007, NANOMED-NANOTECHNOL, V3, P246, DOI 10.1016/j.nano.2007.09.004; Ying XY, 2008, PHARMAZIE, V63, P878, DOI 10.1691/ph.2008.8162; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Zamboni WC, 2008, ONCOLOGIST, V13, P248, DOI 10.1634/theoncologist.2007-0180	61	55	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7240	10.1371/journal.pone.0007240	http://dx.doi.org/10.1371/journal.pone.0007240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19806207	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593300005
J	Hudson, NJ; Reverter, A; Wang, YH; Greenwood, PL; Dalrymple, BP				Hudson, Nicholas J.; Reverter, Antonio; Wang, YongHong; Greenwood, Paul L.; Dalrymple, Brian P.			Inferring the Transcriptional Landscape of Bovine Skeletal Muscle by Integrating Co-Expression Networks	PLOS ONE			English	Article								Background: Despite modern technologies and novel computational approaches, decoding causal transcriptional regulation remains challenging. This is particularly true for less well studied organisms and when only gene expression data is available. In muscle a small number of well characterised transcription factors are proposed to regulate development. Therefore, muscle appears to be a tractable system for proposing new computational approaches. Methodology/Principal Findings: Here we report a simple algorithm that asks "which transcriptional regulator has the highest average absolute co-expression correlation to the genes in a co-expression module?'' It correctly infers a number of known causal regulators of fundamental biological processes, including cell cycle activity (E2F1), glycolysis (HLF), mitochondrial transcription (TFB2M), adipogenesis (PIAS1), neuronal development (TLX3), immune function (IRF1) and vasculogenesis (SOX17), within a skeletal muscle context. However, none of the canonical pro-myogenic transcription factors (MYOD1, MYOG, MYF5, MYF6 and MEF2C) were linked to muscle structural gene expression modules. Co-expression values were computed using developing bovine muscle from 60 days post conception (early foetal) to 30 months post natal (adulthood) for two breeds of cattle, in addition to a nutritional comparison with a third breed. A number of transcriptional landscapes were constructed and integrated into an always correlated landscape. One notable feature was a 'metabolic axis' formed from glycolysis genes at one end, nuclear-encoded mitochondrial protein genes at the other, and centrally tethered by mitochondrially-encoded mitochondrial protein genes. Conclusions/Significance: The new module-to-regulator algorithm complements our recently described Regulatory Impact Factor analysis. Together with a simple examination of a co-expression module's contents, these three gene expression approaches are starting to illuminate the in vivo transcriptional regulation of skeletal muscle development.			Hudson, NJ (corresponding author), CSIRO, Brisbane, Qld, Australia.	Brian.Dalrymple@csiro.au	Hudson, Nick/C-1201-2008; Hudson, Nicholas J/D-1606-2011; Dalrymple, Brian P/F-8721-2010; Hudson, Nick/AAF-5644-2020; Greenwood, Paul L/G-9747-2013; Reverter, Antonio/C-9699-2013	Hudson, Nicholas J/0000-0002-3549-9396; Dalrymple, Brian P/0000-0003-3891-5233; Hudson, Nick/0000-0002-3549-9396; Greenwood, Paul L/0000-0002-7719-8233; Reverter, Antonio/0000-0002-4681-9404				AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Almenar-Queralt A, 1999, J BIOL CHEM, V274, P28466, DOI 10.1074/jbc.274.40.28466; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berry C, 2002, AM J PHYSIOL-CELL PH, V283, pC135, DOI 10.1152/ajpcell.00458.2001; Bicer S, 2004, J MUSCLE RES CELL M, V25, P623, DOI 10.1007/s10974-004-5070-9; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen L, 2002, P NATL ACAD SCI USA, V99, P14320, DOI 10.1073/pnas.212532399; Chen Q, 2000, INVEST OPHTH VIS SCI, V41, P4223; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dal Rhee S, 2008, MOL CELL ENDOCRINOL, V294, P61, DOI 10.1016/j.mce.2008.08.018; de la Cruz CC, 1999, DEV BIOL, V216, P595, DOI 10.1006/dbio.1999.9528; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Farrall M, 2004, HUM MOL GENET, V13, pR1, DOI 10.1093/hmg/ddh084; Finocchietto P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001749; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gradin K, 2002, J BIOL CHEM, V277, P23508, DOI 10.1074/jbc.M201307200; Grifone R, 2004, MOL CELL BIOL, V24, P6253, DOI 10.1128/MCB.24.14.6253-6267.2004; Hartemink AJ, 2005, NAT BIOTECHNOL, V23, P554, DOI 10.1038/nbt0505-554; Hawley JA, 2007, SPORTS MED, V37, P328, DOI 10.2165/00007256-200737040-00014; Hayashi R, 2006, J BIOL CHEM, V281, P35633, DOI 10.1074/jbc.M603800200; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; HOLLAND PWH, 1992, DEVELOPMENT, V116, P653; Hong SK, 1999, BIOCHEM BIOPH RES CO, V255, P116, DOI 10.1006/bbrc.1999.0158; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; HUDSON NJ, 2009, PLOS COMPUT IN PRESS; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Issa LL, 2006, DEV BIOL, V293, P104, DOI 10.1016/j.ydbio.2006.01.019; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lehnert SA, 2006, J ANIM SCI, V84, P3239, DOI 10.2527/jas.2006-192; Lehnert SA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-95; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu Li, 2007, Chinese Journal of Pathology, V36, P390; MacIntosh B.R., 2006, SKELETAL MUSCLE FORM; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Michoel T, 2009, ANN NY ACAD SCI, V1158, P36, DOI 10.1111/j.1749-6632.2008.03943.x; Ong VH, 2009, EXP CELL RES, V315, P151, DOI 10.1016/j.yexcr.2008.11.001; Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Qian Y, 2001, GENE DEV, V15, P2533, DOI 10.1101/gad.921501; Qin XQ, 1997, ONCOGENE, V14, P53, DOI 10.1038/sj.onc.1200809; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2006, PHYSIOL GENOMICS, V28, P76, DOI 10.1152/physiolgenomics.00105.2006; SAGE EH, 1991, J BIOL CHEM, V266, P14831; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Scherf M, 2005, BRIEF BIOINFORM, V6, P287, DOI 10.1093/bib/6.3.287; Setoyama C, 1995, Nihon Rinsho, V53, P1081; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheng HZ, 1997, DEV DYNAM, V208, P266, DOI 10.1002/(SICI)1097-0177(199702)208:2<266::AID-AJA13>3.0.CO;2-1; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Toresson H, 1999, DEVELOPMENT, V126, P1317; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; WATT PM, 1994, BIOCHEM J, V303, P681, DOI 10.1042/bj3030681; Xu Y, 2004, J BIOL CHEM, V279, P41179, DOI 10.1074/jbc.M400292200; Zampieri M, 2008, BIOINFORMATICS, V24, P1510, DOI 10.1093/bioinformatics/btn220; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	90	46	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e7249	10.1371/journal.pone.0007249	http://dx.doi.org/10.1371/journal.pone.0007249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794913	gold, Green Published, Green Submitted			2022-12-25	WOS:000270354200004
J	Jaworski, T; Dewachter, I; Lechat, B; Croes, S; Termont, A; Demedts, D; Borghgraef, P; Devijver, H; Filipkowski, RK; Kaczmarek, L; Kugler, S; Van Leuven, F				Jaworski, Tomasz; Dewachter, Ilse; Lechat, Benoit; Croes, Sophie; Termont, Annelies; Demedts, David; Borghgraef, Peter; Devijver, Herman; Filipkowski, Robert K.; Kaczmarek, Leszek; Kuegler, Sebastian; Van Leuven, Fred			AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type Mice	PLOS ONE			English	Article								In Alzheimer's disease tauopathy is considered secondary to amyloid, and the duality obscures their relation and the definition of their respective contributions. Transgenic mouse models do not resolve this problem conclusively, i.e. the relative hierarchy of amyloid and tau pathology depends on the actual model and the genes expressed or inactivated. Here, we approached the problem in non-transgenic models by intracerebral injection of adeno-associated viral vectors to express protein tau or amyloid precursor protein in the hippocampus in vivo. AAV-APP mutant caused neuronal accumulation of amyloid peptides, and eventually amyloid plaques at 6 months post-injection, but with only marginal hippocampal cell-death. In contrast, AAV-Tau, either wild-type or mutant P301L, provoked dramatic degeneration of pyramidal neurons in CA1/2 and cortex within weeks. Tau-mediated neurodegeneration proceeded without formation of large fibrillar tau-aggregates or tangles, but with increased expression of cell-cycle markers. We present novel AAV-based models, which demonstrate that protein tau mediates pyramidal neurodegeneration in vivo. The data firmly support the unifying hypothesis that post-mitotic neurons are forced to re-enter the cell-cycle in primary and secondary tauopathies, including Alzheimer's disease.			Jaworski, T (corresponding author), Katholieke Univ Leuven VIB, Dept Human Genet, Expt Genet Grp, KULeuven Campus, B-3000 Leuven, Belgium.	fred.vanleuven@med.kuleuven.be	Kaczmarek, Leszek/AHA-0076-2022; Kaczmarek, Leszek/B-6171-2008; Dewachter, Ilse/AAZ-5661-2020	Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; Dewachter, Ilse/0000-0001-7202-515X; Jaworski, Tomasz/0000-0002-6387-9249				Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Arnaud L, 2006, NEURODEGENER DIS, V3, P313, DOI 10.1159/000095638; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CLAVAGUERA F, 2009, NAT CELL BI IN PRESS; Dewachter I, 2002, LANCET NEUROL, V1, P409, DOI 10.1016/S1474-4422(02)00188-6; DUYCKAERTS C, 2009, ACTA NEUROP IN PRESS; Frank S, 2008, ACTA NEUROPATHOL, V115, P39, DOI 10.1007/s00401-007-0291-9; FRANKLIN KBJ, 1997, MOUSE BRAIN STEREOTA, P360; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hoozemans JJM, 2002, J NEUROPATH EXP NEUR, V61, P678, DOI 10.1093/jnen/61.8.678; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KLEIN RL, 2009, NEUROBIOL AGING; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Kugler S, 2007, AM J HUM GENET, V80, P291, DOI 10.1086/511281; Kumar-Singh S, 2000, HUM MOL GENET, V9, P2589, DOI 10.1093/hmg/9.18.2589; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Melino G, 2005, CELL DEATH DIFFER, V12, P1457, DOI 10.1038/sj.cdd.4401781; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Muyllaert D, 2008, AM J PATHOL, V172, P470, DOI 10.2353/ajpath.2008.070693; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Takashima A, 2008, J ALZHEIMERS DIS, V14, P371; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; TERWEL D, 2002, NEUROMOL MED, V2, P161; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; van Leuven F, 2000, PROG NEUROBIOL, V61, P305, DOI 10.1016/S0301-0082(99)00055-6; Vincent I, 1997, J NEUROSCI, V17, P3588	49	59	62	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e7280	10.1371/journal.pone.0007280	http://dx.doi.org/10.1371/journal.pone.0007280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794916	Green Published, Green Submitted, gold			2022-12-25	WOS:000270354200007
J	Dubreuil, P; Letard, S; Ciufolini, M; Gros, L; Humbert, M; Casteran, N; Borge, L; Hajem, B; Lermet, A; Sippl, W; Voisset, E; Arock, M; Auclair, C; Leventhal, PS; Mansfield, CD; Moussy, A; Hermine, O				Dubreuil, Patrice; Letard, Sebastien; Ciufolini, Marco; Gros, Laurent; Humbert, Martine; Casteran, Nathalie; Borge, Laurence; Hajem, Berengere; Lermet, Anne; Sippl, Wolfgang; Voisset, Edwige; Arock, Michel; Auclair, Christian; Leventhal, Phillip S.; Mansfield, Colin D.; Moussy, Alain; Hermine, Olivier			Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT	PLOS ONE			English	Article								Background: The stem cell factor receptor, KIT, is a target for the treatment of cancer, mastocytosis, and inflammatory diseases. Here, we characterise the in vitro and in vivo profiles of masitinib (AB1010), a novel phenylaminothiazole-type tyrosine kinase inhibitor that targets KIT. Methodology/Principal Findings: In vitro, masitinib had greater activity and selectivity against KIT than imatinib, inhibiting recombinant human wild-type KIT with an half inhibitory concentration (IC(50)) of 200 +/- 40 nM and blocking stem cell factor-induced proliferation and KIT tyrosine phosphorylation with an IC(50) of 150 +/- 80 nM in Ba/F3 cells expressing human or mouse wild-type KIT. Masitinib also potently inhibited recombinant PDGFR and the intracellular kinase Lyn, and to a lesser extent, fibroblast growth factor receptor 3. In contrast, masitinib demonstrated weak inhibition of ABL and c-Fms and was inactive against a variety of other tyrosine and serine/threonine kinases. This highly selective nature of masitinib suggests that it will exhibit a better safety profile than other tyrosine kinase inhibitors; indeed, masitinib-induced cardiotoxicity or genotoxicity has not been observed in animal studies. Molecular modelling and kinetic analysis suggest a different mode of binding than imatinib, and masitinib more strongly inhibited degranulation, cytokine production, and bone marrow mast cell migration than imatinib. Furthermore, masitinib potently inhibited human and murine KIT with activating mutations in the juxtamembrane domain. In vivo, masitinib blocked tumour growth in mice with subcutaneous grafts of Ba/F3 cells expressing a juxtamembrane KIT mutant. Conclusions: Masitinib is a potent and selective tyrosine kinase inhibitor targeting KIT that is active, orally bioavailable in vivo, and has low toxicity.			Dubreuil, P (corresponding author), Ctr Reference Mastocytoses, Ctr Rech Cancerol Marseille Signalisat Hematopoie, INSERM, U891, Marseille, France.	patrice.dubreuil@inserm.fr; olivier.hermine@nck.aphp.fr	Voisset, Edwige/GSE-5113-2022; Dubreuil, Patrice/V-4816-2019; Sippl, Wolfgang/P-5944-2014; Hermine, Olivier/Q-7072-2018; Voisset, Edwige/AAM-3503-2021; dubreuil, patrice/F-5346-2011	Voisset, Edwige/0000-0002-0943-4847; Dubreuil, Patrice/0000-0003-1155-1150; Sippl, Wolfgang/0000-0002-5985-9261; Voisset, Edwige/0000-0002-0943-4847; dubreuil, patrice/0000-0003-1155-1150; Hermine, Olivier/0000-0003-2574-3874; LETARD, Sebastien/0000-0002-6508-7376				Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Buchdunger E, 1996, CANCER RES, V56, P100; BUCHDUNGER E, 1995, P NATL ACAD SCI USA, V92, P2558, DOI 10.1073/pnas.92.7.2558; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Fernandez A, 2007, J CLIN INVEST, V117, P4044, DOI 10.1172/JCI32373; Frost MJ, 2002, MOL CANCER THER, V1, P1115; Gabillot-Carre M, 2006, BLOOD, V108, P1065, DOI 10.1182/blood-2005-06-2433; Hahn KA, 2008, J VET INTERN MED, V22, P1301, DOI 10.1111/j.1939-1676.2008.0190.x; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Ma YS, 2002, BLOOD, V99, P1741, DOI 10.1182/blood.V99.5.1741; MEININGER CJ, 1992, BLOOD, V79, P958; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nagar B, 2002, CANCER RES, V62, P4236; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; Reber L, 2006, EUR J PHARMACOL, V533, P327, DOI 10.1016/j.ejphar.2005.12.067; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Royer B, 2001, J ALLERGY CLIN IMMUN, V108, P80, DOI 10.1067/mai.2001.115753; Rubin BP, 2006, LAB INVEST, V86, P981, DOI 10.1038/labinvest.3700466; Shchemelinin I, 2006, FOLIA BIOL-PRAGUE, V52, P137; Small D, 2006, FLT3 MUTATIONS BIOL, P178; Testa U, 2008, DRUG FUTURE, V33, P161, DOI 10.1358/dof.2008.033.02.1164207; Tsujimura T, 1996, BLOOD, V87, P273; Ueda S, 2002, INT J HEMATOL, V76, P427, DOI 10.1007/BF02982808; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269; 1996, J OFFICIEL      0602, P8167; GLEEVEC PHARM REV	37	280	297	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7258	10.1371/journal.pone.0007258	http://dx.doi.org/10.1371/journal.pone.0007258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789626	Green Submitted, Green Published, gold			2022-12-25	WOS:000270354100017
J	Ma, CH; Kachroo, AH; Macieszak, A; Chen, TY; Guga, P; Jayaram, M				Ma, Chien-Hui; Kachroo, Aashiq H.; Macieszak, Anna; Chen, Tzu-Yang; Guga, Piotr; Jayaram, Makkuni			Reactions of Cre with Methylphosphonate DNA: Similarities and Contrasts with Flp and Vaccinia Topoisomerase	PLOS ONE			English	Article								Background: Reactions of vaccinia topoisomerase and the tyrosine site-specific recombinase Flp with methylphosphonate (MeP) substituted DNA substrates, have provided important insights into the electrostatic features of the strand cleavage and strand joining steps catalyzed by them. A conserved arginine residue in the catalytic pentad, Arg-223 in topoisomerase and Arg-308 in Flp, is not essential for stabilizing the MeP transition state. Topoisomerase or its R223A variant promotes cleavage of the MeP bond by the active site nucleophile Tyr-274, followed by the rapid hydrolysis of the MeP-tyrosyl intermediate. Flp(R308A), but not wild type Flp, mediates direct hydrolysis of the activated MeP bond. These findings are consistent with a potential role for phosphate electrostatics and active site electrostatics in protecting DNA relaxation and site-specific recombination, respectively, against abortive hydrolysis. Methodology/Principal Findings: We have examined the effects of DNA containing MeP substitution in the Flp related Cre recombination system. Neutralizing the negative charge at the scissile position does not render the tyrosyl intermediate formed by Cre susceptible to rapid hydrolysis. Furthermore, combining the active site R292A mutation in Cre (equivalent to the R223A and R308A mutations in topoisomerase and Flp, respectively) with MeP substitution does not lead to direct hydrolysis of the scissile MeP bond in DNA. Whereas Cre follows the topoisomerase paradigm during the strand cleavage step, it follows the Flp paradigm during the strand joining step. Conclusions/Significance: Collectively, the Cre, Flp and topoisomerase results highlight the contribution of conserved electrostatic complementarity between substrate and active site towards transition state stabilization during site-specific recombination and DNA relaxation. They have potential implications for how transesterification reactions in nucleic acids are protected against undesirable abortive side reactions. Such protective mechanisms are significant, given the very real threat of hydrolytic genome damage or disruption of RNA processing due to the cellular abundance and nucleophilicity of water.			Ma, CH (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA.	Jayaram@icmb.utexas.edu	Kachroo, Aashiq/Z-2505-2019; Kachroo, Aashiq/C-3714-2009; Guga, Piotr J/Y-5582-2018	Kachroo, Aashiq/0000-0001-9770-778X; Kachroo, Aashiq/0000-0001-9770-778X; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035654] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM035654, R01 GM035654] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGARWAL KL, 1979, NUCLEIC ACIDS RES, V6, P3009, DOI 10.1093/nar/6.9.3009; An S, 2008, NUCLEIC ACIDS RES, V36, P2514, DOI 10.1093/nar/gkn063; Belfort Marlene, 2002, P761; CECH TR, 1983, CELL, V34, P713, DOI 10.1016/0092-8674(83)90527-5; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chen Y, 2003, J BIOL CHEM, V278, P24800, DOI 10.1074/jbc.M300853200; Conway AB, 2003, J MOL BIOL, V326, P425, DOI 10.1016/S0022-2836(02)01370-0; Craig N. L., 2002, MOBILE DNA, P3; Dash C, 2008, NUCLEIC ACIDS RES, V36, P6363, DOI 10.1093/nar/gkn678; Dertinger D, 2001, RNA, V7, P622, DOI 10.1017/S1355838201002217; Ghosh K, 2002, METHODS, V28, P374, DOI 10.1016/S1046-2023(02)00244-X; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Jayaram M, 2004, PROG NUCLEIC ACID RE, V77, P127, DOI 10.1016/S0079-6603(04)77004-X; Jayaram M., 2002, MOBILE DNA, P192; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; LEE J, 1993, J BIOL CHEM, V268, P17564; Lee J, 1996, J MOL BIOL, V257, P532, DOI 10.1006/jmbi.1996.0183; Ma CH, 2009, EMBO J, V28, P1745, DOI 10.1038/emboj.2009.131; Mizuuchi K, 1997, GENES CELLS, V2, P1, DOI 10.1046/j.1365-2443.1997.970297.x; Mizuuchi Kiyoshi, 2002, P12; NOBLE SA, 1984, NUCLEIC ACIDS RES, V12, P3387, DOI 10.1093/nar/12.7.3387; Parker JB, 2008, BIOCHEMISTRY-US, V47, P8614, DOI 10.1021/bi800854g; PRITCHARD CE, 1994, NUCLEIC ACIDS RES, V22, P2592, DOI 10.1093/nar/22.13.2592; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Rice P. A., 2002, MOBILE DNA, P219; Rosati O, 2002, BIOCHEM BIOPH RES CO, V295, P198, DOI 10.1016/S0006-291X(02)00645-9; San AK, 2001, J BIOL CHEM, V276, P46612, DOI 10.1074/jbc.M106492200; Shaikh AC, 1997, J BIOL CHEM, V272, P5695, DOI 10.1074/jbc.272.9.5695; Tian LG, 2005, STRUCTURE, V13, P513, DOI 10.1016/j.str.2005.02.001; Tian LG, 2003, MOL CELL, V12, P199, DOI 10.1016/S1097-2765(03)00263-6; Van Duyne G.D., 2002, MOBILE DNA, VII, P93; Woods KC, 2001, J MOL BIOL, V313, P49, DOI 10.1006/jmbi.2001.5012; Xu CJ, 1998, MOL CELL, V1, P729, DOI 10.1016/S1097-2765(00)80072-6	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7248	10.1371/journal.pone.0007248	http://dx.doi.org/10.1371/journal.pone.0007248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789629	Green Published, gold, Green Submitted			2022-12-25	WOS:000270354100013
J	Gibson, NJ; Tolbert, LP; Oland, LA				Gibson, Nicholas J.; Tolbert, Leslie P.; Oland, Lynne A.			Roles of Specific Membrane Lipid Domains in EGF Receptor Activation and Cell Adhesion Molecule Stabilization in a Developing Olfactory System	PLOS ONE			English	Article							MOTH MANDUCA-SEXTA; EPIDERMAL-GROWTH-FACTOR; DETERGENT-RESISTANT MEMBRANES; DEAFFERENTED ANTENNAL LOBES; SENSORY AXON GUIDANCE; LABIAL PIT ORGAN; FASCICLIN-II; NERVOUS-SYSTEM; GLIAL-CELLS; IMMUNOGLOBULIN SUPERFAMILY	Background: Reciprocal interactions between glial cells and olfactory receptor neurons (ORNs) cause ORN axons entering the brain to sort, to fasciculate into bundles destined for specific glomeruli, and to form stable protoglomeruli in the developing olfactory system of an experimentally advantageous animal species, the moth Manduca sexta. Epidermal growth factor receptors (EGFRs) and the cell adhesion molecules (IgCAMs) neuroglian and fasciclin II are known to be important players in these processes. Methodology/Principal Findings: We report in situ and cell-culture studies that suggest a role for glycosphingolipid-rich membrane subdomains in neuron-glia interactions. Disruption of these subdomains by the use of methyl-beta-cyclodextrin results in loss of EGFR activation, depletion of fasciclin II in ORN axons, and loss of neuroglian stabilization in the membrane. At the cellular level, disruption leads to aberrant ORN axon trajectories, small antennal lobes, abnormal arrays of olfactory glomerul, and loss of normal glial cell migration. Conclusions/Significance: We propose that glycosphingolipid-rich membrane subdomains (possible membrane rafts or platforms) are essential for IgCAM-mediated EGFR activation and for anchoring of neuroglian to the cytoskeleton, both required for normal extension and sorting of ORN axons.			Gibson, NJ (corresponding author), Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA.	njgibson@neurobio.arizona.edu			NIDCD NIH HHS [R01 DC004598, DC004598, DC008597, R01 DC008597] Funding Source: Medline; NINDS NIH HHS [P01-NS28495, P01 NS028495] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS028495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004598, R01DC008597] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abeytunga DTU, 2004, J LIPID RES, V45, P1221, DOI 10.1194/jlr.M300392-JLR200; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allende D, 2004, TRENDS BIOCHEM SCI, V29, P325, DOI 10.1016/j.tibs.2004.04.002; Baumann PM, 1996, J COMP NEUROL, V373, P118; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Chang MC, 2006, MOL CELL NEUROSCI, V31, P525, DOI 10.1016/j.mcn.2005.11.006; Chen CL, 1997, DEV BIOL, V181, P1, DOI 10.1006/dbio.1996.8437; Cheng L, 2005, J NEUROSCI, V25, P395, DOI 10.1523/JNEUROSCI.4097-04.2005; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Dubreuil RR, 1996, J CELL BIOL, V133, P647, DOI 10.1083/jcb.133.3.647; Falk J, 2004, MOL BIOL CELL, V15, P4695, DOI 10.1091/mbc.E04-03-0171; Forni JJ, 2004, MOL CELL NEUROSCI, V26, P282, DOI 10.1016/j.mcn.2004.02.003; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Fullekrug J, 2004, ANN NY ACAD SCI, V1014, P164, DOI 10.1196/annals.1294.017; Garcia-Alonso L, 2000, NEURON, V28, P741, DOI 10.1016/S0896-6273(00)00150-1; Gibson NJ, 2006, J COMP NEUROL, V495, P554, DOI 10.1002/cne.20890; Gibson NJ, 2001, DEV BIOL, V240, P326, DOI 10.1006/dbio.2001.0463; Gibson NJ, 2004, J COMP NEUROL, V476, P1, DOI 10.1002/cne.20178; Gil OD, 2003, J CELL BIOL, V162, P719, DOI 10.1083/jcb.200211011; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Golub T, 2004, CURR OPIN NEUROBIOL, V14, P542, DOI 10.1016/j.conb.2004.08.003; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hall SG, 1997, J NEUROBIOL, V32, P325, DOI 10.1002/(SICI)1097-4695(199703)32:3<325::AID-NEU6>3.3.CO;2-N; Hamlin JA, 2004, J COMP NEUROL, V474, P438, DOI 10.1002/cne.20133; HARPER JR, 1991, J NEUROCHEM, V56, P797, DOI 10.1111/j.1471-4159.1991.tb01994.x; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HAYASHI JH, 1990, J NEUROSCI, V10, P848; Herincs Z, 2005, J CELL SCI, V118, P1687, DOI 10.1242/jcs.02296; Hering H, 2003, J NEUROSCI, V23, P3262; Higgins MR, 2002, DEV BIOL, V244, P134, DOI 10.1006/dbio.2002.0583; HILDEBRAND JG, 1979, P NATL ACAD SCI USA, V76, P499, DOI 10.1073/pnas.76.1.499; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hortsch M, 1998, J CELL BIOL, V142, P251, DOI 10.1083/jcb.142.1.251; Hortsch M, 1996, NEURON, V17, P587, DOI 10.1016/S0896-6273(00)80192-0; Hou QM, 2008, MOL CELL NEUROSCI, V38, P213, DOI 10.1016/j.mcn.2008.02.010; Huetteroth W, 2005, CELL TISSUE RES, V319, P513, DOI 10.1007/s00441-004-1016-1; Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.e03-05-0333; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jefford G, 2000, J BIOL CHEM, V275, P27726; Jenkins SM, 2001, J CELL SCI, V114, P3823; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; Kamiguchi H, 2000, CURR OPIN CELL BIOL, V12, P598, DOI 10.1016/S0955-0674(00)00138-1; Kamiguchi H, 2006, J NEUROCHEM, V98, P330, DOI 10.1111/j.1471-4159.2006.03888.x; Kent KS, 1999, J NEUROBIOL, V40, P28, DOI 10.1002/(SICI)1097-4695(199907)40:1<28::AID-NEU3>3.0.CO;2-E; KENT KS, 1986, CELL TISSUE RES, V245, P237; KENT KS, 1985, THESIS HARVARD U; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Kristiansen LV, 2005, MOL CELL NEUROSCI, V28, P141, DOI 10.1016/j.mcn.2004.09.003; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Ma L, 2003, J NEUROSCI, V23, P3164; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; McIntosh TJ, 2003, BIOPHYS J, V85, P1656, DOI 10.1016/S0006-3495(03)74595-0; Mintz CD, 2003, J COMP NEUROL, V464, P438, DOI 10.1002/cne.10809; MIRAGALL F, 1989, DEV BIOL, V135, P272, DOI 10.1016/0012-1606(89)90179-6; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; MORTON DB, 1985, J COMP PHYSIOL A, V157, P423, DOI 10.1007/BF00615142; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Nardi JB, 2006, DEV COMP IMMUNOL, V30, P447, DOI 10.1016/j.dci.2005.06.026; NARDI JB, 1993, DEVELOPMENT, V118, P967; NARDI JB, 1994, DEV DYNAM, V199, P315, DOI 10.1002/aja.1001990406; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; OLAND LA, 1988, J NEUROSCI, V8, P353; Oland LA, 1998, J COMP NEUROL, V398, P119; OLAND LA, 1989, GLIA, V2, P10, DOI 10.1002/glia.440020103; OLAND LA, 1987, J COMP NEUROL, V255, P196, DOI 10.1002/cne.902550204; OLAND LA, 1990, J NEUROSCI, V10, P2096; Oland LA, 1996, J NEUROBIOL, V30, P92; Oland LA, 2003, ANNU REV ENTOMOL, V48, P89, DOI 10.1146/annurev.ento.48.091801.112654; Oland LA, 1996, J NEUROSCI METH, V69, P103, DOI 10.1016/S0165-0270(96)00025-8; Oland LA, 1999, CELL TISSUE RES, V297, P527, DOI 10.1007/s004410051379; Oland LA, 1998, J NEUROBIOL, V36, P41, DOI 10.1002/(SICI)1097-4695(199807)36:1<41::AID-NEU4>3.0.CO;2-A; Parker RJ, 2006, SEMIN CELL DEV BIOL, V17, P66, DOI 10.1016/j.semcdb.2005.11.012; Parker RJ, 2004, BIOCHEM CELL BIOL, V82, P694, DOI 10.1139/O04-119; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P10315, DOI 10.1021/bi025943i; Ridyard MS, 2003, J BIOL CHEM, V278, P13803, DOI 10.1074/jbc.M210245200; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; ROSPARS JP, 1992, CELL TISSUE RES, V270, P205, DOI 10.1007/BF00328007; Rospars JP, 2000, CHEM SENSES, V25, P119, DOI 10.1093/chemse/25.2.119; Rossler W, 1999, J NEUROSCI, V19, P9865; SANES JR, 1976, DEV BIOL, V51, P282, DOI 10.1016/0012-1606(76)90144-5; SANES JR, 1977, BRAIN RES, V119, P389, DOI 10.1016/0006-8993(77)90318-3; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sepp KJ, 2003, J NEUROSCI, V23, P8221; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sinakevitch I, 2001, J COMP NEUROL, V439, P352, DOI 10.1002/cne.1355; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Takebayashi M, 2004, SYNAPSE, V53, P90, DOI 10.1002/syn.20041; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; TOLBERT LP, 1990, J COMP NEUROL, V298, P69, DOI 10.1002/cne.902980106; TOLBERT LP, 1981, PROC R SOC SER B-BIO, V213, P279, DOI 10.1098/rspb.1981.0067; TOLBERT LP, 1983, J NEUROSCI, V3, P1158; Tolbert LP, 2004, PROG NEUROBIOL, V73, P73, DOI 10.1016/j.pneurobio.2004.04.004; Treloar H, 1997, J NEUROBIOL, V32, P643, DOI 10.1002/(SICI)1097-4695(19970620)32:7<643::AID-NEU1>3.0.CO;2-4; Treloar HB, 1999, J COMP NEUROL, V413, P289; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Tucker ES, 2004, J COMP NEUROL, V472, P478, DOI 10.1002/cne.20058; Tucker ES, 2003, DEV BIOL, V260, P9, DOI 10.1016/S0012-1606(03)00207-0; Vyas KA, 2001, BIOL CHEM, V382, P241, DOI 10.1515/BC.2001.031; Whittard JD, 2006, MOL BIOL CELL, V17, P2696, DOI 10.1091/mbc.E06-01-0090; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Wright JW, 1999, DEVELOPMENT, V126, P3217; Yang XL, 2004, LIFE SCI, V75, P2495, DOI 10.1016/j.lfs.2004.04.036; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	137	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7222	10.1371/journal.pone.0007222	http://dx.doi.org/10.1371/journal.pone.0007222			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787046	Green Submitted, Green Published, gold			2022-12-25	WOS:000270290100019
J	Villani, AC; Lemire, M; Louis, E; Silverberg, MS; Collette, C; Fortin, G; Nimmo, ER; Renaud, Y; Brunet, S; Libioulle, C; Belaiche, J; Bitton, A; Gaudet, D; Cohen, A; Langelier, D; Rioux, JD; Arnott, IDR; Wild, GE; Rutgeerts, P; Satsangi, J; Vermeire, S; Hudson, TJ; Franchimont, D				Villani, Alexandra-Chloe; Lemire, Mathieu; Louis, Edouard; Silverberg, Mark S.; Collette, Catherine; Fortin, Genevieve; Nimmo, Elaine R.; Renaud, Yannick; Brunet, Sebastien; Libioulle, Cecile; Belaiche, Jacques; Bitton, Alain; Gaudet, Daniel; Cohen, Albert; Langelier, Diane; Rioux, John D.; Arnott, Ian D. R.; Wild, Gary E.; Rutgeerts, Paul; Satsangi, Jack; Vermeire, Severine; Hudson, Thomas J.; Franchimont, Denis			Genetic Variation in the Familial Mediterranean Fever Gene (MEFV) and Risk for Crohn's Disease and Ulcerative Colitis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY LOCI; FLIP-FLOP; PYRIN; MUTATIONS; EXPRESSION; CONTRIBUTE; INTERACTS; CASPASE-1	Background and Aims: The familial Mediterranean fever (FMF) gene (MEFV) encodes pyrin, a major regulator of the inflammasome platform controlling caspase-1 activation and IL-1 beta processing. Pyrin has been shown to interact with the gene product of NLRP3, NALP3/cryopyrin, also an important active member of the inflammasome. The NLRP3 region was recently reported to be associated with Crohn's disease (CD) susceptibility. We therefore sought to evaluate MEFV as an inflammatory bowel disease (IBD) susceptibility gene. Methodology and Results: MEFV colonic mucosal gene expression was significantly increased in experimental colitis mice models (TNBS p < 0.0003; DSS p < 0.006), in biopsies from CD (p < 0.02) and severe ulcerative colitis (UC) patients (p < 0.008). Comprehensive genetic screening of the MEFV region in the Belgian exploratory sample set (440 CD trios, 137 UC trios, 239 CD cases, 96 UC cases, and 107 healthy controls) identified SNPs located in the MEFV 59 haplotype block that were significantly associated with UC (rs224217; p = 0.003; A allele frequency: 56% cases, 45% controls), while no CD associations were observed. Sequencing and subsequent genotyping of variants located in this associated haplotype block identified three synonymous variants (D102D/rs224225, G138G/rs224224, A165A/rs224223) and one non-synonymous variant (R202Q/rs224222) located in MEFV exon 2 that were significantly associated with UC (rs224222: p = 0.0005; A allele frequency: 32% in cases, 23% in controls). No consistent associations were observed in additional Canadian (256 CD trios, 91 UC trios) and Scottish (495 UC, 370 controls) sample sets. We note that rs224222 showed marginal association (p = 0.012; G allele frequency: 82% in cases, 70% in controls) in the Canadian sample, but with a different risk allele. None of the NLRP3 common variants were associated with UC in the Belgian-Canadian UC samples and no significant interactions were observed between NLRP3 and MEFV that could explain the observed flip-flop of the rs224222 risk allele. Conclusion: The differences in association levels observed between the sample sets may be a consequence of distinct founder effects or of the relative small sample size of the cohorts evaluated in this study. However, the results suggest that common variants in the MEFV region do not contribute to CD and UC susceptibility.			Villani, AC (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Gastroenterol, Montreal, PQ H3G 1A4, Canada.	alexandra-chloe.villani@mail.mcgill.ca	Rioux, John D/A-9599-2015; Silverberg, Mark/B-4183-2008	Rioux, John D/0000-0001-7560-8326; Vermeire, Severine/0000-0001-9942-3019	Medical Research Council [G0600329, G0800759, G0800675] Funding Source: Medline; NIAID NIH HHS [AI065687, P01 AI065687, U19 AI067152, AI067152] Funding Source: Medline; NIDDK NIH HHS [DK062432, R01 DK064869, DK064869, U01 DK062432, DK624230] Funding Source: Medline; Wellcome Trust [072789/Z/03/Z] Funding Source: Medline; Chief Scientist Office [CZB/4/540] Funding Source: Medline; MRC [G0600329, G0800675, G0800759] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152, P01AI065687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064869, U01DK062432] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 1997, CELL, V90, P797; Aldea A, 2004, HUM MUTAT, V23, P399, DOI 10.1002/humu.9229; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bell PA, 2002, BIOTECHNIQUES, P70; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cattan D, 2000, LANCET, V355, P378, DOI 10.1016/S0140-6736(99)02134-0; Chae JJ, 2008, BLOOD, V112, P1794, DOI 10.1182/blood-2008-01-134932; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Day TG, 2008, ARTHRITIS RHEUM-US, V58, P2142, DOI 10.1002/art.23604; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fidder H, 2005, AM J GASTROENTEROL, V100, P338, DOI 10.1111/j.1572-0241.2005.40810.x; Fidder HH, 2002, MEDICINE, V81, P411, DOI 10.1097/00005792-200211000-00001; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Giaglis S, 2006, DIGEST DIS SCI, V51, P687, DOI 10.1007/s10620-006-3192-1; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Hsu TM, 2001, BIOTECHNIQUES, V31, P560, DOI 10.2144/01313rr01; Karban A, 2005, GENES IMMUN, V6, P134, DOI 10.1038/sj.gene.6364156; Kramer M, 2006, J LEUKOCYTE BIOL, V79, P860, DOI 10.1189/jlb.0805484; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lichtenberger GS, 2004, INFLAMM BOWEL DIS, V10, pS58, DOI 10.1097/00054725-200402001-00012; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; McDermott MF, 2004, TRENDS IMMUNOL, V25, P457, DOI 10.1016/j.it.2004.07.007; Milhavet F, 2008, HUM MUTAT, V29, P803, DOI 10.1002/humu.20720; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Plevy SE, 1997, J IMMUNOL, V159, P6276; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sari S, 2008, EUR J PEDIATR, V167, P391, DOI 10.1007/s00431-007-0508-x; SILVERBERG MS, 2005, CAN J GASTROENTEROL, V5, P36; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Whitcombe D, 1998, CLIN CHEM, V44, P918; Zaykin DV, 2008, AM J HUM GENET, V82, P794, DOI 10.1016/j.ajhg.2008.02.001	54	41	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7154	10.1371/journal.pone.0007154	http://dx.doi.org/10.1371/journal.pone.0007154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784369	Green Published, gold			2022-12-25	WOS:000270290000003
J	Xu, YZ; Zhang, ZY; Hu, J; Stillman, IE; Leopold, JA; Handy, DE; Loscalzo, J; Stanton, RC				Xu, Yizhen; Zhang, Zhaoyun; Hu, Ji; Stillman, Isaac E.; Leopold, Jane A.; Handy, Diane E.; Loscalzo, Joseph; Stanton, Robert C.			Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria	FASEB JOURNAL			English	Article						pentose phosphate pathway; inflammation; mouse kidney	CHRONIC KIDNEY-DISEASE; ENDOTHELIAL DYSFUNCTION; DIABETES-MELLITUS; OXIDANT STRESS; NITRIC-OXIDE; ENZYME; G6PD; MUTATION; GROWTH	Glucose-6-phosphate dehydrogenase (G6PD) is the rate-limiting enzyme of the pentose phosphate pathway and the principal source of NADPH, a major cellular reductant, and is central to cell survival. Our previous work showed that diabetes and increased aldosterone are acquired forms of G6PD deficiency, leading to decreased G6PD activity and NADPH levels and damage to kidney tissue and endothelial cells. In this study, G6PD-deficient mice were studied to test the hypothesis that decreased G6PD activity per se can cause changes similar to those seen in the acquired conditions of G6PD deficiency. Results show that as compared with control mice, G6PD-deficient mice had increased oxidative stress, as manifested by decreased NADPH levels and decreased GSH levels, and increased markers of lipid peroxidation. G6PD-deficient mice had increased protein kinase C activity, increased nuclear factor-kappa B activity, and increased urinary albumin levels, all of which is similar to changes seen in diabetic mice. Changes persisted as the mice aged, as old G6PD-deficient mice (17-20 mo) had higher urine albumin levels and also had evidence for increased apoptosis in the renal cortex. These results show that decreased G6PD activity per se is sufficient to cause changes similar to those seen in diabetic mice.-Xu, Y., Zhang, Z., Hu, J., Stillman, I. E., Leopold, J. A., Handy, D. E., Loscalzo, J., Stanton, R. C. Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria. FASEB J. 24, 609-616 (2010). www.fasebj.org	[Xu, Yizhen; Zhang, Zhaoyun; Hu, Ji; Stanton, Robert C.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Brigham & Womens Hosp,Res Div, Boston, MA 02115 USA; [Leopold, Jane A.; Handy, Diane E.; Loscalzo, Joseph] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Stillman, Isaac E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Stillman, Isaac E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Renal, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Stanton, RC (corresponding author), Joslin Diabet Ctr, Div Renal, 1 Joslin Pl, Boston, MA 02215 USA.	robert.stanton@joslin.harvard.edu	Loscalzo, Joseph/ABD-8980-2021; Stillman, Isaac E/ABC-7278-2020; Stanton, Robert C/AAG-7584-2020	Stanton, Robert C/0000-0002-3056-1277; Handy, Diane/0000-0002-4310-8527	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK54380]; NIH/National Heart, Lung, and Blood Institute [R37HL61795, R01-HL58796, P01-HL81587, K02 HL081110, U54-HL70819]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL070819, P01HL081587, R37HL061795, R01HL058976, K02HL081110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01-DK54380 to R. C. S.; NIH/National Heart, Lung, and Blood Institute grants R37HL61795, R01-HL58796, and P01-HL81587 to J. L.; and grants K02 HL081110 and U54-HL70819 to J. A. L.	Ahmad FK, 2005, CURR DRUG TARGETS, V6, P487, DOI 10.2174/1389450054021990; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Fornoni A, 2008, CURR DIABETES REV, V4, P10, DOI 10.2174/157339908783502361; Gaskin Robert St. C., 2001, Ethnicity and Disease, V11, P749; Ho HY, 2000, FREE RADICAL BIO MED, V29, P156, DOI 10.1016/S0891-5849(00)00331-2; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; KEHRER JP, 1994, FREE RADICAL BIO MED, V17, P65, DOI 10.1016/0891-5849(94)90008-6; KIRKMAN HN, 1984, P NATL ACAD SCI-BIOL, V81, P4343, DOI 10.1073/pnas.81.14.4343; LEE CY, 1980, MOL CELL BIOCHEM, V30, P143; Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200; Leopold JA, 2003, ARTERIOSCL THROM VAS, V23, P411, DOI 10.1161/01.ATV.0000056744.26901.BA; Leopold JA, 2001, FASEB J, V15, P1771, DOI 10.1096/fj.00-0893fje; Longo L, 2002, EMBO J, V21, P4229, DOI 10.1093/emboj/cdf426; Muller G, 2009, HORM METAB RES, V41, P152, DOI 10.1055/s-0028-1086023; Munro AW, 2007, BBA-GEN SUBJECTS, V1770, P345, DOI 10.1016/j.bbagen.2006.08.018; NIAZI GA, 1991, INT J HEMATOL, V54, P295; Nicol CJ, 2000, FASEB J, V14, P111, DOI 10.1096/fasebj.14.1.111; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; PANICH V, 1980, HUM GENET, V55, P123, DOI 10.1007/BF00329138; PRETSCH W, 1988, BIOCHEM GENET, V26, P89, DOI 10.1007/BF00555491; Rahangdale S, 2009, FRONT BIOSCI-LANDMRK, V14, P192, DOI 10.2741/3240; ROSENSTRAUS M, 1975, P NATL ACAD SCI USA, V72, P493, DOI 10.1073/pnas.72.2.493; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Suliman ME, 2008, CLIN J AM SOC NEPHRO, V3, P976, DOI 10.2215/CJN.03960907; SUZUKI Y, 1989, JPN J PHARMACOL, V51, P181, DOI 10.1254/jjp.51.181; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Tian WN, 1999, AM J PHYSIOL-CELL PH, V276, pC1121, DOI 10.1152/ajpcell.1999.276.5.C1121; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Wan GH, 2002, ENDOCRINE, V19, P191, DOI 10.1385/ENDO:19:2:191; Xu YZ, 2005, AM J PHYSIOL-RENAL, V289, pF1040, DOI 10.1152/ajprenal.00076.2005; Zhang ZQ, 2000, J BIOL CHEM, V275, P40042, DOI 10.1074/jbc.M007505200	32	67	69	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					609	616		10.1096/fj.09-135731	http://dx.doi.org/10.1096/fj.09-135731			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19805580	Green Published			2022-12-25	WOS:000274045000028
J	Heyes, DJ; Levy, C; Lafite, P; Roberts, IS; Goldrick, M; Stachulski, AV; Rossington, SB; Stanford, D; Rigby, SEJ; Scrutton, NS; Leys, D				Heyes, Derren J.; Levy, Colin; Lafite, Pierre; Roberts, Ian S.; Goldrick, Marie; Stachulski, Andrew V.; Rossington, Steven B.; Stanford, Deborah; Rigby, Stephen E. J.; Scrutton, Nigel S.; Leys, David			Structure-based Mechanism of CMP-2-keto-3-deoxymanno-octulonic Acid Synthetase CONVERGENT EVOLUTION OF A SUGAR-ACTIVATING ENZYME WITH DNA/RNA POLYMERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-CMP-3-DEOXY-D-MANNO-OCTULOSONATE CYTIDYLYLTRANSFERASE; 3-DEOXY-D-MANNO-2-OCTULOSONIC ACID; LIPOPOLYSACCHARIDE; COMPLEXES; MODEL; KDO	The enzyme CMP-Kdo synthetase (KdsB) catalyzes the addition of 2-keto-3-deoxymanno-octulonic acid (Kdo) to CTP to form CMP-Kdo, a key reaction in the biosynthesis of lipopolysaccharide. The reaction catalyzed by KdsB and the related CMP-acylneuraminate synthase is unique among the sugar-activating enzymes in that the respective sugars are directly coupled to a cytosine monophosphate. Using inhibition studies, in combination with isothermal calorimetry, we show the substrate analogue 2 beta-deoxy-Kdo to be a potent competitive inhibitor. The ligand-free Escherichia coli KdsB and ternary complex KdsB-CTP-2 beta-deoxy-Kdo crystal structures reveal that Kdo binding leads to active site closure and repositioning of the CTP phosphates and associated Mg2+ ion (Mg-B). Both ligands occupy conformations compatible with an S(n)2-type attack on the alpha-phosphate by the Kdo 2-hydroxyl group. Based on strong similarity with DNA/RNA polymerases, both in terms of overall chemistry catalyzed as well as active site configuration, we postulate a second Mg2+ ion (Mg-A) is bound by the catalytically competent KdsB-CTP-Kdo ternary complex. Modeling of this complex reveals the Mg-A coordinated to the conserved Asp(100) and Asp(235) in addition to the CTP alpha-phosphate and both the Kdo carboxylic and 2-hydroxyl groups. EPR measurements on the Mn2+-substituted ternary complex support this model. We propose the KdsB/CNS sugar-activating enzymes catalyze the formation of activated sugars, such as the abundant CMP-5-N-acetylneuraminic acid, by recruitment of two Mg2+ to the active site. Although each metal ion assists in correct positioning of the substrates and activation of the alpha-phosphate, Mg-A is responsible for activation of the sugar-hydroxyl group.	[Heyes, Derren J.; Levy, Colin; Lafite, Pierre; Rigby, Stephen E. J.; Scrutton, Nigel S.; Leys, David] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Roberts, Ian S.; Goldrick, Marie; Stanford, Deborah] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Stachulski, Andrew V.; Rossington, Steven B.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England	University of Manchester; University of Manchester; University of Liverpool	Scrutton, NS (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk; david.leys@manchester.ac.uk	Lafite, Pierre/F-6806-2011	Lafite, Pierre/0000-0003-1637-4966; Heyes, Derren/0000-0002-7453-1571	Biotechnology and Biological Sciences Research Council, United Kingdom; BBSRC [BB/E013007/1, BB/D01963X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01963X/1, BB/E013007/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, United Kingdom.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADE H, 1984, CARBOHYD RES, V134, P157, DOI 10.1016/0008-6215(84)85030-2; Bravo IG, 2004, TRENDS MICROBIOL, V12, P120, DOI 10.1016/j.tim.2004.01.004; CLAESSON A, 1987, BIOCHEM BIOPH RES CO, V143, P1063, DOI 10.1016/0006-291X(87)90360-3; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CORNFORTH JW, 1958, BIOCHEM J, V68, P57, DOI 10.1042/bj0680057; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOLDMAN R, 1987, NATURE, V329, P162, DOI 10.1038/329162a0; GOLDMAN RC, 1986, J BIOL CHEM, V261, P5831; GOLDMAN RC, 1985, J BACTERIOL, V163, P256, DOI 10.1128/JB.163.1.256-261.1985; HAMMOND SM, 1987, NATURE, V327, P730, DOI 10.1038/327730a0; HERSHBERGER C, 1968, J BIOL CHEM, V243, P1585; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jelakovic S, 2002, BIOCHEMISTRY-US, V41, P1174, DOI 10.1021/bi0119060; Jelakovic S, 2001, J MOL BIOL, V312, P143, DOI 10.1006/jmbi.2001.4948; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEAN E L, 1991, Glycobiology, V1, P441, DOI 10.1093/glycob/1.5.441; KOHLBRENNER WE, 1985, J BIOL CHEM, V260, P4695; Krapp S, 2003, J MOL BIOL, V334, P625, DOI 10.1016/j.jmb.2003.09.080; LUTHMAN K, 1987, J ORG CHEM, V52, P3777, DOI 10.1021/jo00226a010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosimann SC, 2001, J BIOL CHEM, V276, P8190, DOI 10.1074/jbc.M007235200; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAY PH, 1981, J BACTERIOL, V145, P1273, DOI 10.1128/JB.145.3.1273-1280.1981; Reed G. H., 1984, BIOL MAGN RESON, P73; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; SHIRAI R, 1989, TETRAHEDRON LETT, V30, P2263, DOI 10.1016/S0040-4039(00)99665-5; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005	36	28	29	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35514	35523		10.1074/jbc.M109.056630	http://dx.doi.org/10.1074/jbc.M109.056630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19815542	Green Published, hybrid			2022-12-25	WOS:000272645600028
J	Sowd, G; Wang, H; Pretto, D; Chazin, WJ; Opresko, PL				Sowd, Gregory; Wang, Hong; Pretto, Dalyir; Chazin, Walter J.; Opresko, Patricia L.			Replication Protein A Stimulates the Werner Syndrome Protein Branch Migration Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-ANNEALING ACTIVITIES; ROTHMUND-THOMSON-SYNDROME; DNA-UNWINDING ACTIVITY; MOBILE D-LOOPS; HOMOLOGOUS RECOMBINATION; SYNDROME HELICASE; RECQ HELICASES; SUBSTRATE-SPECIFICITY; PHYSICAL INTERACTION; MAMMALIAN TELOMERES	Loss of the RecQ DNA helicase WRN protein causes Werner syndrome, in which patients exhibit features of premature aging and increased cancer. WRN deficiency induces cellular defects in DNA replication, mitotic homologous recombination (HR), and telomere stability. In addition to DNA unwinding activity, WRN also possesses exonuclease, strand annealing, and branch migration activities. The single strand binding proteins replication protein A (RPA) and telomere-specific POT1 specifically stimulate WRN DNA unwinding activity. To determine whether RPA and POT1 also modulate WRN branch migration activity, we examined biologically relevant mobile D-loops that mimic structures in HR strand invasion and at telomere ends. Both RPA and POT1 block WRN exonuclease digestion of the invading strand by loading on the strand. However, only RPA robustly stimulates WRN branch migration activity and increases the percentage of D-loops that are disrupted. Our results are consistent with cellular data that support RPA enhancement of branch migration during HR repair and, conversely, POT1 limitation of inappropriate recombination and branch migration at telomeric ends. This is, to our knowledge, the first evidence that RPA can stimulate branch migration activity.	[Sowd, Gregory; Opresko, Patricia L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Wang, Hong] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Wang, Hong] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Pretto, Dalyir; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Dept Biochem, Nashville, TN 37232 USA; [Pretto, Dalyir; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Dept Chem, Nashville, TN 37232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Vanderbilt University	Opresko, PL (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA.	plo4@pitt.edu	Wang, Hong/F-3164-2014; Classen, Scott/AAY-8176-2020	Wang, Hong/0000-0003-0165-3559; Opresko, Patricia/0000-0002-6470-2189	National Institutes of Health [ES0515052, GM065484, CA092584, K99ES016758-01]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES016758, K99ES016758, R01ES015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES0515052 ( to P.L.O.), GM065484 and CA092584 ( to W.J.C.), and K99ES016758-01 ( to H. W.). This work was also supported by a grant from the Ellison Medical Foundation ( to P.L.O.).	Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bai YL, 2003, HUM GENET, V113, P337, DOI 10.1007/s00439-003-0972-y; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Gari K, 2008, P NATL ACAD SCI USA, V105, P16107, DOI 10.1073/pnas.0804777105; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-6; Machwe A, 2002, J BIOL CHEM, V277, P4492, DOI 10.1074/jbc.M108880200; Machwe A, 2007, NUCLEIC ACIDS RES, V35, P5729, DOI 10.1093/nar/gkm561; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Opresko PL, 2007, MECH AGEING DEV, V128, P423, DOI 10.1016/j.mad.2007.05.009; Opresko PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004825; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Sakaguchi K, 2009, FEBS J, V276, P943, DOI 10.1111/j.1742-4658.2008.06841.x; Sakamoto S, 2001, GENES CELLS, V6, P421, DOI 10.1046/j.1365-2443.2001.00433.x; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Siitonen HA, 2003, HUM MOL GENET, V12, P2837, DOI 10.1093/hmg/ddg306; Sowd G, 2008, NUCLEIC ACIDS RES, V36, P4242, DOI 10.1093/nar/gkn385; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tarsounas M, 2005, CELL CYCLE, V4, P672, DOI 10.4161/cc.4.5.1689; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	71	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34682	34691		10.1074/jbc.M109.049031	http://dx.doi.org/10.1074/jbc.M109.049031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19812417	Green Published, hybrid			2022-12-25	WOS:000272439600024
J	Li, HT; Kundu, TK; Zweier, JL				Li, Haitao; Kundu, Tapan Kumar; Zweier, Jay L.			Characterization of the Magnitude and Mechanism of Aldehyde Oxidase-mediated Nitric Oxide Production from Nitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE XANTHINE-OXIDASE; FREE-RADICAL GENERATION; BIOLOGICAL TISSUES; MYOCARDIAL-INFARCTION; POSTISCHEMIC HEART; SYNTHASE ACTIVITY; RELAXING FACTOR; ANOXIC TISSUES; CDNA CLONING; REDUCTASE	Aldehyde oxidase (AO) is a cytosolic enzyme with an important role in drug and xenobiotic metabolism. Although AO has structural similarity to bacterial nitrite reductases, it is unknown whether AO-catalyzed nitrite reduction can be an important source of NO. The mechanism, magnitude, and quantitative importance of AO-mediated nitrite reduction in tissues have not been reported. To investigate this pathway and its quantitative importance, EPR spectroscopy, chemiluminescence NO analyzer, and immunoassays of cGMP formation were performed. The kinetics and magnitude of AO-dependent NO formation were characterized. In the presence of typical aldehyde substrates or NADH, AO reduced nitrite to NO. Kinetics of AO-catalyzed nitrite reduction followed Michaelis-Menten kinetics under anaerobic conditions. Under physiological conditions, nitrite levels are far below its measured Km value in the presence of either the flavin site electron donor NADH or molybdenum site aldehyde electron donors. Under aerobic conditions with the FAD site-binding substrate, NADH, AO-mediated NO production was largely maintained, although with aldehyde substrates oxygen-dependent inhibition was seen. Oxygen tension, substrate, and pH levels were important regulators of AO-catalyzed NO generation. From kinetic data, it was determined that during ischemia hepatic, pulmonary, or myocardial AO and nitrite levels were sufficient to result in NO generation comparable to or exceeding maximal production by constitutive NO synthases. Thus, AO-catalyzed nitrite reduction can be an important source of NO generation, and its NO production will be further increased by therapeutic administration of nitrite.	Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Ctr Biomed EPR Spect & Imaging, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Div Cardiovasc Med, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Li, HT (corresponding author), 110 G Davis Heart & Lung Res Inst,473 W 12th Ave, Columbus, OH 43210 USA.	haitao.li@osumc.edu; jay.zweier@osumc.edu			National Institutes of Health [HL63744, HL65608, HL38324]; Ohio Valley Affiliate of the American Heart Association [BGIA-0565249B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063744, R29HL038324, R01HL038324, P01HL065608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Valley Affiliate of the American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63744, HL65608, and HL38324 ( to J.L.Z.). This work was also supported by the Ohio Valley Affiliate of the American Heart Association Grant BGIA-0565249B ( to H.L.).	ANDO H, 1993, CLIN CARDIOL, V16, P443, DOI 10.1002/clc.4960160514; AZNAR J, 1983, J CLIN PATHOL, V36, P712, DOI 10.1136/jcp.36.6.712; Baker JE, 2007, J MOL CELL CARDIOL, V43, P437, DOI 10.1016/j.yjmcc.2007.07.057; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beedham C, 1987, Prog Med Chem, V24, P85, DOI 10.1016/S0079-6468(08)70420-X; BEEDHAM C, 1987, EUR J DRUG METAB PH, V12, P303, DOI 10.1007/BF03189918; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Calzi ML, 1995, J BIOL CHEM, V270, P31037, DOI 10.1074/jbc.270.52.31037; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Giraldez RR, 1998, ANAL BIOCHEM, V261, P29, DOI 10.1006/abio.1998.2721; Gladwin MT, 2005, AM J RESP CELL MOL, V32, P363, DOI 10.1165/rcmb.F294; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IGNARRO LJ, 1987, CIRC RES, V60, P82, DOI 10.1161/01.RES.60.1.82; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; KRENITSKY TA, 1972, ARCH BIOCHEM BIOPHYS, V150, P585, DOI 10.1016/0003-9861(72)90078-1; Kundu TK, 2007, ARCH BIOCHEM BIOPHYS, V460, P113, DOI 10.1016/j.abb.2006.12.032; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Li HT, 2004, J BIOL CHEM, V279, P16939, DOI 10.1074/jbc.M314336200; Li HT, 2005, J BIOL CHEM, V280, P16594, DOI 10.1074/jbc.M411905200; Li HT, 2003, BIOCHEMISTRY-US, V42, P1150, DOI 10.1021/bi026385a; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; MIRA L, 1995, ARCH BIOCHEM BIOPHYS, V318, P53, DOI 10.1006/abbi.1995.1203; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moriwaki Y, 1996, HISTOCHEM CELL BIOL, V105, P71, DOI 10.1007/BF01450880; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Samouilov A, 1998, ANAL BIOCHEM, V258, P322, DOI 10.1006/abio.1998.2609; Samouilov A, 1998, ARCH BIOCHEM BIOPHYS, V357, P1, DOI 10.1006/abbi.1998.0785; Sarnesto A, 1996, LAB INVEST, V74, P48; SHINOBU LA, 1984, ACTA PHARMACOL TOX, V54, P189; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; TISCHLER ME, 1977, ARCH BIOCHEM BIOPHYS, V184, P222, DOI 10.1016/0003-9861(77)90346-0; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Williamson J R, 1979, Methods Enzymol, V55, P200; WITTENBERG JB, 1956, J BIOL CHEM, V219, P39; WRIGHT RM, 1993, P NATL ACAD SCI USA, V90, P10690, DOI 10.1073/pnas.90.22.10690; XIA Y, 1995, J BIOL CHEM, V270, P18797, DOI 10.1074/jbc.270.32.18797; YOSHIHARA S, 1985, ARCH BIOCHEM BIOPHYS, V242, P213, DOI 10.1016/0003-9861(85)90495-3; Zhang Z, 1998, BIOCHEM BIOPH RES CO, V249, P767, DOI 10.1006/bbrc.1998.9226; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3; ZWEIER JL, 1995, J BIOL CHEM, V270, P304, DOI 10.1074/jbc.270.1.304	49	98	101	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33850	33858		10.1074/jbc.M109.019125	http://dx.doi.org/10.1074/jbc.M109.019125			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801639	Green Published, hybrid			2022-12-25	WOS:000272165200017
J	Xue, WF; Hellewell, AL; Gosal, WS; Homans, SW; Hewitt, EW; Radford, SE				Xue, Wei-Feng; Hellewell, Andrew L.; Gosal, Walraj S.; Homans, Steve W.; Hewitt, Eric W.; Radford, Sheena E.			Fibril Fragmentation Enhances Amyloid Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGGREGATION; BETA(2)-MICROGLOBULIN; OLIGOMERS; BRAIN; BETA-2-MICROGLOBULIN; MECHANISM; TOXICITY; PEPTIDE; GROWTH; PATHOGENESIS	Fibrils associated with amyloid disease are molecular assemblies of key biological importance, yet how cells respond to the presence of amyloid remains unclear. Cellular responses may not only depend on the chemical composition or molecular properties of the amyloid fibrils, but their physical attributes such as length, width, or surface area may also play important roles. Here, we report a systematic investigation of the effect of fragmentation on the structural and biological properties of amyloid fibrils. In addition to the expected relationship between fragmentation and the ability to seed, we show a striking finding that fibril length correlates with the ability to disrupt membranes and to reduce cell viability. Thus, despite otherwise unchanged molecular architecture, shorter fibrillar samples show enhanced cytotoxic potential than their longer counterparts. The results highlight the importance of fibril length in amyloid disease, with fragmentation not only providing a mechanism by which fibril load can be rapidly increased but also creating fibrillar species of different dimensions that can endow new or enhanced biological properties such as amyloid cytotoxicity.	[Xue, Wei-Feng; Hellewell, Andrew L.; Gosal, Walraj S.; Homans, Steve W.; Hewitt, Eric W.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Mol & Cellular Biol, Garstang Bldg, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk	Xue, Wei-Feng/C-6038-2013; Gosal, Walraj/J-5260-2012	Gosal, Walraj/0000-0003-3396-1505; Hellewell, Andrew/0000-0002-7803-2884; Xue, Wei-Feng/0000-0002-6504-0404; Radford, Sheena/0000-0002-3079-8039; Hewitt, Eric/0000-0002-6238-6303	Wellcome Trust [075675]; Biotechnology and Biological Sciences Research Council [BB/526502/1]	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust (Grant 075675) and Biotechnology and Biological Sciences Research Council (Grant BB/526502/1)	Campbell A, 2001, MED HYPOTHESES, V56, P388, DOI 10.1054/mehy.2000.1212; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Devanathan S, 2006, FEBS J, V273, P1389, DOI 10.1111/j.1742-4658.2006.05162.x; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fabian H, 2008, BIOCHEMISTRY-US, V47, P6895, DOI 10.1021/bi800279y; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Giorgetti S, 2009, NEPHROL DIAL TRANSPL, V24, P1176, DOI 10.1093/ndt/gfn623; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hirakura Y, 2001, AMYLOID, V8, P94, DOI 10.3109/13506120109007350; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Lee HG, 2004, J ALZHEIMERS DIS, V6, P137; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; PRESS WH, 2002, NUMERICAL RECIPES C, P666; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Smith AM, 2006, J MOL BIOL, V364, P9, DOI 10.1016/j.jmb.2006.08.081; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; van der Wel PCA, 2007, J AM CHEM SOC, V129, P5117, DOI 10.1021/ja068633m; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2009, PROTEIN ENG DES SEL, V22, P489, DOI 10.1093/protein/gzp026	48	283	288	1	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34272	34282		10.1074/jbc.M109.049809	http://dx.doi.org/10.1074/jbc.M109.049809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808677	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000272165200058
J	Chang, CW; Tsai, WH; Chuang, WJ; Lin, YS; Wu, JJ; Liu, CC; Tsai, PJ; Lin, MT				Chang, Chia-Wen; Tsai, Wan-Hua; Chuang, Woei-Jer; Lin, Yee-Shin; Wu, Jiunn-Jong; Liu, Ching-Chuan; Tsai, Pei-Jane; Lin, Ming T.			Procaspase 8 and Bax Are Up-regulated by Distinct Pathways in Streptococcal Pyrogenic Exotoxin B-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-INDUCED APOPTOSIS; SHOCK-LIKE SYNDROME; PROTEIN-KINASE; INTERFERON-GAMMA; GENE-EXPRESSION; DEPENDENT PATHWAY; A549 CELLS; TOXIN-A; ACTIVATION; INDUCTION	We have previously identified integrin alpha(v)beta(3) and Fas as receptors for the streptococcal pyrogenic exotoxin B (SPE B), and G308S, a mutant of SPE B that binds to Fas only. In the current study we found that after binding to alpha(v)beta(3), SPE B stimulated the tyrosine phosphorylation of JAK2 and STAT1. STAT1 tyrosine phosphorylation was inhibited by a JAK2 inhibitor, AG490, short interfering RNA(siRNA) silencing of JAK2, and anti-alpha(v)beta(3) antibody. AG490 also decreased the binding of tyrosine-phosphorylated STAT1 to the procaspase 8 promoter, decreasing procaspase 8 expression, suggesting that SPE B up-regulates procaspase 8 expression via the JAK2/STAT1 pathway. Alternatively, both SPEB and G308S increased STAT1 phosphorylation at serine 727, which was inhibited by anti-Fas antibody, a p38 inhibitor, SB203580, and siRNA silencing of p38. In addition, SPE B and G308S increased binding of serine-phosphorylated STAT1 to the Bax promoter and Bax expression, which was decreased by SB203580. SPE B and G308S-stimulated Bax expression was also inhibited by anti-Fas antibody. These findings suggest that Fas mediate SPE B-induced Bax expression through p38. Silencing of JAK2 or p38 by siRNA blocked procaspase 8 expression, whereas only p38 siRNA decreased Bax expression. Furthermore, JAK2 inhibition and p38 inhibition reduced SPE B-induced apoptosis, but only p38 inhibition blocked G308S-induced apoptosis.	[Lin, Ming T.] Tzu Chi Univ, Sch Med, Inst Med Sci, Hualien 97004, Taiwan; [Chang, Chia-Wen; Tsai, Wan-Hua; Chuang, Woei-Jer; Lin, Yee-Shin; Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan; [Chang, Chia-Wen; Tsai, Wan-Hua; Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Dept Biochem, Tainan 701, Taiwan; [Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan; [Wu, Jiunn-Jong; Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan; [Liu, Ching-Chuan] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 701, Taiwan; [Tsai, Pei-Jane] Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei 115, Taiwan	Tzu Chi University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Applied Research Laboratories - Taiwan	Lin, MT (corresponding author), Tzu Chi Univ, Sch Med, Inst Med Sci, Hualien 97004, Taiwan.	lin1223@mail.tcu.edu	Wu, Jiunn-Jong/E-6075-2011; Tsai, Pei-Jane/G-3563-2011		National Health Research Institute [NHRI-EX 96-9027SP]; National Science Council, Taiwan [NSC96-2745B-320-003-URD]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institute Grant NHRI-EX 96-9027SP and the National Science Council Grant NSC96-2745B-320-003-URD, Taiwan.	Aiyar A, 1996, Methods Mol Biol, V57, P177; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Bentley CC, 2005, CELL MICROBIOL, V7, P945, DOI 10.1111/j.1462-5822.2005.00525.x; Brizzi MF, 1999, MOL BIOL CELL, V10, P3463, DOI 10.1091/mbc.10.10.3463; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Chang CW, 2007, J BIOMED SCI, V14, P419, DOI 10.1007/s11373-007-9154-6; CHAUSSEE MS, 1993, INFECT IMMUN, V61, P3719, DOI 10.1128/IAI.61.9.3719-3723.1993; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Dai CH, 1999, BLOOD, V93, P3309, DOI 10.1182/blood.V93.10.3309.410k04_3309_3316; De Zutter GS, 2001, P NATL ACAD SCI USA, V98, P6168, DOI 10.1073/pnas.111027698; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Fu XY, 1999, CELL DEATH DIFFER, V6, P1201, DOI 10.1038/sj.cdd.4400613; HAUSER AR, 1990, J BACTERIOL, V172, P4536, DOI 10.1128/jb.172.8.4536-4542.1990; Holmstrom TH, 1999, MOL CELL BIOL, V19, P5991; Huang YQ, 2000, J BIOL CHEM, V275, P6462, DOI 10.1074/jbc.275.9.6462; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Kim H, 2005, GASTROENTEROLOGY, V129, P1875, DOI 10.1053/j.gastro.2005.09.011; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Medan D, 2002, J CELL PHYSIOL, V191, P320, DOI 10.1002/jcp.10105; Meistey N, 2007, EUR J CANCER, V43, P1833, DOI 10.1016/j.ejca.2007.05.028; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Ossina NK, 1997, J BIOL CHEM, V272, P16351, DOI 10.1074/jbc.272.26.16351; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schlievert PM, 1996, J LAB CLIN MED, V127, P13, DOI 10.1016/S0022-2143(96)90161-4; Stephanou A, 2000, J BIOL CHEM, V275, P10002, DOI 10.1074/jbc.275.14.10002; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Townsend PA, 2004, J BIOL CHEM, V279, P5811, DOI 10.1074/jbc.M302637200; Tsai WH, 2008, INFECT IMMUN, V76, P1349, DOI 10.1128/IAI.01162-07; Tsai WH, 2004, INFECT IMMUN, V72, P7055, DOI 10.1128/IAI.72.12.7055-7062.2004; Wang HY, 2007, APOPTOSIS, V12, P535, DOI 10.1007/s10495-006-0008-x; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	42	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33195	33205		10.1074/jbc.M109.020586	http://dx.doi.org/10.1074/jbc.M109.020586			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801665	Green Published, hybrid			2022-12-25	WOS:000272028500024
J	Pillai, BK; Jasuja, R; Simard, JR; Hamilton, JA				Pillai, Biju K.; Jasuja, Ravi; Simard, Jeffrey R.; Hamilton, James A.			Fast Diffusion of Very Long Chain Saturated Fatty Acids across a Bilayer Membrane and Their Rapid Extraction by Cyclodextrins IMPLICATIONS FOR ADRENOLEUKODYSTROPHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; FAST FLIP-FLOP; CELLULAR CHOLESTEROL; MODEL MEMBRANES; BETA-OXIDATION; SERUM-ALBUMIN; LORENZOS OIL; PHOSPHOLIPID-MEMBRANES; PEROXISOMAL DISORDERS; FLUORESCENT-PROBE	Abnormalities in the transport of saturated very long chain fatty acids (LCFA; >C18:0) contribute to their toxic levels in peroxisomal disorders of fatty acid metabolism, such as adrenoleukodystrophy and adrenomyeloneuropathy. We previously showed that VLCFA desorb much slower than normal dietary fatty acids from both albumin and protein-free lipid bilayers. The important step of transbilayer movement (flip-flop) was not measured directly as a consequence of this very slow desorption from donors, and the extremely low aqueous solubility of VLCFA precludes addition of unbound VLCFA to lipid membranes. We have overcome these limitations using methyl-beta-cyclodextrin to solubilize VLCFA for rapid delivery to "acceptor" phosphatidylcholine vesicles (small and large unilamellar) and to cells. VLCFA binding was monitored in real time with the fluorescent probe fluorescein-labeled phosphatidylethanolamine in the outer membrane leaflet, and entrapped pyranine was used to detect flip-flop across the membrane. The upper limit of the rate of flip-flop across the membrane was independent of temperature and media viscosity and was similar for model raft and non-raft membranes as well as living cells. We further showed that cyclodextrins can extract VLCFA rapidly (within seconds) from vesicles and cells, which have implications for the mechanism and potential alternative approaches to treat adrenoleukodystrophy. Because VLCFA diffuse through the lipid bilayer, proteins may not be required for their transport across the peroxisomal membrane.	[Pillai, Biju K.; Simard, Jeffrey R.; Hamilton, James A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Jasuja, Ravi] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Simard, Jeffrey R.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Hamilton, James A.] Boston Univ, Dept Biomed Engn, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Hamilton, JA (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, 715 Albany St, Boston, MA 02118 USA.	jhamilt@bu.edu		Hamilton, James/0000-0002-4747-7071	National Institutes of Health [NHLBI 2P01 HL26335-21]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL026335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant NHLBI 2P01 HL26335-21.	Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Bondar OP, 1999, BIOPHYS J, V76, P956, DOI 10.1016/S0006-3495(99)77259-0; BOYLAN JG, 1992, BIOCHEMISTRY-US, V31, P557, DOI 10.1021/bi00117a037; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; CARTIER N, 1995, P NATL ACAD SCI USA, V92, P1674, DOI 10.1073/pnas.92.5.1674; Choi JK, 2002, J LIPID RES, V43, P1000, DOI 10.1194/jlr.M200041-JLR200; Corzo D, 2002, AM J HUM GENET, V70, P1520, DOI 10.1086/340849; Covey SD, 2007, BIOCHEM BIOPH RES CO, V355, P67, DOI 10.1016/j.bbrc.2007.01.135; Deon M, 2008, METAB BRAIN DIS, V23, P43, DOI 10.1007/s11011-007-9079-9; DiBiase A, 1997, NEUROCHEM RES, V22, P327, DOI 10.1023/A:1022451108063; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Eichler FS, 2008, ANN NEUROL, V63, P729, DOI 10.1002/ana.21391; Frank PG, 2002, BIOCHEMISTRY-US, V41, P11931, DOI 10.1021/bi0257078; Grkovic Sanja, 2007, Med Pregl, V60, P401; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Hamilton JA, 2007, J MOL NEUROSCI, V33, P12, DOI 10.1007/s12031-007-0050-3; Hein S, 2008, HUM MOL GENET, V17, P1750, DOI 10.1093/hmg/ddn066; Heinzer AK, 2003, HUM MOL GENET, V12, P1145, DOI 10.1093/hmg/ddg126; Hettema EH, 2000, BBA-MOL CELL BIOL L, V1486, P18, DOI 10.1016/S1388-1981(00)00045-7; HO JK, 1995, J CLIN INVEST, V96, P1455, DOI 10.1172/JCI118182; Kamp F, 2003, J BIOL CHEM, V278, P7988, DOI 10.1074/jbc.M206648200; KAMP F, 1995, BIOCHEMISTRY-US, V34, P11928, DOI 10.1021/bi00037a034; KAMP F, 1992, P NATL ACAD SCI USA, V89, P11367, DOI 10.1073/pnas.89.23.11367; Kemp S, 2005, MOL GENET METAB, V84, P144, DOI 10.1016/j.ymgme.2004.09.015; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kleinfeld AM, 1997, BIOCHEMISTRY-US, V36, P14146, DOI 10.1021/bi971440e; Klymchenko AS, 2004, BIOPHYS J, V86, P2929, DOI 10.1016/S0006-3495(04)74344-1; Krasnowska EK, 1998, BIOPHYS J, V74, P1984, DOI 10.1016/S0006-3495(98)77905-6; Krasnowska EK, 2001, BBA-BIOMEMBRANES, V1511, P330, DOI 10.1016/S0005-2736(01)00286-3; Kritharides L, 1996, J BIOL CHEM, V271, P27450, DOI 10.1074/jbc.271.44.27450; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; MACGREGOR RB, 1986, NATURE, V319, P70, DOI 10.1038/319070a0; MASSEY JB, 1985, BIOCHEMISTRY-US, V24, P6973, DOI 10.1021/bi00345a033; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Moser HW, 2007, J MOL NEUROSCI, V33, P105, DOI 10.1007/s12031-007-0041-4; MOSER HW, 1995, ANNU REV NUTR, V15, P379, DOI 10.1146/annurev.nu.15.070195.002115; Moser HW, 1996, LIPIDS, V31, pS141, DOI 10.1007/BF02637066; MOSER HW, 1995, J NEUROPATH EXP NEUR, V54, P740, DOI 10.1097/00005072-199509000-00017; OROSZ DE, 1993, ANAL BIOCHEM, V210, P7, DOI 10.1006/abio.1993.1143; PoggiTravert F, 1995, J INHERIT METAB DIS, V18, P1, DOI 10.1007/BF00711425; Putzel GG, 2009, BIOPHYS J, V96, P4935, DOI 10.1016/j.bpj.2009.04.019; Rawicz W, 2008, BIOPHYS J, V94, P4725, DOI 10.1529/biophysj.107.121731; Rawyler A, 1996, BBA-BIOMEMBRANES, V1278, P89, DOI 10.1016/0005-2736(95)00190-5; Simard JR, 2008, BIOCHEMISTRY-US, V47, P9081, DOI 10.1021/bi800697q; Simard JR, 2008, BIOPHYS J, V94, P4493, DOI 10.1529/biophysj.107.121186; SIMARD JR, 2009, J LIPID RES, DOI DOI 10.1194/JLR.M900251-JLR200; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V257, P302, DOI 10.1016/0003-9861(87)90570-4; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V259, P382, DOI 10.1016/0003-9861(87)90504-2; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V254, P526, DOI 10.1016/0003-9861(87)90133-0; Steinberg S., 2008, CURR PROTOC HUM GENE; Tamai N, 2008, COLLOID SURFACE B, V65, P213, DOI 10.1016/j.colsurfb.2008.04.004; THEDA C, 1992, J NEUROL SCI, V110, P195, DOI 10.1016/0022-510X(92)90028-J; van Geel BM, 1999, J NEUROL NEUROSUR PS, V67, P290, DOI 10.1136/jnnp.67.3.290; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; WALL J, 1995, MOL MEMBR BIOL, V12, P183, DOI 10.3109/09687689509027506; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; WHITCOMB RW, 1988, J CLIN INVEST, V81, P185, DOI 10.1172/JCI113292; Wilson-Ashworth HA, 2006, BIOPHYS J, V91, P4091, DOI 10.1529/biophysj.106.090860; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Zhang FL, 1996, BIOCHEMISTRY-US, V35, P16055, DOI 10.1021/bi961685b	62	18	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33296	33304		10.1074/jbc.M109.043737	http://dx.doi.org/10.1074/jbc.M109.043737			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801636	Green Published, hybrid			2022-12-25	WOS:000272028500034
J	Tiedemann, K; Hussein, O; Sadvakassova, G; Guo, YB; Siegel, PM; Komarova, SV				Tiedemann, Kerstin; Hussein, Osama; Sadvakassova, Gulzhakhan; Guo, Yubin; Siegel, Peter M.; Komarova, Svetlana V.			Breast Cancer-derived Factors Stimulate Osteoclastogenesis through the Ca2+/Protein Kinase C and Transforming Growth Factor-beta/MAPK Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR GROWTH; FACTOR-KAPPA-B; TGF-BETA; PROSTATE-CANCER; DEPENDENT MECHANISM; RECEPTOR ACTIVATOR; BONE METASTASIS; GIANT-CELLS; RANK LIGAND; IN-VITRO	Breast cancer commonly metastasizes to bone where its growth depends on the action of bone-resorbing osteoclasts. We have previously shown that breast cancer cells secrete factors able to directly stimulate osteoclastogenesis from receptor activator of nuclear factor kappa B ligand (RANKL)-primed precursors and that transforming growth factor-beta (TGF beta) plays a permissive role in this process. Now, we evaluate the signaling events triggered in osteoclast precursors by soluble factors produced by MDA-MB-231-human breast carcinoma cells. In mouse bone marrow cultures and RAW 264.7 murine monocytic cells, MDA-MB-231-derived factors increased osteoclast number, size, and nucleation. These factors failed to induce Smad2 phosphorylation, and short interfering RNAs against Smad4 did not affect their ability to induce osteoclastogenesis. In contrast, MDA-MB-231 factors induced phosphorylation of p38 and ERK1/2, and pharmacological inhibitors against p38 (SB203580) and MEK1/2(PD98059) impeded the osteoclastogenic effects of cancer-derived factors. Neutralizing antibodies against TGF beta attenuated p38 activation, whereas activation of ERK1/2 was shortened in duration, but not decreased in amplitude. ERK1/2 phosphorylation induced by cancer-derived factors was blocked by MEK1/2 inhibitor, but not by Ras (manumycin A) or Raf (GW5074) inhibitors. Inhibition of protein kinase C alpha using Go6976 prevented both ERK1/2 phosphorylation and osteoclast formation in response to MDA-MB-231-derived factors. Using microspectrofluorimetry of fura-2-AM-loaded osteoclast precursors, we have found that cancer-derived factors, similar to RANKL, induced sustained oscillations in cytosolic free calcium. The calcium chelator BAPTA prevented calcium elevations and osteoclast formation in response to MDA-MB-231-derived factors. Thus, we have shown that breast cancer-derived factors induce osteoclastogenesis through the activation of calcium/protein kinase C alpha and TGF beta-dependent ERK1/2 and p38 signaling pathways.	[Tiedemann, Kerstin; Hussein, Osama; Sadvakassova, Gulzhakhan; Guo, Yubin; Komarova, Svetlana V.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada; [Siegel, Peter M.] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 2B2, Canada; [Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B2, Canada; [Siegel, Peter M.; Komarova, Svetlana V.] McGill Univ, Dept Med, Montreal, PQ H3A 2B2, Canada	McGill University; McGill University; McGill University; McGill University	Komarova, SV (corresponding author), McGill Univ, Fac Dent, 740 Dr Penfield Ave, Montreal, PQ H3A 1A4, Canada.	svetlana.komarova@mcgill.ca	Hussein, Osama/AAA-2620-2019; Tiedemann, one/A-9739-2016	Hussein, Osama/0000-0002-9563-0528; 	Government of Quebec; Lloyd-Carr Harris Fellowship; McGill University	Government of Quebec; Lloyd-Carr Harris Fellowship; McGill University	Supported by Government of Quebec's Merit Doctoral Research Scholarship Program, by Lloyd-Carr Harris Fellowship, and by McGill University.	Akchurin T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002104; Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Barrett JM, 2006, PROSTATE, V66, P632, DOI 10.1002/pros.20370; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dehvari N, 2008, NEUROSCI LETT, V436, P77, DOI 10.1016/j.neulet.2008.02.063; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Fili S, 2009, CANCER LETT, V283, P10, DOI 10.1016/j.canlet.2009.01.011; Futakuchi M, 2009, CANCER SCI, V100, P71, DOI 10.1111/j.1349-7006.2008.01012.x; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Guo YB, 2008, BONE, V43, P386, DOI 10.1016/j.bone.2008.03.026; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishii M, 2008, MOD RHEUMATOL, V18, P220, DOI 10.1007/s10165-008-0051-2; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalikin LM, 2003, CANCER BIOL THER, V2, P656; KAYE M, 1985, KIDNEY INT, V27, P574, DOI 10.1038/ki.1985.49; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Komarova SV, 2003, CALCIFIED TISSUE INT, V73, P265, DOI 10.1007/s00223-002-1051-4; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; KRISHNAMURTHY GT, 1977, JAMA-J AM MED ASSOC, V237, P2504, DOI 10.1001/jama.237.23.2504; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lee SE, 2001, J BIOL CHEM, V276, P49343, DOI 10.1074/jbc.M103642200; Lee SW, 2003, BONE, V32, P217, DOI 10.1016/S8756-3282(02)00976-6; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Lees RL, 2001, BONE, V28, P187, DOI 10.1016/S8756-3282(00)00433-6; MAKRIS GP, 1982, ARCH ORAL BIOL, V27, P965, DOI 10.1016/0003-9969(82)90104-2; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; Mourskaia AA, 2009, ONCOGENE, V28, P1005, DOI 10.1038/onc.2008.454; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Nakamura H, 2003, J BONE MINER RES, V18, P1198, DOI 10.1359/jbmr.2003.18.7.1198; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oyajobi BO, 2003, CANCER-AM CANCER SOC, V97, P813, DOI 10.1002/cncr.11133; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Roodman GD, 2008, CANCER TREAT REV, V34, P92, DOI 10.1016/j.ctrv.2007.09.002; Rucci N, 2005, J CELL SCI, V118, P3263, DOI 10.1242/jcs.02436; Schneider A, 2005, ENDOCRINOLOGY, V146, P1727, DOI 10.1210/en.2004-1211; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Siclari VA, 2006, CANCER METAST REV, V25, P621, DOI 10.1007/s10555-006-9023-1; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Trebec DP, 2007, J CELL BIOCHEM, V101, P205, DOI 10.1002/jcb.21171; van der Westhuizen ET, 2007, MOL PHARMACOL, V71, P1618, DOI 10.1124/mol.106.032763; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	61	33	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33662	33670		10.1074/jbc.M109.010785	http://dx.doi.org/10.1074/jbc.M109.010785			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801662	hybrid, Green Published			2022-12-25	WOS:000272028500070
J	Halskau, O; Ying, M; Baumann, A; Kleppe, R; Rodriguez-Larrea, D; Almas, B; Haavik, J; Martinez, A				Halskau, Oyvind, Jr.; Ying, Ming; Baumann, Anne; Kleppe, Rune; Rodriguez-Larrea, David; Almas, Bjorg; Haavik, Jan; Martinez, Aurora			Three-way Interaction between 14-3-3 Proteins, the N-terminal Region of Tyrosine Hydroxylase, and Negatively Charged Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; ADRENAL CHROMAFFIN CELLS; SUBCELLULAR-LOCALIZATION; PHOSPHOLIPID BICELLES; AMPHITROPIC PROTEINS; ALPHA-LACTALBUMIN; REGULATORY DOMAIN; STRUCTURAL BASIS; SENSOR CHIP; BINDING	Tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of catecholamines, is activated by phosphorylation-dependent binding to 14-3-3 proteins. The N-terminal domain of TH is also involved in interaction with lipid membranes. We investigated the binding of the N-terminal domain to its different partners, both in the unphosphorylated (TH-(1-43)) and Ser(19)-phosphorylated (THp-(1-43)) states by surface plasmon resonance. THp-(1-43) showed high affinity for 14-3-3 proteins (K-d similar to 0.5 mu M for 14-3-3 gamma and -zeta and 7 mu M for 14-3-3 eta). The domains also bind to negatively charged membranes with intermediate affinity (concentration at half-maximal binding S-0.5 = 25-58 mu M (TH-(1-43)) and S-0.5 = 135-475 mu M (THp-(1-43)), depending on phospholipid composition) and concomitant formation of helical structure. 14-3-3 gamma showed a preferential binding to membranes, compared with 14-3-3 zeta, both in chromaffin granules and with liposomes at neutral pH. The affinity of 14-3-3 gamma for negatively charged membranes (S-0.5 = 1-9 mu M) is much higher than the affinity of TH for the same membranes, compatible with the formation of a ternary complex between Ser(19)-phosphorylated TH, 14-3-3 gamma, and membranes. Our results shed light on interaction mechanisms that might be relevant for the modulation of the distribution of TH in the cytoplasm and membrane fractions and regulation of L-DOPA and dopamine synthesis.	[Halskau, Oyvind, Jr.; Ying, Ming; Baumann, Anne; Kleppe, Rune; Haavik, Jan; Martinez, Aurora] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Almas, Bjorg] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Rodriguez-Larrea, David] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain	University of Bergen; University of Bergen; Haukeland University Hospital; University of Granada	Martinez, A (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	aurora.martinez@biomed.uib.no	Haavik, Jan/ABE-1535-2020; Martinez, Aurora/M-3088-2019; Haavik, Jan/AAI-3974-2020; Rodriguez-Larrea, David/ABH-3171-2020	Martinez, Aurora/0000-0003-1643-6506; Haavik, Jan/0000-0001-7865-2808; Rodriguez-Larrea, David/0000-0002-5580-7413; Halskau, Oyvind/0000-0003-2517-1060; Kleppe, Rune/0000-0002-6086-755X	Norwegian Cancer Society; Research Council of Norway; Helse-Vest	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Helse-Vest	This work was supported by grants from the Norwegian Cancer Society, the Research Council of Norway, and Helse-Vest.	Agasoster AV, 2003, J BIOL CHEM, V278, P21790, DOI 10.1074/jbc.M211466200; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Chen R, 2003, J BIOMED SCI, V10, P774, DOI 10.1159/000073965; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Clokie SJ, 2005, FEBS J, V272, P3767, DOI 10.1111/j.1742-4658.2005.04765.x; Cooper MA, 2000, ANAL BIOCHEM, V277, P196, DOI 10.1006/abio.1999.4389; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Erb EM, 2000, ANAL BIOCHEM, V280, P29, DOI 10.1006/abio.1999.4469; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Ginovart N, 1996, BRAIN RES, V719, P45, DOI 10.1016/0006-8993(96)00075-3; Glomm WR, 2007, J PHYS CHEM B, V111, P14329, DOI 10.1021/jp074839d; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; HAAVIK J, 1991, EUR J BIOCHEM, V199, P371, DOI 10.1111/j.1432-1033.1991.tb16133.x; HAAVIK J, 1980, J CHROMATOGR, V198, P511, DOI 10.1016/S0021-9673(00)80522-1; Halskau O, 2002, J MOL BIOL, V321, P99, DOI 10.1016/S0022-2836(02)00565-X; Hekman M, 2006, J BIOL CHEM, V281, P17321, DOI 10.1074/jbc.M600292200; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; ICHIMURA T, 1987, FEBS LETT, V219, P79, DOI 10.1016/0014-5793(87)81194-8; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; JONES DHA, 1995, J MOL BIOL, V245, P375, DOI 10.1006/jmbi.1994.0031; Kaufman S, 1995, Adv Enzymol Relat Areas Mol Biol, V70, P103; Kleppe R, 2001, J NEUROCHEM, V77, P1097, DOI 10.1046/j.1471-4159.2001.00318.x; Kokkinou I, 2009, BLOOD CELL MOL DIS, V42, P92, DOI 10.1016/j.bcmd.2008.10.010; KUCZENSKI RT, 1972, J BIOL CHEM, V247, P3114; KUHN DM, 1990, J BIOL CHEM, V265, P5780; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; MARTIN H, 1994, J NEUROCHEM, V63, P2259; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; MCGEER EG, 1971, J NEUROCHEM, V18, P1647, DOI 10.1111/j.1471-4159.1971.tb03738.x; Meier S, 2006, J CHROMATOGR A, V1104, P291, DOI 10.1016/j.chroma.2005.11.045; Moreira JMA, 2008, MOL CELL PROTEOMICS, V7, P1225, DOI 10.1074/mcp.M700439-MCP200; MORGAN A, 1992, NATURE, V355, P833, DOI 10.1038/355833a0; MORITA K, 1994, NEUROCHEM INT, V25, P403, DOI 10.1016/0197-0186(94)90015-9; MORITA K, 1987, J BIOL CHEM, V262, P5654; Murphy KL, 2008, J BIOL CHEM, V283, P13216, DOI 10.1074/jbc.M706749200; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Ober RJ, 1999, ANAL BIOCHEM, V271, P70, DOI 10.1006/abio.1999.4129; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsilova V, 2008, BIOCHEMISTRY-US, V47, P1768, DOI 10.1021/bi7019468; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Poulikakos P, 2001, NEUROCHEM RES, V26, P479, DOI 10.1023/A:1010952610387; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; Schindler CK, 2006, J NEUROCHEM, V99, P561, DOI 10.1111/j.1471-4159.2006.04153.x; Strochlic L, 2004, P NATL ACAD SCI USA, V101, P18189, DOI 10.1073/pnas.0406905102; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; TERLAND O, 1980, BIOCHIM BIOPHYS ACTA, V597, P318, DOI 10.1016/0005-2736(80)90109-1; Thorolfsson M, 2002, FEBS LETT, V519, P221, DOI 10.1016/S0014-5793(02)02745-X; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; TREIMAN M, 1983, J NEUROCHEM, V40, P661, DOI 10.1111/j.1471-4159.1983.tb08031.x; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; VAZ WLC, 1978, EUR J BIOCHEM, V83, P299, DOI 10.1111/j.1432-1033.1978.tb12094.x; Vold RR, 1997, J BIOMOL NMR, V9, P329, DOI 10.1023/A:1018643312309; VULLIET PR, 1984, J BIOL CHEM, V259, P3680; WEISSMANN D, 1989, J NEUROCHEM, V53, P793, DOI 10.1111/j.1471-4159.1989.tb11775.x; WESTHEAD EW, 1987, ANN NY ACAD SCI, V493, P92, DOI 10.1111/j.1749-6632.1987.tb27186.x; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Winge I, 2008, BIOCHEM J, V410, P195, DOI 10.1042/BJ20071033; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	74	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32758	32769		10.1074/jbc.M109.027706	http://dx.doi.org/10.1074/jbc.M109.027706			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801645	hybrid, Green Published			2022-12-25	WOS:000272028400061
J	Renner, O; Harsch, S; Schaeffeler, E; Winter, S; Schwab, M; Krawczyk, M; Rosendahl, J; Wittenburg, H; Lammert, F; Stange, EF				Renner, Olga; Harsch, Simone; Schaeffeler, Elke; Winter, Stefan; Schwab, Matthias; Krawczyk, Marcin; Rosendahl, Jonas; Wittenburg, Henning; Lammert, Frank; Stange, Eduard F.			A Variant of the SLC10A2 Gene Encoding the Apical Sodium-Dependent Bile Acid Transporter Is a Risk Factor for Gallstone Disease	PLOS ONE			English	Article							SUSCEPTIBILITY FACTOR; DIETARY-CHOLESTEROL; GALLBLADDER-DISEASE; RECEPTOR GENES; POLYMORPHISMS; EXPRESSION; MUTATION; PLASMA; CHOLELITHIASIS; COTRANSPORTER	Background: Cholelithiasis is a multifactorial process and several mechanisms of gallstone formation have been postulated. As one of these mechanisms, a decreased expression of the ileal apical sodium-dependent bile acid transporter gene SLC10A2 in gallstone carriers was described previously. In this study the SLC10A2 gene was investigated to identify novel genetic variants and their association with gallstone formation. Methodology/Principal Findings: Study subjects were selected with the presence or absence of gallstones confirmed by ultrasound and medical history. Genomic DNA was obtained from blood leukocytes. Sequence analysis was performed of all six exonic and flanking regions as well as of 2,400 base pairs of the SLC10A2 promoter in a cohort of gallstone carriers and control subjects from Stuttgart, Germany. Genotype frequencies of newly identified genetic variants (n = 6) and known single nucleotide polymorphisms (n = 24) were established using MALDI-TOF mass spectrometry. Six new genetic variants were found within the SLC10A2 gene. Although none of the variants was linked to gallstone disease in the Stuttgart cohort overall, the minor allele of SNP rs9514089 was more prevalent in male non-obese gallstone carriers (p = 0.06680, OR = 11.00). In a separate population from Aachen, Germany, the occurrence of rs9514089 was two-fold higher in gallstone patients (22%) than in corresponding controls (11%) ( p = 0.00995, OR = 2.19). In the pooled Aachen/Stuttgart cohort rs9514089 was highly significantly linked to cholelithiasis (p = 0.00767, OR = 2.04). A more frequent occurrence was observed for male gallstone carriers (22%) compared to controls (9%) (p = 0.01017, OR = 2.99), for the total normal weight group (p = 0.00754, OR = 2.90), and for male non-obese gallstone patients (p = 0.01410, OR = 6.85). Moreover, for the minor allele of rs9514089 an association with low plasma cholesterol levels was found especially in gallstone carriers (p = 0.05). Conclusions/Significance: We have identified SLC10A2 as a novel susceptibility gene for cholelithiasis in humans. Comprehensive statistical analysis provides strong evidence that rs9514089 is a genetic determinant especially in male non-obese gallstone carriers. The minor allele of rs9514089 is related to differences in plasma cholesterol levels among the subjects.			Renner, O (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-7000 Stuttgart, Germany.	eduard.stange@rbk.de	Schwab, Matthias/ABH-7449-2020; Krawczyk, Marcin/AAG-4356-2020	Krawczyk, Marcin/0000-0002-0113-0777; Renner, Olga/0000-0003-0985-4515				ACALOVSCHI M, 2009, LIPIDS; Acalovschi M, 2006, EUR J INTERN MED, V17, P490, DOI 10.1016/j.ejim.2006.04.012; Berge KE, 2002, J LIPID RES, V43, P486; Bergheim I, 2006, J LIPID RES, V47, P42, DOI 10.1194/jlr.M500215-JLR200; BERR F, 1992, J CLIN INVEST, V90, P859, DOI 10.1172/JCI115961; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dowling RH, 2000, ALIMENT PHARM THER, V14, P39, DOI 10.1046/j.1365-2036.2000.014s2039.x; Duane WC, 2000, J LIPID RES, V41, P1384; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Grunhage F, 2007, HEPATOLOGY, V46, P793, DOI 10.1002/hep.21847; Gylling H, 2004, J LIPID RES, V45, P1660, DOI 10.1194/jlr.M300522-JLR200; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Holzer A, 2008, DIGESTION, V78, P52, DOI 10.1159/000159379; Jiang ZY, 2004, WORLD J GASTROENTERO, V10, P1508; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; KERN F, 1994, J CLIN INVEST, V93, P1186, DOI 10.1172/JCI117072; Klass DM, 2007, AM J GASTROENTEROL, V102, P2482, DOI 10.1111/j.1572-0241.2007.01430.x; Klass DM, 2006, ALIMENT PHARM THER, V23, P895, DOI 10.1111/j.1365-2036.2006.02836.x; Kovacs P, 2008, J HEPATOL, V48, P116, DOI 10.1016/j.jhep.2007.07.027; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; Lammert F, 2004, HEPATOLOGY, V39, P117, DOI 10.1002/hep.20022; Lamont J T, 1992, Prog Liver Dis, V10, P165; Love MW, 2001, ARTERIOSCL THROM VAS, V21, P2039, DOI 10.1161/hq1201.100262; Mella JG, 2007, J LIPID RES, V48, P1378, DOI 10.1194/jlr.M700059-JLR200; Montagnani M, 2001, SCAND J GASTROENTERO, V36, P1077, DOI 10.1080/003655201750422693; Montagnani M, 2006, WORLD J GASTROENTERO, V12, P7710, DOI 10.3748/wjg.v12.i47.7710; Nakken KE, 2009, LIVER INT, V29, P743, DOI 10.1111/j.1478-3231.2008.01914.x; Oelkers P, 1997, J CLIN INVEST, V99, P1880, DOI 10.1172/JCI119355; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Poupon Raoul, 2007, Rev Prat, V57, P2115; Puppala S, 2006, AM J HUM GENET, V78, P377, DOI 10.1086/500274; Renner O, 2008, J LIPID RES, V49, P2045, DOI 10.1194/jlr.M800162-JLR200; Renner O, 2009, HUM GENET, V125, P381, DOI 10.1007/s00439-009-0630-0; Rosmorduc O, 2003, GASTROENTEROLOGY, V125, P452, DOI 10.1016/S0016-5085(03)00898-9; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wittenburg H, 2003, GASTROENTEROLOGY, V125, P868, DOI 10.1016/S0016-5085(03)01053-9; Wittenburg H, 2003, DIGEST LIVER DIS, V35, pS2, DOI 10.1016/S1590-8658(03)00085-9; Wittenburg H, 2007, SEMIN LIVER DIS, V27, P109, DOI 10.1055/s-2006-960174; WONG MH, 1995, J BIOL CHEM, V270, P27228, DOI 10.1074/jbc.270.45.27228; Zanlungo S, 2004, CURR OPIN LIPIDOL, V15, P279, DOI 10.1097/00041433-200406000-00007; Zanlungo S, 2003, FRONT BIOSCI-LANDMRK, V8, pS1166, DOI 10.2741/1193	45	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7321	10.1371/journal.pone.0007321	http://dx.doi.org/10.1371/journal.pone.0007321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823678	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808300003
J	Niemann, S; Koser, CU; Gagneux, S; Plinke, C; Homolka, S; Bignell, H; Carter, RJ; Cheetham, RK; Cox, A; Gormley, NA; Kokko-Gonzales, P; Murray, LJ; Rigatti, R; Smith, VP; Arends, FPM; Cox, HS; Smith, G; Archer, JAC				Niemann, Stefan; Koeser, Claudio U.; Gagneux, Sebastien; Plinke, Claudia; Homolka, Susanne; Bignell, Helen; Carter, Richard J.; Cheetham, R. Keira; Cox, Anthony; Gormley, Niall A.; Kokko-Gonzales, Paula; Murray, Lisa J.; Rigatti, Roberto; Smith, Vincent P.; Arends, Felix P. M.; Cox, Helen S.; Smith, Geoff; Archer, John A. C.			Genomic Diversity among Drug Sensitive and Multidrug Resistant Isolates of Mycobacterium tuberculosis with Identical DNA Fingerprints	PLOS ONE			English	Article							BEIJING/W STRAINS; GENE; MUTATIONS; SUSCEPTIBILITY; PYRAZINAMIDE; EMERGENCE; SEQUENCE; SYSTEM; PHYLOGEOGRAPHY; GENOTYPE	Background: Mycobacterium tuberculosis complex (MTBC), the causative agent of tuberculosis (TB), is characterized by low sequence diversity making this bacterium one of the classical examples of a genetically monomorphic pathogen. Because of this limited DNA sequence variation, routine genotyping of clinical MTBC isolates for epidemiological purposes relies on highly discriminatory DNA fingerprinting methods based on mobile and repetitive genetic elements. According to the standard view, isolates exhibiting the same fingerprinting pattern are considered direct progeny of the same bacterial clone, and most likely reflect ongoing transmission or disease relapse within individual patients. Methodology/Principal Findings: Here we further investigated this assumption and used massively parallel whole-genome sequencing to compare one drug-susceptible (K-1) and one multidrug resistant (MDR) isolate (K-2) of a rapidly spreading M. tuberculosis Beijing genotype clone from a high incidence region (Karakalpakstan, Uzbekistan). Both isolates shared the same IS6110 RFLP pattern and the same allele at 23 out of 24 MIRU-VNTR loci. We generated 23.9 million (K-1) and 33.0 million (K-2) paired 50 bp purity filtered reads corresponding to a mean coverage of 483.5 fold and 656.1 fold respectively. Compared with the laboratory strain H37Rv both Beijing isolates shared 1,209 SNPs. The two Beijing isolates differed by 130 SNPs and one large deletion. The susceptible isolate had 55 specific SNPs, while the MDR variant had 75 specific SNPs, including the five known resistance-conferring mutations. Conclusions: Our results suggest that M. tuberculosis isolates exhibiting identical DNA fingerprinting patterns can harbour substantial genomic diversity. Because this heterogeneity is not captured by traditional genotyping of MTBC, some aspects of the transmission dynamics of tuberculosis could be missed or misinterpreted. Furthermore, a valid differentiation between disease relapse and exogenous reinfection might be impossible using standard genotyping tools if the overall diversity of circulating clones is limited. These findings have important implications for clinical trials of new anti-tuberculosis drugs.			Niemann, S (corresponding author), Res Ctr Borstel, Borstel, Germany.	sniemann@fz-borstel.de	Niemann, Stefan/C-9327-2011; Gagneux, Sebastien/ABE-7909-2020; Archer, John/D-5200-2012; Archer, John/AAW-1990-2021; Köser, Claudio/I-3740-2013	Archer, John/0000-0002-3302-3933; Köser, Claudio/0000-0002-0232-846X; Niemann, Stefan/0000-0002-6604-0684; Cox, Anthony/0000-0002-6534-749X; Cox, Helen/0000-0002-6538-7192; Gagneux, Sebastien/0000-0001-7783-9048	Medical Research Council [MC_U117588500] Funding Source: Medline; NIAID NIH HHS [R01 AI034238] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238] Funding Source: NIH RePORTER; MRC [MC_U117588500] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abe C, 2008, J CLIN MICROBIOL, V46, P2263, DOI 10.1128/JCM.00561-08; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; [Anonymous], 2008, 4 WHO; Bemer P, 2002, J CLIN MICROBIOL, V40, P150, DOI 10.1128/JCM.40.1.150-154.2002; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bousquet J., 2007, GLOBAL SURVEILLANCE, P146; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chan RCY, 2007, J ANTIMICROB CHEMOTH, V59, P866, DOI 10.1093/jac/dkm054; Cole ST, 1999, FEBS LETT, V452, P7, DOI 10.1016/S0014-5793(99)00536-0; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Cox HS, 2008, NEW ENGL J MED, V359, P2398, DOI 10.1056/NEJMc0805644; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; Cox HS, 2004, EMERG INFECT DIS, V10, P865, DOI 10.3201/eid1005.030718; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Koenig R, 2007, SCIENCE, V318, P901; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lee KW, 2001, J KOREAN MED SCI, V16, P537, DOI 10.3346/jkms.2001.16.5.537; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Musser JM, 2000, GENETICS, V155, P7; NAIR J, 1993, MOL MICROBIOL, V10, P521, DOI 10.1111/j.1365-2958.1993.tb00924.x; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Pfyffer GE, 2002, J CLIN MICROBIOL, V40, P1670, DOI 10.1128/JCM.40.5.1670-1674.2002; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Van Soolingen Dick, 2003, VVolume 2, P17; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; ZHANG Y, 2008, HDB TUBERCULOSIS; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	57	114	114	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7407	10.1371/journal.pone.0007407	http://dx.doi.org/10.1371/journal.pone.0007407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823582	Green Submitted, gold, Green Published			2022-12-25	WOS:000270728500008
J	Zhou, CX; Tiberi, M; Liang, BH; Alper, SL; Baltz, JM				Zhou, Chenxi; Tiberi, Mario; Liang, Binhui; Alper, Seth L.; Baltz, Jay M.			HCO3-/Cl- Exchange Inactivation and Reactivation during Mouse Oocyte Meiosis Correlates with MEK/MAPK-Regulated Ae2 Plasma Membrane Localization	PLOS ONE			English	Article								Background: Germinal Vesicle (GV) stage mouse oocytes in first meiotic prophase exhibit highly active HCO3-/Cl- exchange-a class of transport nearly ubiquitously involved in regulation of intracellular pH and cell volume. During meiosis, however, oocyte HCO3-/Cl- exchange becomes inactivated during first metaphase (MI), remains inactive in second metaphase (MII), and is reactivated only after egg activation. Previous work using pharmacological manipulations had indicated that activity of the MEK/MAPK signaling pathway was negatively correlated with HCO3-/Cl- exchange activity during meiosis. However, the mechanism by which the exchanger is inactivated during meiotic progression had not been determined, nor had the role of MEK/MAPK been directly established. Methodology/Principal Findings: Expression of a constitutively active form of MEK (MAP kinase kinase), which prevented the normal downregulation of MAPK after egg activation, also prevented reactivation of HCO3-/Cl- exchange. Conversely, suppression of endogenous MAPK activity with dominant negative MEK activated the normally quiescent HCO3-/Cl- exchange in mature MII eggs. A GFP-tagged form of the HCO3-/Cl- exchanger isoform Ae2 (Slc4a2) was strongly expressed at the GV oocyte plasma membrane, but membrane localization decreased markedly during meiotic progression. A similar pattern for endogenous Ae2 was confirmed by immunocytochemistry. The loss of membrane-localized Ae2 appeared selective, since membrane localization of a GFP-tagged human dopamine D1 receptor did not change during meiotic maturation. Conclusions: Direct manipulation of MAPK activity indicated that GFP-tagged Ae2 localization depended upon MAPK activity. Inactivation of HCO3-/Cl- exchange during the meiotic cell cycle may therefore reflect the loss of Ae2 from the oocyte plasma membrane, downstream of MEK/MAPK signaling. This identifies a novel role for MEK/MAPK-mediated cytostatic factor (CSF) activity during meiosis in membrane protein trafficking in mouse oocytes, and shows for the first time that selective retrieval of membrane proteins is a feature of meiosis in mammalian oocytes.			Zhou, CX (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	jmbaltz@ohri.ca		Baltz, Jay/0000-0002-9749-2480	NIDDK NIH HHS [DK43495, R37 DK043495] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043495, R37DK043495] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; ALPER SL, 1991, ANNU REV PHYSIOL, V53, P549, DOI 10.1146/annurev.physiol.53.1.549; Baltz JM, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P123; BALTZ JM, 1991, MOL REPROD DEV, V28, P351, DOI 10.1002/mrd.1080280407; BALTZ JM, 1991, J BIOL CHEM, V266, P17212; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; BORON WF, 1986, ANNU REV PHYSIOL, V48, P377; BOSMIKICH A, 1995, MOL REPROD DEV, V41, P84, DOI 10.1002/mrd.1080410113; Cetinkaya A, 2008, J REPROD DEVELOP, V54, P492, DOI 10.1262/jrd.20029; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; El-Jouni W, 2007, DEVELOPMENT, V134, P3307, DOI 10.1242/dev.005454; El-Jouni W, 2008, DEV BIOL, V324, P99, DOI 10.1016/j.ydbio.2008.09.007; Erdogan S, 2005, DEV BIOL, V286, P352, DOI 10.1016/j.ydbio.2005.08.009; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; FitzHarris G, 2006, DEVELOPMENT, V133, P591, DOI 10.1242/dev.02246; FitzHarris G, 2007, DEVELOPMENT, V134, P4283, DOI 10.1242/dev.005272; FRASER LR, 1987, GAMETE RES, V18, P363, DOI 10.1002/mrd.1120180410; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HAGHIGHAT N, 1990, J EXP ZOOL, V253, P71, DOI 10.1002/jez.1402530110; Hang JS, 2008, CURR BIOL, V18, pR416, DOI 10.1016/j.cub.2008.03.033; Jensen LJ, 1999, BIOL REPROD, V61, P973, DOI 10.1095/biolreprod61.4.973; JIANG LW, 1994, AM J PHYSIOL, V267, pC845, DOI 10.1152/ajpcell.1994.267.3.C845; Jiang LW, 1997, AM J PHYSIOL-CELL PH, V272, pC191, DOI 10.1152/ajpcell.1997.272.1.C191; JOHNSON JD, 1976, NATURE, V262, P661, DOI 10.1038/262661a0; Kline D, 1995, ZYGOTE, V3, P305, DOI 10.1017/S0967199400002732; Lane M, 1999, BIOL REPROD, V61, P452, DOI 10.1095/biolreprod61.2.452; Madgwick S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-4; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Moos J, 1996, DEV BIOL, V175, P358, DOI 10.1006/dbio.1996.0121; MOOS J, 1995, BIOL REPROD, V53, P692, DOI 10.1095/biolreprod53.3.692; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; MULLER HAJ, 1995, DEV DYNAM, V202, P405; Muller HAJ, 2001, DEV GROWTH DIFFER, V43, P327, DOI 10.1046/j.1440-169x.2001.00587.x; NORD EP, 1988, J BIOL CHEM, V263, P5599; Pelland AMD, 2009, BIOL REPROD, V81, P1041, DOI 10.1095/biolreprod.109.079046; PETRUNEWICH MA, 2008, J REPROD DEV; Phillips KP, 1999, DEV BIOL, V208, P392, DOI 10.1006/dbio.1999.9199; Phillips KP, 1996, MOL REPROD DEV, V45, P52, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;52::AID-MRD8&gt;3.0.CO;2-R; Phillips KP, 2000, HUM REPROD, V15, P896, DOI 10.1093/humrep/15.4.896; Phillips KP, 2002, DEV BIOL, V247, P210, DOI 10.1006/dbio.2002.0680; Phillips KP, 2002, MOL BIOL CELL, V13, P3800, DOI 10.1091/mbc.E02-04-0242; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; SCHMALZING G, 1990, AM J PHYSIOL, V258, pC179, DOI 10.1152/ajpcell.1990.258.1.C179; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; SCHULTZ RM, 1995, CURR TOP DEV BIOL, V30, P21, DOI 10.1016/S0070-2153(08)60563-3; Sedaghat K, 2006, MOL BIOTECHNOL, V34, P1, DOI 10.1385/MB:34:1:1; Sheng YL, 2001, CURR BIOL, V11, P405, DOI 10.1016/S0960-9822(01)00123-3; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Steeves CL, 2005, J CELL PHYSIOL, V204, P273, DOI 10.1002/jcp.20284; Steeves CL, 2003, P NATL ACAD SCI USA, V100, P13982, DOI 10.1073/pnas.2334537100; Stewart AK, 2007, AM J PHYSIOL-CELL PH, V292, pC909, DOI 10.1152/ajpcell.00265.2006; STUARTTILLEY A, 1994, AM J PHYSIOL, V266, pC559, DOI 10.1152/ajpcell.1994.266.2.C559; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Takakura I, 2005, J REPROD DEVELOP, V51, P617, DOI 10.1262/jrd.17034; Tartia AP, 2009, DEVELOPMENT, V136, P2247, DOI 10.1242/dev.036756; Tumova K, 2003, J BIOL CHEM, V278, P8146, DOI 10.1074/jbc.M208059200; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Zhao YY, 1996, AM J PHYSIOL-CELL PH, V271, pC1512, DOI 10.1152/ajpcell.1996.271.5.C1512; ZHAO YY, 1995, J BIOL CHEM, V270, P24428, DOI 10.1074/jbc.270.41.24428; Zhao YY, 1997, DEV BIOL, V189, P148, DOI 10.1006/dbio.1997.8651	63	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7417	10.1371/journal.pone.0007417	http://dx.doi.org/10.1371/journal.pone.0007417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823673	Green Published, gold, Green Submitted			2022-12-25	WOS:000270728500015
J	Meinke, D; Sweeney, C; Muralla, R				Meinke, David; Sweeney, Colleen; Muralla, Rosanna			Integrating the Genetic and Physical Maps of Arabidopsis thaliana: Identification of Mapped Alleles of Cloned Essential (EMB) Genes	PLOS ONE			English	Article							LETHAL MUTANTS; INSERTIONAL MUTAGENESIS; CELL FATE; ARRESTED EMBRYOS; PROTEIN; GENOME; PLANT; BIOSYNTHESIS; REVEALS; INVITRO	The classical genetic map of Arabidopsis includes more than 130 genes with an embryo-defective (emb) mutant phenotype. Many of these essential genes remain to be cloned. Hundreds of additional EMB genes have been cloned and catalogued (www.seedgenes.org) but not mapped. To facilitate EMB gene identification and assess the current level of saturation, we updated the classical map, compared the physical and genetic locations of mapped loci, and performed allelism tests between mapped ( but not cloned) and cloned (but not mapped) emb mutants with similar chromosome locations. Two hundred pairwise combinations of genes located on chromosomes 1 and 5 were tested and more than 1100 total crosses were screened. Sixteen of 51 mapped emb mutants examined were found to be disrupted in a known EMB gene. Alleles of a wide range of published EMB genes (YDA, GLA1, TIL1, AtASP38, AtDEK1, EMB506, DG1, OEP80) were discovered. Two EMS mutants isolated 30 years ago, T-DNA mutants with complex insertion sites, and a mutant with an atypical, embryo-specific phenotype were resolved. The frequency of allelism encountered was consistent with past estimates of 500 to 1000 EMB loci. New EMB genes identified among mapped T-DNA insertion mutants included CHC1, which is required for chromatin remodeling, and SHS1/AtBT1, which encodes a plastidial nucleotide transporter similar to the maize Brittle1 protein required for normal endosperm development. Two classical genetic markers (PY, ALB1) were identified based on similar map locations of known genes required for thiamine (THIC) and chlorophyll (PDE166) biosynthesis. The alignment of genetic and physical maps presented here should facilitate the continued analysis of essential genes in Arabidopsis and further characterization of a broad spectrum of mutant phenotypes in a model plant.			Meinke, D (corresponding author), Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA.	david.meinke@okstate.edu						Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BAUS AD, 1986, THEOR APPL GENET, V72, P577, DOI 10.1007/BF00288994; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Berg M, 2005, PLANT J, V44, P866, DOI 10.1111/j.1365-313X.2005.02580.x; CASTLE LA, 1993, MOL GEN GENET, V241, P504, DOI 10.1007/BF00279892; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Crane YM, 2007, P NATL ACAD SCI USA, V104, P15156, DOI 10.1073/pnas.0706986104; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; ERRAMPALLI D, 1991, PLANT CELL, V3, P149, DOI 10.1105/tpc.3.2.149; FEENSTRA WJ, 1964, GENETICA, V35, P259, DOI 10.1007/BF01804894; FRANZMANN L, 1989, THEOR APPL GENET, V77, P609, DOI 10.1007/BF00261231; FRANZMANN LH, 1995, PLANT J, V7, P341, DOI 10.1046/j.1365-313X.1995.7020341.x; FURNER IJ, 1992, DEVELOPMENT, V115, P755; Furner IJ, 1996, DEVELOPMENT, V122, P1041; Garcion C, 2006, PLANT J, V48, P895, DOI 10.1111/j.1365-313X.2006.02922.x; Ge XC, 2005, EMBO REP, V6, P282, DOI 10.1038/sj.embor.7400357; Inan G, 2007, PLANT MOL BIOL, V65, P295, DOI 10.1007/s11103-007-9219-y; Ishikawa T, 2003, PLANT J, V33, P235, DOI 10.1046/j.1365-313X.2003.01621.x; Jenik PD, 2005, PLANT CELL, V17, P3362, DOI 10.1105/tpc.105.036889; Johnson KL, 2008, PLANT CELL, V20, P2619, DOI 10.1105/tpc.108.059964; JURGENS G, 1991, DEVELOPMENT, P27; Kirchberger S, 2008, PLANT J, V56, P51, DOI 10.1111/j.1365-313X.2008.03583.x; Kobayashi K, 2008, PHOTOCH PHOTOBIO SCI, V7, P1188, DOI 10.1039/b802604c; Kong DY, 2008, CELL RES, V18, P566, DOI 10.1038/cr.2008.35; KOORNNEEF M, 1983, J HERED, V74, P265, DOI 10.1093/oxfordjournals.jhered.a109781; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; LI SL, 1969, BIOCHEM GENET, V3, P163, DOI 10.1007/BF00520351; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Liu CM, 2002, PLANT J, V29, P405, DOI 10.1046/j.1365-313x.2002.01224.x; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; McElver J, 2001, GENETICS, V159, P1751; MEINKE D, 1989, MOL BASIS PLANT DEV, P121; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; MEINKE DW, 1985, THEOR APPL GENET, V69, P543, DOI 10.1007/BF00251102; Meinke DW, 2003, PLANT PHYSIOL, V131, P409, DOI 10.1104/pp.014134; MEINKE DW, 1979, DEV BIOL, V72, P62, DOI 10.1016/0012-1606(79)90098-8; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; MEINKE DW, 1982, THEOR APPL GENET, V63, P381, DOI 10.1007/BF00303912; Meinke DW, 1994, ARABIDOPSIS THALIANA, P253; MULLER A. J., 1963, BIOL ZENTRALBL, V82, P133; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Patel R, 2008, PLANT PHYSIOL, V148, P235, DOI 10.1104/pp.108.122754; PATTON DA, 1991, MOL GEN GENET, V227, P337, DOI 10.1007/BF00273921; Preuss SB, 2003, GENETICS, V164, P323; Raschke M, 2007, P NATL ACAD SCI USA, V104, P19637, DOI 10.1073/pnas.0709597104; REDEI GP, 1975, ANNU REV GENET, V9, P111, DOI 10.1146/annurev.ge.09.120175.000551; ROBBELEN G, 1957, Z INDUKT ABSTAMM VER, V88, P189, DOI 10.1007/BF00308341; ROBBELEN G, 1972, ARAB INF SERV, V9, P21; Ronceret A, 2005, PLANT J, V44, P223, DOI 10.1111/j.1365-313X.2005.02521.x; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Stephenson PG, 2008, PHOTOCH PHOTOBIO SCI, V7, P1243, DOI 10.1039/b802596g; Tax FE, 2001, PLANT PHYSIOL, V126, P1527, DOI 10.1104/pp.126.4.1527; Terauchi R, 2000, MOL GEN GENET, V263, P554, DOI 10.1007/s004380051201; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; VANDERVEEN JH, 1973, ARABID INF SERV, V10, P11; VERNON DM, 1995, DEV GENET, V16, P311, DOI 10.1002/dvg.1020160404; Winkler RG, 1998, METH MOL B, V82, P129; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	63	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7386	10.1371/journal.pone.0007386	http://dx.doi.org/10.1371/journal.pone.0007386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812694	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594200011
J	Wen, J; Zhang, H; Li, G; Mao, GP; Chen, XF; Wang, JW; Guo, M; Mu, XY; Ouyang, H; Zhang, MJ; Xia, GL				Wen, Jing; Zhang, Hua; Li, Ge; Mao, Guanping; Chen, Xiufen; Wang, Jianwei; Guo, Meng; Mu, Xinyi; Ouyang, Hong; Zhang, Meijia; Xia, Guoliang			PAR6, A Potential Marker for the Germ Cells Selected to Form Primordial Follicles in Mouse Ovary	PLOS ONE			English	Article							JUNCTIONAL COMMUNICATION; AXIS FORMATION; STEM-CELLS; DROSOPHILA; OOCYTE; POLARITY; DIFFERENTIATION; POLARIZATION; MAINTENANCE; INHIBITION	Partitioning-defective proteins (PAR) are detected to express mainly in the cytoplast, and play an important role in cell polarity. However, we showed here that PAR6, one kind of PAR protein, was localized in the nuclei of mouse oocytes that formed primordial follicles during the perinatal period, suggesting a new role of PAR protein. It is the first time we found that, in mouse fetal ovaries, PAR6 appeared in somatic cell cytoplasm and fell weak when somatic cells invaded germ cell cysts at 17.5 days post coitus (dpc). Meanwhile, the expression of PAR6 was observed in cysts, and became strong in the nuclei of some germ cells at 19.5 dpc and all primordial follicular oocytes at 3 day post parturition (dpp), and then obviously declined when the primordial follicles entered the folliculogenic growth phase. During the primordial follicle pool foundation, the number of PAR6 positive germ cells remained steady and was consistent with that of formed follicles at 3 dpp. There were no TUNEL (apoptosis examination) positive germ cells stained with PAR6 at any time studied. The number of follicles significantly declined when 15.5 dpc ovaries were treated with the anti-PAR6 antibody and PAR6 RNA interference. Carbenoxolone (CBX, a known blocker of gap junctions) inhibited the expression of PAR6 in germ cells and the formation of follicles. Our results suggest that PAR6 could be used as a potential marker of germ cells for the primordial follicle formation, and the expression of PAR6 by a gap junction-dependent process may contribute to the formation of primordial follicles and the maintenance of oocytes at the diplotene stage.			Wen, J (corresponding author), Univ Agr, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.	zmeijia@cau.edu.cn; glxiachina@sohu.com		Xia, Guoliang/0000-0003-3674-0142; Ouyang, Hong/0000-0002-7622-7733				Albertini DF, 2004, REPRODUCTION, V127, P513, DOI 10.1530/rep.1.00247; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Bruzzone R, 1996, BIOESSAYS, V18, P709, DOI 10.1002/bies.950180906; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; DAVIDSON JS, 1986, BIOCHEM BIOPH RES CO, V134, P29, DOI 10.1016/0006-291X(86)90522-X; Deng W, 2001, INT REV CYTOL, V203, P93; Duncan FE, 2005, DEV BIOL, V280, P38, DOI 10.1016/j.ydbio.2004.12.034; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; Greenfeld C, 2004, BIOESSAYS, V26, P829, DOI 10.1002/bies.20094; Hong A, 2003, DEVELOPMENT, V130, P1235, DOI 10.1242/dev.00352; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Lei L, 2006, J CELL PHYSIOL, V208, P640, DOI 10.1002/jcp.20702; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; MACKAY S, 1989, CELL DIFFER DEV, V27, P19, DOI 10.1016/0922-3371(89)90041-5; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Perez-Armendariz EM, 2003, ANAT REC PART A, V271A, P360, DOI 10.1002/ar.a.10040; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Telfer W. H., 1975, Advances Insect Physiol, V11, P223, DOI 10.1016/S0065-2806(08)60164-2; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; Vaccari T, 2002, CURR BIOL, V12, P1524, DOI 10.1016/S0960-9822(02)01079-5; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Vinot S, 2004, CURR BIOL, V14, P520, DOI 10.1016/j.cub.2004.02.061; Wang DH, 1997, MOL REPROD DEV, V48, P154, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;154::AID-MRD2&gt;3.0.CO;2-R; Wang HB, 2001, CHINESE SCI BULL, V46, P672, DOI 10.1007/BF03182833	40	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7372	10.1371/journal.pone.0007372	http://dx.doi.org/10.1371/journal.pone.0007372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809506	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594000020
J	Zerbib, J; Seddon, JM; Richard, F; Reynolds, R; Leveziel, N; Benlian, P; Borel, P; Feingold, J; Munnich, A; Soubrane, G; Kaplan, J; Rozet, JM; Souied, EH				Zerbib, Jennyfer; Seddon, Johanna M.; Richard, Florence; Reynolds, Robyn; Leveziel, Nicolas; Benlian, Pascale; Borel, Patrick; Feingold, Josue; Munnich, Arnold; Soubrane, Gisele; Kaplan, Josseline; Rozet, Jean-Michel; Souied, Eric H.			rs5888 Variant of SCARB1 Gene Is a Possible Susceptibility Factor for Age-Related Macular Degeneration	PLOS ONE			English	Article							B TYPE-I; COMPLEMENT FACTOR-H; SCAVENGER RECEPTOR; SR-BI; CIGARETTE-SMOKING; APOLIPOPROTEIN-E; RISK-FACTORS; VITAMIN-E; CARDIOVASCULAR-DISEASE; POOLED FINDINGS	Major genetic factors for age-related macular degeneration (AMD) have recently been identified as susceptibility risk factors, including variants in the CFH gene and the ARMS2 LOC387715/HTRA1locus. Our purpose was to perform a case-control study in two populations among individuals who did not carry risk variants for CFHY402H and LOC387715 A69S (ARMS2), called "study'' individuals, in order to identify new genetic risk factors. Based on a candidate gene approach, we analyzed SNP rs5888 of the SCARB1 gene, coding for SRBI, which is involved in the lipid and lutein pathways. This study was conducted in a French series of 1241 AMD patients and 297 controls, and in a North American series of 1257 patients with advanced AMD and 1732 controls. Among these individuals, we identified 61 French patients, 77 French controls, 85 North American patients and 338 North American controls who did not carry the CFH nor ARMS2 polymorphisms. An association between AMD and the SCARB1 gene was seen among the study subjects. The genotypic distribution of the rs5888 polymorphism was significantly different between cases and controls in the French population (p<0.006). Heterozygosity at the rs5888 SNP increased risk of AMD compared to the CC genotypes in the French study population (odds ratio (OR) = 3.5, CI95%: 1.4-8.9, p<0.01) and after pooling the 2 populations (OR = 2.9, 95% CI: 1.6-5.3, p<0.002). Subgroup analysis in exudative forms of AMD revealed a pooled OR of 3.6 for individuals heterozygous for rs5888 (95% CI: 1.7-7.6, p<0.0015). These results suggest the possible contribution of SCARB1, a new genetic factor in AMD, and implicate a role for cholesterol and antioxidant micronutrient (lutein and vitamin E) metabolism in AMD.			Zerbib, J (corresponding author), Creteil Univ, Eye Clin, Fac Med Henri Mondor, Creteil, France.	eric.souied@chicreteil.fr	Borel, Patrick/A-4057-2015; ROZET, Jean-Michel/E-5737-2016; Benlian, Pascale/I-7964-2016; KAPLAN, Josseline/I-2622-2017	Borel, Patrick/0000-0001-9977-3238; ROZET, Jean-Michel/0000-0001-7951-7886; Nicolas, Leveziel/0000-0001-8533-9457; Benlian, Pascale/0000-0002-3423-8979; KAPLAN, Josseline/0000-0002-1849-8658				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Borel P, 2007, J NUTR, V137, P2653, DOI 10.1093/jn/137.12.2653; Delcourt C, 1999, ARCH OPHTHALMOL-CHIC, V117, P1384, DOI 10.1001/archopht.117.10.1384; Duncan KG, 2002, BIOCHEM BIOPH RES CO, V292, P1017, DOI 10.1006/bbrc.2002.6756; During A, 2008, J LIPID RES, V49, P1715, DOI 10.1194/jlr.M700580-JLR200; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fazio S, 2005, CIRCULATION, V111, P3349, DOI 10.1161/CIRCULATIONAHA.105.545996; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hsu Chin-Chun, 2003, MULTINATIONAL BUSINE, V11, P23, DOI DOI 10.1108/1525383X200300015; Huang ZH, 2002, J LIPID RES, V43, P375; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Leveziel N, 2007, MOL VIS, V13, P2153; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Morabia A, 2004, ATHEROSCLEROSIS, V175, P159, DOI 10.1016/j.atherosclerosis.2004.03.014; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Ritsch A, 2007, METABOLISM, V56, P1135, DOI 10.1016/j.metabol.2007.04.009; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Roberts CGP, 2007, HUM HERED, V64, P107, DOI 10.1159/000101962; Rodriguez-Esparragon F, 2005, ARTERIOSCL THROM VAS, V25, P854, DOI 10.1161/01.ATV.0000157581.88838.03; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Seddon J, 2007, PRINCIPLES PRACTICE, P413; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Shuler RK, 2007, ARCH OPHTHALMOL-CHIC, V125, P63, DOI 10.1001/archopht.125.1.63; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Snow K K, 1999, Ophthalmic Epidemiol, V6, P125, DOI 10.1076/opep.6.2.125.1558; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Souied EH, 2005, MOL VIS, V11, P1135; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Tan JSL, 2008, BRIT J OPHTHALMOL, V92, P509, DOI 10.1136/bjo.2007.131706; Tanaka T, 2007, J NUTR, V137, P578, DOI 10.1093/jn/137.3.578; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	64	51	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7341	10.1371/journal.pone.0007341	http://dx.doi.org/10.1371/journal.pone.0007341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19806217	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593600014
J	Sung, MH; Salvatore, L; De Lorenzi, R; Indrawan, A; Pasparakis, M; Hager, GL; Bianchi, ME; Agresti, A				Sung, Myong-Hee; Salvatore, Luigi; De Lorenzi, Rossana; Indrawan, Anindya; Pasparakis, Manolis; Hager, Gordon L.; Bianchi, Marco E.; Agresti, Alessandra			Sustained Oscillations of NF-kappa B Produce Distinct Genome Scanning and Gene Expression Profiles	PLOS ONE			English	Article							IN-SILICO; GLUCOCORTICOID-RECEPTOR; TEMPORAL CONTROL; DYNAMICS; TRANSCRIPTION; CHROMATIN; PATHWAY; BINDING	NF-kappa B is a prototypic stress-responsive transcription factor that acts within a complex regulatory network. The signaling dynamics of endogenous NF-kappa B in single cells remain poorly understood. To examine real time dynamics in living cells, we monitored NF-kappa B activities at multiple timescales using GFP-p65 knock-in mouse embryonic fibroblasts. Oscillations in NFkB were sustained in most cells, with several cycles of transient nuclear translocation after TNF-alpha stimulation. Mathematical modeling suggests that NF-kappa B oscillations are selected over other non-oscillatory dynamics by fine-tuning the relative strengths of feedback loops like I kappa B alpha. The ability of NF-kappa B to scan and interact with the genome in vivo remained remarkably constant from early to late cycles, as observed by fluorescence recovery after photobleaching (FRAP). Perturbation of long-term NF-kappa B oscillations interfered with its short-term interaction with chromatin and balanced transcriptional output, as predicted by the mathematical model. We propose that negative feedback loops do not simply terminate signaling, but rather promote oscillations of NF-kappa B in the nucleus, and these oscillations are functionally advantageous.			Sung, MH (corresponding author), NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA.	sungm@mail.nih.gov; agresti.alessandra@hsr.it	Bianchi, Marco Emilio/K-3417-2018; Pasparakis, Manolis/N-4350-2019; Agresti, Alessandra/K-5228-2016; Agresti, Alessandra/Q-4394-2019; Pasparakis, Manolis/H-9292-2017; Sung, Myong-Hee/AAC-7316-2020	Bianchi, Marco Emilio/0000-0002-5329-6445; Pasparakis, Manolis/0000-0002-9870-0966; Agresti, Alessandra/0000-0001-5006-9506; Agresti, Alessandra/0000-0001-5006-9506; Pasparakis, Manolis/0000-0002-9870-0966; Sung, Myong-Hee/0000-0002-9739-8558	Intramural NIH HHS Funding Source: Medline; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL CANCER INSTITUTE [ZIABC005450] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Braeckmans K, 2007, BIOPHYS J, V92, P2172, DOI 10.1529/biophysj.106.099838; Carlotti F, 1999, J BIOL CHEM, V274, P37941, DOI 10.1074/jbc.274.53.37941; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; De Lorenzi R, 2009, GENESIS, V47, P323, DOI 10.1002/dvg.20468; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Harhaj EW, 1999, MOL CELL BIOL, V19, P7088; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ihekwaba AEC, 2007, FEBS J, V274, P1678, DOI 10.1111/j.1742-4658.2007.05713.x; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Schaaf MJM, 2006, J BIOL CHEM, V281, P22409, DOI 10.1074/jbc.M511086200; Sillitoe K, 2007, BIOCHEM SOC T, V35, P263, DOI 10.1042/BST0350263; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Sung MH, 2004, MOL PHARMACOL, V66, P70, DOI 10.1124/mol.66.1.70; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; Zi ZK, 2005, FEBS LETT, V579, P1101, DOI 10.1016/j.febslet.2005.01.009	30	86	86	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7163	10.1371/journal.pone.0007163	http://dx.doi.org/10.1371/journal.pone.0007163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787057	gold, Green Submitted, Green Published			2022-12-25	WOS:000270290100005
J	Jimenez, AP; Mohamed, MK; Eldin, NS; Abou Seif, H; El Aidi, S; Sultan, Y; Elsaid, N; Rekacewicz, C; El-Hoseiny, M; El-Daly, M; Abdel-Hamid, M; Fontanet, A				Jimenez, Adela Paez; Mohamed, Mostafa K.; Eldin, Noha Sharaf; Abou Seif, Hasnaa; El Aidi, Said; Sultan, Yehia; Elsaid, Nasr; Rekacewicz, Claire; El-Hoseiny, Mostafa; El-Daly, May; Abdel-Hamid, Mohamed; Fontanet, Arnaud			Injection Drug Use Is a Risk Factor for HCV Infection in Urban Egypt	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; VOLUNTEER BLOOD-DONORS; SEXUAL TRANSMISSION; NILE DELTA; COMMUNITY; SPREAD; EPIDEMIOLOGY; POPULATION; PREVALENCE; ROUTES	Objective: To identify current risk factors for hepatitis C virus (HCV) transmission in Greater Cairo. Design and Setting: A 1: 1 matched case-control study was conducted comparing incident acute symptomatic hepatitis C patients in two "fever'' hospitals of Greater Cairo with two control groups: household members of the cases and acute hepatitis A patients diagnosed at the same hospitals. Controls were matched on the same age and sex to cases and were all anti-HCV antibody negative. Iatrogenic, community and household exposures to HCV in the one to six months before symptoms onset for cases, and date of interview for controls, were exhaustively assessed. Results: From 2002 to 2007, 94 definite acute symptomatic HCV cases and 188 controls were enrolled in the study. In multivariate analysis, intravenous injections (OR = 5.0; 95% CI = 1.2-20.2), medical stitches (OR = 4.2; 95% CI = 1.6-11.3), injection drug use (IDU) (OR = 7.9; 95% CI = 1.4-43.5), recent marriage (OR = 3.3; 95% CI = 1.1-9.9) and illiteracy (OR = 3.9; 95% CI = 1.8-8.5) were independently associated with an increased HCV risk. Conclusion: In urban Cairo, invasive health care procedures remain a source of HCV transmission and IDU is an emerging risk factor. Strict application of standard precautions during health care is a priority. Implementation of comprehensive infection prevention programs for IDU should be considered.			Jimenez, AP (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.	adelapaez@yahoo.com	mohamed, mostafa/AFE-7371-2022; El-Daly, Mai/C-4704-2013	mohamed, mostafa/0000-0002-1421-2667; PAEZ JIMENEZ, Adela/0000-0002-8653-610X; El-Daly, Mai/0000-0002-3864-523X; , arnaud/0000-0002-5239-6110				Aaron S, 2008, CLIN INFECT DIS, V47, P931, DOI 10.1086/591699; Abdel-Aziz F, 2000, HEPATOLOGY, V32, P111, DOI 10.1053/jhep.2000.8438; Abdel-Hamid M, 1997, J Hum Virol, V1, P58; Abdel-Hamid M, 2007, J GEN VIROL, V88, P1526, DOI 10.1099/vir.0.82626-0; Akhtar S, 2004, J VIRAL HEPATITIS, V11, P527, DOI 10.1111/j.1365-2893.2004.00518.x; Alavian SM, 2002, J GASTROEN HEPATOL, V17, P1092, DOI 10.1046/j.1440-1746.2002.02843.x; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Alter MJ, 2002, HEPATOLOGY, V36, pS93, DOI 10.1053/jhep.2002.36389; Arafa N, 2005, J HEPATOL, V43, P418, DOI 10.1016/j.jhep.2005.03.021; Bari A, 2001, TROP MED INT HEALTH, V6, P732, DOI 10.1046/j.1365-3156.2001.00779.x; Brandao Ajacio B M, 2002, BMC Gastroenterol, V2, P18, DOI 10.1186/1471-230X-2-18; Brewer DD, 2006, J INFECT DIS, V194, P764, DOI 10.1086/505585; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Edlin BR, 2006, CLIN INFECT DIS, V42, P673, DOI 10.1086/499960; El Gaafary MM, 2005, J MED VIROL, V76, P520, DOI 10.1002/jmv.20392; el-Sadawy Mahmoud, 2004, J Egypt Soc Parasitol, V34, P367; ELDIN NIS, 2000, PLOS ONE, V3; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Fabris P, 2008, CURR PHARM DESIGN, V14, P1661, DOI 10.2174/138161208784746789; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Gates JA, 2004, J URBAN HEALTH, V81, P448, DOI 10.1093/jurban/jth129; Guadagnino V, 1997, HEPATOLOGY, V26, P1006, DOI 10.1053/jhep.1997.v26.pm0009328327; Habib M, 2001, HEPATOLOGY, V33, P248, DOI 10.1053/jhep.2001.20797; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hajiani E, 2006, WORLD J GASTROENTERO, V12, P4884; Karmochkine M, 2006, J VIRAL HEPATITIS, V13, P775, DOI 10.1111/j.1365-2893.2006.00742.x; Magder LS, 2005, INT J EPIDEMIOL, V34, P160, DOI 10.1093/ije/dyh370; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Mariano A, 2004, J MED VIROL, V74, P216, DOI 10.1002/jmv.20182; Marzouk D, 2007, GUT, V56, P1105, DOI 10.1136/gut.2006.091983; McMahon James M, 2004, Ann Clin Microbiol Antimicrob, V3, P6, DOI 10.1186/1476-0711-3-6; Medhat A, 2002, AM J TROP MED HYG, V66, P633, DOI 10.4269/ajtmh.2002.66.633; Mohamed MK, 2005, HEPATOLOGY, V42, P683, DOI 10.1002/hep.20811; Murphy EL, 2000, HEPATOLOGY, V31, P756, DOI 10.1002/hep.510310329; Nafeh MA, 2000, AM J TROP MED HYG, V63, P236, DOI 10.4269/ajtmh.2000.63.236; PLANCOULAINE S, 2008, GUT; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P102, DOI 10.1016/j.trstmh.2005.05.021; Tahan V, 2005, AM J GASTROENTEROL, V100, P821, DOI 10.1111/j.1572-0241.2005.40879.x; Talaat M, 2006, AM J INFECT CONTROL, V34, P193, DOI 10.1016/j.ajic.2005.05.028; Thaikruea L, 2004, TRANSFUSION, V44, P1433, DOI 10.1111/j.1537-2995.2004.04073.x; Todd CS, 2007, EMERG INFECT DIS, V13, P1327, DOI 10.3201/eid1309.070036; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; Yazdanpanah Y, 2005, CLIN INFECT DIS, V41, P1423, DOI 10.1086/497131; Zakaria S, 2007, CLIN INFECT DIS, V44, pE30, DOI 10.1086/511074	45	40	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7193	10.1371/journal.pone.0007193	http://dx.doi.org/10.1371/journal.pone.0007193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784363	gold, Green Submitted, Green Published			2022-12-25	WOS:000270290000010
J	Shu, N; Liu, Y; Li, J; Li, YH; Yu, CS; Jiang, TZ				Shu, Ni; Liu, Yong; Li, Jun; Li, Yonghui; Yu, Chunshui; Jiang, Tianzi			Altered Anatomical Network in Early Blindness Revealed by Diffusion Tensor Tractography	PLOS ONE			English	Article							BRAIN STRUCTURAL NETWORKS; CROSS-MODAL PLASTICITY; PRIMARY VISUAL-CORTEX; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; WHITE-MATTER; ACTIVATION PATTERNS; CORTICAL THICKNESS; POSTCENTRAL GYRUS; NEURAL SYSTEMS	The topological architecture of the cerebral anatomical network reflects the structural organization of the human brain. Recently, topological measures based on graph theory have provided new approaches for quantifying large-scale anatomical networks. Diffusion MRI studies have revealed the efficient small-world properties and modular structure of the anatomical network in normal subjects. However, no previous study has used diffusion MRI to reveal changes in the brain anatomical network in early blindness. Here, we utilized diffusion tensor imaging to construct binary anatomical networks for 17 early blind subjects and 17 age- and gender-matched sighted controls. We established the existence of structural connections between any pair of the 90 cortical and sub-cortical regions using deterministic tractography. Compared with controls, early blind subjects showed a decreased degree of connectivity, a reduced global efficiency, and an increased characteristic path length in their brain anatomical network, especially in the visual cortex. Moreover, we revealed some regions with motor or somatosensory function have increased connections with other brain regions in the early blind, which suggested experience-dependent compensatory plasticity. This study is the first to show alterations in the topological properties of the anatomical network in early blindness. From the results, we suggest that analyzing the brain's anatomical network obtained using diffusion MRI data provides new insights into the understanding of the brain's re-organization in the specific population with early visual deprivation.			Shu, N (corresponding author), Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, LIAMA Ctr Computat Med, Beijing, Peoples R China.	chunshuiyu@yahoo.cn; jiangtz@nlpr.ia.ac.cn	Shu, Ni/B-9583-2014; QIN, WEN/F-3783-2015; Jiang, Tianzi/I-4256-2012; Li, Yonghui/G-8539-2012; Liu, Yong/F-2682-2011	QIN, WEN/0000-0002-9121-8296; Jiang, Tianzi/0000-0001-9531-291X; Liu, Yong/0000-0002-1862-3121; Yu, Chunshui/0000-0001-5648-5199				Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Bullmore E, 2009, NAT REV NEUROSCI, V10, DOI 10.1038/nrn2618; Burns GAPC, 2000, PHILOS T R SOC B, V355, P55, DOI 10.1098/rstb.2000.0549; Burton H, 2006, HUM BRAIN MAPP, V27, P325, DOI 10.1002/hbm.20188; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; CARLSON M, 1981, BRAIN RES, V204, P424, DOI 10.1016/0006-8993(81)90602-8; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; FROMM C, 1984, EXP BRAIN RES, V54, P177; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gizewski ER, 2003, NEUROIMAGE, V19, P968, DOI 10.1016/S1053-8119(03)00114-9; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; HONEY CJ, 2009, P NATL ACAD SCI US; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hubel D H, 1978, Harvey Lect, V72, P1; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kujala T, 2005, NEUROSCI LETT, V379, P127, DOI 10.1016/j.neulet.2004.12.070; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Noppeney U, 2005, CURR BIOL, V15, pR488, DOI 10.1016/j.cub.2005.06.053; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pan WJ, 2007, NEUROIMAGE, V37, P212, DOI 10.1016/j.neuroimage.2007.05.014; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Ptito Maurice, 2005, Journal of Integrative Neuroscience, V4, P479, DOI 10.1142/S0219635205000951; Rodrigo S, 2007, AM J NEURORADIOL, V28, P1526, DOI 10.3174/ajnr.A0584; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Shu N, 2009, HUM BRAIN MAPP, V30, P220, DOI 10.1002/hbm.20507; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stephan KE, 2001, PHILOS T ROY SOC B, V356, P1159, DOI 10.1098/rstb.2001.0908; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; WANG J, 2008, HUM BRAIN MAPP; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Weeks R, 2000, J NEUROSCI, V20, P2664; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Wittenberg GF, 2004, EUR J NEUROSCI, V20, P1923, DOI 10.1111/j.1460-9568.2004.03630.x; YOUNG MP, 1993, P ROY SOC B-BIOL SCI, V252, P13, DOI 10.1098/rspb.1993.0040; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Yu CS, 2007, NEUROIMAGE, V36, P411, DOI 10.1016/j.neuroimage.2007.03.003; ZALESKY A, 2009, IEEE T MED IMAGING	96	110	114	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7228	10.1371/journal.pone.0007228	http://dx.doi.org/10.1371/journal.pone.0007228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784379	Green Published, Green Submitted, gold			2022-12-25	WOS:000270290000019
J	Herron, TJ; Devaney, E; Mundada, L; Arden, E; Day, S; Guerrero-Serna, G; Turner, I; Westfall, M; Metzger, JM				Herron, Todd J.; Devaney, Eric; Mundada, Lakshmi; Arden, Erik; Day, Sharlene; Guerrero-Serna, Guadalupe; Turner, Immanuel; Westfall, Margaret; Metzger, Joseph M.			Ca2+-independent positive molecular inotropy for failing rabbit and human cardiac muscle by alpha-myosin motor gene transfer	FASEB JOURNAL			English	Article						cardiac gene transfer; ischemic heart failure; adenoviral gene transfer	CHAIN ISOFORM EXPRESSION; HUMAN HEART-FAILURE; HEAVY-CHAIN; VENTRICULAR MYOCARDIUM; FORCE DEVELOPMENT; RAT MYOCARDIUM; POWER OUTPUT; CROSSBRIDGE KINETICS; THIN FILAMENT; MYOCYTES	Current inotropic therapies used to increase cardiac contractility of the failing heart center on increasing the amount of calcium available for contraction, but their long-term use is associated with increased mortality due to fatal arrhythmias. Thus, there is a need to develop and explore novel inotropic therapies that can act via calcium-independent mechanisms. The purpose of this study was to determine whether fast alpha-myosin molecular motor gene transfer can confer calcium-independent positive inotropy in slow beta-myosin-dominant rabbit and human failing ventricular myocytes. To this end, we generated a recombinant adenovirus (AdMYH6) to deliver the full-length human alpha-myosin gene to adult rabbit and human cardiac myocytes in vitro. Fast alpha-myosin motor expression was determined by Western blotting and immunocytochemical analysis and confocal imaging. In experiments using electrically stimulated myocytes from ischemic failing hearts, AdMYH6 increased the contractile amplitude of failing human [23.9 +/- 7.8 nm (n = 10) vs. AdMYH6 amplitude 78.4 +/- 16.5 nm (n = 6)] and rabbit myocytes. The intracellular calcium transient amplitude was not altered. Control experiments included the use of a green fluorescent protein or a beta-myosin heavy chain adenovirus. Our data provide evidence for a novel form of calcium-independent positive inotropy in failing cardiac myocytes by fast alpha-myosin motor protein gene transfer.-Herron, T. J., Devaney, E., Mundada, L., Arden, E., Day, S., Guerrero-Serna, G., Turner, I., Westfall, M., Metzger, J. M. Ca2+-independent positive molecular inotropy for failing rabbit and human cardiac muscle by alpha-myosin motor gene transfer. FASEB J. 24, 415-424 (2010). www.fasebj.org	[Arden, Erik; Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Herron, Todd J.; Turner, Immanuel; Westfall, Margaret] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Herron, Todd J.; Guerrero-Serna, Guadalupe] Univ Michigan, Sch Med, Ctr Arrhythmia Res, Ann Arbor, MI USA; [Devaney, Eric; Mundada, Lakshmi; Westfall, Margaret] Univ Michigan, Sch Med, Dept Cardiac Surg, Ann Arbor, MI USA; [Day, Sharlene] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Metzger, JM (corresponding author), Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, 6-125 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	metzgerj@umn.edu		Westfall, Margaret/0000-0001-9491-0125	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL080880] Funding Source: NIH RePORTER; NHLBI NIH HHS [L30 HL082192, F32 HL080880] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antoniades C, 2007, PHARMACOL THERAPEUT, V114, P184, DOI 10.1016/j.pharmthera.2007.01.008; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Butter C, 2008, J AM COLL CARDIOL, V51, P1784, DOI 10.1016/j.jacc.2008.01.036; Cleland JGF, 2006, EUR J HEART FAIL, V8, P105, DOI 10.1016/j.ejheart.2005.12.003; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; Cross HR, 2003, AM J PHYSIOL-HEART C, V284, pH683, DOI 10.1152/ajpheart.00567.2002; Day SM, 2006, NAT MED, V12, P181, DOI 10.1038/nm1346; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; Fitzsimons DP, 1999, AM J PHYSIOL-HEART C, V276, pH1511; Fitzsimons DP, 1998, J PHYSIOL-LONDON, V513, P171, DOI 10.1111/j.1469-7793.1998.171by.x; GORZA L, 1984, CIRC RES, V54, P694, DOI 10.1161/01.RES.54.6.694; HARRIS DE, 1994, J MUSCLE RES CELL M, V15, P11, DOI 10.1007/BF00123828; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; Herron TJ, 2001, AM J PHYSIOL-HEART C, V281, pH1217, DOI 10.1152/ajpheart.2001.281.3.H1217; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; HOH JFY, 1978, J MOL CELL CARDIOL, V10, P1053, DOI 10.1016/0022-2828(78)90401-7; HOLUBARSCH C, 1985, CIRC RES, V56, P78, DOI 10.1161/01.RES.56.1.78; James J, 2005, CIRCULATION, V111, P2339, DOI 10.1161/01.CIR.0000164233.09448.B1; Korte FS, 2005, AM J PHYSIOL-HEART C, V289, pH801, DOI 10.1152/ajpheart.01227.2004; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; LITTEN RZ, 1985, CIRC RES, V57, P406, DOI 10.1161/01.RES.57.3.406; Locher MR, 2009, AM J PHYSIOL-HEART C, V297, pH247, DOI 10.1152/ajpheart.00922.2008; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; MAHAFFEY KW, 1995, CIRCULATION, V91, P794, DOI 10.1161/01.CIR.91.3.794; Marian AJ, 2005, CIRCULATION, V111, P2276, DOI 10.1161/01.CIR.0000167559.13502.9A; Maurice JP, 1999, AM J PHYSIOL-HEART C, V276, pH1853, DOI 10.1152/ajpheart.1999.276.6.H1853; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; MERCADIER JJ, 1981, CIRC RES, V49, P525, DOI 10.1161/01.RES.49.2.525; METZGER JM, 1995, BIOPHYS J, V68, P1430, DOI 10.1016/S0006-3495(95)80316-4; Metzger JM, 1999, CIRC RES, V84, P1310, DOI 10.1161/01.RES.84.11.1310; Michele DE, 2000, TRENDS CARDIOVAS MED, V10, P177, DOI 10.1016/S1050-1738(00)00067-0; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Palmer S, 1998, CIRC RES, V83, P179, DOI 10.1161/01.RES.83.2.179; Perrone SV, 2005, INT J CARDIOL, V103, P248, DOI 10.1016/j.ijcard.2004.12.012; Rastogi S, 2005, HEART FAIL REV, V10, P157, DOI 10.1007/s10741-005-4643-z; Rundell VLM, 2004, AM J PHYSIOL-HEART C, V287, pH408, DOI 10.1152/ajpheart.00049.2004; Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schoffstall B, 2006, J PHYSIOL-LONDON, V577, P935, DOI 10.1113/jphysiol.2006.120105; Solaro RJ, 2009, IDRUGS, V12, P243; Sugiura S, 1998, CIRC RES, V82, P1029, DOI 10.1161/01.RES.82.10.1029; Suzuki T, 2009, CIRC-HEART FAIL, V2, P334, DOI 10.1161/CIRCHEARTFAILURE.108.802298; Tardiff JC, 2000, AM J PHYSIOL-HEART C, V278, pH412, DOI 10.1152/ajpheart.2000.278.2.H412; Teerlink JR, 2009, HEART FAIL REV, V14, P289, DOI 10.1007/s10741-009-9135-0; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089	49	24	25	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					415	424		10.1096/fj.09-140566	http://dx.doi.org/10.1096/fj.09-140566			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19801488	Green Published			2022-12-25	WOS:000274045000010
J	Morales-Rios, E; de la Rosa-Morales, F; Mendoza-Hernandez, G; Rodriguez-Zavala, JS; Celis, H; Zarco-Zavala, M; Garcia-Trejo, JJ				Morales-Rios, Edgar; de la Rosa-Morales, Fernanda; Mendoza-Hernandez, Guillermo; Rodriguez-Zavala, Jose S.; Celis, Heliodoro; Zarco-Zavala, Mariel; Garcia-Trejo, Jose J.			A novel 11-kDa inhibitory subunit in the F1FO ATP synthase of Paracoccus denitrificans and related alpha-proteobacteria	FASEB JOURNAL			English	Article						inhibitor; F1FO ATPase; nanomotor; rhodobacteraceae	BLUE NATIVE ELECTROPHORESIS; OXIDATIVE-PHOSPHORYLATION; RHODOSPIRILLUM-RUBRUM; F1F0-ATP SYNTHASE; STRUCTURAL BASIS; EPSILON-SUBUNIT; PURIFICATION; PROTEIN; RESOLUTION; ROTATION	The F1FO and F-1-ATPase complexes of Paracoccus denitrificans were isolated for the first time by ion exchange, gel filtration, and density gradient centrifugation into functional native preparations. The liposome-reconstituted holoenzyme preserves its tight coupling between F-1 and F-O sectors, as evidenced by its high sensitivity to the FO inhibitors venturicidin and diciclohexylcarbodiimide. Comparison and N-terminal sequencing of the band profile in SDS-PAGE of the F-1 and F1FO preparations showed a novel 11-kDa protein in addition to the 5 canonical alpha, beta, gamma, delta, and epsilon subunits present in all known F-1-ATPase complexes. BN-PAGE followed by 2D-SDS-PAGE confirmed the presence of this 11-kDa protein bound to the native F1FO-ATP synthase of P. denitrificans, as it was observed after being isolated. The recombinant 11 kDa and epsilon subunits of P. denitrificans were cloned, overexpressed, isolated, and reconstituted in particulate F1FO and soluble F-1-ATPase complexes. The 11-kDa protein, but not the epsilon subunit, inhibited the F1FO and F-1-ATPase activities of P. denitrificans. The 11-kDa protein was also found in Rhodobacter sphaeroides associated to its native F1FO-ATPase. Taken together, the data unveil a novel inhibitory mechanism exerted by this 11-kDa protein on the F1FO-ATPase nanomotor of P. denitrificans and closely related alpha-proteobacteria.-Morales-Rios, E., de la Rosa-Morales, F., Mendoza-Hernandez, G., Rodriguez-Zavala, J. S., Celis, H., Zarco-Zavala, M., Garcia-Trejo, J. J. A novel 11-kDa inhibitory subunit in the F1FO ATP synthase of Paracoccus denitrificans and related alpha-proteobacteria. FASEB J. 24, 599-608 (2010). www.fasebj.org	[Morales-Rios, Edgar; Zarco-Zavala, Mariel; Garcia-Trejo, Jose J.] Univ Nacl Autonoma Mexico, Fac Chem, Dept Biol, Mexico City 04510, DF, Mexico; [Mendoza-Hernandez, Guillermo] Univ Nacl Autonoma Mexico, Dept Biochem, Fac Med, Mexico City 04510, DF, Mexico; [Celis, Heliodoro] Univ Nacl Autonoma Mexico, Cell Physiol Inst, Mexico City 04510, DF, Mexico; [de la Rosa-Morales, Fernanda; Rodriguez-Zavala, Jose S.] Natl Inst Cardiol, Dept Biochem, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; National Institute of Cardiology - Mexico	Garcia-Trejo, JJ (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Ciudad Univ,Edificio F,Lab 117, Mexico City 04510, DF, Mexico.	jjgartre@unam.mx	Rodriguez-Zavala, Jose S/AAI-3604-2020	Rodriguez-Zavala, Jose S/0000-0002-7094-5523; Morales-Rios, Edgar/0000-0003-1139-2292	National Research Council of Mexico [J34744-N, V43814-M]; UNAM	National Research Council of Mexico; UNAM(Universidad Nacional Autonoma de Mexico)	The experimental work of Alicia Castillo-Martinez and Fermin Pacheco-Moises in the initial part of this project is gratefully acknowledged. The excellent assistance of Paulina Cortes-Hernandez in the preparation of the polyclonal antibody against the 11-kDa subunit is acknowledged. Monoclonal antibodies against E. coli F1-ATPase subunits (subunit alpha) were kindly given by Prof. Roderick A. Capaldi (University of Oregon, Eugene, OR, USA). The supply of the PD1222 strain of P. denitrificans was provided by Juan Carlos Estrada-Mora (director of the Collection of Microbial Cultures, CIN-VESTAV-IPN, Mexico City, Mexico). This strain is also known as CDBB-B-912, according to the registration in the World Federation for Culture Collection. The collaborative efforts of Mario F. Fuentes-Iniestra [head librarian, Instituto Nacional de Cardiologia (INC), Mexico City, Mexico], in literature acquisition and submission of data are also acknowledged. The critical reading and excellent suggestions for the manuscript of Prof. Armando Gomez-Puyou are gratefully acknowledged. This work was supported by two consecutive research projects from the National Research Council of Mexico (CONACyT; projects J34744-N and V43814-M) and by a recent grant from UNAM under the program Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Technologica (DGAPA-PAPIIT) 2009, (project IN213809-3).	Aggeler R, 2002, J BIOL CHEM, V277, P33906, DOI 10.1074/jbc.M204538200; Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Brosche M, 1998, EUR J BIOCHEM, V255, P87, DOI 10.1046/j.1432-1327.1998.2550087.x; Cook GM, 2003, J BACTERIOL, V185, P4442, DOI 10.1128/JB.185.15.4442-4449.2003; Cortes-Hernandez P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200; DEVRIES GE, 1989, ARCH MICROBIOL, V152, P52, DOI 10.1007/BF00447011; Enroth C, 2008, BBA-PROTEINS PROTEOM, V1784, P379, DOI 10.1016/j.bbapap.2007.11.005; Etzold C, 1997, EUR J BIOCHEM, V243, P336, DOI 10.1111/j.1432-1033.1997.0336a.x; FALK G, 1988, BIOCHEM J, V254, P109, DOI 10.1042/bj2540109; FALK G, 1985, BIOCHEM J, V228, P391, DOI 10.1042/bj2280391; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Fiske CH, 1925, J BIOL CHEM, V66, P375; Garcia JJ, 1998, J BIOL CHEM, V273, P15940, DOI 10.1074/jbc.273.26.15940; Garcia-Trejo JJ, 2008, J BIOL PHYS, V34, P197, DOI 10.1007/s10867-008-9114-z; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; HARRIS DA, 1977, BIOCHIM BIOPHYS ACTA, V459, P546, DOI 10.1016/0005-2728(77)90053-6; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; JOHANSSON BC, 1975, FEBS LETT, V53, P221, DOI 10.1016/0014-5793(75)80024-X; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; Keis S, 2006, J BACTERIOL, V188, P3796, DOI 10.1128/JB.00040-06; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Minauro-Sanmiguel F, 2002, J BIOENERG BIOMEMBR, V34, P433, DOI 10.1023/A:1022514008462; MULLER H, 1982, EUR J BIOCHEM, V127, P559; NORLING B, 1988, BIOCHIM BIOPHYS ACTA, V935, P123, DOI 10.1016/0005-2728(88)90209-5; OHKUBO S, 1986, J BIOCHEM, V100, P1261, DOI 10.1093/oxfordjournals.jbchem.a121832; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; Pacheco-Moises F, 2002, J BIOENERG BIOMEMBR, V34, P269, DOI 10.1023/A:1020252401675; Pacheco-Moises F, 2000, EUR J BIOCHEM, V267, P993, DOI 10.1046/j.1432-1327.2000.01088.x; PENNOYER JD, 1988, BIOCHIM BIOPHYS ACTA, V935, P195, DOI 10.1016/0005-2728(88)90216-2; PEREZ JA, 1990, BIOCHEMISTRY-US, V29, P10503, DOI 10.1021/bi00498a013; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PRINGLE MJ, 1985, BIOCHEMISTRY-US, V24, P7366, DOI 10.1021/bi00346a051; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; SCHAGGER H, 1995, ELECTROPHORESIS, V16, P763, DOI 10.1002/elps.11501601125; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SOSA A, 1995, ARCH BIOCHEM BIOPHYS, V316, P421, DOI 10.1006/abbi.1995.1056; STERNWEIS PC, 1980, BIOCHEMISTRY-US, V19, P526, DOI 10.1021/bi00544a021; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; TUENADEGOMEZPUYOU M, 1977, ARCH BIOCHEM BIOPHYS, V182, P82; WILLIAMS N, 1986, METHOD ENZYMOL, V126, P477; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Zharova TV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1101, DOI 10.1023/A:1026306611821	48	41	43	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					599	608		10.1096/fj.09-137356	http://dx.doi.org/10.1096/fj.09-137356			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19783785				2022-12-25	WOS:000274045000027
J	Yoo, Y; Ho, HJ; Wang, C; Guan, JL				Yoo, Y.; Ho, H. J.; Wang, C.; Guan, J-L			Tyrosine phosphorylation of cofilin at Y68 by v-Src leads to its degradation through ubiquitin-proteasome pathway	ONCOGENE			English	Article						cofilin; protein phosphorylation; protein degradation; cell spreading	FOCAL ADHESION KINASE; ACTIN DEPOLYMERIZING FACTOR; CELL-MIGRATION; CANCER-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; DOWN-REGULATION; N-WASP; ADF/COFILIN; DYNAMICS; MOTILITY	Cofilin is a major regulator of actin dynamics involved in the regulation of cell spreading and migration through its actin depolymerizing and severing activities. v-Src is an activated Src tyrosine kinase and a potent oncogene known to phosphorylate a variety of cellular proteins in cell transformation process including altered cell adhesion, spreading and migration. Recently, it has been suggested that cofilin is a potential substrate of v-Src (Rush et al., 2005). Here, we show direct tyrosine phosphorylation of cofilin by v-Src and identify Y68 as the major phosphorylation site. Cofilin phosphorylation at Y68 did not change its activity per se, but induced increased ubiquitination of cofilin and its degradation through the proteosome pathway. Furthermore, the negative effect of cofilin on cellular F-actin contents was inhibited by coexpression of v-Src, whereas that of cofilin mutant Y68F (Y68 mutated to F) was not affected, suggesting that v-Src-mediated cofilin phosphorylation at Y68 is required for the degradation of cofilin in vivo. Lastly, inhibition of cell spreading by v-Src was rescued partially by coexpression of cofilin, and to a greater extent by the Y68F mutant, which is not subjected to v-Src-induced degradation through phosphorylation, suggesting that v-Src-mediated changes in cell spreading is, at least in part, through inhibiting the function of cofilin through phosphorylating it at Y68. Together, these results suggest a novel mechanism by which cofilin is regulated by v-Src through tyrosine phosphorylation at Y68 that triggers the degradation of cofilin through ubiquitination proteosome pathway and consequently inhibits cofilin activity in reducing cellular F-actin contents and cell spreading. Oncogene (2010) 29, 263-272; doi:10.1038/onc.2009.319; published online 5 October 2009	[Yoo, Y.; Ho, H. J.; Wang, C.; Guan, J-L] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Guan, J-L] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	wang, chenran/N-6629-2013		NIH [GM48050]; NATIONAL CANCER INSTITUTE [R01CA150926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr Xiaoyang Wu for discussions during the initial stages of the project. We thank our colleagues Huijun Wei, Ming Luo, Huaping Fan, Fei Liu, Chenran Wang, Richard Liang, Ann Park and Xiaofeng Zhao for their critical reading of the paper and helpful comments. This research was supported by NIH grant GM48050 to J-L Guan.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Bailly M, 2003, CURR BIOL, V13, pR128, DOI 10.1016/S0960-9822(03)00072-1; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Bianchi F, 2006, P NATL ACAD SCI USA, V103, P18981, DOI 10.1073/pnas.0605821103; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; BOSCHEK CB, 1981, CELL, V24, P175, DOI 10.1016/0092-8674(81)90513-4; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chaar Z, 2006, J BIOL CHEM, V281, P28193, DOI 10.1074/jbc.M605665200; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Christopher RA, 2000, INT J MOL MED, V5, P575; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; KELLIE S, 1986, EXP CELL RES, V165, P216, DOI 10.1016/0014-4827(86)90546-X; LaLonde DP, 2005, J BIOL CHEM, V280, P21680, DOI 10.1074/jbc.m500752200; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lin R, 2006, CELL COMMUN ADHES, V13, P199, DOI 10.1080/15419060600848516; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; Meberg PJ, 2000, MOL NEUROBIOL, V21, P97, DOI 10.1385/MN:21:1-2:097; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Samstag Y, 1996, J IMMUNOL, V156, P4167; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; SHRIVER K, 1981, J CELL BIOL, V89, P525, DOI 10.1083/jcb.89.3.525; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tsumura Y, 2005, BIOCHEM J, V387, P627, DOI 10.1042/BJ20041181; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Wakatsuki T, 2003, J CELL SCI, V116, P1617, DOI 10.1242/jcs.00340; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yap CT, 2005, CELL MOTIL CYTOSKEL, V60, P153, DOI 10.1002/cm.20053; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yoo YD, 2006, J BIOL CHEM, V281, P15352, DOI 10.1074/jbc.M511825200; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	62	48	55	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2010	29	2					263	272		10.1038/onc.2009.319	http://dx.doi.org/10.1038/onc.2009.319			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19802004	Green Accepted			2022-12-25	WOS:000273650000009
J	Duan, L; Chen, GS; Virmani, S; Ying, GG; Raja, SM; Chung, BM; Rainey, MA; Dimri, M; Ortega-Cava, CF; Zhao, XS; Clubb, RJ; Tu, C; Reddi, AL; Naramura, M; Band, V; Band, H				Duan, Lei; Chen, Gengsheng; Virmani, Sumeet; Ying, GuoGuang; Raja, Srikumar M.; Chung, Byung Min; Rainey, Mark A.; Dimri, Manjari; Ortega-Cava, Cesar F.; Zhao, Xiangshan; Clubb, Robert J.; Tu, Chun; Reddi, Alagarsamy L.; Naramura, Mayumi; Band, Vimla; Band, Hamid			Distinct Roles for Rho Versus Rac/Cdc42 GTPases Downstream of Vav2 in Regulating Mammary Epithelial Acinar Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; GROWTH-FACTOR RECEPTORS; BASEMENT-MEMBRANE CULTURES; GTP-BINDING PROTEIN; HUMAN BREAST-CANCER; RAC1 SMALL GTPASES; MDCK CELLS; BRANCHING MORPHOGENESIS; NUCLEAR-ORGANIZATION; SIGNALING PATHWAYS	Non-malignant mammary epithelial cells (MECs) undergo acinar morphogenesis in three-dimensional Matrigel culture, a trait that is lost upon oncogenic transformation. Rho GTPases are thought to play important roles in regulating epithelial cell-cell junctions, but their contributions to acinar morphogenesis remain unclear. Here we report that the activity of Rho GTPases is down-regulated in non-malignant MECs in three-dimensional culture with particular suppression of Rac1 and Cdc42. Inducible expression of a constitutively active form of Vav2, a Rho GTPase guanine nucleotide exchange factor activated by receptor tyrosine kinases, in three-dimensional MEC culture activated Rac1 and Cdc42; Vav2 induction from early stages of culture impaired acinar morphogenesis, and induction in preformed acini disrupted the pre-established acinar architecture and led to cellular outgrowths. Knockdown studies demonstrated that Rac1 and Cdc42 mediate the constitutively active Vav2 phenotype, whereas in contrast, RhoA knockdown intensified the Vav2-induced disruption of acini, leading to more aggressive cell outgrowth and branching morphogenesis. These results indicate that RhoA plays an antagonistic role to Rac1/Cdc42 in the control of mammary epithelial acinar morphogenesis.	[Duan, Lei; Raja, Srikumar M.; Chung, Byung Min; Rainey, Mark A.; Ortega-Cava, Cesar F.; Clubb, Robert J.; Tu, Chun; Naramura, Mayumi; Band, Vimla; Band, Hamid] Univ Nebraska, Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE 68198 USA; [Zhao, Xiangshan; Band, Vimla; Band, Hamid] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Naramura, Mayumi; Band, Hamid] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Band, Vimla; Band, Hamid] Univ Nebraska, Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA; [Duan, Lei; Chen, Gengsheng; Virmani, Sumeet; Ying, GuoGuang; Raja, Srikumar M.; Chung, Byung Min; Rainey, Mark A.; Dimri, Manjari; Ortega-Cava, Cesar F.; Zhao, Xiangshan; Clubb, Robert J.; Tu, Chun; Reddi, Alagarsamy L.; Naramura, Mayumi; Band, Vimla; Band, Hamid] Northwestern Univ, Feinberg Sch Med, Dept Med, NorthShore Univ HealthSyst, Evanston, IL 60201 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; NorthShore University Health System; Northwestern University; Feinberg School of Medicine	Duan, L (corresponding author), Rush Univ, Dept Radiat Oncol, Med Ctr, 1750 W Harrison St,Jelke Bldg Rm 1306A, Chicago, IL 60612 USA.	lei_duan@rush.edu; vband@unmc.edu; hband@unmc.edu	Chung, Byung Min/H-6219-2019	Chung, Byung Min/0000-0003-1262-5107; Naramura, Mayumi/0000-0003-3658-0767	National Institutes of Health [CA105489, CA87986, CA99900, CA99163, CA116552, CA94143, CA96844]; Department of Defense Breast Cancer Research [W81XVVH-08-10617, W81XWH-05-1-0231, DAMD17-02-1-0508, W81XWH-07-1-0351]; Jean Ruggles-Romoser Chair of Cancer Research; Duckworth Family Chair of Breast Cancer Research; Nebraska Department of Health and Human Services [LB506]; University of Nebraska Medical Center-Eppley Cancer Center; NATIONAL CANCER INSTITUTE [R01CA099163, R01CA094143, R01CA116552, R01CA099900, R01CA105489, R01CA087986, R01CA096844, P30CA036727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); Jean Ruggles-Romoser Chair of Cancer Research; Duckworth Family Chair of Breast Cancer Research; Nebraska Department of Health and Human Services; University of Nebraska Medical Center-Eppley Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105489, CA87986, CA99900, CA99163, and CA116552 (to H.B.) and CA94143 and CA96844 (to V.B.). This work was also supported by Department of Defense Breast Cancer Research Grants W81XVVH-08-10617 (to H.B.), W81XWH-05-1-0231 (to V.B.), DAMD17-02-1-0508 (to V.B.), and W81XWH-07-1-0351 (to V.B.); the Jean Ruggles-Romoser Chair of Cancer Research (to H.B.); the Duckworth Family Chair of Breast Cancer Research (to V.B.); Nebraska Department of Health and Human Services Grant LB506 (to S.M.R.); and a Pilot Project grant from the University of Nebraska Medical Center-Eppley Cancer Center (to M.N.).	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Ansquer Y, 2005, ANTICANCER RES, V25, P4535; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; Bissell MJ, 1999, CANCER RES, V59, p1763S; Bissell MJ, 1999, CANCER RES, V59, p1757S; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; FLIER JS, 1989, NEW ENGL J MED, V321, P1383, DOI 10.1056/NEJM198911163212007; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fujita Y., 2005, NOVART FDN SYMP, V269; Fujita Y., 2005, NOVART FDN SYMP, V269, P223; Fujita Yasuyuki, 2005, Novartis Found Symp, V269, P144; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Liu H, 2005, CELL CYCLE, V4, P646, DOI 10.4161/cc.4.5.1674; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Magkou C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2103; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Miao H, 2003, J CELL BIOL, V162, P1281, DOI 10.1083/jcb.200304018; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; RAJKUMAR T, 1994, BREAST CANCER RES TR, V29, P3, DOI 10.1007/BF00666177; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; TAKAISHI K, 1994, ONCOGENE, V9, P273; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Weaver VM, 1996, BIOCHEM CELL BIOL, V74, P833, DOI 10.1139/o96-089; WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Yahara I, 1996, CELL STRUCT FUNCT, V21, P421, DOI 10.1247/csf.21.421	64	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1555	1568		10.1074/jbc.M109.057976	http://dx.doi.org/10.1074/jbc.M109.057976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19826000	Green Published, hybrid			2022-12-25	WOS:000273258200074
J	Cayli, S; Klug, J; Chapiro, J; Frohlich, S; Krasteva, G; Orel, L; Meinhardt, A				Cayli, Sevil; Klug, Joerg; Chapiro, Julius; Froehlich, Suada; Krasteva, Gabriela; Orel, Lukas; Meinhardt, Andreas			COP9 Signalosome Interacts ATP-dependently with p97/Valosin-containing Protein (VCP) and Controls the Ubiquitination Status of Proteins Bound to p97/VCP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION INHIBITORY FACTOR; AAA-ATPASE; DEUBIQUITINATING ENZYME; DNA-DAMAGE; CELL-CYCLE; MPN DOMAIN; P97; BINDING; DEGRADATION; COMPLEX	Ubiquitinated proteins can alternatively be delivered directly to the proteasome or via p97/VCP (valosin-containing protein). Whereas the proteasome degrades ubiquitinated proteins, the homohexameric ATPase p97/VCP seems to control the ubiquitination status of recruited substrates. The COP9 signalosome (CSN) is also involved in the ubiquitin/proteasome system (UPS) as exemplified by regulating the neddylation of ubiquitin E3 ligases. Here, we show that p97/VCP colocalizes and directly interacts with subunit 5 of the CSN (CSN5) in vivo and is associated with the entire CSN complex in an ATP-dependent manner. Furthermore, we provide evidence that the CSN and in particular the isopeptidase activity of its subunit CSN5 as well as the associated deubiquitinase USP15 are required for proper processing of polyubiquitinated substrates bound to p97/VCP. Moreover, we show that in addition to NEDD8, CSN5 binds to oligoubiquitin chains in vitro. Therefore, CSN and p97/VCP could form an ATP-dependent complex that resembles the 19 S proteasome regulatory particle and serves as a key mediator between ubiquitination and degradation pathways.	[Cayli, Sevil; Klug, Joerg; Chapiro, Julius; Froehlich, Suada; Meinhardt, Andreas] Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, D-35385 Giessen, Germany; [Krasteva, Gabriela] Univ Giessen, Dept Anat & Cell Biol, Unit Cardiopulm Neurobiol, D-35385 Giessen, Germany; [Orel, Lukas] Med Univ Vienna, Ctr Biomol Med & Pharmacol, A-1090 Vienna, Austria	Justus Liebig University Giessen; Justus Liebig University Giessen; Medical University of Vienna	Meinhardt, A (corresponding author), Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, Aulweg 123, D-35385 Giessen, Germany.	andreas.meinhardt@anatomie.med.uni-giessen.de	Meinhardt, Andreas/B-3688-2009; Cayli, Sevil/V-2342-2019; Krasteva-Christ, Gabriela/K-7253-2015; Krasteva-Christ, Gabriela/CAI-9036-2022	Krasteva-Christ, Gabriela/0000-0002-0113-521X; Krasteva-Christ, Gabriela/0000-0002-0113-521X; Cayli, Sevil/0000-0003-2465-5389	University Medical Center Giessen and Marburg	University Medical Center Giessen and Marburg	This work was supported in part by a research grant from the University Medical Center Giessen and Marburg (to A. M.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Alves BSC, 2006, BIOCHEM BIOPH RES CO, V347, P608, DOI 10.1016/j.bbrc.2006.06.133; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bellare P, 2006, RNA, V12, P292, DOI 10.1261/rna.2152306; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Burger-Kentischer A, 2005, FEBS LETT, V579, P1693, DOI 10.1016/j.febslet.2005.01.080; Chamovitz DA, 2009, EMBO REP, V10, P352, DOI 10.1038/embor.2009.33; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Filip AM, 2009, J BIOL CHEM, V284, P7977, DOI 10.1074/jbc.M808620200; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hetfeld BKJ, 2005, METHOD ENZYMOL, V398, P481, DOI 10.1016/S0076-6879(05)98039-7; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Huang XH, 2005, FEBS J, V272, P3909, DOI 10.1111/j.1742-4658.2005.04807.x; Indig FE, 2004, J STRUCT BIOL, V146, P251, DOI 10.1016/j.jsb.2003.11.009; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Kim BC, 2004, MOL CELL BIOL, V24, P2251, DOI 10.1128/MCB.24.6.2251-2262.2004; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Nemajerova A, 2007, CELL CYCLE, V6, P1030, DOI 10.4161/cc.6.9.4163; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Peth Andreas, 2007, BMC Biochemistry, V8, P27, DOI 10.1186/1471-2091-8-27; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Sambrook SJ, 2001, MOL CLONING LAB MANU; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Stoeckelhuber M, 2006, HISTOCHEM CELL BIOL, V126, P103, DOI 10.1007/s00418-005-0137-2; Suh MH, 2005, ANAL BIOCHEM, V343, P166, DOI 10.1016/j.ab.2005.05.016; Tresaugues Lionel, 2004, Journal of Structural and Functional Genomics, V5, P195, DOI 10.1023/B:JSFG.0000029017.46332.e3; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	47	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34944	34953		10.1074/jbc.M109.037952	http://dx.doi.org/10.1074/jbc.M109.037952			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826004	Green Published, hybrid			2022-12-25	WOS:000272439600050
J	Han, YH; Garron, ML; Kim, HY; Kim, WS; Zhang, ZQ; Ryu, KS; Shaya, D; Xiao, ZP; Cheong, C; Kim, YS; Linhardt, RJ; Jeon, YH; Cygler, M				Han, Young-Hyun; Garron, Marie-Line; Kim, Hye-Yeon; Kim, Wan-Seok; Zhang, Zhenqing; Ryu, Kyeong-Seok; Shaya, David; Xiao, Zhongping; Cheong, Chaejoon; Kim, Yeong Shik; Linhardt, Robert J.; Jeon, Young Ho; Cygler, Miroslaw			Structural Snapshots of Heparin Depolymerization by Heparin Lyase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVOBACTERIUM-HEPARINUM; ENZYME; ALGINATE; OLIGOSACCHARIDES; CRYSTALLOGRAPHY; PURIFICATION; ELIMINATION; DEGRADATION; HYDROLASES; DISTORTION	Heparin lyase I (heparinase I) specifically depolymerizes heparin, cleaving the glycosidic linkage next to iduronic acid. Here, we show the crystal structures of heparinase I from Bacteroides thetaiotaomicron at various stages of the reaction with heparin oligosaccharides before and just after cleavage and product disaccharide. The heparinase I structure is comprised of a beta-jelly-roll domain harboring a long and deep substrate binding groove and an unusual thumb-resembling extension. This thumb, decorated with many basic residues, is of particular importance in activity especially on short heparin oligosaccharides. Unexpected structural similarity of the active site to that of heparinase II with an (alpha/alpha)(6) fold is observed. Mutational studies and kinetic analysis of this enzyme provide insights into the catalytic mechanism, the substrate recognition, and processivity.	[Cheong, Chaejoon; Jeon, Young Ho] Korea Basic Sci Inst, Magnet Resonance Team, Ochang 363883, Chungbuk, South Korea; [Garron, Marie-Line; Shaya, David; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3A 2T5, Canada; [Kim, Wan-Seok; Kim, Yeong Shik] Seoul Natl Univ, Coll Pharm, Inst Nat Prod Res, Seoul 151742, South Korea; [Zhang, Zhenqing; Xiao, Zhongping; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Zhang, Zhenqing; Xiao, Zhongping; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Troy, NY 12180 USA; [Zhang, Zhenqing; Xiao, Zhongping; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Cygler, Miroslaw] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Han, Young-Hyun] Chungbuk Natl Univ, Coll Nat Sci, Dept Biochem, Cheongju 361763, South Korea; [Jeon, Young Ho] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon 305333, South Korea	Korea Basic Science Institute (KBSI); McGill University; Seoul National University (SNU); Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; National Research Council Canada; Chungbuk National University	Jeon, YH (corresponding author), Korea Basic Sci Inst, Magnet Resonance Team, Ochang 363883, Chungbuk, South Korea.	yhjeon@kbsi.re.kr; mirek@bri.nrc.ca	Jeon, Young Ho/F-4483-2011; Cheong, Chaejoon/GWC-3135-2022	Garron, Marie-Line/0000-0001-5846-1246	National Institutes of Health [GM38060, HL62244]; Top-brand Research Program [T29220]; 21C Frontier Microbial Genomics and Applications Center program; Canadian Institutes of Health Research [MOP-48370]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Top-brand Research Program; 21C Frontier Microbial Genomics and Applications Center program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM38060 and HL62244 (to R. J. L.). This work was also supported by the Top-brand Research Program (T29220, Korea Basic Science Institute) (to Y. H. J.), the 21C Frontier Microbial Genomics and Applications Center program (to Y. H. J.), and the Canadian Institutes of Health Research Grant MOP-48370 (to M. C.).	Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CASU B, 1985, ADV CARBOHYD CHEM BI, V43, P51, DOI 10.1016/S0065-2318(08)60067-0; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; GERLT JA, 1992, J AM CHEM SOC, V114, P5928, DOI 10.1021/ja00041a004; Godavarti R, 1996, BIOCHEM BIOPH RES CO, V229, P770, DOI 10.1006/bbrc.1996.1879; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; Kato-Toma Y, 2003, BIOCHEM J, V371, P175, DOI 10.1042/BJ20021447; KUROKI R, 1993, SCIENCE, V262, P2030, DOI 10.1126/science.8266098; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Money VA, 2006, ANGEW CHEM INT EDIT, V45, P5136, DOI 10.1002/anie.200600802; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Rigden DJ, 2006, J MOL BIOL, V358, P1165, DOI 10.1016/j.jmb.2006.02.066; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Strynadka N C, 1996, EXS, V75, P185; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1763, DOI 10.1107/S0907444901013749; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; YANG VC, 1985, J BIOL CHEM, V260, P1849; Yip VL, 2006, CURR OPIN CHEM BIOL, V10, P147, DOI 10.1016/j.cbpa.2006.02.005	37	45	50	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34019	34027		10.1074/jbc.M109.025338	http://dx.doi.org/10.1074/jbc.M109.025338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801541	Green Published, hybrid			2022-12-25	WOS:000272165200034
J	Sarajarvi, T; Haapasalo, A; Viswanathan, J; Makinen, P; Laitinen, M; Soininen, H; Hiltunen, M				Sarajarvi, Timo; Haapasalo, Annakaisa; Viswanathan, Jayashree; Makinen, Petra; Laitinen, Marjo; Soininen, Hilkka; Hiltunen, Mikko			Down-regulation of Seladin-1 Increases BACE1 Levels and Activity through Enhanced GGA3 Depletion during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SECRETASE ACTIVITY; STRESS-INDUCED APOPTOSIS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; A-BETA; CHOLESTEROL-BIOSYNTHESIS; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; GENERATION; NEURODEGENERATION	Seladin-1 is a neuroprotective protein selectively down-regulated in brain regions affected in Alzheimer disease (AD). Seladin-1 protects cells against beta-amyloid (A beta) peptide 42- and oxidative stress-induced apoptosis activated by caspase-3, a key mediator of apoptosis. Here, we have employed RNA interference to assess the molecular effects of seladin-1 down-regulation on the beta-secretase (BACE1) function and beta-amyloid precursor protein (APP) processing in SH-SY5Y human neuroblastoma cells in both normal and apoptotic conditions. Our results show that similar to 60% reduction in seladin-1 protein levels, resembling the decrease observed in AD brain, did not significantly affect APP processing or A beta secretion in normal growth conditions. However, under apoptosis, seladin-1 small interfering RNA (siRNA)-transfected cells showed increased caspase-3 activity on average by 2-fold when compared with control siRNA-transfected cells. Increased caspase-3 activity coincided with a significant depletion of the BACE1-sorting protein, GGA3 (Golgi-localized gamma-ear-containing ADP-ribosylation factor-binding protein), and subsequently augmented BACE1 protein levels and activity. Augmented BACE1 activity in turn correlated with the enhanced beta-amyloidogenic processing of APP and ultimately increased A beta production. These adverse changes associated with decreased cell viability in seladin-1 siRNA-transfected cells under apoptosis. No changes in GGA3 or BACE1 levels were found after seladin-1 knockdown in normal growth conditions. Collectively, our results suggest that under stress conditions, reduced seladin-1 expression results in enhanced GGA3 depletion, which further leads to augmented post-translational stabilization of BACE1 and increased beta-amyloidogenic processing of APP. These mechanistic findings related to seladin-1 down-regulation are important in the context of AD as the oxidative stress-induced apoptosis plays a key role in the disease pathogenesis.	[Hiltunen, Mikko] Univ Kuopio, Dept Neurol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, FIN-70211 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital	Hiltunen, M (corresponding author), Univ Kuopio, Dept Neurol, POB 1627, FIN-70211 Kuopio, Finland.	mikko.hiltunen@uku.fi	Sarajärvi, Timo/AAN-3855-2021	Sarajärvi, Timo/0000-0001-8710-1282; Haapasalo, Annakaisa/0000-0003-0959-2957; Chadchankar, Jayashree/0000-0002-0189-569X	Academy of Finland, EVO [5772708]; Nordic Centre of Excellence in Neurodegeneration	Academy of Finland, EVO(Academy of Finland); Nordic Centre of Excellence in Neurodegeneration	This work was supported by the Health Research Council of the Academy of Finland, EVO Grant 5772708 of Kuopio University Hospital, and the Nordic Centre of Excellence in Neurodegeneration.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; Di Stasi D, 2005, INT J CANCER, V115, P224, DOI 10.1002/ijc.20885; Fernandez A, 2009, J NEUROSCI, V29, P6394, DOI 10.1523/JNEUROSCI.4909-08.2009; Greeve I, 2000, J NEUROSCI, V20, P7345; Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hiltunen M, 2009, NEUROBIOL DIS, V35, P103, DOI 10.1016/j.nbd.2009.04.009; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Iivonen S, 2002, NEUROSCIENCE, V113, P301, DOI 10.1016/S0306-4522(02)00180-X; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kuehnle K, 2008, MOL CELL BIOL, V28, P539, DOI 10.1128/MCB.00584-07; Lamsa R, 2007, AM J MED GENET B, V144B, P906, DOI 10.1002/ajmg.b.30532; Lu X, 2008, ENDOCRINOLOGY, V149, P3267, DOI 10.1210/en.2008-0024; Luciani P, 2005, J CLIN ENDOCR METAB, V90, P6156, DOI 10.1210/jc.2005-0633; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173	26	53	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34433	34443		10.1074/jbc.M109.036202	http://dx.doi.org/10.1074/jbc.M109.036202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815556	hybrid, Green Published			2022-12-25	WOS:000272165200073
J	Bibby, RA; Tang, C; Faisal, A; Drosopoulos, K; Lubbe, S; Houlston, R; Bayliss, R; Linardopoulos, S				Bibby, Rachel Ann; Tang, Chan; Faisal, Amir; Drosopoulos, Konstantinos; Lubbe, Steven; Houlston, Richard; Bayliss, Richard; Linardopoulos, Spiros			A Cancer-associated Aurora A Mutant Is Mislocalized and Misregulated Due to Loss of Interaction with TPX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-DIVISION; CENTROSOME AMPLIFICATION; CHROMOSOME SEGREGATION; SUSCEPTIBILITY GENE; A KINASE; ACTIVATION; SPINDLE; FAMILY; PHOSPHORYLATION	Mutations in protein kinases can drive cancer through alterations of the kinase activity or by uncoupling kinase activity from regulation. Changes to protein expression in Aurora A, a mitotic Ser/Thr kinase, are associated with the development of several human cancers, but the effects of somatic cancer-associated mutations have not been determined. In this study we show that Aurora A kinase activity is altered in different ways in three somatic cancer-associated mutations located within the catalytic domain; Aurora A(V174M) shows constitutively increased kinase activity, Aurora A(S155R) activity is decreased primarily due to misregulation, and Aurora A(S361*) activity is ablated due to loss of structural integrity. These alterations suggest vastly different mechanisms for the role of these three mutations in human cancer. We have further characterized the Aurora A(S155R) mutant protein, found that its reduced cellular activity and mislocalization are due to loss of interaction with TPX2, and deciphered the structural basis of the disruption at 2.5 angstrom resolution. Previous studies have shown that disruption of the Aurora A/TPX2 interaction results in defective spindles that generate chromosomal abnormalities. In a panel of 40 samples from microsatellite instability-positive colon cancer patients, we found one example in which the tumor contained only Aurora A(S155R), whereas the normal tissue contained only wild-type Aurora A. We propose that the S155R mutation is an example of a somatic mutation associated with this tumor type, albeit at modest frequency, that could promote aneuploidy through the loss of regulated interactions between Aurora A and its protein partners.	[Bibby, Rachel Ann; Bayliss, Richard] Chester Beatty Labs, Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; [Tang, Chan; Drosopoulos, Konstantinos; Linardopoulos, Spiros] Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Faisal, Amir; Linardopoulos, Spiros] Inst Canc Res, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England; [Lubbe, Steven; Houlston, Richard] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK	Bayliss, R (corresponding author), Chester Beatty Labs, Inst Canc Res, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	richard.bayliss@icr.ac.uk; linardopoulos@icr.ac.uk	Lubbe, Steven/L-8261-2013; Faisal, Amir/AAE-8992-2020	Lubbe, Steven/0000-0002-7103-6671; Faisal, Amir/0000-0002-7376-8286; Houlston, Richard/0000-0002-5268-0242; Linardopoulos, Spiros/0000-0002-6600-400X; Bayliss, Richard/0000-0003-0604-2773	Royal Society University Research Fellowship; Institute of Cancer Research Studentship; Cancer Research UK [C309/A8274]; Breakthrough Breast Cancer	Royal Society University Research Fellowship(Royal Society of London); Institute of Cancer Research Studentship; Cancer Research UK(Cancer Research UK); Breakthrough Breast Cancer	This work was supported by a Royal Society University Research Fellowship and an Institute of Cancer Research Studentship ( to R. A. B.) and Cancer Research UK Grant C309/A8274 and a grant from Breakthrough Breast Cancer ( to S. L.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewart-Toland A, 2005, CARCINOGENESIS, V26, P1368, DOI 10.1093/carcin/bgi085; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Giet R, 1999, J CELL SCI, V112, P3591; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kimura M, 1999, J BIOL CHEM, V274, P7334, DOI 10.1074/jbc.274.11.7334; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mao JH, 2007, CANCER CELL, V11, P161, DOI 10.1016/j.ccr.2006.11.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Reichardt W, 2003, ONCOL REP, V10, P1275; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005; Tanaka T, 1999, CANCER RES, V59, P2041; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Toyooka S, 2003, HUM MUTAT, V21, P229, DOI 10.1002/humu.10177; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; ZHUO S, 1993, J BIOL CHEM, V268, P17754	46	35	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33177	33184		10.1074/jbc.M109.032722	http://dx.doi.org/10.1074/jbc.M109.032722			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801554	Green Published, hybrid			2022-12-25	WOS:000272028500022
J	Costanzo, G; Pino, S; Ciciriello, F; Di Mauro, E				Costanzo, Giovanna; Pino, Samanta; Ciciriello, Fabiana; Di Mauro, Ernesto			Generation of Long RNA Chains in Water	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPLATE-DIRECTED LIGATION; INFORMATIONAL POLYMERS; AQUEOUS-SOLUTION; DIFFERENTIAL STABILITY; TEMPERATURE-DEPENDENCE; POLYRIBOADENYLIC ACID; PREBIOTIC CHEMISTRY; PHOSPHATE MINERALS; ORIGIN; FORMAMIDE	The synthesis of RNA chains from 3',5'-cAMP and 3',5'-cGMP was observed. The RNA chains formed in water, at moderate temperatures (40-90 degrees C), in the absence of enzymes or inorganic catalysts. As determined by RNase analyses, the bonds formed were canonical 3',5'-phosphodiester bonds. The polymerizations are based on two reactions not previously described: 1) oligomerization of 3',5'-cGMP to similar to 25-nucleotide-long RNA molecules, and of 3',5'-cAMP to 4- to 8-nucleotide-long molecules. Oligonucleotide A molecules were further extended by reciprocal terminal ligation to yield RNA molecules up to > 120 nucleotides long and 2) chain extension by terminal ligation of newly polymerized products of 3',5'-cGMP on preformed oligonucleotides. The enzyme- and template-independent synthesis of long oligomers in water from prebiotically affordable precursors approaches the concept of spontaneous generation of (pre)genetic information.	[Di Mauro, Ernesto] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur Fdn Cenci Bolognett, I-00185 Rome, Italy; [Costanzo, Giovanna] CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Di Mauro, E (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur Fdn Cenci Bolognett, Ple Aldo Moro 5, I-00185 Rome, Italy.	Ernesto.dimauro@uniroma1.it	Ciciriello, Fabiana/AAA-8065-2020	Ciciriello, Fabiana/0000-0003-1493-9767	Italian Space Agency; MoMa project; Agenzia Spaziale Italiana-Istituto Nazionale di Astrofisica, Italy [I/015/07/0]	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); MoMa project; Agenzia Spaziale Italiana-Istituto Nazionale di Astrofisica, Italy(Istituto Nazionale Astrofisica (INAF))	This work was supported by the Italian Space Agency, the MoMa project, and Agenzia Spaziale Italiana-Istituto Nazionale di Astrofisica ( Grant I/015/07/0, Esplorazione del Sistema Solare) Italy.	Alberty RA, 2006, BIOPHYS CHEM, V121, P157, DOI 10.1016/j.bpc.2006.01.004; BECK A, 1965, P NATL ACAD SCI USA, V54, P664, DOI 10.1073/pnas.54.3.664; BERNAL JD, 1949, P PHYS SOC LOND A, V62, P537, DOI 10.1088/0370-1298/62/9/301; BRAHMS J, 1966, J MOL BIOL, V15, P467, DOI 10.1016/S0022-2836(66)80122-5; BRAHMS J, 1967, J MOL BIOL, V25, P481, DOI 10.1016/0022-2836(67)90200-8; CAIRNSSMITH AG, 1966, J THEOR BIOL, V10, P53, DOI 10.1016/0022-5193(66)90178-0; Ciciriello F, 2008, BIOCHEMISTRY-US, V47, P2732, DOI 10.1021/bi7021014; Ciciriello F, 2007, ASTROBIOLOGY, V7, P616, DOI 10.1089/ast.2006.0044; Costanzo G, 2007, J BIOL CHEM, V282, P16729, DOI 10.1074/jbc.M611346200; DARWIN F, 1988, LIFE LETT C DARWIN, V3, P18; DAVIS RC, 1968, BIOPOLYMERS, V6, P223, DOI 10.1002/bip.1968.360060206; EUN HM, 1996, ENZYMOLOGY PRIMER RE, P647; FERRIS JP, 1993, J AM CHEM SOC, V115, P12270, DOI 10.1021/ja00079a006; Ferris JP, 2004, ADV SPACE RES, V33, P100, DOI 10.1016/j.asr.2003.02.010; FINCH JT, 1969, J MOL BIOL, V46, P597, DOI 10.1016/0022-2836(69)90201-0; FRECHET D, 1979, NUCLEIC ACIDS RES, V7, P1981, DOI 10.1093/nar/7.7.1981; Gao K, 2000, ORIGINS LIFE EVOL B, V30, P45, DOI 10.1023/A:1006683507864; HOLCOMB DN, 1965, BIOPOLYMERS, V3, P121, DOI 10.1002/bip.360030203; Huang WH, 2003, CHEM COMMUN, P1458, DOI 10.1039/b303134a; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kanavarioti A, 2001, ASTROBIOLOGY, V1, P271, DOI 10.1089/15311070152757465; KANG H, 1992, BIOPOLYMERS, V32, P1351, DOI 10.1002/bip.360321009; KAWAMURA K, 1994, J AM CHEM SOC, V116, P7564, DOI 10.1021/ja00096a013; LOHRMANN R, 1977, J MOL EVOL, V10, P137, DOI 10.1007/BF01751807; LUTAY AV, 2006, BIOGEOSCI DISCUSS, V3, P1; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; MILLER SL, 1964, NATURE, V204, P1248, DOI 10.1038/2041248a0; Monnard PA, 2003, J AM CHEM SOC, V125, P13734, DOI 10.1021/ja036465h; NORBERG J, 1995, J AM CHEM SOC, V117, P10832, DOI 10.1021/ja00149a006; NORBERG J, 1995, J PHYS CHEM-US, V99, P13056, DOI 10.1021/j100035a002; OLSON WK, 1975, NUCLEIC ACIDS RES, V2, P2055, DOI 10.1093/nar/2.11.2055; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Orgel LE, 1998, TRENDS BIOCHEM SCI, V23, P491, DOI 10.1016/S0968-0004(98)01300-0; Pino S, 2008, J BIOL CHEM, V283, P36494, DOI 10.1074/jbc.M805333200; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Rajamani S, 2008, ORIGINS LIFE EVOL B, V38, P57, DOI 10.1007/s11084-007-9113-2; RENZ M, 1971, BIOCHIM BIOPHYS ACTA, V240; Rohatgi R, 1996, J AM CHEM SOC, V118, P3340, DOI 10.1021/ja9537134; Saladino R, 2006, J BIOL CHEM, V281, P5790, DOI 10.1074/jbc.M512545200; Saladino R, 2005, J BIOL CHEM, V280, P35658, DOI 10.1074/jbc.M504537200; Saladino R, 2003, CHEMBIOCHEM, V4, P514, DOI 10.1002/cbic.200300567; Saladino R, 2007, CHEM BIODIVERS, V4, P694, DOI 10.1002/cbdv.200790059; Saladino R, 2006, CHEMBIOCHEM, V7, P1707, DOI 10.1002/cbic.200600139; Saladino R, 2009, RES MICROBIOL, V160, P441, DOI 10.1016/j.resmic.2009.06.001; Saladino R, 2008, J AM CHEM SOC, V130, P15512, DOI 10.1021/ja804782e; Sawai H, 2006, CHEMBIOCHEM, V7, P605, DOI 10.1002/cbic.200500291; Sawai H, 1998, NUCLEIC ACIDS RES, V26, P2995, DOI 10.1093/nar/26.12.2995; SCHWARTZ A, 1968, NATURE, V218, P443, DOI 10.1038/218443a0; SMITH M, 1960, J AM CHEM SOC, V83, P698; STEINMAN G, 1964, P NATL ACAD SCI USA, V52, P27, DOI 10.1073/pnas.52.1.27; Steyaert J, 1997, EUR J BIOCHEM, V247, P1, DOI 10.1111/j.1432-1033.1997.t01-1-00001.x; USHER DA, 1976, SCIENCE, V192, P53, DOI 10.1126/science.1257755; VANHOLDE K, 1980, ORIGINS LIFE EVOL B, P31; VERLANDER MS, 1973, J MOL EVOL, V2, P303, DOI 10.1007/BF01654098	55	87	90	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33206	33216		10.1074/jbc.M109.041905	http://dx.doi.org/10.1074/jbc.M109.041905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801553	hybrid, Green Published			2022-12-25	WOS:000272028500025
J	Sharma, V; Heriot, W; Trisler, K; Smider, V				Sharma, Vikram; Heriot, William; Trisler, Kirk; Smider, Vaughn			A Human Germ Line Antibody Light Chain with Hydrolytic Properties Associated with Multimerization Status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BENCE-JONES PROTEINS; CATALYTIC ANTIBODIES; HEMOPHILIA-A; FACTOR-VIII; EVOLUTION; AFFINITY; AUTOANTIBODIES; DECOMPOSITION; DEGRADATION	Antibodies with nucleophilic or catalytic properties often have these characteristics encoded in their germ line genes. Because hydrolytic activity has been reported to be associated with light chain V regions, we have begun an analysis of germ line light chain proteins that could be the basis for affinity maturation into hydrolytic or other reactive antibodies. We produced the germ line A18b light chain and characterized its hydrolytic, nucleophilic, and tertiary structural activities. This light chain was purified to > 99% purity and found to hydrolyze aminomethylcoumarin-peptide and larger protein substrates and bind a fluorophosphonate probe. Mutation of putative catalytic residues only resulted in loss of activity of a tetrameric but not dimeric form of the light chain. These biochemical properties provide a framework for understanding the structure-function relationships of germ line antibodies.	[Sharma, Vikram; Heriot, William; Trisler, Kirk; Smider, Vaughn] Integrigen Inc, Novato, CA 94949 USA		Smider, V (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,SR202, La Jolla, CA 92037 USA.	vvsmider@scripps.edu		Smider, Vaughn/0000-0003-3488-6383				ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; GAO QS, 1994, J BIOL CHEM, V269, P32389; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gololobov G, 1999, MOL IMMUNOL, V36, P1215, DOI 10.1016/S0161-5890(99)00141-8; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Hifumi E, 1999, J BIOSCI BIOENG, V88, P323, DOI 10.1016/S1389-1723(00)80018-3; Hifumi E, 2000, APPL BIOCHEM BIOTECH, V83, P209, DOI 10.1385/ABAB:83:1-3:209; Huang DB, 1996, P NATL ACAD SCI USA, V93, P7017, DOI 10.1073/pnas.93.14.7017; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; Lacroix-Desmazes S, 2006, IMMUNOL LETT, V103, P3, DOI 10.1016/j.imlet.2005.10.007; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Lacroix-Desmazes S, 2002, NEW ENGL J MED, V346, P662, DOI 10.1056/NEJMoa011979; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Matsuura K, 2006, BIOL CHEM, V387, P543, DOI 10.1515/BC.2006.070; Mitsuda Y, 2005, IMMUNOL LETT, V96, P63, DOI 10.1016/j.imlet.2004.07.018; Nevinsky GA, 2003, J CELL MOL MED, V7, P265, DOI 10.1111/j.1582-4934.2003.tb00227.x; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Reshetnyak AV, 2007, J AM CHEM SOC, V129, P16175, DOI 10.1021/ja076528m; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; Sambrook J., 2002, MOL CLONING LAB MANU; SCHULTZ PG, 1995, SCIENCE, V269, P1835, DOI 10.1126/science.7569920; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Smider V, 1997, Semin Immunol, V9, P189, DOI 10.1006/smim.1997.0070; Sreedharan SK, 1996, BIOCHEM J, V316, P777, DOI 10.1042/bj3160777; STEVENS FJ, 1980, P NATL ACAD SCI-BIOL, V77, P1144, DOI 10.1073/pnas.77.2.1144; SUN M, 1994, J IMMUNOL, V153, P5121; Sun M, 1997, J MOL BIOL, V271, P374, DOI 10.1006/jmbi.1997.1196; Trisler K, 2007, J BIOL CHEM, V282, P26344, DOI 10.1074/jbc.M704675200; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Zhu XY, 2004, J MOL BIOL, V343, P1269, DOI 10.1016/j.jmb.2004.08.102; Zimmermann J, 2006, P NATL ACAD SCI USA, V103, P13722, DOI 10.1073/pnas.0603282103	38	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33079	33087		10.1074/jbc.M109.036087	http://dx.doi.org/10.1074/jbc.M109.036087			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801545	hybrid, Green Published			2022-12-25	WOS:000272028500011
J	Torres-Bacete, J; Sinha, PK; Castro-Guerrero, N; Matsuno-Yagi, A; Yagi, T				Torres-Bacete, Jesus; Sinha, Prem Kumar; Castro-Guerrero, Norma; Matsuno-Yagi, Akemi; Yagi, Takao			Features of Subunit NuoM (ND4) in Escherichia coli NDH-1 TOPOLOGY AND IMPLICATION OF CONSERVED GLU(144) FOR COUPLING SITE 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; RESPIRATORY COMPLEX-I; MEMBRANE DOMAIN; UBIQUINONE OXIDOREDUCTASE; PARACOCCUS-DENITRIFICANS; PERIPHERAL SUBUNITS; ACIDIC RESIDUES; SUBMITOCHONDRIAL PARTICLES; FUNCTIONAL-ANALYSIS; HYDROPHILIC DOMAIN	The bacterial H+-pumping NADH-quinone oxidoreductase (NDH-1) is an L-shaped membrane-bound enzymatic complex. Escherichia coli NDH-1 is composed of 13 subunits (NuoA-N). NuoM (ND4) subunit is one of the hydrophobic subunits that constitute the membrane arm of NDH-1 and was predicted to bear 14 helices. We attempted to clarify the membrane topology of NuoM by the introduction of histidine tags into different positions by chromosomal site-directed mutagenesis. From the data, we propose a topology model containing 12 helices (helices I-IX and XII-XIV) located in transmembrane position and two (helices X and XI) present in the cytoplasm. We reported previously that residue Glu(144) of NuoM was located in the membrane (helix V) and was essential for the energy-coupling activities of NDH-1 (Torres-Bacete, J., Nakamaru-Ogiso, E., Matsuno-Yagi, A., and Yagi, T. (2007) J. Biol. Chem. 282, 36914-36922). Using mutant E144A, we studied the effect of shifting the glutamate residue to all sites within helix V and three sites each in helix IV and VI on the function of NDH-1. Twenty double site-directed mutants including the mutation E144A were constructed and characterized. None of the mutants showed alteration in the detectable levels of expressed NuoM or on the NDH-1 assembly. In addition, most of the double mutants did not restore the energy transducing NDH-1 activities. Only two mutants E144A/F140E and E144A/L147E, one helix turn downstream and upstream restored the energy transducing activities of NDH-1. Based on these results, a role of Glu(144) for proton translocation has been discussed.	[Torres-Bacete, Jesus; Sinha, Prem Kumar; Castro-Guerrero, Norma; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, MEM256,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930	National Institutes of Health [R01GM033712]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM033712 ( to T. Y. and A. M.- Y.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Amarneh B, 2006, BBA-BIOENERGETICS, V1757, P1557, DOI 10.1016/j.bbabio.2006.08.003; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Bertsova YV, 2004, FEBS LETT, V563, P207, DOI 10.1016/S0014-5793(04)00312-6; Caputo GA, 2004, BIOCHEMISTRY-US, V43, P8794, DOI 10.1021/bi049696p; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3275, DOI 10.1021/bi026697d; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P591; COPELAND RA, 1989, ANNU REV PHYS CHEM, V40, P671; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Ghelli A, 1997, J BIOCHEM, V121, P746; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Kajiyama Y, 2009, MICROBIOL-SGM, V155, P2137, DOI 10.1099/mic.0.025205-0; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kao MC, 2003, BIOCHEMISTRY-US, V42, P4534, DOI 10.1021/bi034166z; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; Kosono S, 2006, BBA-BIOMEMBRANES, V1758, P627, DOI 10.1016/j.bbamem.2006.04.012; Krishnakumar SS, 2007, J MOL BIOL, V374, P1251, DOI 10.1016/j.jmb.2007.10.032; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; LEWIS MJ, 1990, J BIOL CHEM, V265, P10541; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2003, FEBS LETT, V549, P43, DOI 10.1016/S0014-5793(03)00766-X; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; NEWTON G, 1991, MOL MICROBIOL, V5, P2511, DOI 10.1111/j.1365-2958.1991.tb02097.x; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Patsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866; Satoh T, 1996, BBA-BIOENERGETICS, V1273, P21, DOI 10.1016/0005-2728(95)00131-X; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Steuber J, 2001, BBA-BIOENERGETICS, V1505, P45, DOI 10.1016/S0005-2728(00)00276-0; Steuber J, 2003, J BIOL CHEM, V278, P26817, DOI 10.1074/jbc.M301682200; Steuber J, 2000, MOL MICROBIOL, V35, P428, DOI 10.1046/j.1365-2958.2000.01712.x; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; Takano S, 1996, BIOCHEMISTRY-US, V35, P9120, DOI 10.1021/bi9605853; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; YAGI T, 2004, RESP ARCHAEA BACTERI, P15; Yano T, 1999, J BIOL CHEM, V274, P28606, DOI 10.1074/jbc.274.40.28606	64	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33062	33069		10.1074/jbc.M109.059154	http://dx.doi.org/10.1074/jbc.M109.059154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19815558	Green Published, hybrid			2022-12-25	WOS:000272028500009
J	de Leeuw, M; Reuveni, S; Klafter, J; Granek, R				de Leeuw, Marina; Reuveni, Shlomi; Klafter, Joseph; Granek, Rony			Coexistence of Flexibility and Stability of Proteins: An Equation of State	PLOS ONE			English	Article								We consider a recently suggested "equation of state" for natively folded proteins, and verify its validity for a set of about 5800 proteins. The equation is based on a fractal viewpoint of proteins, on a generalization of the Landau-Peierls instability, and on a marginal stability criterion. The latter allows for coexistence of stability and flexibility of proteins, which is required for their proper function. The equation of state relates the protein fractal dimension d(f), its spectral dimension d(s), and the number of amino acids N. Using structural data from the protein data bank (PDB) and the Gaussian network model (GNM), we compute d(f) and d(s) for the entire set and demonstrate that the equation of state is well obeyed. Addressing the fractal properties and making use of the equation of state may help to engineer biologically inspired catalysts.			de Leeuw, M (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.	rgranek@bgu.ac.il	GRANEK, RONY/F-1987-2012; Reuveni, Shlomi/M-3296-2016	GRANEK, RONY/0000-0001-6839-5393; Reuveni, Shlomi/0000-0003-2292-8005; de Leeuw, Marina/0000-0003-1858-8685				ALEXANDER S, 1989, PHYS REV B, V40, P7953, DOI 10.1103/PhysRevB.40.7953; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, J MOL BIOL, V266, P195, DOI 10.1006/jmbi.1996.0758; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Burioni R, 2002, EUROPHYS LETT, V58, P806, DOI 10.1209/epl/i2002-00445-5; Burioni R, 2004, PROTEINS, V55, P529, DOI 10.1002/prot.20072; Chennubhotla C, 2005, PHYS BIOL, V2, pS173, DOI 10.1088/1478-3975/2/4/S12; ELBER R, 1986, PHYS REV LETT, V56, P394, DOI 10.1103/PhysRevLett.56.394; Enright MB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011912; Granek R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098106; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Kou SC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180603; Li MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268107; Lushnikov SG, 2005, JETP LETT+, V82, P30, DOI 10.1134/1.2045334; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; Neusius T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.188103; Peierls RE., 1934, HELV PHYS ACTA, V7, P81, DOI DOI 10.5169/SEALS-110415; Reuveni S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.208101; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Senet P, 2008, P NATL ACAD SCI USA, V105, P19708, DOI 10.1073/pnas.0810679105; STAPLETON HJ, 1980, PHYS REV LETT, V45, P1456, DOI 10.1103/PhysRevLett.45.1456; STAUFFER D, 1994, INTRO PERCOLATION TH; Yang LW, 2007, STRUCTURE, V15, P741, DOI 10.1016/j.str.2007.04.014	25	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7296	10.1371/journal.pone.0007296	http://dx.doi.org/10.1371/journal.pone.0007296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816577	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594300003
J	Willner, D; Furlan, M; Haynes, M; Schmieder, R; Angly, FE; Silva, J; Tammadoni, S; Nosrat, B; Conrad, D; Rohwer, F				Willner, Dana; Furlan, Mike; Haynes, Matthew; Schmieder, Robert; Angly, Florent E.; Silva, Joas; Tammadoni, Sassan; Nosrat, Bahador; Conrad, Douglas; Rohwer, Forest			Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals	PLOS ONE			English	Article								The human respiratory tract is constantly exposed to a wide variety of viruses, microbes and inorganic particulates from environmental air, water and food. Physical characteristics of inhaled particles and airway mucosal immunity determine which viruses and microbes will persist in the airways. Here we present the first metagenomic study of DNA viral communities in the airways of diseased and non-diseased individuals. We obtained sequences from sputum DNA viral communities in 5 individuals with cystic fibrosis (CF) and 5 individuals without the disease. Overall, diversity of viruses in the airways was low, with an average richness of 175 distinct viral genotypes. The majority of viral diversity was uncharacterized. CF phage communities were highly similar to each other, whereas Non-CF individuals had more distinct phage communities, which may reflect organisms in inhaled air. CF eukaryotic viral communities were dominated by a few viruses, including human herpesviruses and retroviruses. Functional metagenomics showed that all Non-CF viromes were similar, and that CF viromes were enriched in aromatic amino acid metabolism. The CF metagenomes occupied two different metabolic states, probably reflecting different disease states. There was one outlying CF virome which was characterized by an over-representation of Guanosine-5'-triphosphate, 3'-diphosphate pyrophosphatase, an enzyme involved in the bacterial stringent response. Unique environments like the CF airway can drive functional adaptations, leading to shifts in metabolic profiles. These results have important clinical implications for CF, indicating that therapeutic measures may be more effective if used to change the respiratory environment, as opposed to shifting the taxonomic composition of resident microbiota.			Willner, D (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	willner9@aol.com	Angly, Florent E/A-7717-2011; Rohwer, Forest/AAC-5315-2019; Silva, joas/AAS-6484-2021; Silva, Joas L/C-1407-2012	Angly, Florent E/0000-0002-8999-0738; Silva, joas/0000-0003-3967-5286; Rohwer, Forest/0000-0003-1548-5429				Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; [Anonymous], 2008, CYST FIBR FDN PAT RE; Azeredo J, 2008, CURR PHARM BIOTECHNO, V9, P261, DOI 10.2174/138920108785161604; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Beringer P M, 2000, Curr Opin Pulm Med, V6, P545, DOI 10.1097/00063198-200011000-00015; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Everitt B. S., 2006, HDB STAT ANAL USING; Fuhrman JA, 2003, BIOL BULL-US, V204, P192, DOI 10.2307/1543557; Gentles AJ, 2001, GENOME RES, V11, P540, DOI 10.1101/gr.163101; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Goldman MJ, 1997, HUM GENE THER, V8, P2261, DOI 10.1089/hum.1997.8.18-2261; Green P., PHRAP; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Heyder Joachim, 2004, Proc Am Thorac Soc, V1, P315, DOI 10.1513/pats.200409-046TA; Jain V, 2006, J MICROBIOL, V44, P1; KLEIN F, 2008, LUNG CANC; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kulczycki LL, 2003, AM J MED GENET A, V116A, P262, DOI 10.1002/ajmg.a.10886; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Livraghi A, 2007, TOXICOL PATHOL, V35, P116, DOI 10.1080/01926230601060025; Lohavanichbutr P, 2009, ARCH OTOLARYNGOL, V135, P180, DOI 10.1001/archoto.2008.540; McManus TE, 2008, RESP MED, V102, P1575, DOI 10.1016/j.rmed.2008.06.006; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MILLER RV, 1984, J CLIN MICROBIOL, V19, P717, DOI 10.1128/JCM.19.5.717-719.1984; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rogers DF, 2004, CURR OPIN PHARMACOL, V4, P241, DOI 10.1016/j.coph.2004.01.011; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; See H, 2008, PAEDIATR RESPIR REV, V9, P243, DOI 10.1016/j.prrv.2008.04.001; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vadivukarasi T, 2007, J BIOSCIENCES, V32, P17, DOI 10.1007/s12038-007-0003-6; van Ewijk Bart E, 2005, J Cyst Fibros, V4 Suppl 2, P31, DOI 10.1016/j.jcf.2005.05.011; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; WILLNER D, 2009, ENV MICROBIOL; WINNIE GB, 1992, PEDIATR INFECT DIS J, V11, P722, DOI 10.1097/00006454-199209000-00010; Xiang XY, 2002, J VIROL METHODS, V101, P127, DOI 10.1016/S0166-0934(01)00431-1; Zawadzka-Glos L, 2003, INT J PEDIATR OTORHI, V67, P1117, DOI 10.1016/S0165-5876(03)00191-5; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	65	283	291	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7370	10.1371/journal.pone.0007370	http://dx.doi.org/10.1371/journal.pone.0007370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816605	Green Submitted, Green Published, gold			2022-12-25	WOS:000270594300006
J	Kohler, MJ; Lushington, K; van den Heuvel, CJ; Martin, J; Pamula, Y; Kennedy, D				Kohler, Mark J.; Lushington, Kurt; van den Heuvel, Cameron J.; Martin, James; Pamula, Yvonne; Kennedy, Declan			Adenotonsillectomy and Neurocognitive Deficits in Children with Sleep Disordered Breathing	PLOS ONE			English	Article							COGNITIVE DYSFUNCTION; BEHAVIOR; APNEA; PERFORMANCE; ADENOIDECTOMY; TONSILLECTOMY	Background: Sleep Disordered Breathing (SDB) is a common childhood disorder that encompasses a range of sleep-related upper airway obstruction. Children with SDB demonstrate significant neurocognitive deficits. Adenotonsillectomy is the first line of treatment for SDB and whilst this improves respiratory disturbance, it remains to be established whether neurocognitive gains also result. Methods: A total of 44 healthy snoring children aged 3-12 years awaiting adenotonsillectomy (SDB group), and 48 age and gender matched non-snoring controls from the general community, completed the study. All children underwent polysomnography and neurocognitive assessment at baseline and after a 6-month follow-up (after surgery in the snoring group). Our primary aim was to determine whether neurocognitive deficits in snoring children were significantly improved following adenotonsillectomy. Results: Wide ranging neurocognitive deficits were found at baseline in SDB children compared to controls, most notably a 10 point IQ difference (P<.001) and similar deficits in language and executive function. Whilst adenotonsillectomy improved respiratory parameters and snoring frequency at 6 months post surgery, neurocognitive performance did not improve relative to controls. Conclusion: Adenotonsillectomy successfully treated the respiratory effects of SDB in children. However, neurocognitive deficits did not improve 6-months post-operatively.			Kohler, MJ (corresponding author), Univ Adelaide, Childrens Res Ctr, Adelaide, SA, Australia.	mark.kohler@adelaide.edu.au	van den Heuvel, Cameron J./E-1993-2012; Lushington, Kurt/D-1699-2009; Kohler, Mark J/F-4538-2013	van den Heuvel, Cameron J./0000-0001-7264-4655; Lushington, Kurt/0000-0001-8371-273X; Kohler, Mark J/0000-0001-7265-6242				Ali NJ, 1996, EUR J PEDIATR, V155, P56, DOI 10.1007/BF02115629; Arens R, 2004, SLEEP, V27, P997, DOI 10.1093/sleep/27.5.997; Avior G, 2004, OTOLARYNG HEAD NECK, V131, P367, DOI 10.1016/j.otohns.2004.04.015; Bandla P, 2008, SLEEP, V31, P534, DOI 10.1093/sleep/31.4.534; Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; Bellizzi MC, 1999, AM J CLIN NUTR, V70, p173S; Blunden S, 2000, J CLIN EXP NEUROPSYC, V22, P554, DOI 10.1076/1380-3395(200010)22:5;1-9;FT554; Boets B, 2008, BRAIN LANG, V106, P29, DOI 10.1016/j.bandl.2007.12.004; BONNET M, 1993, SLEEP, V16, P748; BONNET MH, 1992, SLEEP, V15, P526; Brietzke SE, 2006, OTOLARYNG HEAD NECK, V134, P979, DOI 10.1016/j.otohns.2006.02.033; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Chervin RD, 2006, PEDIATRICS, V117, pE769, DOI 10.1542/peds.2005-1837; Friedman BC, 2003, SLEEP, V26, P999, DOI 10.1093/sleep/26.8.999; Galland BC, 2006, PEDIATR RES, V59, P711, DOI 10.1203/01.pdr.0000214992.69847.6f; Garetz SL, 2008, OTOLARYNG HEAD NECK, V138, pS19, DOI 10.1016/j.otohns.2007.06.738; Giordani B, 2008, J INT NEUROPSYCH SOC, V14, P571, DOI 10.1017/S1355617708080776; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; Gozal D, 2007, NEUROLOGY, V69, P243, DOI 10.1212/01.wnl.0000265818.88703.83; Gozal D, 2007, AM J RESP CRIT CARE, V176, P188, DOI 10.1164/rccm.200610-1519OC; Gozal D, 2009, SLEEP MED, V10, P167, DOI 10.1016/j.sleep.2008.01.001; GUILLEMINAULT C, 1982, EUR J PEDIATR, V139, P165, DOI 10.1007/BF01377349; Hansen DE, 1997, J CLIN CHILD PSYCHOL, V26, P304, DOI 10.1207/s15374424jccp2603_9; Harvey JMM, 1999, J PAEDIATR CHILD H, V35, P136, DOI 10.1046/j.1440-1754.1999.t01-1-00336.x; KAIL R, 1994, DEV PSYCHOL, V30, P949, DOI 10.1037/0012-1649.30.6.949; Korkman M., 2007, NEPSY 2, V2nd; Lamberg L, 2007, JAMA-J AM MED ASSOC, V297, P2681, DOI 10.1001/jama.297.24.2681; Li HY, 2006, LARYNGOSCOPE, V116, P1142, DOI 10.1097/01.mlg.0000217542.84013.b5; Loughlin GM, 1996, AM J RESP CRIT CARE, V153, P866; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Marcus CL, 2004, J APPL PHYSIOL, V97, P98, DOI 10.1152/japplphysiol.00462.2003; Montgomery-Downs HE, 2005, EUR RESPIR J, V25, P336, DOI 10.1183/09031936.05.00082904; O'Brien LM, 2004, PEDIATRICS, V114, P44, DOI 10.1542/peds.114.1.44; Owens Judith, 2000, Sleep Breath, V4, P67, DOI 10.1055/s-2000-19814; Rechtschaffen A, 1968, MANUAL STANDARDIZED; Roid GH., 2003, STANFORD BINET INTEL, V5th; Russo PM, 2007, J SLEEP RES, V16, P163, DOI 10.1111/j.1365-2869.2007.00584.x; Scarborough HS, 1998, SPECIFIC READING DISABILITY, P75; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841	39	82	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7343	10.1371/journal.pone.0007343	http://dx.doi.org/10.1371/journal.pone.0007343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806214	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000270593800026
J	Nordenfelt, P; Bauer, S; Lonnbro, P; Tapper, H				Nordenfelt, Pontus; Bauer, Susanne; Lonnbro, Per; Tapper, Hans			Phagocytosis of Streptococcus pyogenes by All-Trans Retinoic Acid-Differentiated HL-60 Cells: Roles of Azurophilic Granules and NADPH Oxidase	PLOS ONE			English	Article							RESPIRATORY BURST; GENERATING-SYSTEM; HUMAN NEUTROPHILS; LINE HL-60; M-PROTEIN; MONOCYTES; COMPONENT; MEMBRANE; MYELOPEROXIDASE; TRANSLOCATION	Background: New experimental approaches to the study of the neutrophil phagosome and bacterial killing prompted a reassessment of the usefulness of all-trans retinoic acid (ATRA)-differentiated HL-60 cells as a neutrophil model. HL-60 cells are special in that they possess azurophilic granules while lacking the specific granules with their associated oxidase components. The resulting inability to mount an effective intracellular respiratory burst makes these cells more dependent on other mechanisms when killing internalized bacteria. Methodology/Principal Findings: In this work phagocytosis and phagosome-related responses of ATRA-differentiated HL-60 cells were compared to those earlier described in human neutrophils. We show that intracellular survival of wild-type S. pyogenes bacteria in HL-60 cells is accompanied by inhibition of azurophilic granule-phagosome fusion. A mutant S. pyogenes bacterium, deficient in M-protein expression, is, on the other hand, rapidly killed in phagosomes that avidly fuse with azurophilic granules. Conclusions/Significance: The current data extend our previous findings by showing that a system lacking in oxidase involvement also indicates a link between inhibition of azurophilic granule fusion and the intraphagosomal fate of S. pyogenes bacteria. We propose that differentiated HL-60 cells can be a useful tool to study certain aspects of neutrophil phagosome maturation, such as azurophilic granule fusion.			Nordenfelt, P (corresponding author), Lund Univ, Dept Clin Sci, Sect Clin & Expt Infect Med, Lund, Sweden.	hans.tapper@med.lu.se	Nordenfelt, Pontus/H-5310-2019	Nordenfelt, Pontus/0000-0002-9481-9951				ABO A, 1992, J BIOL CHEM, V267, P16767; BAEHNER RL, 1976, BLOOD, V48, P309; Bassoe CF, 2000, METHODS, V21, P203, DOI 10.1006/meth.2000.1001; Bauer S, 2004, J LEUKOCYTE BIOL, V76, P1142, DOI 10.1189/jlb.0404260; BIANCO C, 1975, J EXP MED, V141, P1278, DOI 10.1084/jem.141.6.1278; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; BUNCE CM, 1994, LEUKEMIA, V8, P595; BUNCE CM, 1995, LEUKEMIA, V9, P410; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; COLLINS SJ, 1987, BLOOD, V70, P1233; CRABTREE GR, 1980, J IMMUNOL, V125, P448; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAHLGREN C, 1989, J LEUKOCYTE BIOL, V46, P15, DOI 10.1002/jlb.46.1.15; EMMENDORFFER A, 1990, J IMMUNOL METHODS, V131, P269, DOI 10.1016/0022-1759(90)90198-5; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fleck RA, 2003, IN VITRO CELL DEV-AN, V39, P235; GALLIN JI, 1984, BLOOD, V63, P977; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Kihlberg BM, 1995, MICROB PATHOGENESIS, V19, P299, DOI 10.1016/S0882-4010(96)80003-9; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; LACAL P, 1988, J BIOL CHEM, V263, P9946; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; LeCabec V, 1997, BLOOD, V89, P2113, DOI 10.1182/blood.V89.6.2113; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lonnbro P, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-35; NAKAMURA T, 1988, EUR J HAEMATOL, V41, P258; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; NEWBURGER PE, 1979, J CELL BIOL, V82, P315, DOI 10.1083/jcb.82.2.315; Ozeki M, 2008, J LEUKOCYTE BIOL, V84, P769, DOI 10.1189/jlb.1207817; Pantelic M, 2004, FEMS IMMUNOL MED MIC, V42, P261, DOI 10.1016/j.femsim.2004.05.010; REPINE JE, 1979, AM J CLIN PATHOL, V71, P582; ROBERTS PJ, 1982, J CELL BIOL, V95, P720, DOI 10.1083/jcb.95.3.720; ROTHE G, 1988, NATURWISSENSCHAFTEN, V75, P354, DOI 10.1007/BF00368326; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; SENGELOV H, 1992, J BIOL CHEM, V267, P14912; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Staali L, 2006, CELL MICROBIOL, V8, P690, DOI 10.1111/j.1462-5822.2005.00662.x; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; Trayner ID, 1998, LEUKEMIA RES, V22, P537, DOI 10.1016/S0145-2126(98)00041-1; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Voyich JM, 2004, MICROBES INFECT, V6, P1117, DOI 10.1016/j.micinf.2004.05.022; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557	49	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7363	10.1371/journal.pone.0007363	http://dx.doi.org/10.1371/journal.pone.0007363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806211	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593800032
J	Mazzone, PJ; Marchi, N; Fazio, V; Taylor, JM; Masaryk, T; Bury, L; Mekhail, T; Janigro, D				Mazzone, Peter J.; Marchi, Nicola; Fazio, Vince; Taylor, J. Michael; Masaryk, Thomas; Bury, Luke; Mekhail, Tarek; Janigro, Damir			Small Vessel Ischemic Disease of the Brain and Brain Metastases in Lung Cancer Patients	PLOS ONE			English	Article							WHITE-MATTER LESIONS; LONGER SURVIVAL; PATHOGENESIS; BARRIER; RISK; MRI	Background: Brain metastases occur commonly in patients with lung cancer. Small vessel ischemic disease is frequently found when imaging the brain to detect metastases. We aimed to determine if the presence of small vessel ischemic disease (SVID) of the brain is protective against the development of brain metastases in lung cancer patients. Methodology/Principal Findings: A retrospective cohort of 523 patients with biopsy confirmed lung cancer who had received magnetic resonance imaging of the brain as part of their standard initial staging evaluation was reviewed. Information collected included demographics, comorbidities, details of the lung cancer, and the presence of SVID of the brain. A portion of the cohort had the degree of SVID graded. The primary outcome measure was the portion of study subjects with and without SVID of the brain who had evidence of brain metastases at the time of initial staging of their lung cancer. 109 patients (20.8%) had evidence of brain metastases at presentation and 345 (66.0%) had evidence of SVID. 13.9% of those with SVID and 34.3% of those without SVID presented with brain metastases (p<0.0001). In a model including age, diabetes mellitus, hypertension, hyperlipidemia, and tobacco use, SVID of the brain was found to be the only protective factor against the development of brain metastases, with an OR of 0.31 (0.20, 0.48; p<0.001). The grade of SVID was higher in those without brain metastases. Conclusions/Significance: These findings suggest that vascular changes in the brain are protective against the development of brain metastases in lung cancer patients.			Mazzone, PJ (corresponding author), Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA.	mazzonp@ccf.org	Marchi, Nicola/J-8607-2016; Mazzone, Peter/AAW-5401-2021	Marchi, Nicola/0000-0001-9124-0226; Mazzone, Peter/0000-0003-2121-0595; Janigro, Damir/0000-0003-2165-5826	NINDS NIH HHS [R01NS049514, R01 NS049514] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049514] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boiten J, 1996, NEUROLOGY, V47, P1109, DOI 10.1212/WNL.47.4.1109; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; BRANTZAWADZKI M, 1985, AM J NEURORADIOL, V6, P675; De Giorgio R, 2000, ARCH INTERN MED, V160, P2217, DOI 10.1001/archinte.160.14.2217; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fokas E, 2007, CANCER METAST REV, V26, P705, DOI 10.1007/s10555-007-9088-5; Gerstner ER, 2007, J CLIN ONCOL, V25, P2306, DOI 10.1200/JCO.2006.10.0677; Grant G.A., 2004, YOUMANS NEUROLOGICAL, P153; HAIK BG, 1987, ANN OPHTHALMOL, V19, P218; Hanbali A, 2007, ARCH INTERN MED, V167, P513, DOI 10.1001/archinte.167.5.513-a; Hodi FS, 2008, NAT CLIN PRACT ONCOL, V5, P557, DOI 10.1038/ncponc1183; Lodder J, 1993, Adv Neurol, V62, P213; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Marchi N, 2008, CANCER, V112, P1313, DOI 10.1002/cncr.23314; Marchi N, 2009, EPILEPSIA, V50, P664, DOI 10.1111/j.1528-1167.2008.01989.x; Mazzone P, 2007, NEUROLOGY INTERNAL M, P139; McCarthy BJ, 2002, NEURO-ONCOLOGY, V4, P134, DOI 10.1093/neuonc/4.2.134; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Satoh H, 2001, ARCH INTERN MED, V161, P485, DOI 10.1001/archinte.161.3.485; Seymour K, 1999, BRIT J SURG, V86, P1237, DOI 10.1046/j.1365-2168.1999.01228.x; Silvestri GA, 2007, CHEST, V132, p178S, DOI 10.1378/chest.07-1360; Tosoni A, 2004, CRIT REV ONCOL HEMAT, V52, P199, DOI 10.1016/j.critrevonc.2004.08.006; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; VANSWIETEN JC, 1991, BRAIN, V114, P761; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; 2005, CANC FACTS FIGURES 2	30	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7242	10.1371/journal.pone.0007242	http://dx.doi.org/10.1371/journal.pone.0007242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789633	Green Published, Green Submitted, gold			2022-12-25	WOS:000270354100010
J	Kumar, AA; Bhaskar, E; Shantha, GPS; Swaminathan, P; Abraham, G				Kumar, Anita A.; Bhaskar, Emmanuel; Shantha, Ghanshyam Palamaner Subash; Swaminathan, Porchelvan; Abraham, Georgi			Rhabdomyolysis in Community Acquired Bacterial Sepsis - A Retrospective Cohort Study	PLOS ONE			English	Article								Background and Objectives: Rhabdomyolysis is often associated with sepsis and gram positive bacterial pathogens are reported to be the most frequent cause of sepsis induced rhabdomyolysis. We report the pattern of infecting bacterial pathogens and associated causal factors in a South-Indian cohort. Design, Setting, Participants & Measurements: Retrospective cohort study of adult patients with community acquired bacterial sepsis complicated by rhabdomyolysis from March 2003-August 2008. Rhabdomyolysis was defined as serum creatine kinase >2000 IU/L. The study population was divided into group-I (sepsis with gram positive pathogens), group-II (sepsis with gram negative pathogens) and group-III (culture negative sepsis). Results: 103 patients (group I-15, group II-34 and group III-54) formed the study cohort. Mean age was 55 years and two-third had diabetes. Mean creatine kinase was 7114 IU/L and mean serum creatinine on admission was 2.4 mg/dl. Causative pathogen of sepsis was identified in 47.5%. Gram negative pathogens were more frequently (33%) associated with rhabdomyolysis than gram positive pathogens (14.5%). Lung was the commonest foci of sepsis (38.8%). 78.6% of the study population had one or more additional causal factor for rhabdomyolysis like statin intake, chronic alcoholism, hypokalemia, hypernatremia and hypophosphatemia. Mortality was 59%. Conclusions: Gram negative bacterial pathogens were more frequently associated with rhabdomyolysis than gram positive pathogens. Rhabdomyolysis in patients with sepsis is multifactorial and is associated with high mortality.			Kumar, AA (corresponding author), Sri Ramachandra Univ, Dept Gen Med, Madras, Tamil Nadu, India.	drpssghanshyam@yahoo.co.in	Bhaskar, Emmanuel/ABG-2158-2020	Bhaskar, Emmanuel/0000-0002-3524-641X				Allison RC, 2003, AM J MED SCI, V326, P79, DOI 10.1097/00000441-200308000-00005; ASAO K, 1995, INTERNAL MED, V34, P785, DOI 10.2169/internalmedicine.34.785; BANDO T, 1994, INTERNAL MED, V33, P454, DOI 10.2169/internalmedicine.33.454; BARACOS V, 1983, NEW ENGL J MED, V308, P553, DOI 10.1056/NEJM198303103081002; Betrosian A, 1999, INTENS CARE MED, V25, P469, DOI 10.1007/s001340050882; Brown CVR, 2004, J TRAUMA, V56, P1191, DOI 10.1097/01.TA.0000130761.78627.10; Byrd RP, 1998, RESP MED, V92, P359, DOI 10.1016/S0954-6111(98)90123-8; Bywaters EGL, 1941, BRIT MED J, V1941, P427, DOI 10.1136/bmj.1.4185.427; CADNAPAPHORNCHAI P, 1980, AM J MED SCI, V280, P66, DOI 10.1097/00000441-198009000-00001; CARON F, 1994, REV MED INTERNE, V15, P240, DOI 10.1016/S0248-8663(94)80027-8; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Evans M, 2002, CURR OPIN LIPIDOL, V13, P415, DOI 10.1097/00041433-200208000-00009; FERGUSON ER, 1984, AM J PHYSIOL, V246, pF700, DOI 10.1152/ajprenal.1984.246.5.F700; Fernandez WG, 2005, AM J EMERG MED, V23, P1, DOI 10.1016/j.ajem.2004.09.025; Funada H, 1996, INTERNAL MED, V35, P36, DOI 10.2169/internalmedicine.35.36; GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002; Garcia M Carmina C, 2002, Tenn Med, V95, P67; GROSSMAN RA, 1974, NEW ENGL J MED, V291, P807, DOI 10.1056/NEJM197410172911601; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; KNOCHEL JP, 1982, AM J MED, V72, P521, DOI 10.1016/0002-9343(82)90522-8; KNOCHEL JP, 1975, ANN NY ACAD SCI, V252, P274, DOI 10.1111/j.1749-6632.1975.tb19168.x; Morton SE, 2001, SOUTH MED J, V94, P67, DOI 10.1097/00007611-200194010-00013; Ojukwu IC, 2001, SCAND J INFECT DIS, V33, P227, DOI 10.1080/00365540151060969; Qiu LL, 2004, J AM BOARD FAM PRACT, V17, P54, DOI 10.3122/jabfm.17.1.54; Shih KY, 2002, J FORMOS MED ASSOC, V101, P429; Singh U, 1996, CLIN INFECT DIS, V22, P642, DOI 10.1093/clinids/22.4.642; SMITH LH, 1976, WESTERN J MED, V125, P298; Teramoto S, 1997, Nihon Ronen Igakkai Zasshi, V34, P49; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; TURNER MC, 1987, CLIN PEDIATR, V26, P189, DOI 10.1177/000992288702600408; van Deuren M, 1998, CLIN INFECT DIS, V26, P214, DOI 10.1086/517026; VEENSTRA J, 1994, NEPHROL DIAL TRANSPL, V9, P637, DOI 10.1093/ndt/9.6.637; Visweswaran P, 1999, CRIT CARE CLIN, V15, P415, DOI 10.1016/S0749-0704(05)70061-0; WARD MM, 1988, ARCH INTERN MED, V148, P1553, DOI 10.1001/archinte.148.7.1553; WU AW, 1990, WESTERN J MED, V152, P716	35	20	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7182	10.1371/journal.pone.0007182	http://dx.doi.org/10.1371/journal.pone.0007182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787056	Green Submitted, Green Published, gold			2022-12-25	WOS:000270290100009
J	Markakis, EA; Sasaki, M; Lankford, KL; Kocsis, JD				Markakis, Eleni A.; Sasaki, Masanori; Lankford, Karen L.; Kocsis, Jeffery D.			Convergence of Cells from the Progenitor Fraction of Adult Olfactory Bulb Tissue to Remyelinating Glia in Demyelinating Spinal Cord Lesions	PLOS ONE			English	Article								Background: Progenitor cells isolated from adult brain tissue are important tools for experimental studies of remyelination. Cells harvested from neurogenic regions in the adult brain such as the subependymal zone have demonstrated remyelination potential. Multipotent cells from the progenitor fraction have been isolated from the adult olfactory bulb ( OB) but their potential to remyelinate has not been studied. Methodology/Principal Findings: We used the buoyant density gradient centrifugation method to isolate the progenitor fraction and harvest self-renewing multipotent neural cells grown in monolayers from the adult green-fluorescent protein (GFP) transgenic rat OB. OB tissue was mechanically and chemically dissociated and the resultant cell suspension fractionated on a Percoll gradient. The progenitor fraction was isolated and these cells were plated in growth media with serum for 24 hrs. Cells were then propagated in N2 supplemented serum-free media containing b-FGF. Cells at passage 4 (P4) were introduced into a demyelinated spinal cord lesion. The GFP(+) cells survived and integrated into the lesion, and extensive remyelination was observed in plastic sections. Immunohistochemistry revealed GFP(+) cells in the spinal cord to be glial fibrillary acidic protein (GFAP), neuronal nuclei (NeuN), and neurofilament negative. The GFP(+) cells were found among primarily P0(+) myelin profiles, although some myelin basic protein (MBP) profiles were present. Immuno-electron microscopy for GFP revealed GFP(+) cell bodies adjacent to and surrounding peripheral-type myelin rings. Conclusions/Significance: We report that neural cells from the progenitor fraction of the adult rat OB grown in monolayers can be expanded for several passages in culture and that upon transplantation into a demyelinated spinal cord lesion provide extensive remyelination without ectopic neuronal differentiation.			Markakis, EA (corresponding author), Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06520 USA.	eleni.markakis@yale.edu	Sasaki, Masanori/B-3246-2008	Sasaki, Masanori/0000-0001-7961-9698	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043432] Funding Source: NIH RePORTER; NCI NIH HHS [CA1009A10] Funding Source: Medline; NINDS NIH HHS [R01 NS043432, NS43432] Funding Source: Medline; CSR NIH HHS [RG4028] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CSR NIH HHS		Akiyama Y, 2001, EXP NEUROL, V167, P27, DOI 10.1006/exnr.2000.7539; Akiyama Y, 2004, NEURON GLIA BIOL, V1, P47, DOI 10.1017/s1740925x04000079; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Au WW, 2002, J COMP NEUROL, V446, P68, DOI 10.1002/cne.10182; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Barnett SC, 2000, BRAIN, V123, P1581, DOI 10.1093/brain/123.8.1581; BAYER SA, 1983, EXP BRAIN RES, V50, P329; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; BLAKEMORE WF, 1978, ACTA NEUROPATHOL, V42, P105, DOI 10.1007/BF00690975; CHUAH MI, 1993, BRAIN RES, V601, P213, DOI 10.1016/0006-8993(93)91713-3; Craig CG, 1996, J NEUROSCI, V16, P2649; Doetsch F, 1997, J NEUROSCI, V17, P5046; DOUCETTE JR, 1984, ANAT REC, V210, P385, DOI 10.1002/ar.1092100214; Franklin RJM, 1996, GLIA, V17, P217, DOI 10.1002/(SICI)1098-1136(199607)17:3<217::AID-GLIA4>3.0.CO;2-Y; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; GRACA DL, 1986, NEUROPATH APPL NEURO, V12, P593, DOI 10.1111/j.1365-2990.1986.tb00162.x; GREENFIELD S, 1973, J NEUROCHEM, V20, P1207, DOI 10.1111/j.1471-4159.1973.tb00089.x; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hardison JL, 2006, EXP NEUROL, V197, P420, DOI 10.1016/j.expneurol.2005.10.016; Honmou O, 1996, J NEUROSCI, V16, P3199; Imaizumi T, 1998, J NEUROSCI, V18, P6176; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Lankford KL, 2008, GLIA, V56, P1664, DOI 10.1002/glia.20718; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; Markakis EA, 1999, J COMP NEUROL, V406, P449; Mothe AJ, 2008, EXP NEUROL, V213, P176, DOI 10.1016/j.expneurol.2008.05.024; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Petreanu L, 2002, J NEUROSCI, V22, P6106; RAMONCUETO A, 1992, NEUROSCIENCE, V47, P213, DOI 10.1016/0306-4522(92)90134-N; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Sasaki M, 2006, GLIA, V53, P352, DOI 10.1002/glia.20285; Sasaki M, 2006, J NEUROSCI, V26, P1803, DOI 10.1523/JNEUROSCI.3611-05.2006; Sasaki M, 2004, J NEUROSCI, V24, P8485, DOI 10.1523/JNEUROSCI.1998-04.2004; Sasaki M, 2007, PROG BRAIN RES, V161, P419, DOI 10.1016/S0079-6123(06)61030-3; Talbott JF, 2006, GLIA, V54, P147, DOI 10.1002/glia.20369; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Westergaard E, 1970, THESIS U AARHUS DENM	48	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7260	10.1371/journal.pone.0007260	http://dx.doi.org/10.1371/journal.pone.0007260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787061	Green Published, Green Submitted, gold			2022-12-25	WOS:000270290100026
J	Keenen, B; Qi, H; Saladi, SV; Yeung, M; de la Serna, IL				Keenen, B.; Qi, H.; Saladi, S. V.; Yeung, M.; de la Serna, I. L.			Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma	ONCOGENE			English	Article						SWI/SNF; BRG1; MITF; melanoma; chromatin; differentiation	CELL-CYCLE ARREST; LINEAGE-SURVIVAL; RETINOBLASTOMA PROTEIN; MALIGNANT-MELANOMA; MASTER REGULATOR; LUNG-CANCER; IN-VITRO; DIFFERENTIATION; MITF; BRG1	The microphthalmia-associated transcription factor (MITF) promotes melanocyte differentiation and cell-cycle arrest. Paradoxically, MITF also promotes melanoma survival and proliferation, acting like a lineage survival oncogene. Thus, it is critically important to understand the mechanisms that regulate MITF activity in melanoma cells. SWI/SNF chromatin remodeling enzymes are multiprotein complexes composed of one of two related ATPases, BRG1 or BRM, and 9-12-associated factors (BAFs). We previously determined that BRG1 interacts with MITF to promote melanocyte differentiation. However, it was unclear whether SWI/SNF enzymes regulate the expression of different classes of MITF target genes in melanoma. In this study, we characterized SWI/SNF subunit expression in melanoma cells and observed downregulation of BRG1 or BRM, but not concomitant loss of both ATPases. Re-introduction of BRG1 in BRG1-deficient SK-MEL5 cells enhanced expression of differentiation-specific MITF target genes and resistance to cisplatin. Downregulation of the single ATPase, BRM, in SK-MEL5 cells inhibited expression of both differentiation-specific and pro-proliferative MITF target genes and inhibited tumorigenicity in vitro. Our data suggest that heterogeneous SWI/SNF complexes composed of either the BRG1 or BRM subunit promote expression of distinct and overlapping MITF target genes and that at least one ATPase is required for melanoma tumorigenicity.	[Keenen, B.; Qi, H.; Saladi, S. V.; Yeung, M.; de la Serna, I. L.] Univ Toledo, Dept Biochem & Canc Biol, Coll Med, Toledo, OH 43614 USA	University System of Ohio; University of Toledo	de la Serna, IL (corresponding author), Univ Toledo, Dept Biochem & Canc Biol, Coll Med, 3035 Arlington Ave, Toledo, OH 43614 USA.	ivana.delaserna@utoledo.edu	Saladi, SrinivasVinod/AAM-3146-2020	Saladi, SrinivasVinod/0000-0001-8147-4379	National Institute of Environmental Health Sciences; Ohio Cancer Research Associates, American Cancer Society, Ohio Division [5K22ES12981]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES012981] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ohio Cancer Research Associates, American Cancer Society, Ohio Division(American Cancer Society); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr David Fisher (Dana Farber) for the MITF antibody, Ruth Halaban (Yale Tissue Culture Facility) for melanocytes and melanoma cells, and Stephen Smale (Howard Hughes Medical Institute, UCLA) for shRNA constructs. ILD was supported by the National Institute of Environmental Health Sciences; Grant number: 5K22ES12981, Ohio Cancer Research Associates, American Cancer Society, Ohio Division.	Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; Caramel J, 2008, ONCOGENE, V27, P2035, DOI 10.1038/sj.onc.1210847; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Chen KG, 2006, P NATL ACAD SCI USA, V103, P9903, DOI 10.1073/pnas.0600213103; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; Chu W, 2000, ONCOGENE, V19, P395, DOI 10.1038/sj.onc.1203315; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; de la Serna IL, 2006, J BIOL CHEM, V281, P20233, DOI 10.1074/jbc.M512052200; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; Eberle J, 1995, PIGM CELL RES, V8, P307, DOI 10.1111/j.1600-0749.1995.tb00679.x; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Machida Y, 2001, J BIOCHEM, V129, P43, DOI 10.1093/oxfordjournals.jbchem.a002834; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Pak BJ, 2000, MELANOMA RES, V10, P499, DOI 10.1097/00008390-200010000-00013; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; POLLACK MS, 1981, J NATL CANCER I, V66, P1003, DOI 10.1093/jnci/66.6.1003; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Reisman DN, 2003, CANCER RES, V63, P560; Rosson GB, 2005, J CELL PHYSIOL, V205, P286, DOI 10.1002/jcp.20397; Shen LL, 2007, CANCER RES, V67, P11335, DOI 10.1158/0008-5472.CAN-07-1502; Sif S, 2004, J CELL BIOCHEM, V91, P1087, DOI 10.1002/jcb.20005; Svensson SPS, 2003, PIGM CELL RES, V16, P351, DOI 10.1034/j.1600-0749.2003.00030.x; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; VINK J, 1993, LAB INVEST, V68, P192; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601	54	59	64	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					81	92		10.1038/onc.2009.304	http://dx.doi.org/10.1038/onc.2009.304			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19784067	Green Accepted			2022-12-25	WOS:000273373500008
J	Sen, S; Webber, PJ; West, AB				Sen, Saurabh; Webber, Philip J.; West, Andrew B.			Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; ACTIVATION LOOP; GTP-BINDING; AUTOPHOSPHORYLATION; PHOSPHORYLATION; IDENTIFICATION; PENETRANCE; EXPRESSION	Dominant missense mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common known genetic cause of Parkinson disease. LRRK2 encodes a serine/threonine protein kinase, and pathogenic mutations may increase kinase activity. Intrinsic GTP binding in the GTPase domain may govern kinase activity through an internal signal transduction cascade. As with many protein kinases, LRRK2 self-interacts through mechanisms that may regulate enzymatic activity. We find that the disruption of either GTPase or kinase activity enhances the formation of high molecular weight oligomers and prevents the formation of LRRK2 dimer structures. In addition, brief application of the broad spectrum kinase inhibitor staurosporine ablates LRRK2 dimers and promotes LRRK2 high molecular weight oligomers. LRRK2 interactions with other proteins in cell lines are kinase-independent and include chaperones and cell cytoskeleton components, suggesting that LRRK2 self-assembly principally dictates complex size. To further explore the mechanics of kinase activation, we separate soluble LRRK2 protein that encodes the pathogenic G2019S mutation into high molecular weight oligomers, dimers, and monomers and find that kinase activity resides with dimeric LRRK2. Some PD-associated mutations that increase kinase activity in vitro significantly increase the proportion of dimer structures relative to total LRRK2 protein, providing additional insight into how pathogenic mutations may alter normal enzymatic regulation. Targeting and tracking LRRK2 dimerization may provide a clear way to observe LRRK2 kinase activity in living cells, and disruption of dimeric LRRK2 through kinase inhibition or other means may attenuate pathogenic increases in LRRK2 enzymatic output.	[Sen, Saurabh; Webber, Philip J.; West, Andrew B.] Univ Alabama, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	West, AB (corresponding author), 1719 6th Ave S, Birmingham, AL 35226 USA.	abwest@uab.edu		West, Andrew/0000-0002-3034-4061	National Institutes of Health [R00 NS058111]; Michael J. Fox Foundation for Parkinson's Research; American Parkinson's Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS058111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation for Parkinson's Research; American Parkinson's Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 NS058111. This work was also supported by the Michael J. Fox Foundation for Parkinson's Research, the American Parkinson's Disease Association, and the benevolence of John A. and Ruth R. Jurenko.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; BISKUP S, 2008, BIOCHIM BIOPHYS ACTA, V1792, P625; Biskup S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-102; Cheng JK, 2005, J BIOL CHEM, V280, P13477, DOI 10.1074/jbc.M414258200; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Funayama M, 2007, NEUROREPORT, V18, P273, DOI 10.1097/WNR.0b013e32801254b6; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hulihan MM, 2008, LANCET NEUROL, V7, P591, DOI 10.1016/S1474-4422(08)70116-9; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Leung IWL, 2001, J BIOL CHEM, V276, P1961, DOI 10.1074/jbc.M004092200; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Melrose HL, 2007, NEUROSCIENCE, V147, P1047, DOI 10.1016/j.neuroscience.2007.05.027; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nitta RT, 2008, J BIOL CHEM, V283, P34935, DOI 10.1074/jbc.M804970200; Pelech Steven, 2006, J Biol, V5, P12, DOI 10.1186/jbiol45; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zabetian CP, 2009, MOVEMENT DISORD, V24, P1034, DOI 10.1002/mds.22514	33	140	141	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36346	36356		10.1074/jbc.M109.025437	http://dx.doi.org/10.1074/jbc.M109.025437			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19826009	Green Published, hybrid			2022-12-25	WOS:000272970500036
J	Settivari, R; LeVora, J; Nass, R				Settivari, Raja; LeVora, Jennifer; Nass, Richard			The Divalent Metal Transporter Homologues SMF-1/2 Mediate Dopamine Neuron Sensitivity in Caenorhabditis elegans Models of Manganism and Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; OXIDATIVE STRESS; C-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; HEAVY-METAL; IRON; EXPOSURE; CELLS; DMT1	Parkinson disease (PD) and manganism are characterized by motor deficits and a loss of dopamine (DA) neurons in the substantia nigra pars compacta. Epidemiological studies indicate significant correlations between manganese exposure and the propensity to develop PD. The vertebrate divalent metal transporter-1 (DMT-1) contributes to maintaining cellular Mn2+ homeostasis and has recently been implicated in Fe2+-mediated neurodegeneration in PD. In this study we describe a novel model for manganism that incorporates the genetically tractable nematode Caenorhabditis elegans. We show that a brief exposure to Mn2+ increases reactive oxygen species and glutathione production, decreases oxygen consumption and head mitochondria membrane potential, and confers DA neuronal death. DA neurodegeneration is partially dependent on a putative homologue to DMT-1, SMF-1, as genetic knockdown or deletion partially inhibits the neuronal death. Mn2+ also amplifies the DA neurotoxicity of the PD-associated protein alpha-synuclein. Furthermore, both SMF-1 and SMF-2 are expressed in DA neurons and contribute to PD-associated neurotoxicant-induced DA neuron death. These studies describe a C. elegans model for manganism and show that DMT-1 homologues contribute to Mn2+- and PD-associated DA neuron vulnerability.	[Settivari, Raja; Nass, Richard] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Settivari, Raja; Nass, Richard] Indiana Univ Sch Med, Ctr Environm Hlth, Indianapolis, IN 46202 USA; [LeVora, Jennifer; Nass, Richard] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Nass, R (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	ricnass@iupui.edu	Settivari, Raja/I-5200-2012	Settivari, Raja/0000-0001-9003-5917	NIEHS [R011ES014459, R01ES010563]; Dept. of Defense Manganese Health Research Program [W81XWH-05-1-0239]; National Institutes of Health Center for Research Resources; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563, R01ES014459] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Dept. of Defense Manganese Health Research Program(United States Department of Defense); National Institutes of Health Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R011ES014459 and R01ES010563 from NIEHS. This work was also supported by Grant W81XWH-05-1-0239 from the Dept. of Defense Manganese Health Research Program (to R.N.).; We gratefully appreciate the technical assistance of Michelle Fullard, Marketa Marvanova, Shaoyu Zhou, and Randy Hunter. We are thankful to Eric A. Engleman and Gabriel Filippelli for assistance with determining C. elegans DA and Mn<SUP>2+</SUP> concentrations, respectively. We also appreciate early discussions with Michael Aschner. Some of the strains were provided by the Caenorhabditis Genetics Center, which is supported by the National Institutes of Health Center for Research Resources.	Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Bianchi L, 2006, WORMBOOK; BRENNER S, 1974, GENETICS, V77, P71; Bressler JP, 2004, ANN NY ACAD SCI, V1012, P142, DOI 10.1196/annals.1306.011; Brown DR, 2009, BIOCHEM BIOPH RES CO, V380, P377, DOI 10.1016/j.bbrc.2009.01.103; Burton NC, 2009, ENVIRON HEALTH PERSP, V117, P325, DOI [10.1289/ehp.0800035, 10.1289/ehp.1173c25]; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; CELLIER M, 1995, P NATL ACAD SCI USA, V92, P10089, DOI 10.1073/pnas.92.22.10089; Chen JY, 2001, TOXICOL APPL PHARM, V175, P160, DOI 10.1006/taap.2001.9245; Chen MK, 2006, NEUROTOXICOLOGY, V27, P229, DOI 10.1016/j.neuro.2005.10.008; CHIA SE, 1993, SCAND J WORK ENV HEA, V19, P264, DOI 10.5271/sjweh.1475; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Culotta VC, 2005, EUKARYOT CELL, V4, P1159, DOI 10.1128/EC.4.7.1159-1165.2005; de Bie RMA, 2007, ARCH NEUROL-CHICAGO, V64, P886, DOI 10.1001/archneur.64.6.886; DESOLE MS, 1994, ARCH TOXICOL, V68, P566, DOI 10.1007/s002040050115; Dobson AW, 2003, BIOL TRACE ELEM RES, V93, P113, DOI 10.1385/BTER:93:1-3:113; Domico LM, 2006, NEUROTOXICOLOGY, V27, P816, DOI 10.1016/j.neuro.2006.07.009; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; ELNABY SA, 1965, J NEUROL NEUROSUR PS, V28, P282; Erikson KM, 2007, TOXICOL SCI, V97, P459, DOI 10.1093/toxsci/kfm044; Fahn S, 2008, PARKINSON'S DISEASE: MOLECULAR AND THERAPEUTIC INSIGHTS FROM MODEL SYSTEMS, P3; FISHMAN BE, 1987, TOXICOLOGY, V45, P193, DOI 10.1016/0300-483X(87)90105-3; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; HaMai D, 2004, ANN NY ACAD SCI, V1012, P129, DOI 10.1196/annals.1306.010; Higashi Y, 2004, J NEUROCHEM, V89, P1490, DOI 10.1111/j.1471-4159.2004.02445.x; HOLZGRAEFE M, 1986, J TOXICOL-CLIN TOXIC, V24, P235, DOI 10.3109/15563658608990461; HOPE IA, 1999, C ELEGANS PRACTICAL, P1; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; HURLEY LS, 1963, AM J PHYSIOL, V204, P493, DOI 10.1152/ajplegacy.1963.204.3.493; Jiang YM, 2006, J OCCUP ENVIRON MED, V48, P644, DOI 10.1097/01.jom.0000204114.01893.3e; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kampkotter A, 2007, PHARMACOL RES, V55, P139, DOI 10.1016/j.phrs.2006.11.006; Keen CL, 2000, MET IONS BIOL SYST, V37, P89; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levenson CW, 2004, EXP NEUROL, V190, P506, DOI 10.1016/j.expneurol.2004.08.014; Lin YT, 2006, FREE RADICAL BIO MED, V40, P1185, DOI 10.1016/j.freeradbiomed.2005.11.007; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Migheli R, 1999, J NEUROCHEM, V73, P1155, DOI 10.1046/j.1471-4159.1999.0731155.x; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Nass R, 2005, J NEUROCHEM, V94, P774, DOI 10.1111/j.1471-4159.2005.03205.x; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Nass R, 2001, PARKINSONISM RELAT D, V7, P185, DOI 10.1016/S1353-8020(00)00056-0; Nass R., 2007, CURR PROTOC TOXICOL; Nass R, 2008, PARKINSON'S DISEASE: MOLECULAR AND THERAPEUTIC INSIGHTS FROM MODEL SYSTEMS, P347, DOI 10.1016/B978-0-12-374028-1.00026-9; Nass R, 2008, MOL INTERV, V8, P284, DOI 10.1124/mi.8.6.6; Novillo A, 2005, INTEGR COMP BIOL, V45, P61, DOI 10.1093/icb/45.1.61; OESTREICHER E, 1994, BRAIN RES, V660, P8, DOI 10.1016/0006-8993(94)90833-8; Olivares D, 2009, INT J MOL SCI, V10, P1226, DOI 10.3390/ijms10031226; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; PARENTI M, 1988, BRAIN RES, V473, P236, DOI 10.1016/0006-8993(88)90852-9; Pifl C, 2004, NEUROSCI LETT, V354, P34, DOI 10.1016/j.neulet.2003.09.064; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rand JB, 1995, METHOD CELL BIOL, V48, P187; Rodier J, 1955, BRIT J IND MED, V12, P21; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Salvatore MF, 2005, MOL BRAIN RES, V139, P341, DOI 10.1016/j.molbrainres.2005.06.002; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; SHI MM, 1994, J BIOL CHEM, V269, P26512; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Springer W, 2005, HUM MOL GENET, V14, P3407, DOI 10.1093/hmg/ddi371; Stredrick DL, 2004, NEUROTOXICOLOGY, V25, P543, DOI 10.1016/j.neuro.2003.08.006; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Thiruchelvam M, 2003, EUR J NEUROSCI, V18, P589, DOI 10.1046/j.1460-9568.2003.02781.x; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tomas-Camardiel M, 2002, MOL BRAIN RES, V103, P116, DOI 10.1016/S0169-328X(02)00192-4; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Vartiainen S, 2006, NEUROBIOL DIS, V22, P477, DOI 10.1016/j.nbd.2005.12.021; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Wang XQ, 2006, BRAIN RES, V1097, P1, DOI 10.1016/j.brainres.2006.04.046; Watts RJ, 2005, J ENVIRON ENG-ASCE, V131, P158, DOI 10.1061/(ASCE)0733-9372(2005)131:1(158); Witholt R, 2000, NEUROTOXICOL TERATOL, V22, P851, DOI 10.1016/S0892-0362(00)00108-2; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zarse K, 2007, FASEB J, V21, P1271, DOI 10.1096/fj.06-6994com; ZAYED J, 1990, CAN J NEUROL SCI, V17, P286, DOI 10.1017/S0317167100030584; Zhang SZ, 2009, NEUROBIOL AGING, V30, P1466, DOI 10.1016/j.neurobiolaging.2007.11.025; Zhao F, 2009, TOXICOL SCI, V107, P156, DOI 10.1093/toxsci/kfn213	91	65	74	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35758	35768		10.1074/jbc.M109.051409	http://dx.doi.org/10.1074/jbc.M109.051409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19801673	Green Published, hybrid			2022-12-25	WOS:000272645600053
J	Maruyama, M; Arisaka, N; Goto, Y; Ohsawa, Y; Inoue, H; Fujiwara, H; Hattori, A; Tsujimoto, M				Maruyama, Masato; Arisaka, Naomi; Goto, Yoshikuni; Ohsawa, Yosuke; Inoue, Hideshi; Fujiwara, Hiroshi; Hattori, Akira; Tsujimoto, Masafumi			Histidine 379 of Human Laeverin/Aminopeptidase Q, a Nonconserved Residue within the Exopeptidase Motif, Defines Its Distinctive Enzymatic Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL LEUCINE AMINOPEPTIDASE; MOLECULAR-CLONING; OXYTOCINASE SUBFAMILY; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CDNA CLONING; CELL-LINES; EXPRESSION; SUBSTRATE	Human laeverin/aminopeptidase Q (LVRN/APQ) is a novel member of the M1 family of zinc aminopeptidases and is specifically expressed on the cell surface of human extravillous trophoblasts. Multiple sequence alignment of human M1 aminopeptidase revealed that the first Gly residue within the conserved exopeptidase motif of the M1 family, GXMEN motif, is uniquely substituted for His in human LVRN/APQ. In this study, we evaluated the roles of nonconserved His(379), comprising the exopeptidase motif in the enzymatic properties of human LVRN/APQ. We revealed that the substitution of His(379) with Gly caused significant changes in substrate specificity both toward fluorogenic substrates and natural peptide hormones. In addition, the susceptibilities of bestatin, a sensitive inhibitor for human LVRN/APQ, and natural inhibitory peptides were decreased in the H379G mutant. A molecular model suggested a conformational difference between wild-type and H379G human LVRN/APQs. These results indicate that His(379) of the enzyme plays essential roles in its distinctive enzymatic properties and contributes to maintaining the appropriate structure of the catalytic cavity of the enzyme. Our data may bring new insight into the biological significance of the unique exopeptidase motif of LVRN/APQ obtained during the evolution of primates.	[Maruyama, Masato; Arisaka, Naomi; Goto, Yoshikuni; Ohsawa, Yosuke; Hattori, Akira; Tsujimoto, Masafumi] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; [Arisaka, Naomi; Tsujimoto, Masafumi] Saitama Univ, Grad Sch Sci & Engn, Dept Regulat Biol, Saitama 3388570, Japan; [Arisaka, Naomi; Inoue, Hideshi] Tokyo Univ Pharm & Life Sci, Lab Mol & Chem Biol, Sch Life Sci, Tokyo 1920392, Japan; [Fujiwara, Hiroshi] Kyoto Univ, Dept Gynecol & Obstet, Fac Med, Sakyo Ku, Kyoto 6068507, Japan; [Hattori, Akira] Kyoto Univ, Dept Syst Chemotherapy & Mol Sci, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Saitama University; Tokyo University of Pharmacy & Life Sciences; Kyoto University; Kyoto University	Hattori, A (corresponding author), RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan.	ahattori@pharm.kyoto-u.ac.jp	FUJIWARA, Hiroshi/J-8401-2015	FUJIWARA, Hiroshi/0000-0003-3098-9406	Ministry of Education, Culture, Sports, Science, and Technology of Japan; RIKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	This work was supported in part by grants- in- aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a grant for the " Chemical Biology Research Program" from RIKEN.	Addlagatta A, 2006, P NATL ACAD SCI USA, V103, P13339, DOI 10.1073/pnas.0606167103; Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Claperon M, 2008, BIOCHEM J, V416, P37, DOI 10.1042/BJ20080471; Claperon C, 2009, J BIOL CHEM, V284, P10618, DOI 10.1074/jbc.M806783200; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; Diaz-Perales A, 2005, J BIOL CHEM, V280, P14310, DOI 10.1074/jbc.M413222200; Fujiwara H, 2004, BIOCHEM BIOPH RES CO, V313, P962, DOI 10.1016/j.bbrc.2003.12.024; Fukasawa KM, 1996, J BIOL CHEM, V271, P30731, DOI 10.1074/jbc.271.48.30731; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Goto Y, 2008, BIOCHEM J, V416, P109, DOI 10.1042/BJ20080965; Goto Y, 2007, J BIOL CHEM, V282, P37074, DOI 10.1074/jbc.M707251200; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Haas CS, 2006, ARTHRITIS RHEUM-US, V54, P2047, DOI 10.1002/art.21953; Hattori A, 2004, BIOL PHARM BULL, V27, P777, DOI 10.1248/bpb.27.777; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; IMAI K, 1992, BIOL REPROD, V46, P328, DOI 10.1095/biolreprod46.3.328; Ino K, 2003, LAB INVEST, V83, P1799, DOI 10.1097/01.LAB.0000101728.93907.75; Ino K, 2000, PLACENTA, V21, P63, DOI 10.1053/plac.1999.0456; INO K, 1994, JPN J CANCER RES, V85, P927, DOI 10.1111/j.1349-7006.1994.tb02970.x; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Iturrioz X, 2001, BIOCHEMISTRY-US, V40, P14440, DOI 10.1021/bi011409j; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; Laustsen PG, 2001, EUR J BIOCHEM, V268, P98, DOI 10.1046/j.1432-1327.2001.01848.x; LI L, 1993, GENOMICS, V17, P657, DOI 10.1006/geno.1993.1386; Lkhagvaa B, 2008, CYTOKINE, V44, P386, DOI 10.1016/j.cyto.2008.10.011; LOOK AT, 1986, J CLIN INVEST, V78, P914, DOI 10.1172/JCI112680; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Maruyama M, 2007, J BIOL CHEM, V282, P20088, DOI 10.1074/jbc.M702650200; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; MINAMI M, 1987, J BIOL CHEM, V262, P13873; Mishima Y, 2002, J NATL CANCER I, V94, P1020; Mitsui T, 2004, BIOL PHARM BULL, V27, P768, DOI 10.1248/bpb.27.768; Mizutani S, 2008, HEART FAIL REV, V13, P273, DOI 10.1007/s10741-007-9065-7; NANUS DM, 1993, P NATL ACAD SCI USA, V90, P7069, DOI 10.1073/pnas.90.15.7069; Nomura M, 2002, PLACENTA, V23, P631, DOI 10.1053/plac.2002.0861; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; Rogi T, 1996, J BIOL CHEM, V271, P56, DOI 10.1074/jbc.271.1.56; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Sato Y, 2004, BIOL PHARM BULL, V27, P772, DOI 10.1248/bpb.27.772; Schomburg L, 1999, EUR J BIOCHEM, V265, P415, DOI 10.1046/j.1432-1327.1999.00753.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Tachibana T, 1996, HUM REPROD, V11, P497, DOI 10.1093/HUMREP/11.3.497; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Vazeux G, 1996, J BIOL CHEM, V271, P9069, DOI 10.1074/jbc.271.15.9069; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Vazeux G, 1997, BIOCHEM J, V327, P883, DOI 10.1042/bj3270883; Ye SY, 2007, BIOL CHEM, V388, P399, DOI 10.1515/BC.2007.044	55	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34692	34702		10.1074/jbc.M109.066712	http://dx.doi.org/10.1074/jbc.M109.066712			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19819873	Green Published, hybrid			2022-12-25	WOS:000272439600025
J	Pertschy, B; Schneider, C; Gnadig, M; Schafer, T; Tollervey, D; Hurt, E				Pertschy, Brigitte; Schneider, Claudia; Gnaedig, Maren; Schaefer, Thorsten; Tollervey, David; Hurt, Ed			RNA Helicase Prp43 and Its Co-factor Pfa1 Promote 20 to 18 S rRNA Processing Catalyzed by the Endonuclease Nob1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL TRANSCRIBED SPACER-1; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; PRE-RIBOSOMES; NUCLEAR EXPORT; LARIAT-INTRON; BOX PROTEIN; PIN DOMAIN; YEAST; SUBUNIT	Many RNA nucleases and helicases participate in ribosome biogenesis, but how they cooperate with each other is largely unknown. Here we report that in vivo cleavage of the yeast pre-rRNA at site D, the 3'-end of the 18 S rRNA, requires functional interactions between PIN (PilT N terminus) domain protein Nob1 and the DEAH box RNA helicase Prp43. Nob1 showed specific cleavage on a D-site substrate analogue in vitro, which was abolished by mutations in the Nob1 PIN domain or the RNA substrate. Genetic analyses linked Nob1 to the late pre-40 S-associated factor Ltv1, the RNA helicase Prp43, and its cofactor Pfa1. In strains lacking Ltv1, mutation of Prp43 or Pfa1 led to a striking accumulation of 20 S pre-rRNA in the cytoplasm due to inhibition of site D cleavage. This phenotype was suppressed by increased dosage of wildtype Nob1 but not by Nob1 variants mutated in the catalytic site. In ltv1/pfa1 mutants the 20 S pre-rRNA was susceptible to 3' to 5' degradation by the cytoplasmic exosome. This degraded into the 3' region of the 18 S rRNA, strongly indicating that the pre-ribosomes are structurally defective.	[Pertschy, Brigitte; Gnaedig, Maren; Schaefer, Thorsten; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Schneider, Claudia; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Ruprecht Karls University Heidelberg; University of Edinburgh	Hurt, E (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Tollervey, David/AAR-6662-2020; Ed Hurt, Dr./AAE-8874-2019	Tollervey, David/0000-0003-2894-2772; Ed Hurt, Dr./0000-0002-4535-8255; Schaefer, Thorsten/0000-0003-4867-8374; Schneider, Claudia/0000-0001-5597-2489; Pertschy, Brigitte/0000-0003-3558-0191	Austrian Science Fund (FWF) [J2612]; Human Frontiers Science Program; Wellcome Trust; Deutsche Forschungsgemeinschaft [Hu363/9-2]; Gottfried Wilhelm Leibniz Program; Fonds der Chemischen Industrie	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Human Frontiers Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gottfried Wilhelm Leibniz Program; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	Recipient of an Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF; J2612).; Supported by a long term fellowship of the Human Frontiers Science Program and by the Wellcome Trust.; Recipient of grants from the Deutsche Forschungsgemeinschaft (Hu363/9-2 and the Gottfried Wilhelm Leibniz Program) and Fonds der Chemischen Industrie.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Bohnsack MT, 2008, EMBO REP, V9, P1230, DOI 10.1038/embor.2008.184; BOHNSACK MT, 2009, MOL CELL IN PRESS; Boon KL, 2006, MOL CELL BIOL, V26, P6016, DOI 10.1128/MCB.02347-05; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Grosshans H, 2000, GENE DEV, V14, P830; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kos M, 2005, MOL CELL, V20, P53, DOI 10.1016/j.molcel.2005.08.022; Kressler D, 1999, MOL CELL BIOL, V19, P8633; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; Lebaron S, 2005, MOL CELL BIOL, V25, P9269, DOI 10.1128/MCB.25.21.9269-9282.2005; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Leeds NB, 2006, MOL CELL BIOL, V26, P513, DOI 10.1128/MCB.26.2.513-522.2006; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mangiarotti G, 1997, J BIOL CHEM, V272, P27818, DOI 10.1074/jbc.272.44.27818; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; Mitchell P, 1996, GENE DEV, V10, P502, DOI 10.1101/gad.10.4.502; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Skruzny M, 2009, PLOS BIOL, V7, P164, DOI 10.1371/journal.pbio.1000008; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; STEVENS A, 1991, J BACTERIOL, V173, P7024, DOI 10.1128/jb.173.21.7024-7028.1991; Tanaka N, 2007, GENE DEV, V21, P2312, DOI 10.1101/gad.1580507; Tsai RT, 2007, MOL CELL BIOL, V27, P8027, DOI 10.1128/MCB.01213-07; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; van Beekvelt CA, 2001, RNA, V7, P896, DOI 10.1017/S1355838201010196; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Weaver PL, 1997, MOL CELL BIOL, V17, P1354, DOI 10.1128/MCB.17.3.1354; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; YEH LCC, 1990, BIOCHEMISTRY-US, V29, P5911, DOI 10.1021/bi00477a005	55	139	140	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35079	35091		10.1074/jbc.M109.040774	http://dx.doi.org/10.1074/jbc.M109.040774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801658	Green Published, hybrid			2022-12-25	WOS:000272439600062
J	Huet, G; Merot, Y; Percevault, F; Tiffoche, C; Arnal, JF; Boujrad, N; Pakdel, F; Metivier, R; Flouriot, G				Huet, Guillaume; Merot, Yohann; Percevault, Frederic; Tiffoche, Christophe; Arnal, Jean-Francois; Boujrad, Noureddine; Pakdel, Farzad; Metivier, Raphael; Flouriot, Gilles			Repression of the Estrogen Receptor-alpha Transcriptional Activity by the Rho/Megakaryoblastic Leukemia 1 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SERUM RESPONSE FACTOR; RHO-GTPASES; DISTINCT MECHANISMS; COACTIVATOR; SRF; ACTIVATION; PROTEIN-1; AF-2; MEGAKARYOBLASTIC-LEUKEMIA-1	Although involved in processes leading to the emergence and development of hormone-dependent breast cancers, the estrogen receptor alpha (ER alpha) also prevents transformed cells from progressing toward a more aggressive phenotype. The transcriptional activity of ER alpha is mediated through two transactivation functions, called activation function 1 and 2, whose respective involvement varies in a cell-specific manner. Here, we identify the Rho/megakaryoblastic leukemia 1 (MKL1) signaling pathway as a main actor in controlling the cell-specific activity of both transactivation functions of ER alpha. Notably, we show that, when the coregulator MKL1 is sequestered in an inactive form by unpolymerized actin, the transcriptional activity of ER alpha mainly relies on the activation function 1. The activation of MKL1, which results from its dissociation from unpolymerized actin, promoted by the ability of Rho to support polymeric actin accumulation, silences the activation function 1 of ER alpha and allows the receptor to mainly act through its activation function 2. Importantly, this switch in the respective contribution exerted by both transactivation functions is correlated with an impaired ability of ER alpha to efficiently transactivate estrogen-regulated reporter genes. MKL1 is further shown to be present on estrogen-responsive genes in vivo. Interestingly, the Rho/MKL1 signaling pathway is activated during the epithelial-mesenchymal transition. A reduced transactivation efficiency of ER alpha, resulting from the activation of this pathway, may therefore suppress the protective role exerted by ER alpha toward tumor progression and invasiveness.	[Huet, Guillaume; Merot, Yohann; Percevault, Frederic; Boujrad, Noureddine; Pakdel, Farzad; Flouriot, Gilles] Univ Rennes 1, CNRS, Equipe Recepteurs Estrogenes & Destinee Cellulair, UMR 6026, F-35042 Rennes, France; [Tiffoche, Christophe; Metivier, Raphael] Univ Rennes 1, CNRS, Equipe Regulat Spatiotemporelle Transcript, UMR 6026, F-35042 Rennes, France; [Arnal, Jean-Francois] Inst Med Mol Rangueil, INSERM, U858, F-31432 Toulouse 4, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Flouriot, G (corresponding author), Univ Rennes 1, CNRS, Equipe Recepteurs Estrogenes & Destinee Cellulair, UMR 6026, Campus Beaulieu,Bat 13, F-35042 Rennes, France.	gilles.flouriot@univ-rennes1.fr	BOUJRAD, Noureddine/L-1367-2015; Flouriot, Gilles/K-1833-2015; percevault, frederic/K-1836-2015; Pakdel, Farzad/K-1700-2015; ARNAL, Jean Francois/K-7004-2014	Flouriot, Gilles/0000-0001-6250-4173; Pakdel, Farzad/0000-0002-3067-3156; ARNAL, Jean Francois/0000-0003-2229-6300	ARC; Ligue Contre le Cancer; Rennes Metropole; CNRS; University of Rennes	ARC(Australian Research Council); Ligue Contre le Cancer(Ligue nationale contre le cancer); Rennes Metropole(Region Bretagne); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes	This work was supported by the ARC, the Ligue Contre le Cancer, Rennes Metropole, the CNRS, and the University of Rennes 1.	AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Cho HJ, 2007, CELL BIOL INT, V31, P1225, DOI 10.1016/j.cellbi.2007.04.006; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Huet G, 2008, BIOCHEM BIOPH RES CO, V365, P304, DOI 10.1016/j.bbrc.2007.10.178; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McInerney EM, 1996, J BIOL CHEM, V271, P24172, DOI 10.1074/jbc.271.39.24172; Merot Y, 2004, J BIOL CHEM, V279, P26184, DOI 10.1074/jbc.M402148200; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Nakagawa K, 2005, GENES CELLS, V10, P835, DOI 10.1111/j.1365-2443.2005.00880.x; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schultz JR, 2005, J BIOL CHEM, V280, P347, DOI 10.1074/jbc.M407879200; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Su LF, 2002, J BIOL CHEM, V277, P37037, DOI 10.1074/jbc.M111607200; Su LF, 2001, J BIOL CHEM, V276, P3231, DOI 10.1074/jbc.M005547200; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672	37	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33729	33739		10.1074/jbc.M109.045534	http://dx.doi.org/10.1074/jbc.M109.045534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19826002	Green Published, hybrid			2022-12-25	WOS:000272165200003
J	Townsend, K; Mason, H; Blackford, AN; Miller, ES; Chapman, JR; Sedgwick, GG; Barone, G; Turnell, AS; Stewart, GS				Townsend, Kelly; Mason, Helen; Blackford, Andrew N.; Miller, Edward S.; Chapman, J. Ross; Sedgwick, Garry G.; Barone, Giancarlo; Turnell, Andrew S.; Stewart, Grant S.			Mediator of DNA Damage Checkpoint 1 (MDC1) Regulates Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE CHECKPOINT; CENTROSOME; INTEGRITY; CDC20; BRCA1; CYCLE	Human mediator of DNA damage checkpoint 1 (hMDC1) is an essential component of the cellular response to DNA double strand breaks. Recently, hMDC1 has been shown to associate with a subunit of the anaphase-promoting complex/cyclosome (APC/C) (Coster, G., Hayouka, Z., Argaman, L., Strauss, C., Friedler, A., Brandeis, M., and Goldberg, M. (2007) J. Biol. Chem. 282, 32053-32064), a key regulator of mitosis, suggesting a possible role for hMDC1 in controlling normal cell cycle progression. Here, we extend this work to show that hMDC1 regulates normal metaphase-to-anaphase transition through its ability to bind directly to the APC/C and modulate its E3 ubiquitin ligase activity. In support of a role for hMDC1 in controlling mitotic progression, depletion of hMDC1 by small interfering RNA results in a metaphase arrest that appears to be independent of both BubR1-dependent signaling pathways and ATM/ATR activation. Mitotic cells lacking hMDC1 exhibit markedly reduced levels of APC/C activity characterized by reduced levels of Cdc20, and a failure of Cdc20 to bind the APC/C and CREB-binding protein. We suggest therefore that hMDC1 functionally regulates the normal metaphase-to-anaphase transition by modulating the Cdc20-dependent activation of the APC/C.	[Barone, Giancarlo; Turnell, Andrew S.; Stewart, Grant S.] Univ Birmingham, Sch Med, Canc Res United Kingdon Inst Canc Sci, Birmingham B15 2TT, W Midlands, England; [Chapman, J. Ross] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Chapman, J. Ross] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of Birmingham; University of Cambridge; University of Cambridge	Stewart, GS (corresponding author), Univ Birmingham, Sch Med, Canc Res United Kingdon Inst Canc Sci, Birmingham B15 2TT, W Midlands, England.	g.s.stewart@bham.ac.uk	Chapman, J Ross/C-7973-2012; Blackford, Andrew N/H-6575-2019	Blackford, Andrew N/0000-0003-1979-021X; Stewart, Grant/0000-0002-0960-3241; Chapman, Ross/0000-0002-6477-4254	Cancer Research-United Kingdom (CR-UK) [GSS C17183/A5592]; CR-UK Project [AST C10000/A7542]	Cancer Research-United Kingdom (CR-UK)(Cancer Research UK); CR-UK Project	This work was supported by Cancer Research-United Kingdom (CR-UK) Career Development Fellowship GSS C17183/A5592 and CR-UK Project Grant AST C10000/A7542.	Adelman CA, 2009, MOL CELL BIOL, V29, P483, DOI 10.1128/MCB.01525-08; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Huang XX, 2005, P NATL ACAD SCI USA, V102, P1065, DOI 10.1073/pnas.0409130102; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Ko MJ, 2006, ONCOGENE, V25, P298, DOI 10.1038/sj.onc.1209028; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rai R, 2008, CELL CYCLE, V7, P2225, DOI 10.4161/cc.7.14.6303; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Tang JB, 2006, P NATL ACAD SCI USA, V103, P11964, DOI 10.1073/pnas.0604987103; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027	21	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33939	33948		10.1074/jbc.M109.009191	http://dx.doi.org/10.1074/jbc.M109.009191			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19826003	Green Published, hybrid			2022-12-25	WOS:000272165200026
J	Brown, NG; Shanker, S; Prasad, BVV; Palzkill, T				Brown, Nicholas G.; Shanker, Sreejesh; Prasad, B. V. Venkataram; Palzkill, Timothy			Structural and Biochemical Evidence That a TEM-1 beta-Lactamase N170G Active Site Mutant Acts via Substrate-assisted Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-ENZYME INTERMEDIATE; EXTENDED-SPECTRUM; DIRECTED MUTAGENESIS; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; KLEBSIELLA-PNEUMONIAE; BACTERIAL-RESISTANCE; RESOLUTION; SPECIFICITY; MECHANISM	TEM-1 beta-lactamase is the most common plasmid-encoded beta-lactamase in Gram-negative bacteria and is a model class A enzyme. The active site of class A beta-lactamases share several conserved residues including Ser(70), Glu(166), and Asn(170) that coordinate a hydrolytic water involved in deacylation. Unlike Ser(70) and Glu(166), the functional significance of residue Asn(170) is not well understood even though it forms hydrogen bonds with both Glu(166) and the hydrolytic water. The goal of this study was to examine the importance of Asn(170) for catalysis and substrate specificity of beta-lactam antibiotic hydrolysis. The codon for position 170 was randomized to create a library containing all 20 possible amino acids. The random library was introduced into Escherichia coli, and functional clones were selected on agar plates containing ampicillin. DNA sequencing of the functional clones revealed that only asparagine (wild type) and glycine at this position are consistent with wild-type function. The determination of kinetic parameters for several substrates revealed that the N170G mutant is very efficient at hydrolyzing substrates that contain a primary amine in the antibiotic R-group that would be close to the Asn(170) side chain in the acyl-intermediate. In addition, the x-ray structure of the N170G enzyme indicated that the position of an active site water important for deacylation is altered compared with the wildtype enzyme. Taken together, the results suggest the N170G TEM-1 enzyme hydrolyzes ampicillin efficiently because of substrate-assisted catalysis where the primary amine of the ampicillin R-group positions the hydrolytic water and allows for efficient deacylation.	[Brown, Nicholas G.; Shanker, Sreejesh; Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Palzkill, T (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	timothyp@bcm.tmc.edu		Prasad, B.V.Venkataram/0000-0002-1172-2071; Brown, Nicholas/0000-0002-6141-0164	National Institutes of Health [AI32956]; Gulf Coast Consortia (National Institutes of Health) [T90 DK070109-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032956, R37AI032956, R01AI032956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gulf Coast Consortia (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant AI32956 (to T. P.). This work was also supported by a training fellowship from the Keck Center Pharmacoinformatics Training Program of the lulf Coast Consortia (National Institutes of Health Grant T90 DK070109-05).	ADACHI H, 1991, J BIOL CHEM, V266, P3186; Ali Shah A, 2004, RES MICROBIOL, V155, P409, DOI 10.1016/j.resmic.2004.02.009; ANDERSEN JF, 1992, J BACTERIOL, V174, P725, DOI 10.1128/jb.174.3.725-735.1992; Bae IK, 2007, DIAGN MICR INFEC DIS, V58, P465, DOI 10.1016/j.diagmicrobio.2007.02.013; Bouthors AT, 1998, BIOCHEM J, V330, P1443, DOI 10.1042/bj3301443; Bouthors AT, 1999, PROTEIN ENG, V12, P313, DOI 10.1093/protein/12.4.313; Cantu C, 1997, J BIOL CHEM, V272, P29144, DOI 10.1074/jbc.272.46.29144; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Chaibi EB, 1999, J ANTIMICROB CHEMOTH, V43, P447, DOI 10.1093/jac/43.4.447; Chen CC, 1996, BIOCHEMISTRY-US, V35, P12251, DOI 10.1021/bi961153v; CHRISTENSEN H, 1990, BIOCHEM J, V266, P853; CuppVickery JR, 1996, NAT STRUCT BIOL, V3, P632, DOI 10.1038/nsb0796-632; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; Damblon C, 1996, P NATL ACAD SCI USA, V93, P1747, DOI 10.1073/pnas.93.5.1747; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESCOBAR WA, 1994, BIOCHEMISTRY-US, V33, P7619, DOI 10.1021/bi00190a015; ESCOBAR WA, 1991, BIOCHEMISTRY-US, V30, P10783, DOI 10.1021/bi00108a025; Fersht A., 1985, ENZYME STRUCTURE MEC, P99; FRERE JM, 1985, CRC CR REV MICROBIOL, V11, P299; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Georgopapadakou NH, 2004, EXPERT OPIN INV DRUG, V13, P1307, DOI 10.1517/13543784.13.10.1307; Giakkoupi P, 2000, ANTIMICROB AGENTS CH, V44, P2247, DOI 10.1128/AAC.44.9.2247-2253.2000; Guillaume G, 1997, J BIOL CHEM, V272, P5438, DOI 10.1074/jbc.272.9.5438; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; KNOX JR, 1995, ANTIMICROB AGENTS CH, V39, P2593, DOI 10.1128/AAC.39.12.2593; LAMOTTEBRASSEUR J, 1991, BIOCHEM J, V279, P213, DOI 10.1042/bj2790213; LEUNG YC, 1994, BIOCHEM J, V299, P671, DOI 10.1042/bj2990671; Lietz EJ, 2000, BIOCHEMISTRY-US, V39, P4971, DOI 10.1021/bi992681k; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Marciano DC, 2008, J MOL BIOL, V384, P151, DOI 10.1016/j.jmb.2008.09.009; Marciano DC, 2009, PROTEIN SCI, V18, P2080, DOI 10.1002/pro.220; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Mustafi D, 2001, BIOCHEMISTRY-US, V40, P2397, DOI 10.1021/bi0021075; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; NORDMANN P, 1993, ANTIMICROB AGENTS CH, V37, P962, DOI 10.1128/AAC.37.5.962; NORDMANN P, 1994, ANTIMICROB AGENTS CH, V38, P104, DOI 10.1128/AAC.38.1.104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Petrosino J, 1999, J BIOL CHEM, V274, P2394, DOI 10.1074/jbc.274.4.2394; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000; Poirel L, 2001, ANTIMICROB AGENTS CH, V45, P2598, DOI 10.1128/AAC.45.9.2598-2603.2001; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Smith CA, 2007, ACTA CRYSTALLOGR D, V63, P982, DOI 10.1107/S0907444907036955; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P688, DOI 10.1038/nsb0896-688; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tranier S, 2000, J BIOL CHEM, V275, P28075; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Walsh TR, 2008, CURR OPIN INFECT DIS, V21, P367, DOI 10.1097/QCO.0b013e328303670b; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Wang CX, 2006, J ANTIMICROB CHEMOTH, V57, P1261, DOI 10.1093/jac/dkl116; Zawadzke LE, 1996, BIOCHEMISTRY-US, V35, P16475, DOI 10.1021/bi962242a; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	63	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33703	33712		10.1074/jbc.M109.053819	http://dx.doi.org/10.1074/jbc.M109.053819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19812041	Green Published, hybrid			2022-12-25	WOS:000272028500074
J	Kereszturi, E; Sahin-Toth, M				Kereszturi, Eva; Sahin-Toth, Miklos			Intracellular Autoactivation of Human Cationic Trypsinogen Mutants Causes Reduced Trypsinogen Secretion and Acinar Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PROTEINASE-INHIBITOR; HEREDITARY PANCREATITIS; ENDOPLASMIC-RETICULUM; CATHEPSIN-B; ACTIVATION; MUTATION; PEPTIDE; SPECIFICITY; EXPRESSION; PATHWAY	Mutations in the activation peptide of human cationic trypsinogen have been found in patients with chronic pancreatitis. Previous biochemical studies demonstrated that mutations p.D19A, p.D22G, and p.K23R strongly stimulate trypsinogen autoactivation. In the present study, we characterized the cell biological effects of these mutants using human embryonic kidney 293T and AR42J rat acinar cells. We found that relative to wild-type trypsinogen, secretion of the mutants from transfected cells was markedly decreased. This apparent secretion defect was completely rescued by inhibition of autoactivation via (1) inclusion of the small molecule trypsin inhibitor benzamidine in the growth medium; or (2) cotransfection with the physiological trypsin inhibitor SPINK1; or (3) by mutation of the catalytic Ser200 residue in trypsinogen. In contrast, extracellularly added SPINK1 or other nonpermeable proteinaceous trypsin inhibitors did not restore normal secretion of the mutants, indicating that intracellular autoactivation is responsible for the observed secretion loss. Acinar cells expressing the p. D22G mutant detached from the culture plate over time, became terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling-positive, and exhibited elevated levels of the proapoptotic transcription factor CHOP. The observations indicate that activation peptide mutants of human cationic trypsinogen undergo autoactivation intracellularly, which leads to decreased trypsinogen secretion and eventual acinar cell death. The results thus define a novel pathological pathway for parenchymal injury in hereditary chronic pancreatitis.	[Kereszturi, Eva; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA	Boston University	Sahin-Toth, M (corresponding author), 72 E Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [DK058088]; Rosztoczy Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosztoczy Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK058088 (to M.S.-T.). This work was also supported by a scholarship from the Rosztoczy Foundation (to E. K.).	Chen JM, 2003, MOL BIOL EVOL, V20, P1767, DOI 10.1093/molbev/msg183; Ferec C, 1999, J MED GENET, V36, P228; FIGARELLA C, 1988, BIOL CHEM H-S, V369, P293; Gaiser S, 2005, BIOCHEM BIOPH RES CO, V334, P721, DOI 10.1016/j.bbrc.2005.06.148; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; JESSOP NW, 1980, IN VITRO CELL DEV B, V16, P212; Ji BA, 2009, J BIOL CHEM, V284, P17488, DOI 10.1074/jbc.M109.005520; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kiraly O, 2007, HUM MUTAT, V28, P469, DOI 10.1002/humu.20471; Kiraly O, 2006, PROTEIN EXPRES PURIF, V48, P104, DOI 10.1016/j.pep.2006.01.023; Kukor Z, 2002, J BIOL CHEM, V277, P21389, DOI 10.1074/jbc.M200878200; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; LOGSDON CD, 1985, J CELL BIOL, V100, P1200, DOI 10.1083/jcb.100.4.1200; LOGSDON CD, 1986, J BIOL CHEM, V261, P2096; Lu DS, 1999, J MOL BIOL, V292, P361, DOI 10.1006/jmbi.1999.3089; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Nemoda Z, 2005, J BIOL CHEM, V280, P29645, DOI 10.1074/jbc.M505661200; Ozsvari B, 2008, PANCREAS, V37, P182, DOI 10.1097/MPA.0b013e3181663066; Pal G, 1996, FEBS LETT, V385, P165, DOI 10.1016/0014-5793(96)00376-6; PAL G, 1994, FEBS LETT, V342, P57, DOI 10.1016/0014-5793(94)80584-9; RAJASEKARAN AK, 1993, J CELL SCI, V105, P333; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Simon P, 2002, J BIOL CHEM, V277, P5404, DOI 10.1074/jbc.M108073200; SWAROVSKY B, 1988, EUR J CELL BIOL, V47, P101; Szepessy E, 2006, FEBS J, V273, P2942, DOI 10.1111/j.1742-4658.2006.05305.x; Teich N, 2000, GASTROENTEROLOGY, V119, P461, DOI 10.1053/gast.2000.9312; Teich N, 2002, J GASTROENTEROL, V37, P1, DOI 10.1007/s535-002-8125-1; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	35	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33392	33399		10.1074/jbc.M109.056812	http://dx.doi.org/10.1074/jbc.M109.056812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801634	Green Published, hybrid			2022-12-25	WOS:000272028500045
J	Aneja, R; Datt, M; Singh, B; Kumar, S; Sahni, G				Aneja, Rachna; Datt, Manish; Singh, Balwinder; Kumar, Shekhar; Sahni, Girish			Identification of a New Exosite Involved in Catalytic Turnover by the Streptokinase-Plasmin Activator Complex during Human Plasminogen Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MACROMOLECULAR SUBSTRATE; CONFORMATIONAL ACTIVATION; SYNTHETIC PEPTIDES; KINETIC MECHANISM; CRYSTAL-STRUCTURE; SERINE PROTEASES; BETA-DOMAIN; AMINO-ACID; BINDING	With the goal of identifying hitherto unknown surface exosites of streptokinase involved in substrate human plasminogen recognition and catalytic turnover, synthetic peptides encompassing the 170 loop (CQFTPLNPDDDFRPGLKDTKLLC) in the beta-domain were tested for selective inhibition of substrate human plasminogen activation by the streptokinase-plasmin activator complex. Although a disulfide-constrained peptide exhibited strong inhibition, a linear peptide with the same sequence, or a disulfide-constrained variant with a single lysine to alanine mutation showed significantly reduced capabilities of inhibition. Alanine-scanning mutagenesis of the 170 loop of the beta-domain of streptokinase was then performed to elucidate its importance in streptokinase-mediated plasminogen activation. Some of the 170 loop mutants showed a remarkable decline in k(cat) without any alteration in apparent substrate affinity (K-m) as compared with wild-type streptokinase and identified the importance of Lys(180) as well as Pro(177) in the functioning of this loop. Remarkably, these mutants were able to generate amidolytic activity and non-proteolytic activation in "partner" plasminogen as wild-type streptokinase. Moreover, cofactor activities of the 170 loop mutants, pre-complexed with plasmin, against microplasminogen as the substrate showed a similar pattern of decline in k(cat) as that observed in the case of full-length plasminogen, with no concomitant change in K-m. These results strongly suggest that the 170 loop of the beta-domain of streptokinase is important for catalysis by the streptokinase-plasmin(ogen) activator complex, particularly in catalytic processing/turnover of substrate, although it does not seem to contribute significantly toward enzyme-substrate affinity per se.	[Aneja, Rachna; Datt, Manish; Singh, Balwinder; Kumar, Shekhar; Sahni, Girish] CSIR, Inst Microbial Technol, Dept Mol Biol & Prot Engn, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sahni, G (corresponding author), CSIR, Inst Microbial Technol, Dept Mol Biol & Prot Engn, Sector 39-A, Chandigarh 160036, India.	sahni@imtech.res.in	Datt, Manish/AAD-6989-2019	Datt, Manish/0000-0002-9578-4113	The Institute of Microbial Technology, India	The Institute of Microbial Technology, India	This work was supported by intra-mural funds from The Institute of Microbial Technology, India.	BAJAJ SP, 1977, J BIOL CHEM, V252, P492; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; Chaudhary A, 1999, PROTEIN SCI, V8, P2791; DERENZO EC, 1967, J BIOL CHEM, V242, P533; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Dhar J, 2002, J BIOL CHEM, V277, P13257, DOI 10.1074/jbc.M108422200; FURIE B, 1982, J BIOL CHEM, V257, P3875; GONZALEZGRONOW M, 1978, J BIOL CHEM, V253, P1090; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Kim DM, 2000, THROMB RES, V99, P93, DOI 10.1016/S0049-3848(00)00225-5; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LEE PP, 1988, BIOCHEMISTRY-US, V27, P7506, DOI 10.1021/bi00419a049; LIJNEN HR, 1991, THROMB HAEMOSTASIS, V66, P468; Lin LF, 2000, BIOCHEMISTRY-US, V39, P4740, DOI 10.1021/bi992028x; Lizano S, 2005, INFECT IMMUN, V73, P4451, DOI 10.1128/IAI.73.7.4451-4453.2005; MARKUS G, 1964, J BIOL CHEM, V239, P2637; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; Nihalani D, 1997, PROTEIN SCI, V6, P1284, DOI 10.1002/pro.5560060616; Nihalani D, 1998, PROTEIN SCI, V7, P637, DOI 10.1002/pro.5560070313; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; RADEK JT, 1993, METHOD ENZYMOL, V223, P145; Rajamohan G, 2002, BIOCHEM J, V365, P379, DOI 10.1042/BJ20011647; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; REED GL, 1995, BIOCHEMISTRY-US, V34, P10266, DOI 10.1021/bi00032a021; SHI GY, 1988, J BIOL CHEM, V263, P17071; SUMMARIA L, 1982, BIOCHEMISTRY-US, V21, P2056, DOI 10.1021/bi00538a012; Sundram V, 2003, J BIOL CHEM, V278, P30569, DOI 10.1074/jbc.M303799200; Tachias K, 1996, J BIOL CHEM, V271, P28749, DOI 10.1074/jbc.271.46.28749; Tharp AC, 2009, J BIOL CHEM, V284, P19511, DOI 10.1074/jbc.M109.005512; Wakeham N, 2002, PROTEIN ENG, V15, P753, DOI 10.1093/protein/15.9.753; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Wang XQ, 1999, FEBS LETT, V459, P85, DOI 10.1016/S0014-5793(99)01214-4; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOHL RC, 1984, BIOCHEMISTRY-US, V23, P3799, DOI 10.1021/bi00312a002; Yadav S, 2008, BBA-PROTEINS PROTEOM, V1784, P1310, DOI 10.1016/j.bbapap.2008.05.013	47	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32642	32650		10.1074/jbc.M109.046573	http://dx.doi.org/10.1074/jbc.M109.046573			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801674	Green Published, hybrid			2022-12-25	WOS:000272028400047
J	Fluman, N; Cohen-Karni, D; Weiss, T; Bibi, E				Fluman, Nir; Cohen-Karni, Devora; Weiss, Tali; Bibi, Eitan			A Promiscuous Conformational Switch in the Secondary Multidrug Transporter MdfA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE P-GLYCOPROTEIN; ESCHERICHIA-COLI; TRANSMEMBRANE SEGMENTS; SIMULTANEOUS BINDING; PROMOTE MATURATION; PROTEIN; MEMBRANE; RECOGNITION; DRUGS; IDENTIFICATION	Multidrug (Mdr) transporters are membrane proteins that actively export structurally dissimilar drugs from the cell, thereby rendering the cell resistant to toxic compounds. Similar to substrate-specific transporters, Mdr transporters also undergo substrate-induced conformational changes. However, the mechanism by which a variety of dissimilar substrates are able to induce similar transport-compatible conformational responses in a single transporter remains unclear. To address this major aspect of Mdr transport, we studied the conformational behavior of the Escherichia coli Mdr transporter MdfA. Our results show that indeed, different substrates induce similar conformational changes in the transporter. Intriguingly, in addition, we observed that compounds other than substrates are able to confer similar conformational changes when covalently attached at the putative Mdr recognition pocket of MdfA. Taken together, the results suggest that the Mdr-binding pocket of MdfA is conformationally sensitive. We speculate that the same conformational switch that usually drives active transport is triggered promiscuously by merely occupying the Mdr-binding site.	[Fluman, Nir; Cohen-Karni, Devora; Weiss, Tali; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il	Weiss, Tali/AAA-5530-2022	Fluman, Nir/0000-0001-9909-0779; Bibi, Eitan/0000-0003-3700-2707	Israel Cancer Research Foundation; Minerva Foundation; Israel Science Foundation	Israel Cancer Research Foundation; Minerva Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by the Israel Cancer Research Foundation, the Minerva Foundation, and the Israel Science Foundation.	Adler J, 2005, J BIOL CHEM, V280, P2721, DOI 10.1074/jbc.M412332200; Adler J, 2004, J BIOL CHEM, V279, P8957, DOI 10.1074/jbc.M313422200; Adler J, 2004, BIOCHEMISTRY-US, V43, P518, DOI 10.1021/bi035485t; Adler J, 2002, J BACTERIOL, V184, P3313, DOI 10.1128/JB.184.12.3313-3320.2002; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Fluman N, 2009, BBA-PROTEINS PROTEOM, V1794, P738, DOI 10.1016/j.bbapap.2008.11.020; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; KOSOWER EM, 1995, METHOD ENZYMOL, V251, P133, DOI 10.1016/0076-6879(95)51117-2; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; Neyfakh AA, 2002, MOL MICROBIOL, V44, P1123, DOI 10.1046/j.1365-2958.2002.02965.x; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sigal N, 2005, BIOCHEMISTRY-US, V44, P14870, DOI 10.1021/bi051574p; Sigal N, 2006, J MOL MICROB BIOTECH, V11, P308, DOI 10.1159/000095633; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vazquez-Laslop N, 2000, BIOCHEM SOC T, V28, P517, DOI 10.1042/0300-5127:0280517; Venter H, 2005, BIOCHEM SOC T, V33, P1008, DOI 10.1042/BST20051008	36	15	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32296	32304		10.1074/jbc.M109.050658	http://dx.doi.org/10.1074/jbc.M109.050658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19808670	Green Published, hybrid			2022-12-25	WOS:000272028400011
J	Mirghomizadeh, F; Bullwinkel, J; Orinska, Z; Janssen, O; Petersen, A; Singh, PB; Bulfone-Paus, S				Mirghomizadeh, Farhad; Bullwinkel, Joern; Orinska, Zane; Janssen, Ottmar; Petersen, Arnd; Singh, Prim B.; Bulfone-Paus, Silvia			Transcriptional Regulation of Mouse Mast Cell Protease-2 by Interleukin-15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; NON-CPG METHYLATION; BINDING PROTEIN; C/EBP-BETA; COMPLEX; REGION; GENES; YY1	Mast cells (MCs) play a critical role in innate and adaptive immunity through the release of cytokines, chemokines, lipid mediators, biogenic amines, and proteases. We recently showed that the activities of MC proteases are transcriptionally regulated by intracellularly retained interleukin-15 (IL-15), and we provided evidence that this cytokine acts as a specific regulator of mouse mast cell protease-2 (mMCP-2). Here, we show that in wild-type bone marrow-derived mast cells (BMMCs) IL-15 inhibits mMCP-2 transcription indirectly by inducing differential expression and mMCP-2 promoter binding of the bifunctional transcription factors C/EBP beta and YY1. In wild-type BMMCs, C/EBP beta expression predominates over YY1 expression, and thus C/EBP beta preferentially binds to the mMCP-2 promoter. In IL-15-deficient BMMCs, the opposite is found: YY1 expression predominates and binds to them MCP-2 promoter at the expense of C/EBP beta. Hypertranscription of the mMCP-2 gene in IL-15-deficient BMMCs is associated with histone acetylation and, intriguingly, with methylation of non-CpG dinucleotides within the MCP-2 promoter. This suggests a novel model of cytokine-controlled protease transcription: non-CpG methylation maintains a chromosomal domain in an "open" configuration that is permissive for gene expression.	[Bulfone-Paus, Silvia] Res Ctr Borstel, Dept Immunol & Cell Biol, Div Immunobiol, D-23845 Borstel, Germany; [Bullwinkel, Joern; Singh, Prim B.] Res Ctr Borstel, Dept Immunol & Cell Biol, Div Immunoepigenet, D-23845 Borstel, Germany; [Petersen, Arnd] Res Ctr Borstel, Dept Pneumol, Div Clin & Mol Allergol, D-23845 Borstel, Germany; [Janssen, Ottmar] Univ Kiel, Inst Immunol, D-24105 Kiel, Germany	Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel; University of Kiel	Bulfone-Paus, S (corresponding author), Res Ctr Borstel, Dept Immunol & Cell Biol, Div Immunobiol, Parkallee 22, D-23845 Borstel, Germany.	sbulfone@fz-borstel.de	Singh, Prim/G-1088-2014; Janssen, Ottmar/E-9735-2010; Janssen, Ottmar/N-8769-2019; Bullwinkel, Jörn/AAW-4318-2021	Singh, Prim/0000-0002-9571-0974; Janssen, Ottmar/0000-0002-9612-8900; Janssen, Ottmar/0000-0002-9612-8900; Bullwinkel, Jörn/0000-0002-7525-6057	Deutsche Forschungsgemeinschaft [SFB415/A10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported in part by the Deutsche Forschungsgemeinschaft Grant SFB415/A10 (to S.B.-P.).	Bauknecht T, 1996, J VIROL, V70, P7695, DOI 10.1128/JVI.70.11.7695-7705.1996; Bauknecht T, 1998, J VIROL, V72, P2113, DOI 10.1128/JVI.72.3.2113-2124.1998; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Dodge JE, 2002, GENE, V289, P41, DOI 10.1016/S0378-1119(02)00469-9; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; GASTON K, 1995, NUCLEIC ACIDS RES, V23, P901, DOI 10.1093/nar/23.6.901; Huang CF, 1998, J CLIN IMMUNOL, V18, P169, DOI 10.1023/A:1020574820797; Ikeda R, 2008, INT J BIOCHEM CELL B, V40, P1956, DOI 10.1016/j.biocel.2008.02.004; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	22	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32635	32641		10.1074/jbc.M109.015446	http://dx.doi.org/10.1074/jbc.M109.015446			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801677	Green Published, hybrid			2022-12-25	WOS:000272028400046
J	Asai, H; Iwamori, S; Kawai, K; Ehira, S; Ishihara, J; Aihara, K; Shoji, S; Iwasaki, H				Asai, Hironori; Iwamori, Shunsuke; Kawai, Kentaro; Ehira, Shigeki; Ishihara, Jun-ichi; Aihara, Kazuyuki; Shoji, Shuichi; Iwasaki, Hideo			Cyanobacterial Cell Lineage Analysis of the Spatiotemporal hetR Expression Profile during Heterocyst Pattern Formation in Anabaena sp PCC 7120	PLOS ONE			English	Article								Diazotrophic heterocyst formation in the filamentous cyanobacterium, Anabaena sp. PCC 7120, is one of the simplest pattern formations known to occur in cell differentiation. Most previous studies on heterocyst patterning were based on statistical analysis using cells collected or observed at different times from a liquid culture, which would mask stochastic fluctuations affecting the process of pattern formation dynamics in a single bacterial filament. In order to analyze the spatiotemporal dynamics of heterocyst formation at the single filament level, here we developed a culture system to monitor simultaneously bacterial development, gene expression, and phycobilisome fluorescence. We also developed micro-liquid chamber arrays to analyze multiple Anabaena filaments at the same time. Cell lineage analyses demonstrated that the initial distributions of hetR::gfp and phycobilisome fluorescence signals at nitrogen step-down were not correlated with the resulting distribution of developed heterocysts. Time-lapse observations also revealed a dynamic hetR expression profile at the single-filament level, including transient upregulation accompanying cell division, which did not always lead to heterocyst development. In addition, some cells differentiated into heterocysts without cell division after nitrogen step-down, suggesting that cell division in the mother cells is not an essential requirement for heterocyst differentiation.			Asai, H (corresponding author), Waseda Univ TWIns, Dept Elect Engn & Biol Sci, Tokyo, Japan.	hideo-iwasaki@waseda.jp	Ehira, Shigeki/D-6081-2013; Kawai, Kentaro/B-6770-2015	Ehira, Shigeki/0000-0002-4121-7367; Kawai, Kentaro/0000-0002-3030-9493; Iwasaki, Hideo/0000-0002-3754-4955				Aldea MR, 2007, J BACTERIOL, V189, P8392, DOI 10.1128/JB.00821-07; Allard JF, 2007, DEV BIOL, V312, P427, DOI 10.1016/j.ydbio.2007.09.045; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Borthakur PB, 2005, MOL MICROBIOL, V57, P111, DOI 10.1111/j.1365-2958.2005.04678.x; BRADLEY S, 1976, J GEN MICROBIOL, V96, P175, DOI 10.1099/00221287-96-1-175; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; Callahan SM, 2001, MOL MICROBIOL, V40, P941, DOI 10.1046/j.1365-2958.2001.02437.x; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; ELHAI J, 1998, METHOD ENZYMOL, V167, P747; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Haselkorn R, 2008, MOL MICROBIOL, V70, P783, DOI 10.1111/j.1365-2958.2008.06475.x; Huang X, 2004, P NATL ACAD SCI USA, V101, P4848, DOI 10.1073/pnas.0400429101; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; MITCHISON GJ, 1976, SCIENCE, V191, P866, DOI 10.1126/science.814620; Sakr S, 2006, J BACTERIOL, V188, P1396, DOI 10.1128/JB.188.4.1396-1404.2006; Sakr S, 2006, J BACTERIOL, V188, P5958, DOI 10.1128/JB.00524-06; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; WILCOX M, 1973, J CELL SCI, V13, P637; WOLK CP, 1975, DEV BIOL, V46, P370, DOI 10.1016/0012-1606(75)90113-X; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Yoon HS, 2001, J BACTERIOL, V183, P2605, DOI 10.1128/JB.183.8.2605-2613.2001; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Zhou RB, 1998, P NATL ACAD SCI USA, V95, P4959, DOI 10.1073/pnas.95.9.4959	24	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7371	10.1371/journal.pone.0007371	http://dx.doi.org/10.1371/journal.pone.0007371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823574	Green Submitted, Green Published, gold			2022-12-25	WOS:000270728500002
J	Mortensen, OH; Nielsen, AR; Erikstrup, C; Plomgaard, P; Fischer, CP; Krogh-Madsen, R; Lindegaard, B; Petersen, AM; Taudorf, S; Pedersen, BK				Mortensen, Ole Hartvig; Nielsen, Anders Rinnov; Erikstrup, Christian; Plomgaard, Peter; Fischer, Christian Philip; Krogh-Madsen, Rikke; Lindegaard, Birgitte; Petersen, Anne Marie; Taudorf, Sarah; Pedersen, Bente Klarlund			Calprotectin - A Novel Marker of Obesity	PLOS ONE			English	Article								Background: The two inflammatory molecules, S100A8 and S100A9, form a heterodimer, calprotectin. Plasma calprotectin levels are elevated in various inflammatory disorders. We hypothesized that plasma calprotectin levels would be increased in subjects with low-grade systemic inflammation i.e. either obese subjects or subjects with type 2 diabetes. Methodology/Principal Findings: Plasma calprotectin and skeletal muscle S100A8 mRNA levels were measured in a cohort consisting of 199 subjects divided into four groups depending on presence or absence of type 2 diabetes (T2D), and presence or absence of obesity. There was a significant interaction between obesity and T2D (p = 0.012). Plasma calprotectin was increased in obese relative to non-obese controls (p<0.0001), whereas it did not differ between obese and non-obese patients with T2D (p = 0.62). S100A8 mRNA levels in skeletal muscle were not influenced by obesity or T2D. Multivariate regression analysis (adjusting for age, sex, smoking and HOMA2-IR) showed plasma calprotectin to be strongly associated with BMI, even when further adjusted for fitness, CRP, TNF-alpha or neutrophil number. Conclusions/Significance: Plasma calprotectin is a marker of obesity in individuals without type 2 diabetes.			Mortensen, OH (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Infect Dis, Ctr Inflammat & Metab, Copenhagen, Denmark.	bkp@rh.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Mortensen, Ole Hartvig/AAA-8835-2019; Lindegaard, Birgitte/AGY-9629-2022	Pedersen, Bente Klarlund/0000-0001-6508-6288; Mortensen, Ole Hartvig/0000-0003-1118-6317; Erikstrup, Christian/0000-0001-6551-6647; Rinnov, Anders Rasmussen/0000-0003-3859-3289; Fischer, Christian/0000-0002-0657-9143; Plomgaard, Peter/0000-0002-2404-2702; Lindegaard, Birgitte/0000-0002-5236-8427; Krogh-Madsen, Rikke/0000-0003-4914-2715				Bouma G, 2004, DIABETES, V53, P1979, DOI 10.2337/diabetes.53.8.1979; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Mooren FC, 2006, INT J SPORTS MED, V27, P751, DOI 10.1055/s-2005-872909; Mortensen OH, 2008, J PHYSIOL-LONDON, V586, P3551, DOI 10.1113/jphysiol.2008.153551; Plomgaard P, 2007, DIABETOLOGIA, V50, P2562, DOI 10.1007/s00125-007-0834-6; Rodriguez A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-379; Striz I, 2004, PHYSIOL RES, V53, P245; Xu K, 2000, J IMMUNOL, V164, P4916, DOI 10.4049/jimmunol.164.9.4916	10	93	94	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7419	10.1371/journal.pone.0007419	http://dx.doi.org/10.1371/journal.pone.0007419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823685	Green Published, gold, Green Submitted			2022-12-25	WOS:000270728500017
J	Roduit, R; Escher, P; Schorderet, DF				Roduit, Raphael; Escher, Pascal; Schorderet, Daniel F.			Mutations in the DNA-Binding Domain of NR2E3 Affect In Vivo Dimerization and Interaction with CRX	PLOS ONE			English	Article								Background: NR2E3 (PNR) is an orphan nuclear receptor essential for proper photoreceptor determination and differentiation. In humans, mutations in NR2E3 have been associated with the recessively inherited enhanced short wavelength sensitive (S-) cone syndrome (ESCS) and, more recently, with autosomal dominant retinitis pigmentosa (adRP). NR2E3 acts as a suppressor of the cone generation program in late mitotic retinal progenitor cells. In adult rod photoreceptors, NR2E3 represses cone-specific gene expression and acts in concert with the transcription factors CRX and NRL to activate rod-specific genes. NR2E3 and CRX have been shown to physically interact in vitro through their respective DNA-binding domains (DBD). The DBD also contributes to homo-and heterodimerization of nuclear receptors. Methodology/Principal Findings: We analyzed NR2E3 homodimerization and NR2E3/CRX complex formation in an in vivo situation by Bioluminescence Resonance Energy Transfer (BRET(2)). NR2E3 wild-type protein formed homodimers in transiently transfected HEK293T cells. NR2E3 homodimerization was impaired in presence of disease-causing mutations in the DBD, except for the p. R76Q and p. R104W mutant proteins. Strikingly, the adRP-linked p. G56R mutant protein interacted with CRX with a similar efficiency to that of NR2E3 wild-type and p. R311Q proteins. In contrast, all other NR2E3 DBD-mutant proteins did not interact with CRX. The p. G56R mutant protein was also more effective in abolishing the potentiation of rhodospin gene transactivation by the NR2E3 wild-type protein. In addition, the p. G56R mutant enhanced the transrepression of the M-and S-opsin promoter, while all other NR2E3 DBD-mutants did not. Conclusions/Significance: These results suggest different disease mechanisms in adRP- and ESCS-patients carrying NR2E3 mutations. Titration of CRX by the p. G56R mutant protein acting as a repressor in trans may account for the severe clinical phenotype in adRP patients.			Roduit, R (corresponding author), IRO, Inst Res Ophthalmol, Sion, Switzerland.	raphael.roduit@irovision.ch	Roduit, Raphael/AAC-3890-2021	Roduit, Raphael/0000-0001-7440-2799; Schorderet, Daniel/0000-0002-1331-504X				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Escher P, 2009, HUM MUTAT, V30, P342, DOI 10.1002/humu.20858; Gire AI, 2007, MOL VIS, V13, P1970; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X; Hamdan Fadi F, 2006, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0523s34; Hayashi T, 2005, OPHTHALMOLOGY, V112, P2115, DOI 10.1016/j.ophtha.2005.07.002; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Owen GI, 2000, CELL MOL LIFE SCI, V57, P809, DOI 10.1007/s000180050043; PANKRATZ MJ, 1992, SCIENCE, V255, P986, DOI 10.1126/science.1546296; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; SCHORDERET DF, 2009, HUM MUTAT; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Wright Alan F, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9285; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Yu RT, 2000, P NATL ACAD SCI USA, V97, P2621, DOI 10.1073/pnas.050566897; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2	36	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7379	10.1371/journal.pone.0007379	http://dx.doi.org/10.1371/journal.pone.0007379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823680	Green Published, gold, Green Submitted			2022-12-25	WOS:000270728500005
J	Rohrbeck, A; Borlak, J				Rohrbeck, Astrid; Borlak, Juergen			Cancer Genomics Identifies Regulatory Gene Networks Associated with the Transition from Dysplasia to Advanced Lung Adenocarcinomas Induced by c-Raf-1	PLOS ONE			English	Article							BONE-MORPHOGENETIC PROTEIN; ENDOTHELIAL GROWTH-FACTOR; HORMONE-RELATED PEPTIDE; ADHESION MOLECULE L1; CELL-ADHESION; DOWN-REGULATION; BETA-CATENIN; VE-CADHERIN; MOUSE LUNG; L-SELECTIN	Background: Lung cancer is a leading cause of cancer morbidity. To improve an understanding of molecular causes of disease a transgenic mouse model was investigated where targeted expression of the serine threonine kinase c-Raf to respiratory epithelium induced initialy dysplasia and subsequently adenocarcinomas. This enables dissection of genetic events associated with precancerous and cancerous lesions. Methodology/Principal Findings: By laser microdissection cancer cell populations were harvested and subjected to whole genome expression analyses. Overall 473 and 541 genes were significantly regulated, when cancer versus transgenic and non-transgenic cells were compared, giving rise to three distinct and one common regulatory gene network. At advanced stages of tumor growth predominately repression of gene expression was observed, but genes previously shown to be up-regulated in dysplasia were also up-regulated in solid tumors. Regulation of developmental programs as well as epithelial mesenchymal and mesenchymal endothelial transition was a hall mark of adenocarcinomas. Additionaly, genes coding for cell adhesion, i.e. the integrins and the tight and gap junction proteins were repressed, whereas ligands for receptor tyrosine kinase such as epi- and amphiregulin were up-regulated. Notably, Vegfr-2 and its ligand Vegfd, as well as Notch and Wnt signalling cascades were regulated as were glycosylases that influence cellular recognition. Other regulated signalling molecules included guanine exchange factors that play a role in an activation of the MAP kinases while several tumor suppressors i.e. Mcc, Hey1, Fat3, Armcx1 and Reck were significantly repressed. Finally, probable molecular switches forcing dysplastic cells into malignantly transformed cells could be identified. Conclusions/Significance: This study provides insight into molecular pertubations allowing dysplasia to progress further to adenocarcinoma induced by exaggerted c-Raf kinase activity.			Rohrbeck, A (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany.	borlak@item.fraunhofer.de						Achen MG, 2002, GROWTH FACTORS, V20, P99, DOI 10.1080/08977190290031969; Ackerman KG, 2007, AM J RESP CELL MOL, V36, P391, DOI 10.1165/rcmb.2006-0211RC; Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; Anborgh PH, 1999, MOL CELL BIOL, V19, P4611; ANGGARD E, 1966, ACTA PHYSIOL SCAND, V66, P509, DOI 10.1111/j.1748-1716.1966.tb03231.x; ANGGARD E, 1964, J BIOL CHEM, V239, P4097; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-62; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Bakre MM, 2002, NAT MED, V8, P995, DOI 10.1038/nm753; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; BASTIDE B, 1993, CIRC RES, V73, P1138, DOI 10.1161/01.RES.73.6.1138; Beale G, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-200; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; BERGHOLTE JM, 1987, ARCH BIOCHEM BIOPHYS, V257, P444, DOI 10.1016/0003-9861(87)90589-3; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; Bhattacharya R, 2008, CELL MOTIL CYTOSKEL, V65, P708, DOI 10.1002/cm.20292; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Brunner TB, 2003, CANCER RES, V63, P5656; Burstein HJ, 2008, CLIN CANCER RES, V14, P7871, DOI 10.1158/1078-0432.CCR-08-0593; BURTON PBJ, 1992, FEBS LETT, V305, P228, DOI 10.1016/0014-5793(92)80674-6; BURTON PBJ, 1990, BIOCHEM BIOPH RES CO, V167, P1134, DOI 10.1016/0006-291X(90)90641-Y; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Cao GY, 2002, AM J PHYSIOL-CELL PH, V282, pC1181, DOI 10.1152/ajpcell.00524.2001; Cao HN, 2001, J HUM GENET, V46, P730, DOI 10.1007/s100380170008; Cekanova M, 2007, CANCER-AM CANCER SOC, V109, P1164, DOI 10.1002/cncr.22520; CENTRELLA M, 1989, ENDOCRINOLOGY, V125, P199, DOI 10.1210/endo-125-1-199; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chelly N, 1999, AM J RESP CELL MOL, V20, P423, DOI 10.1165/ajrcmb.20.3.3201; CHEN AJ, 1995, J EXP MED, V182, P519, DOI 10.1084/jem.182.2.519; CHOI PM, 1990, MOL CELL BIOL, V10, P4650, DOI 10.1128/MCB.10.9.4650; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; CONNOLLY DJ, 1995, DEV GENET, V17, P65, DOI 10.1002/dvg.1020170108; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Crijns APG, 2007, EUR J CANCER, V43, P2495, DOI 10.1016/j.ejca.2007.08.025; Dai ZY, 2004, ONCOGENE, V23, P3521, DOI 10.1038/sj.onc.1207441; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Debiec H, 1998, J CELL BIOL, V143, P2067, DOI 10.1083/jcb.143.7.2067; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Di Sciullo G, 1998, J EXP MED, V187, P1953, DOI 10.1084/jem.187.12.1953; Diehl D, 2009, INT J CANCER, V124, P2220, DOI 10.1002/ijc.24193; DIRKS RPH, 1993, EUR J BIOCHEM, V216, P487, DOI 10.1111/j.1432-1033.1993.tb18167.x; Dome B, 2006, CANCER RES, V66, P7341, DOI 10.1158/0008-5472.CAN-05-4654; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; Drimal J, 2000, EUR J PHARMACOL, V396, P19, DOI 10.1016/S0014-2999(00)00198-9; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Eberhardt C, 1999, ADV EXP MED BIOL, V469, P351; Eberhart CG, 2001, PEDIATR DEVEL PATHOL, V4, P351, DOI 10.1007/s10024001-0037-y; ENSOR CM, 1995, J LIPID MEDIAT CELL, V12, P313, DOI 10.1016/0929-7855(95)00040-W; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ferletta M, 2007, MOL CANCER RES, V5, P891, DOI 10.1158/1541-7786.MCR-07-0113; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Fogel M, 2003, LANCET, V362, P869, DOI 10.1016/S0140-6736(03)14342-5; FONG KM, 1995, CANCER RES, V55, P220; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Futaki S, 2004, MOL CELL BIOL, V24, P10492, DOI 10.1128/MCB.24.23.10492-10503.2004; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Geerts D, 2003, CANCER LETT, V197, P87, DOI 10.1016/S0304-3835(03)00087-9; GEORGE JN, 1984, NEW ENGL J MED, V311, P1084, DOI 10.1056/NEJM198410253111705; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Gramantieri L, 2007, LIVER INT, V27, P997, DOI 10.1111/j.1478-3231.2007.01544.x; Grusch M, 2006, J HEPATOL, V45, P673, DOI 10.1016/j.jhep.2006.06.014; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guo LH, 2008, MOL CANCER RES, V6, P1421, DOI 10.1158/1541-7786.MCR-07-2175; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; HANSEN H, 1974, PROSTAGLANDINS, V12, P647; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Hershko AY, 2003, GENE, V302, P65, DOI 10.1016/S0378111902010910; Hiesberger T, 2005, J BIOL CHEM, V280, P10578, DOI 10.1074/jbc.M414121200; Hilden JM, 1997, BLOOD, V89, P3801, DOI 10.1182/blood.V89.10.3801.3801_3801_3805; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hsu SJ, 2004, GENOME, V47, P931, DOI 10.1139/G04-043; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Hurbin A, 2002, J BIOL CHEM, V277, P49127, DOI 10.1074/jbc.M207584200; Huuskonen J, 2001, ATHEROSCLEROSIS, V155, P269, DOI 10.1016/S0021-9150(01)00447-6; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Isakson BE, 2003, AM J RESP CELL MOL, V29, P552, DOI 10.1165/rcmb.2002-0281OC; IWAMURA M, 1994, UROLOGY, V43, P675, DOI 10.1016/0090-4295(94)90183-X; Izumoto S, 1996, CANCER RES, V56, P1440; Ju Z, 2005, MOL GENET GENOMICS, V274, P141, DOI 10.1007/s00438-005-0014-7; KANG W, 2008, BIOCH BIOPHYS RES CO; Kaplan-Albuquerque N, 2005, J BIOL CHEM, V280, P19966, DOI 10.1074/jbc.M500917200; Katoh M, 2002, INT J MOL MED, V9, P363; Katoh Y, 2006, INT J MOL MED, V17, P1163; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; KIKUCHI K, 1993, BIOCHEM BIOPH RES CO, V196, P409, DOI 10.1006/bbrc.1993.2264; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kitareewan S, 2008, INT J ONCOL, V33, P397, DOI 10.3892/ijo_00000021; KOHNO T, 1995, HUM MOL GENET, V4, P667, DOI 10.1093/hmg/4.4.667; Kraunz KS, 2005, BRIT J CANCER, V93, P949, DOI 10.1038/sj.bjc.6602790; Krupp M, 2006, INT J MOL MED, V17, P129; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Lamberti A, 2007, CELL DEATH DIFFER, V14, P952, DOI 10.1038/sj.cdd.4402102; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Li DX, 2000, J CELL BIOL, V148, P791, DOI 10.1083/jcb.148.4.791; Li X, 2008, CANCER SCI, V99, P1326, DOI 10.1111/j.1349-7006.2008.00816.x; Liang S, 2007, J NEUROCHEM, V102, P1466, DOI 10.1111/j.1471-4159.2007.04507.x; Lindvall C, 2003, CANCER RES, V63, P1743; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Liu Y, 2009, LUNG CANCER, V63, P210, DOI 10.1016/j.lungcan.2008.05.010; Lories RJU, 2005, CYTOKINE GROWTH F R, V16, P287, DOI 10.1016/j.cytogfr.2005.02.009; Ma LL, 2006, J EXP CLIN CANC RES, V25, P585; Manenti G, 2000, ONCOGENE, V19, P5324, DOI 10.1038/sj.onc.1203916; Mansson-Broberg A, 2008, BIOCHEM BIOPH RES CO, V373, P355, DOI 10.1016/j.bbrc.2008.06.036; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Matakidou A, 2007, BRIT J CANCER, V96, P1904, DOI 10.1038/sj.bjc.6603816; Matsumine A, 1996, J BIOL CHEM, V271, P10341, DOI 10.1074/jbc.271.17.10341; Matsumura T, 1997, J IMMUNOL, V158, P3408; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; Micke P, 2004, TUMOR BIOL, V25, P235, DOI 10.1159/000081386; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Moldvay J, 2007, LUNG CANCER, V57, P159, DOI 10.1016/j.lungcan.2007.02.018; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Nolte C, 1999, CELL TISSUE RES, V298, P261, DOI 10.1007/s004419900063; NOMOTO K, 1995, MOL CARCINOGEN, V12, P146, DOI 10.1002/mc.2940120306; Oram JF, 2003, J BIOL CHEM, V278, P52379, DOI 10.1074/jbc.M310695200; Oreffo VIC, 1998, MOL CARCINOGEN, V21, P37, DOI 10.1002/(SICI)1098-2744(199801)21:1<37::AID-MC6>3.0.CO;2-M; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Packer AI, 2000, DEV DYNAM, V217, P62, DOI 10.1002/(SICI)1097-0177(200001)217:1<62::AID-DVDY6>3.0.CO;2-U; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Pirinen RT, 2001, J CLIN PATHOL, V54, P391, DOI 10.1136/jcp.54.5.391; Plastaras JP, 2007, CANCER RES, V67, P9443, DOI 10.1158/0008-5472.CAN-07-1473; Polakis P, 2000, GENE DEV, V14, P1837; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Rabbani SA, 2000, INT J ONCOL, V16, P197; RACHWAL WJ, 1995, BRIT J CANCER, V72, P56, DOI 10.1038/bjc.1995.277; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; RECK M, 2008, J LUNG CANC; Ren RQ, 2007, BLOOD, V109, P2847, DOI 10.1182/blood-2006-08-039743; Rieger S, 2008, DEV DYNAM, V237, P276, DOI 10.1002/dvdy.21410; Rohrbeck A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005637; Rom WN, 2000, AM J RESP CRIT CARE, V161, P1355, DOI 10.1164/ajrccm.161.4.9908012; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Russell ST, 2002, BRIT J CANCER, V87, P580, DOI 10.1038/sj.bjc.6600493; Sales KJ, 2005, CANCER RES, V65, P7707, DOI 10.1158/0008-5472.CAN-05-0101; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Scurr LL, 2008, CLIN CANCER RES, V14, P6924, DOI 10.1158/1078-0432.CCR-07-5189; SERHAN CN, 1993, BIOCHEMISTRY-US, V32, P6313, DOI 10.1021/bi00076a002; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shen R, 2002, MOL CELL BIOL, V22, P3230, DOI 10.1128/MCB.22.10.3230-3236.2002; Shepard CR, 2007, ONCOGENE, V26, P3020, DOI 10.1038/sj.onc.1210115; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; Simone NL, 1998, TRENDS GENET, V14, P272, DOI 10.1016/S0168-9525(98)01489-9; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; SMITS A, 1992, AM J PATHOL, V140, P639; Smolen JE, 2000, J BIOL CHEM, V275, P15876, DOI 10.1074/jbc.M906232199; Smythe WR, 1999, LUNG CANCER-J IASLC, V24, P157, DOI 10.1016/S0169-5002(99)00032-X; SOMERSALO K, 1995, J BIOL CHEM, V270, P8629, DOI 10.1074/jbc.270.15.8629; Soriano JV, 2000, INT J CANCER, V86, P652; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Strathdee G, 2007, CLIN CANCER RES, V13, P5048, DOI 10.1158/1078-0432.CCR-07-0919; Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takai E, 1996, CANCER-AM CANCER SOC, V78, P1384, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1384::AID-CNCR3>3.0.CO;2-L; Tanaka H, 2004, CLIN CANCER RES, V10, P4885, DOI 10.1158/1078-0432.CCR-0393-03; Tardif G, 2004, ARTHRITIS RHEUM-US, V50, P2521, DOI 10.1002/art.20441; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Thies A, 2002, EUR J CANCER, V38, P1708, DOI 10.1016/S0959-8049(02)00105-3; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; Thomas RK, 2006, CLIN CANCER RES, V12, p4384S, DOI 10.1158/1078-0432.CCR-06-0098; Tonary AM, 2000, INT J CANCER, V89, P242, DOI 10.1002/1097-0215(20000520)89:3<242::AID-IJC6>3.0.CO;2-6; Toyoda H, 1997, BIOCHEM J, V326, P69, DOI 10.1042/bj3260069; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Udaka N, 2007, CANCER LETT, V246, P224, DOI 10.1016/j.canlet.2006.02.020; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; ULICH TR, 1994, J CLIN INVEST, V93, P1298, DOI 10.1172/JCI117086; Ulrich K, 2005, AM J PHYSIOL-LUNG C, V288, pL1179, DOI 10.1152/ajplung.00450.2004; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574; Vidal VPI, 2008, J CUTAN PATHOL, V35, P373, DOI 10.1111/j.1600-0560.2007.00815.x; Volpe MV, 2000, BBA-GEN SUBJECTS, V1475, P337, DOI 10.1016/S0304-4165(00)00087-8; WADDELL TK, 1995, J BIOL CHEM, V270, P15403, DOI 10.1074/jbc.270.25.15403; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Wang FS, 2003, AM J RESP CELL MOL, V29, P62, DOI 10.1165/rcmb.2002-0180OC; Warn-Cramer BJ, 2004, BBA-BIOMEMBRANES, V1662, P81, DOI 10.1016/j.bbamem.2003.10.018; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wikstrom P, 2002, PROSTATE, V51, P268, DOI 10.1002/pros.10083; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Woenckhaus M, 2006, J PATHOL, V210, P192, DOI 10.1002/path.2039; Wolfbauer G, 1999, BBA-MOL CELL BIOL L, V1439, P65, DOI 10.1016/S1388-1981(99)00077-3; Wright JK, 2008, TUMOR BIOL, V29, P130, DOI 10.1159/000141918; Wu DF, 2007, J BIOL CHEM, V282, P22239, DOI 10.1074/jbc.M700941200; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Xie Y, 2007, CARCINOGENESIS, V28, P2122, DOI 10.1093/carcin/bgm147; Yamada Y, 2000, P NATL ACAD SCI USA, V97, P320, DOI 10.1073/pnas.97.1.320; Yamayoshi T, 2004, J PATHOL, V204, P110, DOI 10.1002/path.1617; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Younes R N, 2000, Rev Hosp Clin Fac Med Sao Paulo, V55, P181; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; ZAKUT R, 1993, ONCOGENE, V8, P2221; Zhang W, 2008, LEUKEMIA, V22, P808, DOI 10.1038/sj.leu.2405098; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720; Zhou YH, 1998, EMBO J, V17, P6689, DOI 10.1093/emboj/17.22.6689	226	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7315	10.1371/journal.pone.0007315	http://dx.doi.org/10.1371/journal.pone.0007315			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812696	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594200001
J	Gras, L; Jurriaans, S; Bakker, M; van Sighem, A; Bezemer, D; Fraser, C; Lange, J; Prins, JM; Berkhout, B; de Wolf, F				Gras, Luuk; Jurriaans, Suzanne; Bakker, Margreet; van Sighem, Ard; Bezemer, Daniela; Fraser, Christophe; Lange, Joep; Prins, Jan M.; Berkhout, Ben; de Wolf, Frank		ATHENA Natl Observational Cohort S	Viral Load Levels Measured at Set-Point Have Risen Over the Last Decade of the HIV Epidemic in the Netherlands	PLOS ONE			English	Article								Background: HIV-1 RNA plasma concentration at viral set-point is associated not only with disease outcome but also with the transmission dynamics of HIV-1. We investigated whether plasma HIV-1 RNA concentration and CD4 cell count at viral set-point have changed over time in the HIV epidemic in the Netherlands. Methodology/Principal Findings: We selected 906 therapy-naive patients with at least one plasma HIV-1 RNA concentration measured 9 to 27 months after estimated seroconversion. Changes in HIV-1 RNA and CD4 cell count at viral set-point over time were analysed using linear regression models. The ATHENA national observational cohort contributed all patients who seroconverted in or after 1996; the Amsterdam Cohort Studies (ACS) contributed seroconverters before 1996. The mean of the first HIV-1 RNA concentration measured 9-27 months after seroconversion was 4.30 log(10) copies/ml (95% CI 4.17-4.42) for seroconverters from 1984 through 1995 (n = 163); 4.27 (4.16-4.37) for seroconverters 1996-2002 (n = 232), and 4.59 (4.52-4.66) for seroconverters 2003-2007 (n = 511). Compared to patients seroconverting between 2003-2007, the adjusted mean HIV-1 RNA concentration at set-point was 0.28 log(10) copies/ml (95% CI 0.16-0.40; p < 0.0001) and 0.26 (0.11-0.41; p = 0.0006) lower for those seroconverting between 1996-2002 and 1984-1995, respectively. Results were robust regardless of type of HIV-1 RNA assay, HIV-1 subtype, and interval between measurement and seroconversion. CD4 cell count at viral set-point declined over calendar time at approximately 5 cells/mm(3)/year. Conclusion: The HIV-1 RNA plasma concentration at viral set-point has increased over the last decade of the HIV epidemic in the Netherlands. This is accompanied by a decreasing CD4 cell count over the period 1984-2007 and may have implications for both the course of the HIV infection and the epidemic.			Gras, L (corresponding author), Stichting HIV Monitoring, Amsterdam, Netherlands.	l.a.gras@amc.uva.nl	Prins, Jan M./AAF-4945-2020; Fraser, Christophe/A-8109-2008	Fraser, Christophe/0000-0003-2399-9657	MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719] Funding Source: Medline; Medical Research Council [G0600719B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91; Berger A, 2005, J CLIN VIROL, V33, P43, DOI 10.1016/j.jcv.2004.09.025; BRANGER J, 2008, SEX TRANSM DIS; Bruisten SM, 1997, J VIROL METHODS, V67, P199, DOI 10.1016/S0166-0934(97)00097-9; Crum-Cianflone N, 2009, CLIN INFECT DIS, V48, P1285, DOI 10.1086/597777; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Donnelly CA, 2005, HIV MED, V6, P170, DOI 10.1111/j.1468-1293.2005.00285.x; Dorrucci M, 2005, AIDS, V19, P331; Dorrucci M, 2007, J INFECT DIS, V195, P525, DOI 10.1086/510911; Dukers-Muijrers NHTM, 2009, SEX TRANSM INFECT, V85, P226, DOI 10.1136/sti.2008.033191; Elbeik T, 2002, J ACQ IMMUN DEF SYND, V29, P330; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Galai N, 1996, AM J EPIDEMIOL, V143, P278; Gali Y, 2007, VIROLOGY, V364, P140, DOI 10.1016/j.virol.2007.02.021; Galli R, 2005, J CLIN VIROL, V34, P245, DOI 10.1016/j.jcv.2004.12.012; Geskus RB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-65; Ginocchio CC, 1997, J CLIN MICROBIOL, V35, P2886, DOI 10.1128/JCM.35.11.2886-2893.1997; GRAS L, 2008, MONITORING HUMAN IMM; Griffith BP, 1997, J CLIN MICROBIOL, V35, P3288, DOI 10.1128/JCM.35.12.3288-3291.1997; Heijman RLJ, 2009, SEX TRANSM INFECT, V85, P249, DOI 10.1136/sti.2008.033258; Herbeck JT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001525; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Johnson Victoria A, 2008, Top HIV Med, V16, P62; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keet IPM, 1996, AIDS, V10, P1601, DOI 10.1097/00002030-199611000-00025; Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; KOEDIJK FDH, 2009, 2102610042008 RIVM; Levering WHBM, 2008, CYTOM PART B-CLIN CY, V74B, P79, DOI 10.1002/cyto.b.20370; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Muller V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000454; Muller V, 2009, AIDS, V23, P1269, DOI 10.1097/QAD.0b013e32832d4096; Muller V, 2006, AIDS, V20, P889, DOI 10.1097/01.aids.0000218553.51908.6b; Murphy DG, 2000, J CLIN MICROBIOL, V38, P4034, DOI 10.1128/JCM.38.11.4034-4041.2000; Notermans DW, 2000, AIDS RES HUM RETROV, V16, P1507, DOI 10.1089/088922200750006038; Pasquier C, 1999, J VIROL METHODS, V81, P123, DOI 10.1016/S0166-0934(99)00057-9; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Stolte IG, 2004, AIDS, V18, P303, DOI 10.1097/00002030-200401230-00021; Stolte IG, 2001, SEX TRANSM INFECT, V77, P184, DOI 10.1136/sti.77.3.184; Swanson P, 2006, J VIROL METHODS, V137, P184, DOI 10.1016/j.jviromet.2006.06.010; Tang JM, 2004, AIDS RES HUM RETROV, V20, P19, DOI 10.1089/088922204322749468; Troude P, 2009, AIDS, V23, P1261, DOI 10.1097/QAD.0b013e32832b51ef; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; VANGRIENSVEN GJP, 1987, AM J EPIDEMIOL, V125, P1048, DOI 10.1093/oxfordjournals.aje.a114620; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	48	36	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7365	10.1371/journal.pone.0007365	http://dx.doi.org/10.1371/journal.pone.0007365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809510	gold, Green Published, Green Submitted			2022-12-25	WOS:000270594000015
J	Meerow, AW; Noblick, L; Borrone, JW; Couvreur, TLP; Mauro-Herrera, M; Hahn, WJ; Kuhn, DN; Nakamura, K; Oleas, NH; Schnell, RJ				Meerow, Alan W.; Noblick, Larry; Borrone, James W.; Couvreur, Thomas L. P.; Mauro-Herrera, Margarita; Hahn, William J.; Kuhn, David N.; Nakamura, Kyoko; Oleas, Nora H.; Schnell, Raymond J.			Phylogenetic Analysis of Seven WRKY Genes across the Palm Subtribe Attaleinae (Areceaceae) Identifies Syagrus as Sister Group of the Coconut	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; DIVERGENCE TIMES; HISTORICAL BIOGEOGRAPHY; MOLECULAR EVOLUTION; ANDEAN TECTONICS; ABSOLUTE RATES; SPECIES TREES; DNA-BINDING; SEED SIZE; FAMILY	Background: The Cocoseae is one of 13 tribes of Arecaceae subfam. Arecoideae, and contains a number of palms with significant economic importance, including the monotypic and pantropical Cocos nucifera L., the coconut, the origins of which have been one of the "abominable mysteries'' of palm systematics for decades. Previous studies with predominantly plastid genes weakly supported American ancestry for the coconut but ambiguous sister relationships. In this paper, we use multiple single copy nuclear loci to address the phylogeny of the Cocoseae subtribe Attaleinae, and resolve the closest extant relative of the coconut. Methodology/Principal Findings: We present the results of combined analysis of DNA sequences of seven WRKY transcription factor loci across 72 samples of Arecaceae tribe Cocoseae subtribe Attaleinae, representing all genera classified within the subtribe, and three outgroup taxa with maximum parsimony, maximum likelihood, and Bayesian approaches, producing highly congruent and well-resolved trees that robustly identify the genus Syagrus as sister to Cocos and resolve novel and well-supported relationships among the other genera of the Attaleinae. We also address incongruence among the gene trees with gene tree reconciliation analysis, and assign estimated ages to the nodes of our tree. Conclusions/Significance: This study represents the as yet most extensive phylogenetic analyses of Cocoseae subtribe Attaleinae. We present a well-resolved and supported phylogeny of the subtribe that robustly indicates a sister relationship between Cocos and Syagrus. This is not only of biogeographic interest, but will also open fruitful avenues of inquiry regarding evolution of functional genes useful for crop improvement. Establishment of two major clades of American Attaleinae occurred in the Oligocene (ca. 37 MYBP) in Eastern Brazil. The divergence of Cocos from Syagrus is estimated at 35 MYBP. The biogeographic and morphological congruence that we see for clades resolved in the Attaleinae suggests that WRKY loci are informative markers for investigating the phylogenetic relationships of the palm family.			Meerow, AW (corresponding author), ARS, USDA, SHRS Natl Germplasm Repository, Miami, FL USA.	alan.meerow@ars.usda.gov	Couvreur, Thomas LP/D-8172-2011; Meerow, Alan/U-9019-2019; Oleas, Nora/D-3869-2013; Noblick, Larry/S-6599-2019	Couvreur, Thomas LP/0000-0002-8509-6587; Meerow, Alan/0000-0003-1882-8327; Oleas, Nora/0000-0002-1948-4119; 				Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1987, BIOGEOGRAPHY QUATERN, DOI DOI 10.1890/03-5369; [Anonymous], 2008, ENCY FRUITS NUTS; Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Asmussen CB, 2006, BOT J LINN SOC, V151, P15, DOI 10.1111/j.1095-8339.2006.00521.x; ASMUSSEN CB, 2000, SYSTEMATICS EVOLUTIO, P525; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; Baker WJ, 2009, SYST BIOL, V58, P240, DOI 10.1093/sysbio/syp021; BALICK MJ, 1987, AM J BOT, V74, P1013, DOI 10.2307/2443941; Baudouin L, 2009, GENET RESOUR CROP EV, V56, P257, DOI 10.1007/s10722-008-9362-6; BECCARI O, 1963, PRINCIPES, V7, P57; Beck H. T., 1990, USEFUL PALMS WORLD; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Borrone JW, 2007, MOL PHYLOGENET EVOL, V44, P1141, DOI 10.1016/j.ympev.2007.06.012; Borrone JW, 2004, THEOR APPL GENET, V109, P495, DOI 10.1007/s00122-004-1662-4; BORRONE JW, 2004, THESIS FLORIDA INT U; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BROOKS DR, 1990, SYST ZOOL, V39, P14, DOI 10.2307/2992205; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Cunningham CW, 1997, SYST BIOL, V46, P464, DOI 10.2307/2413692; Davis JI, 1998, SYST BIOL, V47, P282, DOI 10.1080/106351598260923; de Candolle A., 1886, ORIGIN CULTIVATED PL, VXLIX, P376; DeSalle R, 1997, SYST BIOL, V46, P751, DOI 10.2307/2413504; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Dransfield J, 2008, GENERA PALMARUM EVOL; Dransfield John, 2005, Kew Bulletin, V60, P559; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Flynn JJ, 1998, MOL PHYLOGENET EVOL, V9, P414, DOI 10.1006/mpev.1998.0504; Franzosa EA, 2007, TREEROT VERSION 3; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; GLASSMAN S, 1972, FIELDIANA BOT, V32, P241; GLASSMAN S., 1987, ILLINOIS BIOL MONOGR, V56, P1; GLASSMAN S.F., 1999, ILLINOIS BIOL MONOGR, V59, P1, DOI DOI 10.5962/BHL.TITLE.49920; Gomez-Navarro C, 2009, AM J BOT, V96, P1300, DOI 10.3732/ajb.0800378; Grover CE, 2004, GENOME RES, V14, P1474, DOI 10.1101/gr.2673204; GRUEZO WS, 1984, BIOTROPICA, V16, P140, DOI 10.2307/2387846; Gunn BF, 2004, ANN MO BOT GARD, V91, P505; Haffer J, 1987, BIOGEOGRAPHY QUATERN, P1; Hahn WJ, 2002, SYST BIOL, V51, P92, DOI 10.1080/106351502753475899; Hahn WJ, 2002, MOL PHYLOGENET EVOL, V23, P189, DOI 10.1016/S1055-7903(02)00022-2; HARRIES HC, 1978, BOT REV, V44, P265, DOI 10.1007/BF02957852; HENDERSON A, 1991, BRITTONIA, V43, P198; HENDERSON A, 1995, FIELD GUIDE PALMS AM; HERNGREEN G F W, 1981, Pollen et Spores, V23, P441; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1355, DOI 10.1093/molbev/msi125; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes CE, 2006, PHILOS T R SOC B, V361, P211, DOI 10.1098/rstb.2005.1735; Hungerbuhler D, 2002, EARTH-SCI REV, V57, P75, DOI 10.1016/S0012-8252(01)00071-X; Jobb G., 2008, TREEFINDER; JOHNSON MAT, 1989, GENOME, V32, P328, DOI 10.1139/g89-449; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KUNTZE CEO, 1891, REV GEN PL, V2, P726; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Lundberg John G., 1998, P13; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Martin AP, 2002, SYST BIOL, V51, P570, DOI 10.1080/10635150290069995; Mauro-Herrera M, 2007, SCI HORTIC-AMSTERDAM, V115, P19, DOI 10.1016/j.scienta.2007.07.005; Mauro-Herrera M, 2006, MOL ECOL NOTES, V6, P904, DOI 10.1111/j.1471-8286.2006.01393.x; Mauro-Herrera M, 2010, GENET RESOUR CROP EV, V57, P203, DOI 10.1007/s10722-009-9463-x; MCDOUGALL I, 1988, EARTH PLANET SC LETT, V89, P207, DOI 10.1016/0012-821X(88)90173-2; Meerow AW, 2006, SYST BOT, V31, P42, DOI 10.1600/036364406775971787; Meerow AW, 2004, SYST BOT, V29, P511, DOI 10.1600/0363644041744400; Meerow AW, 2003, BOT J LINN SOC, V141, P349, DOI 10.1046/j.1095-8339.2003.00142.x; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; MOORE H E JR, 1973, Gentes Herbarum, V11, P27; MORAES M, 1990, BRITTONIA, V42, P92; Moraes R. M., 1996, Novon, V6, P85, DOI 10.2307/3392218; Morley RJ, 2003, PERSPECT PLANT ECOL, V6, P5, DOI 10.1078/1433-8319-00039; Morley RJ, 2000, ORIGIN EVOLUTION TRO; Muller Kai, 2005, Appl Bioinformatics, V4, P65; NOBLICK LR, 1994, ACTA HORTIC, V360, P85; Nuttall C.P., 1990, Bulletin of the British Museum (Natural History) Geology, V45, P165; Page RDM, 1997, MOL PHYLOGENET EVOL, V7, P231, DOI 10.1006/mpev.1996.0390; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; Pintaud Jean-Christophe, 2008, Rev. peru biol., V15, P55; PLATNICK NI, 1978, SYST ZOOL, V27, P1, DOI 10.2307/2412808; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rambaut A, 2014, TRACER V1 6; READ R. W., 1966, Principes, V10, P55; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; RODRIGUES JB, 1901, CONTR JARD BOT RIO J, V1, P7; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RONQUIST F, 1996, DIVA 1 1 1 2 COMPUTE; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rossberg M, 2001, PLANT CELL, V13, P979, DOI 10.1105/tpc.13.4.979; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sanmartin I, 2003, J BIOGEOGR, V30, P1883, DOI 10.1046/j.0305-0270.2003.00982.x; Santos C, 2008, PALAEOGEOGR PALAEOCL, V264, P140, DOI 10.1016/j.palaeo.2008.04.010; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seubert E., 1998, Feddes Repertorium, V109, P89; Seubert E., 1998, Feddes Repertorium, V109, P231; Shono H, 2000, FISHERIES SCI, V66, P608, DOI 10.1046/j.1444-2906.2000.00095.x; Siddall ME, 1997, SYST BIOL, V46, P765, DOI 10.2307/2413505; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Steinmann M, 1999, TECTONOPHYSICS, V307, P255, DOI 10.1016/S0040-1951(99)00100-6; Sullivan J, 1996, SYST BIOL, V45, P375, DOI 10.2307/2413571; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; THIEDE J, 1977, AAPG BULL, V61, P929; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Uhl N., 1987, GENERA PALMARUM CLAS; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Van Der Hammen T., 1979, TROPICAL BOT, P25; VANDERHAMMEN T, 1973, REV PALAEOBOT PALYNO, V16, P1, DOI 10.1016/0034-6667(73)90031-6; Wendel J. F, 1998, MOL SYSTEMATICS PLAN, P265, DOI DOI 10.1007/978-1-4615-5419-6_10; WENDLAND H, 1878, PALMIERS, P247; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P1; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Yamasaki K, 2008, PLANT PHYSIOL BIOCH, V46, P394, DOI 10.1016/j.plaphy.2007.12.015; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1	140	58	68	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7353	10.1371/journal.pone.0007353	http://dx.doi.org/10.1371/journal.pone.0007353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806212	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800028
J	Lerner, HRL; Johnson, JA; Lindsay, AR; Kiff, LF; Mindell, DP				Lerner, Heather R. L.; Johnson, Jeff A.; Lindsay, Alec R.; Kiff, Lloyd F.; Mindell, David P.			It's not too Late for the Harpy Eagle (Harpia harpyja): High Levels Of Genetic Diversity and Differentiation Can Fuel Conservation Programs	PLOS ONE			English	Article							EFFECTIVE POPULATION SIZES; MAXIMUM-LIKELIHOOD-ESTIMATION; DNA CONTROL REGION; STATISTICAL TESTS; PAIRWISE; HISTORY; PHYLOGEOGRAPHY; COALESCENT; VEGETATION; NEUTRALITY	Background: The harpy eagle (Harpia harpyja) is the largest Neotropical bird of prey and is threatened by human persecution and habitat loss and fragmentation. Current conservation strategies include local education, captive rearing and reintroduction, and protection or creation of trans-national habitat blocks and corridors. Baseline genetic data prior to reintroduction of captive-bred stock is essential for guiding such efforts but has not been gathered previously. Methodology/Findings: We assessed levels of genetic diversity, population structure and demographic history for harpy eagles using samples collected throughout a large portion of their geographic distribution in Central America (n = 32) and South America (n = 31). Based on 417 bp of mitochondrial control region sequence data, relatively high levels of haplotype and nucleotide diversity were estimated for both Central and South America, although haplotype diversity was significantly higher for South America. Historical restriction of gene flow across the Andes (i.e. between our Central and South American subgroups) is supported by coalescent analyses, the haplotype network and significant F-ST values, however reciprocally monophyletic lineages do not correspond to geographical locations in maximum likelihood analyses. A sudden population expansion for South America is indicated by a mismatch distribution analysis, and further supported by significant (p<0.05) negative values of Fu and Li's D-F and F, and Fu's F-S. This expansion, estimated at approximately 60 000 years BP (99 000-36 000 years BP 95% CI), encompasses a transition from a warm and dry time period prior to 50 000 years BP to an interval of maximum precipitation (50 000-36 000 years BP). Notably, this time period precedes the climatic and habitat changes associated with the last glacial maximum. In contrast, a multimodal distribution of haplotypes was observed for Central America suggesting either population equilibrium or a recent decline. Significance: High levels of mitochondrial genetic diversity in combination with genetic differentiation among subgroups within regions and between regions highlight the importance of local population conservation in order to preserve maximal levels of genetic diversity in this species. Evidence of historically restricted female-mediated gene flow is an important consideration for captive-breeding programs.			Lerner, HRL (corresponding author), Smithsonian Inst, Genet Lab, Natl Zool Pk, Washington, DC 20560 USA.	lernerh@si.edu						ALVAREZCORDERO E, 1996, BIOL CONSERVATION HA; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banhos A, 2008, GENET MOL BIOL, V31, P146, DOI 10.1590/S1415-47572008000100025; Bates JM, 1998, J BIOGEOGR, V25, P783, DOI 10.1046/j.1365-2699.1998.2540783.x; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BOLLMER JL, 2005, MOL PHYLOGENETICS EV; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; CABEZA M, 2007, J APPL ECOL IN PRESS; Cadahia L, 2007, J ORNITHOL, V148, P99, DOI 10.1007/s10336-006-0107-z; Cassens I, 2003, MOL ECOL, V12, P1781, DOI 10.1046/j.1365-294X.2003.01876.x; Chepstow-Lusty A, 2005, QUATERNARY RES, V63, P90, DOI 10.1016/j.yqres.2004.09.008; Collar N.J., 2001, THREATENED BIRDS ASI; COOPER RA, 1994, ANCIENT DNA RECOVERY, P149; Cortes-Ortiz L, 2003, MOL PHYLOGENET EVOL, V26, P64, DOI 10.1016/S1055-7903(02)00308-1; Crandall KA, 1999, ANIM CONSERV, V2, P317, DOI 10.1111/j.1469-1795.1999.tb00078.x; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; CURTI M, 2007, RELEASED HARPY EAGLE; Curti M, 2009, J ENVIRON EDUC, V40, P3, DOI 10.3200/JOEE.40.4.3-16; Dick CW, 2003, AM NAT, V162, P691, DOI 10.1086/379795; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Drovetski SV, 2003, J BIOGEOGR, V30, P1173, DOI 10.1046/j.1365-2699.2003.00920.x; EASON P, 1989, CONDOR, V91, P469, DOI 10.2307/1368327; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; Eizirik E, 1998, J MOL EVOL, V47, P613, DOI 10.1007/PL00006418; Elliott A., 1994, HDB BIRDS WORLD; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOLUTIONARY BIOINFO, V1; FAO, 2006, 147 FAO; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; Ferguson-Lees J, 2001, RAPTORS WORLD; FOWLER JAMES M., 1964, AUK, V81, P257; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Fraser DJ, 2007, MOL ECOL, V16, P3866, DOI 10.1111/j.1365-294X.2007.03453.x; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gemmell NJ, 2001, TRENDS ECOL EVOL, V16, P115, DOI 10.1016/S0169-5347(00)02087-5; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Godoy JA, 2004, MOL ECOL, V13, P371, DOI 10.1046/j.1365-294X.2003.02075.x; *GRIN, 2007, GLOB RAPT INF NETW S; Gutierrez JR, 1997, OECOLOGIA, V109, P398, DOI 10.1007/s004420050099; Hailer F, 2007, J BIOGEOGR, V34, P1193, DOI 10.1111/j.1365-2699.2007.01697.x; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; IUCN, 2007, IUCN RED LIST THREAT; Johnson JA, 2007, ANIM CONSERV, V10, P349, DOI 10.1111/j.1469-1795.2007.00118.x; Johnson JA, 2008, BIOL CONSERV, V141, P2403, DOI 10.1016/j.biocon.2008.07.001; Johnson JA, 2007, MOL ECOL, V16, P2203, DOI 10.1111/j.1365-294X.2007.03285.x; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Letourneau DK, 1998, ECOLOGY, V79, P1678, DOI 10.1890/0012-9658(1998)079[1678:ETILTF]2.0.CO;2; Letourneau DK, 1998, BIOTROPICA, V30, P162, DOI 10.1111/j.1744-7429.1998.tb00051.x; Lopez GO, 2005, J TROP ECOL, V21, P445, DOI 10.1017/S0266467405002415; MADDISON WP, 2005, MESQUITE MODULAR SYS; Martinez-Cruz B, 2004, MOL ECOL, V13, P2243, DOI 10.1111/j.1365-294X.2004.02220.x; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Milot E, 2007, P ROY SOC B-BIOL SCI, V274, P779, DOI 10.1098/rspb.2006.0221; MUELA A., 2005, WINGSPAN, V14, P14; Muniz-Lopez R., 2007, NEOTROPICAL RAPTORS, P22; Nielsen R, 2001, GENETICS, V158, P885; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; Omland KE, 2006, MOL ECOL, V15, P795, DOI 10.1111/j.1365-294X.2005.02827.x; Piana Renzo P., 2007, Revista Peruana de Biologia, V14, P135; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; RETTIG NL, 1978, AUK, V95, P629; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roques S, 2005, BIOL CONSERV, V126, P41, DOI 10.1016/j.biocon.2005.04.020; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schneider S, 1999, GENETICS, V152, P1079; Schulenberg TS., 2009, NEOTROPICAL BIRDS ON; Seltzer GO, 2002, SCIENCE, V296, P1685, DOI 10.1126/science.1070136; Sergio F, 2005, NATURE, V436, P192, DOI 10.1038/436192a; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Shephard JM, 2005, CONSERV GENET, V6, P413, DOI 10.1007/s10592-005-4987-x; SLATKIN M, 1991, GENETICS, V129, P555; Sorenson MD, 1996, P NATL ACAD SCI USA, V93, P15239, DOI 10.1073/pnas.93.26.15239; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Strong AM, 2000, OECOLOGIA, V125, P370, DOI 10.1007/s004420000467; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Terborgh J, 2006, J ECOL, V94, P253, DOI 10.1111/j.1365-2745.2006.01106.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh J, 1997, ECOLOGY, V78, P1494, DOI 10.1890/0012-9658(1997)078[1494:BCITTL]2.0.CO;2; Trinca Cristiano Trape, 2008, Cotinga, V30, P12; Van Bael SA, 2003, P NATL ACAD SCI USA, V100, P8304, DOI 10.1073/pnas.1431621100; Vargas JD, 2006, ORNITOL NEOTROP, V17, P39; Wakeley J, 2004, EVOLUTION OF POPULATION BIOLOGY, P193, DOI 10.1017/CBO9780511542619.013; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Weber DS, 2004, J HERED, V95, P144, DOI 10.1093/jhered/esh018; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231	95	28	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7336	10.1371/journal.pone.0007336	http://dx.doi.org/10.1371/journal.pone.0007336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802391	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593600011
J	Waldemarsson, J; Stalhammar-Carlemalm, M; Sandin, C; Castellino, FJ; Lindahl, G				Waldemarsson, Johan; Stalhammar-Carlemalm, Margaretha; Sandin, Charlotta; Castellino, Francis J.; Lindahl, Gunnar			Functional Dissection of Streptococcus pyogenes M5 Protein: the Hypervariable Region is Essential for Virulence	PLOS ONE			English	Article							CELL-SURFACE PROTEIN; GROUP-A STREPTOCOCCI; BINDING REGIONS; FIBRINOGEN; PHAGOCYTOSIS; COLONIZATION; PLASMINOGEN; EXPRESSION; ADHESION; SEQUENCE	The surface-localized M protein of Streptococcus pyogenes is a major virulence factor that inhibits phagocytosis, as determined ex vivo. Because little is known about the role of M protein in vivo we analyzed the contribution of different M protein regions to virulence, using the fibrinogen (Fg)-binding M5 protein and a mouse model of acute invasive infection. This model was suitable, because M5 is required for mouse virulence and binds mouse and human Fg equally well, as shown here. Mixed infection experiments with wild type bacteria demonstrated that mutants lacking the N-terminal hypervariable region (HVR) or the Fg-binding B-repeat region were strongly attenuated, while a mutant lacking the conserved C-repeats was only slightly attenuated. Because the HVR of M5 is not required for phagocytosis resistance, our data imply that this HVR plays a major but unknown role during acute infection. The B-repeat region is required for phagocytosis resistance and specifically binds Fg, suggesting that it promotes virulence by binding Fg. However, B-repeat mutants were attenuated even in Fg-deficient mice, implying that the B-repeats may have a second function, in addition to Fg-binding. These data demonstrate that two distinct M5 regions, including the HVR, are essential to virulence during the early stages of an infection. In particular, our data provide the first in vivo evidence that the HVR of an M protein plays a major role in virulence, focusing interest on the molecular role of this region.			Waldemarsson, J (corresponding author), Lund Univ, Div Med Microbiol, Dept Lab Med, Lund, Sweden.	gunnar.lindahl@med.lu.se						Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; AKERSTROM B, 1991, MOL IMMUNOL, V28, P349, DOI 10.1016/0161-5890(91)90147-C; AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Andre I, 2006, BIOCHEMISTRY-US, V45, P4559, DOI 10.1021/bi052455c; Ashbaugh CD, 2000, CELL MICROBIOL, V2, P283, DOI 10.1046/j.1462-5822.2000.00050.x; Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; FISCHETTI VA, 1991, SCI AM, V264, P58, DOI 10.1038/scientificamerican0691-58; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Johnsson E, 1998, J IMMUNOL, V161, P4894; KEHOE MA, 1994, BACTERIAL CELL WALL, P217; Kemper C, 2001, CLIN EXP IMMUNOL, V124, P180, DOI 10.1046/j.1365-2249.2001.01458.x; Kotarsky H, 2001, MOL MICROBIOL, V41, P817, DOI 10.1046/j.1365-2958.2001.02496.x; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; MILLER L, 1988, J BIOL CHEM, V263, P5668; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Persson J, 2005, J IMMUNOL METHODS, V297, P83, DOI 10.1016/j.jim.2004.11.024; Persson Jenny, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020047; Ploplis VA, 2000, AM J PATHOL, V157, P703, DOI 10.1016/S0002-9440(10)64582-8; Price JD, 2005, J IMMUNOL, V175, P677, DOI 10.4049/jimmunol.175.2.677; RETNONINGRUM DS, 1994, INFECT IMMUN, V62, P2387, DOI 10.1128/IAI.62.6.2387-2394.1994; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; STALHAMMARCARLEMALM M, 1993, J EXP MED, V177, P1593, DOI 10.1084/jem.177.6.1593; STENBERG L, 1994, J BIOL CHEM, V269, P13458; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2009, BLOOD, V113, P1358, DOI 10.1182/blood-2008-07-170506; Taylor FB, 1999, CLIN INFECT DIS, V29, P167, DOI 10.1086/520147; Thern A, 1998, J IMMUNOL, V160, P860; THERN A, 1995, J IMMUNOL, V154, P375; Todd EW, 1927, BRIT J EXP PATHOL, V8, P289; Todd EW, 1928, J EXP MED, V48, P751, DOI 10.1084/jem.48.6.751; Todd EW, 1927, BRIT J EXP PATHOL, V8, P1; Virgin HW, 2007, NAT IMMUNOL, V8, P1143, DOI 10.1038/ni1529; Waldemarsson J, 2006, J BACTERIOL, V188, P378, DOI 10.1128/JB.188.2.378-388.2006; WANG H, 1995, J INFECT DIS, V171, P85, DOI 10.1093/infdis/171.1.85; WHITNACK E, 1982, J CLIN INVEST, V69, P1042, DOI 10.1172/JCI110508; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x	48	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e7279	10.1371/journal.pone.0007279	http://dx.doi.org/10.1371/journal.pone.0007279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794915	Green Published, Green Submitted, gold			2022-12-25	WOS:000270354200006
J	Leal, WS; Ishida, Y; Pelletier, J; Xu, W; Rayo, J; Xu, XZ; Ames, JB				Leal, Walter S.; Ishida, Yuko; Pelletier, Julien; Xu, Wei; Rayo, Josep; Xu, Xianzhong; Ames, James B.			Olfactory Proteins Mediating Chemical Communication in the Navel Orangeworm Moth, Amyelois transitella	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEIN; MOLECULAR-CLONING; NMR STRUCTURE; OSTRINIA-NUBILALIS; LEPIDOPTERA; RELEASE; PH; ATTRACTANTS; BEHAVIOR; ANTENNAE	Background: The navel orangeworm, Amyelois transitella Walker (Lepidoptera: Pyralidae), is the most serious insect pest of almonds and pistachios in California for which environmentally friendly alternative methods of control - like pheromone-based approaches - are highly desirable. Some constituents of the sex pheromone are unstable and could be replaced with parapheromones, which may be designed on the basis of molecular interaction of pheromones and pheromone-detecting olfactory proteins. Methodology: By analyzing extracts from olfactory and non-olfactory tissues, we identified putative olfactory proteins, obtained their N-terminal amino acid sequences by Edman degradation, and used degenerate primers to clone the corresponding cDNAs by SMART RACE. Additionally, we used degenerate primers based on conserved sequences of known proteins to fish out other candidate olfactory genes. We expressed the gene encoding a newly identified pheromone-binding protein, which was analyzed by circular dichroism, fluorescence, and nuclear magnetic resonance, and used in a binding assay to assess affinity to pheromone components. Conclusion: We have cloned nine cDNAs encoding olfactory proteins from the navel orangeworm, including two pheromone-binding proteins, two general odorant-binding proteins, one chemosensory protein, one glutathione S-transferase, one antennal binding protein X, one sensory neuron membrane protein, and one odorant receptor. Of these, AtraPBP1 is highly enriched in male antennae. Fluorescence, CD and NMR studies suggest a dramatic pH-dependent conformational change, with high affinity to pheromone constituents at neutral pH and no binding at low pH.			Leal, WS (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021; Xu, Wei/G-4709-2010; Rayo, Josep/C-2394-2015; Xu, Xianzhong/B-6311-2014	Rayo, Josep/0000-0002-8459-8235; Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240; Xu, Wei/0000-0003-4019-5140	NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0918177] Funding Source: National Science Foundation	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		BREER H, 1990, INSECT BIOCHEM, V20, P735, DOI 10.1016/0020-1790(90)90088-C; COFFELT JA, 1979, J CHEM ECOL, V5, P955, DOI 10.1007/BF00990218; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; HAMMOCK BD, 1982, PESTIC BIOCHEM PHYS, V17, P1158; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; HUSSEINY MOHAMED MAMDOUH, 1964, HILGARDIA, V36, P113; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Jansen S, 2007, ARCH INSECT BIOCHEM, V66, P135, DOI 10.1002/arch.20205; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; Kaissling K-E, 1987, RH WRIGHT LECT INSEC; KEIL TA, 1987, ANN NY ACAD SCI, V510, P403; KEIL TA, 1984, TISSUE CELL, V16, P705, DOI 10.1016/0040-8166(84)90004-1; KRIEGER J, 1991, BIOCHIM BIOPHYS ACTA, V1088, P277, DOI 10.1016/0167-4781(91)90064-S; KRIEGER J, 1993, INSECT BIOCHEM MOLEC, V23, P449, DOI 10.1016/0965-1748(93)90052-T; Krieger J, 1996, INSECT BIOCHEM MOLEC, V26, P297, DOI 10.1016/0965-1748(95)00096-8; KRIEGER J, 1996, INSECT BIOCHEM MOLEC, P26; Krieger Juergen, 1997, Invertebrate Neuroscience, V3, P137, DOI 10.1007/BF02480368; Lautenschlager C, 2005, BIOCHEM BIOPH RES CO, V335, P1044, DOI 10.1016/j.bbrc.2005.07.176; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Leal Walter S., 2003, P447, DOI 10.1016/B978-012107151-6/50017-7; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, J CHEM ECOL, V31, P2493, DOI 10.1007/s10886-005-7458-4; Leal WS, 2000, BIOCHEM BIOPH RES CO, V268, P521, DOI 10.1006/bbrc.2000.2158; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 2005, NATURWISSENSCHAFTEN, V92, P139, DOI 10.1007/s00114-004-0598-5; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mohanty S, 2004, J MOL BIOL, V338, P1037, DOI 10.1016/j.jmb.2004.03.052; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Parra-Pedrazzoli AL, 2006, NEOTROP ENTOMOL, V35, P769, DOI 10.1590/S1519-566X2006000600008; Pophof B, 2000, J COMP PHYSIOL A, V186, P315, DOI 10.1007/s003590050432; RAMING K, 1989, FEBS LETT, V256, P215, DOI 10.1016/0014-5793(89)81751-X; Riba M, 2005, J AGR FOOD CHEM, V53, P1158, DOI 10.1021/jf048994q; Rogers ME, 1999, J EXP BIOL, V202, P1625; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sole J, 2008, ENTOMOL EXP APPL, V126, P28, DOI 10.1111/j.1570-7458.2007.00630.x; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; VOGT RG, 1991, J NEUROSCI, V11, P2972; Willett CS, 2000, J MOL EVOL, V50, P175, DOI 10.1007/s002399910019; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu W, 2008, BIOCHEM BIOPH RES CO, V372, P559, DOI 10.1016/j.bbrc.2008.05.087; Xu XZ, 2008, BIOMOL NMR ASSIGN, V2, P105, DOI 10.1007/s12104-008-9096-6	48	40	45	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7235	10.1371/journal.pone.0007235	http://dx.doi.org/10.1371/journal.pone.0007235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789654	gold, Green Published, Green Submitted			2022-12-25	WOS:000270354100007
J	Liu, S; Li, Z; Gui, JF				Liu, Sha; Li, Zhi; Gui, Jian-Fang			Fish-Specific Duplicated dmrt2b Contributes to a Divergent Function through Hedgehog Pathway and Maintains Left-Right Asymmetry Establishment Function	PLOS ONE			English	Article							PROTEIN-KINASE-A; ZEBRAFISH EMBRYO; SONIC-HEDGEHOG; NEURAL-TUBE; VERTEBRATE DEVELOPMENT; SIGNAL-TRANSDUCTION; GENE DUPLICATION; EXPRESSION; EMBRYOGENESIS; REVEALS	Gene duplication is thought to provide raw material for functional divergence and innovation. Fish-specific dmrt2b has been identified as a duplicated gene of the dmrt2a/terra in fish genomes, but its function has remained unclear. Here we reveal that Dmrt2b knockdown zebrafish embryos display a downward tail curvature and have U-shaped somites. Then, we demonstrate that Dmrt2b contributes to a divergent function in somitogenesis through Hedgehog pathway, because Dmrt2b knockdown reduces target gene expression of Hedgehog signaling, and also impairs slow muscle development and neural tube patterning through Hedgehog signaling. Moreover, the Dmrt2b morphants display defects in heart and visceral organ asymmetry, and, some lateral-plate mesoderm (LPM) markers expressed in left side are randomized. Together, these data indicate that fish-specific duplicated dmrt2b contributes to a divergent function in somitogenesis through Hedgehog pathway and maintains the common function for left-right asymmetry establishment.			Liu, S (corresponding author), Chinese Acad Sci, Grad Sch, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	jfgui@ihb.ac.cn		Liu, Sha/0000-0002-7168-330X				Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Dong CH, 2004, DEV BIOL, V265, P341, DOI 10.1016/j.ydbio.2003.08.028; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hong CS, 2007, DEV BIOL, V310, P1, DOI 10.1016/j.ydbio.2007.07.035; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koudijs MJ, 2005, PLOS GENET, V1, P223, DOI 10.1371/journal.pgen.0010019; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu Jing-Xia, 2005, Acta Hydrobiologica Sinica, V29, P359; Liu Jun, 2005, Acta Genetica Sinica, V32, P253; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; Mei J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004979; Meng AM, 1999, DEVELOPMENT, V126, P1259; Nakano Y, 2004, DEV BIOL, V269, P381, DOI 10.1016/j.ydbio.2004.01.022; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saude L, 2005, NAT CELL BIOL, V7, P918, DOI 10.1038/ncb1294; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schilling TF, 1999, DEV BIOL, V210, P277, DOI 10.1006/dbio.1999.9214; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Seo KW, 2006, DEV BIOL, V290, P200, DOI 10.1016/j.ydbio.2005.11.027; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Woods IG, 2005, PLOS BIOL, V3, P476, DOI 10.1371/journal.pbio.0030066; Xia JH, 2008, INT J DEV BIOL, V52, P1089, DOI 10.1387/ijdb.072519jx; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Xie J, 2001, GENE, V271, P109, DOI 10.1016/S0378-1119(01)00491-7; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Yin J, 2007, INT J DEV BIOL, V51, P761, DOI 10.1387/ijdb.072346jy; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou L, 2000, J MOL EVOL, V51, P498, DOI 10.1007/s002390010113; Zhou X, 2008, BIOCHIMIE, V90, P878, DOI 10.1016/j.biochi.2008.02.021	53	31	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7261	10.1371/journal.pone.0007261	http://dx.doi.org/10.1371/journal.pone.0007261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789708	gold, Green Published, Green Submitted			2022-12-25	WOS:000270354100018
J	Prokunina-Olsson, L; Kaplan, LM; Schadt, EE; Collins, FS				Prokunina-Olsson, Ludmila; Kaplan, Lee M.; Schadt, Eric E.; Collins, Francis S.			Alternative Splicing of TCF7L2 Gene in Omental and Subcutaneous Adipose Tissue and Risk of Type 2 Diabetes	PLOS ONE			English	Article								Background: Single nucleotide polymorphisms (SNPs) rs7903146 and rs12255372 located within TCF7L2 gene have been identified as the strongest common genetic risk factors for development of type 2 diabetes (T2D). We hypothesized that these genetic variants might increase the risk of T2D through regulation of alternative splicing or expression level of TCF7L2 in human adipose tissue. Methodology/Principal Findings: Expression of 13 assays detecting alternatively spliced forms of TCF7L2 was measured by quantitative reverse-transcriptase PCR (qRT-PCR) in paired biopsies of omental and subcutaneous adipose tissue from 159 obese individuals (BMI 54.6+/212.2 kg/m(2)). TCF7L2 expression in both types of adipose tissue was not associated with SNPs rs7903146 and rs12255372, T2D status and blood levels of glucose or glycosylated hemoglobin (HbA1c). Expression of assays "ex12-13", "ex12-14" and "ex13-13a" detecting C-terminal alternative exons of TCF7L2 was higher in subcutaneous compared to omental adipose tissue by 1.46 fold (p=6.5x10(-15)), 1.41 fold (p=1.4x10(-9)) and 1.26 fold (p=4.7x10(-6)) in the control group and by 1.86 fold (p=1.7x10(-4)), 1.77 fold (p=7.3x10(-4)) and 1.58 fold (p=6.1x10(-4)) in the T2D group. A pathway enrichment analysis on transcripts significantly co-expressed with TCF7L2 in a microarray set combined with individual expression assays, suggested tissue-specific roles of TCF7L2 splicing forms in regulation of transcription, signal transduction and cell adhesion. Conclusions: Expression of TCF7L2 alternatively spliced forms may have different functional roles in omental and subcutaneous adipose tissue but is not associated with SNPs rs7903146 and rs12255372 or T2D status.			Prokunina-Olsson, L (corresponding author), NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	prokuninal@mail.nih.gov	Prokunina-Olsson, Ludmila/A-8240-2019; Prokunina-Olsson, Ludmila/V-7960-2019	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [P30 DK040561, P30 DK040561-14] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cauchi S, 2008, OBESITY, V16, P476, DOI 10.1038/oby.2007.77; Cauchi S, 2006, DIABETES, V55, P3189, DOI 10.2337/db06-0692; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Elbein SC, 2007, DIABETOLOGIA, V50, P1621, DOI 10.1007/s00125-007-0717-x; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Kovacs P, 2008, METABOLISM, V57, P1227, DOI 10.1016/j.metabol.2008.04.016; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; OSMARK P, 2009, DIABETOLOGIA; PROKUNINAOLSSON L, 2009, HUM MOL GENET; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; WEGNER L, 2008, J CLIN ENDOCRINOL ME; ZHANG W, 2008, HUM GENET; ZHONG H, 2009, PLOS BIOL IN PRESS	26	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7231	10.1371/journal.pone.0007231	http://dx.doi.org/10.1371/journal.pone.0007231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789636	Green Published, gold, Green Submitted			2022-12-25	WOS:000270354100005
J	Wei, W; Huang, J; Hao, YJ; Zou, HF; Wang, HW; Zhao, JY; Liu, XY; Zhang, WK; Ma, B; Zhang, JS; Chen, SY				Wei, Wei; Huang, Jian; Hao, Yu-Jun; Zou, Hong-Feng; Wang, Hui-Wen; Zhao, Jing-Yun; Liu, Xue-Yi; Zhang, Wan-Ke; Ma, Biao; Zhang, Jin-Song; Chen, Shou-Yi			Soybean GmPHD-Type Transcription Regulators Improve Stress Tolerance in Transgenic Arabidopsis Plants	PLOS ONE			English	Article								Background: Soybean [Glycine max ( L.) Merr.] is one of the most important crops for oil and protein resource. Improvement of stress tolerance will be beneficial for soybean seed production. Principal Findings: Six GmPHD genes encoding Alfin1-type PHD finger protein were identified and their expressions differentially responded to drought, salt, cold and ABA treatments. The six GmPHDs were nuclear proteins and showed ability to bind the cis-element "GTGGAG". The N-terminal domain of GmPHD played a major role in DNA binding. Using a protoplast assay system, we find that GmPHD1 to GmPHD5 had transcriptional suppression activity whereas GmPHD6 did not have. In yeast assay, the GmPHD6 can form homodimer and heterodimer with the other GmPHDs except GmPHD2. The N-terminal plus the variable regions but not the PHD-finger is required for the dimerization. Transgenic Arabidopsis plants overexpressing the GmPHD2 showed salt tolerance when compared with the wild type plants. This tolerance was likely achieved by diminishing the oxidative stress through regulation of downstream genes. Significance: These results provide important clues for soybean stress tolerance through manipulation of PHD-type transcription regulator.			Wei, W (corresponding author), Chinese Acad Sci, Plant Gene Res Ctr, Natl Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing, Peoples R China.	jszhang@genetics.ac.cn; sychen@genetics.ac.cn			NIAAA NIH HHS [R01 AA021402] Funding Source: Medline	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Anderson M, 2002, DEV GENES EVOL, V212, P107, DOI 10.1007/s00427-002-0213-8; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Bastola DR, 1998, PLANT MOL BIOL, V38, P1123, DOI 10.1023/A:1006081926699; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Sanchez MD, 2009, P NATL ACAD SCI USA, V106, P2065, DOI 10.1073/pnas.0811093106; Eulgem T, 2007, PLANT J, V49, P829, DOI 10.1111/j.1365-313X.2006.02999.x; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Gao L, 2008, PLANT MOL BIOL, V67, P125, DOI 10.1007/s11103-008-9306-8; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Halbach T, 2000, NUCLEIC ACIDS RES, V28, P3542, DOI 10.1093/nar/28.18.3542; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lee WY, 2009, PLANT J, V58, P511, DOI 10.1111/j.1365-313X.2009.03795.x; Liao Y, 2008, CELL RES, V18, P1047, DOI 10.1038/cr.2008.280; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Linder B, 2000, J MOL BIOL, V299, P369, DOI 10.1006/jmbi.2000.3766; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Mansouri M, 2003, J VIROL, V77, P1427, DOI 10.1128/JVI.77.2.1427-1440.2003; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pineiro M, 2003, PLANT CELL, V15, P1552, DOI 10.1105/tpc.012153; Reddy TV, 2003, DEVELOPMENT, V130, P5975, DOI 10.1242/dev.00827; Saiga S, 2008, DEVELOPMENT, V135, P1751, DOI 10.1242/dev.014993; Scheel H, 2003, TRENDS CELL BIOL, V13, P285, DOI 10.1016/S0962-8924(03)00102-8; SCHINDLER U, 1993, PLANT J, V4, P137, DOI 10.1046/j.1365-313X.1993.04010137.x; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sebastian J, 2009, PLANT J, V59, P1, DOI 10.1111/j.1365-313X.2009.03845.x; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Skowyra D, 2001, J BIOL CHEM, V276, P8734, DOI 10.1074/jbc.M007664200; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Thomas CL, 2009, PLANT J, V59, P426, DOI 10.1111/j.1365-313X.2009.03874.x; Townsley FM, 2004, J BIOL CHEM, V279, P5177, DOI 10.1074/jbc.M309722200; Tripoulas N, 1996, GENETICS, V143, P913; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Wang YJ, 2005, PLANTA, V221, P831, DOI 10.1007/s00425-005-1496-6; Wang YJ, 2003, THEOR APPL GENET, V107, P1402, DOI 10.1007/s00122-003-1378-x; Wilson ZA, 2001, PLANT J, V28, P27, DOI 10.1046/j.1365-313X.2001.01125.x; Winicov I, 2004, PLANTA, V219, P925, DOI 10.1007/s00425-004-1296-4; Winicov I, 1999, PLANT PHYSIOL, V120, P473, DOI 10.1104/pp.120.2.473; Winicov I, 2000, PLANTA, V210, P416, DOI 10.1007/PL00008150; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xie C, 2003, PLANT J, V33, P385, DOI 10.1046/j.1365-313X.2003.01631.x; Yang XH, 2003, PLANT CELL, V15, P1281, DOI 10.1105/tpc.010447; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	64	75	88	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7209	10.1371/journal.pone.0007209	http://dx.doi.org/10.1371/journal.pone.0007209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789627	gold, Green Submitted, Green Published			2022-12-25	WOS:000270354100001
J	Morris, TJ; Vickers, M; Gluckman, P; Gilmour, S; Affara, N				Morris, Tiffany J.; Vickers, Mark; Gluckman, Peter; Gilmour, Stewart; Affara, Nabeel			Transcriptional Profiling of Rats Subjected to Gestational Undernourishment: Implications for the Developmental Variations in Metabolic Traits	PLOS ONE			English	Article								A link has been established between prenatal nutrition and the development of metabolic and cardiovascular diseases later in life, a process referred to as developmental programming. It has been suggested that the trajectory of development is shifted by alterations in the maternal nutritional state leading to changes in developmental plasticity, in part underpinned by epigenetic changes in gene regulation. However, to date, only candidate gene approaches have been used to assess expression and molecular changes in the offspring of maternally undernourished animals. Furthermore, most work has focused on animals at an age where the programmed phenotype is already manifest and little is known about changes in gene expression in the offspring prior to development of obesity and related metabolic disorders. Gene expression profiles of liver, retroperitoneal white adipose fat, and biceps femoris skeletal muscle tissue from young adult male rats (55 days old) in which nutritional status had been manipulated in utero by maternal undernutrition ( UN) were compared to the profiles of offspring of ad libitum fed mothers serving as the control group (AD) (8 offspring/group). The expression profiles were determined using the Illumina RatRef-12 BeadChip. No significant changes in expression were identified for skeletal muscle or white adipose tissue. However, studies of liver tissue showed 249 differentially expressed genes (143 up regulated, 106 down regulated). Although the animals at day 55 have yet to develop obesity they already show biochemical abnormalities and by day 110 express a phenotype characterized by increased adiposity and altered insulin sensitivity. An analysis of pathways affected suggests that intrauterine programming of UN animals to favor fat as an energy source results in mitochondrial dysfunction which initially affects the postnatal hepatic function and subsequently, via the resultant metabolic changes in other organs leads to the evolution of a phenotype similar to that of the metabolic syndrome.			Morris, TJ (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	tjm42@cam.ac.uk		Vickers, Mark/0000-0003-4876-9356				Barker D J, 2001, Med Health Care Philos, V4, P31, DOI 10.1023/A:1009934412988; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bateson P, 2001, INT J EPIDEMIOL, V30, P928, DOI 10.1093/ije/30.5.928; BEGINHEICK N, 1994, AM J PHYSIOL, V266, pC1664, DOI 10.1152/ajpcell.1994.266.6.C1664; Bertram C, 2001, ENDOCRINOLOGY, V142, P2841, DOI 10.1210/en.142.7.2841; Bertram CE, 2002, REPRODUCTION, V124, P459, DOI 10.1530/rep.0.1240459; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burcelin R, 2004, J BIOL CHEM, V279, P1108, DOI 10.1074/jbc.M307788200; Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703; Dahlman I, 2005, DIABETES, V54, P3032, DOI 10.2337/diabetes.54.10.3032; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eisenhaber F, 2001, TRENDS BIOCHEM SCI, V26, P345, DOI 10.1016/S0968-0004(01)01851-5; Farias EF, 2005, ONCOGENE, V24, P1598, DOI 10.1038/sj.onc.1208347; Gerecke DR, 2004, MATRIX BIOL, V22, P593, DOI 10.1016/j.matbio.2003.11.004; Gluckman PD, 2005, BIOL NEONATE, V87, P127, DOI 10.1159/000082311; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; GRANNER D, 1990, J BIOL CHEM, V265, P10173; Gummesson A, 2007, J CLIN ENDOCR METAB, V92, P4759, DOI 10.1210/jc.2007-1136; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Iwahashi H, 2002, DIABETES, V51, P910, DOI 10.2337/diabetes.51.4.910; KELLER SR, 1993, MOL REPROD DEV, V35, P346, DOI 10.1002/mrd.1080350405; Kmiec Z, 2001, Adv Anat Embryol Cell Biol, V161, pIII; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; KUNOS G, 1987, BIOCHEM PHARMACOL, V36, P1185, DOI 10.1016/0006-2952(87)90068-2; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Lam NT, 2006, J MOL ENDOCRINOL, V36, P163, DOI 10.1677/jme.1.01937; Lepreux S, 2004, J HEPATOL, V40, P774, DOI 10.1016/j.jhep.2004.01.008; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lisinski I, 2006, BIOCHEM BIOPH RES CO, V344, P1179, DOI 10.1016/j.bbrc.2006.04.017; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; MILANI S, 1994, HEPATOLOGY, V20, P908, DOI 10.1002/hep.1840200420; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Min KW, 2005, BIOCHEM BIOPH RES CO, V334, P867, DOI 10.1016/j.bbrc.2005.06.188; Ozanne SE, 2006, DIABETOLOGIA, V49, P2993, DOI 10.1007/s00125-006-0466-2; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Ozanne Susan E, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005240; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; STEWART PM, 1994, J CLIN ENDOCR METAB, V78, P1529, DOI 10.1210/jc.78.6.1529; Uchio K, 2002, LAB INVEST, V82, P619, DOI 10.1038/labinvest.3780456; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Wheatcroft SB, 2007, DIABETES, V56, P285, DOI 10.2337/db06-0436; Woodall SM, 1996, J ENDOCRINOL, V150, P231, DOI 10.1677/joe.0.1500231; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081	62	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7271	10.1371/journal.pone.0007271	http://dx.doi.org/10.1371/journal.pone.0007271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787071	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000270290100030
J	Sontag, CA; Sage, H; Erickson, HP				Sontag, Christopher A.; Sage, Harvey; Erickson, Harold P.			BtubA-BtubB Heterodimer Is an Essential Intermediate in Protofilament Assembly	PLOS ONE			English	Article							TUBULIN; ASSAY; FTSZ	Background: BtubA and BtubB are two tubulin-like genes found in the bacterium Prosthecobacter. Our work and a previous crystal structure suggest that BtubB corresponds to alpha-tubulin and BtubA to beta-tubulin. A 1: 1 mixture of the two proteins assembles into tubulin-like protofilaments, which further aggregate into pairs and bundles. The proteins also form a BtubA/B heterodimer, which appears to be a repeating subunit in the protofilament. Methodology/Principal Findings: We have designed point mutations to disrupt the longitudinal interfaces bonding subunits into protofilaments. The mutants are in two classes, within dimers and between dimers. We have characterized one mutant of each class for BtubA and BtubB. When mixed 1: 1 with a wild type partner, none of the mutants were capable of assembly. An excess of between-dimer mutants could depolymerize preformed wild type polymers, while within-dimer mutants had no activity. Conclusions: An essential first step in assembly of BtubA + BtubB is formation of a heterodimer. An excess of between-dimer mutants depolymerize wild type BtubA/B by sequestering the partner wild type subunit into inactive dimers. Within-dimer mutants cannot form dimers and have no activity.			Sontag, CA (corresponding author), Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA.	h.erickson@cellbio.duke.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066014, R01-GM66014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Caplow M, 2002, MOL BIOL CELL, V13, P2120, DOI 10.1091/mbc.E01-10-0089; Cowan NJ, 2002, ADV PROTEIN CHEM, V59, P73; ERICKSON HP, 1981, BIOPHYS J, V34, P293, DOI 10.1016/S0006-3495(81)84850-3; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Jackson AP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-261; Jenkins C, 2002, P NATL ACAD SCI USA, V99, P17049, DOI 10.1073/pnas.012516899; Laue T.M., 1992, COMPUTER AIDED INTER; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Pilhofer M, 2007, MOL BIOL EVOL, V24, P1439, DOI 10.1093/molbev/msm069; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; SCHLIEPER D, 2005, P NATL ACAD SCI US; Sontag CA, 2005, J CELL BIOL, V169, P233, DOI 10.1083/jcb.200410027; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999	16	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7253	10.1371/journal.pone.0007253	http://dx.doi.org/10.1371/journal.pone.0007253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787042	Green Published, gold, Green Submitted			2022-12-25	WOS:000270290100024
J	Padua, MB; Kowalski, AA; Canas, MY; Hansen, PJ				Padua, Maria B.; Kowalski, Andres A.; Canas, Miryan Y.; Hansen, Peter J.			The molecular phylogeny of uterine serpins and its relationship to evolution of placentation	FASEB JOURNAL			English	Article						uterine milk proteins; SERPINA14; pregnancy; hinge region; positive selection	PROGESTERONE-INDUCED PROTEINS; CODON-SUBSTITUTION MODELS; OVINE; SUPERFAMILY; SECRETIONS; BINDING; UTEROFERRIN; DIVERGENCE; GENETICS; ACCURACY	Uterine serpins (USs), designated as SERPINA14, are expressed in the endometrium in response to progesterone. All species identified as having USs exhibit epitheliochorial placentation and are in the Ruminantia and Suidae orders of the Laurasiatheria superorder. The objective was to identify US genes in species within and outside Laurasiatheria and evaluate whether evolution of the US gene was associated with development of the epitheliochorial placenta. Through queries of nucleotide and genomic databases, known US genes were identified (caprine, bovine, porcine, water buffalo), and new US coding sequences were found in dolphins, horses, dogs, and cats. The cat sequence contained several stop codons. No sequence was found in completed genomic sequences for primates, rodents, rabbits, opossums, or duck-billed platypuses. Reverse transcription-polymerase chain reaction confirmed expression of the US gene in the uterus of pregnant horses and dogs. The ratio of nonsynonymous/synonymous substitutions suggests that the US gene evolved under positive selection. In conclusion, the US gene evolved within the Laurasiatheria superorder to play a role in pregnancy for species with epitheliochorial placentation and some but not all Laurasiatheria species that have a different form of placentation. The positive selection taking place in the gene suggests development of species-specific functions.-Padua, M. B., Kowalski, A. A., Canas, M. Y., Hansen, P. J. The molecular phylogeny of uterine serpins and its relationship to evolution of placentation. FASEB J. 24, 526-537 (2010). www.fasebj.org	[Padua, Maria B.; Hansen, Peter J.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Kowalski, Andres A.; Canas, Miryan Y.] Univ Centroccidental Lisandro Alvarado, Lab Embriol & Endocrinol Mol, Barquisimeto, Edo Lara, Venezuela	State University System of Florida; University of Florida	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, POB 110910, Gainesville, FL 32611 USA.	pjhansen@ufl.edu	Hansen, Peter/AAI-4693-2021	Hansen, Peter/0000-0003-3061-9333				Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Barbour KW, 2002, MOL BIOL EVOL, V19, P718, DOI 10.1093/oxfordjournals.molbev.a004130; BAUMBACH GA, 1986, J BIOL CHEM, V261, P2869; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bielawski JP, 2003, J STRUCT FUNCT GENOM, V3, P201, DOI DOI 10.1007/978-94-010-0263-9_20; BROWN AL, 1987, NATURE, V326, P12, DOI 10.1038/326012b0; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goodwin RL, 1996, MOL BIOL EVOL, V13, P346, DOI 10.1093/oxfordjournals.molbev.a025594; HANSEN PJ, 1988, ARCH BIOCHEM BIOPHYS, V260, P208, DOI 10.1016/0003-9861(88)90442-0; HANSEN PJ, 1985, J REPROD FERTIL, V73, P411, DOI 10.1530/jrf.0.0730411; ING NH, 1989, J BIOL CHEM, V264, P3372; Irving JA, 2002, MOL BIOL EVOL, V19, P1881, DOI 10.1093/oxfordjournals.molbev.a004012; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Khatib H, 2007, J DAIRY SCI, V90, P2427, DOI 10.3168/jds.2006-722; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; LEISER R, 1977, MICROSC RES TECHNIQ, V38, P76; LESLIE MV, 1991, STEROIDS, V56, P589, DOI 10.1016/0039-128X(91)90022-N; LESLIE MV, 1990, DOMEST ANIM ENDOCRIN, V7, P517, DOI 10.1016/0739-7240(90)90009-O; LIU WJ, 1995, ENDOCRINOLOGY, V136, P779, DOI 10.1210/en.136.2.779; Louis EJ, 2007, NATURE, V449, P673, DOI 10.1038/449673a; MALATHY PV, 1990, MOL ENDOCRINOL, V4, P428, DOI 10.1210/mend-4-3-428; Mathialagan N, 1996, P NATL ACAD SCI USA, V93, P13653, DOI 10.1073/pnas.93.24.13653; McFarlane JR, 1999, ENDOCRINOLOGY, V140, P4745, DOI 10.1210/en.140.10.4745; Mess A, 2007, COMP BIOCHEM PHYS A, V148, P769, DOI 10.1016/j.cbpa.2007.01.029; MOFFATT J, 1987, BIOL REPROD, V36, P419, DOI 10.1095/biolreprod36.2.419; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Padua MB, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-5; Padua MB, 2005, MOL REPROD DEV, V71, P347, DOI 10.1002/mrd.20301; Peltier MR, 2000, J EXP ZOOL, V288, P165, DOI 10.1002/1097-010X(20000815)288:2&lt;165::AID-JEZ7&gt;3.0.CO;2-R; Peltier MR, 2000, BBA-PROTEIN STRUCT M, V1479, P37, DOI 10.1016/S0167-4838(00)00063-7; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sheng SJ, 2006, J CELL PHYSIOL, V209, P631, DOI 10.1002/jcp.20786; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Steenbakkers PJM, 2008, MYCOL RES, V112, P999, DOI 10.1016/j.mycres.2008.01.021; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tekin S, 2005, MOL REPROD DEV, V70, P262, DOI 10.1002/mrd.20206; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Vogel P, 2005, PLACENTA, V26, P591, DOI 10.1016/j.placenta.2004.11.005; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Whisstock JC, 2000, J MOL BIOL, V295, P651, DOI 10.1006/jmbi.1999.3375; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	55	14	14	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					526	537		10.1096/fj.09-138453	http://dx.doi.org/10.1096/fj.09-138453			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19825977				2022-12-25	WOS:000274045000020
J	Polge, C; Jaquinod, M; Holzer, F; Bourguignon, J; Walling, L; Brouquisse, R				Polge, Cecile; Jaquinod, Michel; Holzer, Frances; Bourguignon, Jacques; Walling, Linda; Brouquisse, Renaud			Evidence for the Existence in Arabidopsis thaliana of the Proteasome Proteolytic Pathway ACTIVATION IN RESPONSE TO CADMIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYMES; LENS EPITHELIAL-CELLS; LEUCINE AMINOPEPTIDASE; OXIDATIVE STRESS; 20S PROTEASOME; 26S PROTEASOME; OXIDIZED PROTEINS; PEA-PLANTS; IMMUNOLOGICAL CHARACTERIZATION; DEPENDENT PROTEOLYSIS	Heavy metals are known to generate reactive oxygen species that lead to the oxidation and fragmentation of proteins, which become toxic when accumulated in the cell. In this study, we investigated the role of the proteasome during cadmium stress in the leaves of Arabidopsis thaliana plants. Using biochemical and proteomics approaches, we present the first evidence of an active proteasome pathway in plants. We identified and characterized the peptidases acting sequentially downstream from the proteasome in animal cells as follows: tripeptidyl-peptidase II, thimet oligopeptidase, and leucine aminopeptidase. We investigated the proteasome proteolytic pathway response in the leaves of 6-week-old A. thaliana plants grown hydroponically for 24, 48, and 144 h in the presence or absence of 50 mu M cadmium. The gene expression and proteolytic activity of the proteasome and the different proteases of the pathway were found to be up-regulated in response to cadmium. In an in vitro assay, oxidized bovine serum albumin and lysozyme were more readily degraded in the presence of 20 S proteasome and tripeptidyl-peptidase II than their nonoxidized form, suggesting that oxidized proteins are preferentially degraded by the Arabidopsis 20 S proteasome pathway. These results show that, in response to cadmium, the 20 S proteasome proteolytic pathway is up-regulated at both RNA and activity levels in Arabidopsis leaves and may play a role in degrading oxidized proteins generated by the stress.	[Polge, Cecile; Bourguignon, Jacques; Brouquisse, Renaud] Univ Grenoble 1, INRA, CNRS,CEA,UMR5168, Lab Physiol Cellulaire Vegetale,CEA,IRTSV, F-38054 Grenoble, France; [Jaquinod, Michel] Etud Dynam Proteomes, F-38054 Grenoble, France; [Holzer, Frances; Walling, Linda] Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; University of California System; University of California Riverside	Brouquisse, R (corresponding author), Ctr INRA Sophia Antipolis, UMR, BP 167, F-06903 Sophia Antipolis, France.	renaud.brouquisse@sophia.inra.fr	Polge, Cécile/AAM-2467-2020; Schlattner, Uwe/D-1267-2009	Polge, Cécile/0000-0002-8730-5776; Schlattner, Uwe/0000-0003-1159-5911; Bourguignon, jacques/0000-0001-7517-0600	French "Program Inter-organismes CEA CNRS INRA INSERM de Toxicologie Nucleaire Environnementale"	French "Program Inter-organismes CEA CNRS INRA INSERM de Toxicologie Nucleaire Environnementale"	This work was supported by the French "Program Inter-organismes CEA CNRS INRA INSERM de Toxicologie Nucleaire Environnementale."	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Balestrasse KB, 2003, FUNCT PLANT BIOL, V30, P57, DOI 10.1071/FP02074; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; BARTLING D, 1992, EUR J BIOCHEM, V205, P425, DOI 10.1111/j.1432-1033.1992.tb16796.x; BARTLING D, 1994, PLANT SCI, V99, P199, DOI 10.1016/0168-9452(94)90177-5; Basset G, 2002, PLANT PHYSIOL, V128, P1149, DOI 10.1104/pp.010612; Bestel-Corre G, 2002, ELECTROPHORESIS, V23, P122, DOI 10.1002/1522-2683(200201)23:1&lt;122::AID-ELPS122&gt;3.0.CO;2-4; Bolumar T, 2003, APPL ENVIRON MICROB, V69, P227, DOI 10.1128/AEM.69.1.227-232.2003; Book AJ, 2005, PLANT PHYSIOL, V138, P1046, DOI 10.1104/pp.104.057406; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouquisse R, 1998, PLANT PHYSIOL, V117, P1281, DOI 10.1104/pp.117.4.1281; CARPENTER FH, 1973, J BIOL CHEM, V248, P294; Chao WS, 2000, PLANTA, V210, P563, DOI 10.1007/s004250050045; CHENG L, 1994, MOL GEN GENET, V243, P358, DOI 10.1007/BF00301072; Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Djebali W, 2008, PLANTA, V227, P625, DOI 10.1007/s00425-007-0644-6; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; Fu HY, 1999, PLANT J, V18, P529, DOI 10.1046/j.1365-313X.1999.00479.x; Fu HY, 1998, GENETICS, V149, P677; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Gu YQ, 1999, EUR J BIOCHEM, V263, P726, DOI 10.1046/j.1432-1327.1999.00548.x; Gu YQ, 1996, PLANT PHYSIOL, V110, P1257, DOI 10.1104/pp.110.4.1257; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kurepa J, 2008, PLANT J, V53, P102, DOI 10.1111/j.1365-313X.2007.03322.x; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Liu J, 2008, FREE RADICAL BIO MED, V45, P475, DOI 10.1016/j.freeradbiomed.2008.04.041; Liu YZ, 2007, MOL VIS, V13, P31; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; McCarthy I, 2001, PLANT CELL ENVIRON, V24, P1065, DOI 10.1046/j.1365-3040.2001.00750.x; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Obin M, 1998, FASEB J, V12, P561, DOI 10.1096/fasebj.12.7.561; PACIFICI RE, 1993, J BIOL CHEM, V268, P15405; Pena LB, 2007, PHYTOCHEMISTRY, V68, P1139, DOI 10.1016/j.phytochem.2007.02.022; Pena LB, 2006, PLANT SCI, V171, P531, DOI 10.1016/j.plantsci.2006.06.003; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Romero A., 2008, ELECT J ENV AGR FOOD, V7, P3363; Romero-Puertas MC, 2002, PLANT CELL ENVIRON, V25, P677, DOI 10.1046/j.1365-3040.2002.00850.x; Sanchez-Moran E, 2004, PLANT CELL, V16, P2895, DOI 10.1105/tpc.104.024992; Sandalio LM, 2001, J EXP BOT, V52, P2115, DOI 10.1093/jexbot/52.364.2115; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Sarry JE, 2006, PROTEOMICS, V6, P2180, DOI 10.1002/pmic.200500543; Saveanu L, 2002, MOL IMMUNOL, V39, P203, DOI 10.1016/S0161-5890(02)00102-5; SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297; Shringarpure R, 2001, CELL MOL LIFE SCI, V58, P1442, DOI 10.1007/PL00000787; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; SKODA B, 1992, PLANT PHYSIOL, V99, P1515, DOI 10.1104/pp.99.4.1515; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; TISLJAR U, 1990, BIOCHEM J, V267, P531, DOI 10.1042/bj2670531; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386; WAGNER GJ, 1993, ADV AGRON, V51, P173, DOI 10.1016/S0065-2113(08)60593-3; Walling LL, 2006, CURR OPIN PLANT BIOL, V9, P227, DOI 10.1016/j.pbi.2006.03.009; WALLING LL, 1996, AMINOPEPTIDASES, P174; WANG CS, 1992, PLANT PHYSIOL, V99, P822, DOI 10.1104/pp.99.3.822; Xu GZ, 1999, CHEM RES TOXICOL, V12, P855, DOI 10.1021/tx990056a; Yang PZ, 2004, J BIOL CHEM, V279, P6401, DOI 10.1074/jbc.M311977200	67	83	84	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35412	35424		10.1074/jbc.M109.035394	http://dx.doi.org/10.1074/jbc.M109.035394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19822524	Green Published, hybrid			2022-12-25	WOS:000272645600017
J	Lu, L; Wang, SY; Zheng, L; Li, XL; Suswam, EA; Zhang, XW; Wheeler, CG; Nabors, LB; Filippova, N; King, PH				Lu, Liang; Wang, Shuying; Zheng, Lei; Li, Xuelin; Suswam, Esther A.; Zhang, Xiaowen; Wheeler, Crystal G.; Nabors, L. B.; Filippova, Natalia; King, Peter H.			Amyotrophic Lateral Sclerosis-linked Mutant SOD1 Sequesters Hu Antigen R (HuR) and TIA-1-related Protein (TIAR) IMPLICATIONS FOR IMPAIRED POST-TRANSCRIPTIONAL REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; 3' UNTRANSLATED REGION; AU-RICH ELEMENTS; GROWTH-FACTOR; OXIDATIVE STRESS; BINDING PROTEINS; STABILIZATION; APOPTOSIS; BCL-2; GENE	Down-regulation of vascular endothelial growth factor (VEGF) in the mouse leads to progressive and selective degeneration of motor neurons similar to amyotrophic lateral sclerosis (ALS). In mice expressing ALS-associated mutant superoxide dismutase 1 (SOD1), VEGF mRNA expression in the spinal cord declines significantly prior to the onset of clinical manifestations. In vitro models suggest that dysregulation of VEGF mRNA stability contributes to that decline. Here, we show that the major RNA stabilizer, Hu Antigen R (HuR), and TIA-1-related protein (TIAR) colocalize with mutant SOD1 in mouse spinal cord extracts and cultured glioma cells. The colocalization was markedly reduced or abolished by RNase treatment. Immunoanalysis of transfected cells indicated that colocalization occurred in insoluble aggregates and inclusions. RNA immunoprecipitation showed a significant loss of VEGF mRNA binding to HuR and TIAR in mutant SOD1 cells, and there was marked depletion of HuR from polysomes. Ectopic expression of HuR in mutant SOD1 cells more than doubled the mRNA half-life of VEGF and significantly increased expression to that of wild-type SOD1 control. Cellular effects produced by mutant SOD1, including impaired mitochondrial function and oxidative stress-induced apoptosis, were reversed by HuR in a gene dose-dependent pattern. In summary, our findings indicate that mutant SOD1 impairs post-transcriptional regulation by sequestering key regulatory RNA-binding proteins. The rescue effect of HuR suggests that this impairment, whether related to VEGF or other potential mRNA targets, contributes to cytotoxicity in ALS.	[Lu, Liang; Wang, Shuying; Zheng, Lei; Li, Xuelin; Suswam, Esther A.; Zhang, Xiaowen; Nabors, L. B.; Filippova, Natalia; King, Peter H.] Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA; [King, Peter H.] Univ Alabama, Dept Genet, Birmingham, AL 35294 USA; [Wheeler, Crystal G.] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; [King, Peter H.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Lu, Liang; Zheng, Lei; Li, Xuelin; King, Peter H.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	King, PH (corresponding author), Sparks Ctr, Suite 260,1720-7th Ave S, Birmingham, AL 35233 USA.	pking@uab.edu	wang, shuying/HHZ-4516-2022; Nabors, Louis/ABB-8223-2021	Nabors, Louis/0000-0001-5926-2230; King, Peter/0000-0001-9391-7464; Filippova, Natalia/0000-0003-2128-5511	National Institutes of Health [NS058538, NS064133, NS057664]; NINDS [R01 CA112397]; NCI; Dept. of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA112397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058538, R01NS064133, K08NS057664] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dept. of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants NS058538, NS064133 (to P. H. K.), NS057664 (to L. L.) from the NINDS, R01 CA112397 (to L. B. N.) from the NCI, and a Merit Review award from the Dept. of Veterans Affairs (to P. H. K.).	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cherradi N, 2006, MOL ENDOCRINOL, V20, P916, DOI 10.1210/me.2005-0121; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Forch P, 2001, APOPTOSIS, V6, P463, DOI 10.1023/A:1012441824719; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Hong X, 2007, J EXP THER ONCOL, V6, P219; Kawai T, 2004, MOL CELL BIOL, V24, P6773, DOI 10.1128/MCB.24.15.6773-6787.2004; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Keil U, 2006, BRIT J PHARMACOL, V147, P199, DOI 10.1038/sj.bjp.0706459; Kim HH, 2008, CELL CYCLE, V7, P3124, DOI 10.4161/cc.7.20.6884; King P H, 2000, Nucleic Acids Res, V28, pE20, DOI 10.1093/nar/28.7.e20; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li XL, 2009, J NEUROCHEM, V108, P1032, DOI 10.1111/j.1471-4159.2008.05856.x; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Lu L, 2007, J NEUROSCI, V27, P7929, DOI 10.1523/JNEUROSCI.1877-07.2007; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nabors LLB, 2003, CANCER RES, V63, P4181; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schiavone N, 2000, FASEB J, V14, P174, DOI 10.1096/fasebj.14.1.174; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Slater K, 2001, CURR OPIN BIOTECH, V12, P70, DOI 10.1016/S0958-1669(00)00177-4; Suswam EA, 2005, NUCLEIC ACIDS RES, V33, P4507, DOI 10.1093/nar/gki763; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200	44	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33989	33998		10.1074/jbc.M109.067918	http://dx.doi.org/10.1074/jbc.M109.067918			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19805546	Green Published, hybrid			2022-12-25	WOS:000272165200031
J	Cuneo, MJ; Beese, LS; Hellinga, HW				Cuneo, Matthew J.; Beese, Lorena S.; Hellinga, Homme W.			Structural Analysis of Semi-specific Oligosaccharide Recognition by a Cellulose-binding Protein of Thermotoga maritima Reveals Adaptations for Functional Diversification of the Oligopeptide Periplasmic Binding Protein Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PEPTIDE BINDING; LIGAND-BINDING; TRANSPORT; SEQUENCE; BACTERIA; RECEPTOR; GENE; DISACCHARIDE; DEGRADATION	Periplasmic binding proteins (PBPs) constitute a protein superfamily that binds a wide variety of ligands. In prokaryotes, PBPs function as receptors for ATP-binding cassette or tripartite ATP-independent transporters and chemotaxis systems. In many instances, PBPs bind their cognate ligands with exquisite specificity, distinguishing, for example, between sugar epimers or structurally similar anions. By contrast, oligopeptide-binding proteins bind their ligands through interactions with the peptide backbone but do not distinguish between different side chains. The extremophile Thermotoga maritima possesses a remarkable array of carbohydrate-processing metabolic systems, including the hydrolysis of cellulosic polymers. Here, we present the crystal structure of a T. maritima cellobiose-binding protein (tm0031) that is homologous to oligopeptide-binding proteins. T. maritima cellobiose-binding protein binds a variety of lengths of beta(1 -> 4)-linked glucose oligomers, ranging from two rings (cellobiose) to five (cellopentaose). The structure reveals that binding is semi-specific. The disaccharide at the nonreducing end binds specifically; the other rings are located in a large solvent-filled groove, where the reducing end makes several contacts with the protein, thereby imposing an upper limit of the oligosaccharides that are recognized. Semi-specific recognition, in which a molecular class rather than individual species is selected, provides an efficient solution for the uptake of complex mixtures.	[Cuneo, Matthew J.; Beese, Lorena S.; Hellinga, Homme W.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Hellinga, HW (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Nanaline Duke Bldg, Durham, NC 27710 USA.	hwh@biochem.duke.edu	beese, lorena/G-4993-2010	Cuneo, Matthew/0000-0002-1475-6656	National Institutes of Health Pioneer Award [5 DP1 OD000122-02]; Homeland Security Advanced Research Projects Agency [W81XWH-05-C-0161]; United States Department of Energy; Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000122] Funding Source: NIH RePORTER	National Institutes of Health Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Homeland Security Advanced Research Projects Agency; United States Department of Energy(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Pioneer Award 5 DP1 OD000122-02 and Homeland Security Advanced Research Projects Agency Grant W81XWH-05-C-0161 (to H.W.H.). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	AKSAMIT RR, 1974, BIOCHEMISTRY-US, V13, P4473, DOI 10.1021/bi00719a001; Alderkamp AC, 2007, FEMS MICROBIOL ECOL, V59, P108, DOI 10.1111/j.1574-6941.2006.00219.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; Blow N, 2008, NAT METHODS, V5, P203, DOI 10.1038/nmeth0208-203; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Bruns CM, 1997, NAT STRUCT BIOL, V4, P919, DOI 10.1038/nsb1197-919; BULIGA GS, 1986, CARBOHYD RES, V157, P139, DOI 10.1016/0008-6215(86)85065-0; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; COHEN DS, 1994, PROTEIN SCI, V3, P1253, DOI 10.1002/pro.5560030811; Conners SB, 2005, J BACTERIOL, V187, P7267, DOI 10.1128/JB.187.21.7267-7282.2005; Conners SB, 2006, FEMS MICROBIOL REV, V30, P872, DOI 10.1111/j.1574-6976.2006.00039.x; Cuneo MJ, 2006, J MOL BIOL, V362, P259, DOI 10.1016/j.jmb.2006.06.084; Cuneo MJ, 2009, J MOL BIOL, V389, P157, DOI 10.1016/j.jmb.2009.04.008; Cuneo MJ, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-50; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Kelly DJ, 2001, FEMS MICROBIOL REV, V25, P405, DOI 10.1111/j.1574-6976.2001.tb00584.x; Kondoh O, 1997, J BACTERIOL, V179, P7734, DOI 10.1128/jb.179.24.7734-7741.1997; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nanavati DA, 2006, APPL ENVIRON MICROB, V72, P1336, DOI 10.1128/AEM.72.2.1336-1345.2006; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shouldice SR, 2003, J BIOL CHEM, V278, P41093, DOI 10.1074/jbc.M306821200; Sleigh SH, 1999, J MOL BIOL, V291, P393, DOI 10.1006/jmbi.1999.2929; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; Tame JRH, 1995, STRUCTURE, V3, P1395, DOI 10.1016/S0969-2126(01)00276-3; Tame JRH, 1996, NAT STRUCT BIOL, V3, P998, DOI 10.1038/nsb1296-998; TAME JRH, 1994, SCIENCE, V264, P1578, DOI 10.1126/science.8202710; VanFossen AL, 2008, ANN NY ACAD SCI, V1125, P322, DOI 10.1196/annals.1419.017	42	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33217	33223		10.1074/jbc.M109.041624	http://dx.doi.org/10.1074/jbc.M109.041624			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801540	Green Published, hybrid			2022-12-25	WOS:000272028500026
J	Koike, S; Keino-Masu, K; Ohto, T; Sugiyama, F; Takahashi, S; Masu, M				Koike, Seiichi; Keino-Masu, Kazuko; Ohto, Tatsuyuki; Sugiyama, Fumihiro; Takahashi, Satoru; Masu, Masayuki			Autotaxin/Lysophospholipase D-mediated Lysophosphatidic Acid Signaling Is Required to Form Distinctive Large Lysosomes in the Visceral Endoderm Cells of the Mouse Yolk Sac	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; LIM-KINASE; LYSOPHOSPHOLIPASE-D; ACTIN; AUTOTAXIN; FUSION; PHOSPHORYLATION; TRAFFICKING; RECEPTORS; YEAST	Autotaxin, a lysophospholipase D encoded by the Enpp2 gene, is an exoenzyme that produces lysophosphatidic acid in the extracellular space. Lysophosphatidic acid acts on specific G protein-coupled receptors, thereby regulating cell growth, migration, and survival. Previous studies have revealed that Enpp2(-/-) mouse embryos die at about embryonic day (E) 9.5 because of angiogenic defects in the yolk sac. However, what cellular defects occur in Enpp2(-/-) embryos and what intracellular signaling pathways are involved in the phenotype manifestation remain unknown. Here, we show that Enpp2 is required to form distinctive large lysosomes in the yolk sac visceral endoderm cells. From E7.5 to E9.5, Enpp2 mRNA is abundantly expressed in the visceral endoderm cells. In Enpp2(-/-) mouse embryos, lysosomes in the visceral endoderm cells are fragmented. By using a whole embryo culture system combined with specific pharmacological inhibitors for intracellular signaling molecules, we show that lysophosphatidic acid receptors and the Rho-Rho-associated coiled-coil containing protein kinase (ROCK)-LIM kinase pathway are required to form large lysosomes. In addition, electroporation of dominant negative forms of Rho, ROCK, or LIM kinase also leads to the size reduction of lysosomes in wild-type visceral endoderm cells. In Enpp2(-/-) visceral endoderm cells, the steady-state levels of cofilin phosphorylation and actin polymerization are reduced. In addition, perturbations of actin turnover dynamics by actin inhibitors cytochalasin B and jasplakinolide result in the defect in lysosome formation. These results suggest that constitutive activation of the Rho-ROCK-LIM kinase pathway by extracellular production of lysophosphatidic acid by the action of autotaxin is required to maintain the large size of lysosomes in visceral endoderm cells.	[Koike, Seiichi; Keino-Masu, Kazuko; Ohto, Tatsuyuki; Masu, Masayuki] Univ Tsukuba, Inst Basic Med Sci, Dept Mol Neurobiol, Tsukuba, Ibaraki 3058577, Japan; [Ohto, Tatsuyuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Clin Med, Dept Pediat, Tsukuba, Ibaraki 3058577, Japan; [Sugiyama, Fumihiro; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Masu, M (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Mol Neurobiol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	mmasu@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mitsubishi Foundation; Novartis Foundation (Japan)	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Novartis Foundation (Japan)(Novartis)	This work was supported in part by grants-in-aid for scientific research on priority areas and the 21st Century COE Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and grants from The Mitsubishi Foundation and The Novartis Foundation (Japan).	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Barois N, 1998, J CELL SCI, V111, P1791; Bielinska M, 1999, INT J DEV BIOL, V43, P183; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Clair T, 2003, CANCER RES, V63, P5446; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Huijbregts RPH, 2000, TRAFFIC, V1, P195, DOI 10.1034/j.1600-0854.2000.010301.x; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; Kjeken R, 2004, MOL BIOL CELL, V15, P345, DOI 10.1091/mbc.e03-05-0334; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; LLOYD JB, 1990, TERATOLOGY, V41, P383, DOI 10.1002/tera.1420410404; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Smythe E, 2006, J CELL SCI, V119, P4589, DOI 10.1242/jcs.03247; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Tam PPL, 1998, INT J DEV BIOL, V42, P895; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; VANDEURS B, 1995, EUR J CELL BIOL, V66, P309; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	43	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33561	33570		10.1074/jbc.M109.012716	http://dx.doi.org/10.1074/jbc.M109.012716			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808661	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000272028500061
J	Aquino, VH; Amarilla, AA; Alfonso, HL; Batista, WC; Figueiredo, LTM				Aquino, Victor Hugo; Amarilla, Alberto Anastacio; Alfonso, Helda Liz; Batista, Weber Cheli; Moraes Figueiredo, Luiz Tadeu			New Genotype of Dengue Type 3 Virus Circulating in Brazil and Colombia Showed a Close Relationship to Old Asian Viruses	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; EMERGENCE; EVOLUTION	Dengue type 3 genotype V viruses have been recently detected in Brazil and Colombia. In this study, we described another Brazilian isolate belonging to this genotype. Phylogenetic analysis including dengue type 3 viruses isolated worldwide showed that Brazilian and Colombian viruses were closely related to viruses isolated in Asia more than two decades ago. The characteristic evolutionary pattern of dengue type 3 virus cannot explain the close similarity of new circulating viruses with old viruses. Further studies are needed to confirm the origin of the new dengue type III genotype circulating in Brazil and Colombia.			Aquino, VH (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin, Sao Paulo, Brazil.	vhugo@fcfrp.usp.br	Aquino, Victor Hugo/C-1922-2012; Amarilla, Alberto Anastacio/AFO-4805-2022; Ortiz, Alberto Anastacio Amarilla/C-3112-2012; Figueiredo, Luiz T/E-3702-2012	Aquino, Victor Hugo/0000-0003-1910-0776; Amarilla, Alberto Anastacio/0000-0002-6640-3377; Ortiz, Alberto Anastacio Amarilla/0000-0002-4151-2024; 				[Anonymous], 1995, JAMA, V273, P840; Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710; ARAUJO J, 2008, INFECT GENET EVOL; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kochel T, 2008, INFECT GENET EVOL, V8, P682, DOI 10.1016/j.meegid.2008.06.008; LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65; Li W.H., 1997, MOL EVOLUTION, P487; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Nogueira MB, 2008, MEM I OSWALDO CRUZ, V103, P483, DOI 10.1590/S0074-02762008000500013; Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; SCHREIBER M, 2009, J VIROL; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010; Usme-Ciro JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-101; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549	23	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7299	10.1371/journal.pone.0007299	http://dx.doi.org/10.1371/journal.pone.0007299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823677	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808300002
J	Fessenden, JD				Fessenden, James D.			Forster Resonance Energy Transfer Measurements of Ryanodine Receptor Type 1 Structure Using a Novel Site-Specific Labeling Method.	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CALCIUM-RELEASE CHANNEL; SKELETAL-MUSCLE; 3-DIMENSIONAL ARCHITECTURE; BINDING-SITES; LIVE CELLS; LOCALIZATION; FRET; CALMODULIN; SEQUENCES	Background: While the static structure of the intracellular Ca(2+) release channel, the ryanodine receptor type 1 (RyR1) has been determined using cryo electron microscopy, relatively little is known concerning changes in RyR1 structure that accompany channel gating. Forster resonance energy transfer (FRET) methods can resolve small changes in protein structure although FRET measurements of RyR1 are hampered by an inability to site-specifically label the protein with fluorescent probes. Methodology/Principal Findings: A novel site-specific labeling method is presented that targets a FRET acceptor, Cy3NTA to 10-residue histidine (His) tags engineered into RyR1. Cy3NTA, comprised of the fluorescent dye Cy3, coupled to two Ni(2+)/nitrilotriacetic acid moieties, was synthesized and functionally tested for binding to His-tagged green fluorescent protein (GFP). GFP fluorescence emission and Cy3NTA absorbance spectra overlapped significantly, indicating that FRET could occur (Forster distance = 6.3 nm). Cy3NTA bound to His(10)-tagged GFP, quenching its fluorescence by 88%. GFP was then fused to the N-terminus of RyR1 and His(10) tags were placed either at the N-terminus of the fused GFP or between GFP and RyR1. Cy3NTA reduced fluorescence of these fusion proteins by 75% and this quenching could be reversed by photobleaching Cy3, thus confirming GFP-RyR1 quenching via FRET. A His10 tag was then placed at amino acid position 1861 and FRET was measured from GFP located at either the N-terminus or at position 618 to Cy3NTA bound to this His tag. While minimal FRET was detected between GFP at position 1 and Cy3NTA at position 1861, 53% energy transfer was detected from GFP at position 618 to Cy3NTA at position 1861, thus indicating that these sites are in close proximity to each other. Conclusions/Significance: These findings illustrate the potential of this site-specific labeling system for use in future FRET-based experiments to elucidate novel aspects of RyR1 structure.			Fessenden, JD (corresponding author), Boston Biomed Res Inst, Watertown, MA USA.	Fessenden@bbri.org			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056406, K01AR052120] Funding Source: NIH RePORTER; NIAMS NIH HHS [R21 AR056406, K01 AR052120] Funding Source: Medline; PHS HHS [R21ARO56406, K01ARO52120] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; Guignet EG, 2004, NAT BIOTECHNOL, V22, P440, DOI 10.1038/nbt954; Guignet EG, 2007, CHEMPHYSCHEM, V8, P1221, DOI 10.1002/cphc.200700065; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; Kapanidis AN, 2001, J AM CHEM SOC, V123, P12123, DOI 10.1021/ja017074a; Kim MJ, 2008, ANAL BIOCHEM, V379, P124, DOI 10.1016/j.ab.2008.04.032; Krishnan B, 2007, CHEM BIOL DRUG DES, V69, P31, DOI 10.1111/j.1747-0285.2007.00463.x; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Lorenzon NM, 2001, ARCH BIOCHEM BIOPHYS, V388, P13, DOI 10.1006/abbi.2000.2263; Orlova EV, 1996, NAT STRUCT BIOL, V3, P547, DOI 10.1038/nsb0696-547; Peneva K, 2008, J AM CHEM SOC, V130, P5398, DOI 10.1021/ja711322g; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Reichel A, 2007, ANAL CHEM, V79, P8590, DOI 10.1021/ac0714922; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Richmond TA, 2000, BIOCHEM BIOPH RES CO, V268, P462, DOI 10.1006/bbrc.1999.1244; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Soh N, 2006, MOL BIOSYST, V2, P128, DOI 10.1039/b515777c; SORRENTINO V, 1993, TRENDS PHARMACOL SCI, V14, P98, DOI 10.1016/0165-6147(93)90072-R; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; WAGENKNECHT T, 1989, NATURE, V338, P167, DOI 10.1038/338167a0; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200	27	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7338	10.1371/journal.pone.0007338	http://dx.doi.org/10.1371/journal.pone.0007338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823671	Green Submitted, gold, Green Published			2022-12-25	WOS:000270728500001
J	Armesto, M; Cavanagh, D; Britton, P				Armesto, Maria; Cavanagh, Dave; Britton, Paul			The Replicase Gene of Avian Coronavirus Infectious Bronchitis Virus Is a Determinant of Pathogenicity	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; DEFECTIVE RNAS; SPIKE PROTEIN; SEQUENCE; STRAINS; GENOME; EXPRESSION; IDENTIFICATION; PATHOGENESIS; BEAUDETTE	We have previously demonstrated that the replacement of the S gene from an avirulent strain (Beaudette) of infectious bronchitis virus (IBV) with an S gene from a virulent strain (M41) resulted in a recombinant virus (BeauR-M41(S)) with the in vitro cell tropism of the virulent virus but that was still avirulent. In order to investigate whether any of the other structural or accessory genes played a role in pathogenicity we have now replaced these from the Beaudette strain with those from M41. The recombinant IBV was in effect a chimaeric virus with the replicase gene derived from Beaudette and the rest of the genome from M41. This demonstrated that it is possible to exchange a large region of the IBV genome, approximately 8.4 kb, using our transient dominant selection method. Recovery of a viable recombinant IBV also demonstrated that it is possible to interchange a complete replicase gene as we had in effect replaced the M41 replicase gene with the Beaudette derived gene. Analysis of the chimaeric virus showed that it was avirulent indicating that none of the structural or accessory genes derived from a virulent isolate of IBV were able to restore virulence and that therefore, the loss of virulence associated with the Beaudette strain resides in the replicase gene.			Armesto, M (corresponding author), AFRC, Inst Anim Hlth, Compton Lab, Div Microbiol, Newbury RG16 0NN, Berks, England.	paul.britton@bbsrc.ac.uk			Biotechnology and Biological Sciences Research Council [BBS/E/I/00001145, BBS/E/I/00001256] Funding Source: Medline; BBSRC [BBS/E/I/00001256] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ammayappan A, 2009, ARCH VIROL, V154, P495, DOI 10.1007/s00705-009-0325-9; [Anonymous], [No title captured]; Armesto Maria, 2008, V454, P255, DOI 10.1007/978-1-59745-181-9_19; Bijlenga G, 2004, AVIAN PATHOL, V33, P550, DOI 10.1080/03079450400013154; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BOURSNELL MEG, 1987, J GEN VIROL, V68, P57, DOI 10.1099/0022-1317-68-1-57; BOURSNELL MEG, 1985, J GEN VIROL, V66, P573, DOI 10.1099/0022-1317-66-3-573; Britton P, 2005, J VIROL METHODS, V123, P203, DOI 10.1016/j.jviromet.2004.09.017; Britton P, 1996, J GEN VIROL, V77, P963, DOI 10.1099/0022-1317-77-5-963; Britton P, 2008, NIDOVIRUSES, P29; Britton Paul, 2007, P161; Cao J, 2008, VIRUS RES, V136, P43, DOI 10.1016/j.virusres.2008.04.015; Casais R, 2005, J VIROL, V79, P8065, DOI 10.1128/JVI.79.13.8065-8078.2005; Casais R, 2003, J VIROL, V77, P9084, DOI 10.1128/JVI.77.16.9084-9089.2003; Casais R, 2001, J VIROL, V75, P12359, DOI 10.1128/JVI.75.24.12359-12369.2001; CAVANAGH D, 1986, VIRUS RES, V4, P133, DOI 10.1016/0168-1702(86)90037-7; Cavanagh D, 2002, AVIAN PATHOL, V31, P81, DOI 10.1080/03079450120106651; Cavanagh D, 2001, AVIAN PATHOL, V30, P355, DOI 10.1080/03079450120066368; CAVANAGH D, 2008, DIS POULTRY, P117; Cavanagh D., 2003, DIS POULTRY, P101; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; COOK JKA, 1976, ARCH VIROL, V50, P109, DOI 10.1007/BF01318005; Curtis KM, 2002, J VIROL, V76, P1422, DOI 10.1128/JVI.76.3.1422-1434.2002; Dalton K, 2001, J VIROL, V75, P125, DOI 10.1128/JVI.75.1.125-133.2001; DARBYSHIRE JH, 1979, ARCH VIROL, V61, P227, DOI 10.1007/BF01318057; Dong BQ, 2007, J VIROL, V81, P6920, DOI 10.1128/JVI.00299-07; Eriksson KK, 2008, J VIROL, V82, P12325, DOI 10.1128/JVI.02082-08; GEILHAUSEN HE, 1973, ARCH GES VIRUSFORSCH, V40, P285, DOI 10.1007/BF01242547; GELB J, 1983, AVIAN DIS, V27, P679, DOI 10.2307/1590310; Gomaa MH, 2008, VIRUS RES, V135, P237, DOI 10.1016/j.virusres.2008.03.020; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; Guy JS, 2000, AVIAN PATHOL, V29, P207, DOI 10.1080/03079450050045459; Haijema BJ, 2004, J VIROL, V78, P3863, DOI 10.1128/JVI.78.8.3863-3871.2004; Hodgson T, 2006, J VIROL, V80, P296, DOI 10.1128/JVI.80.1.296-305.2006; Hodgson T, 2004, J VIROL, V78, P13804, DOI 10.1128/JVI.78.24.13804-13811.2004; HODGSON TS, 2005, THESIS U BRISTOL; Jackwood MW, 2003, AVIAN DIS, V47, P627, DOI 10.1637/6094; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; Liu SW, 2009, VACCINE, V27, P4630, DOI 10.1016/j.vaccine.2009.05.072; Mihindukulasuriya KA, 2008, J VIROL, V82, P5084, DOI 10.1128/JVI.02722-07; Navas-Martin S, 2007, J VIROL, V81, P1022, DOI 10.1128/JVI.01944-06; Ortego J, 2003, VIROLOGY, V308, P13, DOI 10.1016/S0042-6822(02)00096-X; PENZES Z, 1994, VIROLOGY, V203, P286, DOI 10.1006/viro.1994.1486; Penzes Z, 1996, J VIROL, V70, P8660; Sola I, 2003, J VIROL, V77, P4357, DOI 10.1128/JVI.77.7.4357-4369.2003; Sperry SM, 2005, J VIROL, V79, P3391, DOI 10.1128/JVI.79.6.3391-3400.2005; Stirrups K, 2000, J GEN VIROL, V81, P791, DOI 10.1099/0022-1317-81-3-791; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Ziebuhr J, 2008, NIDOVIRUSES, P65; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	51	88	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7384	10.1371/journal.pone.0007384	http://dx.doi.org/10.1371/journal.pone.0007384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816578	Green Submitted, Green Published, gold			2022-12-25	WOS:000270594300008
J	Caspani, O; Zurborg, S; Labuz, D; Heppenstall, PA				Caspani, Ombretta; Zurborg, Sandra; Labuz, Dominika; Heppenstall, Paul A.			The Contribution of TRPM8 and TRPA1 Channels to Cold Allodynia and Neuropathic Pain	PLOS ONE			English	Article								Cold allodynia is a common feature of neuropathic pain however the underlying mechanisms of this enhanced sensitivity to cold are not known. Recently the transient receptor potential (TRP) channels TRPM8 and TRPA1 have been identified and proposed to be molecular sensors for cold. Here we have investigated the expression of TRPM8 and TRPA1 mRNA in the dorsal root ganglia (DRG) and examined the cold sensitivity of peripheral sensory neurons in the chronic construction injury (CCI) model of neuropathic pain in mice. In behavioral experiments, chronic constriction injury (CCI) of the sciatic nerve induced a hypersensitivity to both cold and the TRPM8 agonist menthol that developed 2 days post injury and remained stable for at least 2 weeks. Using quantitative RT-PCR and in situ hybridization we examined the expression of TRPM8 and TRPA1 in DRG. Both channels displayed significantly reduced expression levels after injury with no change in their distribution pattern in identified neuronal subpopulations. Furthermore, in calcium imaging experiments, we detected no alterations in the number of cold or menthol responsive neurons in the DRG, or in the functional properties of cold transduction following injury. Intriguingly however, responses to the TRPA1 agonist mustard oil were strongly reduced. Our results indicate that injured sensory neurons do not develop abnormal cold sensitivity after chronic constriction injury and that alterations in the expression of TRPM8 and TRPA1 are unlikely to contribute directly to the pathogenesis of cold allodynia in this neuropathic pain model.			Caspani, O (corresponding author), Charite, Klin Anaesthesiol & Operat Intens Med, Campus Benjamin Franklin, Berlin, Germany.	paul.heppenstall@embl.it		Caspani, Ombretta/0000-0002-9700-3149				Babes A, 2004, EUR J NEUROSCI, V20, P2276, DOI 10.1111/j.1460-9568.2004.03695.x; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; CLIFF MA, 1994, PHYSIOL BEHAV, V56, P1021, DOI 10.1016/0031-9384(94)90338-7; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Djouhri L, 2004, NEUROREPORT, V15, P457, DOI 10.1097/00001756-200403010-00015; Frederick J, 2007, BIOCHEM BIOPH RES CO, V358, P1058, DOI 10.1016/j.bbrc.2007.05.029; GREEN BG, 1992, SOMATOSENS MOT RES, V9, P235, DOI 10.3109/08990229209144774; Hammond DL, 2004, J COMP NEUROL, V475, P575, DOI 10.1002/cne.20209; Hatem S, 2006, PAIN, V122, P190, DOI 10.1016/j.pain.2006.01.026; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Hogan QH, 2007, CROAT MED J, V48, P9; Jensen TS, 2001, EUR J PHARMACOL, V429, P1, DOI 10.1016/S0014-2999(01)01302-4; Ji G, 2007, NEUROSCIENCE, V150, P182, DOI 10.1016/j.neuroscience.2007.09.002; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kwan KY, 2009, J GEN PHYSIOL, V133, P251, DOI 10.1085/jgp.200810146; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; Lee BH, 1998, EXP BRAIN RES, V120, P432, DOI 10.1007/s002210050416; LINDBLOM U, 1979, J NEUROL NEUROSUR PS, V42, P422, DOI 10.1136/jnnp.42.5.422; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Martinez-Caro L, 2000, NEUROREPORT, V11, P1213, DOI 10.1097/00001756-200004270-00014; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; NAHIN RL, 1994, PAIN, V58, P95, DOI 10.1016/0304-3959(94)90189-9; Namer B, 2005, NEUROREPORT, V16, P955, DOI 10.1097/00001756-200506210-00015; Nealen ML, 2003, J NEUROPHYSIOL, V90, P515, DOI 10.1152/jn.00843.2002; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; OCHOA JL, 1994, BRAIN, V117, P185, DOI 10.1093/brain/117.1.185; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Persson AK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-7; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Roza C, 2006, PAIN, V120, P24, DOI 10.1016/j.pain.2005.10.006; Sawada Y, 2007, BRAIN RES, V1160, P39, DOI 10.1016/j.brainres.2007.05.047; Seifert F, 2007, NEUROIMAGE, V35, P1168, DOI 10.1016/j.neuroimage.2007.01.021; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 1999, J NEUROSCI, V19, P6497; Thut PD, 2003, NEUROSCIENCE, V119, P1071, DOI 10.1016/S0306-4522(03)00225-2; WAHREN LK, 1992, PAIN, V48, P237, DOI 10.1016/0304-3959(92)90063-H; Walczak JS, 2006, NEUROSCI LETT, V399, P240, DOI 10.1016/j.neulet.2006.01.058; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; YARNITSKY D, 1990, BRAIN, V113, P893, DOI 10.1093/brain/113.4.893; Yosipovitch G, 1996, ARCH DERMATOL RES, V288, P245, DOI 10.1007/s004030050053; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	58	119	120	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7383	10.1371/journal.pone.0007383	http://dx.doi.org/10.1371/journal.pone.0007383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812688	Green Submitted, Green Published, gold			2022-12-25	WOS:000270594200009
J	Lai, HJ; Lo, SJ; Kage-Nakadai, E; Mitani, S; Xue, D				Lai, Huey-Jen; Lo, Szecheng J.; Kage-Nakadai, Eriko; Mitani, Shohei; Xue, Ding			The Roles and Acting Mechanism of Caenorhabditis elegans DNase II Genes in Apoptotic DNA Degradation and Development	PLOS ONE			English	Article								DNase II enzymes are acidic endonucleases that have been implicated in mediating apoptotic DNA degradation, a critical cell death execution event. C. elegans genome contains three DNase II homologues, NUC-1, CRN-6, and CRN-7, but their expression patterns, acting sites, and roles in apoptotic DNA degradation and development are unclear. We have conducted a comprehensive analysis of three C. elegans DNase II genes and found that nuc-1 plays a major role, crn-6 plays an auxiliary role, and crn-7 plays a negligible role in resolving 3' OH DNA breaks generated in apoptotic cells. Promoter swapping experiments suggest that crn-6 but not crn-7 can partially substitute for nuc-1 in mediating apoptotic DNA degradation and both fail to replace nuc-1 in degrading bacterial DNA in intestine. Despite of their restricted and largely non-overlapping expression patterns, both CRN-6 and NUC-1 can mediate apoptotic DNA degradation in many cells, suggesting that they are likely secreted nucleases that are retaken up by other cells to exert DNA degradation functions. Removal or disruption of NUC-1 secretion signal eliminates NUC-1's ability to mediate DNA degradation across its expression border. Furthermore, blocking cell corpse engulfment does not affect apoptotic DNA degradation mediated by nuc-1, suggesting that NUC-1 acts in apoptotic cells rather than in phagocytes to resolve 3' OH DNA breaks. Our study illustrates how multiple DNase II nucleases play differential roles in apoptotic DNA degradation and development and reveals an unexpected mode of DNase II action in mediating DNA degradation.			Lai, HJ (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	losj@mail.cgu.edu.tw; ding.xue@colorado.edu		XUE, DING/0000-0002-8429-8136	NIGMS NIH HHS [R01 GM079097, R01 GM059083] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059083, R01GM079097] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALNEMRI ES, 1990, J BIOL CHEM, V265, P17323; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; Baker KP, 1998, GENE, V215, P281, DOI 10.1016/S0378-1119(98)00280-7; BERNARDI G, 1971, HYDROLYSIS, P271; BRENNER S, 1974, GENETICS, V77, P71; Counis MF, 2006, BIOCHIMIE, V88, P1851, DOI 10.1016/j.biochi.2006.07.008; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, GENETICS, V129, P79; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P654, DOI 10.1073/pnas.93.2.654; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; HODGKIN J, 1979, GENETICS, V91, P67; HODGKIN J, 1983, GENETICS, V103, P43; Kaufmann SH, 2000, METHOD ENZYMOL, V322, P3; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Krieser RJ, 2001, GENE, V269, P205, DOI 10.1016/S0378-1119(01)00434-6; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lyon CJ, 2000, GENE, V252, P147, DOI 10.1016/S0378-1119(00)00213-4; MacLea KS, 2002, BIOCHEM BIOPH RES CO, V292, P415, DOI 10.1006/bbrc.2002.6687; MADURO M, 1995, GENETICS, V141, P977; McIlroy D, 2000, GENE DEV, V14, P549; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; Praitis V, 2001, GENETICS, V157, P1217; Seong CS, 2006, CELL IMMUNOL, V240, P5, DOI 10.1016/j.cellimm.2006.05.007; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shaham S, 1999, GENETICS, V153, P1655; Shiokawa D, 1998, BIOCHEM BIOPH RES CO, V247, P864, DOI 10.1006/bbrc.1998.8839; Shiokawa D, 1999, NUCLEIC ACIDS RES, V27, P4083, DOI 10.1093/nar/27.20.4083; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Widlak P, 2001, MOL CELL BIOCHEM, V218, P125, DOI 10.1023/A:1007231822086; Wu YC, 2000, GENE DEV, V14, P536; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YAMANAKA M, 1974, J BIOL CHEM, V249, P3884; Yasuda T, 1998, J BIOL CHEM, V273, P2610, DOI 10.1074/jbc.273.5.2610; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	48	11	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7348	10.1371/journal.pone.0007348	http://dx.doi.org/10.1371/journal.pone.0007348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809494	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594000011
J	Terrados, G; Capp, JP; Canitrot, Y; Garcia-Diaz, M; Bebenek, K; Kirchhoff, T; Villanueva, A; Boudsocq, F; Bergoglio, V; Cazaux, C; Kunkel, TA; Hoffmann, JS; Blanco, L				Terrados, Gloria; Capp, Jean-Pascal; Canitrot, Yvan; Garcia-Diaz, Miguel; Bebenek, Katarzyna; Kirchhoff, Tomas; Villanueva, Alberto; Boudsocq, Francois; Bergoglio, Valerie; Cazaux, Christophe; Kunkel, Thomas A.; Hoffmann, Jean-Sebastien; Blanco, Luis			Characterization of a Natural Mutator Variant of Human DNA Polymerase lambda which Promotes Chromosomal Instability by Compromising NHEJ	PLOS ONE			English	Article							BASE EXCISION-REPAIR; END-JOINING PATHWAY; POL LAMBDA; BETA; MUTANT; DAMAGE; OVEREXPRESSION; IDENTIFICATION; SUBSTITUTION; CHECKPOINT	Background: DNA polymerase lambda (Pol lambda) is a DNA repair polymerase, which likely plays a role in base excision repair (BER) and in non-homologous end joining (NHEJ) of DNA double-strand breaks (DSB). Principal Findings: Here, we described a novel natural allelic variant of human Pol lambda (hPol lambda) characterized by a single nucleotide polymorphism (SNP), C/T variation in the first base of codon 438, resulting in the amino acid change Arg to Trp. In vitro enzyme activity assays of the purified W438 Pol lambda variant revealed that it retained both DNA polymerization and deoxyribose phosphate (dRP) lyase activities, but had reduced base substitution fidelity. Ectopic expression of the W438 hPol lambda variant in mammalian cells increases mutation frequency, affects the DSB repair NHEJ pathway, and generates chromosome aberrations. All these phenotypes are dependent upon the catalytic activity of the W438 hPol lambda. Conclusions: The expression of a cancer-related natural variant of one specialized DNA polymerase can be associated to generic instability at the cromosomal level, probably due a defective NHEJ. These results establish that chromosomal aberrations can result from mutations in specialized DNA repair polymerases.			Terrados, G (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jseb@ipbs.fr; lblanco@cbm.uam.es	Bergoglio, Valérie VB/P-1624-2014; Blanco, Luis/I-1848-2015; Kunkel, Thomas A./D-5088-2019; Hoffmann, Jean-Sebastien/O-9183-2014	Bergoglio, Valérie VB/0000-0003-2773-3178; Kunkel, Thomas A./0000-0002-9900-1788; Hoffmann, Jean-Sebastien/0000-0003-2222-354X; Capp, Jean-Pascal/0000-0002-6470-079X; Terrados/0000-0002-0513-3692; Kirchhoff, Tomas/0000-0002-9055-2364	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065070] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Bergoglio V, 2002, CANCER RES, V62, P3511; Bhattacharyya N, 1997, P NATL ACAD SCI USA, V94, P10324, DOI 10.1073/pnas.94.19.10324; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Canitrot Y, 1998, P NATL ACAD SCI USA, V95, P12586, DOI 10.1073/pnas.95.21.12586; Capp JP, 2006, NUCLEIC ACIDS RES, V34, P2998, DOI 10.1093/nar/gkl380; Dalal S, 2005, BIOCHEMISTRY-US, V44, P15664, DOI 10.1021/bi051179z; DOBASHI Y, 1995, HUM GENET, V95, P389; Fan W, 2004, BIOCHEM BIOPH RES CO, V323, P1328, DOI 10.1016/j.bbrc.2004.09.002; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Garcia-Diaz M, 2001, J BIOL CHEM, V276, P34659, DOI 10.1074/jbc.M106336200; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Kirchhoff T, 1999, NEOPLASMA, V46, P290; Kosa JL, 1999, J BIOL CHEM, V274, P35866, DOI 10.1074/jbc.274.50.35866; Kunkel TA, 2003, CANCER CELL, V3, P105, DOI 10.1016/S1535-6108(03)00027-8; Lang TM, 2004, P NATL ACAD SCI USA, V101, P6074, DOI 10.1073/pnas.0308571101; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Miyamoto H, 1999, INT J CANCER, V83, P708, DOI 10.1002/(SICI)1097-0215(19991126)83:5<708::AID-IJC24>3.0.CO;2-C; Nagasawa K, 2000, J BIOL CHEM, V275, P31233, DOI 10.1074/jbc.M004263200; Opresko PL, 1998, BIOCHEMISTRY-US, V37, P2111, DOI 10.1021/bi9722711; Osheroff WP, 1999, J BIOL CHEM, V274, P20749, DOI 10.1074/jbc.274.30.20749; Osheroff WP, 1999, J BIOL CHEM, V274, P3642, DOI 10.1074/jbc.274.6.3642; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Picher AJ, 2007, DNA REPAIR, V6, P1749, DOI 10.1016/j.dnarep.2007.06.007; Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200; Shah AM, 2001, BIOCHEMISTRY-US, V40, P11372, DOI 10.1021/bi010755y; Shcherbakova Polina V, 2003, Sci Aging Knowledge Environ, V2003, pRE3, DOI 10.1126/sageke.2003.8.re3; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Tomka M, 1998, NEOPLASMA, V45, P345; WANG LM, 1992, CANCER RES, V52, P4824	49	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7290	10.1371/journal.pone.0007290	http://dx.doi.org/10.1371/journal.pone.0007290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806195	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593800007
J	Abe, M; Setoguchi, Y; Tanaka, T; Awano, W; Takahashi, K; Ueda, R; Nakamura, A; Goto, S				Abe, Masato; Setoguchi, Yuka; Tanaka, Tsubasa; Awano, Wakae; Takahashi, Kuniaki; Ueda, Ryu; Nakamura, Akira; Goto, Satoshi			Membrane Protein Location-Dependent Regulation by PI3K (III) and Rabenosyn-5 in Drosophila Wing Cells	PLOS ONE			English	Article								The class III phosphatidylinositol-3 kinase (PI3K (III)) regulates intracellular vesicular transport at multiple steps through the production of phosphatidylinositol-3-phosphate (PI(3)P). While the localization of proteins at distinct membrane domains are likely regulated in different ways, the roles of PI3K (III) and its effectors have not been extensively investigated in a polarized cell during tissue development. In this study, we examined in vivo functions of PI3K (III) and its effector candidate Rabenosyn-5 (Rbsn-5) in Drosophila wing primordial cells, which are polarized along the apical-basal axis. Knockdown of the PI3K (III) subunit Vps15 resulted in an accumulation of the apical junctional proteins DE-cadherin and Flamingo and also the basal membrane protein beta-integrin in intracellular vesicles. By contrast, knockdown of PI3K (III) increased lateral membrane-localized Fasciclin III (Fas III). Importantly, loss-of-function mutation of Rbsn-5 recapitulated the aberrant localization phenotypes of beta-integrin and Fas III, but not those of DE-cadherin and Flamingo. These results suggest that PI3K (III) differentially regulates localization of proteins at distinct membrane domains and that Rbsn-5 mediates only a part of the PI3K (III)-dependent processes.			Abe, M (corresponding author), Takeda Pharmaceut Co Ltd, Biol Prod Dept, Yamaguchi, Japan.	sgoto@mitils.jp	Nakamura, Akira/V-6869-2019	Nakamura, Akira/0000-0001-6506-9146				APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; BOMSEL M, 1989, J CELL BIOL, V109, P3243, DOI 10.1083/jcb.109.6.3243; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown PS, 2000, TRAFFIC, V1, P124, DOI 10.1034/j.1600-0854.2000.010205.x; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Ellson CD, 2002, J CELL SCI, V115, P1099; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; JONES AT, 1995, BIOCHEM J, V311, P31, DOI 10.1042/bj3110031; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; MORRISON HA, 2008, MOL BIOL CELL; Muller HAJ, 2000, DEV DYNAM, V218, P52; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; PARTON RG, 1989, J CELL BIOL, V109, P3259, DOI 10.1083/jcb.109.6.3259; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Reaves BJ, 1996, J CELL SCI, V109, P749; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Roggo L, 2002, EMBO J, V21, P1673, DOI 10.1093/emboj/21.7.1673; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tuma PL, 2001, J CELL BIOL, V154, P1197, DOI 10.1083/jcb.200105138; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	48	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7306	10.1371/journal.pone.0007306	http://dx.doi.org/10.1371/journal.pone.0007306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798413	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593300011
J	Bohland, JW; Bokil, H; Allen, CB; Mitra, PP				Bohland, Jason W.; Bokil, Hemant; Allen, Cara B.; Mitra, Partha P.			The Brain Atlas Concordance Problem: Quantitative Comparison of Anatomical Parcellations	PLOS ONE			English	Article							FUNCTIONAL IMAGING DATA; HUMAN CEREBRAL-CORTEX; HUMAN NEOCORTEX; TEMPORAL-LOBE; TALAIRACH; MNI; COORDINATE; SEGMENTATION; LOCALIZATION; ONTOLOGY	Many neuroscientific reports reference discrete macro-anatomical regions of the brain which were delineated according to a brain atlas or parcellation protocol. Currently, however, no widely accepted standards exist for partitioning the cortex and subcortical structures, or for assigning labels to the resulting regions, and many procedures are being actively used. Previous attempts to reconcile neuroanatomical nomenclatures have been largely qualitative, focusing on the development of thesauri or simple semantic mappings between terms. Here we take a fundamentally different approach, discounting the names of regions and instead comparing their definitions as spatial entities in an effort to provide more precise quantitative mappings between anatomical entities as defined by different atlases. We develop an analytical framework for studying this brain atlas concordance problem, and apply these methods in a comparison of eight diverse labeling methods used by the neuroimaging community. These analyses result in conditional probabilities that enable mapping between regions across atlases, which also form the input to graph-based methods for extracting higher-order relationships between sets of regions and to procedures for assessing the global similarity between different parcellations of the same brain. At a global scale, the overall results demonstrate a considerable lack of concordance between available parcellation schemes, falling within chance levels for some atlas pairs. At a finer level, this study reveals spatial relationships between sets of defined regions that are not obviously apparent; these are of high potential interest to researchers faced with the challenge of comparing results that were based on these different anatomical models, particularly when coordinate-based data are not available. The complexity of the spatial overlap patterns revealed points to problems for attempts to reconcile anatomical parcellations and nomenclatures using strictly qualitative and/or categorical methods. Detailed results from this study are made available via an interactive web site at http://obart.info.			Bohland, JW (corresponding author), Boston Univ, Dept Hlth Sci, Sargent Coll, Boston, MA 02215 USA.	jbohland@bu.edu	Bohland, Jason/L-4807-2016	Bohland, Jason/0000-0002-6305-5848; Mitra, Partha/0000-0001-8818-6804	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084802] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH084802] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anthoney T. R, 1994, NEUROANATOMY NEUROLO; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bezgin G, 2008, NEURAL NETWORKS, V21, P1132, DOI 10.1016/j.neunet.2008.05.010; Bezgin G, 2009, NEUROINFORMATICS, V7, P7, DOI 10.1007/s12021-008-9039-5; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Bowden DM, 2003, NEUROINFORMATICS, V1, P43, DOI 10.1385/NI:1:1:043; BOWDEN DM, 1995, NEUROIMAGE, V2, P63, DOI 10.1006/nimg.1995.1009; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Brodmann, 1909, VERGLEICHENDE LOKALI; Burns Gully A P C, 2006, J Biomed Discov Collab, V1, P10, DOI 10.1186/1747-5333-1-10; Carmack PS, 2004, NEUROIMAGE, V22, P367, DOI 10.1016/j.neuroimage.2004.01.022; Caviness VS, 1996, J COGNITIVE NEUROSCI, V8, P566, DOI 10.1162/jocn.1996.8.6.566; Chau W, 2005, NEUROIMAGE, V25, P408, DOI 10.1016/j.neuroimage.2004.12.007; Chung F., 1997, SPECTRAL GRAPH THEOR; Crespo-Facorro B, 1999, NEUROIMAGE, V10, P500, DOI 10.1006/nimg.1999.0489; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; FIEDLER M, 1973, CZECH MATH J, V23, P298; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jaccard P., 1901, B SOCIT VAUDOISE SCI, V37, P547, DOI DOI 10.5169/SEALS-266450; Kennedy DN, 1998, CEREB CORTEX, V8, P372, DOI 10.1093/cercor/8.4.372; Kim JJ, 2000, NEUROIMAGE, V11, P271, DOI 10.1006/nimg.2000.0543; Klein A, 2005, NEUROIMAGE, V24, P261, DOI 10.1016/j.neuroimage.2004.09.016; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Muller HM, 2008, NEUROINFORMATICS, V6, P195, DOI 10.1007/s12021-008-9031-0; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; Nielsen FA, 2002, HUM BRAIN MAPP, V15, P146, DOI 10.1002/hbm.10012; Nieto-Castanon A, 2003, NEUROIMAGE, V19, P1303, DOI 10.1016/S1053-8119(03)00188-5; PAPADIMITRIOU CH, 1976, COMPUTING, V16, P263, DOI 10.1007/BF02280884; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pohl KM, 2007, IEEE T MED IMAGING, V26, P1201, DOI 10.1109/TMI.2007.901433; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Rubin DL, 2006, OMICS, V10, P185, DOI 10.1089/omi.2006.10.185; Salton G., 1989, AUTOMATIC TEXT PROCE, VVolume 169; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Stephan KE, 2000, PHILOS T R SOC B, V355, P37, DOI 10.1098/rstb.2000.0548; Swanson L. W., 2003, BRAIN MAPS STRUCTURE; Talairach J., 1988, COPLANAR STEREOTAXIC; Tourville J. A., 2003, CASCNS03022 BOST U; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Essen DC, 2005, DATABASING BRAIN DAT, P369; Whitmore I., 1998, TERMINOLOGIA ANATOMI; Wilder BG, 1896, J COMP NEUROL, V6, P216, DOI DOI 10.1002/CNE.910060306	57	102	102	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7200	10.1371/journal.pone.0007200	http://dx.doi.org/10.1371/journal.pone.0007200			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	500HR	19787067	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000270290100013
J	Ormond, J; Woodin, MA				Ormond, Jake; Woodin, Melanie A.			Disinhibition Mediates a Form of Hippocampal Long-Term Potentiation in Area CA1	PLOS ONE			English	Article								The hippocampus plays a central role in memory formation in the mammalian brain. Its ability to encode information is thought to depend on the plasticity of synaptic connections between neurons. In the pyramidal neurons constituting the primary hippocampal output to the cortex, located in area CA1, firing of presynaptic CA3 pyramidal neurons produces monosynaptic excitatory postsynaptic potentials (EPSPs) followed rapidly by feedforward (disynaptic) inhibitory postsynaptic potentials (IPSPs). Long-term potentiation (LTP) of the monosynaptic glutamatergic inputs has become the leading model of synaptic plasticity, in part due to its dependence on NMDA receptors (NMDARs), required for spatial and temporal learning in intact animals. Using whole-cell recording in hippocampal slices fromadult rats, we find that the efficacy of synaptic transmission from CA3 to CA1 can be enhanced without the induction of classic LTP at the glutamatergic inputs. Taking care not to directly stimulate inhibitory fibers, we show that the induction of GABAergic plasticity at feedforward inhibitory inputs results in the reduced shunting of excitatory currents, producing a long-term increase in the amplitude of Schaffer collateral-mediated postsynaptic potentials. Like classic LTP, disinhibition-mediated LTP requires NMDAR activation, suggesting a role in types of learning and memory attributed primarily to the former and raising the possibility of a previously unrecognized target for therapeutic intervention in disorders linked to memory deficits, as well as a potentially overlooked site of LTP expression in other areas of the brain.			Ormond, J (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	jake.ormond@utoronto.ca; m.woodin@utoronto.ca	Woodin, Melanie A/A-2761-2008	Woodin, Melanie A/0000-0003-2984-8630				ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; ASZTELY F, 1994, HIPPOCAMPUS, V4, P148, DOI 10.1002/hipo.450040205; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Christie BR, 1996, LEARN MEMORY, V3, P160, DOI 10.1101/lm.3.2-3.160; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gusev PA, 2001, J NEUROPHYSIOL, V86, P881, DOI 10.1152/jn.2001.86.2.881; Hardie J, 2009, J NEUROSCI, V29, P3233, DOI 10.1523/JNEUROSCI.6000-08.2009; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HESS G, 1990, NEUROSCIENCE, V37, P61, DOI 10.1016/0306-4522(90)90192-7; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Janssen WGM, 2005, EXP NEUROL, V191, pS28, DOI 10.1016/j.expneurol.2004.08.020; Karnup S, 1999, J PHYSIOL-LONDON, V516, P485, DOI 10.1111/j.1469-7793.1999.0485v.x; Kitamura A, 2008, NEUROSCI RES, V62, P270, DOI 10.1016/j.neures.2008.09.002; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; Marder CP, 2004, J NEUROSCI, V24, P8873, DOI 10.1523/JNEUROSCI.2661-04.2004; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Meredith RM, 2003, J NEUROSCI, V23, P11142, DOI 10.1523/jneurosci.23-35-11142.2003; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; ORMOND J, 2006, SOC NEUR ANN M; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; SAYER RJ, 1990, J NEUROSCI, V10, P826; Staff NP, 2003, HIPPOCAMPUS, V13, P801, DOI 10.1002/hipo.10129; STELZER A, 1994, P NATL ACAD SCI USA, V91, P3058, DOI 10.1073/pnas.91.8.3058; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	46	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7224	10.1371/journal.pone.0007224	http://dx.doi.org/10.1371/journal.pone.0007224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787049	Green Published, Green Submitted, gold			2022-12-25	WOS:000270290100021
J	Rosenblum, M; Deeks, SG; van der Laan, M; Bangsberg, DR				Rosenblum, Michael; Deeks, Steven G.; van der Laan, Mark; Bangsberg, David R.			The Risk of Virologic Failure Decreases with Duration of HIV Suppression, at Greater than 50% Adherence to Antiretroviral Therapy	PLOS ONE			English	Article							VIRAL SUPPRESSION; INDUCTION THERAPY; INHIBITOR THERAPY; DRUG-RESISTANCE; PLUS EFAVIRENZ; INFECTION; PROTEASE; CD4(+); MAINTENANCE; HOMELESS	Background: We hypothesized that the percent adherence to antiretroviral therapy necessary to maintain HIV suppression would decrease with longer duration of viral suppression. Methodology: Eligible participants were identified from the REACH cohort of marginally housed HIV infected adults in San Francisco. Adherence to antiretroviral therapy was measured through pill counts obtained at unannounced visits by research staff to each participant's usual place of residence. Marginal structural models and targeted maximum likelihood estimation methodologies were used to determine the effect of adherence to antiretroviral therapy on the probability of virologic failure during early and late viral suppression. Principal Findings: A total of 221 subjects were studied (median age 44.1 years; median CD4+ T cell nadir 206 cells/mm(3)). Most subjects were taking the following types of antiretroviral regimens: non-nucleoside reverse transcriptase inhibitor based (37%), ritonavir boosted protease inhibitor based (28%), or unboosted protease inhibitor based (25%). Comparing the probability of failure just after achieving suppression vs. after 12 consecutive months of suppression, there was a statistically significant decrease in the probability of virologic failure for each range of adherence proportions we considered, as long as adherence was greater than 50%. The estimated risk difference, comparing the probability of virologic failure after 1 month vs. after 12 months of continuous viral suppression was 0.47 (95% CI 0.23-0.63) at 50-74% adherence, 0.29 (CI 0.03-0.50) at 75-89% adherence, and 0.36 (CI 0.23-0.48) at 90-100% adherence. Conclusions: The risk of virologic failure for adherence greater than 50% declines with longer duration of continuous suppression. While high adherence is required to maximize the probability of durable viral suppression, the range of adherence capable of sustaining viral suppression is wider after prolonged periods of viral suppression.			Rosenblum, M (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	david_bangsberg@harvard.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105, R01MH054907] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR023566-01] Funding Source: Medline; NIMH NIH HHS [T32 MH019105, 5 T32 MH-19105-19, R01 MH054907] Funding Source: Medline; PHS HHS [NIAAA 015287, A1074345-01, R01A1074345-01, 54907] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bangsberg DR., 2001, AIDS BEHAV, V5, P275, DOI DOI 10.1023/A:1011396711486; Cameron DW, 2008, J INFECT DIS, V198, P234, DOI 10.1086/589622; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Delfraissy JFO, 2008, AIDS, V22, P385, DOI 10.1097/QAD.0b013e3282f3f16d; Efron B., 1994, INTRO BOOTSTRAP; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Lempicki RA, 2000, P NATL ACAD SCI USA, V97, P13778, DOI 10.1073/pnas.250472097; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Mallolas J, 2008, AIDS, V22, P377, DOI 10.1097/QAD.0b013e3282f3db2c; Markowitz M, 2005, JAIDS-J ACQ IMM DEF, V39, P257, DOI 10.1097/01.qai.0000169664.15536.20; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Moss AR, 2004, CLIN INFECT DIS, V39, P1190, DOI 10.1086/424008; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; NEUGEBAUER R, 2002, UC BERKELEY DIVISION; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Petersen ML, 2007, CLIN INFECT DIS, V45, P908, DOI 10.1086/521250; Petersen ML, 2006, JAIDS-J ACQ IMM DEF, V43, pS96, DOI 10.1097/01.qai.0000248344.95135.8d; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; Robertson MJ, 2004, AM J PUBLIC HEALTH, V94, P1207, DOI 10.2105/AJPH.94.7.1207; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Robins JM, 2001, STAT SINICA, V11, P920; ROBINS JM, 1987, J CHRONIC DIS S2, V40; ROBINS JM, 2000, P AM STAT ASS SECTIO, V69; Robins JM, 1998, 1997 P AM STAT ASS S, P1, DOI DOI 10.1097/EDE.0B013E318245847E; Shuter J, 2008, J ANTIMICROB CHEMOTH, V61, P769, DOI 10.1093/jac/dkn020; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; van der Laan M.J., 2003, UNIFIED METHODS CENS, V5, DOI 10.1007/978-0-387-21700-0; van der Laan MJ, 2006, INT J BIOSTAT, V2, P11, DOI [10.2202/1557-4679.1043, DOI 10.2202/1557-4679.1043]; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; ZOLOPA AR, 1994, JAMA-J AM MED ASSOC, V272, P455, DOI 10.1001/jama.272.6.455	41	92	92	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7196	10.1371/journal.pone.0007196	http://dx.doi.org/10.1371/journal.pone.0007196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787058	Green Published, Green Submitted, gold			2022-12-25	WOS:000270290100011
J	Chen, Q; Pinon, DI; Miller, LJ; Dong, MQ				Chen, Quan; Pinon, Delia I.; Miller, Laurence J.; Dong, Maoqing			Molecular Basis of Glucagon-like Peptide 1 Docking to Its Intact Receptor Studied with Carboxyl-terminal Photolabile Probes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; PHOTOAFFINITY CROSS-LINKING; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; AMINO-TERMINUS; PARATHYROID-HORMONE; SECRETIN RECEPTOR; SPATIAL APPROXIMATION; CALCITONIN RECEPTOR; GLP-1 RECEPTOR	The glucagon-like peptide 1 (GLP1) receptor is a member of Family B G protein-coupled receptors and represents an important drug target for type 2 diabetes. Despite recent solution of the structure of the amino-terminal domain of this receptor and that of several close family members, understanding of the molecular basis of natural ligand GLP1 binding to its intact receptor remains limited. The goal of this study was to explore spatial approximations between specific receptor residues within the carboxyl terminus of GLP1 and its receptor as normally docked. Therefore, we developed and characterized two high affinity, full-agonist photolabile GLP1 probes having sites for covalent attachment in positions 24 and 35. Both probes labeled the receptor specifically and saturably. Subsequent peptide mapping using chemical and proteinase cleavages of purified wild-type and mutant GLP1 receptor identified that the Arg(131)-Lys(136) segment at the juxtamembrane region of the receptor amino terminus contained the site of labeling for the position 24 probe, and the specific receptor residue labeled by this probe was identified as Glu(133) by radiochemical sequencing. Similarly, nearby residue Glu(125) within the same region of the receptor amino-terminal domain was identified as the site of labeling by the position 35 probe. These data represent the first direct demonstration of spatial approximation between GLP1 and its intact receptor as docked, providing two important constraints for the modeling of this interaction. This should expand our understanding of the molecular basis of natural agonist ligand binding to the GLP1 receptor and may be relevant to other family members.	[Chen, Quan; Pinon, Delia I.; Miller, Laurence J.; Dong, Maoqing] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Dong, MQ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	dongmq@mayo.edu			National Institutes of Health [DK46577]; American Diabetes Association [1-08-RA-42]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577. This work was also supported by American Diabetes Association Grant 1-08-RA-42.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Andersen NH, 2002, BIOORGAN MED CHEM, V10, P79, DOI 10.1016/S0968-0896(01)00263-2; Behar V, 2000, J BIOL CHEM, V275, P9, DOI 10.1074/jbc.275.1.9; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; BUGGY JJ, 1995, J BIOL CHEM, V270, P7474, DOI 10.1074/jbc.270.13.7474; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; Ceraudo E, 2008, MOL ENDOCRINOL, V22, P147, DOI 10.1210/me.2007-0361; Ceraudo E, 2008, J MOL NEUROSCI, V36, P245, DOI 10.1007/s12031-008-9073-7; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2008, MOL ENDOCRINOL, V22, P1489, DOI 10.1210/me.2008-0025; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; Gallwitz B, 1996, REGUL PEPTIDES, V63, P17, DOI 10.1016/0167-0115(96)00019-5; Gelling RW, 1997, ENDOCRINOLOGY, V138, P2640, DOI 10.1210/en.138.6.2640; Gensure RC, 2001, J BIOL CHEM, V276, P42692, DOI 10.1074/jbc.M106215200; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Mann R, 2007, BIOCHEM SOC T, V35, P713, DOI 10.1042/BST0350713; Mannstadt M, 1998, J BIOL CHEM, V273, P16890, DOI 10.1074/jbc.273.27.16890; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Parker JC, 1998, J PEPT RES, V52, P398; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Stroop SD, 1996, ENDOCRINOLOGY, V137, P4752, DOI 10.1210/en.137.11.4752; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; THORNTON K, 1994, BIOCHEMISTRY-US, V33, P3532, DOI 10.1021/bi00178a009; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993	55	33	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34135	34144		10.1074/jbc.M109.038109	http://dx.doi.org/10.1074/jbc.M109.038109			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815559	Green Published, hybrid			2022-12-25	WOS:000272165200046
J	Collar, CJ; Al-Salabi, MI; Stewart, ML; Barrett, MP; Wilson, WD; de Koning, HP				Collar, Catharine J.; Al-Salabi, Mohammed I.; Stewart, Mhairi L.; Barrett, Michael P.; Wilson, W. David; de Koning, Harry P.			Predictive Computational Models of Substrate Binding by a Nucleoside Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI-BRUCEI; AFRICAN TRYPANOSOMES; SACCHAROMYCES-CEREVISIAE; FERRIPROTOPORPHYRIN-IX; NUCLEOBASE TRANSPORTER; RECOGNITION MOTIFS; ADENOSINE TRANSPORTER; ALLOPURINOL UPTAKE; CRYSTAL-STRUCTURE; RESISTANCE	Transporters play a vital role in both the resistance mechanisms of existing drugs and effective targeting of their replacements. Melarsoprol and diamidine compounds similar to pentamidine and furamidine are primarily taken up by trypanosomes of the genus Trypanosoma brucei through the P2 aminopurine transporter. In standardized competition experiments with [H-3] adenosine, P2 transporter inhibition constants (K-i) have been determined for a diverse dataset of adenosine analogs, diamidines, Food and Drug Administration-approved compounds and analogs thereof, and custom-designed trypanocidal compounds. Computational biology has been employed to investigate compound structure diversity in relation to P2 transporter interaction. These explorations have led to models for inhibition predictions of known and novel compounds to obtain information about the molecular basis for P2 transporter inhibition. A common pharmacophore for P2 transporter inhibition has been identified along with other key structural characteristics. Our model provides insight into P2 transporter interactions with known compounds and contributes to strategies for the design of novel antiparasitic compounds. This approach offers a quantitative and predictive tool for molecular recognition by specific transporters without the need for structural or even primary sequence information of the transport protein.	[de Koning, Harry P.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow Biomed Res Ctr, Div Infect & Immun,Dept INfect & Immun, Glasgow G12 8TA, Lanark, Scotland; [Collar, Catharine J.; Wilson, W. David] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University of Glasgow; University System of Georgia; Georgia State University	de Koning, HP (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Glasgow Biomed Res Ctr, Div Infect & Immun,Dept INfect & Immun, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.			Barrett, Mike/0000-0001-9447-3519; De Koning, Harry/0000-0002-9963-1827	Bill and Melinda Gates Foundation; Consortium for Parasitic Drug Development; Georgia State University; David W. Boykin Graduate Fellowship in Medicinal Chemistry	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Consortium for Parasitic Drug Development; Georgia State University; David W. Boykin Graduate Fellowship in Medicinal Chemistry	This work was supported by the Bill and Melinda Gates Foundation through the Consortium for Parasitic Drug Development (to W. D. W., M. P. B., and H. d. K.), the Georgia State University Molecular Basis of Disease Fellowship, and the David W. Boykin Graduate Fellowship in Medicinal Chemistry (to C. J. C.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Al-Salabi MI, 2005, ANTIMICROB AGENTS CH, V49, P3682, DOI 10.1128/AAC.49.9.3682-3689.2005; Al-Salabi MI, 2003, MOL PHARMACOL, V63, P814, DOI 10.1124/mol.63.4.814; Al-Salabi MI, 2007, MOL PHARMACOL, V71, P921, DOI 10.1124/mol.106.031559; [Anonymous], 2008, SYBYL MOL MOD SOFTW; Baliani A, 2005, J MED CHEM, V48, P5570, DOI 10.1021/jm050177+; Barrett MP, 1999, PARASITOL TODAY, V15, P136, DOI 10.1016/S0169-4758(99)01414-3; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; Bray PG, 1999, J CELL BIOL, V145, P363, DOI 10.1083/jcb.145.2.363; CARTER NS, 1995, J BIOL CHEM, V270, P28153, DOI 10.1074/jbc.270.47.28153; CARTER NS, 1993, NATURE, V361, P173, DOI 10.1038/361173a0; Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009; Congreve M, 2005, DRUG DISCOV TODAY, V10, P895, DOI 10.1016/S1359-6446(05)03484-7; De Koning HP, 1999, MOL PHARMACOL, V56, P1162, DOI 10.1124/mol.56.6.1162; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; de Koning HP, 2004, ANTIMICROB AGENTS CH, V48, P1515, DOI 10.1128/AAC.48.5.1515-1519.2004; De Koning HP, 2003, INT J PARASITOL, V33, P821, DOI 10.1016/S0020-7519(03)00091-2; de Koning HP, 2001, INT J PARASITOL, V31, P512, DOI 10.1016/S0020-7519(01)00167-9; de Koning HP, 2001, MOL PHARMACOL, V59, P586; Fitch CD, 2004, LIFE SCI, V74, P1957, DOI 10.1016/j.lfs.2003.10.003; Geiser F, 2005, MOL PHARMACOL, V68, P589, DOI 10.1124/mol.104.010298; Kim SK, 2007, J CHEM INF MODEL, V47, P1225, DOI 10.1021/ci600501z; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Matovu E, 2003, EUKARYOT CELL, V2, P1003, DOI 10.1128/EC.2.5.1003-1008.2003; Matovu E, 2001, MOL BIOCHEM PARASIT, V117, P73, DOI 10.1016/S0166-6851(01)00332-2; Molina-Arcas M, 2008, NUCLEOS NUCLEOT NUCL, V27, P769, DOI 10.1080/15257770802145819; Muegge I., 2006, DRUG DISCOV TODAY-TE, V3, P405, DOI [10.1016/j.ddtec.2006.12.002, DOI 10.1016/j.ddtec.2006.12.002, DOI 10.1016/J.DDTEC.2006.12.002]; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Papageorgiou IG, 2005, PARASITOLOGY, V130, P275, DOI 10.1017/S0031182004006626; Scrutton NS, 1996, BIOCHEM J, V319, P1; Song CM, 2009, BRIEF BIOINFORM, V10, P579, DOI 10.1093/bib/bbp023; Stewart ML, 2005, ANTIMICROB AGENTS CH, V49, P5169, DOI 10.1128/AAC.49.12.5169-5171.2005; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Vickers MF, 2004, NUCLEOS NUCLEOT NUCL, V23, P361, DOI 10.1081/NCN-120028333; Wallace LJM, 2002, J BIOL CHEM, V277, P26149, DOI 10.1074/jbc.M202835200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang J, 2003, MOL PHARMACOL, V64, P1512, DOI 10.1124/mol.64.6.1512	40	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34028	34035		10.1074/jbc.M109.049726	http://dx.doi.org/10.1074/jbc.M109.049726			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808668	Green Published, hybrid			2022-12-25	WOS:000272165200035
J	Cai, ZY; Shi, ZC; Sanchez, A; Zhang, TT; Liu, MY; Yang, JH; Wang, F; Zhang, DK				Cai, Zhenyu; Shi, Zhongcheng; Sanchez, Amir; Zhang, Tingting; Liu, Mingyao; Yang, Jianghua; Wang, Fen; Zhang, Dekai			Transcriptional Regulation of Tlr11 Gene Expression in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; INNATE IMMUNITY; DENDRITIC CELLS; IFN-GAMMA; INFLAMMATION; ETS; ESE-1; LIPOPOLYSACCHARIDE; RECOGNITION	As sensors of invading microorganisms, Toll-like receptors (TLRs) are expressed not only on macrophages and dendritic cells (DCs) but also on epithelial cells. In the TLR family, Tlr11 appears to have the unique feature in that it is expressed primarily on epithelial cells, although it is also expressed on DCs and macrophages. Here, we demonstrate that transcription of the Tlr11 gene is regulated through two cis-acting elements, one Ets-binding site and one interferon regulatory factor (IRF)-binding site. The Ets element interacts with the epithelium-specific transcription factors, ESE-1 and ESE-3, and the IRF motif interacts with IRF-8. Thus, Tlr11 expression on epithelial cells is regulated by the transcription factors that are presumably distinct from transcription factors that regulate the expression of TLRs in innate immune cells such as macrophages and DCs. Our results imply that the distinctive transcription regulatory machinery for TLRs on epithelium may represent a promising new avenue for the development of epithelia-specific therapeutic interventions.	[Cai, Zhenyu; Shi, Zhongcheng; Sanchez, Amir; Zhang, Tingting; Zhang, Dekai] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Liu, Mingyao; Wang, Fen] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA; [Yang, Jianghua] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Zhang, DK (corresponding author), 2121 W Holcombe Blvd, Houston, TX 77030 USA.	dzhang@ibt.tamhsc.edu		Liu, Mingyao/0000-0001-7339-5048	National Institutes of Health [AI072263]; Texas A&M University Health Science Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Health Science Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI072263. This work was also supported by the Texas A&M University Health Science Center.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Clement CG, 2008, AM J RESP CRIT CARE, V177, P1322, DOI 10.1164/rccm.200607-1038OC; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; EVANS SE, 2009, AM J RESP C IN PRESS; Grall FT, 2005, FEBS J, V272, P1676, DOI 10.1111/j.1742-4658.2005.04592.x; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Guo Z, 2005, J IMMUNOL, V175, P7407, DOI 10.4049/jimmunol.175.11.7407; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Iwamura C, 2008, CURR ALLERGY ASTHM R, V8, P7, DOI 10.1007/s11882-008-0003-0; Johnson CM, 2007, J BIOL CHEM, V282, P31197, DOI 10.1074/jbc.M705151200; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; POLITIS AD, 1992, J IMMUNOL, V148, P801; Rehli M, 2002, TRENDS IMMUNOL, V23, P375, DOI 10.1016/S1471-4906(02)02259-7; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Schroder K, 2007, J LEUKOCYTE BIOL, V81, P1577, DOI 10.1189/jlb.0107036; Severa M, 2007, J IMMUNOL, V178, P6208, DOI 10.4049/jimmunol.178.10.6208; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Wang TY, 2001, J IMMUNOL, V167, P6924, DOI 10.4049/jimmunol.167.12.6924; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	39	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33088	33096		10.1074/jbc.M109.050757	http://dx.doi.org/10.1074/jbc.M109.050757			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801549	Green Published, hybrid			2022-12-25	WOS:000272028500012
J	Jonsson, TJ; Johnson, LC; Lowther, WT				Joensson, Thomas J.; Johnson, Lynnette C.; Lowther, W. Todd			Protein Engineering of the Quaternary Sulfiredoxin center dot Peroxiredoxin Enzyme center dot Substrate Complex Reveals the Molecular Basis for Cysteine Sulfinic Acid Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; THIOSULFINATE INTERMEDIATE; MAMMALIAN SULFIREDOXIN; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; REDUCTION; MECHANISM; DSBD	Oxidative stress can damage the active site cysteine of the antioxidant enzyme peroxiredoxin (Prx) to the sulfinic acid form, Prx-SO2-. This modification leads to inactivation. Sulfiredoxin (Srx) utilizes a unique ATP-Mg2+-dependent mechanism to repair the Prx molecule. Using selective protein engineering that involves disulfide bond formation and site-directed mutagenesis, a mimic of the enzyme.substrate complex has been trapped. Here, we present the 2.1 angstrom crystal structure of human Srx in complex with PrxI, ATP, and Mg2+. The Cys(52) sulfinic acid moiety was substituted by mutating this residue to Asp, leading to a replacement of the sulfur atom with a carbon atom. Because the Srx reaction cannot occur, the structural changes in the Prx active site that lead to the attack on ATP may be visualized. The local unfolding of the helix containing C52D resulted in the packing of Phe(50) in PrxI within a hydrophobic pocket of Srx. Importantly, this structural rearrangement positioned one of the oxygen atoms of Asp(52) within 4.3 angstrom of the gamma-phosphate of ATP bound to Srx. These observations support a mechanism where phosphorylation of Prx-SO2- is the first chemical step.	[Lowther, W. Todd] Wake Forest Univ, Sch Med, Struct Biol Ctr, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	Lowther, WT (corresponding author), Wake Forest Univ, Sch Med, Struct Biol Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu			National Institutes of Health [R01GM072866]; American Heart Association Postdoctoral Fellowship [0725399U]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM072866 ( to W. T. L.). This work was also supported by American Heart Association Postdoctoral Fellowship 0725399U ( to T. J. J.).	Banatao DR, 2006, P NATL ACAD SCI USA, V103, P16230, DOI 10.1073/pnas.0607674103; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Corn JE, 2007, STRUCTURE, V15, P773, DOI 10.1016/j.str.2007.05.006; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Joensson Thomas J., 2007, V44, P115; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; Karplus P. Andrew, 2007, V44, P41; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; MATSUMURA M, 1991, METHOD ENZYMOL, V202, P336; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Purich DL, 2002, METHOD ENZYMOL, V354, P1; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	35	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33305	33310		10.1074/jbc.M109.036400	http://dx.doi.org/10.1074/jbc.M109.036400			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19812042	Green Published, hybrid			2022-12-25	WOS:000272028500035
J	Muradov, H; Boyd, KK; Haeri, M; Kerov, V; Knox, BE; Artemyev, NO				Muradov, Hakim; Boyd, Kimberly K.; Haeri, Mohammad; Kerov, Vasily; Knox, Barry E.; Artemyev, Nikolai O.			Characterization of Human Cone Phosphodiesterase-6 Ectopically Expressed in Xenopus laevis Rods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR CGMP PHOSPHODIESTERASE; CYCLIC-GMP PHOSPHODIESTERASE; LEBER CONGENITAL AMAUROSIS; ACID-RICH PROTEINS; LATERAL DIFFUSION; FUSION PROTEIN; GATED CHANNEL; BETA-SUBUNIT; RHODOPSIN; PHOTOTRANSDUCTION	PDE6 (phosphodiesterase-6) is the effector molecule in the vertebrate phototransduction cascade. Progress in understanding the structure and function of PDE6 has been hindered by lack of an expression system of the enzyme. Here we report ectopic expression and analysis of compartmentalization and membrane dynamics of the enhanced green fluorescent protein (EGFP) fusion protein of human cone PDE6C in rods of transgenic Xenopus laevis. EGFP-PDE6C is correctly targeted to the rod outer segments in transgenic Xenopus, where it displayed a characteristic striated pattern of EGFP fluorescence. Immunofluorescence labeling indicated significant and light-independent co-localization of EGFP-PDE6C with the disc rim marker peripherin-2 and endogenous frog PDE6. The diffusion of EGFP-PDE6C on disc membranes investigated with fluorescence recovery after photobleaching was markedly slower than theoretically predicted. The enzymatic characteristics of immunoprecipitated recombinant PDE6C were similar to known properties of the native bovine PDE6C. PDE6C was potently inhibited by the cone- and rod-specific PDE6 gamma-subunits. Thus, transgenic Xenopus laevis is a unique expression system for PDE6 well suited for analysis of the mechanisms of visual diseases linked to PDE6 mutations.	Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Haeri, Mohammad; Knox, Barry E.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Knox, Barry E.] SUNY Upstate Med Univ, Dept Ophthalmol, Syracuse, NY 13210 USA	University of Iowa; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center		nikolai-artemyev@uiowa.edu		Artemyev, Nikolai/0000-0002-5266-6854	National Institutes of Health [EY-10843]; NATIONAL EYE INSTITUTE [R01EY010843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-10843 (to N. O. A.).	ANANT JS, 1992, J BIOL CHEM, V267, P687; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; CHANG B, 2009, P NATL ACAD IN PRESS; Chen J, 2008, MOL VIS, V14, P2509; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cook TA, 2000, BIOCHEMISTRY-US, V39, P13516, DOI 10.1021/bi001070l; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GILLESPIE PG, 1989, J BIOL CHEM, V264, P12187; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Granovsky AE, 1998, J BIOL CHEM, V273, P24485, DOI 10.1074/jbc.273.38.24485; Granovsky AE, 2001, J BIOL CHEM, V276, P21698, DOI 10.1074/jbc.M100626200; Granovsky AE, 2000, J BIOL CHEM, V275, P41258, DOI 10.1074/jbc.M008094200; HAMILTON SE, 1993, FEBS LETT, V318, P157, DOI 10.1016/0014-5793(93)80012-J; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; Jin S, 2003, FEBS LETT, V542, P142, DOI 10.1016/S0014-5793(03)00368-5; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; Loewen CJR, 2003, MOL BIOL CELL, V14, P3400, DOI 10.1091/mbc.e03-02-0077; Mani SS, 2001, J BIOL CHEM, V276, P36557, DOI 10.1074/jbc.M101685200; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov H, 2007, BIOCHEMISTRY-US, V46, P9992, DOI 10.1021/bi700535s; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Pentia DC, 2006, J BIOL CHEM, V281, P5500, DOI 10.1074/jbc.M507488200; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Wang Q, 2008, J BIOL CHEM, V283, P30015, DOI 10.1074/jbc.M803953200; WEY CL, 1981, BIOPHYS J, V33, P225, DOI 10.1016/S0006-3495(81)84883-7; White JB, 2004, MOL VIS, V10, P738; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612	41	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32662	32669		10.1074/jbc.M109.049916	http://dx.doi.org/10.1074/jbc.M109.049916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801642	Green Published, hybrid			2022-12-25	WOS:000272028400049
J	Shulla, A; Gallagher, T				Shulla, Ana; Gallagher, Tom			Role of Spike Protein Endodomains in Regulating Coronavirus Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE RESPIRATORY SYNDROME; INFLUENZA-VIRUS HEMAGGLUTININ; MOUSE HEPATITIS-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; MEDIATED MEMBRANE-FUSION; CYSTEINE-RICH DOMAIN; MURINE CORONAVIRUS; CELL-FUSION; CYTOPLASMIC TAIL; PORE FORMATION	Enveloped viruses enter cells by viral glycoprotein-mediated binding to host cells and subsequent fusion of virus and host cell membranes. For the coronaviruses, viral spike (S) proteins execute these cell entry functions. The S proteins are set apart from other viral and cellular membrane fusion proteins by their extensively palmitoylated membrane-associated tails. Palmitate adducts are generally required for protein-mediated fusions, but their precise roles in the process are unclear. To obtain additional insights into the S-mediated membrane fusion process, we focused on these acylated carboxyl-terminal intravirion tails. Substituting alanines for the cysteines that are subject to palmitoylation had effects on both S incorporation into virions and S-mediated membrane fusions. In specifically dissecting the effects of endodomain mutations on the fusion process, we used antiviral heptad repeat peptides that bind only to folding intermediates in the S-mediated fusion process and found that mutants lacking three palmitoylated cysteines remained in transitional folding states nearly 10 times longer than native S proteins. This slower refolding was also reflected in the paucity of postfusion six-helix bundle configurations among the mutant S proteins. Viruses with fewer palmitoylated S protein cysteines entered cells slowly and had reduced specific infectivities. These findings indicate that lipid adducts anchoring S proteins into virus membranes are necessary for the rapid, productive S protein refolding events that culminate in membrane fusions. These studies reveal a previously unappreciated role for covalently attached lipids on the endodomains of viral proteins eliciting membrane fusion reactions.	[Shulla, Ana; Gallagher, Tom] Loyola Univ, Dept Microbiol & Immunol, Med Ctr, Maywood, IL 60153 USA	Loyola University Chicago	Gallagher, T (corresponding author), Loyola Univ, Dept Microbiol & Immunol, Med Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA.	tgallag@lumc.edu			National Institutes of Health [R01 AI60030]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI60030.	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Aoki Y, 1998, VIROLOGY, V250, P140, DOI 10.1006/viro.1998.9361; Bissonnette MLZ, 2009, J MOL BIOL, V386, P14, DOI 10.1016/j.jmb.2008.12.029; Bos ECW, 1995, VIROLOGY, V214, P453, DOI 10.1006/viro.1995.0056; Boscarino JA, 2008, J VIROL, V82, P2989, DOI 10.1128/JVI.01906-07; Bosch BJ, 2005, VIROLOGY, V334, P306, DOI 10.1016/j.virol.2005.02.001; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Broer R, 2006, J VIROL, V80, P1302, DOI 10.1128/JVI.80.3.1302-1310.2006; Cathomen T, 1998, J VIROL, V72, P1224, DOI 10.1128/JVI.72.2.1224-1234.1998; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chang KW, 2001, ADV EXP MED BIOL, V494, P205; Chang KW, 2000, VIROLOGY, V269, P212, DOI 10.1006/viro.2000.0219; Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; de Haan CAM, 2003, J VIROL, V77, P11312, DOI 10.1128/JVI.77.21.11312-11323.2003; de Haan CAM, 1999, J VIROL, V73, P7441, DOI 10.1128/JVI.73.9.7441-7452.1999; DEGROOT RJ, 1987, J MOL BIOL, V196, P963, DOI 10.1016/0022-2836(87)90422-0; DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990; FLEMING JO, 1983, VIROLOGY, V131, P296, DOI 10.1016/0042-6822(83)90498-1; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallagher TM, 1997, J VIROL, V71, P3129, DOI 10.1128/JVI.71.4.3129-3137.1997; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN N, 1981, P NATL ACAD SCI-BIOL, V78, P6023, DOI 10.1073/pnas.78.10.6023; GROSSE B, 1994, VIROLOGY, V202, P814, DOI 10.1006/viro.1994.1403; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HELSETH E, 1990, J VIROL, V64, P6314, DOI 10.1128/JVI.64.12.6314-6318.1990; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55; Krueger DK, 2001, J VIROL, V75, P2792, DOI 10.1128/JVI.75.6.2792-2802.2001; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Langosch D, 2007, CELL MOL LIFE SCI, V64, P850, DOI 10.1007/s00018-007-6439-x; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Masters PS, 2006, ADV EXP MED BIOL, V581, P163; Masters PS, 2005, CURR TOP MICROBIOL, V287, P133, DOI 10.1007/3-540-26765-4_5; Matsuyama S, 2002, J VIROL, V76, P11819, DOI 10.1128/JVI.76.23.11819-11826.2002; McReynolds S, 2008, BIOCHEMISTRY-US, V47, P6802, DOI 10.1021/bi800622t; McShane Marisa P, 2005, Methods Mol Biol, V292, P187; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 1999, MOL BIOL CELL, V10, P1821, DOI 10.1091/mbc.10.6.1821; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339; PEDERSEN NC, 1981, AM J VET RES, V42, P368; Petit CM, 2007, VIROLOGY, V360, P264, DOI 10.1016/j.virol.2006.10.034; Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06; Rao PV, 1998, J VIROL, V72, P3278, DOI 10.1128/JVI.72.4.3278-3288.1998; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Sakai T, 2002, J VIROL, V76, P4603, DOI 10.1128/JVI.76.9.4603-4611.2002; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STURMAN LS, 1972, INFECT IMMUN, V6, P501, DOI 10.1128/IAI.6.4.501-507.1972; Supekar VM, 2004, P NATL ACAD SCI USA, V101, P17958, DOI 10.1073/pnas.0406128102; Thorp EB, 2006, J VIROL, V80, P1280, DOI 10.1128/JVI.80.3.1280-1289.2006; TOOZE J, 1984, EUR J CELL BIOL, V33, P281; Tripet B, 2004, J BIOL CHEM, V279, P20836, DOI 10.1074/jbc.M400759200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VEIT M, 1991, J VIROL, V65, P2491, DOI 10.1128/JVI.65.5.2491-2500.1991; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Xu YH, 2004, J BIOL CHEM, V279, P30514, DOI 10.1074/jbc.M403760200; Yan Z, 2006, J STRUCT BIOL, V155, P162, DOI 10.1016/j.jsb.2006.03.024; Yang CL, 1996, J VIROL, V70, P248, DOI 10.1128/JVI.70.1.248-254.1996; YANG CL, 1995, P NATL ACAD SCI USA, V92, P9871, DOI 10.1073/pnas.92.21.9871; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354; Ye R, 2004, J VIROL, V78, P9904, DOI 10.1128/JVI.78.18.9904-9917.2004; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zelus BD, 2003, J VIROL, V77, P830, DOI 10.1128/JVI.77.2.830-840.2003; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	82	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32725	32734		10.1074/jbc.M109.043547	http://dx.doi.org/10.1074/jbc.M109.043547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801669	Green Published, hybrid			2022-12-25	WOS:000272028400057
J	Feng, HZ; Wei, B; Jin, JP				Feng, Han-Zhong; Wei, Bin; Jin, Jian-Ping			Deletion of a Genomic Segment Containing the Cardiac Troponin I Gene Knocks Down Expression of the Slow Troponin T Gene and Impairs Fatigue Tolerance of Diaphragm Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLU(180) NONSENSE MUTATION; N-TERMINAL TRUNCATION; SKELETAL-MUSCLE; NEMALINE MYOPATHY; FUNCTIONAL ADAPTATION; PROTEIN ISOFORMS; CONTRACTILITY; EVOLUTION; DISEASE; FIBERS	The loss of slow skeletal muscle troponin T (TnT) results in a recessive nemaline myopathy in the Amish featured with lethal respiratory failure. The genes encoding slow TnT and cardiac troponin I (TnI) are closely linked. Ex vivo promoter analysis suggested that the 5'-enhancer region of the slow TnT gene overlaps with the structure of the upstream cardiac TnI gene. Using transgenic expression of exogenous cardiac TnI to rescue the postnatal lethality of a mouse line in which the entire cardiac TnI gene was deleted, we investigated the effect of enhancer deletion on slow TnT gene expression in vivo and functional consequences. The levels of slow TnT mRNA and protein were significantly reduced in the diaphragm muscle of adult double transgenic mice. The slow TnT-deficient (ssTnT-KD) diaphragm muscle exhibited atrophy and decreased ratios of slow versus fast isoforms of TnT, TnI, and myosin. Consistent with the changes toward more fast myofilament contents, ssTnT-KD diaphragm muscle required stimulation at higher frequency for optimal tetanic force production. The ssTnT-KD diaphragm muscle also exhibited significantly reduced fatigue tolerance, showing faster and more declines of force with slower and less recovery from fatigue as compared with the wild type controls. The natural switch to more slow fiber contents during aging was partially blunted in the ssTnT-KD skeletal muscle. The data demonstrated a critical role of slow TnT in diaphragm function and in the pathogenesis and pathophysiology of Amish nemaline myopathy.	[Feng, Han-Zhong; Wei, Bin; Jin, Jian-Ping] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA	Wayne State University	Jin, JP (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.	jjin@med.wayne.edu	Jin, Jian-Ping/AAD-1149-2020; Wei, Bin/M-2017-2014	Jin, JP/0000-0001-9932-1063	National Institutes of Health [AR-048816, HL-078773]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR-048816 and HL-078773 ( to J.- P. J.).	Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Brotto MA, 2006, AM J PHYSIOL-CELL PH, V290, pC567, DOI 10.1152/ajpcell.00422.2005; Cairns SP, 2007, J APPL PHYSIOL, V103, P359, DOI 10.1152/japplphysiol.01267.2006; Cairns SP, 2009, J APPL PHYSIOL, V106, P101, DOI 10.1152/japplphysiol.90878.2008; Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0; Degens H., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P56; Feng HZ, 2008, J PHYSIOL-LONDON, V586, P3537, DOI 10.1113/jphysiol.2008.153577; Feng HZ, 2009, ARCH BIOCHEM BIOPHYS, V487, P36, DOI 10.1016/j.abb.2009.05.001; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Gannon J, 2009, EUR J CELL BIOL, V88, P685, DOI 10.1016/j.ejcb.2009.06.004; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; Huang QQ, 1999, J MOL EVOL, V49, P780, DOI 10.1007/PL00006600; Huang XP, 1999, CIRC RES, V84, P1; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jin JP, 1998, GENE, V214, P121, DOI 10.1016/S0378-1119(98)00214-5; Jin JP, 2003, J BIOL CHEM, V278, P26159, DOI 10.1074/jbc.M303469200; Jin JP, 1996, BIOCHEM BIOPH RES CO, V225, P883, DOI 10.1006/bbrc.1996.1267; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; LIN JJC, 1981, P NATL ACAD SCI-BIOL, V78, P2335, DOI 10.1073/pnas.78.4.2335; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; REISER PJ, 1994, AM J PHYSIOL-HEART C, V267, pH1589; SUBRAMANIAM A, 1993, J BIOL CHEM, V268, P4331; van Lunteren E, 2003, RESPIRATION, V70, P636, DOI 10.1159/000075211; Wang X, 2005, J BIOL CHEM, V280, P13241, DOI 10.1074/jbc.M413696200; Yu ZB, 2001, J BIOL CHEM, V276, P15753, DOI 10.1074/jbc.M011048200; Yu ZB, 2007, AM J PHYSIOL-CELL PH, V292, pC1192, DOI 10.1152/ajpcell.00462.2006	27	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31798	31806		10.1074/jbc.M109.020826	http://dx.doi.org/10.1074/jbc.M109.020826			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797054	Green Published, hybrid			2022-12-25	WOS:000271572700034
J	Chandrasekar, A; Kumar, S; Sreenath, J; Sarkar, BN; Urade, BP; Mallick, S; Bandopadhyay, SS; Barua, P; Barik, SS; Basu, D; Kiran, U; Gangopadhyay, P; Sahani, R; Prasad, BVR; Gangopadhyay, S; Lakshmi, GR; Ravuri, RR; Padmaja, K; Venugopal, PN; Sharma, MB; Rao, VR				Chandrasekar, Adimoolam; Kumar, Satish; Sreenath, Jwalapuram; Sarkar, Bishwa Nath; Urade, Bhaskar Pralhad; Mallick, Sujit; Bandopadhyay, Syam Sundar; Barua, Pinuma; Barik, Subihra Sankar; Basu, Debasish; Kiran, Uttaravalli; Gangopadhyay, Prodyot; Sahani, Ramesh; Prasad, Bhagavatula Venkata Ravi; Gangopadhyay, Shampa; Lakshmi, Gandikota Rama; Ravuri, Rajasekhara Reddy; Padmaja, Koneru; Venugopal, Pulamaghatta N.; Sharma, Madhu Bala; Rao, Vadlamudi Raghavendra			Updating Phylogeny of Mitochondrial DNA Macrohaplogroup M in India: Dispersal of Modern Human in South Asian Corridor	PLOS ONE			English	Article							MTDNA VARIATION; GENOME VARIATION; EVOLUTIONARY HISTORY; GENETIC-EVIDENCE; ETHNIC INDIA; POPULATIONS; LINEAGES; ORIGIN; SETTLEMENT; DIVERSITY	To construct maternal phylogeny and prehistoric dispersals of modern human being in the Indian sub continent, a diverse subset of 641 complete mitochondrial DNA (mtDNA) genomes belonging to macrohaplogroup M was chosen from a total collection of 2,783 control-region sequences, sampled from 26 selected tribal populations of India. On the basis of complete mtDNA sequencing, we identified 12 new haplogroups - M53 to M64; redefined/ascertained and characterized haplogroups M2, M3, M4, M5, M6, M8'C'Z, M9, M10, M11, M12-G, D, M18, M30, M33, M35, M37, M38, M39, M40, M41, M43, M45 and M49, which were previously described by control and/or coding-region polymorphisms. Our results indicate that the mtDNA lineages reported in the present study (except East Asian lineages M8'C'Z, M9, M10, M11, M12-G, D) are restricted to Indian region. The deep rooted lineages of macrohaplogroup 'M' suggest in-situ origin of these haplogroups in India. Most of these deep rooting lineages are represented by multiple ethnic/linguist groups of India. Hierarchical analysis of molecular variation (AMOVA) shows substantial subdivisions among the tribes of India (F-ST = 0.16164). The current Indian mtDNA gene pool was shaped by the initial settlers and was galvanized by minor events of gene flow from the east and west to the restricted zones. Northeast Indian mtDNA pool harbors region specific lineages, other Indian lineages and East Asian lineages. We also suggest the establishment of an East Asian gene in North East India through admixture rather than replacement.			Chandrasekar, A (corresponding author), Anthropol Survey India, So Reg Ctr, Mysore, Karnataka, India.	director_ansi@yahoo.co.in						Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; Barik SS, 2008, AM J PHYS ANTHROPOL, V136, P19, DOI 10.1002/ajpa.20773; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chandrasekar A, 2007, ANN HUM BIOL, V34, P582, DOI 10.1080/03014460701556262; Chaubey G, 2008, INT J HUM GENET, V8, P41, DOI 10.1080/09723757.2008.11886018; CHEN YS, 1995, AM J HUM GENET, V57, P133; Clark VJ, 2000, HUM BIOL, V72, P273; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Derenko MV, 2000, HUM BIOL, V72, P945; EDWIN D, 2002, CURRENT SCI, V83, P25; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Forster P, 1996, AM J HUM GENET, V59, P935; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Horai S, 1996, AM J HUM GENET, V59, P579; Howell N, 2004, MOL BIOL EVOL, V21, P1843, DOI 10.1093/molbev/msh184; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; KIVISILD T, 2000, MCDONALD I MONOGRAPH, P267; Kivisild T, 2003, EXAMINING FARMING LA, P215; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; KONG QP, 2003, AM J HUM GENET, V75, P157; Kosambi DD., 1991, CULTURE CIVILISATION; Kumar S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-173; Kumar S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-230; LEWIN R, 1987, SCIENCE, V237, P1292, DOI 10.1126/science.3114877; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Majumder PP, 2001, J BIOSCIENCES, V26, P533, DOI 10.1007/BF02704750; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; MATISOFF JA, 1991, ANNU REV ANTHROPOL, V20, P469, DOI 10.1146/annurev.an.20.100191.002345; Merriwether DA, 2005, P NATL ACAD SCI USA, V102, P13034, DOI 10.1073/pnas.0506195102; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Palanichamy MG, 2006, SCIENCE, V311, DOI 10.1126/science.1120176; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Passarino G, 1996, AM J HUM GENET, V59, P927; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rajkumar R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-26; Reddy BM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001141; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Roychoudhury S, 2000, CURR SCI INDIA, V79, P1182; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; SINGH KS, 1997, SCHEDULED TRIBES; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Thangaraj K, 2008, HUM HERED, V66, P1, DOI 10.1159/000114160; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; TORRONI A, 1993, AM J HUM GENET, V53, P563; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	80	95	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7447	10.1371/journal.pone.0007447	http://dx.doi.org/10.1371/journal.pone.0007447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823670	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808300019
J	Meng, PH; Raynaud, C; Tcherkez, G; Blanchet, S; Massoud, K; Domenichini, S; Henry, Y; Soubigou-Taconnat, L; Lelarge-Trouverie, C; Saindrenan, P; Renou, JP; Bergounioux, C				Meng, Ping Hong; Raynaud, Cecile; Tcherkez, Guillaume; Blanchet, Sophie; Massoud, Kamal; Domenichini, Severine; Henry, Yves; Soubigou-Taconnat, Ludivine; Lelarge-Trouverie, Caroline; Saindrenan, Patrick; Renou, Jean Pierre; Bergounioux, Catherine			Crosstalks between Myo-Inositol Metabolism, Programmed Cell Death and Basal Immunity in Arabidopsis	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; NUCLEAR ANTIGEN PCNA; SALICYLIC-ACID; HYPERSENSITIVE RESPONSE; SIGNAL-TRANSDUCTION; D-MYO-INOSITOL-3-PHOSPHATE SYNTHASE; GENE-EXPRESSION; GIGANTEA GENE; PLANTS; DEFENSE	Background: Although it is a crucial cellular process required for both normal development and to face stress conditions, the control of programmed cell death in plants is not fully understood. We previously reported the isolation of ATXR5 and ATXR6, two PCNA-binding proteins that could be involved in the regulation of cell cycle or cell death. A yeast two-hybrid screen using ATXR5 as bait captured AtIPS1, an enzyme which catalyses the committed step of myo-inositol (MI) biosynthesis. atips1 mutants form spontaneous lesions on leaves, raising the possibility that MI metabolism may play a role in the control of PCD in plants. In this work, we have characterised atips1 mutants to gain insight regarding the role of MI in PCD regulation. Methodology/Principal Findings: - lesion formation in atips1 mutants depends of light intensity, is due to PCD as evidenced by TUNEL labelling of nuclei, and is regulated by phytohormones such as salicylic acid - MI and galactinol are the only metabolites whose accumulation is significantly reduced in the mutant, and supplementation of the mutant with these compounds is sufficient to prevent PCD - the transcriptome profile of the mutant is extremely similar to that of lesion mimic mutants such as cpr5, or wild-type plants infected with pathogens. Conclusion/Significance: Taken together, our results provide strong evidence for the role of MI or MI derivatives in the regulation of PCD. Interestingly, there are three isoforms of IPS in Arabidopsis, but AtIPS1 is the only one harbouring a nuclear localisation sequence, suggesting that nuclear pools of MI may play a specific role in PCD regulation and opening new research prospects regarding the role of MI in the prevention of tumorigenesis. Nevertheless, the significance of the interaction between AtIPS1 and ATXR5 remains to be established.	[Meng, Ping Hong; Raynaud, Cecile; Blanchet, Sophie; Massoud, Kamal; Domenichini, Severine; Henry, Yves; Saindrenan, Patrick; Bergounioux, Catherine] Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, Orsay, France; [Tcherkez, Guillaume; Lelarge-Trouverie, Caroline] Univ Paris 11, Inst Biotechnol Plantes, Plateforme Metab Meabolome IFR87, Orsay, France; [Soubigou-Taconnat, Ludivine; Renou, Jean Pierre] Unite Rech Genom Vegetale, Evry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Meng, PH (corresponding author), Guizhou Acad Agr Sci, Inst Hort, Guiyang, Guizhou Prov, Peoples R China.	cecile.raynaud@u-psud.fr	Raynaud, Cécile/H-9711-2012; HENRY, Yves/B-8941-2008; Tcherkez, Guillaume/L-1300-2015	Raynaud, Cécile/0000-0002-5231-8120; DOMENICHINI, Severine/0000-0002-5997-2694				Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BAILLIEUL F, 1995, PLANT J, V8, P551, DOI 10.1046/j.1365-313X.1995.8040551.x; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; Crowe ML, 2003, NUCLEIC ACIDS RES, V31, P156, DOI 10.1093/nar/gkg071; DELANCY TP, 1994, SCIENCE, V18, P1247; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Ishikawa A, 2005, BIOSCI BIOTECH BIOCH, V69, P1929, DOI 10.1271/bbb.69.1929; Ishitani M, 1996, PLANT J, V9, P537, DOI 10.1046/j.1365-313X.1996.09040537.x; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jasinski S, 2002, J CELL SCI, V115, P973; JOHNSON MD, 1995, PLANT PHYSIOL, V107, P613, DOI 10.1104/pp.107.2.613; Keller R, 1998, PLANT J, V16, P403, DOI 10.1046/j.1365-313x.1998.00309.x; Kim MS, 2008, MOL PLANT MICROBE IN, V21, P1643, DOI 10.1094/MPMI-21-12-1643; Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x; Lackey KH, 2003, PLANT PHYSIOL, V132, P2240, DOI 10.1104/pp.103.020610; Lawton K, 1995, MOL PLANT MICROBE IN, V8, P863, DOI 10.1094/MPMI-8-0863; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; LOEWUS FA, 1983, ANNU REV PLANT PHYS, V34, P137, DOI 10.1146/annurev.pp.34.060183.001033; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Love AJ, 2008, TRENDS PLANT SCI, V13, P589, DOI 10.1016/j.tplants.2008.08.006; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mateo A, 2004, PLANT PHYSIOL, V136, P2818, DOI 10.1104/pp.104.043646; Morel JB, 1997, CELL DEATH DIFFER, V4, P671, DOI 10.1038/sj.cdd.4400309; Muhlenbock P, 2008, PLANT CELL, V20, P2339, DOI 10.1105/tpc.108.059618; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; Murray JA, 2009, PLANT MOL BIOL; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Noctor G, 2007, METABOLOMICS, V3, P161, DOI 10.1007/s11306-007-0057-3; Nunes ACS, 2006, PLANTA, V224, P125, DOI 10.1007/s00425-005-0201-0; Ortega X, 2005, BIOL RES, V38, P89, DOI 10.4067/S0716-97602005000100011; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Perennes C, 1999, J CELL SCI, V112, P1181; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Raboy V, 2000, PLANT PHYSIOL, V124, P355, DOI 10.1104/pp.124.1.355; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Raynaud C, 2005, P NATL ACAD SCI USA, V102, P8216, DOI 10.1073/pnas.0502564102; Raynaud C, 2006, PLANT J, V47, P395, DOI 10.1111/j.1365-313X.2006.02799.x; Reape TJ, 2008, NEW PHYTOL, V180, P13, DOI 10.1111/j.1469-8137.2008.02549.x; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Sambrook J., 1989, MOL CLONING; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Smart CC, 1997, PLANT MOL BIOL, V33, P811, DOI 10.1023/A:1005754425440; SMART CC, 1993, PLANT J, V4, P279, DOI 10.1046/j.1365-313X.1993.04020279.x; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Wang WM, 2008, PLANT CELL, V20, P3163, DOI 10.1105/tpc.108.060053; Weckwerth W, 2004, P NATL ACAD SCI USA, V101, P7809, DOI 10.1073/pnas.0303415101; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Williams B, 2008, MOL PLANT PATHOL, V9, P531, DOI [10.1111/j.1364-3703.2008.00473.x, 10.1111/J.1364-3703.2008.00473.X]; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	69	90	95	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7364	10.1371/journal.pone.0007364	http://dx.doi.org/10.1371/journal.pone.0007364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812700	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594200005
J	Olivier, V; Queen, J; Satchell, KJF				Olivier, Verena; Queen, Jessica; Satchell, Karla J. F.			Successful Small Intestine Colonization of Adult Mice by Vibrio cholerae Requires Ketamine Anesthesia and Accessory Toxins	PLOS ONE			English	Article								Vibrio cholerae colonizes the small intestine of adult C57BL/6 mice. In this study, the physical and genetic parameters that facilitate this colonization were investigated. Successful colonization was found to depend upon anesthesia with ketamine-xylazine and neutralization of stomach acid with sodium bicarbonate, but not streptomycin treatment. A variety of common mouse strains were colonized by O1, O139, and non-O1/non-O139 strains. All combinations of mutants in the genes for hemolysin, the multifunctional, autoprocessing RTX toxin (MARTX), and hemagglutinin/protease were assessed, and it was found that hemolysin and MARTX are each sufficient for colonization after a low dose infection. Overall, this study suggests that, after intragastric inoculation, V. cholerae encounters barriers to infection including an acidic environment and an immediate immune response that is circumvented by sodium bicarbonate and the anti-inflammatory effects of ketamine-xylazine. After initial adherence in the small intestine, the bacteria are subjected to additional clearance mechanisms that are evaded by the independent toxic action of hemolysin or MARTX. Once colonization is established, it is suggested that, in humans, these now persisting bacteria initiate synthesis of the major virulence factors to cause cholera disease. This adult mouse model of intestinal V. cholerae infection, now well-characterized and fully optimized, should serve as a valuable tool for studies of pathogenesis and testing vaccine efficacy.			Olivier, V (corresponding author), Intercell AG, Vienna, Austria.	k-satchell@northwestern.edu	Sears, Cynthia L/AAJ-6704-2020; Satchell, Karla/GSN-3100-2022	Sears, Cynthia L/0000-0003-4059-1661; Queen, Jessica/0000-0002-4924-6621	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490, R21AI072461] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI072461-01A2, AI051490, R01 AI051490, R21 AI072461, AI072461] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALM RA, 1988, MOL MICROBIOL, V2, P481; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; CASH RA, 1974, J INFECT DIS, V129, P45, DOI 10.1093/infdis/129.1.45; Chiang SL, 1999, INFECT IMMUN, V67, P976, DOI 10.1128/IAI.67.2.976-980.1999; Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; FREYE E, 1994, ANAESTHESIST, V43, P87, DOI 10.1007/s001010050036; Fullner KJ, 2000, EMBO J, V19, P5315, DOI 10.1093/emboj/19.20.5315; Fullner KJ, 2002, J EXP MED, V195, P1455, DOI 10.1084/jem.20020318; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; Ghosh A, 2006, INFECT IMMUN, V74, P2937, DOI 10.1128/IAI.74.5.2937-2946.2006; GOLDBERG I, 1986, J BACTERIOL, V165, P715, DOI 10.1128/jb.165.3.715-722.1986; HANNE LF, 1982, INFECT IMMUN, V36, P209, DOI 10.1128/IAI.36.1.209-214.1982; Helmer KS, 2003, J SURG RES, V112, P70, DOI 10.1016/S0022-4804(03)00138-0; Helmer KS, 2003, SHOCK, V20, P63, DOI 10.1097/01.shk.0000065766.72937.cf; Herbert J, 1998, EXP GERONTOL, V33, P713, DOI 10.1016/S0531-5565(98)00039-4; Hsiao A, 2006, P NATL ACAD SCI USA, V103, P14542, DOI 10.1073/pnas.0604650103; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; KNOP J, 1975, AUST J EXP BIOL MED, V53, P137, DOI 10.1038/icb.1975.14; Li MR, 2002, INFECT IMMUN, V70, P2441, DOI 10.1128/IAI.70.5.2441-2453.2002; MEKALANOS JJ, 1983, CELL, V35, P253, DOI 10.1016/0092-8674(83)90228-3; NIYOGI SG, 1979, INDIAN J MED RES, V70, P892; NYGREN E, 2009, INFECT IMMUN; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Suliburk JW, 2005, J SURG RES, V127, P203, DOI 10.1016/j.jss.2005.03.021; Valeva A, 2008, MED MICROBIOL IMMUN, V197, P285, DOI 10.1007/s00430-007-0061-2; WALDOR MK, 1994, INFECT IMMUN, V62, P72, DOI 10.1128/IAI.62.1.72-78.1994	28	64	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7352	10.1371/journal.pone.0007352	http://dx.doi.org/10.1371/journal.pone.0007352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812690	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594200004
J	Prasobh, R; Manoj, N				Prasobh, R.; Manoj, Narayanan			The Repertoire of Heterotrimeric G Proteins and RGS Proteins in Ciona intestinalis	PLOS ONE			English	Article								Background: Heterotrimeric G proteins and regulators of G protein signaling (RGS) proteins are key downstream interacting partners in the G protein coupled receptor (GPCR) signaling pathway. The highly versatile GPCR transmembrane signaling system is a consequence of the coupling of a diverse set of receptors to downstream partners that include multiple subforms of G proteins and regulatory proteins including RGS proteins, among others. While the GPCR repertoire of Ciona intestinalis, representing the basal chordate is known, the repertoire of the heterotrimeric G proteins and RGS proteins is unknown. Methodology/Principal Findings: In the present study, we performed an in-silico genome-wide search of C. intestinalis for its complement of G proteins and RGS proteins. The identification of several one-to-one orthologs of human G proteins at the levels of families, subfamilies and types and of homologs of the human RGS proteins suggests an evolutionarily conserved structure function relationship of the GPCR signaling mechanism in the chordates. Conclusions: The C. intestinalis genome encodes a highly conserved, albeit, limited repertoire of the heterotrimeric G protein complexes with the size of subunit types comparable with that in lower eukaryotes.			Prasobh, R (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	nmanoj@iitm.ac.in	Manoj, Narayanan/W-2301-2019	Manoj, Narayanan/0000-0002-8144-1566				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Burchett SA, 2000, J NEUROCHEM, V75, P1335, DOI 10.1046/j.1471-4159.2000.0751335.x; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen SH, 2006, DEV CELL, V11, P436, DOI 10.1016/j.devcel.2006.09.011; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Corbo JC, 2001, CELL, V106, P535, DOI 10.1016/S0092-8674(01)00481-0; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRAF R, 1992, EUR J BIOCHEM, V210, P609, DOI 10.1111/j.1432-1033.1992.tb17461.x; Grishina G, 2000, MOL PHARMACOL, V57, P1081; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HIGGINS JB, 1994, J BIOL CHEM, V269, P9067; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Kamesh N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-129; LAMBRIGHT DG, 2004, HDB CELL SIGNALING, P575; Liang JJ, 1998, J NEUROCHEM, V71, P345; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Marsh SR, 1998, MOL PHARMACOL, V53, P981; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Preininger A.M., 2004, SCI STKE, V218, pre3; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; Satoh N, 2003, TRENDS GENET, V19, P376, DOI 10.1016/S0168-9525(03)00144-6; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; SPRANG SR, 1997, ANNU REV BIOCHEM, V639, P678; Theodoropoulou MC, 2008, BIOINFORMATICS, V24, P1471, DOI 10.1093/bioinformatics/btn206; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yost EA, 2007, MOL PHARMACOL, V72, P812, DOI 10.1124/mol.107.038075; CIONA INTESTINALIS V	44	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7349	10.1371/journal.pone.0007349	http://dx.doi.org/10.1371/journal.pone.0007349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806206	gold, Green Published, Green Submitted			2022-12-25	WOS:000270593800027
J	Sim, SH; Liu, YC; Wang, DL; Novem, V; Sivalingam, SP; Thong, TW; Ooi, EE; Tan, G				Sim, Siew Hoon; Liu, Yichun; Wang, Dongling; Novem, Vidhya; Sivalingam, Suppiah Paramalingam; Thong, Tuck Weng; Ooi, Eng Eong; Tan, Gladys			Innate Immune Responses of Pulmonary Epithelial Cells to Burkholderia pseudomallei Infection	PLOS ONE			English	Article								Background: Burkholderia pseudomallei, a facultative intracellular pathogen, causes systemic infection in humans with high mortality especially when infection occurs through an infectious aerosol. Previous studies indicated that the epithelial cells in the lung are an active participant in host immunity. In this study, we aimed to investigate the innate immune responses of lung epithelial cells against B. pseudomallei. Methodology and Principal Findings: Using a murine lung epithelial cell line, primary lung epithelial cells and an inhalational murine infection model, we characterized the types of innate immunity proteins and peptides produced upon B. pseudomallei infection. Among a wide panel of immune components studied, increased levels of major pro-inflammatory cytokines IL-6 and TNF alpha, chemokine MCP-1, and up-regulation of secretory leukocyte protease inhibitor (SLPI) and chemokine (C-C motif) ligand 20 (CCL20) were observed. Inhibition assays using specific inhibitors suggested that NF-kappa B and p38 MAPK pathways were responsible for these B. pseudomallei-induced antimicrobial peptides. Conclusions: Our findings indicate that the respiratory epithelial cells, which form the majority of the cells lining the epithelial tract and the lung, have important roles in the innate immune response against B. pseudomallei infection.			Sim, SH (corresponding author), Def Med & Environm Res Inst, DSO Natl Labs, Singapore, Singapore.	tgekyen@dso.org.sg	liu, yi/GXE-9662-2022	Ooi, Eng Eong/0000-0002-0520-1544				Abe T, 1997, AM J RESP CRIT CARE, V156, P1235, DOI 10.1164/ajrccm.156.4.9701075; Akinbi HT, 2000, J IMMUNOL, V165, P5760, DOI 10.4049/jimmunol.165.10.5760; Baier J, 2000, J INVEST MED, V48, P457; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Barnes JL, 2001, IMMUNOL CELL BIOL, V79, P490, DOI 10.1046/j.1440-1711.2001.01038.x; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; BOONSAWAT W, 1990, Journal of the Medical Association of Thailand, V73, P345; Borgatti M, 2007, BIOCHEM BIOPH RES CO, V357, P977, DOI 10.1016/j.bbrc.2007.04.081; Breitbach K, 2006, INFECT IMMUN, V74, P6300, DOI 10.1128/IAI.00966-06; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Choi SC, 2006, WORLD J GASTROENTERO, V12, P4850; Currie Bart, 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P436; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-1; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; FRIEDLAND JS, 1992, INFECT IMMUN, V60, P2402, DOI 10.1128/IAI.60.6.2402-2408.1992; Gentry M, 2007, INFECT IMMUN, V75, P3969, DOI 10.1128/IAI.00157-07; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Hauber Hans-Peter, 2005, Can Respir J, V12, P13; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Liu Y, 2006, T ROY SOC TROP MED H, V100, P687, DOI 10.1016/j.trstmh.2005.08.017; Mendez-Samperio P, 2008, PEPTIDES, V29, P1657, DOI 10.1016/j.peptides.2008.05.019; Miyagi K, 1997, INFECT IMMUN, V65, P4108, DOI 10.1128/IAI.65.10.4108-4113.1997; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; O'Brien AD, 1999, AM J PHYSIOL-LUNG C, V276, pL961, DOI 10.1152/ajplung.1999.276.6.L961; Popov S. F., 1992, Mikrobiologicheskii Zhurnal (Kiev), V54, P3; Potera C, 2005, ENVIRON HEALTH PERSP, V113, pA734, DOI 10.1289/ehp.113-a734; Reviglio VE, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93857; Rogan MP, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-29; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Simian M, 2001, DEVELOPMENT, V128, P3117; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Tomimori K, 2007, INFECT IMMUN, V75, P5223, DOI 10.1128/IAI.00731-07; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V138, P61, DOI 10.1111/j.1365-2249.2004.02601.x; Utaisincharoen P, 2000, CLIN EXP IMMUNOL, V122, P324, DOI 10.1046/j.1365-2249.2000.01386.x; Weldon S, 2007, EXP LUNG RES, V33, P485, DOI 10.1080/01902140701756547; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Wu YY, 2007, INFECT IMMUN, V75, P4357, DOI 10.1128/IAI.01660-06; Yang J, 2002, INFECT IMMUN, V70, P3649, DOI 10.1128/IAI.70.7.3649-3655.2002; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	52	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7308	10.1371/journal.pone.0007308	http://dx.doi.org/10.1371/journal.pone.0007308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806192	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593800016
J	Clausell, J; Happel, N; Hale, TK; Doenecke, D; Beato, M				Clausell, Jaime; Happel, Nicole; Hale, Tracy K.; Doenecke, Detlef; Beato, Miguel			Histone H1 Subtypes Differentially Modulate Chromatin Condensation without Preventing ATP-Dependent Remodeling by SWI/SNF or NURF	PLOS ONE			English	Article							NUCLEOSOME REPEAT LENGTH; ATOMIC-FORCE MICROSCOPY; DNA-BINDING SITES; CELL-FREE SYSTEM; LINKER HISTONE; GLOBULAR DOMAIN; DROSOPHILA EMBRYOS; SELF-ASSOCIATION; IN-VITRO; POSITIONED NUCLEOSOMES	Although ubiquitously present in chromatin, the function of the linker histone subtypes is partly unknown and contradictory studies on their properties have been published. To explore whether the various H1 subtypes have a differential role in the organization and dynamics of chromatin we have incorporated all of the somatic human H1 subtypes into minichromosomes and compared their influence on nucleosome spacing, chromatin compaction and ATP-dependent remodeling. H1 subtypes exhibit different affinities for chromatin and different abilities to promote chromatin condensation, as studied with the Atomic Force Microscope. According to this criterion, H1 subtypes can be classified as weak condensers (H1.1 and H1.2), intermediate condensers (H1.3) and strong condensers (H1.0, H1.4, H1.5 and H1x). The variable C-terminal domain is required for nucleosome spacing by H1.4 and is likely responsible for the chromatin condensation properties of the various subtypes, as shown using chimeras between H1.4 and H1.2. In contrast to previous reports with isolated nucleosomes or linear nucleosomal arrays, linker histones at a ratio of one per nucleosome do not preclude remodeling of minichromosomes by yeast SWI/SNF or Drosophila NURF. We hypothesize that the linker histone subtypes are differential organizers of chromatin, rather than general repressors.			Clausell, J (corresponding author), Univ Pompeu Fabra, CRG, Barcelona, Spain.	miguel.beato@crg.es	Beato, Miguel/B-5564-2015	Beato, Miguel/0000-0002-2878-2222				Albig W, 1998, FEBS LETT, V435, P245, DOI 10.1016/S0014-5793(98)01084-9; ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; ALLAN J, 1981, J CELL BIOL, V90, P279, DOI 10.1083/jcb.90.2.279; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Becker PB, 2002, EMBO J, V21, P4749, DOI 10.1093/emboj/cdf486; BECKER PB, 1992, MOL CELL BIOL, V12, P2241, DOI 10.1128/MCB.12.5.2241; BERKOWITZ EM, 1981, BIOCHEMISTRY-US, V20, P7284, DOI 10.1021/bi00528a036; BLANK TA, 1995, J MOL BIOL, V252, P305, DOI 10.1006/jmbi.1995.0498; Bonte E, 1999, METH MOL B, V119, P187; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Brown KS, 1997, J INSECT CONSERV, V1, P25, DOI 10.1023/A:1018422807610; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; BUCCI LR, 1982, EXP CELL RES, V140, P111, DOI 10.1016/0014-4827(82)90162-8; BUTLER PJG, 1980, J MOL BIOL, V140, P505, DOI 10.1016/0022-2836(80)90268-5; Cano S, 2006, EUR BIOPHYS J BIOPHY, V35, P495, DOI 10.1007/s00249-006-0057-7; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Carter GJ, 1998, BIOCHEMISTRY-US, V37, P12477, DOI 10.1021/bi980716v; Chadee DN, 1997, J BIOL CHEM, V272, P8113, DOI 10.1074/jbc.272.13.8113; CHADEE DN, 1995, J BIOL CHEM, V270, P20098, DOI 10.1074/jbc.270.34.20098; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Doenecke D, 1997, HISTOCHEM CELL BIOL, V107, P1, DOI 10.1007/s004180050083; DOMINGUEZ V, 1992, DEVELOPMENT, V115, P181; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Drabent B, 1996, HISTOCHEM CELL BIOL, V106, P247; DRABENT B, 1991, GENE, V103, P263, DOI 10.1016/0378-1119(91)90284-I; DRAVES PH, 1992, J MOL BIOL, V225, P1105, DOI 10.1016/0022-2836(92)90108-V; DUBOCHET J, 1986, EMBO J, V5, P519, DOI 10.1002/j.1460-2075.1986.tb04241.x; Duggan MM, 2000, J MOL BIOL, V304, P21, DOI 10.1006/jmbi.2000.4205; ELGIN SCR, 1973, BIOCHEMISTRY-US, V12, P4984, DOI 10.1021/bi00748a026; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Franke K, 1998, BBA-GENE STRUCT EXPR, V1398, P232, DOI 10.1016/S0167-4781(98)00062-1; Goytisolo FA, 1996, EMBO J, V15, P3421, DOI 10.1002/j.1460-2075.1996.tb00708.x; Gunjan A, 1999, J BIOL CHEM, V274, P37950, DOI 10.1074/jbc.274.53.37950; HALL JM, 1985, BIOCHEMISTRY-US, V24, P7765, DOI 10.1021/bi00347a040; Hamiche A, 2004, METHOD ENZYMOL, V377, P353; Hamiche A, 1996, J MOL BIOL, V257, P30, DOI 10.1006/jmbi.1996.0144; Happel N, 2005, BIOL CHEM, V386, P541, DOI 10.1515/BC.2005.064; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; HIGURASHI M, 1987, J BIOL CHEM, V262, P13075; Hill DA, 2000, BIOCHEMISTRY-US, V39, P11649, DOI 10.1021/bi001330z; Horn PJ, 2002, NAT STRUCT BIOL, V9, P263, DOI 10.1038/nsb776; HUANG HC, 1984, J BIOL CHEM, V259, P4237; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; KELLER W, 1977, COLD SPRING HARB SYM, V42, P227, DOI 10.1101/SQB.1978.042.01.025; KHADAKE JR, 1995, BIOCHEMISTRY-US, V34, P15792, DOI 10.1021/bi00048a025; Khochbin S, 2001, GENE, V271, P1, DOI 10.1016/S0378-1119(01)00495-4; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; Lee K, 2007, MOL BIOL CELL, V18, P4013, DOI 10.1091/mbc.E07-05-0437; LENNOX RW, 1982, J BIOL CHEM, V257, P5183; LENNOX RW, 1983, J BIOL CHEM, V258, P262; LENNOX RW, 1984, DEV BIOL, V103, P80, DOI 10.1016/0012-1606(84)90009-5; Leuba SH, 1998, BIOPHYS J, V74, P2830, DOI 10.1016/S0006-3495(98)77990-1; LIAO LW, 1981, J BIOL CHEM, V256, P124; Loborg H, 2000, CYTOMETRY, V40, P1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Maier VK, 2008, BIOL CHEM, V389, P345, DOI 10.1515/BC.2008.040; Maier VK, 2008, EMBO J, V27, P817, DOI 10.1038/sj.emboj.7601902; MAMAN JD, 1994, BIOCHEMISTRY-US, V33, P1300, DOI 10.1021/bi00172a003; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Orrego M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-22; PANYIM S, 1969, BIOCHEM BIOPH RES CO, V37, P1042, DOI 10.1016/0006-291X(69)90237-X; Parseghian MH, 2000, CHROMOSOME RES, V8, P405, DOI 10.1023/A:1009262819961; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Ponte I, 1998, MOL BIOL EVOL, V15, P702, DOI 10.1093/oxfordjournals.molbev.a025973; Ramachandran A, 2003, J BIOL CHEM, V278, P48590, DOI 10.1074/jbc.M309033200; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; RASHEED BKA, 1989, J CELL SCI, V94, P61; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Rodriguez-Campos A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh107; RODRIGUEZCAMPOS A, 1989, J MOL BIOL, V209, P135, DOI 10.1016/0022-2836(89)90177-0; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Saeki H, 2005, P NATL ACAD SCI USA, V102, P5697, DOI 10.1073/pnas.0409824102; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Sandbrink R, 1994, Neurobiol Dis, V1, P13, DOI 10.1006/nbdi.1994.0003; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Stoldt S, 2007, BIOL CELL, V99, P541, DOI 10.1042/BC20060117; Takata H, 2007, FEBS LETT, V581, P3783, DOI 10.1016/j.febslet.2007.06.076; Talasz H, 1998, J BIOL CHEM, V273, P32236, DOI 10.1074/jbc.273.48.32236; Tanaka M, 2001, DEVELOPMENT, V128, P655; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMA F, 1988, CELL, V55, P945, DOI 10.1016/0092-8674(88)90240-1; THOMAS JO, 1992, NUCLEIC ACIDS RES, V20, P187, DOI 10.1093/nar/20.2.187; URA K, 1995, EMBO J, V14, P3752, DOI 10.1002/j.1460-2075.1995.tb00045.x; VARGAWEISZ PD, 1995, EMBO J, V14, P2209, DOI 10.1002/j.1460-2075.1995.tb07215.x; VARSHAVSKY AJ, 1977, COLD SPRING HARB SYM, V42, P457; Venditti P, 1998, NUCLEIC ACIDS RES, V26, P3657, DOI 10.1093/nar/26.16.3657; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Zhou YB, 1998, NATURE, V395, P402, DOI 10.1038/26521; ZLATANOVA J, 1994, FASEB J, V8, P1260, DOI 10.1096/fasebj.8.15.8001738; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	103	104	108	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e0007243	10.1371/journal.pone.0007243	http://dx.doi.org/10.1371/journal.pone.0007243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794910	Green Submitted, Green Published, gold			2022-12-25	WOS:000270354200003
J	Scholefield, J; Greenberg, LJ; Weinberg, MS; Arbuthnot, PB; Abdelgany, A; Wood, MJA				Scholefield, Janine; Greenberg, L. Jacquie; Weinberg, Marc S.; Arbuthnot, Patrick B.; Abdelgany, Amr; Wood, Matthew J. A.			Design of RNAi Hairpins for Mutation-Specific Silencing of Ataxin-7 and Correction of a SCA7 Phenotype	PLOS ONE			English	Article								Spinocerebellar ataxia type 7 is a polyglutamine disorder caused by an expanded CAG repeat mutation that results in neurodegeneration. Since no treatment exists for this chronic disease, novel therapies such post-transcriptional RNA interference-based gene silencing are under investigation, in particular those that might enable constitutive and tissue-specific silencing, such as expressed hairpins. Given that this method of silencing can be abolished by the presence of nucleotide mismatches against the target RNA, we sought to identify expressed RNA hairpins selective for silencing the mutant ataxin-7 transcript using a linked SNP. By targeting both short and full-length tagged ataxin-7 sequences, we show that mutation-specific selectivity can be obtained with single nucleotide mismatches to the wild-type RNA target incorporated 39 to the centre of the active strand of short hairpin RNAs. The activity of the most effective short hairpin RNA incorporating the nucleotide mismatch at position 16 was further studied in a heterozygous ataxin-7 disease model, demonstrating significantly reduced levels of toxic mutant ataxin-7 protein with decreased mutant protein aggregation and retention of normal wild-type protein in a non-aggregated diffuse cellular distribution. Allele-specific mutant ataxin7 silencing was also obtained with the use of primary microRNA mimics, the most highly effective construct also harbouring the single nucleotide mismatch at position 16, corroborating our earlier findings. Our data provide understanding of RNA interference guide strand anatomy optimised for the allele-specific silencing of a polyglutamine mutation linked SNP and give a basis for the use of allele-specific RNA interference as a viable therapeutic approach for spinocerebellar ataxia 7.			Scholefield, J (corresponding author), Univ Cape Town, Div Human Genet, MRC,Fac Hlth Sci, UCT Human Genet Res Unit,Inst Infect Dis & Mol Me, ZA-7925 Cape Town, South Africa.	matthew.wood@dpag.ox.ac.uk	Weinberg, Marc/B-4669-2009; Wood, Matthew/HDN-1469-2022	Weinberg, Marc/0000-0002-1997-2171; Scholefield, Janine/0000-0001-9610-3976; Wood, Matthew/0000-0002-5436-6011	Medical Research Council [G0500822] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdelgany A, 2003, HUM MOL GENET, V12, P2637, DOI 10.1093/hmg/ddg280; Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; An CI, 2006, RNA, V12, P710, DOI 10.1261/rna.2299306; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Bryer A, 2003, J NEUROL SCI, V216, P47, DOI 10.1016/S0022-510X(03)00209-0; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caplen NJ, 2002, HUM MOL GENET, V11, P175, DOI 10.1093/hmg/11.2.175; Castanotto D, 2002, RNA, V8, P1454, DOI 10.1017/S1355838202021362; Coldwell MJ, 2006, MOL CELL BIOL, V26, P8448, DOI 10.1128/MCB.01248-06; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Dykxhoorn DM, 2006, P NATL ACAD SCI USA, V103, P5953, DOI 10.1073/pnas.0601309103; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Ely A, 2008, MOL THER, V16, P1105, DOI 10.1038/mt.2008.82; Feng XR, 2006, GENE, V371, P68, DOI 10.1016/j.gene.2005.11.006; Garden GA, 2008, CEREBELLUM, V7, P138, DOI 10.1007/s12311-008-0027-y; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Greenberg J, 2006, CLIN GENET, V70, P415, DOI 10.1111/j.1399-0004.2006.00680.x; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Latouche M, 2007, J NEUROSCI, V27, P2483, DOI 10.1523/JNEUROSCI.5453-06.2007; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Thomas PS, 2006, HUM MOL GENET, V15, P2225, DOI 10.1093/hmg/ddl148; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019; Zander C, 2001, HUM MOL GENET, V10, P2569, DOI 10.1093/hmg/10.22.2569	50	51	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7232	10.1371/journal.pone.0007232	http://dx.doi.org/10.1371/journal.pone.0007232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789634	Green Published, Green Submitted, gold			2022-12-25	WOS:000270354100006
J	Natesan, SKA; Peacock, L; Leung, KF; Matthews, KR; Gibson, W; Field, MC				Natesan, Senthil Kumar A.; Peacock, Lori; Leung, Ka Fai; Matthews, Keith R.; Gibson, Wendy; Field, Mark C.			The Trypanosome Rab-Related Proteins RabX1 and RabX2 Play No Role in IntraCellular Trafficking but May Be Involved in Fly Infectivity	PLOS ONE			English	Article								Background: Rab GTPases constitute the largest subgroup of the Ras superfamily and are primarily involved in vesicle targeting. The full extent of Rab family function is unexplored. Several divergent Rab-like proteins are known but few have been characterized. In Trypanosoma brucei there are sixteen Rab genes, but RabX1, RabX2 and RabX3 are divergent within canonical sequence regions. Where known, trypanosome Rab functions are broadly conserved when orthologous relationships may be robustly established, but specific functions for RabX1, X2 and X3 have yet to be determined. RabX1 and RabX2 originated via tandem duplication and subcellular localization places RabX1 at the endoplasmic reticulum, while RabX2 is at the Golgi complex, suggesting distinct functions. We wished to determine whether RabX1 and RabX2 are involved in vesicle transport or other cellular processes. Methodology/Principal Findings: Using comparative genomics we find that RabX1 and RabX2 are restricted to trypanosomatids. Gene knockout indicates that RabX1 and RabX2 are non-essential. Simultaneous RNAi knockdown of both RabX1 and RabX2, while partial, was also non-lethal and may suggest non-redundant function, consistent with the distinct locations of the proteins. Analysis of the knockout cell lines unexpectedly failed to uncover a defect in exocytosis, endocytosis or in the morphology or location of multiple markers for the endomembrane system, suggesting that neither RabX1 nor RabX2 has a major role in intracellular transport. However, it was apparent that RabX1 and RabX2 knockout cells displayed somewhat enhanced survival within flies. Conclusions/Significance: RabX1 and RabX2, two members of the trypanosome Rab subfamily, were shown to have no major detectable role in intracellular transport, despite the localization of each gene product to highly specific endomembrane compartments. These data extend the functional scope of Rab proteins in trypanosomes to include non-canonical roles in differentiation-associated processes in protozoa.			Natesan, SKA (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mcf34@cam.ac.uk	Field, Mark/AAD-6455-2021; Gibson, Wendy/E-4182-2014	Matthews FRS FMedSci FRSE, Professor Keith/0000-0003-0309-9184; Field, Mark/0000-0002-4866-2885	Wellcome Trust [073358, 074242] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ackers JP, 2005, MOL BIOCHEM PARASIT, V141, P89, DOI 10.1016/j.molbiopara.2005.01.017; Alexander DL, 2002, J CELL SCI, V115, P3253; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; BANGS JD, 1993, J CELL SCI, V105, P1101; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; BARRY JD, 1979, J CELL SCI, V37, P287; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BRUN R, 1979, ACTA TROP, V36, P289; Dacks JB, 2009, INT J BIOCHEM CELL B, V41, P330, DOI 10.1016/j.biocel.2008.08.041; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; Denny PW, 2002, MOL BIOCHEM PARASIT, V123, P105, DOI 10.1016/S0166-6851(02)00133-0; Dhir V, 2004, MOL BIOCHEM PARASIT, V137, P253, DOI 10.1016/j.molbiopara.2004.06.007; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Field H, 1997, J BIOL CHEM, V272, P10498, DOI 10.1074/jbc.272.16.10498; Field H, 2000, MOL BIOCHEM PARASIT, V106, P21, DOI 10.1016/S0166-6851(99)00192-9; Field H, 1998, J BIOL CHEM, V273, P32102, DOI 10.1074/jbc.273.48.32102; Field H, 1999, J CELL SCI, V112, P147; Field MC, 2008, TRENDS PARASITOL, V24, P253, DOI 10.1016/j.pt.2008.03.005; Field MC, 2007, ADV EXP MED BIOL, V607, P84; Field MC, 2005, TRENDS PARASITOL, V21, P447, DOI 10.1016/j.pt.2005.08.008; Field MC, 2004, TRAFFIC, V5, P905, DOI 10.1111/j.1600-0854.2004.00234.x; Field MC, 2004, MICROSC MICROANAL, V10, P621, DOI 10.1017/S1431927604040942; Field MC, 1995, EXP PARASITOL, V81, P313, DOI 10.1006/expr.1995.1122; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Hall BS, 2005, EUKARYOT CELL, V4, P971, DOI 10.1128/EC.4.5.971-980.2005; Hall BS, 2004, J BIOL CHEM, V279, P45047, DOI 10.1074/jbc.M407271200; Hendriks EF, 2005, MOL MICROBIOL, V57, P706, DOI 10.1111/j.1365-2958.2005.04679.x; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Herder S, 2007, EXP PARASITOL, V117, P111, DOI 10.1016/j.exppara.2007.05.011; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Jeffries TR, 2001, J CELL SCI, V114, P2617; Kumar S, 2007, EUKARYOT CELL, V6, P2029, DOI 10.1128/EC.00213-07; Macleod ET, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000239; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Maudlin I., 1991, Advances in Disease Vector Research, V7, P117; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Morgan GW, 2002, TRENDS PARASITOL, V18, P540, DOI 10.1016/S1471-4922(02)02392-9; Morgan GW, 2002, TRENDS PARASITOL, V18, P491, DOI 10.1016/S1471-4922(02)02391-7; Morgan GW, 2001, J CELL SCI, V114, P2605; Pal A, 2002, J BIOL CHEM, V277, P9529, DOI 10.1074/jbc.M110055200; Peacock L, 2008, MOL BIOCHEM PARASIT, V160, P100, DOI 10.1016/j.molbiopara.2008.04.009; Quijada L, 2002, NUCLEIC ACIDS RES, V30, P4414, DOI 10.1093/nar/gkf577; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Reuner B, 1997, MOL BIOCHEM PARASIT, V90, P269, DOI 10.1016/S0166-6851(97)00160-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHELL D, 1991, PARASITOL RES, V77, P558, DOI 10.1007/BF00931012; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Skepper JN, 2000, J MICROSC-OXFORD, V199, P1, DOI 10.1046/j.1365-2818.2000.00704.x; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; Triggs VP, 2003, EUKARYOT CELL, V2, P76, DOI 10.1128/EC.2.1.76-83.2003; Vassella E, 1997, J CELL SCI, V110, P2661; VICKERMAN K, 1988, BIOL CELL, V64, P109, DOI 10.1016/0248-4900(88)90070-6; Welburn SC, 1999, PARASITOL TODAY, V15, P399, DOI 10.1016/S0169-4758(99)01512-4	55	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7217	10.1371/journal.pone.0007217	http://dx.doi.org/10.1371/journal.pone.0007217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787065	Green Published, gold, Green Submitted			2022-12-25	WOS:000270290100016
J	White, C; Lee, J; Kambe, T; Fritsche, K; Petris, MJ				White, Carine; Lee, Jaekwon; Kambe, Taiho; Fritsche, Kevin; Petris, Michael J.			A Role for the ATP7A Copper-transporting ATPase in Macrophage Bactericidal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-PATHOGEN INTERACTIONS; ACUTE-PHASE RESPONSE; TRACE-ELEMENTS; HYDROGEN-PEROXIDE; MENKES-DISEASE; SERUM COPPER; DEFICIENCY; ZINC; INFLAMMATION; MEMBRANE	Copper is an essential micronutrient that is necessary for healthy immune function. This requirement is underscored by an increased susceptibility to bacterial infection in copper-deficient animals; however, a molecular understanding of its importance in immune defense is unknown. In this study, we investigated the effect of proinflammatory agents on copper homeostasis in RAW264.7 macrophages. Interferon-gamma was found to increase expression of the high affinity copper importer, CTR1, and stimulate copper uptake. This was accompanied by copper-stimulated trafficking of the ATP7A copper exporter from the Golgi to vesicles that partially overlapped with phagosomal compartments. Silencing of ATP7A expression attenuated bacterial killing, suggesting a role for ATP7A-dependent copper transport in the bactericidal activity of macrophages. Significantly, a copper-sensitive mutant of Escherichia coli lacking the CopA copper-transporting ATPase was hypersensitive to killing by RAW264.7 macrophages, and this phenotype was dependent on ATP7A expression. Collectively, these data suggest that copper-transporting ATPases, CopA and ATP7A, in both bacteria and macrophage are unique determinants of bacteria survival and identify an unexpected role for copper at the host-pathogen interface.	[Petris, Michael J.] Univ Missouri, Dept Biochem, Christopher S Bond Life Sci Ctr 540D, Columbia, MO 65211 USA; [White, Carine; Petris, Michael J.] Univ Missouri, Dept Nutr Sci, Columbia, MO 65211 USA; [Fritsche, Kevin] Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA; [Petris, Michael J.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln	Petris, MJ (corresponding author), Univ Missouri, Dept Biochem, Christopher S Bond Life Sci Ctr 540D, Columbia, MO 65211 USA.	petrism@missouri.edu	Johnson, Michael D. L./B-4352-2012		National Institutes of Health [DK66333, DK59893, DK79209]; National Institutes of Health, NCI [R24 CA86307]; NATIONAL CANCER INSTITUTE [R24CA086307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK066333, R01DK066333, R01DK059893, R01DK079209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK66333 and DK59893 (to M. J. P.) and DK79209 (to J. L.). The production of <SUP>64</SUP>Cu at Washington University School of Medicine is supported by National Institutes of Health, NCI, Grant R24 CA86307.	Agertt F, 2007, ARQ NEURO-PSIQUIAT, V65, P157, DOI 10.1590/S0004-282X2007000100032; Akcil E, 2003, BIOL TRACE ELEM RES, V93, P95, DOI 10.1385/BTER:93:1-3:95; AUER DE, 1989, VET REC, V124, P235, DOI 10.1136/vr.124.10.235; BABU U, 1990, J NUTR, V120, P1700, DOI 10.1093/jn/120.12.1700; BABU U, 1990, J NUTR, V120, P1692, DOI 10.1093/jn/120.12.1692; BEVERIDGE SJ, 1985, AGENTS ACTIONS, V17, P104, DOI 10.1007/BF01966692; BOYNE R, 1981, J COMP PATHOL, V91, P271, DOI 10.1016/0021-9975(81)90032-3; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cesur S, 2005, J INFECTION, V50, P31, DOI 10.1016/j.jinf.2004.05.001; Chen YT, 2004, GENE, V337, P189, DOI 10.1016/j.gene.2004.05.008; Cobbold C, 2002, HUM MOL GENET, V11, P2855, DOI 10.1093/hmg/11.23.2855; CONFORTI A, 1983, BRIT J PHARMACOL, V79, P45, DOI 10.1111/j.1476-5381.1983.tb10493.x; CROCKER A, 1992, J NATL MED ASSOC, V84, P697; DEGHAIDY F S, 1989, Journal of the Egyptian Society of Parasitology, V19, P205; Del Rio MJ, 2004, ARCH MED RES, V35, P185, DOI 10.1016/j.arcmed.2004.01.001; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Doherty CP, 2007, J NUTR, V137, P1341, DOI 10.1093/jn/137.5.1341; DOLLWET HHA, 1985, TRACE ELEM MED, V2, P80; El Hawy Ahmed M., 1993, Journal of the Egyptian Society of Parasitology, V23, P55; ELZANOWSKA H, 1995, FREE RADICAL BIO MED, V18, P437, DOI 10.1016/0891-5849(94)00150-I; Failla ML, 2003, J NUTR, V133, p1443S, DOI 10.1093/jn/133.5.1443S; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; FOX PL, 1995, LIFE SCI, V56, P1749, DOI 10.1016/0024-3205(95)00146-W; FREELAND JH, 1976, AM J CLIN NUTR, V29, P745, DOI 10.1093/ajcn/29.7.745; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; GUNN TR, 1984, CLIN PEDIATR, V23, P514, DOI 10.1177/000992288402300915; HALLGREN R, 1987, J RHEUMATOL, V14, P548; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Hopkins RG, 1997, J NUTR, V127, P257, DOI 10.1093/jn/127.2.257; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jiang Y, 2005, PLASMID, V54, P149, DOI 10.1016/j.plasmid.2005.03.002; JONES DG, 1981, RES VET SCI, V31, P151, DOI 10.1016/S0034-5288(18)32485-8; JONES DG, 1983, J COMP PATHOL, V93, P143, DOI 10.1016/0021-9975(83)90052-X; Jones P W, 2001, J Wound Care, V10, P205; Kadiiska MB, 2002, SPECTROCHIM ACTA A, V58, P1227, DOI 10.1016/S1386-1425(01)00713-2; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Koyanagi A, 2004, ANN TROP MED PARASIT, V98, P391, DOI 10.1179/000349804225003424; KREUDER J, 1993, EUR J PEDIATR, V152, P828, DOI 10.1007/BF02073380; LAMAND M, 1981, ANN RECH VET, V12, P133; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; MILANINO R, 1993, AGENTS ACTIONS, V39, P195, DOI 10.1007/BF01998974; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; MORIMOTO A, 1989, AM J PHYSIOL, V256, pR35, DOI 10.1152/ajpregu.1989.256.1.R35; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; NEWBERNE PM, 1968, BRIT J EXP PATHOL, V49, P448; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Prentice AM, 2007, J NUTR, V137, P1334, DOI 10.1093/jn/137.5.1334; PROHASKA JR, 1981, SCIENCE, V213, P559; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Rankin S, 2002, INFECT IMMUN, V70, P3637, DOI 10.1128/IAI.70.7.3637-3648.2002; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Scaletti RW, 2003, J DAIRY SCI, V86, P1240, DOI 10.3168/jds.S0022-0302(03)73708-4; Schwan WR, 2005, INT J MED MICROBIOL, V295, P237, DOI 10.1016/j.ijmm.2005.05.005; Seyrek A, 2005, BIOL TRACE ELEM RES, V106, P107, DOI 10.1385/BTER:106:2:107; SHAH I, 1983, CANCER-AM CANCER SOC, V51, P851, DOI 10.1002/1097-0142(19830301)51:5<851::AID-CNCR2820510518>3.0.CO;2-Y; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; SRINIVAS U, 1988, SCAND J CLIN LAB INV, V48, P495, DOI 10.3109/00365518809085763; Stoyanov JV, 2003, FEBS LETT, V546, P391, DOI 10.1016/S0014-5793(03)00640-9; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Uno H, 1987, Am J Med Genet Suppl, V3, P367; Voruganti VS, 2005, BURNS, V31, P711, DOI 10.1016/j.burns.2005.04.026; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; WARD WF, 1989, ADV EXP MED BIOL, V258, P287; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; Yilmaz A, 2005, CLIN RHEUMATOL, V24, P331, DOI 10.1007/s10067-004-1028-y	68	340	342	4	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33949	33956		10.1074/jbc.M109.070201	http://dx.doi.org/10.1074/jbc.M109.070201			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808669	Green Published, hybrid			2022-12-25	WOS:000272165200027
J	Hadian, K; Vincendeau, M; Maeusbacher, N; Nagel, D; Hauck, SM; Ueffing, M; Loyter, A; Werner, T; Wolff, H; Brack-Werner, R				Hadian, Kamyar; Vincendeau, Michelle; Maeusbacher, Nina; Nagel, Daniel; Hauck, Stefanie M.; Ueffing, Marius; Loyter, Abraham; Werner, Thomas; Wolff, Horst; Brack-Werner, Ruth			Identification of a Heterogeneous Nuclear Ribonucleoprotein-recognition Region in the HIV Rev Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; VIRUS PRODUCTION; HNRNP; TRANSLATION; RETROVIRUSES; REQUIREMENT; INFECTION; INTERACTS; TARGETS; EXPORT	The Rev protein is a key regulator of human immunodeficiency virus type 1 (HIV-1) gene expression. Rev is primarily known as an adaptor protein for nuclear export of HIV RNAs. However, Rev also contributes to numerous other processes by less well known mechanisms. Understanding the functional nature of Rev requires extensive knowledge of its cellular interaction partners. Here we demonstrate that Rev interacts with members of a large family of multifunctional host cell factors called hnRNPs. Rev employs amino acids 9-14 for specific binding to the heterogeneous nuclear ribonucleoproteins (hnRNP) A1, Q, K, R, and U. In addition, Rev interacts with hnRNP E1 and E2 by a different mechanism. The set of hnRNPs recognized by the N terminus of Rev feature RGG boxes. Exemplary testing of hnRNP A1 revealed a critical role of arginine residues within the RGG box for interaction with Rev. Finally, we demonstrate that expression levels of hnRNP A1, Q, K, R, and U influence HIV-1 production by persistently infected astrocytes, linking these hnRNPs to HIV replication. The novel interaction of HIV-1 Rev with functionally diverse hnRNPs lends further support to the idea that Rev is a multifunctional protein and may be involved in coupling HIV replication to diverse cellular processes and promoting virus-host cell interactions.	[Hadian, Kamyar; Vincendeau, Michelle; Maeusbacher, Nina; Nagel, Daniel; Wolff, Horst; Brack-Werner, Ruth] Helmholtz Zentrum Munchen, Res Ctr Environm Hlth, Inst Virol, D-85764 Neuherberg, Germany; [Hauck, Stefanie M.; Ueffing, Marius] Helmholtz Zentrum Munchen, Res Ctr Environm Hlth, Dept Prot Sci, D-85764 Neuherberg, Germany; [Loyter, Abraham] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Werner, Thomas] Genomatix Software GmbH, D-80335 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hebrew University of Jerusalem	Brack-Werner, R (corresponding author), Helmholtz Zentrum Munchen, Res Ctr Environm Hlth, Inst Virol, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.	brack@helmholtz-muenchen.de	Hauck, Stefanie/B-3300-2013; Vincendeau, Michelle/AAD-4320-2022; Hadian, Kamyar/B-6314-2013; Brack-Werner, Ruth/M-4615-2014	Hauck, Stefanie/0000-0002-1630-6827; Hadian, Kamyar/0000-0001-8727-2575; Brack-Werner, Ruth/0000-0002-8651-9318	Deutsche Forschungsgemeinschaft [1710/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant 1710/1-3 (to R.B.W.).	ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; BRACKWERNER R, 1992, AIDS, V6, P273, DOI 10.1097/00002030-199203000-00003; Brandt S, 2007, PLOS PATHOG, V3, P518, DOI 10.1371/journal.ppat.0030054; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; DAGOSTINO DM, 1992, MOL CELL BIOL, V12, P1375, DOI 10.1128/MCB.12.3.1375; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; Felber BK, 2007, ADV PHARMACOL, V55, P161, DOI 10.1016/S1054-3589(07)55005-2; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Groom HCT, 2009, J GEN VIROL, V90, P1303, DOI 10.1099/vir.0.011460-0; Groom HCT, 2009, J GEN VIROL, V90, P1141, DOI 10.1099/vir.0.007963-0; Hauck SM, 2005, PROTEOMICS, V5, P3623, DOI 10.1002/pmic.200401223; He YW, 2009, MOL CARCINOGEN, V48, P167, DOI 10.1002/mc.20467; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; Kammler S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-89; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kjems J, 2000, Adv Pharmacol, V48, P251; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lever AML, 2007, ADV PHARMACOL, V55, P1, DOI 10.1016/S1054-3589(07)55001-5; Ludwig E, 1999, J VIROL, V73, P8279, DOI 10.1128/JVI.73.10.8279-8289.1999; Ma J, 2008, VIROLOGY, V375, P253, DOI 10.1016/j.virol.2008.01.025; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Nekhai S, 2006, FUTURE MICROBIOL, V1, P417, DOI 10.2217/17460913.1.4.417; Peters Reiner, 2006, V322, P259; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Reed R, 2001, NAT CELL BIOL, V3, pE201, DOI 10.1038/ncb0901-e201; Stauber RH, 1998, BIOTECHNIQUES, V24, P462, DOI 10.2144/98243rr01; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; Tschodrich-Rotter M, 1998, J MICROSC-OXFORD, V192, P114, DOI 10.1046/j.1365-2818.1998.00411.x; Valente ST, 2006, MOL CELL, V23, P597, DOI 10.1016/j.molcel.2006.07.021; Wadd S, 1999, J BIOL CHEM, V274, P28991, DOI 10.1074/jbc.274.41.28991; Wolff H, 2006, EXP CELL RES, V312, P443, DOI 10.1016/j.yexcr.2005.11.020; Wolff H, 2003, NUCLEIC ACIDS RES, V31, P2839, DOI 10.1093/nar/gkg390; Wolff H, 2006, BIOTECHNIQUES, V41, P688, DOI 10.2144/000112291; Woolaway K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-28; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	44	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33384	33391		10.1074/jbc.M109.021659	http://dx.doi.org/10.1074/jbc.M109.021659			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808671	Green Published, hybrid			2022-12-25	WOS:000272028500044
J	Pacheco, S; Gomez, I; Arenas, I; Saab-Rincon, G; Rodriguez-Almazan, C; Gill, SS; Bravo, A; Soberon, M				Pacheco, Sabino; Gomez, Isabel; Arenas, Ivan; Saab-Rincon, Gloria; Rodriguez-Almazan, Claudia; Gill, Sarjeet S.; Bravo, Alejandra; Soberon, Mario			Domain II Loop 3 of Bacillus thuringiensis Cry1Ab Toxin Is Involved in a "Ping Pong" Binding Mechanism with Manduca sexta Aminopeptidase-N and Cadherin Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; PORE-FORMING TOXIN; HELIOTHIS-VIRESCENS; INSECTICIDAL TOXIN; MEMBRANE INSERTION; OLIGOMER FORMATION; DELTA-ENDOTOXINS; BT-R-1 RECEPTOR; LARVAL MIDGUT; PRE-PORE	Bacillus thuringiensis Cry toxins are used worldwide as insecticides in agriculture, in forestry, and in the control of disease transmission vectors. In the lepidopteran Manduca sexta, cadherin (Bt-R-1) and aminopeptidase-N (APN) function as Cry1A toxin receptors. The interaction with Bt-R-1 promotes cleavage of the amino-terminal end, including helix alpha-1 and formation of prepore oligomer that binds to APN, leading to membrane insertion and pore formation. Loops of domain II of Cry1Ab toxin are involved in receptor interaction. Here we show that Cry1Ab mutants located in domain II loop 3 are affected in binding to both receptors and toxicity against Manduca sexta larvae. Interaction with both receptors depends on the oligomeric state of the toxin. Monomers of loop 3 mutants were affected in binding to APN and to a cadherin fragment corresponding to cadherin repeat 12 but not with a fragment comprising cadherin repeats 7-12. In contrast, the oligomers of loop 3 mutants were affected in binding to both Bt-R-1 fragments but not to APN. Toxicity assays showed that either monomeric or oligomeric structures of Cry1Ab loop 3 mutations were severely affected in insecticidal activity. These data suggest that loop 3 is differentially involved in the binding with both receptor molecules, depending on the oligomeric state of the toxin and also that possibly a "ping pong" binding mechanism with both receptors is involved in toxin action.	[Pacheco, Sabino; Gomez, Isabel; Arenas, Ivan; Saab-Rincon, Gloria; Rodriguez-Almazan, Claudia; Bravo, Alejandra; Soberon, Mario] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico; [Gill, Sarjeet S.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92506 USA	Universidad Nacional Autonoma de Mexico; University of California System; University of California Riverside	Soberon, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo Postal 510-3, Cuernavaca 62250, Morelos, Mexico.	mario@ibt.unam.mx	Pacheco, Sabino/AFJ-9017-2022; Saab-RIncon, Gloria/AFO-4892-2022; de la Parra, Maria Alejandra Bravo/R-6740-2017	Saab-RIncon, Gloria/0000-0002-5251-1000; ARENAS, IVAN/0000-0003-0384-7437; Pacheco, Sabino/0000-0002-0208-0046; Bravo, Alejandra/0000-0002-7573-7475	National Institutes of Health [1R01 AI066014]; Consejo Nacional de Ciencia y Tecnologia [83135, 81639]; DGAPA-UNAM [IN218608-3, IN210208]; United States Department of Agriculture [2207-35607-17780]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 AI066014. This work was also supported by Consejo Nacional de Ciencia y Tecnologia Grants 83135 and 81639, DGAPA-UNAM Grants IN218608-3 and IN210208, and United States Department of Agriculture Grant 2207-35607-17780.	Abrami L, 2003, INFECT IMMUN, V71, P739, DOI 10.1128/IAI.71.2.739-746.2003; Atsumi S, 2005, APPL ENVIRON MICROB, V71, P3966, DOI 10.1128/AEM.71.7.3966-3977.2005; Atsumi S, 2008, FEBS J, V275, P4913, DOI 10.1111/j.1742-4658.2008.06634.x; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bel Y, 2006, GENE, V381, P71, DOI 10.1016/j.gene.2006.07.001; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Chen J, 2005, CELL TISSUE RES, V321, P123, DOI 10.1007/s00441-005-1124-6; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gomez I, 2003, BIOCHEMISTRY-US, V42, P10482, DOI 10.1021/bi034440p; Gomez I, 2001, J BIOL CHEM, V276, P28906, DOI 10.1074/jbc.M103007200; Gomez I, 2002, J BIOL CHEM, V277, P30137, DOI 10.1074/jbc.M203121200; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Hasuwa H, 2001, BIOCHEM BIOPH RES CO, V289, P782, DOI 10.1006/bbrc.2001.6053; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Jenkins J L, 2000, Genet Eng (N Y), V22, P33; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Lopez S, 2004, TRENDS MICROBIOL, V12, P271, DOI 10.1016/j.tim.2004.04.003; Lorence A, 1997, FEBS LETT, V414, P303, DOI 10.1016/S0014-5793(97)01014-4; MASSON L, 1995, J BIOL CHEM, V270, P20309, DOI 10.1074/jbc.270.35.20309; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1998, BIOSCI BIOTECH BIOCH, V62, P727, DOI 10.1271/bbb.62.727; Nair MS, 2008, J BIOL CHEM, V283, P26324, DOI 10.1074/jbc.M802895200; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; RAJAMOHAN F, 1995, J BACTERIOL, V177, P2276, DOI 10.1128/jb.177.9.2276-2282.1995; Rajamohan F, 1996, J BIOL CHEM, V271, P25220, DOI 10.1074/jbc.271.41.25220; Sangadala S, 2001, INSECT BIOCHEM MOLEC, V32, P97, DOI 10.1016/S0965-1748(01)00086-8; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Smedley DP, 1996, MICROBIOL-SGM, V142, P1617, DOI 10.1099/13500872-142-7-1617; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	45	101	110	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32750	32757		10.1074/jbc.M109.024968	http://dx.doi.org/10.1074/jbc.M109.024968			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19808680	hybrid, Green Published			2022-12-25	WOS:000272028400060
J	Podobnik, M; Tyagi, R; Matange, N; Dermol, U; Gupta, AK; Mattoo, R; Seshadri, K; Visweswariah, SS				Podobnik, Marjetka; Tyagi, Richa; Matange, Nishad; Dermol, Urska; Gupta, Arun K.; Mattoo, Rohini; Seshadri, Kothandaraman; Visweswariah, Sandhya S.			A Mycobacterial Cyclic AMP Phosphodiesterase That Moonlights as a Modifier of Cell Wall Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE PHOSPHODIESTERASE; TUBERCULOSIS; GLYCEROPHOSPHODIESTERASE; BIOSYNTHESIS; BIOCHEMISTRY; ARCHITECTURE; NUCLEASE; MEMBERS; RV1647	Mycobacterium tuberculosis utilizes many mechanisms to establish itself within the macrophage, and bacterially derived cAMP is important in modulating the host cellular response. Although the genome of M. tuberculosis is endowed with a number of mammalian-like adenylyl cyclases, only a single cAMP phosphodiesterase has been identified that can decrease levels of cAMP produced by the bacterium. We present the crystal structure of the full-length and sole cAMP phosphodiesterase, Rv0805, found in M. tuberculosis, whose orthologs are present only in the genomes of slow growing and pathogenic mycobacteria. The dimeric core catalytic domain of Rv0805 adopts a metallophosphoesterase-fold, and the C-terminal region builds the active site and contributes to multiple substrate utilization. Localization of Rv0805 to the cell wall is dependent on its C terminus, and expression of either wild type or mutationally inactivated Rv0805 in M. smegmatis alters cell permeability to hydrophobic cytotoxic compounds. Rv0805 may therefore play a key role in the pathogenicity of mycobacteria, not only by hydrolyzing bacterial cAMP, but also by moonlighting as a protein that can alter cell wall functioning.	[Podobnik, Marjetka; Dermol, Urska] Natl Inst Chem Slovenia, Lab Biosynth & Biotransformat, Ljubljana 1000, Slovenia; [Tyagi, Richa; Matange, Nishad; Mattoo, Rohini; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Seshadri, Kothandaraman] AstraZeneca India Private Ltd, Bangalore 560024, Karnataka, India	National Institute of Chemistry - Slovenia; Indian Institute of Science (IISC) - Bangalore; AstraZeneca	Podobnik, M (corresponding author), Natl Inst Chem Slovenia, Lab Biosynth & Biotransformat, Hajdrihova 19, Ljubljana 1000, Slovenia.	marjetka.podobnik@ki.si; sandhya@mrdg.iisc.ernet.in	tyagi, richa/A-7261-2015; Visweswariah, Sandhya/Q-7500-2019; matange, nishad/AAF-9653-2020	Visweswariah, Sandhya/0000-0003-2786-7344; Matange, Nishad/0000-0002-2947-3931; Mattoo, Rohini/0000-0003-2185-0031	Slovenian Research Agency; Department of Biotechnology, Government of India; Department of Science and Technology, Government of India	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported in part by grants from the Slovenian Research Agency (to M. P. and U. D.), the Department of Biotechnology, Government of India, and the Department of Science and Technology, Government of India for an Indo-Slovenian joint project.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyne ME, 2007, ANTIMICROB AGENTS CH, V51, P3562, DOI 10.1128/AAC.00383-07; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Hadler KS, 2008, J AM CHEM SOC, V130, P14129, DOI 10.1021/ja803346w; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Jackson CJ, 2007, J MOL BIOL, V367, P1047, DOI 10.1016/j.jmb.2007.01.032; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liu J, 1999, P NATL ACAD SCI USA, V96, P4011, DOI 10.1073/pnas.96.7.4011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Richter W, 2002, PROTEINS, V46, P278, DOI 10.1002/prot.10049; Shenoy AR, 2005, BIOCHEM J, V387, P541, DOI 10.1042/BJ20041040; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Tyagi R, 2009, J BIOL CHEM, V284, P5217, DOI 10.1074/jbc.M805996200; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	34	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32846	32857		10.1074/jbc.M109.049635	http://dx.doi.org/10.1074/jbc.M109.049635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801656	Green Published, hybrid			2022-12-25	WOS:000272028400069
J	Feldhammer, M; Durand, S; Pshezhetsky, AV				Feldhammer, Matthew; Durand, Stephanie; Pshezhetsky, Alexey V.			Protein Misfolding as an Underlying Molecular Defect in Mucopolysaccharidosis III Type C	PLOS ONE			English	Article							GLUCOSAMINIDE N-ACETYLTRANSFERASE; LYSOSOMAL STORAGE DISORDERS; DISEASE TYPE-C; SANFILIPPO-SYNDROME; ACETYL-COA; TRANSMEMBRANE PROTEIN; SKIN FIBROBLASTS; PURIFICATION; NETHERLANDS; PREVALENCE	Mucopolysaccharidosis type IIIC or Sanfilippo syndrome type C (MPS IIIC, MIM #252930) is an autosomal recessive disorder caused by deficiency of the lysosomal membrane enzyme, heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT, EC 2.3.1.78), which catalyses transmembrane acetylation of the terminal glucosamine residues of heparan sulfate prior to their hydrolysis by alpha-N-acetylglucosaminidase. Lysosomal storage of undegraded heparan sulfate in the cells of affected patients leads to neuronal death causing neurodegeneration and is accompanied by mild visceral and skeletal abnormalities, including coarse facies and joint stiffness. Surprisingly, the majority of MPS IIIC patients carrying missense mutations are as severely affected as those with splicing errors, frame shifts or nonsense mutations resulting in the complete absence of HGSNAT protein. In order to understand the effects of the missense mutations in HGSNAT on its enzymatic activity and biogenesis, we have expressed 21 mutant proteins in cultured human fibroblasts and COS-7 cells and studied their folding, targeting and activity. We found that 17 of the 21 missense mutations in HGSNAT caused misfolding of the enzyme, which is abnormally glycosylated and not targeted to the lysosome, but retained in the endoplasmic reticulum. The other 4 mutants represented rare polymorphisms which had no effect on the activity, processing and targeting of the enzyme. Treatment of patient cells with a competitive HGSNAT inhibitor, glucosamine, partially rescued several of the expressed mutants. Altogether our data provide an explanation for the severity of MPS IIIC and suggest that search for pharmaceutical chaperones can in the future result in therapeutic options for this disease.			Feldhammer, M (corresponding author), Univ Montreal, Dept Med Genet, CHU St Justine, Montreal, PQ, Canada.	alexei.pchejetski@umontreal.ca		A, Pshezhetsky/0000-0002-6612-1062				Ausseil K, 2006, MOL GENET METAB, V87, P22, DOI 10.1016/j.ymgme.2005.09.021; BAME KJ, 1986, SCIENCE, V233, P1087, DOI 10.1126/science.3090688; BARTSOCAS C, 1979, EUR J PEDIATR, V130, P251, DOI 10.1007/BF00441361; Berger-Plantinga EG, 2004, J NEUROL, V251, P479, DOI 10.1007/s00415-004-0368-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Fan XL, 2006, AM J HUM GENET, V79, P738, DOI 10.1086/508068; Fedele Anthony Olind, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9488; Feldhammer M, 2009, HUM MUTAT, V30, P918, DOI 10.1002/humu.20986; Gregersen N, 2001, J INHERIT METAB DIS, V24, P189, DOI 10.1023/A:1010319001722; HE W, 1994, PRENATAL DIAG, V14, P17, DOI 10.1002/pd.1970140104; Hrebicek M, 2006, AM J HUM GENET, V79, P807, DOI 10.1086/508294; KLEIN U, 1981, CLIN GENET, V20, P55; KLEIN U, 1978, P NATL ACAD SCI USA, V75, P5185, DOI 10.1073/pnas.75.10.5185; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Pinto R, 2004, EUR J HUM GENET, V12, P87, DOI 10.1038/sj.ejhg.5201044; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ruijter GJG, 2008, MOL GENET METAB, V93, P104, DOI 10.1016/j.ymgme.2007.09.011; Seyrantepe V, 2006, HUM GENET, V120, P293, DOI 10.1007/s00439-006-0211-4; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5	26	58	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7434	10.1371/journal.pone.0007434	http://dx.doi.org/10.1371/journal.pone.0007434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823584	Green Submitted, Green Published, gold			2022-12-25	WOS:000270808300012
J	Rosenbaum, HC; Pomilla, C; Mendez, M; Leslie, MS; Best, PB; Findlay, KP; Minton, G; Erststs, PJ; Collins, T; Engel, MH; Bonatto, SL; Kotze, DPGH; Meyer, M; Barendse, J; Thornton, M; Razafindrakoto, Y; Ngouessono, S; Vely, M; Kiszka, J				Rosenbaum, Howard C.; Pomilla, Cristina; Mendez, Martin; Leslie, Matthew S.; Best, Peter B.; Findlay, Ken P.; Minton, Gianna; Erststs, Peter J.; Collins, Timothy; Engel, Marcia H.; Bonatto, Sandro L.; Kotze, Deon P. G. H.; Meyer, Mike; Barendse, Jaco; Thornton, Meredith; Razafindrakoto, Yvette; Ngouessono, Solange; Vely, Michel; Kiszka, Jeremy			Population Structure of Humpback Whales from Their Breeding Grounds in the South Atlantic and Indian Oceans	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DIVERSITY; MEGAPTERA-NOVAEANGLIAE; PHYLOGEOGRAPHY	Although humpback whales are among the best-studied of the large whales, population boundaries in the Southern Hemisphere (SH) have remained largely untested. We assess population structure of SH humpback whales using 1,527 samples collected from whales at fourteen sampling sites within the Southwestern and Southeastern Atlantic, the Southwestern Indian Ocean, and Northern Indian Ocean (Breeding Stocks A, B, C and X, respectively). Evaluation of mtDNA population structure and migration rates was carried out under different statistical frameworks. Using all genetic evidence, the results suggest significant degrees of population structure between all ocean basins, with the Southwestern and Northern Indian Ocean most differentiated from each other. Effective migration rates were highest between the Southeastern Atlantic and the Southwestern Indian Ocean, followed by rates within the Southeastern Atlantic, and the lowest between the Southwestern and Northern Indian Ocean. At finer scales, very low gene flow was detected between the two neighbouring sub-regions in the Southeastern Atlantic, compared to high gene flow for whales within the Southwestern Indian Ocean. Our genetic results support the current management designations proposed by the International Whaling Commission of Breeding Stocks A, B, C, and X as four strongly structured populations. The population structure patterns found in this study are likely to have been influenced by a combination of long-term maternally directed fidelity of migratory destinations, along with other ecological and oceanographic features in the region.	[Rosenbaum, Howard C.; Pomilla, Cristina; Mendez, Martin; Leslie, Matthew S.; Erststs, Peter J.; Collins, Timothy] Wildlife Conservat Soc, Cetacean Conservat & Res Program, Bronx, NY USA; [Rosenbaum, Howard C.; Pomilla, Cristina; Mendez, Martin; Leslie, Matthew S.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Rosenbaum, Howard C.; Pomilla, Cristina; Mendez, Martin; Leslie, Matthew S.] Amer Museum Nat Hist, Conservat Genet Program, New York, NY 10024 USA; [Rosenbaum, Howard C.; Pomilla, Cristina; Erststs, Peter J.] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Rosenbaum, Howard C.; Mendez, Martin] Columbia Univ, Dept E3B, New York, NY USA; [Best, Peter B.; Barendse, Jaco; Thornton, Meredith] Univ Pretoria, Mammal Res Inst, Cape Town, South Africa; [Minton, Gianna; Collins, Timothy] Environm Soc Oman, Muscat, Oman; [Engel, Marcia H.] Inst Baleia Jubarte, Caravelas, BA, Brazil; [Findlay, Ken P.] Univ Cape Town, Dept Oceanog, ZA-7700 Rondebosch, South Africa; [Kotze, Deon P. G. H.; Meyer, Mike] Marine & Coastal Management, Cape Town, South Africa; [Engel, Marcia H.; Bonatto, Sandro L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Razafindrakoto, Yvette] Madagascar Country Program, Wildlife Conservat Soc, Antananarivo, Madagascar; [Ngouessono, Solange] Minist Tourisme & Parcs Nationaux, Agence Natl Parcs Nationaux, Libreville, Gabon; [Vely, Michel] Assoc Megaptera, Paris, France; [Kiszka, Jeremy] Univ La Rochelle, LIENSS, Inst Littoral & Environm, La Rochelle, France	Wildlife Conservation Society; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Columbia University; University of Pretoria; University of Cape Town; Pontificia Universidade Catolica Do Rio Grande Do Sul; La Rochelle Universite	Rosenbaum, HC (corresponding author), Wildlife Conservat Soc, Cetacean Conservat & Res Program, Bronx, NY USA.	hrosenbaum@wcs.org	Kiszka, Jeremy J./AAH-2588-2020; Barendse, Jaco/F-7064-2012; Pomilla, Cristina/AAC-4035-2020; Pomilla, Cristina/GYD-9678-2022; Findlay, Ken P/A-5766-2019; Bonatto, Sandro L/A-1240-2010	Kiszka, Jeremy J./0000-0003-1095-8979; Barendse, Jaco/0000-0003-2859-4501; Pomilla, Cristina/0000-0002-2581-8365; Findlay, Ken P/0000-0001-7154-8805; Bonatto, Sandro L/0000-0002-0064-467X; Collins, Tim/0000-0002-7124-4876	National Research Foundation (South Africa) [2053539]; Lenfest Oceans Program	National Research Foundation (South Africa)(National Research Foundation - South Africa); Lenfest Oceans Program	This material is based upon work supported by the National Research Foundation (South Africa) under Grant number 2053539. We also acknowledge Marine and Coastal Management, South Africa, for the cruises of the research vessel Algoa and collection of samples in South Africa and Mozambique, and special thanks go to Herman Oosthuizen. The Instituto Baleia Jubarte was sponsored by Petrleo Brasileiro S.A (PETROBRAS) and Norsul Cia. De Navegao. Funding to HCR was provided by numerous individuals and foundations, especially the Lenfest Oceans Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CS, 1986, MAR ECOL PROG SER, V31, P105, DOI 10.3354/meps031105; Bourjea J, 2007, MOL ECOL, V16, P175, DOI 10.1111/j.1365-294X.2006.03122.x; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Calambokidis J, 1996, MAR MAMMAL SCI, V12, P215, DOI 10.1111/j.1748-7692.1996.tb00572.x; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Clapham PJ, 1999, MAMMAL REV, V29, P35; DAVIES JL, 1963, EVOLUTION, V17, P107, DOI 10.2307/2406339; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Engel MH, 2008, CONSERV GENET, V9, P1253, DOI 10.1007/s10592-007-9453-5; Findlay KP, 1996, MAR MAMMAL SCI, V12, P354, DOI 10.1111/j.1748-7692.1996.tb00589.x; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Leduc R.G., 2007, Journal of Cetacean Research and Management, V9, P73; MARKINTUDA NA, 1942, DISCOVERY REP, V22, P197; MINTON G, 2006, IUCN REDLIST, V1, P3; Olavarria C, 2007, MAR ECOL PROG SER, V330, P257, DOI 10.3354/meps330257; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; PALSBOLL PJ, 1995, MAR ECOL PROG SER, V116, P1, DOI 10.3354/meps116001; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Reeves R.R., 1991, Marine Mammal Technical Report, V3, P259	21	72	83	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7318	10.1371/journal.pone.0007318	http://dx.doi.org/10.1371/journal.pone.0007318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YN	19812698	Green Published, gold, Green Submitted			2022-12-25	WOS:000207567000001
J	Lambert-Langlais, S; Pointud, JC; Lefrancois-Martinez, AM; Volat, F; Manin, M; Coudore, F; Val, P; Sahut-Barnola, I; Ragazzon, B; Louiset, E; Delarue, C; Lefebvre, H; Urade, Y; Martinez, A				Lambert-Langlais, Sarah; Pointud, Jean-Christophe; Lefrancois-Martinez, Anne-Marie; Volat, Fanny; Manin, Michele; Coudore, Francois; Val, Pierre; Sahut-Barnola, Isabelle; Ragazzon, Bruno; Louiset, Estelle; Delarue, Catherine; Lefebvre, Herve; Urade, Yoshihiro; Martinez, Antoine			Aldo Keto Reductase 1B7 and Prostaglandin F-2 alpha Are Regulators of Adrenal Endocrine Functions	PLOS ONE			English	Article							MOUSE VAS-DEFERENS; SIDE-CHAIN CLEAVAGE; GENE AKR1B7 EXPRESSION; AGOUTI-RELATED PROTEIN; ADRENOCORTICAL-CELLS; LEYDIG-CELLS; DEVELOPMENTAL REGULATION; FACTOR-I; GLAND; SYNTHASE	Prostaglandin F-2 alpha (PGF(2 alpha)), represses ovarian steroidogenesis and initiates parturition in mammals but its impact on adrenal gland is unknown. Prostaglandins biosynthesis depends on the sequential action of upstream cyclooxygenases (COX) and terminal synthases but no PGF(2 alpha) synthases (PGFS) were functionally identified in mammalian cells. In vitro, the most efficient mammalian PGFS belong to aldo-keto reductase 1B (AKR1B) family. The adrenal gland is a major site of AKR1B expression in both human (AKR1B1) and mouse (AKR1B3, AKR1B7). Thus, we examined the PGF(2 alpha) biosynthetic pathway and its functional impact on both cortical and medullary zones. Both compartments produced PGF(2 alpha) but expressed different biosynthetic isozymes. In chromaffin cells, PGF(2 alpha) secretion appeared constitutive and correlated to continuous expression of COX1 and AKR1B3. In steroidogenic cells, PGF(2 alpha) secretion was stimulated by adrenocorticotropic hormone (ACTH) and correlated to ACTH-responsiveness of both COX2 and AKR1B7/B1. The pivotal role of AKR1B7 in ACTH-induced PGF(2 alpha) release and functional coupling with COX2 was demonstrated using over-and down-expression in cell lines. PGF(2 alpha) receptor was only detected in chromaffin cells, making medulla the primary target of PGF(2 alpha) action. By comparing PGF(2 alpha)-responsiveness of isolated cells and whole adrenal cultures, we demonstrated that PGF(2 alpha) repressed glucocorticoid secretion by an indirect mechanism involving a decrease in catecholamine release which in turn decreased adrenal steroidogenesis. PGF(2 alpha) may be regarded as a negative autocrine/paracrine regulator within a novel intra-adrenal feedback loop. The coordinated cell-specific regulation of COX2 and AKR1B7 ensures the generation of this stress-induced corticostatic signal.			Lambert-Langlais, S (corresponding author), Clermont Univ, CNRS, Genet Reprod & Dev UMR6247, Aubiere, France.	antoine.martinez@univ-bpclermont.fr	Ragazzon, Bruno/E-6541-2017; Louiset, Estelle/N-5530-2018	Ragazzon, Bruno/0000-0001-9476-4973; Lefebvre, Herve/0000-0002-6181-9648; Louiset, Estelle/0000-0002-4723-095X; Val, Pierre/0000-0001-7648-5567				Aida K, 2000, BIOCHEM BIOPH RES CO, V277, P281, DOI 10.1006/bbrc.2000.3648; Aigueperse C, 1999, J ENDOCRINOL, V160, P147, DOI 10.1677/joe.0.1600147; Aigueperse C, 2001, MOL ENDOCRINOL, V15, P93, DOI 10.1210/me.15.1.93; Albertin G, 2006, INT J MOL MED, V17, P1111; Baron S, 2003, J MOL ENDOCRINOL, V31, P71, DOI 10.1677/jme.0.0310071; Bielohuby M, 2007, AM J PHYSIOL-ENDOC M, V293, pE139, DOI 10.1152/ajpendo.00705.2006; Bornstein SR, 1997, DIABETES, V46, P1235, DOI 10.2337/diabetes.46.7.1235; Brockstedt E, 2000, ENDOCRINOLOGY, V141, P2574, DOI 10.1210/en.141.7.2574; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Charbonneau C, 2004, BIOCHEM BIOPH RES CO, V319, P518, DOI 10.1016/j.bbrc.2004.05.022; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Contesse V, 1999, MOL PHARMACOL, V56, P552, DOI 10.1124/mol.56.3.552; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Doghman M, 2004, ENDOCRINOLOGY, V145, P541, DOI 10.1210/en.2003-0605; DONOHUE PJ, 1994, J BIOL CHEM, V269, P8604; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Fortier MA, 2008, J PHYSIOL PHARMACOL, V59, P65; Frungieri MB, 2006, ENDOCRINOLOGY, V147, P4476, DOI 10.1210/en.2006-0090; Haidan A, 1998, ENDOCRINOLOGY, V139, P772, DOI 10.1210/en.139.2.772; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; Hsu HT, 2006, J CLIN ENDOCR METAB, V91, P2761, DOI 10.1210/jc.2005-2383; Hyndman D, 2003, CHEM-BIOL INTERACT, V143, P621, DOI 10.1016/S0009-2797(02)00193-X; Hyndman DJ, 1998, BBA-GENE STRUCT EXPR, V1399, P198, DOI 10.1016/S0167-4781(98)00109-2; Ichitani Y, 2001, CELL TISSUE RES, V303, P235, DOI 10.1007/s004410000296; JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117; Kabututu Z, 2009, J BIOCHEM, V145, P161, DOI 10.1093/jb/mvn152; LAU ET, 1995, BIOCHEM J, V312, P609, DOI 10.1042/bj3120609; Lefrancois-Martinez AM, 1999, J BIOL CHEM, V274, P32875, DOI 10.1074/jbc.274.46.32875; Lefrancois-Martinez AM, 2004, J CLIN ENDOCR METAB, V89, P3010, DOI 10.1210/jc.2003-031830; Madore E, 2003, J BIOL CHEM, V278, P11205, DOI 10.1074/jbc.M208318200; Martinez A, 2001, CHEM-BIOL INTERACT, V130, P903, DOI 10.1016/S0009-2797(00)00244-1; MARTINEZ A, 1990, MOL CELL ENDOCRINOL, V72, P201, DOI 10.1016/0303-7207(90)90144-W; Matsuura K, 1996, ARCH BIOCHEM BIOPHYS, V328, P265, DOI 10.1006/abbi.1996.0172; McCracken JA, 1999, PHYSIOL REV, V79, P263, DOI 10.1152/physrev.1999.79.2.263; Mohn CE, 2005, P NATL ACAD SCI USA, V102, P6213, DOI 10.1073/pnas.0502136102; Morel L, 2001, J ANDROL, V22, P549; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; PAILHOUX EA, 1990, J BIOL CHEM, V265, P19932; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Pralong FP, 1998, ENDOCRINOLOGY, V139, P4264, DOI 10.1210/en.139.10.4264; Ragazzon B, 2006, ENDOCRINOLOGY, V147, P1805, DOI 10.1210/en.2005-1279; Ramsay RG, 2003, INT J IMMUNOPATH PH, V16, P59; Scher JU, 2009, J INVEST MED, V57, P703, DOI 10.2310/JIM.0b013e31819aaa76; Sicard F, 2006, J CLIN ENDOCR METAB, V91, P3131, DOI 10.1210/jc.2006-0105; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Suzuki-Yamamoto T, 2007, HISTOCHEM CELL BIOL, V128, P317, DOI 10.1007/s00418-007-0316-4; TARAGNAT C, 1988, J REPROD FERTIL, V83, P835, DOI 10.1530/jrf.0.0830835; Tirard J, 2007, ENDOCRINOLOGY, V148, P1996, DOI 10.1210/en.2006-1707; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Val P, 2002, ENDOCRINOLOGY, V143, P3435, DOI 10.1210/en.2002-220293; Volle DH, 2004, MOL ENDOCRINOL, V18, P888, DOI 10.1210/me.2003-0338; WILTBANK MC, 1995, BIOL REPROD, V52, P74, DOI 10.1095/biolreprod52.1.74; Yang JY, 2006, AM J PHYSIOL-RENAL, V291, pF186, DOI 10.1152/ajprenal.00506.2005	55	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7309	10.1371/journal.pone.0007309	http://dx.doi.org/10.1371/journal.pone.0007309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809495	Green Submitted, Green Published, gold			2022-12-25	WOS:000270594000003
J	Leypoldt, F; Choe, CU; Gelderblom, M; von Leitner, EC; Atzler, D; Schwedhelm, E; Gerloff, C; Sydow, K; Boger, RH; Magnus, T				Leypoldt, Frank; Choe, Chi-Un; Gelderblom, Mathias; von Leitner, Eike-Christin; Atzler, Dorothee; Schwedhelm, Edzard; Gerloff, Christian; Sydow, Karsten; Boeger, Rainer H.; Magnus, Tim			Dimethylarginine Dimethylaminohydrolase-1 Transgenic Mice Are Not Protected from Ischemic Stroke	PLOS ONE			English	Article								Background: Methylated arginines are endogenous analogues of L-arginine, the substrate for nitric oxide (NO) synthase. Asymmetric dimethylarginine (ADMA) interferes with NO formation, causing endothelial dysfunction. ADMA is a predictor of cardiovascular events and mortality in humans. It is eliminated primarily by enzymatic activity of dimethylarginine dimethylaminohydrolase (DDAH). Methodology/Principal Findings: We investigated whether human DDAH-1 (hDDAH-1) transgenicity protects from ischemic tissue damage in temporary middle cerebral artery occlusion (tMCAO) in mice. Infarct sizes did not significantly differ between hDDAH-1 transgenic (TG) mice and wild-type littermates (WT). As expected, ADMA plasma concentrations were significantly decreased, cerebral hDDAH expression and protein significantly increased in transgenic animals. Interestingly, neither brain tissue DDAH activity nor ADMA concentrations were different between TG and WT mice. In contrast, muscular DDAH activity was generally lower than in brain but significantly increased in TG mice. Conclusion/Significance: Our study demonstrates that hDDAH-1 transgenic mice are not protected from ischemic cerebral tissue damage in tMCAO. This lack of protection is due to high basal cerebral DDAH activity, which is not further increasable by transgenic overexpression of DDAH.			Leypoldt, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.		Leypoldt, Frank/ABC-3186-2021	Atzler, Dorothee/0000-0002-6551-1544; Leypoldt, Frank/0000-0002-8972-515X				Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Boger RH, 2006, ANN MED, V38, P126, DOI 10.1080/07853890500472151; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Dayoub H, 2008, STROKE, V39, P180, DOI 10.1161/STROKEAHA.107.490631; FARACI FM, 1995, AM J PHYSIOL-HEART C, V269, pH1522, DOI 10.1152/ajpheart.1995.269.5.H1522; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Jacobi J, 2005, CIRCULATION, V111, P1431, DOI 10.1161/01.CIR.0000158487.80483.09; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Konishi H, 2007, J AM COLL CARDIOL, V49, P1099, DOI 10.1016/j.jacc.2006.10.068; MAAS R, 2009, STROKE; Maas R, 2007, J CHROMATOGR B, V851, P220, DOI 10.1016/j.jchromb.2007.01.020; Maas R, 2007, CLIN CHEM, V53, P693, DOI 10.1373/clinchem.2006.081893; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Wanby P, 2006, ATHEROSCLEROSIS, V185, P271, DOI 10.1016/j.atherosclerosis.2005.06.033	15	14	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7337	10.1371/journal.pone.0007337	http://dx.doi.org/10.1371/journal.pone.0007337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809508	Green Submitted, Green Published, gold			2022-12-25	WOS:000270594000009
J	Kim, PJ; Lee, DY; Jeong, H				Kim, Pan-Jun; Lee, Dong-Yup; Jeong, Hawoong			Centralized Modularity of N-Linked Glycosylation Pathways in Mammalian Cells	PLOS ONE			English	Article							GLYCAN STRUCTURES; SYSTEMS; GLYCOFORMS; GLYCOMICS; MECHANISMS; EXPRESSION; LETHALITY; NETWORK; BIOLOGY; IA	Glycosylation is a highly complex process to produce a diverse repertoire of cellular glycans that are attached to proteins and lipids. Glycans are involved in fundamental biological processes, including protein folding and clearance, cell proliferation and apoptosis, development, immune responses, and pathogenesis. One of the major types of glycans, N-linked glycans, is formed by sequential attachments of monosaccharides to proteins by a limited number of enzymes. Many of these enzymes can accept multiple N-linked glycans as substrates, thereby generating a large number of glycan intermediates and their intermingled pathways. Motivated by the quantitative methods developed in complex network research, we investigated the large-scale organization of such N-linked glycosylation pathways in mammalian cells. The N-linked glycosylation pathways are extremely modular, and are composed of cohesive topological modules that directly branch from a common upstream pathway of glycan synthesis. This unique structural property allows the glycan production between modules to be controlled by the upstream region. Although the enzymes act on multiple glycan substrates, indicating cross-talk between modules, the impact of the cross-talk on the module-specific enhancement of glycan synthesis may be confined within a moderate range by transcription-level control. The findings of the present study provide experimentally-testable predictions for glycosylation processes, and may be applicable to therapeutic glycoprotein engineering.	[Kim, Pan-Jun] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Lee, Dong-Yup] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore, Singapore; [Lee, Dong-Yup] ASTAR, Bioproc Technol Inst, Singapore, Singapore; [Jeong, Hawoong] Korea Adv Inst Sci & Technol, Inst BioCentury, Daejeon, South Korea; [Jeong, Hawoong] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, PJ (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	cheld@nus.edu.sg; hjeong@kaist.edu	Jeong, Hawoong/AAR-2524-2021; Jeong, Hawoong/A-2469-2009; Lee, Dong-Yup/D-6650-2011; Jeong, Hawoong/C-1587-2011	Jeong, Hawoong/0000-0002-2491-8620; Jeong, Hawoong/0000-0002-2491-8620; Lee, Dong-Yup/0000-0003-0901-708X; Kim, Pan-Jun/0000-0002-9329-4997				Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brooks SA, 2006, EXPERT REV PROTEOMIC, V3, P345, DOI 10.1586/14789450.3.3.345; Butler M, 2005, APPL MICROBIOL BIOT, V68, P283, DOI 10.1007/s00253-005-1980-8; CAMPBELL C, 1984, J BIOL CHEM, V259, P3370; Campbell CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-236; Chen H, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P1; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Davies J, 2001, BIOTECHNOL BIOENG, V74, P288, DOI 10.1002/bit.1119.abs; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Ghim CM, 2005, J THEOR BIOL, V237, P401, DOI 10.1016/j.jtbi.2005.04.025; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hossler P, 2006, BIOTECHNOL BIOENG, V95, P946, DOI 10.1002/bit.21062; Hossler P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000713; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kim DH, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046126; Kim JH, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.058701; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; Lal A, 1998, GLYCOBIOLOGY, V8, P981, DOI 10.1093/glycob/8.10.981; Lee EJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056108; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Murrell MF, 2004, CHEMBIOCHEM, V5, P1334, DOI 10.1002/cbic.200400143; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sburlati AR, 1998, BIOTECHNOL PROGR, V14, P189, DOI 10.1021/bp970118s; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Tempel W, 2004, J BIOL CHEM, V279, P29774, DOI 10.1074/jbc.M403065200; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Varki A., 2008, ESSENTIALS GLYCOBIOL; von der Lieth CW, 2004, BRIEF BIOINFORM, V5, P164, DOI 10.1093/bib/5.2.164; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yusufi FNK, 2009, BIOPROC BIOSYST ENG, V32, P97, DOI 10.1007/s00449-008-0226-4	44	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7317	10.1371/journal.pone.0007317	http://dx.doi.org/10.1371/journal.pone.0007317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802388	Green Submitted, Green Published, gold			2022-12-25	WOS:000270593600007
J	Robertson, HT; Allison, DB				Robertson, Henry T.; Allison, David B.			Drugs Associated with More Suicidal Ideations Are also Associated with More Suicide Attempts	PLOS ONE			English	Article							CONTROLLED-TRIALS; WEIGHT-LOSS	Context: In randomized controlled trials (RCTs), some drugs, including CB1 antagonists for obesity treatment, have been shown to cause increased suicidal ideation. A key question is whether drugs that increase or are associated with increased suicidal ideations are also associated with suicidal behavior, or whether drug-induced suicidal ideations are unlinked epiphenomena that do not presage the more troubling and potentially irrevocable outcome of suicidal behavior. This is difficult to determine in RCTs because of the rarity of suicidal attempts and completions. Objective: To determine whether drugs associated with more suicidal ideations are also associated with more suicide attempts in large spontaneous adverse event (AE) report databases. Methodology: Generalized linear models with negative binomial distribution were fitted to Food and Drug Administration (FDA) Adverse Event (AE) Reporting System (AERS) data from 2004 to 2008. A total of 1,404,470 AEs from 832 drugs were analyzed as a function of reports of suicidal ideations; other non-suicidal adverse reactions; drug class; proportion of reports from males; and average age of subject for which AE was filed. Drug was treated as the unit of analysis, thus the statistical models effectively had 832 observations. Main Outcome Measures: Reported suicide attempts and completed suicides per drug. Results: 832 drugs, ranging from abacavir to zopiclone, were evaluated. The 832 drugs, as primary suspect drugs in a given adverse event, accounted for over 99.9% of recorded AERS. Suicidal ideations had a significant positive association with suicide attempts (p<.0001) and had an approximately 131-fold stronger magnitude of association than non- suicidal AERs, after adjusting for drug class, gender, and age. Conclusions: In AE reports, drugs that are associated with increased suicidal ideations are also associated with increased suicidal attempts or completions. This association suggests that drug-induced suicidal ideations observed in RCTs plausibly represent harbingers that presage the more serious suicide attempts and completions and should be a cause for concern.			Robertson, HT (corresponding author), Univ Alabama, Dept Biostat, Ryals Sch Publ Hlth, Birmingham, AL 35294 USA.	dallison@uab.edu		Allison, David/0000-0003-3566-9399	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK056336, P30DK056336] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AERS, LAT Q DAT FIL; Astrup A, 2007, OBESITY, V15, P1717, DOI 10.1038/oby.2007.205; Borges G, 2008, J AFFECT DISORDERS, V105, P25, DOI 10.1016/j.jad.2007.01.036; COOPER D, 2008, MERCKS DISCONTINUATI; Despres JP, 2008, LANCET, V371, P555, DOI 10.1016/S0140-6736(08)60261-5; Gadde KM, 2006, CIRCULATION, V114, P974, DOI 10.1161/CIRCULATIONAHA.105.596130; Gibbons RD, 2008, STAT MED, V27, P1814, DOI 10.1002/sim.3241; GOLDSTEIN DJ, 1993, J CLIN PSYCHIAT, V54, P309; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Miaou S.-P., 1996, FHWARD96040 OAK RIDG; Neal DJ, 2007, PSYCHOL ADDICT BEHAV, V21, P441, DOI 10.1037/0893-164X.21.4.441; SURRENCE K, 2009, BEHAV RES THER  0612	12	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7312	10.1371/journal.pone.0007312	http://dx.doi.org/10.1371/journal.pone.0007312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	504DD	19798416	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593300012
J	Hocknull, SA; Piper, PJ; van den Bergh, GD; Due, RA; Morwood, MJ; Kurniawan, I				Hocknull, Scott A.; Piper, Philip J.; van den Bergh, Gert D.; Due, Rokus Awe; Morwood, Michael J.; Kurniawan, Iwan			Dragon's Paradise Lost: Palaeobiogeography, Evolution and Extinction of the Largest-Ever Terrestrial Lizards (Varanidae)	PLOS ONE			English	Article							SQUAMATA; FLORES	Background: The largest living lizard species, Varanus komodoensis Ouwens 1912, is vulnerable to extinction, being restricted to a few isolated islands in eastern Indonesia, between Java and Australia, where it is the dominant terrestrial carnivore. Understanding how large-bodied varanids responded to past environmental change underpins long-term management of V. komodoensis populations. Methodology/Principal Findings: We reconstruct the palaeobiogeography of Neogene giant varanids and identify a new (unnamed) species from the island of Timor. Our data reject the long-held perception that V. komodoensis became a giant because of insular evolution or as a specialist hunter of pygmy Stegodon. Phyletic giantism, coupled with a westward dispersal from mainland Australia, provides the most parsimonious explanation for the palaeodistribution of V. komodoensis and the newly identified species of giant varanid from Timor. Pliocene giant varanid fossils from Australia are morphologically referable to V. komodoensis suggesting an ultimate origin for V. komodoensis on mainland Australia (>3.8 million years ago). Varanus komodoensis body size has remained stable over the last 900,000 years (ka) on Flores, a time marked by major faunal turnovers, extinction of the island's megafauna, the arrival of early hominids by 880 ka, co-existence with Homo floresiensis, and the arrival of modern humans by 10 ka. Within the last 2000 years their populations have contracted severely. Conclusions/Significance: Giant varanids were once a ubiquitous part of Subcontinental Eurasian and Australasian faunas during the Neogene. Extinction played a pivotal role in the reduction of their ranges and diversity throughout the late Quaternary, leaving only V. komodoensis as an isolated long-term survivor. The events over the last two millennia now threaten its future survival.			Hocknull, SA (corresponding author), Queensland Museum, POB 300, Brisbane, Qld 4101, Australia.	scott.hocknull@qm.qld.gov.au	van den Bergh, Gerrit D/I-7670-2016	van den Bergh, Gerrit Dirk/0000-0003-1507-3336; Hocknull, Scott/0000-0003-4157-8434; Piper, Philip/0000-0001-9494-4341				Ast JC, 2001, CLADISTICS, V17, P211, DOI 10.1111/j.1096-0031.2001.tb00118.x; Auffenberg W., 1981, BEHAV ECOLOGY KOMODO; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Christian A, 1996, J HERPETOL, V30, P219, DOI 10.2307/1565513; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Dawson Lyndall, 1999, Records of the Western Australian Museum Supplement, V57, P265; de Smet M.E.M., 1990, Journal of Southeast Asian Earth Sciences, V4, P337, DOI 10.1016/0743-9547(90)90005-X; Dennell R, 2006, PALAEOGEOGR PALAEOCL, V234, P168, DOI 10.1016/j.palaeo.2005.10.008; DIAMOND JM, 1987, NATURE, V326, P832, DOI 10.1038/326832a0; DUNN EMMETT REID, 1927, AMER MUS NOVITATES, V286, P1; Falconer H. P., 1868, PALEONTOLOGICAL MEMO; Fitch AJ, 2006, AUST J ZOOL, V54, P253, DOI 10.1071/ZO05038; Fuller S, 1998, MOL PHYLOGENET EVOL, V9, P294, DOI 10.1006/mpev.1997.0476; Gaulke M., 2004, VARANOID LIZARDS WOR, P244; GOULD GC, 2005, B AM MUS NAT HIST, V285, P219; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Head JJ, 2009, ZOOL J LINN SOC-LOND, V155, P445, DOI 10.1111/j.1096-3642.2008.00448.x; Hocknull SA, 2007, EARTH PLANET SC LETT, V264, P317, DOI 10.1016/j.epsl.2007.10.004; HOOIJER D A, 1972, Zoologische Mededelingen (Leiden), V47, P445; Lydekker R., 1886, Palaeontologia Indica, V(10), P1; Lydekker R., 1888, CATALOGUE FOSSIL R 1; Mackness BS, 2000, AUST J EARTH SCI, V47, P807, DOI 10.1046/j.1440-0952.2000.00812.x; Molnar R.E., 2004, DRAGONS DUST PALAEOB; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Murphy J. B, 2002, KOMODO DRAGONS BIOL; OWEN R, 1859, PHILOS T ROY SOC LON, V149, P43; Pianka ER, 2004, VARANOID LIZARDS OF THE WORLD, P549; PIANKA ER, 1995, AM NAT, V146, P398, DOI 10.1086/285806; Price GJ, 2009, REC AUST MUS, V61, P39, DOI 10.3853/j.0067-1975.61.2009.1518; Reed Elizabeth, 2005, Memoirs of the Queensland Museum, V51, P203; SETIYABUDI E, 2006, THESIS KAGOSHIMA U J; SUWITODIRDJO K, 1975, GEOLOGIC QUADRANGLE; Van den Bergh GD, 2008, QUATERN INT, V182, P16, DOI 10.1016/j.quaint.2007.02.001; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3	34	40	42	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7241	10.1371/journal.pone.0007241	http://dx.doi.org/10.1371/journal.pone.0007241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789642	Green Published, Green Submitted, gold			2022-12-25	WOS:000270354100009
J	Thu, MS; Najbauer, J; Kendall, SE; Harutyunyan, I; Sangalang, N; Gutova, M; Metz, MZ; Garcia, E; Frank, RT; Kim, SU; Moats, RA; Aboody, KS				Thu, Mya S.; Najbauer, Joseph; Kendall, Stephen E.; Harutyunyan, Ira; Sangalang, Nicole; Gutova, Margarita; Metz, Marianne Z.; Garcia, Elizabeth; Frank, Richard T.; Kim, Seung U.; Moats, Rex A.; Aboody, Karen S.			Iron Labeling and Pre-Clinical MRI Visualization of Therapeutic Human Neural Stem Cells in a Murine Glioma Model	PLOS ONE			English	Article							PROGENITOR CELLS; TARGETED DELIVERY; BRAIN; MIGRATION; FERUMOXIDES; TROPISM; TRANSPLANTATION; NANOPARTICLES; RADIOTHERAPY; TRAFFICKING	Background: Treatment strategies for the highly invasive brain tumor, glioblastoma multiforme, require that cells which have invaded into the surrounding brain be specifically targeted. The inherent tumor-tropism of neural stem cells (NSCs) to primary and invasive tumor foci can be exploited to deliver therapeutics to invasive brain tumor cells in humans. Use of the strategy of converting prodrug to drug via therapeutic transgenes delivered by immortalized therapeutic NSC lines have shown efficacy in animal models. Thus therapeutic NSCs are being proposed for use in human brain tumor clinical trials. In the context of NSC-based therapies, MRI can be used both to non-invasively follow dynamic spatio-temporal patterns of the NSC tumor targeting allowing for the optimization of treatment strategies and to assess efficacy of the therapy. Iron-labeling of cells allows their presence to be visualized and tracked by MRI. Thus we aimed to iron-label therapeutic NSCs without affecting their cellular physiology using a method likely to gain United States Federal Drug Administration (FDA) approval. Methodology: For human use, the characteristics of therapeutic Neural Stem Cells must be clearly defined with any pertubation to the cell including iron labeling requiring reanalysis of cellular physiology. Here, we studied the effect of iron-loading of the therapeutic NSCs, with ferumoxide-protamine sulfate complex (FE-Pro) on viability, proliferation, migratory properties and transgene expression, when compared to non-labeled cells. FE-Pro labeled NSCs were imaged by MRI at tumor sites, after intracranial administration into the hemisphere contralateral to the tumor, in an orthotopic human glioma xenograft mouse model. Conclusion: FE-Pro labeled NSCs retain their proliferative status, tumor tropism, and maintain stem cell character, while allowing in vivo cellular MRI tracking at 7 Tesla, to monitor their real-time migration and distribution at brain tumor sites. Of significance, this work directly supports the use of FE-Pro-labeled NSCs for real-time tracking in the clinical trial under development: "A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically modified Neural Stem Cells Expressing Escherichia coli Cytosine Deaminase for Treatment of Recurrent High-Grade Gliomas''.			Thu, MS (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA.	mthu@coh.org; kaboody@coh.org	Moats, Rex A/F-5995-2015					Aboody KS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000023; Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Aboody KS, 2006, NEURO-ONCOLOGY, V8, P119, DOI 10.1215/15228517-2005-012; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Brekke C, 2007, NEUROIMAGE, V37, P769, DOI 10.1016/j.neuroimage.2007.06.006; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Castro MG, 2003, PHARMACOL THERAPEUT, V98, P71, DOI 10.1016/S0163-7258(03)00014-7; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Daldrup-Link HE, 2003, RADIOLOGY, V228, P760, DOI 10.1148/radiol.2283020322; Danks MK, 2007, CANCER RES, V67, P22, DOI 10.1158/0008-5472.CAN-06-3607; Dickson PV, 2007, J PEDIATR SURG, V42, P48, DOI 10.1016/j.jpedsurg.2006.09.050; Dwain Irvin, 2006, Curr Stem Cell Res Ther, V1, P79, DOI 10.2174/157488806775269070; Ehtesham M, 2004, NEOPLASIA, V6, P287, DOI 10.1593/neo.03427; Ehtesham M, 2002, CANCER RES, V62, P5657; Ehtesham Moneeb, 2005, Neurosurg Focus, V19, pE5; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Gutova M, 2008, STEM CELLS, V26, P1406, DOI 10.1634/stemcells.2008-0141; Guzman R, 2008, J NEUROSCI RES, V86, P873, DOI 10.1002/jnr.21542; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Heese O, 2005, NEURO-ONCOLOGY, V7, P476, DOI 10.1215/S1152851704000754; Heyn C, 2006, MAGNET RESON MED, V55, P23, DOI 10.1002/mrm.20747; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Jendelova P, 2003, MAGNET RESON MED, V50, P767, DOI 10.1002/mrm.10585; Kendall SE, 2008, STEM CELLS, V26, P1575, DOI 10.1634/stemcells.2007-0887; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; Kim DE, 2006, RADIOLOGY, V241, P822, DOI 10.1148/radiol.2413050466; Kim Seung U, 2002, Methods Mol Biol, V198, P55; Kim SK, 2006, CLIN CANCER RES, V12, P5550, DOI 10.1158/1078-0432.CCR-05-2508; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Lepore AC, 2006, EXP NEUROL, V201, P49, DOI 10.1016/j.expneurol.2006.03.032; Lesniak MS, 2006, EXPERT REV ANTICANC, V6, pS1, DOI 10.1586/14737140.6.9s.S1; Lin D, 2007, NEUROIMAGE, V37, pS18, DOI 10.1016/j.neuroimage.2007.03.076; Modo M, 2002, NEUROIMAGE, V17, P803, DOI 10.1006/nimg.2002.1194; Modo M, 2004, NEUROIMAGE, V21, P311, DOI 10.1016/j.neuroimage.2003.08.030; Modo Mike, 2006, Curr Stem Cell Res Ther, V1, P55, DOI 10.2174/157488806775269106; Neri M, 2008, STEM CELLS, V26, P505, DOI 10.1634/stemcells.2007-0251; Noble M, 2000, P NATL ACAD SCI USA, V97, P12393, DOI 10.1073/pnas.97.23.12393; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Price SJ, 2007, EUR RADIOL, V17, P1675, DOI 10.1007/s00330-006-0561-2; Schmidt NO, 2005, NEOPLASIA, V7, P623, DOI 10.1593/neo.04781; Shah K, 2005, ANN NEUROL, V57, P34, DOI 10.1002/ana.20306; Stupp R, 2005, ONKOLOGIE, V28, P315, DOI 10.1159/000085575; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; SYKOVA E, 2007, CELL DEATH DIFFER; Sykova E, 2006, NEURODEGENER DIS, V3, P62, DOI 10.1159/000092095; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Yip S, 2003, CANCER J, V9, P189, DOI 10.1097/00130404-200305000-00007; Zhang ZG, 2004, NEUROIMAGE, V23, P281, DOI 10.1016/j.neuroimage.2004.05.019	59	81	84	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7218	10.1371/journal.pone.0007218	http://dx.doi.org/10.1371/journal.pone.0007218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787043	Green Published, Green Submitted, gold			2022-12-25	WOS:000270290100017
J	Inoue, A; Aoki, F				Inoue, Azusa; Aoki, Fugaku			Role of the nucleoplasmin 2 C-terminal domain in the formation of nucleolus-like bodies in mouse oocytes	FASEB JOURNAL			English	Article						oogenesis; embryo; development; nucleogenesis	PREIMPLANTATION EMBRYOS; IMMUNOELECTRON MICROSCOPY; LOCALIZATION SIGNAL; COILED BODY; PROTEIN; NUCLEAR; CHROMATIN; GROWTH; TRANSCRIPTION; PHOSPHATASE	Nucleolus-like bodies (NLBs) are characteristic structures found in the germinal vesicles of mammalian oocytes. Although these structures are essential for embryonic development, their composition, precise function, and mechanism of formation have not been elucidated. Here, we used immunoblotting and EGFP fusion protein fluorescence to demonstrate that murine nucleoplasmin 2 (NPM2) is a component of mouse NLBs and that the targeting of NPM2 to NLBs is regulated by a lysine-rich, 16-aa C-terminal motif (K-rich motif). When the K-rich motif was fused to another nuclear protein, MafG, the resultant fusion protein accumulated in NLBs but not in the nucleoli of somatic cells, suggesting that the K-rich motif functions to target NPM2 specifically to NLBs. To investigate the role of the K-rich motif in NLB formation, we replaced the endogenous NPM2 in growing oocytes with a mutant NPM2 protein lacking the K-rich motif (NPM2(C16del)). Growing oocytes surrounded by granulosa layers were coinjected with NPM2C16del mRNA and with small-interfering RNA targeting NPM2 (siNpm2), which was used to degrade the endogenous NPM2 mRNA. After culture in vitro, the NLBs in the resulting full-grown oocytes were significantly smaller than those in control oocytes that had been coinjected with siNpm2 and NPM2 mRNA, indicating that the K-rich motif is necessary for NLB development. Together, these results suggest that NPM2 targeting of NLBs is regulated by the K-rich motif and is essential for the formation of NLBs.-Inoue, A., Aoki, F. Role of the nucleoplasmin 2 C-terminal domain in the formation of nucleolus-like bodies in mouse oocytes. FASEB J. 24, 485-494 (2010). www.fasebj.org	[Inoue, Azusa; Aoki, Fugaku] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	University of Tokyo	Aoki, F (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan.	aokif@k.u-tokyo.ac.jp	AOKI, FUGAKU/AAO-7617-2021					Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; BARAN V, 1995, MOL REPROD DEV, V40, P305, DOI 10.1002/mrd.1080400306; BIGGIOGERA M, 1990, DEVELOPMENT, V110, P1263; BIGGIOGERA M, 1994, EXP CELL RES, V213, P55, DOI 10.1006/excr.1994.1172; Borsuk E, 1996, MOL REPROD DEV, V43, P376, DOI 10.1002/(SICI)1098-2795(199603)43:3&lt;376::AID-MRD12&gt;3.0.CO;2-#; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; CHOUINARD LA, 1971, J CELL SCI, V9, P637; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; FERREIRA J, 1995, DEVELOPMENT, V121, P601; Flechon JE, 1998, ZYGOTE, V6, P183, DOI 10.1017/S0967199498000112; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; GEUSKENS M, 1984, CELL DIFFER DEV, V14, P125, DOI 10.1016/0045-6039(84)90037-X; Hartshorne G M, 1997, Rev Reprod, V2, P94; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Huang N, 2005, J BIOL CHEM, V280, P5496, DOI 10.1074/jbc.M407856200; KOPECNY V, 1995, MOL REPROD DEV, V41, P449, DOI 10.1002/mrd.1080410407; Kopecny V, 1996, REPROD NUTR DEV, V36, P667; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Lechertier T, 2007, J CELL SCI, V120, P265, DOI 10.1242/jcs.03345; Liu JY, 2006, FEBS LETT, V580, P1405, DOI 10.1016/j.febslet.2006.01.064; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; Longo F, 2003, MOL REPROD DEV, V66, P279, DOI 10.1002/mrd.10354; MacArthur CA, 1997, GENOMICS, V42, P137, DOI 10.1006/geno.1997.4353; Maddox-Hyttel P, 2005, REPROD FERT DEVELOP, V17, P3, DOI 10.1071/RD04108; Nagahama M, 2004, MOL BIOL CELL, V15, P5712, DOI 10.1091/mbc.E04-08-0692; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Parfenov VN, 2003, J CELL BIOCHEM, V89, P720, DOI 10.1002/jcb.10545; Pesty A, 2007, MOL HUM REPROD, V13, P3, DOI 10.1093/molehr/gal089; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; QUINN P, 1984, AUST J BIOL SCI, V37, P147, DOI 10.1071/BI9840147; Rao MRKS, 2006, J MOL BIOL, V364, P637, DOI 10.1016/j.jmb.2006.09.007; Sheng Z, 2004, J BIOL CHEM, V279, P40153, DOI 10.1074/jbc.M400123200; Takagi M, 1999, J CELL SCI, V112, P2463; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; WANG DR, 1993, CELL MOL BIOL RES, V39, P33; Zatsepina O, 2003, DEV BIOL, V253, P66, DOI 10.1006/dbio.2002.0865; Zatsepina OV, 2000, DEV BIOL, V223, P354, DOI 10.1006/dbio.2000.9762	41	36	38	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					485	494		10.1096/fj.09-143370	http://dx.doi.org/10.1096/fj.09-143370			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19805576				2022-12-25	WOS:000274045000016
J	Giorgio, V; Bisetto, E; Soriano, ME; Dabbeni-Sala, F; Basso, E; Petronilli, V; Forte, MA; Bernardi, P; Lippe, G				Giorgio, Valentina; Bisetto, Elena; Soriano, Maria Eugenia; Dabbeni-Sala, Federica; Basso, Emy; Petronilli, Valeria; Forte, Michael A.; Bernardi, Paolo; Lippe, Giovanna			Cyclophilin D Modulates Mitochondrial F0F1-ATP Synthase by Interacting with the Lateral Stalk of the Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; BOVINE HEART-MITOCHONDRIA; BLUE NATIVE PAGE; ATP SYNTHASE; INHIBITOR PROTEIN; CYCLOSPORINE-A; F(0)F(1)ATP SYNTHASE; SUBUNIT COMPOSITION; RESPIRATORY-CHAIN; F1F0-ATP SYNTHASE	Blue native gel electrophoresis purification and immunoprecipitation of F0F1-ATP synthase from bovine heart mitochondria revealed that cyclophilin (CyP) D associates to the complex. Treatment of intact mitochondria with the membrane-permeable bifunctional reagent dimethyl 3,3-dithiobis-propionimidate (DTBP) cross-linked CyPD with the lateral stalk of ATP synthase, whereas no interactions with F-1 sector subunits, the ATP synthase natural inhibitor protein IF1, and the ATP/ADP carrier were observed. The ATP synthase-CyPD interactions have functional consequences on enzyme catalysis and are modulated by phosphate (increased CyPD binding and decreased enzyme activity) and cyclosporin (Cs) A (decreased CyPD binding and increased enzyme activity). Treatment of MgATP submitochondrial particles or intact mitochondria with CsA displaced CyPD from membranes and activated both hydrolysis and synthesis of ATP sustained by the enzyme. No effect of CsA was detected in CyPD-null mitochondria, which displayed a higher specific activity of the ATP synthase than wild-type mitochondria. Modulation by CyPD binding appears to be independent of IF1, whose association to ATP synthase was not affected by CsA treatment. These findings demonstrate that CyPD association to the lateral stalk of ATP synthase modulates the activity of the complex.	[Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Petronilli, Valeria; Bernardi, Paolo] Univ Padua, CNR, Inst Neurosci, I-35121 Padua, Italy; [Dabbeni-Sala, Federica] Univ Padua, Dept Pharmacol & Anesthesiol, I-35121 Padua, Italy; [Bisetto, Elena; Lippe, Giovanna] Univ Udine, Dept Biomed Sci, I-33100 Udine, Italy; [Forte, Michael A.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; University of Udine; Oregon Health & Science University	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@bio.unipd.it; giovanna.lippe@uniud.it	Petronilli, Valeria/C-3558-2015; Bernardi, Paolo/C-3656-2008; Giorgio, Valentina/O-1969-2015; Giorgio, Valentina/I-6110-2016; Basso, Emy/F-7687-2015	Petronilli, Valeria/0000-0003-4026-6404; Bernardi, Paolo/0000-0001-9187-3736; Giorgio, Valentina/0000-0002-4229-3054; Basso, Emy/0000-0003-2962-7213; Soriano, Maria Eugenia/0000-0002-7971-2961	National Institutes of Health [GM69883]; USPHS; Fondazione Cariparo "Models of mitochondrial diseases"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Fondazione Cariparo "Models of mitochondrial diseases"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69883 (to M. A. F. and P. B.) from the USPHS. This work was also supported by a grant from Fondazione Cariparo "Models of mitochondrial diseases" (to P. B.).	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Baines CP, 2009, J MOL CELL CARDIOL, V46, P850, DOI 10.1016/j.yjmcc.2009.02.007; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; BELOGRUDOV GI, 1995, J BIOL CHEM, V270, P2053, DOI 10.1074/jbc.270.5.2053; Belogrudov GI, 2008, ARCH BIOCHEM BIOPHYS, V473, P76, DOI 10.1016/j.abb.2008.02.022; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bisetto E, 2007, ELECTROPHORESIS, V28, P3178, DOI 10.1002/elps.200700066; Bisetto E, 2008, J BIOENERG BIOMEMBR, V40, P257, DOI 10.1007/s10863-008-9183-5; BOREL JF, 1977, IMMUNOLOGY, V32, P1017; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Chen C, 2006, J BIOL CHEM, V281, P13777, DOI 10.1074/jbc.M513369200; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; DAS AM, 1990, BIOCHEM J, V266, P355, DOI 10.1042/bj2660355; Di Pancrazio F, 2004, BBA-BIOENERGETICS, V1659, P52, DOI 10.1016/j.bbabio.2004.07.009; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Dienhart M, 2002, J BIOL CHEM, V277, P39289, DOI 10.1074/jbc.M205720200; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Gavin PD, 2003, BBA-BIOENERGETICS, V1607, P167, DOI 10.1016/j.bbabio.2003.09.013; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Krauskopf A, 2003, J BIOL CHEM, V278, P41685, DOI 10.1074/jbc.M301181200; Krauskopf A, 2002, BRIT J PHARMACOL, V135, P977, DOI 10.1038/sj.bjp.0704544; LIPPE G, 1991, BIOCHEM BIOPH RES CO, V181, P764, DOI 10.1016/0006-291X(91)91256-C; LIPPE G, 1988, BIOCHIM BIOPHYS ACTA, V933, P1, DOI 10.1016/0005-2728(88)90050-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; RITOV VB, 1992, GEN PHYSIOL BIOPHYS, V11, P49; Senior AE, 2007, CELL, V130, P220, DOI 10.1016/j.cell.2007.07.004; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Thomas D, 2008, BIOL CELL, V100, P591, DOI 10.1042/BC20080022; Tomasetig L, 2002, BBA-BIOENERGETICS, V1556, P133, DOI 10.1016/S0005-2728(02)00344-4; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zharova TV, 2006, BIOCHEMISTRY-US, V45, P14552, DOI 10.1021/bi061520v	46	221	229	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33982	33988		10.1074/jbc.M109.020115	http://dx.doi.org/10.1074/jbc.M109.020115			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801635	Green Published, hybrid			2022-12-25	WOS:000272165200030
J	Namkung, Y; Dipace, C; Urizar, E; Javitch, JA; Sibley, DR				Namkung, Yoon; Dipace, Concetta; Urizar, Eneko; Javitch, Jonathan A.; Sibley, David R.			G Protein-coupled Receptor Kinase-2 Constitutively Regulates D-2 Dopamine Receptor Expression and Signaling Independently of Receptor Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE; DESENSITIZATION; TRAFFICKING; SENSITIZATION; ARRESTINS; MEMBRANE; BINDING; EZRIN; GAMMA; GRKS	We investigated the regulatory effects of GRK2 on D2 dopamine receptor signaling and found that this kinase inhibits both receptor expression and functional signaling in a phosphorylation-independent manner, apparently through different mechanisms. Overexpression of GRK2 was found to suppress receptor expression at the cell surface and enhance agonist-induced internalization, whereas short interfering RNA knockdown of endogenous GRK2 led to an increase in cell surface receptor expression and decreased agonist-mediated endocytosis. These effects were not due to GRK2-mediated phosphorylation of the D2 receptor as a phosphorylation-null receptor mutant was regulated similarly, and overexpression of a catalytically inactive mutant of GRK2 produced the same effects. The suppression of receptor expression is correlated with constitutive association of GRK2 with the receptor complex as we found that GRK2 and several of its mutants were able to co-immunoprecipitate with the D-2 receptor. Agonist pretreatment did not enhance the ability of GRK2 to co-immunoprecipitate with the receptor. We also found that overexpression of GRK2 attenuated the functional coupling of the D2 receptor and that this activity required the kinase activity of GRK2 but did not involve receptor phosphorylation, thus suggesting the involvement of an additional GRK2 substrate. Interestingly, we found that the suppression of functional signaling also required the G beta gamma binding activity of GRK2 but did not involve the GRK2 N-terminal RH domain. Our results suggest a novel mechanism by which GRK2 negatively regulates G protein-coupled receptor signaling in a manner that is independent of receptor phosphorylation.	[Namkung, Yoon; Sibley, David R.] NINDS, Mol Neuropharmacol Sect, NIH, Bethesda, MD 20892 USA; [Dipace, Concetta; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Dipace, Concetta; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Dipace, Concetta; Urizar, Eneko; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Columbia University; Columbia University; Columbia University	Sibley, DR (corresponding author), NINDS, Mol Neuropharmacol Sect, NIH, Rm 4S-04,MSC 9405,5625 Fishers Lane, Bethesda, MD 20892 USA.	sibley@helix.nih.gov	Sibley, David/AAC-3591-2019	Javitch, Jonathan/0000-0001-7395-2967	National Institutes of Health [MH54137 and DA022413]; NINDS competitive fellowship; Lieber Center for Schizophrenia Research and Treatment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS competitive fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lieber Center for Schizophrenia Research and Treatment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health through the intramural research program of NINDS (to D. R. S.), Grants MH54137 and DA022413 (to J. A. J.), and a NINDS competitive fellowship (to Y. N.). This work was also supported by the Lieber Center for Schizophrenia Research and Treatment (to J. A. J.).	Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Freeman JLR, 2002, BIOCHEMISTRY-US, V41, P12850, DOI 10.1021/bi020145d; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gardner B, 1996, BRIT J PHARMACOL, V118, P1544, DOI 10.1111/j.1476-5381.1996.tb15572.x; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Kapur S, 2001, BIOL PSYCHIAT, V50, P873, DOI 10.1016/S0006-3223(01)01251-3; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KONG GH, 1994, J BIOL CHEM, V269, P13084; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Pao Christina S, 2002, Sci STKE, V2002, ppe42, DOI 10.1126/stke.2002.153.pe42; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Reiter E, 2001, BIOCHEM BIOPH RES CO, V282, P71, DOI 10.1006/bbrc.2001.4534; Seeman P, 2007, SYNAPSE, V61, P1013, DOI 10.1002/syn.20453; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Tandon R, 2008, SCHIZOPHR RES, V100, P4, DOI 10.1016/j.schres.2008.01.022; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Watts VJ, 1996, MOL PHARMACOL, V50, P966; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Willets JM, 2003, TRENDS PHARMACOL SCI, V24, P626, DOI 10.1016/j.tips.2003.10.003	33	59	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34103	34115		10.1074/jbc.M109.055707	http://dx.doi.org/10.1074/jbc.M109.055707			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815545	Green Published, hybrid			2022-12-25	WOS:000272165200043
J	Wong-Mauldin, K; Raussens, V; Forte, TM; Ryan, RO				Wong-Mauldin, Kasuen; Raussens, Vincent; Forte, Trudy M.; Ryan, Robert O.			Apolipoprotein A-V N-terminal Domain Lipid Interaction Properties in Vitro Explain the Hypertriglyceridemic Phenotype Associated with Natural Truncation Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; SECONDARY STRUCTURE; PARTICLE-SIZE; HELIX; ORIENTATION; DIMYRISTOYLPHOSPHATIDYLCHOLINE; CHYLOMICRONS; TRIGLYCERIDE; CONFORMATION; PROTEINS	The N-terminal 146 residues of apolipoprotein (apo) A-V adopt a helix bundle conformation in the absence of lipid. Because similarly sized truncation mutants in human subjects correlate with severe hypertriglyceridemia, the lipid binding properties of apoA-V(1-146) were studied. Upon incubation with phospholipid in vitro, apoA-V(1-146) forms reconstituted high density lipoproteins 15-17 nm in diameter. Far UV circular dichroism spectroscopy analyses of lipid-bound apoA-V( 1-146) yielded an alpha-helix secondary structure content of 60%. Fourier transformed infrared spectroscopy analysis revealed that apoA-V(1-146) alpha-helix segments align perpendicular with respect to particle phospholipid fatty acyl chains. Fluorescence spectroscopy of single Trp variant apoA-V(1-146) indicates that lipid interaction is accompanied by a conformational change. The data are consistent with a model wherein apoA-V(1-146) alpha-helices circumscribe the perimeter of a disk-shaped bilayer. The ability of apoA-V(1-146) to solubilize dimyristoylphosphatidyl-choline vesicles at a rate faster than full-length apoA-V suggests that N- and C-terminal interactions in the full-length protein modulate its lipid binding properties. Preferential association of apoA-V(1-146) with murine plasma HDL, but not with VLDL, suggests that particle size is a determinant of its lipoprotein binding specificity. It may be concluded that defective lipoprotein binding of truncated apoA-V contributes to the hypertriglyceridemia phenotype associated with truncation mutations in human subjects.	[Wong-Mauldin, Kasuen; Forte, Trudy M.; Ryan, Robert O.] Childrens Hosp Oakland, Res Inst, Ctr Prevent Obes Diabet & Cardiovasc Dis, Oakland, CA 94609 USA; [Wong-Mauldin, Kasuen; Ryan, Robert O.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Raussens, Vincent] Univ Libre Bruxelles, Fac Sci, Lab Struct & Funct Biol Membranes, Ctr Struct Biol & Bioinformat, B-1050 Brussels, Belgium	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley; Universite Libre de Bruxelles	Ryan, RO (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Prevent Obes Diabet & Cardiovasc Dis, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	rryan@chori.org		Mauldin, Kasuen/0000-0001-9220-8033	National Institutes of Health [HL-073061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-073061.	Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; Beckstead JA, 2003, BIOCHEMISTRY-US, V42, P9416, DOI 10.1021/bi034509t; Beckstead JA, 2007, J BIOL CHEM, V282, P15484, DOI 10.1074/jbc.M611797200; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; BREITER DR, 1991, BIOCHEMISTRY-US, V30, P603, DOI 10.1021/bi00217a002; CONNELLY PW, 1981, BIOCHIM BIOPHYS ACTA, V666, P80, DOI 10.1016/0005-2760(81)90093-X; Fisher CA, 1997, BIOCHEM CELL BIOL, V75, P45, DOI 10.1139/bcb-75-1-45; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; JI Y, 1995, J BIOL CHEM, V270, P11290, DOI 10.1074/jbc.270.19.11290; KAMTEKAR S, 1995, FASEB J, V9, P1013, DOI 10.1096/fasebj.9.11.7649401; LINDGREN FT, 1972, BLOOD LIPIDS LIPOPRO, P181; LIU H, 1993, FEBS LETT, V316, P27, DOI 10.1016/0014-5793(93)81730-N; Lookene A, 2005, J BIOL CHEM, V280, P25383, DOI 10.1074/jbc.M501589200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marcais C, 2005, J CLIN INVEST, V115, P2862, DOI 10.1172/JCI24471; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Narayanaswami V, 2004, J BIOL CHEM, V279, P14273, DOI 10.1074/jbc.M313318200; Nelbach L, 2008, J LIPID RES, V49, P572, DOI 10.1194/jlr.M700281-JLR200; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; O'Brien PJ, 2005, CLIN CHEM, V51, P351, DOI 10.1373/clinchem.2004.040824; Oliva CP, 2006, ATHEROSCLEROSIS, V188, P215, DOI 10.1016/j.atherosclerosis.2006.04.010; Oliva CP, 2005, ARTERIOSCL THROM VAS, V25, P411, DOI 10.1161/01.ATV.0000153087.36428.dd; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Raussens V, 2005, BIOCHEM J, V387, P747, DOI 10.1042/BJ20041536; RAUSSENS V, 1995, J BIOL CHEM, V270, P12542, DOI 10.1074/jbc.270.21.12542; Raussens V, 1998, J BIOL CHEM, V273, P25825, DOI 10.1074/jbc.273.40.25825; REIJNGOUD DJ, 1982, BIOCHEMISTRY-US, V21, P2969, DOI 10.1021/bi00541a026; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SEGREST JP, 1992, J LIPID RES, V33, P141; Shu X, 2008, J LIPID RES, V49, P1670, DOI 10.1194/jlr.M800111-JLR200; Silva RAGD, 2007, J BIOL CHEM, V282, P9713, DOI 10.1074/jbc.M610380200; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; SUITS AG, 1989, P NATL ACAD SCI USA, V86, P2713, DOI 10.1073/pnas.86.8.2713; TAJIMA S, 1983, J BIOL CHEM, V258, P73; TALLMADGE DH, 1989, PHOTOCHEM PHOTOBIOL, V49, P381, DOI 10.1111/j.1751-1097.1989.tb09183.x; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; WALD JH, 1990, J BIOL CHEM, V265, P20037; Weers PMM, 2001, EUR J BIOCHEM, V268, P3728, DOI 10.1046/j.1432-1327.2001.02282.x; WETTERAU JR, 1982, J BIOL CHEM, V257, P961; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Wong K, 2008, BIOCHEMISTRY-US, V47, P8768, DOI 10.1021/bi800515c	45	8	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33369	33376		10.1074/jbc.M109.040972	http://dx.doi.org/10.1074/jbc.M109.040972			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19825998	hybrid, Green Published			2022-12-25	WOS:000272028500042
J	Malmgren, S; Nicholls, DG; Taneera, J; Bacos, K; Koeck, T; Tamaddon, A; Wibom, R; Groop, L; Ling, C; Mulder, H; Sharoyko, VV				Malmgren, Siri; Nicholls, David G.; Taneera, Jalal; Bacos, Karl; Koeck, Thomas; Tamaddon, Ashkan; Wibom, Rolf; Groop, Leif; Ling, Charlotte; Mulder, Hindrik; Sharoyko, Vladimir V.			Tight Coupling between Glucose and Mitochondrial Metabolism in Clonal beta-Cells Is Required for Robust Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTATE-DEHYDROGENASE; REGULATED ANAPLEROSIS; PYRUVATE; LINES; OVEREXPRESSION; EXPRESSION; SHUTTLE; CANCER	The biochemical mechanisms underlying glucose-stimulated insulin secretion from pancreatic beta-cells are not completely understood. To identify metabolic disturbances in beta-cells that impair glucose-stimulated insulin secretion, we compared two INS-1-derived clonal beta-cell lines, which are glucose-responsive (832/13 cells) or glucose-unresponsive (832/2 cells). To this end, we analyzed a number of parameters in glycolytic and mitochondrial metabolism, including mRNA expression of genes involved in cellular energy metabolism. We found that despite a marked impairment of glucose-stimulated insulin secretion, 832/2 cells exhibited a higher rate of glycolysis. Still, no glucose-induced increases in respiratory rate, ATP production, or respiratory chain complex I, III, and IV activities were seen in the 832/2 cells. Instead, 832/2 cells, which expressed lactate dehydrogenase A, released lactate regardless of ambient glucose concentrations. In contrast, the glucose-responsive 832/13 line lacked lactate dehydrogenase and did not produce lactate. Accordingly, in 832/2 cells mRNA expression of genes for glycolytic enzymes were up-regulated, whereas mitochondria-related genes were down-regulated. This could account for a Warburg-like effect in the 832/2 cell clone, lacking in 832/13 cells as well as primary beta-cells. In human islets, mRNA expression of genes such as lactate dehydrogenase A and hexokinase I correlated positively with HbA(1c) levels, reflecting perturbed long term glucose homeostasis, whereas that of Slc2a2 (glucose transporter 2) correlated negatively with HbA(1c) and thus better metabolic control. We conclude that tight metabolic regulation enhancing mitochondrial metabolism and restricting glycolysis in 832/13 cells is required for clonal beta-cells to secrete insulin robustly in response to glucose. Moreover, a similar expression pattern of genes controlling glycolytic and mitochondrial metabolism in clonal beta-cells and human islets was observed, suggesting that a similar prioritization of mitochondrial metabolism is required in healthy human beta-cells. The 832 beta-cell lines may be helpful tools to resolve metabolic perturbations occurring in Type 2 diabetes.	[Malmgren, Siri; Nicholls, David G.; Bacos, Karl; Koeck, Thomas; Tamaddon, Ashkan; Mulder, Hindrik; Sharoyko, Vladimir V.] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Unit Mol Metab, S-20502 Malmo, Sweden; [Malmgren, Siri; Taneera, Jalal; Groop, Leif; Ling, Charlotte] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Unit Diabet & Endocrinol, S-20502 Malmo, Sweden; [Wibom, Rolf] Huddinge Univ Hosp, Karolinska Inst, Dept Lab Med, S-14186 Huddinge, Sweden	Lund University; Lund University; Karolinska Institutet	Sharoyko, VV (corresponding author), Malmo Univ Hosp, Clin Res Ctr, S-20502 Malmo, Sweden.	Vladimir.Sharoyko@med.lu.se	NICHOLLS, DAVID G/K-4300-2012; Ling, Charlotte/Q-2432-2015; Sharoyko, Vladimir/J-3625-2014; Mulder, Hindrik/E-1045-2012; Bacos, Karl/S-2236-2019	Ling, Charlotte/0000-0003-0587-7154; Sharoyko, Vladimir/0000-0002-3717-0471; Malmgren, Siri/0000-0002-4540-1102; Mulder, Hindrik/0000-0002-6593-8417; Bacos, Karl/0000-0002-2461-9073; Taneera, Jalal/0000-0002-3341-1063	Swedish Research Council [14196-06-3]; Crafoord and Albert Pahlsson Foundations; Faculty of Medicine at Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord and Albert Pahlsson Foundations; Faculty of Medicine at Lund University	This work was supported by Swedish Research Council Grant 14196-06-3, the Crafoord and Albert Pahlsson Foundations, and the Faculty of Medicine at Lund University. We thank the Nordic Center for Islet Transplantation (Uppsala, Sweden) for providing human islets.	AIZAWA T, 1994, AM J PHYSIOL, V266, pC622, DOI 10.1152/ajpcell.1994.266.3.C622; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Gribble FM, 2009, NAT MED, V15, P247, DOI 10.1038/nm0309-247; Hirose H, 1996, J BIOL CHEM, V271, P5633, DOI 10.1074/jbc.271.10.5633; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jeppsson JO, 2002, CLIN CHEM LAB MED, V40, P78, DOI 10.1515/CCLM.2002.016; KELLY RP, 1991, J PHYSIOL-LONDON, V443, P175, DOI 10.1113/jphysiol.1991.sp018829; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Nitert MD, 2008, J MOL ENDOCRINOL, V41, P1, DOI 10.1677/JME-07-0133; Rabilloud Thierry, 2008, V432, P83, DOI 10.1007/978-1-59745-028-7_6; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Yang SM, 2004, MOL ENDOCRINOL, V18, P2312, DOI 10.1210/me.2004-0148; Zawalich WS, 1996, AM J PHYSIOL-ENDOC M, V271, pE409, DOI 10.1152/ajpendo.1996.271.3.E409; Zhao C, 1998, FEBS LETT, V430, P213, DOI 10.1016/S0014-5793(98)00600-0	30	81	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32395	32404		10.1074/jbc.M109.026708	http://dx.doi.org/10.1074/jbc.M109.026708			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19797055	hybrid, Green Published			2022-12-25	WOS:000272028400022
J	Sun, Q; Taurin, S; Sethakorn, N; Long, XC; Imamura, M; Wang, DZ; Zimmer, WE; Dulin, NO; Miano, JM				Sun, Qiang; Taurin, Sebastien; Sethakorn, Nan; Long, Xiaochun; Imamura, Masaaki; Wang, Da-Zhi; Zimmer, Warren E.; Dulin, Nickolai O.; Miano, Joseph M.			Myocardin-dependent Activation of the CArG Box-rich Smooth Muscle gamma-Actin Gene PREFERENTIAL UTILIZATION OF A SINGLE CArG ELEMENT THROUGH FUNCTIONAL ASSOCIATION WITH THE NKX3.1 HOMEODOMAIN PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; TINMAN HOMOLOG NKX-2.5; MASTER REGULATOR; EXPRESSION; PROMOTER; DIFFERENTIATION; SEQUENCE; TARGET; TISSUE; CELLS	Serum response factor (SRF) is a ubiquitously expressed transcription factor that binds a 10-bp element known as the CArG box, located in the proximal regulatory region of hundreds of target genes. SRF activates target genes in a cell- and context-dependent manner by assembling unique combinations of cofactors over CArG elements. One particularly strong SRF cofactor, myocardin (MYOCD), acts as a component of a molecular switch for smooth muscle cell (SMC) differentiation by activating cytoskeletal and contractile genes harboring SRF-binding CArG elements. Here we report that the human ACTG2 promoter, containing four conserved CArG elements, displays SMC-specific basal activity and is highly induced in the presence of MYOCD. Stable transfection of a non-SMC cell type with Myocd elicits elevations in endogenous Actg2 mRNA. Gel shift and luciferase assays reveal a strong bias for MYOCD-dependent transactivation through CArG2 of the human ACTG2 promoter. Substitution of CArG2 with other CArGs, including a consensus CArG element, fails to reconstitute full MYOCD-dependent ACTG2 promoter stimulation. Mutation of an adjacent binding site for NKX3.1 reduces MYOCD-dependent transactivation of the ACTG2 promoter. Co-immunoprecipitation, glutathione S-transferase pulldown, and luciferase assays show a physical and functional association between MYOCD and NKX3.1; no such functional relationship is evident with the related NKX2.5 transcription factor despite its interaction with MYOCD. These results demonstrate the ability of MYOCD to discriminate among several juxtaposed CArG elements, presumably through its novel partnership with NKX3.1, to optimally transactivate the human ACTG2 promoter.	[Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Taurin, Sebastien; Sethakorn, Nan; Dulin, Nickolai O.] Univ Chicago, Sect Pulm & Crit Care, Chicago, IL 60637 USA; [Wang, Da-Zhi] Univ N Carolina, Dept Cell & Dev Biol, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA; [Zimmer, Warren E.] Texas A&M Hlth Sci Ctr, Coll Med, College Stn, TX 77840 USA	University of Rochester; University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Miano, JM (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Box CVRI,601 Elmwood Ave, Rochester, NY 14642 USA.	j.m.miano@rochester.edu	Sethakorn, Nan/AAH-7721-2020; Miano, Joseph/L-5634-2018	Sethakorn, Nan/0000-0002-7395-3182; Miano, Joseph/0000-0001-7522-3207; Long, Xiaochun/0000-0001-9714-0023; Taurin, Sebastien/0000-0003-2167-5253; Zimmer, Warren/0000-0002-0668-6096	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095608] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085635, R01HL075251, R01HL091168, R01HL071755, R01HL062572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health grants.	Belaguli NS, 1999, MOL CELL BIOL, V19, P4582; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Browning CL, 1998, DEV BIOL, V194, P18, DOI 10.1006/dbio.1997.8808; Carson JA, 2000, J BIOL CHEM, V275, P39061, DOI 10.1074/jbc.M006532200; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chen CY, 1997, MOL ENDOCRINOL, V11, P812, DOI 10.1210/me.11.6.812; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chi JT, 2007, PLOS GENET, V3, P1770, DOI 10.1371/journal.pgen.0030164; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fillmore RA, 2002, GENE EXPRESSION, V10, P201, DOI 10.3727/000000002783992424; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hoggatt AM, 2002, CIRC RES, V91, P1151, DOI 10.1161/01.RES.0000047508.30800.4F; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Kovacs AM, 1998, GENE EXPRESSION, V7, P115; LEUNG S, 1989, NUCLEIC ACIDS RES, V17, P1177, DOI 10.1093/nar/17.3.1177; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pipes GCT, 2005, DEV BIOL, V288, P502, DOI 10.1016/j.ydbio.2005.10.014; Qian J, 1996, DEV DYNAM, V207, P135; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; REECY JM, 1999, HEART DEV, P273; Rensen SSM, 2006, CARDIOVASC RES, V70, P136, DOI 10.1016/j.cardiores.2005.12.018; SAWTELL NM, 1989, J CELL BIOL, V109, P2929, DOI 10.1083/jcb.109.6.2929; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; SCHWARTZ RJ, 1981, BIOCHEMISTRY-US, V20, P4122, DOI 10.1021/bi00517a027; Stanfel MN, 2006, GENESIS, V44, P550, DOI 10.1002/dvg.20250; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tanaka M, 1998, DEV GENET, V22, P239, DOI 10.1002/(SICI)1520-6408(1998)22:3<239::AID-DVG6>3.3.CO;2-G; van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200	49	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32582	32590		10.1074/jbc.M109.033910	http://dx.doi.org/10.1074/jbc.M109.033910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19797053	Green Published, hybrid			2022-12-25	WOS:000272028400040
J	Mathew, SJ; Kerridge, S; Leptin, M				Mathew, Sam J.; Kerridge, Stephen; Leptin, Maria			A Small Genomic Region Containing Several Loci Required for Gastrulation in Drosophila	PLOS ONE			English	Article							CYTOGENETIC ANALYSIS; MELANOGASTER; GENES; MORPHOGENESIS; EXPRESSION; EMBRYO; DUMPY; REARRANGEMENTS; LOCALIZATION; COLLECTION	Genetic screens in Drosophila designed to search for loci involved in gastrulation have identified four regions of the genome that are required zygotically for the formation of the ventral furrow. For three of these, the genes responsible for the mutant phenotypes have been found. We now describe a genetic characterization of the fourth region, which encompasses the cytogenetic interval 24C3-25B, and the mapping of genes involved in gastrulation in this region. We have determined the precise breakpoints of several existing deficiencies and have generated new deficiencies. Our results show that the region contains at least three different loci associated with gastrulation effects. One maternal effect gene involved in ventral furrow formation maps at 24F but could not be identified. For a second maternal effect gene which is required for germ band extension, we identify a candidate gene, CG31660, which encodes a G protein coupled receptor. Finally, one gene acts zygotically in ventral furrow formation and we identify it as Traf4.			Mathew, SJ (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-5000 Cologne, Germany.	mleptin@uni-koeln.de		Mathew, Sam/0000-0001-7908-6094				Ashburner M., 1989, DROSOPHILA LAB HDB; Carmon A, 2007, GENETICS, V176, P309, DOI 10.1534/genetics.106.060897; Cha GH, 2003, MOL CELL BIOL, V23, P7982, DOI 10.1128/MCB.23.22.7982-7991.2003; DAWES H, 1998, DROS RES C, V39, pA399; FRASCH M, 1987, GENE DEV, V1, P981, DOI 10.1101/gad.1.9.981; Golic KG, 1996, GENETICS, V144, P1693; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; GRAU Y, 1984, GENETICS, V108, P347; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Grosshans J, 2003, DEV CELL, V5, P285, DOI 10.1016/S1534-5807(03)00208-9; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Kuranaga E, 2002, NAT CELL BIOL, V4, P705, DOI 10.1038/ncb842; LEPTIN M, 2008, RE NAMING GENES TRAF; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; MERRILL PT, 1988, DEVELOPMENT, V104, P495; Muller HAJ, 1999, DEVELOPMENT, V126, P577; Oh SW, 2003, GENETICS, V163, P195; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Preiss A, 2001, MECH DEVELOP, V100, P109, DOI 10.1016/S0925-4773(00)00506-2; RASMUSSEN I, 1960, ATTACHED 2R 2L0, P53; REUTER G, 1983, CHROMOSOMA, V88, P277, DOI 10.1007/BF00292904; REUTER R, 1990, DEVELOPMENT, V110, P1031; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Seher TC, 2007, MECH DEVELOP, V124, P167, DOI 10.1016/j.mod.2006.12.004; SZIDONYA J, 1988, GENET RES, V51, P197, DOI 10.1017/S0016672300024290; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Wang HS, 2006, EMBO J, V25, P5783, DOI 10.1038/sj.emboj.7601461; Wieschaus E., 1986, P199; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6	32	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7437	10.1371/journal.pone.0007437	http://dx.doi.org/10.1371/journal.pone.0007437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823683	gold, Green Published, Green Submitted			2022-12-25	WOS:000270808300013
J	Verkoczy, L; Moody, MA; Holl, TM; Bouton-Verville, H; Scearce, RM; Hutchinson, J; Alam, SM; Kelsoe, G; Haynes, BF				Verkoczy, Laurent; Moody, M. Anthony; Holl, T. Matt; Bouton-Verville, Hilary; Scearce, Richard M.; Hutchinson, Jennifer; Alam, S. Munir; Kelsoe, Garnett; Haynes, Barton F.			Functional, Non-Clonal IgM(a)-Restricted B Cell Receptor Interactions with the HIV-1 Envelope gp41 Membrane Proximal External Region	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUPERANTIGEN-BINDING-SITE; HUMAN MONOCLONAL-ANTIBODIES; CLASS-SWITCH RECOMBINATION; NEUTRALIZING ANTIBODY; MARGINAL-ZONE; SUBTYPE-B; EPITOPE; 2F5; GP120	The membrane proximal external region (MPER) of HIV-1 gp41 has several features that make it an attractive antibody-based vaccine target, but eliciting an effective gp41 MPER-specific protective antibody response remains elusive. One fundamental issue is whether the failure to make gp41 MPER-specific broadly neutralizing antibodies like 2F5 and 4E10 is due to structural constraints with the gp41 MPER, or alternatively, if gp41 MPER epitope-specific B cells are lost to immunological tolerance. An equally important question is how B cells interact with, and respond to, the gp41 MPER epitope, including whether they engage this epitope in a non-canonical manner i.e., by non-paratopic recognition via B cell receptors (BCR). To begin understanding how B cells engage the gp41 MPER, we characterized B cell-gp41 MPER interactions in BALB/c and C57BL/6 mice. Surprisingly, we found that a significant (similar to 7%) fraction of splenic B cells from BALB/c, but not C57BL/6 mice, bound the gp41 MPER via their BCRs. This strain-specific binding was concentrated in IgM(hi) subsets, including marginal zone and peritoneal B1 B cells, and correlated with enriched fractions (similar to 15%) of gp41 MPER-specific IgM secreted by in vitro-activated splenic B cells. Analysis of Igh(a) (BALB/c) and Igh(b) (C57BL/6) congenic mice demonstrated that gp41 MPER binding was controlled by determinants of the Igh(a) locus. Mapping of MPER gp41 interactions with IgM(a) identified MPER residues distinct from those to which mAb 2F5 binds and demonstrated the requirement of Fc C-H regions. Importantly, gp41 MPER ligation produced detectable BCR-proximal signaling events, suggesting that interactions between gp41 MPER and IgM(a) determinants may elicit partial B cell activation. These data suggest that low avidity, non-paratopic interactions between the gp41 MPER and membrane Ig on naive B cells may interfere with or divert bnAb responses.			Verkoczy, L (corresponding author), Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27706 USA.	laurent.verkoczy@duke.edu	Alam, S. Munir/AAC-6711-2019; Moody, M/AAB-6947-2020	Moody, M/0000-0002-3890-5855				ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.iy.13.040195.002331; Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; BERBERIAN L, 1994, J ACQ IMMUN DEF SYND, V7, P641; BIKOFF E, 1986, J IMMUNOL, V137, P28; BIKOFF EK, 1991, EUR J IMMUNOL, V21, P1411, DOI 10.1002/eji.1830210613; BLOMBERG B, 1972, SCIENCE, V177, P178, DOI 10.1126/science.177.4044.178; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Bures R, 2000, AIDS RES HUM RETROV, V16, P2019, DOI 10.1089/088922200750054756; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Chang Q, 2004, J INFECTION, V49, P274, DOI 10.1016/j.jinf.2004.04.007; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; Earl PL, 1997, J VIROL, V71, P2674, DOI 10.1128/JVI.71.4.2674-2684.1997; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; FORSGREN A, 1966, J IMMUNOL, V97, P822; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Gaynor B, 1997, P NATL ACAD SCI USA, V94, P1955, DOI 10.1073/pnas.94.5.1955; Goodyear CS, 2005, SPRINGER SEMIN IMMUN, V26, P463, DOI 10.1007/s00281-004-0190-2; Gorelik L, 2004, J IMMUNOL, V172, P762, DOI 10.4049/jimmunol.172.2.762; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; Haynes BF, 2008, IMMUNITY, V28, P10, DOI 10.1016/j.immuni.2007.12.005; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2006, VIROLOGY, V345, P44, DOI 10.1016/j.virol.2005.08.042; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Karray S, 1997, P NATL ACAD SCI USA, V94, P1356, DOI 10.1073/pnas.94.4.1356; Karray S, 1998, J IMMUNOL, V161, P6681; Korber B., 1998, HUMAN RETROVIRUSES A, V3, P102; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Liang XP, 1999, VACCINE, V17, P2862, DOI 10.1016/S0264-410X(99)00125-5; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MOODY MA, 2008, NATURE BIOTECH UNPUB; MORAHAN G, 1983, NATURE, V301, P720, DOI 10.1038/301720a0; Muller S, 1997, Int Rev Immunol, V14, P339, DOI 10.3109/08830189709116524; MULLER S, 1993, SCAND J IMMUNOL, V38, P327, DOI 10.1111/j.1365-3083.1993.tb01734.x; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Neshat MN, 2000, INT IMMUNOL, V12, P305, DOI 10.1093/intimm/12.3.305; Newman J, 2003, J IMMUNOL METHODS, V272, P177, DOI 10.1016/S0022-1759(02)00499-4; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; PENNELL CA, 1989, EUR J IMMUNOL, V19, P2115, DOI 10.1002/eji.1830191122; Rice JS, 2005, P NATL ACAD SCI USA, V102, P1608, DOI 10.1073/pnas.0409217102; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN PW, 1995, J IMMUNOL, V154, P6437; Sanchez-Martinez S, 2006, AIDS RES HUM RETROV, V22, P998, DOI 10.1089/aid.2006.22.998; Scamurra RW, 2000, J IMMUNOL, V164, P5482, DOI 10.4049/jimmunol.164.10.5482; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; SILVERMAN GP, 1998, J EXP MED, V192, P87; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tian Y, 2002, J PEPT RES, V59, P264, DOI 10.1034/j.1399-3011.2002.02988.x; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	81	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7215	10.1371/journal.pone.0007215	http://dx.doi.org/10.1371/journal.pone.0007215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806186	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800002
J	Djikeng, A; Kuzmickas, R; Anderson, NG; Spiro, DJ				Djikeng, Appolinaire; Kuzmickas, Ryan; Anderson, Norman G.; Spiro, David J.			Metagenomic Analysis of RNA Viruses in a Fresh Water Lake	PLOS ONE			English	Article							OCEAN SAMPLING EXPEDITION; VIRAL COMMUNITY; MARINE; GENOMES	Freshwater lakes and ponds present an ecological interface between humans and a variety of host organisms. They are a habitat for the larval stage of many insects and may serve as a medium for intraspecies and interspecies transmission of viruses such as avian influenza A virus. Furthermore, freshwater bodies are already known repositories for disease-causing viruses such as Norwalk Virus, Coxsackievirus, Echovirus, and Adenovirus. While RNA virus populations have been studied in marine environments, to this date there has been very limited analysis of the viral community in freshwater. Here we present a survey of RNA viruses in Lake Needwood, a freshwater lake in Maryland, USA. Our results indicate that just as in studies of other aquatic environments, the majority of nucleic acid sequences recovered did not show any significant similarity to known sequences. The remaining sequences are mainly from viral types with significant similarity to approximately 30 viral families. We speculate that these novel viruses may infect a variety of hosts including plants, insects, fish, domestic animals and humans. Among these viruses we have discovered a previously unknown dsRNA virus closely related to Banna Virus which is responsible for a febrile illness and is endemic to Southeast Asia. Moreover we found multiple viral sequences distantly related to Israeli Acute Paralysis virus which has been implicated in honeybee colony collapse disorder. Our data suggests that due to their direct contact with humans, domestic and wild animals, freshwater ecosystems might serve as repositories of a wide range of viruses (both pathogenic and non-pathogenic) and possibly be involved in the spread of emerging and pandemic diseases.			Djikeng, A (corresponding author), JCVI, Infect Dis Grp, Rockville, MD USA.	adjikeng@jcvi.org; dspiro@jcvi.org		Djikeng, Appolinaire/0000-0001-9271-3419				Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Biagini P, 2004, VET MICROBIOL, V98, P95, DOI 10.1016/j.vetmic.2003.10.004; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Chen BQ, 1996, CHINESE MED J-PEKING, V109, P13; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Culley AI, 2003, NATURE, V424, P1054, DOI 10.1038/nature01886; Culley AI, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-69; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; de Miranda JR, 2004, J GEN VIROL, V85, P2263, DOI 10.1099/vir.0.79990-0; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Nabeshima T, 2008, EMERG INFECT DIS, V14, P1276, DOI 10.3201/eid1408.080100; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; VAN MM, 2002, J GEN VIROL, V83, P3131; WATANABE RA, 1988, APPL ENVIRON MICROB, V54, P1606, DOI 10.1128/AEM.54.6.1606-1609.1988; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	34	132	135	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7264	10.1371/journal.pone.0007264	http://dx.doi.org/10.1371/journal.pone.0007264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787045	Green Submitted, gold, Green Published			2022-12-25	WOS:000270290100028
J	Hellemans, KH; Hannaert, JC; Denys, B; Steffensen, KR; Raemdonck, C; Martens, GA; Van Veldhoven, PP; Gustafsson, JA; Pipeleers, D				Hellemans, Karine H.; Hannaert, Jean-Claude; Denys, Bart; Steffensen, Knut R.; Raemdonck, Cindy; Martens, Geert A.; Van Veldhoven, Paul P.; Gustafsson, Jan-Ake; Pipeleers, Daniel			Susceptibility of Pancreatic Beta Cells to Fatty Acids Is Regulated by LXR/PPAR alpha-Dependent Stearoyl-Coenzyme A Desaturase	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; ENDOPLASMIC-RETICULUM STRESS; INSULIN-SECRETION; COA DESATURASE-1; RECEPTOR-ALPHA; ER STRESS; ADIPOSE-TISSUE; A DESATURASE; ISLET CELLS; GLUCOSE	Chronically elevated levels of fatty acids-FA can cause beta cell death in vitro. Beta cells vary in their individual susceptibility to FA-toxicity. Rat beta cells were previously shown to better resist FA-toxicity in conditions that increased triglyceride formation or mitochondrial and peroxisomal FA-oxidation, possibly reducing cytoplasmic levels of toxic FA-moieties. We now show that stearoyl-CoA desaturase-SCD is involved in this cytoprotective mechanism through its ability to transfer saturated FA into monounsaturated FA that are incorporated in lipids. In purified beta cells, SCD expression was induced by LXR- and PPAR alpha-agonists, which were found to protect rat, mouse and human beta cells against palmitate toxicity. When their SCD was inhibited or silenced, the agonist-induced protection was also suppressed. A correlation between beta cell-SCD expression and susceptibility to palmitate was also found in beta cell preparations isolated from different rodent models. In mice with LXR- deletion (LXR beta(-/-) and LXR alpha beta(-/-)), beta cells presented a reduced SCD-expression as well as an increased susceptibility to palmitate-toxicity, which could not be counteracted by LXR or PPAR alpha agonists. In Zucker fatty rats and in rats treated with the LXR- agonist TO1317, beta cells show an increased SCD-expression and lower palmitate-toxicity. In the normal rat beta cell population, the subpopulation with lower metabolic responsiveness to glucose exhibits a lower SCD1 expression and a higher susceptibility to palmitate toxicity. These data demonstrate that the beta cell susceptibility to saturated fatty acids can be reduced by stearoyl-coA desaturase, which upon stimulation by LXR and PPAR alpha agonists favors their desaturation and subsequent incorporation in neutral lipids.			Hellemans, KH (corresponding author), Brussels Free Univ VUB, Diabet Res Ctr, Brussels, Belgium.	karine.hellemans@vub.ac.be	Martens, Geert/ABA-6297-2020; Martens, Geert A./F-6920-2015; , Van Veldhoven Paul/U-6359-2019; Hellemans, Karine/B-7573-2013	Martens, Geert/0000-0003-1208-6289; Martens, Geert A./0000-0003-1208-6289; , Van Veldhoven Paul/0000-0002-4478-2564; Hellemans, Karine/0000-0001-9306-4369; Pipeleers, Daniel/0000-0002-6440-2485				AssimacopoulosJeannet F, 1997, J BIOL CHEM, V272, P1659, DOI 10.1074/jbc.272.3.1659; Biddinger SB, 2006, DIABETES, V55, P2032, DOI 10.2337/db05-0742; Borg J, 2009, ENDOCRINOLOGY, V150, P3049, DOI 10.1210/en.2008-0913; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Choe SS, 2007, DIABETES, V56, P1534, DOI 10.2337/db06-1059; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Diakogiannaki E, 2008, BIOCHEM SOC T, V36, P959, DOI 10.1042/BST0360959; Diraison F, 2004, BIOCHEM J, V378, P769, DOI 10.1042/BJ20031277; Diraison F, 2008, J LIPID RES, V49, P814, DOI 10.1194/jlr.M700533-JLR200; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Efanov AM, 2004, DIABETES, V53, pS75, DOI 10.2337/diabetes.53.suppl_3.S75; Eitel K, 2002, BIOCHEM BIOPH RES CO, V299, P853, DOI 10.1016/S0006-291X(02)02752-3; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gerin I, 2005, J BIOL CHEM, V280, P23024, DOI 10.1074/jbc.M412564200; Green CD, 2009, ENDOCRINOLOGY, V150, P2637, DOI 10.1210/en.2008-1039; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; HEIMBERG H, 1993, EMBO J, V12, P2873, DOI 10.1002/j.1460-2075.1993.tb05949.x; Hellemans K, 2007, FEBS J, V274, P6094, DOI 10.1111/j.1742-4658.2007.06131.x; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hu TH, 2005, ENDOCRINOLOGY, V146, P5380, DOI 10.1210/en.2005-0591; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Kaiser N, 2009, FRONT BIOSCI-LANDMRK, V14, P1099, DOI 10.2741/3296; Kakuma T, 2002, BIOCHEM BIOPH RES CO, V297, P1259, DOI 10.1016/S0006-291X(02)02375-6; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kato T, 2008, DIABETES, V57, P2382, DOI 10.2337/db06-1806; Kato T, 2006, CELL METAB, V4, P143, DOI 10.1016/j.cmet.2006.06.009; KIEKENS R, 1992, J CLIN INVEST, V89, P117, DOI 10.1172/JCI115551; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Lalloyer F, 2006, DIABETES, V55, P1605, DOI 10.2337/db06-0016; Lazar MA, 2007, CELL METAB, V5, P159, DOI 10.1016/j.cmet.2007.02.001; Ling ZD, 2006, DIABETES, V55, P78, DOI 10.2337/diabetes.55.01.06.db05-0820; Ling ZD, 1996, J CLIN INVEST, V98, P2805, DOI 10.1172/JCI119108; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Martens GA, 2007, J BIOL CHEM, V282, P21134, DOI 10.1074/jbc.M700083200; Meng ZX, 2009, DIABETOLOGIA, V52, P125, DOI 10.1007/s00125-008-1174-x; Moffitt JH, 2005, DIABETOLOGIA, V48, P1819, DOI 10.1007/s00125-005-1861-9; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Morgan NG, 2008, BIOCHEM SOC T, V36, P905, DOI 10.1042/BST0360905; Parton LE, 2006, AM J PHYSIOL-ENDOC M, V291, pE982, DOI 10.1152/ajpendo.00067.2006; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Pinnamaneni SK, 2006, DIABETOLOGIA, V49, P3027, DOI 10.1007/s00125-006-0427-9; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Qin Y, 2009, BBA-MOL CELL BIOL L, V1791, P140, DOI 10.1016/j.bbalip.2008.12.003; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Riserus U, 2007, DIABETES CARE, V30, P2928, DOI 10.2337/dc07-0360; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shimano H, 2007, DIABETES OBES METAB, V9, P133, DOI 10.1111/j.1463-1326.2007.00779.x; Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x; Sol ERM, 2008, BIOCHEM BIOPH RES CO, V375, P517, DOI 10.1016/j.bbrc.2008.08.013; Steffensen KR, 2003, BIOCHEM BIOPH RES CO, V310, P589, DOI 10.1016/j.bbrc.2003.08.139; Takahashi A, 2005, DIABETES, V54, P492, DOI 10.2337/diabetes.54.2.492; Tenenbaum H, 2007, ATHEROSCLEROSIS, V194, P265, DOI 10.1016/j.atherosclerosis.2006.08.005; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; WAHLE KWJ, 1994, COMP BIOCHEM PHYS A, V109, P235, DOI 10.1016/0300-9629(94)90126-0; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Wente W, 2007, ENDOCRINOLOGY, V148, P1843, DOI 10.1210/en.2006-1247; ZHANG Y, 2009, J LIPID RES; Zitzer H, 2006, ENDOCRINOLOGY, V147, P3898, DOI 10.1210/en.2005-1483	76	38	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7266	10.1371/journal.pone.0007266	http://dx.doi.org/10.1371/journal.pone.0007266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787047	gold, Green Submitted, Green Published			2022-12-25	WOS:000270290100029
J	Yang, XY; Kathuria, SV; Vadrevu, R; Matthews, CR				Yang, Xiaoyan; Kathuria, Sagar V.; Vadrevu, Ramakrishna; Matthews, C. Robert			beta alpha-Hairpin Clamps Brace beta alpha beta Modules and Can Make Substantive Contributions to the Stability of TIM Barrel Proteins	PLOS ONE			English	Article								Non-local hydrogen bonding interactions between main chain amide hydrogen atoms and polar side chain acceptors that bracket consecutive beta alpha or alpha beta elements of secondary structure in alpha TS from E. coli, a TIM barrel protein, have previously been found to contribute 4-6 kcal mol(-1) to the stability of the native conformation. Experimental analysis of similar beta alpha-hairpin clamps in a homologous pair of TIM barrel proteins of low sequence identity, IGPS from S. solfataricus and E. coli, reveals that this dramatic enhancement of stability is not unique to alpha TS. A survey of 71 TIM barrel proteins demonstrates a 4-fold symmetry for the placement of beta alpha-hairpin clamps, bracing the fundamental beta alpha beta building block and defining its register in the (beta alpha)(8) motif. The preferred sequences and locations of beta alpha-hairpin clamps will enhance structure prediction algorithms and provide a strategy for engineering stability in TIM barrel proteins.			Yang, XY (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	C.Robert.Matthews@umassmed.edu	Kathuria, Sagar/A-7473-2008		NIGMS NIH HHS [R01 GM023303, GM 23303] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023303] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altamirano MM, 2000, NATURE, V403, P617, DOI 10.1038/35001001; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bilsel O, 1999, BIOCHEMISTRY-US, V38, P1018, DOI 10.1021/bi982365q; Branden C., 1999, INTRO PROTEIN STRUCT; Brylinski M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000405; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; delPino MMS, 1997, BIOCHEMISTRY-US, V36, P5560, DOI 10.1021/bi963133z; FarzadFard F, 2008, J STRUCT BIOL, V161, P101, DOI 10.1016/j.jsb.2007.09.024; Forsyth WR, 2002, J MOL BIOL, V320, P1119, DOI 10.1016/S0022-2836(02)00557-0; Frenkel ZM, 2005, J BIOMOL STRUCT DYN, V22, P643, DOI 10.1080/07391102.2005.10507032; Gao JM, 2009, NAT STRUCT MOL BIOL, V16, P684, DOI 10.1038/nsmb.1610; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; Gerstein M, 1997, J MOL BIOL, V274, P562, DOI 10.1006/jmbi.1997.1412; Gromiha MM, 2004, PROTEINS, V55, P316, DOI 10.1002/prot.20052; Gu ZY, 2007, J MOL BIOL, V368, P582, DOI 10.1016/j.jmb.2007.02.027; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Ibarra-Molero B, 2004, J MOL BIOL, V336, P989, DOI 10.1016/j.jmb.2003.12.069; Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kunin V, 2001, J MOL BIOL, V307, P939, DOI 10.1006/jmbi.2001.4466; MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498; MATTHEWS CR, 1981, BIOCHEMISTRY-US, V20, P784, DOI 10.1021/bi00507a021; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Myers JK, 1996, BIOPHYS J, V71, P2033, DOI 10.1016/S0006-3495(96)79401-8; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider B, 2005, BIOCHEMISTRY-US, V44, P16405, DOI 10.1021/bi051640n; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Vadrevu R, 2008, J MOL BIOL, V377, P294, DOI 10.1016/j.jmb.2007.11.010; Wieczorek SJ, 1999, J AM CHEM SOC, V121, P4540, DOI 10.1021/ja990500w; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; Wu Y, 2007, J MOL BIOL, V366, P1624, DOI 10.1016/j.jmb.2006.12.005; Yang XY, 2007, PROTEIN SCI, V16, P1398, DOI 10.1110/ps.062704507; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; Zitzewitz JA, 1999, PROTEIN SCI, V8, P1200, DOI 10.1110/ps.8.6.1200	47	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7179	10.1371/journal.pone.0007179	http://dx.doi.org/10.1371/journal.pone.0007179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787060	Green Published, gold, Green Submitted			2022-12-25	WOS:000270290100007
J	Goff, LA; Davila, J; Swerdel, MR; Moore, JC; Cohen, RI; Wu, H; Sun, YE; Hart, RP				Goff, Loyal A.; Davila, Jonathan; Swerdel, Mavis R.; Moore, Jennifer C.; Cohen, Rick I.; Wu, Hao; Sun, Yi E.; Hart, Ronald P.			Ago2 Immunoprecipitation Identifies Predicted MicroRNAs in Human Embryonic Stem Cells and Neural Precursors	PLOS ONE			English	Article							GENES; DIFFERENTIATION; EVOLUTION; DISCOVERY; EXPANSION; PATTERN; TARGETS; ROLES; LINES	Background: MicroRNAs are required for maintenance of pluripotency as well as differentiation, but since more microRNAs have been computationally predicted in genome than have been found, there are likely to be undiscovered microRNAs expressed early in stem cell differentiation. Methodology/Principal Findings: SOLiD ultra-deep sequencing identified > 10(7) unique small RNAs from human embryonic stem cells (hESC) and neural-restricted precursors that were fit to a model of microRNA biogenesis to computationally predict 818 new microRNA genes. These predicted genomic loci are associated with chromatin patterns of modified histones that are predictive of regulated gene expression. 146 of the predicted microRNAs were enriched in Ago2-containing complexes along with 609 known microRNAs, demonstrating association with a functional RISC complex. This Ago2 IP-selected subset was consistently expressed in four independent hESC lines and exhibited complex patterns of regulation over development similar to previously-known microRNAs, including pluripotency-specific expression in both hESC and iPS cells. More than 30% of the Ago2 IP-enriched predicted microRNAs are new members of existing families since they share seed sequences with known microRNAs. Conclusions/Significance: Extending the classic definition of microRNAs, this large number of new microRNA genes, the majority of which are less conserved than their canonical counterparts, likely represent evolutionarily recent regulators of early differentiation. The enrichment in Ago2 containing complexes, the presence of chromatin marks indicative of regulated gene expression, and differential expression over development all support the identification of 146 new microRNAs active during early hESC differentiation.			Goff, LA (corresponding author), Rutgers State Univ, Rutgers Stem Cell Res Ctr, Piscataway, NJ 08855 USA.	rhart@rci.rutgers.edu	Hart, Ronald P/G-6530-2019; Wu, Hao/G-4145-2013; Hart, Ronald P/D-5219-2009	Hart, Ronald P/0000-0003-4836-8712; Wu, Hao/0000-0002-1256-6891; Hart, Ronald P/0000-0003-4836-8712; Goff, Loyal/0000-0003-2875-451X; Wu, Hao/0000-0003-4395-6929	NIMH NIH HHS [R01 MH084095, 1R01MH084095-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084095] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Cao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002820; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shin S, 2007, STEM CELLS, V25, P1298, DOI 10.1634/stemcells.2006-0660; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Ware CB, 2006, STEM CELLS, V24, P2677, DOI 10.1634/stemcells.2005-0452; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	52	94	226	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7192	10.1371/journal.pone.0007192	http://dx.doi.org/10.1371/journal.pone.0007192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784364	Green Published, gold, Green Submitted			2022-12-25	WOS:000270290000009
J	Gaspar, E; Hardenbicker, C; Bodo, E; Wenzel, B; Ramot, Y; Funk, W; Kromminga, A; Paus, R				Gaspar, Erzsebet; Hardenbicker, Celine; Bodo, Eniko; Wenzel, Bjoern; Ramot, Yuval; Funk, Wolfgang; Kromminga, Arno; Paus, Ralf			Thyrotropin releasing hormone (TRH): a new player in human hair-growth control	FASEB JOURNAL			English	Article						hair follicle; hair cycle regulation; cell cycle	PITUITARY-THYROID AXIS; CHECKPOINT KINASE CHK2; IN-VITRO; ATAXIA-TELANGIECTASIA; CUTANEOUS EXPRESSION; FOLLICLE REGRESSION; RANA-PIPIENS; HPA AXIS; SKIN; ACTIVATION	Thyrotropin-releasing hormone (TRH) is the most proximal component of the hypothalamic-pituitary-thyroid axis that regulates thyroid hormone synthesis. Since transcripts for members of this axis were detected in cultured normal human skin cells and since human hair follicles (HFs) respond to stimulation with thyrotropin, we now have studied whether human HF functions are also modulated by TRH. Here we report that the epithelium of normal human scalp HFs expresses not only TRH receptors (TRH-R) but also TRH itself at the gene and protein level. Stimulation of microdissected, organ-cultured HFs with TRH promotes hair-shaft elongation, prolongs the hair cycle growth phase (anagen), and antagonizes its termination by TGF-beta 2. It also increases proliferation and inhibits apoptosis of hair matrix keratinocytes. These TRH effects may be mediated in part by reducing the ATM/Atr-dependent phosphorylation of p53. By microarray analysis, several differentially up-or down-regulated TRH-target genes were detected (e. g., selected keratins). Thus, human scalp HFs are both a source and a target of TRH, which operates as a potent hair-growth stimulator. Human HFs provide an excellent discovery tool for identifying and dissecting nonclassical functions of TRH and TRH-mediated signaling in situ, which emerge as novel players in human epithelial biology.-Gaspar, E., Hardenbicker, C., Bodo, E., Wenzel, B., Ramot, Y., Funk, W., Kromminga, A., Paus, R. Thyrotropin releasing hormone (TRH): a new player in human hair-growth control. FASEB J. 24, 393-403 (2010). www.fasebj.org	[Gaspar, Erzsebet; Hardenbicker, Celine; Bodo, Eniko; Ramot, Yuval; Paus, Ralf] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Wenzel, Bjoern] Med Univ Lubeck, Dept Internal Med, D-23538 Lubeck, Germany; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester, Lancs, England; [Bodo, Eniko] Coll Nyiregyhaza, Agr & Mol Res Inst, Nyiregyhaza, Hungary; [Ramot, Yuval] Hadassah Hebrew Univ, Med Ctr, Dept Dermatol, Jerusalem, Israel; [Funk, Wolfgang] Klin Dr Kozlowski, Munich, Germany; [Kromminga, Arno] Inst Immunol, Hamburg, Germany	University of Lubeck; University of Lubeck; University of Manchester; Hebrew University of Jerusalem; Hadassah University Medical Center	Paus, R (corresponding author), Med Univ Lubeck, Dept Dermatol, Univ Hosp Schleswig Holstein, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany.	ralf.paus@uk-sh.de	Paus, Ralf/F-6243-2011; Paus, Ralf/B-5279-2015	Paus, Ralf/0000-0002-3492-9358	Deutsche Forschungsgemeinschaft (DFG); Minerva Research Followship	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Minerva Research Followship	We thank Dr. Burkhard Poeggeler for help throughout this study and gratefully acknowledge his expert advice. We also thank S. Grammerstorf and G. Scheel for excellent technical assistance and Dr. Ewan Langan for editing the manuscript. This study was supported in part by a grant from Deutsche Forschungsgemeinschaft (DFG) to R. P., as well as by a Minerva Research Followship to Y.R.	Bilek R, 2000, PHYSIOL RES, V49, pS19; Bodo E, 2005, AM J PATHOL, V166, P985, DOI 10.1016/S0002-9440(10)62320-6; BODO E, 2008, J INVEST DERMATOL, V89, P131; Bodo E, 2007, AM J PATHOL, V171, P1153, DOI 10.2353/ajpath.2007.061164; BOLAFFI JL, 1979, CELL TISSUE RES, V202, P505; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; BOWERS CY, 1971, BIOCHEM BIOPH RES CO, V45, P1033, DOI 10.1016/0006-291X(71)90441-4; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Castro CP, 1999, ENDOCRINOLOGY, V140, P690, DOI 10.1210/en.140.2.690; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Ellerhorst JA, 2004, CLIN CANCER RES, V10, P5531, DOI 10.1158/1078-0432.CCR-03-0368; Foitzik K, 2006, AM J PATHOL, V168, P748, DOI 10.2353/ajpath.2006.050468; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Garcia SI, 2005, REGUL PEPTIDES, V128, P239, DOI 10.1016/j.regpep.2005.01.002; Hibino T, 2004, J DERMATOL SCI, V35, P9, DOI 10.1016/j.jdermsci.2003.12.003; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Ito N, 2004, J INVEST DERMATOL, V122, P235, DOI 10.1046/j.1523-1747.2003.22145.x; JACKSON IMD, 1977, NATURE, V267, P853, DOI 10.1038/267853a0; JACKSON IMD, 1977, SCIENCE, V198, P414, DOI 10.1126/science.410104; JACKSON IMD, 1994, REGULATION THYROTROP; Kamath J, 2009, PHARMACOL THERAPEUT, V121, P20, DOI 10.1016/j.pharmthera.2008.09.004; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; KLOEPPER EJ, 2009, J EXP DERMATOL, DOI DOI 10.1111/J.1600-0625.2009.00939.X; Kobayashi H, 2005, FASEB J, V19, P1710, DOI 10.1096/fj.04-2293fje; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lechan RM, 2003, ENCY HORMONES, P510; LUO LG, 2007, ACTA BIOMED S, V1, P216; Luo LG, 2008, BIOCHEM BIOPH RES CO, V374, P69, DOI 10.1016/j.bbrc.2008.06.111; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Nikrodhanond AA, 2006, J BIOL CHEM, V281, P5000, DOI 10.1074/jbc.M511530200; Paus R, 2004, DIFFERENTIATION, V72, P489, DOI 10.1111/j.1432-0436.2004.07209004.x; Philpott M P, 1994, J Dermatol Sci, V7 Suppl, pS55, DOI 10.1016/0923-1811(94)90036-1; PHILPOTT MP, 1990, J CELL SCI, V97, P463; Pommier Y, 2005, CURR PHARM DESIGN, V11, P2855, DOI 10.2174/1381612054546716; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; SEIBERG M, 1995, J INVEST DERMATOL, V104, P78, DOI 10.1111/1523-1747.ep12613555; SHAMBAUGH G, 1979, J CLIN ENDOCR METAB, V48, P483, DOI 10.1210/jcem-48-3-483; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2002, J INVEST DERMATOL, V119, P1449, DOI 10.1046/j.1523-1747.2002.19617.x; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski AT, 1999, ANN NY ACAD SCI, V885, P287; Socci R, 1996, GEN PHYSIOL BIOPHYS, V15, P309; Soma T, 2002, J INVEST DERMATOL, V118, P993, DOI 10.1046/j.1523-1747.2002.01746.x; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Telek A, 2007, FASEB J, V21, P3534, DOI 10.1096/fj.06-7689com; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Vaudry H, 1999, ANN NY ACAD SCI, V885, P41; WIBER JF, 1968, P SOC EXP BIOL MED, V127, P488; Wilber JF, 1998, THYROID, V8, P897, DOI 10.1089/thy.1998.8.897; Zhang ST, 2006, CELL CYCLE, V5, P2787, DOI 10.4161/cc.5.23.3523; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	55	58	63	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					393	403		10.1096/fj.08-126417	http://dx.doi.org/10.1096/fj.08-126417			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19825978				2022-12-25	WOS:000274045000008
J	Mo, ZY; Zhu, YZ; Zhu, HL; Fan, JB; Chen, J; Liang, Y				Mo, Zhong-Ying; Zhu, Ying-Zhu; Zhu, Hai-Li; Fan, Jun-Bao; Chen, Jie; Liang, Yi			Low Micromolar Zinc Accelerates the Fibrillization of Human Tau via Bridging of Cys-291 and Cys-322	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ISOTHERMAL TITRATION CALORIMETRY; ALZHEIMERS-DISEASE; PROTEIN-TAU; AMYLOID-BETA; PHF-TAU; AGGREGATION; BINDING; METALS; FIBRILLATION	A hallmark of a group of neurodegenerative diseases such as Alzheimer disease is the formation of neurofibrillary tangles, which are principally composed of bundles of filaments formed by microtubule-associated protein Tau. Clarifying how natively unstructured Tau protein forms abnormal aggregates is of central importance for elucidating the etiology of these diseases. There is considerable evidence showing that zinc, as an essential element that is highly concentrated in brain, is linked to the development or progression of these diseases. Herein, by using recombinant human Tau fragment Tau(244-372) and its mutants, we have investigated the effect of zinc on the aggregation of Tau. Low micromolar concentrations of Zn2+ dramatically accelerate fibril formation of wild-type Tau(244-372) under reducing conditions, compared with no Zn2+. Higher concentrations of Zn2+, however, induce wild-type Tau(244-372) to form granular aggregates in reducing conditions. Moreover, these non-fibrillar aggregates assemble into mature Tau filaments when Zn2+ has been chelated by EDTA. Unlike wild-type Tau(244-372), low micromolar concentrations of Zn2+ have no obvious effects on fibrillization kinetics of single mutants C291A and C322A and double mutant C291A/C322A under reducing conditions. The results from isothermal titration calorimetry show that one Zn2+ binds to one Tau molecule via tetrahedral coordination to Cys-291 and Cys-322 as well as two histidines, with moderate, micromolar affinity. Our data demonstrate that low micromolar zinc accelerates the fibrillization of human Tau protein via bridging Cys-291 and Cys-322 in physiological reducing conditions, providing clues to understanding the relationship between zinc dyshomeostasis and the etiology of neurodegenerative diseases.	[Mo, Zhong-Ying; Zhu, Ying-Zhu; Zhu, Hai-Li; Fan, Jun-Bao; Chen, Jie; Liang, Yi] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Liang, Y (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; mo, zhongying/C-1955-2013; Fan, Jun-bao/E-7155-2012	Liang, Yi/0000-0002-7349-8300; Fan, Junbao/0000-0002-1709-3659	National Key Basic Research Foundation of China [2006CB910301]; National Natural Science Foundation of China [30770421, 30970599]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Foundation of China Grant 2006CB910301 and by National Natural Science Foundation of China Grants 30770421 and 30970599.	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; An WL, 2005, J NEUROCHEM, V92, P1104, DOI 10.1111/j.1471-4159.2004.02948.x; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bhattacharya K, 2001, BIOCHEM BIOPH RES CO, V285, P20, DOI 10.1006/bbrc.2001.5116; Blumenthal J, 2008, J CELL SCI, V121, P3253, DOI 10.1242/jcs.033266; Boom A, 2009, BBA-MOL CELL RES, V1793, P1058, DOI 10.1016/j.bbamcr.2008.11.011; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; Dong JJ, 2006, J AM CHEM SOC, V128, P3540, DOI 10.1021/ja055973j; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Friedhoff P, 2000, BBA-MOL BASIS DIS, V1502, P122, DOI 10.1016/S0925-4439(00)00038-7; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gaggelli E, 2005, J AM CHEM SOC, V127, P996, DOI 10.1021/ja045958z; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Hutchinson RW, 2005, ANAL BIOCHEM, V346, P225, DOI 10.1016/j.ab.2005.08.024; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Lee YM, 2008, J MOL BIOL, V379, P545, DOI 10.1016/j.jmb.2008.04.004; Li DW, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000238; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; MANDELKOW E, 1995, NEUROBIOL AGING, V16, P347, DOI 10.1016/0197-4580(95)00026-B; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; MANDELKOW EM, 1993, TRENDS BIOCHEM SCI, V18, P480, DOI 10.1016/0968-0004(93)90011-B; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nolan EM, 2009, ACCOUNTS CHEM RES, V42, P193, DOI 10.1021/ar8001409; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SHIN RW, 1994, J NEUROSCI, V14, P7221; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Soragni A, 2008, BIOCHEMISTRY-US, V47, P10841, DOI 10.1021/bi8008856; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Talmard C, 2007, BIOCHEMISTRY-US, V46, P13658, DOI 10.1021/bi701355j; THOMPSON CM, 1988, NEUROTOXICOLOGY, V9, P1; Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Xu H, 2005, J BIOL INORG CHEM, V10, P529, DOI 10.1007/s00775-005-0007-3; Yamin G, 2003, J BIOL CHEM, V278, P27630, DOI 10.1074/jbc.M303302200; Yang F, 2006, J MOL BIOL, V362, P821, DOI 10.1016/j.jmb.2006.07.059; Yang LS, 1999, J NEUROSCI RES, V55, P36, DOI 10.1002/(SICI)1097-4547(19990101)55:1<36::AID-JNR5>3.3.CO;2-5; Yu WH, 2001, J NEUROSCI, V21, P2240, DOI 10.1523/JNEUROSCI.21-07-02240.2001	69	141	146	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34648	34657		10.1074/jbc.M109.058883	http://dx.doi.org/10.1074/jbc.M109.058883			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826005	hybrid, Green Published			2022-12-25	WOS:000272439600020
J	Astuti, P; Pike, T; Widberg, C; Payne, E; Harding, A; Hancock, J; Gabrielli, B				Astuti, Puji; Pike, Tanya; Widberg, Charlotte; Payne, Elizabeth; Harding, Angus; Hancock, John; Gabrielli, Brian			MAPK Pathway Activation Delays G(2)/M Progression by Destabilizing Cdc25B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; CELL-CYCLE ARREST; PROTEIN-KINASE; DNA-DAMAGE; HELA-CELLS; G2 PHASE; MAMMALIAN-CELLS; EGG EXTRACTS; MITOSIS; PHOSPHORYLATION	Activation of the mitogen-activated protein kinase (MAPK) pathway by growth factors or phorbol esters during G(2) phase delays entry into mitosis; however, the role of the MAPK pathway during G(2)/M progression remains controversial. Here, we demonstrate that activation of the MAPK pathway with either epidermal growth factor or 12-O-tetradecanoylphorbol-13-acetate induces a G(2) phase delay independent of known G(2) phase checkpoint pathways but was specifically dependent on MAPK/extracellular signal-regulated kinase kinase (MEK1). Activation of MAPK signaling also blocked exit from a G(2) phase checkpoint arrest. Both the G(2) phase delay and blocked exit from the G(2) checkpoint arrest were mediated by the MEK1-dependent destabilization of the critical G(2)/M regulator cdc25B. Reintroduction of cdc25B overcame the MEK1-dependent G(2) phase delay. Thus, we have demonstrated a new function for MEK1 that controls G(2)/M progression by regulating the stability of cdc25B. This represents a novel mechanism by which factors that activate MAPK signaling can influence the timing of entry into mitosis, particularly exit from a G(2) phase checkpoint arrest.	[Gabrielli, Brian] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia; [Harding, Angus] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4102, Australia; [Hancock, John] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4102, Australia	University of Queensland; University of Queensland; University of Queensland	Gabrielli, B (corresponding author), Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.	brianG@uq.edu.au	Harding, Angus/B-4120-2012; Payne, Elizabeth/H-8603-2013; Gabrielli, Brian G/B-3655-2011; Astuti, Puji/GLV-5075-2022	Gabrielli, Brian G/0000-0003-3933-1651; Astuti, Puji/0000-0003-3316-6149; Soliman, Tanya/0000-0002-4687-629X	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by grants from the Australian Research Council.	Bansal P, 2007, CANCER RES, V67, P3356, DOI 10.1158/0008-5472.CAN-06-3685; Barboule N, 1999, FEBS LETT, V444, P32, DOI 10.1016/S0014-5793(99)00022-8; BARTH H, 1995, J CELL PHYSIOL, V162, P44, DOI 10.1002/jcp.1041620107; BARTH H, 1994, EXP CELL RES, V212, P383, DOI 10.1006/excr.1994.1158; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Chun J, 2005, CELL CYCLE, V4, P148, DOI 10.4161/cc.4.1.1323; Colanzi A, 2003, J CELL BIOL, V161, P27, DOI 10.1083/jcb.200208099; Dangi S, 2006, CELL PROLIFERAT, V39, P261, DOI 10.1111/j.1365-2184.2006.00388.x; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Edelmann HML, 1996, J BIOL CHEM, V271, P963, DOI 10.1074/jbc.271.2.963; El-Shemerly MYM, 1997, J BIOL CHEM, V272, P30599, DOI 10.1074/jbc.272.49.30599; Eymin B, 2006, CELL CYCLE, V5, P759, DOI 10.4161/cc.5.7.2625; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gabrielli BG, 1997, ONCOGENE, V15, P749, DOI 10.1038/sj.onc.1201254; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Goldstone S, 2001, ONCOGENE, V20, P921, DOI 10.1038/sj.onc.1204177; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Isoda M, 2009, MOL BIOL CELL, V20, P2186, DOI 10.1091/mbc.E09-01-0008; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Klingler-Hoffmann M, 2005, EUR J CELL BIOL, V84, P719, DOI 10.1016/j.ejcb.2005.04.002; Kohn EA, 2003, CANCER RES, V63, P31; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lemaire M, 2006, CELL CYCLE, V5, P1649, DOI 10.4161/cc.5.15.3006; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mayor F, 2007, CELL CYCLE, V6, P528, DOI 10.4161/cc.6.5.3920; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Nam HJ, 2008, CELL SIGNAL, V20, P1349, DOI 10.1016/j.cellsig.2008.03.008; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; ROSSOMANDO AJ, 1994, MOL CELL BIOL, V14, P1594, DOI 10.1128/MCB.14.3.1594; Schmitt E, 2006, J CELL SCI, V119, P4269, DOI 10.1242/jcs.03200; Scholl FA, 2009, CANCER RES, V69, P3772, DOI 10.1158/0008-5472.CAN-08-1963; Shinohara M, 2006, MOL BIOL CELL, V17, P5227, DOI 10.1091/mbc.E06-04-0284; Theis-Febvre N, 2003, ONCOGENE, V22, P220, DOI 10.1038/sj.onc.1206107; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Walter SA, 2000, MOL BIOL CELL, V11, P887, DOI 10.1091/mbc.11.3.887; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Yan Y, 2005, ONCOGENE, V24, P3285, DOI 10.1038/sj.onc.1208492	51	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33781	33788		10.1074/jbc.M109.027516	http://dx.doi.org/10.1074/jbc.M109.027516			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801682	Green Published, hybrid			2022-12-25	WOS:000272165200008
J	Dennler, S; Andre, J; Verrecchia, F; Mauviel, A				Dennler, Sylviane; Andre, Jocelyne; Verrecchia, Franck; Mauviel, Alain			Cloning of the Human GLI2 Promoter TRANSCRIPTIONAL ACTIVATION BY TRANSFORMING GROWTH FACTOR-beta VIA SMAD3/beta-CATENIN COOPERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; SIGNALING PATHWAY; HEDGEHOG; CATENIN; WNT; CANCER; MEDIATORS; COACTIVATOR; DOMAIN; SMAD2	GLI2 (GLI-Kruppel family member 2), a zinc finger transcription factor that mediates Hedgehog signaling, is implicated in the progression of an ever-growing number of human malignancies, including prostate and pancreatic cancer, as well as basal cell carcinoma of the skin. Its expression is up-regulated by transforming growth factor-beta (TGF-beta) in a variety of cell types, both normal and transformed. We report herein that TGF-beta driven GLI2 expression is transcriptional and does not result from stabilization of GLI2 transcripts. We describe the characterization of the 5'-flanking sequence of human GLI2 mRNA, the identification of a transcription start site, the cloning of similar to 1,600 bp of the regulatory promoter region and the identification and functional analysis of a TGF-beta-responsive region mapped to a 91-bp sequence between nucleotides -119 and -29 of the promoter. This region harbors SMAD and lymphoid enhancer factor/T cell factor binding sites that allow functional cooperation between SMAD3 and beta-catenin, recruited to the promoter in response to TGF-beta to drive GLI2 gene transcription.	[Dennler, Sylviane; Andre, Jocelyne; Verrecchia, Franck; Mauviel, Alain] Univ Paris Diderot, INSERM, U697, F-75010 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mauviel, A (corresponding author), Hop St Louis, INSERM, U697, 1 Ave Claude Vellefaux, F-75010 Paris, France.	alain.mauviel@inserm.fr	Verrecchia, Franck/G-5535-2018; MAUVIEL, Alain/F-6251-2013	Verrecchia, Franck/0000-0003-4920-2554; Mauviel, Alain/0000-0002-0438-2793	Donation Henriette et Emile Goutiere; Canceropole Ile-de-France; INSERM	Donation Henriette et Emile Goutiere; Canceropole Ile-de-France(Region Ile-de-France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Donation Henriette et Emile Goutiere (to A. M.), Canceropole Ile-de-France, and INSERM.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Hirota M, 2008, CELL SIGNAL, V20, P1632, DOI 10.1016/j.cellsig.2008.05.003; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Javelaud D, 2004, INT J BIOCHEM CELL B, V36, P1161, DOI 10.1016/S1357-2725(03)00255-3; Ji J, 2008, INT J CANCER, V122, P50, DOI 10.1002/ijc.23023; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kelleher FC, 2006, ACTA ONCOL, V45, P375, DOI 10.1080/02841860600602946; Kim Y, 2007, CANCER RES, V67, P3583, DOI 10.1158/0008-5472.CAN-06-3040; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Maeda O, 2006, ONCOL REP, V16, P91; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mullor JL, 2001, CURR BIOL, V11, P769, DOI 10.1016/S0960-9822(01)00229-9; Narita S, 2008, CLIN CANCER RES, V14, P5769, DOI 10.1158/1078-0432.CCR-07-4282; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Paul S, 2008, NEOPLASMA, V55, P165; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Thiyagarajan S, 2007, CANCER RES, V67, P10642, DOI 10.1158/0008-5472.CAN-07-2015; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200	38	103	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31523	31531		10.1074/jbc.M109.059964	http://dx.doi.org/10.1074/jbc.M109.059964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797115	Green Published, hybrid			2022-12-25	WOS:000271572700005
J	Korur, S; Huber, RM; Sivasankaran, B; Petrich, M; Morin, P; Hemmings, BA; Merlo, A; Lino, MM				Korur, Serdar; Huber, Roland M.; Sivasankaran, Balasubramanian; Petrich, Michael; Morin, Pier, Jr.; Hemmings, Brian A.; Merlo, Adrian; Lino, Maria Maddalena			GSK3 beta Regulates Differentiation and Growth Arrest in Glioblastoma	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CANCER STEM-CELLS; FACTOR-KAPPA-B; SELF-RENEWAL; BMI-1; GENE; SENESCENCE; POLYCOMB; SURVIVAL; TUMORS	Cancers are driven by a population of cells with the stem cell properties of self-renewal and unlimited growth. As a subpopulation within the tumor mass, these cells are believed to constitute a tumor cell reservoir. Pathways controlling the renewal of normal stem cells are deregulated in cancer. The polycomb group gene Bmi1, which is required for neural stem cell self-renewal and also controls anti-oxidant defense in neurons, is upregulated in several cancers, including medulloblastoma. We have found that Bmi1 is consistently and highly expressed in GBM. Downregulation of Bmi1 by shRNAs induced a differentiation phenotype and reduced expression of the stem cell markers Sox2 and Nestin. Interestingly, expression of glycogen synthase kinase 3 beta (GSK3 beta), which was found to be consistently expressed in primary GBM, also declined. This suggests a functional link between Bmi1 and GSK3b. Interference with GSK3b activity by siRNA, the specific inhibitor SB216763, or lithium chloride (LiCl) induced tumor cell differentiation. In addition, tumor cell apoptosis was enhanced, the formation of neurospheres was impaired, and clonogenicity reduced in a dose-dependent manner. GBM cell lines consist mainly of CD133-negative (CD133-) cells. Interestingly, ex vivo cells from primary tumor biopsies allowed the identification of a CD133- subpopulation of cells that express stem cell markers and are depleted by inactivation of GSK3b. Drugs that inhibit GSK3, including the psychiatric drug LiCl, may deplete the GBM stem cell reservoir independently of CD133 status.			Korur, S (corresponding author), Univ Basel Hosp, Mol Neurooncol Lab, CH-4031 Basel, Switzerland.	adrian.merlo@gmx.ch	Sivasankaran, Balasubramanian/D-1527-2015	Sivasankaran, Balasubramanian/0000-0001-6207-5516				Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen Y, 1998, MED ONCOL, V15, P32, DOI 10.1007/BF02787342; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GANGEMI RM, 2008, STEM CELLS; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; HAUPT Y, 1993, ONCOGENE, V8, P3161; HEMMINGS BA, 1981, EUR J BIOCHEM, V119, P443, DOI 10.1111/j.1432-1033.1981.tb05628.x; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jacobs, 1999, Curr Infect Dis Rep, V1, P13, DOI 10.1007/s11908-999-0004-8; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Labuhn M, 2001, ONCOGENE, V20, P1103, DOI 10.1038/sj.onc.1204197; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Merlo A, 2003, NEUROSURG REV, V26, P145, DOI 10.1007/s10143-003-0267-8; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MOLOFSKY AV, 2006, NATURE; NEWTON HB, 1994, AM FAM PHYSICIAN, V49, P787; Newton Herbert B, 2004, Expert Rev Anticancer Ther, V4, P803, DOI 10.1586/14737140.4.5.803; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Piccirillo SGM, 2007, ERNST SCHERING FOUND, V5, P59, DOI 10.1007/2789_2007_044; Ryder J, 2003, BIOCHEM BIOPH RES CO, V312, P922, DOI 10.1016/j.bbrc.2003.11.014; Shakhova O, 2005, J MOL MED, V83, P596, DOI 10.1007/s00109-005-0682-0; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang Z, 2008, NATURE; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	53	115	116	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7443	10.1371/journal.pone.0007443	http://dx.doi.org/10.1371/journal.pone.0007443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823589	Green Submitted, gold, Green Published			2022-12-25	WOS:000270808300018
J	Shortridge, MD; Powers, R				Shortridge, Matthew D.; Powers, Robert			Structural and Functional Similarity between the Bacterial Type III Secretion System Needle Protein PrgI and the Eukaryotic Apoptosis Bcl-2 Proteins	PLOS ONE			English	Article							LIGAND-BINDING; FAMILY PROTEINS; FAST-NMR; EVOLUTION; BAX; INHIBITOR; IDENTIFICATION; MECHANISMS; CHELERYTHRINE; ANNOTATION	Background: Functional similarity is challenging to identify when global sequence and structure similarity is low. Active-sites or functionally relevant regions are evolutionarily more stable relative to the remainder of a protein structure and provide an alternative means to identify potential functional similarity between proteins. We recently developed the FAST-NMR methodology to discover biochemical functions or functional hypotheses of proteins of unknown function by experimentally identifying ligand binding sites. FAST-NMR utilizes our CPASS software and database to assign a function based on a similarity in the structure and sequence of ligand binding sites between proteins of known and unknown function. Methodology/Principal Findings: The PrgI protein from Salmonella typhimurium forms the needle complex in the type III secretion system (T3SS). A FAST-NMR screen identified a similarity between the ligand binding sites of PrgI and the Bcl-2 apoptosis protein Bcl-xL. These ligand binding sites correlate with known protein-protein binding interfaces required for oligomerization. Both proteins form membrane pores through this oligomerization to release effector proteins to stimulate cell death. Structural analysis indicates an overlap between the PrgI structure and the pore forming motif of Bcl-xL. A sequence alignment indicates conservation between the PrgI and Bcl-xL ligand binding sites and pore formation regions. This active-site similarity was then used to verify that chelerythrine, a known Bcl-xL inhibitor, also binds PrgI. Conclusions/Significance: A structural and functional relationship between the bacterial T3SS and eukaryotic apoptosis was identified using our FAST-NMR ligand affinity screen in combination with a bioinformatic analysis based on our CPASS program. A similarity between PrgI and Bcl-xL is not readily apparent using traditional global sequence and structure analysis, but was only identified because of conservation in ligand binding sites. These results demonstrate the unique opportunity that ligand-binding sites provide for the identification of functional relationships when global sequence and structural information is limited.			Shortridge, MD (corresponding author), Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA.	rpowers3@unl.edu	Powers, Robert/AAK-3431-2020	Powers, Robert/0000-0001-9948-6837	NCRR NIH HHS [RR015468-01, C06 RR015468] Funding Source: Medline; NIAID NIH HHS [R21 AI081154, R21AI081154] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081154] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234; ARMOUGOM F, 2006, EXPRESSO AUTOMATIC I, V34, pW604; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Bystroff Christopher, 2008, V413, P173; Campbell SJ, 2003, CURR OPIN STRUC BIOL, V13, P389, DOI 10.1016/S0959-440X(03)00075-7; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Chan SL, 2003, J BIOL CHEM, V278, P20453, DOI 10.1074/jbc.C300138200; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Er E, 2007, J BIOL CHEM, V282, P24938, DOI 10.1074/jbc.M703823200; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gauthier A, 2003, J BIOL CHEM, V278, P25273, DOI 10.1074/jbc.R300012200; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Grassme H, 2001, APOPTOSIS, V6, P441, DOI 10.1023/A:1012485506972; Gray MW, 2001, GENOME BIOL, V2; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-444; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kimbrough TG, 2002, MICROBES INFECT, V4, P75, DOI 10.1016/S1286-4579(01)01512-X; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; McCann HC, 2008, NEW PHYTOL, V177, P33, DOI 10.1111/j.1469-8137.2007.02293.x; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Mercier KA, 2006, J AM CHEM SOC, V128, P15292, DOI 10.1021/ja0651759; Mercier KA, 2006, COMB CHEM HIGH T SCR, V9, P515, DOI 10.2174/138620706777935342; Mercier KA, 2009, COMB CHEM HIGH T SCR, V12, P285, DOI 10.2174/138620709787581738; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Morett E, 1998, FEBS LETT, V433, P108, DOI 10.1016/S0014-5793(98)00888-6; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Muller Simone, 2001, Expert Opin Ther Targets, V5, P327, DOI 10.1517/14728222.5.3.327; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Notredame C, 2003, BIOINFORMATICS AND GENOMES: CURRENT PERSPECTIVES, P27; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806; Park K, 2008, PROTEINS, V71, P960, DOI 10.1002/prot.21780; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Powers R, 2007, COMB CHEM HIGH T SCR, V10, P676, DOI 10.2174/138620707782507331; Powers R, 2008, DRUG DISCOV TODAY, V13, P172, DOI 10.1016/j.drudis.2007.11.001; Powers R, 2006, PROTEINS, V65, P124, DOI 10.1002/prot.21092; Rosinski JA, 1999, J MOL EVOL, V49, P301, DOI 10.1007/PL00006552; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Shapiro R, 2006, Q REV BIOL, V81, P105, DOI 10.1086/506024; Shortridge MD, 2008, J COMB CHEM, V10, P948, DOI 10.1021/cc800122m; Stark J, 2008, J AM CHEM SOC, V130, P535, DOI 10.1021/ja0737974; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Wendt MD, 2008, EXPERT OPIN DRUG DIS, V3, P1123, DOI 10.1517/17460441.3.9.1123; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yan L, 2003, FEBS LETT, V555, P545, DOI 10.1016/s0014-5793(03)01346-2; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Zhang YH, 2006, J MOL BIOL, V364, P536, DOI 10.1016/j.jmb.2006.09.023	78	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7442	10.1371/journal.pone.0007442	http://dx.doi.org/10.1371/journal.pone.0007442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823588	Green Published, gold			2022-12-25	WOS:000270808300017
J	Vasilescu, C; Rossi, S; Shimizu, M; Tudor, S; Veronese, A; Ferracin, M; Nicoloso, MS; Barbarotto, E; Popa, M; Stanciulea, O; Fernandez, MH; Tulbure, D; Bueso-Ramos, CE; Negrini, M; Calin, GA				Vasilescu, Catalin; Rossi, Simona; Shimizu, Masayoshi; Tudor, Stefan; Veronese, Angelo; Ferracin, Manuela; Nicoloso, Milena S.; Barbarotto, Elisa; Popa, Monica; Stanciulea, Oana; Fernandez, Michael H.; Tulbure, Dan; Bueso-Ramos, Carlos E.; Negrini, Massimo; Calin, George A.			MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis	PLOS ONE			English	Article							EXPRESSION; MACROPHAGES; INFLAMMATION; APOPTOSIS; DEPLETION; PATHWAY; CELLS; IL-18; ICU	Background: The physiopathology of sepsis continues to be poorly understood, and despite recent advances in its management, sepsis is still a life-threatening condition with a poor outcome. If new diagnostic markers related to sepsis pathogenesis will be identified, new specific therapies might be developed and mortality reduced. Small regulatory non-coding RNAs, microRNAs (miRNAs), were recently linked to various diseases; the aim of our prospective study was to identify miRNAs that can differentiate patients with early-stage sepsis from healthy controls and to determine if miRNA levels correlate with the severity assessed by the Sequential Organ Failure Assessment (SOFA) score. Methodology/Principal Findings: By using genome-wide miRNA profiling by microarray in peripheral blood leukocytes, we found that miR-150, miR-182, miR-342-5p, and miR-486 expression profiles differentiated sepsis patients from healthy controls. We also proved by quantitative reverse transcription-polymerase chain reaction that miR-150 levels were significantly reduced in plasma samples of sepsis patients and correlated with the level of disease severity measured by the SOFA score, but were independent of the white blood counts (WBC). We found that plasma levels of tumor necrosis factor alpha, interleukin-10, and interleukin-18, all genes with sequence complementarity to miR-150, were negatively correlated with the plasma levels of this miRNA. Furthermore, we identified that the plasma levels ratio for miR-150/interleukin-18 can be used for assessing the severity of the sepsis. Conclusions/Significance: We propose that miR-150 levels in both leukocytes and plasma correlate with the aggressiveness of sepsis and can be used as a marker of early sepsis. Furthermore, we envision miR-150 restoration as a future therapeutic option in sepsis patients.			Vasilescu, C (corresponding author), Fundeni Clin Hosp, Dept Surg, Bucharest, Romania.	gcalin@mdanderson.org	Vasilescu, Catalin/B-8859-2011; Negrini, Massimo/J-2377-2016; Nicoloso, Milena S/K-6411-2012; Tudor, Stefan/C-2162-2011; Tudor, Ștefan/GWD-6211-2022; Ferracin, Manuela/K-2097-2016; stanciulea, oana/C-5062-2011; Veronese, Angelo/I-4292-2019; Calin, George/E-9390-2011	Negrini, Massimo/0000-0002-0007-1920; Nicoloso, Milena S/0000-0003-4231-9303; Tudor, Stefan/0000-0003-2933-2060; Ferracin, Manuela/0000-0002-1595-6887; Calin, George/0000-0001-6704-5615; Veronese, Angelo/0000-0002-1451-1392				Abe R, 2008, J SURG RES, V147, P1, DOI 10.1016/j.jss.2007.07.009; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anglicheau D, 2009, P NATL ACAD SCI USA, V106, P5330, DOI 10.1073/pnas.0813121106; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; BARKHAUSEN T, 2009, INJURY; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; DAS S, 2008, METAB SYNDR RELAT DI; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Zaki ME, 2007, IMMUNOL INVEST, V36, P403, DOI 10.1080/08820130701244275; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; George SJ, 2008, ARTERIOSCL THROM VAS, V28, P400, DOI 10.1161/ATVBAHA.107.160952; Grobmyer SR, 2000, J CLIN IMMUNOL, V20, P212, DOI 10.1023/A:1006641630904; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hotchkiss RS, 2002, J IMMUNOL, V168, P2493, DOI 10.4049/jimmunol.168.5.2493; Hutchins RR, 2004, WORLD J SURG, V28, P137, DOI 10.1007/s00268-003-7067-8; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Libert C, 2003, NATURE, V421, P328, DOI 10.1038/421328a; Lichtenstern C, 2007, DIGEST SURG, V24, P1, DOI 10.1159/000099009; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Oberholzer A, 2001, SHOCK, V16, P411, DOI 10.1097/00024382-200116060-00001; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Tili Esmerina, 2008, Int J Med Sci, V5, P73; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021	35	248	286	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7405	10.1371/journal.pone.0007405	http://dx.doi.org/10.1371/journal.pone.0007405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823581	Green Published, gold, Green Submitted			2022-12-25	WOS:000270728500006
J	Khiabanian, H; Trifonov, V; Rabadan, R				Khiabanian, Hossein; Trifonov, Vladimir; Rabadan, Raul			Reassortment Patterns in Swine Influenza Viruses	PLOS ONE			English	Article							A VIRUSES; GENETIC-CHARACTERIZATION; H1N2; PIGS; IDENTIFICATION; DIVERSITY; EVOLUTION; DATABASE; HUMANS; CANADA	Three human influenza pandemics occurred in the twentieth century, in 1918, 1957, and 1968. Influenza pandemic strains are the results of emerging viruses from non-human reservoirs to which humans have little or no immunity. At least two of these pandemic strains, in 1957 and in 1968, were the results of reassortments between human and avian viruses. Also, many cases of swine influenza viruses have reportedly infected humans, in particular, the recent H1N1 influenza virus of swine origin, isolated in Mexico and the United States. Pigs are documented to allow productive replication of human, avian, and swine influenza viruses. Thus it has been conjectured that pigs are the "mixing vessel'' that create the avian-human reassortant strains, causing the human pandemics. Hence, studying the process and patterns of viral reassortment, especially in pigs, is a key to better understanding of human influenza pandemics. In the last few years, databases containing sequences of influenza A viruses, including swine viruses, collected since 1918 from diverse geographical locations, have been developed and made publicly available. In this paper, we study an ensemble of swine influenza viruses to analyze the reassortment phenomena through several statistical techniques. The reassortment patterns in swine viruses prove to be similar to the previous results found in human viruses, both in vitro and in vivo, that the surface glycoprotein coding segments reassort most often. Moreover, we find that one of the polymerase segments (PB1), reassorted in the strains responsible for the last two human pandemics, also reassorts frequently.			Khiabanian, H (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10027 USA.	hossein@c2b2.columbia.edu	Khiabanian, Hossein/N-7207-2019; Rabadan, Raul/AAZ-7367-2020	Khiabanian, Hossein/0000-0003-1446-4394; Rabadan, Raul/0000-0001-7946-9255				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Boni MF, 2008, J VIROL, V82, P4807, DOI 10.1128/JVI.02683-07; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Chutinimitkul S, 2008, ARCH VIROL, V153, P1049, DOI 10.1007/s00705-008-0097-7; Downie JC, 2004, INT CONGR SER, V1263, P714, DOI 10.1016/j.ics.2004.02.140; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; Karasin AI, 2006, J CLIN MICROBIOL, V44, P1123, DOI 10.1128/JCM.44.3.1123-1126.2006; Karasin AI, 2002, J CLIN MICROBIOL, V40, P1073, DOI 10.1128/JCM.40.3.1073-1079.2002; Komar N, 2008, EMERG INFECT DIS, V14, P1176, DOI 10.3201/eid1407.080161; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; Lekcharoensuk P, 2006, EMERG INFECT DIS, V12, P787; Lindstrom SE, 2004, VIROLOGY, V328, P101, DOI 10.1016/j.virol.2004.06.009; LUBECK MD, 1979, VIROLOGY, V95, P269, DOI 10.1016/0042-6822(79)90430-6; LUDWIG S, 1995, VIROLOGY, V212, P555, DOI 10.1006/viro.1995.1513; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Marozin S, 2002, J GEN VIROL, V83, P735, DOI 10.1099/0022-1317-83-4-735; Marsh GA, 2008, J VIROL, V82, P2295, DOI 10.1128/JVI.02267-07; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132, DOI 10.3201/eid1207.060268; Qi X, 2006, ARCH VIROL, V151, P2289, DOI 10.1007/s00705-006-0796-x; Rabadan R, 2008, INFLUENZA OTHER RESP, V2, P9, DOI 10.1111/j.1750-2659.2007.00030.x; Rabadan R, 2006, J VIROL, V80, P11887, DOI 10.1128/JVI.01414-06; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Saito T, 2008, J VET MED SCI, V70, P423, DOI 10.1292/jvms.70.423; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; SCHOLTISSEK C, 1990, Medical Principles and Practice, V2, P65; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Trifonov V, 2009, EURO SURVEILL, V14; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; YOO GJ, 2008, VIRUS RES, V138, P43; Zell R, 2008, J GEN VIROL, V89, P271, DOI 10.1099/vir.0.83338-0; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	41	39	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7366	10.1371/journal.pone.0007366	http://dx.doi.org/10.1371/journal.pone.0007366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809504	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594000016
J	Patani, R; Compston, A; Puddifoot, CA; Wyllie, DJA; Hardingham, GE; Allen, ND; Chandran, S				Patani, Rickie; Compston, Alastair; Puddifoot, Clare A.; Wyllie, David J. A.; Hardingham, Giles E.; Allen, Nicholas D.; Chandran, Siddharthan			Activin/Nodal Inhibition Alone Accelerates Highly Efficient Neural Conversion from Human Embryonic Stem Cells and Imposes a Caudal Positional Identity	PLOS ONE			English	Article								Background: Neural conversion from human embryonic stem cells (hESCs) has been demonstrated in a variety of systems including chemically defined suspension culture, not requiring extrinsic signals, as well as in an adherent culture method that involves dual SMAD inhibition using Noggin and SB431542 (an inhibitor of activin/nodal signaling). Previous studies have also determined a role for activin/nodal signaling in development of the neural plate and anterior fate specification. We therefore sought to investigate the independent influence of SB431542 both on neural commitment of hESCs and positional identity of derived neural progenitors in chemically defined substrate-free conditions. Methodology/Principal Findings: We show that in non-adherent culture conditions, treatment with SB431542 alone for 8 days is sufficient for highly efficient and accelerated neural conversion from hESCs with negligible mesendodermal, epidermal or trophectodermal contamination. In addition the resulting neural progenitor population has a predominantly caudal identity compared to the more anterior positional fate of non-SB431542 treated cultures. Finally we demonstrate that resulting neurons are electro-physiologically competent. Conclusions: This study provides a platform for the efficient generation of caudal neural progenitors under defined conditions for experimental study.			Patani, R (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England.	sc222@cam.ac.uk	Wyllie, David J A/AAK-4678-2021; allen, nick d/A-4336-2010; Patani, R/J-3107-2018	Wyllie, David J A/0000-0002-4957-6049; Patani, R/0000-0002-3825-7675; Hardingham, Giles/0000-0002-7629-5314; Allen, Nicholas/0000-0003-4009-186X	Medical Research Council [G0700711B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish; MRC [G0701499] Funding Source: UKRI; Medical Research Council [G0701499] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Baxter AW, 2006, J NEUROSCI, V26, P5456, DOI 10.1523/JNEUROSCI.4101-05.2006; Bouhon IA, 2005, BRAIN RES BULL, V68, P62, DOI 10.1016/j.brainresbull.2005.08.022; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; CHAMBERS SM, 2009, NAT BIOTECHNOL; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Erceg S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002122; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; MINTA A, 1989, J BIOL CHEM, V264, P8171; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier Ludovic, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01d04s4; Varlet I, 1997, DEVELOPMENT, V124, P1033; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	26	67	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7327	10.1371/journal.pone.0007327	http://dx.doi.org/10.1371/journal.pone.0007327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806200	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000270593800021
J	Rodrigues-Ferreira, S; Di Tommaso, A; Dimitrov, A; Cazaubon, S; Gruel, N; Colasson, H; Nicolas, A; Chaverot, N; Molinie, V; Reyal, F; Sigal-Zafrani, B; Terris, B; Delattre, O; Radvanyi, F; Perez, F; Vincent-Salomon, A; Nahmias, C				Rodrigues-Ferreira, Sylvie; Di Tommaso, Anne; Dimitrov, Ariane; Cazaubon, Sylvie; Gruel, Nadege; Colasson, Helene; Nicolas, Andre; Chaverot, Nathalie; Molinie, Vincent; Reyal, Fabien; Sigal-Zafrani, Brigitte; Terris, Benoit; Delattre, Olivier; Radvanyi, Francois; Perez, Franck; Vincent-Salomon, Anne; Nahmias, Clara			8p22 MTUS1 Gene Product ATIP3 Is a Novel Anti-Mitotic Protein Underexpressed in Invasive Breast Carcinoma of Poor Prognosis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR RASSF1A; CANCER CELL-LINES; AT2 RECEPTOR; EXPRESSION; CORRELATE; PATTERNS; KINASES; TARGETS; BASAL; DNA	Background: Breast cancer is a heterogeneous disease that is not totally eradicated by current therapies. The classification of breast tumors into distinct molecular subtypes by gene profiling and immunodetection of surrogate markers has proven useful for tumor prognosis and prediction of effective targeted treatments. The challenge now is to identify molecular biomarkers that may be of functional relevance for personalized therapy of breast tumors with poor outcome that do not respond to available treatments. The Mitochondrial Tumor Suppressor (MTUS1) gene is an interesting candidate whose expression is reduced in colon, pancreas, ovary and oral cancers. The present study investigates the expression and functional effects of MTUS1 gene products in breast cancer. Methods and Findings: By means of gene array analysis, real-time RT-PCR and immunohistochemistry, we show here that MTUS1/ATIP3 is significantly down-regulated in a series of 151 infiltrating breast cancer carcinomas as compared to normal breast tissue. Low levels of ATIP3 correlate with high grade of the tumor and the occurrence of distant metastasis. ATIP3 levels are also significantly reduced in triple negative (ER-PR-HER2-) breast carcinomas, a subgroup of highly proliferative tumors with poor outcome and no available targeted therapy. Functional studies indicate that silencing ATIP3 expression by siRNA increases breast cancer cell proliferation. Conversely, restoring endogenous levels of ATIP3 expression leads to reduced cancer cell proliferation, clonogenicity, anchorage-independent growth, and reduces the incidence and size of xenografts grown in vivo. We provide evidence that ATIP3 associates with the microtubule cytoskeleton and localizes at the centrosomes, mitotic spindle and intercellular bridge during cell division. Accordingly, live cell imaging indicates that ATIP3 expression alters the progression of cell division by promoting prolonged metaphase, thereby leading to a reduced number of cells ungergoing active mitosis. Conclusions: Our results identify for the first time ATIP3 as a novel microtubule-associated protein whose expression is significantly reduced in highly proliferative breast carcinomas of poor clinical outcome. ATIP3 re-expression limits tumor cell proliferation in vitro and in vivo, suggesting that this protein may represent a novel useful biomarker and an interesting candidate for future targeted therapies of aggressive breast cancer.			Rodrigues-Ferreira, S (corresponding author), Univ Paris 05, INSERM, CNRS, Inst Cochin,U567,UMR8104, Paris, France.	clara.nahmias@inserm.fr	Terris, Benoit/P-1497-2017; Perez, Franck/A-1558-2014	Perez, Franck/0000-0002-9129-9401; Radvanyi, Francois/0000-0002-5696-6424; Nahmias, Clara/0000-0001-6863-370X; delattre, olivier/0000-0002-8730-2276				Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; COOMBS LM, 1990, ANAL BIOCHEM, V188, P338, DOI 10.1016/0003-2697(90)90617-I; Di Benedetto M, 2006, GENE, V380, P127, DOI 10.1016/j.gene.2006.05.021; Di Benedetto M, 2006, MOL CELL ENDOCRINOL, V252, P207, DOI 10.1016/j.mce.2006.03.014; Dimitrov A, 2009, HUM MOL GENET, V18, P440, DOI 10.1093/hmg/ddn371; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; Frank B, 2007, CARCINOGENESIS, V28, P1442, DOI 10.1093/carcin/bgm033; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hirano A, 2001, CLIN CANCER RES, V7, P876; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Huszar D, 2009, CANCER METAST REV, V28, P197, DOI 10.1007/s10555-009-9185-8; Ishii H, 2001, P NATL ACAD SCI USA, V98, P10374, DOI 10.1073/pnas.181222898; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Lee S, 2006, ONCOL REP, V16, P747; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nizak C, 2003, TRAFFIC, V4, P739, DOI 10.1034/j.1600-0854.2003.00132.x; Nouet S, 2004, J BIOL CHEM, V279, P28989, DOI 10.1074/jbc.M403880200; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pils D, 2005, CANCER-AM CANCER SOC, V104, P2417, DOI 10.1002/cncr.21538; Pirollo KF, 2008, CLIN CANCER RES, V14, P2190, DOI 10.1158/1078-0432.CCR-07-1951; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rakha EA, 2008, J CLIN ONCOL, V26, P3153, DOI 10.1200/JCO.2007.15.5986; Reyal F, 2005, CANCER RES, V65, P1376, DOI 10.1158/0008-5472.CAN-04-2706; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Seibold S, 2003, FASEB J, V17, P1180, DOI 10.1096/fj.02-0934fje; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Warner SL, 2006, SEMIN ONCOL, V33, P436, DOI 10.1053/j.seminoncol.2006.04.007; Wolff AC, 2007, J CLIN ONCOL, V25, P4021, DOI 10.1200/JCO.2007.11.4363; Wruck CJ, 2005, ARTERIOSCL THROM VAS, V25, P57, DOI 10.1161/01.ATV.0000150662.51436.14; Ye H, 2007, CANCER GENET CYTOGEN, V176, P100, DOI 10.1016/j.cancergencyto.2007.04.003	38	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e7239	10.1371/journal.pone.0007239	http://dx.doi.org/10.1371/journal.pone.0007239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794912	Green Submitted, Green Published, gold			2022-12-25	WOS:000270354200002
J	O'Connell, MP; Fiori, JL; Xu, M; Carter, AD; Frank, BP; Camilli, TC; French, AD; Dissanayake, SK; Indig, FE; Bernier, M; Taub, DD; Hewitt, SM; Weeraratna, AT				O'Connell, M. P.; Fiori, J. L.; Xu, M.; Carter, A. D.; Frank, B. P.; Camilli, T. C.; French, A. D.; Dissanayake, S. K.; Indig, F. E.; Bernier, M.; Taub, D. D.; Hewitt, S. M.; Weeraratna, A. T.			The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma	ONCOGENE			English	Article						Ror2; Wnt5A; melanoma; metastasis; endosome; clathrin	RECESSIVE ROBINOW-SYNDROME; BREAST-CANCER METASTASIS; BRACHYDACTYLY TYPE-B; GENE-EXPRESSION; PROSTATE-CANCER; CELL-MIGRATION; PATHWAY; INHIBITION; ACTIVATION; MOTILITY	Tyrosine kinase receptors represent targets of great interest for cancer therapy. Here we show, for the first time, the importance of the orphan tyrosine kinase receptor, ROR2, in melanoma progression. Using melanoma tissue microarrays, we show that ROR2 is expressed predominantly in metastatic melanoma. As ROR2 has been shown to specifically interact with the non-canonical Wnt ligand, Wnt5A, this corroborates our earlier data implicating Wnt5A as a mediator of melanoma metastasis. We show here that increases in Wnt5A cause increases in ROR2 expression, as well as the PKC-dependent, clathrin-mediated internalization of ROR2. WNT5A knockdown by siRNA decreases ROR2 expression, but silencing of ROR2 has no effect on WNT5A levels. ROR2 knockdown does, however, result in a decrease in signaling downstream of Wnt5A. Using in vitro and in vivo metastasis assays, we show that ROR2 is necessary for the Wnt5A-mediated metastasis of melanoma cells. These data imply that ROR2 may represent a novel target for melanoma therapy.	[Weeraratna, A. T.] NIA, Immunol Lab, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Fiori, J. L.; Bernier, M.] NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA; [Indig, F. E.] NIA, Confocal Imaging Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Hewitt, S. M.] NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Weeraratna, AT (corresponding author), NIA, Immunol Lab, NIH, Biomed Res Ctr, 251 Bayview Blvd,Suite 100,Rm 08C226, Baltimore, MD 21224 USA.	prubinstein@nybloodcenter.org	Bernier, Michel/AAO-3983-2021; Bernier, Michel/Y-7139-2019; O'Connell, Michael/F-9236-2017	Bernier, Michel/0000-0002-5948-368X; O'Connell, Michael/0000-0002-8615-7660; Hewitt, Stephen/0000-0001-8283-1788	National Institute on Aging, Baltimore, USA [MD 21224]; NATIONAL CANCER INSTITUTE [ZICBC010923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000615, ZIAAG000450, ZIAAG000442, ZIAAG000764] Funding Source: NIH RePORTER	National Institute on Aging, Baltimore, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ms Ana Lustig for assistance with animal experiments. This work was supported by the Intramural Research Program of the National Institute on Aging, Baltimore, MD 21224, USA.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Akbarzadeh S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001873; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dissanayake SK, 2008, CANCER RES, V68, P10205, DOI 10.1158/0008-5472.CAN-08-2149; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Jonsson M, 1998, BRIT J CANCER, V78, P430, DOI 10.1038/bjc.1998.511; Katoh M, 2005, ONCOL REP, V14, P1583; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Liang ZX, 2005, CANCER RES, V65, P967; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; *NAT RES COUNC, 1985, GUID CAR USE LAB AN; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; O'Connell MP, 2009, J BIOL CHEM, V284, P28704, DOI 10.1074/jbc.M109.028498; O'Connell MP, 2009, J INVEST DERMATOL, V129, P1782, DOI 10.1038/jid.2008.433; O'Connell Michael P., 2008, V468, P243, DOI 10.1007/978-1-59745-249-6_19; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Romanowska M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005354; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Saldanha J, 1998, PROTEIN SCI, V7, P1632, DOI 10.1002/pro.5560070718; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.3.CO;2-C; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Weeraratna AT, 2001, CLIN CANCER RES, V7, P2237; Weeraratna AT, 2000, PROSTATE, V45, P140, DOI 10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x	36	148	154	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					34	44		10.1038/onc.2009.305	http://dx.doi.org/10.1038/onc.2009.305			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19802008	Green Accepted			2022-12-25	WOS:000273373500004
J	Abe, N; Almenar-Queralt, A; Lillo, C; Shen, ZX; Lozach, J; Briggs, SP; Williams, DS; Goldstein, LSB; Cavalli, V				Abe, Namiko; Almenar-Queralt, Angels; Lillo, Concepcion; Shen, Zhouxin; Lozach, Jean; Briggs, Steven P.; Williams, David S.; Goldstein, Lawrence S. B.; Cavalli, Valeria			Sunday Driver Interacts with Two Distinct Classes of Axonal Organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL-SPECIFIC PHOSPHOPROTEIN; I PROTEIN-I; SYNAPTIC VESICLE; SCAFFOLD PROTEIN; RETROGRADE TRANSPORT; MULTIVESICULAR BODIES; PLASMA-MEMBRANE; EARLY ENDOSOMES; INJURED NERVE; TETANUS-TOXIN	The extreme polarized morphology of neurons poses a challenging problem for intracellular trafficking pathways. The distant synaptic terminals must communicate via axonal transport with the cell soma for neuronal survival, function, and repair. Multiple classes of organelles transported along axons may establish and maintain the polarized morphology of neurons, as well as control signaling and neuronal responses to extracellular cues such as neurotrophic or stress factors. We reported previously that the motor-binding protein Sunday Driver (syd), also known as JIP3 or JSAP1, links vesicular axonal transport to injury signaling. To better understand syd function in axonal transport and in the response of neurons to injury, we developed a purification strategy based on anti-syd antibodies conjugated to magnetic beads to identify syd-associated axonal vesicles. Electron microscopy analyses revealed two classes of syd-associated vesicles of distinct morphology. To identify the molecular anatomy of syd vesicles, we determined their protein composition by mass spectrometry. Gene Ontology analyses of each vesicle protein content revealed their unique identity and indicated that one class of syd vesicles belongs to the endocytic pathway, whereas another may belong to an anterogradely transported vesicle pool. To validate these findings, we examined the transport and localization of components of syd vesicles within axons of mouse sciatic nerve. Together, our results lead us to propose that endocytic syd vesicles function in part to carry injury signals back to the cell body, whereas anterograde syd vesicles may play a role in axonal outgrowth and guidance.	[Abe, Namiko; Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Almenar-Queralt, Angels; Lozach, Jean; Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Lillo, Concepcion; Williams, David S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Lillo, Concepcion; Williams, David S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Williams, David S.] Univ Calif Los Angeles, Dept Ophthalmol, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Williams, David S.] Univ Calif Los Angeles, Dept Neurosci, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cavalli, V (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu	Lillo, Concepcion/A-6321-2009; 2009, Secribsal/A-1266-2012	Lillo, Concepcion/0000-0001-5814-9826; 	NINDS National Institutes of Health [R01 NS060709]; NIGMS National Institutes of Health [GM35252]; NEI National Institutes of Health [EY07042]; National Science Foundation [0619411]; NATIONAL EYE INSTITUTE [R01EY007042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060709] Funding Source: NIH RePORTER	NINDS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS National Institutes of Health Grant R01 NS060709 ( to V. C.) and NIGMS National Institutes of Health Grant GM35252 ( to L. S. B. G.) and NEI National Institutes of Health Grant EY07042 ( to D. S. W.). This work was also supported by National Science Foundation Grant IBN 0619411 ( to S. P. B.).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Altick AL, 2009, J COMP NEUROL, V514, P641, DOI 10.1002/cne.22047; Ambron RT, 1996, J NEUROSCI, V16, P7469; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Brown HM, 2009, DEV NEUROBIOL, V69, P174, DOI 10.1002/dneu.20690; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; CHILCOTE TJ, 1995, J CELL BIOL, V129, P219, DOI 10.1083/jcb.129.1.219; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Ha HY, 2005, DEV BIOL, V277, P184, DOI 10.1016/j.ydbio.2004.09.019; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; Hirling H, 2009, NEUROSCIENCE, V158, P36, DOI 10.1016/j.neuroscience.2008.02.057; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ibanez CF, 2007, TRENDS CELL BIOL, V17, P519, DOI 10.1016/j.tcb.2007.09.003; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kelkar N, 2003, P NATL ACAD SCI USA, V100, P9843, DOI 10.1073/pnas.1733944100; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Miura E, 2006, J NEUROCHEM, V97, P1431, DOI 10.1111/j.1471-4159.2006.03835.x; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; NIXON RA, 1995, TRENDS NEUROSCI, V18, P489, DOI 10.1016/0166-2236(95)92772-I; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Prekeris R, 1999, J NEUROSCI, V19, P10324; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rishal I, 2010, EXP NEUROL, V223, P5, DOI 10.1016/j.expneurol.2009.08.010; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; Takamori S, 2000, J NEUROSCI, V20, P4904; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Trischler M, 1999, J CELL SCI, V112, P4773; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; van Niekerk EA, 2007, P NATL ACAD SCI USA, V104, P12913, DOI 10.1073/pnas.0611562104; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Wang Y, 2006, MOL MEMBR BIOL, V23, P377, DOI 10.1080/09687860600776734; Weible MW, 2004, J NEUROBIOL, V58, P230, DOI 10.1002/neu.10318; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4	59	46	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34628	34639		10.1074/jbc.M109.035022	http://dx.doi.org/10.1074/jbc.M109.035022			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801628	Green Published, hybrid			2022-12-25	WOS:000272439600018
J	Cassola, A; Frasch, AC				Cassola, Alejandro; Frasch, Alberto C.			An RNA Recognition Motif Mediates the Nucleocytoplasmic Transport of a Trypanosome RNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; RICH ELEMENT-BINDING; CELLULAR-LOCALIZATION; EXPORT PATHWAY; MESSENGER-RNAS; IN-VIVO; CRUZI; CYTOPLASM; EXPRESSION; SHUTTLES	RNA-binding proteins (RBPs) and RNA metabolism are considered to be important for modulating gene expression in trypanosomes, because these protozoan parasites mainly rely on post-transcriptional mechanisms to regulate protein levels. Previously, we have identified TcUBP1, a single RNA recognition motif (RRM)-type RBP from Trypanosoma cruzi. TcUBP1 is a cytoplasmic protein with roles in stabilization/degradation of mRNAs and in the protection of transcripts through their recruitment into cytoplasmic granules. We now show that TcUBP1, and the closely related protein TcUBP2, can be found in small amounts in the nucleus under normal conditions, and are able to accumulate in the nucleus under arsenite stress. The kinetics of nuclear accumulation, and export to the cytoplasm, are consistent with the shuttling of TcUBP1 between the nucleus and the cytoplasm. The sequence required for TcUBP1 nuclear accumulation was narrowed to the RRM, and point mutations affecting RNA binding abolished nuclear import. This RRM was also shown to be efficiently exported from the nucleus in unstressed parasites, a property that relied on the binding to RNA. TcUBP1 nuclear accumulation was dependent on active transcription, and colocalized with transcripts in the nucleus, suggesting nuclear binding of the mRNA. We propose that TcUBP1 could be linking the mRNA metabolism at both sides of the nuclear pore complex, using the RRM as a nuclear localization signal, and being exported as a cargo on mRNA.	[Cassola, Alejandro; Frasch, Alberto C.] Consejo Nacl Invest Cient & Tecn, UNSAM, Inst Tecnol Chascomus, Inst Invest Biotecnol, RA-1650 San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Frasch, AC (corresponding author), Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	cfrasch@iib.unsam.edu.ar		Frasch, Alberto Carlos/0000-0001-7532-653X; Cassola, Alejandro/0000-0001-7366-5327	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina); Howard Hughes Medical Institute	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)(ANPCyT); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina) (to A.C.F.) and an International Research Scholars Grant from the Howard Hughes Medical Institute (to A.C.F.).	Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Cuevas IC, 2005, MOL BIOCHEM PARASIT, V139, P15, DOI 10.1016/j.molbiopara.2004.11.002; D'Orso I, 2003, TRENDS PARASITOL, V19, P151, DOI 10.1016/S1471-4922(03)00035-7; D'Orso I, 2002, J BIOL CHEM, V277, P50520, DOI 10.1074/jbc.M209092200; D'Orso I, 2001, J BIOL CHEM, V276, P34801, DOI 10.1074/jbc.M102120200; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; De Gaudenzi JG, 2003, J BIOL CHEM, V278, P18884, DOI 10.1074/jbc.M301756200; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fritz J, 2009, MOL CELL BIOL, V29, P1487, DOI 10.1128/MCB.01519-08; Hartmann C, 2007, EUKARYOT CELL, V6, P1964, DOI 10.1128/EC.00279-07; Hellman K, 2007, EUKARYOT CELL, V6, P2206, DOI 10.1128/EC.00176-07; Hoek M, 2000, J CELL SCI, V113, P3959; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jager AV, 2007, P NATL ACAD SCI USA, V104, P2035, DOI 10.1073/pnas.0611125104; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kumar AO, 2008, BIOCHEM BIOPH RES CO, V367, P813, DOI 10.1016/j.bbrc.2008.01.027; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lei EP, 2002, DEV CELL, V2, P261, DOI 10.1016/S1534-5807(02)00134-X; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Lichtenstein M, 2001, TRAFFIC, V2, P261, DOI 10.1034/j.1600-0854.2001.1o002.x; Marchetti MA, 2000, J CELL SCI, V113, P899; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Noe G, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-107; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Reed R, 2001, NAT CELL BIOL, V3, pE201, DOI 10.1038/ncb0901-e201; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Sim S, 2009, MOL BIOL CELL, V20, P1555, DOI 10.1091/mbc.E08-11-1094; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Volpon L, 2005, BIOCHEMISTRY-US, V44, P3708, DOI 10.1021/bi047450e; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; Wilkinson SM, 2002, J BIOL CHEM, V277, P17062, DOI 10.1074/jbc.M111126200; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669	49	39	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35015	35028		10.1074/jbc.M109.031633	http://dx.doi.org/10.1074/jbc.M109.031633			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801539	hybrid, Green Published			2022-12-25	WOS:000272439600056
J	Flint-Garcia, SA; Buckler, ES; Tiffin, P; Ersoz, E; Springer, NM				Flint-Garcia, Sherry A.; Buckler, Edward S.; Tiffin, Peter; Ersoz, Elhan; Springer, Nathan M.			Heterosis Is Prevalent for Multiple Traits in Diverse Maize Germplasm	PLOS ONE			English	Article							GENE-EXPRESSION; INBRED LINES; HYBRID; ARABIDOPSIS; YIELD; LOCI	Background: Heterosis describes the superior phenotypes observed in hybrids relative to their inbred parents. Maize is a model system for studying heterosis due to the high levels of yield heterosis and commercial use of hybrids. Methods: The inbred lines from an association mapping panel were crossed to a common inbred line, B73, to generate nearly 300 hybrid genotypes. Heterosis was evaluated for seventeen phenotypic traits in multiple environments. The majority of hybrids exhibit better-parent heterosis in most of the hybrids measured. Correlations between the levels of heterosis for different traits were generally weak, suggesting that the genetic basis of heterosis is trait-dependent. Conclusions: The ability to predict heterosis levels using inbred phenotype or genetic distance between the parents varied for the different traits. For some traits it is possible to explain a significant proportion of the heterosis variation using linear modeling while other traits are more difficult to predict.			Flint-Garcia, SA (corresponding author), Univ Missouri, USDA, ARS, Plant Genet Res Unit, Columbia, MO 65211 USA.	sherry.flint-garcia@ars.usda.gov; springer@umn.edu	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022; Springer, Nathan/F-2680-2013	Buckler, Edward/0000-0002-3100-371X; Springer, Nathan/0000-0002-7301-4759; Flint-Garcia, Sherry/0000-0003-4156-5318; Tiffin, Peter/0000-0003-1975-610X				Auger DL, 2005, GENETICS, V169, P389, DOI 10.1534/genetics.104.032987; Barth S, 2003, HEREDITY, V91, P36, DOI 10.1038/sj.hdy.6800276; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; EAST EM, 1908, REP CONN AGR EXP STN, V1907, P419; Falconer D. S, 1996, INTRO QUANTITATIVE G; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Garcia AAF, 2008, GENETICS, V180, P1707, DOI 10.1534/genetics.107.082867; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; HAMBLIN MT, 2008, PLOSONE; Hoecker N, 2006, THEOR APPL GENET, V112, P421, DOI 10.1007/s00122-005-0139-4; Holland JB, 2002, PL BRED RE, V22, P9; Kearsey MJ, 2003, HEREDITY, V91, P456, DOI 10.1038/sj.hdy.6800306; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Liu KJ, 2003, GENETICS, V165, P2117; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Melchinger AE, 1998, CSSA SPEC PUBL, P29; Meyer RC, 2004, PLANT PHYSIOL, V134, P1813, DOI 10.1104/pp.103.033001; MOLL RH, 1965, GENETICS, V52, P139; Riddle NC, 2008, THEOR APPL GENET, V116, P563, DOI 10.1007/s00122-007-0691-1; Semel Y, 2006, P NATL ACAD SCI USA, V103, P12981, DOI 10.1073/pnas.0604635103; Shull G.H., 1908, J HERED, V4, P296, DOI [10.1093/jhered/os-4.1.296, DOI 10.1093/JHERED/OS-4.1.296]; SORENSEN DA, 1984, J ANIM SCI, V59, P1213, DOI 10.2527/jas1984.5951213x; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; STUBER CW, 1992, GENETICS, V132, P823; Stupar RM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-33; Tollenaar M, 2004, CROP SCI, V44, P2086, DOI 10.2135/cropsci2004.2086; Tracy WF, 2006, PLANT BREEDING: ARNEL R HALLAUER INTERNATIONAL SYMPOSIUM, P219; Troyer AF, 2006, CROP SCI, V46, P528, DOI 10.2135/cropsci2005.0065; WILLIAMS W, 1959, NATURE, V184, P527, DOI 10.1038/184527a0	31	120	123	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7433	10.1371/journal.pone.0007433	http://dx.doi.org/10.1371/journal.pone.0007433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823591	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808300011
J	Im, HI; Nakajima, A; Gong, B; Xiong, XL; Mamiya, T; Gershon, ES; Zhuo, M; Tang, YP				Im, Heh-In; Nakajima, Akira; Gong, Bo; Xiong, Xiaoli; Mamiya, Takayoshi; Gershon, Elliot S.; Zhuo, Min; Tang, Ya-Ping			Post-Training Dephosphorylation of eEF-2 Promotes Protein Synthesis for Memory Consolidation	PLOS ONE			English	Article							LONG-TERM-POTENTIATION; SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; MOLECULAR-MECHANISMS; RECEPTOR ACTIVATION; ALZHEIMERS-DISEASE; FEAR MEMORY; KINASE-III; HIPPOCAMPUS; ELONGATION	Memory consolidation, which converts acquired information into long-term storage, is new protein synthesis-dependent. As protein synthesis is a dynamic process that is under the control of multiple translational mechanisms, however, it is still elusive how these mechanisms are recruited in response to learning for memory consolidation. Here we found that eukaryotic elongation factor-2 (eEF-2) was dramatically dephosphorylated within 0.5-2 hr in the hippocampus and amygdala of mice following training in a fear-conditioning test, whereas genome-wide microarrays did not reveal any significant change in the expression level of the mRNAs for translational machineries or their related molecules. Moreover, blockade of NMDA receptors with MK-801 immediately following the training significantly impeded both the post-training eEF-2 dephosphorylation and memory retention. Notably, with an elegant sophisticated transgenic strategy, we demonstrated that hippocampus-specific overexpression of eEF-2 kinase, a kinase that specifically phosphorylates and hence inactivates eEF-2, significantly inhibited protein synthesis in the hippocampus, and this effects was more robust during an "ongoing'' protein synthesis process. As a result, late phase long-term potentiation (L-LTP) in the hippocampus and long-term hippocampus-dependent memory in the mice were significantly impaired, whereas short-term memory and long-term hippocampus-independent memory remained intact. These results reveal a novel translational underpinning for protein synthesis pertinent to memory consolidation in the mammalian brain.			Im, HI (corresponding author), Scripps Florida, Dept Mol Therapeut, Jupiter, FL USA.	ytang1@lsuhsc.edu	Gong, Bo/E-6820-2011; Zhuo, Min/A-2072-2008; Tang, Ya-Ping/A-1035-2011; Nakajima, Akira/I-7077-2014	Gong, Bo/0000-0001-6028-1818; Zhuo, Min/0000-0001-9062-3241; Tang, Ya-Ping/0000-0002-0445-4072	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066243] Funding Source: NIH RePORTER; NIMH NIH HHS [MH066243, R01 MH066243] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Baubet V, 1996, NEUROSCI LETT, V219, P187, DOI 10.1016/S0304-3940(96)13209-2; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Carroll M, 2004, J NEUROCHEM, V90, P1464, DOI 10.1111/j.1471-4159.2004.02634.x; Chen Q, 2006, P NATL ACAD SCI USA, V103, P3881, DOI 10.1073/pnas.0505407103; Chen Q, 2008, J NEUROSCI RES, V86, P1615, DOI 10.1002/jnr.21601; Cheng MF, 2008, HORM BEHAV, V53, P1, DOI 10.1016/j.yhbeh.2007.08.007; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; D'Agata V, 2002, REV NEUROSCIENCE, V13, P209; DAVIES JM, 1992, PSYCHOANALYTIC DIALO, V2, P5, DOI DOI 10.1080/10481889209538920; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Diggle TA, 1998, BIOCHEM J, V336, P525, DOI 10.1042/bj3360525; Dorovkov MV, 2002, BIOCHEMISTRY-US, V41, P13444, DOI 10.1021/bi026494p; Flint J, 1999, BRAIN, V122, P2015, DOI 10.1093/brain/122.11.2015; Flint J, 2008, NATURE, V456, P724, DOI 10.1038/nature07630; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Friedman D, 2007, CLIN EEG NEUROSCI, V38, P2, DOI 10.1177/155005940703800105; Germano C, 2005, NEUROPSYCHOL REV, V15, P1, DOI 10.1007/s11065-005-3583-7; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GOLD PE, 2007, NEUROBIOL LEARN MEM; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Holahan MR, 2007, HIPPOCAMPUS, V17, P93, DOI 10.1002/hipo.20245; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly A, 2000, HIPPOCAMPUS, V10, P431, DOI 10.1002/1098-1063(2000)10:4<431::AID-HIPO9>3.0.CO;2-Z; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lombroso P, 2009, J AM ACAD CHILD PSY, V48, P5, DOI 10.1097/CHI.0b013e318190c4b3; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Mayes AR, 2001, PHILOS T ROY SOC B, V356, P1395, DOI 10.1098/rstb.2001.0941; McDonald RJ, 2005, EUR J NEUROSCI, V22, P1201, DOI 10.1111/j.1460-9568.2005.04272.x; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Millecamps S, 2004, METHOD CELL BIOL, V78, P555; MITSUI K, 1993, J BIOL CHEM, V268, P13422; MIYASHITA T, 2007, NEUROBIOL LEARN MEM; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Quevedo J, 2004, BEHAV BRAIN RES, V154, P339, DOI 10.1016/j.bbr.2004.03.001; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Richardson JTE, 2007, CORTEX, V43, P635, DOI 10.1016/S0010-9452(08)70493-3; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1993, TRANSLATIONAL REGULA, P295; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Scheetz AJ, 1997, P NATL ACAD SCI USA, V94, P14770, DOI 10.1073/pnas.94.26.14770; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Vendrell M, 1998, MOL BRAIN RES, V63, P25, DOI 10.1016/S0169-328X(98)00248-4; Wanisch K, 2005, BEHAV BRAIN RES, V157, P63, DOI 10.1016/j.bbr.2004.06.009; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	68	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7424	10.1371/journal.pone.0007424	http://dx.doi.org/10.1371/journal.pone.0007424			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506WQ	19823585	Green Published, Green Submitted, gold			2022-12-25	WOS:000270808300007
J	Erickson, GM; Rauhut, OWM; Zhou, ZH; Turner, AH; Inouye, BD; Hu, DY; Norell, MA				Erickson, Gregory M.; Rauhut, Oliver W. M.; Zhou, Zhonghe; Turner, Alan H.; Inouye, Brian D.; Hu, Dongyu; Norell, Mark A.			Was Dinosaurian Physiology Inherited by Birds? Reconciling Slow Growth in Archaeopteryx	PLOS ONE			English	Article							PERIOSTEAL BONE; EVOLUTION; PATTERNS; FLIGHT; SIZE; ORIGIN; RATES	Background: Archaeopteryx is the oldest and most primitive known bird (Avialae). It is believed that the growth and energetic physiology of basalmost birds such as Archaeopteryx were inherited in their entirety from non-avialan dinosaurs. This hypothesis predicts that the long bones in these birds formed using rapidly growing, well-vascularized woven tissue typical of non-avialan dinosaurs. Methodology/Principal Findings: We report that Archaeopteryx long bones are composed of nearly avascular parallel-fibered bone. This is among the slowest growing osseous tissues and is common in ectothermic reptiles. These findings dispute the hypothesis that non-avialan dinosaur growth and physiology were inherited in totality by the first birds. Examining these findings in a phylogenetic context required intensive sampling of outgroup dinosaurs and basalmost birds. Our results demonstrate the presence of a scale-dependent maniraptoran histological continuum that Archaeopteryx and other basalmost birds follow. Growth analysis for Archaeopteryx suggests that these animals showed exponential growth rates like non-avialan dinosaurs, three times slower than living precocial birds, but still within the lowermost range for all endothermic vertebrates. Conclusions/Significance: The unexpected histology of Archaeopteryx and other basalmost birds is actually consistent with retention of the phylogenetically earlier paravian dinosaur condition when size is considered. The first birds were simply feathered dinosaurs with respect to growth and energetic physiology. The evolution of the novel pattern in modern forms occurred later in the group's history.			Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	gerickson@bio.fsu.edu	Rauhut, Oliver/AAG-1029-2020	Rauhut, Oliver/0000-0003-3958-603X				ALEXANDER RM, 1983, J ZOOL, V200, P215; Bakker R. T., 1986, DINOSAUR HERESIES NE, P481; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Boarman William I., 1999, Birds of North America, V476, P1; Calder WA., 1984, SIZE FUNCTION LIFE H; Cambra-Moo O, 2006, CR PALEVOL, V5, P685, DOI 10.1016/j.crpv.2005.12.018; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; Chatterjee S, 2003, NATURWISSENSCHAFTEN, V90, P27, DOI 10.1007/s00114-002-0385-0; Chiappe L. M., 2002, MESOZOIC BIRDS HEADS; Chiappe L.M., 2007, GLORIFIED DINOSAURS; CHIAPPE LM, 1995, NATURE, V378, P349, DOI 10.1038/378349a0; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Chinsamy A, 2001, NATURE, V412, P402, DOI 10.1038/35086650; Chinsamy A., 2005, MICROSTRUCTURE DINOS; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Chinsamy Anusuya, 2002, P421; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; De Ricqles AJ, 2003, J VERTEBR PALEONTOL, V23, P373, DOI 10.1671/0272-4634(2003)023[0373:OOCSTA]2.0.CO;2; Enlow D. E., 1958, Texas Journal of Science, V10, P187; Enlow D. H., 1956, Texas Journal of Science, V8, P405; Enlow D. H., 1969, pUnpaginated; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Foote J. S., 1916, Washington DC Smithsonian Institution Cont Knowl, V35; Francillon-Vieillot H., 1990, P471; Gauthier J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P7; GILL FB, 2007, ORNITHOLOGY; Goloboff P.A., 2003, TREE ANAL USING NEW; HOUCK MA, 1990, SCIENCE, V247, P195, DOI 10.1126/science.247.4939.195; Klevezal G., 1996, RECORDING STRUCTURES; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; McLennan JA, 2004, NEW ZEAL J ECOL, V28, P241; McNab BK, 1996, AUK, V113, P687, DOI 10.2307/4088996; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; RUBEN J, 1991, EVOLUTION, V45, P1, DOI 10.1111/j.1558-5646.1991.tb05261.x; Sander P.M., 2003, PALAEONTOL Z, V77, P161, DOI DOI 10.1007/BF03004566; Senter P, 2003, J VERTEBR PALEONTOL, V23, P961, DOI 10.1671/22; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Wellnhofer P., 2008, ARCHAEOPTERYX; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; YALDEN DW, 1971, BIOL REV, V113, P349; Zhang Fucheng, 1998, Vertebrata Palasiatica, V36, P126; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930	56	124	129	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7390	10.1371/journal.pone.0007390	http://dx.doi.org/10.1371/journal.pone.0007390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816582	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594300010
J	Yang, OO				Yang, Otto O.			Candidate Vaccine Sequences to Represent Intra- and Inter-Clade HIV-1 Variation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; CRYSTAL-STRUCTURE; INFECTION; LYMPHOCYTES; DEPLETION; ESCAPE; CLEARANCE; SELECTION; EFFICACY	A likely key factor in the failure of a HIV-1 vaccine based on cytotoxic T lymphocytes (CTL) is the natural immunodominance of epitopes that fall in variable regions of the proteome, which both increases the chance of epitope sequence mismatch with the incoming challenge strain and replicates the pathogenesis of early CTL failure due to epitope escape mutation during natural infection. To identify potential vaccine sequences to focus the CTL response on highly conserved epitopes, the whole proteomes of HIV-1 clades A1, B, C, and D were assessed for Shannon entropy at each amino acid position. Highly conserved regions in Gag (cGag-1, Gag 148-214, and cGag-2, Gag 253-331), Env (cEnv, Env 521-606), and Nef (cNef, Nef 106-148) were identified across clades. Inter- and intra-clade variability of amino acids within the regions tended to overlap, suggesting that polyvalent representation of consensus sequences for the four clades would allow broad HIV-1 strain representation. These four conserved regions were rich in both known and predicted CTL epitopes presented by a breadth of HLA types, and screening of 54 persons with chronic HIV-1 infection revealed that these regions are commonly immunogenic in the context of natural infection. These data suggest that vaccine delivery of a 16-valent mixture of these regions could focus the CTL response against conserved epitopes that are broadly representative of circulating HIV-1 strains.			Yang, OO (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA.	oyang@mednet.ucla.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043203, R01AI051970] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI051970, AI043203, R01 AI043203, AI051970] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bennett MS, 2008, J INFECT DIS, V197, P390, DOI 10.1086/525281; Bennett MS, 2007, J VIROL, V81, P4973, DOI 10.1128/JVI.02362-06; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; FRAHM N, 2008, HIV MOL IMMUNOLOGY 2, P3; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Hartikka J, 2008, VACCINE; HECKERMAN D, 2009, VACCINE INDUCED TARG; Ibarrondo FJ, 2005, J VIROL, V79, P4289, DOI 10.1128/JVI.79.7.4289-4297.2005; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Jones N, 2003, J IMMUNOL METHODS, V274, P139, DOI 10.1016/S0022-1759(02)00510-0; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Matthews PC, 2009, J VIROL, V83, P4605, DOI 10.1128/JVI.02017-08; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Palmowski MJ, 2002, J IMMUNOL, V168, P4391, DOI 10.4049/jimmunol.168.9.4391; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Reisinger KS, 2007, PEDIATR INFECT DIS J, V26, P201, DOI 10.1097/01.inf.0000253970.29190.5a; RIVIERE Y, 1995, AIDS RES HUM RETROV, V11, P903, DOI 10.1089/aid.1995.11.903; Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yang OO, 2008, AIDS, V22, P325, DOI 10.1097/QAD.0b013e3282f29491	42	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7388	10.1371/journal.pone.0007388	http://dx.doi.org/10.1371/journal.pone.0007388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812689	Green Submitted, Green Published, gold			2022-12-25	WOS:000270594200012
J	Ahmed, SU; Milner, J				Ahmed, Shafiq Uddin; Milner, Jo			Basal Cancer Cell Survival Involves JNK2 Suppression of a Novel JNK1/c-Jun/Bcl-3 Apoptotic Network	PLOS ONE			English	Article								Background: The regulation of apoptosis under basal (non-stress) conditions is crucial for normal mammalian development and also for normal cellular turnover in different tissues throughout life. Deficient regulation of basal apoptosis, or its perturbation, can result in impaired development and/or disease states including cancer. In contrast to stress-induced apoptosis the regulation of apoptosis under basal conditions is poorly understood. To address this issue we have compared basal-and stress-induced apoptosis in human epithelial cells of normal and cancerous origins. For this purpose we focussed our study on the opposing pro-apoptotic JNK/anti-apoptotic NF kappa B pathways. Methodology/Principal Findings: Combinatorial RNAi plus gene knockout were employed to access and map basal regulatory pathways of apoptosis. Follow-on, in-depth analyses included exogenous expression of phosphorylation mutants and chromatin immunoprecipitation. We demonstrate that basal apoptosis is constitutively suppressed by JNK2 in a range of human cancer cell lines. This effect was not observed in non-cancer cells. Silencing JNK2 by RNAi resulted in JNK1-dependent apoptosis of cancer cells via up-regulation of the AP-1 factor c-Jun. Unexpectedly we discovered that JNK1 and c-Jun promote basal apoptosis in the absence of "activating phosphorylations'' typically induced by stress. Hypophosphorylated c-Jun accumulated to high levels following JNK2 silencing, auto-regulated its own expression and suppressed expression of Bcl-3, an unusual I kappa B protein and regulator of NF kappa B. Basal apoptosis was mediated by components of the TNF alpha response pathway but was mechanistically distinct from TNF alpha-induced apoptosis. Conclusions/Significance: Our results demonstrate that mechanistically distinct pathways operate to regulate apoptosis in mammalian cells under basal (physiological) versus stress-induced conditions. We also describe a novel apoptotic network which governs the basal survival of cancer cells. Such information is crucial for understanding normal cellular turnover during mammalian development and subsequently throughout life. This information also opens new avenues for therapeutic intervention in human proliferative disease states including cancer.			Ahmed, SU (corresponding author), Univ York, Dept Biol, YCR Res Unit P53, York YO10 5DD, N Yorkshire, England.	ajm24@york.ac.uk		Ahmed, Shafiq U/0000-0001-8701-6889				Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Anzi S, 2008, CELL SIGNAL, V20, P862, DOI 10.1016/j.cellsig.2007.12.020; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grummt I, 2008, CELL, V133, P577, DOI 10.1016/j.cell.2008.04.026; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Mocellin S, 2008, FRONT BIOSCI-LANDMRK, V13, P2774, DOI 10.2741/2884; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287; Pratt MAC, 2003, MOL CELL BIOL, V23, P6887, DOI 10.1128/MCB.23.19.6887-6900.2003; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Rebollo A, 2000, MOL CELL BIOL, V20, P3407, DOI 10.1128/MCB.20.10.3407-3416.2000; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	41	30	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7305	10.1371/journal.pone.0007305	http://dx.doi.org/10.1371/journal.pone.0007305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806201	Green Submitted, gold, Green Published			2022-12-25	WOS:000270593800014
J	Sirovich, L; Stoeckle, MY; Zhang, Y				Sirovich, Lawrence; Stoeckle, Mark Y.; Zhang, Yu			A Scalable Method for Analysis and Display of DNA Sequences	PLOS ONE			English	Article							ORGANIZATION; DELIMITATION; BARCODE	Background: Comparative DNA sequence analysis provides insight into evolution and helps construct a natural classification reflecting the Tree of Life. The growing numbers of organisms represented in DNA databases challenge tree-building techniques and the vertical hierarchical classification may obscure relationships among some groups. Approaches that can incorporate sequence data from large numbers of taxa and enable visualization of affinities across groups are desirable. Methodology/Principal Findings: Toward this end, we developed a procedure for extracting diagnostic patterns in the form of indicator vectors from DNA sequences of taxonomic groups. In the present instance the indicator vectors were derived from mitochondrial cytochrome c oxidase I (COI) sequences of those groups and further analyzed on this basis. In the first example, indicator vectors for birds, fish, and butterflies were constructed from a training set of COI sequences, then correlations with test sequences not used to construct the indicator vector were determined. In all cases, correlation with the indicator vector correctly assigned test sequences to their proper group. In the second example, this approach was explored at the species level within the bird grouping; this also gave correct assignment, suggesting the possibility of automated procedures for classification at various taxonomic levels. A false-color matrix of vector correlations displayed affinities among species consistent with higher-order taxonomy. Conclusions/Significance: The indicator vectors preserved DNA character information and provided quantitative measures of correlations among taxonomic groups. This method is scalable to the largest datasets envisioned in this field, provides a visually-intuitive display that captures relational affinities derived from sequence data across a diversity of life forms, and is potentially a useful complement to current tree-building techniques for studying evolutionary processes based on DNA sequence data.			Sirovich, L (corresponding author), Mt Sinai Sch Med, Lab Appl Math, New York, NY USA.	lawrence.sirovich@mssm.edu	Stoeckle, Mark/D-3729-2011	Stoeckle, Mark/0000-0002-8280-4795	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; *AM ORN UN, AM ORN UN CHECK LIST; Ausubel JH, 2009, P NATL ACAD SCI USA, V106, P12569, DOI 10.1073/pnas.0906757106; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; DESALLE R, 2000, TECHNIQUES MOL SYSTE; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; Hillis DM, 2004, ASSEMBLING THE TREE OF LIFE, P545; HILLIS DM, 2005, SYST BIOL; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; NEI M, 2000, MOL EVOLUTION PHYLOG; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Sanderson MJ, 2006, BIOINFORMATICS, V22, P1004, DOI 10.1093/bioinformatics/btl044; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sirovich L, 2004, P NATL ACAD SCI USA, V101, P16941, DOI 10.1073/pnas.0407450101; Sirovich L, 1996, PHYSICA D, V96, P355, DOI 10.1016/0167-2789(96)00033-4; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; WILSON EO, 1985, BIOSCIENCE, V35, P700, DOI 10.2307/1310051; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	26	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7051	10.1371/journal.pone.0007051	http://dx.doi.org/10.1371/journal.pone.0007051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798412	Green Published, gold			2022-12-25	WOS:000270593300002
J	Tassi, E; Braga, M; Longhi, R; Gavazzi, F; Parmiani, G; Di Carlo, V; Protti, MP				Tassi, Elena; Braga, Marco; Longhi, Renato; Gavazzi, Francesca; Parmiani, Giorgio; Di Carlo, Valerio; Protti, Maria Pia			Non-Redundant Role for IL-12 and IL-27 in Modulating Th2 Polarization of Carcinoembryonic Antigen Specific CD4 T Cells from Pancreatic Cancer Patients	PLOS ONE			English	Article								Background: Pancreatic cancer is a very aggressive disease with dismal prognosis; peculiar is the tumor microenvironment characterized by an extensive fibrotic stroma, which favors rapid tumor progression. We previously reported that pancreatic cancer patients have a selective Th2 skew in the anti-carcinoembryonic antigen (CEA) CD4(+) T cell immunity, which correlates with the presence of a predominant GATA-3(+) tumor lymphoid infiltrate. This has negative effects in both effective anti-tumor immunity and further favoring fibrinogenesis. Aim of this study was to evaluate whether the Th2 polarization of CEA-specific CD4(+) T cells from pancreatic cancer patients is stable or can be reverted by immunomodulating cytokines. Methodology/Principal Findings: We first evaluated the influence of IL-12 and IL-27, as single agents and in association, on the polarization of CEA-specific Th2 CD4+ T cell clones from a pancreatic cancer patient. We found that only the combination of IL-12 and IL-27 modified the polarization of Th2 effectors by both reduction of IL-5, GM-CSF and IL-13 and induction of IFN-gamma production, which lasted after cytokine removal. Second, we evaluated the effect of the combined treatment on polyclonal CEA-specific CD4(+) T cells in short-time re-stimulation assays. In agreement with the data obtained with the clones, we found that the combined treatment functionally modulated the Th2 polarization of CEA-specific CD4(+) T cells and enhanced pre-existing Th1 type immunity. Conclusions/Significance: Collectively, our results demonstrate that tumor antigen specific Th2 CD4(+) T cells in pancreatic cancer are endowed with functional plasticity. Hence, loco-regional cytokines delivery or targeted therapy based on antibodies or molecules directed to the tumor stroma might improve anti-tumor immunity and ameliorate fibrosis, without systemic toxicity.			Tassi, E (corresponding author), Ist Sci San Raffaele, Tumor Immunol Unit, I-20132 Milan, Italy.	m.protti@hsr.it	Tassi, Enrico/K-3958-2015; Tassi, Elena/C-1982-2017; Protti, Maria Pia/J-7899-2016	Tassi, Elena/0000-0002-2921-8666; Protti, Maria Pia/0000-0001-9079-2336; Gavazzi, Francesca/0000-0003-3207-0292				Annunziato F, 2001, J ALLERGY CLIN IMMUN, V108, P815; Bellone M, 2008, TRENDS IMMUNOL, V29, P235, DOI 10.1016/j.it.2008.02.003; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Campi G, 2003, CANCER RES, V63, P8481; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Crosti M, 2006, J IMMUNOL, V176, P5093, DOI 10.4049/jimmunol.176.8.5093; Curnis F, 2004, CANCER RES, V64, P565, DOI 10.1158/0008-5472.CAN-03-1753; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Heinzerling L, 2005, HUM GENE THER, V16, P35, DOI 10.1089/hum.2005.16.35; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Roa RIL, 2008, INT IMMUNOPHARMACOL, V8, P1715, DOI 10.1016/j.intimp.2008.07.010; Marturano J, 2008, CANCER RES, V68, P1555, DOI 10.1158/0008-5472.CAN-07-5233; Mazzolini G, 2005, J CLIN ONCOL, V23, P999, DOI 10.1200/JCO.2005.00.463; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Seresini S, 2007, J IMMUNOL, V179, P7176, DOI 10.4049/jimmunol.179.10.7176; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Smits HH, 2001, EUR J IMMUNOL, V31, P1055, DOI 10.1002/1521-4141(200104)31:4<1055::AID-IMMU1055>3.0.CO;2-7; Tassi E, 2008, J IMMUNOL, V181, P6595, DOI 10.4049/jimmunol.181.9.6595; Tatsumi T, 2003, CANCER RES, V63, P4481; Tatsumi T, 2002, J EXP MED, V196, P619, DOI 10.1084/jem.20012142; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Triozzi PL, 2005, HUM GENE THER, V16, P91, DOI 10.1089/hum.2005.16.91; Vagliani M, 1996, CANCER RES, V56, P467; Varga EM, 2000, J IMMUNOL, V165, P2877, DOI 10.4049/jimmunol.165.5.2877; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yoshimoto T, 2007, J IMMUNOL, V179, P4415, DOI 10.4049/jimmunol.179.7.4415	39	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7234	10.1371/journal.pone.0007234	http://dx.doi.org/10.1371/journal.pone.0007234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798410	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593300003
J	Pascoal, S; Creer, S; Taylor, MI; Queiroga, H; Carvalho, G; Mendo, S				Pascoal, Sonia; Creer, Simon; Taylor, Martin I.; Queiroga, Henrique; Carvalho, Gary; Mendo, Sonia			Development and Application of Microsatellites in Carcinus maenas: Genetic Differentiation between Northern and Central Portuguese Populations	PLOS ONE			English	Article							EUROPEAN GREEN CRAB; PROPAGULE DISPERSAL; INVASIVE CRAB; SHORE CRAB; DYNAMICS; BEHAVIOR; LARVAL; SIZE; PREDATION; PATTERNS	Carcinus maenas, the common shore crab of European coastal waters, has recently gained notoriety due to its globally invasive nature associated with drastic ecological and economic effects. The native ubiquity and worldwide importance of C. maenas has resulted in it becoming one of the best-studied estuarine crustacean species globally. Accordingly, there is significant interest in investigating the population genetic structure of this broadly distributed crab along European and invaded coastlines. Here, we developed polymerase chain reaction (PCR) primers for one dinucleotide and two trinucleotide microsatellite loci, resulting from an enrichment process based on Portuguese populations. Combining these three new markers with six existing markers, we examined levels of genetic diversity and population structure of C. maenas in two coastal regions from Northern and Central Portugal. Genotypes showed that locus polymorphism ranged from 10 to 42 alleles (N = 135) and observed heterozygosity per locus ranged from 0.745 to 0.987 with expected heterozygosity ranging from 0.711 to 0.960; values typical of marine decapods. The markers revealed weak, but significant structuring among populations (global F-ST = 0.004) across a 450 km (over-water distance) spatial scale. Combinations of these and existing markers will be useful for studying population genetic parameters at a range of spatial scales of C. maenas throughout its expanding species range.			Pascoal, S (corresponding author), Univ Aveiro, CESAM, Campus Univ Santiago, P-3800 Aveiro, Portugal.	spascoal@ua.pt	Queiroga, Henrique/C-5134-2008; Mendo, Sónia A/E-1095-2011; Taylor, Martin I/B-4298-2013	Queiroga, Henrique/0000-0002-2338-0013; Mendo, Sónia A/0000-0001-5057-5660; 				BROEKHUYSEN GJ, 1936, ARCH NEERL ZOOL, V2, P255; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Chambers GK, 2000, COMP BIOCHEM PHYS B, V126, P455, DOI 10.1016/S0305-0491(00)00233-9; Clark PF, 2001, J CRUSTACEAN BIOL, V21, P288, DOI 10.1651/0278-0372(2001)021[0288:AMAORV]2.0.CO;2; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; DAWIRS RR, 1985, MAR ECOL PROG SER, V24, P297, DOI 10.3354/meps024297; Diekmann OE, 2005, MAR ECOL PROG SER, V290, P89, DOI 10.3354/meps290089; Diz AP, 2008, MAR BIOL, V154, P277, DOI 10.1007/s00227-008-0921-3; Ford BA, 1998, AM J BOT, V85, P546, DOI 10.2307/2446439; Geller JB, 1997, MOL ECOL, V6, P901, DOI 10.1046/j.1365-294X.1997.00256.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Grosholz ED, 2000, ECOLOGY, V81, P1206, DOI 10.2307/177202; GROSHOLZ ED, 1995, MAR BIOL, V122, P239; Hidalgo FJ, 2005, BIOL INVASIONS, V7, P547, DOI 10.1007/s10530-004-5452-3; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lima FP, 2006, J BIOGEOGR, V33, P812, DOI 10.1111/j.1365-2699.2006.01457.x; Lowe S., 2000, ENCY BIOL INVASIONS; Mascaro M, 2000, J SHELLFISH RES, V19, P283; MOHAMEDEEN H, 1989, J EXP MAR BIOL ECOL, V134, P1, DOI 10.1016/0022-0981(90)90053-F; Park SDE, 2001, THESIS U DUBLIN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peliz A, 2005, DEEP-SEA RES PT I, V52, P621, DOI 10.1016/j.dsr.2004.11.005; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Queiroga H, 2005, ADV MAR BIOL, V47, P107; Queiroga H, 1997, MAR ECOL PROG SER, V149, P121, DOI 10.3354/meps149121; Raymond M, 2004, GENEPOP POPULATION G; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; ROUGHGARDEN J, 1985, ECOLOGY, V66, P54, DOI 10.2307/1941306; ROUSSET F, 1995, GENETICS, V140, P1413; Rozen S, 2000, Methods Mol Biol, V132, P365; Shanks AL, 2003, ECOL APPL, V13, pS159; Sotelo G, 2008, MAR ECOL PROG SER, V362, P211, DOI 10.3354/meps07433; Sotelo G, 2009, MAR BIOL, V156, P1039, DOI 10.1007/s00227-009-1148-7; SPAARGAREN DH, 1989, J EXP MAR BIOL ECOL, V129, P251, DOI 10.1016/0022-0981(89)90107-X; Tepolt CK, 2006, MOL ECOL NOTES, V6, P343, DOI 10.1111/j.1471-8286.2006.01226.x; THOMAS NJ, 1981, MAR BEHAV PHYSIOL, V7, P277, DOI 10.1080/10236248109386988; Thresher R, 2003, MAR BIOL, V142, P867, DOI 10.1007/s00227-003-1011-1; Udekem d'Acoz C d', 1999, INVENTAIRE DISTRIBUT; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walton WC, 2002, J EXP MAR BIOL ECOL, V272, P171, DOI 10.1016/S0022-0981(02)00127-2; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	42	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7268	10.1371/journal.pone.0007268	http://dx.doi.org/10.1371/journal.pone.0007268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789651	Green Published, Green Submitted, gold			2022-12-25	WOS:000270354100021
J	Krauss, V; Eisenhardt, C; Unger, T				Krauss, Veiko; Eisenhardt, Carina; Unger, Tina			The Genome of the Stick Insect Medauroidea extradentata Is Strongly Methylated within Genes and Repetitive DNA	PLOS ONE			English	Article							NON-CPG METHYLATION; CYTOSINE METHYLATION; RESOLUTION; CELLS; 5-METHYLCYTOSINE; TRANSCRIPTION; ARABIDOPSIS; CHROMOSOME; MARKERS; SYSTEM	Background: Cytosine DNA methylation has been detected in many eukaryotic organisms and has been shown to play an important role in development and disease of vertebrates including humans. Molecularly, DNA methylation appears to be involved in the suppression of initiation or of elongation of transcription. Resulting organismal functions are suggested to be the regulation of gene silencing, the suppression of transposon activity and the suppression of initiation of transcription within genes. However, some data concerning the distribution of methylcytosine in insect species appear to contradict such roles. Principal Findings: By comparison of MspI and HpaII restriction patterns in genomic DNA of several insects we show that stick insects (Phasmatodea) have highly methylated genomes. We isolated methylated DNA fragments from the Vietnamese Walking Stick Medauroidea extradentata (formerly known as Baculum extradentatum) and demonstrated that most of the corresponding sequences are repetitive. Bisulfite sequencing of one of these fragments and of parts of conserved protein-coding genes revealed a methylcytosine content of 12.6%, mostly found at CpG, but also at CpT and CpA dinucleotides. Corresponding depletions of CpG and enrichments of TpG and CpA dinucleotides in some highly conserved protein-coding genes of Medauroidea reach a similar degree as in vertebrates and show that CpG methylation has occurred in the germline of these insects. Conclusions: Using four different methods, we demonstrate that the genome of Medauroidea extradentata is strongly methylated. Both repetitive DNA and coding genes appear to contain high levels of methylcytosines. These results argue for similar functions of DNA methylation in stick insects as those already known for vertebrates.			Krauss, V (corresponding author), Univ Leipzig, Dept Bioinformat, Leipzig, Germany.	krauss@rz.uni-leipzig.de		Krauss, Veiko/0000-0002-2868-8367				Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bongiorni S, 2003, GENETICA, V117, P271, DOI 10.1023/A:1022964700446; Colot V, 1999, BIOESSAYS, V21, P402, DOI 10.1002/(SICI)1521-1878(199905)21:5<402::AID-BIES7>3.3.CO;2-2; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DEOBAGKAR DN, 1982, J BIOSCIENCE, V4, P513, DOI 10.1007/BF02704646; Field LM, 2000, BIOCHEM J, V349, P863, DOI 10.1042/bj3490863; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Grandjean V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001136; GREGORY TR, 2009, ANIMAL GENOME SIZE D; Grimaldi David, 2005, pi; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Krauss V, 2008, MOL BIOL EVOL, V25, P821, DOI 10.1093/molbev/msn013; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Mandrioli M, 2003, GENETICA, V119, P187, DOI 10.1023/A:1026016021415; Mandrioli M, 2007, CHROMOSOME RES, V15, P1015, DOI 10.1007/s10577-007-1176-4; Mazin AL, 2009, AGEING RES REV, V8, P314, DOI 10.1016/j.arr.2009.04.005; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mohan KN, 2005, MOL GENET GENOMICS, V274, P557, DOI 10.1007/s00438-005-0004-9; PATEL CV, 1987, ANAL BIOCHEM, V164, P164, DOI 10.1016/0003-2697(87)90381-2; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; REBASE, RESTR ENZ DAT; Regev A, 1998, MOL BIOL EVOL, V15, P880, DOI 10.1093/oxfordjournals.molbev.a025992; Rein T, 1998, NUCLEIC ACIDS RES, V26, P2255, DOI 10.1093/nar/26.10.2255; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Simmen MW, 1999, SCIENCE, V283, P1164, DOI 10.1126/science.283.5405.1164; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	40	24	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7223	10.1371/journal.pone.0007223	http://dx.doi.org/10.1371/journal.pone.0007223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787064	gold, Green Submitted, Green Published			2022-12-25	WOS:000270290100020
J	Lim, S; Pnueli, L; Tan, JH; Naor, Z; Rajagopal, G; Melamed, P				Lim, Stefan; Pnueli, Lilach; Tan, Jing Hui; Naor, Zvi; Rajagopal, Gunaretnam; Melamed, Philippa			Negative Feedback Governs Gonadotrope Frequency-Decoding of Gonadotropin Releasing Hormone Pulse-Frequency	PLOS ONE			English	Article							N-TERMINAL KINASE; SIGNAL-REGULATED KINASE; SUBUNIT GENE-EXPRESSION; DIFFERENTIAL REGULATION; STIMULATED ACTIVITY; DEPENDENT ACTIVATION; PROTEIN-KINASE; MAPK CASCADES; RECEPTOR GENE; CROSS-TALK	The synthesis of the gonadotropin subunits is directed by pulsatile gonadotropin-releasing hormone (GnRH) from the hypothalamus, with the frequency of GnRH pulses governing the differential expression of the common alpha-subunit, luteinizing hormone beta-subunit (LH beta) and follicle-stimulating hormone beta-subunit (FSH beta). Three mitogen-activated protein kinases, (MAPKs), ERK1/2, JNK and p38, contribute uniquely and combinatorially to the expression of each of these subunit genes. In this study, using both experimental and computational methods, we found that dual specificity phosphatase regulation of the activity of the three MAPKs through negative feedback is required, and forms the basis for decoding the frequency of pulsatile GnRH. A fourth MAPK, ERK5, was shown also to be activated by GnRH. ERK5 was found to stimulate FSH beta promoter activity and to increase FSH beta mRNA levels, as well as enhancing its preference for low GnRH pulse frequencies. The latter is achieved through boosting the ultrasensitive behavior of FSH beta gene expression by increasing the number of MAPK dependencies, and through modulating the feedforward effects of JNK activation on the GnRH receptor (GnRH-R). Our findings contribute to understanding the role of changing GnRH pulse-frequency in controlling transcription of the pituitary gonadotropins, which comprises a crucial aspect in regulating reproduction. Pulsatile stimuli and oscillating signals are integral to many biological processes, and elucidation of the mechanisms through which the pulsatility is decoded explains how the same stimulant can lead to various outcomes in a single cell.			Melamed, P (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	philippa@technion.ac.il		Rajagopal, Gunaretnam/0000-0003-0111-1936				Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bonfil D, 2004, ENDOCRINOLOGY, V145, P2228, DOI 10.1210/en.2003-1418; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; DAVIDSON JS, 1994, BIOCHEM J, V300, P299, DOI 10.1042/bj3000299; Ellsworth BS, 2003, ENDOCRINOLOGY, V144, P839, DOI 10.1210/en.2002-220784; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Goldbeter A, 2001, CHAOS, V11, P247, DOI 10.1063/1.1345727; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; GRUMBACH MM, 2003, WILLIAMS TXB ENDOCRI, P115; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; HAISENLEDER DJ, 1990, ENDOCRINOLOGY, V127, P2869, DOI 10.1210/endo-127-6-2869; Harris D, 2002, ENDOCRINOLOGY, V143, P1018, DOI 10.1210/en.143.3.1018; Harris D, 2003, ENDOCRINOLOGY, V144, P612, DOI 10.1210/en.2002-220690; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Ivakhno S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-27; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; KATT JA, 1985, ENDOCRINOLOGY, V116, P2113, DOI 10.1210/endo-116-5-2113; Koschorreck M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-336; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Luo M, 2005, MOL CELL BIOL, V25, P7386, DOI 10.1128/MCB.25.16.7386-7398.2005; Melamed P, 2006, MOL CELL ENDOCRINOL, V252, P167, DOI 10.1016/j.mce.2006.03.024; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; PAPAVASILIOU SS, 1986, P NATL ACAD SCI USA, V83, P4026, DOI 10.1073/pnas.83.11.4026; Pawson AJ, 2008, ENDOCRINOLOGY, V149, P1415, DOI 10.1210/en.2007-1159; Ruf F, 2004, TRENDS ENDOCRIN MET, V15, P331, DOI 10.1016/j.tem.2004.07.008; Ruf F, 2003, FRONT NEUROENDOCRIN, V24, P181, DOI 10.1016/S0091-3022(03)00027-X; Sadie H, 2003, ENDOCRINOLOGY, V144, P1958, DOI 10.1210/en.2002-220874; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Zhang T, 2006, J MOL ENDOCRINOL, V36, P41, DOI 10.1677/jme.1.01881	46	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7244	10.1371/journal.pone.0007244	http://dx.doi.org/10.1371/journal.pone.0007244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787048	Green Published, Green Submitted, gold			2022-12-25	WOS:000270290100022
J	GeurtsvanKessel, CH; Bergen, IM; Muskens, F; Boon, L; Hoogsteden, HC; Osterhaus, ADME; Rimmelzwaan, GF; Lambrecht, BN				GeurtsvanKessel, Corine H.; Bergen, Ingrid M.; Muskens, Femke; Boon, Louis; Hoogsteden, Henk C.; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.; Lambrecht, Bart N.			Both Conventional and Interferon Killer Dendritic Cells Have Antigen-Presenting Capacity during Influenza Virus Infection	PLOS ONE			English	Article								Natural killer cells are innate effector cells known for their potential to produce interferon-gamma and kill tumour and virus-infected cells. Recently, B220(+)CD11c(int)NK1.1(+) NK cells were found to also have antigen-presenting capacity like dendritic cells (DC), hence their name interferon-producing killer DC (IKDC). Shortly after discovery, it has already been questioned if IKDC really represent a separate subset of NK cells or merely represent a state of activation. Despite similarities with DCs, in vivo evidence that they behave as bona fide APCs is lacking. Here, using a model of influenza infection, we found recruitment of both conventional B220(-) NK cells and IKDCs to the lung. To study antigen-presenting capacity of NK cell subsets and compare it to cDCs, all cell subsets were sorted from lungs of infected mice and co-cultured ex vivo with antigen specific T cells. Both IKDCs and conventional NK cells as well as cDCs presented virus-encoded antigen to CD8 T cells, whereas only cDCs presented to CD4 T cells. The absence of CD4 responses was predominantly due to a deficiency in MHCII processing, as preprocessed peptide antigen was presented equally well by cDCs and IKDCs. In vivo, the depletion of NK1.1-positive NK cells and IKDCs reduced the expansion of viral nucleoprotein-specific CD8 T cells in the lung and spleen, but did finally not affect viral clearance from the lung. In conclusion, we found evidence for APC function of lung NK cells during influenza infection, but this is a feature not exclusive to the IKDC subset.			GeurtsvanKessel, CH (corresponding author), Erasmus Univ, Med Ctr, Dept Pulm Med, Rotterdam, Netherlands.	bart.lambrecht@ugent.be	Boon, Laurence/HCI-3629-2022; Lambrecht, Bart N/K-2484-2014	Lambrecht, Bart N/0000-0003-4376-6834; Boon, Louis/0000-0002-0937-9171; Osterhaus, Albert/0000-0002-6074-1172				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Bonmort M, 2008, CURR OPIN IMMUNOL, V20, P558, DOI 10.1016/j.coi.2008.04.006; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Caminschi I, 2007, J EXP MED, V204, P2579, DOI 10.1084/jem.20071351; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; HENNET T, 1992, J GEN VIROL, V73, P39, DOI 10.1099/0022-1317-73-1-39; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Kambayashi T, 2000, J IMMUNOL, V165, P4964, DOI 10.4049/jimmunol.165.9.4964; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Kim GG, 2007, J IMMUNOL METHODS, V325, P51, DOI 10.1016/j.jim.2007.05.013; Kos FJ, 1996, CELL IMMUNOL, V173, P1, DOI 10.1006/cimm.1996.0245; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lambrecht BN, 2000, J IMMUNOL, V164, P2937, DOI 10.4049/jimmunol.164.6.2937; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; RONCAROLO MG, 1991, J IMMUNOL, V147, P781; Spits H, 2007, IMMUNITY, V26, P11, DOI 10.1016/j.immuni.2007.01.004; STEINSTREILEIN J, 1983, J IMMUNOL, V131, P2699; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; Ullrich E, 2008, J IMMUNOL, V180, P7887, DOI 10.4049/jimmunol.180.12.7887; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711	45	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7187	10.1371/journal.pone.0007187	http://dx.doi.org/10.1371/journal.pone.0007187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784375	Green Published, gold			2022-12-25	WOS:000270290000007
J	Zhang, CK; Truong, KK; Zhou, QY				Zhang, Chengkang; Truong, Kimberly K.; Zhou, Qun-Yong			Efferent Projections of Prokineticin 2 Expressing Neurons in the Mouse Suprachiasmatic Nucleus	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; ORGANIZATION; CLOCK; RAT; LOCALIZATION; OSCILLATIONS; FLUOROGOLD; TRANSPORT; PATTERNS; HAMSTER	The suprachiasmatic nucleus (SCN) in the hypothalamus is the predominant circadian clock in mammals. To function as a pacemaker, the intrinsic timing signal from the SCN must be transmitted to different brain regions. Prokineticin 2 (PK2) is one of the candidate output molecules from the SCN. In this study, we investigated the efferent projections of PK2-expressing neurons in the SCN through a transgenic reporter approach. Using a bacterial artificial chromosome (BAC) transgenic mouse line, in which the enhanced green fluorescence protein (EGFP) reporter gene expression was driven by the PK2 promoter, we were able to obtain an efferent projections map from the EGFP-expressing neurons in the SCN. Our data revealed that EGFP-expressing neurons in the SCN, hence representing some of the PK2-expressing neurons, projected to many known SCN target areas, including the ventral lateral septum, medial preoptic area, subparaventricular zone, paraventricular nucleus, dorsomedial hypothalamic nucleus, lateral hypothalamic area and paraventricular thalamic nucleus. The efferent projections of PK2-expressing neurons supported the role of PK2 as an output molecule of the SCN.			Zhang, CK (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	qzhou@uci.edu	ZHANG, CHENGKANG/A-8141-2008	Zhang, Chengkang/0000-0002-3746-2095	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067753] Funding Source: NIH RePORTER; NIMH NIH HHS [MH67753] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Buijs RM, 1996, PROG BRAIN RES, V111, P229, DOI 10.1016/S0079-6123(08)60411-2; Burgoon PW, 2004, J COMP PHYSIOL A, V190, P167, DOI 10.1007/s00359-003-0486-z; CARD JP, 1981, J NEUROSCI, V1, P1289; Cheng MY, 2006, J COMP NEUROL, V498, P796, DOI 10.1002/cne.21087; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; CHENG MY, 2005, BMC NEUROSCI, V17, P2; CHIBA T, 1985, BRAIN RES BULL, V14, P261, DOI 10.1016/0361-9230(85)90091-7; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; DAAN S, 1978, J THEOR BIOL, V70, P297, DOI 10.1016/0022-5193(78)90378-8; Daan S, 2001, J BIOL RHYTHM, V16, P105, DOI 10.1177/074873001129001809; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hamada T, 2004, EUR J NEUROSCI, V19, P1741, DOI 10.1111/j.1460-9568.2004.03275.x; Hu WP, 2007, SLEEP, V30, P247; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Jethwa PH, 2008, AM J PHYSIOL-REG I, V294, pR1968, DOI 10.1152/ajpregu.00778.2007; KALSBEEK A, 1993, J COMP NEUROL, V332, P293, DOI 10.1002/cne.903320304; Leak RK, 2001, J COMP NEUROL, V433, P312, DOI 10.1002/cne.1142; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Masumoto K, 2006, EUR J NEUROSCI, V23, P2959, DOI 10.1111/j.1460-9568.2006.04834.x; Meyer-Bernstein EL, 1999, ENDOCRINOLOGY, V140, P207, DOI 10.1210/en.140.1.207; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; MORIN LP, 2006, BRAIN RES REV, V1, P60; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Paxinos G, 2001, MOUSE BRAIN STEREOTA, pxxv; Piggins HD, 2005, CURR BIOL, V15, pR455, DOI 10.1016/j.cub.2005.06.019; Prosser HM, 2007, P NATL ACAD SCI USA, V104, P648, DOI 10.1073/pnas.0606884104; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; SCHMUED LC, 1986, BRAIN RES, V377, P147, DOI 10.1016/0006-8993(86)91199-6; Silver R, 2005, METHOD ENZYMOL, V393, P451, DOI 10.1016/S0076-6879(05)93022-X; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Thompson RH, 1998, BRAIN RES REV, V27, P89, DOI 10.1016/S0165-0173(98)00010-1; Ueyama T, 1999, NAT NEUROSCI, V2, P1051, DOI 10.1038/15973; van Esseveldt LKE, 2000, BRAIN RES REV, V33, P34, DOI 10.1016/S0165-0173(00)00025-4; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Yan L, 2005, J NEUROSCI, V25, P9017, DOI 10.1523/JNEUROSCI.2538-05.2005; Zhang CK, 2007, J BIOL CHEM, V282, P6917, DOI 10.1074/jbc.C600290200; Zhou QY, 2005, FEBS J, V272, P5703, DOI 10.1111/j.1742-4658.2005.04984.x	44	54	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7151	10.1371/journal.pone.0007151	http://dx.doi.org/10.1371/journal.pone.0007151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784373	gold, Green Published			2022-12-25	WOS:000270290000002
J	Chakrabarty, P; Jansen-West, K; Beccard, A; Ceballos-Diaz, C; Levites, Y; Verbeeck, C; Zubair, AC; Dickson, D; Golde, TE; Das, P				Chakrabarty, Paramita; Jansen-West, Karen; Beccard, Amanda; Ceballos-Diaz, Carolina; Levites, Yona; Verbeeck, Christophe; Zubair, Abba C.; Dickson, Dennis; Golde, Todd E.; Das, Pritam			Massive gliosis induced by interleukin-6 suppresses A beta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition	FASEB JOURNAL			English	Article						Alzheimer's disease; neuroinflammation; APP; recombinant adeno-associated virus	ALZHEIMERS-DISEASE PATIENTS; MOUSE MODEL; PLAQUE-FORMATION; TRANSGENIC MICE; MICROGLIA; ACTIVATION; CLEARANCE; PATHOLOGY; CYTOKINE; GENE	Proinflammatory stimuli, after amyloid beta (A beta) deposition, have been hypothesized to create a self-reinforcing positive feedback loop that increases amyloidogenic processing of the A beta precursor protein (APP), promoting further A beta accumulation and neuroinflammation in Alzheimer's disease (AD). Interleukin-6 (IL-6), a proinflammatory cytokine, has been shown to be increased in AD patients implying a pathological interaction. To assess the effects of IL-6 on A beta deposition and APP processing in vivo, we overexpressed murine IL-6 (mIL-6) in the brains of APP transgenic TgCRND8 and TG2576 mice. mIL-6 expression resulted in extensive gliosis and concurrently attenuated A beta deposition in TgCRND8 mouse brains. This was accompanied by up-regulation of glial phagocytic markers in vivo and resulted in enhanced microglia-mediated phagocytosis of A beta aggregates in vitro. Further, mIL-6-induced neuroinflammation had no effect on APP processing in TgCRND8 and had no effect on APP processing or steady-state levels of A beta in young Tg2576 mice. These results indicate that mIL-6-mediated reactive gliosis may be beneficial early in the disease process by potentially enhancing A beta plaque clearance rather than mediating a neurotoxic feedback loop that exacerbates amyloid pathology. This is the first study that methodically dissects the contribution of mIL-6 with regard to its potential role in modulating A beta deposition in vivo.-Chakrabarty, P., Jansen-West, K., Beccard, A., Ceballos-Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., Das, P. Massive gliosis induced by interleukin-6 suppresses A beta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J. 24, 548-559 (2010). www.fasebj.org	[Chakrabarty, Paramita; Jansen-West, Karen; Beccard, Amanda; Ceballos-Diaz, Carolina; Levites, Yona; Verbeeck, Christophe; Dickson, Dennis; Golde, Todd E.; Das, Pritam] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Zubair, Abba C.] Mayo Clin, Dept Lab Med & Pathol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic	Das, P (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd,457 Birdsall Bldg, Jacksonville, FL 32224 USA.	das.pritam@mayo.edu		Dickson, Dennis W/0000-0001-7189-7917	Mayo Clinic; National Institutes of Health/National Institute on Aging [RO1AG18454, RO1AG29886, P01AG25531, P01AG71216]; American Health Assistance Foundation [AHAF3J]; Robert H. and Clarice Smith Foundation; NATIONAL INSTITUTE ON AGING [R01AG029886, P01AG025531, R01AG018454] Funding Source: NIH RePORTER	Mayo Clinic; National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Health Assistance Foundation(BrightFocus Foundation); Robert H. and Clarice Smith Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Monica Castanedes-Casey, V. A. Phillips, and Linda Rousseau for assistance with tissue processing and immunohistochemical analyses; Sunita Malik for help with FACS recording; and Faith Conkle, Deborah Maloy, and the Mayo Clinic Veterinary Medicine staff for animal maintenance. This work was supported by the Mayo Clinic (to T. G.), the National Institutes of Health/National Institute on Aging (grants RO1AG18454, RO1AG29886, and P01AG25531 to T. G. and P01AG71216 to D. D.), the American Health Assistance Foundation (grant AHAF3J to P. D.), and the Robert H. and Clarice Smith Foundation postdoctoral fellowship (to P. C.).	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Baranowska-Bik A, 2008, NEUROENDOCRINOL LETT, V29, P75; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Cho HJ, 2007, GLIA, V55, P253, DOI 10.1002/glia.20451; Dickson DW, 1999, AM J PATHOL, V154, P1627, DOI 10.1016/S0002-9440(10)65416-8; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Galimberti D, 2008, J NEUROL, V255, P539, DOI 10.1007/s00415-008-0737-6; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; Giri RK, 2003, J IMMUNOL, V170, P5281, DOI 10.4049/jimmunol.170.10.5281; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Heneka MT, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-22; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; HUELL M, 1995, ACTA NEUROPATHOL, V89, P544; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Lahiri DK, 2003, J ALZHEIMERS DIS, V5, P81, DOI 10.3233/JAD-2003-5203; Licastro F, 2000, J NEUROIMMUNOL, V103, P97, DOI 10.1016/S0165-5728(99)00226-X; Licastro F, 2003, NEUROBIOL AGING, V24, P921, DOI 10.1016/S0197-4580(03)00013-7; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Ravaglia G, 2006, EXP GERONTOL, V41, P85, DOI 10.1016/j.exger.2005.10.005; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Ringheim GE, 1998, MOL BRAIN RES, V55, P35, DOI 10.1016/S0169-328X(97)00356-2; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Shibata N, 2002, AM J MED GENET, V114, P436, DOI 10.1002/ajmg.10417; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sokolova A, 2009, BRAIN PATHOL, V19, P392, DOI 10.1111/j.1750-3639.2008.00188.x; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; STRAUSS S, 1992, LAB INVEST, V66, P223; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	50	235	247	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					548	559		10.1096/fj.09-141754	http://dx.doi.org/10.1096/fj.09-141754			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19825975	Green Published			2022-12-25	WOS:000274045000022
J	Chen, Z; Li, ZZ; Wei, B; Yin, WX; Xu, T; Kotlikoff, MI; Ji, GJ				Chen, Zheng; Li, Zhengzheng; Wei, Bin; Yin, Wenxuan; Xu, Tao; Kotlikoff, Michael I.; Ji, Guangju			FKBP12.6-knockout mice display hyperinsulinemia and resistance to high-fat diet-induced hyperglycemia	FASEB JOURNAL			English	Article						pancreatic islets; diabetes; Ca2+; insulin secretion	PANCREATIC BETA-CELLS; INSULIN-SECRETION; RYANODINE RECEPTORS; SIGNALING SYSTEM; SMOOTH-MUSCLE; CA2+ RELEASE; CHANNEL	FK506 binding protein 12.6 kDa (FKBP12.6), a protein that regulates ryanodine Ca2+ release channels, may act as an important regulator of insulin secretion. In this study, the role of FKBP12.6 in the control of insulin secretion and blood glucose is clarified using FKBP12.6(-/-) mice. FKBP12.6(-/-) mice showed significant fed hyperinsulinemia but exhibited normoglycemia, fasting normoinsulinemia, and normal body weight compared with wild-type (WT) littermate control mice. Deletion of FKBP12.6 resulted in enhanced glucose-stimulated insulin secretion (GSIS) both in vivo and in vitro, a result that is due to enhanced glucose-induced islet Ca2+ elevation. After a high-fat dietary challenge (HF diet) for 3 mo, FKBP12.6(-/-) mice displayed higher body weight, hyperinsulinemia, and lower fed blood glucose concentrations compared with WT mice. FKBP12.6(-/-) mice displayed hyperinsulinemia, and resistance to HF diet-induced hyperglycemia, suggesting that FKBP12.6 plays an important role in insulin secretion and blood glucose control, and raising the possibility that it may be a potential therapeutic target for the treatment of type 2 diabetes.-Chen, Z., Li, Z., Wei, B., Yin, W., Xu, T., Kotlikoff, M. I., Ji, G. FKBP12.6-knockout mice display hyperinsulinemia and resistance to high-fat diet-induced hyperglycemia. FASEB J. 24, 357-363 (2010). www.fasebj.org	[Chen, Zheng; Li, Zhengzheng; Wei, Bin; Yin, Wenxuan; Xu, Tao; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Kotlikoff, Michael I.; Ji, Guangju] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Cornell University	Ji, GJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	mik7@cornell.edu; gj28@ibp.ac.cn	Wei, Bin/M-2017-2014; Li, Zhengzheng/N-1415-2013; chen, zheng/J-4600-2014	chen, zheng/0000-0003-2161-6106; , zheng/0000-0001-7129-6644; Ji, Guangju/0000-0001-8626-3490	National Basic Research Program of China [007CB512100]; U.S. National Institutes of Health [HL45239, DK65992]; Chinese Academy of Sciences [KSCX2-YW-R-50]; National Foundation of Science and Technology [30770520, 2009CB918701]; 863 research program [2006AA02A106]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065992] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); National Foundation of Science and Technology; 863 research program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Basic Research Program of China (007CB512100 to G.J.), the U.S. National Institutes of Health (HL45239 and DK65992 to M. K.), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-50 to G.J.), the National Foundation of Science and Technology (30770520 and 2009CB918701); and the 863 research program (2006AA02A106).	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Bruton JD, 2002, FASEB J, V16, P301, DOI 10.1096/fj.02-0481fje; Chen LY, 2003, DIABETES, V52, P1723, DOI 10.2337/diabetes.52.7.1723; Empson RM, 1997, J BIOL CHEM, V272, P20967, DOI 10.1074/jbc.272.34.20967; Gamberucci A, 1999, FEBS LETT, V446, P309, DOI 10.1016/S0014-5793(99)00220-3; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; Ji GJ, 2006, J GEN PHYSIOL, V127, P225, DOI 10.1085/jgp.200509422; Ji GJ, 2004, J GEN PHYSIOL, V123, P377, DOI 10.1085/jgp.200308999; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Noguchi N, 2008, BIOCHEM BIOPH RES CO, V371, P735, DOI 10.1016/j.bbrc.2008.04.142; Okamoto H, 1999, MOL CELL BIOCHEM, V193, P115, DOI 10.1023/A:1006980630912; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a	19	14	17	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					357	363		10.1096/fj.09-138446	http://dx.doi.org/10.1096/fj.09-138446			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19805579	Green Published			2022-12-25	WOS:000274045000004
J	Seo, M; Lee, WH; Suk, K				Seo, Minchul; Lee, Won-Ha; Suk, Kyoungho			Identification of novel cell migration-promoting genes by a functional genetic screen	FASEB JOURNAL			English	Article						chchd2; hyaluronic acid-binding protein 1; NIH3T3 mouse fibroblast cells; retroviral cDNA library	ACID-BINDING-PROTEIN; SPLICING FACTOR SF2; IN-VIVO SELECTION; ENDOTHELIAL-CELLS; P-32 PROTEIN; EXPRESSION; ACTIN; HYALURONAN; KINASE; GROWTH	Here we describe the identification of novel cell migration-promoting genes based on an unbiased functional genetic screen in cultured cells. After the introduction of the retroviral mouse brain cDNA library into NIH3T3 mouse fibroblast cells, migration-promoted cells were selected by a 3-dimensional migration assay using cell culture inserts. After 5 rounds of enrichment, cDNAs were retrieved from the cells with a selected phenotype. Cell migration-promoting activity was confirmed by independent migration assays for the retrieved cDNAs, among which further investigation was focused on coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (chchd2). Whereas overexpression of chchd2 promoted cell migration, knockdown of endogenous chchd2 expression reduced cell migration. Chchd2-induced cell migration was associated with augmented formation of actin stress fibers and focal adhesion, which was mediated through Akt, RhoA/ROCK, and Jnk pathways. CHCHD2 protein directly interacted with hyaluronic acid-binding protein 1 (HABP1) that possessed migration-suppressing activity. Intracellular localization and further functional studies suggested that CHCHD2 and HABP1 may mutually regulate each other to balance cell migration. Thus, chchd2 is a novel cell migration determinant identified by an in vitro functional genetic selection strategy. The selection method can also be useful for the isolation of genes that give other phenotypes of interest.-Seo, M., Lee, W.-H., Suk, K. Identification of novel cell migration-promoting genes by a functional genetic screen. FASEB J. 24, 464-478 (2010). www.fasebj.org	[Seo, Minchul; Suk, Kyoungho] Kyungpook Natl Univ, Brain Sci & Engn Inst, Sch Med, Dept Pharmacol,CMRI, Taegu 700422, South Korea; [Seo, Minchul; Lee, Won-Ha] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Dept Genet Engn, Taegu 700422, South Korea	Kyungpook National University; Kyungpook National University	Suk, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	ksuk@knu.ac.kr			Korean government (Ministry of Education, Science, and Technology) [2009-0078941, 200804090, KRF-2006-005-J04202]	Korean government (Ministry of Education, Science, and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	We thank Dr. Frederick P. Roth at Harvard Medical School for critical reading of the manuscript. This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (Ministry of Education, Science, and Technology; 2009-0078941) and by the Bio R&D program through KOSEF funded by the Ministry of Education, Science, and Technology (200804090). K. S. is a recipient of a Korea Research Foundation grant funded by the Korean government (Basic Research Promotion Fund; KRF-2006-005-J04202).	Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Barthe P, 1999, J BIOMOL NMR, V15, P271, DOI 10.1023/A:1008336418418; Barthe P, 2000, PROTEIN SCI, V9, P942, DOI 10.1110/ps.9.5.942; Bassi R, 2008, J NEURO-ONCOL, V87, P23, DOI 10.1007/s11060-007-9488-y; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Charpentier AH, 2000, CANCER RES, V60, P5977; Chen XY, 2009, PHARMACOLOGY, V83, P67, DOI 10.1159/000178814; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chilov D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng115; Chowdhury AR, 2008, EXP CELL RES, V314, P651, DOI 10.1016/j.yexcr.2007.10.033; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; Deb TB, 1996, J BIOL CHEM, V271, P2206, DOI 10.1074/jbc.271.4.2206; Dedio J, 1998, J IMMUNOL, V160, P3534; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Demene H, 2002, J BIOMOL NMR, V22, P47, DOI 10.1023/A:1013821123201; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dunn C, 2002, CELL SIGNAL, V14, P585, DOI 10.1016/S0898-6568(01)00275-3; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Ghebrehiwet B, 1998, IMMUNOBIOLOGY, V199, P225, DOI 10.1016/S0171-2985(98)80029-6; Ghosh I, 2004, MOL CELL BIOCHEM, V267, P133, DOI 10.1023/B:MCBI.0000049362.04033.ea; Ghosh I, 2002, J REPROD IMMUNOL, V53, P45, DOI 10.1016/S0165-0378(01)00095-X; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giretti MS, 2008, STEROIDS, V73, P895, DOI 10.1016/j.steroids.2008.01.011; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; GUPTA S, 1991, EUR J CELL BIOL, V56, P58; GUPTA S, 1991, EXP CELL RES, V195, P386, DOI 10.1016/0014-4827(91)90388-B; HARADA K, 2000, NUCL ACIDS S SER, V44, P269; Herwald H, 1996, J BIOL CHEM, V271, P13040, DOI 10.1074/jbc.271.22.13040; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang Z, 2008, CELL SIGNAL, V20, P2002, DOI 10.1016/j.cellsig.2008.07.014; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Jin C, 1997, CURR GENET, V31, P228, DOI 10.1007/s002940050199; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kim S, 2007, J NEUROCHEM, V103, P2640, DOI 10.1111/j.1471-4159.2007.04995.x; Kito H, 2000, J APPL PHYSIOL, V89, P2391, DOI 10.1152/jappl.2000.89.6.2391; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Komarov AP, 2008, P NATL ACAD SCI USA, V105, P14453, DOI 10.1073/pnas.0807549105; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Lim BL, 1996, J BIOL CHEM, V271, P26739, DOI 10.1074/jbc.271.43.26739; Madani A, 1996, BLOOD, V87, P1923; Majumdar M, 2002, BIOCHEM BIOPH RES CO, V291, P829, DOI 10.1006/bbrc.2002.6491; Mallick J, 2005, EXP CELL RES, V309, P250, DOI 10.1016/j.yexcr.2005.05.025; Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677; Meenakshi J, 2003, BIOCHEM BIOPH RES CO, V300, P686, DOI 10.1016/S0006-291X(02)02788-2; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mummert ME, 2003, MOL CANCER THER, V2, P295; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Ozawa T, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni032; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Ranganathan S, 1995, CELL MOL BIOL RES, V41, P467; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rout UK, 1997, CELL CALCIUM, V22, P463, DOI 10.1016/S0143-4160(97)90074-9; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Santra S, 2001, J BIOMED OPT, V6, P160, DOI 10.1117/1.1353590; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Sengupta A, 2004, BIOCHEM J, V380, P837, DOI 10.1042/BJ20040264; Seo MC, 2008, J NEUROSCI RES, V86, P1087, DOI 10.1002/jnr.21552; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Soltys BJ, 2000, HISTOCHEM CELL BIOL, V114, P245; Stitz J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni039; Suzuki H, 2007, NEUROSCI LETT, V421, P152, DOI 10.1016/j.neulet.2007.03.077; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Uchida C, 2008, CELL BIOL INT, V32, P769, DOI 10.1016/j.cellbi.2008.03.005; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Westerman BA, 2004, GENOMICS, V83, P1094, DOI 10.1016/j.ygeno.2003.12.006; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wiesner C, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf079; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; YOKOTA T, 1985, P NATL ACAD SCI USA, V82, P68, DOI 10.1073/pnas.82.1.68; Zhang WW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000248	93	42	47	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					464	478		10.1096/fj.09-137562	http://dx.doi.org/10.1096/fj.09-137562			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19812375				2022-12-25	WOS:000274045000014
J	Watson, IR; Li, BK; Roche, O; Blanch, A; Ohh, M; Irwin, MS				Watson, I. R.; Li, B. K.; Roche, O.; Blanch, A.; Ohh, M.; Irwin, M. S.			Chemotherapy induces NEDP1-mediated destabilization of MDM2	ONCOGENE			English	Article						chemotherapy; MDM2; NEDD8; NEDP1; p53	DNA-DAMAGE; IN-VIVO; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; COP9 SIGNALOSOME; P53; NEDD8; PROTEINS; PROTEASE; PATHWAY	MDM2 is an E3 ligase that promotes ubiquitin-mediated destruction of p53. Cellular stresses such as DNA damage can lead to p53 activation due in part to MDM2 destabilization. Here, we show that the stability of MDM2 is regulated by an ubiquitin-like NEDD8 pathway and identify NEDP1 as a chemotherapy-induced isopeptidase that deneddylates MDM2, resulting in MDM2 destabilization concomitant with p53 activation. Concordantly, RNAi-mediated knockdown of endogenous NEDP1 blocked diminution of MDM2 levels and increased chemoresistance of tumor cells. These findings unveil the regulation of MDM2 stability through NEDP1 as a common molecular determinant governing chemotherapy-induced p53-dependent cell death. Oncogene (2010) 29, 297-304; doi:10.1038/onc.2009.314; published online 28 September 2009	[Watson, I. R.; Li, B. K.; Roche, O.; Ohh, M.; Irwin, M. S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Irwin, M. S.] Hosp Sick Children, Dept Paediat & Cell Biol, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Irwin, M. S.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Irwin, M. S.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Irwin, MS (corresponding author), Hosp Sick Children, Dept Paediat & Cell Biol, Cell Biol Program, 555 Univ Ave,Black Wing 9th Floor, Toronto, ON M5G 1X8, Canada.	michael.ohh@utoronto.ca; meredith.irwin@sickkids.ca	Roche, UCLM/F-5697-2019; Roche, Olga/K-9342-2014	Roche, UCLM/0000-0003-1884-8256; Watson, Ian/0000-0002-6025-3080; Li, Kincheon/0000-0001-6640-2625	Canadian Cancer Society Research Institute (CCSRI) [018460, 018054]; Hospital for Sick Children Foundation; Canadian Institutes of Health Research (CIHR) Canada	Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Hospital for Sick Children Foundation; Canadian Institutes of Health Research (CIHR) Canada(Canadian Institutes of Health Research (CIHR))	We thank Lynn Cheng, Joanne Lau, Roxana Sufan and Ryan Russell for their technical assistance. We thank Drs Uri Tabori and Loretta Lau for helpful discussions. We thank Drs Stephen Meyn and Paul Bradshaw for providing AT reagents. This work was supported by funds from the Canadian Cancer Society Research Institute (CCSRI 018460 to MO and 018054 to MSI). IRW is a recipient of the Hospital for Sick Children Foundation Student Scholarship and the Canadian Institutes of Health Research (CIHR) Canada Graduate Scholarship. OR is a recipient of the CIHR Fellowship. MO and MSI are Canada Research Chairs.	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chan Y, 2008, J CELL SCI, V121, P3218, DOI 10.1242/jcs.030445; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Hetfeld BKJ, 2008, APOPTOSIS, V13, P187, DOI 10.1007/s10495-007-0164-7; Huang HY, 2008, CLIN CANCER RES, V14, P6023, DOI 10.1158/1078-0432.CCR-08-0252; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Koschny R, 2006, PATHOL RES PRACT, V202, P23, DOI 10.1016/j.prp.2005.10.010; Lau L, 2007, ONCOGENE, V26, P1920, DOI 10.1038/sj.onc.1209981; Lee MH, 2006, NAT CELL BIOL, V8, P1424, DOI 10.1038/ncb1512; Levav-Cohen Y, 2005, GROWTH FACTORS, V23, P183, DOI 10.1080/08977190500196218; Lowe Scott W., 1995, Current Opinion in Oncology, V7, P547, DOI 10.1097/00001622-199511000-00013; LUNA RMD, 1995, NATURE, V378, P203; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Paunu N, 2002, CANCER RES, V62, P3798; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Suzuki H, 2008, LUNG CANCER, V59, P24, DOI 10.1016/j.lungcan.2007.08.002; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Watson IR, 2006, J BIOL CHEM, V281, P34096, DOI 10.1074/jbc.M603654200; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yamoah K, 2005, METHOD ENZYMOL, V398, P509, DOI 10.1016/S0076-6879(05)98042-7; Zhang XC, 2008, J CELL BIOCHEM, V103, P1219, DOI 10.1002/jcb.21504; Zhou LH, 2005, BIOCHEM J, V389, P307, DOI 10.1042/BJ20041991	34	39	43	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2010	29	2					297	304		10.1038/onc.2009.314	http://dx.doi.org/10.1038/onc.2009.314			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19784069				2022-12-25	WOS:000273650000012
J	Nirde, P; Derocq, D; Maynadier, M; Chambon, M; Basile, I; Gary-Bobo, M; Garcia, M				Nirde, P.; Derocq, D.; Maynadier, M.; Chambon, M.; Basile, I.; Gary-Bobo, M.; Garcia, M.			Heat shock cognate 70 protein secretion as a new growth arrest signal for cancer cells	ONCOGENE			English	Article						cancer; growth inhibition; Hsc70; secretion; extracellular; cathepsin D	TRANSFECTED CATHEPSIN-D; BREAST-CANCER; TUMOR-CELLS; HSP70-LIKE PROTEIN; CRYSTAL-STRUCTURES; HEAT-SHOCK-PROTEIN-70; EXPRESSION; HSC70; RELEASE; DEGRADATION	Earlier studies indicated that density-arrested cancer cells released an unidentified growth inhibitor whose secretion was prevented by overexpression of the lysosomal protease cathepsin D (cath D). In this study, this growth inhibitor was purified by affinity chromatography and identified as the heat shock cognate 70 protein (hsc70) based on its peptide microsequencing and specific antibody recognition. Among intracellular proteins, including other heat shock proteins, only constitutive hsc70 was secreted in response to the high-cell density. Moreover, hsc70 secretion from cancer cells was generated by serum deprivation, whereas its cellular concentration did not change. Prevention of Hsc70 secretion by cath D overexpression was associated with the formation of multilayer cell cultures, thus indicating a loss of contact inhibition. In addition, we showed that supplementing the culture medium with purified hsc70 inhibited cell proliferation in the nanomolar range. Conversely, removal of this extracellular hsc70 from the medium by either retention on ADP-agarose or competition at the Hsc70 binding site restored cell proliferation. Hsc70 appears active in human breast cancer cells and hypersecreted by direct cath D inhibition. These results suggest a new role of this secreted hsc70 chaperone in cell proliferation that might account for the higher tumor growth of cancer cells overexpressing cath D.	[Garcia, M.] CRLC Val dAurelle Paul Lamarque, IRCM, F-34298 Montpellier 5, France; [Nirde, P.; Derocq, D.; Maynadier, M.; Chambon, M.; Basile, I.; Gary-Bobo, M.; Garcia, M.] INSERM, U896, Montpellier, France; [Nirde, P.; Derocq, D.; Maynadier, M.; Chambon, M.; Basile, I.; Gary-Bobo, M.; Garcia, M.] Univ Montpellier I, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Garcia, M (corresponding author), CRLC Val dAurelle Paul Lamarque, IRCM, 208 Rue Apothicaires, F-34298 Montpellier 5, France.	marcel.garcia@valdorel.fnclcc.fr			Institut National de la Sante et de la Recherche Medicale; Association pour la Recherche sur le Cancer; Ligue contre le cancer; Comite de l'Herault; CNRS	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue contre le cancer(Ligue nationale contre le cancer); Comite de l'Herault; CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank Jean Derancourt, (Centre de Recherches de Biochimie Macromoleculaire du CNRS, 1919 Route de Mende, 34293 Montpellier Cedex 5, France) for peptide fragments analysis. The authors thank the Centre Regional d'Imagerie Cellulaire (Montpellier-France) for access to the scanning microscopy facilities. This work was supported by the Institut National de la Sante et de la Recherche Medicale, the Association pour la Recherche sur le Cancer, the Ligue contre le cancer, Comite de l'Herault (fellowship to MM), and CNRS.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Anagnostopouloua A, 2006, CANCER LETT, V242, P120, DOI 10.1016/j.canlet.2005.10.047; BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; Barreto A, 2003, CELL IMMUNOL, V222, P97, DOI 10.1016/S0008-8749(03)00115-1; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Bossard N, 2003, BREAST CANCER RES TR, V82, P47, DOI 10.1023/B:BREA.0000003919.75055.e8; Brighty DW, 2001, J VIROL, V75, P10472, DOI 10.1128/JVI.75.21.10472-10478.2001; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Chen S, 2007, J NEUROSCI RES, V85, P402, DOI 10.1002/jnr.21124; CHIANG HL, 1988, J BIOL CHEM, V263, P6797; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CIOCCA DR, 1992, CANCER RES, V52, P3648; Ciocca DR, 2003, CELL STRESS CHAPERON, V8, P26, DOI 10.1379/1466-1268(2003)8<26:HAHIRT>2.0.CO;2; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; COHEN LA, 1974, IN VITRO CELL DEV B, V10, P51, DOI 10.1007/BF02615338; Dressel R, 2003, CANCER RES, V63, P8212; DWORNICZAK B, 1987, NUCLEIC ACIDS RES, V15, P5181, DOI 10.1093/nar/15.13.5181; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; ELLEDGE RM, 1994, CANCER RES, V54, P3752; Florin L, 2004, J VIROL, V78, P5546, DOI 10.1128/JVI.78.11.5546-5553.2004; Fouchaq B, 1999, EUR J BIOCHEM, V259, P379, DOI 10.1046/j.1432-1327.1999.00053.x; GARCIA M, 1990, ONCOGENE, V5, P1809; Garcia M, 1996, STEM CELLS, V14, P642, DOI 10.1002/stem.140642; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; Glondu M, 2002, ONCOGENE, V21, P5127, DOI 10.1038/sj.onc.1205657; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; HIGHTOWER LE, 1989, J CELL PHYSIOL, V138, P257, DOI 10.1002/jcp.1041380206; Kao RH, 2003, INT J EXP PATHOL, V84, P207, DOI 10.1111/j.1365-2613.2003.00356.x; Lazaris AC, 1997, BREAST CANCER RES TR, V43, P43, DOI 10.1023/A:1005706110275; LIAUDET E, 1995, CELL GROWTH DIFFER, V6, P1045; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marnbula SS, 2007, METHODS, V43, P168, DOI 10.1016/j.ymeth.2007.06.009; Melendez K, 2006, CELL STRESS CHAPERON, V11, P334, DOI 10.1379/CSC-187.1; METCALF P, 1993, EMBO J, V12, P1293, DOI 10.1002/j.1460-2075.1993.tb05774.x; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nylandsted J, 2002, CANCER RES, V62, P7139; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; ROTHMAN JE, 1986, CELL, V46, P5, DOI 10.1016/0092-8674(86)90852-4; Saito K, 2005, EXP CELL RES, V310, P229, DOI 10.1016/j.yexcr.2005.07.014; SORGER PK, 1987, EMBO J, V6, P993, DOI 10.1002/j.1460-2075.1987.tb04850.x; Soulier S, 1996, GENE, V172, P285, DOI 10.1016/0378-1119(96)00169-2; Srivastava Pramod K, 2005, Curr Oncol Rep, V7, P104, DOI 10.1007/s11912-005-0035-8; TERLECKY SR, 1993, J BIOL CHEM, V268, P23490; Thanner F, 2003, ANTICANCER RES, V23, P1057; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Torronteguy C, 2006, CELL STRESS CHAPERON, V11, P34, DOI 10.1379/CSC-159R.1; Tsukahara F, 2000, MOL PHARMACOL, V58, P1257, DOI 10.1124/mol.58.6.1257; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Tutar Y, 2006, GENETICS, V172, P851, DOI 10.1534/genetics.105.048926; Tytell M, 2005, INT J HYPERTHER, V21, P445, DOI 10.1080/02656730500041921; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; Vargas-Roig LM, 1998, INT J CANCER, V79, P468, DOI 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z; VargasRoig LM, 1997, CANCER DETECT PREV, V21, P441; Zou N, 2008, AM J PHYSIOL-HEART C, V294, pH2805, DOI 10.1152/ajpheart.00299.2008	61	30	37	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					117	127		10.1038/onc.2009.311	http://dx.doi.org/10.1038/onc.2009.311			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19802014	Green Submitted, Green Accepted			2022-12-25	WOS:000273373500011
J	Miyagi, K; Kiyonaka, S; Yamada, K; Miki, T; Mori, E; Kato, K; Numata, T; Sawaguchi, Y; Numaga, T; Kimura, T; Kanai, Y; Kawano, M; Wakamori, M; Nomura, H; Koni, I; Yamagishi, M; Mori, Y				Miyagi, Kyoko; Kiyonaka, Shigeki; Yamada, Kazunori; Miki, Takafumi; Mori, Emiko; Kato, Kenta; Numata, Tomohiro; Sawaguchi, Yuichi; Numaga, Takuro; Kimura, Toru; Kanai, Yoshikatsu; Kawano, Mitsuhiro; Wakamori, Minoru; Nomura, Hideki; Koni, Ichiro; Yamagishi, Masakazu; Mori, Yasuo			A Pathogenic C Terminus-truncated Polycystin-2 Mutant Enhances Receptor-activated Ca2+ Entry via Association with TRPC3 and TRPC7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-PERMEABLE CATION CHANNEL; KIDNEY-DISEASE; TRANSIENT RECEPTOR; EPITHELIAL-CELLS; CALCIUM-ENTRY; PKD2 GENE; G-PROTEIN; COMPLEX; IDENTIFICATION; LOCALIZATION	Mutations in PKD2 gene result in autosomal dominant polycystic kidney disease (ADPKD). PKD2 encodes polycystin-2 (TRPP2), which is a homologue of transient receptor potential (TRP) cation channel proteins. Here we identify a novel PKD2 mutation that generates a C-terminal tail-truncated TRPP2 mutant 697fsX with a frameshift resulting in an aberrant 17-amino acid addition after glutamic acid residue 697 from a family showing mild ADPKD symptoms. When recombinantly expressed in HEK293 cells, wild-type (WT) TRPP2 localized at the endoplasmic reticulum (ER) membrane significantly enhanced Ca2+ release from the ER upon muscarinic acetylcholine receptor (mAChR) stimulation. In contrast, 697fsX, which showed a predominant plasma membrane localization characteristic of TRPP2 mutants with C terminus deletion, prominently increased mAChR-activated Ca2+ influx in cells expressing TRPC3 or TRPC7. Coimmunoprecipitation, pulldown assay, and cross-linking experiments revealed a physical association between 697fsX and TRPC3 or TRPC7. 697fsX but not WT TRPP2 elicited a depolarizing shift of reversal potentials and an enhancement of single-channel conductance indicative of altered ion-permeating pore properties of mAChR-activated currents. Importantly, in kidney epithelial LLC-PK1 cells the recombinant 679fsX construct was codistributed with native TRPC3 proteins at the apical membrane area, but the WT construct was distributed in the basolateral membrane and adjacent intracellular areas. Our results suggest that heteromeric cation channels comprised of the TRPP2 mutant and the TRPC3 or TRPC7 protein induce enhanced receptor-activated Ca2+ influx that may lead to dysregulated cell growth in ADPKD.	[Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Japan Sci & Technol Agcy, CREST, Kyoto 6158510, Japan; [Miyagi, Kyoko; Yamada, Kazunori; Kawano, Mitsuhiro; Koni, Ichiro; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med, Dept Internal Med, Div Rheumatol, Kanazawa, Ishikawa 9208641, Japan; [Nomura, Hideki] Kanazawa Univ Hosp, Dept Gen Med, Kanazawa, Ishikawa 9208641, Japan; [Kimura, Toru; Kanai, Yoshikatsu] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; [Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kanazawa University; Kanazawa University; Kyorin University; Osaka University	Mori, Y (corresponding author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Katsura Campus, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Numata, Tomohiro/AAW-2453-2020; Wakamori, Minoru/AAE-2661-2019; Kiyonaka, Shigeki/AAM-7303-2021; Numata, Tomohiro/AAC-2330-2021	Numata, Tomohiro/0000-0002-5719-4884; Numata, Tomohiro/0000-0002-5719-4884; Wakamori, Minoru/0000-0001-8574-3310	Ministry of Education, Culture, Sport, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sport, Science, and Technology of Japan.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Ambudkar IS, 2006, TRENDS PHARMACOL SCI, V27, P25, DOI 10.1016/j.tips.2005.11.008; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; BEAR JC, 1984, AM J MED GENET, V18, P45, DOI 10.1002/ajmg.1320180108; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Brenner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000802; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chang MY, 2006, NEPHROL DIAL TRANSPL, V21, P2078, DOI 10.1093/ndt/gfl150; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Chen XZ, 2001, BIOCHEM BIOPH RES CO, V282, P1251, DOI 10.1006/bbrc.2001.4720; Foggensteiner L, 2000, J AM SOC NEPHROL, V11, P814, DOI 10.1681/ASN.V115814; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Grimm DH, 2006, J BIOL CHEM, V281, P137, DOI 10.1074/jbc.M507845200; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Hateboer N, 2000, KIDNEY INT, V57, P1444, DOI 10.1046/j.1523-1755.2000.00989.x; Hayashi T, 1997, GENOMICS, V44, P131, DOI 10.1006/geno.1997.4851; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; JEFF H, 1997, CURRENT PROTOCOLS HU, P2; Jerman JC, 2000, BRIT J PHARMACOL, V130, P916, DOI 10.1038/sj.bjp.0703390; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Konoshita T, 2001, AM J KIDNEY DIS, V37, P113, DOI 10.1053/ajkd.2001.20595; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lehtonen S, 2000, J BIOL CHEM, V275, P32888, DOI 10.1074/jbc.M006624200; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Mori Y, 1998, NEUROREPORT, V9, P507; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Numata T, 2008, CHANNELS, V2, P283, DOI 10.4161/chan.2.4.6695; Obermuller N, 1999, AM J PHYSIOL-RENAL, V277, pF914, DOI 10.1152/ajprenal.1999.277.6.F914; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Onoe T, 2003, CLIN NEPHROL, V59, P406; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Qian Q, 2003, HUM MOL GENET, V12, P1875, DOI 10.1093/hmg/ddg190; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; Rundle DR, 2004, J BIOL CHEM, V279, P29728, DOI 10.1074/jbc.M400544200; Shamshirsaz A, 2005, KIDNEY INT, V68, P2218, DOI 10.1111/j.1523-1755.2005.00678.x; Shimizu T, 2009, PFLUG ARCH EUR J PHY, V457, P795, DOI 10.1007/s00424-008-0558-6; Torra P, 1999, KIDNEY INT, V56, P28, DOI 10.1046/j.1523-1755.1999.00534.x; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200	72	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34400	34412		10.1074/jbc.M109.015149	http://dx.doi.org/10.1074/jbc.M109.015149			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19812035	Green Published, hybrid			2022-12-25	WOS:000272165200070
J	Ralat, LA; Ren, M; Schilling, AB; Tang, WJ				Ralat, Luis A.; Ren, Min; Schilling, Alexander B.; Tang, Wei-Jen			Protective Role of Cys-178 against the Inactivation and Oligomerization of Human Insulin-degrading Enzyme by Oxidation and Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE MASS-SPECTROMETRY; AMYLOID BETA-PROTEIN; ELECTRON-CAPTURE DISSOCIATION; S-NITROSYLATION; NITRIC-OXIDE; MICROGLIAL CELLS; REACTIVE OXYGEN; MOLECULAR-BASIS; DEGRADATION; SUBSTRATE	Insulin-degrading enzyme (IDE), a 110-kDa metalloendopeptidase, hydrolyzes several physiologically relevant peptides, including insulin and amyloid-beta (A beta). Human IDE has 13 cysteines and is inhibited by hydrogen peroxide and S-nitrosoglutathione (GSNO), donors of reactive oxygen and nitrogen species, respectively. Here, we report that the oxidative burst of BV-2 microglial cells leads to oxidation or nitrosylation of secreted IDE, leading to the reduced activity. Hydrogen peroxide and GSNO treatment of IDE reduces the V-max for A beta degradation, increases IDE oligomerization, and decreases IDE thermostability. Additionally, this inhibitory response of IDE is substrate-dependent, biphasic for A beta degradation but monophasic for a shorter bradykinin-mimetic substrate. Our mutational analysis of IDE and peptide mass fingerprinting of GSNO-treated IDE using Fourier transformion cyclotron resonance mass spectrometer reveal a surprising interplay of Cys-178 with Cys-110 and Cys-819 for catalytic activity and with Cys-789 and Cys-966 for oligomerization. Cys-110 is near the zinc-binding catalytic center and is normally buried. The oxidation and nitrosylation of Cys-819 allow Cys-110 to be oxidized or nitrosylated, leading to complete inactivation of IDE. Cys-789 is spatially adjacent to Cys-966, and their nitrosylation and oxidation together trigger the oligomerization and inhibition of IDE. Interestingly, the Cys-178 modification buffers the inhibition caused by Cys-819 modification and prevents the oxidation or nitrosylation of Cys-110. The Cys-178 modification can also prevent the oligomerization-mediated inhibition. Thus, IDE can be intricately regulated by reactive oxygen or nitrogen species. The structure of IDE reveals the molecular basis for the long distance interactions of these cysteines and how they regulate IDE function.	[Ralat, Luis A.; Ren, Min; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Schilling, Alexander B.] Univ Illinois, Prote & Informat Serv Facil, Chicago, IL 60612 USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tang, WJ (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu		Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [GM 81539, F32 GM 87093]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087093, R01GM081539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 81539 (to W. J. T.) and Fellowship F32 GM 87093 (to L. A. R.). S The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S3.	Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chalmers MJ, 2004, PROTEOMICS, V4, P970, DOI 10.1002/pmic.200300650; Chalmers MJ, 2003, J PROTEOME RES, V2, P373, DOI 10.1021/pr030004d; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Cooper HJ, 2005, ANAL CHEM, V77, P6310, DOI 10.1021/ac058019d; Cordes CM, 2009, BIOCHEM PHARMACOL, V77, P1064, DOI 10.1016/j.bcp.2008.12.006; Dalpathado DS, 2006, BIOCHEMISTRY-US, V45, P8665, DOI 10.1021/bi060435k; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hakansson K, 2001, ANAL CHEM, V73, P4530, DOI 10.1021/ac0103470; Hanafy K A, 2001, Med Sci Monit, V7, P801; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HEY C, 1995, N-S ARCH PHARMACOL, V351, P651; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Huynh Mai-Loan, 2009, V519, P507, DOI 10.1007/978-1-59745-281-6_34; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Johnson GD, 2000, ANAL BIOCHEM, V286, P112, DOI 10.1006/abio.2000.4772; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, V1, P72; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Mehlhase J, 2000, IUBMB LIFE, V50, P331, DOI 10.1080/15216540051081137; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; MULLER D, 1991, EUR J BIOCHEM, V202, P285, DOI 10.1111/j.1432-1033.1991.tb16374.x; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Renfrow MB, 2005, J BIOL CHEM, V280, P19136, DOI 10.1074/jbc.M411368200; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143	42	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34005	34018		10.1074/jbc.M109.030627	http://dx.doi.org/10.1074/jbc.M109.030627			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808678	Green Published, hybrid			2022-12-25	WOS:000272165200033
J	Diacovich, L; Dumont, A; Lafitte, D; Soprano, E; Guilhon, AA; Bignon, C; Gorvel, JP; Bourne, Y; Meresse, S				Diacovich, Lautaro; Dumont, Audrey; Lafitte, Daniel; Soprano, Elodie; Guilhon, Aude-Agnes; Bignon, Christophe; Gorvel, Jean-Pierre; Bourne, Yves; Meresse, Stephane			Interaction between the SifA Virulence Factor and Its Host Target SKIP Is Essential for Salmonella Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON; ESCHERICHIA-COLI; III SECRETION; PROTEIN SIFA; EFFECTOR; IDENTIFICATION; EXPRESSION; VACUOLE; DOMAINS; GTPASES	SifA is a Salmonella effector that is translocated into infected cells by the pathogenicity island 2-encoded type 3 secretion system. SifA is a critical virulence factor. Previous studies demonstrated that, upon translocation, SifA binds the pleckstrin homology motif of the eukaryotic host protein SKIP. In turn, the SifA-SKIP complex regulates the mobilization of the molecular motor kinesin-1 on the bacterial vacuole. SifA exhibits multiple domains containing functional motifs. Here we performed a molecular dissection and a mutational study of SifA to evaluate the relative contribution of the different domains to SifA functions. Biochemical and crystallographic analysis confirmed that the N-terminal domain of SifA is sufficient to interact with the pleckstrin homology domain of SKIP, forming a 1:1 complex with a micromolar dissociation constant. Mutation of the tryptophan residue in the WXXXE motif, which has been proposed to mimic active form of GTPase, deeply affected the stability and the translocation of SifA while mutations of the glutamic residue had no functional impact. A SifA L130D mutant that does not bind SKIP showed a Delta sifA-like phenotype both in infected cells and in the mouse model of infection. We concluded that the WXXXE motif is essential for maintaining the tertiary structure of SifA, the functions of which require the interaction with the eukaryotic protein SKIP.	[Diacovich, Lautaro; Dumont, Audrey; Guilhon, Aude-Agnes; Gorvel, Jean-Pierre; Meresse, Stephane] Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM,UMR 6102,U631, F-13288 Marseille 9, France; [Soprano, Elodie; Bignon, Christophe; Bourne, Yves] Univ Aix Marseille, CNRS, UMR 6098, F-13288 Marseille 9, France; [Lafitte, Daniel] Aix Marseille Univ, INSERM, UMR 911, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Meresse, S (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM,UMR 6102,U631, Parc Sci Luminy,Case 906, F-13288 Marseille 9, France.	meresse@ciml.univ-mrs.fr	Gorvel, Jean-Pierre/O-1332-2018; Meresse, Stephane/E-2192-2012; Bourne, Yves/AAC-4635-2022	Gorvel, Jean-Pierre/0000-0002-2829-9804; Meresse, Stephane/0000-0001-6578-5177; Bourne, Yves/0000-0003-3850-0548; lafitte, daniel/0000-0001-9921-7522; Diacovich, Lautaro/0000-0002-3339-0100	Equipe FRM; ANR [ANR-05-BLAN-0028-01]; CNRS; INSERM	Equipe FRM; ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by Grant "Equipe FRM" ( to S. M.), the ANR ( Grant ANR-05-BLAN-0028-01 to Y. B. and S. M.), and institutional grants from CNRS and INSERM.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; Boyer L, 2006, MOL BIOL CELL, V17, P2489, DOI 10.1091/mbc.E05-09-0876; Brown NF, 2006, MICROBIOL-SGM, V152, P2323, DOI 10.1099/mic.0.28995-0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dumont Audrey, 2007, V394, P275, DOI 10.1007/978-1-59745-512-1_13; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Jackson LK, 2008, P NATL ACAD SCI USA, V105, P14141, DOI 10.1073/pnas.0801872105; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; LEVINE WC, 1991, J INFECT DIS, V164, P81, DOI 10.1093/infdis/164.1.81; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; Meresse S, 2001, CELL MICROBIOL, V3, P567, DOI 10.1046/j.1462-5822.2001.00141.x; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Poh J, 2008, CELL MICROBIOL, V10, P20, DOI 10.1111/j.1462-5822.2007.01010.x; Ramsden AE, 2007, CELL MICROBIOL, V9, P2517, DOI 10.1111/j.1462-5822.2007.00977.x; Reinicke AT, 2005, J BIOL CHEM, V280, P14620, DOI 10.1074/jbc.M500076200; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tsolis RM, 1999, ADV EXP MED BIOL, V473, P261; Vincentelli R, 2005, ANAL BIOCHEM, V346, P77, DOI 10.1016/j.ab.2005.07.039; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0	39	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33151	33160		10.1074/jbc.M109.034975	http://dx.doi.org/10.1074/jbc.M109.034975			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801640	Green Published, hybrid			2022-12-25	WOS:000272028500019
J	Ding, J; Ning, BF; Gong, WF; Wen, W; Wu, K; Liang, JQ; He, GP; Huang, SN; Sun, W; Han, T; Huang, L; Cao, GW; Wu, MC; Xie, WF; Wang, HY				Ding, Jin; Ning, Beifang; Gong, Wenfeng; Wen, Wen; Wu, Kun; Liang, Junqing; He, Guoping; Huang, Shanna; Sun, Wen; Han, Tao; Huang, Lei; Cao, Guangwen; Wu, Mengchao; Xie, Weifen; Wang, Hongyang			Cyclin D1 Induction by Benzo[a]pyrene-7,8-diol-9,10-epoxide via the Phosphatidylinositol 3-Kinase/Akt/MAPK- and p70(s6k)-dependent Pathway Promotes Cell Transformation and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AP-1 TRANSACTIVATION; PHOSPHOINOSITIDE 3-KINASE; MAMMALIAN TARGET; NUCLEAR FACTOR; P53 MUTATIONS; DIOL-EPOXIDE; FACTOR-ALPHA; LUNG-CANCER; DNA-ADDUCTS	Benzo[a]pyrene-7,8-diol-9,10-epoxide (B[a]PDE), the major metabolite of B[a] P, has been well recognized as one ubiquitous carcinogen, but the molecular mechanism involved in its carcinogenic effect remains obscure. In the present study, we found that bronchial epithelial cells (Beas-2B) and hepatocytes treated with B[a]PDE presented a significant increase of cyclin D1 expression. Moreover, Akt, p70(s6k), and MAPKs including JNK, Erks, and p38 were notably activated in B[a]PDE-treated Beas-2B cells, whereas NF-kappa B, NFAT, and Egr-1 were not. Our results demonstrated that JNK and Erks were required in B[a]PDE-induced cyclin D1 expression because the inhibition of JNK or Erks by a selective chemical inhibitor or dominant negative mutant robustly impaired the cyclin D1 induction by B[a]PDE. Furthermore, we found that overexpression of the dominant negative mutant of p85 (regulatory subunit of phosphatidylinositol 3-kinase) or Akt dramatically suppressed B[a]PDE-induced JNK and Erk activation as well as cyclin D1 expression, suggesting that cyclin D1 induction by B[a]PDE is via the phosphatidylinositol 3-kinase/Akt/MAPK-dependent pathway. In addition, we clarified that p70s6k is also involved in B[a]PDE-induced cyclin D1 expression because rampamycin pretreatment dramatically reduced cyclin D1 induction by B[a]PDE. More importantly, we demonstrated that up-regulated cyclin D1 by B[a]PDE plays a critical role in oncogenic transformation and tumorigenesis of Beas-2B cells. These results not only broaden our knowledge of the molecular mechanism of B[a]PDE carcinogenicity but also lead to the further study of chemoprevention of B[a]PDE-associated human cancers.	[Ding, Jin; Gong, Wenfeng; Wen, Wen; Wu, Kun; Liang, Junqing; He, Guoping; Huang, Shanna; Sun, Wen; Han, Tao; Huang, Lei; Wu, Mengchao; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China; [Ning, Beifang; Xie, Weifen] Second Mil Med Univ, Changzheng Hosp, Dept Gastroenterol, Shanghai 200438, Peoples R China; [Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai 200438, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Wang, HY (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, 225 Changhai Rd, Shanghai 200438, Peoples R China.	hywangk@vip.sina.com	Wang, Hongyang/B-1340-2010		National Natural Science Foundation of China [30530790, 30921006, 2008ZX10002]; National High Tech Research and Development Program [2006AA02A412]; Shanghai Key Basic Science Foundation [07DJ14006, 06DJ14009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Research and Development Program(National High Technology Research and Development Program of China); Shanghai Key Basic Science Foundation	This work was supported in part by National Natural Science Foundation of China Grants 30530790, 30921006, and 2008ZX10002; National High Tech Research and Development Program Grant 2006AA02A412; and Shanghai Key Basic Science Foundation Grants 07DJ14006 and 06DJ14009.	ALBERT RE, 1991, CARCINOGENESIS, V12, P1273, DOI 10.1093/carcin/12.7.1273; Alexandrov K, 2002, CARCINOGENESIS, V23, P1969, DOI 10.1093/carcin/23.12.1969; Arber N, 1997, CANCER RES, V57, P1569; Baird WM, 2005, ENVIRON MOL MUTAGEN, V45, P106, DOI 10.1002/em.20095; Baldo P, 2008, CURR CANCER DRUG TAR, V8, P647, DOI 10.2174/156800908786733513; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; Ding J, 2006, MOL CELL BIOCHEM, V287, P117, DOI 10.1007/s11010-005-9087-1; Eder AM, 1998, J BIOL CHEM, V273, P28025, DOI 10.1074/jbc.273.43.28025; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Gladden AB, 2005, J CELL BIOCHEM, V96, P906, DOI 10.1002/jcb.20613; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang CS, 1999, J BIOL CHEM, V274, P29672, DOI 10.1074/jbc.274.42.29672; Huang CS, 1997, P NATL ACAD SCI USA, V94, P11957, DOI 10.1073/pnas.94.22.11957; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Huang CS, 2001, MOL CELL BIOCHEM, V222, P29, DOI 10.1023/A:1017974131948; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kashima H, 2009, ENDOCR-RELAT CANCER, V16, P113, DOI 10.1677/ERC-08-0117; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Krawczak M, 1998, MUTAGENESIS, V13, P319, DOI 10.1093/mutage/13.4.319; Li JX, 2004, ONCOGENE, V23, P3932, DOI 10.1038/sj.onc.1207501; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Ouyang W, 2006, CARCINOGENESIS, V27, P864, DOI 10.1093/carcin/bgi321; Ouyang WM, 2008, ENVIRON HEALTH PERSP, V116, P1, DOI 10.1289/ehp.10403; Ouyang WM, 2007, MOL CARCINOGEN, V46, P32, DOI 10.1002/mc.20260; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Pervin S, 2007, CANCER RES, V67, P289, DOI 10.1158/0008-5472.CAN-05-4623; PHILLIPS DH, 1983, NATURE, V303, P468, DOI 10.1038/303468a0; Pontano LL, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-12; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Smith LE, 2000, JNCI-J NATL CANCER I, V92, P803, DOI 10.1093/jnci/92.10.803; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Watts RG, 1998, ONCOGENE, V17, P3493, DOI 10.1038/sj.onc.1202259; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; WINSTON JT, 1993, MOL BIOL CELL, V4, P1133, DOI 10.1091/mbc.4.11.1133; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; Yan YX, 1997, J BIOL CHEM, V272, P33181, DOI 10.1074/jbc.272.52.33181; Yang C, 2008, BIOCHEM J, V410, P167, DOI 10.1042/BJ20070781; Yasui M, 2006, CLIN CANCER RES, V12, P4720, DOI 10.1158/1078-0432.CCR-05-1213; Zhang XH, 2007, CURR CANCER DRUG TAR, V7, P305, DOI 10.2174/156800907780809741	52	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33311	33319		10.1074/jbc.M109.046417	http://dx.doi.org/10.1074/jbc.M109.046417			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801633	Green Published, hybrid			2022-12-25	WOS:000272028500036
J	Wang, M; Bridges, JP; Na, CL; Xu, Y; Weaver, TE				Wang, Mei; Bridges, James P.; Na, Cheng-Lun; Xu, Yan; Weaver, Timothy E.			Meckel-Gruber Syndrome Protein MKS3 Is Required for Endoplasmic Reticulum-associated Degradation of Surfactant Protein C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTITIAL LUNG-DISEASE; WPK RAT; SP-B; MUTATION; GENE; EXPRESSION; MECHANISMS; DOMINANT; DELETION; STRESS	Autosomal dominant mutations in the SFTPC gene are associated with idiopathic pulmonary fibrosis, a progressive lethal interstitial lung disease. Mutations that cause misfolding of the encoded proprotein surfactant protein C (SP-C) trigger endoplasmic reticulum (ER)-associated degradation, a pathway that segregates terminally misfolded substrate for retrotranslocation to the cytosol and degradation by proteasome. Microarray screens for genes involved in SP-C ER-associated degradation identified MKS3/TMEM67, a locus previously linked to the ciliopathy Meckel-Gruber syndrome. In this study, MKS3 was identified as a membrane glycoprotein predominantly localized to the ER. Expression of MKS3 was up-regulated by genetic or pharmacological inducers of ER stress. The ER lumenal domain of MKS3 interacted with a complex that included mutant SP-C and associated chaperones, whereas the region predicted to encode the transmembrane domains of MKS3 interacted with cytosolic p97. Deletion of the transmembrane and cytosolic domains abrogated interaction of MKS3 with p97 and resulted in accumulation of mutant SP-C proprotein; knockdown of MKS3 also inhibited degradation of mutant SP-C. These results support a model in which MKS3 links the ER lumenal quality control machinery with the cytosolic degradation apparatus.	Univ Cincinnati, Coll Med, Cincinnati Childrens Res Fdn, Div Pulm Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Weaver, TE (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, MLC 7029,3333 Burnet Ave, Cincinnati, OH 45229 USA.	tim.weaver@cchmc.org		Bridges, James P./0000-0002-4815-117X; , Yan/0000-0003-2025-027X	National Institutes of Health; NHLBI [P01-HL61646, R01-HL086492]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL061646, R01HL086492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-HL61646 and R01-HL086492 from NHLBI.	Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Brancati F, 2009, HUM MUTAT, V30, pE432, DOI 10.1002/humu.20924; Bridges JP, 2006, J CELL BIOL, V172, P395, DOI 10.1083/jcb.200508016; Bridges JP, 2003, J BIOL CHEM, V278, P52739, DOI 10.1074/jbc.M309599200; Chibbar R, 2004, MODERN PATHOL, V17, P973, DOI 10.1038/modpathol.3800149; CONKRIGHT J, 2009, AM J RESP C IN PRESS; Cook SA, 2009, J AM SOC NEPHROL, V20, P753, DOI 10.1681/ASN.2008040412; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Guo FK, 2004, ONCOGENE, V23, P5577, DOI 10.1038/sj.onc.1207752; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Khaddour Rana, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9489; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Lin S, 1996, BBA-MOL CELL RES, V1312, P177, DOI 10.1016/0167-4889(95)00201-4; Mayhew TM, 2009, ANN ANAT, V191, P153, DOI 10.1016/j.aanat.2008.11.001; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Mulugeta S, 2007, AM J PHYSIOL-LUNG C, V293, pL720, DOI 10.1152/ajplung.00025.2007; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Nogee LM, 2004, ANNU REV PHYSIOL, V66, P601, DOI 10.1146/annurev.physiol.66.032102.134711; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Soraisham AS, 2006, J PERINATOL, V26, P67, DOI 10.1038/sj.jp.7211417; TARTAKOFF AM, 1983, J CELL BIOL, V97, P1243, DOI 10.1083/jcb.97.4.1243; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Ueno T, 2004, J BIOL CHEM, V279, P16178, DOI 10.1074/jbc.M312029200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	37	9	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33377	33383		10.1074/jbc.M109.034371	http://dx.doi.org/10.1074/jbc.M109.034371			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19815549	hybrid, Green Published			2022-12-25	WOS:000272028500043
J	Liu, B; Lin, YH; Darwanto, A; Song, XH; Xu, GL; Zhang, KL				Liu, Bo; Lin, Yihui; Darwanto, Agus; Song, Xuehui; Xu, Guoliang; Zhang, Kangling			Identification and Characterization of Propionylation at Histone H3 Lysine 23 in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATION; LINE; BUTYRYLATION; ACETYLATION; HDOT1L; U937; GENE	Propionylation has been identified recently as a new type of protein post-translational modification. Bacterial propionyl-CoA synthetase and human histone H4 are propionylated at specific lysine residues that have been known previously to be acetylated. However, other proteins subject to this modification remain to be identified, and the modifying enzymes involved need to be characterized. In this work, we report the discovery of histone H3 propionylation in mammalian cells. Propionylation at H3 lysine Lys(23) was detected in the leukemia cell line U937 by mass spectrometry and Western analysis using a specific antibody. In this cell line, the propionylated form of Lys(23) accounted for 7%, a level at least 6-fold higher than in other leukemia cell lines (HL-60 and THP-1) or non-leukemia cell lines (HeLa and IMR-90). The propionylation level in U937 cells decreased remarkably during monocytic differentiation, indicating that this modification is dynamically regulated. Moreover, in vitro assays demonstrated that histone acetyltransferase p300 can catalyze H3 Lys(23) propionylation, whereas histone deacetylase Sir2 can remove this modification in the presence of NAD(+). These results suggest that histone propionylation might be generated by the same set of enzymes as for histone acetylation and that selection of donor molecules (propionyl-CoA versus acetylCoA) may determine the difference of modifications. Because like acetyl-CoA, propionyl-CoA is an important intermediate in biosynthesis and energy production, histone H3 Lys(23) propionylation may provide a novel epigenetic regulatory mark for cell metabolism.	[Liu, Bo; Lin, Yihui; Song, Xuehui; Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Darwanto, Agus; Zhang, Kangling] Loma Linda Univ, Sch Med, Dept Biochem, Loma Linda, CA 92350 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Loma Linda University	Xu, GL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	glxu@sibs.ac.cn; kzhang@llu.edu	Liu, Bo/AAU-9183-2020		Ministry of Science and Technology of China [2005CB522400, 2006CB943900]; National Science Foundation of China; Biochemistry Department of Loma Linda University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biochemistry Department of Loma Linda University	This work was supported by Grants 2005CB522400 and 2006CB943900 from the Ministry of Science and Technology of China and the National Science Foundation of China (to G.X.) and by the Biochemistry Department of Loma Linda University.	Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Dutnall RN, 1998, COLD SPRING HARB SYM, V63, P501, DOI 10.1101/sqb.1998.63.501; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; GRATTAGE LP, 1992, IMMUNOL CELL BIOL, V70, P97, DOI 10.1038/icb.1992.14; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; KING MT, 1985, ANAL BIOCHEM, V146, P173, DOI 10.1016/0003-2697(85)90412-9; Leemhuis H, 2008, CHEMBIOCHEM, V9, P499, DOI 10.1002/cbic.200700556; Lin YH, 2009, BLOOD, V114, P651, DOI 10.1182/blood-2009-03-209395; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Ragg SJ, 1998, J IMMUNOL, V161, P1390; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719	22	84	87	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32288	32295		10.1074/jbc.M109.045856	http://dx.doi.org/10.1074/jbc.M109.045856			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801601	hybrid, Green Published			2022-12-25	WOS:000272028400010
J	Pena, MMO; Melo, SP; Xing, YY; White, K; Barbour, KW; Berger, FG				Pena, Maria Marjorette O.; Melo, Sandra P.; Xing, Yang-Yang; White, Kenneth; Barbour, Karen W.; Berger, Franklin G.			The Intrinsically Disordered N-terminal Domain of Thymidylate Synthase Targets the Enzyme to the Ubiquitin-independent Proteasomal Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; ORNITHINE-DECARBOXYLASE; METHIONINE EXCISION; EUKARYOTIC PROTEINS; C-FOS; ACETYLATION; PROTEOMICS; TURNOVER; CELLS; DRUG	The ubiquitin-independent proteasomal degradation pathway is increasingly being recognized as important in regulation of protein turnover in eukaryotic cells. One substrate of this pathway is the pyrimidine biosynthetic enzyme thymidylate synthase (TS; EC 2.1.1.45), which catalyzes the reductive methylation of dUMP to form dTMP and is essential for DNA replication during cell growth and proliferation. Previous work from our laboratory showed that degradation of TS is ubiquitin-independent and mediated by an intrinsically disordered 27-residue region at the N-terminal end of the molecule. In the current study we show that this region, in cooperation with an alpha-helix formed by the next 15 residues, functions as a degron, i.e. it is capable of destabilizing a heterologous protein to which it is fused. Comparative analysis of the primary sequence of TS from a number of mammalian species revealed that the N-terminal domain is hypervariable among species yet is conserved with regard to its disordered nature, its high Pro content, and the occurrence of Pro at the penultimate site. Characterization of mutant proteins showed that Pro-2 protects the N terminus against N-alpha-acetylation, a post-translational process that inhibits TS degradation. However, although a free amino group at the N terminus is necessary, it is not sufficient for degradation of the polypeptide. The implications of these findings to the proteasome-targeting function of the N-terminal domain, particularly with regard to its intrinsic flexibility, are discussed.	[Pena, Maria Marjorette O.; Melo, Sandra P.; Xing, Yang-Yang; White, Kenneth; Barbour, Karen W.; Berger, Franklin G.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Berger, FG (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	fgberger@mailbox.sc.edu			National Institutes of Health [CA44013]; NATIONAL CANCER INSTITUTE [R01CA044013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA44013.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Berger FG, 2006, CANCER BIOL THER, V5, P1238, DOI 10.4161/cbt.5.9.3414; BERGER SH, 1985, MOL PHARMACOL, V28, P461; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; CIEOELA J, 2006, ACTA BIOCHIM POL, V53, P189; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Isono O, 2008, J BIOL CHEM, V283, P34273, DOI 10.1074/jbc.M802527200; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; JOHNSON GG, 1988, J BIOL CHEM, V263, P9079; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Lin SB, 2001, MOL PHARMACOL, V60, P474; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; Meinnel T, 2005, BIOCHIMIE, V87, P701, DOI 10.1016/j.biochi.2005.03.011; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P1192; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; Phan J, 2001, J BIOL CHEM, V276, P14170, DOI 10.1074/jbc.M009493200; Phan J, 2001, BIOCHEMISTRY-US, V40, P1897, DOI 10.1021/bi002413i; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schiffer CA, 1995, BIOCHEMISTRY-US, V34, P16279, DOI 10.1021/bi00050a007; SHIMIZU K, 1985, J BIOCHEM-TOKYO, V97, P845, DOI 10.1093/oxfordjournals.jbchem.a135125; Stapley BJ, 1999, PROTEIN SCI, V8, P587; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Yang Z, 2006, CANCER GENE THER, V13, P107, DOI 10.1038/sj.cgt.7700880; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200	50	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31597	31607		10.1074/jbc.M109.038455	http://dx.doi.org/10.1074/jbc.M109.038455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797058	hybrid, Green Published			2022-12-25	WOS:000271572700014
J	Akcay, E; Roughgarden, J				Akcay, Erol; Roughgarden, Joan			The Perfect Family: Decision Making in Biparental Care	PLOS ONE			English	Article							PARENTAL CARE; SEXUAL SELECTION; OFFSPRING CARE; NEGOTIATION; TITS; MANIPULATION; CONFLICT; BEHAVIOR; FEMALES; PARUS	Background: Previous theoretical work on parental decisions in biparental care has emphasized the role of the conflict between evolutionary interests of parents in these decisions. A prominent prediction from this work is that parents should compensate for decreases in each other's effort, but only partially so. However, experimental tests that manipulate parents and measure their responses fail to confirm this prediction. At the same time, the process of parental decision making has remained unexplored theoretically. We develop a model to address the discrepancy between experiments and the theoretical prediction, and explore how assuming different decision making processes changes the prediction from the theory. Model Description: We assume that parents make decisions in behavioral time. They have a fixed time budget, and allocate it between two parental tasks: provisioning the offspring and defending the nest. The proximate determinant of the allocation decisions are parents' behavioral objectives. We assume both parents aim to maximize the offspring production from the nest. Experimental manipulations change the shape of the nest production function. We consider two different scenarios for how parents make decisions: one where parents communicate with each other and act together (the perfect family), and one where they do not communicate, and act independently (the almost perfect family). Conclusions/Significance: The perfect family model is able to generate all the types of responses seen in experimental studies. The kind of response predicted depends on the nest production function, i.e. how parents' allocations affect offspring production, and the type of experimental manipulation. In particular, we find that complementarity of parents' allocations promotes matching responses. In contrast, the relative responses do not depend on the type of manipulation in the almost perfect family model. These results highlight the importance of the interaction between nest production function and how parents make decisions, factors that have largely been overlooked in previous models.			Akcay, E (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	erol@nimbios.org	Akcay, Erol/G-3167-2011	Akcay, Erol/0000-0001-8149-7124				AKCAY E, EVOLUTION O IN PRESS; Andre JB, 2007, J THEOR BIOL, V247, P11, DOI 10.1016/j.jtbi.2007.02.007; Arnqvist Goran, 2005, pUnpaginated; CHASE ID, 1980, AM NAT, V115, P827, DOI 10.1086/283603; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Dekel E, 2007, REV ECON STUD, V74, P685; Dobler R, 2009, ANIM BEHAV, V77, P1427, DOI 10.1016/j.anbehav.2009.02.013; Hinde CA, 2006, BEHAV ECOL, V17, P6, DOI 10.1093/beheco/ari092; Houston A.I., 1985, P471; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Houston AI, 2002, PHILOS T ROY SOC B, V357, P351, DOI 10.1098/rstb.2001.0925; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; Lessells CM, 2002, PHILOS T R SOC B, V357, P381, DOI 10.1098/rstb.2001.0928; MARKMAN S, 1995, ANIM BEHAV, V50, P655, DOI 10.1016/0003-3472(95)80127-8; Martin T.E., 1992, Current Ornithology, V9, P163; Maynard-Smith J, 1977, ANIM BEHAV, V25, P1, DOI [10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8)]; McFarland DJ., 1981, QUANTITATIVE ETHOLOG; McNamara JM, 1999, NATURE, V401, P368, DOI 10.1038/43869; Roughgarden J, 2006, SCIENCE, V311, P965, DOI 10.1126/science.1110105; Sanz JJ, 2000, J ANIM ECOL, V69, P74, DOI 10.1046/j.1365-2656.2000.00373.x; Schwagmeyer PL, 2002, BEHAV ECOL, V13, P713, DOI 10.1093/beheco/13.5.713; SLAGSVOLD T, 1994, NATURE, V370, P136, DOI 10.1038/370136a0; SLAGSVOLD T, 1990, ECOLOGY, V71, P1258, DOI 10.2307/1938263; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WINKLER DW, 1987, AM NAT, V130, P526, DOI 10.1086/284729; WRIGHT J, 1989, BEHAV ECOL SOCIOBIOL, V25, P171, DOI 10.1007/BF00302916	27	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7345	10.1371/journal.pone.0007345	http://dx.doi.org/10.1371/journal.pone.0007345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823687	gold, Green Published, Green Submitted			2022-12-25	WOS:000270808300005
J	Sasvari, Z; Bach, S; Blondel, M; Nagy, PD				Sasvari, Zsuzsanna; Bach, Stephane; Blondel, Marc; Nagy, Peter D.			Inhibition of RNA Recruitment and Replication of an RNA Virus by Acridine Derivatives with Known Anti-Prion Activities	PLOS ONE			English	Article							BUSHY-STUNT-VIRUS; CUCUMBER-NECROSIS-VIRUS; HEPATITIS-C VIRUS; PROTEIN-FOLDING ACTIVITY; TOMBUSVIRUS REPLICATION; IN-VITRO; GENOME REPLICATION; HOST FACTORS; MODEL HOST; VIRAL-RNA	Background: Small molecule inhibitors of RNA virus replication are potent antiviral drugs and useful to dissect selected steps in the replication process. To identify antiviral compounds against Tomato bushy stunt virus (TBSV), a model positive stranded RNA virus, we tested acridine derivatives, such as chlorpromazine (CPZ) and quinacrine (QC), which are active against prion-based diseases. Methodology/Principal Findings: Here, we report that CPZ and QC compounds inhibited TBSV RNA accumulation in plants and in protoplasts. In vitro assays revealed that the inhibitory effects of these compounds were manifested at different steps of TBSV replication. QC was shown to have an effect on multiple steps, including: (i) inhibition of the selective binding of the p33 replication protein to the viral RNA template, which is required for recruitment of viral RNA for replication; (ii) reduction of minus-strand synthesis by the tombusvirus replicase; and (iii) inhibition of translation of the uncapped TBSV genomic RNA. In contrast, CPZ was shown to inhibit the in vitro assembly of the TBSV replicase, likely due to binding of CPZ to intracellular membranes, which are important for RNA virus replication. Conclusion/Significance: Since we found that CPZ was also an effective inhibitor of other plant viruses, including Tobacco mosaic virus and Turnip crinkle virus, it seems likely that CPZ has a broad range of antiviral activity. Thus, these inhibitors constitute effective tools to study similarities in replication strategies of various RNA viruses.			Sasvari, Z (corresponding author), Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA.	pdnagy2@uky.edu	Blondel, Marc/AAJ-9049-2020; BACH, Stéphane/ABD-5865-2020	Blondel, Marc/0000-0003-4897-2995; 				Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Caramelli M, 2006, CNS DRUGS, V20, P15, DOI 10.2165/00023210-200620010-00002; Carlson CB, 2003, CHEM BIOL, V10, P663, DOI 10.1016/S1074-5521(03)00147-9; Comer JE, 2006, J TOXICOL ENV HEAL A, V69, P1083, DOI 10.1080/15287390500360281; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Dolphin GT, 2008, CHEMBIOCHEM, V9, P952, DOI 10.1002/cbic.200700602; Fasano C, 2008, J NEUROCHEM, V105, P239, DOI 10.1111/j.1471-4159.2007.05140.x; Giri P, 2008, ARCH BIOCHEM BIOPHYS, V474, P183, DOI 10.1016/j.abb.2008.03.013; Graci JD, 2008, ANTIMICROB AGENTS CH, V52, P971, DOI 10.1128/AAC.01056-07; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Jiang Y, 2006, J VIROL, V80, P7394, DOI 10.1128/JVI.02686-05; Jin H, 2008, HEPATOL RES, V38, P909, DOI 10.1111/j.1872-034X.2008.00352.x; Kalia S, 2007, DERMATOL THER, V20, P160, DOI 10.1111/j.1529-8019.2007.00131.x; KARAMANAKOS PN, 2008, ARCH TOXICOL; Koch U, 2007, CURR TOP MED CHEM, V7, P1302; Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Leyssen P, 2008, ANTIVIR RES, V78, P9, DOI 10.1016/j.antiviral.2008.01.004; Li ZH, 2008, J VIROL, V82, P6911, DOI 10.1128/JVI.00702-08; Li ZH, 2009, VIROLOGY, V385, P245, DOI 10.1016/j.virol.2008.11.041; Liang GW, 2008, FUND CLIN PHARMACOL, V22, P429, DOI 10.1111/j.1472-8206.2008.00613.x; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Monkewich S, 2005, J VIROL, V79, P4848, DOI 10.1128/JVI.79.8.4848-4858.2005; Nagy PD, 2000, VIROLOGY, V276, P279, DOI 10.1006/viro.2000.0577; Nagy PD, 2006, VIROLOGY, V344, P211, DOI 10.1016/j.virol.2005.09.017; Nagy PD, 2008, ANNU REV PHYTOPATHOL, V46, P217, DOI 10.1146/annurev.phyto.121407.093958; Nagy Peter D., 2008, V451, P55, DOI 10.1007/978-1-59745-102-4_4; NUGENT KM, 1984, ARCH VIROL, V81, P163, DOI 10.1007/BF01309305; Nussio MR, 2009, LANGMUIR, V25, P1086, DOI 10.1021/la803288s; Oster SK, 1998, J VIROL, V72, P5845, DOI 10.1128/JVI.72.7.5845-5851.1998; Panavas T, 2005, VIROLOGY, V338, P81, DOI 10.1016/j.virol.2005.04.025; Panavas T, 2005, P NATL ACAD SCI USA, V102, P7326, DOI 10.1073/pnas.0502604102; Panavas T, 2003, VIROLOGY, V314, P315, DOI 10.1016/S0042-6822(03)00436-7; Panavas T, 2002, VIROLOGY, V296, P263, DOI 10.1006/viro.2002.1423; Panavas T, 2002, VIROLOGY, V296, P275, DOI 10.1006/viro.2002.1422; Panaviene Z, 2005, J VIROL, V79, P10608, DOI 10.1128/JVI.79.16.10608-10618.2005; Panaviene Z, 2004, J VIROL, V78, P8254, DOI 10.1128/JVI.78.15.8254-8263.2004; Panaviene Z, 2003, VIROLOGY, V308, P191, DOI 10.1016/S0042-6822(02)00132-0; Pogany J, 2005, J VIROL, V79, P4859, DOI 10.1128/JVI.79.8.4859-4869.2005; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Pogany J, 2008, J VIROL, V82, P5967, DOI 10.1128/JVI.02737-07; Pu YH, 2008, J VIROL, V82, P8112, DOI 10.1128/JVI.00837-08; Rajendran KS, 2006, VIROLOGY, V345, P270, DOI 10.1016/j.virol.2005.09.038; Rajendran KS, 2003, J VIROL, V77, P9244, DOI 10.1128/JVI.77.17.9244-9258.2003; SCHLESINGER MJ, 1989, VIROLOGY, V168, P187, DOI 10.1016/0042-6822(89)90421-2; Sebastian L, 2009, INT J ANTIMICROB AG, V33, P168, DOI 10.1016/j.ijantimicag.2008.07.013; Sebestik J, 2007, CURR PROTEIN PEPT SC, V8, P471, DOI 10.2174/138920307782411400; Serva S, 2006, J VIROL, V80, P2162, DOI 10.1128/JVI.80.5.2162-2169.2006; Simon M, 2009, J GEN VIROL, V90, P210, DOI 10.1099/vir.0.006387-0; Sinha R, 2007, BBA-GEN SUBJECTS, V1770, P1636, DOI 10.1016/j.bbagen.2007.08.018; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Thi HTN, 2008, BIOORGAN MED CHEM, V16, P6737, DOI 10.1016/j.bmc.2008.05.060; Thompson A, 2009, J HEPATOL, V50, P184, DOI 10.1016/j.jhep.2008.10.011; Toniutto P, 2008, IDRUGS, V11, P738; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002174; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vogtherr M, 2003, J MED CHEM, V46, P3563, DOI 10.1021/jm034093h; Voisset Cecile, 2008, Biotechnology Journal, V3, P1033, DOI 10.1002/biot.200800134; Wang RYL, 2008, CELL HOST MICROBE, V3, P178, DOI 10.1016/j.chom.2008.02.005; Wang RYL, 2009, J VIROL, V83, P3276, DOI 10.1128/JVI.02313-08; WHITE KA, 1994, J VIROL, V68, P14, DOI 10.1128/JVI.68.1.14-24.1994; White KA, 2004, PROG NUCLEIC ACID RE, V78, P187, DOI 10.1016/S0079-6603(04)78005-8; Yan ZH, 2004, BIOORG MED CHEM LETT, V14, P5889, DOI 10.1016/j.bmcl.2004.09.021	70	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7376	10.1371/journal.pone.0007376	http://dx.doi.org/10.1371/journal.pone.0007376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823675	Green Submitted, Green Published, gold			2022-12-25	WOS:000270808300006
J	Pasupuleti, M; Roupe, M; Rydengard, V; Surewicz, K; Surewicz, WK; Chalupka, A; Malmsten, M; Sorensen, OE; Schmidtchen, A				Pasupuleti, Mukesh; Roupe, Markus; Rydengard, Victoria; Surewicz, Krystyna; Surewicz, Witold K.; Chalupka, Anna; Malmsten, Martin; Sorensen, Ole E.; Schmidtchen, Artur			Antimicrobial Activity of Human Prion Protein Is Mediated by Its N-Terminal Region	PLOS ONE			English	Article								Background: Cellular prion-related protein (PrP(c)) is a cell-surface protein that is ubiquitously expressed in the human body. The multifunctionality of PrP(c), and presence of an exposed cationic and heparin-binding N-terminus, a feature characterizing many antimicrobial peptides, made us hypotesize that PrP(c) could exert antimicrobial activity. Methodology and Principal Findings: Intact recombinant PrP exerted antibacterial and antifungal effects at normal and low pH. Studies employing recombinant PrP and N-and C-terminally truncated variants, as well as overlapping peptide 20mers, demonstrated that the antimicrobial activity is mediated by the unstructured N-terminal part of the protein. Synthetic peptides of the N-terminus of PrP killed the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, and the Gram-positive Bacillus subtilis and Staphylococcus aureus, as well as the fungus Candida parapsilosis. Fluorescence studies of peptide-treated bacteria, paired with analysis of peptide effects on liposomes, showed that the peptides exerted membrane-breaking effects similar to those seen after treatment with the "classical'' human antimicrobial peptide LL-37. In contrast to LL-37, however, no marked helix induction was detected for the PrP-derived peptides in presence of negatively charged (bacteria-mimicking) liposomes. PrP furthermore showed an inducible expression during wounding of human skin ex vivo and in vivo, as well as stimulation of keratinocytes with TGF-alpha in vitro. Conclusions: The demonstration of an antimicrobial activity of PrP, localisation of its activity to the N-terminal and heparin-binding region, combined with results showing an increased expression of PrP during wounding, indicate that PrPs could have a previously undisclosed role in host defense.			Pasupuleti, M (corresponding author), Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.	mukesh.pasupuleti@med.lu.se; artur.schmidtchen@med.lu.se	Pasupuleti, Mukesh/H-7605-2013; Pasupuleti, Mukesh/AAF-4066-2020; Roupé, Karl/K-6502-2014; Pasupuleti, Mukesh/AAD-9977-2020; Schmidtchen, Artur/F-9507-2015	Pasupuleti, Mukesh/0000-0001-6337-6257; Roupé, Karl/0000-0001-5472-8134; Sorensen, Ole E./0000-0001-8681-6921				Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown DR, 1998, BIOCHEM J, V334, P423, DOI 10.1042/bj3340423; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Ganz T, 2001, Semin Respir Infect, V16, P4; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Harris B, 2003, CLIO MED, V71, P85; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Jiang ZQ, 2008, CHEM BIOL DRUG DES, V72, P483, DOI 10.1111/j.1747-0285.2008.00728.x; Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020; Konturek PC, 2005, WORLD J GASTROENTERO, V11, P7651, DOI 10.3748/wjg.v11.i48.7651; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Magzoub M, 2005, BBA-BIOMEMBRANES, V1716, P126, DOI 10.1016/j.bbamem.2005.09.009; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; McBride SM, 2005, MED HYPOTHESES, V65, P570, DOI 10.1016/j.mehy.2005.02.038; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Pammer J, 1998, AM J PATHOL, V153, P1353, DOI 10.1016/S0002-9440(10)65720-3; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Pasupuleti M, 2007, J BIOL CHEM, V282, P2520, DOI 10.1074/jbc.M607848200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PEREIRA HA, 1995, J LEUKOCYTE BIOL, V57, P805, DOI 10.1002/jlb.57.6.805; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k; Ringstad L, 2007, BBA-BIOMEMBRANES, V1768, P715, DOI 10.1016/j.bbamem.2006.11.016; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; ROUPE KM, 2009, J INVEST DERMATOL; Rydengard V, 2006, FEBS J, V273, P2399, DOI 10.1111/j.1742-4658.2006.05246.x; Rydengard V, 2007, FEBS J, V274, P377, DOI 10.1111/j.1742-4658.2006.05586.x; Rydengard V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000116; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Sjogren H, 2005, BIOPHYS CHEM, V116, P11, DOI 10.1016/j.bpc.2005.01.007; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475; Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	58	58	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7358	10.1371/journal.pone.0007358	http://dx.doi.org/10.1371/journal.pone.0007358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809501	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594000013
J	Arsac, JN; Betemps, D; Morignat, E; Feraudet, C; Bencsik, A; Aubert, D; Grassi, J; Baron, T				Arsac, Jean-Noeel; Betemps, Dominique; Morignat, Eric; Feraudet, Cecile; Bencsik, Anna; Aubert, Denise; Grassi, Jacques; Baron, Thierry			Transmissibility of Atypical Scrapie in Ovine Transgenic Mice: Major Effects of Host Prion Protein Expression and Donor Prion Genotype	PLOS ONE			English	Article								Atypical scrapie or Nor98 has been identified as a transmissible spongiform encephalopathy (TSE) that is clearly distinguishable from classical scrapie and BSE, notably regarding the biochemical features of the protease-resistant prion protein PrP(res) and the genetic factors involved in susceptibility to the disease. In this study we transmitted the disease from a series of 12 French atypical scrapie isolates in a transgenic mouse model (TgOvPrP4) overexpressing in the brain similar to 0.25, 1.5 or 6x the levels of the PrP(ARQ) ovine prion protein under the control of the neuron-specific enolase promoter. We used an approach based on serum PrP(c) measurements that appeared to reflect the different PrP(c) expression levels in the central nervous system. We found that transmission of atypical scrapie, much more than in classical scrapie or BSE, was strongly influenced by the PrP(c) expression levels of TgOvPrP4 inoculated mice. Whereas TgOvPrP4 mice overexpressing similar to 6x the normal PrP(c) level died after a survival periods of 400 days, those with similar to 1.5x the normal PrP(c) level died at around 700 days. The transmission of atypical scrapie in TgOvPrP4 mouse line was also strongly influenced by the prnp genotypes of the animal source of atypical scrapie. Isolates carrying the AF(141)RQ or AHQ alleles, associated with increased disease susceptibility in the natural host, showed a higher transmissibility in TgOvPrP4 mice. The biochemical analysis of PrP(res) in TgOvPrP4 mouse brains showed a fully conserved pattern, compared to that in the natural host, with three distinct PrP(res) products. Our results throw light on the transmission features of atypical scrapie and suggest that the risk of transmission is intrinsically lower than that of classical scrapie or BSE, especially in relation to the expression level of the prion protein.			Arsac, JN (corresponding author), Agence Francaise Secur Sanit Aliments, Lyon, France.	t.baron@afssa.fr	BENCSIK, Anna A/HGC-4260-2022	BENCSIK, Anna A/0000-0002-8671-6290; Aubert, Denise/0000-0002-1442-3384				Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Baron T, 2004, J VIROL, V78, P6243, DOI 10.1128/JVI.78.12.6243-6251.2004; Baron TGM, 2000, NEUROSCI LETT, V284, P175, DOI 10.1016/S0304-3940(00)01047-8; Baron TGM, 1999, FEMS IMMUNOL MED MIC, V25, P379, DOI 10.1111/j.1574-695X.1999.tb01363.x; Baron T, 2007, J VIROL, V81, P7230, DOI 10.1128/JVI.02475-06; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Barron RM, 2003, J GEN VIROL, V84, P3165, DOI 10.1099/vir.0.19147-0; Baylis M, 2004, CURR MOL MED, V4, P385, DOI 10.2174/1566524043360672; Bencsik AA, 2008, HISTOCHEM CELL BIOL, V129, P643, DOI 10.1007/s00418-008-0382-2; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; Bruce ME, 2007, VET REC, V160, P665, DOI 10.1136/vr.160.19.665; Bruce ME, 2002, J GEN VIROL, V83, P695, DOI 10.1099/0022-1317-83-3-695; Buschmann A, 2004, J VIROL METHODS, V117, P27, DOI 10.1016/j.jviromet.2003.11.017; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CHANDLER RL, 1961, LANCET, V1, P1378; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Cordier C, 2006, J GEN VIROL, V87, P3763, DOI 10.1099/vir.0.82062-0; Crozet C, 2001, EMBO REP, V2, P952, DOI 10.1093/embo-reports/kve204; Crozet C, 2001, J VIROL, V75, P5328, DOI 10.1128/JVI.75.11.5328-5334.2001; Crozet C, 2007, J INFECT DIS, V195, P997, DOI 10.1086/512085; DAVIS BP, 1988, GENE DEV, V2, P13, DOI 10.1101/gad.2.1.13; Dawson M, 1998, VET REC, V142, P623; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; *EFSA, 2005, EFSA J, V276, P1; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; *EUR COMM, 2006, REP MON TEST RUM PRE; Fediaevsky A, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-19; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Fitzmaurice TJ, 2008, BIOCHEM J, V409, P367, DOI 10.1042/BJ20071122; FOSTER JD, 1988, VET REC, V123, P5, DOI 10.1136/vr.123.1.5; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Giraldo P, 2003, TRANSGENIC RES, V12, P751, DOI 10.1023/B:TRAG.0000005089.30408.25; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grassi J, 2000, ARCH VIROL, P197; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hopp P, 2006, J GEN VIROL, V87, P3729, DOI 10.1099/vir.0.81951-0; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HUNTER N, 1994, ARCH VIROL, V137, P171, DOI 10.1007/BF01311184; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Krasemann S, 1999, J BIOTECHNOL, V73, P119, DOI 10.1016/S0168-1656(99)00115-7; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lezmi S, 2004, J VIROL, V78, P3654, DOI 10.1128/JVI.78.7.3654-3662.2004; Luhken G, 2007, VET RES, V38, P65, DOI 10.1051/vetres:2006046; Luhken G, 2004, ARCH VIROL, V149, P1571, DOI 10.1007/s00705-004-0303-1; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Madec JY, 2004, J GEN VIROL, V85, P3483, DOI 10.1099/vir.0.80220-0; Moreno CR, 2007, ARCH VIROL, V152, P1229, DOI 10.1007/s00705-007-0956-7; Moudjou M, 2001, J GEN VIROL, V82, P2017, DOI 10.1099/0022-1317-82-8-2017; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Nentwig A, 2007, PLOS PATHOG, V3, P743, DOI 10.1371/journal.ppat.0030082; Orge L, 2004, J GEN VIROL, V85, P3487, DOI 10.1099/vir.0.80246-0; ORourke KI, 1997, J GEN VIROL, V78, P975, DOI 10.1099/0022-1317-78-4-975; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Saunders GC, 2006, J GEN VIROL, V87, P3141, DOI 10.1099/vir.0.81779-0; Simmons HA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-8; Simmons Marion M, 2007, BMC Vet Res, V3, P20, DOI 10.1186/1746-6148-3-20; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; Thackray AM, 2008, J VIROL, V82, P11197, DOI 10.1128/JVI.01454-08; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001	72	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7300	10.1371/journal.pone.0007300	http://dx.doi.org/10.1371/journal.pone.0007300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806224	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800012
J	Downing, BPB; Rutenberg, AD; Touhami, A; Jericho, M				Downing, Benjamin P. B.; Rutenberg, Andrew D.; Touhami, Ahmed; Jericho, Manfred			Subcellular Min Oscillations as a Single-Cell Reporter of the Action of Polycations, Protamine, and Gentamicin on Escherichia coli	PLOS ONE			English	Article								Background: In Escherichia coli, MinD-GFP fusion proteins show rapid pole to pole oscillations. The objective was to investigate the effects of extracellular cations on the subcellular oscillation of cytoplasmic MinD within Escherichia coli. Methodology/Principal Findings: We exposed bacteria to the extracellular cations Ca(++), Mg(++), the cationic antimicrobial peptide (CAP) protamine, and the cationic aminoglycoside gentamicin. We found rapid and substantial increases in the average MinD oscillation periods in the presence of any of these polyvalent cations. For Ca(++) and Mg(++) the increases in period were transient, even with a constant extracellular concentration, while increases in period for protamine or gentamicin were apparently irreversible. We also found striking interdependence in the action of the small cations with protamine or gentamicin, distorted oscillations under the action of intermediate levels of gentamicin and Ca(++), and reversible freezing of the Min oscillation at high cationic concentrations. Conclusions/Significance: Intracellular Min oscillations provide a fast single-cell reporter of bacterial response to extracellular polycations, which can be explained by the penetration of polycations into cells.			Downing, BPB (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	Jericho@fizz.phys.dal.ca		Rutenberg, Andrew/0000-0002-4264-6809				Aires JR, 2005, J BACTERIOL, V187, P1923, DOI 10.1128/JB.187.6.1923-1929.2005; ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Aldridge C, 2005, J BIOL CHEM, V280, P31673, DOI 10.1074/jbc.M505126200; Aspedon A, 1996, MICROBIOL-SGM, V142, P3389, DOI 10.1099/13500872-142-12-3389; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; BRYAN LE, 1975, J ANTIBIOT, V28, P696, DOI 10.7164/antibiotics.28.696; De Kerchove AJ, 2008, LANGMUIR, V24, P3392, DOI 10.1021/la7036229; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Farruggia G, 2006, J AM CHEM SOC, V128, P344, DOI 10.1021/ja056523u; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; HANCOCK REW, 1981, J ANTIMICROB CHEMOTH, V8, P249, DOI 10.1093/jac/8.4.249; Hayashi I, 2001, EMBO J, V20, P1819, DOI 10.1093/emboj/20.8.1819; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Johansen C, 1996, APPL ENVIRON MICROB, V62, P1058, DOI 10.1128/AEM.62.3.1058-1064.1996; Jones HE, 2002, CELL CALCIUM, V32, P183, DOI 10.1016/S0143416002001537; Jones HE, 1999, CELL CALCIUM, V25, P265, DOI 10.1054/ceca.1999.0028; JOSEPOVITZ C, 1982, J PHARMACOL EXP THER, V223, P314; KADURUGAMUWA JL, 1993, J BACTERIOL, V175, P5798, DOI 10.1128/JB.175.18.5798-5805.1993; LEPEZUNIGA JL, 1987, J IMMUNOL METHODS, V103, P145, DOI 10.1016/0022-1759(87)90253-5; LEVITON IM, 1995, ANTIMICROB AGENTS CH, V39, P467, DOI 10.1128/AAC.39.2.467; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; LORIAN V, 1982, J CLIN MICROBIOL, V16, P70, DOI 10.1128/JCM.16.1.70-76.1982; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Naseem R, 2008, BBA-BIOMEMBRANES, V1778, P1415, DOI 10.1016/j.bbamem.2008.02.006; Naseem R, 2007, BIOCHEM BIOPH RES CO, V360, P33, DOI 10.1016/j.bbrc.2007.05.223; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; OLIVEIRA RG, 2008, CR CHIM, V12, P209; Pink DA, 2003, LANGMUIR, V19, P8852, DOI 10.1021/la030193e; Potter R, 2005, INT J FOOD MICROBIOL, V103, P23, DOI 10.1016/j.ijfoodmicro.2004.12.019; RAMOS S, 1976, P NATL ACAD SCI USA, V73, P1892, DOI 10.1073/pnas.73.6.1892; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Ripoll C, 2004, BIOESSAYS, V26, P549, DOI 10.1002/bies.20019; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Touhami A, 2006, J BACTERIOL, V188, P7661, DOI 10.1128/JB.00911-06; WATKINS NJ, 1995, BIOCHEM J, V306, P865, DOI 10.1042/bj3060865; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	47	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7285	10.1371/journal.pone.0007285	http://dx.doi.org/10.1371/journal.pone.0007285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789705	Green Published, gold			2022-12-25	WOS:000270354100030
J	Not, F; del Campo, J; Balague, V; de Vargas, C; Massana, R				Not, Fabrice; del Campo, Javier; Balague, Vanessa; de Vargas, Colomban; Massana, Ramon			New Insights into the Diversity of Marine Picoeukaryotes	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DNA; PCR; SEQUENCES; LIBRARIES; OCEAN; GENE; AMPLIFICATION	Over the last decade, culture-independent surveys of marine picoeukaryotic diversity based on 18S ribosomal DNA clone libraries have unveiled numerous sequences of novel high-rank taxa. This newfound diversity has significantly altered our understanding of marine microbial food webs and the evolution of eukaryotes. However, the current picture of marine eukaryotic biodiversity may be significantly skewed by PCR amplification biases, occurrence of rDNA genes in multiple copies within a single cell, and the capacity of DNA to persist as extracellular material. In this study we performed an analysis of the metagenomic dataset from the Global Ocean Survey (GOS) expedition, seeking eukaryotic ribosomal signatures. This PCR-free approach revealed similar phylogenetic patterns to clone library surveys, suggesting that PCR steps do not impose major biases in the exploration of environmental DNA. The different cell size fractions within the GOS dataset, however, displayed a distinct picture. High protistan diversity in the <0.8 mu m size fraction, in particular sequences from radiolarians and ciliates (and their absence in the 0.8-3 mu m fraction), suggest that most of the DNA in this fraction comes from extracellular material from larger cells. In addition, we compared the phylogenetic patterns from rDNA and reverse transcribed rRNA 18S clone libraries from the same sample harvested in the Mediterranean Sea. The libraries revealed major differences, with taxa such as pelagophytes or picobiliphytes only detected in the 18S rRNA library. MAST (Marine Stramenopiles) appeared as potentially prominent grazers and we observed a significant decrease in the contribution of alveolate and radiolarian sequences, which overwhelmingly dominated rDNA libraries. The rRNA approach appears to be less affected by taxon-specific rDNA copy number and likely better depicts the biogeochemical significance of marine protists.			Not, F (corresponding author), CSIC, Inst Ciencies Mar, Barcelona, Spain.	not@sb-roscoff.fr	Massana, Ramon/F-4205-2016; del Campo, Javier/B-5233-2008	del Campo, Javier/0000-0002-5292-1421; Massana, Ramon/0000-0001-9172-5418; de Vargas, Colomban/0000-0002-6476-6019				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buckley BA, 2004, MAR ECOL PROG SER, V282, P143, DOI 10.3354/meps282143; Chambouvet A, 2008, SCIENCE, V322, P1254, DOI 10.1126/science.1164387; Cottrell MT, 2005, ENVIRON MICROBIOL, V7, P1883, DOI 10.1111/j.1462-2920.2005.00762.x; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; Epstein S, 2008, BIODIVERS CONSERV, V17, P261, DOI 10.1007/s10531-007-9250-y; Fuller NJ, 2006, AQUAT MICROB ECOL, V43, P79, DOI 10.3354/ame043079; Gentile G, 2006, ENVIRON MICROBIOL, V8, P2150, DOI 10.1111/j.1462-2920.2006.01097.x; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P720, DOI 10.1128/jb.170.2.720-726.1988; GODHE A, 2008, APPL ENV MICROBIOLOG; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; JIANG SC, 1995, APPL ENVIRON MICROB, V61, P317, DOI 10.1128/AEM.61.1.317-325.1995; Jurgens K., 2008, MICROB ECOL OCEAN, P383, DOI [DOI 10.1002/9780470281840.CH11, 10.1002/9780470281840.ch11]; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Liles MR, 2003, APPL ENVIRON MICROB, V69, P2684, DOI 10.1128/AEM.69.5.2684-2691.2003; LIU H, 2009, P NATL ACAD IN PRESS; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Mills HJ, 2005, APPL ENVIRON MICROB, V71, P3235, DOI 10.1128/AEM.71.6.3235-3247.2005; Moeseneder MM, 2005, FEMS MICROBIOL ECOL, V51, P341, DOI 10.1016/j.femsec.2004.09.012; Not F, 2004, APPL ENVIRON MICROB, V70, P4064, DOI 10.1128/AEM.70.7.4064-4072.2004; Not F, 2008, DEEP-SEA RES PT I, V55, P1456, DOI 10.1016/j.dsr.2008.06.007; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Not F, 2007, SCIENCE, V315, P253, DOI 10.1126/science.1136264; PAUL JH, 1990, APPL ENVIRON MICROB, V56, P1963, DOI 10.1128/AEM.56.6.1963-1966.1990; Piganeau G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r5; POULSEN LK, 1993, APPL ENVIRON MICROB, V59, P1354, DOI 10.1128/AEM.59.5.1354-1360.1993; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; SHI X, NOVEL PHOTOSYN UNPUB; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Stoeck T, 2007, MICROB ECOL, V53, P328, DOI 10.1007/s00248-006-9166-1; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Vaulot D, 2002, TRENDS MICROBIOL, V10, P266, DOI 10.1016/S0966-842X(02)02366-1; Vlassov VV, 2007, BIOESSAYS, V29, P654, DOI 10.1002/bies.20604; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Worden A Z, 2008, MICROECOL OCEANS, V2, P159, DOI [10.1002/9780470281840.ch6, DOI 10.1002/9780470281840.CH6]; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	47	168	170	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7143	10.1371/journal.pone.0007143	http://dx.doi.org/10.1371/journal.pone.0007143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787059	Green Published, gold			2022-12-25	WOS:000270290100004
J	Dawson, W; Yamamoto, K				Dawson, Wayne; Yamamoto, Kenji			Home Educating in an Extended Family Culture and Aging Society May Fare Best during a Pandemic	PLOS ONE			English	Article							INFLUENZA; EPIDEMIC; TIME; STRATEGIES; FARMERS	Large cities can contain populations that move rapidly from one section to another in an efficient transportation network. An emerging air-borne or contact based pathogen could use these transportation routes to rapidly spread an infection throughout an entire population in a short time. Further, in many developed countries, the aging population is increasing. The family structure in these societies may also affect the course of a disease. To help understand the impact of an epidemic on family structure in a networked population, an individual based computer model that randomly generates networked cities with a specified range of population and disease characteristics and individual schedules, infectivity, transmission and hygiene factors was developed. Several salient issues emerged. First, a city of highly active individuals may in fact diminish the number of fatalities because the average duration of the interactions between agents is reduced. Second, home schooling can significantly improve survival because the institutional clustering of weak individuals is minimized. Third, the worst scenario for an aging population is the nuclear family where the aged population is confined to large housing facilities. Naturally, hygiene is the first barrier to infection. The results suggest that societies where extended families and small groups manage most of their own affairs may also be the most suitable for defense against a pandemic. This may prove applicable in city planning and policy making.			Dawson, W (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bioinformat Engn Lab,Bunkyo Ku, Tokyo, Japan.	dawson@bi.a.u-tokyo.ac.jp	Dawson, Wayne/AAY-5576-2020; YAMAMOTO, Kenji/I-1758-2013	Dawson, Wayne/0000-0001-7751-7778; 				Anderson GF, 2000, HEALTH AFFAIR, V19, P191, DOI 10.1377/hlthaff.19.3.191; ATTI MLC, 2008, PLOS ONE, V3, P1790; BARRETT CL, 2005, SMALLPOX STRIKES POR, P32; Bartlett H P, 1995, Korea J Popul Dev, V24, P181; Beggs CB, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-114; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Bolzoni L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000747; Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143; Chaix R, 2007, CURR BIOL, V17, P43, DOI 10.1016/j.cub.2006.10.058; Chowell G, 2003, J THEOR BIOL, V224, P1, DOI 10.1016/S0022-5193(03)00228-5; Curry A, 2008, SCIENCE, V319, P278, DOI 10.1126/science.319.5861.278; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Guan Y, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-132; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Iwami S, 2008, J THEOR BIOL, V252, P732, DOI 10.1016/j.jtbi.2008.02.020; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kerneis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001478; Lawler A, 2008, SCIENCE, V320, P1276, DOI 10.1126/science.320.5881.1276; Lawler A, 2008, SCIENCE, V320, P1281, DOI 10.1126/science.320.5881.1281; Le Souef PN, 2000, LANCET, V356, P242; LEVINE J, 2006, SCI AGING KNOWLEDGE, pPE16, DOI DOI 10.1126/SAGEKE.2006.10.PE16; Martin L G, 1989, Popul Bull, V44, P1; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Neumann K, 2003, SCIENCE, V301, P180, DOI 10.1126/science.1086677; Patel MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002269; POIRIER FE, 1987, UNDERSTANDING HUMAN; Skeik N, 2008, INT J INFECT DIS, V12, P233, DOI 10.1016/j.ijid.2007.07.002; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Takeuchi F, 2006, J THEOR BIOL, V243, P39, DOI 10.1016/j.jtbi.2006.05.033; Taleb NN, 2005, FOOLED RANDOMNESS HI; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Ur JA, 2007, SCIENCE, V317, P1188, DOI 10.1126/science.1138728; Uys PW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000757; Yashiro N, 1997, J Asian Econ, V8, P245; YASUDA H, 2008, J URBAN HLTH B NEW Y; Zietz BP, 2004, INT J HYG ENVIR HEAL, V207, P165, DOI 10.1078/1438-4639-00259	37	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7221	10.1371/journal.pone.0007221	http://dx.doi.org/10.1371/journal.pone.0007221			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784366	gold, Green Submitted, Green Published			2022-12-25	WOS:000270290000018
J	Jin, HW; Chemaly, ER; Lee, A; Kho, C; Hadri, L; Hajjar, RJ; Akar, FG				Jin, Hongwei; Chemaly, Elie R.; Lee, Ahyoung; Kho, Changwon; Hadri, Lahouaria; Hajjar, Roger J.; Akar, Fadi G.			Mechanoelectrical remodeling and arrhythmias during progression of hypertrophy	FASEB JOURNAL			English	Article						heart failure; pressure overload hypertrophy; connexin; conduction	ECHOCARDIOGRAPHIC-ASSESSMENT; CONNEXIN43 EXPRESSION; CARDIAC-HYPERTROPHY; HEART-FAILURE; GENE-TRANSFER; MECHANISMS; ARRHYTHMOGENESIS; MICE	Despite a clear association between left ventricular (LV) mechanical dysfunction in end-stage heart failure and the incidence of arrhythmias, the majority of sudden cardiac deaths occur at earlier stages of disease development. The mechanisms by which structural, mechanical, and molecular alterations predispose to arrhythmias at the tissue level before the onset of LV dysfunction remain unclear. In a rat model of pressure overload hypertrophy (PoH) produced by ascending aortic banding, we correlated mechanical and structural changes measured in vivo with key electrophysiological changes measured ex vivo in the same animals. We found that action potential prolongation, a hallmark of electrical remodeling at the tissue level, is highly correlated with changes in LV wall thickness but not mechanical function. In contrast, conduction delays are not predicted by either mechanical or structural changes during disease development. Moreover, disrupted Cx43 phosphorylation at intermediate (increased) and late (decreased) stages of PoH are associated with moderate and severe conduction delays, respectively. Interestingly, the level of interaction between Cx43 and the cytoskeletal protein ZO-1 is exclusively decreased at the late stage of PoH. Closely coupled action potentials consistent with afterdepolarization-mediated triggered beats were readily observed in 6 of 15 PoH hearts but never in controls. Similarly, PoH (8/15) but not control hearts exhibited sustained episodes of ventricular tachycardia after rapid stimulation. The initiation and early maintenance of arrhythmias in PoH were formed by rapid and highly uniform activation wave-fronts emanating from sites distal to the former site of stimulation. In conclusion, repolarization but not conduction delays are predicted by structural remodeling in PoH. Cx43 phosphorylation is disrupted at intermediate (increased) and late (decreased) stages, which are associated with conduction delays. Dephosphorylation of Cx43 is associated with loss of interaction with ZO-1 and severe conduction delays. Remodeling at all stages of PoH predisposes to triggers and focal arrhythmias.-Jin, H., Chemaly, E. R., Lee, A., Kho, C., Hadri, L., Hajjar, R. J., Akar, F. G. Mechanoelectrical remodeling and arrhythmias during progression of hypertrophy. FASEB J. 24, 451-463 (2010). www.fasebj.org	[Akar, Fadi G.] Mt Sinai Sch Med, Inst Computat Med, Div Cardiol, Cardiovasc Res Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Akar, FG (corresponding author), Mt Sinai Sch Med, Inst Computat Med, Div Cardiol, Cardiovasc Res Ctr, 1 Gustave L Levy Pl, New York, NY 10029 USA.	fadi.akar@mssm.edu	Hadri, Lahouaria/AAP-6415-2020	Hadri, Lahouaria/0000-0001-8108-7993	National Institutes of Health [HL-091923, HL-080498]; American Heart Association [0830126N]; Irma T. Hirschl and Monique Weill Caullier Trusts; Celladon Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091923, K01HL103176, R01HL080498, T32HL007824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Irma T. Hirschl and Monique Weill Caullier Trusts; Celladon Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (HL-091923; to F. G. A.), the American Heart Association (0830126N; to F. G. A.), the Irma T. Hirschl and Monique Weill Caullier Trusts (to F. G. A.), Celladon Corporation (to F. G. A.), and the National Institutes of Health (HL-080498; to R.J.H.). F. G. A. is on the Scientific Advisory Board of Celladon Corporation.	Akar FG, 2007, AM J PHYSIOL-HEART C, V293, pH1223, DOI 10.1152/ajpheart.00079.2007; Akar FG, 2004, CIRC RES, V95, P717, DOI 10.1161/01.RES.0000144125.61927.1c; Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; Danik SB, 2008, FASEB J, V22, P1204, DOI 10.1096/fj.07-8974com; Del Monte F, 2002, PHYSIOL GENOMICS, V9, P49, DOI 10.1152/physiolgenomics.00035.2001; Eloff BC, 2001, CARDIOVASC RES, V51, P681, DOI 10.1016/S0008-6363(01)00341-8; Escudero Eduardo Manuel, 2004, Eur J Echocardiogr, V5, P169, DOI 10.1016/j.euje.2003.11.004; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Hall DG, 2000, PEDIATR RES, V48, P36, DOI 10.1203/00006450-200007000-00009; Henkens IR, 2007, AM J PHYSIOL-HEART C, V293, pH1300, DOI 10.1152/ajpheart.01359.2006; Jalife J, 1999, J CARDIOVASC ELECTR, V10, P1649, DOI 10.1111/j.1540-8167.1999.tb00230.x; Jin HW, 2008, CIRCULATION, V118, pS531; Kang YJ, 2006, TOXICOL PATHOL, V34, P58, DOI 10.1080/01926230500419421; Kontogeorgis A, 2008, AM J PHYSIOL-HEART C, V295, pH1905, DOI 10.1152/ajpheart.590.2008; Kostin S, 2004, CARDIOVASC RES, V62, P426, DOI 10.1016/j.cardiores.2003.12.010; Lyon AR, 2008, CIRCULATION, V118, pS528; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Morley GE, 2000, J CARDIOVASC ELECTR, V11, P375, DOI 10.1111/j.1540-8167.2000.tb01811.x; Peters NS, 1996, CLIN SCI, V90, P447, DOI 10.1042/cs0900447; Peters NS, 1997, CIRCULATION, V95, P988; Poelzing S, 2004, AM J PHYSIOL-HEART C, V286, pH2001, DOI 10.1152/ajpheart.00987.2003; POGWIZD SM, 1995, CIRCULATION, V92, P1034, DOI 10.1161/01.CIR.92.4.1034; Qu JX, 2009, CIRC RES, V104, P365, DOI 10.1161/CIRCRESAHA.108.184044; QUAN WL, 1990, CIRC RES, V66, P367, DOI 10.1161/01.RES.66.2.367; Reisner Y, 2009, J CELL MOL MED, V13, P562, DOI 10.1111/j.1582-4934.2008.00361.x; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Saffitz JE, 1999, CARDIOVASC RES, V42, P309, DOI 10.1016/S0008-6363(99)00023-1; Salemi VMC, 2004, ARTIF ORGANS, V28, P332, DOI 10.1111/j.1525-1594.2004.47350.x; SCOTT BD, 1993, AM HEART J, V125, P1047, DOI 10.1016/0002-8703(93)90113-N; Stein AB, 2007, BASIC RES CARDIOL, V102, P28, DOI 10.1007/s00395-006-0627-y; Wickenden AD, 1998, CARDIOVASC RES, V37, P312, DOI 10.1016/S0008-6363(97)00256-3; Yan GX, 2001, AM J PHYSIOL-HEART C, V281, pH1968, DOI 10.1152/ajpheart.2001.281.5.H1968	32	36	37	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					451	463		10.1096/fj.09-136622	http://dx.doi.org/10.1096/fj.09-136622			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19825979	Green Published			2022-12-25	WOS:000274045000013
J	Wu, MS; Le, HD; Wang, MT; Yurkov, V; Omelchenko, A; Hnatowich, M; Nix, J; Hryshko, LV; Zheng, L				Wu, Mousheng; Le, Hoa Dinh; Wang, Meitian; Yurkov, Vladimir; Omelchenko, Alexander; Hnatowich, Mark; Nix, Jay; Hryshko, Larry V.; Zheng, Lei			Crystal Structures of Progressive Ca2+ Binding States of the Ca2+ Sensor Ca2+ Binding Domain 1 (CBD1) from the CALX Na+/Ca2+ Exchanger Reveal Incremental Conformational Transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-CA2+ EXCHANGER; DROSOPHILA-MELANOGASTER; CA2+-BINDING DOMAIN; MUTATIONAL ANALYSIS; MUTAGENESIS; ISOFORMS; MODEL; NCX1; SITE	Na+/Ca2+ exchangers (NCX) constitute a major Ca2+ export system that facilitates the re-establishment of cytosolic Ca2+ levels in many tissues. Ca2+ interactions at its Ca2+ binding domains (CBD1 and CBD2) are essential for the allosteric regulation of Na+/Ca2+ exchange activity. The structure of the Ca2+-bound form of CBD1, the primary Ca2+ sensor from canine NCX1, but not the Ca2+-free form, has been reported, although the molecular mechanism of Ca2+ regulation remains unclear. Here, we report crystal structures for three distinct Ca2+ binding states of CBD1 from CALX, a Na+/Ca2+ exchanger found in Drosophila sensory neurons. The fully Ca2+-bound CALX-CBD1 structure shows that four Ca2+ atoms bind at identical Ca2+ binding sites as those found in NCX1 and that the partial Ca2(+) occupancy and apoform structures exhibit progressive conformational transitions, indicating incremental regulation of CALX exchange by successive Ca2+ binding at CBD1. The structures also predict that the primary Ca2+ pair plays the main role in triggering functional conformational changes. Confirming this prediction, mutagenesis of Glu(455), which coordinates the primary Ca2+ pair, produces dramatic reductions of the regulatory Ca2+ affinity for exchange current, whereas mutagenesis of Glu(520), which coordinates the secondary Ca2+ pair, has much smaller effects. Furthermore, our structures indicate that Ca2+ binding only enhances the stability of the Ca2+ binding site of CBD1 near the hinge region while the overall structure of CBD1 remains largely unaffected, implying that the Ca2+ regulatory function of CBD1, and possibly that for the entire NCX family, is mediated through domain interactions between CBD1 and the adjacent CBD2 at this hinge.	[Wu, Mousheng; Zheng, Lei] Univ Texas Houston, Ctr Membrane Biol, Dept Biochem & Mol Biol, Med Sch Houston, Houston, TX 77030 USA; [Le, Hoa Dinh; Yurkov, Vladimir; Omelchenko, Alexander; Hnatowich, Mark; Hryshko, Larry V.] Univ Manitoba, Inst Cardiovasc Sci, St Boniface Hosp, Res Ctr, Winnipeg, MB R2H 2A6, Canada; [Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Nix, Jay] Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Biol Consortium, Adv Light Source, Berkeley, CA 94720 USA	University of Texas System; University of Texas Health Science Center Houston; University of Manitoba; Children's Hospital Research Institute of Manitoba; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zheng, L (corresponding author), 6431 Fannin St, Houston, TX 77030 USA.	lei.zheng@uth.tmc.edu	Wang, Meitian/D-3208-2013	Wang, Meitian/0000-0002-5340-3036; Hryshko, Larry/0000-0003-1079-8549	American Heart Association [0830353N]; Canadian Institutes of Health Research	American Heart Association(American Heart Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work supported by grants from the American Heart Association (0830353N to L. Z.) and the Canadian Institutes of Health Research (to L. V. H.).	BERS DM, 1994, METHOD CELL BIOL, V40, P3; BERS DM, 1991, EXCITATION CONTRACTI, P71; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 1996, ANN NY ACAD SCI, V779, P300, DOI 10.1111/j.1749-6632.1996.tb44803.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dyck C, 1998, J BIOL CHEM, V273, P12981, DOI 10.1074/jbc.273.21.12981; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicoll DA, 2002, ANN NY ACAD SCI, V976, P11; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Omelchenko A, 1998, J GEN PHYSIOL, V111, P691, DOI 10.1085/jgp.111.5.691; Ottolia M, 2004, BIOPHYS J, V87, P899, DOI 10.1529/biophysj.104.043471; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	28	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2554	2561		10.1074/jbc.M109.059162	http://dx.doi.org/10.1074/jbc.M109.059162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19815561	hybrid, Green Published			2022-12-25	WOS:000273697800034
J	Lucs, AV; Muller, WJ; Muthuswamy, SK				Lucs, A. V.; Muller, W. J.; Muthuswamy, S. K.			Shc is required for ErbB2-induced inhibition of apoptosis but is dispensable for cell proliferation and disruption of cell polarity	ONCOGENE			English	Article						ErbB2; apoptosis; 3D culture; taxol; Shc; MCF-10A	HUMAN-BREAST-CANCER; MAMMARY TUMORIGENESIS; ADAPTER PROTEINS; ERBB2; ACTIVATION; RESISTANCE; RECEPTORS; FAMILY; GROWTH; ACTIN	Amplification and overexpression of ErbB2 strongly correlates with aggressive breast cancers. A deeper understanding of pathways downstream of ErbB2 signaling that are required for the transformation of human mammary epithelial cells will identify novel strategies for therapeutic intervention in breast cancer. Using an inducible activation of ErbB2 autophosphorylation qsite mutants and the MCF-10A three-dimensional (3D) culture system, we investigated pathways used by ErbB2 to transform the epithelia. We report that ErbB2 induces cell proliferation and loss of 3D organization by redundant mechanisms, whereas it disrupts apical basal polarity and inhibits apoptosis using Tyr 1201 and Tyr 1226/7, respectively. Signals downstream of Tyr 1226/7 were also sufficient to confer paclitaxel resistance. The Tyr 1226/7 binds Shc, and the knockdown of Shc blocks the ability of ErbB2 to inhibit apoptosis and mediate paclitaxel resistance. Tyr 1226/7 is known to activate the Ras/Erk pathway; however, paclitaxel resistance did not correlate with the activation of Erk or Akt, suggesting the presence of a novel mechanism. Thus, our results show that targeting pathways used by ErbB2 to inhibit cell death is a better option than targeting cell proliferation pathways. Furthermore, we identify a novel function for Shc as a regulator of apoptosis and drug resistance in human mammary epithelial cells transformed by ErbB2. Oncogene (2010) 29, 174-187; doi:10.1038/onc.2009.312; published online 12 October 2009	[Lucs, A. V.; Muthuswamy, S. K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Muller, W. J.] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Lucs, A. V.; Muthuswamy, S. K.] SUNY Stony Brook, Dept Microbiol & Mol Genet, Stony Brook, NY 11794 USA; [Muthuswamy, S. K.] Univ Toronto, Dept Med Biophys, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Toronto, ON M5S 1A1, Canada	Cold Spring Harbor Laboratory; McGill University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Muthuswamy, SK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	muthuswa@cshl.edu	Muthuswamy, Senthil K/AGY-2834-2022	Muthuswamy, Senthil K/0000-0001-6564-9634	NCI [CA098830, CA105388]; DOD [BC075024, DAMD17-03-1-0196]; Rita Allen Foundation; FACT foundation; Lee K Margaret Lau Chair in Breast Cancer Research; NATIONAL CANCER INSTITUTE [R56CA098830, R01CA098830, U01CA105388] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); Rita Allen Foundation; FACT foundation; Lee K Margaret Lau Chair in Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Muthuswamy Laboratory for critical discussions and comments on the paper. This work was supported by CA098830 and CA105388 Grants from NCI, DOD BC075024 from DOD Breast Cancer Research Program, Rita Allen Foundation, FACT foundation and Lee K Margaret Lau Chair in Breast Cancer Research to SKM and DAMD17-03-1-0196 from DOD Breast Cancer Research Program to AL.	AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dankort DL, 2000, ONCOGENE, V19, P1038, DOI 10.1038/sj.onc.1203272; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Habib T, 1998, J BIOL CHEM, V273, P18605, DOI 10.1074/jbc.273.29.18605; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; JANES PW, 1994, ONCOGENE, V9, P3601; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Leung WH, 2007, J IMMUNOL, V179, P95, DOI 10.4049/jimmunol.179.1.95; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nelson JM, 2001, J BIOL CHEM, V276, P14842, DOI 10.1074/jbc.M008786200; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Pupa SM, 2005, J CELL PHYSIOL, V205, P10, DOI 10.1002/jcp.20387; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Saucier C, 2004, P NATL ACAD SCI USA, V101, P2345, DOI 10.1073/pnas.0308065101; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; THOMAS D, 1995, J BIOL CHEM, V270, P28924, DOI 10.1074/jbc.270.48.28924; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Verrills NM, 2006, J NATL CANCER I, V98, P1363, DOI 10.1093/jnci/djj372; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu DH, 1998, MOL CELL, V2, P581, DOI 10.1016/S1097-2765(00)80157-4; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027	39	12	13	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2010	29	2					174	187		10.1038/onc.2009.312	http://dx.doi.org/10.1038/onc.2009.312			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19826412	Green Accepted			2022-12-25	WOS:000273650000002
J	Buvinic, S; Almarza, G; Bustamante, M; Casas, M; Lopez, J; Riquelme, M; Saez, JC; Huidobro-Toro, JP; Jaimovich, E				Buvinic, Sonja; Almarza, Gonzalo; Bustamante, Mario; Casas, Mariana; Lopez, Javiera; Riquelme, Manuel; Carlos Saez, Juan; Pablo Huidobro-Toro, Juan; Jaimovich, Enrique			ATP Released by Electrical Stimuli Elicits Calcium Transients and Gene Expression in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 SIZE FORMS; EXTRACELLULAR ATP; NUCLEOTIDE RECEPTOR; CA2+ SIGNALS; ECTO-ATPASE; DIHYDROPYRIDINE RECEPTOR; FUNCTIONAL EXPRESSION; ADENINE-NUCLEOTIDES; P2Y(2) RECEPTORS; CELL-ACTIVATION	ATP released from cells is known to activate plasma membrane P2X (ionotropic) or P2Y (metabotropic) receptors. In skeletal muscle cells, depolarizing stimuli induce both a fast calcium signal associated with contraction and a slow signal that regulates gene expression. Here we show that nucleotides released to the extracellular medium by electrical stimulation are partly involved in the fast component and are largely responsible for the slow signals. In rat skeletal myotubes, a tetanic stimulus (45 Hz, 400 1-ms pulses) rapidly increased extracellular levels of ATP, ADP, and AMP after 15 s to 3 min. Exogenous ATP induced an increase in intracellular free Ca2+ concentration, with an EC50 value of 7.8 +/- 3.1 mu M. Exogenous ADP, UTP, and UDP also promoted calcium transients. Both fast and slow calcium signals evoked by tetanic stimulation were inhibited by either 100 mu M suramin or 2 units/ml apyrase. Apyrase also reduced fast and slow calcium signals evoked by tetanus (45 Hz, 400 0.3-ms pulses) in isolated mouse adult skeletal fibers. A likely candidate for the ATP release pathway is the pannexin-1 hemichannel; its blockers inhibited both calcium transients and ATP release. The dihydropyridine receptor co-precipitated with both the P2Y2 receptor and pannexin-1. As reported previously for electrical stimulation, 500 mu M ATP significantly increased mRNA expression for both c-fos and interleukin 6. Our results suggest that nucleotides released during skeletal muscle activity through pannexin-1 hemichannels act through P2X and P2Y receptors to modulate both Ca2+ homeostasis and muscle physiology.	[Buvinic, Sonja; Almarza, Gonzalo; Bustamante, Mario; Casas, Mariana; Jaimovich, Enrique] Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Santiago 7, Chile; [Lopez, Javiera; Pablo Huidobro-Toro, Juan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Regulac Celular & Patol, Santiago 8, Chile; [Riquelme, Manuel; Carlos Saez, Juan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ciencias Fisiol, Santiago 8, Chile	Universidad de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Jaimovich, E (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Casilla 70005, Santiago 7, Chile.	ejaimovi@med.uchile.cl	Buvinic, Sonja/I-2658-2013; Jaimovich, Enrique/AAY-7632-2020; Riquelme, Manuel/B-1082-2015	Riquelme, Manuel/0000-0002-1915-0434; Bustamante, Mario/0000-0002-0713-1818	Fondo de Investigacion Avanzada en Areas Prioritarias (Chile) [15010006]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (Chile) [1080120]; FONDAP [13980001]; FONDECYT [3080016]	Fondo de Investigacion Avanzada en Areas Prioritarias (Chile); Fondo Nacional de Desarrollo Cientifico y Tecnologico (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Grants from the Fondo de Investigacion Avanzada en Areas Prioritarias (Chile) 15010006, and the Fondo Nacional de Desarrollo Cientifico y Tecnologico (Chile) 1080120, FONDAP 13980001, and FONDECYT 3080016.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Araya R, 2004, BRAIN RES REV, V47, P174, DOI 10.1016/j.brainresrev.2004.06.003; Araya R, 2005, J CELL SCI, V118, P27, DOI 10.1242/jcs.01553; Araya R, 2003, CELL COMMUN ADHES, V10, P451, DOI 10.1080/15419060390263038; BALOGH S, 1993, DEV BIOL, V155, P351, DOI 10.1006/dbio.1993.1034; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Belluardo N, 2005, CELL TISSUE RES, V320, P299, DOI 10.1007/s00441-005-1087-7; BENZ R, 1988, FEBS LETT, V231, P75, DOI 10.1016/0014-5793(88)80706-3; Betto R, 1999, J BIOL CHEM, V274, P7907, DOI 10.1074/jbc.274.12.7907; Braunstein Gavin M, 2004, J Cyst Fibros, V3, P99, DOI 10.1016/j.jcf.2004.01.006; Braunstein GM, 2001, J BIOL CHEM, V276, P6621, DOI 10.1074/jbc.M005893200; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Burnstock G, 2006, PHARMACOL THERAPEUT, V110, P433, DOI 10.1016/j.pharmthera.2005.08.013; Buvinic S, 2002, BRIT J PHARMACOL, V136, P847, DOI 10.1038/sj.bjp.0704789; Buvinic S, 2006, J PHYSIOL-LONDON, V573, P427, DOI 10.1113/jphysiol.2006.105882; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; Carrasco MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1438, DOI 10.1152/ajpcell.00117.2002; Choi RCY, 2001, J NEUROSCI, V21, P9224, DOI 10.1523/JNEUROSCI.21-23-09224.2001; Choi RCY, 2003, J NEUROSCI, V23, P4445; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Collet C, 2002, PFLUG ARCH EUR J PHY, V443, P771, DOI 10.1007/s00424-001-0758-9; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; Cseri J, 2002, PFLUG ARCH EUR J PHY, V443, P731, DOI 10.1007/s00424-001-0757-x; CUNHA RA, 1993, PFLUG ARCH EUR J PHY, V424, P503, DOI 10.1007/BF00374914; da Silva RL, 2007, EXP PHYSIOL, V92, P139, DOI 10.1113/expphysiol.2006.035543; De Waard M, 2005, TRENDS PHARMACOL SCI, V26, P427, DOI 10.1016/j.tips.2005.06.008; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DEJONGH KS, 1991, P NATL ACAD SCI USA, V88, P10778, DOI 10.1073/pnas.88.23.10778; Delgado J, 1997, BIOCHEM J, V327, P899, DOI 10.1042/bj3270899; Deli T, 2007, PFLUG ARCH EUR J PHY, V453, P519, DOI 10.1007/s00424-006-0146-6; Deli T, 2006, J MUSCLE RES CELL M, V27, P617, DOI 10.1007/s10974-006-9096-z; Eltit JM, 2006, J BIOL CHEM, V281, P12143, DOI 10.1074/jbc.M511218200; Eltit JM, 2004, BIOPHYS J, V86, P3042, DOI 10.1016/S0006-3495(04)74353-2; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; FILTZ TM, 1994, MOL PHARMACOL, V46, P8; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; GRIERSON JP, 1995, J BIOL CHEM, V270, P4451, DOI 10.1074/jbc.270.9.4451; Grygorczyk R, 1997, AM J PHYSIOL-CELL PH, V272, pC1058; Hayato R, 2007, J PHYSIOL-LONDON, V584, P473, DOI 10.1113/jphysiol.2007.138370; Hazama A, 2000, J PHYSIOL-LONDON, V523, P1, DOI 10.1111/j.1469-7793.2000.t01-6-00001.x; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iacobas DA, 2007, J MEMBRANE BIOL, V217, P83, DOI 10.1007/s00232-007-9039-7; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jaimovich E, 2002, BIOL RES, V35, P195, DOI 10.4067/S0716-97602002000200010; Jaimovich E, 2000, AM J PHYSIOL-CELL PH, V278, pC998, DOI 10.1152/ajpcell.2000.278.5.C998; Juretic N, 2006, AM J PHYSIOL-CELL PH, V290, pC1428, DOI 10.1152/ajpcell.00449.2005; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Kirley TL, 1997, J BIOL CHEM, V272, P1076, DOI 10.1074/jbc.272.2.1076; LAI Y, 1990, J BIOL CHEM, V265, P20839; Lamb GD, 2002, FRONT BIOSCI-LANDMRK, V7, pD834, DOI 10.2741/lamb; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Leybaert L, 2003, CELL COMMUN ADHES, V10, P251, DOI 10.1080/15419060390262985; Li JH, 2005, CIRCULATION, V111, P2748, DOI 10.1161/CIRCULATIONAHA.104.510669; Li JH, 2003, J APPL PHYSIOL, V95, P577, DOI 10.1152/japplphysiol.00185.2003; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; Martinez-Pinna J, 2004, J PHYSIOL-LONDON, V555, P61, DOI 10.1113/jphysiol.2003.056846; May C, 2006, BIOCHEM PHARMACOL, V71, P1497, DOI 10.1016/j.bcp.2006.02.003; Megias A, 2001, BIOCHEM J, V353, P521, DOI 10.1042/0264-6021:3530521; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Protasi F, 2002, BIOPHYS J, V83, P3230, DOI 10.1016/S0006-3495(02)75325-3; Reigada D, 2008, NEUROSCIENCE, V157, P396, DOI 10.1016/j.neuroscience.2008.08.036; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; Roman RM, 1999, AM J PHYSIOL-GASTR L, V277, pG1222, DOI 10.1152/ajpgi.1999.277.6.G1222; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Ryten M, 2001, DEV DYNAM, V221, P331, DOI 10.1002/dvdy.1147; SACKIN H, 1995, KIDNEY INT, V48, P1134, DOI 10.1038/ki.1995.397; Sandona D, 2005, FASEB J, V19, P1184, DOI 10.1096/fj.04-3333fje; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Scrivens M, 2006, EUR J PHARMACOL, V543, P166, DOI 10.1016/j.ejphar.2006.05.037; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; SILINSKY EM, 1975, J PHYSIOL-LONDON, V247, P145, DOI 10.1113/jphysiol.1975.sp010925; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Stanfield P, 2006, NAT CELL BIOL, V8, P1323, DOI 10.1038/ncb1206-1323; Sugita M, 1998, EMBO J, V17, P898, DOI 10.1093/emboj/17.4.898; Szigeti GP, 2007, PFLUG ARCH EUR J PHY, V453, P509, DOI 10.1007/s00424-006-0145-7; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Todorov LD, 1996, J PHYSIOL-LONDON, V496, P731, DOI 10.1113/jphysiol.1996.sp021723; Tsim KWK, 2002, NEUROSIGNALS, V11, P58, DOI 10.1159/000057322; Urano T, 1997, CANCER RES, V57, P3281; Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006; Vizi ES, 2000, J AUTONOM NERV SYST, V81, P278, DOI 10.1016/S0165-1838(00)00129-6; von Maltzahn J, 2006, CELL COMMUN ADHES, V13, P55, DOI 10.1080/15419060600631508; VONKUGELGEN I, 1985, J PHYSIOL-LONDON, V367, P435, DOI 10.1113/jphysiol.1985.sp015834; Watt WC, 1998, J BIOL CHEM, V273, P14053, DOI 10.1074/jbc.273.22.14053; Wells DG, 1995, DEV BIOL, V172, P585, DOI 10.1006/dbio.1995.8062; Yegutkin G, 2000, BRIT J PHARMACOL, V129, P921, DOI 10.1038/sj.bjp.0703136; Yeung D, 2006, FASEB J, V20, P610, DOI 10.1096/fj.05-4022com; Zimmermann H, 1999, TRENDS PHARMACOL SCI, V20, P231, DOI 10.1016/S0165-6147(99)01293-6	97	116	120	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34490	34505		10.1074/jbc.M109.057315	http://dx.doi.org/10.1074/jbc.M109.057315			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19822518	Green Published, hybrid			2022-12-25	WOS:000272439600003
J	Bettuzzi, S; Davalli, P; Davoli, S; Chayka, O; Rizzi, F; Belloni, L; Pellacani, D; Fregni, G; Astancolle, S; Fassan, M; Corti, A; Baffa, R; Sala, A				Bettuzzi, S.; Davalli, P.; Davoli, S.; Chayka, O.; Rizzi, F.; Belloni, L.; Pellacani, D.; Fregni, G.; Astancolle, S.; Fassan, M.; Corti, A.; Baffa, R.; Sala, A.			Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread	ONCOGENE			English	Article						immunohistochemistry; tumour suppressor gene; cell cycle; NF-kappa B	NF-KAPPA-B; TRANSGENIC MOUSE MODEL; EPITHELIAL-CELLS; CANCER CELLS; CLUSTERIN; EXPRESSION; PROGRESSION; INDUCTION; APOPTOSIS; ACTIVATION	ApoJ/Clusterin (CLU) is a heterodimeric protein localized in the nucleus, cytoplasm or secretory organelles and involved in cell survival and neoplastic transformation. Its function in human cancer is still highly controversial. In this study, we examined the prostate of mice in which CLU has been genetically inactivated. Surprisingly, we observed transformation of the prostate epithelium in the majority of CLU knockout mice. Either PIN (prostate intraepithelial neoplasia) or differentiated carcinoma was observed in 100 and 87% of mice with homozygous or heterozygous deletion of CLU, respectively. Crossing CLU knockout with TRAMP (prostate cancer prone) mice results in a strong enhancement of metastatic spread. Finally, CLU depletion causes tumourigenesis in female TRAMP mice, which are normally cancer free. Mechanistically, deletion of CLU induces activation of nuclear factor-kB, a potentially oncogenic transcription factor important for the proliferation and survival of prostate cells. Oncogene (2009) 28, 4344-4352; doi: 10.1038/onc.2009.286; published online 28 September 2009	[Bettuzzi, S.; Davoli, S.; Rizzi, F.; Belloni, L.] Univ Parma, Dept Expt Med, I-43100 Parma, Italy; [Davalli, P.; Pellacani, D.; Fregni, G.; Astancolle, S.; Corti, A.] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Chayka, O.; Sala, A.] Inst Child Hlth, Mol Haematol & Canc Biol Unit, London, England; [Fassan, M.; Baffa, R.] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA; [Baffa, R.] MedImmune LLC, Res, Gaithersburg, MD USA	University of Parma; Universita di Modena e Reggio Emilia; University of London; University College London; Jefferson University; AstraZeneca; Medimmune	Bettuzzi, S (corresponding author), Univ Parma, Dept Expt Med, Via Volturno 39, I-43100 Parma, Italy.	saverio.bettuzzi@unipr.it; a.sala@ich.ucl.ac.uk	Fassan, Matteo/F-5152-2012; sala, arturo/C-4959-2008; Bettuzzi, Saverio/B-2609-2009	Fassan, Matteo/0000-0001-6515-5482; Bettuzzi, Saverio/0000-0003-2080-6979; Rizzi, Federica/0000-0002-6670-2588; Sala, Arturo/0000-0002-2841-7866; Davoli, Serena Alba/0000-0002-8731-0305	Worldwide Cancer Research [06-0711] Funding Source: Medline	Worldwide Cancer Research		BETTUZZI S, 1989, BIOCHEM J, V257, P293, DOI 10.1042/bj2570293; Caccamo AE, 2005, CELL DEATH DIFFER, V12, P101, DOI 10.1038/sj.cdd.4401491; Caccamo AE, 2003, ANN NY ACAD SCI, V1010, P514, DOI 10.1196/annals.1299.095; Caporali A, 2004, CARCINOGENESIS, V25, P2217, DOI 10.1093/carcin/bgh235; Chayka O, 2009, JNCI-J NATL CANCER I, V101, P663, DOI 10.1093/jnci/djp063; Chen CD, 2002, MOL CELL BIOL, V22, P2862, DOI 10.1128/MCB.22.8.2862-2870.2002; Chen TG, 2004, CANCER RES, V64, P7412, DOI 10.1158/0008-5472.CAN-04-2077; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; CUSSENOT O, 1991, J UROLOGY, V146, P881, DOI 10.1016/S0022-5347(17)37953-3; FRITZ IB, 1983, BIOL REPROD, V28, P1173, DOI 10.1095/biolreprod28.5.1173; Gleave M, 2005, WORLD J UROL, V23, P38, DOI 10.1007/s00345-004-0474-0; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hellebrekers DMEI, 2007, CANCER RES, V67, P4138, DOI 10.1158/0008-5472.CAN-06-3032; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; July LV, 2002, PROSTATE, V50, P179, DOI 10.1002/pros.10047; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Mclaughlin L, 2000, J CLIN INVEST, V106, P1105, DOI 10.1172/JCI9037; Miyake H, 2000, CANCER RES, V60, P170; Miyake H, 2006, UROLOGY, V68, P609, DOI 10.1016/j.urology.2006.03.017; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Nomura T, 2005, ONCOL REP, V14, P993; Nuutinen T, 2005, NEUROCHEM INT, V47, P528, DOI 10.1016/j.neuint.2005.07.007; Rauhala HE, 2008, INT J CANCER, V123, P1601, DOI 10.1002/ijc.23658; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Scaltriti M, 2004, INT J CANCER, V108, P23, DOI 10.1002/ijc.11496; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; Shukla S, 2005, PROSTATE, V64, P224, DOI 10.1002/pros.20217; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Thomas-Tikhonenko A, 2004, CANCER RES, V64, P3126, DOI 10.1158/0008-5472.CAN-03-1953; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	38	35	35	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC 10	2009	28	49					4344	4352		10.1038/onc.2009.286	http://dx.doi.org/10.1038/onc.2009.286			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DT	19784068				2022-12-25	WOS:000272876400003
J	Imgrund, S; Hartmann, D; Farwanah, H; Eckhardt, M; Sandhoff, R; Degen, J; Gieselmann, V; Sandhoff, K; Willecke, K				Imgrund, Silke; Hartmann, Dieter; Farwanah, Hany; Eckhardt, Matthias; Sandhoff, Roger; Degen, Joachim; Gieselmann, Volkmar; Sandhoff, Konrad; Willecke, Klaus			Adult Ceramide Synthase 2 (CERS2)-deficient Mice Exhibit Myelin Sheath Defects, Cerebellar Degeneration, and Hepatocarcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBERS; SPHINGOLIPIDS; SPHINGOSINE; BIOSYNTHESIS; SPHINGANINE; DIHYDROCERAMIDE; METABOLISM; REDUCTASE; PATHWAYS; BRAIN	(Dihydro) ceramide synthase 2 (cers2, formerly called lass2) is the most abundantly expressed member of the ceramide synthase gene family, which includes six isoforms in mice. CERS2 activity has been reported to be specific toward very long fatty acid residues (C22-C24). In order to study the biological role of CERS2, we have inactivated its coding region in transgenic mice using gene-trapped embryonic stem cells that express lacZ reporter DNA under control of the cers2 promoter. The resulting mice lack ceramide synthase activity toward C24:1 in the brain as well as the liver and show only very low activity toward C18:0-C22:0 in liver and reduced activity toward C22: 0 residues in the brain. In addition, these mice exhibit strongly reduced levels of ceramide species with very long fatty acid residues (>= C22) in the liver, kidney, and brain. From early adulthood on, myelin stainability is progressively lost, biochemically accompanied by about 50% loss of compacted myelin and 80% loss of myelin basic protein. Starting around 9 months, both the medullary tree and the internal granular layer of the cerebellum show significant signs of degeneration associated with the formation of microcysts. Predominantly in the peripheral nervous system, we observed vesiculation and multifocal detachment of the inner myelin lamellae in about 20% of the axons. Beyond 7 months, the CERS2-deficient mice developed hepatocarcinomas with local destruction of tissue architecture and discrete gaps in renal parenchyma. Our results indicate that CERS2 activity supports different biological functions: maintenance of myelin, stabilization of the cerebellar as well as renal histological architecture, and protection against hepatocarcinomas.	[Imgrund, Silke; Degen, Joachim; Willecke, Klaus] Univ Bonn, Div Mol Genet, Inst Genet, D-53117 Bonn, Germany; [Hartmann, Dieter] Univ Bonn, Div Neuroanat, Inst Anat, D-53117 Bonn, Germany; [Farwanah, Hany; Sandhoff, Konrad] Univ Bonn, Inst Mol Biomed, LIMES Inst, D-53117 Bonn, Germany; [Eckhardt, Matthias; Gieselmann, Volkmar] Univ Bonn, Inst Biochem & Mol Biol, D-53117 Bonn, Germany; [Sandhoff, Roger] German Canc Res Ctr, D-69120 Heidelberg, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ)	Willecke, K (corresponding author), Univ Bonn, Div Mol Genet, Inst Genet, Romerstr 164, D-53117 Bonn, Germany.	k.willecke@uni-bonn.de			German Research Association [SFB 645]	German Research Association(German Research Foundation (DFG))	This work was supported by several grants from the Bonn Collaborative Research Center (SFB 645) "Regulation and Manipulation of Information Flow within Dynamic Protein and Lipid Environments" sponsored by the German Research Association (to K. W. (B2), K. S. (B3), and M. E. and V. G. (B5)).	Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAUN PE, 1968, J BIOL CHEM, V243, P3775; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Kolter T, 1999, ANGEW CHEM INT EDIT, V38, P1532, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Min Y, 2009, P NATL ACAD SCI USA, V106, P3154, DOI 10.1073/pnas.0813110106; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; NAGY A, 2003, MANIPULATING MOUSE E, P476; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; PEWZNERJUNG Y, 2009, CHARL CER C CHARL SC; Rabionet M, 2008, J BIOL CHEM, V283, P13357, DOI 10.1074/jbc.M800870200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; ROTHER J, 1992, BIOCHEM BIOPH RES CO, V189, P14, DOI 10.1016/0006-291X(92)91518-U; Sambrook J., 2001, MOL CLONING LAB MANU; Sandhoff R, 2002, J BIOL CHEM, V277, P20386, DOI 10.1074/jbc.M110641200; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; SRIBNEY M, 1966, BIOCHIM BIOPHYS ACTA, V125, P542, DOI 10.1016/0005-2760(66)90042-7; STOFFEL W, 1968, H-S Z PHYSIOL CHEM, V349, P1637, DOI 10.1515/bchm2.1968.349.2.1637; Tettamanti G, 2003, BIOCHIMIE, V85, P423, DOI 10.1016/S0300-9084(03)00047-6; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang BH, 2007, DNA SEQUENCE, V18, P92, DOI 10.1080/10425170601060947; Yaghootfam A, 2005, EUR J NEUROSCI, V21, P711, DOI 10.1111/j.1460-9568.2005.03891.x	34	199	206	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33549	33560		10.1074/jbc.M109.031971	http://dx.doi.org/10.1074/jbc.M109.031971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801672	Green Published, hybrid			2022-12-25	WOS:000272028500060
J	Yu, MJ; Moreno, JL; Stains, JP; Keegan, AD				Yu, Minjun; Moreno, Jose L.; Stains, Joseph P.; Keegan, Achsah D.			Complex Regulation of Tartrate-resistant Acid Phosphatase (TRAP) Expression by Interleukin 4 (IL-4) IL-4 INDIRECTLY SUPPRESSES RECEPTOR ACTIVATOR OF NF-kappa B LIGAND (RANKL)-MEDIATED TRAP EXPRESSION BUT MODESTLY INDUCES ITS EXPRESSION DIRECTLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; RANKL-INDUCED TRANSCRIPTION; MULTINUCLEATED GIANT-CELLS; OSTEOCLAST DIFFERENTIATION; BONE-RESORPTION; GENE-EXPRESSION; DENDRITIC CELLS; ACP 5; MICE; MACROPHAGES	Interleukin 4 (IL-4) inhibits receptor activator of NF-kappa B ligand (RANKL)-induced osteoclast formation and functional activity in a STAT6-dependent manner. IL-4 down-regulates expression of tartrate-resistant acid phosphatase (TRAP) in mature osteoclasts. To determine whether IL-4 regulates TRAP promoter activity, RAW264.7 cells were transfected with a TRAP promoter-luciferase reporter. Treatment with IL-4 alone modestly enhanced TRAP luciferase activity. However, IL-4 suppressed the ability of RANKL to up-regulate TRAP-luciferase activity, suggesting that IL-4 has multiple effects on TRAP transcription. IL-4 also reduced the RANKL-induced association of RNA polymerase II with the TRAP gene in osteoclasts. The TRAP promoter contains a STAT6-binding motif, and STAT6 bound to the endogenous TRAP promoter after IL-4 treatment. To determine the impact of STAT6 binding, we transfected cells with STAT6VT, a constitutively active STAT6 mutant. STAT6VT alone up-regulated TRAP-luciferase activity; this effect was abrogated by mutating the STAT6 binding site in the minimal TRAP promoter. STAT6VT did not inhibit the potent up-regulation of TRAP promoter activity caused by overexpression of NFATc1, PU.1, and microphthalmia transcription factor, downstream targets of macrophage colony-stimulating factor and RANKL. IL-4 down-regulated the expression of c-Fos and NFATc1 in mature osteoclasts. Knockdown of NFATc1 by short interfering RNA caused TRAP expression to be down-regulated, and ectopic expression of NFATc1 abrogated the IL-4-induced down-regulation of TRAP. These results suggest that STAT6 plays two distinct roles in TRAP expression. The IL-4-induced activation of STAT6 mediates suppression of the RANKL-induced TRAP promoter activity indirectly by inhibiting NFATc1 expression. However, in the absence of RANKL and osteoclast differentiation, STAT6 binds the TRAP promoter after IL-4 treatment and directly enhances TRAP expression.	[Yu, Minjun; Keegan, Achsah D.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Yu, Minjun; Keegan, Achsah D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Moreno, Jose L.; Stains, Joseph P.] Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA; [Keegan, Achsah D.] Univ Maryland, Sch Med, Program Oncol, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Keegan, AD (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St, Baltimore, MD 21201 USA.	akeegan@som.umaryland.edu	yu, minjun/A-1617-2014; Yu, Minjun/B-6152-2015	yu, minjun/0000-0002-1154-5255; Yu, Minjun/0000-0001-8285-068X	National Institutes of Health [AI059775, AI038985]; USPHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038985, R01AI038985, R01AI059775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI059775 and AI038985 from USPHS (to A.D.K.).	Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; Akagawa KS, 1996, BLOOD, V88, P4029, DOI 10.1182/blood.V88.10.4029.bloodjournal88104029; ALCANTARA O, 1994, BIOCHEM J, V298, P421, DOI 10.1042/bj2980421; Angel NZ, 2000, J BONE MINER RES, V15, P103, DOI 10.1359/jbmr.2000.15.1.103; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bendixen AC, 2001, P NATL ACAD SCI USA, V98, P2443, DOI 10.1073/pnas.041493198; Bennett BL, 1997, J BIOL CHEM, V272, P10212; BIZZARRI C, 1994, J BIOL CHEM, V269, P13817; Bune AJ, 2001, IMMUNOLOGY, V102, P103, DOI 10.1046/j.1365-2567.2001.01145.x; Cassady AI, 2003, J BONE MINER RES, V18, P1901, DOI 10.1359/jbmr.2003.18.10.1901; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Daniel C, 2000, J BIOL CHEM, V275, P14255, DOI 10.1074/jbc.C000129200; Esfandiari E, 2006, J BONE MINER RES, V21, P1367, DOI 10.1359/JBMR.060611; Halleen JM, 1999, J BIOL CHEM, V274, P22907, DOI 10.1074/jbc.274.33.22907; Halleen JM, 2000, J BONE MINER RES, V15, P1337, DOI 10.1359/jbmr.2000.15.7.1337; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Hayman AR, 2003, J BONE MINER RES, V18, P1905, DOI 10.1359/jbmr.2003.18.10.1905; Hayman AR, 2001, J HISTOCHEM CYTOCHEM, V49, P675, DOI 10.1177/002215540104900601; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Hirayama T, 2005, ARTHRITIS RHEUM-US, V52, P2719, DOI 10.1002/art.21286; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Janckila AJ, 2005, J LEUKOCYTE BIOL, V77, P209, DOI 10.1189/jlb.0504287; Janckila AJ, 2007, AM J CLIN PATHOL, V127, P556, DOI 10.1309/DGEA9BE2VE5VCFYH; Kaplan MH, 2007, BLOOD, V110, P4367, DOI 10.1182/blood-2007-06-098244; KASONO K, 1993, BONE MINER, V21, P179, DOI 10.1016/S0169-6009(08)80229-2; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LACEY DL, 1994, J CELL BIOCHEM, V54, P365, DOI 10.1002/jcb.240540312; LEWIS DB, 1993, P NATL ACAD SCI USA, V90, P11618, DOI 10.1073/pnas.90.24.11618; Liu Y, 2003, J BIOL CHEM, V278, P20603, DOI 10.1074/jbc.M212093200; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Mangashetti LS, 2005, J IMMUNOL, V175, P917, DOI 10.4049/jimmunol.175.2.917; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsumoto M, 2001, J BIOL CHEM, V276, P33086, DOI 10.1074/jbc.M104299200; Mohamed SGK, 2005, BIOCHEM BIOPH RES CO, V329, P839, DOI 10.1016/j.bbrc.2005.02.049; Moreno JL, 2003, BLOOD, V102, P1078, DOI 10.1182/blood-2002-11-3437; Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058; NAKANO Y, 1994, J BONE MINER RES, V9, P1533, DOI 10.1002/jbmr.5650091005; Okada Y, 1998, BONE, V22, P361, DOI 10.1016/S8756-3282(97)00296-2; Partington GA, 2004, BONE, V34, P237, DOI 10.1016/j.bone.2003.11.010; REDDY SV, 1993, J BONE MINER RES, V8, P1263; RIANCHO JA, 1993, BONE MINER, V21, P53, DOI 10.1016/S0169-6009(08)80120-1; RIANCHO JA, 1993, BIOCHEM BIOPH RES CO, V196, P678, DOI 10.1006/bbrc.1993.2303; RIANCHO JA, 1993, J BONE MINER RES, V8, P1337; ROODMAN GD, 1993, CALCIFIED TISSUE INT, V53, pS94, DOI 10.1007/BF01673412; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Schroder AJ, 2002, J IMMUNOL, V168, P996, DOI 10.4049/jimmunol.168.3.996; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shi ZQ, 2004, GENE, V343, P117, DOI 10.1016/j.gene.2004.08.009; SHIOI A, 1991, J CELL BIOCHEM, V47, P272, DOI 10.1002/jcb.240470313; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Wang HY, 1998, J BIOL CHEM, V273, P9898, DOI 10.1074/jbc.273.16.9898; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200	56	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32968	32979		10.1074/jbc.M109.001016	http://dx.doi.org/10.1074/jbc.M109.001016			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801646	Green Published, hybrid			2022-12-25	WOS:000272028400080
J	Wong, A				Wong, Albert			Modified Epidermal Growth Factor Receptor (EGFR)-Bearing Liposomes (MRBLs) Are Sensitive to EGF in Solution	PLOS ONE			English	Article							HUMAN PANCREATIC-CARCINOMA; DRUG-DELIVERY; RECONSTITUTION; CHEMOTHERAPY; RADIOTHERAPY; INHIBITORS; H-1-NMR	Cancers often overexpress EGF and other growth factors to promote cell replication and migration. Previous work has not produced targeted drug carriers sensitive to abnormal amounts of growth factors. This work demonstrates that liposomes bearing EGF receptors covalently crosslinked to p-toluic acid or methyl-PEO4-NHS ester (or, in short, MRBLs) exhibit an increased rate of release of encapsulated drug compounds when EGF is present in solution. Furthermore, the modified EGF receptors retain the abilities to form dimers in the presence of EGF and bind specifically to EGF. These results demonstrate that MRBLs are sensitive to EGF in solution and indicate that MRBL-reconstituted modified EGF receptors, in the presence of EGF in solution, form dimers which increase MRBL permeability to encapsulated compounds.			Wong, A (corresponding author), Yale Univ, Program Biol & Biomed Sci, New Haven, CT 06520 USA.	albert.wong@yale.edu						Agero ALC, 2006, J AM ACAD DERMATOL, V55, P657, DOI 10.1016/j.jaad.2005.10.010; ARNUM PV, 2006, PHARM TECH EPT; DeAngelis LM, 2002, J CLIN ONCOL, V20, P4643, DOI 10.1200/JCO.2002.11.013; DeSilva NS, 2003, AM J RESP CELL MOL, V29, P757, DOI 10.1165/rcmb.2003-0186OC; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; FEIGENSON GW, 1974, NUCL MAGNETIC RELAXA; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Galimont-Collen AFS, 2007, EUR J CANCER, V43, P845, DOI 10.1016/j.ejca.2006.11.016; Gansauge F, 1998, LANGENBECK ARCH SURG, V383, P152, DOI 10.1007/PL00008076; Ge GX, 2001, BIOCHEM BIOPH RES CO, V282, P511, DOI 10.1006/bbrc.2001.4600; Gerasimov OV, 1999, ADV DRUG DELIVER REV, V38, P317, DOI 10.1016/S0169-409X(99)00035-6; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; JURETSCHKE HP, 1984, EUR J BIOCHEM, V143, P651, DOI 10.1111/j.1432-1033.1984.tb08418.x; Kumar V., 2004, ROBBINS COTRAN PATHO; LAX I, 1991, J BIOL CHEM, V266, P13828; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Maurer N, 1998, BBA-BIOMEMBRANES, V1374, P9, DOI 10.1016/S0005-2736(98)00125-4; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; PANAYOTOU GN, 1985, FEBS LETT, V183, P321, DOI 10.1016/0014-5793(85)80802-4; PATEL TB, 2006, EPIDERMAL GROWTH FAC; Poch B, 2001, PANCREAS, V23, P280, DOI 10.1097/00006676-200110000-00009; Robert C, 2006, TARGET ONCOL, V1, P100, DOI 10.1007/s11523-006-0013-6; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHNEIDER WJ, 1983, J CELL BIOCHEM, V23, P95, DOI 10.1002/jcb.240230110; Tuthill TJ, 2006, J VIROL, V80, P172, DOI 10.1128/JVI.80.1.172-180.2006	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7391	10.1371/journal.pone.0007391	http://dx.doi.org/10.1371/journal.pone.0007391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816581	gold, Green Published, Green Submitted			2022-12-25	WOS:000270594300011
J	Cain, JE; Islam, E; Haxho, F; Chen, L; Bridgewater, D; Nieuwenhuis, E; Hui, CC; Rosenblum, ND				Cain, Jason E.; Islam, Epshita; Haxho, Fiona; Chen, Lin; Bridgewater, Darren; Nieuwenhuis, Erica; Hui, Chi-Chung; Rosenblum, Norman D.			GLI3 Repressor Controls Nephron Number via Regulation of Wnt11 and Ret in Ureteric Tip Cells	PLOS ONE			English	Article								Truncating GLI3 mutations in Pallister-Hall Syndrome with renal malformation suggests a requirement for Hedgehog signaling during renal development. HH-dependent signaling increases levels of GLI transcriptional activators and decreases processing of GLI3 to a shorter transcriptional repressor. Previously, we showed that Shh-deficiency interrupts early inductive events during renal development in a manner dependent on GLI3 repressor. Here we identify a novel function for GLI3 repressor in controlling nephron number. During renal morphogenesis, HH signaling activity, assayed by expression of Ptc1-lacZ, is localized to ureteric cells of the medulla, but is undetectable in the cortex. Targeted inactivation of Smo, the HH effector, in the ureteric cell lineage causes no detectable abnormality in renal morphogenesis. The functional significance of absent HH signaling activity in cortical ureteric cells was determined by targeted deletion of Ptc1, the SMO inhibitor, in the ureteric cell lineage. Ptc1(-/-UB) mice demonstrate ectopic Ptc1-lacZ expression in ureteric branch tips and renal hypoplasia characterized by reduced kidney size and a paucity of mature and intermediate nephrogenic structures. Ureteric tip cells are remarkable for abnormal morphology and impaired expression of Ret and Wnt11, markers of tip cell differentiation. A finding of renal hypoplasia in Gli3(-/-) mice suggests a pathogenic role for reduced GLI3 repressor in the Ptc1(-/-UB) mice. Indeed, constitutive expression of GLI3 repressor via the Gli3(D699) allele in Ptc1(-/-UB) mice restores the normal pattern of HH signaling, and expression of Ret and Wnt11 and rescued the renal phenotype. Thus, GLI3 repressor controls nephron number by regulating ureteric tip cell expression of Wnt11 and Ret.			Cain, JE (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto Med Discovery Towers, Toronto, ON M5G 1X8, Canada.	norman.rosenblum@sickkids.ca	islam, Ejazul/G-2130-2015; Rosenblum, Norman D/H-4737-2015	Rosenblum, Norman D/0000-0003-1767-6464				Bai CB, 2002, DEVELOPMENT, V129, P4753; Bertram JF, 1995, INT REV CYTOL, V161, P111; Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Cain JE, 2005, KIDNEY INT, V67, P420, DOI 10.1111/j.1523-1755.2005.67098.x; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Ding Q, 1998, DEVELOPMENT, V125, P2533; Dziarmaga A, 2003, J AM SOC NEPHROL, V14, P2767, DOI 10.1097/01.ASN.0000094082.11026.EE; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; HALL JG, 1980, AM J MED GENET, V7, P47, DOI 10.1002/ajmg.1320070110; Hoy WE, 2006, KIDNEY INT, V70, P104, DOI 10.1038/sj.ki.5000397; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; JOHNSON DR, 1967, J EMBRYOL EXP MORPH, V17, P543; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Long FX, 2001, DEVELOPMENT, V128, P5099; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marigo V, 1996, DEVELOPMENT, V122, P1225; Michael L, 2007, J ANAT, V210, P89, DOI 10.1111/j.1469-7580.2006.00670.x; Mo R, 1997, DEVELOPMENT, V124, P113; Motoyama J, 2003, DEV BIOL, V259, P150, DOI 10.1016/S0012-1606(03)00159-3; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Park HL, 2000, DEVELOPMENT, V127, P1593; Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008; Srinivas S, 1999, DEV GENET, V24, P241; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Yu J, 2002, DEVELOPMENT, V129, P5301; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhang Z, 2008, J AM SOC NEPHROL, V19, P2027, DOI 10.1681/ASN.2007101098; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	54	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7313	10.1371/journal.pone.0007313	http://dx.doi.org/10.1371/journal.pone.0007313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809516	Green Submitted, Green Published, gold			2022-12-25	WOS:000270594000004
J	Olsen, L; Klausen, M; Helboe, L; Nielsen, FC; Werge, T				Olsen, Line; Klausen, Mikkel; Helboe, Lone; Nielsen, Finn Cilius; Werge, Thomas			MicroRNAs Show Mutually Exclusive Expression Patterns in the Brain of Adult Male Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; NEURONAL DIFFERENTIATION; MAMMALIAN MICRORNAS; MICROARRAY ANALYSIS; IMPACT; MIRNA; NORMALIZATION; PATHWAY; CELLS	Background: The brain is a major site of microRNA (miRNA) gene expression, but the spatial expression patterns of miRNAs within the brain have not yet been fully covered. Methodology/Principal Findings: We have characterized the regional expression profiles of miRNAs in five distinct regions of the adult rat brain: amygdala, cerebellum, hippocampus, hypothalamus and substantia nigra. Microarray profiling uncovered 48 miRNAs displaying more than three-fold enrichment between two or more brain regions. Notably, we found reciprocal expression profiles for a subset of the miRNAs predominantly found (>ten times) in either the cerebellum (miR-206 and miR-497) or the forebrain regions (miR-132, miR-212, miR-221 and miR-222). Conclusions/Significance: The results indicate that some miRNAs could be important for area-specific functions in the brain. Our data, combined with previous studies in mice, provides additional guidance for future investigations of miRNA functions in the brain.			Olsen, L (corresponding author), Psychiat Ctr Sct Hans, Inst Biol Psychiat, Roskilde, Denmark.	thomas.werge@shh.regionh.dk	Klausen, Mikkel/C-6254-2008; Werge, Thomas/G-7263-2012; Nielsen, Finn Cilius/AAA-4926-2020	Klausen, Mikkel/0000-0002-5741-0794; Nielsen, Finn Cilius/0000-0002-9829-1031				ADAMS BD, 2007, MOL ENDOCRINOL; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cooke J, 2004, BIOL REV, V79, P377, DOI 10.1017/S1464793103006298; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Halpern ME, 2005, J NEUROSCI, V25, P10351, DOI 10.1523/JNEUROSCI.3439-05.2005; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Hua YJ, 2008, GENOMICS, V92, P122, DOI 10.1016/j.ygeno.2008.04.002; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Martinez V, 2004, BEHAV NEUROSCI, V118, P984, DOI 10.1037/0735-7044.118.5.984; MCCARTHY JJ, 2008, BIOCH BIOPHYS ACTA; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Mendez P, 2006, FRONT NEUROENDOCRIN, V27, P391, DOI 10.1016/j.yfrne.2006.09.001; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Moskal JR, 2006, HIPPOCAMPUS, V16, P629, DOI 10.1002/hipo.20198; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Paxinos G, 1998, RAT BRAIN; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Sillitoe RV, 2005, PROG BRAIN RES, V148, P283, DOI 10.1016/S0079-6123(04)48022-4; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Thuringer D, 2004, ANN NY ACAD SCI, V1030, P14, DOI 10.1196/annals.1329.003; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VELLECA MA, 1994, MOL CELL BIOL, V14, P7095, DOI 10.1128/MCB.14.11.7095; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	60	90	106	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7225	10.1371/journal.pone.0007225	http://dx.doi.org/10.1371/journal.pone.0007225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806225	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800003
J	Qin, Z; Kreplak, L; Buehler, MJ				Qin, Zhao; Kreplak, Laurent; Buehler, Markus J.			Hierarchical Structure Controls Nanomechanical Properties of Vimentin Intermediate Filaments	PLOS ONE			English	Article								Intermediate filaments (IFs), in addition to microtubules and microfilaments, are one of the three major components of the cytoskeleton in eukaryotic cells, playing a vital role in mechanotransduction and in providing mechanical stability to cells. Despite the importance of IF mechanics for cell biology and cell mechanics, the structural basis for their mechanical properties remains unknown. Specifically, our understanding of fundamental filament properties, such as the basis for their great extensibility, stiffening properties, and their exceptional mechanical resilience remains limited. This has prevented us from answering fundamental structure-function relationship questions related to the biomechanical role of intermediate filaments, which is crucial to link structure and function in the protein material's biological context. Here we utilize an atomistic-level model of the human vimentin dimer and tetramer to study their response to mechanical tensile stress, and describe a detailed analysis of the mechanical properties and associated deformation mechanisms. We observe a transition from alpha-helices to beta-sheets with subsequent interdimer sliding under mechanical deformation, which has been inferred previously from experimental results. By upscaling our results we report, for the first time, a quantitative comparison to experimental results of IF nanomechanics, showing good agreement. Through the identification of links between structures and deformation mechanisms at distinct hierarchical levels, we show that the multi-scale structure of IFs is crucial for their characteristic mechanical properties, in particular their ability to undergo severe deformation of approximate to 300% strain without breaking, facilitated by a cascaded activation of a distinct deformation mechanisms operating at different levels. This process enables IFs to combine disparate properties such as mechanosensitivity, strength and deformability. Our results enable a new paradigm in studying biological and mechanical properties of IFs from an atomistic perspective, and lay the foundation to understanding how properties of individual protein molecules can have profound effects at larger length-scales.			Qin, Z (corresponding author), MIT, Lab Atomist & Mol Mech, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mbuehler@MIT.EDU	Qin, Zhao/B-4667-2010; Buehler, Markus/C-4580-2008	Qin, Zhao/0000-0001-5696-8553; kreplak, laurent/0000-0001-9370-9809; Buehler, Markus/0000-0002-4173-9659				Ackbarow T, 2009, EXP MECH, V49, P79, DOI 10.1007/s11340-007-9100-6; Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Ackbarow T, 2007, J MATER SCI, V42, P8771, DOI 10.1007/s10853-007-1719-2; Ackbarow T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006015; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Brown JH, 1996, PROTEINS, V26, P134; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fudge D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002327; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goldie KN, 2007, J STRUCT BIOL, V158, P378, DOI 10.1016/j.jsb.2006.12.007; Guzman C, 2006, J MOL BIOL, V360, P623, DOI 10.1016/j.jmb.2006.05.030; Hearle JWS, 2000, INT J BIOL MACROMOL, V27, P123, DOI 10.1016/S0141-8130(00)00116-1; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Keten S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198301; Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670; Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021; Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749; Kreplak L, 2002, BIOPHYS J, V82, P2265, DOI 10.1016/S0006-3495(02)75572-0; Kreplak L, 2009, J MOL BIOL, V385, P1043, DOI 10.1016/j.jmb.2008.10.095; Kreplak L, 2001, BIOPOLYMERS, V58, P526, DOI 10.1002/1097-0282(20010415)58:5<526::AID-BIP1028>3.0.CO;2-L; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leduc P, 2007, CELL BIOCHEM BIOPHYS, V48, P16, DOI 10.1007/s12013-007-0012-y; Lewis MK, 2003, J STRUCT BIOL, V143, P56, DOI 10.1016/S1047-8477(03)00121-7; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Nelson MT, 1996, INT J SUPERCOMPUT AP, V10, P251, DOI 10.1177/109434209601000401; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Paci E, 2000, P NATL ACAD SCI USA, V97, P6521, DOI 10.1073/pnas.100124597; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Qin Z, 2009, INT J APPL MECH, V1, P85, DOI 10.1142/S1758825109000058; Rafik E, 2004, BIOPHYS J, V86, P3893, DOI 10.1529/biophysj.103.034694; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Smith TA, 2002, J STRUCT BIOL, V137, P128, DOI 10.1006/jsbi.2002.4438; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; Stultz CM, 2006, PROTEIN SCI, V15, P2166, DOI 10.1110/ps.062124606; Sulkowska JI, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/283201; Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; West DK, 2006, BIOPHYS J, V90, P287, DOI 10.1529/biophysj.105.071035; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6	55	136	139	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7294	10.1371/journal.pone.0007294	http://dx.doi.org/10.1371/journal.pone.0007294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806221	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593800009
J	Sardiu, ME; Gilmore, JM; Carrozza, MJ; Li, B; Workman, JL; Florens, L; Washburn, MP				Sardiu, Mihaela E.; Gilmore, Joshua M.; Carrozza, Michael J.; Li, Bing; Workman, Jerry L.; Florens, Laurence; Washburn, Michael P.			Determining Protein Complex Connectivity Using a Probabilistic Deletion Network Derived from Quantitative Proteomics	PLOS ONE			English	Article							COREPRESSOR COMPLEX; SIGNAL-TRANSDUCTION; IDENTIFICATION; SIN3; COMPONENT; METHYLATION; REPRESSION; REVEALS; DOMAIN	Protein complexes are key molecular machines executing a variety of essential cellular processes. Despite the availability of genome-wide protein-protein interaction studies, determining the connectivity between proteins within a complex remains a major challenge. Here we demonstrate a method that is able to predict the relationship of proteins within a stable protein complex. We employed a combination of computational approaches and a systematic collection of quantitative proteomics data from wild-type and deletion strain purifications to build a quantitative deletion-interaction network map and subsequently convert the resulting data into an interdependency-interaction model of a complex. We applied this approach to a data set generated from components of the Saccharomyces cerevisiae Rpd3 histone deacetylase complexes, which consists of two distinct small and large complexes that are held together by a module consisting of Rpd3, Sin3 and Ume1. The resulting representation reveals new protein-protein interactions and new submodule relationships, providing novel information for mapping the functional organization of a complex.			Sardiu, ME (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	mpw@stowers-institute.org		Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	NIGMS NIH HHS [R37 GM047867] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047867] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Lottersberger F, 2007, MOL CELL BIOL, V27, P3266, DOI 10.1128/MCB.01767-06; Meunier B, 2007, J PROTEOME RES, V6, P358, DOI 10.1021/pr060343h; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Pang CNI, 2008, PROTEOMICS, V8, P425, DOI 10.1002/pmic.200700801; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Sahu SC, 2008, J MOL BIOL, V375, P1444, DOI 10.1016/j.jmb.2007.11.079; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; van Ingen H, 2006, J MOL BIOL, V358, P485, DOI 10.1016/j.jmb.2006.01.100; Viiri KM, 2006, NUCLEIC ACIDS RES, V34, P3288, DOI 10.1093/nar/gkl401; WANG HM, 1990, MOL CELL BIOL, V10, P5927, DOI 10.1128/MCB.10.11.5927; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	33	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7310	10.1371/journal.pone.0007310	http://dx.doi.org/10.1371/journal.pone.0007310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806189	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800017
J	Smith, LP; Nierstenhoefer, M; Yoo, SW; Penzias, AS; Tobiasch, E; Usheva, A				Smith, Laura P.; Nierstenhoefer, Maik; Yoo, Sang Wook; Penzias, Alan S.; Tobiasch, Edda; Usheva, Anny			The Bile Acid Synthesis Pathway Is Present and Functional in the Human Ovary	PLOS ONE			English	Article							LIVER RECEPTOR HOMOLOG-1; NUCLEAR RECEPTOR; CHOLESTEROL; ACTIVATION; EXPRESSION; LRH-1; CELLS; RAT; LXR	Background: Bile acids, end products of the pathway for cholesterol elimination, are required for dietary lipid and fat-soluble vitamin absorption and maintain the balance between cholesterol synthesis in the liver and cholesterol excretion. They are composed of a steroid structure and are primarily made in the liver by the oxidation of cholesterol. Cholesterol is also highly abundant in the human ovarian follicle, where it is used in the formation of the sex steroids. Methodology/Principal Findings: Here we describe for the first time evidence that all aspects of the bile acid synthesis pathway are present in the human ovarian follicle, including the enzymes in both the classical and alternative pathways, the nuclear receptors known to regulate the pathway, and the end product bile acids. Furthermore, we provide functional evidence that bile acids are produced by the human follicular granulosa cells in response to cholesterol presence in the culture media. Conclusions/Significance: These findings establish a novel pathway present in the human ovarian follicle that has the capacity to compete directly with sex steroid synthesis.			Smith, LP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Boston, MA 02215 USA.	ausheva@bidmc.harvard.edu		Penzias, Alan/0000-0002-7160-494X				Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Ferdinandusse S, 2006, BBA-MOL CELL RES, V1763, P1427, DOI 10.1016/j.bbamcr.2006.09.001; Fiorucci S, 2005, J PHARMACOL EXP THER, V313, P604, DOI 10.1124/jpet.104.079665; FRANCHIMONT P, 1989, FERTIL STERIL, V52, P1006; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Hall E, 2001, AM J PHYSIOL-GASTR L, V281, pG293, DOI 10.1152/ajpgi.2001.281.1.G293; Hasler Julia A., 1999, Molecular Aspects of Medicine, V20, P1, DOI 10.1016/S0098-2997(99)00005-9; Hinshelwood MM, 2005, DEV DYNAM, V234, P159, DOI 10.1002/dvdy.20490; Ishida H, 1999, J BIOCHEM-TOKYO, V126, P19, DOI 10.1093/oxfordjournals.jbchem.a022422; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; JAVITT NB, 1994, FASEB J, V8, P1308, DOI 10.1096/fasebj.8.15.8001744; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MCNATTY KP, 1979, J CLIN ENDOCR METAB, V49, P687, DOI 10.1210/jcem-49-5-687; Mendelson CR, 2007, J STEROID BIOCHEM, V106, P62, DOI 10.1016/j.jsbmb.2007.05.001; NG TB, 1993, INT J FERTIL, V38, P316; Nguyen LB, 1999, METABOLISM, V48, P1542, DOI 10.1016/S0026-0495(99)90243-3; Norlin M, 2007, CURR MOL MED, V7, P199, DOI 10.2174/156652407780059168; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Raufman JP, 2003, DIGEST DIS SCI, V48, P1431, DOI 10.1023/A:1024733500950; Saxena D, 2007, ENDOCRINOLOGY, V148, P726, DOI 10.1210/en.2006-0108; SUCHANEK E, 1988, J CLIN CHEM CLIN BIO, V26, P543; Torchia EC, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-11; Wu ZL, 1999, J LIPID RES, V40, P2195; Zimon A, 2006, NUCLEIC ACIDS RES, V34, P3279, DOI 10.1093/nar/gkl387	29	33	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7333	10.1371/journal.pone.0007333	http://dx.doi.org/10.1371/journal.pone.0007333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806215	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800024
J	Wilson, JA; Marsicano, CA; Smith, RMH				Wilson, Jeffrey A.; Marsicano, Claudia A.; Smith, Roger M. H.			Dynamic Locomotor Capabilities Revealed by Early Dinosaur Trackmakers from Southern Africa	PLOS ONE			English	Article							EARLY EVOLUTION; THEROPOD DINOSAUR; TETRAPOD FAUNA; UPPER ELLIOT	Background: A new investigation of the sedimentology and ichnology of the Early Jurassic Moyeni tracksite in Lesotho, southern Africa has yielded new insights into the behavior and locomotor dynamics of early dinosaurs. Methodology/Principal Findings: The tracksite is an ancient point bar preserving a heterogeneous substrate of varied consistency and inclination that includes a ripple-marked riverbed, a bar slope, and a stable algal-matted bar top surface. Several basal ornithischian dinosaurs and a single theropod dinosaur crossed its surface within days or perhaps weeks of one another, but responded to substrate heterogeneity differently. Whereas the theropod trackmaker accommodated sloping and slippery surfaces by gripping the substrate with its pedal claws, the basal ornithischian trackmakers adjusted to the terrain by changing between quadrupedal and bipedal stance, wide and narrow gauge limb support (abduction range = 31 degrees), and plantigrade and digitigrade foot posture. Conclusions/Significance: The locomotor adjustments coincide with changes in substrate consistency along the trackway and appear to reflect 'real time' responses to a complex terrain. It is proposed that these responses foreshadow important locomotor transformations characterizing the later evolution of the two main dinosaur lineages. Ornithischians, which shifted from bipedal to quadrupedal posture at least three times in their evolutionary history, are shown to have been capable of adopting both postures early in their evolutionary history. The substrate-gripping behavior demonstrated by the early theropod, in turn, is consistent with the hypothesized function of pedal claws in bird ancestors.			Wilson, JA (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	wilsonja@umich.edu	Wilson, Jeffrey/C-2737-2008; Smith, Roger/AAF-7947-2019					[Anonymous], [No title captured]; BOCK WALTER J., 1959, AMER MUS NOVITATES, V1931, P1; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2041, DOI 10.1098/rspb.2007.0367; Butler RJ, 2005, ZOOL J LINN SOC-LOND, V145, P175, DOI 10.1111/j.1096-3642.2005.00182.x; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; Carrano MT, 2000, PALEOBIOLOGY, V26, P489, DOI 10.1666/0094-8373(2000)026<0489:HATEOD>2.0.CO;2; CASAMIQUELA RM, 1967, AMEGHINIANA, V4, P47; COLBERT EH, 1981, MUSEUM NO ARIZONA B, V53, P1; Day JJ, 2002, NATURE, V415, P494, DOI 10.1038/415494a; Dial KP, 2006, BIOSCIENCE, V56, P437, DOI 10.1641/0006-3568(2006)056[0437:WUIHAW]2.0.CO;2; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; ELLENBERGER F, 1967, INT S GONDW GEOL UNE, P333; ELLENBERGER F, 1963, C R SOMM SEANCE SOC, P315; ELLENBERGER P, 1974, PALEOVERTEBRATA MEMO, V1, P1; Ezquerra R, 2007, GEOLOGY, V35, P507, DOI 10.1130/G23452A.1; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; GIERLINSKI G, 1991, PALAEOGEOGR PALAEOCL, V85, P137, DOI 10.1016/0031-0182(91)90030-U; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; HAUBOLD H, 1986, BEGINNING AGE DINOSA, P189; Henderson Donald M., 2003, Ichnos, V10, P99, DOI 10.1080/10420940390257914; Knoll F, 2005, B SOC GEOL FR, V176, P81, DOI 10.2113/176.1.81; Knoll F, 2004, B SOC GEOL FR, V175, P73, DOI 10.2113/175.1.73; Lockley Martin, 2003, Ichnos, V10, P169, DOI 10.1080/10420940390256249; LULL RS, 1953, B CONNECTICUT STATE, V81, P1; LULL RS, 1915, B CONNECTICUT STATE, V24, P1; Milner ARC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004591; MILNER ARC, 2006, MUS NAT HIST SCI B, V37, P315; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P325; OLSEN P E, 1984, Palaeontologia Africana, V25, P87; Olsen P.E., 1986, P61; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Olsen PE, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P314; Owen R., 1861, MONOGRAPHS PALAEONTO, V13, P1; RAINFORTH E.C., 2002, GEOLOGICAL SOC AM AB, V34, P61; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Santa Luca A.P., 1980, Annals of the South African Museum, V79, P159; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P168; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SMITH RMH, PALAIOS IN PRESS, V24; THULBORN R A, 1972, Palaeontology (Oxford), V15, P29; Thulborn RA., 1990, DINOSAUR TRACKS; Yates Adam M., 2005, Palaeontologia Africana, V41, P105	45	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7331	10.1371/journal.pone.0007331	http://dx.doi.org/10.1371/journal.pone.0007331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806213	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800023
J	Rose, AMC; Gerstl, S; Mahamane, AEH; Sidikou, F; Djibo, S; Bonte, L; Caugant, DA; Guerin, PJ; Chanteau, S				Rose, Angela M. C.; Gerstl, Sibylle; Mahamane, Ali E. -H.; Sidikou, Fati; Djibo, Saacou; Bonte, Laurence; Caugant, Dominique A.; Guerin, Philippe J.; Chanteau, Suzanne			Field Evaluation of Two Rapid Diagnostic Tests for Neisseria meningitidis Serogroup A during the 2006 Outbreak in Niger	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MENINGOCOCCAL MENINGITIS; BACTERIAL-MENINGITIS; IDENTIFICATION; SURVEILLANCE; ASSAY; BELT	The Pastorex (R) (BioRad) rapid agglutination test is one of the main rapid diagnostic tests (RDTs) for meningococcal disease currently in use in the "meningitis belt''. Earlier evaluations, performed after heating and centrifugation of cerebrospinal fluid (CSF) samples, under good laboratory conditions, showed high sensitivity and specificity. However, during an epidemic, the test may be used without prior sample preparation. Recently a new, easy-to-use dipstick RDT for meningococcal disease detection on CSF was developed by the Centre de Recherche Medicale et Sanitaire in Niger and the Pasteur Institute in France. We estimate diagnostic accuracy in the field during the 2006 outbreak of Neisseria meningitidis serogroup A in Maradi, Niger, for the dipstick RDT and Pastorex (R) on unprepared CSF, (a) by comparing each test's sensitivity and specificity with previously reported values; and (b) by comparing results for each test on paired samples, using McNemar's test. We also (c) estimate diagnostic accuracy of the dipstick RDT on diluted whole blood. We tested unprepared CSF and diluted whole blood from 126 patients with suspected meningococcal disease presenting at four health posts. (a) Pastorex (R) sensitivity (69%; 95%CI 57-79) was significantly lower than found previously for prepared CSF samples [87% (81-91); or 88% (85-91)], as was specificity [81% (95%CI 68-91) vs 93% (90-95); or 93% (87-96)]. Sensitivity of the dipstick RDT [89% (95%CI 80-95)] was similar to previously reported values for ideal laboratory conditions [89% (84-93) and 94% (90-96)]. Specificity, at 62% (95%CI 48-75), was significantly lower than found previously [94% (92-96) and 97% (94-99)]. (b) McNemar's test for the dipstick RDT vs Pastorex (R) was statistically significant (p<0.001). (c) The dipstick RDT did not perform satisfactorily on diluted whole blood (sensitivity 73%; specificity 57%). Sensitivity and specificity of Pastorex (R) without prior CSF preparation were poorer than previously reported results from prepared samples; therefore we caution against using this test during an epidemic if sample preparation is not possible. For the dipstick RDT, sensitivity was similar to, while specificity was not as high as previously reported during a more stable context. Further studies are needed to evaluate its field performance, especially for different populations and other serogroups.			Rose, AMC (corresponding author), Epictr, Paris, France.	angela.rose@cavehill.uwi.edu	, dcaugant/AAH-6843-2019; Rose, Angela MC/O-1645-2019; Rose, Angela/I-5584-2014; Guerin, Philippe/AAH-8873-2021	, dcaugant/0000-0003-2765-9844; Rose, Angela MC/0000-0002-2493-8082; Rose, Angela/0000-0002-2493-8082; Guerin, Philippe/0000-0002-6008-2963				Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Borel T, 2006, T ROY SOC TROP MED H, V100, P964, DOI 10.1016/j.trstmh.2006.03.002; Caugant DA, 1996, SCAND J INFECT DIS, V28, P149, DOI 10.3109/00365549609049066; Chanteau S, 2006, T ROY SOC TROP MED H, V100, P677, DOI 10.1016/j.trstmh.2005.09.006; Chanteau S, 2006, PLOS MED, V3, P1579, DOI 10.1371/journal.pmed.0030337; Chanteau S, 2007, VACCINE, V25, pA30, DOI 10.1016/j.vaccine.2007.04.037; Djibo S, 2006, T ROY SOC TROP MED H, V100, P573, DOI 10.1016/j.trstmh.2005.10.002; FERMON F, 2004, MANAGEMENT EPIDEMIC; Nathan N, 2007, EMERG INFECT DIS, V13, P920, DOI 10.3201/eid1306.060940; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Sidikou F, 2003, EMERG INFECT DIS, V9, P1486, DOI 10.3201/eid0911.030462; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000	12	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7326	10.1371/journal.pone.0007326	http://dx.doi.org/10.1371/journal.pone.0007326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802392	gold, Green Submitted, Green Published			2022-12-25	WOS:000270593600008
J	Tsui, M; Xie, T; Orth, JD; Carpenter, AE; Rudnicki, S; Kim, S; Shamu, CE; Mitchison, TJ				Tsui, Melody; Xie, Tiao; Orth, James D.; Carpenter, Anne E.; Rudnicki, Stewart; Kim, Suejong; Shamu, Caroline E.; Mitchison, Timothy J.			An Intermittent Live Cell Imaging Screen for siRNA Enhancers and Suppressors of a Kinesin-5 Inhibitor	PLOS ONE			English	Article								Kinesin-5 (also known as Eg5, KSP and Kif11) is required for assembly of a bipolar mitotic spindle. Small molecule inhibitors of Kinesin-5, developed as potential anti-cancer drugs, arrest cell in mitosis and promote apoptosis of cancer cells. We performed a genome-wide siRNA screen for enhancers and suppressors of a Kinesin-5 inhibitor in human cells to elucidate cellular responses, and thus identify factors that might predict drug sensitivity in cancers. Because the drug's actions play out over several days, we developed an intermittent imaging screen. Live HeLa cells expressing GFP-tagged histone H2B were imaged at 0, 24 and 48 hours after drug addition, and images were analyzed using open-source software that incorporates machine learning. This screen effectively identified siRNAs that caused increased mitotic arrest at low drug concentrations (enhancers), and vice versa (suppressors), and we report siRNAs that caused both effects. We then classified the effect of siRNAs for 15 genes where 3 or 4 out of 4 siRNA oligos tested were suppressors as assessed by time lapse imaging, and by testing for suppression of mitotic arrest in taxol and nocodazole. This identified 4 phenotypic classes of drug suppressors, which included known and novel genes. Our methodology should be applicable to other screens, and the suppressor and enhancer genes we identified may open new lines of research into mitosis and checkpoint biology.			Tsui, M (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	timothy_mitchison@hms.harvard.edu	Carpenter, Anne/C-4982-2008; Orth, James/Q-4905-2019	Carpenter, Anne/0000-0003-1555-8261; ORTH, JAMES/0000-0002-8559-6186	NATIONAL CANCER INSTITUTE [P01CA078048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089652] Funding Source: NIH RePORTER; NCI NIH HHS [CA078048, P01 CA078048] Funding Source: Medline; NIGMS NIH HHS [R01 GM089652] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartz SR, 2006, MOL CELL BIOL, V26, P9377, DOI 10.1128/MCB.01229-06; Bergnes G, 2005, CURR TOP MED CHEM, V5, P127, DOI 10.2174/1568026053507697; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen JG, 2002, CANCER RES, V62, P1935; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; HERMAN B, 2002, CURR PROTOC CELL BIO, pCH4; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Rines DR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r44; SAWIN KE, 1992, J CELL SCI, V101, P303; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Shibue T, 2006, INT J CANCER, V119, P2036, DOI 10.1002/ijc.21751; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697	28	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7339	10.1371/journal.pone.0007339	http://dx.doi.org/10.1371/journal.pone.0007339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802393	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593600012
J	Nan, J; Brostromer, E; Liu, XY; Kristensen, O; Su, XD				Nan, Jie; Brostromer, Erik; Liu, Xiang-Yu; Kristensen, Ole; Su, Xiao-Dong			Bioinformatics and Structural Characterization of a Hypothetical Protein from Streptococcus mutans: Implication of Antibiotic Resistance	PLOS ONE			English	Article								As an oral bacterial pathogen, Streptococcus mutans has been known as the aetiologic agent of human dental caries. Among a total of 1960 identified proteins within the genome of this organism, there are about 500 without any known functions. One of these proteins, SMU. 440, has very few homologs in the current protein databases and it does not fall into any protein functional families. Phylogenetic studies showed that SMU. 440 is related to a particular ecological niche and conserved specifically in some oral pathogens, due to lateral gene transfer. The co-occurrence of a MarR protein within the same operon among these oral pathogens suggests that SMU. 440 may be associated with antibiotic resistance. The structure determination of SMU. 440 revealed that it shares the same fold and a similar pocket as polyketide cyclases, which indicated that it is very likely to bind some polyketide-like molecules. From the interlinking structural and bioinformatics studies, we have concluded that SMU. 440 could be involved in polyketide-like antibiotic resistance, providing a better understanding of this hypothetical protein. Besides, the combination of multiple methods in this study can be used as a general approach for functional studies of a protein with unknown function.			Nan, J (corresponding author), Peking Univ, Natl Lab Prot Engn & Plant Genet Engn, Coll Life Sci, Beijing 100871, Peoples R China.	xdsu@pku.edu.cn	Nan, Jie/I-5327-2013	Nan, Jie/0000-0003-1054-5082				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P., 2005, CCP4 NEWSLETTER; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Beiko Robert G., 2008, V452, P457, DOI 10.1007/978-1-60327-159-2_21; Carlsson J, 1997, Adv Dent Res, V11, P75; Chevalier M, 2008, BIOL PLANTARUM, V52, P718, DOI 10.1007/s10535-008-0138-9; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng DM, 2009, J BACTERIOL, V191, P394, DOI 10.1128/JB.00838-08; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOSHINO E, 1985, J DENT RES, V64, P1195, DOI 10.1177/00220345850640100301; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kado CI, 2009, MOL PLANT PATHOL, V10, P143, DOI 10.1111/j.1364-3703.2008.00518.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lawrence JG, 1997, TRENDS MICROBIOL, V5, P355, DOI 10.1016/S0966-842X(97)01110-4; Lawrence JG, 1999, CURR OPIN MICROBIOL, V2, P519, DOI 10.1016/S1369-5274(99)00010-7; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Niu GQ, 2008, J BACTERIOL, V190, P7268, DOI 10.1128/JB.00967-08; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ochman H, 2005, P NATL ACAD SCI USA, V102, P6595, DOI 10.1073/pnas.0502035102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Ragan MA, 2006, TRENDS MICROBIOL, V14, P4, DOI 10.1016/j.tim.2005.11.004; Su XD, 2006, ACTA CRYSTALLOGR D, V62, P843, DOI 10.1107/S0907444906024395; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waterhouse A.M., 2009, BIOINFORMATICS; Wen J, 1997, MOL PHYLOGENET EVOL, V8, P317, DOI 10.1006/mpev.1997.0447; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Zawada RJX, 1999, CHEM BIOL, V6, P607	43	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7245	10.1371/journal.pone.0007245	http://dx.doi.org/10.1371/journal.pone.0007245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798411	gold, Green Published, Green Submitted			2022-12-25	WOS:000270593300006
J	Bauer, J; Liebisch, G; Hofmann, C; Huy, C; Schmitz, G; Obermeier, F; Bock, J				Bauer, Jessica; Liebisch, Gerhard; Hofmann, Claudia; Huy, Christian; Schmitz, Gerd; Obermeier, Florian; Bock, Juergen			Lipid Alterations in Experimental Murine Colitis: Role of Ceramide and Imipramine for Matrix Metalloproteinase-1 Expression	PLOS ONE			English	Article								Background: Dietary lipids or pharmacologic modulation of lipid metabolism are potential therapeutic strategies in inflammatory bowel disease (IBD). Therefore, we analysed alterations of bioactive lipids in experimental models of colitis and examined the functional consequence of the second messenger ceramide in inflammatory pathways leading to tissue destruction. Methodology/Principal Findings: Chronic colitis was induced by dextran-sulphate-sodium (DSS) or transfer of CD4(+)CD62L(+) cells into RAG1(-/-)-mice. Lipid content of isolated murine intestinal epithelial cells (IEC) was analysed by tandem mass spectrometry. Concentrations of MMP-1 in supernatants of Caco-2-IEC and human intestinal fibroblasts from patients with ulcerative colitis were determined by ELISA. Imipramine was used for pharmacologic inhibition of acid sphingomyelinase (ASM). Ceramide increased by 71% in chronic DSS-induced colitis and by 159% in the transfer model of colitis. Lysophosphatidylcholine (LPC) decreased by 22% in both models. No changes were detected for phosphatidylcholine. Generation of ceramide by exogenous SMase increased MMP-1-protein production of Caco-2-IEC up to 7-fold. Inhibition of ASM completely abolished the induction of MMP-1 by TNF or IL-1 beta in Caco-2-IEC and human intestinal fibroblasts. Conclusions/Significance: Mucosal inflammation leads to accumulation of ceramide and decrease of LPC in the intestinal epithelium. One aspect of ceramide generation is an increase of MMP-1. Induction of MMP-1 by TNF or IL-1 beta is completely blocked by inhibition of ASM with imipramine. Therefore, inhibition of ASM may offer a treatment strategy to reduce MMP-1 expression and tissue destruction in inflammatory conditions.			Bauer, J (corresponding author), Univ Med Ctr, Dept Internal Med 1, Regensburg, Germany.	juergen.bock@klinik.uni-regensburg.de	Bauer, Jessica/AAT-7399-2020; Liebisch, Gerhard/G-6130-2010	Bauer, Jessica/0000-0001-9022-9877; Liebisch, Gerhard/0000-0003-4886-0811				ALBOUZ S, 1981, BIOMED EXPRESS, V35, P218; Ballou LR, 1996, BBA-LIPID LIPID MET, V1301, P273, DOI 10.1016/0005-2760(96)00004-5; Bauer J, 2009, FEBS LETT, V583, P915, DOI 10.1016/j.febslet.2009.02.008; Baugh MD, 1999, GASTROENTEROLOGY, V117, P814, DOI 10.1016/S0016-5085(99)70339-2; Bock J, 2003, BIOCHEM BIOPH RES CO, V305, P890, DOI 10.1016/S0006-291X(03)00763-0; Bock J, 2007, WORLD J GASTROENTERO, V13, P5217, DOI 10.3748/wjg.v13.i39.5217; Brenmoehl J, 2008, INT J COLORECTAL DIS, V23, P947, DOI 10.1007/s00384-008-0523-z; Bu Shizhong, 2006, FASEB J, V20, P184; Daig R, 2000, GUT, V46, P350, DOI 10.1136/gut.46.3.350; Duan RD, 2006, BBA-MOL CELL BIOL L, V1761, P281, DOI 10.1016/j.bbalip.2006.03.007; Ehehalt R, 2008, WORLD J GASTROENTERO, V14, P1528, DOI 10.3748/wjg.14.1528; Esmaeili A, 2008, GASTROENTEROLOGY, V134, pA100; FABIA R, 1992, DIGESTION, V53, P35, DOI 10.1159/000200969; FARR A, 1991, J HISTOCHEM CYTOCHEM, V39, P645, DOI 10.1177/39.5.2016514; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Gulbins E, 2003, PHARMACOL RES, V47, P393, DOI 10.1016/S1043-6618(03)00052-5; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HELLER RA, 1994, J CELL BIOL, V126, P5, DOI 10.1083/jcb.126.1.5; Heuschkel RB, 2000, GUT, V47, P57, DOI 10.1136/gut.47.1.57; Hofmeister R, 1997, J BIOL CHEM, V272, P27730, DOI 10.1074/jbc.272.44.27730; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Jensen JM, 1999, J CLIN INVEST, V104, P1761, DOI 10.1172/JCI5307; KOLESNICK RN, 1994, BIOCHEM CELL BIOL, V72, P471, DOI 10.1139/o94-063; LAFUMA C, 1994, J INVEST DERMATOL, V102, P945, DOI 10.1111/1523-1747.ep12384118; Lang F, 2007, ARCH BIOCHEM BIOPHYS, V462, P189, DOI 10.1016/j.abb.2006.12.028; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Leeb SN, 2002, GROWTH FACTORS, V20, P81, DOI 10.1080/08977190290031941; Liebisch G, 2005, BBA-MOL CELL BIOL L, V1734, P86, DOI 10.1016/j.bbalip.2005.01.002; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liu-Wu Y, 1998, ATHEROSCLEROSIS, V137, P351, DOI 10.1016/S0021-9150(97)00295-5; MACKAY AR, 1992, INVAS METAST, V12, P168; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; MCKEAN ML, 1981, J BIOL CHEM, V256, P1522; Meijer MJW, 2007, WORLD J GASTROENTERO, V13, P2960, DOI 10.3748/wjg.v13.i21.2960; Mourelle M, 1996, GASTROENTEROLOGY, V110, P1093, DOI 10.1053/gast.1996.v110.pm8612998; Mudter J, 2002, PATHOBIOLOGY, V70, P170, DOI 10.1159/000068150; Naito Yuji, 2005, Molecular Aspects of Medicine, V26, P379; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Olofsson KE, 2008, BIOCHEM BIOPH RES CO, V370, P348, DOI 10.1016/j.bbrc.2008.03.087; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Sakata A, 2007, IMMUNOLOGY, V122, P54, DOI 10.1111/j.1365-2567.2007.02612.x; Sakata A, 2007, CELL IMMUNOL, V245, P24, DOI 10.1016/j.cellimm.2007.03.005; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SCHUTZE S, 1994, J LEUKOCYTE BIOL, V56, P533, DOI 10.1002/jlb.56.5.533; Sengupta N, 2007, PHYSIOLOGY, V22, P401, DOI 10.1152/physiol.00027.2007; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stremmel W, 2005, GUT, V54, P966, DOI 10.1136/gut.2004.052316; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Treede I, 2007, J BIOL CHEM, V282, P27155, DOI 10.1074/jbc.M704408200; Wang YD, 2007, WORLD J GASTROENTERO, V13, P5926, DOI 10.3748/wjg.v13.i44.5926; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; WLASCHEK M, 1994, PHOTOCHEM PHOTOBIOL, V59, P550, DOI 10.1111/j.1751-1097.1994.tb02982.x; WojtowiczPraga SM, 1997, INVEST NEW DRUG, V15, P61, DOI 10.1023/A:1005722729132; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335	57	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7197	10.1371/journal.pone.0007197	http://dx.doi.org/10.1371/journal.pone.0007197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787068	gold, Green Published, Green Submitted			2022-12-25	WOS:000270290100012
J	Horlitz, M; Lucas, A; Sprenger-Haussels, M				Horlitz, Martin; Lucas, Annabelle; Sprenger-Haussels, Markus			Optimized Quantification of Fragmented, Free Circulating DNA in Human Blood Plasma Using a Calibrated Duplex Real-Time PCR	PLOS ONE			English	Article							FETAL DNA	Background: Duplex real-time PCR assays have been widely used to determine amounts and concentrations of free circulating DNA in human blood plasma samples. Circulatory plasma DNA is highly fragmented and hence a PCR-based determination of DNA concentration may be affected by the limited availability of full-length targets in the DNA sample. This leads to inaccuracies when counting PCR target copy numbers as whole genome equivalents. Methodology/Principal Findings: A model system was designed allowing for assessment of bias in a duplex real-time PCR research assay. We collected blood plasma samples from male donors in pools of 6 to 8 individuals. Circulatory plasma DNA was extracted and separated by agarose gel electrophoresis. Separated DNA was recovered from the gel in discrete size fractions and analyzed with different duplex real-time PCR Taqman assays detecting a Y chromosome-specific target and an autosomal target. The real-time PCR research assays used differed significantly in their ability to determine the correct copy number ratio of 0.5 between Y chromosome and autosome targets in DNA of male origin. Longer PCR targets did not amplify quantitatively in circulatory DNA, due to limited presence of full-length target sequence in the sample. Conclusions: PCR targets of the same small size are preferred over longer targets when comparing fractional circulatory DNA concentrations by real-time PCR. As an example, a DYS14/18S duplex real-time PCR research assay is presented that correctly measures the fractional concentration of male DNA in a male/female mixture of circulatory, fragmented DNA.			Horlitz, M (corresponding author), QIAGEN GmbH, R&D Dept, Hilden, Germany.	martin.horlitz@qiagen.com						Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Atamaniuk J, 2006, CLIN CHEM, V52, P523, DOI 10.1373/clinchem.2005.058883; Boom R, 2002, J CLIN MICROBIOL, V40, P4105, DOI 10.1128/JCM.40.11.4105-4113.2002; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Hein AE, 2007, ANAL BIOCHEM, V360, P41, DOI 10.1016/j.ab.2006.10.016; Hiromadnikova I, 2006, DNA CELL BIOL, V25, P635, DOI 10.1089/dna.2006.25.635; Ishii T, 2007, ANAL BIOCHEM, V362, P201, DOI 10.1016/j.ab.2006.12.004; Koide K, 2005, PRENATAL DIAG, V25, P604, DOI 10.1002/pd.1213; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Nicklas JA, 2006, J FORENSIC SCI, V51, P1005, DOI 10.1111/j.1556-4029.2006.00211.x; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; van der Vaart M, 2007, CLIN CHEM, V53, P2215, DOI 10.1373/clinchem.2007.092734; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020; Zhong XY, 2001, SWISS MED WKLY, V131, P70; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235	16	16	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7207	10.1371/journal.pone.0007207	http://dx.doi.org/10.1371/journal.pone.0007207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784371	gold, Green Submitted, Green Published			2022-12-25	WOS:000270290000013
J	Al-Ansary, D; Bogeski, I; Disteldorf, BMJ; Becherer, U; Niemeyer, BA				Al-Ansary, Dalia; Bogeski, Ivan; Disteldorf, Barbara M. J.; Becherer, Ute; Niemeyer, Barbara A.			ATP modulates Ca2+ uptake by TRPV6 and is counteracted by isoform-specific phosphorylation	FASEB JOURNAL			English	Article						Ca2+ homeostasis; PKC beta II; TRP channels; ATP regulation; allele-specific selection; polymorphism	PROTEIN-KINASE-C; ANKYRIN REPEAT DOMAIN; EPITHELIAL CA2+; CHANNEL ACTIVITY; CALCIUM-CHANNEL; CAT-LIKE; INHIBITION; EXPRESSION; INACTIVATION; TRANSPORTERS	Ca2+ homeostasis requires balanced uptake and extrusion, and dysregulation leads to disease. TRPV6 channels are homeostasis regulators, are up-regulated in certain cancers, and show an unusual allelespecific evolution in humans. To understand how Ca2+ uptake can be adapted to changes in metabolic status, we investigate regulation of Ca2+-influx by ATP and phosphorylation. We show that ATP binds to TRPV6, reduces whole-cell current increments, and prevents channel rundown with an EC50 of 380 mu M. By using both biochemical binding studies and patch-clamp analyses of wild-type and mutant channels, we have mapped one relevant site for regulation by ATP to residues within the ankyrin repeat domain (ARD) and identify an additional C-terminal binding region. Stimulation of PKC largely prevented the effects of ATP. This regulation requires PKC beta II and defined phosphorylation sites within the ARD and the C-terminus. Both regulatory sites act synergistically to constitute a novel mechanism by which ATP stabilizes channel activity and acts as a metabolic switch for Ca2+ influx. Decreases in ATP concentration or activation of PKC beta II disable regulation of the channels by ATP, rendering them more susceptible to inactivation and rundown and preventing Ca2+ overload.-Al-Ansary, D., Bogeski, I., Disteldorf, B. M. J., Becherer, U., Niemeyer, B. A. ATP modulates Ca2+ uptake by TRPV6 and is counteracted by isoform-specific phosphorylation. FASEB J. 24, 425-435 (2010). www.fasebj.org	[Al-Ansary, Dalia; Bogeski, Ivan; Disteldorf, Barbara M. J.; Niemeyer, Barbara A.] Univ Saarland, Dept Biophys, D-66421 Homburg, Germany; [Becherer, Ute] Univ Saarland, Dept Physiol, D-66421 Homburg, Germany; [Al-Ansary, Dalia; Niemeyer, Barbara A.] Univ Saarland, Dept Pharmacol & Toxicol, D-66421 Homburg, Germany	Saarland University; Saarland University; Saarland University	Niemeyer, BA (corresponding author), Univ Saarland, Dept Biophys, Kirrberger Str,Geb 58, D-66421 Homburg, Germany.	barbara.niemeyer@uks.eu	Niemeyer, Barbara A./AAL-8972-2021; Becherer, Ute/AGW-2576-2022; Bogeski, Ivan/ABA-2141-2021; Becherer, Ute/F-6711-2010	Bogeski, Ivan/0000-0001-9879-7174; Becherer, Ute/0000-0001-6005-7517; Alansary, Dalia/0000-0002-7541-6057; Niemeyer, Barbara A./0000-0002-6963-0575	Deutsche Forschungsgemeinschaft (DFG) [NI 671, GK 1326]; HOMFOR	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); HOMFOR	We especially thank Dr. Veit Flockerzi and Dr. Ulrich Wissenbach (University of Saarland, Homburg, Germany) for the stable TRPV6 cell lines, for antibodies against TRPV6 and the HIS tag, and, together with Dr. Hoth, for discussions and critical reading of the manuscript. We also thank Dr. Yusuf Hannun (Medical University of South Carolina, Charleston, SC, USA) and Dr. Peter Lipp (University of Saarland) for kindly providing us with the cDNA for GFP-PKC<INF>beta II</INF> and GFP-PKC<INF>alpha</INF>; Dr. Marcel Meissner (University of Saarland) for fusion proteins of mTRPV6; Heidi Lohr, Anja Ludes, and Bettina Strauss for cell culture work; and members of the labs for critical input. This work was supported, in part, by the Deutsche Forschungsgemeinschaft (DFG; NI 671 to B.N.) and HOMFOR (B.N.). D.A.-A. is a member of the DFG-sponsored graduate program GK 1326.	Abdalla I, 1998, UROLOGY, V51, P300, DOI 10.1016/S0090-4295(97)00617-1; Akey JM, 2006, HUM MOL GENET, V15, P2106, DOI 10.1093/hmg/ddl134; Bodding M, 2002, J BIOL CHEM, V277, P36656, DOI 10.1074/jbc.M202822200; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Craig TJ, 2008, J GEN PHYSIOL, V132, P131, DOI 10.1085/jgp.200709874; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Dhar-Chowdhury P, 2007, CELL MOL LIFE SCI, V64, P3069, DOI 10.1007/s00018-007-7332-3; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; Fixemer T, 2003, ONCOGENE, V22, P7858, DOI 10.1038/sj.onc.1206895; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerini D, 2005, CELL CALCIUM, V38, P281, DOI 10.1016/j.ceca.2005.06.032; Guerini D, 1998, CELL TISSUE RES, V292, P191, DOI 10.1007/s004410051050; Hilgemann DW, 1997, ANNU REV PHYSIOL, V59, P193, DOI 10.1146/annurev.physiol.59.1.193; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hughes DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001686; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kameyama M, 1998, PFLUG ARCH EUR J PHY, V435, P344, DOI 10.1007/s004240050521; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Nilius B, 2002, J BIOL CHEM, V277, P30852, DOI 10.1074/jbc.M202418200; Nilius B, 2001, CELL CALCIUM, V29, P417, DOI 10.1054/ceca.2001.0201; OKASHIRO T, 1992, EXP PHYSIOL, V77, P719, DOI 10.1113/expphysiol.1992.sp003638; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; ROMANIN C, 1991, PFLUG ARCH EUR J PHY, V418, P86, DOI 10.1007/BF00370456; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Suzuki Y, 2008, ANNU REV PHYSIOL, V70, P257, DOI 10.1146/annurev.physiol.69.031905.161003; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Thyagarajan B, 2008, J BIOL CHEM, V283, P14980, DOI 10.1074/jbc.M704224200; van de Graaf SFJ, 2007, REV PHYSIOL BIOCH P, V158, P77, DOI 10.1007/11220060607; van de Graaf SFJ, 2008, J BIOL CHEM, V283, P4077, DOI 10.1074/jbc.M706959200; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Zhang XD, 2008, J GEN PHYSIOL, V132, P421, DOI 10.1085/jgp.200810023	42	20	20	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					425	435		10.1096/fj.09-141481	http://dx.doi.org/10.1096/fj.09-141481			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19805577	Green Accepted			2022-12-25	WOS:000274045000011
J	Bui, C; Ouzzine, M; Talhaoui, I; Sharp, S; Prydz, K; Coughtrie, MWH; Fournel-Gigleux, S				Bui, Catherine; Ouzzine, Mohamed; Talhaoui, Ibtissam; Sharp, Sheila; Prydz, Kristian; Coughtrie, Michael W. H.; Fournel-Gigleux, Sylvie			Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells	FASEB JOURNAL			English	Article						tumor pathogenesis; proteoglycan synthesis; epigenetic regulation; glycosyltransferase	PROTEIN LINKAGE REGION; CANINE KIDNEY-CELLS; MOLECULAR-CLONING; CANCER-CELLS; GLYCOSAMINOGLYCAN BIOSYNTHESIS; PROTEOGLYCAN SYNTHESIS; HUMAN BREAST; GROWTH; EXT1; FIBROBLASTS	Heparan sulfate proteoglycans (HSPGs), strategically located at the cell-tissue-organ interface, regulate major biological processes, including cell proliferation, migration, and adhesion. These vital functions are compromised in tumors, due, in part, to alterations in heparan sulfate (HS) expression and structure. How these modifications occur is largely unknown. Here, we investigated whether epigenetic abnormalities involving aberrant DNA methylation affect HS biosynthetic enzymes in cancer cells. Analysis of the methylation status of glycosyltransferase and sulfotransferase genes in H-HEMC-SS chondrosarcoma cells showed a typical hypermethylation profile of 3-OST sulfotransferase genes. Exposure of chondrosarcoma cells to 5-aza-2'-deoxycytidine (5-Aza-dc), a DNA-methyltransferase inhibitor, up-regulated expression of 3-OST1, 3-OST2, and 3-OST3A mRNAs, indicating that aberrant methylation affects transcription of these genes. Furthermore, HS expression was restored on 5-Aza-dc treatment or reintroduction of 3-OST expression, as shown by indirect immunofluorescence microscopy and/or analysis of HS chains by anion-exchange and gel-filtration chromatography. Notably, 5-Aza-dc treatment of HEMC cells or expression of 3-OST3A cDNA reduced their proliferative and invading properties and augmented adhesion of chondrosarcoma cells. These results provide the first evidence for specific epigenetic regulation of 3-OST genes resulting in altered HSPG sulfation and point to a defect of HS-3-O-sulfation as a factor in cancer progression.-Bui, C., Ouzzine, M., Talhaoui, I., Sharp, S., Prydz, K., Coughtrie, M. W. H., Fournel-Gigleux, S. Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells. FASEB J. 24, 436-450 (2010). www.fasebj.org	[Bui, Catherine; Ouzzine, Mohamed; Talhaoui, Ibtissam; Fournel-Gigleux, Sylvie] Univ Nancy 1, CNRS, UMR 7561, Fac Med, F-54505 Vandoeuvre Les Nancy, France; [Sharp, Sheila; Coughtrie, Michael W. H.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland; [Prydz, Kristian] Univ Oslo, Dept Mol Biosci, Oslo, Norway	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Dundee; University of Oslo	Fournel-Gigleux, S (corresponding author), Univ Nancy 1, CNRS, UMR 7561, Fac Med, BP 184, F-54505 Vandoeuvre Les Nancy, France.	sfg@medecine.uhp-nancy.fr	Ouzzine, Mohamed/G-4368-2013; Coughtrie, Michael/C-3855-2009	Coughtrie, Michael/0000-0003-1989-1416; OUZZINE, Mohamed/0000-0003-0058-4950	Institut National de la Sante et de la Recherche Medicale (INSERM)-University of Dundee International Collaboration Contract (C2I); Agence Nationale de la Recherche [ANR-08-PCVI-0023-01]; Ligue Regionale contre le Cancer; Royal Society International Joint Grant; Region Lorraine; Stevenson Exchange Scholarship	Institut National de la Sante et de la Recherche Medicale (INSERM)-University of Dundee International Collaboration Contract (C2I)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Regionale contre le Cancer(Ligue nationale contre le cancer); Royal Society International Joint Grant; Region Lorraine(Region Grand-Est); Stevenson Exchange Scholarship	This work was supported by an Institut National de la Sante et de la Recherche Medicale (INSERM)-University of Dundee International Collaboration Contract (C2I), the Agence Nationale de la Recherche (GAG Network ANR-08-PCVI-0023-01), the Ligue Regionale contre le Cancer, a Royal Society International Joint Grant (to M. W. H. C., and S. F.-G.), and the Region Lorraine. C. B. was the recipient of a Stevenson Exchange Scholarship. We are grateful to Theodora Tucker (University of Dundee, Dundee, UK) for her expertise and assistance with the indirect immunofluorescence microscopy studies, to Dr. Celine Pourreyron (University of Dundee, Dundee, UK) for her helpful advice regarding the cell migration assays, and Sandrine Gulberti for critical reading of the manuscript. Dr. Narayanan Venkatesan (McGill University, Montreal, Quebec) is gratefully acknowledged for his help in performing statistical analysis and for critical reading of the manuscript.	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; Barre L, 2006, FASEB J, V20, P1692, DOI 10.1096/fj.05-5073fje; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Chandrasekaran EV, 2006, CARBOHYD RES, V341, P983, DOI 10.1016/j.carres.2006.02.017; Chow WA, 2007, CURR OPIN ONCOL, V19, P371, DOI 10.1097/CCO.0b013e32812143d9; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Dick G, 2008, GLYCOBIOLOGY, V18, P53, DOI 10.1093/glycob/cwm121; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; Gulberti S, 2003, J BIOL CHEM, V278, P32219, DOI 10.1074/jbc.M207899200; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8; Kadenhe-Chiweshe A, 2008, MOL CANCER RES, V6, P1, DOI 10.1158/1541-7786.MCR-07-0101; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; Kaminski A, 2006, INT J MOL MED, V18, P941; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Leteux C, 2001, J BIOL CHEM, V276, P12539, DOI 10.1074/jbc.M010291200; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200; Mani K, 2004, GLYCOBIOLOGY, V14, P599, DOI 10.1093/glycob/cwh067; McCormick C, 1999, MOL MED TODAY, V5, P481, DOI 10.1016/S1357-4310(99)01593-2; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Mochizuki H, 2008, J BIOL CHEM, V283, P31237, DOI 10.1074/jbc.M801586200; Ouzzine M, 1999, FEBS LETT, V454, P187, DOI 10.1016/S0014-5793(99)00797-8; Petitou M, 2003, BIOCHIMIE, V85, P83, DOI 10.1016/S0300-9084(03)00078-6; Prydz K, 2000, J CELL SCI, V113, P193; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; Ropero S, 2004, HUM MOL GENET, V13, P2753, DOI 10.1093/hmg/ddh298; Sanderson RD, 2005, J CELL BIOCHEM, V96, P897, DOI 10.1002/jcb.20602; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Svennevig K, 2006, DIABETOLOGIA, V49, P2214, DOI 10.1007/s00125-006-0330-4; Tsuchiya T, 2005, CANCER GENET CYTOGEN, V158, P148, DOI 10.1016/j.cancergencyto.2004.08.031; Tveit H, 2005, J BIOL CHEM, V280, P29596, DOI 10.1074/jbc.M503691200; Urbaniak MD, 2006, BIOORG MED CHEM LETT, V16, P5744, DOI 10.1016/j.bmcl.2006.08.091; Uzan B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004734; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; Venkatesan N, 2004, P NATL ACAD SCI USA, V101, P18087, DOI 10.1073/pnas.0404504102; Venkatesan N, 2009, FASEB J, V23, P813, DOI 10.1096/fj.08-118166; Vucic EA, 2008, PHARMACOGENOMICS, V9, P215, DOI 10.2217/14622416.9.2.215; Vuong TT, 2006, GLYCOBIOLOGY, V16, P326, DOI 10.1093/glycob/cwj075; Weissmann G, 2008, FASEB J, V22, P4033, DOI 10.1096/fj.08-1201ufm; Xu D, 2005, BIOCHEM J, V385, P451, DOI 10.1042/BJ20040908; YANAGISHITA M, 1987, METHOD ENZYMOL, V138, P279; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u	61	51	51	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					436	450		10.1096/fj.09-136291	http://dx.doi.org/10.1096/fj.09-136291			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19812376	Green Submitted			2022-12-25	WOS:000274045000012
J	Shaw, A; Gipp, J; Bushman, W				Shaw, A.; Gipp, J.; Bushman, W.			The Sonic Hedgehog pathway stimulates prostate tumor growth by paracrine signaling and recapitulates embryonic gene expression in tumor myofibroblasts	ONCOGENE			English	Article						Hedgehog; prostate cancer; reactive stroma; myofibroblast; paracrine; tumor microenvironment	GLI TRANSCRIPTION FACTORS; REACTIVE STROMA; CANCER CELLS; ACTIVATION; PROLIFERATION; INHIBITION; NETWORKS; THERAPY	The Hedgehog (Hh) pathway contributes to prostate cancer growth and progression. The presence of robust Sonic Hedgehog (Shh) expression in both normal prostate and localized cancer challenged us to explain the unique growth-promoting effect in cancer. We show here that paracrine Hh signaling exerts a non-cell autonomous effect on xenograft tumor growth and that Hh pathway activation in myofibroblasts alone is sufficient to stimulate tumor growth. Nine genes regulated by Hh in the mesenchyme of the developing prostate were found to be regulated in the stroma of Hh overexpressing xenograft tumors. Correlation analysis of gene expression in matched specimens of benign and malignant human prostate tissue revealed a partial five-gene fingerprint of Hh-regulated expression in stroma of all cancers and the complete nine-gene fingerprint in the subset of tumors exhibiting a reactive stroma. No expression fingerprint was observed in benign tissues. We conclude that changes in the prostate stroma due to association with cancer result in an altered transcriptional response to Hh that mimics the growth-promoting actions of the fetal mesenchyme. Patients with an abundance of myofibroblasts in biopsy tissue may comprise a subgroup that will exhibit a particularly good response to anti-Hh therapy. Oncogene (2009) 28, 4480-4490; doi:10.1038/onc.2009.294; published online 28 September 2009	[Shaw, A.; Gipp, J.; Bushman, W.] Univ Wisconsin, Dept Surg, Div Urol, Madison, WI 53792 USA; [Shaw, A.; Bushman, W.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53792 USA; [Shaw, A.; Gipp, J.; Bushman, W.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bushman, W (corresponding author), Univ Wisconsin, Dept Surg, Div Urol, 600 Highland Ave, Madison, WI 53792 USA.	bushman@surgery.wisc.edu		Shaw, Aubie/0000-0002-5298-801X	Department of Defense [W81XWH-06-1-0060, W81XWH-04-1-0263]; NIDDK [DK056238-06]; Robert and Delores Schnoes Chair in Urologic Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056238] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Robert and Delores Schnoes Chair in Urologic Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Alejandro Munoz, PhD, and Glen Leverson, PhD, for assistance with statistical analysis. The Gli2-mutB expression construct was generously provided by Maximilian Muenke at NIH (Bethesda, MD, USA). This work was supported by the Department of Defense Prostate Cancer Program Graduate Training Award W81XWH-06-1-0060 (AS), Department of Defense Award W81XWH-04-1-0263 (WB), the NIDDK Award DK056238-06 (WB) and the Robert and Delores Schnoes Chair in Urologic Research.	Bai CB, 2002, DEVELOPMENT, V129, P4753; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Bierhoff E, 1997, PROSTATE, V31, P234, DOI 10.1002/(SICI)1097-0045(19970601)31:4<234::AID-PROS4>3.0.CO;2-K; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Gustin MP, 2008, PHYSIOL GENOMICS, V34, P34, DOI 10.1152/physiolgenomics.00008.2008; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; JANIK P, 1975, CANCER RES, V35, P3698; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kelleher FC, 2006, ACTA ONCOL, V45, P375, DOI 10.1080/02841860600602946; Lauth M, 2007, CURR OPIN INVEST DR, V8, P457; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Levitt RJ, 2007, CANCER LETT, V255, P300, DOI 10.1016/j.canlet.2007.05.006; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; McCarthy FRK, 2008, BIOCHEM BIOPH RES CO, V373, P109, DOI 10.1016/j.bbrc.2008.05.169; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; SCHIMMANG T, 1993, PROG CLIN BIOL RES, V383, P153; Schwarze SR, 2005, PROSTATE, V64, P67, DOI 10.1002/pros.20215; Shaw A, 2006, PROSTATE, V66, P1347, DOI 10.1002/pros.20357; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Yanagisawa N, 2008, HUM PATHOL, V39, P282, DOI 10.1016/j.humpath.2007.04.025; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200; Zhang JX, 2007, J UROLOGY, V177, P1179, DOI 10.1016/j.juro.2006.10.032	33	60	73	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 17	2009	28	50					4480	4490		10.1038/onc.2009.294	http://dx.doi.org/10.1038/onc.2009.294			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DU	19784071	Green Accepted			2022-12-25	WOS:000272876500007
J	Marjoram, RJ; Voss, B; Pan, YM; Dickeson, SK; Zutter, MM; Hamm, HE; Santoro, SA				Marjoram, Robin J.; Voss, Bryan; Pan, Yumei; Dickeson, S. Kent; Zutter, Mary M.; Hamm, Heidi E.; Santoro, Samuel A.			Suboptimal Activation of Protease-activated Receptors Enhances alpha(2)beta(1) Integrin-mediated Platelet Adhesion to Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT THROMBUS FORMATION; GLYCOPROTEIN-VI; ALPHA-2-BETA-1 INTEGRIN; GAMMA-CHAIN; PAR4; PEPTIDES; BINDING; MOUSE; FLOW; DETERMINANTS	Thrombin and fibrillar collagen are potent activators of platelets at sites of vascular injury. Both agonists cause platelet shape change, granule secretion, and aggregation to form the primary hemostatic plug. Human platelets express two thrombin receptors, protease-activated receptors 1 and 4 (PAR1 and PAR4) and two collagen receptors, the alpha(2)beta(1) integrin (alpha(2)beta(1)) and the glycoprotein VI (GPVI)/FcR gamma chain complex. Although these receptors and their signaling mechanisms have been intensely studied, it is not known whether and how these receptors cooperate in the hemostatic function of platelets. This study examined cooperation between the thrombin and collagen receptors in platelet adhesion by utilizing a collagen-related peptide (alpha 2-CRP) containing the alpha(2)beta(1)-specific binding motif, GFOGER, in conjunction with PAR-activating peptides. We demonstrate that platelet adhesion to alpha 2-CRP is substantially enhanced by suboptimal PAR activation (agonist concentrations that do not stimulate platelet aggregation) using the PAR4 agonist peptide and thrombin. The enhanced adhesion induced by suboptimal PAR4 activation was alpha(2)beta(1)-dependent and GPVI/FcR gamma-independent as revealed in experiments with alpha(2)beta(1)- or FcR gamma-deficient mouse platelets. We further show that suboptimal activation of other platelet G(q)-linked G protein-coupled receptors (GPCRs) produces enhanced platelet adhesion to alpha 2-CRP. The enhanced alpha(2)beta(1)-mediated platelet adhesion is controlled by phospholipase C (PLC), but is not dependent on granule secretion, activation of alpha(IIb)beta(3) integrin, or on phosphoinositol-3 kinase (PI3K) activity. In conclusion, we demonstrate a platelet priming mechanism initiated by suboptimal activation of PAR4 or other platelet G(q)-linked GPCRs through a PLC-dependent signaling cascade that promotes enhanced alpha(2)beta(1) binding to collagens containing GFOGER sites.	[Santoro, Samuel A.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Voss, Bryan; Hamm, Heidi E.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Santoro, SA (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol, C3322 MCN 2561, Nashville, TN 37232 USA.	samuel.santoro@vanderbilt.edu			National Institutes of Health [P50 HLO81009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 HLO81009.	Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; BAUMGARTNER HR, 1977, THROMB HAEMOSTASIS, V37, P1; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Chen H, 2003, MOL CELL BIOL, V23, P4764, DOI 10.1128/MCB.23.14.4764-4777.2003; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; CORDINGLEY MG, 1989, J VIROL, V63, P5037, DOI 10.1128/JVI.63.12.5037-5045.1989; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; DAVEY MG, 1967, NATURE, V216, P857, DOI 10.1038/216857a0; Dickeson SK, 1997, J BIOL CHEM, V272, P7661, DOI 10.1074/jbc.272.12.7661; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; He L, 2003, BLOOD, V102, P3652, DOI 10.1182/blood-2003-04-1323; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Jung SM, 2000, J BIOL CHEM, V275, P8016, DOI 10.1074/jbc.275.11.8016; Jung SM, 1998, J BIOL CHEM, V273, P14827, DOI 10.1074/jbc.273.24.14827; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; Kehrel B, 1998, BLOOD, V91, P491; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; Munnix ICA, 2008, J THROMB HAEMOST, V6, P2132, DOI 10.1111/j.1538-7836.2008.03167.x; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; SANTORO SA, 1991, CELL REGUL, V2, P905, DOI 10.1091/mbc.2.11.905; SANTORO SA, 1994, METHOD ENZYMOL, V245, P147; Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; STAATZ WD, 1989, J CELL BIOL, V108, P1917, DOI 10.1083/jcb.108.5.1917; Stricker TP, 2001, J BIOL CHEM, V276, P29375, DOI 10.1074/jbc.M102217200; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; Zou ZY, 2009, BLOOD, V113, P6428, DOI 10.1182/blood-2008-08-175356	47	13	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34640	34647		10.1074/jbc.M109.020990	http://dx.doi.org/10.1074/jbc.M109.020990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19815553	hybrid, Green Published			2022-12-25	WOS:000272439600019
J	Viarre, V; Cascales, E; Ball, G; Michel, GPF; Filloux, A; Voulhoux, R				Viarre, Veronique; Cascales, Eric; Ball, Genevieve; Michel, Gerard P. F.; Filloux, Alain; Voulhoux, Rome			HxcQ Liposecretin Is Self-piloted to the Outer Membrane by Its N-terminal Lipid Anchor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL SECRETORY PATHWAY; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; II SECRETION; PILUS; SPECIFICITY; LIPOPROTEIN; CHAPERONE; SYSTEM	Secretins are an unusual and important class of bacterial outer membrane (OM) proteins. They are involved in the transport of single proteins or macromolecular structures such as pili, needle complexes, and bacteriophages across the OM. Secretins are multimeric ring-shaped structures that form large pores in the OM. The targeting of such macromolecular structures to the OM often requires special assistance, conferred by specific pilotins or pilot proteins. Here, we investigated HxcQ, the OM component of the second Pseudomonas aeruginosa type II secretion system. We found that HxcQ forms high molecular mass structures resistant to heat and SDS, revealing its secretin nature. Interestingly, we showed that HxcQ is a lipoprotein. Construction of a recombinant nonlipidated HxcQ (HxcQnl) revealed that lipidation is essential for HxcQ function. Further phenotypic analysis indicated that HxcQnl accumulates as multimers in the inner membrane of P. aeruginosa, a typical phenotype observed for secretins in the absence of their cognate pilotin. Our observations led us to the conclusion that the lipid anchor of HxcQ plays a pilotin role. The self-piloting of HxcQ to the OM was further confirmed by its correct multimeric OM localization when expressed in the heterologous host Escherichia coli. Altogether, our results reveal an original and unprecedented pathway for secretin transport to the OM.	[Voulhoux, Rome] CNRS, Lab Ingn Syst Macromol, IMM, UPR 9027, F-13402 Marseille 20, France; [Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London	Voulhoux, R (corresponding author), CNRS, Lab Ingn Syst Macromol, IMM, UPR 9027, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	voulhoux@ifr88.cnrs-mrs.fr	CASCALES, ERIC/G-7420-2011; Voulhoux, Rome/AAT-5333-2021	CASCALES, ERIC/0000-0003-0611-9179; 	Agence Nationale de la Recherche [ANR-JC07-183230]; "ERA-NET Pathogenomics" [ANR-08-PATH-004-01]	Agence Nationale de la Recherche(French National Research Agency (ANR)); "ERA-NET Pathogenomics"	Research in the Rome 'Voulhoux laboratory was supported by Agence Nationale de la Recherche programs, "Young researcher" (Grant ANR-JC07-183230) and "ERA-NET Pathogenomics" (Grant ANR-08-PATH-004-01).	Babu MM, 2002, BIOINFORMATICS, V18, P641, DOI 10.1093/bioinformatics/18.4.641; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x; Bitter W, 2003, ARCH MICROBIOL, V179, P307, DOI 10.1007/s00203-003-0541-8; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Bose N, 2005, J BACTERIOL, V187, P2225, DOI 10.1128/JB.187.7.2225-2232.2005; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x; Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x; Daniel A, 2006, MICROBIOL-SGM, V152, P2405, DOI 10.1099/mic.0.28860-0; De Groot A, 2001, J BACTERIOL, V183, P959, DOI 10.1128/JB.183.3.959-967.2001; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883; Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402; Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HU NT, 1995, MICROBIOL-UK, V141, P1395, DOI 10.1099/13500872-141-6-1395; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x; Linderoth NA, 1996, J BACTERIOL, V178, P1962, DOI 10.1128/jb.178.7.1962-1970.1996; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Michel GPF, 2007, J BACTERIOL, V189, P3776, DOI 10.1128/JB.00205-07; Michel Gerard P. F., 2009, P67; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schmidt SA, 2001, J BACTERIOL, V183, P4848, DOI 10.1128/JB.183.16.4848-4859.2001; Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001; Seo J, 2009, J BACTERIOL, V191, P898, DOI 10.1128/JB.01443-08; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Sohel I, 1996, J BACTERIOL, V178, P2613, DOI 10.1128/jb.178.9.2613-2628.1996; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6	51	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33815	33823		10.1074/jbc.M109.065938	http://dx.doi.org/10.1074/jbc.M109.065938			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815547	Green Published, hybrid			2022-12-25	WOS:000272165200013
J	Li, F; Tian, L; Gu, LY; Li, GM				Li, Feng; Tian, Lei; Gu, Liya; Li, Guo-Min			Evidence That Nucleosomes Inhibit Mismatch Repair in Eukaryotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLIDING-CLAMP; MOLECULAR SWITCH; HMUTS-ALPHA; DNA-DAMAGE; BINDING; MUTL; RECONSTITUTION; ACETYLATION; RECOGNITION; MSH2-MSH6	The influence of chromatin structure on DNA metabolic processes, including DNA replication and repair, has been a matter of intensive studies in recent years. Although the human mismatch repair (MMR) reaction has been reconstituted using purified proteins, the influence of chromatin structure on human MMR is unknown. This study examines the interaction between human MutS alpha and a mismatch located within a nucleosome or between two nucleosomes. The results show that, whereas MutS alpha specifically recognizes both types of nucleosomal heteroduplexes, the protein bound the mismatch within a nucleosome with much lower efficiency than a naked heteroduplex or a heterology free of histone proteins but between two nucleosomes. Additionally, MutS alpha displays reduced ATPase- and ADP-binding activity when interacting with nucleosomal heteroduplexes. Interestingly, nucleosomes block ATP-induced MutS alpha sliding along the DNA helix when the mismatch is in between two nucleosomes. These findings suggest that nucleosomes may inhibit MMR in eukaryotic cells. The implications of these findings for our understanding of eukaryotic MMR are discussed.	[Li, Feng; Tian, Lei; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA	University of Kentucky	Li, GM (corresponding author), Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA.	gmli@uky.edu	Li, Guo-Min/I-5016-2014	Li, Guo-Min/0000-0002-9842-4578; Li, Feng/0000-0002-9201-1668	National Institutes of Health [GM072756]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM072756 ( to G. M. L.).	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Gu LY, 2006, METHOD ENZYMOL, V408, P303, DOI 10.1016/S0076-6879(06)08019-0; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Hawk JD, 2005, P NATL ACAD SCI USA, V102, P8639, DOI 10.1073/pnas.0503415102; Iaccarino I, 2000, J BIOL CHEM, V275, P2080, DOI 10.1074/jbc.275.3.2080; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li F, 2008, MUTAT RES-FUND MOL M, V637, P101, DOI 10.1016/j.mrfmmm.2007.07.008; Li GM, 1999, ONCOL RES, V11, P393; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; de Saro FJL, 2006, J BIOL CHEM, V281, P14340, DOI 10.1074/jbc.M601264200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Loyola A, 2003, METHODS, V31, P96, DOI 10.1016/S1046-2023(03)00093-8; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Pluciennik A, 2007, P NATL ACAD SCI USA, V104, P12709, DOI 10.1073/pnas.0705129104; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simmons LA, 2008, MOL CELL, V29, P291, DOI 10.1016/j.molcel.2007.10.036; SIMPSON RT, 1976, BIOCHEMISTRY-US, V15, P4305, DOI 10.1021/bi00664a026; Smith BT, 2001, MOL CELL, V8, P1197, DOI 10.1016/S1097-2765(01)00402-6; Tian L, 2009, J BIOL CHEM, V284, P11557, DOI 10.1074/jbc.M900908200; Widlund HR, 1999, J BIOL CHEM, V274, P31847, DOI 10.1074/jbc.274.45.31847; Zhang Y, 2008, J BIOL CHEM, V283, P12730, DOI 10.1074/jbc.M800460200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	38	49	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33056	33061		10.1074/jbc.M109.049874	http://dx.doi.org/10.1074/jbc.M109.049874			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808662	hybrid, Green Published			2022-12-25	WOS:000272028500008
J	Pedraza, N; Rafel, M; Navarro, I; Encinas, M; Aldea, M; Gallego, C				Pedraza, Neus; Rafel, Marta; Navarro, Isis; Encinas, Mario; Aldea, Marti; Gallego, Carme			Mixed Lineage Kinase Phosphorylates Transcription Factor E47 and Inhibits TrkB Expression to Link Neuronal Death and Survival Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; LOOP-HELIX PROTEINS; C-JUN; SIGNALING PATHWAY; FAMILY; GROWTH; DOMAIN; MEMBER; CELLS; JNK	E47 is a basic helix-loop-helix transcription factor involved in neuronal differentiation and survival. Wehad previously shown that the basic helix-loop-helix protein E47 binds to E-box sequences within the promoter of the TrkB gene and activates its transcription. Proper expression of the TrkB receptor plays a key role in development and function of the vertebrate nervous system, and altered levels of TrkB have been associated with important human diseases. Here we show that E47 interacts with MLK2, a mixed lineage kinase (MLK) involved in JNK-mediated activation of programmed cell death. MLK2 enhances phosphorylation of the AD2 activation domain of E47 in vivo in a JNK-independent manner and phosphorylates in vitro defined serine and threonine residues within a loop-helix structure of AD2 that also contains a putative MLK docking site. Although these residues are essential for MLK2-mediated inactivation of E47, inhibition of MLKs by CEP11004 causes up-regulation of TrkB at a transcriptional level in cerebellar granule neurons and differentiating neuroblastoma cells. These findings allow us to propose a novel mechanism by which MLK regulates TrkB expression through phosphorylation of an activation domain of E47. This molecular link would explain why MLK inhibitors not only prevent activation of cell death processes but also enhance cell survival signaling as a key aspect of their neuroprotective potential.	[Pedraza, Neus; Rafel, Marta; Navarro, Isis; Encinas, Mario; Aldea, Marti; Gallego, Carme] Univ Lleida, IRBLLEIDA, Dept Ciencies Med Basiques, Lleida 25008, Catalonia, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Gallego, C (corresponding author), Mt Serrat Roig 2, Lleida 25008, Catalonia, Spain.	carme.gallego@cmb.udl.cat	Gallego, Carme/B-3151-2010; Rafel-Borrell, Marta/W-4613-2019; Pedraza González, Neus/C-6390-2011; Encinas, Mario/B-5600-2009; Gallego, Carme/K-6573-2014; Rafel Borrell, Marta/C-6428-2011; Aldea, Marti/K-3962-2014	Rafel-Borrell, Marta/0000-0001-9266-4696; Pedraza González, Neus/0000-0003-4749-5111; Encinas, Mario/0000-0003-3509-7431; Gallego, Carme/0000-0001-6961-3524; Rafel Borrell, Marta/0000-0001-9266-4696; Aldea, Marti/0000-0002-8710-5336	Ministry of Science and Innovation of Spain; Consolider-Ingenio 2010; Fundacio La Caixa; European Union	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio 2010(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Caixa(La Caixa FoundationEuropean Commission); European Union(European Commission)	This work was supported by the Ministry of Science and Innovation of Spain, Consolider-Ingenio 2010, Fundacio La Caixa, and the European Union (Fondo Europeo de Desarrollo Regional).	ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Boissiere F, 1997, EXP NEUROL, V145, P245, DOI 10.1006/exnr.1997.6443; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; DOROW DS, 1993, EUR J BIOCHEM, V213, P701, DOI 10.1111/j.1432-1033.1993.tb17810.x; Eckey M, 2003, MOL CELL ENDOCRINOL, V213, P71, DOI 10.1016/j.mce.2003.10.035; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gines S, 2006, EUR J NEUROSCI, V23, P649, DOI 10.1111/j.1460-9568.2006.04590.x; Handley ME, 2007, INT IMMUNOL, V19, P923, DOI 10.1093/intimm/dxm050; Handley ME, 2007, INT J EXP PATHOL, V88, P111, DOI 10.1111/j.1365-2613.2007.00531.x; Harris CA, 2002, J NEUROSCI, V22, P103, DOI 10.1523/JNEUROSCI.22-01-00103.2002; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; ING YL, 1994, ONCOGENE, V9, P1745; Johnson SE, 1996, MOL CELL BIOL, V16, P1604; King AM, 2007, J IMMUNOL, V178, P3521, DOI 10.4049/jimmunol.178.6.3521; Lei L, 2007, CELL MOL LIFE SCI, V64, P522, DOI 10.1007/s00018-006-6328-8; Leung IWL, 2001, J BIOL CHEM, V276, P1961, DOI 10.1074/jbc.M004092200; Liu YF, 2000, J BIOL CHEM, V275, P19035, DOI 10.1074/jbc.C000180200; Liu YH, 2004, MOL CELL BIOL, V24, P2662, DOI 10.1128/MCB.24.7.2662-2672.2004; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Marcora E, 2003, P NATL ACAD SCI USA, V100, P9578, DOI 10.1073/pnas.1133382100; Maroney AC, 1998, J NEUROSCI, V18, P104; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Massari ME, 1996, MOL CELL BIOL, V16, P121; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Page JL, 2004, J BIOL CHEM, V279, P30966, DOI 10.1074/jbc.M402224200; Phelan DR, 2001, J BIOL CHEM, V276, P10801, DOI 10.1074/jbc.M008237200; Phelan DR, 1999, MOL REPROD DEV, V52, P135, DOI 10.1002/(SICI)1098-2795(199902)52:2&lt;135::AID-MRD3&gt;3.0.CO;2-N; QUONG MW, 1993, MOL CELL BIOL, V13, P792, DOI 10.1128/MCB.13.2.792; ROBINSON GLWG, 1995, MOL CELL BIOL, V15, P1398; Sakuma H, 1997, J BIOL CHEM, V272, P28622, DOI 10.1074/jbc.272.45.28622; Silva RM, 2005, MOVEMENT DISORD, V20, P653, DOI 10.1002/mds.20390; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Swenson KI, 2003, MOL BIOL CELL, V14, P156, DOI 10.1091/mbc.E02-02-0115; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wang LH, 2005, J PHARMACOL EXP THER, V312, P1007, DOI 10.1124/jpet.104.077800; Wang LH, 2004, ANNU REV PHARMACOL, V44, P451, DOI 10.1146/annurev.pharmtox.44.101802.121840; YAN MH, 1994, NATURE, V372, P798; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	49	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32980	32988		10.1074/jbc.M109.038729	http://dx.doi.org/10.1074/jbc.M109.038729			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801649	Green Published, hybrid			2022-12-25	WOS:000272028400081
J	Wray, JA; Sugden, MC; Zeldin, DC; Greenwood, GK; Samsuddin, S; Miller-Degraff, L; Bradbury, JA; Holness, MJ; Warner, TD; Bishop-Bailey, D				Wray, Jessica A.; Sugden, Mary C.; Zeldin, Darryl C.; Greenwood, Gemma K.; Samsuddin, Salma; Miller-Degraff, Laura; Bradbury, J. Alyce; Holness, Mark J.; Warner, Timothy D.; Bishop-Bailey, David			The Epoxygenases CYP2J2 Activates the Nuclear Receptor PPAR alpha In Vitro and In Vivo	PLOS ONE			English	Article								Background: Peroxisome proliferator-activated receptors (PPARs) are a family of three (PPAR alpha, -beta/delta, and -gamma) nuclear receptors. In particular, PPAR alpha is involved in regulation of fatty acid metabolism, cell growth and inflammation. PPAR alpha mediates the cardiac fasting response, increasing fatty acid metabolism, decreasing glucose utilisation, and is the target for the fibrate lipid-lowering class of drugs. However, little is known regarding the endogenous generation of PPAR ligands. CYP2J2 is a lipid metabolising cytochrome P450, which produces anti-inflammatory mediators, and is considered the major epoxygenase in the human heart. Methodology/Principal Findings: Expression of CYP2J2 in vitro results in an activation of PPAR responses with a particular preference for PPAR alpha. The CYP2J2 products 8,9-and 11-12-EET also activate PPAR alpha. In vitro, PPAR alpha activation by its selective ligand induces the PPAR alpha target gene pyruvate dehydrogenase kinase (PDK) 4 in cardiac tissue. In vivo, in cardiac-specific CYP2J2 transgenic mice, fasting selectively augments the expression of PDK4. Conclusions/Significance: Our results establish that CYP2J2 produces PPAR alpha ligands in vitro and in vivo, and suggests that lipid metabolising CYPs are prime candidates for the integration of global lipid changes to transcriptional signalling events.				d.bishop-bailey@qmul.ac.uk	Zeldin, Darryl C/Y-7091-2018; Warner, Timothy D/A-1980-2009	Zeldin, Darryl C/0000-0002-2087-7307; Warner, Timothy D/0000-0003-3988-4408; Bishop-Bailey, David/0000-0003-2455-596X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025034] Funding Source: NIH RePORTER; British Heart Foundation [FS/04/075, BS/02/002, FS/04/047, PG/08/070/25464] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); British Heart Foundation(British Heart Foundation); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		Athirakul K, 2008, FASEB J, V22, P4096, DOI 10.1096/fj.08-114413; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Bishop-Bailey D, 2003, PROSTAG OTH LIPID M, V71, P1, DOI 10.1016/S0090-6980(03)00003-0; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Delerive P, 2000, FEBS LETT, V471, P34, DOI 10.1016/S0014-5793(00)01364-8; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Fang X, 2006, AM J PHYSIOL-HEART C, V290, pH55, DOI 10.1152/ajpheart.00427.2005; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Lee CR, 2007, PHARMACOGENET GENOM, V17, P349, DOI 10.1097/FPC.0b013e32809913ea; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Liu Y, 2004, CIRCULATION, V110, P1128, DOI 10.1161/01.CIR.0000139850.08365.EC; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; PRICE S, EUR J PHARM, V449, P279; Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Spiecker M, 2005, ARCH BIOCHEM BIOPHYS, V433, P413, DOI 10.1016/j.abb.2004.10.009; Spiecker M, 2006, TRENDS CARDIOVAS MED, V16, P204, DOI 10.1016/j.tcm.2006.04.001; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sugden MC, 2001, ARCH BIOCHEM BIOPHYS, V395, P246, DOI 10.1006/abbi.2001.2586; Swales KE, 2006, CANCER RES, V66, P10120, DOI 10.1158/0008-5472.CAN-06-2399; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Wu S, 1996, J BIOL CHEM, V271, P3460; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	28	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7421	10.1371/journal.pone.0007421	http://dx.doi.org/10.1371/journal.pone.0007421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823578	Green Published, gold, Green Submitted			2022-12-25	WOS:000270728500019
J	Rice, SH; Papadopoulos, A				Rice, Sean H.; Papadopoulos, Anthony			Evolution with Stochastic Fitness and Stochastic Migration	PLOS ONE			English	Article							NATURAL-SELECTION; PRICE EQUATION; POPULATION-SIZE; DISPERSAL; DENSITY; MODELS; POLYMORPHISMS; COEVOLUTION; ADAPTATION; SPECIATION	Background: Migration between local populations plays an important role in evolution - influencing local adaptation, speciation, extinction, and the maintenance of genetic variation. Like other evolutionary mechanisms, migration is a stochastic process, involving both random and deterministic elements. Many models of evolution have incorporated migration, but these have all been based on simplifying assumptions, such as low migration rate, weak selection, or large population size. We thus have no truly general and exact mathematical description of evolution that incorporates migration. Methodology/Principal Findings: We derive an exact equation for directional evolution, essentially a stochastic Price equation with migration, that encompasses all processes, both deterministic and stochastic, contributing to directional change in an open population. Using this result, we show that increasing the variance in migration rates reduces the impact of migration relative to selection. This means that models that treat migration as a single parameter tend to be biassed overestimating the relative impact of immigration. We further show that selection and migration interact in complex ways, one result being that a strategy for which fitness is negatively correlated with migration rates ( high fitness when migration is low) will tend to increase in frequency, even if it has lower mean fitness than do other strategies. Finally, we derive an equation for the effective migration rate, which allows some of the complex stochastic processes that we identify to be incorporated into models with a single migration parameter. Conclusions/Significance: As has previously been shown with selection, the role of migration in evolution is determined by the entire distributions of immigration and emigration rates, not just by the mean values. The interactions of stochastic migration with stochastic selection produce evolutionary processes that are invisible to deterministic evolutionary theory.			Rice, SH (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	sean.h.rice@ttu.edu						Alleaume-Benharira M, 2006, J EVOLUTION BIOL, V19, P203, DOI 10.1111/j.1420-9101.2005.00976.x; Altwegg R, 2003, J ANIM ECOL, V72, P391, DOI 10.1046/j.1365-2656.2003.00706.x; Catchpole EA, 2004, J AGR BIOL ENVIR ST, V9, P1, DOI 10.1198/1085711043172; Charnov EL, 2006, AM NAT, V167, P578, DOI 10.1086/501141; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; FRANK SA, 1986, J THEOR BIOL, V122, P303, DOI 10.1016/S0022-5193(86)80122-9; Gaggiotti OE, 1996, AM NAT, V147, P919, DOI 10.1086/285886; Gaggiotti OE, 1996, THEOR POPUL BIOL, V50, P178, DOI 10.1006/tpbi.1996.0028; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gardner A, 2006, J EVOLUTION BIOL, V19, P1707, DOI 10.1111/j.1420-9101.2006.01104.x; Gavrilets S, 2004, FITNESS LANDSCAPES O; GILLESPIE JH, 1973, GENET RES, V21, P115, DOI 10.1017/S001667230001329X; GILLESPIE JH, 1977, AM NAT, V111, P1010, DOI 10.1086/283230; Grafen A, 2000, P ROY SOC B-BIOL SCI, V267, P1223, DOI 10.1098/rspb.2000.1131; Haldane J. B. S., 1963, Journal of Genetics, V58, P237, DOI 10.1007/BF02986143; Haldane J. B. S., 1932, CAUSES EVOLUTION; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; HARTL DL, 1973, THEOR POPUL BIOL, V4, P163, DOI 10.1016/0040-5809(73)90026-9; Heywood JS, 2005, EVOLUTION, V59, P2287, DOI 10.1111/j.0014-3820.2005.tb00939.x; Hochberg ME, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-238; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Kasuya E, 2000, ANIM BEHAV, V59, P629, DOI 10.1006/anbe.1999.1334; Kawecki TJ, 1997, EVOLUTION, V51, P1751, DOI 10.1111/j.1558-5646.1997.tb05099.x; Kawecki TJ, 2002, AM NAT, V160, P333, DOI 10.1086/341519; Kerr B, 2009, EVOLUTION, V63, P531, DOI 10.1111/j.1558-5646.2008.00570.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Lande R, 2007, EVOLUTION, V61, P1835, DOI 10.1111/j.1558-5646.2007.00170.x; Le Galliard JF, 2003, P ROY SOC B-BIOL SCI, V270, P1163, DOI 10.1098/rspb.2003.2360; Lena JP, 1998, BEHAV ECOL, V9, P500, DOI 10.1093/beheco/9.5.500; Lundy IJ, 1998, GENET RES, V71, P237, DOI 10.1017/S0016672398003139; MARUYAMA T, 1970, Theoretical Population Biology, V1, P273, DOI 10.1016/0040-5809(70)90047-X; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Nager RG, 1996, OECOLOGIA, V107, P204, DOI 10.1007/BF00327904; NAGYLAKI T, 1979, GENETICS, V91, P163; Peck SL, 2000, EVOLUTION, V54, P324, DOI 10.1111/j.0014-3820.2000.tb00035.x; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Proulx SR, 2004, J EVOLUTION BIOL, V17, P924, DOI 10.1111/j.1420-9101.2004.00723.x; Rehmeier RL, 2004, J MAMMAL, V85, P562, DOI 10.1644/1545-1542(2004)085<0562:LMOTDM>2.0.CO;2; Rice S. H., 2004, EVOLUTIONARY THEORY; Rice SH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-262; Servedio MR, 2000, EVOLUTION, V54, P21, DOI 10.1111/j.0014-3820.2000.tb00003.x; Servedio MR, 1997, EVOLUTION, V51, P1764, DOI 10.1111/j.1558-5646.1997.tb05100.x; TAYLOR PD, 1988, J THEOR BIOL, V130, P363, DOI 10.1016/S0022-5193(88)80035-3; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; VANBALEN JH, 1989, ORNIS SCAND, V20, P99, DOI 10.2307/3676875; WAHLSTROM LK, 1995, J ZOOL, V235, P455, DOI 10.1111/j.1469-7998.1995.tb01762.x; Wauters LA, 2004, J ANIM ECOL, V73, P11, DOI 10.1111/j.1365-2656.2004.00792.x; WHITLOCK MC, 1992, EVOLUTION, V46, P608, DOI [10.2307/2409631, 10.1111/j.1558-5646.1992.tb02069.x]; Wright S, 1931, GENETICS, V16, P0097	52	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7130	10.1371/journal.pone.0007130	http://dx.doi.org/10.1371/journal.pone.0007130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816580	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594300001
J	Sims, DW; Queiroz, N; Humphries, NE; Lima, FP; Hays, GC				Sims, David W.; Queiroz, Nuno; Humphries, Nicolas E.; Lima, Fernando P.; Hays, Graeme C.			Long-Term GPS Tracking of Ocean Sunfish Mola mola Offers a New Direction in Fish Monitoring	PLOS ONE			English	Article								Satellite tracking of large pelagic fish provides insights on free-ranging behaviour, distributions and population structuring. Up to now, such fish have been tracked remotely using two principal methods: direct positioning of transmitters by Argos polar-orbiting satellites, and satellite relay of tag-derived light-level data for post hoc track reconstruction. Error fields associated with positions determined by these methods range from hundreds of metres to hundreds of kilometres. However, low spatial accuracy of tracks masks important details, such as foraging patterns. Here we use a fast-acquisition global positioning system (Fastloc GPS) tag with remote data retrieval to track long-term movements, in near real time and position accuracy of <70 m, of the world's largest bony fish, the ocean sunfish Mola mola. Search-like movements occurred over at least three distinct spatial scales. At fine scales, sunfish spent longer in highly localised areas with faster, straighter excursions between them. These 'stopovers' during long-distance movement appear consistent with finding and exploiting food patches. This demonstrates the feasibility of GPS tagging to provide tracks of unparalleled accuracy for monitoring movements of large pelagic fish, and with nearly four times as many locations obtained by the GPS tag than by a conventional Argos transmitter. The results signal the potential of GPS-tagged pelagic fish that surface regularly to be detectors of resource 'hotspots' in the blue ocean and provides a new capability for understanding large pelagic fish behaviour and habitat use that is relevant to ocean management and species conservation.			Sims, DW (corresponding author), Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England.	dws@mba.ac.uk	Lima, Fernando P./C-1398-2008; Humphries, Nick/AAE-7170-2019; Queiroz, Nuno/G-3850-2010	Lima, Fernando P./0000-0001-9575-9834; Humphries, Nick/0000-0003-3741-1594; Queiroz, Nuno/0000-0002-3860-7356; Hays, Graeme/0000-0002-3314-8189; Sims, David/0000-0002-0916-7363				Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Cartamil DP, 2004, MAR ECOL PROG SER, V266, P245, DOI 10.3354/meps266245; DAWSON C. E., 1965, PROC LOUISIANA ACAD SCI, V28, P86; Gudger EW, 1928, SCI MON, V26, P257; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Metcalfe JD, 2006, J FISH BIOL, V69, P48, DOI 10.1111/j.1095-8649.2006.01275.x; MYERS GS, 1930, COPEIA, V1, P11; PRIEDE IG, 1984, FISH RES, V2, P201, DOI 10.1016/0165-7836(84)90003-1; Riding TAC, 2009, MAR ECOL PROG SER, V377, P255, DOI 10.3354/meps07809; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Sims DW, 2009, J EXP MAR BIOL ECOL, V370, P127, DOI 10.1016/j.jembe.2008.12.011; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Sims DW, 2002, J MAR BIOL ASSOC UK, V82, P927, DOI 10.1017/S0025315402006409; SIMS DW, 2009, BIOL SHARKS IN PRESS; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Watanabe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003446; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034	27	54	57	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7351	10.1371/journal.pone.0007351	http://dx.doi.org/10.1371/journal.pone.0007351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816576	Green Published, gold			2022-12-25	WOS:000270594300004
J	Lee, CH; Subramanian, S; Beck, AH; Espinosa, I; Senz, J; Zhu, SX; Huntsman, D; van de Rijn, M; Gilks, CB				Lee, Cheng-Han; Subramanian, Subbaya; Beck, Andrew H.; Espinosa, Inigo; Senz, Janine; Zhu, Shirley X.; Huntsman, David; van de Rijn, Matt; Gilks, C. Blake			MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary	PLOS ONE			English	Article							FALLOPIAN-TUBE; EXPRESSION PROFILES; GENE-EXPRESSION; NEW-MODEL; CANCER; P53; CELL; IDENTIFICATION; TUMORIGENESIS; ACCUMULATION	Background: MicroRNAs (miRNA) are 20,25 nucleotide non-coding RNAs that inhibit the translation of targeted mRNA, and they have been implicated in the development of human malignancies. High grade serous ovarian carcinomas, the most common and lethal subtype of ovarian cancer, can occur sporadically or in the setting of BRCA1/2 syndromes. Little is known regarding the miRNA expression profiles of high grade serous carcinoma in relation to BRCA1/2 status, and compared to normal tubal epithelium, the putative tissue of origin for high grade serous carcinomas. Methodology/Principal Findings: Global miRNA expression profiling was performed on a series of 33 high grade serous carcinomas, characterized with respect to BRCA1/2 status ( mutation, epigenetic silencing with loss of expression or normal), and with clinical follow-up, together with 2 low grade serous carcinomas, 2 serous borderline tumors, and 3 normal fallopian tube samples, using miRNA microarrays ( 328 human miRNA). Unsupervised hierarchical clustering based on miRNA expression profiles showed no clear separation between the groups of carcinomas with different BRCA1/2 status. There were relatively few miRNAs that were differentially expressed between the genotypic subgroups. Comparison of 33 high grade serous carcinomas to 3 normal fallopian tube samples identified several dysregulated miRNAs (false discovery rate <5%), including miR-422b and miR-34c. Quantitative RT-PCR analysis performed on selected miRNAs confirmed the pattern of differential expression shown by microarray analysis. Prognostically, lower level miR-422b and miR-34c in high grade serous carcinomas were both associated with decreased disease-specific survival by Kaplan-Meier analysis (p<0.05). Conclusions/Significance: High grade serous ovarian carcinomas with and without BRCA1/2 abnormalities demonstrate very similar miRNA expression profiles. High grade serous carcinomas as a group exhibit significant miRNA dysregulation in comparison to tubal epithelium and the levels of miR-34c and miR-422b appear to be prognostically important.			Lee, CH (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	chenghan@interchange.ubc.ca	Huntsman, David/ABE-6082-2020	Subramanian, Subbaya/0000-0002-2544-480X; van de Rijn, Matt/0000-0002-1909-9739				Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2006, ONCOL REP, V16, P845; Asangani I. A., 2007, ONCOGENE; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Corney DC, 2008, HISTOL HISTOPATHOL, V23, P1161, DOI 10.14670/HH-23.1161; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Crum CP, 2007, CLIN MED RES, V5, P35, DOI 10.3121/cmr.2007.702; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Folkins AK, 2009, GYNECOL ONCOL, V113, P391, DOI 10.1016/j.ygyno.2009.01.013; Gilks CB, 2005, GYNECOL ONCOL, V96, P684, DOI 10.1016/j.ygyno.2004.11.039; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hirst JE, 2009, INT J GYNECOL CANCER, V19, P826, DOI 10.1111/IGC.0b013e3181a1b5dc; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Koebel Martin, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800077X; KUPRYJANCZYK J, 1993, P NATL ACAD SCI USA, V90, P4961, DOI 10.1073/pnas.90.11.4961; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michael MZ, 2003, MOL CANCER RES, V1, P882; MILNER BJ, 1993, CANCER RES, V53, P2128; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; O'Neill CJ, 2005, AM J SURG PATHOL, V29, P1034; OZEN M, 2007, ONCOGENE; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Salvador S, 2008, GYNECOL ONCOL, V110, P408, DOI 10.1016/j.ygyno.2008.05.010; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; SUBRAMANIAN S, 2007, ONCOGENE; Thrall M, 2006, INT J GYNECOL CANCER, V16, P166, DOI 10.1111/j.1525-1438.2006.00504.x; Tong GX, 2007, MODERN PATHOL, V20, P856, DOI 10.1038/modpathol.3800827; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	61	75	79	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7314	10.1371/journal.pone.0007314	http://dx.doi.org/10.1371/journal.pone.0007314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798417	gold, Green Submitted, Green Published			2022-12-25	WOS:000270593300013
J	van Donkelaar, P; Lin, Y; Hewlett, D				van Donkelaar, Paul; Lin, Yu; Hewlett, David			The Human Frontal Oculomotor Cortical Areas Contribute Asymmetrically to Motor Planning in a Gap Saccade Task	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; EYE FIELD; BRAIN-STEM; MOVEMENTS; LATENCY; CORTEX; TMS; FEF	Background: Saccadic eye movements are used to rapidly align the fovea with the image of objects of interest in peripheral vision. We have recently shown that in children there is a high preponderance of quick latency but poorly planned saccades that consistently fall short of the target goal. The characteristics of these multiple saccades are consistent with a lack of proper inhibitory control of cortical oculomotor areas on the brainstem saccade generation circuitry. Methodology/Principal Findings: In the present paper, we directly tested this assumption by using single pulse transcranial magnetic stimulation (TMS) to transiently disrupt neuronal activity in the frontal eye fields (FEF) and supplementary eye fields (SEF) in adults performing a gap saccade task. The results showed that the incidence of multiple saccades was increased for ispiversive but not contraversive directions for the right and left FEF, the left SEF, but not for the right SEF. Moreover, this disruption was most substantial during the similar to 50 ms period around the appearance of the peripheral target. A control condition in which the dorsal motor cortex was stimulated demonstrated that this was not due to any non-specific effects of the TMS influencing the spatial distribution of attention. Conclusions/Significance: Taken together, the results are consistent with a direction-dependent role of the FEF and left SEF in delaying the release of saccadic eye movements until they have been fully planned.			van Donkelaar, P (corresponding author), Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA.	paulvd@uoregon.edu						Bisley James W, 2003, Adv Neurol, V93, P141; BRAUN D, 1992, BRAIN, V115, P1359, DOI 10.1093/brain/115.5.1359; Campana G, 2007, NEUROPSYCHOLOGIA, V45, P2340, DOI 10.1016/j.neuropsychologia.2007.02.009; Carpenter RHS, 2004, CURR BIOL, V14, P1576, DOI 10.1016/j.cub.2004.08.058; Drew AS, 2007, CEREB CORTEX, V17, P2618, DOI 10.1093/cercor/bhl169; Enderle JD, 2002, PROG BRAIN RES, V140, P21; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Gagnon D, 2006, J NEUROSCI, V26, P458, DOI 10.1523/JNEUROSCI.2789-05.2006; Girard B, 2005, PROG NEUROBIOL, V77, P215, DOI 10.1016/j.pneurobio.2005.11.001; Isa T, 2004, PROG BRAIN RES, V143, P299, DOI 10.1016/S0079-6123(03)43029-X; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2248, DOI 10.1152/jn.01021.2003; Juan CH, 2008, CEREB CORTEX, V18, P2410, DOI 10.1093/cercor/bhn001; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; MURI RM, 1991, EXP BRAIN RES, V86, P219; Neggers SFW, 2005, EUR J NEUROSCI, V21, P2853, DOI 10.1111/j.1460-9568.2005.04129.x; Nyffeler T, 2008, J COGNITIVE NEUROSCI, V20, P1583, DOI 10.1162/jocn.2008.20073; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; O'Shea J, 2004, J COGNITIVE NEUROSCI, V16, P1060, DOI 10.1162/0898929041502634; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Prime SL, 2010, CEREB CORTEX, V20, P759, DOI 10.1093/cercor/bhp148; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Ro T, 1999, NEUROPSYCHOLOGIA, V37, P225; SALAPATEK P, 1980, CHILD DEV, V51, P1090, DOI 10.1111/j.1467-8624.1980.tb02657.x; Schall JD, 2004, ANNU REV PSYCHOL, V55, P23, DOI 10.1146/annurev.psych.55.090902.141907; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; Taylor PCJ, 2007, CEREB CORTEX, V17, P391, DOI 10.1093/cercor/bhj156; van Donkelaar P, 2007, J NEUROPHYSIOL, V97, P3148, DOI 10.1152/jn.01339.2006	29	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7278	10.1371/journal.pone.0007278	http://dx.doi.org/10.1371/journal.pone.0007278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501BO	19789706	Green Published, gold, Green Submitted			2022-12-25	WOS:000270354100026
J	Orriss, GL; Patel, TR; Sorensen, J; Stetefeld, J				Orriss, George L.; Patel, Trushar R.; Sorensen, John; Stetefeld, Joerg			Absence of a catalytic water confers resistance to the neurotoxin gabaculine	FASEB JOURNAL			English	Article						drug resistance; microevolution; integrated approach; protein X-ray crystallography; chlorophyll biosynthesis	GLUTAMATE 1-SEMIALDEHYDE AMINOTRANSFERASE; ASPARTATE-AMINOTRANSFERASE; SEMIALDEHYDE AMINOTRANSFERASE; CRYSTAL-STRUCTURE; ENZYMES; PROTEINS; SITE; 2,1-AMINOMUTASE; SYNECHOCOCCUS; PURIFICATION	Gabaculine is a potent inhibitor of the vitamin B6-dependent key enzyme in chlorophyll biosynthesis, glutamate-1-semialdehyde aminomutase (GSAM). The inhibition effect is caused by an enzymatic deprotonation of the neurotoxin and requires the aldimine (PLP) form of the cofactor at the active site. In this study, we show that a single-point mutation confers resistance to gabaculine. A combined functional and structural analysis of wild-type GSAM in complex with gabaculine and the GSAM(M248I) form allowed us to decipher in atomic detail the molecular basis of this unique resistance. Interestingly, the gabaculine tolerance is caused by the absence of an essential water molecule that has a dual functional role. It serves as a nucleophilic shuttle for the hydroxyl anion along the reaction pathway and holds active-site Lys273 in a catalytically competent conformation. The single-point mutant is not able to fix this catalytic water between the beta-branched side chain of Ile248 and Lys273. As a consequence, the mutant enzyme is trapped in a gabaculine-insensitive but still enzymatically active amine (PMP) form.-Orriss, G. L., Patel, T. R., Sorensen, J., Stetefeld, J. Absence of a catalytic water confers resistance to the neurotoxin gabaculine. FASEB J. 24, 404-414 (2010). www.fasebj.org	[Orriss, George L.; Patel, Trushar R.; Sorensen, John; Stetefeld, Joerg] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Stetefeld, J (corresponding author), Univ Manitoba, Dept Chem, 144 Dysart Rd, Winnipeg, MB R3T 2N2, Canada.	stetefel@cc.manitoba.ca	Patel, Trushar R./AAB-6250-2020; Patel, Trushar R/F-2776-2011; Stetefeld, Joerg/H-7630-2017	Patel, Trushar R./0000-0003-0627-2923; Patel, Trushar R/0000-0003-0627-2923; Stetefeld, Joerg/0000-0003-1478-3248	Natural Science and Engineering Council of Canada	Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank Dr. Suat Oezbek for helpful discussions and critical reading of the manuscript and Clemens Schulze-Briese (Swiss Light Source, Villigen, Switzerland) for assistance during data collection. This work was supported by the Natural Science and Engineering Council of Canada. J.S. is a Canada Research Chair in Structural Biology.	ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budisa N, 1998, EUR J BIOCHEM, V253, P1, DOI 10.1046/j.1432-1327.1998.2530001.x; Budisa N, 1998, P NATL ACAD SCI USA, V95, P455, DOI 10.1073/pnas.95.2.455; Contestabile R, 2000, J BIOL CHEM, V275, P3879, DOI 10.1074/jbc.275.6.3879; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Eads JC, 1999, BIOCHEMISTRY-US, V38, P9840, DOI 10.1021/bi990018q; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; GOLDBERG JM, 1991, BIOCHEMISTRY-US, V30, P305, DOI 10.1021/bi00215a041; GRIMM B, 1989, CARLSBERG RES COMMUN, V54, P67, DOI 10.1007/BF02907586; GRIMM B, 1991, J BIOL CHEM, V266, P12495; Hennig M, 1997, P NATL ACAD SCI USA, V94, P4866, DOI 10.1073/pnas.94.10.4866; HOFRICHTER J, 1976, ANNU REV BIOPHYS BIO, V5, P511, DOI 10.1146/annurev.bb.05.060176.002455; INOUE K, 1991, J BIOCHEM, V109, P570, DOI 10.1093/oxfordjournals.jbchem.a123421; JORDAN PM, 1973, J BIOL CHEM, V248, P1019; KANNANGARA CG, 1988, TRENDS BIOCHEM SCI, V13, P139; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; Krauss M, 2001, J PHYS CHEM B, V105, P8040, DOI 10.1021/jp012099h; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leslie AGW, 1994, MOSFLM USERS GUIDE; Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; MURAKAMI K, 1993, APPL ENVIRON MICROB, V59, P347, DOI 10.1128/AEM.59.1.347-350.1993; Ozbek S, 2005, ACTA CRYSTALLOGR D, V61, P477, DOI 10.1107/S0907444905001204; PAULING L, 1948, NATURE, V161, P707, DOI 10.1038/161707a0; Piquemal JP, 2003, J COMPUT CHEM, V24, P1963, DOI 10.1002/jcc.10354; PUGH CE, 1991, ANAL BIOCHEM, V198, P43, DOI 10.1016/0003-2697(91)90503-L; RANDO RR, 1977, J AM CHEM SOC, V99, P5141, DOI 10.1021/ja00457a039; RANDO RR, 1977, BIOCHEMISTRY-US, V16, P4604, DOI 10.1021/bi00640a012; Schulze JO, 2006, J MOL BIOL, V358, P1212, DOI 10.1016/j.jmb.2006.02.064; SMITH MA, 1992, BIOCHEMISTRY-US, V31, P4122, DOI 10.1021/bi00131a031; SMITH MA, 1992, BIOCHEMISTRY-US, V31, P11249, DOI 10.1021/bi00160a041; SOPER TS, 1982, J BIOL CHEM, V257, P3930; Stetefeld J, 2006, P NATL ACAD SCI USA, V103, P13688, DOI 10.1073/pnas.0600306103; TYACKE RJ, 1993, BIOCHEM J, V293, P697, DOI 10.1042/bj2930697	39	10	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					404	414		10.1096/fj.09-138297	http://dx.doi.org/10.1096/fj.09-138297			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19786580				2022-12-25	WOS:000274045000009
J	Villaronga, MA; Lavery, DN; Bevan, CL; Llanos, S; Belandia, B				Villaronga, M. A.; Lavery, D. N.; Bevan, C. L.; Llanos, S.; Belandia, B.			HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions	ONCOGENE			English	Article						HEY1; androgen receptor; p53; Notch; single-nucleotide polymorphism	MESENCHYMAL TRANSITION; SIGNALING PATHWAYS; PROSTATE-CANCER; NOTCH PATHWAY; TARGET GENES; P53; CELLS; GROWTH; HERP; DIFFERENTIATION	The hairy/enhancer-of-split related with YRPW motif 1 (HEY1) is a member of the basic-helix-loop-helix-Orange (bHLH-O) family of transcriptional repressors that mediate Notch signaling. Several cancer-related pathways also regulate HEY1 expression, and HEY1 itself acts as an indirect positive regulator of the p53 tumor suppressor protein and a negative regulator of androgen receptor activity. In this study we show how a naturally occurring non-synonymous polymorphism at codon 94 of HEY1, which results in a substitution of leucine by methionine (Leu94Met), converts HEY1 from an androgen receptor corepressor to an androgen receptor co-activator without affecting its intrinsic transcriptional repressive domains. The polymorphism Leu94Met also abolishes HEY1-mediated activation of p53 and suppresses the ability of HEY1 to induce p53-dependent cell-cycle arrest and aberrant cell differentiation in human osteosarcoma U2OS cells. Moreover, expression of HEY1, but not of the variant Leu94Met, confers sensitivity to p53-activating chemotherapeutic drugs on U2OS cells. In addition, we have identified motifs in HEY1 that are critical for the regulation of its subcellular localization and analysed how mutations in those motifs affect both HEY1 and HEY1-Leu94Met functions. These findings suggest that the polymorphism Leu94Met in HEY1 radically alters its biological activities and may affect oncogenic processes. Oncogene (2010) 29, 411-420; doi:10.1038/onc.2009.309; published online 5 October 2009	[Villaronga, M. A.; Belandia, B.] Univ Autonoma Madrid, CSIC, Dept Canc Biol, Inst Invest Biomed, Madrid 28029, Spain; [Lavery, D. N.; Bevan, C. L.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Oncol, Androgen Signalling Lab, London, England; [Llanos, S.] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Imperial College London; Centro Nacional de Investigaciones Oncologicas (CNIO)	Belandia, B (corresponding author), Univ Autonoma Madrid, CSIC, Dept Canc Biol, Inst Invest Biomed, Arturo Duperier 4, Madrid 28029, Spain.	sllanos@cnio.es; bbelandia@iib.uam.es	Bevan, Charlotte L/K-2276-2012; Belandia, Borja/H-1509-2015; Lavery, Derek/C-6706-2011; , Susana/AAA-9282-2019; Bevan, Charlotte/T-7769-2019	Bevan, Charlotte L/0000-0002-7533-0552; Belandia, Borja/0000-0003-2448-206X; Llanos, Susana/0000-0002-8555-9326	MICINN [SAF2007-62642, SAF2006-07785]; Fundacion de Investigacion Medica Mutua Madrilena; FIS [RD06/0020/0036]; CRESCENDO [FP-018652]; Cancer Research UK [C11509/A8570]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena; FIS(Instituto de Salud Carlos III); CRESCENDO(European Commission); Cancer Research UK(Cancer Research UK)	We thank Ana Aranda for her continuous support and Linn Markert for technical assistance. This study was supported by the MICINN (SAF2007-62642, SAF2006-07785), the Fundacion de Investigacion Medica Mutua Madrilena, the FIS (RD06/0020/0036), the CRESCENDO (FP-018652) and Cancer Research UK (C11509/A8570).	Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Fuke S, 2005, J BIOCHEM, V137, P205, DOI 10.1093/jb/mvi020; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Giovannini C, 2009, J HEPATOL, V50, P969, DOI 10.1016/j.jhep.2008.12.032; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Hulleman E, 2009, J CELL MOL MED, V13, P136, DOI 10.1111/j.1582-4934.2008.00307.x; Hunter KW, 2006, CANCER RES, V66, P1251, DOI 10.1158/0008-5472.CAN-05-3705; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Pietsch EC, 2006, ONCOGENE, V25, P1602, DOI 10.1038/sj.onc.1209367; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sakamoto M, 2003, J BIOL CHEM, V278, P44808, DOI 10.1074/jbc.M300448200; Satow T, 2001, J NEUROSCI, V21, P1265; Sivertsen EA, 2007, EUR J IMMUNOL, V37, P2937, DOI 10.1002/eji.200636759; Tanaka M, 2009, BRIT J CANCER, V100, P1957, DOI 10.1038/sj.bjc.6605060; Undevia SD, 2005, NAT REV CANCER, V5, P447, DOI 10.1038/nrc1629; Villaronga MA, 2008, CURR CANCER DRUG TAR, V8, P566, DOI 10.2174/156800908786241096; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang YX, 2006, INT J CANCER, V119, P2071, DOI 10.1002/ijc.22077	36	21	21	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2010	29	3					411	420		10.1038/onc.2009.309	http://dx.doi.org/10.1038/onc.2009.309			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	546EO	19802006	Green Accepted, Green Published			2022-12-25	WOS:000273793200010
J	Monsel, G; Ortonne, N; Bagot, M; Bensussan, A; Dumaz, N				Monsel, G.; Ortonne, N.; Bagot, M.; Bensussan, A.; Dumaz, N.			c-Kit mutants require hypoxia-inducible factor 1 alpha to transform melanocytes	ONCOGENE			English	Article						c-Kit; imatinib; MAPK pathway; melanoma; PI3K/Akt pathway	TYROSINE KINASE; FACTOR-RECEPTOR; MELANOMA-CELLS; INHIBITION; ACTIVATION; IMATINIB; MUTATION; EXPRESSION; ONCOGENE; SURVIVAL	Many studies have highlighted the critical role of c-Kit in normal melanocyte development but its role in melanoma development remains unclear. Although c-Kit expression is often lost during melanoma progression, a subset of melanoma has been found to overexpress c-Kit and mutations activating c-Kit have recently been identified in some acral and mucosal melanoma. To address the role of these c-Kit mutants in the transformation of melanocytes, we characterized the physiological responses of melanocytes expressing the most frequent c-Kit mutants found in melanoma (K642E and L576P) and a novel mutant we identified in an acral melanoma. We analysed signaling pathways activated downstream of c-Kit and showed that all three mutants led to a strong activation of the phosphatidyl-inositol-3 kinase (PI3K) pathway but only weak activation of the Ras/Raf/Mek/Erk pathway, which was not sufficient to promote uncontrolled melanocyte proliferation and transformation. However, in hypoxic conditions or coexpressed with a constitutively active form of hypoxia-inducible factor 1 alpha (HIF-1 alpha), c-Kit mutants activate the Ras/Raf/Mek/Erk pathway, stimulate proliferation and transform melanocytes. Proliferation of melanocytes transformed by these mutants was specifically inhibited by imatinib. These results show for the first time that melanocytes require a specific epigenetic environment to be transformed by c-Kit mutants and highlight a distinct molecular mechanism of melanocyte transformation. Oncogene (2010) 29, 227-236; doi:10.1038/onc.2009.320; published online 5 October 2009	[Monsel, G.; Ortonne, N.; Bagot, M.; Bensussan, A.; Dumaz, N.] Hop St Louis, INSERM, U976, F-75475 Paris 10, France; [Ortonne, N.] Grp Hosp Henri Mondor Albert Chenevier, AP HP, Dept Pathol, Creteil, France; [Bagot, M.; Bensussan, A.] Grp Hosp Henri Mondor Albert Chenevier, AP HP, Dept Dermatol, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Dumaz, N (corresponding author), Hop St Louis, INSERM, U976, Pavillon Bazin,1 Ave Claude Vellefaux, F-75475 Paris 10, France.	nicolas.dumaz@inserm.fr	Dumaz, Nicolas/B-5907-2008; Bensussan, Armand/E-5434-2017	Dumaz, Nicolas/0000-0003-3511-2160; Bensussan, Armand/0000-0002-0409-2497	INSERM; Universite Paris XII, Societe Francaise de Dermatologie; Ligue Contre le Cancer (Comite du Val de Marne); Institut National du Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris XII, Societe Francaise de Dermatologie; Ligue Contre le Cancer (Comite du Val de Marne); Institut National du Cancer(Institut National du Cancer (INCA) France)	We thank Professor Richard Marais for 501mel cells and pMCEF vector, Dr Lars Ronnstrand for a wild-type c-Kit expression vector and Dr Frank Bunn for the vector expressing HIF-1 alpha (401 Delta 603). This work was funded by INSERM, Universite Paris XII, Societe Francaise de Dermatologie, Ligue Contre le Cancer (Comite du Val de Marne) and Institut National du Cancer.	Alexeev V, 2006, J INVEST DERMATOL, V126, P1102, DOI 10.1038/sj.jid.5700125; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GIEBEL LB, 1991, P NATL ACAD SCI USA, V88, P8696, DOI 10.1073/pnas.88.19.8696; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Jiang XF, 2008, CLIN CANCER RES, V14, P7726, DOI 10.1158/1078-0432.CCR-08-1144; LASSAM N, 1992, ONCOGENE, V7, P51; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; Muchemwa FC, 2008, BRIT J DERMATOL, V158, P411, DOI 10.1111/j.1365-2133.2007.08292.x; NATALI PG, 1992, CANCER RES, V52, P6139; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Voytyuk O, 2003, J BIOL CHEM, V278, P9159, DOI 10.1074/jbc.M211726200	25	59	63	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2010	29	2					227	236		10.1038/onc.2009.320	http://dx.doi.org/10.1038/onc.2009.320			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19802003				2022-12-25	WOS:000273650000006
J	Novakova, Z; Hubackova, S; Kosar, M; Janderova-Rossmeislova, L; Dobrovolna, J; Vasicova, P; Vancurova, M; Horejsi, Z; Hozak, P; Bartek, J; Hodny, Z				Novakova, Z.; Hubackova, S.; Kosar, M.; Janderova-Rossmeislova, L.; Dobrovolna, J.; Vasicova, P.; Vancurova, M.; Horejsi, Z.; Hozak, P.; Bartek, J.; Hodny, Z.			Cytokine expression and signaling in drug-induced cellular senescence	ONCOGENE			English	Article						cytokines; JAK/STAT signaling; interleukins; cellular senescence; 5-bromo-2 '-deoxyuridine; distamycin A	ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE RESPONSE; TUMOR SUPPRESSION; PML PROTEIN; HUMAN-CELLS; HELA-CELLS; CANCER; PATHWAY; STRESS; INDUCTION	Cellular senescence guards against cancer and modulates aging; however, the underlying mechanisms remain poorly understood. Here, we show that genotoxic drugs capable of inducing premature senescence in normal and cancer cells, such as 5-bromo-2'-deoxyuridine (BrdU), distamycin A (DMA), aphidicolin and hydroxyurea, persistently activate Janus kinase-signal transducer and activator of transcription (JAK/STAT) signaling and expression of interferon-stimulated genes (ISGs), such as MX1, OAS, ISG15, STAT1, PML, IRF1 and IRF7, in several human cancer cell lines. JAK1/STAT-activating ligands, interleukin 10 (IL10), IL20, IL24, interferon gamma (IFN gamma), IFN beta and IL6, were also expressed by senescent cells, supporting autocrine/paracrine activation of JAK1/STAT. Furthermore, cytokine genes, including proinflammatory IL1, tumor necrosis factor and transforming growth factor families, were highly expressed. The strongest inducer of JAK/STAT signaling, cytokine production and senescence was BrdU combined with DMA. RNA interference-mediated knockdown of JAK1 abolished expression of ISGs, but not DNA damage signaling or senescence. Thus, although DNA damage signaling, p53 and RB activation, and the cytokine/chemokine secretory phenotype are apparently shared by all types of senescence, our data reveal so far unprecedented activation of the IFN beta-STAT1-ISGs axis, and indicate a less prominent causative role of IL6-JAK/STAT signaling in genotoxic drug-induced senescence compared with reports on oncogene-induced or replicative senescence. These results highlight shared and unique features of drug-induced cellular senescence, and implicate induction of cancer secretory phenotype in chemotherapy. Oncogene (2010) 29, 273-284; doi:10.1038/onc.2009.318; published online 5 October 2009	[Novakova, Z.; Hubackova, S.; Kosar, M.; Vancurova, M.; Bartek, J.; Hodny, Z.] Acad Sci Czech Republ, Inst Mol Genet, Vvi, Dept Genome Integr, CR-14220 Prague, Czech Republic; [Novakova, Z.; Janderova-Rossmeislova, L.; Dobrovolna, J.; Hozak, P.; Hodny, Z.] Acad Sci Czech Republ, Inst Mol Genet, Vvi, Dept Biol Cell Nucleus, CR-14220 Prague, Czech Republic; [Vasicova, P.] Acad Sci Czech Republ, Inst Microbiol, Vvi, Lab Cell Reprod, CR-14220 Prague, Czech Republic; [Horejsi, Z.] Acad Sci Czech Republ, Inst Mol Genet, Vvi, Dept Mol Virol, CR-14220 Prague, Czech Republic; [Bartek, J.] Danish Canc Soc, Inst Canc Biol, Dept Cell Cycle & Canc, DK-2100 Copenhagen O, Denmark; [Bartek, J.] Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Res, DK-2100 Copenhagen O, Denmark	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Danish Cancer Society; Danish Cancer Society	Hodny, Z (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Vvi, Dept Genome Integr, Videnska 1083, CR-14220 Prague, Czech Republic.	jb@cancer.dk; hodny@img.cas.cz	Dobrovolna, Jana/G-5873-2014; Hodny, Zdenek/C-9384-2009; Bartek, Jiri/G-5870-2014; Vasicova, Pavla/I-2010-2014; Hozak, Pavel/AAB-5359-2021; Vasicova, Pavla/AAL-6466-2021; Rossmeislová, Lenka/D-1931-2013; Novakova, Zora/G-8665-2014; Kosar, Martin/B-7143-2018; Hozak, Pavel/J-4182-2014	Hozak, Pavel/0000-0003-1901-1394; Rossmeislová, Lenka/0000-0002-7611-7585; Novakova, Zora/0000-0001-9804-6346; Kosar, Martin/0000-0002-9400-2327; Hozak, Pavel/0000-0003-1901-1394; Vasicova, Pavla/0000-0002-9733-9929; Stemberkova Hubackova, Sona/0000-0002-3454-6840; Dobrovolna, Jana/0000-0003-2412-2080; Licenikova Horejsi, Zuzana/0000-0002-9943-1649	Agency of the Academy of Sciences of the Czech Republic [IAA500390501]; Grant Agency of the Czech Republic [204/08/1418]; European Commission [TRIREME]; Ministry of Education, Youth and Sports of the Czech Republic [LC545]; Institutional Grant [AV0Z5039906]	Agency of the Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institutional Grant	We thank Ondrej Horvath and Michal Koc for assistance, and Jan Fric and Ondrej Stanek for help with ELISA. This work was supported by the Grant Agency of the Academy of Sciences of the Czech Republic (Project IAA500390501), the Grant Agency of the Czech Republic (Project 204/08/1418), the European Commission (project TRIREME), Grant LC545 of the Ministry of Education, Youth and Sports of the Czech Republic, and the Institutional Grant (Project AV0Z5039906).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang BD, 1999, CANCER RES, V59, P3761; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Engstrom JU, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199/8/9; Fisher PB, 2005, CANCER RES, V65, P10128, DOI 10.1158/0008-5472.CAN-05-3127; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Janderovd-Rossmeislova L, 2007, J STRUCT BIOL, V159, P56, DOI 10.1016/j.jsb.2007.02.008; Kaynor C, 2002, J INTERF CYTOK RES, V22, P1089, DOI 10.1089/10799900260442511; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Kulaeva OI, 2003, ONCOGENE, V22, P4118, DOI 10.1038/sj.onc.1206594; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Michishita E, 1999, J BIOCHEM-TOKYO, V126, P1052; Minagawa S, 2005, EXP CELL RES, V304, P552, DOI 10.1016/j.yexcr.2004.10.036; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; Mushinski JF, 2009, J BIOL CHEM, V284, P15206, DOI 10.1074/jbc.M806324200; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Ronni T, 1998, J INTERF CYTOK RES, V18, P773, DOI 10.1089/jir.1998.18.773; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Suzuki T, 2002, EXP CELL RES, V276, P174, DOI 10.1006/excr.2002.5524; Suzuki T, 2001, EXP CELL RES, V266, P53, DOI 10.1006/excr.2001.5194; Timmermann S, 1998, ONCOGENE, V17, P3445, DOI 10.1038/sj.onc.1202244; Toussaint O, 2002, BIOCHEM PHARMACOL, V64, P1007, DOI 10.1016/S0006-2952(02)01170-X; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Yogev O, 2006, J BIOL CHEM, V281, P34475, DOI 10.1074/jbc.M602865200	50	78	82	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2010	29	2					273	284		10.1038/onc.2009.318	http://dx.doi.org/10.1038/onc.2009.318			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19802007				2022-12-25	WOS:000273650000010
J	Lawrence, SH; Ramirez, UD; Selwood, T; Stith, L; Jaffe, EK				Lawrence, Sarah H.; Ramirez, Ursula D.; Selwood, Trevor; Stith, Linda; Jaffe, Eileen K.			Allosteric Inhibition of Human Porphobilinogen Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUATERNARY STRUCTURE ISOFORMS; ALAD PORPHYRIA; MORPHEEINS; MODEL; IODOCHLORHYDROXYQUIN; PURIFICATION; CATALYSIS; PROTEINS; ENSEMBLE; KINETICS	Porphobilinogen synthase (PBGS) catalyzes the first common step in tetrapyrrole (e.g. heme, chlorophyll) biosynthesis. Human PBGS exists as an equilibrium of high activity octamers, low activity hexamers, and alternate dimer configurations that dictate the stoichiometry and architecture of further assembly. It is posited that small molecules can be found that inhibit human PBGS activity by stabilizing the hexamer. Such molecules, if present in the environment, could potentiate disease states associated with reduced PBGS activity, such as lead poisoning and ALAD porphyria, the latter of which is associated with human PBGS variants whose quaternary structure equilibrium is shifted toward the hexamer (Jaffe, E. K., and Stith, L. (2007) Am. J. Hum. Genet. 80, 329-337). Hexamer-stabilizing inhibitors of human PBGS were identified using in silico pre-screening (docking) of similar to 111,000 structures to a hexamer-specific surface cavity of a human PBGS crystal structure. Seventy-seven compounds were evaluated in vitro; three provided 90-100% conversion of octamer to hexamer in a native PAGE mobility shift assay. Based on chemical purity, two (ML-3A9 and ML-3H2) were subjected to further evaluation of their effect on the quaternary structure equilibrium and enzymatic activity. Naturally occurring ALAD porphyria-associated human PBGS variants are shown to have an increased susceptibility to inhibition by both ML-3A9 and ML-3H2. ML-3H2 is a structural analog of amebicidal drugs, which have porphyria-like side effects. Data support the hypothesis that human PBGS hexamer stabilization may explain these side effects. The current work identifies allosteric ligands of human PBGS and, thus, identifies human PBGS as a medically relevant allosteric enzyme.	[Lawrence, Sarah H.; Ramirez, Ursula D.; Selwood, Trevor; Stith, Linda; Jaffe, Eileen K.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Jaffe, EK (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	Eileen.Jaffe@fccc.edu			National Institutes of Health [R01 ES003654, R21 AI063324, P30 CA006927, T32 CA009035]; Cynthia Myers; NATIONAL CANCER INSTITUTE [T32CA009035, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI063324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cynthia Myers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES003654 (to E. K. J.), R21 AI063324 (to E. K. J.), P30 CA006927 (to the Fox Chase Cancer Center), and T32 CA009035 (to the Institute for Cancer Research).; We acknowledge the contributions of Cynthia Myers of the Fox Chase Cancer Center Organic Synthesis Facility for the chemical and spectral analyses reported.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ANDERSON PM, 1979, J BIOL CHEM, V254, P6924; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; BURCKHALTER JH, 1951, J AM CHEM SOC, V73, P4837, DOI 10.1021/ja01154a108; DESPAUX N, 1979, BIOCHIMIE, V61, P1021; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hilser VJ, 2006, CHEM REV, V106, P1545, DOI 10.1021/cr040423+; Jaffe EK, 2007, AM J HUM GENET, V80, P329, DOI 10.1086/511444; JAFFE EK, 1995, BIOCHEMISTRY-US, V34, P244, DOI 10.1021/bi00001a029; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jorgensen WL, 2000, BIOORG MED CHEM LETT, V10, P1155, DOI 10.1016/S0960-894X(00)00172-4; Kashlan OB, 2003, BIOCHEMISTRY-US, V42, P1696, DOI 10.1021/bi020634d; KAUFFMAN RE, 1990, PEDIATRICS, V86, P797; KAYA AH, 1994, GENOMICS, V19, P242, DOI 10.1006/geno.1994.1054; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lawrence SH, 2008, CHEM BIOL, V15, P586, DOI 10.1016/j.chembiol.2008.04.012; Lawrence SH, 2008, BIOCHEM MOL BIOL EDU, V36, P274, DOI 10.1002/bmb.20211; Linderstrom-Lang K, 1959, ENZYMES, P443; Maruno M, 2001, BLOOD, V97, P2972, DOI 10.1182/blood.V97.10.2972; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Selwood T, 2008, BIOCHEMISTRY-US, V47, P3245, DOI 10.1021/bi702113z; Shekhar C, 2008, CHEM BIOL, V15, P413, DOI 10.1016/j.chembiol.2008.05.001; STOHS SJ, 1984, J INVEST DERMATOL, V82, P195, DOI 10.1111/1523-1747.ep12259839; Tang L, 2006, J BIOL CHEM, V281, P6682, DOI 10.1074/jbc.M511134200; Tang L, 2005, J BIOL CHEM, V280, P15786, DOI 10.1074/jbc.M500218200; Whitten ST, 2006, BIOCHEMISTRY-US, V45, P10163, DOI 10.1021/bi060855+	34	24	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35807	35817		10.1074/jbc.M109.026294	http://dx.doi.org/10.1074/jbc.M109.026294			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19812033	Green Published, hybrid			2022-12-25	WOS:000272645600057
J	Sato, A; Arimura, T; Makita, N; Ishikawa, T; Aizawa, Y; Ushinohama, H; Aizawa, Y; Kimura, A				Sato, Akinori; Arimura, Takuro; Makita, Naomasa; Ishikawa, Taisuke; Aizawa, Yoshiyasu; Ushinohama, Hiroya; Aizawa, Yoshifusa; Kimura, Akinori			Novel Mechanisms of Trafficking Defect Caused by KCNQ1 Mutations Found in Long QT Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL GENE; ENDOPLASMIC-RETICULUM; CARDIAC-ARRHYTHMIAS; DILATED CARDIOMYOPATHY; PROTEIN TRAFFICKING; HERG; KVLQT1; IDENTIFICATION; EXPRESSION; JERVELL	Long QT syndrome (LQTS) is a hereditary arrhythmia caused by mutations in genes for cardiac ion channels, including a potassium channel, KvLQT1. Inheritance of LQTS is usually autosomal-dominant, but autosomal-recessive inheritance can be observed in patients with LQTS accompanied by hearing loss. In this study, we investigated the functional alterations caused by KCNQ1 mutations, a deletion (delV595) and a frameshift (P631fs/19), which were identified in compound heterozygous state in two patients with autosomal-recessive LQTS not accompanied by hearing loss. Functional analyses showed that both mutations impaired cell surface expression due to trafficking defects. The mutations severely affected outward potassium currents without apparent dominant negative effects. It was found that delV595 impaired subunit binding, whereas P631fs/19 was retained in endoplasmic reticulum due to the newly added 19-amino acid sequence containing two retention motifs (R(633)GR and (RLR)-L-646). This is the first report of novel mechanisms for trafficking abnormality of cardiac ion channels, providing us new insights into the molecular mechanisms of LQTS.	[Sato, Akinori; Arimura, Takuro; Ishikawa, Taisuke; Kimura, Akinori] Tokyo Med & Dent Univ, Dept Mol Pathogenesis, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Sato, Akinori; Aizawa, Yoshiyasu; Aizawa, Yoshifusa] Niigata Univ, Div Cardiol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Makita, Naomasa] Nagasaki Univ, Dept Mol Physiol, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Ushinohama, Hiroya] Fukuoka Childrens Hosp, Dept Pediat Cardiol, Fukuoka 8100063, Japan	Tokyo Medical & Dental University (TMDU); Niigata University; Nagasaki University	Kimura, A (corresponding author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138510, Japan.	akitis@mri.tmd.ac.jp	Aizawa, Yoshiyasu/L-8334-2013; Kimura, Akinori/I-5989-2018; Arimura, Takuro/AAA-2745-2022; Ishikawa, Taisuke/D-1567-2019	Aizawa, Yoshiyasu/0000-0002-8323-4229; Kimura, Akinori/0000-0002-4933-2132; Arimura, Takuro/0000-0002-0929-3140; Ishikawa, Taisuke/0000-0001-8195-4700	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan-Korea Collaboration Program; Japan Society for Promotion of Science; Ministry of Health, Labor, and Welfare, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-Korea Collaboration Program; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, grants from the Japan-Korea Collaboration Program and from the Japan-France Collaboration Program from the Japan Society for Promotion of Science, and research grants from the Ministry of Health, Labor, and Welfare, Japan.	Aizawa Y, 2007, J CARDIOVASC ELECTR, V18, P972, DOI 10.1111/j.1540-8167.2007.00889.x; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Arimura T, 2007, BIOCHEM BIOPH RES CO, V357, P162, DOI 10.1016/j.bbrc.2007.03.128; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P2291, DOI 10.1016/j.jacc.2008.02.068; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kanki H, 2004, J BIOL CHEM, V279, P33976, DOI 10.1074/jbc.M404539200; Lehnart SE, 2007, CIRCULATION, V116, P2325, DOI 10.1161/CIRCULATIONAHA.107.711689; Li XD, 1997, J BIOL CHEM, V272, P705, DOI 10.1074/jbc.272.2.705; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Margeta-Mitrovic M, 2002, METHODS, V27, P311, DOI 10.1016/S1046-2023(02)00088-9; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Neyroud N, 1999, CIRC RES, V84, P290, DOI 10.1161/01.RES.84.3.290; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Novotny T, 2006, PACE, V29, P1013, DOI 10.1111/j.1540-8159.2006.00478.x; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schmitt N, 2007, BIOCHEM BIOPH RES CO, V358, P304, DOI 10.1016/j.bbrc.2007.04.127; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Wu L, 2008, J BIOL CHEM, V283, P6968, DOI 10.1074/jbc.M709721200; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	37	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35122	35133		10.1074/jbc.M109.017293	http://dx.doi.org/10.1074/jbc.M109.017293			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19825999	hybrid, Green Published			2022-12-25	WOS:000272439600066
J	Wang, Z; Cui, BW; Gorovsky, MA				Wang, Zhe; Cui, Bowen; Gorovsky, Martin A.			Histone H2B Ubiquitylation Is Not Required for Histone H3 Methylation at Lysine 4 in Tetrahymena	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; REPAIR GENE RAD6; TRANSCRIPTIONAL ACTIVATION; CHROMATIN MODIFICATIONS; UBIQUITINATION; THERMOPHILA; YEAST; COMPLEX; MONOUBIQUITINATION; TRANSFORMATION	Ubiquitylation of histone H2B and/or a component of the system that ubiquitylates H2B is required for methylation of histone H3 at lysine 4 (H3K4) in yeasts and probably in humans. In this study, the single ubiquitylation site was mapped to conserved lysine 115 of the C-terminal region of histone H2B in the single-cell model organism Tetrahymena thermophila. In strains lacking H2B ubiquitylation, H3K4 methylation was not detectably affected. As in other organisms, the E2 ubiquitin-conjugating enzyme Ubc2 and the E3 ubiquitin ligase Bre1 were required for H2B ubiquitylation. However, neither enzyme was required for H3K4 methylation. These studies argue that, in T. thermophila, the histone ubiquitylation mechanism is not required for H3K4 methylation, demonstrating that different organisms can speak different languages in the "cross-talk" among post-translational modifications on different histones.	[Wang, Zhe; Cui, Bowen; Gorovsky, Martin A.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Gorovsky, MA (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	goro@mail.rochester.edu	Cui, Bowen/F-1038-2011		National Institutes of Health [R01 GM021793]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM021793.	ALLIS CD, 1979, P NATL ACAD SCI USA, V76, P4857, DOI 10.1073/pnas.76.10.4857; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; BRUNS PJ, 1974, J EXP ZOOL, V188, P337, DOI 10.1002/jez.1401880309; CassidyHanley D, 1997, GENETICS, V146, P135; Chen HY, 1998, J BIOL CHEM, V273, P13165, DOI 10.1074/jbc.273.21.13165; Cui BW, 2006, MOL CELL BIOL, V26, P7719, DOI 10.1128/MCB.01139-06; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Foster ER, 2009, J CELL BIOL, V184, P631, DOI 10.1083/jcb.200812088; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; GAERTIG J, 1992, P NATL ACAD SCI USA, V89, P9196, DOI 10.1073/pnas.89.19.9196; GLOVER CV, 1979, THESIS U ROCHESTER R; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; Hai B, 1997, P NATL ACAD SCI USA, V94, P1310, DOI 10.1073/pnas.94.4.1310; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; KOKEN M, 1991, P NATL ACAD SCI USA, V88, P3832, DOI 10.1073/pnas.88.9.3832; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu XW, 1996, NUCLEIC ACIDS RES, V24, P3023, DOI 10.1093/nar/24.15.3023; LIU Y, 2003, THESIS U ROCHESTER R; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Pogulis R J, 1996, Methods Mol Biol, V57, P167; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; STARGELL LA, 1993, GENE DEV, V7, P2641, DOI 10.1101/gad.7.12b.2641; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; THORNE AW, 1987, EMBO J, V6, P1005, DOI 10.1002/j.1460-2075.1987.tb04852.x; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Wolffe A., 1998, CHROMATIN STRUCTURE; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zofall M, 2007, J BIOL CHEM, V282, P14065, DOI 10.1074/jbc.M700292200	51	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34870	34879		10.1074/jbc.M109.046250	http://dx.doi.org/10.1074/jbc.M109.046250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19822522	Green Published, hybrid			2022-12-25	WOS:000272439600042
J	Ricks, TK; Trejo, J				Ricks, Tiffany K.; Trejo, JoAnn			Phosphorylation of Protease-activated Receptor-2 Differentially Regulates Desensitization and Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; ARRESTIN-DEPENDENT ENDOCYTOSIS; BREAST-CANCER CELLS; COUPLED RECEPTOR; BETA-ARRESTIN; CLATHRIN ADAPTER; DOWN-REGULATION; FACTOR VIIA; BETA(2)-ADRENERGIC RECEPTOR; MEDIATES UBIQUITINATION	Protease-activated receptor 2 (PAR2) is a G protein-coupled receptor irreversibly activated by extracellular proteases. Activated PAR2 couples to multiple heterotrimeric G-protein subtypes including G alpha(q), G alpha(i), and G alpha(12/13). Most activated G protein-coupled receptors are rapidly desensitized and internalized following phosphorylation and beta-arrestin binding. However, the role of phosphorylation in regulation of PAR2 signaling and trafficking is not known. To investigate the function of phosphorylation, we generated a PAR2 mutant in which all serines and threonines in the C-tail were converted to alanines and designated it PAR2 0P. In mammalian cells, the addition of agonist induced a rapid and robust increase in phosphorylation of wild-type PAR2 but not the 0P mutant, suggesting that the major sites of phosphorylation occur within the C-tail domain. Moreover, desensitization of PAR2 0P signaling was markedly impaired compared with the wild-type receptor. Wild-type phosphorylated PAR2 internalized through a canonical dynamin, clathrin- and beta-arrestin-dependent pathway. Strikingly, PAR20P mutant internalization proceeded through a dynamin-dependent but clathrin- and beta-arrestin-independent pathway in both a constitutive and agonist-dependent manner. Collectively, our studies show that PAR2 phosphorylation is essential for beta-arrestin binding and uncoupling from heterotrimeric G-protein signaling and that the presence of serine and threonine residues in the PAR2 C-tail hinder constitutive internalization through a non-canonical pathway. Thus, our studies reveal a novel function for phosphorylation that differentially regulates PAR2 desensitization and endocytic trafficking.	[Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Trejo, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr,Biomed Sci Bldg,Rm 3018, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [HL073328]; American Heart Association Established Investigator; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL073328 (to J.T.) and an American Heart Association Established Investigator Award (to J.T.).	Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Awasthi V, 2007, ARTERIOSCL THROM VAS, V27, P1447, DOI 10.1161/ATVBAHA.107.143438; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Murray SR, 1998, J BIOL CHEM, V273, P24987, DOI 10.1074/jbc.273.39.24987; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	49	48	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34444	34457		10.1074/jbc.M109.048942	http://dx.doi.org/10.1074/jbc.M109.048942			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815543	hybrid, Green Published			2022-12-25	WOS:000272165200074
J	Lerat, H; Kammoun, HL; Hainault, I; Merour, E; Higgs, MR; Callens, C; Lemon, SM; Foufelle, F; Pawlotsky, JM				Lerat, Herve; Kammoun, Helene L.; Hainault, Isabelle; Merour, Emilie; Higgs, Martin R.; Callens, Celine; Lemon, Stanley M.; Foufelle, Fabienne; Pawlotsky, Jean-Michel			Hepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; ENDOPLASMIC-RETICULUM STRESS; CORE PROTEIN; NONSTRUCTURAL PROTEINS; LIPID DROPLET; STEATOSIS; LIVER; HYPOBETALIPOPROTEINEMIA; HEPATOCYTES; CHOLESTEROL	Chronic hepatitis C virus (HCV) infection is associated with altered lipid metabolism and hepatocellular steatosis. Virus-induced steatosis is a cytopathic effect of HCV replication. The goal of this study was to examine the mechanisms underlying HCV-induced lipid metabolic defects in a transgenic mouse model expressing the full HCV protein repertoire at levels corresponding to natural human infection. In this model, expression of the HCV full-length open reading frame was associated with hepatocellular steatosis and reduced plasma triglyceride levels. Triglyceride secretion was impaired, whereas lipogenesis was activated. Increased lipogenic enzyme transcription was observed, resulting from maturational activation and nuclear translocation of sterol regulatory element-binding protein 1c (SREBP1c). However, endoplasmic reticulum (ER) stress markers were expressed at similar levels in both HCV transgenic mice and their wild type counterparts, suggesting that SREBP1c proteolytic cleavage in the presence of HCV proteins was independent of ER stress. In conclusion, transgenic mice expressing the HCV full-length polyprotein at low levels have decreased plasma triglyceride levels and develop hepatocellular steatosis in the same way as HCV-infected patients. In these mice, SREBP1c activation by one or several HCV proteins induces de novo triglyceride synthesis via the lipogenic pathway, in a manner independent of ER stress, whereas triglyceride secretion is simultaneously reduced.	[Lerat, Herve; Merour, Emilie; Higgs, Martin R.; Pawlotsky, Jean-Michel] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Kammoun, Helene L.; Hainault, Isabelle; Callens, Celine; Foufelle, Fabienne] Univ Paris 06, INSERM, U872, F-75270 Paris, France; [Lemon, Stanley M.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Pawlotsky, Jean-Michel] Univ Paris 12, Hop Henri Mondor, Dept Virol, Natl Reference Ctr Viral Hepatitis B C & Delta, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Texas System; University of Texas Medical Branch Galveston; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Lerat, H (corresponding author), Hop Henri Mondor, INSERM, U955, 51 Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.	herve.lerat@inserm.fr	Pawlotsky, Jean-Michel/R-8159-2018; Higgs, Martin/AAK-2108-2021; LERAT, Hervé/D-4331-2019	Higgs, Martin/0000-0002-8218-0089; LERAT, Hervé/0000-0002-8505-378X; FOUFELLE, Fabienne/0000-0002-0752-622X; Pawlotsky, Jean-Michel/0000-0003-0745-7559	National Institutes of Health [U19-AI40035]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U19-AI40035.	[Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; BACH N, 1992, HEPATOLOGY, V15, P572, DOI 10.1002/hep.1840150403; Baiocchi L, 1998, LIVER TRANSPLANT SUR, V4, P441, DOI 10.1002/lt.500040613; BLAKE WL, 1994, BIOCHEM BIOPH RES CO, V205, P1257, DOI 10.1006/bbrc.1994.2800; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Castera L, 2003, GUT, V52, P288, DOI 10.1136/gut.52.2.288; Castera L, 2005, AM J GASTROENTEROL, V100, P711, DOI 10.1111/j.1572-0241.2005.40898.x; Choukhi A, 1998, J VIROL, V72, P3851, DOI 10.1128/JVI.72.5.3851-3858.1998; Dai CY, 2008, J HEPATOL, V49, P9, DOI 10.1016/j.jhep.2008.03.016; Disson O, 2004, GASTROENTEROLOGY, V126, P859, DOI 10.1053/j.gastro.2003.12.005; Domitrovich AM, 2005, J BIOL CHEM, V280, P39802, DOI 10.1074/jbc.M510391200; Erdtmann L, 2003, J BIOL CHEM, V278, P18256, DOI 10.1074/jbc.M209732200; Gerber M A, 1997, Clin Liver Dis, V1, P529, DOI 10.1016/S1089-3261(05)70319-6; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Hezode C, 2004, J VIRAL HEPATITIS, V11, P455, DOI 10.1111/j.1365-2893.2004.00528.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Keasler VV, 2006, VIROLOGY, V347, P466, DOI 10.1016/j.virol.2005.11.050; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; McPherson S, 2008, J HEPATOL, V49, P1046, DOI 10.1016/j.jhep.2008.06.022; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Negro F, 2002, HEPATOLOGY, V36, P1050, DOI 10.1053/jhep.2002.37118; Oem JK, 2008, J GEN VIROL, V89, P1225, DOI 10.1099/vir.0.83491-0; Pavio N, 2003, J VIROL, V77, P3578, DOI 10.1128/JVI.77.6.3578-3585.2003; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Petit JM, 2003, AM J GASTROENTEROL, V98, P1150, DOI 10.1016/S0002-9270(03)00106-0; Piodi A, 2008, HEPATOLOGY, V48, P16, DOI 10.1002/hep.22288; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Serfaty L, 2001, J HEPATOL, V34, P428, DOI 10.1016/S0168-8278(00)00036-2; SERFATY L, 2007, GASTROENTEROL CLIN B, V31; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Siagris D, 2006, J VIRAL HEPATITIS, V13, P56, DOI 10.1111/j.1365-2893.2005.00655.x; Spahr L, 2001, J HEPATOL, V35, P308, DOI 10.1016/S0168-8278(01)00082-4; Tada S, 2009, HEPATOL RES, V39, P195, DOI 10.1111/j.1872-034X.2008.00439.x; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508	44	74	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33466	33474		10.1074/jbc.M109.019810	http://dx.doi.org/10.1074/jbc.M109.019810			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808675	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-25	WOS:000272028500053
J	Nagy, R; Grob, H; Weder, B; Green, P; Klein, M; Frelet-Barrand, A; Schjoerring, JK; Brearley, C; Martinoia, E				Nagy, Reka; Grob, Hanne; Weder, Barbara; Green, Porntip; Klein, Markus; Frelet-Barrand, Annie; Schjoerring, Jan K.; Brearley, Charles; Martinoia, Enrico			The Arabidopsis ATP-binding Cassette Protein AtMRP5/AtABCC5 Is a High Affinity Inositol Hexakisphosphate Transporter Involved in Guard Cell Signaling and Phytate Storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPHOSPHATE KINASES; SOYBEAN SEEDS; THALIANA; PHOSPHATE; VACUOLES; RESISTANCE; CHANNELS; CALCIUM; ATMRP5; FAMILY	Arabidopsis possesses a superfamily of ATP-binding cassette (ABC) transporters. Among these, the multidrug resistance-associated protein AtMRP5/AtABCC5 regulates stomatal aperture and controls plasma membrane anion channels of guard cells. Remarkably, despite the prominent role of AtMRP5 in conferring partial drought insensitivity upon Arabidopsis, we know little of the biochemical function of AtMRP5. Our phylogenetic analysis showed that AtMRP5 is closely related to maize MRP4, mutation of which confers a low inositol hexakisphosphate kernel phenotype. We now show that insertion mutants of AtMRP5 display a low inositol hexakisphosphate phenotype in seed tissue and that this phenotype is associated with alterations of mineral cation and phosphate status. By heterologous expression in yeast, we demonstrate that AtMRP5 encodes a specific and high affinity ATP-dependent inositol hexakisphosphate transporter that is sensitive to inhibitors of ABC transporters. Moreover, complementation of the mrp5-1 insertion mutants of Arabidopsis with the AtMRP5 cDNA driven from a guard cell-specific promoter restores the sensitivity of the mutant to abscisic acid-mediated inhibition of stomatal opening. Additionally, we show that mutation of residues of the Walker B motif prevents restoring the multiple phenotypes associated with mrp5-1. Our findings highlight a novel function of plant ABC transporters that may be relevant to other kingdoms. They also extend the signaling repertoire of this ubiquitous inositol polyphosphate signaling molecule.	[Nagy, Reka; Grob, Hanne; Weder, Barbara; Frelet-Barrand, Annie; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Martinoia, Enrico] Pohang Univ Sci & Technol, Div Mol Life Sci, POSTECH UZH Global Res Lab, Pohang 790784, South Korea; [Klein, Markus] R&D Innnovat Cube, Philip Morris Int, Tobacco Appl Biol, Tobacco Technol, CH-2000 Neuchatel, Switzerland; [Schjoerring, Jan K.] Univ Copenhagen, Fac Life Sci, DK-1871 Frederiksberg C, Denmark; [Green, Porntip; Brearley, Charles] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Zurich; Pohang University of Science & Technology (POSTECH); Philip Morris International Inc; University of Copenhagen; University of East Anglia	Nagy, R (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	rnagy@botinst.uzh.ch; C.Brearley@uea.ac.uk	Schjoerring, Jan K./A-5387-2009; frelet barrand, annie/E-5479-2015; FRELET-BARRAND, Annie/AFX-2878-2022; Martinoia, Enrico/AAH-8712-2021; Frelet-Barrand, Annie/S-1951-2017	Schjoerring, Jan K./0000-0002-2852-3298; FRELET-BARRAND, Annie/0000-0002-0849-9040; Brearley, Charles/0000-0001-6179-9109; Green, Porntip/0000-0002-1968-0574	Swiss National Foundation [3100AO-117790]; Forschungskredit der Universitat Zurich; European Union [FOOD-CT-2006-0016253]; Biotechnology and Biological Sciences Research Council [BB/C514090/1]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Forschungskredit der Universitat Zurich; European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Swiss National Foundation Grant 3100AO-117790 (to E. M.), by funds from the Forschungskredit der Universitat Zurich (to R. N.), by European Union Project Public Health Impact on Long Term, Low Level Mixed Element Exposure (PHIME) Contract FOOD-CT-2006-0016253 (to J. K. S.), and by Biotechnology and Biological Sciences Research Council Grant BB/C514090/1 (to C. B.).	ADAMS CA, 1985, CROP SCI, V25, P255, DOI 10.2135/cropsci1985.0011183X002500020013x; Bentsink L, 2003, THEOR APPL GENET, V106, P1234, DOI 10.1007/s00122-002-1177-9; Casaravilla C, 2006, FEBS J, V273, P3192, DOI 10.1111/j.1742-4658.2006.05328.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Craxton A, 1997, BIOCHEM J, V328, P75, DOI 10.1042/bj3280075; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dorsch JA, 2003, PHYTOCHEMISTRY, V62, P691, DOI 10.1016/S0031-9422(02)00610-6; Frelet A, 2006, FEBS LETT, V580, P1064, DOI 10.1016/j.febslet.2006.01.024; Gaedeke N, 2001, EMBO J, V20, P1875, DOI 10.1093/emboj/20.8.1875; Hatzack F, 2001, BIOCHEM J, V354, P473, DOI 10.1042/0264-6021:3540473; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Klein M, 2003, PLANT J, V33, P119, DOI 10.1046/j.1365-313X.2003.016012.x; Lebaudy A, 2008, P NATL ACAD SCI USA, V105, P5271, DOI 10.1073/pnas.0709732105; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lemtiri-Chlieh F, 2003, P NATL ACAD SCI USA, V100, P10091, DOI 10.1073/pnas.1133289100; Lemtiri-Chlieh F, 2000, P NATL ACAD SCI USA, V97, P8687, DOI 10.1073/pnas.140217497; Lott JNA., 1984, SEED PHYSL, P139; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Marty F, 1997, ADV BOT RES, V25, P1, DOI 10.1016/S0065-2296(08)60146-9; Mitchell J, 2008, CURR BIOL, V18, P1600, DOI 10.1016/j.cub.2008.08.073; Mitsuhashi N, 2005, PLANT PHYSIOL, V138, P1607, DOI 10.1104/pp.105.060269; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Raboy V, 2000, PLANT PHYSIOL, V124, P355, DOI 10.1104/pp.124.1.355; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Shi JR, 2003, PLANT PHYSIOL, V131, P507, DOI 10.1104/pp.014258; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Suh SJ, 2007, J BIOL CHEM, V282, P1916, DOI 10.1074/jbc.M607926200; Sweetman D, 2006, BIOCHEM J, V394, P95, DOI 10.1042/BJ20051331; Sweetman D, 2007, FEBS LETT, V581, P4165, DOI 10.1016/j.febslet.2007.07.046; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; Turner BL, 2002, PHILOS T ROY SOC B, V357, P449, DOI 10.1098/rstb.2001.0837; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; VAJANAPHANICH M, 1994, NATURE, V371, P711, DOI 10.1038/371711a0; Yang L, 2006, J CELL SCI, V119, P1320, DOI 10.1242/jcs.02836; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	47	139	154	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33614	33622		10.1074/jbc.M109.030247	http://dx.doi.org/10.1074/jbc.M109.030247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19797057	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000272028500065
J	Noma, K; Kimura, K; Minatohara, K; Nakashima, H; Nagao, Y; Mizoguchi, A; Fujiyoshi, Y				Noma, Kentaro; Kimura, Kazushi; Minatohara, Keiichiro; Nakashima, Hisako; Nagao, Yasuaki; Mizoguchi, Akira; Fujiyoshi, Yoshinori			Triple N-Glycosylation in the Long S5-P Loop Regulates the Activation and Trafficking of the Kv12.2 Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMULATED ACTION-POTENTIALS; CELL-SURFACE EXPRESSION; K+ CHANNEL; BETA-SUBUNITS; SIALIC-ACID; FUNCTIONAL-PROPERTIES; LINKED GLYCOSYLATION; HERG CHANNEL; IN-VITRO; GLYCANS	Mammalian voltage-dependent potassium (Kv) channels regulate the excitability of nerve and muscle cells. Kv12.2 features the longest S5-P loop among all known mammalian Kv channels with the most N-linked glycosylation sites (three sites). Despite its unique structural features, Kv12.2 is not well characterized. Because glycosylation plays important roles in the folding, trafficking, and function of various Kv channels, we focused on the N-glycosylation of Kv12.2. We show that Kv12.2 is N-glycosylated in Chinese hamster ovary (CHO) cells and in cultured neurons as well as in the mouse brain. As an effect of N-glycosylation on the function of Kv12.2, we demonstrate that removal of sugar chains causes a depolarizing shift in the steady-state activation without a significant reduction in current amplitude. Unlike the previously reported shift for Shaker-type Kv channels, this shift does not appear to be due to negatively charged sialic acid residues in the sugar chains. We next examined the trafficking in CHO cells to address whether the unglycosylated Kv12.2 channels are utilized in vivo. Although double mutants, retaining only one glycosylation site, are trafficked to the surface of CHO cells irrespective of the position of the glycosylated site, unglycosylated channels are not trafficked to the cell surface. Furthermore, we could not detect unglycosylated channels in the mouse brain. Our data suggest that only glycosylated Kv12.2 channels show proper voltage dependence and are utilized in vivo.	[Noma, Kentaro; Minatohara, Keiichiro; Fujiyoshi, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Kimura, Kazushi; Nakashima, Hisako; Nagao, Yasuaki; Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, Tsu, Mie 5148507, Japan	Kyoto University; Mie University	Fujiyoshi, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	yoshi@em.biophys.kyoto-u.ac.jp	Kimura, Kazushi/ABB-4007-2020; Fujiyoshi, Yoshinori/E-5989-2012	Fujiyoshi, Yoshinori/0000-0002-8070-1493	Japan New Energy and Industrial Technology Development Organization	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by Grants-in-aid for Specially Promoted Research and the Japan New Energy and Industrial Technology Development Organization.	Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Bennett ES, 2002, J PHYSIOL-LONDON, V538, P675, DOI 10.1113/jphysiol.2001.013285; Brooks NL, 2006, FEBS J, V273, P3287, DOI 10.1111/j.1742-4658.2006.05339.x; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Clancy SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006330; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Dun W, 1999, PFLUG ARCH EUR J PHY, V439, P141, DOI 10.1007/s004240051138; Engeland B, 1998, J PHYSIOL-LONDON, V513, P647, DOI 10.1111/j.1469-7793.1998.647ba.x; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Grosso S, 2004, J CHILD NEUROL, V19, P604, DOI 10.1177/088307380401900807; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang M, 2005, J PHYSIOL-LONDON, V569, P75, DOI 10.1113/jphysiol.2005.093682; Johnson D, 2008, PFLUG ARCH EUR J PHY, V456, P393, DOI 10.1007/s00424-007-0378-0; LANDOLTMARTICORENA C, 1994, BIOCHEM J, V302, P253, DOI 10.1042/bj3020253; Liu J, 2002, J GEN PHYSIOL, V120, P723, DOI 10.1085/jgp.20028687; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Miyake A, 1999, J BIOL CHEM, V274, P25018, DOI 10.1074/jbc.274.35.25018; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; RECIOPINTO E, 1990, NEURON, V5, P675, DOI 10.1016/0896-6273(90)90221-Z; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Sutachan JJ, 2005, BRAIN RES, V1058, P30, DOI 10.1016/j.brainres.2005.07.050; Thornhill WB, 1996, J BIOL CHEM, V271, P19093, DOI 10.1074/jbc.271.32.19093; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Trudeau MC, 1999, J NEUROSCI, V19, P2906; Ufret-Vincenty CA, 2001, AM J PHYSIOL-CELL PH, V281, pC464, DOI 10.1152/ajpcell.2001.281.2.C464; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vanoni O, 2008, MOL BIOL CELL, V19, P4086, DOI 10.1091/mbc.E08-05-0459; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; YU FH, 2004, SCI STKE; Zhu I, 2009, BRAIN RES, V1251, P16, DOI 10.1016/j.brainres.2008.11.033; Zou AR, 2003, AM J PHYSIOL-CELL PH, V285, pC1356, DOI 10.1152/ajpcell.00179.2003	47	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33139	33150		10.1074/jbc.M109.021519	http://dx.doi.org/10.1074/jbc.M109.021519			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808681	hybrid, Green Published			2022-12-25	WOS:000272028500018
J	Matamoros, T; Nevot, M; Martinez, MA; Menendez-Arias, L				Matamoros, Tania; Nevot, Maria; Angel Martinez, Miguel; Menendez-Arias, Luis			Thymidine Analogue Resistance Suppression by V75I of HIV-1 Reverse Transcriptase EFFECTS OF SUBSTITUTING VALINE 75 ON STAVUDINE EXCISION AND DISCRIMINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BORANOPHOSPHATE NUCLEOTIDE ANALOGS; PRIMER UNBLOCKING ACTIVITY; TERMINATED DNA-SYNTHESIS; DRUG-RESISTANCE; ZIDOVUDINE RESISTANCE; MULTIDRUG-RESISTANCE; 3'-AZIDO-3'-DEOXYTHYMIDINE AZT; DIDEOXYNUCLEOSIDE RESISTANCE; PHYSIOLOGICAL CONCENTRATIONS	Val(75) of HIV-1 reverse transcriptase (RT) plays a role in positioning the template nucleotide +1 during the formation of the ternary complex. Mutations, such as V75M and V75A, emerge in patients infected with HIV-1 group M subtype B and group O variants, after failing treatment with stavudine (d4T) and other nucleoside RT inhibitors. V75I is an accessory mutation of the Q151M multidrug resistance complex of HIV-1 RT and is rarely associated with thymidine analogue resistance mutations (TAMs). In vitro, it confers resistance to acyclovir. TAMs confer resistance to zidovudine (AZT) and d4T by increasing the rate of ATP-mediated excision of the terminal nucleotide monophosphate (primer unblocking). In a wild-type HIV-1 group O RT sequence context, V75A and V75M conferred increased excision activity on d4T-terminated primers, in the presence of PPi. In contrast, V75I decreased the PPi-mediated unblocking efficiency on AZT and d4T-terminated primers, in different sequence contexts (i.e. wild-type group M subtype B or group O RTs). Interestingly, in the sequence context of an excision-proficient RT (i.e. M41L/A62V/T69SSS/K70R/T215Y), the introduction of V75I led to a significant decrease of its ATP-dependent excision activity on AZT-, d4T-, and acyclovir-terminated primers. The excision rate of d4T- monophosphate in the presence of ATP(3.2mM) was about 10 times higher for M41L/A62V/T69SSS/K70R/T215Y than for the mutant M41L/A62V/T69SSS/K70R/V75I/T215Y RT. The antagonistic effect of V75I with TAMs was further demonstrated in phenotypic assays. Recombinant HIV-1 containing the M41L/A62V/T69SSS/K70R/V75I/T215Y RT showed 18.3- and 1.5-fold increased susceptibility to AZT and d4T, respectively, in comparison with virus containing the M41L/A62V/T69SSS/K70R/T215Y RT.	[Matamoros, Tania; Menendez-Arias, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Matamoros, Tania; Menendez-Arias, Luis] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Nevot, Maria; Angel Martinez, Miguel] Hosp Badalona Germans Trias & Pujol, Lab Retrovirol, Fundacio IrsiCaixa, Barcelona 08916, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Menendez-Arias, L (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1,Campus Cantoblanco, Madrid 28049, Spain.	lmenendez@cbm.uam.es	Martinez, Miguel Angel/K-6435-2014; Nevot, Maria/AAC-7839-2022; Nevot, Maria/E-6187-2016; Arias, Luis Menendez/N-7447-2016; Menendez Arias, Luis/G-2436-2016; Matamoros, Tania/F-2580-2016	Martinez, Miguel Angel/0000-0002-6681-4950; Nevot, Maria/0000-0003-4947-4648; Nevot, Maria/0000-0003-4947-4648; Arias, Luis Menendez/0000-0002-1251-6640; Matamoros, Tania/0000-0001-9268-0696	Spanish Ministry of Science and Innovation [BIO2007/60319, BFU2006/01066, PI07/0098]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [36771/08]; Fondo de Investigacion Sanitaria [RD06/0006]; Fundacion Ramon Areces	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Ramon Areces	This work was supported by Spanish Ministry of Science and Innovation Grant BIO2007/60319, Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) Grant 36771/08, the Fondo de Investigacion Sanitaria (through "Red Tematica de Investigacion Cooperativa en SIDA" Grant RD06/0006), and an institutional grant from the Fundacion Ramon Areces. This work was also supported by Spanish Ministry of Science and Innovation Grants BFU2006/01066 and PI07/0098 (to M. A. M.).	Alvarez M, 2009, J MOL BIOL, V392, P872, DOI 10.1016/j.jmb.2009.07.081; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Arion D, 2000, J BIOL CHEM, V275, P9251, DOI 10.1074/jbc.275.13.9251; Ariyoshi K, 2003, JAIDS-J ACQ IMM DEF, V33, P336, DOI 10.1097/00126334-200307010-00007; Basavapathruni A, 2007, FASEB J, V21, P3795, DOI 10.1096/fj.07-8697rev; Boretto J, 2001, ANAL BIOCHEM, V292, P139, DOI 10.1006/abio.2001.5045; Boyer PL, 2006, PLOS PATHOG, V2, P101, DOI 10.1371/journal.ppat0020010; Boyer PL, 2002, J VIROL, V76, P3248, DOI 10.1128/JVI.76.7.3248-3256.2002; Brandin E, 2003, AIDS RES HUM RETROV, V19, P543, DOI 10.1089/088922203322230905; Cases-Gonzalez CE, 2007, J MOL BIOL, V365, P298, DOI 10.1016/j.jmb.2006.09.073; Coakley EP, 2000, AIDS, V14, pF9, DOI 10.1097/00002030-200001280-00002; De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3; Descamps D, 2004, J MED VIROL, V74, P197, DOI 10.1002/jmv.20174; Deval J, 2005, J BIOL CHEM, V280, P3838, DOI 10.1074/jbc.M411559200; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Fitzgibbon JE, 2001, ANTIVIR THER, V6, P231; Frankel FA, 2005, ANTIMICROB AGENTS CH, V49, P2657, DOI 10.1128/AAC.49.7.2657-2664.2005; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; Gotte M, 2000, J VIROL, V74, P3579, DOI 10.1128/JVI.74.8.3579-3585.2000; Hammond JL, 2001, ANTIMICROB AGENTS CH, V45, P1621, DOI 10.1128/AAC.45.6.1621-1628.2001; He KH, 1998, J ORG CHEM, V63, P5769, DOI 10.1021/jo972002g; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Iversen AKN, 1996, J VIROL, V70, P1086, DOI 10.1128/JVI.70.2.1086-1090.1996; KATI WM, 1992, J BIOL CHEM, V267, P25988; KELLAM P, 1994, ANTIMICROB AGENTS CH, V38, P23, DOI 10.1128/AAC.38.1.23; Kisic M, 2008, J MOL BIOL, V382, P327, DOI 10.1016/j.jmb.2008.07.030; Kosalaraksa P, 1999, J VIROL, V73, P5356, DOI 10.1128/JVI.73.7.5356-5363.1999; LACEY SF, 1994, ANTIMICROB AGENTS CH, V38, P1428, DOI 10.1128/AAC.38.6.1428; LARDER BA, 1990, ANTIMICROB AGENTS CH, V34, P436, DOI 10.1128/AAC.34.3.436; LIN PF, 1994, J INFECT DIS, V170, P1157, DOI 10.1093/infdis/170.5.1157; Maeda Y, 1998, J INFECT DIS, V177, P1207, DOI 10.1086/515282; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Mas A, 2002, J MOL BIOL, V323, P181, DOI 10.1016/S0022-2836(02)00911-7; Mas A, 2000, EMBO J, V19, P5752, DOI 10.1093/emboj/19.21.5752; Matamoros T, 2005, J MOL BIOL, V349, P451, DOI 10.1016/j.jmb.2005.04.004; Matamoros T, 2004, J BIOL CHEM, V279, P24569, DOI 10.1074/jbc.M312658200; Matamoros T, 2008, J MOL BIOL, V375, P1234, DOI 10.1016/j.jmb.2007.11.021; MCCARTHY JG, 1990, BIOCHEMISTRY-US, V29, P6071, DOI 10.1021/bi00477a027; McColl DJ, 2008, ANTIVIR THER, V13, P189; McMahon MA, 2008, J BIOL CHEM, V283, P31289, DOI 10.1074/jbc.C800188200; Menendez-Arias L, 2001, J BIOL CHEM, V276, P27470, DOI 10.1074/jbc.M104342200; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Menendez-Arias L, 2006, CURR PHARM DESIGN, V12, P1811, DOI 10.2174/138161206776873608; Meyer P, 2000, EMBO J, V19, P3520, DOI 10.1093/emboj/19.14.3520; Meyer PR, 2007, J MOL BIOL, V369, P41, DOI 10.1016/j.jmb.2007.03.006; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Miranda LR, 2005, ANTIMICROB AGENTS CH, V49, P2648, DOI 10.1128/AAC.49.7.2648-2656.2005; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Pellegrin I, 1999, AIDS, V13, P1705, DOI 10.1097/00002030-199909100-00014; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200; Rhee SY, 2007, PLOS COMPUT BIOL, V3, P836, DOI 10.1371/journal.pcbi.0030087; Rhee SY, 2004, ANTIMICROB AGENTS CH, V48, P3122, DOI 10.1128/AAC.48.8.3122-3126.2004; Rodes B, 2005, AIDS RES HUM RETROV, V21, P602, DOI 10.1089/aid.2005.21.602; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schinazi RF, 2006, ANTIVIR RES, V71, P322, DOI 10.1016/j.antiviral.2006.03.012; Selmi B, 2003, J BIOL CHEM, V278, P40464, DOI 10.1074/jbc.M302928200; Selmi B, 2001, J BIOL CHEM, V276, P13965, DOI 10.1074/jbc.M009837200; Shaw BR, 2000, METHOD ENZYMOL, V313, P226; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; Smith AJ, 2006, CURR PHARM DESIGN, V12, P1827, DOI 10.2174/138161206776873572; Tachedjian G, 1996, J VIROL, V70, P7171, DOI 10.1128/JVI.70.10.7171-7181.1996; Tchesnokov EP, 2009, J BIOL CHEM, V284, P21496, DOI 10.1074/jbc.M109.024026; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; van der Ende ME, 2003, AIDS, V17, pS55, DOI 10.1097/00002030-200317003-00008; Villena C, 2007, J VIROL, V81, P4713, DOI 10.1128/JVI.02135-06; Vivet-Boudou V, 2006, CELL MOL LIFE SCI, V63, P163, DOI 10.1007/s00018-005-5367-x; White KL, 2006, ANTIVIR THER, V11, P155; White KL, 2005, AIDS, V19, P1751, DOI 10.1097/01.aids.0000189851.21441.f1	75	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32792	32802		10.1074/jbc.M109.038885	http://dx.doi.org/10.1074/jbc.M109.038885			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801659	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000272028400064
J	Wang, XM; She, H; Mao, ZX				Wang, Xuemin; She, Hua; Mao, Zixu			Phosphorylation of Neuronal Survival Factor MEF2D by Glycogen Synthase Kinase 3 beta in Neuronal Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE-ENHANCER FACTOR-2; CEREBELLAR GRANULE NEURONS; CYCLIN-DEPENDENT KINASE-5; TRANSCRIPTION FACTOR MEF2; PROTEIN-KINASE; SIGNALING PATHWAY; GENE-EXPRESSION; BETA-CATENIN; CELLS; TAU	Glycogen synthase kinase 3 beta (GSK3 beta) has been identified to play important roles in neuronal death. Evidence from both in vitro and in vivo studies indicates that increased GSK3 beta activity contributes to neurodegeneration and to the pathogenesis of Alzheimer disease. But the molecular mechanisms that underlie GSK3 beta-mediated neurotoxicity remain poorly understood. We reported here that myocyte enhancer factor 2D (MEF2D), a nuclear transcription factor known to promote neuronal survival, is directly phosphorylated by GSK3 beta. Our data showed that phosphorylation of MEF2D by GSK3 beta at three specific residues in its transactivation domain inhibits MEF2D transcriptional activity. Withdrawal of neuronal activity in cerebellar granule neurons activated GSK3 beta in the nucleus, leading to GSK3 beta-dependent inhibition of MEF2 function. This inhibition contributed to GSK3 beta-mediated neuronal toxicity. Overexpression of MEF2D mutant that is resistant to GSK3 beta inhibition protected cerebellar granule neurons from either GSK3 beta activation-or neuronal activity deprivation-induced toxicity. These results identify survival factor MEF2D as a novel downstream effector targeted by GSK3 beta and define a molecular link between activation of GSK3 beta and neuronal survival machinery which may underlie in part GSK3 beta-mediated neurotoxicity.	[Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA	Emory University; Emory University	Mao, ZX (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu			National Institutes of Health [NS048254, AG023695, ES015317, ES016731-010002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731, R01ES015317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS048254, AG023695, ES015317, and ES016731-010002 (to Z. M.).	Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Blair LAC, 1999, J NEUROSCI, V19, P1940; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Engel T, 2008, NEURODEGENER DIS, V5, P247, DOI 10.1159/000113715; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Hetman M, 2000, J NEUROSCI, V20, P2567; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; LIU ML, 1994, J BIOL CHEM, V269, P28514; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; Mora A, 2001, J NEUROCHEM, V78, P199, DOI 10.1046/j.1471-4159.2001.00410.x; Mussmann R, 2007, J BIOL CHEM, V282, P12030, DOI 10.1074/jbc.M609637200; Nair VD, 2008, J BIOL CHEM, V283, P15469, DOI 10.1074/jbc.M707238200; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Wang HZ, 2008, J IMMUNOL, V181, P6797, DOI 10.4049/jimmunol.181.10.6797; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wen Y, 2008, J NEUROSCI, V28, P2624, DOI 10.1523/JNEUROSCI.5245-07.2008; Wiedmann M, 2005, J NEUROSCI RES, V81, P226, DOI 10.1002/jnr.20556; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200	33	47	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32619	32626		10.1074/jbc.M109.067785	http://dx.doi.org/10.1074/jbc.M109.067785			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801631	Green Published, hybrid			2022-12-25	WOS:000272028400044
J	Jung, K; Lee, JE; Kim, HZ; Kim, HM; Park, BS; Hwang, SI; Lee, JO; Kim, SC; Koh, GY				Jung, Keehoon; Lee, Jung-Eun; Kim, Hak-Zoo; Kim, Ho Min; Park, Beom Seok; Hwang, Seong-Ik; Lee, Jie-Oh; Kim, Sun Chang; Koh, Gou Young			Toll-Like Receptor 4 Decoy, TOY, Attenuates Gram-Negative Bacterial Sepsis	PLOS ONE			English	Article								Lipopolysaccharide (LPS), the Gram-negative bacterial outer membrane glycolipid, induces sepsis through its interaction with myeloid differentiation protein-2 (MD-2) and Toll-like receptor 4 (TLR4). To block interaction between LPS/MD-2 complex and TLR4, we designed and generated soluble fusion proteins capable of binding MD-2, dubbed TLR4 decoy receptor (TOY) using 'the Hybrid leucine-rich repeats (LRR) technique'. TOY contains the MD-2 binding ectodomain of TLR4, the LRR motif of hagfish variable lymphocyte receptor (VLR), and the Fc domain of IgG1 to make it soluble, productive, and functional. TOY exhibited strong binding to MD-2, but not to the extracellular matrix (ECM), resulting in a favorable pharmacokinetic profile in vivo. TOY significantly extended the lifespan, when administered in either preventive or therapeutic manners, in both the LPS- and cecal ligation/puncture-induced sepsis models in mice. TOY markedly attenuated LPS-triggered NF-kappa B activation, secretion of proinflammatory cytokines, and thrombus formation in multiple organs. Taken together, the targeting strategy for sequestration of LPS/MD-2 complex using the decoy receptor TOY is effective in treating LPS-and bacteria-induced sepsis; furthermore, the strategy used in TOY development can be applied to the generation of other novel decoy receptor proteins.	[Jung, Keehoon; Lee, Jung-Eun; Kim, Hak-Zoo; Hwang, Seong-Ik; Koh, Gou Young] Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol, Taejon 305701, South Korea; [Jung, Keehoon; Lee, Jung-Eun; Kim, Hak-Zoo; Hwang, Seong-Ik; Kim, Sun Chang; Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Ho Min; Park, Beom Seok; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Lee, Jie-Oh; Kim, Sun Chang; Koh, Gou Young] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Jung, K (corresponding author), Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol, Taejon 305701, South Korea.	gykoh@kaist.ac.kr	Lee, Jie-Oh/C-1581-2011; Kim, Sun/GSN-4867-2022; Koh, Gou Young/C-1615-2011; Kim, Sun Chang/C-2026-2011; Lee, Jie-Oh/AAG-4302-2020; Kim, Ho Min/G-2712-2011	Jung, Keehoon/0000-0002-2199-5292; Lee, Jie-Oh/0000-0001-6519-6049				Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Hwang SJ, 2005, PROTEIN EXPRES PURIF, V39, P175, DOI 10.1016/j.pep.2004.09.005; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tasaka S, 2003, AM J RESP CELL MOL, V29, P252, DOI 10.1165/rcmb.2002-0132OC; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; Wright K, 1990, Science, V249, P22, DOI 10.1126/science.2367850; Wu X, 2005, INFLAMM RES, V54, P451, DOI 10.1007/s00011-005-1378-1	31	21	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7403	10.1371/journal.pone.0007403	http://dx.doi.org/10.1371/journal.pone.0007403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816595	gold, Green Published, Green Submitted			2022-12-25	WOS:000270594300017
J	Roy, S; Lavine, J; Chiaromonte, F; Terwee, J; VandeWoude, S; Bjornstad, O; Poss, M				Roy, Sunando; Lavine, Jennie; Chiaromonte, Francesca; Terwee, Julie; VandeWoude, Sue; Bjornstad, Ottar; Poss, Mary			Multivariate Statistical Analyses Demonstrate Unique Host Immune Responses to Single and Dual Lentiviral Infection	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; PROTECTION; EVOLUTION; CATS; RESISTANCE; WILD	Background: Feline immunodeficiency virus (FIV) and human immunodeficiency virus (HIV) are recently identified lentiviruses that cause progressive immune decline and ultimately death in infected cats and humans. It is of great interest to understand how to prevent immune system collapse caused by these lentiviruses. We recently described that disease caused by a virulent FIV strain in cats can be attenuated if animals are first infected with a feline immunodeficiency virus derived from a wild cougar. The detailed temporal tracking of cat immunological parameters in response to two viral infections resulted in high-dimensional datasets containing variables that exhibit strong co-variation. Initial analyses of these complex data using univariate statistical techniques did not account for interactions among immunological response variables and therefore potentially obscured significant effects between infection state and immunological parameters. Methodology and Principal Findings: Here, we apply a suite of multivariate statistical tools, including Principal Component Analysis, MANOVA and Linear Discriminant Analysis, to temporal immunological data resulting from FIV superinfection in domestic cats. We investigated the co-variation among immunological responses, the differences in immune parameters among four groups of five cats each (uninfected, single and dual infected animals), and the "immune profiles'' that discriminate among them over the first four weeks following superinfection. Dual infected cats mount an immune response by 24 days post superinfection that is characterized by elevated levels of CD8 and CD25 cells and increased expression of IL4 and IFN gamma, and FAS. This profile discriminates dual infected cats from cats infected with FIV alone, which show high IL-10 and lower numbers of CD8 and CD25 cells. Conclusions: Multivariate statistical analyses demonstrate both the dynamic nature of the immune response to FIV single and dual infection and the development of a unique immunological profile in dual infected cats, which are protected from immune decline.			Roy, S (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	mposs@bx.psu.edu	Bjornstad, Ottar N/I-4518-2012	VandeWoude, Sue/0000-0001-9227-1622	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092791] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL092791, R01HL092791] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Biek R, 2006, CAN J ZOOL, V84, P365, DOI 10.1139/z06-006; Biek R, 2003, J VIROL, V77, P9578, DOI 10.1128/JVI.77.17.9578-9589.2003; Biek R, 2006, J WILDLIFE DIS, V42, P606, DOI 10.7589/0090-3558-42.3.606; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; Collette A, 2004, J IMMUNOL, V173, P4568, DOI 10.4049/jimmunol.173.7.4568; Dabo-Niang S., 2008, FUNCTIONAL OPERATORI; de Monte M, 2002, J VIROL METHODS, V103, P157, DOI 10.1016/S0166-0934(02)00024-1; de Rozieres S, 2004, J VIROL, V78, P8971, DOI 10.1128/JVI.78.17.8971-8982.2004; DRAY S., 2003, T GIS, V7, P411, DOI DOI 10.1111/1467-9671.00153; Everitt B.S., 2005, R S PLUS COMPANION M; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Friedrich TC, 2008, CURR OPIN HIV AIDS, V3, P393, DOI 10.1097/COH.0b013e3282faa461; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Gnanadesikan R, 1997, METHODS STAT DATA AN; Gollob KJ, 2008, INT IMMUNOPHARMACOL, V8, P1338, DOI 10.1016/j.intimp.2008.03.016; Keil D, 1999, TOXICOL SCI, V51, P245, DOI 10.1093/toxsci/51.2.245; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Krzanowski W. J., 1988, PRINCIPLES MULTIVARI; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lionel A, 2005, IMMUNOL LETT, V97, P55, DOI 10.1016/j.imlet.2004.09.014; McLachlan G., 1992, WILEY SERIES PROBABI, DOI DOI 10.1002/0471725293; OLSON CL, 1974, J AM STAT ASSOC, V69, P894, DOI 10.2307/2286159; OLSON CL, 1976, PSYCHOL BULL, V83, P579, DOI 10.1037/0033-2909.83.4.579; Poss M, 2006, J VIROL, V80, P2728, DOI 10.1128/JVI.80.6.2728-2737.2006; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; SAMARADASA W, 2004, GEN INFERENCE REPEAT; Seber G.A.F., 2004, MULTIVARIATE OBSERVA; TerWee JA, 2005, J VIROL, V79, P2797, DOI 10.1128/JVI.79.5.2797-2806.2005; TerWee JA, 2008, VIROLOGY, V377, P63, DOI 10.1016/j.virol.2008.03.037; TRAVERS K, 1995, SCIENCE, V268, P1612, DOI 10.1126/science.7539936; VandeWoude S, 2002, J ACQ IMMUN DEF SYND, V29, P1; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06	32	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7359	10.1371/journal.pone.0007359	http://dx.doi.org/10.1371/journal.pone.0007359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806226	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593800031
J	Lebarbenchon, C; Albespy, F; Brochet, AL; Grandhomme, V; Renaud, F; Fritz, H; Green, AJ; Thomas, F; van der Werf, S; Aubry, P; Guillemain, M; Gauthier-Clerc, M				Lebarbenchon, Camille; Albespy, Frederic; Brochet, Anne-Laure; Grandhomme, Viviane; Renaud, Francois; Fritz, Herve; Green, Andy J.; Thomas, Frederic; van der Werf, Sylvie; Aubry, Philippe; Guillemain, Matthieu; Gauthier-Clerc, Michel			Spread of Avian Influenza Viruses by Common Teal (Anas crecca) in Europe	PLOS ONE			English	Article							WATER-BORNE TRANSMISSION; WILD BIRDS; A VIRUS; MIGRATORY WATERFOWL; H5N1; CAMARGUE; PERSISTENCE; DUCKS; SURVEILLANCE; INFECTIVITY	Since the recent spread of highly pathogenic (HP) H5N1 subtypes, avian influenza virus (AIV) dispersal has become an increasing focus of research. As for any other bird-borne pathogen, dispersal of these viruses is related to local and migratory movements of their hosts. In this study, we investigated potential AIV spread by Common Teal (Anas crecca) from the Camargue area, in the South of France, across Europe. Based on bird-ring recoveries, local duck population sizes and prevalence of infection with these viruses, we built an individual-based spatially explicit model describing bird movements, both locally (between wintering areas) and at the flyway scale. We investigated the effects of viral excretion duration and inactivation rate in water by simulating AIV spread with varying values for these two parameters. The results indicate that an efficient AIV dispersal in space is possible only for excretion durations longer than 7 days. Virus inactivation rate in the environment appears as a key parameter in the model because it allows local persistence of AIV over several months, the interval between two migratory periods. Virus persistence in water thus represents an important component of contamination risk as ducks migrate along their flyway. Based on the present modelling exercise, we also argue that HP H5N1 AIV is unlikely to be efficiently spread by Common Teal dispersal only.	[Lebarbenchon, Camille; Albespy, Frederic; Brochet, Anne-Laure; Gauthier-Clerc, Michel] Ctr Rech Tour Valat, Arles, France; [Lebarbenchon, Camille; Grandhomme, Viviane; Renaud, Francois; Thomas, Frederic] IRD, UMR CNRS IRD 2724, GEMI, Montpellier, France; [Lebarbenchon, Camille; Grandhomme, Viviane; van der Werf, Sylvie] Univ Paris Diderot, Unite Genet Mol Virus ARN, CNRS, URA3015,EA302,Inst Pasteur, Paris, France; [Albespy, Frederic; Brochet, Anne-Laure; Guillemain, Matthieu] CNERA Avifaune Migratrice Tour Du Valat, ONCFS, Arles, France; [Albespy, Frederic; Aubry, Philippe] Direct Etud & Rech, ONCFS, Le Perray En Yvelines, France; [Fritz, Herve] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, UMR 5558 Biometrie & Biol Evolut, Villeurbanne, France; [Green, Andy J.] CSIC, Dept Wetland Ecol, Estn Biol Donana, Seville, Spain; [Thomas, Frederic] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ, Canada	Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universite de Montreal	Lebarbenchon, C (corresponding author), Ctr Rech Tour Valat, Arles, France.	cleb@uga.edu	Fritz, Herve/D-1729-2014; Lebarbenchon, Camille/H-7245-2013; Green, Andy J/A-5189-2008; Lebarbenchon, Camille/GLQ-7287-2022	Fritz, Herve/0000-0002-7106-3661; Lebarbenchon, Camille/0000-0002-0922-7573; Green, Andy J/0000-0002-1268-4951; Lebarbenchon, Camille/0000-0002-0922-7573; Aubry, Philippe/0000-0002-0964-1942; THOMAS, Frederic/0000-0003-2238-1978; van der WERF, Sylvie/0000-0002-1148-4456				Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; BROCHET A, POTENTIAL DIST UNPUB; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen R, 2009, VIROLOGY, V383, P156, DOI 10.1016/j.virol.2008.10.015; Clausen P, 2002, ACTA OECOL, V23, P191, DOI 10.1016/S1146-609X(02)01150-5; Cramp S., 1977, HDB BIRDS EUROPE MID; Delany S, 2006, WATERBIRD POPULATION; Donnelly A, 2009, INT J BIOMETEOROL, V53, P211, DOI 10.1007/s00484-009-0206-7; Duncan P, 1999, J APPL ECOL, V36, P11, DOI 10.1046/j.1365-2664.1999.00363.x; *EUR ENV AG OP GUI, 2006, GUID GEOGR DAT MAPS; Feare CJ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-96; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Fransson T, 2001, SWEDISH BIRD RINGING, V1; Gaidet N, 2008, EMERG INFECT DIS, V14, P1164, DOI 10.3201/eid1407.071477; Gaidet N, 2007, J WILDLIFE DIS, V43, pS22; Gaidet N, 2007, EMERG INFECT DIS, V13, P626, DOI 10.3201/eid1304.061011; Gaidet N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000127; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gauthier-Clerc M, 2001, ARDEA, V89, P221; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Guillemain M, 2005, IBIS, V147, P688, DOI 10.1111/j.1474-919X.2005.00446.x; Guillemain M, 2005, WILDLIFE BIOL, V11, P81, DOI 10.2981/0909-6396(2005)11[81:LCTABS]2.0.CO;2; GUILLEMAIN M, COMP MIGRAT IN PRESS; Guillemain M, 2007, WILDLIFE BIOL, V13, P102, DOI 10.2981/0909-6396(2007)13[102:WTOLDD]2.0.CO;2; Guillemain M, 2006, WILDLIFE BIOL, V12, P163, DOI 10.2981/0909-6396(2006)12[163:SMDOTA]2.0.CO;2; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301; Kayser Y, 2008, REV ECOL-TERRE VIE, V63, P299; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Khalenkov A, 2008, J VIROL METHODS, V149, P180, DOI 10.1016/j.jviromet.2008.01.001; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Le Gall-Recule G, 2008, AVIAN PATHOL, V37, P15, DOI 10.1080/03079450701774835; LEBARBENCHON C, AVIAN DIS IN PRESS; Lebarbenchon C, 2007, INFECT GENET EVOL, V7, P604, DOI 10.1016/j.meegid.2007.05.009; LEBRETON JD, 1973, CR ACAD SCI D NAT, V277, P2417; Leung YHC, 2007, EMERG INFECT DIS, V13, P1380, DOI 10.3201/eid1309.070517; Lu HG, 2004, AVIAN DIS, V48, P263, DOI 10.1637/7064; MARKWELL DD, 1982, APPL ENVIRON MICROB, V43, P110, DOI 10.1128/AEM.43.1.110-115.1982; Matthiopoulos J, 2003, ECOL MODEL, V159, P239, DOI 10.1016/S0304-3800(02)00293-4; Melville DS, 2006, LETT APPL MICROBIOL, V42, P435, DOI 10.1111/j.1472-765X.2006.01892.x; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nagy A, 2009, VET MICROBIOL, V133, P257, DOI 10.1016/j.vetmic.2008.07.013; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; OGILVIE M, 1983, THESIS U BRISTOL UK; OIE, 2009, UPD HIGHL PATH AV IN; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pradel R, 1997, J WILDLIFE MANAGE, V61, P816, DOI 10.2307/3802189; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Ridgill, 1990, COLD WEATHER MOVEMEN; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Rubolini D, 2007, CLIM RES, V35, P135, DOI 10.3354/cr00720; Scott D.A., 1996, ATLAS ANATIDAE POPUL; Smith GJD, 2009, EMERG INFECT DIS, V15, P402, DOI 10.3201/eid1503.081190; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Tamisier A., 1999, CAMARGUE CANARDS FOU; Teifke JP, 2007, VET PATHOL, V44, P137, DOI 10.1354/vp.44-2-137; Tottrup AP, 2008, BIOL LETTERS, V4, P685, DOI 10.1098/rsbl.2008.0290; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Weber TP, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-57; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WOLFF WJ, 1966, ARDEA, V54, P230	73	41	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7289	10.1371/journal.pone.0007289	http://dx.doi.org/10.1371/journal.pone.0007289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802387	gold, Green Published, Green Submitted			2022-12-25	WOS:000270593600005
J	van de Sluis, B; Groot, AJ; Vermeulen, J; van der Wall, E; van Diest, PJ; Wijmenga, C; Klomp, LW; Vooijs, M				van de Sluis, Bart; Groot, Arjan J.; Vermeulen, Jeroen; van der Wall, Elsken; van Diest, Paul J.; Wijmenga, Cisca; Klomp, Leo W.; Vooijs, Marc			COMMD1 Promotes pVHL and O-2-Independent Proteolysis of HIF-1 alpha via HSP90/70	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HIF-ALPHA; UBIQUITIN LIGASE; COPPER TOXICOSIS; FACTOR-I; DEGRADATION; PROTEIN; BINDING; INHIBITORS; MURR1	Background: The Copper Metabolism MURR1 Domain containing 1 protein COMMD1 has been associated with copper homeostasis, NF-kappa B signaling, and sodium transport. Recently, we identified COMMD1 as a novel protein in HIF-1 signaling. Mouse embryos deficient for Commd1 have increased expression of hypoxia/HIF-regulated genes i.e. VEGF, PGK and Bnip3. Hypoxia-inducible factors (HIFs) are master regulators of oxygen homeostasis, which control angiogenesis, erythropoiesis, glycolysis and cell survival/proliferation under normal and pathologic conditions. Although HIF activity is mainly controlled by ubiquitination and protein degradation by the von Hippel Lindau (pVHL) tumor suppressor gene other mechanisms have recently been identified that regulate HIF signaling independently of pVHL. Principal Findings: Here we characterized the mechanism by which COMMD1 regulates HIF-1 alpha protein degradation. We show that COMMD1 competes with the chaperone heat shock protein HSP90b for binding to the NH2-terminal DNA-binding and heterodimerization domain of HIF-1 alpha to regulate HIF-1 alpha stability together with HSP70. Inhibition of HSP90 activity with 17-Allylamino-17-demethoxygeldanamycin (17-AAG) increased COMMD1-mediated HIF-1 alpha degradation independent of ubiquitin and pVHL. Conclusion/Significance: These data reveal a novel role for COMMD1 in conjunction with HSP90 beta/HSP70 in the ubiquitin and O-2-independent regulation of HIF-1 alpha.			van de Sluis, B (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9713 AV Groningen, Netherlands.	m.vooijs@umcutrecht.nl	Vooijs, Marc/K-3522-2019; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365				Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Cho S, 2001, FEBS LETT, V498, P62, DOI 10.1016/S0014-5793(01)02499-1; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; Fath DM, 2006, J BIOL CHEM, V281, P13612, DOI 10.1074/jbc.M600456200; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; KULKA RG, 1988, J BIOL CHEM, V263, P15726; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maine GN, 2009, BIOCHEM J, V417, P601, DOI 10.1042/BJ20080854; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; MULLER PA, 2009, NUCL CYTOSOLIC TRANS; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, CELL CYCLE, V6, P2091, DOI 10.4161/cc.6.17.4646; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	35	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7332	10.1371/journal.pone.0007332	http://dx.doi.org/10.1371/journal.pone.0007332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802386	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593600010
J	Fayad, W; Fryknas, M; Brnjic, S; Olofsson, MH; Larsson, R; Linder, S				Fayad, Walid; Fryknas, Marten; Brnjic, Slavica; Olofsson, Maria Haegg; Larsson, Rolf; Linder, Stig			Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters	PLOS ONE			English	Article								Background: Natural product structures have high chemical diversity and are attractive as lead structures for discovery of new drugs. One of the disease areas where natural products are most frequently used as therapeutics is oncology. Method and Findings: A library of natural products (NCI Natural Product set) was screened for compounds that induce apoptosis of HCT116 colon carcinoma cells using an assay that measures an endogenous caspase-cleavage product. One of the apoptosis-inducing compounds identified in the screen was thaspine ( taspine), an alkaloid from the South American tree Croton lechleri. The cortex of this tree is used for medicinal purposes by tribes in the Amazonas basin. Thaspine was found to induce conformational activation of the pro-apoptotic proteins Bak and Bax, mitochondrial cytochrome c release and mitochondrial membrane permeabilization in HCT116 cells. Analysis of the gene expression signature of thaspine-treated cells suggested that thaspine is a topoisomerase inhibitor. Inhibition of both topoisomerase I and II was observed using in vitro assays, and thaspine was found to have a reduced cytotoxic effect on a cell line with a mutated topoisomerase II enzyme. Interestingly, in contrast to the topoisomerase II inhibitors doxorubicin, etoposide and mitoxantrone, thaspine was cytotoxic to cell lines overexpressing the PgP or MRP drug efflux transporters. We finally show that thaspine induces wide-spread apoptosis in colon carcinoma multicellular spheroids and that apoptosis is induced in two xenograft mouse models in vivo. Conclusions: The alkaloid thaspine from the cortex of Croton lechleri is a dual topoisomerase inhibitor effective in cells overexpressing drug efflux transporters and induces wide-spread apoptosis in multicellular spheroids.			Fayad, W (corresponding author), Karolinska Hosp & Inst, Dept Pathol & Oncol, Stockholm, Sweden.	Stig.Linder@ki.se	Fayad, Walid M. O. H./O-7269-2018	Fayad, Walid M. O. H./0000-0002-7975-0343				Arcamone FM, 1998, BIOCHIMIE, V80, P201, DOI 10.1016/S0300-9084(98)80003-5; Baldo P, 2008, CURR CANCER DRUG TAR, V8, P647, DOI 10.2174/156800908786733513; BODLEY A, 1989, CANCER RES, V49, P5969; BROCKMAN RW, 1976, CANCER TREAT REP, V60, P1317; BUGG BY, 1991, P NATL ACAD SCI USA, V88, P7654, DOI 10.1073/pnas.88.17.7654; CHANCE B, 1963, J BIOL CHEM, V238, P418; Cummings J, 2008, BRIT J PHARMACOL, V153, P646, DOI 10.1038/sj.bjp.0707441; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; DANKS MK, 1988, BIOCHEMISTRY-US, V27, P8861, DOI 10.1021/bi00424a026; Denny WA, 2003, CURR TOP MED CHEM, V3, P339, DOI 10.2174/1568026033452555; Dittrich C, 2003, INVEST NEW DRUG, V21, P347, DOI 10.1023/A:1025476813365; DURAND RE, 1981, CANCER RES, V41, P3495; ERLICHMAN C, 1984, CANCER RES, V44, P5369; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; GUPTA RS, 1983, CANCER RES, V43, P505; Hagg M, 2002, INVEST NEW DRUG, V20, P253, DOI 10.1023/A:1016249728664; Herrmann R, 2008, J BIOMOL SCREEN, V13, P1, DOI 10.1177/1087057107310442; ITOKAWA H, 1991, CHEM PHARM BULL, V39, P1041, DOI 10.1248/cpb.39.1041; Jonsson E, 1997, BRIT J CANCER, V76, P211, DOI 10.1038/bjc.1997.364; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; LEVINSON C, 1967, NATURE, V216, P74, DOI 10.1038/216074a0; Lindhagen E, 2008, NAT PROTOC, V3, P1364, DOI 10.1038/nprot.2008.114; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; Lloyd DG, 2006, DRUG DISCOV TODAY, V11, P149, DOI 10.1016/S1359-6446(05)03688-3; Mandic A, 2001, MOL CELL BIOL, V21, P3684, DOI 10.1128/MCB.21.11.3684-3691.2001; Nakashima T, 2000, CANCER RES, V60, P1229; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nygren P, 2003, J INTERN MED, V253, P46, DOI 10.1046/j.1365-2796.2003.01098.x; OLOFSSON MH, CANC BIOMAR IN PRESS; PERDUE G P, 1979, Journal of Pharmaceutical Sciences, V68, P124, DOI 10.1002/jps.2600680145; PIETERS L, 1993, J NAT PROD, V56, P899, DOI 10.1021/np50096a013; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Seibert SF, 2006, ORG BIOMOL CHEM, V4, P2233, DOI 10.1039/b601386d; Srivastava V, 2005, BIOORGAN MED CHEM, V13, P5892, DOI 10.1016/j.bmc.2005.05.066; SUTHERLAND R M, 1976, Current Topics in Radiation Research Quarterly, V11, P87; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; TAKAHASHI M, 1987, BIOCHIM BIOPHYS ACTA, V926, P215, DOI 10.1016/0304-4165(87)90206-6; Teicher BA, 2008, BIOCHEM PHARMACOL, V75, P1262, DOI 10.1016/j.bcp.2007.10.016; Uehara Y, 2003, CURR CANCER DRUG TAR, V3, P325, DOI 10.2174/1568009033481796; Vandenberghe I, 2008, BIOCHEM PHARMACOL, V76, P453, DOI 10.1016/j.bcp.2008.05.031; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wickstrom M, 2007, BIOCHEM PHARMACOL, V73, P25, DOI 10.1016/j.bcp.2006.08.016; YAGI M, 1981, BIOCHEM BIOPH RES CO, V98, P642, DOI 10.1016/0006-291X(81)91162-1; YAMASHITA Y, 1990, CANCER RES, V50, P5841; YORK J, 1981, BIOCHEM PHARMACOL, V30, P3239, DOI 10.1016/0006-2952(81)90524-4; ZHANG Y, 2008, CANC LETT; Zhang Yan-Min, 2007, Zhongguo Zhong Yao Za Zhi, V32, P953; Zhang Yan-min, 2007, Zhong Yao Cai, V30, P429	57	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7238	10.1371/journal.pone.0007238	http://dx.doi.org/10.1371/journal.pone.0007238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798419	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593300004
J	Tocchini-Valentini, GP; Tocchini-Valentini, MA; Schlessinger, D				Tocchini-Valentini, Glauco P.; Tocchini-Valentini, Marta A.; Schlessinger, David			How to build a kangaroo the way a kangaroo builds itself	FASEB JOURNAL			English	Editorial Material									[Tocchini-Valentini, Glauco P.] CNR, Ist Biol Cellulare, I-00015 Rome, Italy; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA	Consiglio Nazionale delle Ricerche (CNR); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tocchini-Valentini, GP (corresponding author), CNR, Ist Biol Cellulare, I-00015 Rome, Italy.				NATIONAL INSTITUTE ON AGING [ZIAAG000676] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRENNER S, 1975, COMMUNICATION; Calvino Italo, 1974, INVISIBLE CITIES, P76; CHAITIN GJ, 1999, UNKNOWABLE, P122; Godel K, 1983, PHILOS MATH SELECTED, V2; Isalan M, 2009, NATURE, V458, P969, DOI 10.1038/458969a; LEIBNIZ GW, 1695, COMMUNICATION   0930; Lewis D., 1986, PLURALITY WORLDS; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; Tegmark M, 2004, SCI ULTIMATE REALITY; VONNEUMANN J, 1966, THEORY SELF REPROD A	10	0	0	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2009	23	10					3257	3259		10.1096/fj.09-1002	http://dx.doi.org/10.1096/fj.09-1002			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19797299				2022-12-25	WOS:000270354300002
J	Pichard, V; Aubert, D; Ferry, N				Pichard, Virginie; Aubert, Dominique; Ferry, Nicolas			Direct In Vivo Cell Lineage Analysis in the Retrorsine and 2AAF Models of Liver Injury after Genetic Labeling in Adult and Newborn Rats	PLOS ONE			English	Article								Backgrounds and Aims: When hepatocyte proliferation is impaired, liver regeneration proceeds from the division of non parenchymal hepatocyte progenitors. Oval cells and Small Hepatocyte-like Progenitor Cells (SHPCs) represent the two most studied examples of such epithelial cells with putative stem cell capacity. In the present study we wished to compare the origin of SHPCs proliferating after retrorsine administration to the one of oval cells observed after 2-Acetyl-Amino fluorene (2-AAF) treatment. Methodology/Principal Findings: We used retroviral-mediated nlslacZ genetic labeling of dividing cells to study the fate of cells in the liver. Labeling was performed either in adult rats before treatment or in newborn animals. Labeled cells were identified and characterised by immunohistochemistry. In adult-labeled animals, labeling was restricted to mature hepatocytes. Retrorsine treatment did not modify the overall number of labeled cells in the liver whereas after 2-AAF administration unlabeled oval cells were recorded and the total number of labeled cells decreased significantly. When labeling was performed in newborn rats, results after retrorsine administration were identical to those obtained in adult-labeled rats. In contrast, in the 2-AAF regimen numerous labeled oval cells were present and were able to generate new labeled hepatocytes. Furthermore, we also observed labeled biliary tracts in 2-AAF treated rats. Conclusions: Our results srongly suggest that SHPCs are derived from hepatocytes and we confirm that SHPCs and oval cells do not share the same origin. We also show that hepatic progenitors are labeled in newborn rats suggesting future directions for in vivo lineage studies.			Pichard, V (corresponding author), CHU Hotel Dieu, INSERM, U948, Nantes, France.	nicolas.ferry@inserm.fr						Aubert D, 2002, MOL THER, V5, P388, DOI 10.1006/mthe.2002.0561; Avril A, 2004, J HEPATOL, V41, P737, DOI 10.1016/j.jhep.2004.07.029; Bellodi-Privato M, 2005, HEPATOLOGY, V42, P431, DOI 10.1002/hep.20794; Best DH, 2007, HEPATOLOGY, V46, P1611, DOI 10.1002/hep.21876; Best DH, 2007, J HEPATOL, V46, P1055, DOI 10.1016/j.jhep.2007.01.040; Bralet MP, 1996, LAB INVEST, V74, P871; Braun KM, 2000, AM J PATHOL, V157, P561, DOI 10.1016/S0002-9440(10)64566-X; Dezso K, 2007, AM J PATHOL, V171, P1529, DOI 10.2353/ajpath.2007.070273; EVARTS RP, 1989, CANCER RES, V49, P1541; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; FARBER E, 1956, CANCER RES, V16, P142; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Gordon GJ, 2000, AM J PATHOL, V157, P771, DOI 10.1016/S0002-9440(10)64591-9; Gordon GJ, 2000, AM J PATHOL, V156, P607, DOI 10.1016/S0002-9440(10)64765-7; Higgins GM, 1931, ARCH PATHOL, V12, P186; Kitten O, 1997, HUM GENE THER, V8, P1491, DOI 10.1089/hum.1997.8.12-1491; Kofman AV, 2005, HEPATOLOGY, V41, P1252, DOI 10.1002/hep.20696; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Menthena A, 2004, STEM CELLS, V22, P1049, DOI 10.1634/stemcells.22-6-1049; Oertel M, 2007, HEPATOLOGY, V46, P1236, DOI 10.1002/hep.21775; Oh SH, 2007, GASTROENTEROLOGY, V132, P1077, DOI 10.1053/j.gastro.2007.01.001; Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Petersen B, 2008, HEPATOLOGY, V47, P1810, DOI 10.1002/hep.22333; Pichard V, 2001, BIOCHEM BIOPH RES CO, V286, P929, DOI 10.1006/bbrc.2001.5495; Pichard V, 2008, J HEPATOL, V48, P368, DOI 10.1016/j.jhep.2007.11.001; Puppi J, 2004, J HEPATOL, V41, P222, DOI 10.1016/j.jhep.2004.04.015; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; TATEMATSU M, 1984, AM J PATHOL, V114, P418; Vig P, 2006, HEPATOLOGY, V43, P316, DOI 10.1002/hep.21018; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Yovchev MI, 2007, HEPATOLOGY, V45, P139, DOI 10.1002/hep.21448	32	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7267	10.1371/journal.pone.0007267	http://dx.doi.org/10.1371/journal.pone.0007267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789635	gold, Green Published, Green Submitted			2022-12-25	WOS:000270354100020
J	Abedini, MR; Muller, EJ; Bergeron, R; Gray, DA; Tsang, BK				Abedini, M. R.; Muller, E. J.; Bergeron, R.; Gray, D. A.; Tsang, B. K.			Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein	ONCOGENE			English	Article						FLIP; Akt; p53; chemoresistance; ovarian cancer	X-LINKED INHIBITOR; FAS-MEDIATED APOPTOSIS; TRAIL-INDUCED APOPTOSIS; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; DOWN-REGULATION; UP-REGULATION; CELLULAR FLIP; PATHWAY; P53; RESISTANCE	Although Akt is a determinant of cisplatin (cis-diaminedi-chloroplatinum (CDDP)) resistance in ovarian cancer cells, which is related in part to its inhibitory action on p53 activation, precisely how Akt confers CDDP resistance is unclear. In this study, we show that CDDP induced p53-dependent Fas-associated death domain-like interleukin-1 beta-converting enzyme (FLICE)-like inhibitory protein (FLIP) degradation in chemosensitive ovarian cancer cells but not their resistant counterparts. CDDP induced FLIP-p53-Itch interaction, colocalization and FLIP ubiquitination in chemosensitive but not chemoresistant ovarian cancer cells. Moreover, although activated Akt inhibited CDDP-induced FLIP degradation and apoptosis in sensitive cells, these responses were facilitated by dominant-negative Akt expression in chemoresistant cells. Inhibition of Akt function also facilitated p53-FLIP interaction and FLIP ubiquitination, which were attenuated by p53 silencing. These results suggest that Akt confers resistance, in part, by modulating CDDP-induced, p53-dependent FLIP ubiquitination. Understanding the precise etiology of chemoresistance may improve treatment for ovarian cancer.	[Tsang, B. K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON K1Y 4E9, Canada; [Abedini, M. R.; Muller, E. J.; Bergeron, R.; Tsang, B. K.] Univ Ottawa, Dept Cellular, Ottawa, ON, Canada; [Abedini, M. R.; Muller, E. J.; Bergeron, R.; Tsang, B. K.] Univ Ottawa, Dept Mol Med, Ottawa, ON, Canada; [Abedini, M. R.] Birjand Univ Med Sci, Dept Physiol & Pharmacol, Birjand, Iran; [Muller, E. J.; Bergeron, R.] Ottawa Hosp Res Inst, Neurosci Program, Ottawa, ON K1Y 4E9, Canada; [Bergeron, R.] Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; [Gray, D. A.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Gray, D. A.] Univ Ottawa, Dept Biochem, Ottawa, ON, Canada; [Gray, D. A.] Univ Ottawa, Dept Microbiol, Ottawa, ON, Canada; [Gray, D. A.] Univ Ottawa, Dept Immunol, Ottawa, ON, Canada; [Gray, D. A.] Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON K1Y 4E9, Canada; [Tsang, B. K.] Univ Ottawa, Dept Obstet, Ottawa, ON, Canada; [Tsang, B. K.] Univ Ottawa, Dept Gynaecol, Ottawa, ON, Canada; [Tsang, B. K.] Seoul Natl Univ, World Class Univ Major Biomodulat, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Seoul National University (SNU)	Tsang, BK (corresponding author), Ottawa Hosp Res Inst, Chron Dis Program, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.	btsang@ohri.ca	amiri, omolbanin/G-4425-2017; Darmian, Faezeh Vahedi/AAF-7755-2019; /U-3554-2018	amiri, omolbanin/0000-0002-3815-5716; Bergeron, Richard/0000-0002-5632-750X; Tsang, Benjamin K./0000-0003-1213-3946; /0000-0002-8634-4984	Cancer Research Society [11181]; Canadian Institutes of Health Research [MOP-79360]; National Research Foundation of Korea [R31-10056]; Ministry of Health and Medical Education Scholarship, Iran; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA [A2780s-AAkt2, A2780s-PHM6]	Cancer Research Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Health and Medical Education Scholarship, Iran; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA	This work was supported by grants from the Cancer Research Society (# 11181 to BKT) and the Canadian Institutes of Health Research (# MOP-79360 to RB), the WCU (World Class University) program through the Korea Science and Engineering Foundation funded by the National Research Foundation of Korea (R31-10056) and a New Investigator Award to RB. MRA was the recipient of a Ministry of Health and Medical Education Scholarship, Iran. We thank Dr Qiao Li (University of Ottawa, Canada) and Dr Kenneth Walsh (St Elizabeth's Medical Centre, Boston, MA, USA) for providing HA-tagged ubiquitin and adenoviral HA-tagged DN-Akt, respectively. A2780s-AAkt2 and A2780s-PHM6 cells were generously provided by Dr Jin Cheng (H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA).	Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Alladina SJ, 2005, J VASC RES, V42, P337, DOI 10.1159/000086599; Buttitta F, 1997, BRIT J CANCER, V75, P230, DOI 10.1038/bjc.1997.38; Chandrasekaran Y, 2006, BIOL REPROD, V74, P560, DOI 10.1095/biolreprod.105.045146; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen SZ, 2007, MOL PHARMACOL, V72, P1269, DOI 10.1124/mol.107.037465; Cheng JQ, 2002, DRUG RESIST UPDATE, V5, P131, DOI 10.1016/S1368-7646(02)00003-1; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Hagopian GS, 1999, CLIN CANCER RES, V5, P655; Kamarajan P, 2003, BIOCHEM J, V376, P253, DOI 10.1042/BJ20030659; Li JL, 2001, ENDOCRINOLOGY, V142, P370, DOI 10.1210/en.142.1.370; Li JL, 2000, BIOL SIGNAL RECEPT, V9, P122; Mansouri A, 2003, ONCOL RES, V13, P399; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meinander A, 2007, J IMMUNOL, V178, P3944, DOI 10.4049/jimmunol.178.6.3944; Milne D, 2004, FEBS LETT, V577, P270, DOI 10.1016/j.febslet.2004.09.081; Moriyama H, 2007, IMMUNOL LETT, V109, P36, DOI 10.1016/j.imlet.2006.12.009; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Muller E, 2004, EUR J NEUROSCI, V20, P3286, DOI 10.1111/j.1460-9568.2004.03785.x; Nam SY, 2003, CANCER SCI, V94, P1066, DOI 10.1111/j.1349-7006.2003.tb01402.x; Nam SY, 2002, ONCOGENE, V21, P337, DOI 10.1038/sj.onc.1205068; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Sasaki H, 2000, CANCER RES, V60, P5659; Schneiderman D, 1999, APOPTOSIS, V4, P271, DOI 10.1023/A:1008186323178; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shim E, 2007, BIOTECHNOL LETT, V29, P141, DOI 10.1007/s10529-006-9213-5; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Starck L, 2005, EUR J IMMUNOL, V35, P1257, DOI 10.1002/eji.200425686; Suhara T, 2001, CIRC RES, V89, P13, DOI 10.1161/hh1301.092506; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	38	95	100	5	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					11	25		10.1038/onc.2009.300	http://dx.doi.org/10.1038/onc.2009.300			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19802016				2022-12-25	WOS:000273373500002
J	Luo, Y; Jian, W; Stavreva, D; Fu, XQ; Hager, G; Bungert, J; Huang, SM; Qiu, Y				Luo, Yi; Jian, Wei; Stavreva, Diana; Fu, Xueqi; Hager, Gordon; Bungert, Joerg; Huang, Suming; Qiu, Yi			Trans-regulation of Histone Deacetylase Activities through Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IN-VIVO; COMPLEX; TRANSCRIPTION; PROTEIN; YEAST; METHYLATION; INHIBITION; REPRESSION; DOMAINS	HDAC1 and -2 are highly conserved enzymes and often coexist in the same coregulator complexes. Understanding the regulation of histone deacetylase activities is extremely important because these enzymes play key roles in epigenetic regulation in normal and cancer cells. We previously showed that HDAC1 is required for glucocorticoid receptor-mediated transcription activation and that its activity is regulated through acetylation by p300 during the induction cycle. Here, we showed that HDAC2 is also required for glucocorticoid receptor-mediated gene activation. HDAC2, however, is regulated through a different mechanism from that of HDAC1. HDAC2 is not acetylated by p300, although 5 of 6 acetylated lysine residues in HDAC1 are also present in HDAC2. More importantly, the activity of HDAC2 is inhibited by acetylated HDAC1. Additionally, we showed that acetylated HDAC1 can trans-regulate HDAC2 through heterodimerization. Thus, this study uncovered fundamental differences between HDAC1 and HDAC2. It also unveiled a new mechanism of collaborative regulation by HDAC1/2 containing coregulator complexes.	[Luo, Yi; Jian, Wei; Qiu, Yi] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Bungert, Joerg; Huang, Suming] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Stavreva, Diana; Hager, Gordon] NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Luo, Yi; Fu, Xueqi] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jilin University	Qiu, Y (corresponding author), Rm 356,1376 Mowry Rd, Gainesville, FL 32610 USA.	qiuy@ufl.edu	Stavreva, Diana/AAW-8964-2020	, Yi/0000-0002-3282-6072	National Institutes of Health [R01 HL090589, R01 HL091929, R01 DK52356]; Florida Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091929, R01HL090589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL090589 and R01 HL091929 (to S. H.) and R01 DK52356 (to J. B.). This work was also supported by grants from the Florida Department of Health (to Y. Q. and S. H.).	Barnes PJ, 2005, EXPERT OPIN THER TAR, V9, P1111, DOI 10.1517/14728222.9.6.1111; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Kramer PR, 1999, J BIOL CHEM, V274, P28590, DOI 10.1074/jbc.274.40.28590; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tsai CC, 2004, VITAM HORM, V68, P93; Tsai SC, 2002, J BIOL CHEM, V277, P31826, DOI 10.1074/jbc.M204149200; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	37	53	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34901	34910		10.1074/jbc.M109.038356	http://dx.doi.org/10.1074/jbc.M109.038356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19822520	Green Published, hybrid			2022-12-25	WOS:000272439600045
J	Hong, SK; Yoon, S; Moelling, C; Arthan, D; Park, JI				Hong, Seung-Keun; Yoon, Seunghee; Moelling, Cas; Arthan, Dumrongkiet; Park, Jong-In			Noncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; THYROID CARCINOMA-CELLS; INHIBITORY FACTOR/JAK/STAT PATHWAY; ONCOGENE INDUCES DIFFERENTIATION; LUNG-CANCER CELLS; REGULATED KINASE; CYCLE ARREST; INDUCED SENESCENCE; HA-RAS; CELLULAR SENESCENCE	Kinase activity is known as the key biochemical property of MAPKs. Here, we report that ERK1/2 also utilizes its noncatalytic function to mediate certain signal transductions. Sustained activation of the Raf/MEK/ERK pathway induces growth arrest, accompanied by changes in cell cycle regulators (decreased retinoblastoma phosphorylation, E2F1 down-regulation, and/or p21(CIP1) up-regulation) and cell type-specific changes in morphology and expression of c-Myc or RET in the human tumor lines LNCaP, U251, and TT. Ablation of ERK1/2 by RNA interference abrogated all these effects. However, active site-disabled ERK mutants (ERK1-K71R, ERK2-K52R, and ERK2-D147A), which competitively inhibit activation of endogenous ERK1/2, could not block Raf/MEK-induced growth arrest as well as changes in the cell cycle regulators, although they effectively blocked phosphorylation of the ERK1/2 catalytic activity readouts, p90(RSK) and ELK1, as well as the cell type-specific changes. Because this indicated a potential noncatalytic ERK1/2 function, we generated stable lines of the tumor cells in which both ERK1 and ERK2 were significantly knocked down, and we further investigated the possibility using rat-derived kinase-deficient ERK mutants (ERK2-K52R and ERK2-T183A/Y185F) that were not targeted by human small hairpin RNA. Indeed, ERK2-K52R selectively restored Raf-induced growth inhibitory signaling in ERK1/2-depleted cells, as manifested by regained cellular ability to undergo growth arrest and to control the cell cycle regulators without affecting c-Myc and morphology. However, ERK2-T183A/Y185F was less effective, indicating the requirement of TEY site phosphorylation. Our study suggests that functions of ERK1/2 other than its "canonical" kinase activity are also involved in the pathway-mediated growth arrest signaling.	[Hong, Seung-Keun; Yoon, Seunghee; Moelling, Cas; Arthan, Dumrongkiet; Park, Jong-In] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Park, JI (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jipark@mcw.edu		Park, Jong-In/0000-0001-7248-4735	FAMRI Young Investigator Award [062438]; Department of Defense Prostate Cancer Research Program Grant [W81XWH-07-01-0089]; American Cancer Society IRG [2204256]; Wisconsin Breast Cancer Showhouse	FAMRI Young Investigator Award; Department of Defense Prostate Cancer Research Program Grant(United States Department of Defense); American Cancer Society IRG(American Cancer Society); Wisconsin Breast Cancer Showhouse	This work was supported by FAMRI Young Investigator Award 062438, Department of Defense Prostate Cancer Research Program Grant W81XWH-07-01-0089, American Cancer Society IRG Grant 2204256, and the Wisconsin Breast Cancer Showhouse ( to J. P.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; BESSARD A, 2008, ONCOGENE; Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; CARSON EB, 1995, CANCER RES, V55, P2048; Carson-Walter EB, 1998, ONCOGENE, V17, P367, DOI 10.1038/sj.onc.1201938; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fanton CP, 2001, J BIOL CHEM, V276, P18871, DOI 10.1074/jbc.M011514200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; Groth A, 2000, J BIOL CHEM, V275, P27473; Turjanski AG, 2009, J AM CHEM SOC, V131, P6141, DOI 10.1021/ja8071995; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Kim EJ, 2005, J BIOL CHEM, V280, P4913, DOI 10.1074/jbc.M410542200; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; KORTENJANN M, 1994, MOL CELL BIOL, V14, P4815, DOI 10.1128/MCB.14.7.4815; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu SY, 2008, P NATL ACAD SCI USA, V105, P5248, DOI 10.1073/pnas.0704242105; MABRY M, 1989, J CLIN INVEST, V84, P194, DOI 10.1172/JCI114140; Malumbres M, 2000, MOL CELL BIOL, V20, P2915, DOI 10.1128/MCB.20.8.2915-2925.2000; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; NAKAGAWA T, 1987, P NATL ACAD SCI USA, V84, P5923, DOI 10.1073/pnas.84.16.5923; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Park JI, 2005, CYTOKINE, V29, P125, DOI 10.1016/j.cyto.2004.10.005; Park JI, 2005, EXP CELL RES, V303, P79, DOI 10.1016/j.yexcr.2004.09.028; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; Philipova R, 2005, J CELL SCI, V118, P5767, DOI 10.1242/jcs.02683; Ravi RK, 1998, J CLIN INVEST, V101, P153, DOI 10.1172/JCI831; Ravi RK, 1999, J CELL BIOCHEM, V72, P458, DOI 10.1002/(SICI)1097-4644(19990315)72:4<458::AID-JCB2>3.0.CO;2-C; Ravi RK, 1999, AM J RESP CELL MOL, V20, P543, DOI 10.1165/ajrcmb.20.4.3406; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roper E, 2001, EMBO REP, V2, P145, DOI 10.1093/embo-reports/kve020; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; Sanz-Moreno V, 2003, MOL CELL BIOL, V23, P3079, DOI 10.1128/MCB.23.9.3079-3090.2003; SEGER R, 1992, J BIOL CHEM, V267, P14373; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	72	65	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33006	33018		10.1074/jbc.M109.012591	http://dx.doi.org/10.1074/jbc.M109.012591			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19805545	Green Published, hybrid			2022-12-25	WOS:000272028500003
J	Sinha, S; Dutta, S; Datta, K; Ghosh, AK; Mukhopadhyay, D				Sinha, Sutapa; Dutta, Shamit; Datta, Kaustubh; Ghosh, Asish K.; Mukhopadhyay, Debabrata			Von Hippel-Lindau Gene Product Modulates TIS11B Expression in Renal Cell Carcinoma IMPACT ON VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN HYPOXIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; PRIMARY RESPONSE GENE; FACTOR MESSENGER-RNA; ZINC-FINGER PROTEIN; PERMEABILITY FACTOR; HIF-ALPHA; ANGIOGENESIS; INDUCTION; DISEASE; FAMILY	TIS11B belongs to a group of RNA-binding proteins (including TIS11/tristetraprolin and TIS11D) that share characteristic tandem CCCH-type zinc-finger domains and can be rapidly induced by multiple stimuli. TIS11B has been shown to regulate vascular endothelial growth factor (VEGF) mRNA stability in adrenocorticotropic hormone-stimulated primary adrenocortical cells. TIS11B has also been documented as a negative regulator of VEGF during development, but nothing has yet been reported in the context of human cancers. The Von Hippel-Lindau (VHL) tumor suppressor protein regulates VEGF gene expression at both the transcriptional and post-transcriptional levels in normoxia. However, whether it can do so in hypoxia is still unclear. Here, we report a unique regulatory function of VHL in VEGF expression in hypoxia that is mediated through modulation of TIS11B protein levels in renal cancer cells. In normoxia, we detected increased expression of the microRNA hsa-miR-29b in the VHL-overexpressing renal cancer cell line 786-O. We also show that this increased expression of hsa-miR29b decreased TIS11B protein expression by post-transcriptional regulation in normoxia. In contrast, in hypoxia, increased TIS11B expression paralleled an increased TIS11B mRNA stability in VHL-overexpressing 786-O cells. This VHL-mediated TIS11B up-regulation in hypoxia may be important for TIS11B-regulated gene expression: we observed a down-regulation of VEGF mRNA in hypoxia in VHL-overexpressing cells compared with parental 786-O cells, and this effect was reversible by silencing TIS11B expression.	[Sinha, Sutapa; Dutta, Shamit; Mukhopadhyay, Debabrata] Mayo Clin Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Datta, Kaustubh] Mayo Clin Fdn, Dept Urol Res, Rochester, MN 55905 USA; [Ghosh, Asish K.] Mayo Clin Fdn, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Mukhopadhyay, D (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Gugg 1321C,200 1st St SW, Rochester, MN 55905 USA.	mukhopadhyay.debabrata@mayo.edu			National Institutes of Health [CA78383]; NATIONAL CANCER INSTITUTE [R01CA078383, R29CA078383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA78383.	Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; BROWN LF, 1993, AM J PATHOL, V143, P1255; Busse M, 2008, EUR J CELL BIOL, V87, P31, DOI 10.1016/j.ejcb.2007.07.005; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cherradi N, 2006, MOL ENDOCRINOL, V20, P916, DOI 10.1210/me.2005-0121; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; CORPS AN, 1995, FEBS LETT, V368, P160, DOI 10.1016/0014-5793(95)00635-M; Datta K, 2005, ONCOGENE, V24, P7850, DOI 10.1038/sj.onc.1208912; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Folkman J, 1996, SCI AM, V275, P150, DOI 10.1038/scientificamerican0996-150; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; GOMPERTS M, 1992, FEBS LETT, V306, P1, DOI 10.1016/0014-5793(92)80825-2; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Levy AP, 1997, KIDNEY INT, V51, P575, DOI 10.1038/ki.1997.82; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Mukhopadhyay D, 2004, SEMIN CANCER BIOL, V14, P123, DOI 10.1016/j.semcancer.2003.09.019; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; SHWEIKI D, 1992, NATURE, V359, P845; Siemeister G, 1996, CANCER RES, V56, P2299; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; TAKAHASHI A, 1994, CANCER RES, V54, P4233; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; WIZIGMANNVOOS S, 1995, CANCER RES, V55, P1358	43	22	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32610	32618		10.1074/jbc.M109.058065	http://dx.doi.org/10.1074/jbc.M109.058065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801654	hybrid, Green Published			2022-12-25	WOS:000272028400043
J	Pennacchietti, E; Lammens, TM; Capitani, G; Franssen, MCR; John, RA; Bossa, F; De Biase, D				Pennacchietti, Eugenia; Lammens, Tijs M.; Capitani, Guido; Franssen, Maurice C. R.; John, Robert A.; Bossa, Francesco; De Biase, Daniela			Mutation of His(465) Alters the pH-dependent Spectroscopic Properties of Escherichia coli Glutamate Decarboxylase and Broadens the Range of Its Activity toward More Alkaline pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXAL 5'-PHOSPHATE; ACID DECARBOXYLASE; AMINO-ACIDS; PHOSPHORYLASE; RESISTANCE; BINDING; ENZYME; SITE; AMINOTRANSFERASE; ACTIVATION	Glutamate decarboxylase (GadB) from Escherichia coli is a hexameric, pyridoxal 5'-phosphate-dependent enzyme catalyzing CO2 release from the alpha-carboxyl group of L-glutamate to yield gamma-aminobutyrate. GadB exhibits an acidic pH optimum and undergoes a spectroscopically detectable and strongly cooperative pH-dependent conformational change involving at least six protons. Crystallographic studies showed that at mildly alkaline pH GadB is inactive because all active sites are locked by the C termini and that the 340 nm absorbance is an aldamine formed by the pyridoxal 5'-phosphate-Lys(276) Schiff base with the distal nitrogen of His(465), the penultimate residue in the GadB sequence. Herein we show that His(465) has a massive influence on the equilibrium between active and inactive forms, the former being favored when this residue is absent. His(465) contributes with n approximate to 2.5 to the overall cooperativity of the system. The residual cooperativity (n approximate to 3) is associated with the conformational changes still occurring at the N-terminal ends regardless of the mutation. His(465), dispensable for the cooperativity that affects enzyme activity, is essential to include the conformational change of the N termini into the cooperativity of the whole system. In the absence of His(465,) a 330-nm absorbing species appears, with fluorescence emission spectra more complex than model compounds and consisting of two maxima at 390 and 510 nm. Because His(465) mutants are active at pH well above 5.7, they appear to be suitable for biotechnological applications.	[Pennacchietti, Eugenia; Bossa, Francesco; De Biase, Daniela] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Franssen, Maurice C. R.] Univ Wageningen & Res Ctr, Organ Chem Lab, NL-6703 HB Wageningen, Netherlands; [Capitani, Guido] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [John, Robert A.] Cardiff Univ, Sch Biosci, Cardiff CF1 3US, S Glam, Wales	Fondazione Cenci Bolognetti; Sapienza University Rome; Wageningen University & Research; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Cardiff University	De Biase, D (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	daniela.debiase@uniroma1.it	Messier, Claude/A-2322-2008; De Biase, Daniela/H-3678-2019; Franssen, Maurice C.R./R-4026-2019	Messier, Claude/0000-0002-4791-1763; De Biase, Daniela/0000-0003-3536-9927; Franssen, Maurice C.R./0000-0002-3615-9115	Istituto Pasteur-Fondazione Cenci Bolognetti; Italian Ministero dell'Istruzione dell'Universita e della Ricerca	Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Italian Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Istituto Pasteur-Fondazione Cenci Bolognetti and the Italian Ministero dell'Istruzione dell'Universita e della Ricerca (to D. D. B. and F. B.).	Amend JP, 1997, PURE APPL CHEM, V69, P935, DOI 10.1351/pac199769050935; Bertoldi M, 2002, BIOCHEMISTRY-US, V41, P9153, DOI 10.1021/bi025649q; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; DeBiase D, 1996, PROTEIN EXPRES PURIF, V8, P430; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gale EF, 1940, BIOCHEM J, V34, P392, DOI 10.1042/bj0340392; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; Gut H, 2009, J MOL BIOL, V392, P334, DOI 10.1016/j.jmb.2009.06.080; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; HONIKEL KO, 1972, J BIOL CHEM, V247, P1057; Hurst LD, 2002, TRENDS GENET, V18, P604, DOI 10.1016/S0168-9525(02)02813-5; Ikushiro H, 1998, BIOCHEMISTRY-US, V37, P3043, DOI 10.1021/bi971995+; JOHNSON GF, 1970, J BIOL CHEM, V245, P5560; Kulikova T, 2007, NUCLEIC ACIDS RES, V35, pD16, DOI 10.1093/nar/gkl913; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammens TM, 2009, GREEN CHEM, V11, P1562, DOI 10.1039/b913741f; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; METZLER DE, 1973, BIOCHEMISTRY-US, V12, P5377, DOI 10.1021/bi00750a022; MISONO H, 1977, J BIOCHEM-TOKYO, V82, P535; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OLEARY MH, 1971, BIOCHIM BIOPHYS ACTA, V242, P484, DOI 10.1016/0005-2744(71)90241-5; OLEARY MH, 1974, J BIOL CHEM, V249, P3737; PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045; Ro HS, 1996, FEBS LETT, V398, P141, DOI 10.1016/S0014-5793(96)01222-7; SHALTIEL S, 1970, BIOCHEM BIOPH RES CO, V41, P594, DOI 10.1016/0006-291X(70)90054-9; SHUKUYA R, 1960, J BIOL CHEM, V235, P1653; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Tramonti A, 2002, EUR J BIOCHEM, V269, P4913, DOI 10.1046/j.1432-1033.2002.03149.x; Tramonti A, 1998, J BIOL CHEM, V273, P1939, DOI 10.1074/jbc.273.4.1939; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; VAZQUEZ MA, 1991, BIOCHEM J, V279, P759, DOI 10.1042/bj2790759; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Zhang JS, 2005, PROTEIN SCI, V14, P1190, DOI 10.1110/ps.041258305; Zhou XZ, 1999, BIOCHEMISTRY-US, V38, P311, DOI 10.1021/bi981455s	35	39	45	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31587	31596		10.1074/jbc.M109.049577	http://dx.doi.org/10.1074/jbc.M109.049577			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797049	hybrid, Green Published			2022-12-25	WOS:000271572700013
J	Hans, CP; Feng, YM; Naura, AS; Zerfaoui, M; Rezk, BM; Xia, HJ; Kaye, AD; Matrougui, K; Lazartigues, E; Boulares, AH				Hans, Chetan P.; Feng, Yumei; Naura, Amarjit S.; Zerfaoui, Mourad; Rezk, Bashir M.; Xia, Huijing; Kaye, Alan D.; Matrougui, Khalid; Lazartigues, Eric; Boulares, A. Hamid			Protective Effects of PARP-1 Knockout on Dyslipidemia-Induced Autonomic and Vascular Dysfunction in ApoE(-/-) Mice: Effects on eNOS and Oxidative Stress	PLOS ONE			English	Article							E-DEFICIENT MICE; DECREASED BAROREFLEX SENSITIVITY; POLY(ADP-RIBOSE) POLYMERASE; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; PHARMACOLOGICAL INHIBITION; HEART-RATE; OVEREXPRESSION; HYPERTENSION; REFLEX	The aims of this study were to investigate the role of poly(ADP-ribose) polymerase (PARP)-1 in dyslipidemia-associated vascular dysfunction as well as autonomic nervous system dysregulation. Apolipoprotein (ApoE)(-/-) mice fed a high-fat diet were used as a model of atherosclerosis. Vascular and autonomic functions were measured in conscious mice using telemetry. The study revealed that PARP-1 plays an important role in dyslipidemia-associated vascular and autonomic dysfunction. Inhibition of this enzyme by gene knockout partially restored baroreflex sensitivity in ApoE(-/-) mice without affecting baseline heart-rate and arterial pressure, and also improved heart-rate responses following selective blockade of the autonomic nervous system. The protective effect of PARP-1 gene deletion against dyslipidemia-induced endothelial dysfunction was associated with preservation of eNOS activity. Dyslipidemia induced PARP-1 activation was accompanied by oxidative tissue damage, as evidenced by increased expression of iNOS and subsequent protein nitration. PARP-1 gene deletion reversed these effects, suggesting that PARP-1 may contribute to vascular and autonomic pathologies by promoting oxidative tissue injury. Further, inhibition of this oxidative damage may account for protective effects of PARP-1 gene deletion on vascular and autonomic functions. This study demonstrates that PARP-1 participates in dyslipidemia-mediated dysregulation of the autonomic nervous system and that PARP-1 gene deletion normalizes autonomic and vascular dysfunctions. Maintenance of eNOS activity may be associated with the protective effect of PARP-1 gene deletion against dyslipidemia-induced endothelial dysfunction.			Hans, CP (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA.	hboulr@lsuhsc.edu	Hans, Chetan/C-5490-2012	Lazartigues, Eric/0000-0001-7290-0786	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER; NCRR NIH HHS [1P20RR18766, P20 RR018766] Funding Source: Medline; NHLBI NIH HHS [R01 HL072889, HL072889] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Anderson TJ, 2003, HEART FAIL REV, V8, P71, DOI 10.1023/A:1022199021949; Benko R, 2004, LIFE SCI, V75, P1255, DOI 10.1016/j.lfs.2004.04.007; Bishop V S, 1994, New Horiz, V2, P415; Braam B, 2007, CURR PHARM DESIGN, V13, P1727, DOI 10.2174/138161207780831275; CAMPOS C, 2008, EXP TOXICOL PATHOL; Crauwels HM, 2003, CARDIOVASC RES, V59, P189, DOI 10.1016/S0008-6363(03)00353-5; Feng YM, 2008, CIRC RES, V102, P729, DOI 10.1161/CIRCRESAHA.107.169110; Gava AL, 2008, CAN J PHYSIOL PHARM, V86, P458, DOI [10.1139/Y08-044, 10.1139/y08-044]; Gero D, 2008, CURR OPIN ANESTHESIO, V21, P111, DOI 10.1097/ACO.0b013e3282f63c15; Godecke A, 2002, CARDIOVASC RES, V53, P253, DOI 10.1016/S0008-6363(01)00432-1; Grassi G, 2005, DIABETOLOGIA, V48, P1359, DOI 10.1007/s00125-005-1798-z; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hans CP, 2008, CARDIOVASC RES, V78, P429, DOI 10.1093/cvr/cvn018; HANS CP, 2009, J PHARM EXPT THERAPE; Jessani S, 2007, AM J HYPERTENS, V20, P676, DOI 10.1016/j.amjhyper.2007.02.003; Kawashima S, 2004, J PHARMACOL SCI, V96, P411, DOI 10.1254/jphs.FMJ04006X6; Kovacs K, 2006, BIOCHEM PHARMACOL, V71, P441, DOI 10.1016/j.bcp.2005.05.036; Kukreja RC, 2007, J MOL CELL CARDIOL, V42, P280, DOI 10.1016/j.yjmcc.2006.10.011; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Lai CJ, 2006, J APPL PHYSIOL, V100, P1974, DOI 10.1152/japplphysiol.01051.2005; Lazartigues E, 2004, FASEB J, V18, pA299; Liao SJ, 2007, CLIN EXP PHARMACOL P, V34, P1260, DOI 10.1111/j.1440-1681.2007.04719.x; Libby P, 2006, AM J CARDIOL, V98, p3Q, DOI 10.1016/j.amjcard.2006.09.020; Manea A., 2007, Archives of Physiology and Biochemistry, V113, P163, DOI 10.1080/13813450701531235; Mustapha O, 2006, J IMMUNOL, V177, P6489, DOI 10.4049/jimmunol.177.9.6489; Nasr N, 2005, STROKE, V36, P1891, DOI 10.1161/01.STR.0000177890.30065.cb; Naura AS, 2009, EUR RESPIR J, V33, P252, DOI 10.1183/09031936.00089008; NAURA AS, 2008, EUR RESP J; O'Connell BJ, 2001, CIRCULATION, V104, P1978, DOI 10.1161/hc3901.096667; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Pacher P, 2004, J PHARMACOL EXP THER, V311, P485, DOI 10.1124/jpet.104.069658; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; Rose RA, 2007, CIRC RES, V101, P1274, DOI 10.1161/CIRCRESAHA.107.158428; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; Soriano FG, 2001, CIRC RES, V89, P684, DOI 10.1161/hh2001.097797; Stauss HM, 2006, AM J PHYSIOL-HEART C, V291, pH482, DOI 10.1152/ajpheart.00228.2006; Szabo C, 2002, CIRCULATION, V106, P2680, DOI 10.1161/01.CIR.0000038365.78031.9C; Takasaki Yuji, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P511, DOI 10.2114/jpa.24.511; Tank J, 2004, HYPERTENSION, V43, P1042, DOI 10.1161/01.HYP.0000125884.49812.72; von Lukowicz T, 2008, CARDIOVASC RES, V78, P158, DOI 10.1093/cvr/cvm110; Wang YX, 2005, NEUROBIOL AGING, V26, P309, DOI 10.1016/j.neurobiolaging.2004.06.018; Xia HJ, 2009, HYPERTENSION, V53, P210, DOI 10.1161/HYPERTENSIONAHA.108.123844; Zheng W, 2004, AM J PHYSIOL-HEART C, V286, pH1994, DOI 10.1152/ajpheart.00991.2003	46	32	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7430	10.1371/journal.pone.0007430	http://dx.doi.org/10.1371/journal.pone.0007430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823587	Green Submitted, gold, Green Published			2022-12-25	WOS:000270808300009
J	Montesinos, A; Tonsor, SJ; Alonso-Blanco, C; Pico, FX				Montesinos, Alicia; Tonsor, Stephen J.; Alonso-Blanco, Carlos; Xavier Pico, F.			Demographic and Genetic Patterns of Variation among Populations of Arabidopsis thaliana from Contrasting Native Environments	PLOS ONE			English	Article							EVOLUTIONARY ECOLOGY; NATURAL-POPULATIONS; GERMINATION; PLANT; RESPONSES; SELECTION; TRAIT; CONSEQUENCES; BIOGEOGRAPHY; ADAPTATION	Background: Understanding the relationship between environment and genetics requires the integration of knowledge on the demographic behavior of natural populations. However, the demographic performance and genetic composition of Arabidopsis thaliana populations in the species' native environments remain largely uncharacterized. This information, in combination with the advances on the study of gene function, will improve our understanding on the genetic mechanisms underlying adaptive evolution in A. thaliana. Methodology/Principal Findings: We report the extent of environmental, demographic, and genetic variation among 10 A. thaliana populations from Mediterranean (coastal) and Pyrenean (montane) native environments in northeast Spain. Geographic, climatic, landscape, and soil data were compared. Demographic traits, including the dynamics of the soil seed bank and the attributes of aboveground individuals followed over a complete season, were also analyzed. Genetic data based on genome-wide SNP markers were used to describe genetic diversity, differentiation, and structure. Coastal and montane populations significantly differed in terms of environmental, demographic, and genetic characteristics. Montane populations, at higher altitude and farther from the sea, are exposed to colder winters and prolonged spring moisture compared to coastal populations. Montane populations showed stronger secondary seed dormancy, higher seedling/juvenile mortality in winter, and initiated flowering later than coastal populations. Montane and coastal regions were genetically differentiated, montane populations bearing lower genetic diversity than coastal ones. No significant isolation-by-distance pattern and no shared multilocus genotypes among populations were detected. Conclusions/Significance: Between-region variation in climatic patterns can account for differences in demographic traits, such as secondary seed dormancy, plant mortality, and recruitment, between coastal and montane A. thaliana populations. In addition, differences in plant mortality can partly account for differences in the genetic composition of coastal and montane populations. This study shows how the interplay between variation in environmental, demographic, and genetic parameters may operate in natural A. thaliana populations.	[Montesinos, Alicia; Xavier Pico, F.] CSIC, Estn Biol Donana EBD, Dept Ecol Integrat, E-41080 Seville, Spain; [Montesinos, Alicia; Tonsor, Stephen J.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Alonso-Blanco, Carlos] CSIC, Ctr Nacl Biol CNB, Dept Genet Mol Plantas, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Consejo Superior de Investigaciones Cientificas (CSIC)	Pico, FX (corresponding author), CSIC, Estn Biol Donana EBD, Dept Ecol Integrat, E-41080 Seville, Spain.	xpico@ebd.csic.es	Pico, Xavier/E-5697-2016; Navarro, Alicia Montesinos/K-6707-2012; Alonso-Blanco, Carlos/F-8864-2016	Pico, Xavier/0000-0003-2849-4922; Navarro, Alicia Montesinos/0000-0003-4656-0321; Alonso-Blanco, Carlos/0000-0002-4738-5556				Alonso-Blanco C, 2005, INT J DEV BIOL, V49, P717, DOI 10.1387/ijdb.051994ca; ARANY AM, 2005, PLANT BIOLOGY, V7, P1; Arany AM, 2009, PLANT ECOL, V201, P651, DOI 10.1007/s11258-008-9530-y; Archibold O.W., 1995, ECOLOGY WORLD VEGETA, VDordrecht; Ausin I, 2005, INT J DEV BIOL, V49, P689, DOI 10.1387/ijdb.052022ia; Bakker EG, 2006, MOL ECOL, V15, P1405, DOI 10.1111/j.1365-294X.2006.02884.x; Banta JA, 2007, EVOLUTION, V61, P2419, DOI 10.1111/j.1558-5646.2007.00189.x; BASKIN JM, 1983, BOT GAZ, V144, P540, DOI 10.1086/337408; BASKIN JM, 1972, CAN J BOTANY, V50, P353, DOI 10.1139/b72-049; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; BERNATZKY R, 1986, THEOR APPL GENET, V72, P314, DOI 10.1007/BF00288567; CASTROVIEJO S, 1989, FLORA IBERICA PLANTA, V4; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Corbesier L, 2005, PLANT CELL ENVIRON, V28, P54, DOI 10.1111/j.1365-3040.2005.01283.x; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2005, EVOLUTION, V59, P740, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; Ehrlen J, 2009, AM NAT, V173, P819, DOI 10.1086/598492; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feder ME, 2003, NAT REV GENET, V4, P651, DOI 10.1038/nrg1128; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; Gomez JM, 2000, AM NAT, V155, P657, DOI 10.1086/303353; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Griffith C, 2004, AM J BOT, V91, P837, DOI 10.3732/ajb.91.6.837; Herrera CM, 2000, ECOLOGY, V81, P3036, DOI 10.1890/0012-9658(2000)081[3036:IDIPVI]2.0.CO;2; Hoffmann MH, 2005, EVOLUTION, V59, P1425; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; Hutchings Michael J., 1997, P325; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KALISZ S, 1992, ECOLOGY, V73, P1082, DOI 10.2307/1940182; Karrenberg S, 2008, CURR OPIN PLANT BIOL, V11, P156, DOI 10.1016/j.pbi.2008.01.004; Lawton-Rauh A, 2008, CURR OPIN PLANT BIOL, V11, P103, DOI 10.1016/j.pbi.2008.02.009; Le Corre V, 2005, MOL ECOL, V14, P4181, DOI 10.1111/j.1365-294X.2005.02722.x; MANTEL N, 1967, CANCER RES, V27, P209; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Metcalf CJE, 2007, TRENDS ECOL EVOL, V22, P205, DOI 10.1016/j.tree.2006.12.001; Mitchell-Olds T, 2008, HEREDITY, V100, P101, DOI 10.1038/sj.hdy.6801015; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ostrowski MF, 2006, MOL ECOL, V15, P1507, DOI 10.1111/j.1365-294X.2006.02865.x; Pico FX, 2008, PLANT BIOLOGY, V10, P374, DOI 10.1111/j.1438-8677.2008.00044.x; Pico FX, 2008, GENETICS, V180, P1009, DOI 10.1534/genetics.108.089581; Pigliucci M, 2003, AM NAT, V161, P68, DOI 10.1086/345460; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; SLATKIN M, 1995, GENETICS, V139, P457; Stenoien HK, 2005, MOL ECOL, V14, P137, DOI 10.1111/j.1365-294X.2004.02359.x; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Tonsor SJ, 2008, MOL ECOL, V17, P1614, DOI 10.1111/j.1365-294X.2008.03690.x; Tonsor SJ, 2005, PLANT CELL ENVIRON, V28, P2, DOI 10.1111/j.1365-3040.2004.01264.x; Tonsor SJ, 2007, AM NAT, V169, pE119, DOI 10.1086/513493; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; Vergeer P, 2003, J ECOL, V91, P18, DOI 10.1046/j.1365-2745.2003.00736.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WESTERMAN JM, 1970, HEREDITY, V25, P609, DOI 10.1038/hdy.1970.66; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	63	66	66	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7213	10.1371/journal.pone.0007213	http://dx.doi.org/10.1371/journal.pone.0007213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787050	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000270290100015
J	Hauge, B; Oggero, C; Nguyen, N; Fu, CL; Dong, FG				Hauge, Brian; Oggero, Christopher; Nguyen, Nicole; Fu, Changlin; Dong, Fenggao			Single Tube, High Throughput Cloning of Inverted Repeat Constructs for Double-Stranded RNA Expression	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; TRANSCRIPTIONAL INTERFERENCE; PCR PRODUCTS; DNA; EFFICIENT; VECTORS; PRIMERS	Background: RNA interference (RNAi) has emerged as a powerful tool for the targeted knockout of genes for functional genomics, system biology studies and drug discovery applications. To meet the requirements for high throughput screening in plants we have developed a new method for the rapid assembly of inverted repeat-containing constructs for the in vivo production of dsRNAs. Methodology/Principal Findings: The procedure that we describe is based on tagging the sense and antisense fragments with unique single-stranded (ss) tails which are then assembled in a single tube Ligase Independent Cloning (LIC) reaction. Since the assembly reaction is based on the annealing of unique complementary single stranded tails which can only assemble in one orientation, greater than ninety percent of the resultant clones contain the desired insert. Conclusion/Significance: Our single-tube reaction provides a highly efficient method for the assembly of inverted repeat constructs for gene suppression applications. The single tube assembly is directional, highly efficient and readily adapted for high throughput applications.			Hauge, B (corresponding author), Biotechnol Monsanto Co, St Louis, MO USA.	Brian.hauge@monsanto.com						ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Bao S, 2006, RNA, V12, P2020, DOI 10.1261/rna.258406; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Coljee VW, 2000, NAT BIOTECHNOL, V18, P789, DOI 10.1038/77363; Donahue WF, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf094; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gal J, 1999, MOL GEN GENET, V260, P569, DOI 10.1007/s004380050930; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; HUNT HD, 1989, GENE, V77, P51; LEACH DRF, 1983, NATURE, V305, P448, DOI 10.1038/305448a0; LEE I, 1997, Patent No. 9708185; Li CA, 1997, NUCLEIC ACIDS RES, V25, P4165, DOI 10.1093/nar/25.20.4165; NEWTON CR, 1993, NUCLEIC ACIDS RES, V21, P1155, DOI 10.1093/nar/21.5.1155; Pawloski LC, 2005, PLANT CELL PHYSIOL, V46, P1872, DOI 10.1093/pcp/pci191; RASHTCHIAN A, 1992, ANAL BIOCHEM, V206, P91, DOI 10.1016/S0003-2697(05)80015-6; Seyhan AA, 2005, RNA, V11, P837, DOI 10.1261/rna.7285805; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; WALLACE RB, 1995, Patent No. 5426039; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; WYMAN AR, 1985, P NATL ACAD SCI USA, V82, P2880, DOI 10.1073/pnas.82.9.2880; Yan H, 2006, PLANT PHYSIOL, V141, P1508, DOI 10.1104/pp.106.082271	23	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7205	10.1371/journal.pone.0007205	http://dx.doi.org/10.1371/journal.pone.0007205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784365	Green Published, Green Submitted, gold			2022-12-25	WOS:000270290000012
J	Kapogiannis, D; Barbey, AK; Su, M; Krueger, F; Grafman, J				Kapogiannis, Dimitrios; Barbey, Aron K.; Su, Michael; Krueger, Frank; Grafman, Jordan			Neuroanatomical Variability of Religiosity	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ANTISOCIAL-BEHAVIOR; MENTAL-HEALTH; NEURAL BASIS; CORTEX; MATTER; RELIGIOUSNESS; THICKNESS; MEMORY; BRAIN	We hypothesized that religiosity, a set of traits variably expressed in the population, is modulated by neuroanatomical variability. We tested this idea by determining whether aspects of religiosity were predicted by variability in regional cortical volume. We performed structural magnetic resonance imaging of the brain in 40 healthy adult participants who reported different degrees and patterns of religiosity on a survey. We identified four Principal Components of religiosity by Factor Analysis of the survey items and associated them with regional cortical volumes measured by voxel-based morphometry. Experiencing an intimate relationship with God and engaging in religious behavior was associated with increased volume of R middle temporal cortex, BA 21. Experiencing fear of God was associated with decreased volume of L precuneus and L orbitofrontal cortex BA 11. A cluster of traits related with pragmatism and doubting God's existence was associated with increased volume of the R precuneus. Variability in religiosity of upbringing was not associated with variability in cortical volume of any region. Therefore, key aspects of religiosity are associated with cortical volume differences. This conclusion complements our prior functional neuroimaging findings in elucidating the proximate causes of religion in the brain.			Kapogiannis, D (corresponding author), NIA, Clin Res Branch, NIH, Baltimore, MD 21224 USA.	grafmanj@ninds.nih.gov	Barbey, Aron/L-7312-2015; Kapogiannis, Dimitrios/AAW-4934-2020	Barbey, Aron/0000-0002-6092-0912; Kapogiannis, Dimitrios/0000-0003-2181-3118; Grafman, Jordan H./0000-0001-8645-4457; Lauwereyns, Jan/0000-0003-0551-2550	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000966] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AG000966-03, Z99 AG999999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beauregard M, 2006, NEUROSCI LETT, V405, P186, DOI 10.1016/j.neulet.2006.06.060; Bouchard T J Jr, 1999, Twin Res, V2, P88, DOI 10.1375/twin.2.2.88; Boyer P, 2003, TRENDS COGN SCI, V7, P119, DOI 10.1016/S1364-6613(03)00031-7; Boyer P, 2008, ANNU REV ANTHROPOL, V37, P111, DOI 10.1146/annurev.anthro.37.081407.085201; Boyer P, 2008, NATURE, V455, P1038, DOI 10.1038/4551038a; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Bulbulia J, 2004, BIOL PHILOS, V19, P655, DOI 10.1007/s10539-005-5568-6; Bulbulia J., 2004, EVOLUTION COGNITION, V10, P19; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cunningham WA, 2004, J COGNITIVE NEUROSCI, V16, P1717, DOI 10.1162/0898929042947919; Dawkins R, 2006, SELFISH GENE; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Fuster J M, 2003, CORTEX MIND UNIFYING; Gaser C, 2003, J NEUROSCI, V23, P9240; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Goghari VM, 2007, CEREB CORTEX, V17, P415, DOI 10.1093/cercor/bhj158; Goghari VM, 2007, BRIT J PSYCHIAT, V191, P229, DOI 10.1192/bjp.bp.106.034595; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Kennerknecht I, 2008, AM J MED GENET A, V146A, P2863, DOI 10.1002/ajmg.a.32552; Kleim JA, 1996, J NEUROSCI, V16, P4529; Koenig HG, 2009, CAN J PSYCHIAT, V54, P283, DOI 10.1177/070674370905400502; Koenig LB, 2007, J PERS, V75, P265, DOI 10.1111/j.1467-6494.2007.00439.x; Koenig LB, 2009, HEALTH PSYCHOL, V28, P117, DOI 10.1037/a0012984; Koenig LB, 2005, J PERS, V73, P471, DOI 10.1111/j.1467-6494.2005.00316.x; Koenig LB, 2003, BEHAV GENET, V33, P708; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lissek S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002023; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; McCullough ME, 2009, PSYCHOL BULL, V135, P69, DOI 10.1037/a0014213; MCNAMARA P, 2001, RELIG MIND COGNITIVE, P236; Mischel W, 2004, ANNU REV PSYCHOL, V55, P1, DOI 10.1146/annurev.psych.55.042902.130709; Moreira-Almeida A, 2006, REV BRAS PSIQUIATR, V28, P242, DOI 10.1590/S1516-44462006000300018; Mueller PS, 2001, MAYO CLIN PROC, V76, P1225, DOI 10.4065/76.12.1225; Narayan VM, 2008, NEUROREPORT, V19, P1551, DOI 10.1097/WNR.0b013e3283112720; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Noriuchi M, 2008, BIOL PSYCHIAT, V63, P415, DOI 10.1016/j.biopsych.2007.05.018; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; PERSINGER MA, 1983, PERCEPT MOTOR SKILL, V57, P1255, DOI 10.2466/pms.1983.57.3f.1255; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schjodt U, 2008, NEUROSCI LETT, V443, P165, DOI 10.1016/j.neulet.2008.07.068; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; SHAMAYTSOORY SG, 2008, BRAIN; Simeon D, 2000, AM J PSYCHIAT, V157, P1782, DOI 10.1176/appi.ajp.157.11.1782; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spencer MD, 2007, NEUROIMAGE, V35, P1181, DOI 10.1016/j.neuroimage.2007.01.008; Tinbergen N, 2005, ANIM BIOL, V55, P297, DOI 10.1163/157075605774840941; Van den Stock J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003195; Vanderwal T, 2008, NEUROIMAGE, V41, P1437, DOI 10.1016/j.neuroimage.2008.03.058; Wade Nicholas, 2006, DAWN RECOVERING LOST; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Walhovd KB, 2004, NEUROLOGY, V63, P1193, DOI 10.1212/01.WNL.0000140489.33249.95; WALHOVD KB, 2008, NEUROBIOL AGING; Walhovd KB, 2009, NEUROBIOL AGING; Walhovd KB, 2006, NEUROIMAGE, V31, P1343, DOI 10.1016/j.neuroimage.2006.01.011; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080	74	39	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7180	10.1371/journal.pone.0007180	http://dx.doi.org/10.1371/journal.pone.0007180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	500HQ	19784372	Green Published, gold			2022-12-25	WOS:000270290000005
J	Wu, XA; Ye, S; Guo, SY; Yan, WP; Bartlam, M; Rao, ZH				Wu, Xiaoai; Ye, Sheng; Guo, Shuyuan; Yan, Wupeng; Bartlam, Mark; Rao, Zihe			Structural basis for a reciprocating mechanism of negative cooperativity in dimeric phosphagen kinase activity	FASEB JOURNAL			English	Article						crystal structure; arginine kinase; creatine kinase; energy metabolism	MUSCLE CREATINE-KINASE; PROTEIN-PROTEIN INTERFACES; STATE ANALOG COMPLEX; ARGININE KINASE; CRYSTAL-STRUCTURE; INDUCED FIT; EVOLUTION; SUBUNITS; SYSTEMS	Phosphagen kinase (PK) family members catalyze the reversible phosphoryl transfer between phosphagen and ADP to reserve or release energy in cell energy metabolism. The structures of classic quaternary complexes of dimeric creatine kinase (CK) revealed asymmetric ligand binding states of two protomers, but the significance and mechanism remain unclear. To understand this negative cooperativity further, we determined the first structure of dimeric arginine kinase (dAK), another PK family member, at 1.75 angstrom, as well as the structure of its ternary complex with AMPPNP and arginine. Further structural analysis shows that the ligand-free protomer in a ligand-bound dimer opens more widely than the protomers in a ligand-free dimer, which leads to three different states of a dAK protomer. The unexpected allostery of the ligand-free protomer in a ligand-bound dimer should be relayed from the ligand-binding-induced allostery of its adjacent protomer. Mutations that weaken the inter-protomer connections dramatically reduced the catalytic activities of dAK, indicating the importance of the allosteric propagation mediated by the homodimer interface. These results suggest a reciprocating mechanism of dimeric PK, which is shared by other ATP related oligomeric enzymes, e. g., ATP synthase.-Wu, X., Ye, S., Guo, S., Yan, W., Bartlam, M., Rao, Z. Structural basis for a reciprocating mechanism of negative cooperativity in dimeric phosphagen kinase activity. FASEB J. 24, 242-252 ( 2010). www.fasebj.org	[Wu, Xiaoai; Yan, Wupeng; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Sch Med, Beijing 100084, Peoples R China; [Ye, Sheng] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Ye, Sheng] Howard Hughes Med Inst, New York, NY USA; [Guo, Shuyuan] Beijing Inst Technol, Sch Life Sci & Technol, Beijing 100081, Peoples R China; [Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Bartlam, Mark; Rao, Zihe] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100080, Peoples R China	Tsinghua University; Columbia University; Howard Hughes Medical Institute; Beijing Institute of Technology; Nankai University; Nankai University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Rao, ZH (corresponding author), Tsinghua Univ, Struct Biol Lab, Sch Med, Life Sci Bldg, Beijing 100084, Peoples R China.	raozh@xtal.tsinghua.edu.cn	Rao, Zihe/HCH-6944-2022	Bartlam, Mark/0000-0001-5173-5080	Ministry of Science and Technology [2007CB914300]; Ministry of Science, the Technology International Cooperation Project [2006DFB32420]; Natural Science Foundation of China [30221003]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science, the Technology International Cooperation Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Prof. Xicheng Wang (Tsinghua University, Beijing, China) for providing the cDNA of sea cucumber dAK; John Schwanof, Randy Abramowitz, and Dr. Seetharaman Jayaraman for help with synchrotron data collection; and Prof. Bingbin Yu and Jiangang Chen for assistance with catalytic assays. We also thank Prof. Wayne A. Hendrickson (Columbia University, New York, NY, USA) for his kind supervision of the cooperation work in his lab. We are grateful to Dr. Luet Lok Wong (Department of Chemistry, University of Oxford, Oxford, UK) and Dr. K. Christopher Min ( Department of Neurology, Columbia University) for valuable comments and critical discussion. This work was supported by the Ministry of Science and Technology 973 Project ( grant no. 2007CB914300), the Ministry of Science, the Technology International Cooperation Project ( grant 2006DFB32420), and the Natural Science Foundation of China ( grant 30221003). The coordinates and structure factors for SeMet dAK ( PDB accession code 3JU5) and the ternary dAK-AMPPNP-Arg complex ( PDB code 3JU6) have been deposited in the Protein Data Bank.	Aksenov MY, 1997, EXP NEUROL, V146, P458, DOI 10.1006/exnr.1997.6550; Apple FS, 1999, CORONARY ARTERY DIS, V10, P75, DOI 10.1097/00019501-199903000-00003; Bong SM, 2008, FEBS LETT, V582, P3959, DOI 10.1016/j.febslet.2008.10.039; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P13861, DOI 10.1021/bi026655p; Larsen TA, 1998, STRUCT FOLD DES, V6, P421, DOI 10.1016/S0969-2126(98)00044-6; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morrison J. F., 1973, ENZYMES, V8, P457, DOI 10.1016/S1874-6047; NEWSHOLME EA, 1978, BIOCHEM J, V172, P533, DOI 10.1042/bj1720533; Ohren JF, 2007, ACTA CRYSTALLOGR D, V63, P381, DOI 10.1107/S0907444906056204; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozawa E, 1999, MOL CELL BIOCHEM, V190, P143, DOI 10.1023/A:1006974613418; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PRICE NC, 1976, BIOCHIM BIOPHYS ACTA, V445, P364, DOI 10.1016/0005-2744(76)90090-5; Rao JK, 1998, FEBS LETT, V439, P133; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Schiffenbauer YS, 1996, AM J PHYSIOL-CELL PH, V270, pC160, DOI 10.1152/ajpcell.1996.270.1.C160; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simanshu DK, 2005, J MOL BIOL, V352, P876, DOI 10.1016/j.jmb.2005.07.069; Suzuki T, 1999, BIOCHEM J, V340, P671, DOI 10.1042/0264-6021:3400671; Suzuki T, 2009, COMP BIOCHEM PHYS B, V152, P60, DOI 10.1016/j.cbpb.2008.09.087; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Uda K, 2004, PROTEIN J, V23, P53, DOI 10.1023/B:JOPC.0000016258.55991.8a; Uda K, 2006, COMP BIOCHEM PHYS D, V1, P209, DOI 10.1016/j.cbd.2005.10.007; Watts D.C., 1975, Symposia Zool Soc Lond, VNo. 36, P105; WATTS DC, 1971, BIOCH EVOLUTION ORIG, P150; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yousef MS, 2003, PROTEIN SCI, V12, P103, DOI 10.1110/ps.0226303; Yu Z, 2002, PROTEIN PEPTIDE LETT, V9, P545; Zhou GF, 1998, P NATL ACAD SCI USA, V95, P8449, DOI 10.1073/pnas.95.15.8449; Zhou GF, 2000, BIOPHYS J, V78, P1541, DOI 10.1016/S0006-3495(00)76706-3	38	27	27	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2010	24	1					242	252		10.1096/fj.09-140194	http://dx.doi.org/10.1096/fj.09-140194			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19783784				2022-12-25	WOS:000273233600025
J	Lu, XY; Liu, J; Legerski, RJ				Lu, Xiaoyan; Liu, Jia; Legerski, Randy J.			Cyclin E Is Stabilized in Response to Replication Fork Barriers Leading to Prolonged S Phase Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; CELL-CYCLE; DNA-REPLICATION; BREAST-CANCER; DEPENDENT REGULATION; MAMMALIAN CDC6; MESSENGER-RNA; CHECKPOINT; ACTIVATION; COMPLEX	Cyclin E is a regulator of cyclin-dependent protein kinases (Cdks) and is involved in mediating the cell cycle transition from G(1) to S phase. Here, we describe a novel function for cyclin E in the long term maintenance of checkpoint arrest in response to replication barriers. Exposure of cells to mitomycin C or UV irradiation, but not ionizing radiation, induces stabilization of cyclin E. Stabilization of cyclin E reduces the activity of Cdk2-cyclin A, resulting in a slowing of S phase progression and arrest. In addition, cyclin E is shown to be required for stabilization of Cdc6, which is required for activation of Chk1 and the replication checkpoint pathway. Furthermore, the stabilization of cyclin E in response to replication fork barriers depends on ATR, but not Nbs1 or Chk1. These results indicate that in addition to its well studied role in promoting cell cycle progression, cyclin E also has a role in regulating cell cycle arrest in response to DNA damage.	[Lu, Xiaoyan; Liu, Jia; Legerski, Randy J.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Legerski, RJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rlegersk@mdanderson.org			NCI [CA097175]; Cancer Center [CA16672]; NATIONAL CANCER INSTITUTE [P01CA097175, P30CA016672] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA097175 from the NCI. DNA sequencing resources were supported by the Cancer Center Support Grant CA16672.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Borriello A, 2007, CELL CYCLE, V6, P1053, DOI 10.4161/cc.6.9.4142; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; Clay-Farrace L, 2003, EMBO J, V22, P704, DOI 10.1093/emboj/cdg046; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Erlandsson F, 2003, INT J CANCER, V104, P369, DOI 10.1002/ijc.10949; Geng LY, 2007, MOL CELL BIOL, V27, P2625, DOI 10.1128/MCB.02072-06; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hermand D, 2007, MOL CELL, V26, P553, DOI 10.1016/j.molcel.2007.04.014; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Keyomarsi K, 2003, NAT MED, V9, P152, DOI 10.1038/nm0203-152; KEYOMARSI K, 1995, ONCOGENE, V11, P941; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Liu LL, 2009, CELL CYCLE, V8, P628, DOI 10.4161/cc.8.4.7791; Liu LH, 2009, INT J BIOCHEM CELL B, V41, P1410, DOI 10.1016/j.biocel.2008.12.014; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mladenov E, 2007, J CELL PHYSIOL, V211, P468, DOI 10.1002/jcp.20957; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Murakami H, 2002, NAT CELL BIOL, V4, P384, DOI 10.1038/ncb789; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Park EA, 2007, P NATL ACAD SCI USA, V104, P16739, DOI 10.1073/pnas.0707804104; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Sandhu C, 2000, CANCER DETECT PREV, V24, P107; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Spruck CH, 2002, CANCER RES, V62, P4535; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Wang HY, 2009, J BIOL CHEM, V284, P18236, DOI 10.1074/jbc.M109.002584; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; WIMMEL A, 1994, ONCOGENE, V9, P995; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	57	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35325	35337		10.1074/jbc.M109.035949	http://dx.doi.org/10.1074/jbc.M109.035949			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19812034	Green Published, hybrid			2022-12-25	WOS:000272645600009
J	Chen, MY; Philipp, M; Wang, JB; Premont, RT; Garrison, TR; Caron, MG; Lefkowitz, RJ; Chen, W				Chen, Minyong; Philipp, Melanie; Wang, Jiangbo; Premont, Richard T.; Garrison, Tiffany R.; Caron, Marc G.; Lefkowitz, Robert J.; Chen, Wei			G Protein-coupled Receptor Kinases Phosphorylate LRP6 in the Wnt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM; INHIBITION; MESODERM	Wnt ligands conduct their functions in canonical Wnt signaling by binding to two receptors, the single transmembrane low density lipoprotein receptor-related proteins 5 and 6 (LRP5/6) and seven transmembrane (7TM) Frizzled receptors. Subsequently, phosphorylation of serine/threonine residues within five repeating signature PPPSP motifs on LRP6 is responsible for LRP6 activation. GSK3 beta, a cytosolic kinase for phosphorylation of a downstream effector beta-catenin, was proposed to participate in such LRP6 phosphorylation. Here, we report a new class of membrane-associated kinases for LRP6 phosphorylation. We found that G protein-coupled receptor kinases 5 and 6 (GRK5/6), traditionally known to phosphorylate and desensitize 7TM G protein-coupled receptors, directly phosphorylate the PPPSP motifs on single transmembrane LRP6 and regulate Wnt/LRP6 signaling. GRK5/6-induced LRP6 activation is inhibited by the LRP6 antagonist Dickkopf. Depletion of GRK5 markedly reduces Wnt3A-stimulated LRP6 phosphorylation in cells. In zebrafish, functional knock-down of GRK5 results in reduced Wnt signaling, analogous to LRP6 knock-down, as assessed by decreased abundance of beta-catenin and lowered expression of the Wnt target genes cdx4, vent, and axin2. Expression of GRK5 rescues the diminished beta-catenin and axin2 response caused by GRK5 depletion. Thus, our findings identify GRK5/6 as novel kinases for the single transmembrane receptor LRP6 during Wnt signaling.	[Chen, Minyong; Wang, Jiangbo; Premont, Richard T.; Garrison, Tiffany R.; Caron, Marc G.; Lefkowitz, Robert J.; Chen, Wei] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Philipp, Melanie; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Chen, W (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	w.chen@duke.edu	Philipp, Melanie/B-5198-2016; Wang, Jiangbo/F-9246-2011; Lefkowitz, Robert/AAW-2649-2021	Philipp, Melanie/0000-0003-2714-965X; Chen, Wei/0000-0002-9934-4000; Premont, Richard/0000-0002-8053-5026	National Institutes of Health [5R01 CA113656-03]; Pediatric Brain Tumor Foundation; Susan G. Komen for the Cure; Alexander and Margaret Stewart Trust; NATIONAL CANCER INSTITUTE [R01CA113656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Alexander and Margaret Stewart Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01 CA113656-03 (to W.C.). This work was also supported by the Pediatric Brain Tumor Foundation (to W.C.), Susan G. Komen for the Cure (to W.C.), and the Alexander and Margaret Stewart Trust Fund (to W.C.).	Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	32	48	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35040	35048		10.1074/jbc.M109.047456	http://dx.doi.org/10.1074/jbc.M109.047456			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801552	hybrid, Green Published			2022-12-25	WOS:000272439600058
J	Timmerman, P; Barderas, R; Desmet, J; Altschuh, D; Shochat, S; Hollestelle, MJ; Hoppener, JWM; Monasterio, A; Casal, JI; Meloen, RH				Timmerman, Peter; Barderas, Rodrigo; Desmet, Johan; Altschuh, Daniele; Shochat, Susana; Hollestelle, Martine J.; Hoppener, Jo W. M.; Monasterio, Alberto; Ignacio Casal, J.; Meloen, Rob H.			A Combinatorial Approach for the Design of Complementarity-determining Region-derived Peptidomimetics with in Vitro Anti-tumoral Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; MONOCLONAL-ANTIBODY; SYNTHETIC MOLECULE; PANCREATIC-CANCER; VARIABLE REGIONS; GROWTH-FACTOR; PHASE-II; GASTRIN; BINDING; PEPTIDES	The great success of therapeutic monoclonal antibodies has fueled research toward mimicry of their binding sites and the development of new strategies for peptide-based mimetics production. Here, we describe a new combinatorial approach for the production of peptidomimetics using the complementarity-determining regions (CDRs) from gastrin17 (pyroEGP-WLEEEEEAYGWMDF-NH2) antibodies as starting material for cyclic peptide synthesis in a microarray format. Gastrin17 is a trophic factor in gastrointestinal tumors, including pancreatic cancer, which makes it an interesting target for development of therapeutic antibodies. Screening of microarrays containing bicyclic peptidomimetics identified a high number of gastrin binders. A strong correlation was observed between gastrin binding and overall charge of the peptidomimetic. Most of the best gastrin binders proceeded from CDRs containing charged residues. In contrast, CDRs from high affinity antibodies containing mostly neutral residues failed to yield good binders. Our experiments revealed essential differences in the mode of antigen binding between CDR-derived peptidomimetics (K-d values in micromolar range) and the parental monoclonal antibodies (Kd values in nanomolar range). However, chemically derived peptidomimetics from gastrin binders were very effective in gastrin neutralization studies using cell-based assays, yielding a neutralizing activity in pancreatic tumoral cell lines comparable with that of gastrin-specific monoclonal antibodies. These data support the use of combinatorial CDR-peptide microarrays as a tool for the development of a new generation of chemically synthesized cyclic peptidomimetics with functional activity.	[Timmerman, Peter; Meloen, Rob H.] Pepscan Therapeut BV, NL-8243 RC Lelystad, Netherlands; [Timmerman, Peter] Univ Amsterdam, Fac Sci, Vant Hoff Inst Mol Sci, NL-1018 WS Amsterdam, Netherlands; [Barderas, Rodrigo; Ignacio Casal, J.] Ctr Invest Biol, Funct Prote Lab, Madrid 28040, Spain; [Desmet, Johan] Algonomics NV, B-9052 Ghent, Belgium; [Altschuh, Daniele; Shochat, Susana] Univ Strasbourg, Ecole Super Biotechnol Strasbourg, Biosensor Grp, F-67412 Illkirch Graffenstaden, France; [Hollestelle, Martine J.; Hoppener, Jo W. M.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands; [Monasterio, Alberto] Proteomika SL, Derio 48160, Spain; [Meloen, Rob H.] Univ Utrecht, Acad Biomed Ctr, NL-3584 CL Utrecht, Netherlands	Pepscan Therapeutics B.V.; University of Amsterdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Utrecht University; Utrecht University Medical Center; Utrecht University	Timmerman, P (corresponding author), Pepscan Therapeut BV, Zuidersluisweg 2, NL-8243 RC Lelystad, Netherlands.	p.timmerman@pepscan.com; icasal@cib.csic.es	Timmerman, Peter/H-9214-2019; Barderas, Rodrigo/K-3560-2014; Casal, Ignacio/M-2312-2014; Altschuh, Danièle/P-8658-2016	Timmerman, Peter/0000-0001-6687-5297; Barderas, Rodrigo/0000-0003-3539-7469; Casal, Ignacio/0000-0003-1085-2840; 	European Commission [COOP-CT-2004-512691]; Dutch Ministry of Economic Affairs [TSGE2017]	European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported in part by European Commission FP6 Cooperative Research Project COOP-CT-2004-512691.; Supported by the Dutch Ministry of Economic Affairs Grant TSGE2017.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Barderas R, 2008, INT J CANCER, V122, P2351, DOI 10.1002/ijc.23395; Barderas R, 2006, J IMMUNOL METHODS, V312, P182, DOI 10.1016/j.jim.2006.03.005; Blaskovich MA, 2000, NAT BIOTECHNOL, V18, P1065, DOI 10.1038/80257; Braden BC, 1998, IMMUNOL REV, V163, P45, DOI 10.1111/j.1600-065X.1998.tb01187.x; Brett BT, 2002, J CLIN ONCOL, V20, P4225, DOI 10.1200/JCO.2002.11.151; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Casset F, 2003, BIOCHEM BIOPH RES CO, V307, P198, DOI 10.1016/S0006-291X(03)01131-8; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Famulok M, 2001, CHEM BIOL, V8, P931, DOI 10.1016/S1074-5521(01)00070-9; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Gilliam AD, 2007, EXPERT OPIN BIOL TH, V7, P397, DOI 10.1517/14712598.7.3.397; Gilliam AD, 2004, EJSO-EUR J SURG ONC, V30, P536, DOI 10.1016/j.ejso.2004.03.009; Haupt K, 1998, TRENDS BIOTECHNOL, V16, P468, DOI 10.1016/S0167-7799(98)01222-0; Hayden EC, 2008, NAT MED, V14, P108, DOI 10.1038/nm0208-108; Heap CJ, 2005, J GEN VIROL, V86, P1791, DOI 10.1099/vir.0.80812-0; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hur K, 2006, J CANCER RES CLIN, V132, P85, DOI 10.1007/s00432-005-0043-y; KANG CY, 1988, SCIENCE, V240, P1034, DOI 10.1126/science.3368787; KieberEmmons T, 1997, CURR OPIN BIOTECH, V8, P435, DOI 10.1016/S0958-1669(97)80065-1; Kourlas H, 2007, CLIN THER, V29, P1850, DOI 10.1016/j.clinthera.2007.09.008; Laune D, 2000, J IMMUNOL METHODS, V239, P63, DOI 10.1016/S0022-1759(00)00177-0; Laune D, 1997, J BIOL CHEM, V272, P30937, DOI 10.1074/jbc.272.49.30937; Monnet C, 1999, J BIOL CHEM, V274, P3789, DOI 10.1074/jbc.274.6.3789; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Park BW, 2000, NAT BIOTECHNOL, V18, P194, DOI 10.1038/72651; Qiu XQ, 2007, NAT BIOTECHNOL, V25, P921, DOI 10.1038/nbt1320; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Revets H, 2005, EXPERT OPIN BIOL TH, V5, P111, DOI 10.1517/14712598.5.1.111; Roguska MA, 1996, PROTEIN ENG, V9, P895, DOI 10.1093/protein/9.10.895; SINGH P, 1986, CANCER RES, V46, P1612; Singh P, 1996, CANCER RES, V56, P4111; SMITH JP, 1995, AM J PHYSIOL-REG I, V268, pR135, DOI 10.1152/ajpregu.1995.268.1.R135; Smith JP, 1996, AM J PHYSIOL-REG I, V270, pR1078, DOI 10.1152/ajpregu.1996.270.5.R1078; Sun JZ, 2005, ONCOGENE, V24, P4701, DOI 10.1038/sj.onc.1208391; Sun JZ, 2004, CANCER RES, V64, P3586, DOI 10.1158/0008-5472.CAN-03-2673; Takaishi S, 2009, AM J PATHOL, V175, P365, DOI 10.2353/ajpath.2009.081165; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; Timmerman P, 2007, J MOL RECOGNIT, V20, P283, DOI 10.1002/jmr.846; Timmerman P, 2004, MOL DIVERS, V8, P61, DOI 10.1023/B:MODI.0000025650.94399.bb; WATSON SA, 1988, BRIT J SURG, V75, P342, DOI 10.1002/bjs.1800750416; Yu HG, 2004, BIOCHEM PHARMACOL, V67, P135, DOI 10.1016/j.bcp.2003.08.015; Zhang X, 1996, NAT BIOTECHNOL, V14, P472, DOI 10.1038/nbt0496-472	46	27	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34126	34134		10.1074/jbc.M109.041459	http://dx.doi.org/10.1074/jbc.M109.041459			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808684	Green Published, hybrid			2022-12-25	WOS:000272165200045
J	Sossey-Alaoui, K; Bialkowska, K; Plow, EF				Sossey-Alaoui, Khalid; Bialkowska, Katarzyna; Plow, Edward F.			The miR200 Family of MicroRNAs Regulates WAVE3-dependent Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; WISKOTT-ALDRICH-SYNDROME; MIR-200 FAMILY; E-CADHERIN; LAMELLIPODIA FORMATION; REDUCED EXPRESSION; SYNDROME PROTEIN; ACTIN-FILAMENTS; REPRESSORS ZEB1; DOWN-REGULATION	MicroRNAs are small non-coding RNAs that are directly involved in the regulation of gene expression by either translational repression or degradation of target mRNAs. Because of the high level of conservation of the target motifs, known as seed sequences, within the 3'-untranslated regions, a single microRNA can regulate numerous target genes simultaneously, making this class of RNAs a powerful regulator of gene expression. The miR200 family of microRNAs has recently been shown to regulate the process of epithelial to mesenchymal transition during tumor progression and metastasis. Here, we report that the expression of WAVE3, an actin cytoskeleton remodeling and metastasis promoter protein, is regulated by miR200 microRNAs. We show a clear inverse correlation between expression levels of WAVE3 and miR200 microRNAs in invasive versus non-invasive cancer cells. miR200 directly targets the 3'-untranslated regions of the WAVE3 mRNA and inhibits its expression. The miR200-mediated down-regulation of WAVE3 results in a significant reduction in the invasive phenotype of cancer cells, which is specific to the loss of WAVE3 expression. Re-expression of a miR200-resistant WAVE3 reverses miR200-mediated inhibition of cancer cell invasion. Loss of WAVE3 expression downstream of miR200 also results in a dramatic change in cell morphology resembling that of a mesenchymal to epithelial transition. In conclusion, a novel mechanism for the regulation of WAVE3 expression in cancer cells has been identified, which controls the invasive properties and morphology of cancer cells associated with their metastatic potential.	[Sossey-Alaoui, Khalid; Bialkowska, Katarzyna; Plow, Edward F.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sossey-Alaoui, K (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,NB-50, Cleveland, OH 44195 USA.	sosseyk@ccf.org			United States Department of Defense [W81XWH-08-1-0236]; National Institutes of Health [P01HL073311, P50HL077107]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, P50HL077107] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by startup funds from United States Department of Defense Grant W81XWH-08-1-0236 ( to K. S. A.) and by National Institutes of Health Grants P01HL073311 and P50HL077107 ( to E. F. P.).	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Cory GOC, 2002, NATURE, V418, P732, DOI 10.1038/418732a; Dahl JP, 2003, J NEUROSCI, V23, P3343; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fuchs IB, 2002, ANTICANCER RES, V22, P3415; Fukuoka M, 2001, J CELL BIOL, V152, P471, DOI 10.1083/jcb.152.3.471; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Oda A, 2005, BLOOD, V105, P3141, DOI 10.1182/blood-2003-04-1319; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2003, MAMM GENOME, V14, P314, DOI 10.1007/s00335-002-2247-7; Sossey-Alaoui K, 2002, ONCOGENE, V21, P5967, DOI 10.1038/sj.onc.1205734; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Spaderna S, 2007, Verh Dtsch Ges Pathol, V91, P21; Spaderna Simone, 2009, Gastroenterology, V136, P1835, DOI 10.1053/j.gastro.2009.03.009; Stovold CF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-11; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Takenawa T, 2001, J CELL SCI, V114, P1801; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	53	94	98	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33019	33029		10.1074/jbc.M109.034553	http://dx.doi.org/10.1074/jbc.M109.034553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801681	Green Published, hybrid			2022-12-25	WOS:000272028500004
J	Heiss, EH; Schachner, D; Werner, ER; Dirsch, VM				Heiss, Elke H.; Schachner, Daniel; Werner, Ernst R.; Dirsch, Verena M.			Active NF-E2-related Factor (Nrf2) Contributes to Keep Endothelial NO Synthase (eNOS) in the Coupled State ROLE OF REACTIVE OXYGEN SPECIES (ROS), eNOS, AND HEME OXYGENASE (HO-1) LEVELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FLUORESCENT DYE 2'-7'-DICHLOROFLUORESCEIN; TRANSCRIPTION FACTOR NRF2; FREE-RADICAL FORMATION; OXIDATIVE STRESS; CARBON-MONOXIDE; SHEAR-STRESS; HORSERADISH-PEROXIDASE; MOLECULAR-MECHANISMS; DIRECT INHIBITION	The aim of our study was to examine in detail the impact of NF-E2-related factor (Nrf2) activation on endothelial cell function with focus on redox homeostasis and the endothelial nitric oxide synthase (eNOS) system. We administered 2-cyano-3,12-dioxooleana-1,9-dien-28-oic imidazolide (CDDO-IM), a known activator of Nrf2, to primary human umbilical vein endothelial cells. Activation of Nrf2 by CDDO-IM increased the amount of bioavailable nitric oxide (NO), a major contributor to vascular homeostasis, in naive and stressed cells. Concomitantly, intracellular reactive oxygen species were dose-and time-dependently reduced. In apparent contrast to elevated NO levels, eNOS protein expression was transiently decreased in an Nrf2-dependent manner. Employing pharmacological inhibitors as well as a small interfering RNA approach, we identified de novo protein synthesis of heme oxygenase 1 (HO-1) and its enzymatic activity as cause for the observed reduction of eNOS. We hypothesize that under redox stress, when the availability of tetrahydrobiopterin, a pivotal stoichiometric cofactor for eNOS, is limited, activation of Nrf2 leads (a) to transient reduction of eNOS protein levels and (b) to an antioxidant defense in human umbilical vein endothelial cells. Both activities ensure that a stoichiometric ratio of eNOS and tetrahydrobiopterin is sustained and that the risk of eNOS uncoupling is reduced. Our study is the first to provide a causal link between Nrf2 activation and eNOS expression and NO levels, respectively.	[Heiss, Elke H.; Schachner, Daniel; Dirsch, Verena M.] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria; [Werner, Ernst R.] Innsbruck Med Univ, Div Biol Chem, Bioctr, A-6020 Innsbruck, Austria	University of Vienna; Medical University of Innsbruck	Heiss, EH (corresponding author), Univ Vienna, Dept Pharmacognosy, Althanstr 14, A-1090 Vienna, Austria.	elke.heiss@univie.ac.at	Heiss, Elke/B-6086-2015	Heiss, Elke/0000-0001-7618-5505; Werner, Ernst R./0000-0003-1948-3391; Dirsch, Verena/0000-0002-9261-5293	"Hochschuljubilaumsstiftung der Stadt Wien" [H-01509/2007]; Austrian Research Funds "zur Forderung der wissenschaftlichen Forschung" [P19764]	"Hochschuljubilaumsstiftung der Stadt Wien"; Austrian Research Funds "zur Forderung der wissenschaftlichen Forschung"(Austrian Science Fund (FWF))	This work was supported in part by grants from the "Hochschuljubilaumsstiftung der Stadt Wien" (Grant H-01509/2007 to E. H. H.) and the Austrian Research Funds "zur Forderung der wissenschaftlichen Forschung" (Grant P19764 to E. R. W.).	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Ali F, 2009, J BIOL CHEM, V284, P18882, DOI 10.1074/jbc.M109.009886; Batzlsperger CA, 2007, CARDIOVASC DRUG THER, V21, P347, DOI 10.1007/s10557-007-6051-1; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Cosentino F, 2003, CIRCULATION, V107, P1017, DOI 10.1161/01.CIR.0000051367.92927.07; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Durante W, 1998, INT J MOL MED, V2, P255; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Forstermann U, 2006, BIOL CHEM, V387, P1521, DOI 10.1515/BC.2006.190; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; FURCHGOTT RF, 1991, BLOOD VESSELS, V28, P52; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Heller R, 2001, J BIOL CHEM, V276, P40, DOI 10.1074/jbc.M004392200; Hink U, 2001, CIRC RES, V88, pE14; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Iori E, 2008, LIFE SCI, V82, P383, DOI 10.1016/j.lfs.2007.11.021; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kinderlerer AR, 2008, J BIOL CHEM, V283, P14636, DOI 10.1074/jbc.M800362200; Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Leikert JF, 2001, FEBS LETT, V506, P131, DOI 10.1016/S0014-5793(01)02901-5; Levonen AL, 2007, ARTERIOSCL THROM VAS, V27, P741, DOI 10.1161/01.ATV.0000258868.80079.4d; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Marchesi E, 1999, FREE RADICAL BIO MED, V26, P148, DOI 10.1016/S0891-5849(98)00174-9; Noriega GO, 2003, BBA-MOL BASIS DIS, V1638, P173, DOI 10.1016/S0925-4439(03)00081-4; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Rathel Thomas R., 2003, Biol Proced Online, V5, P136, DOI 10.1251/bpo55; Rota C, 1999, J BIOL CHEM, V274, P28161, DOI 10.1074/jbc.274.40.28161; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Samudio I, 2005, J BIOL CHEM, V280, P36273, DOI 10.1074/jbc.M507518200; Sugiyama T, 2009, J BIOL CHEM, V284, P12691, DOI 10.1074/jbc.M809295200; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Tabe Y, 2007, CANCER BIOL THER, V6, P1967, DOI 10.4161/cbt.6.12.4982; Thorup C, 1999, AM J PHYSIOL-RENAL, V277, pF882, DOI 10.1152/ajprenal.1999.277.6.F882; True AL, 2007, CIRC RES, V101, P893, DOI 10.1161/CIRCRESAHA.107.158998; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Werner ER, 1996, REV PHYSIOL BIOCH P, V127, P97, DOI 10.1007/BFb0048266; Xue MZ, 2008, DIABETES, V57, P2809, DOI 10.2337/db06-1003; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zabalgoitia M, 2008, FREE RADICAL BIO MED, V44, P284, DOI 10.1016/j.freeradbiomed.2007.08.012; Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0	56	73	86	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31579	31586		10.1074/jbc.M109.009175	http://dx.doi.org/10.1074/jbc.M109.009175			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797052	Green Published, hybrid			2022-12-25	WOS:000271572700012
J	Noguchi, Y; Hirabayashi, T; Katori, S; Kawamura, Y; Sanbo, M; Hirabayashi, M; Kiyonari, H; Nakao, K; Uchimura, A; Yagi, T				Noguchi, Yukiko; Hirabayashi, Takahiro; Katori, Shota; Kawamura, Yoshimi; Sanbo, Makoto; Hirabayashi, Masumi; Kiyonari, Hiroshi; Nakao, Kazuki; Uchimura, Arikuni; Yagi, Takeshi			Total Expression and Dual Gene-regulatory Mechanisms Maintained in Deletions and Duplications of the Pcdha Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOCADHERIN-ALPHA FAMILY; CENTRAL-NERVOUS-SYSTEM; BETA-GLOBIN; GAMMA PROTOCADHERINS; SEQUENCE-ANALYSIS; PURKINJE-CELLS; CONTROL REGION; MESSENGER-RNA; HOXD COMPLEX; MOUSE	The clustered protocadherin-alpha (Pcdha) genes, which are expressed in the vertebrate brain, encode diverse membrane proteins whose functions are involved in axonal projection and in learning and memory. The Pcdha cluster consists of 14 tandemly arranged genes (Pcdha1-Pcdha12, Pcdhac1, and Pcdhac2, from 5' to 3'). Each first exon ( the variable exons) is transcribed from its own promoter, and spliced to the constant exons, which are common to all the Pcdha genes. Cerebellar Purkinje cells show dual expression patterns for Pcdha. In individual Purkinje cells, different sets of the 5' genes in the cluster, Pcdha1-12, are randomly expressed, whereas both 3' genes, Pcdhac1 and Pcdhac2, are expressed constitutively. To elucidate the relationship between the genomic structure of the Pcdha cluster and their expression in Purkinje cells, we deleted or duplicated multiple variable exons and analyzed the expression of Pcdha genes in the mouse brain. In all mutant mice, transcript levels of the constant exons and the dual expression patterns were maintained. In the deletion mutants, the missing genes were flexibly compensated by the remaining variable exons. On the other hand, in duplication mutants, the levels of the duplicated genes were trimmed. These results indicate that the Pcdha genes are comprehensively regulated as a cluster unit, and that the regulators that randomly and constitutively drive Pcdha gene expression are intact in the deleted or duplicated mutant alleles. These dual regulatory mechanisms may play important roles in the diversity and fundamental functions of neurons.	[Noguchi, Yukiko; Yagi, Takeshi] Osaka Univ, Grad Sch Med, Course Med Biosignaling, Suita, Osaka 5650871, Japan; [Hirabayashi, Takahiro; Katori, Shota; Kawamura, Yoshimi; Uchimura, Arikuni; Yagi, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; [Sanbo, Makoto; Hirabayashi, Masumi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Mammalian Transgenesis, Okazaki, Aichi 4448787, Japan; [Kiyonari, Hiroshi; Nakao, Kazuki] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo 6500047, Japan	Osaka University; Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); RIKEN	Yagi, T (corresponding author), 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	yagi@fbs.osaka-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015; Kawamura, Yoshimi/L-1289-2013; Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Uchimura, Arikuni/0000-0003-2435-7082; Kawamura, Yoshimi/0000-0002-9864-7974	Ministry of Education, Science, Sports, and Culture of Japan; Uehara Memorial Foundation; Takeda Foundation; National Institute for Physiological Sciences, Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); National Institute for Physiological Sciences, Japan	This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan, the Uehara Memorial Foundation, the Takeda Foundation, and in part by a grant from the Co-operative Study Program of the National Institute for Physiological Sciences, Japan.	Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Esumi S, 2006, NAT PROTOC, V1, P2143, DOI 10.1038/nprot.2006.343; FOLEY KP, 1992, GENE DEV, V6, P730, DOI 10.1101/gad.6.5.730; Fukuda E, 2008, EUR J NEUROSCI, V28, P1362, DOI 10.1111/j.1460-9568.2008.06428.x; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Junghans D, 2008, EUR J NEUROSCI, V27, P559, DOI 10.1111/j.1460-9568.2008.06052.x; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; KIM DG, 1992, MOL CELL BIOL, V12, P3636, DOI 10.1128/MCB.12.8.3636; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; LIU YC, 1993, BIOCHEMISTRY-US, V32, P10714, DOI 10.1021/bi00091a023; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Morishita H, 2004, EUR J NEUROSCI, V20, P2843, DOI 10.1111/j.1460-9568.2004.03803.x; Mutoh T, 2004, EXP CELL RES, V294, P494, DOI 10.1016/j.yexcr.2003.11.019; NORDQUIST DT, 1988, J NEUROSCI, V8, P4780; OBATA S, 1995, J CELL SCI, V108, P3765; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Stamatoyannopoulos G, 2001, MOL BASIS BLOOD DIS; Sugino H, 2000, GENOMICS, V63, P75, DOI 10.1006/geno.1999.6066; Takeda J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S14; Takei Y, 2001, GENOMICS, V72, P321, DOI 10.1006/geno.2000.6468; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yagi T, 2008, DEV GROWTH DIFFER, V50, pS131, DOI 10.1111/j.1440-169X.2008.00991.x; Zou C, 2007, NEUROSCIENCE, V144, P579, DOI 10.1016/j.neuroscience.2006.10.011	49	34	35	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32002	32014		10.1074/jbc.M109.046938	http://dx.doi.org/10.1074/jbc.M109.046938			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19797050	Green Published, hybrid			2022-12-25	WOS:000271572700056
J	Heaslip, AT; Ems-McClung, SC; Hu, K				Heaslip, Aoife T.; Ems-McClung, Stephanie C.; Hu, Ke			TgICMAP1 Is a Novel Microtubule Binding Protein in Toxoplasma gondii	PLOS ONE			English	Article							CHROMOSOME CONDENSATION; TUBULIN TYROSINATION; NUCLEAR DIVISION; SMC PROTEINS; COILED COILS; TRANSPORT; INVASION; KINESIN; CYTOSKELETON; ORGANELLES	The microtubule cytoskeleton provides essential structural support for all eukaryotic cells and can be assembled into various higher order structures that perform drastically different functions. Understanding how microtubule-containing assemblies are built in a spatially and temporally controlled manner is therefore fundamental to understanding cell physiology. Toxoplasma gondii, a protozoan parasite, contains at least five distinct tubulin-containing structures, the spindle pole, centrioles, cortical microtubules, the conoid, and the intra-conoid microtubules. How these five structurally and functionally distinct sets of tubulin containing structures are constructed and maintained in the same cell is an intriguing problem. Previously, we performed a proteomic analysis of the T. gondii apical complex, a cytoskeletal complex located at the apical end of the parasite that is composed of the conoid, three ring-like structures, and the two short intra-conoid microtubules. Here we report the characterization of one of the proteins identified in that analysis, TgICMAP1. We show that TgICMAP1 is a novel microtubule binding protein that can directly bind to microtubules in vitro and stabilizes microtubules when ectopically expressed in mammalian cells. Interestingly, in T. gondii, TgICMAP1 preferentially binds to the intra-conoid microtubules, providing us the first molecular tool to investigate the intra-conoid microtubule assembly process during daughter construction.			Heaslip, AT (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	kehu@indiana.edu		Heaslip, Aoife/0000-0002-7838-3617				Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Cerede O, 2005, J EXP MED, V201, P453, DOI 10.1084/jem.20041672; Desai A, 2001, METH MOL B, V164, P109; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hertzer KM, 2006, MOL BIOL CELL, V17, P700, DOI 10.1091/mbc.E05-08-0821; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Holland GN, 1999, AM J OPHTHALMOL, V128, P502, DOI 10.1016/S0002-9394(99)00263-9; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Hu K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040010; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Kessler H, 2008, J CELL SCI, V121, P947, DOI 10.1242/jcs.022350; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; LEVINE ND, 1988, J PROTOZOOL, V35, P518, DOI 10.1111/j.1550-7408.1988.tb04141.x; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mann T, 2002, J BIOL CHEM, V277, P41240, DOI 10.1074/jbc.M205056200; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; MITAL J, 2006, INVESTIGATING ROLE A, V1; Montoya JG, 1996, CLIN INFECT DIS, V23, P277, DOI 10.1093/clinids/23.2.277; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Morrissette NS, 2002, J CELL SCI, V115, P1017; Morrissette NS, 1997, J CELL SCI, V110, P35; NAGEL SD, 1988, MOL BIOCHEM PARASIT, V29, P261, DOI 10.1016/0166-6851(88)90081-3; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; PARK RS, 1984, J MORPHOL, V179, P13, DOI 10.1002/jmor.1051790103; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; SASSE R, 1988, J CELL SCI, V90, P577; Shaw MK, 2000, J CELL SCI, V113, P1241; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Umeshima H, 2007, P NATL ACAD SCI USA, V104, P16182, DOI 10.1073/pnas.0708047104; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; [No title captured]	54	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7406	10.1371/journal.pone.0007406	http://dx.doi.org/10.1371/journal.pone.0007406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823689	gold, Green Published, Green Submitted			2022-12-25	WOS:000270728500007
J	Lange, J; De Lussanet, M; Kuhlmann, S; Zimmermann, A; Lappe, M; Zwitserlood, P; Dobel, C				Lange, Joachim; De Lussanet, Marc; Kuhlmann, Simone; Zimmermann, Anja; Lappe, Markus; Zwitserlood, Pienie; Dobel, Christian			Impairments of Biological Motion Perception in Congenital Prosopagnosia	PLOS ONE			English	Article							FUSIFORM FACE AREA; DEVELOPMENTAL PROSOPAGNOSIA; SEPARATE FACE; IMPAIRED FACE; RECOGNITION; BODY; INVERSION; REPRESENTATION; SPECIFICITY; SELECTIVITY	Prosopagnosia is a deficit in recognizing people from their faces. Acquired prosopagnosia results after brain damage, developmental or congenital prosopagnosia (CP) is not caused by brain lesion, but has presumably been present from early childhood onwards. Since other sensory, perceptual, and cognitive abilities are largely spared, CP is considered to be a stimulus-specific deficit, limited to face processing. Given that recent behavioral and imaging studies indicate a close relationship of face and biological-motion perception in healthy adults, we hypothesized that biological motion processing should be impaired in CP. Five individuals with CP and ten matched healthy controls were tested with diverse biological-motion stimuli and tasks. Four of the CP individuals showed severe deficits in biological-motion processing, while one performed within the lower range of the controls. A discriminant analysis classified all participants correctly with a very high probability for each participant. These findings demonstrate that in CP, impaired perception of faces can be accompanied by impaired biological-motion perception. We discuss implications for dedicated and shared mechanisms involved in the perception of faces and biological motion.			Lange, J (corresponding author), Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany.	joachim.lange@med.uni-duesseldorf.de; cdobel@uni-muenster.de	de Lussanet, Marc H.E./H-2437-2013	de Lussanet, Marc H.E./0000-0003-3754-6675				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Barton JJS, 2004, BRAIN, V127, P1706, DOI 10.1093/brain/awh194; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Beintema JA, 2006, PERCEPT PSYCHOPHYS, V68, P613, DOI 10.3758/BF03208763; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; BERTENTHAL BI, 1987, J EXP PSYCHOL HUMAN, V13, P577, DOI 10.1037/0096-1523.13.4.577; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Bukach CM, 2006, TRENDS COGN SCI, V10, P159, DOI 10.1016/j.tics.2006.02.004; CUTTING JE, 1978, BEHAV RES METH INSTR, V10, P91, DOI 10.3758/BF03205105; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; de Gelder B, 2000, NEUROREPORT, V11, P3145, DOI 10.1097/00001756-200009280-00021; Dobel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002326; Dobel C, 2007, CORTEX, V43, P718, DOI 10.1016/S0010-9452(08)70501-X; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; FARAH MJ, 1990, J CLIN EXP NEUROPSYC, V12, P32; FAST K, 2008, FAMOUS FACES TEST FF; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hefter RL, 2005, NEUROLOGY, V65, P1620, DOI 10.1212/01.wnl.0000184498.16959.c0; Jellema T, 2003, J COGNITIVE NEUROSCI, V15, P961, DOI 10.1162/089892903770007353; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jones RD, 2001, J CLIN EXP NEUROPSYC, V23, P265, DOI 10.1076/jcen.23.3.265.1183; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kress T, 2003, NEUROSCI LETT, V352, P133, DOI 10.1016/j.neulet.2003.08.047; Lange J, 2006, J NEUROSCI, V26, P2894, DOI 10.1523/JNEUROSCI.4915-05.2006; Lange Joachim, 2008, Adv Cogn Psychol, V3, P419, DOI 10.2478/v10053-008-0006-3; LOBMAIER J, 2008, CONFIGURAL FEA UNPUB; Marotta JJ, 2002, COGN NEUROPSYCHOL, V19, P31, DOI 10.1080/02643290143000079; MARR D, 1982, PROC R SOC SER B-BIO, V214, P501, DOI 10.1098/rspb.1982.0024; MATHER G, 1992, P ROY SOC B-BIOL SCI, V249, P149, DOI 10.1098/rspb.1992.0097; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Nunn JA, 2001, NEUROCASE, V7, P15, DOI 10.1093/neucas/7.1.15; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Spiridon M, 2006, HUM BRAIN MAPP, V27, P77, DOI 10.1002/hbm.20169; Steeves JKE, 2006, NEUROPSYCHOLOGIA, V44, P594, DOI 10.1016/j.neuropsychologia.2005.06.013; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tarr MJ, 2003, TRENDS COGN SCI, V7, P23, DOI 10.1016/S1364-6613(02)00010-4; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Thomas SM, 2004, J EXP PSYCHOL HUMAN, V30, P873, DOI 10.1037/0096-1523.30.5.873; Thompson JC, 2008, TRENDS COGN SCI, V12, P283, DOI 10.1016/j.tics.2008.05.002; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Van den Stock J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003195; Warrington E, 1992, TESTBATTERIE VISUELL; WHITELEY AM, 1977, J NEUROL NEUROSUR PS, V40, P395, DOI 10.1136/jnnp.40.4.395; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2006, J COGNITIVE NEUROSCI, V18, P580, DOI 10.1162/jocn.2006.18.4.580; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	69	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7414	10.1371/journal.pone.0007414	http://dx.doi.org/10.1371/journal.pone.0007414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	505VX	19823580	Green Published, gold, Green Submitted			2022-12-25	WOS:000270728500013
J	van der Loo, E; Gais, S; Congedo, M; Vanneste, S; Plazier, M; Menovsky, T; Van de Heyning, P; De Ridder, D				van der Loo, Elsa; Gais, Steffen; Congedo, Marco; Vanneste, Sven; Plazier, Mark; Menovsky, Tomas; Van de Heyning, Paul; De Ridder, Dirk			Tinnitus Intensity Dependent Gamma Oscillations of the Contralateral Auditory Cortex	PLOS ONE			English	Article								Background: Non-pulsatile tinnitus is considered a subjective auditory phantom phenomenon present in 10 to 15% of the population. Tinnitus as a phantom phenomenon is related to hyperactivity and reorganization of the auditory cortex. Magnetoencephalography studies demonstrate a correlation between gamma band activity in the contralateral auditory cortex and the presence of tinnitus. The present study aims to investigate the relation between objective gamma-band activity in the contralateral auditory cortex and subjective tinnitus loudness scores. Methods and Findings: In unilateral tinnitus patients (N = 15; 10 right, 5 left) source analysis of resting state electroencephalographic gamma band oscillations shows a strong positive correlation with Visual Analogue Scale loudness scores in the contralateral auditory cortex (max r = 0.73, p<0.05). Conclusion: Auditory phantom percepts thus show similar sound level dependent activation of the contralateral auditory cortex as observed in normal audition. In view of recent consciousness models and tinnitus network models these results suggest tinnitus loudness is coded by gamma band activity in the contralateral auditory cortex but might not, by itself, be responsible for tinnitus perception.			van der Loo, E (corresponding author), Univ Antwerp Hosp, Brain Res Ctr Antwerp Innovat & Interdisciplinary, Antwerp, Belgium.	elsa.vanderloo@ua.ac.be	Heyning, Paul H Vande/I-8278-2017	Heyning, Paul H Vande/0000-0002-8424-3717; Vanneste, Sven/0000-0003-1513-5752				Andersson G, 2000, ACTA OTO-LARYNGOL, V120, P967, DOI 10.1080/00016480050218717; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Christmann C, 2007, NEUROIMAGE, V34, P1428, DOI 10.1016/j.neuroimage.2006.11.006; CONGEDO MFL, 2004, PERMUTATION MULTIPLE, P22; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2003, AURIS NASUS LARYNX, V30, pS7; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Gross J, 2007, PLOS BIOL, V5, P1168, DOI 10.1371/journal.pbio.0050133; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; Kovacs S, 2006, INVEST RADIOL, V41, P87, DOI 10.1097/01.rli.0000189637.42344.09; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lockwood AH, 1999, SCAND AUDIOL, V28, P47; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Moller AR, 2003, OTOLARYNGOL CLIN N A, V36, pv, DOI DOI 10.1016/S0030-6665(02)00170-6; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Mulert C, 2005, NEUROIMAGE, V28, P49, DOI 10.1016/j.neuroimage.2005.05.041; Nir RR, 2008, J PAIN, V9, P1058, DOI 10.1016/j.jpain.2008.06.008; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Talairach J., 1988, COPLANAR STEREOTAXIC; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007	42	188	189	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7396	10.1371/journal.pone.0007396	http://dx.doi.org/10.1371/journal.pone.0007396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816597	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594300013
J	Spalding, MD; Prigge, ST				Spalding, Maroya D.; Prigge, Sean T.			The Amidase Domain of Lipoamidase Specifically Inactivates Lipoylated Proteins In Vivo	PLOS ONE			English	Article								Background: In the 1950s, Reed and coworkers discovered an enzyme activity in Streptococcus faecalis ( Enterococcus faecalis) extracts that inactivated the Escherichia. coli and E. faecalis pyruvate dehydrogenase complexes through cleavage of the lipoamide bond. The enzyme that caused this lipoamidase activity remained unidentified until Jiang and Cronan discovered the gene encoding lipoamidase (Lpa) through the screening of an expression library. Subsequent cloning and characterization of the recombinant enzyme revealed that lipoamidase is an 80 kDa protein composed of an amidase domain containing a classic Ser-Ser-Lys catalytic triad and a carboxy-terminal domain of unknown function. Here, we show that the amidase domain can be used as an in vivo probe which specifically inactivates lipoylated enzymes. Methodology/Principal Findings: We evaluated whether Lpa could function as an inducible probe of alpha-ketoacid dehydrogenase inactivation using E. coli as a model system. Lpa expression resulted in cleavage of lipoic acid from the three lipoylated proteins expressed in E. coli, but did not result in cleavage of biotin from the sole biotinylated protein, the biotin carboxyl carrier protein. When expressed in lipoylation deficient E. coli, Lpa is not toxic, indicating that Lpa does not interfere with any other critical metabolic pathways. When truncated to the amidase domain, Lpa retained lipoamidase activity without acquiring biotinidase activity, indicating that the carboxy-terminal domain is not essential for substrate recognition or function. Substitution of any of the three catalytic triad amino acids with alanine produced inactive Lpa proteins. Conclusions/Significance: The enzyme lipoamidase is active against a broad range of lipoylated proteins in vivo, but does not affect the growth of lipoylation deficient E. coli. Lpa can be truncated to 60% of its original size with only a partial loss of activity, resulting in a smaller probe that can be used to study the effects of alpha-ketoacid dehydrogenase inactivation in vivo.			Spalding, MD (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	sprigge@jhsph.edu	Prigge, Sean/GVS-9197-2022	Prigge, Sean/0000-0001-9684-1733	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065853] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI065853-04, R01 AI065853] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allary M, 2007, MOL MICROBIOL, V63, P1331, DOI 10.1111/j.1365-2958.2007.05592.x; BERMAN JN, 1981, BIOCHEM J, V199, P513, DOI 10.1042/bj1990513; Cassey B, 1998, FEMS MICROBIOL LETT, V159, P325; Davis R., 1980, ADV BACTERIAL GENETI; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Fujiwara K, 1996, J BIOL CHEM, V271, P12932, DOI 10.1074/jbc.271.22.12932; FUJIWARA K, 1986, J BIOL CHEM, V261, P8836; Gong XM, 2000, J BIOL CHEM, V275, P13645, DOI 10.1074/jbc.275.18.13645; HACKERT ML, 1983, P NATL ACAD SCI-BIOL, V80, P2907, DOI 10.1073/pnas.80.10.2907; HERBERT AA, 1975, ARCH MICROBIOL, V106, P259, DOI 10.1007/BF00446532; Jiang YF, 2005, J BIOL CHEM, V280, P2244, DOI 10.1074/jbc.M408612200; KOIKE M, 1960, J BIOL CHEM, V235, P1924; Lack G, 2006, J BIOL CHEM, V281, P9538, DOI 10.1074/jbc.M509119200; LI SJ, 1993, J BACTERIOL, V175, P332, DOI 10.1128/JB.175.2.332-340.1993; LIU SJ, 1995, J BIOL CHEM, V270, P793, DOI 10.1074/jbc.270.2.793; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Muench SP, 2003, ACTA CRYSTALLOGR D, V59, P1246, DOI 10.1107/S0907444903008813; NAWA H, 1960, J AM CHEM SOC, V82, P896, DOI 10.1021/ja01489a033; Neuburger M, 2000, EUR J BIOCHEM, V267, P2882, DOI 10.1046/j.1432-1327.2000.01301.x; OKANE DJ, 1948, J BACTERIOL, V56, P499, DOI 10.1128/JB.56.4.499-506.1948; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Polyak SW, 2001, J BIOL CHEM, V276, P3037, DOI 10.1074/jbc.M003968200; Prigge ST, 2003, BIOCHEMISTRY-US, V42, P1160, DOI 10.1021/bi026847k; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; Reche P, 1998, BIOCHEM J, V329, P589, DOI 10.1042/bj3290589; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; REED LJ, 1958, J BIOL CHEM, V232, P143; REED LJ, 1990, J BIOL CHEM, V265, P8971; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Roberts EL, 1999, BIOCHEMISTRY-US, V38, P5045, DOI 10.1021/bi982466o; STEPP LR, 1981, BIOCHEMISTRY-US, V20, P4555, DOI 10.1021/bi00519a007; SUZUKI K, 1963, J BIOL CHEM, V238, P4021; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	33	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7392	10.1371/journal.pone.0007392	http://dx.doi.org/10.1371/journal.pone.0007392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812687	Green Submitted, Green Published, gold			2022-12-25	WOS:000270594200013
J	Lehours, P; Zheng, ZL; Skoglund, A; Megraud, F; Engstrand, L				Lehours, Philippe; Zheng, Zongli; Skoglund, Anna; Megraud, Francis; Engstrand, Lars			Is There a Link between the Lipopolysaccharide of Helicobacter pylori Gastric MALT Lymphoma Associated Strains and Lymphoma Pathogenesis?	PLOS ONE			English	Article								The aim of this study was to investigate the Lewis antigen expression in Helicobacter pylori gastric MALT lymphoma associated strains in comparison to chronic gastritis only strains. Forty MALT strains (19 cagPAI (-) and 21 cagPAI (+)) and 39 cagPAI frequency-matched gastritis strains (17 cagPAI (-) and 22 cagPAI (+)) were included in this study. The lipopolyssacharide for each strain was extracted using a hot phenol method and the expression of Le(x) and Le(y) were investigated using Western Blot. The data were analyzed according to the strains' cagPAI status and vacA genotype. Le(x) was identified in 21 (52.5%) MALT strains and 29 (74.3%) gastritis strains. Le(y) was identified in 30 (75%) MALT strains and 31 (79.5%) gastritis strains. There was an association between cagPAI positivity and Le(x) expression among MALT strains (p<0.0001), but not in gastritis strains (p = 0.64). Among cagPAI (-) strains, isolates expressing solely Le(y) were associated with MALT with an odds ratio of 64.2 (95% CI 4.9-841.0) when compared to strains expressing both Le(x) and Le(y). vacA genotypes did not modify the association between Lewis antigen expression and disease status. In conclusion, cagPAI (-) MALT strains have a particular Lewis antigen profile which could represent an adaptive mechanism to the host response or participate in MALT lymphomagenesis.			Lehours, P (corresponding author), INSERM, U853, Bordeaux, France.	philippe.lehours@labhel.u-bordeaux2.fr	zheng, zongli/B-2917-2011; zheng, zongli/C-7309-2008; Lehours, Philippe/I-2780-2014	zheng, zongli/0000-0003-4849-4903; 				[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Aro P, 2004, SCAND J GASTROENTERO, V39, P1280, DOI 10.1080/00365520410008141; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Broutet N, 2002, J INFECT DIS, V185, P503, DOI 10.1086/339016; D'Elios MM, 1999, GASTROENTEROLOGY, V117, P1105, DOI 10.1016/S0016-5085(99)70395-1; DElios MM, 1997, J IMMUNOL, V158, P962; Ferreira-Chagas B, 2007, HELICOBACTER, V12, P616, DOI 10.1111/j.1523-5378.2007.00546.x; Ferreri AJM, 2009, J INTERN MED, V265, P421, DOI 10.1111/j.1365-2796.2009.02083.x; Fukui T, 2004, LAB INVEST, V84, P485, DOI 10.1038/labinvest.3700056; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Gonzalez-Valencia G, 2008, J CLIN MICROBIOL, V46, P2783, DOI 10.1128/JCM.02370-07; Greiner A, 1997, AM J PATHOL, V150, P1583; Heneghan MA, 2000, INFECT IMMUN, V68, P937, DOI 10.1128/IAI.68.2.937-941.2000; HUSSELL T, 1993, LANCET, V342, P571, DOI 10.1016/0140-6736(93)91408-E; Hynes SO, 2000, FEMS MICROBIOL LETT, V190, P67, DOI 10.1016/S0378-1097(00)00323-2; KOBAYASHI K, 1993, AM J GASTROENTEROL, V88, P919; Koehler CI, 2003, J CLIN PATHOL-MOL PA, V56, P36, DOI 10.1136/mp.56.1.36; Lehours P, 2005, Rocz Akad Med Bialymst, V50, P54; Lehours P, 2004, GUT, V53, P931, DOI 10.1136/gut.2003.028811; Lehours P, 2004, INFECT IMMUN, V72, P880, DOI 10.1128/IAI.72.2.880-888.2004; Marshall DG, 1999, FEMS IMMUNOL MED MIC, V24, P79, DOI 10.1111/j.1574-695X.1999.tb01268.x; Monteiro MA, 1998, J BIOL CHEM, V273, P11533, DOI 10.1074/jbc.273.19.11533; Moran AP, 2008, CARBOHYD RES, V343, P1952, DOI 10.1016/j.carres.2007.12.012; Moran AP, 1999, J PHYSIOL PHARMACOL, V50, P787; Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699; Nilsson C, 2006, P NATL ACAD SCI USA, V103, P2863, DOI 10.1073/pnas.0511119103; Nilsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003811; O'Rourke JL, 2008, J GASTROEN HEPATOL, V23, pS151, DOI 10.1111/j.1440-1746.2008.05553.x; Rescigno M, 2008, CURR OPIN IMMUNOL, V20, P669, DOI 10.1016/j.coi.2008.09.007; Skoglund A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005885; Suarez F, 2006, BLOOD, V107, P3034, DOI 10.1182/blood-2005-09-3679; Vandenbroucke-Grauls CMJE, 1998, ITAL J GASTROENTEROL, V30, pS259; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; Wirth HP, 1996, INFECT IMMUN, V64, P4598, DOI 10.1128/IAI.64.11.4598-4605.1996	36	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7297	10.1371/journal.pone.0007297	http://dx.doi.org/10.1371/journal.pone.0007297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806222	Green Submitted, gold, Green Published			2022-12-25	WOS:000270593800010
J	Sullivan, JC; Wolenski, FS; Reitzel, AM; French, CE; Traylor-Knowles, N; Gilmore, TD; Finnerty, JR				Sullivan, James C.; Wolenski, Francis S.; Reitzel, Adam M.; French, Courtney E.; Traylor-Knowles, Nikki; Gilmore, Thomas D.; Finnerty, John R.			Two Alleles of NF-kappa B in the Sea Anemone Nematostella vectensis Are Widely Dispersed in Nature and Encode Proteins with Distinct Activities	PLOS ONE			English	Article								Background: NF-kappa B is an evolutionarily conserved transcription factor that controls the expression of genes involved in many key organismal processes, including innate immunity, development, and stress responses. NF-kappa B proteins contain a highly conserved DNA-binding/dimerization domain called the Rel homology domain. Methods/Principal Findings: We characterized two NF-kappa B alleles in the sea anemone Nematostella vectensis that differ at nineteen single-nucleotide polymorphisms (SNPs). Ten of these SNPs result in amino acid substitutions, including six within the Rel homology domain. Both alleles are found in natural populations of Nematostella. The relative abundance of the two NF-kappa B alleles differs between populations, and departures from Hardy-Weinberg equilibrium within populations indicate that the locus may be under selection. The proteins encoded by the two Nv-NF-kappa B alleles have different molecular properties, in part due to a Cys/Ser polymorphism at residue 67, which resides within the DNA recognition loop. In nearly all previously characterized NF-kappa B proteins, the analogous residue is fixed for Cys, and conversion of human RHD proteins from Cys to Ser at this site has been shown to increase DNA-binding ability and increase resistance to inhibition by thiol-reactive compounds. However, the naturally-occurring Nematostella variant with Cys at position 67 binds DNA with a higher affinity than the Ser variant. On the other hand, the Ser variant activates transcription in reporter gene assays more effectively, and it is more resistant to inhibition by a thiol-reactive compound. Reciprocal Cys <-> Ser mutations at residue 67 of the native Nv-NF-kappa B proteins affect DNA binding as in human NF-kappa B proteins, e. g., a Cys-> Ser mutation increases DNA binding of the native Cys variant. Conclusions/Significance: These results are the first demonstration of a naturally occurring and functionally significant polymorphism in NF-kappa B in any species. The functional differences between these alleles and their uneven distribution in the wild suggest that different genotypes could be favored in different environments, perhaps environments that vary in their levels of peroxides or thiol-reactive compounds.			Sullivan, JC (corresponding author), Vertex Pharmaceut, Cambridge, MA USA.	jrf3@bu.edu	Finnerty, John R/B-6564-2011; Reitzel, Adam M/A-9129-2017; Traylor-Knowles, Nikki G/D-4354-2012	Reitzel, Adam M/0000-0001-5734-7118; 	NATIONAL CANCER INSTITUTE [R01CA047763, R29CA047763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0924749] Funding Source: National Science Foundation; NCI NIH HHS [CA047763, R01 CA047763] Funding Source: Medline; NIEHS NIH HHS [P42 ES007381, 5 P42 ES07381] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AbeleOeschger D, 1997, COMP BIOCHEM PHYS C, V117, P123, DOI 10.1016/S0742-8413(97)00059-5; ABELEOESCHGER D, 1995, DTSCH XOOL GES, V88, P93; Brennan P, 1996, BIOCHEM J, V320, P975, DOI 10.1042/bj3200975; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Darling JA, 2004, MOL ECOL, V13, P2969, DOI 10.1111/j.1365-294X.2004.02313.x; Dryden CL, 2007, MAR CHEM, V103, P276, DOI 10.1016/j.marchem.2006.09.003; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; *EMBL, EBI AL SEQ US CLUSTA; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gauthier M, 2008, DEV GENES EVOL, V218, P23, DOI 10.1007/s00427-007-0197-5; *GEOSP, 2006, FINCHTV 1 4 0; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Glineur C, 2000, BIOCHEM J, V352, P583, DOI 10.1042/0264-6021:3520583; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huguet C, 1997, ONCOGENE, V15, P2965, DOI 10.1038/sj.onc.1201471; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kashuk CS, 2005, P NATL ACAD SCI USA, V102, P8949, DOI 10.1073/pnas.0503259102; KUMAR S, 1992, MOL CELL BIOL, V12, P3094, DOI 10.1128/MCB.12.7.3094; Leeman JR, 2008, ONCOGENE, V27, P6770, DOI 10.1038/onc.2008.284; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Liang MC, 2006, CANCER LETT, V241, P69, DOI 10.1016/j.canlet.2005.10.004; MATTHEWS JR, 1993, NUCLEIC ACIDS RES, V21, P1727, DOI 10.1093/nar/21.8.1727; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MEYER E, 2009, ACROPORA MILLEPORA P; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pearson CVM, 2002, MOL ECOL, V11, P2285, DOI 10.1046/j.1365-294X.2002.01621.x; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel AM, 2008, BIOL INVASIONS, V10, P1197, DOI 10.1007/s10530-007-9196-8; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Sullivan JC, 2007, DEV GENES EVOL, V217, P63, DOI 10.1007/s00427-006-0111-6	39	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7311	10.1371/journal.pone.0007311	http://dx.doi.org/10.1371/journal.pone.0007311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806194	Green Submitted, Green Published, gold			2022-12-25	WOS:000270593800018
J	Ducret, A; Maisonneuve, E; Notareschi, P; Grossi, A; Mignot, T; Dukan, S				Ducret, Adrien; Maisonneuve, Etienne; Notareschi, Philippe; Grossi, Alain; Mignot, Tam; Dukan, Sam			A Microscope Automated Fluidic System to Study Bacterial Processes in Real Time	PLOS ONE			English	Article							ESCHERICHIA-COLI; MYXOCOCCUS-XANTHUS; GLIDING MOTILITY; OXIDATIVE DAMAGE; GENE-EXPRESSION; STRESS DEFENSE; FLOW-CYTOMETRY; CELL; PROTEIN; INDUCTION	Most time lapse microscopy experiments studying bacterial processes ie growth, progression through the cell cycle and motility have been performed on thin nutrient agar pads. An important limitation of this approach is that dynamic perturbations of the experimental conditions cannot be easily performed. In eukaryotic cell biology, fluidic approaches have been largely used to study the impact of rapid environmental perturbations on live cells and in real time. However, all these approaches are not easily applicable to bacterial cells because the substrata are in all cases specific and also because microfluidics nanotechnology requires a complex lithography for the study of micrometer sized bacterial cells. In fact, in many cases agar is the experimental solid substratum on which bacteria can move or even grow. For these reasons, we designed a novel hybrid micro fluidic device that combines a thin agar pad and a custom flow chamber. By studying several examples, we show that this system allows real time analysis of a broad array of biological processes such as growth, development and motility. Thus, the flow chamber system will be an essential tool to study any process that take place on an agar surface at the single cell level.			Ducret, A (corresponding author), Aix Marseille Univ, Chim Bacterienne Lab, UPR 9043, Inst Microbiol Mediterrane,CNRS,IFR 88, 31 Chemin Joseph Aiguier, Marseille, France.	tmignot@ifr88.cnrs-mrs.fr; sdukan@ifr88.cnrs-mrs.fr		Mignot, Tam/0000-0003-4338-9063; maisonneuve, Etienne/0000-0003-3451-1223				Allegra S, 2008, APPL ENVIRON MICROB, V74, P7813, DOI 10.1128/AEM.01364-08; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bodvarsson B, 2008, IMAGE VISION COMPUT, V26, P1073, DOI 10.1016/j.imavis.2007.11.008; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Bustamante VH, 2004, MOL MICROBIOL, V53, P1501, DOI 10.1111/j.1365-2958.2004.04221.x; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Chung BG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-60; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; Cuny C, 2005, J BACTERIOL, V187, P2244, DOI 10.1128/JB.187.7.2244-2248.2005; Desnues B, 2003, EMBO REP, V4, P400, DOI 10.1038/sj.embor.embor799; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Huang SS, 2007, J BACTERIOL, V189, P4681, DOI 10.1128/JB.00282-07; Jaffe JD, 2004, J BACTERIOL, V186, P4254, DOI 10.1128/JB.186.13.4254-4261.2004; JEON H, 2009, BIOMED MICRODEVICES; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Lee HJ, 2003, APPL MICROBIOL BIOT, V60, P577, DOI 10.1007/s00253-002-1168-4; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Massey RC, 2001, CURR BIOL, V11, P1810, DOI 10.1016/S0960-9822(01)00507-3; MCBRIDE MJ, 1992, J BACTERIOL, V174, P4246, DOI 10.1128/JB.174.13.4246-4257.1992; Nystrom T, 2003, CELL MOL LIFE SCI, V60, P1333, DOI 10.1007/s00018-003-2310-X; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9; SETHI IK, 1987, T PATTERN ANAL MACHI, V9; Shapiro Howard M., 2008, V142, P175, DOI 10.1007/978-1-59745-246-5_14; Sliusarenko O, 2007, J BACTERIOL, V189, P611, DOI 10.1128/JB.01206-06; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; SPORMANN AM, 1995, J BACTERIOL, V177, P5846, DOI 10.1128/jb.177.20.5846-5852.1995; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; VEENMAN CJ, 1998, FAST ROBUST POINT TR; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Xu J, 2008, LETT APPL MICROBIOL, V47, P174, DOI 10.1111/j.1472-765X.2008.02407.x; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	46	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7282	10.1371/journal.pone.0007282	http://dx.doi.org/10.1371/journal.pone.0007282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789641	Green Published, gold, Green Submitted			2022-12-25	WOS:000270354100028
J	King, FW; Fong, S; Griffin, C; Shoemaker, M; Staub, R; Zhang, YL; Cohen, I; Shtivelman, E				King, Frank W.; Fong, Sylvia; Griffin, Chandi; Shoemaker, Mark; Staub, Rick; Zhang, Yan-Ling; Cohen, Isaac; Shtivelman, Emma			Timosaponin AIII Is Preferentially Cytotoxic to Tumor Cells through Inhibition of mTOR and Induction of ER Stress	PLOS ONE			English	Article								The aqueous extract of Anemarrhena asphodeloides (BN108) induces apoptosis in various cancer cell lines but is significantly less cytotoxic in non-transformed cells. Chemical fractionation of BN108 showed that its cytotoxicity is associated with timosaponins, steroidal saponins of coprostane type. Timosaponin BII (TBII) is a major saponin in BN108, but it shows little cytotoxicity. A much less abundant TAIII induces cell death in tumor cells but not in normal cells, reproducing the selectivity of the total extract BN108. Glycosidase treatment, by removing the extra sugar moiety in TBII, converts it to TAIII and confers cytotoxic activity. Analysis of the mechanisms of death induced by TAIII revealed activation of two distinct pro-apoptotic pathways: first, inhibition of mTORC1 manifested in much reduced phosphorylation of mTORC1 targets; second, induction of endoplasmic reticulum stress culminating in phosphorylation of eIF2 alpha and activation of caspase 4. These pro-apoptotic pathways are activated by TAIII selectively in tumor cells but not in normal cells. Both pathways play a causative role in TAIII cytotoxicity, as restoration of either mTOR activity or relief of ER stress alone offer only partial protection from TAIII. Inhibition of mTORC1 and induction of ER stress apparently contribute to the induction of the previously reported autophagic response in TAIII-treated cells. TAIII induced autophagy plays a protective role in TAIII induced death signaling, and failure to mount autophagic response is associated with heightened sensitivity to TAIII induced apoptosis. The multiple death-promoting and apparently tumor-selective responses to TAIII, its ability to inhibit mTORC1, and the possibility of further enhancing its cytotoxicity by pharmacological inhibition of autophagy, make TAIII an attractive candidate for development as a cancer therapeutic agent.	[King, Frank W.; Fong, Sylvia; Griffin, Chandi; Shoemaker, Mark; Staub, Rick; Zhang, Yan-Ling; Cohen, Isaac; Shtivelman, Emma] BioNovo Inc, Emeryville, CA USA		King, FW (corresponding author), BioNovo Inc, Emeryville, CA USA.	emmas@bionovo.com		Fong, Sylvia/0000-0002-3818-4146				Audas TE, 2008, MOL CELL BIOL, V28, P3952, DOI 10.1128/MCB.01439-07; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; KAWASAKI T, 1963, Chem Pharm Bull (Tokyo), V11, P1221; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; KOVACS WJ, 2008, J BIOL CHEM; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; SAITO S, 1994, CHEM PHARM BULL, V42, P2342, DOI 10.1248/cpb.42.2342; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shoemaker M, 2005, PHYTOTHER RES, V19, P649, DOI 10.1002/ptr.1702; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Zhang JY, 1999, CLIN CHIM ACTA, V289, P79, DOI 10.1016/S0009-8981(99)00160-6	43	63	70	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7283	10.1371/journal.pone.0007283	http://dx.doi.org/10.1371/journal.pone.0007283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789631	gold, Green Submitted, Green Published			2022-12-25	WOS:000270354100029
J	Schmitt-Ulms, G; Ehsani, S; Watts, JC; Westaway, D; Wille, H				Schmitt-Ulms, Gerold; Ehsani, Sepehr; Watts, Joel C.; Westaway, David; Wille, Holger			Evolutionary Descent of Prion Genes from the ZIP Family of Metal Ion Transporters	PLOS ONE			English	Article							SEQUENCE ALIGNMENTS; MASS-SPECTROMETRY; PROTEIN FUNCTION; TRANSGENIC MICE; COPPER-BINDING; CELL-ADHESION; ZINC; IDENTIFICATION; EXPRESSION; DOPPEL	In the more than twenty years since its discovery, both the phylogenetic origin and cellular function of the prion protein (PrP) have remained enigmatic. Insights into a possible function of PrP may be obtained through the characterization of its molecular neighborhood in cells. Quantitative interactome data demonstrated the spatial proximity of two metal ion transporters of the ZIP family, ZIP6 and ZIP10, to mammalian prion proteins in vivo. A subsequent bioinformatic analysis revealed the unexpected presence of a PrP-like amino acid sequence within the N-terminal, extracellular domain of a distinct sub-branch of the ZIP protein family that includes ZIP5, ZIP6 and ZIP10. Additional structural threading and orthologous sequence alignment analyses argued that the prion gene family is phylogenetically derived from a ZIP-like ancestral molecule. The level of sequence homology and the presence of prion protein genes in most chordate species place the split from the ZIP-like ancestor gene at the base of the chordate lineage. This relationship explains structural and functional features found within mammalian prion proteins as elements of an ancient involvement in the transmembrane transport of divalent cations. The phylogenetic and spatial connection to ZIP proteins is expected to open new avenues of research to elucidate the biology of the prion protein in health and disease.			Schmitt-Ulms, G (corresponding author), Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	g.schmittulms@utoronto.ca	Ehsani, Sepehr/E-9257-2010; Wille, Holger/C-2280-2008	Ehsani, Sepehr/0000-0002-9613-6898; Wille, Holger/0000-0001-5102-8706; Watts, Joel/0000-0002-2604-2925	NATIONAL INSTITUTE ON AGING [P01AG002132, P01AG010770] Funding Source: NIH RePORTER; NIA NIH HHS [AG02132, AG10770, P01 AG010770, P01 AG002132] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Angst BD, 2001, J CELL SCI, V114, P629; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Baldwin MA, 2005, METHOD ENZYMOL, V405, P172, DOI 10.1016/S0076-6879(05)05008-1; BELL LM, 1994, J BIOL CHEM, V269, P22758; Brown DR, 2009, DALTON T, P4069, DOI 10.1039/b822135a; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Camponeschi F, 2009, DALTON T, P4643, DOI 10.1039/b907626n; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chalkley RJ, 2005, MOL CELL PROTEOMICS, V4, P1194, DOI 10.1074/mcp.D500002-MCP200; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Date Shailesh V., 2007, V408, P109, DOI 10.1007/978-1-59745-547-3_7; Davies P, 2008, BIOCHEM J, V410, P237, DOI 10.1042/BJ20071477; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; KAMBE T, 2008, MOL CELL BIOL; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kenward AG, 2007, BIOCHEMISTRY-US, V46, P4261, DOI 10.1021/bi602473r; Kornegay JR, 1996, J MOL EVOL, V42, P676, DOI 10.1007/BF02338801; KRAUT J, 1971, COLD SPRING HARB SYM, V36, P117, DOI 10.1101/SQB.1972.036.01.017; LANIER LL, 1989, SCIENCE, V246, P1611, DOI 10.1126/science.2531919; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee IY, 1998, GENOME RES, V8, P1022, DOI 10.1101/gr.8.10.1022; Li GQ, 2004, BRIEF BIOINFORM, V5, P378, DOI 10.1093/bib/5.4.378; LICHTEN LA, 2009, ANN REV NUTR; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Naghibalhossaini F, 2004, J CELL SCI, V117, P761, DOI 10.1242/jcs.00903; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Premzl M, 2004, MOL BIOL EVOL, V21, P2210, DOI 10.1093/molbev/msh245; Prusiner SB, 1998, P NATL ACAD SCI USA, V117, P421; Qin KF, 2009, J BIOL CHEM, V284, P4582, DOI 10.1074/jbc.M808410200; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Rachidi W, 2009, J TRACE ELEM MED BIO, V23, P214, DOI 10.1016/j.jtemb.2009.02.007; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rivera-Milla E, 2003, TRENDS GENET, V19, P72, DOI 10.1016/S0168-9525(02)00032-X; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Rojas M, 1996, CELL GROWTH DIFFER, V7, P655; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sadreyev RI, 2008, NUCLEIC ACIDS RES, V36, P2240, DOI 10.1093/nar/gkn065; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Silverman GL, 2000, J BIOL CHEM, V275, P26834; Sprenger J, 2008, NUCLEIC ACIDS RES, V36, pD230, DOI 10.1093/nar/gkm950; Szyrwiel L, 2008, DALTON T, P6117, DOI 10.1039/b811224j; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Telling GC, 1997, PROTEIN SCI, V6, P825; Walter ED, 2007, J AM CHEM SOC, V129, P15440, DOI 10.1021/ja077146j; Watt NT, 2003, TRENDS BIOCHEM SCI, V28, P406, DOI 10.1016/S0968-0004(03)00166-X; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	65	97	99	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7208	10.1371/journal.pone.0007208	http://dx.doi.org/10.1371/journal.pone.0007208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784368	Green Published, gold, Green Submitted			2022-12-25	WOS:000270290000014
J	Roussel, X; Kriznik, A; Richard, C; Rahuel-Clermont, S; Branlant, G				Roussel, Xavier; Kriznik, Alexandre; Richard, Christelle; Rahuel-Clermont, Sophie; Branlant, Guy			Catalytic Mechanism of Sulfiredoxin from Saccharomyces cerevisiae Passes through an Oxidized Disulfide Sulfiredoxin Intermediate That Is Reduced by Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; ESCHERICHIA-COLI; THIOSULFINATE INTERMEDIATE; MAMMALIAN SULFIREDOXIN; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; THIOL PEROXIDASE; ACTIVE-SITE; REDUCTION; OXIDATION	Sulfiredoxin catalyzes the ATP-dependent reduction of over-oxidized eukaryotic 2-Cys peroxiredoxin PrxSO(2) into sulfenic PrxSOH. Recent mechanistic studies on sulfiredoxins have validated a catalytic mechanism that includes formation of a phosphoryl intermediate on the sulfinyl moiety of PrxSO(2), followed by an attack of the catalytic cysteine of sulfiredoxin on the phosphoryl intermediate that leads to formation of a thiosulfinate intermediate PrxSO-S-sulfiredoxin. Formation of this intermediate implies the recycling of sulfiredoxin into the reduced form. In this study, we have investigated how the reductase activity of the Saccharomyces cerevisiae sulfiredoxin is regenerated. The results show that an oxidized sulfiredoxin under disulfide state is formed between the catalytic Cys(84) and Cys(48). This oxidized sulfiredoxin species is shown to be catalytically competent along the sulfiredoxin-recycling process and is reduced selectively by thioredoxin. The lack of Cys(48) in the mammalian sulfiredoxins and the low efficiency of reduction of the thiosulfinate intermediate by thioredoxin suggest a recycling mechanism in mammals different from that of sulfiredoxin from Saccharomyces cerevisiae.	[Roussel, Xavier; Kriznik, Alexandre; Richard, Christelle; Rahuel-Clermont, Sophie; Branlant, Guy] Nancy Univ, Fac Sci & Tech, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Unite Mixte Rech CNRS UHP AREMS 7214, F-54506 Vandoeuvre Les Nancy, France	Universite de Lorraine	Rahuel-Clermont, S (corresponding author), Nancy Univ, Fac Sci & Tech, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Unite Mixte Rech CNRS UHP AREMS 7214, Blvd Aiguillettes,BP 70239, F-54506 Vandoeuvre Les Nancy, France.	sophie.rahuel@maem.uhp-nancy.fr	Kriznik, Alexandre/S-1523-2019; Rahuel-Clermont, Sophie/AAB-3451-2020	Kriznik, Alexandre/0000-0003-2627-8273; Rahuel-Clermont, Sophie/0000-0001-5143-0105; Roussel, Xavier/0000-0003-2923-4559	CNRS; University of Nancy I; Institut Fe de ratif de Recherche 111 Bioingenierie; French Agence Nationale de la Recherche Program [ANR-06-BLAN-0369]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Nancy I; Institut Fe de ratif de Recherche 111 Bioingenierie; French Agence Nationale de la Recherche Program(French National Research Agency (ANR))	This work was supported in part by the CNRS, the University of Nancy I, the Institut Fe de ratif de Recherche 111 Bioingenierie, and by the French Agence Nationale de la Recherche Program ANR-06-BLAN-0369.; Supported by the French Research Ministry.	Aran M, 2008, FEBS J, V275, P1450, DOI 10.1111/j.1742-4658.2008.06299.x; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BITEAU B, 2005, THESIS U PARIS SUD F; Bondareva AA, 2007, FREE RADICAL BIO MED, V43, P911, DOI 10.1016/j.freeradbiomed.2007.05.026; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Kong W, 2000, BIOCHEM J, V351, P107, DOI 10.1042/0264-6021:3510107; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mulrooney SB, 1997, PROTEIN SCI, V6, P2188; Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Seo JH, 2009, J BIOL CHEM, V284, P13455, DOI 10.1074/jbc.M900641200; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Woo HA, 2009, ANTIOXID REDOX SIGN, V11, P739, DOI 10.1089/ARS.2008.2360; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	25	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33048	33055		10.1074/jbc.M109.035352	http://dx.doi.org/10.1074/jbc.M109.035352			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801666	hybrid, Green Published			2022-12-25	WOS:000272028500007
J	Saberwal, G; Horvath, E; Hu, LP; Zhu, CL; Hjort, E; Eklund, EA				Saberwal, Gurveen; Horvath, Elizabeth; Hu, Liping; Zhu, Chunliu; Hjort, Elizabeth; Eklund, Elizabeth A.			The Interferon Consensus Sequence Binding Protein (ICSBP/IRF8) Activates Transcription of the FANCF Gene during Myeloid Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE; GP91(PHOX) EXPRESSION; LEUKEMIA; CELLS; PU.1; ANEMIA; DNA; P67(PHOX); COOPERATE; APOPTOSIS	The interferon consensus sequence binding protein ( ICSBP) is an interferon regulatory transcription factor with leukemia-suppressor activity. ICSBP regulates genes that are involved in phagocyte function, proliferation, and apoptosis. In murine models ICSBP deficiency results in a myeloproliferative disorder (MPD) with increased mature neutrophils. Over time this MPD progresses to acute myeloid leukemia (AML), suggesting that ICSBP deficiency is adequate for MPD, but additional genetic lesions are required for AML. The hypothesis of these studies is that dysregulation of key target genes predisposes to disease progression under conditions of decreased ICSBP expression. To investigate this hypothesis, we used chromatin co-immunoprecipitation to identify genes involved the ICSBP-leukemia suppressor effect. In the current studies, we identify the gene encoding Fanconi F (FANCF) as an ICSBP target gene. FancF participates in a repair of cross-linked DNA. We identify a FANCF promoter cis element, which is activated by ICSBP in differentiating myeloid cells. We also determine that DNA cross-link repair is impaired in ICSBP-deficient myeloid cells in a FancF-dependent manner. This effect is observed in differentiating cells, suggesting that ICSBP protects against the genotoxic stress of myelopoiesis. Decreased ICSBP expression is found in human AML and chronic myeloid leukemia during blast crisis (CML-BC). Our studies suggest that ICSBP deficiency may be functionally important for accumulation of chromosomal abnormalities during disease progression in these myeloid malignancies.	[Saberwal, Gurveen; Horvath, Elizabeth; Hu, Liping; Zhu, Chunliu; Hjort, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Saberwal, Gurveen; Horvath, Elizabeth; Hu, Liping; Zhu, Chunliu; Hjort, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Horvath, Elizabeth; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu			National Institutes of Health [R01 HL 088747]; Veterans Affairs Merit Review; Leukemia and Lymphoma Society Translational Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Leukemia and Lymphoma Society Translational Research Award(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL 088747 ( to E. A. E.). This work was also supported by a Veterans Affairs Merit Review and a Leukemia and Lymphoma Society Translational Research Award ( to E. A. E.).	Ahn B, 2004, MOL CELLS, V18, P249; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donahue SL, 2002, J BIOL CHEM, V277, P46243, DOI 10.1074/jbc.M207937200; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Huang WQ, 2007, J BIOL CHEM, V282, P6629, DOI 10.1074/jbc.M607760200; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Kautz B, 2001, J BIOL CHEM, V276, P37868; Kim KM, 2000, EXP MOL MED, V32, P246, DOI 10.1038/emm.2000.41; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; LARRICK JW, 1980, J IMMUNOL, V125, P6; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SARAS J, 1994, J BIOL CHEM, V269, P24082; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schmidt M, 2004, BLOOD, V103, P4142, DOI 10.1182/blood-2003-01-0285; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; *U MICH, ONC RES ADD; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Xie Y, 2000, BRIT J HAEMATOL, V111, P1057, DOI 10.1111/j.1365-2141.2000.02450.x; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Yaneva M, 2006, J IMMUNOL, V176, P6906, DOI 10.4049/jimmunol.176.11.6906; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	34	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33242	33254		10.1074/jbc.M109.010231	http://dx.doi.org/10.1074/jbc.M109.010231			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801548	Green Published, hybrid			2022-12-25	WOS:000272028500029
J	Reubold, TF; Wohlgemuth, S; Eschenburg, S				Reubold, Thomas F.; Wohlgemuth, Sabine; Eschenburg, Susanne			A New Model for the Transition of APAF-1 from Inactive Monomer to Caspase-activating Apoptosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE-EXTRACTS; CYTOCHROME-C; PROCASPASE-9 ACTIVATION; NUCLEOTIDE EXCHANGE; APOPTOTIC PROGRAM; DEATH; DATP; HYDROLYSIS; LIFE; OLIGOMERIZATION	The cytosolic adaptor protein Apaf-1 is a key player in the intrinsic pathway of apoptosis. Binding of mitochondrially released cytochrome c and of dATP or ATP to Apaf-1 induces the formation of the heptameric apoptosome complex, which in turn activates procaspase-9. We have re-investigated the chain of events leading from monomeric autoinhibited Apaf-1 to the functional apoptosome in vitro. We demonstrate that Apaf-1 does not require energy from nucleotide hydrolysis to eventually form the apoptosome. Despite a low intrinsic hydrolytic activity of the autoinhibited Apaf-1 monomer, nucleotide hydrolysis does not occur at any stage of the process. Rather, mere binding of ATP in concert with the binding of cytochrome c primes Apaf-1 for assembly. Contradicting the current view, there is no strict requirement for an adenine base in the nucleotide. On the basis of our results, we present a new model for the mechanism of apoptosome assembly.	[Eschenburg, Susanne] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany	Max Planck Society	Eschenburg, S (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, Otto Hahn Str 11, D-44227 Dortmund, Germany.	susanne.eschenburg@mpi-dortmund.mpg.de			European Union [LSHG-CT-2005-512028]	European Union(European Commission)	This work was supported by European Union Grant 3D Repertoire LSHG-CT-2005-512028.	Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; de Almeida CJG, 2005, CELL MOL LIFE SCI, V62, P1532, DOI 10.1007/s00018-005-4511-y; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Genini D, 2000, J BIOL CHEM, V275, P29, DOI 10.1074/jbc.275.1.29; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Leoni LM, 1998, P NATL ACAD SCI USA, V95, P9567, DOI 10.1073/pnas.95.16.9567; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Marquenet E, 2007, MOL CELL, V28, P187, DOI 10.1016/j.molcel.2007.08.014; Nagata S, 2006, IUBMB LIFE, V58, P358, DOI 10.1080/15216540600746401; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Opferman JT, 2008, CELL DEATH DIFFER, V15, P234, DOI 10.1038/sj.cdd.4402182; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Rathmell JC, 2002, CELL, V109, pS97, DOI 10.1016/S0092-8674(02)00704-3; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Shi YG, 2008, METHOD ENZYMOL, V442, P141, DOI 10.1016/S0076-6879(08)01407-9; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	45	47	51	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32717	32724		10.1074/jbc.M109.014027	http://dx.doi.org/10.1074/jbc.M109.014027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801675	hybrid, Green Published			2022-12-25	WOS:000272028400056
J	Sagana, RL; Yan, M; Cornett, AM; Tsui, JL; Stephenson, DA; Huang, SK; Moore, BB; Ballinger, MN; Melonakos, J; Kontos, CD; Aronoff, DM; Peters-Golden, M; White, ES				Sagana, Rommel L.; Yan, Mei; Cornett, Ashley M.; Tsui, Jessica L.; Stephenson, David A.; Huang, Steven K.; Moore, Bethany B.; Ballinger, Megan N.; Melonakos, Janet; Kontos, Christopher D.; Aronoff, David M.; Peters-Golden, Marc; White, Eric S.			Phosphatase and Tensin Homologue on Chromosome 10 (PTEN) Directs Prostaglandin E-2-mediated Fibroblast Responses via Regulation of E Prostanoid 2 Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; GENOME-WIDE ANALYSIS; GROWTH-FACTOR-BETA; INHIBITS FIBROBLAST; MYOFIBROBLAST DIFFERENTIATION; NEGATIVE REGULATION; LUNG FIBROBLASTS; CARCINOMA CELLS; CANCER CELLS; SUBTYPE EP4	Prostaglandin E-2 (PGE(2)) is an arachidonic acid metabolite that counters transforming growth factor-beta-induced fibroblast activation via E prostanoid 2 (EP2) receptor binding. Phosphatase and tensin homologue on chromosome 10 ( PTEN) is a lipid phosphatase that, by antagonizing the phosphoinositol 3-kinase (PI3K) pathway, also inhibits fibroblast activation. Here, we show that PTEN directly regulates PGE(2) inhibition of fibroblast activation by augmenting EP2 receptor expression. The increase in collagen production and alpha-smooth muscle actin expression observed in fibroblasts in which PTEN is deficient was resistant to the usual suppressive effects of PGE(2). This was due to marked down-regulation of EP2, a G(s) protein-coupled receptor (GPCR) that mediates the inhibitory actions of this prostanoid via cAMP. pten(-/-) or PTEN-inhibited fibroblasts in which the PI3K pathway was blocked demonstrated a restoration of EP2 receptor expression, due to augmented gene transcription and mRNA instability. Importantly, restoration of the balance between PI3K and PTEN reestablished the inhibitory effect of PGE2 on fibroblast activation. No such influence of PTEN was observed on alternative E prostanoid GPCRs. Moreover, our studies identified a positive feedback loop in which cAMP signaling enhanced EP2 receptor expression, independent of PTEN. Therefore, our findings indicate that PTEN regulates the antifibrotic effects of PGE(2) by a specific and permissive effect on EP2 receptor expression. Further, our data imply that cAMP signaling circumvents EP2 down-regulation in pten-deficient cells to restore EP2 receptor expression. This is the first description, to our knowledge, of PI3K/PTEN balance directing GPCR expression, and provides a novel mechanism for cellular effects of PTEN.	[Sagana, Rommel L.; Yan, Mei; Cornett, Ashley M.; Tsui, Jessica L.; Stephenson, David A.; Huang, Steven K.; Moore, Bethany B.; Ballinger, Megan N.; Peters-Golden, Marc; White, Eric S.] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Huang, Steven K.] Univ Michigan, Sch Med, Div Infect Dis, Dept Internal Med, Ann Arbor, MI 48109 USA; [Moore, Bethany B.; Aronoff, David M.; Peters-Golden, Marc; White, Eric S.] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA; [White, Eric S.] Univ Michigan, Sch Med, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Melonakos, Janet] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27708 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University	White, ES (corresponding author), Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Dept Internal Med, 6301 MSRB 3 SPC5642,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	docew@umich.edu		Aronoff, David/0000-0003-4587-6121; Kontos, Christopher/0000-0002-8056-3115; White, Eric/0000-0003-4060-8443; Moore, Bethany/0000-0003-3051-745X; Ballinger, Megan/0000-0002-2202-3049	National Institutes of Health [HL085083, HL094311, AI065543, HL083385]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083385, R01HL085083, R01HL094311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065543, R56AI065543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085083 (to E.S.W.), HL094311 (to M.P.-G.), AI065543 (to B.B.M.), and HL083385 (to C.D.K.). Downloaded from www. jbc. org at unknown institution, on November 23, 2009	Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Dautzenberg FM, 2002, BIOCHEM BIOPH RES CO, V298, P303, DOI 10.1016/S0006-291X(02)02463-4; Eng C, 1998, NAT GENET, V19, P223, DOI 10.1038/897; Han SW, 2007, J BIOL CHEM, V282, P7961, DOI 10.1074/jbc.M610308200; Hjelmeland AB, 2005, CANCER RES, V65, P11276, DOI 10.1158/0008-5472.CAN-05-3016; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Li DM, 1997, CANCER RES, V57, P2124; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McMenamin ME, 1999, CANCER RES, V59, P4291; Mutoh M, 2002, CANCER RES, V62, P28; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Oh JM, 2009, CARCINOGENESIS, V30, P141, DOI 10.1093/carcin/bgn236; Pap T, 2000, ARTHRITIS RES, V2, P59, DOI 10.1186/ar69; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Park MJ, 2007, J BIOL CHEM, V282, P30485, DOI 10.1074/jbc.M701081200; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Smock SL, 1999, GENE, V237, P393, DOI 10.1016/S0378-1119(99)00323-6; Souza JP, 2006, AM J OPHTHALMOL, V142, P625, DOI 10.1016/j.ajo.2006.05.053; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang XY, 2007, MOL CARCINOGEN, V46, P912, DOI 10.1002/mc.20320; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhou P, 2008, NEUROBIOL DIS, V29, P543, DOI 10.1016/j.nbd.2007.11.010	35	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32264	32271		10.1074/jbc.M109.004796	http://dx.doi.org/10.1074/jbc.M109.004796			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19808686	hybrid, Green Published			2022-12-25	WOS:000272028400007
J	Casey, T; Patel, O; Dykema, K; Dover, H; Furge, K; Plaut, K				Casey, Theresa; Patel, Osman; Dykema, Karl; Dover, Heather; Furge, Kyle; Plaut, Karen			Molecular Signatures Reveal Circadian Clocks May Orchestrate the Homeorhetic Response to Lactation	PLOS ONE			English	Article							SHORT-DAY PHOTOPERIOD; GENE-EXPRESSION; ADIPOSE-TISSUE; MAMMARY-GLAND; DIURNAL-VARIATIONS; MILK-PRODUCTION; PREPARTUM PHOTOPERIOD; SHORT COMMUNICATION; LIPID-METABOLISM; GROWTH-HORMONE	Genes associated with lactation evolved more slowly than other genes in the mammalian genome. Higher conservation of milk and mammary genes suggest that species variation in milk composition is due in part to the environment and that we must look deeper into the genome for regulation of lactation. At the onset of lactation, metabolic changes are coordinated among multiple tissues through the endocrine system to accommodate the increased demand for nutrients and energy while allowing the animal to remain in homeostasis. This process is known as homeorhesis. Homeorhetic adaptation to lactation has been extensively described; however how these adaptations are orchestrated among multiple tissues remains elusive. To develop a clearer picture of how gene expression is coordinated across multiple tissues during the pregnancy to lactation transition, total RNA was isolated from mammary, liver and adipose tissues collected from rat dams (n = 5) on day 20 of pregnancy and day 1 of lactation, and gene expression was measured using Affymetrix GeneChips. Two types of gene expression analysis were performed. Genes that were differentially expressed between days within a tissue were identified with linear regression, and univariate regression was used to identify genes commonly up-regulated and down-regulated across all tissues. Gene set enrichment analysis showed genes commonly up regulated among the three tissues enriched gene ontologies primary metabolic processes, macromolecular complex assembly and negative regulation of apoptosis ontologies. Genes enriched in transcription regulator activity showed the common up regulation of 2 core molecular clock genes, ARNTL and CLOCK. Commonly down regulated genes enriched Rhythmic process and included: NR1D1, DBP, BHLHB2, OPN4, and HTR7, which regulate intracellular circadian rhythms. Changes in mammary, liver and adipose transcriptomes at the onset of lactation illustrate the complexity of homeorhetic adaptations and suggest that these changes are coordinated through molecular clocks.			Casey, T (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	ande1218@msu.edu	Casey, Theresa Marie/F-1171-2015	Casey, Theresa Marie/0000-0002-8835-3550	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050201] Funding Source: NIH RePORTER; NICHD NIH HHS [HD50201, R01 HD050201] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aharoni Y, 2000, J DAIRY SCI, V83, P2779, DOI 10.3168/jds.S0022-0302(00)75174-5; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; AMARA U, 2009, CURRENT TOPICS COMPL, V2, P68; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Andrade BR, 2008, J DAIRY SCI, V91, P2299, DOI 10.3168/jds.2007-0687; Auchtung TL, 2005, J DAIRY SCI, V88, P121, DOI 10.3168/jds.S0022-0302(05)72669-2; Augustine RA, 2008, J PHYSIOL-LONDON, V586, P387, DOI 10.1113/jphysiol.2007.146316; Auldist MJ, 2007, J DAIRY RES, V74, P52, DOI 10.1017/S0022029906002160; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Barber MC, 1997, BBA-LIPID LIPID MET, V1347, P101, DOI 10.1016/S0005-2760(97)00079-9; Barkova EN, 2005, B EXP BIOL MED+, V140, P394, DOI 10.1007/s10517-005-0500-2; Barres R, 2006, MOL ENDOCRINOL, V20, P2864, DOI 10.1210/me.2005-0455; BAUMAN DE, 1973, J DAIRY SCI, V56, P1520, DOI 10.3168/jds.S0022-0302(73)85401-3; BAUMAN DE, 1982, FED PROC, V41, P2538; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; BAUMAN DE, 1983, CONTROL NUTR PARTITI, P437; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Bernabucci U, 2006, J DAIRY SCI, V89, P4678, DOI 10.3168/jds.S0022-0302(06)72518-8; Billups SC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-96; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Brown SA, 1999, CURR OPIN GENET DEV, V9, P588, DOI 10.1016/S0959-437X(99)00009-X; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CHAVES JM, 1978, BIOCHEM BIOPH RES CO, V85, P1299, DOI 10.1016/0006-291X(78)91144-0; Connor EE, 2007, J DAIRY SCI, V90, pE55, DOI 10.3168/jds.2006-466; Dahl GE, 2008, J ANIM SCI, V86, P10, DOI 10.2527/jas.2007-0311; Dahl GE, 2003, J ANIM SCI, V81, P11; Dahl GE, 2004, VET CLIN N AM-FOOD A, V20, P675, DOI 10.1016/j.cvfa.2004.06.004; Dahl GE, 2002, REPRODUCTION, P191; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dinulescu DM, 2000, J BIOL CHEM, V275, P6695, DOI 10.1074/jbc.275.10.6695; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Duke-Cohan JS, 2004, J ENVIRON PATHOL TOX, V23, P1, DOI 10.1615/JEnvPathToxOncol.v23.i1.10; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; FAILOR KL, 2007, MOL ENDOCRINOLOGY; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; FUKUDA H, 1985, BIOCHIM BIOPHYS ACTA, V835, P163, DOI 10.1016/0005-2760(85)90269-3; Furge KA, 2007, CANCER RES, V67, P3171, DOI 10.1158/0008-5472.CAN-06-4571; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; Guan Y, 2004, MOL ENDOCRINOL, V18, P214, DOI 10.1210/me.2003-0014; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Gunn TM, 2000, TRENDS CARDIOVAS MED, V10, P76, DOI 10.1016/S1050-1738(00)00052-9; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; HERRERA E, 1994, BRAZ J MED BIOL RES, V27, P2499; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; HERRERA E, 1991, DIABETES, V40, P83, DOI 10.2337/diab.40.2.S83; Higami Y, 2006, J NUTR, V136, P343, DOI 10.1093/jn/136.2.343; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; HOLNESS MJ, 1993, BIOCHEM J, V292, P431, DOI 10.1042/bj2920431; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hoshino K, 2006, ENDOCRINOLOGY, V147, P1916, DOI 10.1210/en.2005-1343; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Johnson MS, 2001, J EXP BIOL, V204, P1925; Jost M, 2000, EUR J DERMATOL, V10, P505; KAELIN CB, INT J OBES, V32, pS19; Kelly PA, 2002, MOL CELL ENDOCRINOL, V197, P127, DOI 10.1016/S0303-7207(02)00286-1; Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159, DOI 10.1016/S1359-6101(99)00039-8; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; Lintault LM, 2007, J APPL PHYSIOL, V102, P2186, DOI 10.1152/japplphysiol.01015.2006; LINTAULT LM, 2007, J APPL PHYSIOL; LIU LB, 2003, INSULIN RECRUITS GLU, P30157; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; MARTINHIDALGO A, 1994, AM J PHYSIOL, V266, pE930, DOI 10.1152/ajpendo.1994.266.6.E930; MCNAMARA JP, 1978, J DAIRY SCI, V61, P156; Metz RP, 2006, DEV DYNAM, V235, P263, DOI 10.1002/dvdy.20605; MICHELE MB, 2008, FEBS J, V275, P2356; Mikolayunas CM, 2008, J DAIRY SCI, V91, P85, DOI 10.3168/jds.2007-0586; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; MUNDAY MR, 1983, BIOCHEM J, V214, P183, DOI 10.1042/bj2140183; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Neville MC, 2001, PEDIATR CLIN N AM, V48, P35, DOI 10.1016/S0031-3955(05)70284-4; Nielsen NI, 2003, J VET MED A, V50, P88, DOI 10.1046/j.1439-0442.2003.00496.x; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Oates JE, 2007, GEN COMP ENDOCR, V150, P445, DOI 10.1016/j.ygcen.2006.11.004; Oftedal OT, 2000, P NUTR SOC, V59, P99, DOI 10.1017/S0029665100000124; Oosterom J, 2001, J BIOL CHEM, V276, P931, DOI 10.1074/jbc.M007261200; ORMANDY CJ, 2003, INVESTIGATION TRANSC, P297; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Patel OV, 2008, EUR J APPL PHYSIOL, V104, P847, DOI 10.1007/s00421-008-0840-5; Plaut K, 1999, P SOC EXP BIOL MED, V222, P85, DOI 10.1111/j.1525-1373.1999.09999.x; Plaut K, 2003, J APPL PHYSIOL, V95, P2350, DOI 10.1152/japplphysiol.00287.2003; PLAUT KI, 1989, J ANIM SCI, V67, P1509; PONCECASTANEDA MV, 1991, J DAIRY SCI, V74, P4013, DOI 10.3168/jds.S0022-0302(91)78596-2; POND CM, 1977, EVOLUTION, V31, P177, DOI [10.2307/2407556, 10.1111/j.1558-5646.1977.tb00995.x]; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rea MA, 1998, CHRONOBIOL INT, V15, P395, DOI 10.3109/07420529808998699; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rius AG, 2006, J DAIRY SCI, V89, P2080, DOI 10.3168/jds.S0022-0302(06)72277-9; RONCA AE, 2003, COMMENTS THEORETICAL, V8, P627; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; SEO S, 2009, HUM MOL GENET; Sheward WJ, 2007, J NEUROSCI, V27, P4351, DOI 10.1523/JNEUROSCI.4843-06.2007; SMYTH GK, 2004, R PROJECT STAT COMPU; Speakman JR, 2000, ADV ECOL RES, V30, P177; Speakman JR, 1996, PHYSIOL ZOOL, V69, P746, DOI 10.1086/physzool.69.4.30164228; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; TUCKER HA, 1987, J DAIRY SCI, V70, P1958, DOI 10.3168/jds.S0022-0302(87)80238-2; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Unger RH, 2003, ANNU REV PHYSIOL, V65, P333, DOI 10.1146/annurev.physiol.65.092101.142622; Virshup DM, 2007, COLD SPRING HARB SYM, V72, P413, DOI 10.1101/sqb.2007.72.048; Wall EH, 2005, J DAIRY SCI, V88, P3145, DOI 10.3168/jds.S0022-0302(05)72997-0; Weber ET, 1998, J BIOL RHYTHM, V13, P209, DOI 10.1177/074873098129000057; Wheatley KE, 2008, OECOLOGIA, V155, P11, DOI 10.1007/s00442-007-0888-7; WILLIAMSON DH, 1984, FED PROC, V43, P2443; WILLIAMSON DH, 1986, REPROD NUTR DEV, V26, P597, DOI 10.1051/rnd:19860409; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Yagita K, 2000, GENE DEV, V14, P1353; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zakrzewska E I, 2004, J Gravit Physiol, V11, pP157	125	29	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7395	10.1371/journal.pone.0007395	http://dx.doi.org/10.1371/journal.pone.0007395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816599	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594300012
J	Palmer, CV; Modi, CK; Mydlarz, LD				Palmer, Caroline V.; Modi, Chintan K.; Mydlarz, Laura D.			Coral Fluorescent Proteins as Antioxidants	PLOS ONE			English	Article							OXIDATIVE STRESS; ULTRAVIOLET-RADIATION; SCLERACTINIAN CORAL; REACTIVE OXYGEN; GREEN; MARINE; DIVERSITY; EVOLUTION; PIGMENTS; DISEASE	Background: A wide array of fluorescent proteins (FP) is present in anthozoans, although their biochemical characteristics and function in host tissue remain to be determined. Upregulation of FP's frequently occurs in injured or compromised coral tissue, suggesting a potential role of coral FPs in host stress responses. Methodology/Principal Findings: The presence of FPs was determined and quantified for a subsample of seven healthy Caribbean coral species using spectral emission analysis of tissue extracts. FP concentration was correlated with the in vivo antioxidant potential of the tissue extracts by quantifying the hydrogen peroxide (H2O2) scavenging rates. FPs of the seven species varied in both type and abundance and demonstrated a positive correlation between H2O2 scavenging rate and FP concentration. To validate this data, the H2O2 scavenging rates of four pure scleractinian FPs, cyan (CFP), green (GFP), red (RFP) and chromoprotein (CP), and their mutant counterparts (without chromophores), were investigated. In vitro, each FP scavenged H2O2 with the most efficient being CP followed by equivalent activity of CFP and RFP. Scavenging was significantly higher in all mutant counterparts. Conclusions/Significance: Both naturally occurring and pure coral FPs have significant H2O2 scavenging activity. The higher scavenging rate of RFP and the CP in vitro is consistent with observed increases of these specific FPs in areas of compromised coral tissue. However, the greater scavenging ability of the mutant counterparts suggests additional roles of scleractinian FPs, potentially pertaining to their color. This study documents H2O2 scavenging of scleractinian FPs, a novel biochemical characteristic, both in vivo across multiple species and in vitro with purified proteins. These data support a role for FPs in coral stress and immune responses and highlights the multi-functionality of these conspicuous proteins.			Palmer, CV (corresponding author), Univ Newcastle, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England.	Caroline.palmer@jcu.edu.au	Palmer, Caroline/B-6498-2011; Mydlarz, Laura/B-8132-2011; Modi, Chintan/N-7177-2013	Palmer, Caroline/0000-0002-5903-995X; Modi, Chintan/0000-0002-9913-3887				Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; ARONSON R, 2008, IUCN 2008 2008 IUCN; Bandaranayake WM, 2006, NAT PROD REP, V23, P223, DOI 10.1039/b307612c; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; BENDICH A, 1989, J NUTR, V119, P112, DOI 10.1093/jn/119.1.112; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; CATALASTUCKI R, 1959, NATURE, V183, P949, DOI 10.1038/183949a0; Cornet S, 2007, BIOLOGY LETT, V3, P284, DOI 10.1098/rsbl.2007.0003; COX G, 2006, MULTIMODAL MICROSCOP; Cox G, 2007, MICROSC RES TECHNIQ, V70, P243, DOI 10.1002/jemt.20410; Croquer A, 2009, DIS AQUAT ORGAN, V83, P209, DOI 10.3354/dao02012; Cvejic J, 2007, MAR BIOL, V152, P855, DOI 10.1007/s00227-007-0738-5; Dove S, 2006, LIMNOL OCEANOGR, V51, P1149, DOI 10.4319/lo.2006.51.2.1149; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Dove SG, 2008, PLANT CELL ENVIRON, V31, P1523, DOI 10.1111/j.1365-3040.2008.01852.x; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Dunlap W, 2003, MAR BIOTECHNOL, V5, P294, DOI 10.1007/s10126-002-0074-1; DYKENS JA, 1984, MAR BIOL LETT, V5, P291; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLEASON DF, 1993, LIMNOL OCEANOGR, V38, P1452, DOI 10.4319/lo.1993.38.7.1452; Gordon MH, 1996, NAT PROD REP, V13, P265, DOI 10.1039/np9961300265; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Griffin SP, 2006, COMP BIOCHEM PHYS A, V144, P155, DOI 10.1016/j.cbpa.2006.02.017; GRUBER DF, 2008, BIOL B, V215; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harvell C. D., 2007, OCEANOGRAPHY, V20, P58; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hawkridge JM, 2000, MAR BIOL, V137, P1, DOI 10.1007/s002270000324; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Kao HT, 2007, MAR BIOTECHNOL, V9, P733, DOI 10.1007/s10126-007-9025-1; Kawaguti S., 1944, Palao Tropical Biological Station Studies Tokyo, V2, P617; Kawaguti S., 1969, Micronesica, V5, P313; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Leutenegger A, 2007, J EXP MAR BIOL ECOL, V353, P221, DOI 10.1016/j.jembe.2007.09.013; Leverette CL, 2008, SPECTROCHIM ACTA A, V69, P1058, DOI 10.1016/j.saa.2007.07.018; Levy O, 2003, J EXP BIOL, V206, P4041, DOI 10.1242/jeb.00622; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; Matz MV, 2002, BIOESSAYS, V24, P953, DOI 10.1002/bies.10154; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Meredith P, 2006, SOFT MATTER, V2, P37, DOI 10.1039/b511922g; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Mydlarz LD, 2007, COMP BIOCHEM PHYS A, V146, P54, DOI 10.1016/j.cbpa.2006.09.005; Mydlarz LD, 2006, MAR FRESHW BEHAV PHY, V39, P143, DOI 10.1080/10236240600708512; Mydlarz LD, 2004, PHYTOCHEMISTRY, V65, P3231, DOI 10.1016/j.phytochem.2004.09.014; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2009, BIOL BULL-US, V216, P68, DOI 10.1086/BBLv216n1p68; Protas ME, 2008, ANNU REV CELL DEV BI, V24, P425, DOI 10.1146/annurev.cellbio.24.110707.175302; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Salih A, 2004, P SOC PHOTO-OPT INS, V5329, P61, DOI 10.1117/12.548926; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Salih A, 1998, P AUSTR COR REEF SOC, P217; SALIH A, 2006, PROGR BIOMEDICAL OPT, V7, P60980; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; SUGUMARAN M, 1993, REGULATION INSECT HE, P317; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; THOMSON CM, 2002, BIOLUMINESENCE CHEMI; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vershinin A, 1999, BIOFACTORS, V10, P99, DOI 10.1002/biof.5520100203; Ward JR, 2006, DIS AQUAT ORGAN, V69, P23, DOI 10.3354/dao069023; Ward WW, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P45; WARD WW, 2002, BIOLUMINESCENCE CHEM, P123; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wiedenmann J, 2004, MAR BIOTECHNOL, V6, P270, DOI 10.1007/s10126-004-3006-4; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P13358, DOI 10.1073/pnas.212371999; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69	83	110	111	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7298	10.1371/journal.pone.0007298	http://dx.doi.org/10.1371/journal.pone.0007298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806218	Green Published, gold, Green Accepted			2022-12-25	WOS:000270593800011
J	Doumanis, J; Wada, K; Kino, Y; Moore, AW; Nukina, N				Doumanis, Joanna; Wada, Koji; Kino, Yoshihiro; Moore, Adrian W.; Nukina, Nobuyuki			RNAi Screening in Drosophila Cells Identifies New Modifiers of Mutant Huntingtin Aggregation	PLOS ONE			English	Article								The fruitfly Drosophila melanogaster is well established as a model system in the study of human neurodegenerative diseases. Utilizing RNAi, we have carried out a high-throughput screen for modifiers of aggregate formation in Drosophila larval CNS-derived cells expressing mutant human Huntingtin exon 1 fused to EGFP with an expanded polyglutamine repeat (62Q). 7200 genes, encompassing around 50% of the Drosophila genome, were screened, resulting in the identification of 404 candidates that either suppress or enhance aggregation. These candidates were subjected to secondary screening in normal length (18Q)-expressing cells and pruned to remove dsRNAs with greater than 10 off-target effects (OTEs). De novo RNAi probes were designed and synthesized for the remaining 68 candidates. Following a tertiary round of screening, 21 high confidence candidates were analyzed in vivo for their ability to modify mutant Huntingtin-induced eye degeneration and brain aggregation. We have established useful models for the study of human HD using the fly, and through our RNAi screen, we have identified new modifiers of mutant human Huntingtin aggregation and aggregate formation in the brain. Newly identified modifiers including genes related to nuclear transport, nucleotide processes, and signaling, may be involved in polyglutamine aggregate formation and Huntington disease cascades.			Doumanis, J (corresponding author), RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama, Japan.	nukina@brain.riken.jp	Moore, Adrian Walton/AAN-5656-2021; Nukina, Nobuyuki/GPP-6265-2022; Moore, Adrian W/A-3339-2013	Moore, Adrian Walton/0000-0002-8242-301X; Moore, Adrian W/0000-0002-8242-301X				Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arziman Z, 2005, NUCLEIC ACIDS RES, V33, pW582, DOI 10.1093/nar/gki468; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bai JW, 2008, DEVELOPMENT, V135, P1439, DOI 10.1242/dev.012849; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Celotto AM, 2005, MOL INTERV, V5, P292, DOI 10.1124/mi.5.5.9; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Desai UA, 2006, HUM MOL GENET, V15, P2114, DOI 10.1093/hmg/ddl135; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Marsh JL, 2004, BIOESSAYS, V26, P485, DOI 10.1002/bies.20029; Murata T, 2008, BIOSCI BIOTECH BIOCH, V72, P2255, DOI 10.1271/bbb.70829; Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; Ui-Tei K, 2000, APOPTOSIS, V5, P133, DOI 10.1023/A:1009676528805; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	25	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7275	10.1371/journal.pone.0007275	http://dx.doi.org/10.1371/journal.pone.0007275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789644	Green Submitted, Green Published, gold			2022-12-25	WOS:000270354100023
J	Ioset, JR; Kaur, H				Ioset, Jean-Robert; Kaur, Harparkash			Simple Field Assays to Check Quality of Current Artemisinin-Based Antimalarial Combination Formulations	PLOS ONE			English	Article								Introduction: Malaria continues to be one of the major public health problems in Africa, Asia and Latin America. Artemisinin derivatives (ARTs; artesunate, artemether, and dihydroartemisinin) derived from the herb, Artemisia annua, are the most effective antimalarial drugs available providing rapid cures. The World Health Organisation ( WHO) has recommended that all antimalarials must be combined with an artemisinin component (artemisinin-based combination therapy; ACT) for use as first line treatment against malaria. This class of drugs is now first-line policy in most malaria-endemic countries. Reports of ad hoc surveys from South East Asia show that up to 50% of the artesunate currently sold is counterfeit. Drug quality is rarely assessed in resource poor countries in part due to lack of dedicated laboratory facilities which are expensive to build, equip and maintain. With a view to address this unmet need we developed two novel colour reaction assays that can be used in the field to check the quality of ARTs. Methods and Findings: Our assays utilise thin layer chromatography silica gel sheets and 2, 4 dinitrophenylhydrazine or 4-Benzoylamino-2, 5-dimethoxybenzenediazonium chloride hemi (zinc chloride) salt as the reagents showing a pink or blue product respectively only in the presence ARTs. We are able to detect as low as 10% of ARTs in ACTs (WINTHROP artesunate/amodiaquine, Coartem (R)-artemether/lumefantrine and Duocortexcin - dihydroartemisinin/piperaquine). The assays have been validated extensively by testing eighty readily accessible and widely used drugs in malaria endemic countries. None of the other antimalarial drugs or a range of commonly used excipients, antiretroviral drugs or other frequently used drugs from the WHO essential drugs list such as analgesics or antibiotics are detected with our assays. Conclusions: Our two independent assays requiring no specialist training are specific, simple to use, rapid, robust, reproducible, inexpensive and, have successfully resulted in detecting two counterfeit drugs within a small scale screening survey of over 100 declared artemisinin-containing drugs collected from various Asian and African countries. These promising results indicate that the assays will provide a useful first test to assure the quality of the ACTs formulations in resource poor malaria endemic areas when there is an absence of dedicated medicines quality laboratory facilities.			Ioset, JR (corresponding author), DNDi, Geneva, Switzerland.	Harparkash.Kaur@lshtm.ac.uk						Aldhous P, 2005, NATURE, V434, P132, DOI 10.1038/434132a; Atemnkeng MA, 2007, TROP MED INT HEALTH, V12, P68, DOI 10.1111/j.1365-3156.2006.01769.x; Bate R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002132; Gabriels M, 2004, J CHROMATOGR SCI, V42, P341, DOI 10.1093/chromsci/42.7.341; Green MD, 2000, J PHARMACEUT BIOMED, V24, P65, DOI 10.1016/S0731-7085(00)00360-5; Green MD, 2001, TROP MED INT HEALTH, V6, P980, DOI 10.1046/j.1365-3156.2001.00793.x; Haynes RK, 2007, CHEMMEDCHEM, V2, P1448, DOI 10.1002/cmdc.200700064; Kaur H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003403; KIBBE AH, HDB PHARM EXCIPIENTS; Lewison G, 2008, ACTA TROP, V106, P96, DOI 10.1016/j.actatropica.2008.01.009; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Newton P, 2001, LANCET, V357, P1948, DOI 10.1016/S0140-6736(00)05085-6; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Phanouvong S., 2005, 7 INT C AIDS AS PAC; Rozendaal J, 2001, LANCET, V357, P890, DOI 10.1016/S0140-6736(05)71830-4; SNOW RW, 2003, 11 NAT I HLTH FOG IN; THOMAS CG, 1992, J CHROMATOGR-BIOMED, V583, P131, DOI 10.1016/0378-4347(92)80355-T; WHO, 2006, GUID TREATM MAL; ZHAO S, 1986, ANAL CHEM, V58, P131; 2007, Patent No. 2007077444	21	29	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7270	10.1371/journal.pone.0007270	http://dx.doi.org/10.1371/journal.pone.0007270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789707	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000270354100022
J	Kroger, B; Servais, T; Zhang, YB				Kroeger, Bjoern; Servais, Thomas; Zhang, Yunbai			The Origin and Initial Rise of Pelagic Cephalopods in the Ordovician	PLOS ONE			English	Article							MIDDLE ORDOVICIAN; SEQUENCE STRATIGRAPHY; BIODIVERSIFICATION; CLASSIFICATION; NAUTILOIDS; ECOLOGY	Background: During the Ordovician the global diversity increased dramatically at family, genus and species levels. Partially the diversification is explained by an increased nutrient, and phytoplankton availability in the open water. Cephalopods are among the top predators of todays open oceans. Their Ordovician occurrences, diversity evolution and abundance pattern potentially provides information on the evolution of the pelagic food chain. Methodology/Principal Findings: We reconstructed the cephalopod departure from originally exclusively neritic habitats into the pelagic zone by the compilation of occurrence data in offshore paleoenvironments from the Paleobiology Database, and from own data, by evidence of the functional morphology, and the taphonomy of selected cephalopod faunas. The occurrence data show, that cephalopod associations in offshore depositional settings and black shales are characterized by a specific composition, often dominated by orthocerids and lituitids. The siphuncle and conch form of these cephalopods indicate a dominant lifestyle as pelagic, vertical migrants. The frequency distribution of conch sizes and the pattern of epibionts indicate an autochthonous origin of the majority of orthocerid and lituitid shells. The consistent concentration of these cephalopods in deep subtidal sediments, starting from the middle Tremadocian indicates the occupation of the pelagic zone early in the Early Ordovician and a subsequent diversification which peaked during the Darriwilian. Conclusions/Significance: The exploitation of the pelagic realm started synchronously in several independent invertebrate clades during the latest Cambrian to Middle Ordovician. The initial rise and diversification of pelagic cephalopods during the Early and Middle Ordovician indicates the establishment of a pelagic food chain sustainable enough for the development of a diverse fauna of large predators. The earliest pelagic cephalopods were slowly swimming vertical migrants. The appearance and early diversification of pelagic cephalopods is interpreted as a consequence of the increased food availability in the open water since the latest Cambrian.			Kroger, B (corresponding author), Humboldt Univ, Museum Nat Kunde, Leibniz Inst Res Evolut & Biodivers, Berlin, Germany.	bjoekroe@gmx.de	Servais, Thomas/S-8045-2019	Servais, Thomas/0000-0002-4089-7874				Achab A, 2007, PALAEOGEOGR PALAEOCL, V245, P5, DOI 10.1016/j.palaeo.2006.02.030; Adrain JM, 2004, CRIT MOM PERSP EARTH, P231; Baird G.C., 1989, Senckenbergiana Lethaea, V69, P439; Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; BAMBACH RK, 1983, BIOTIC INTERACTIONS, P719; BARRANDE J, 1867, CEPHALOPODES, P711; BARSKOV IS, 1966, CEPHALOPODS LATE ORD, P200; Bogolepova Olga K., 1999, Acta Universitatis Carolinae Geologica, V43, P409; BOLL E., 1857, ARCH VEREINS FREUNDE, V11, P58; Boucot A.J., 1975, EVOLUTION EXTINCTION, V1, DOI DOI 10.1016/0012-8252(75)90144-0; Brett CE, 2004, PALAEOGEOGR PALAEOCL, V210, P295, DOI 10.1016/j.palaeo.2004.02.038; BROGGER WC, 1882, SILURISCHEN ETAGEN 2, P376; BRUGUIERE JG, 1789, HIST NATURELLE VER 1, V1, P757; BURRETT CF, 1984, ASPECTS ORDOVICIAN S, P149; Chen J.-y., 1982, Acta Palaeontologica Sinica, V21, P392; Chen J.-y., 1991, Geologica et Palaeontologica, V25, P5; Chen J.Y., 1988, NEW MEXICO BUREAU MI, V44, P387; CHLUPAC I., 2003, B GEOSCI, V78, P91; Cocks LRM, 2004, CRIT MOM PERSP EARTH, P61; Conrad T.A., 1838, NEW YORK GEOLOGICAL, V2, P107; DZIK J, 1981, Acta Palaeontologica Polonica, V26, P161; Dzik J., 1984, PALAENTOL POL, V45, P1; Ebbestad Jan Ove Roysi, 1999, Fossils and Strata, V47, P1; EBBESTAD JOR, 2007, WOGOGOB 2007 9 M WOR, V128, P84; EICHWALD E, 1654, LETHAEA ROSSICA PALO; Engeser Theo, 1996, Topics in Geobiology, V13, P3; Evans D. H, 2005, MONOGRAPH PALAEONTOG, V628, P1; Evans DH, 2002, SPEC PAP PALAEONTOL, P77; Flower R. H., 1957, Memoirs Geological Society of America, V67, P829; FLOWER R. H., 1962, NEW MEXICO BUREAU MI, V10, P21; Foerste A. F., 1924, Journal Sci Nat Denison University Bul Granville, V20, P193; Foerste A. F., 1932, J SCI LAB DENISON U, V27, P47; FOERSTE AF, 1930, U MICHIGAN CONTRIBUT, V3, P109; FORTEY R A, 1985, Transactions of the Royal Society of Edinburgh Earth Sciences, V76, P219; Fortey Richard A., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P391; Frey R.C, 1995, US GEOLOGICAL SURVEY, V1066P, P1, DOI [10.3133/pp1066P, DOI 10.3133/PP1066P]; Gabbott SE, 1999, PALAEONTOLOGY, V42, P123, DOI 10.1111/1475-4983.00065; Hall J., 1843, GEOLOGY NEW YORK 4, P683; Hall J., 1847, NATURAL HIST NEW YOR, V1, P338; HAVLICEK V, 1990, Vestnik Ustredniho Ustavu Geologickeho, V65, P223; HavlYek V., 1982, SB GEOL VED GEOL, V37, P103; Hewitt R.A., 1980, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V160, P96; HEWITT RA, 1985, ALCHERINGA, V9, P229, DOI 10.1080/03115518508618970; Hewitt Roger A., 1996, Palaeontologische Zeitschrift, V70, P405; Holm G, 1899, GEOLOGISKA FORENINGE, V20, P354; Hyatt A., 1884, P BOSTON SOC NAT HIS, V22, P253; JABLONSKI D, 1983, BIOL REV, V58, P21, DOI 10.1111/j.1469-185X.1983.tb00380.x; Kobayashi T, 1934, J FS IMPERIAL U TOKY, V3, P329; KOKELAAR BP, 1985, J GEOL SOC LONDON, V142, P591, DOI 10.1144/gsjgs.142.4.0591; KOLEBABA I, 1974, Vestnik Ustredniho Ustavu Geologickeho, V49, P293; Kroger B, 2008, SPEC PAP PALAEONTOL, P5, DOI 10.1111/j.1475-4983.2008.00764.x; Kroger B, 2007, J PALEONTOL, V81, P1266, DOI 10.1666/06-013.1; Kroger B, 2006, LETHAIA, V39, P129, DOI 10.1080/00241160600623749; Kroger B, 2009, GEOBIOS-LYON, V42, P273, DOI 10.1016/j.geobios.2008.09.006; Kroger B, 2008, ACTA PALAEONTOL POL, V53, P745, DOI 10.4202/app.2008.0417; Kroger B, 2004, J PALEONTOL, V78, P560, DOI 10.1666/0022-3360(2004)078<0560:LCCEON>2.0.CO;2; Kroger B, 2004, ACTA PALAEONTOL POL, V49, P57; KROGER B, 2009, PALAEOGEOGR PALAEOCL, V273, P74; Kroger B., 2006, FOSS REC, V9, P139; LANDING E, 2009, J PALEONTOL, V83, P89, DOI DOI 10.1666/08-078R.1; Landing E, 2007, GEOL MAG, V144, P909, DOI 10.1017/S0016756807003585; MAPES RH, 2008, LETHAIA; MAREK J, 2000, ARENIG CEPHALOPODS B, P56; Marek Jaroslav, 1999, Acta Universitatis Carolinae Geologica, V43, P413; Martin RE, 1996, PALAIOS, V11, P209, DOI 10.2307/3515230; Martin RE, 2008, PALAEOGEOGR PALAEOCL, V258, P277, DOI 10.1016/j.palaeo.2007.11.003; MURCHISON RI, 1859, SILURIA HIST OLDEST, pR9; Mutvei H, 2002, ACTA PALAEONTOL POL, V47, P157; Niko S, 2008, PALEONTOL RES, V12, P195, DOI 10.2517/1342-8144(2008)12[195:IWANLO]2.0.CO;2; Noble PJ, 2004, CRIT MOM PERSP EARTH, P97; Nutzel A, 2006, EVOL DEV, V8, P325, DOI 10.1111/j.1525-142X.2006.00105.x; Peterson KJ, 2005, GEOLOGY, V33, P929, DOI 10.1130/G21697.1; Reyment R. A., 1958, Stockholm Contributions in Geology, V1, P97; Reyment RA, 2008, PALAEONTOL ELECTRON, V11; Rudiger H, 1891, ARCH VEREINS FREUNDE, P1; Ruedemann R., 1912, NEW YORK STATE MUSEU, V162, P1; RUEDEMANN R, 1921, NEW YORK STATE MUSEU, V227, P79; Ruedemann R., 1926, NEW YORK STATE MUSEU, V227, P1; Schindewolf O. H., 1933, Abhandlungen der Preussischen Geologischen Landesanstalt, V148, P1; SCHOENEMANN B, 2008, ADV TRILOBITE RES, P361; Servais T, 2008, LETHAIA, V41, P99, DOI 10.1111/j.1502-3931.2008.00115.x; SHIMIZU S, 1935, SINOCERAS P IMPERIAL, V11, P324; SIGNOR PW, 1994, PALEOBIOLOGY, V20, P297, DOI 10.1017/S0094837300012793; Strand T., 1934, Norsk Geologisk Tidsskrift, V14, P1; THOMAS H, 2007, TRILOBITES FAUNAL DY, P466; Thoral M., 1935, CONTRIBUTION ETUDE P, P363; Tolmacheva TJ, 2001, GEOLOGY, V29, P755, DOI 10.1130/0091-7613(2001)029<0755:EFMYOC>2.0.CO;2; Vannier J, 2003, PALAEOGEOGR PALAEOCL, V195, P173, DOI 10.1016/S0031-0182(03)00307-9; Wani R, 2005, GEOLOGY, V33, P849, DOI 10.1130/G21712.1; Webby BD, 2004, CRIT MOM PERSP EARTH, P41; WESTERMA.GE, 1973, LETHAIA, V6, P383, DOI 10.1111/j.1502-3931.1973.tb01205.x; WESTERMANN G E G, 1977, Paleobiology, V3, P300; WESTERMANN G E G, 1985, Palaeontologische Zeitschrift, V59, P79; Westermann GEG, 1998, FUNCTIONAL MORPHOLOG, P263; Xu C, 2006, GEOL J, V41, P289, DOI 10.1002/gj.1051; ZHAN R, 2004, P C FIELD EXC 10 INT, P169; Zou X.-P, 1987, B NANJING I GEOLOGY, V12, P231	97	60	63	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7262	10.1371/journal.pone.0007262	http://dx.doi.org/10.1371/journal.pone.0007262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789709	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000270354100019
J	Plevneshi, A; Svoboda, T; Armstrong, I; Tyrrell, GJ; Miranda, A; Green, K; Low, D; McGeer, A				Plevneshi, Agron; Svoboda, Tomislav; Armstrong, Irene; Tyrrell, Gregory J.; Miranda, Anna; Green, Karen; Low, Donald; McGeer, Allison		Toronto Invasive Bacterial Dis Net	Population-Based Surveillance for Invasive Pneumococcal Disease in Homeless Adults in Toronto	PLOS ONE			English	Article							SELF-REPORTED COMORBIDITIES; USUAL CARE; PNEUMONIA; VACCINATION; RECOMMENDATIONS; INFECTIONS; BACTEREMIA; VACCINES; OUTBREAK; IMPACT	Background: Identification of high-risk populations for serious infection due to S. pneumoniae will permit appropriately targeted prevention programs. Methods: We conducted prospective, population-based surveillance for invasive pneumococcal disease and laboratory confirmed pneumococcal pneumonia in homeless adults in Toronto, a Canadian city with a total population of 2.5 M, from January 1, 2002 to December 31, 2006. Results: We identified 69 cases of invasive pneumococcal disease and 27 cases of laboratory confirmed pneumococcal pneumonia in an estimated population of 5050 homeless adults. The incidence of invasive pneumococcal disease in homeless adults was 273 infections per 100,000 persons per year, compared to 9 per 100,000 persons per year in the general adult population. Homeless persons with invasive pneumococcal disease were younger than other adults (median age 46 years vs 67 years, P < .001), and more likely than other adults to be smokers (95% vs. 31%, P < .001), to abuse alcohol (62% vs 15%, P < .001), and to use intravenous drugs (42% vs 4%, P < .001). Relative to age matched controls, they were more likely to have underlying lung disease (12/69, 17% vs 17/272, 6%, P = .006), but not more likely to be HIV infected (17/69, 25% vs 58/282, 21%, P = .73). The proportion of patients with recurrent disease was five fold higher for homeless than other adults (7/58, 12% vs. 24/943, 2.5%, P < .001). In homeless adults, 28 (32%) of pneumococcal isolates were of serotypes included in the 7-valent conjugate vaccine, 42 (48%) of serotypes included in the 13-valent conjugate vaccine, and 72 (83%) of serotypes included in the 23-valent polysaccharide vaccine. Although no outbreaks of disease were identified in shelters, there was evidence of clustering of serotypes suggestive of transmission of pathogenic strains within the homeless population. Conclusions: Homeless persons are at high risk of serious pneumococcal infection. Vaccination, physical structure changes or other program to reduce transmission in shelters, harm reduction programs to reduce rates of smoking, alcohol abuse and infection with bloodborne pathogens, and improved treatment programs for HIV infection may all be effective in reducing the risk.			Plevneshi, A (corresponding author), Toronto Invas Bacterial Dis Network, Toronto, ON, Canada.	amcgeer@mtsinai.on.ca	McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014; Tyrrell, Gregory/ABA-7203-2021	McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137; Walmsley, Sharon/0000-0002-3959-5692; Powis, Jeff/0000-0003-2053-6083				Al-Sukhni W, 2008, VACCINE, V26, P1432, DOI 10.1016/j.vaccine.2008.01.001; Birtles A, 2005, J CLIN MICROBIOL, V43, P2004, DOI 10.1128/JCM.43.4.2004-2008.2005; BURMAN LA, 1985, REV INFECT DIS, V7, P133; Christenson B, 2004, EUR RESPIR J, V23, P363, DOI 10.1183/09031936.04.00063504; *CIT TOR PUBL HLTH, 2003, HOML REP CARD STREET; Clinical and Laboratory Standards Institute (CLSI), 2006, M7A5 CLSI; Daneman N, 2006, CLIN INFECT DIS, V43, P432, DOI 10.1086/505871; de Roux A, 2006, CHEST, V129, P1219, DOI 10.1378/chest.129.5.1219; DEMARIA A, 1980, JAMA-J AM MED ASSOC, V244, P1446, DOI 10.1001/jama.244.13.1446; Einarsdottir HM, 2005, CLIN MICROBIOL INFEC, V11, P744, DOI 10.1111/j.1469-0691.2005.01221.x; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Frankish CJ, 2005, CAN J PUBLIC HEALTH, V96, pS23, DOI 10.1007/BF03403700; Garibaldi B, 2005, J GEN INTERN MED, V20, P726, DOI 10.1111/j.1525-1497.2005.0142.x; Greene CM, 2006, CLIN INFECT DIS, V43, P141, DOI 10.1086/505117; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; King MD, 2003, CLIN INFECT DIS, V37, P1029, DOI 10.1086/377736; Kumar D, 2008, BONE MARROW TRANSPL, V41, P743, DOI 10.1038/sj.bmt.1705964; Kumar D, 2007, AM J TRANSPLANT, V7, P1209, DOI 10.1111/j.1600-6143.2006.01705.x; Kyaw MH, 2005, J INFECT DIS, V192, P377, DOI 10.1086/431521; Marra CA, 2000, CAN J PUBLIC HEALTH, V91, P334, DOI 10.1007/BF03404802; McEllistrem MC, 2002, J INFECT DIS, V185, P1364, DOI 10.1086/339882; McKenzie H, 2000, J MED MICROBIOL, V49, P361, DOI 10.1099/0022-1317-49-4-361; MERCAT A, 1991, CHEST, V99, P147, DOI 10.1378/chest.99.1.147; MUFSON MA, 1974, ARCH INTERN MED, V134, P505, DOI 10.1001/archinte.134.3.505; Musher DM, 2000, MEDICINE, V79, P210, DOI 10.1097/00005792-200007000-00002; *NAT ADV COMM IMM, 2006, ACT IMM AG 4; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; O'Brien KL, 2007, LANCET INFECT DIS, V7, P597, DOI 10.1016/S1473-3099(07)70210-4; O'Toole TP, 2002, J URBAN HEALTH, V79, P200, DOI 10.1093/jurban/79.2.200; Ortqvist A, 2005, SEMIN RESP CRIT CARE, V26, P563, DOI 10.1055/s-2005-925523; Pastor P, 1998, CLIN INFECT DIS, V26, P590, DOI 10.1086/514589; Pritchard John W., 2004, Reviews on Environmental Health, V19, P363; RodriguezCreixems M, 1996, ARCH INTERN MED, V156, P1429, DOI 10.1001/archinte.156.13.1429; Shariatzadeh MR, 2005, MEDICINE, V84, P147, DOI 10.1097/01.md.0000164302.03972.d7; Sisk JE, 2003, ANN INTERN MED, V138, P960, DOI 10.7326/0003-4819-138-12-200306170-00007; Targonski PV, 2007, CLEV CLIN J MED, V74, P401, DOI 10.3949/ccjm.74.6.401; Turett GS, 2001, ARCH INTERN MED, V161, P2141, DOI 10.1001/archinte.161.17.2141; Turnbull J, 2007, CAN MED ASSOC J, V177, P1065, DOI 10.1503/cmaj.071294	38	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7255	10.1371/journal.pone.0007255	http://dx.doi.org/10.1371/journal.pone.0007255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787070	Green Published, Green Submitted, gold			2022-12-25	WOS:000270290100025
J	Chen, ZB; Feng, JN; Buzin, CH; Liu, Q; Weiss, L; Kernstine, K; Somlo, G; Sommer, SS				Chen, Zhenbin; Feng, Jinong; Buzin, Carolyn H.; Liu, Qiang; Weiss, Lawrence; Kernstine, Kemp; Somlo, George; Sommer, Steve S.			Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer	PLOS ONE			English	Article							PYROPHOSPHOROLYSIS-ACTIVATED POLYMERIZATION; LUNG-CANCER; RARE ALLELES; TISSUE; GENE; DNA; OLIGONUCLEOTIDES; AMPLIFICATION; SURVIVAL; OCCUR	Tumor DNA has been shown to be present both in circulating tumor cells in blood and as fragments in the plasma of metastatic cancer patients. The identification of ultra-rare tumor-specific mutations in blood would be the ultimate marker to measure efficacy of cancer therapy and/orearly recurrence. Herein we present a method for detecting microinsertions/deletions/indels (MIDIs) at ultra-high analytical selectivity. MIDIs comprise about 15% of mutations. Methods and Findings: We describe MIDI-Activated Pyrophosphorolysis (MAP), a method of ultra-high analytical selectivity for detecting MIDIs. The high analytical selectivity of MAP is putatively due to serial coupling of two rare events: heteroduplex slippage and mis-pyrophosphorolysis. MAP generally has an analytical selectivity of one mutant molecule per 1 billion wild type molecules and an analytical sensitivity of one mutant molecule per reaction. The analytical selectivity of MAP is about 100,000-fold better than that of our previously described method of Pyrophosphorolysis Activated Polymerization-Allele specific amplification (PAP-A) for detecting MIDIs. The utility of this method is illustrated in two ways. 1) We demonstrate that two EGFR deletions commonly found in lung cancers are not present in tissue from four normal human lungs (10(7) copies of gDNA each) or in blood samples from 10 healthy individuals (10(7) copies of gDNA each). This is inconsistent, at least at an analytical sensitivity of 10(-7), with the hypotheses of (a) hypermutation or (b) strong selection of these growth factor-mutated cells during normal lung development leads to accumulation of pre-neoplastic cells with these EGFR mutations, which sometimes can lead to lung cancer in late adulthood. Moreover, MAP was used for large scale, high throughput "gene pool'' analysis. No germline or early embryonic somatic mosaic mutation was detected (at a frequency of > 0.3%) for the 15/18 bp EGFR deletion mutations in 6,400 individuals, suggesting that early embryonic EGFR somatic mutation is very rare, inconsistent with hypermutation or strong selection of these deletions in the embryo. 2) The second illustration of MAP utility is in personalized monitoring of therapy and early recurrence in cancer. Tumor-specific p53 mutations identified at diagnosis in the plasma of six patients with stage II and III breast cancer were undetectable after therapy in four women, consistent with clinical remission, and continued to be detected after treatment in two others, reflecting tumor progression. Conclusions: MAP has an analytical selectivity of one part per billion for detection of MIDIs and an analytical sensitivity of one molecule. MAP provides a general tool for monitoring ultra-rare mutations in tissues and blood. As an example, we show that the personalized cancer signature in six out of six patients with non-metastatic breast cancer can be detected and that levels over time are correlated with the clinical course of disease.			Chen, ZB (corresponding author), City Hope Natl Med Ctr, Dept Mol Genet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ssommer@medomics.com			NATIONAL CANCER INSTITUTE [R33CA094334] Funding Source: NIH RePORTER; NCI NIH HHS [1R33CA94334, R33 CA094334] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Birim O, 2005, ANN THORAC SURG, V79, P1137, DOI 10.1016/j.athoracsur.2004.09.051; Buettner VL, 1999, ENVIRON MOL MUTAGEN, V33, P320, DOI 10.1002/(SICI)1098-2280(1999)33:4<320::AID-EM9>3.0.CO;2-S; Buzin CH, 2005, HUM MUTAT, V25, P177, DOI 10.1002/humu.20132; Chen Z, 2008, ONCOGENE, V27, P4336, DOI 10.1038/onc.2008.71; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Greaves M, 2007, NAT REV CANCER, V7, P213, DOI 10.1038/nrc2071; Gu D, 2007, HUM MUTAT, V28, P760, DOI 10.1002/humu.20512; Halangoda A, 2001, ENVIRON MOL MUTAGEN, V37, P311, DOI 10.1002/em.1038; Hartmann A, 1997, TRENDS GENET, V13, P27, DOI 10.1016/S0168-9525(96)10043-3; Hill KA, 2003, MUTAT RES-GEN TOX EN, V534, P173, DOI 10.1016/S1383-5718(02)00277-2; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; KOVACH JS, 1991, JNCI-J NATL CANCER I, V83, P1004, DOI 10.1093/jnci/83.14.1004; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Liu Q, 2004, BIOTECHNIQUES, V36, P156, DOI 10.2144/04361DD03; Liu Q, 2004, HUM MUTAT, V23, P426, DOI 10.1002/humu.20036; Liu Q, 2002, NUCLEIC ACIDS RES, V30, P598, DOI 10.1093/nar/30.2.598; Liu Q, 2006, BIOTECHNIQUES, V40, P661, DOI 10.2144/000112164; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Parsons BL, 1998, ENVIRON MOL MUTAGEN, V32, P200, DOI 10.1002/(SICI)1098-2280(1998)32:3<200::AID-EM2>3.3.CO;2-F; Port JL, 2003, CHEST, V124, P1828, DOI 10.1378/chest.124.5.1828; SALDIVAR JS, 2006, EGF RECEPTOR TESTING; SARKAR G, 1990, NATURE, V343, P27, DOI 10.1038/343027a0; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Shi JX, 2007, HUM MUTAT, V28, P131, DOI 10.1002/humu.20423; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; SOMMER SS, 1994, HUM MUTAT, V3, P166, DOI 10.1002/humu.1380030214; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vineis P, 2006, INT J EPIDEMIOL, V35, P1151, DOI 10.1093/ije/dyl185; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	40	36	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7220	10.1371/journal.pone.0007220	http://dx.doi.org/10.1371/journal.pone.0007220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19789704	gold, Green Published, Green Submitted			2022-12-25	WOS:000270290000017
J	O'Valle, F; Del Moral, RGM; Benitez, MD; Martin-Oliva, D; Gomez-Morales, M; Aguilar, D; Aneiros-Fernandez, J; Hernandez-Cortes, P; Osuna, A; Moreso, F; Seron, D; Oliver, FJ; Del Moral, RG				O'Valle, Francisco; Del Moral, Raimundo G. M.; del Carmen Benitez, Maria; Martin-Oliva, David; Gomez-Morales, Mercedes; Aguilar, David; Aneiros-Fernandez, Jose; Hernandez-Cortes, Pedro; Osuna, Antonio; Moreso, Francesc; Seron, Daniel; Oliver, Francisco J.; Del Moral, Raimundo G.			Poly[ADP-Ribose] Polymerase-1 Expression Is Related To Cold Ischemia, Acute Tubular Necrosis, and Delayed Renal Function In Kidney Transplantation	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; REPERFUSION INJURY; GRAFT FUNCTION; SYNTHETASE; INHIBITION; DONOR; CELLS; MICE	Cold ischemia time especially impacts on outcomes of expanded-criteria donor (ECD) transplantation. Ischemia-reperfusion (IR) injury produces excessive poly[ADP-Ribose] Polymerase-1 (PARP-1) activation. The present study explored the hypothesis that increased tubular expression of PARP-1 contributes to delayed renal function in suboptimal ECD kidney allografts and in non-ECD allografts that develop posttransplant acute tubular necrosis (ATN). Materials and Methods: Nuclear PARP-1 immunohistochemical expression was studied in 326 paraffin-embedded renal allograft biopsies (193 with different degrees of ATN and 133 controls) and in murine Parp-1 knockout model of IR injury. Results: PARP-1 expression showed a significant relationship with cold ischemia time (r coefficient = 0.603), time to effective diuresis (r = 0.770), serum creatinine levels at biopsy (r = 0.649), and degree of ATN (r = 0.810) (p = 0.001, Pearson test). In the murine IR model, western blot showed an increase in PARP-1 that was blocked by Parp-1 inhibitor. Immunohistochemical study of PARP-1 in kidney allograft biopsies would allow early detection of possible delayed renal function, and the administration of PARP-1 inhibitors may offer a therapeutic option to reduce damage from IR in donor kidneys by preventing or minimizing ATN. In summary, these results suggest a pivotal role for PARP-1 in the ATN of renal transplantation. We propose the immunohistochemical assessment of PARP-1 in kidney allograft biopsies for early detection of a possible delayed renal function.	[O'Valle, Francisco; Del Moral, Raimundo G. M.; del Carmen Benitez, Maria; Gomez-Morales, Mercedes; Aguilar, David; Aneiros-Fernandez, Jose; Del Moral, Raimundo G.] Univ Granada, Dept Pathol, Sch Med, Granada, Spain; [O'Valle, Francisco; Del Moral, Raimundo G. M.; del Carmen Benitez, Maria; Gomez-Morales, Mercedes; Aguilar, David; Aneiros-Fernandez, Jose; Del Moral, Raimundo G.] Univ Granada, Sch Med, Inst Biopathol & Regenerat Med IBIMER, Granada, Spain; [Martin-Oliva, David] Univ Granada, Dept Cell Biol, Granada, Spain; [Hernandez-Cortes, Pedro] San Cecilio Univ Hosp, Dept Traumatol & Orthopaed Surg, Granada, Spain; [Osuna, Antonio] Virgen de las Nieves Univ Hosp, Dept Nephrol, Granada, Spain; [Moreso, Francesc; Seron, Daniel] Bellvitge Univ Hosp, Dept Nephrol, Barcelona, Spain; [Oliver, Francisco J.] CSIC, Inst Parasitol & Biomed, Granada, Spain	University of Granada; University of Granada; University of Granada; Hospital Universitario San Cecilio; Hospital Universitario Virgen de las Nieves; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	O'Valle, F (corresponding author), Univ Granada, Dept Pathol, Sch Med, Granada, Spain.	fovalle@ugr.es	Osuna, Antonio/H-1896-2015; Mateos, Francesc Moreso/O-6451-2016; Aneiros-Fernandez, Jose/AAB-2470-2019; Hernández-Cortés, Pedro/AAS-7691-2020; Martín-Oliva, David/L-8472-2014; Oliver, Javier/S-1725-2018; OValle, Francisco/AAA-9151-2019	Martín-Oliva, David/0000-0002-8095-5442; Oliver, Javier/0000-0001-8468-1998; Moreso, Francesc/0000-0002-7267-3963				Chatterjee PK, 2000, FASEB J, V14, P641, DOI 10.1096/fasebj.14.5.641; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Gueler F, 2004, KIDNEY INT, V66, P523, DOI 10.1111/j.1523-1755.2004.761_11.x; Johnston TD, 2004, CLIN TRANSPLANT, V18, P28, DOI 10.1111/j.1399-0012.2004.00214.x; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V271, pF477, DOI 10.1152/ajprenal.1996.271.3.F477; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Mangino MJ, 2004, AM J PHYSIOL-RENAL, V286, pF838, DOI 10.1152/ajprenal.00230.2003; Martin DR, 2000, AM J PHYSIOL-REG I, V279, pR1834, DOI 10.1152/ajpregu.2000.279.5.R1834; O'Valle F, 2005, TRANSPL P, V37, P1421, DOI 10.1016/j.transproceed.2005.02.040; O'Valle F, 2004, TRANSPL P, V36, P733, DOI 10.1016/j.transproceed.2004.03.029; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; PALLER MS, 1994, J INVEST MED, V42, P632; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Remuzzi G, 2006, NEW ENGL J MED, V354, P343, DOI 10.1056/NEJMoa052891; Salahudeen AK, 2004, J INVEST MED, V52, P296, DOI 10.1136/jim-52-05-28; Salahudeen AK, 2004, KIDNEY INT, V65, P713, DOI 10.1111/j.1523-1755.2004.00416.x; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; SCHRAUFSTATTER IU, 1986, J CLIN INVEST, V77, P1312, DOI 10.1172/JCI112436; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Skaper SD, 2003, ANN NY ACAD SCI, V993, P217, DOI 10.1111/j.1749-6632.2003.tb07532.x; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Thiemermann C, 1997, P NATL ACAD SCI USA, V94, P679, DOI 10.1073/pnas.94.2.679; Weight SC, 1996, BRIT J SURG, V83, P162, DOI 10.1002/bjs.1800830206; WIECEK A, 1996, ANN TRANSPL, V9, P1; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zhang PL, 2008, KIDNEY INT, V73, P608, DOI 10.1038/sj.ki.5002697; Zheng JF, 2005, AM J PHYSIOL-RENAL, V288, pF387, DOI 10.1152/ajprenal.00436.2003	28	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7138	10.1371/journal.pone.0007138	http://dx.doi.org/10.1371/journal.pone.0007138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784367	Green Published, gold, Green Submitted			2022-12-25	WOS:000270290000001
J	Park, SK; Link, CD; Johnson, TE				Park, Sang-Kyu; Link, Christopher D.; Johnson, Thomas E.			Life-span extension by dietary restriction is mediated by NLP-7 signaling and coelomocyte endocytosis in C. elegans	FASEB JOURNAL			English	Article						CUP-4; longevity; regulation of aging; signal transduction; modulation of aging	NEMATODE CAENORHABDITIS-ELEGANS; DECREASES FOOD-INTAKE; OXIDATIVE STRESS; CALORIC RESTRICTION; ENHANCES LONGEVITY; GENE FAMILIES; CHOLECYSTOKININ; AUTOPHAGY; DROSOPHILA; NUTRITION	Recent studies have shown that the rate of aging can be modulated by diverse interventions. Dietary restriction is the most widely used intervention to promote longevity; however, the mechanisms underlying the effect of dietary restriction remain elusive. In a previous study, we identified two novel genes, nlp-7 and cup-4, required for normal longevity in Caenorhabditis elegans. nlp-7 is one of a set of neuropeptide-like protein genes; cup-4 encodes an ion-channel involved in endocytosis by coelomocytes. Here, we assess whether nlp-7 and cup-4 mediate longevity increases by dietary restriction. RNAi of nlp-7 or cup-4 significantly reduces the life span of the eat-2 mutant, a genetic model of dietary restriction, but has no effect on the life span of long-lived mutants resulting from reduced insulin/IGF-1 signaling or dysfunction of the mitochondrial electron transport chain. The life-span extension observed in wild-type N2 worms by dietary restriction using bacterial dilution is prevented significantly in nlp-7 and cup-4 mutants. RNAi knockdown of genes encoding candidate receptors of NLP-7 and genes involved in endocytosis by coelomocytes also specifically shorten the life span of the eat-2 mutant. We conclude that two novel pathways, NLP-7 signaling and endocytosis by coelomocytes, are required for life extension under dietary restriction in C. elegans.-Park, S.-K., Link, C. D., Johnson, T. E. Life-span extension by dietary restriction is mediated by NLP-7 signaling and coelomocyte endocytosis in C. elegans. FASEB J. 24, 383-392 (2010). www.fasebj.org	[Park, Sang-Kyu; Link, Christopher D.; Johnson, Thomas E.] Univ Colorado, Inst Behav Genet, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	Park, SK (corresponding author), Univ Colorado, Inst Behav Genet, Box 447, Boulder, CO 80303 USA.	sangkyu@colorado.edu		/0000-0001-7147-8237	U.S. National Institute on Aging [AG016219]; NATIONAL INSTITUTE ON AGING [R01AG016219, R01AG012423] Funding Source: NIH RePORTER	U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the T.E.J. and C. D. L. laboratories for helpful discussion. We also thank Shohei Mitani (Tokyo Women's Medical University, Tokyo, Japan) for providing strains of nlp-7 deletion mutants. This research was supported by the U.S. National Institute on Aging ( grant AG016219).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Chowdhury P, 2001, ANN CLIN LAB SCI, V31, P376; Clerc P, 2007, ENDOCRINOLOGY, V148, P1039, DOI 10.1210/en.2006-1064; Cypser JR, 2006, EXP GERONTOL, V41, P935, DOI 10.1016/j.exger.2006.09.004; Donovan MJ, 2007, PHYSIOL BEHAV, V92, P969, DOI 10.1016/j.physbeh.2007.07.003; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; Greener T, 2001, NAT CELL BIOL, V3, P215, DOI 10.1038/35055137; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636; Hersh BM, 2002, P NATL ACAD SCI USA, V99, P4355, DOI 10.1073/pnas.062065399; HOSONO R, 1989, EXP GERONTOL, V24, P251, DOI 10.1016/0531-5565(89)90016-8; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Janssen T, 2008, ENDOCRINOLOGY, V149, P2826, DOI 10.1210/en.2007-1772; Johnson TE, 1990, GENETIC EFFECTS AGIN, V2, P101; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KISSILEFF HR, 1981, AM J CLIN NUTR, V34, P154, DOI 10.1093/ajcn/34.2.154; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Li C, 2005, PARASITOLOGY, V131, pS109, DOI 10.1017/S0031182005009376; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Lo CM, 2008, AM J PHYSIOL-REG I, V294, pR803, DOI 10.1152/ajpregu.00682.2007; MANGO SE, 1994, DEVELOPMENT, V120, P3019; MCCAY CM, 1989, NUTRITION, V5, P155; Mckay RM, 2007, EMBO REP, V8, P1183, DOI 10.1038/sj.embor.7401086; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; Patton A, 2005, CURR BIOL, V15, P1045, DOI 10.1016/j.cub.2005.04.057; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Szewczyk NJ, 2006, J EXP BIOL, V209, P4129, DOI 10.1242/jeb.02492	48	36	51	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2010	24	2					383	392		10.1096/fj.09-142984	http://dx.doi.org/10.1096/fj.09-142984			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19783783	Green Published			2022-12-25	WOS:000274045000007
J	Wang, Q; Sun, ZX; Allgayer, H; Yang, HS				Wang, Q.; Sun, Z-X; Allgayer, H.; Yang, H-S			Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells	ONCOGENE			English	Article						Pdcd4; beta-catenin/Tcf-dependent transcription; E-cadherin; u-PAR; c-Myc; stably knockdown	INITIATION-FACTOR 4A; RECEPTOR U-PAR; SUPPRESSOR PDCD4; C-MYC; TRANSFORMATION SUPPRESSOR; PROGRAMMED CELL-DEATH-4; EUKARYOTIC TRANSLATION; AP-1 TRANSACTIVATION; COLORECTAL-CANCER; TUMOR PROGRESSION	We reported earlier that knockdown of tumor suppressor Pdcd4 (programed cell death 4) downregulates E-cadherin expression and activates beta-catenin/Tcf (T-cell factor)dependent transcription in colon tumor cells. However, the underlying mechanism of these observations remains unknown. In this study, we showed that knockdown of Pdcd4 downregulates E-cadherin expression through elevated protein level of Snail. Over-expression of Pdcd4 upregulates E-cadherin expression and inhibits beta-catenin/Tcf-dependent transcription. We then showed that knockdown of E-cadherin activates beta-catenin/Tcf-dependent transcription. Conversely, over-expression of E-cadherin in Pdcd4 knockdown cells inhibits beta-catenin/Tcf-dependent transcription. In addition, Pdcd4 knockdown stimulates urokinase-type plasminogen activator receptor (u-PAR) and c-Myc expression, whereas u-PAR and c-Myc expression can be reversed by over-expressing E-cadherin in Pdcd4 knockdown cells. Using chromatin immunoprecipitation, we showed that beta-catenin/Tcf4 directly binds to the promoters of u-PAR and c-myc in Pdcd4 knockdown cells. Futhermore, knockdown of u-PAR or c-Myc inhibits invasion in Pdcd4 knockdown cells, suggesting that both u-PAR and c-Myc contribute to invasion induced by Pdcd4 knockdown. Taken together, our data showed that elevated Snail expression by Pdcd4 knockdown leads to downregulation of E-cadherin resulting in activating beta-catenin/Tcf-dependent transcription and stimulating the expression of c-Myc and u-PAR, thus providing molecular explanation of how Pdcd4 suppresses tumor invasion.	[Wang, Q.; Yang, H-S] Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA; [Sun, Z-X] Beijing Univ Chinese Med, Dept Pharmaceut, Sch Chinese Pharm, Beijing, Peoples R China; [Allgayer, H.] Univ Heidelberg, Dept Expt Surg & Mol Oncol Solid Tumors, Med Fac Mannheim, D-6800 Mannheim, Germany; [Allgayer, H.] KDFZ Heidelberg, Mannheim, Germany; [Yang, H-S] Univ Kentucky, Lucille P Markey Canc Ctr, Coll Med, Lexington, KY 40536 USA	University of Kentucky; Beijing University of Chinese Medicine; Ruprecht Karls University Heidelberg; University of Kentucky	Yang, HS (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA.	hyang3@uky.edu	Yang, Hsin-Sheng/A-6419-2008; Yang, Hsin-Sheng/AAF-6793-2020	Yang, Hsin-Sheng/0000-0002-0566-3036; Yang, Hsin-Sheng/0000-0002-0566-3036	NCI [R01CA129015]; ACS Institutional Research [IRG-85-001-19]; NCRR CORBE pilot [P20RR020171]; NATIONAL CANCER INSTITUTE [R01CA129015] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS Institutional Research; NCRR CORBE pilot(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr Ji Hshiung Chen (Tzu Chi University, Taiwan) for kindly providing E-cadherin promoter and Dr Xiaoling Guo for technical support. This work was supported by NCI Grant R01CA129015, ACS Institutional Research Grant IRG-85-001-19, and NCRR CORBE pilot grant P20RR020171.	Ahmed N, 2003, BRIT J CANCER, V89, P374, DOI 10.1038/sj.bjc.6601098; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Fuchs SY, 2005, CELL CYCLE, V4, P1522; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; KARIKO K, 1993, CANCER RES, V53, P3109; Kemler R, 1992, Semin Cell Biol, V3, P149; Laufs S, 2006, CELL CYCLE, V5, P1760; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Memarzedeh S, 2002, P NATL ACAD SCI USA, V99, P10647, DOI 10.1073/pnas.152127499; MIYAKI M, 1994, CANCER RES, V54, P3011; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Nestl A, 2001, CANCER RES, V61, P1569; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Ozpolat B, 2007, MOL CANCER RES, V5, P95, DOI 10.1158/1541-7786.MCR-06-0125; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; SMITH DR, 1993, BRIT J CANCER, V68, P407, DOI 10.1038/bjc.1993.350; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	37	73	79	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					128	138		10.1038/onc.2009.302	http://dx.doi.org/10.1038/onc.2009.302			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19784072	Green Accepted			2022-12-25	WOS:000273373500012
J	Pao-Chun, L; Chan, PM; Chan, W; Manser, E				Pao-Chun, Lin; Chan, Perry M.; Chan, Wing; Manser, Ed			Cytoplasmic ACK1 Interaction with Multiple Receptor Tyrosine Kinases Is Mediated by Grb2 AN ANALYSIS OF ACK1 EFFECTS ON Axl SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; EGF RECEPTOR; PROTEIN-KINASE; BREAST-CANCER; AXL RECEPTOR; DOWN-REGULATION; GROWTH ARREST; MAP KINASE; CELL-LINES; EXPRESSION	ACK1 (activated Cdc42-associated kinase 1), a cytoplsmic tyrosine kinase, is implicated in metastatic behavior, cell spreading and migration, and epidermal growth factor receptor (EGFR) signaling. The function of ACK1 in the regulation of receptor tyrosine kinases requires a C-terminal region that demonstrates a significant homology to the EGFR binding domain of MIG6. In this study, we have identified additional receptor tyrosine kinases, including Axl, leukocyte tyrosine kinase, and anaplastic lymphoma kinase, that can bind to the ACK1/MIG6 homology region. Unlike the interaction between MIG6 and EGFR, our data suggest that these receptor tyrosine kinases require the adaptor protein Grb2 for efficient binding, which interacts with highly conserved proline-rich regions that are conserved between ACK1 and MIG6. We have focused on Axl and compared how ACK1/Axl differs from the ACK1/EGFR axis by investigating effects of knockdown of endogenous ACK1. Although EGFR activation promotes ACK1 turnover, Axl activation by GAS6 does not; interestingly, the reciprocal down-regulation of GAS6-stimulated Axl is blocked by removing ACK1. Thus, ACK1 functions in part to control Axl receptor levels. Silencing of ACK1 also leads to diminished ruffling and migration in DU145 and COS7 cells upon GAS6-Axl signaling. The ability of ACK1 to modulate Axl and perhaps anaplastic lymphoma kinase (altered in anaplastic large cell lymphomas) might explain why ACK1 can promote metastatic and transformed behavior in a number of cancers.	[Manser, Ed] ASTAR Neurosci Res Partnership, sGSK Grp, Singapore 138673, Singapore; Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Manser, E (corresponding author), ASTAR Neurosci Res Partnership, sGSK Grp, 61 Biopolis Dr, Singapore 138673, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		GSK (Singapore)	GSK (Singapore)(GlaxoSmithKline)	This work is supported by the GSK (Singapore) research fund.	Allen MP, 2002, MOL CELL BIOL, V22, P599, DOI 10.1128/MCB.22.2.599-613.2002; Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; Berclaz G, 2001, ANN ONCOL, V12, P819, DOI 10.1023/A:1011126330233; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Challier C, 1996, LEUKEMIA, V10, P781; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Goruppi S, 1999, ONCOGENE, V18, P4224, DOI 10.1038/sj.onc.1202788; Goruppi S, 1997, MOL CELL BIOL, V17, P4442, DOI 10.1128/MCB.17.8.4442; Goruppi S, 2001, MOL CELL BIOL, V21, P902, DOI 10.1128/MCB.21.3.902-915.2001; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Gustavsson A, 2004, J BIOL CHEM, V279, P22893, DOI 10.1074/jbc.M309693200; Hackel PO, 2001, BIOL CHEM, V382, P1649, DOI 10.1515/BC.2001.200; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hasanbasic I, 2004, AM J PHYSIOL-HEART C, V287, pH1207, DOI 10.1152/ajpheart.00020.2004; Hoehn GT, 1996, ONCOGENE, V12, P903; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Howlin J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2087; Ito T, 1999, THYROID, V9, P563, DOI 10.1089/thy.1999.9.563; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Jacob ANK, 1999, CANCER DETECT PREV, V23, P325; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; Lee WP, 2002, ONCOGENE, V21, P329, DOI 10.1038/sj.onc.1205066; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Lin M, 2004, BREAST CANCER RES TR, V84, P49, DOI 10.1023/B:BREA.0000018424.43445.f3; Lin WC, 1999, CLIN CANCER RES, V5, P1745; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; LIU E, 1988, P NATL ACAD SCI USA, V85, P1952, DOI 10.1073/pnas.85.6.1952; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MARU Y, 1990, ONCOGENE RES, V5, P199; Meric F, 2002, CLIN CANCER RES, V8, P361; Modzelewska K, 2006, J BIOL CHEM, V281, P37527, DOI 10.1074/jbc.M604342200; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; QUONG RYY, 1994, MELANOMA RES, V4, P313, DOI 10.1097/00008390-199410000-00008; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Satoh T, 1996, FEBS LETT, V386, P230, DOI 10.1016/0014-5793(96)00449-8; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; SHIOTA M, 1995, BLOOD, V86, P1954, DOI 10.1182/blood.V86.5.1954.bloodjournal8651954; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yang WN, 1999, J BIOL CHEM, V274, P8524, DOI 10.1074/jbc.274.13.8524; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	67	28	34	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34954	34963		10.1074/jbc.M109.072660	http://dx.doi.org/10.1074/jbc.M109.072660			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19815557	Green Published, hybrid			2022-12-25	WOS:000272439600051
J	Gilio, K; Munnix, ICA; Mangin, P; Cosemans, JMEM; Feijge, MAH; Van der Meijden, PEJ; Olieslagers, S; Chrzanowska-Wodnicka, MB; Lillian, R; Schoenwaelder, S; Koyasu, S; Sage, SO; Jackson, SP; Heemskerk, JWM				Gilio, Karen; Munnix, Imke C. A.; Mangin, Pierre; Cosemans, Judith M. E. M.; Feijge, Marion A. H.; Van der Meijden, Paola E. J.; Olieslagers, Serve; Chrzanowska-Wodnicka, Magdalena B.; Lillian, Rivka; Schoenwaelder, Simone; Koyasu, Shigeo; Sage, Stewart O.; Jackson, Shaun P.; Heemskerk, Johan W. M.			Non-redundant Roles of Phosphoinositide 3-Kinase Isoforms alpha and beta in Glycoprotein VI-induced Platelet Signaling and Thrombus Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-IA PI3K; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; P85-ALPHA SUBUNIT; COUPLED RECEPTORS; MICE LACKING; GAMMA-CHAIN; GP-VI; COLLAGEN; ACTIVATION; INTEGRIN	Platelets are activated by adhesion to vascular collagen via the immunoglobulin receptor, glycoprotein VI ( GPVI). This causes potent signaling toward activation of phospholipase C gamma 2, which bears similarity to the signaling pathway evoked by T- and B-cell receptors. Phosphoinositide 3-kinase (PI3K) plays an important role in collagen-induced platelet activation, because this activity modulates the autocrine effects of secreted ADP. Here, we identified the PI3K isoforms directly downstream of GPVI in human and mouse platelets and determined their role in GPVI-dependent thrombus formation. The targeting of platelet PI3K alpha or -beta strongly and selectively suppressed GPVI-induced Ca2+ mobilization and inositol 1,4,5-triphosphate production, thus demonstrating enhancement of phospholipase C gamma 2 by PI3K alpha/beta. That PI3K alpha and -beta have a non-redundant function in GPVI-induced platelet activation and thrombus formation was concluded from measurements of: (i) serine phosphorylation of Akt, (ii) dense granule secretion, (iii) intracellular Ca2+ increases and surface expression of phosphatidylserine under flow, and (iv) thrombus formation, under conditions where PI3K alpha/beta was blocked or p85 alpha was deficient. In contrast, GPVI-induced platelet activation was insensitive to inhibition or deficiency of PI3K alpha or -gamma. Furthermore, PI3K alpha/beta, but not PI3K gamma, contributed to GPVI-induced Rap1b activation and, surprisingly, also to Rap1b-independent platelet activation via GPVI. Together, these findings demonstrate that both PI3K alpha and -beta isoforms are required for full GPVI-dependent platelet Ca2+ signaling and thrombus formation, partly independently of Rap1b. This provides a new mechanistic explanation for the anti-thrombotic effect of PI3K inhibition and makes PI3K alpha an interesting new target for anti-platelet therapy.	[Gilio, Karen; Munnix, Imke C. A.; Cosemans, Judith M. E. M.; Feijge, Marion A. H.; Van der Meijden, Paola E. J.; Heemskerk, Johan W. M.] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Olieslagers, Serve] Univ Maastricht, Dept Cardiol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Mangin, Pierre; Lillian, Rivka; Schoenwaelder, Simone; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Alfred Med Res Ctr & Educ Precinct, Melbourne, Vic 3800, Australia; [Chrzanowska-Wodnicka, Magdalena B.] Blood Res Inst, Milwaukee, WI 53233 USA; [Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Sage, Stewart O.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	Maastricht University; Maastricht University; Monash University; Versiti Blood Center of Wisconsin; Keio University; University of Cambridge	Heemskerk, JWM (corresponding author), Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, POB 616, NL-6200 MD Maastricht, Netherlands.	jwm.heemskerk@bioch.unimaas.nl	Mangin, Pierre/H-9354-2016; Schoenwaelder, Simone/E-9506-2011; Koyasu, Shigeo/J-5583-2015; Cosemans, Judith MEM/C-8161-2016; Jackson, Shaun P/E-9633-2011; Heemskerk, Johan/AAM-8323-2021	Koyasu, Shigeo/0000-0001-9585-3038; Cosemans, Judith MEM/0000-0001-7429-0109; Heemskerk, Johan/0000-0002-2848-5121; Sage, Stewart/0000-0001-8578-3558; Chrzanowska, Magdalena/0000-0003-4182-2126; van der Meijden, Paola/0000-0002-6532-2583; Jackson, Shaun/0000-0002-4750-1991; Schoenwaelder, Simone/0000-0003-0465-5840	EU [EST 2005020706]; Netherlands Heart Foundation [2002-B014]; Netherlands Organization for Scientific Research [NWO 11.400.0076]	EU(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Grants from the EU ( Marie Curie EST 2005020706), the Netherlands Heart Foundation (2002-B014), and the Netherlands Organization for Scientific Research (NWO 11.400.0076).	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Cauwenbergbs S, 2007, BRIT J HAEMATOL, V136, P480, DOI 10.1111/j.1365-2141.2006.06453.x; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; Falet H, 2000, BLOOD, V96, P3786, DOI 10.1182/blood.V96.12.3786.h8003786_3786_3792; Feijge MAH, 1998, BRIT J HAEMATOL, V102, P850, DOI 10.1046/j.1365-2141.1998.00844.x; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Heemskerk JWM, 2005, TRENDS CARDIOVAS MED, V15, P86, DOI 10.1016/j.tcm.2005.03.003; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Heemskerk JWM, 2001, J PHYSIOL-LONDON, V535, P625, DOI 10.1111/j.1469-7793.2001.00625.x; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035; Kim S, 2007, BLOOD, V110, P4206, DOI 10.1182/blood-2007-03-080804; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Lagrue AH, 1999, FEBS LETT, V448, P95, DOI 10.1016/S0014-5793(99)00340-3; Lecut C, 2004, ARTERIOSCL THROM VAS, V24, P1727, DOI 10.1161/01.ATV.0000137974.85068.93; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Lu PJ, 1998, BIOCHEMISTRY-US, V37, P9776, DOI 10.1021/bi980163o; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Nesbitt WS, 2006, J MOL MED, V84, P989, DOI 10.1007/s00109-006-0101-1; Nieswandt B, 2001, BLOOD, V97, P3829, DOI 10.1182/blood.V97.12.3829; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Pasquet JM, 1999, BIOCHEM J, V342, P171, DOI 10.1042/0264-6021:3420171; Pasquet JM, 2000, EMBO J, V19, P2793, DOI 10.1093/emboj/19.12.2793; Rittenhouse SE, 1996, BLOOD, V88, P4401, DOI 10.1182/blood.V88.12.4401.bloodjournal88124401; Savage B, 1999, BLOOD, V94, P2704, DOI 10.1182/blood.V94.8.2704.420k41_2704_2715; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schoenwaelder SM, 2007, J BIOL CHEM, V282, P28648, DOI 10.1074/jbc.M704358200; Senis YA, 2005, PLATELETS, V16, P191, DOI 10.1080/09537100400016711; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Stephens L, 2005, CURR OPIN PHARMACOL, V5, P357, DOI 10.1016/j.coph.2005.03.002; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vogt PK, 2008, CANCER CELL, V14, P107, DOI 10.1016/j.ccr.2008.07.008; Watanabe N, 2003, BLOOD, V102, P541, DOI 10.1182/blood-2002-11-3327; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200	52	88	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33750	33762		10.1074/jbc.M109.048439	http://dx.doi.org/10.1074/jbc.M109.048439			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815551	Green Published, hybrid			2022-12-25	WOS:000272165200005
J	Kansanen, E; Jyrkkanen, HK; Volger, OL; Leinonen, H; Kivela, AM; Hakkinen, SK; Woodcock, SR; Schopfer, FJ; Horrevoets, AJ; Yla-Herttuala, S; Freeman, BA; Levonen, AL				Kansanen, Emilia; Jyrkkanen, Henna-Kaisa; Volger, Oscar L.; Leinonen, Hanna; Kivela, Annukka M.; Hakkinen, Sanna-Kaisa; Woodcock, Steven R.; Schopfer, Francisco J.; Horrevoets, Anton J.; Yla-Herttuala, Seppo; Freeman, Bruce A.; Levonen, Anna-Liisa			Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells IDENTIFICATION OF HEAT SHOCK RESPONSE AS THE MAJOR PATHWAY ACTIVATED BY NITRO-OLEIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NRF2 ENHANCES SUSCEPTIBILITY; TRANSCRIPTION FACTOR NRF2; OXIDIZED PHOSPHOLIPIDS; NITROLINOLEIC ACID; OXIDATIVE STRESS; GENE-EXPRESSION; FACTOR-1; INFLAMMATION; APOPTOSIS; PROTEINS	Electrophilic fatty acid derivatives, including nitrolinoleic acid and nitro-oleic acid (OA-NO2), can mediate anti-inflammatory and pro-survival signaling reactions. The transcription factor Nrf2, activated by electrophilic fatty acids, suppresses redox-sensitive pro-inflammatory gene expression and protects against vascular endothelial oxidative injury. It was therefore postulated that activation of Nrf2 by OA-NO2 accounts in part for its anti-inflammatory actions, motivating the characterization of Nrf2-dependent and -independent effects of OA-NO2 on gene expression using genome-wide transcriptional profiling. Control and Nrf2-small interfering RNA-transfected human endothelial cells were treated with vehicle, oleic acid, or OA-NO2, and differential gene expression profiles were determined. Although OA-NO2 significantly induced the expression of Nrf2-dependent genes, including heme oxygenase-1 and glutamatecysteine ligase modifier subunit, the majority of OA-NO2-regulated genes were regulated by Nrf2-independent pathways. Moreover, gene set enrichment analysis revealed that the heat shock response is the major pathway activated by OA-NO2, with robust induction of a number of heat shock genes regulated by the heat shock transcription factor. Inasmuch as the heat shock response mediates anti-inflammatory and cytoprotective actions, this mechanism is proposed to contribute to the protective cell signaling functions of nitro-fatty acids and other electrophilic fatty acid derivatives.	[Woodcock, Steven R.; Schopfer, Francisco J.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Kansanen, Emilia; Jyrkkanen, Henna-Kaisa; Leinonen, Hanna; Kivela, Annukka M.; Hakkinen, Sanna-Kaisa; Yla-Herttuala, Seppo; Levonen, Anna-Liisa] Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland; [Volger, Oscar L.; Horrevoets, Anton J.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Eastern Finland; Vrije Universiteit Amsterdam	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	freerad@pitt.edu; anna-liisa.levonen@uku.fi	Schopfer, Francisco/AAW-6505-2021; Schopfer, Francisco Jose/AAE-8125-2020; Freeman, Bruce A/H-9342-2012; Woodcock, Steven/AAE-9199-2020	Schopfer, Francisco Jose/0000-0001-9526-695X; Levonen, Anna-Liisa/0000-0002-6575-2137; Kansanen, Emilia/0000-0001-6029-8097; Yla-Herttuala, Seppo/0000-0001-7593-2708; Kivela, Annukka/0000-0003-0899-8445	National Institutes of Health [R01 HL58115, R01 HL64937]; Finnish Cultural Foundation; Academy of Finland; Finnish Foundation of Cardiovascular Research; Sigrid Juselius Foundation; American Diabetes Association [7-08-JF-52]; American Heart Association [0665418U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064937, R01HL058115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); Finnish Foundation of Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL58115 and R01 HL64937 ( to B. A. F.). This work was also supported by the Finnish Cultural Foundation ( to E. K. and A. L. L.), the Academy of Finland, the Finnish Foundation of Cardiovascular Research, the Sigrid Juselius Foundation ( to A. L. L.), American Diabetes Association Grant 7-08-JF-52, and American Heart Association Grant 0665418U ( to F. J. S.).	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Fu Q, 2008, CIRC RES, V103, P369, DOI 10.1161/CIRCRESAHA.108.174607; Gil RR, 2008, AM J ROENTGENOL, V191, P1046, DOI 10.2214/AJR.07.2691; Harrison EM, 2008, AM J PHYSIOL-RENAL, V295, pF397, DOI 10.1152/ajprenal.00361.2007; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Ichikawa T, 2008, ENDOCRINOLOGY, V149, P4086, DOI 10.1210/en.2007-1639; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jo SK, 2006, J AM SOC NEPHROL, V17, P3082, DOI 10.1681/ASN.2005101077; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Koizumi S, 2007, J BIOL CHEM, V282, P8715, DOI 10.1074/jbc.M609427200; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Levonen AL, 2007, ARTERIOSCL THROM VAS, V27, P741, DOI 10.1161/01.ATV.0000258868.80079.4d; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rossig L, 2001, BASIC RES CARDIOL, V96, P11, DOI 10.1007/s003950170073; RUBBO H, 1994, J BIOL CHEM, V269, P26066; RUDOLPH V, 2009, CARDIOVASC IN PRESS; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Vila A, 2008, CHEM RES TOXICOL, V21, P432, DOI 10.1021/tx700347w; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103; Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50	62	128	133	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33233	33241		10.1074/jbc.M109.064873	http://dx.doi.org/10.1074/jbc.M109.064873			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808663	Green Published, hybrid			2022-12-25	WOS:000272028500028
J	Takahashi, H; Martin-Brown, S; Washburn, MP; Florens, L; Conaway, JW; Conaway, RC				Takahashi, Hidehisa; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Conaway, Joan W.; Conaway, Ronald C.			Proteomics Reveals a Physical and Functional Link between Hepatocyte Nuclear Factor 4 alpha and Transcription Factor IID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; SPECTRAL ABUNDANCE FACTORS; GENERAL INITIATION-FACTORS; IDENTIFICATION TECHNOLOGY; DEUBIQUITINATING ENZYME; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; IN-VITRO; PROMOTER SELECTIVITY	Proteomic analyses have contributed substantially to our understanding of diverse cellular processes. Improvements in the sensitivity of mass spectrometry approaches are enabling more in-depth analyses of protein-protein networks and, in some cases, are providing surprising new insights into well established, longstanding problems. Here, we describe such a proteomic analysis that exploits MudPIT mass spectrometry and has led to the discovery of a physical and functional link between the orphan nuclear receptor hepatocyte nuclear factor 4 alpha (HNF4 alpha) and transcription factor IID (TFIID). A systematic characterization of the HNF4 alpha-TFIID link revealed that the HNF4 alpha DNA-binding domain binds directly to the TATA box-binding protein (TBP) and, through this interaction, can target TBP or TFIID to promoters containing HNF4 alpha-binding sites in vitro. Supporting the functional significance of this interaction, an HNF4 alpha mutation that blocks binding of TBP to HNF4 alpha interferes with HNF4 alpha transactivation activity in cells. These findings identify an unexpected role for the HNF4 alpha DNA-binding domain in mediating key regulatory interactions and provide new insights into the roles of HNF4 alpha and TFIID in RNA polymerase II transcription.	[Takahashi, Hidehisa; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Conaway, RC (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rcc@stowers-institute.org	Hidehisa, Takahashi/E-2175-2012	Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585; Conaway, Joan/0000-0002-2786-0663	NIGMS [R37 GM41628]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM41628 from NIGMS (to R.C.C.). This work was also supported by the Stowers Institute for Medical Research.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bartoov-Shifman R, 2002, J BIOL CHEM, V277, P25914, DOI 10.1074/jbc.M201582200; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; CAREY M, 1990, SCIENCE, V247, P710, DOI 10.1126/science.2405489; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; COMAI L, 1994, SCIENCE, V266, P1966, DOI 10.1126/science.7801123; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; DYNLACHT BD, 1993, NATURE, V363, P176, DOI 10.1038/363176a0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Ford J, 1997, MOL ENDOCRINOL, V11, P1467, DOI 10.1210/me.11.10.1467; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Gorski JJ, 2007, EMBO J, V26, P1560, DOI 10.1038/sj.emboj.7601601; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; HISATAKE K, 1995, P NATL ACAD SCI USA, V92, P8195, DOI 10.1073/pnas.92.18.8195; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Johnson KM, 2004, METHOD ENZYMOL, V380, P207; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KOKUBO T, 1994, NATURE, V367, P484, DOI 10.1038/367484a0; KOKUBO T, 1993, MOL CELL BIOL, V13, P7859, DOI 10.1128/MCB.13.12.7859; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Li JX, 2000, GENE DEV, V14, P464; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; Lu P, 2008, J BIOL CHEM, V283, P33685, DOI 10.1074/jbc.M806213200; Makino Y, 1999, GENES CELLS, V4, P529, DOI 10.1046/j.1365-2443.1999.00277.x; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; MALIK S, 1995, NUCLEIC ACIDS RES, V23, P1536, DOI 10.1093/nar/23.9.1536; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; MENGUS G, 1995, EMBO J, V14, P1520, DOI 10.1002/j.1460-2075.1995.tb07138.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mousson F, 2008, MOL CELL PROTEOMICS, V7, P845, DOI 10.1074/mcp.M700306-MCP200; Muldrow TA, 1999, MOL CELL BIOL, V19, P2835; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; SCHULMAN IG, 1995, P NATL ACAD SCI USA, V92, P8288, DOI 10.1073/pnas.92.18.8288; SIMMEN KA, 1992, NUCLEIC ACIDS RES, V20, P5889, DOI 10.1093/nar/20.22.5889; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; TAGGART AKP, 1992, CELL, V71, P1015, DOI 10.1016/0092-8674(92)90396-T; Tatarakis A, 2008, MOL CELL, V31, P531, DOI 10.1016/j.molcel.2008.07.013; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WIDOM RL, 1991, MOL CELL BIOL, V11, P677, DOI 10.1128/MCB.11.2.677; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; YOKOMORI K, 1993, GENE DEV, V7, P2587, DOI 10.1101/gad.7.12b.2587; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	80	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32405	32412		10.1074/jbc.M109.017954	http://dx.doi.org/10.1074/jbc.M109.017954			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19805548	Green Published, hybrid			2022-12-25	WOS:000272028400023
J	Gildemeister, OS; Sage, JM; Knight, KL				Gildemeister, Otto S.; Sage, Jay M.; Knight, Kendall L.			Cellular Redistribution of Rad51 in Response to DNA Damage NOVEL ROLE FOR Rad51C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; NUCLEAR FOCI; GLYCOSYLASE MOGG1; REPAIR PROTEINS; BRCA2; XRCC3; LOCALIZATION; EXPRESSION; CELLS; DEFICIENCY	Exposure of cells to DNA-damaging agents results in a rapid increase in the formation of subnuclear complexes containing Rad51. To date, it has not been determined to what extent DNA damage-induced cytoplasmic to nuclear transport of Rad51 may contribute to this process. We have analyzed subcellular fractions of HeLa and HCT116 cells and found a significant increase in nuclear Rad51 levels following exposure to a modest dose of ionizing radiation (2 grays). We also observed a DNA damage-induced increase in nuclear Rad51 in the Brca2-defective cell line Capan-1. To address a possible Brca2-independent mechanism for Rad51 nuclear transport, we analyzed subcellular fractions for two other Rad51-interacting proteins, Rad51C and Xrcc3. Rad51C has a functional nuclear localization signal, and although we found that the subcellular distribution of Xrcc3 was not significantly affected by DNA damage, there was a damage-induced increase in nuclear Rad51C. Furthermore, RNA interference-mediated depletion of Rad51C in HeLa and Capan-1 cells resulted in lower steady-state levels of nuclear Rad51 as well as a diminished DNA damage-induced increase. Our results provide important insight into the cellular regulation of Rad51 nuclear entry and a role for Rad51C in this process.	[Gildemeister, Otto S.; Sage, Jay M.; Knight, Kendall L.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Knight, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Aaron Lazare Med Res Bldg,Rm 913,364 Plantat St, Worcester, MA 01605 USA.	kendall.knight@umassmed.edu			National Institutes of Health [GM044772, GM065851]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065851, R01GM044772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM044772 and GM065851 ( to K. L. K.).	Abbott DW, 1998, J NATL CANCER I, V90, P978, DOI 10.1093/jnci/90.13.978; Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bennett BT, 2009, METHODS, V48, P63, DOI 10.1016/j.ymeth.2009.02.009; Bennett BT, 2005, J CELL BIOCHEM, V96, P1095, DOI 10.1002/jcb.20640; Brieger A, 2005, MOL CARCINOGEN, V43, P51, DOI 10.1002/mc.20081; Chen FQ, 1997, MUTAT RES-DNA REPAIR, V384, P205, DOI 10.1016/S0921-8777(97)00020-7; Chen JJ, 1999, CANCER RES, V59, p1752S; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Conlon KA, 2004, DNA REPAIR, V3, P1601, DOI 10.1016/j.dnarep.2004.06.011; Conlon KA, 2003, DNA REPAIR, V2, P1337, DOI 10.1016/j.dnarep.2003.08.002; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Dosanjh MK, 1998, NUCLEIC ACIDS RES, V26, P1179, DOI 10.1093/nar/26.5.1179; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Forget AL, 2004, J CELL BIOCHEM, V93, P429, DOI 10.1002/jcb.20232; French CA, 2003, J BIOL CHEM, V278, P45445, DOI 10.1074/jbc.M308621200; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Goggins M, 1996, CANCER RES, V56, P5360; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; Henson SE, 2006, MUTAT RES-FUND MOL M, V601, P113, DOI 10.1016/j.mrfmmm.2006.06.016; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Iwanaga R, 2004, ONCOGENE, V23, P8581, DOI 10.1038/sj.onc.1207976; Kanamoto T, 2002, EMBO J, V21, P1219, DOI 10.1093/emboj/21.5.1219; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Knudsen NO, 2007, NUCLEIC ACIDS RES, V35, P2609, DOI 10.1093/nar/gkl1166; Kovalenko OV, 2006, NUCLEIC ACIDS RES, V34, P5081, DOI 10.1093/nar/gkl665; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Lee SA, 2009, DNA REPAIR, V8, P170, DOI 10.1016/j.dnarep.2008.10.002; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lio YC, 2004, J BIOL CHEM, V279, P42313, DOI 10.1074/jbc.M405212200; Liu N, 2005, J CELL BIOCHEM, V95, P942, DOI 10.1002/jcb.20457; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Mladenov E, 2006, GENES CELLS, V11, P513, DOI 10.1111/j.1365-2443.2006.00958.x; Orelli BJ, 2001, BREAST CANCER RES, V3, P294, DOI 10.1186/bcr310; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Raderschall E, 2002, J CELL SCI, V115, P153; Raderschall E, 2002, CANCER RES, V62, P219; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Tashiro S, 1996, ONCOGENE, V12, P2165; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354; Tembe V, 2007, CELL SIGNAL, V19, P1113, DOI 10.1016/j.cellsig.2007.03.001; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; van Veelen LR, 2005, MUTAT RES-FUND MOL M, V574, P22, DOI 10.1016/j.mrfmmm.2005.01.019; Wiese C, 2002, NUCLEIC ACIDS RES, V30, P1001, DOI 10.1093/nar/30.4.1001; Wyman C, 2004, CURR BIOL, V14, pR629, DOI 10.1016/j.cub.2004.07.049; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yoshikawa K, 2000, INT J CANCER, V88, P28, DOI 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4; Yu DS, 2003, MOL CELL, V12, P1029, DOI 10.1016/S1097-2765(03)00394-0; Yuan SSF, 1999, CANCER RES, V59, P3547	84	60	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31945	31952		10.1074/jbc.M109.024646	http://dx.doi.org/10.1074/jbc.M109.024646			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19783859	Green Published, hybrid			2022-12-25	WOS:000271572700050
J	Shi-wen, X; Liu, SX; Eastwood, M; Sonnylal, S; Denton, CP; Abraham, DJ; Leask, A				Shi-wen, Xu; Liu, Shangxi; Eastwood, Mark; Sonnylal, Sonali; Denton, Christopher P.; Abraham, David J.; Leask, Andrew			Rac Inhibition Reverses the Phenotype of Fibrotic Fibroblasts	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; FOCAL ADHESION KINASE; SCLERODERMA FIBROBLASTS; SYSTEMIC-SCLEROSIS; GROWTH-FACTOR; RHO GTPASES; TGF-BETA; IN-VIVO; LUNG FIBROBLASTS; RATIONAL DESIGN	Background: Fibrosis, the excessive deposition of scar tissue by fibroblasts, is one of the largest groups of diseases for which there is no therapy. Fibroblasts from lesional areas of scleroderma patients possess elevated abilities to contract matrix and produce alpha-smooth muscle actin (alpha-SMA), type I collagen and CCN2 (connective tissue growth factor, CTGF). The basis for this phenomenon is poorly understood, and is a necessary prerequisite for developing novel, rational anti-fibrotic strategies. Methods and Findings: Compared to healthy skin fibroblasts, dermal fibroblasts cultured from lesional areas of scleroderma (SSc) patients possess elevated Rac activity. NSC23766, a Rac inhibitor, suppressed the persistent fibrotic phenotype of lesional SSc fibroblasts. NSC23766 caused a decrease in migration on and contraction of matrix, and alpha-SMA, type I collagen and CCN2 mRNA and protein expression. SSc fibroblasts possessed elevated Akt phosphorylation, which was also blocked by NSC23766. Overexpression of rac1 in normal fibroblasts induced matrix contraction and alpha-SMA, type I collagen and CCN2 mRNA and protein expression. Rac1 activity was blocked by PI3kinase/Akt inhibition. Basal fibroblast activity was not affected by NSC23766. Conclusion: Rac inhibition may be considered as a novel treatment for the fibrosis observed in SSc.			Shi-wen, X (corresponding author), UCL, Dept Med, Ctr Rheumatol, Royal Free Campus, London, England.	Andrew.leask@schulich.uwo.ca	Leask, Andy/ABH-9433-2020; Leask, Andrew/G-5217-2015					Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Chen YL, 2006, ARTHRITIS RHEUM-US, V54, P1309, DOI 10.1002/art.21725; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Chen YL, 2008, ARTHRITIS RHEUM-US, V58, P577, DOI 10.1002/art.23146; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Dugina V, 2001, J CELL SCI, V114, P3285; EASTWOOD M, 1994, BBA-GEN SUBJECTS, V1201, P186, DOI 10.1016/0304-4165(94)90040-X; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Ishida W, 2006, J INVEST DERMATOL, V126, P1733, DOI 10.1038/sj.jid.5700303; Jun JB, 2005, J INVEST DERMATOL, V124, P298, DOI 10.1111/j.0022-202X.2004.23559.x; Leask A, 2008, J CELL SCI, V121, P3459, DOI 10.1242/jcs.029215; Leask A, 2008, CELL SIGNAL, V20, P1409, DOI 10.1016/j.cellsig.2008.01.006; Liu SX, 2008, ARTHRITIS RHEUM-US, V58, P2189, DOI 10.1002/art.23595; Liu SX, 2009, AM J PATHOL, V174, P1847, DOI 10.2353/ajpath.2009.080779; Matozaki T, 2000, CELL SIGNAL, V12, P515, DOI 10.1016/S0898-6568(00)00102-9; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Renzoni EA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-24; Rockey DC, 2008, CLIN LIVER DIS, V12, P939, DOI 10.1016/j.cld.2008.07.011; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Trojanowska M, 2007, CURR OPIN RHEUMATOL, V19, P568, DOI 10.1097/BOR.0b013e3282e6f495; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varga John, 2004, Curr Rheumatol Rep, V6, P164, DOI 10.1007/s11926-004-0062-8; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Xu SW, 2007, MATRIX BIOL, V26, P625, DOI 10.1016/j.matbio.2007.06.003; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; Xu SW, 2004, J BIOL CHEM, V279, P23098, DOI 10.1074/jbc.M311430200; Xu SW, 1998, J CARDIOVASC PHARM, V31, pS360, DOI 10.1097/00005344-199800001-00101; Zamir E, 2001, J CELL SCI, V114, P3583	44	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7438	10.1371/journal.pone.0007438	http://dx.doi.org/10.1371/journal.pone.0007438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823586	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808300014
J	Scholl, HPN; Fleckenstein, M; Fritsche, LG; Schmitz-Valckenberg, S; Gobel, A; Adrion, C; Herold, C; Keilhauer, CN; Mackensen, F; Mossner, A; Pauleikhoff, D; Weinberger, AWA; Mansmann, U; Holz, FG; Becker, T; Weber, BHF				Scholl, Hendrik P. N.; Fleckenstein, Monika; Fritsche, Lars G.; Schmitz-Valckenberg, Steffen; Goebel, Arno; Adrion, Christine; Herold, Christine; Keilhauer, Claudia N.; Mackensen, Friederike; Moessner, Andreas; Pauleikhoff, Daniel; Weinberger, Andreas W. A.; Mansmann, Ulrich; Holz, Frank G.; Becker, Tim; Weber, Bernhard H. F.			CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD	PLOS ONE			English	Article								Background: Age-related macular degeneration (AMD) is a prevalent cause of blindness in Western societies. Variants in the genes encoding complement factor H (CFH), complement component 3 (C3) and age-related maculopathy susceptibility 2 (ARMS2) have repeatedly been shown to confer significant risks for AMD; however, their role in disease progression and thus their potential relevance for interventional therapeutic approaches remains unknown. Methodology/Principal Findings: Here, we analyzed association between variants in CFH, C3 and ARMS2 and disease progression of geographic atrophy (GA) due to AMD. A quantitative phenotype of disease progression was computed based on longitudinal observations by fundus autofluorescence imaging. In a subset of 99 cases with pure bilateral GA, variants in CFH (Y402H), C3 (R102G), and ARMS2 (A69S) are associated with disease (P = 1.6 x 10(-9), 3.2 x 10(-3), and P = 2.6 x 10(-12), respectively) when compared to 612 unrelated healthy control individuals. In cases, median progression rate of GA over a mean follow-up period of 3.0 years was 1.61 mm(2)/year with high concordance between fellow eyes. No association between the progression rate and any of the genetic risk variants at the three loci was observed (P>0.13). Conclusions/Significance: This study confirms that variants at CFH, C3, and ARMS2 confer significant risks for GA due to AMD. In contrast, our data indicate no association of these variants with disease progression which may have important implications for future treatment strategies. Other, as yet unknown susceptibilities may influence disease progression.			Scholl, HPN (corresponding author), Univ Bonn, Dept Ophthalmol, D-5300 Bonn, Germany.	bweb@klinik.uni-regensburg.de	Adrion, Christine/AAB-7247-2020; Fritsche, Lars G/AAF-9387-2019	Adrion, Christine/0000-0003-2408-2533; Fritsche, Lars G/0000-0002-2110-1690; Weber, Bernhard H.F./0000-0002-8808-7723; Fleckenstein, Monika/0000-0001-8321-8037				Becker T, 2005, ANN HUM GENET, V69, P747, DOI 10.1111/j.1529-8817.2005.00198.x; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; Bindewald A, 2005, BRIT J OPHTHALMOL, V89, P874, DOI 10.1136/bjo.2004.057794; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Deckert A, 2005, BMC Ophthalmol, V5, P8, DOI 10.1186/1471-2415-5-8; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dreyhaupt J, 2007, METHOD INFORM MED, V46, P432, DOI 10.1160/ME0328; Dreyhaupt J, 2005, OPHTHAL EPIDEMIOL, V12, P353, DOI 10.1080/09286580591005723; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Holz FG, 1998, AM J OPHTHALMOL, V125, P227, DOI 10.1016/S0002-9394(99)80095-6; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lindblad AS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1168, DOI 10.1001/archophthalmol.2009.198; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Pirbhai A, 2005, AM J OPHTHALMOL, V139, P455, DOI 10.1016/j.ajo.2004.09.077; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Schmitz-Valckenberg S, 2004, INVEST OPHTH VIS SCI, V45, P4470, DOI 10.1167/iovs.03-1311; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Scholl HPN, 2007, MOL VIS, V13, P196; Scholl HPN, 2003, GRAEF ARCH CLIN EXP, V241, P39, DOI 10.1007/s00417-002-0602-8; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Sunness JS, 1999, INVEST OPHTH VIS SCI, V40, P1761; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	45	73	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7418	10.1371/journal.pone.0007418	http://dx.doi.org/10.1371/journal.pone.0007418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823576	Green Published, gold, Green Submitted			2022-12-25	WOS:000270728500016
J	Bozek, K; Thielen, A; Sierra, S; Kaiser, R; Lengauer, T				Bozek, Katarzyna; Thielen, Alexander; Sierra, Saleta; Kaiser, Rolf; Lengauer, Thomas			V3 Loop Sequence Space Analysis Suggests Different Evolutionary Patterns of CCR5-and CXCR4-Tropic HIV	PLOS ONE			English	Article								The V3 loop of human immunodeficiency virus type 1 (HIV-1) is critical for coreceptor binding and is the main determinant of which of the cellular coreceptors, CCR5 or CXCR4, the virus uses for cell entry. The aim of this study is to provide a large-scale data driven analysis of HIV-1 coreceptor usage with respect to the V3 loop evolution and to characterize CCR5- and CXCR4-tropic viral phenotypes previously studied in small-and medium-scale settings. We use different sequence similarity measures, phylogenetic and clustering methods in order to analyze the distribution in sequence space of roughly 1000 V3 loop sequences and their tropism phenotypes. This analysis affords a means of characterizing those sequences that are misclassified by several sequence-based coreceptor prediction methods, as well as predicting the coreceptor using the location of the sequence in sequence space and of relating this location to the CD4(+) T-cell count of the patient. We support previous findings that the usage of CCR5 is correlated with relatively high sequence conservation whereas CXCR4-tropic viruses spread over larger regions in sequence space. The incorrectly predicted sequences are mostly located in regions in which their phenotype represents the minority or in close vicinity of regions dominated by the opposite phenotype. Nevertheless, the location of the sequence in sequence space can be used to improve the accuracy of the prediction of the coreceptor usage. Sequences from patients with high CD4+ T-cell counts are relatively highly conserved as compared to those of immunosuppressed patients. Our study thus supports hypotheses of an association of immune system depletion with an increase in V3 loop sequence variability and with the escape of the viral sequence to distant parts of the sequence space.			Bozek, K (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	bozek@mpi-inf.mpg.de						Altmann A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003470; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jensen Mark A., 2003, AIDS Reviews, V5, P104; Low AJ, 2008, AIDS RES HUM RETROV, V24, P219, DOI 10.1089/aid.2007.0140; MCNEARNEY T, 1992, P NATL ACAD SCI USA, V89, P10247, DOI 10.1073/pnas.89.21.10247; MIEDEMA F, 1994, IMMUNOL REV, V140, P35, DOI 10.1111/j.1600-065X.1994.tb00864.x; MILICH L, 1993, J VIROL, V67, P5623, DOI 10.1128/JVI.67.9.5623-5634.1993; Nelson JAE, 1997, J VIROL, V71, P8750, DOI 10.1128/JVI.71.11.8750-8758.1997; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; SCHUITEMAKER H, 1991, J VIROL, V65, P356, DOI 10.1128/JVI.65.1.356-363.1991; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHEPHERD J, 2008, J INFECT DIS, V198; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sing T, 2007, ANTIVIR THER, V12, P1097; Van Rij RP, 2003, AIDS RES HUM RETROV, V19, P389, DOI 10.1089/088922203765551737; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang LQ, 1997, J VIROL, V71, P2555, DOI 10.1128/JVI.71.3.2555-2561.1997; LANL HIV SEQUENCE DA	32	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7387	10.1371/journal.pone.0007387	http://dx.doi.org/10.1371/journal.pone.0007387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816596	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594300009
J	Nuijten, E; van Treuren, R; Struik, PC; Mokuwa, A; Okry, F; Teeken, B; Richards, P				Nuijten, Edwin; van Treuren, Robbert; Struik, Paul C.; Mokuwa, Alfred; Okry, Florent; Teeken, Bela; Richards, Paul			Evidence for the Emergence of New Rice Types of Interspecific Hybrid Origin in West African Farmers' Fields	PLOS ONE			English	Article							ORYZA-SATIVA-L; CULTIVATED RICE; POPULATION-STRUCTURE; GENETIC DIVERSITY; CHLOROPLAST DNA; FOOD SECURITY; UPLAND RICE; GLABERRIMA; INFERENCE; PROGENIES	In West Africa two rice species (Oryza glaberrima Steud. and Oryza sativa L.) co-exist. Although originally it was thought that interspecific hybridization is impossible without biotechnological methods, progenies of hybridization appear to occur in farmer fields. AFLP analysis was used to assess genetic diversity in West Africa (including the countries The Gambia, Senegal, Guinea Bissau, Guinea Conakry, Sierra Leone, Ghana and Togo) using 315 rice samples morphologically classified prior to analysis. We show evidence for farmer interspecific hybrids of African and Asian rice, resulting in a group of novel genotypes, and identify possible mechanisms for in-field hybridization. Spontaneous back-crossing events play a crucial role, resulting in different groups of genetic diversity in different regions developed by natural and cultural selection, often under adverse conditions. These new groups of genotypes may have potential relevance for exploitation by plant breeders. Future advances in crop development could be achieved through co-operation between scientists and marginalized farmer groups in order to address challenges of rapid adaptation in a world of increasing socio-political and climatic uncertainty.			Nuijten, E (corresponding author), Wageningen Univ, Technol & Agr Dev Grp, Wageningen, Netherlands.	Edwin.Nuijten@wur.nl		Teeken, Bela/0000-0002-3150-1532; Richards, Paul/0000-0001-5813-0228				Barry MB, 2007, EUPHYTICA, V154, P127, DOI 10.1007/s10681-006-9278-1; BOUHARMONT J, 1985, EUPHYTICA, V34, P75, DOI 10.1007/BF00022865; BRYDON L, 1981, AFRICA, V51, P658, DOI 10.2307/1158831; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; CHU YE, 1970, EVOLUTION, V24, P344, DOI 10.2307/2406809; DALLY AM, 1990, THEOR APPL GENET, V80, P209, DOI 10.1007/BF00224389; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; HARLAN JR, 1971, SCIENCE, V174, P468, DOI 10.1126/science.174.4008.468; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; ISHII T, 1988, JPN J GENET, V63, P523, DOI 10.1266/jjg.63.523; JONES M, 2004, INT YEAR RIC WORLD F; Jones MP, 1997, EUPHYTICA, V94, P237, DOI 10.1023/A:1002969932224; Jusu Malcolm, 1999, THESIS WAGENINGEN U; LONGLEY C, 1993, CULTIVATING KNOWLEDG, P51; Nei M., 1987, MOL EVOLUTIONARY GEN; Nuijten E, 2007, GENET RESOUR CROP EV, V54, P989, DOI 10.1007/s10722-006-9191-4; Nuijten Edwin, 2005, THESIS WAGENINGEN U; PHAM JL, 1993, HEREDITY, V70, P466, DOI 10.1038/hdy.1993.68; Pham JL, 1996, HEREDITAS, V124, P179, DOI 10.1111/j.1601-5223.1996.00179.x; PORTERES R, 1962, J AFR HIST, V3, P195, DOI 10.1017/S0021853700003030; Pritchard JK, 2000, GENETICS, V155, P945; Richards P, 2006, AFR SPECTR, V41, P77; Richards P., 1997, The ecology of practice: studies of food crop production in Sub-Saharan West Africa., P201; Richards P., 1986, COPING HUNGER HAZARD; Richards P, 2009, INT J TECHNOL MANAGE, V45, P196, DOI 10.1504/IJTM.2009.021528; SANO Y, 1989, HEREDITY, V63, P353, DOI 10.1038/hdy.1989.109; SANO Y, 1980, JPN J GENET, V55, P19, DOI 10.1266/jjg.55.19; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Semon M, 2005, GENETICS, V169, P1639, DOI 10.1534/genetics.104.033175; Spillane C, 2001, BROADENING GENETIC B, P25, DOI DOI 10.1079/9780851994116.0025; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; YABUNO T, 1977, EUPHYTICA, V26, P451, DOI 10.1007/BF00027007	32	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7335	10.1371/journal.pone.0007335	http://dx.doi.org/10.1371/journal.pone.0007335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806197	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800025
J	Zong, F; Fthenou, E; Wolmer, N; Hollosi, P; Kovalszky, I; Szilak, L; Mogler, C; Nilsonne, G; Tzanakakis, G; Dobra, K				Zong, Fang; Fthenou, Eleni; Wolmer, Nina; Hollosi, Peter; Kovalszky, Ilona; Szilak, Laszlo; Mogler, Carolin; Nilsonne, Gustav; Tzanakakis, Georgios; Dobra, Katalin			Syndecan-1 and FGF-2, but Not FGF Receptor-1, Share a Common Transport Route and Co-Localize with Heparanase in the Nuclei of Mesenchymal Tumor Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SULFATE PROTEOGLYCANS; SURFACE; HEPARIN; BINDING; TRANSLOCATION; BFGF; ACCUMULATION; TRAFFICKING; MOLECULES	Syndecan-1 forms complexes with growth factors and their cognate receptors in the cell membrane. We have previously reported a tubulin-mediated translocation of syndecan-1 to the nucleus. The transport route and functional significance of nuclear syndecan-1 is still incompletely understood. Here we investigate the sub-cellular distribution of syndecan-1, FGF-2, FGFR-1 and heparanase in malignant mesenchymal tumor cells, and explore the possibility of their coordinated translocation to the nucleus. To elucidate a structural requirement for this nuclear transport, we have transfected cells with a syndecan-1/EGFP construct or with a short truncated version containing only the tubulin binding RMKKK sequence. The sub-cellular distribution of the EGFP fusion proteins was monitored by fluorescence microscopy. Our data indicate that syndecan-1, FGF-2 and heparanase co-localize in the nucleus, whereas FGFR-1 is enriched mainly in the perinuclear area. Overexpression of syndecan-1 results in increased nuclear accumulation of FGF-2, demonstrating the functional importance of syndecan-1 for this nuclear transport. Interestingly, exogenously added FGF-2 does not follow the route taken by endogenous FGF-2. Furthermore, we prove that the RMKKK sequence of syndecan-1 is necessary and sufficient for nuclear translocation, acting as a nuclear localization signal, and the Arginine residue is vital for this localization. We conclude that syndecan-1 and FGF-2, but not FGFR-1 share a common transport route and co-localize with heparanase in the nucleus, and this transport is mediated by the RMKKK motif in syndecan-1. Our study opens a new perspective in the proteoglycan field and provides more evidence of nuclear interactions of syndecan-1.			Zong, F (corresponding author), Huddinge Univ Hosp, Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden.	fang.zong@ki.se	Kovalszky, Ilona/ABH-2832-2020; Nilsonne, Gustav/C-4579-2008; Tzanakakis, George N/F-6955-2010; Szilak, Laszlo/T-1426-2017; zong, fang/GQZ-6104-2022; Tzanakakis, George/ABH-7725-2020	Kovalszky, Ilona/0000-0002-0179-3378; Tzanakakis, George N/0000-0001-5276-4764; Szilak, Laszlo/0000-0003-0334-272X; Tzanakakis, George/0000-0001-5276-4764; Fthenou, Eleni/0000-0002-1178-6841; Nilsonne, Gustav/0000-0001-5273-0150				AKNER G, 1990, EUR J CELL BIOL, V53, P390; BALDIN V, 1990, EMBO J, V9, P1511, DOI 10.1002/j.1460-2075.1990.tb08269.x; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bonnet H, 1996, J BIOL CHEM, V271, P24781, DOI 10.1074/jbc.271.40.24781; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Cheng F, 2001, J CELL BIOCHEM, V83, P597, DOI 10.1002/jcb.1254; Dobra K, 2000, EXP CELL RES, V258, P12, DOI 10.1006/excr.2000.4915; ELENIUS K, 1994, J CELL SCI, V107, P2975; FEDARKO NS, 1989, J CELL PHYSIOL, V139, P287, DOI 10.1002/jcp.1041390210; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; ISHIHARA M, 1989, J CELL PHYSIOL, V138, P467, DOI 10.1002/jcp.1041380305; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; Joy A, 1997, ONCOGENE, V14, P171, DOI 10.1038/sj.onc.1200823; Keresztes M, 1999, J CELL BIOL, V145, P421, DOI 10.1083/jcb.145.3.421; Kilkenny DM, 1996, ENDOCRINOLOGY, V137, P5078, DOI 10.1210/en.137.11.5078; KLOMINEK J, 1989, CANCER RES, V49, P6118; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Liang Y, 1997, J CELL BIOL, V139, P851, DOI 10.1083/jcb.139.4.851; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; Maher PA, 1996, J CELL BIOL, V134, P529, DOI 10.1083/jcb.134.2.529; Malecki J, 2004, MOL BIOL CELL, V15, P801, DOI 10.1091/mbc.E03-08-0589; PILLAI S, 1994, J INVEST DERMATOL, V103, P647, DOI 10.1111/1523-1747.ep12398386; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Reiland J, 2004, J BIOL CHEM, V279, P8047, DOI 10.1074/jbc.M304872200; Richardson TP, 2001, J CELL SCI, V114, P1613; ROGHANI M, 1992, J BIOL CHEM, V267, P22156; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schrage YM, 2009, AM J PATHOL, V174, P979, DOI 10.2353/ajpath.2009.080623; Sperinde GV, 1998, BIOCHEMISTRY-US, V37, P13153, DOI 10.1021/bi980600z; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Stachowiak EK, 1997, ONCOGENE, V14, P2201, DOI 10.1038/sj.onc.1201057; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; THURZO V, 1976, NEOPLASMA, V23, P577; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZONG F, 2009, CELL PROLIF IN PRESS	47	58	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7346	10.1371/journal.pone.0007346	http://dx.doi.org/10.1371/journal.pone.0007346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802384	Green Published, Green Submitted, gold			2022-12-25	WOS:000270593600015
J	Sartore-Bianchi, A; Di Nicolantonio, F; Nichelatti, M; Molinari, F; De Dosso, S; Saletti, P; Martini, M; Cipani, T; Marrapese, G; Mazzucchelli, L; Lamba, S; Veronese, S; Frattini, M; Bardelli, A; Siena, S				Sartore-Bianchi, Andrea; Di Nicolantonio, Federica; Nichelatti, Michele; Molinari, Francesca; De Dosso, Sara; Saletti, Piercarlo; Martini, Miriam; Cipani, Tiziana; Marrapese, Giovanna; Mazzucchelli, Luca; Lamba, Simona; Veronese, Silvio; Frattini, Milo; Bardelli, Alberto; Siena, Salvatore			Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer	PLOS ONE			English	Article								Background: KRAS mutations occur in 35-45% of metastatic colorectal cancers (mCRC) and preclude responsiveness to EGFR-targeted therapy with cetuximab or panitumumab. However, less than 20% patients displaying wild-type KRAS tumors achieve objective response. Alterations in other effectors downstream of the EGFR, such as BRAF, and deregulation of the PIK3CA/PTEN pathway have independently been found to give rise to resistance. We present a comprehensive analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression in mCRC patients treated with cetuximab or panitumumab, with the aim of clarifying the relative contribution of these molecular alterations to resistance. Methodology/Principal Findings: We retrospectively analyzed objective tumor response, progression-free (PFS) and overall survival ( OS) together with the mutational status of KRAS, BRAF, PIK3CA and expression of PTEN in 132 tumors from cetuximab or panitumumab treated mCRC patients. Among the 106 non-responsive patients, 74 (70%) had tumors with at least one molecular alteration in the four markers. The probability of response was 51% (22/43) among patients with no alterations, 4% (2/47) among patients with 1 alteration, and 0% (0/24) for patients with >= 2 alterations (p<0.0001). Accordingly, PFS and OS were increasingly worse for patients with tumors harboring none, 1, or >= 2 molecular alteration(s) (p<0.001). Conclusions/Significance: When expression of PTEN and mutations of KRAS, BRAF and PIK3CA are concomitantly ascertained, up to 70% of mCRC patients unlikely to respond to anti-EGFR therapies can be identified. We propose to define as 'quadruple negative', the CRCs lacking alterations in KRAS, BRAF, PTEN and PIK3CA. Comprehensive molecular dissection of the EGFR signaling pathways should be considered to select mCRC patients for cetuximab- or panitumumab-based therapies.			Sartore-Bianchi, A (corresponding author), Osped Niguarda Ca Granda, Falck Div Med Oncol, Milan, Italy.	a.bardelli@unito.it; salvatore.siena@ospedaleniguarda.it	Di Nicolantonio, Federica/A-2503-2011; Sartore-Bianchi, Andrea/AAB-9848-2019; SIENA, SALVATORE/AAC-5806-2019; BARDELLI, Alberto/J-9721-2018; Martini, Miriam/K-3053-2016	Di Nicolantonio, Federica/0000-0001-9618-2010; Sartore-Bianchi, Andrea/0000-0003-0780-0409; SIENA, SALVATORE/0000-0002-2681-2846; Lamba, Simona Elena/0000-0003-3207-1594; BARDELLI, Alberto/0000-0003-1647-5070; Martini, Miriam/0000-0002-4262-946X; Veronese, Silvio Marco/0000-0002-5280-3740	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cappuzzo F, 2008, ANN ONCOL, V19, P717, DOI 10.1093/annonc/mdm492; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; European Medicines Agency, EUR PUBL ASS REP; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Marchetti A, 2009, NEW ENGL J MED, V360, P833, DOI 10.1056/NEJMc082346; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Moroni M, 2008, LANCET ONCOL, V9, P402, DOI 10.1016/S1470-2045(08)70109-8; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Personeni N, 2008, CLIN CANCER RES, V14, P5869, DOI 10.1158/1078-0432.CCR-08-0449; Pessino A, 2008, ANN ONCOL, V19, P711, DOI 10.1093/annonc/mdm516; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	38	212	215	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7287	10.1371/journal.pone.0007287	http://dx.doi.org/10.1371/journal.pone.0007287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19806185	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593300007
J	Fimbel, E; Lauzon, S; Rainville, C				Fimbel, Eric; Lauzon, Stephane; Rainville, Constant			Performance of Humans vs. Exploration Algorithms on the Tower of London Test	PLOS ONE			English	Article							OF-LONDON; INDIVIDUAL-DIFFERENCES; PLANNING ABILITIES; SKILL ACQUISITION; TASK; INFORMATION; DETERMINANTS; WORKING; SEARCH; MEMORY	The Tower of London Test (TOL) used to assess executive functions was inspired in Artificial Intelligence tasks used to test problem-solving algorithms. In this study, we compare the performance of humans and of exploration algorithms. Instead of absolute execution times, we focus on how the execution time varies with the tasks and/or the number of moves. This approach used in Algorithmic Complexity provides a fair comparison between humans and computers, although humans are several orders of magnitude slower. On easy tasks (1 to 5 moves), healthy elderly persons performed like exploration algorithms using bounded memory resources, i.e., the execution time grew exponentially with the number of moves. This result was replicated with a group of healthy young participants. However, for difficult tasks (5 to 8 moves) the execution time of young participants did not increase significantly, whereas for exploration algorithms, the execution time keeps on increasing exponentially. A pre-and post-test control task showed a 25% improvement of visuo-motor skills but this was insufficient to explain this result. The findings suggest that naive participants used systematic exploration to solve the problem but under the effect of practice, they developed markedly more efficient strategies using the information acquired during the test.			Fimbel, E (corresponding author), Fatronik Fdn, Biorobot Dept, San Sebastian, Spain.	efimbel@fatronik.com						ACKERMAN PL, 1988, J EXP PSYCHOL GEN, V117, P288, DOI 10.1037/0096-3445.117.3.288; Ackerman PL, 2000, J EXP PSYCHOL-APPL, V6, P259, DOI 10.1037//1076-898X.6.4.259; ANZAI Y, 1979, PSYCHOL REV, V86, P124, DOI 10.1037/0033-295X.86.2.124; Beauchamp MH, 2003, NEUROIMAGE, V20, P1649, DOI 10.1016/j.neuroimage.2003.07.003; Berg WK, 2002, J CLIN EXP NEUROPSYC, V24, P586, DOI 10.1076/jcen.24.5.586.1006; BRASSARD G, 1996, FUNDAMENTALS ALGORIT, P524; Card S. K., 1983, PSYCHOL HUMAN COMPUT; Carder HP, 2004, Q J EXP PSYCHOL-A, V57, P1459, DOI 10.1080/02724980343000864; Churchland P S, 1992, COMPUTATIONAL BRAIN, P544; Cormen TH, 2001, INTRO ALGORITHMS, P1180; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; FIMBEL EJ, 2009, PROBLEM SPACE TOWER; Garson G. D., 2008, TOPICS MULTIVARIATE; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1016/S0364-0213(79)80010-5; Hodgson TL, 2000, J COGNITIVE NEUROSCI, V12, P894, DOI 10.1162/089892900562499; Hogg T, 1996, ARTIF INTELL, V81, P1, DOI 10.1016/0004-3702(95)00044-5; Kaller CP, 2004, COGNITIVE BRAIN RES, V20, P462, DOI 10.1016/j.cogbrainres.2004.04.002; KOTOVSKY K, 1985, COGNITIVE PSYCHOL, V17, P248, DOI 10.1016/0010-0285(85)90009-X; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Marr D., 1982, VISION; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Morris R.G., 1987, COGNITIVE NEUROCHEMI, P21; Newell A., 1972, HUMAN PROBLEM SOLVIN, DOI [10.2307/2063712, DOI 10.2307/2063712]; Phillips LH, 2001, Q J EXP PSYCHOL-A, V54, P579, DOI 10.1080/02724980042000237; Phillips LH, 2002, EMOTION, V2, P263, DOI 10.1037/1528-3542.2.3.263; Rainville C, 2002, ARCH CLIN NEUROPSYCH, V17, P513, DOI 10.1016/S0887-6177(01)00132-9; Saling LL, 2007, BRAIN RES BULL, V73, P1, DOI 10.1016/j.brainresbull.2007.02.009; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sussman G., 1975, COMPUTATIONAL MODEL; Unterrainer JM, 2004, J CLIN EXP NEUROPSYC, V26, P846, DOI 10.1080/13803390490509574; Unterrainer JM, 2003, COGNITIVE BRAIN RES, V17, P675, DOI 10.1016/S0926-6410(03)00191-5	34	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7263	10.1371/journal.pone.0007263	http://dx.doi.org/10.1371/journal.pone.0007263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	500HR	19787066	Green Submitted, gold, Green Published			2022-12-25	WOS:000270290100027
J	Sabourin, J; Lamiche, C; Vandebrouck, A; Magaud, C; Rivet, J; Cognard, C; Bourmeyster, N; Constantin, B				Sabourin, Jessica; Lamiche, Coralie; Vandebrouck, Aurelie; Magaud, Christophe; Rivet, Jerome; Cognard, Christian; Bourmeyster, Nicolas; Constantin, Bruno			Regulation of TRPC1 and TRPC4 Cation Channels Requires an alpha 1-Syntrophin-dependent Complex in Skeletal Mouse Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; NITRIC-OXIDE SYNTHASE; MUSCLE-CELLS; PDZ DOMAIN; MICE LACKING; DYSTROPHIN; SYNTROPHIN; ASSOCIATION; PROTEIN; EXPRESSION	The dystrophin-associated protein complex (DAPC) is essential for skeletal muscle, and the lack of dystrophin in Duchenne muscular dystrophy results in a reduction of DAPC components such as syntrophins and in fiber necrosis. By anchoring various molecules, the syntrophins may confer a role in cell signaling to the DAPC. Calcium disorders and abnormally elevated cation influx in dystrophic muscle cells have suggested that the DAPC regulates some sarcolemmal cationic channels. We demonstrated previously that mini-dystrophin and alpha 1-syntrophin restore normal cation entry in dystrophin-deficient myotubes and that sarcolemmal TRPC1 channels associate with dystrophin and the bound PDZ domain of alpha 1-syntrophin. This study shows that small interfering RNA (siRNA) silencing of alpha 1-syntrophin dysregulated cation influx in myotubes. Moreover, deletion of the PDZ-containing domain prevented restoration of normal cation entry by alpha 1-syntrophin transfection in dystrophin-deficient myotubes. TRPC1 and TRPC4 channels are expressed at the sarcolemma of muscle cells; forced expression or siRNA silencing showed that cation influx regulated by alpha 1-syntrophin is supported by TRPC1 and TRPC4. A molecular association was found between TRPC1 and TRPC4 channels and the alpha 1-syntrophin-dystrophin complex. TRPC1 and TRPC4 channels may form sarcolemmal channels anchored to the DAPC, and alpha 1-syntrophin is necessary to maintain the normal regulation of TRPC-supported cation entry in skeletal muscle. Cation channels with DAPC form a signaling complex that modulates cation entry and may be crucial for normal calcium homeostasis in skeletal muscles.	[Sabourin, Jessica; Lamiche, Coralie; Vandebrouck, Aurelie; Magaud, Christophe; Rivet, Jerome; Cognard, Christian; Bourmeyster, Nicolas; Constantin, Bruno] Univ Poitiers, CNRS, UMR 6187, Inst Physiol & Biol Cellulaires, F-86022 Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Constantin, B (corresponding author), Univ Poitiers, CNRS, UMR 6187, Inst Physiol & Biol Cellulaires, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	bruno.constantin@univ-poitiers.fr	COGNARD, Christian/P-5305-2016; Constantin, Bruno/AAH-6463-2021	Sabourin, Jessica/0000-0002-2980-8455; Constantin, Bruno/0000-0003-1668-581X; Bourmeyster, Nicolas/0000-0002-9563-5142	CNRS; French Ministry of Research; Association Francaise contre les Myopathies	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by the CNRS, the French Ministry of Research, and the Association Francaise contre les Myopathies.	ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Ambudkar IS, 2007, BIOCHEM SOC T, V35, P96, DOI 10.1042/BST0350096; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; COGNARD C, 1986, P NATL ACAD SCI USA, V83, P517, DOI 10.1073/pnas.83.2.517; Compton AG, 2005, J NEUROPATH EXP NEUR, V64, P350, DOI 10.1093/jnen/64.4.350; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Ducret T, 2006, J PHYSIOL-LONDON, V575, P913, DOI 10.1113/jphysiol.2006.115154; Engelke M, 2002, FEBS LETT, V523, P193, DOI 10.1016/S0014-5793(02)02971-X; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Formigli L, 2009, J MOL CELL CARDIOL, V47, P335, DOI 10.1016/j.yjmcc.2009.05.008; FRANCO A, 1990, J PHYSIOL-LONDON, V427, P361, DOI 10.1113/jphysiol.1990.sp018176; Franco-Obregon A, 2002, J PHYSIOL-LONDON, V539, P391, DOI 10.1113/jphysiol.2001.013043; FRANCOOBREGON A, 1994, J PHYSIOL-LONDON, V481, P299, DOI 10.1113/jphysiol.1994.sp020440; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; FRIEDRICH O, 2004, J PHYSIOL-LONDON, V15, P251; Frigeri A, 1998, J CLIN INVEST, V102, P695, DOI 10.1172/JCI2545; Gee SH, 1998, J NEUROSCI, V18, P128; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hopf F. W., 2007, V45, P429; Hopf FW, 1996, J BIOL CHEM, V271, P22358, DOI 10.1074/jbc.271.37.22358; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Imbert N, 2001, J PHYSIOL-LONDON, V534, P343, DOI 10.1111/j.1469-7793.2001.00343.x; Imbert N, 1996, NEUROMUSCULAR DISORD, V6, P351, DOI 10.1016/0960-8966(96)00351-3; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; LYFENKO AD, 2008, J PHYSL, V15, P4815; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mery L, 2002, J CELL SCI, V115, P3497; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Ou YJ, 2003, J BIOL CHEM, V278, P1915, DOI 10.1074/jbc.M209938200; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; RIVET M, 1990, CELL CALCIUM, V11, P507, DOI 10.1016/0143-4160(90)90026-Q; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Stiber JA, 2008, MOL CELL BIOL, V28, P2637, DOI 10.1128/MCB.01601-07; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Vandebrouck A, 2005, FASEB J, V19, P136, DOI 10.1096/fj.04-3633fje; Vandebrouck A, 2007, FASEB J, V21, P608, DOI 10.1096/fj.06-6683com; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vandebrouck C, 2001, NEUROMUSCULAR DISORD, V11, P72, DOI 10.1016/S0960-8966(00)00153-X; Varga-Szabo D, 2008, PFLUG ARCH EUR J PHY, V457, P377, DOI 10.1007/s00424-008-0531-4; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2	60	62	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36248	36261		10.1074/jbc.M109.012872	http://dx.doi.org/10.1074/jbc.M109.012872			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19812031	hybrid, Green Published			2022-12-25	WOS:000272970500027
J	Wu, ZP; Gogonea, V; Lee, X; Wagner, MA; Li, XM; Huang, Y; Undurti, A; May, RP; Haertlein, M; Moulin, M; Gutsche, I; Zaccai, G; DiDonato, JA; Hazen, SL				Wu, Zhiping; Gogonea, Valentin; Lee, Xavier; Wagner, Matthew A.; Li, Xin-Min; Huang, Ying; Undurti, Arundhati; May, Roland P.; Haertlein, Michael; Moulin, Martine; Gutsche, Irina; Zaccai, Giuseppe; DiDonato, Joseph A.; Hazen, Stanley L.			Double Superhelix Model of High Density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; RANDOMIZED CONTROLLED-TRIAL; ESCHERICHIA-COLI RIBOSOMES; LIPID-BOUND CONFORMATION; ANGLE NEUTRON-SCATTERING; APOA-I; X-RAY; CORONARY ATHEROSCLEROSIS; MASS-SPECTROMETRY; HDL-CHOLESTEROL	High density lipoprotein (HDL), the carrier of so-called "good" cholesterol, serves as the major athero-protective lipoprotein and has emerged as a key therapeutic target for cardiovascular disease. We applied small angle neutron scattering (SANS) with contrast variation and selective isotopic deuteration to the study of nascent HDL to obtain the low resolution structure in solution of the overall time-averaged conformation of apolipoprotein AI (apoA-I) versus the lipid (acyl chain) core of the particle. Remarkably, apoA-I is observed to possess an open helical shape that wraps around a central ellipsoidal lipid phase. Using the low resolution SANS shapes of the protein and lipid core as scaffolding, an all-atom computational model for the protein and lipid components of nascent HDL was developed by integrating complementary structural data from hydrogen/deuterium exchange mass spectrometry and previously published constraints from multiple biophysical techniques. Both SANS data and the new computational model, the double superhelix model, suggest an unexpected structural arrangement of protein and lipids of nascent HDL, an anti-parallel double superhelix wrapped around an ellipsoidal lipid phase. The protein and lipid organization in nascent HDL envisages a potential generalized mechanism for lipoprotein biogenesis and remodeling, biological processes critical to sterol and lipid transport, organismal energy metabolism, and innate immunity.	[Wu, Zhiping; Gogonea, Valentin; Lee, Xavier; Wagner, Matthew A.; Li, Xin-Min; Huang, Ying; Undurti, Arundhati; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Wu, Zhiping; Lee, Xavier; Wagner, Matthew A.; Li, Xin-Min; Huang, Ying; Undurti, Arundhati; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [May, Roland P.; Haertlein, Michael; Moulin, Martine; Zaccai, Giuseppe] Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France; [Gutsche, Irina] Univ Grenoble 1, Unit Virus Host Interact, European Mol Biol Lab, CNRS,UMR 5233, F-38042 Grenoble 9, France; [Zaccai, Giuseppe] Univ Grenoble 1, Inst Biol Struct, Commissariat Energie Atom, CNRS, F-38027 Grenoble, France	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Institut Laue-Langevin (ILL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Hazen, SL (corresponding author), Cleveland Clin, Dept Cell Biol, 9500 Euclid Ave,NE-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021		National Institutes of Health [P01 HL076491-055328, P01 HL077107-050004, P01 HL087018-02001, 1R15 GM070469-01]; Case Western Reserve University/Cleveland Clinic Clinical and Translational Science Award [1KL2RR024990]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018, P50HL077107, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM070469, T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University/Cleveland Clinic Clinical and Translational Science Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL076491-055328, P01 HL077107-050004, P01 HL087018-02001, and 1R15 GM070469-01. This work was also supported by Case Western Reserve University/Cleveland Clinic Clinical and Translational Science Award 1KL2RR024990.	Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; Alexander ET, 2005, BIOCHEMISTRY-US, V44, P5409, DOI 10.1021/bi047412v; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Artero JB, 2005, ACTA CRYSTALLOGR D, V61, P1541, DOI 10.1107/S0907444905028532; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Atkinson D, 1980, Ann N Y Acad Sci, V348, P284, DOI 10.1111/j.1749-6632.1980.tb21308.x; Baker PW, 2000, J LIPID RES, V41, P1261; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2006, CURR OPIN LIPIDOL, V17, P399, DOI 10.1097/01.mol.0000236365.40969.af; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Chapman MJ, 2006, PHARMACOL THERAPEUT, V111, P893, DOI 10.1016/j.pharmthera.2006.02.003; Chung EW, 1997, PROTEIN SCI, V6, P1316, DOI 10.1002/pro.5560060620; Cowieson NP, 2008, CURR OPIN STRUC BIOL, V18, P617, DOI 10.1016/j.sbi.2008.07.004; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Fleishman SJ, 2006, TRENDS BIOCHEM SCI, V31, P106, DOI 10.1016/j.tibs.2005.12.005; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Ibanez B, 2008, J AM COLL CARDIOL, V51, P1104, DOI 10.1016/j.jacc.2007.09.071; Imaizumi S, 2008, J AM COLL CARDIOL, V51, P1604, DOI 10.1016/j.jacc.2007.12.040; Jin LH, 1999, BIOCHEMISTRY-US, V38, P15659, DOI 10.1021/bi9916729; Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koppaka V, 1999, J BIOL CHEM, V274, P14541, DOI 10.1074/jbc.274.21.14541; Koukos G, 2007, BIOCHEM J, V406, P167, DOI 10.1042/BJ20070296; Li HH, 2002, J BIOL CHEM, V277, P39093, DOI 10.1074/jbc.M206770200; Li HH, 2001, J LIPID RES, V42, P2084; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Maiorano JN, 2004, BIOCHEMISTRY-US, V43, P11717, DOI 10.1021/bi0496642; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MAY RP, 1992, EMBO J, V11, P373, DOI 10.1002/j.1460-2075.1992.tb05060.x; Meilleur F, 2004, BIOCHEMISTRY-US, V43, P8744, DOI 10.1021/bi049418q; Merzel F, 2002, ACTA CRYSTALLOGR D, V58, P242, DOI 10.1107/S0907444901019576; MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P2416, DOI 10.1161/01.ATV.0000184760.95957.d6; Niemann HH, 2008, J MOL BIOL, V377, P489, DOI 10.1016/j.jmb.2008.01.027; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; PARDON JF, 1977, NUCLEIC ACIDS RES, V4, P3199, DOI 10.1093/nar/4.9.3199; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Peters-Libeu CA, 2007, J LIPID RES, V48, P1035, DOI 10.1194/jlr.M600545-JLR200; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Phillips JC, 1997, BIOPHYS J, V73, P2337, DOI 10.1016/S0006-3495(97)78264-X; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; RAMAKRISHNAN V, 1986, SCIENCE, V231, P1562, DOI 10.1126/science.3513310; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P945, DOI 10.1021/bi9713512; RYE KA, 1992, J LIPID RES, V33, P215; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SERDYUK IN, 2007, METHODS MOL BIOPHYSI, P776; Shah PK, 1998, CIRCULATION, V97, P780, DOI 10.1161/01.CIR.97.8.780; Shaw JA, 2008, CIRC RES, V103, P1084, DOI 10.1161/CIRCRESAHA.108.182063; Shih AY, 2008, BIOPHYS J, V94, pL87, DOI 10.1529/biophysj.108.131581; Shih AY, 2007, J PHYS CHEM B, V111, P11095, DOI 10.1021/jp072320b; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tall AR, 2007, NEW ENGL J MED, V356, P1364, DOI 10.1056/NEJMe078029; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Trigatti B, 2000, CURR OPIN LIPIDOL, V11, P123, DOI 10.1097/00041433-200004000-00004; Willumeit R, 2001, BBA-GENE STRUCT EXPR, V1520, P7, DOI 10.1016/S0167-4781(01)00245-7; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; ZACCAI G, 1983, ANNU REV BIOPHYS BIO, V12, P139, DOI 10.1146/annurev.bb.12.060183.001035; Zhu HL, 2004, BIOCHEMISTRY-US, V43, P13156, DOI 10.1021/bi0487894	81	77	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36605	36619		10.1074/jbc.M109.039537	http://dx.doi.org/10.1074/jbc.M109.039537			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19812036	Green Published, hybrid			2022-12-25	WOS:000272970500061
J	Kawano, MA; Xing, L; Tsukamoto, H; Inoue, T; Handa, H; Cheng, RH				Kawano, Masa-aki; Xing, Li; Tsukamoto, Hiroko; Inoue, Takamasa; Handa, Hiroshi; Cheng, R. Holland			Calcium Bridge Triggers Capsid Disassembly in the Cell Entry Process of Simian Virus 40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUSHY STUNT VIRUS; CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; MURINE POLYOMAVIRUS; SIMIAN VIRUS-40; CAVEOLAR ENDOCYTOSIS; PROTEIN VP1; BK VIRUS; INFECTION; BINDING	The calcium bridge between the pentamers of polyoma viruses maintains capsid metastability. It has been shown that viral infection is profoundly inhibited by the substitution of lysine for glutamate in one calcium-binding residue of the SV40 capsid protein, VP1. However, it is unclear how the calcium bridge affects SV40 infectivity. In this in vitro study, we analyzed the influence of host cell components on SV40 capsid stability. We used an SV40 mutant capsid (E330K) in which lysine had been substituted for glutamate 330 in protein VP1. The mutant capsid retained the ability to interact with the SV40 cellular receptor GM1, and the internalized mutant capsid accumulated in caveolin-1-mediated endocytic vesicles and was then translocated to the endoplasmic reticulum (ER) region. However, when placed in ER-rich microsome, the mutant capsid retained its spherical structure in contrast to the wild type, which disassembled. Structural analysis of the mutant capsid with cryo-electron microscopy and image reconstruction revealed altered pentamer coordination, possibly as a result of electrostatic interaction, although its overall structure resembled that of the wild type. These results indicate that the calcium ion serves as a trigger at the pentamer interface, which switches on capsid disassembly, and that the failure of the E330K mutant capsid to disassemble is attributable to an inadequate triggering system. Our data also indicate that calcium depletion-induced SV40 capsid disassembly may occur in the ER region and that this is essential for successful SV40 infection.	[Kawano, Masa-aki; Xing, Li; Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Tsukamoto, Hiroko; Inoue, Takamasa; Handa, Hiroshi] Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268503, Japan	University of California System; University of California Davis; Tokyo Institute of Technology	Cheng, RH (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	rhch@ucdavis.edu	Cheng, Holland/A-8973-2008	Kawano, Masaaki/0000-0001-8220-4717	STINT foundation; Uehara Memorial Foundation	STINT foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported, in whole or in part, by National Institutes of Health, HIVRAD, grants. This work was also supported by grants from the Discovery Program, the Cancer Research Coordinating Committee, and the STINT foundation (to R. H. C.). This work was also supported in part by a postgraduate fellowship provided by the Uehara Memorial Foundation (to M. K.).	ANDERER FA, 1967, VIROLOGY, V32, P511, DOI 10.1016/0042-6822(67)90302-9; Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Anderson HA, 1998, J GEN VIROL, V79, P1469, DOI 10.1099/0022-1317-79-6-1469; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Aramayo R, 2005, BBA-GEN SUBJECTS, V1724, P345, DOI 10.1016/j.bbagen.2005.05.020; ATWOOD WJ, 1989, J VIROL, V63, P4474, DOI 10.1128/JVI.63.10.4474-4477.1989; BAKER TS, 1989, BIOPHYS J, V55, P243, DOI 10.1016/S0006-3495(89)82799-7; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; BAROUCH DH, 1994, J VIROL, V68, P3982, DOI 10.1128/JVI.68.6.3982-3989.1994; BECKER GL, 1980, J BIOL CHEM, V255, P9009; BRADY JN, 1980, J VIROL, V35, P371, DOI 10.1128/JVI.35.2.371-381.1980; BRADY JN, 1977, J VIROL, V23, P717, DOI 10.1128/JVI.23.3.717-724.1977; Butel JS, 1999, JNCI-J NATL CANCER I, V91, P119, DOI 10.1093/jnci/91.2.119; Chen XJS, 1998, EMBO J, V17, P3233, DOI 10.1093/emboj/17.12.3233; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Eash S, 2004, J VIROL, V78, P11583, DOI 10.1128/JVI.78.21.11583-11590.2004; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Gilbert J, 2004, J VIROL, V78, P12259, DOI 10.1128/JVI.78.22.12259-12267.2004; GRIFFITH JP, 1992, NATURE, V355, P652, DOI 10.1038/355652a0; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hilleman MR, 1998, DEV BIOL STAND, V94, P183; Ji YC, 2006, J STRUCT BIOL, V154, P1, DOI 10.1016/j.jsb.2005.06.009; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; KOCH MA, 1967, VIROLOGY, V32, P503, DOI 10.1016/0042-6822(67)90302-9; Li PP, 2007, J VIROL, V81, P6099, DOI 10.1128/JVI.02195-06; Li PP, 2005, J VIROL, V79, P3859, DOI 10.1128/JVI.79.6.3859-3864.2005; Li PP, 2003, J VIROL, V77, P7527, DOI 10.1128/JVI.77.13.7527-7538.2003; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Low JA, 2006, J VIROL, V80, P1361, DOI 10.1128/JVI.80.3.1361-1366.2006; MACER DRJ, 1988, J CELL SCI, V91, P61; Magnuson B, 2005, MOL CELL, V20, P289, DOI 10.1016/j.molcel.2005.08.034; MOORE L, 1975, J BIOL CHEM, V250, P4562; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; ROBINSON IK, 1982, NATURE, V297, P563, DOI 10.1038/297563a0; Ruiz MC, 1997, J GEN VIROL, V78, P2883, DOI 10.1099/0022-1317-78-11-2883; SALUNKE DM, 1989, BIOPHYS J, V56, P887, DOI 10.1016/S0006-3495(89)82735-3; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Smith AE, 2003, FEBS LETT, V555, P199, DOI 10.1016/S0014-5793(03)01220-1; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Stehle T, 1996, STRUCTURE, V4, P183, DOI 10.1016/S0969-2126(96)00021-4; Stehle T, 1997, EMBO J, V16, P5139, DOI 10.1093/emboj/16.16.5139; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Takahashi R, 2008, J BIOTECHNOL, V135, P385, DOI 10.1016/j.jbiotec.2008.05.012; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439	51	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34703	34712		10.1074/jbc.M109.015107	http://dx.doi.org/10.1074/jbc.M109.015107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19822519	hybrid, Green Published			2022-12-25	WOS:000272439600026
J	Pena, C; Garcia, JM; Larriba, MJ; Barderas, R; Gomez, I; Herrera, M; Garcia, V; Silva, J; Dominguez, G; Rodriguez, R; Cuevas, J; de Herreros, AG; Casal, JI; Munoz, A; Bonilla, F				Pena, C.; Garcia, J. M.; Larriba, M. J.; Barderas, R.; Gomez, I.; Herrera, M.; Garcia, V.; Silva, J.; Dominguez, G.; Rodriguez, R.; Cuevas, J.; de Herreros, A. G.; Casal, J. I.; Munoz, A.; Bonilla, F.			SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue	ONCOGENE			English	Article						colorectal cancer; epithelial-mesenchymal transition; SNAI1; CDH1; normal adjacent tissue	TRANSCRIPTION FACTOR SNAIL; VITAMIN-D-RECEPTOR; CADHERIN GENE-EXPRESSION; TUMOR PROGRESSION; IN-SITU; BREAST; CARCINOMA; CELLS; HETEROZYGOSITY; TRANSITION	SNAI1, ZEB1, E-cadherin (CDH1), and vitamin D receptor (VDR) genes regulate the epithelial-mesenchymal transition (EMT) that initiates the invasion process of many tumor cells. We hypothesized that this process could also affect the behavior of normal cells adjacent to the tumor. To verify this hypothesis, the expression level of these genes was determined by quantitative RT-PCR in tumor, normal adjacent, and normal distant tissues from 32 colorectal cancer (CC) patients. In addition, we extended the study to human HaCaT normal keratinocytes and SW480-ADH colon cancer cells co-cultured with SW480-ADH cells over-expressing the mouse Snai1 gene. Of 18 CC cases with SNAI1 expression in tumor tissue, five also had SNAI1 in normal adjacent tissue (NAT). Expression of SNAI1 in tumor tissue correlated with downregulation of CDH1 and VDR genes in both tumor (P = 0.047 and P = 0.014, respectively) and NAT lacking SNAI1 expression (P = 0.054 and P = 0.003). ZEB1 expression was directly related to VDR expression in tumor tissue (r = 0.39; P = 0.027) and inversely to CDH1 in NAT (r = -0.46; P = 0.010). CDH1 and VDR were also downregulated in SW480-ADH and MaCaT cells, respectively, when they were co-cultured with Snai1-expressing cells. Furthermore, cytokine analysis showed differences in the conditioned media obtained from the two cell types. These results indicate that histologically normal tissue adjacent to tumor tissue expressing the EMT-inducing gene SNAI1 shows alterations in the expression of epithelial differentiation genes such as CDH1 and VDR. Oncogene (2009) 28, 4375-4385; doi: 10.1038/onc.2009.285; published online 5 October 2009	[Pena, C.; Garcia, J. M.; Gomez, I.; Herrera, M.; Garcia, V.; Silva, J.; Dominguez, G.; Bonilla, F.] Hosp Univ Puerta Hierro Majadahonda, Dept Med Oncol, E-28222 Madrid, Spain; [Larriba, M. J.; Munoz, A.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Barderas, R.; Casal, J. I.] CSIC, CIB, Funct Prote Lab, Madrid, Spain; [Rodriguez, R.] Hosp Virgen Salud, Dept Pathol, Toledo, Spain; [Cuevas, J.] Hosp Gen Univ, Dept Pathol, Guadalajara, Spain; [de Herreros, A. G.] Univ Pompeu Fabra, Inst Municipal Invest Med, Unitat Biol Cellular & Mol, Barcelona, Spain	Hospital Puerta de Hierro-Majadahonda; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complejo Hospitalario de Toledo; Pompeu Fabra University	Bonilla, F (corresponding author), Hosp Univ Puerta Hierro Majadahonda, Dept Med Oncol, C Joaquin Rodrigo,2 Majadahonda, E-28222 Madrid, Spain.	fbonilla.hpth@salud.madrid.org	de Herreros, A Garcia/H-3104-2014; LARRIBA, MARIA JESUS/O-4652-2014; Barderas, Rodrigo/K-3560-2014; Casal, Ignacio/M-2312-2014; Munoz, Alberto/O-6393-2014	de Herreros, A Garcia/0000-0001-5270-0808; LARRIBA, MARIA JESUS/0000-0001-9035-7414; Barderas, Rodrigo/0000-0003-3539-7469; Casal, Ignacio/0000-0003-1085-2840; Munoz, Alberto/0000-0003-3890-4251; Garcia-Barberan, Vanesa/0000-0002-2531-0203	Accion Transversal del Cancer (ISCIII);  [SAF2007-60431];  [CAM: S-GEN/0266/2006];  [ISCIII-RETIC RD06/0020 and /0009]	Accion Transversal del Cancer (ISCIII)(Instituto de Salud Carlos III); ; ; 	We thank M Eaude for help with the English paper. This study was supported by the grants SAF2007-60431, CAM: S-GEN/0266/2006, ISCIII-RETIC RD06/0020 and /0009, and a grant from the Accion Transversal del Cancer (ISCIII).	Aboseif S, 1999, DIFFERENTIATION, V65, P113, DOI 10.1046/j.1432-0436.1999.6520113.x; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Baulida J, 1999, BIOCHEM J, V344, P565, DOI 10.1042/0264-6021:3440565; Blanco MJ, 2007, DEVELOPMENT, V134, P4073, DOI 10.1242/dev.006858; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brown LF, 1999, CLIN CANCER RES, V5, P1041; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; Forsti A, 2001, EUR J CANCER, V37, P1372, DOI 10.1016/S0959-8049(01)00118-6; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herzig M, 2002, BBA-REV CANCER, V1602, P97, DOI 10.1016/S0304-419X(02)00039-2; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Lakhani SR, 1999, J PATHOL, V189, P496, DOI 10.1002/(SICI)1096-9896(199912)189:4&lt;496::AID-PATH485&gt;3.0.CO;2-D; Larson PS, 1998, AM J PATHOL, V152, P1591; Larson PS, 2002, AM J PATHOL, V161, P283, DOI 10.1016/S0002-9440(10)64180-6; Lazarova DL, 2001, CELL GROWTH DIFFER, V12, P319; Li YW, 2000, DIFFERENTIATION, V66, P126, DOI 10.1046/j.1432-0436.2000.660207.x; Li Z, 2002, CANCER RES, V62, P1000; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Locascio A, 2002, J BIOL CHEM, V277, P38803, DOI 10.1074/jbc.M205358200; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Menke A, 2001, CANCER RES, V61, P3508; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nilsson E, 2001, J SOC GYNECOL INVEST, V8, pS17, DOI 10.1016/S1071-5576(00)00099-X; Olumi AF, 1999, CANCER RES, V59, P5002; OTO M, 1993, ANAL BIOCHEM, V213, P19, DOI 10.1006/abio.1993.1379; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pena C, 2005, HUM MOL GENET, V14, P3361, DOI 10.1093/hmg/ddi366; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Ren ZP, 1996, ONCOGENE, V12, P765; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; SOZZI G, 1991, CANCER RES, V51, P400; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; TOMITA N, 1992, CANCER RES, V52, P6840; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wu CY, 1998, J BIOL CHEM, V273, P528, DOI 10.1074/jbc.273.1.528	50	47	53	3	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2009	28	49					4375	4385		10.1038/onc.2009.285	http://dx.doi.org/10.1038/onc.2009.285			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DT	19802011	Green Submitted			2022-12-25	WOS:000272876400006
J	Parolini, I; Federici, C; Raggi, C; Lugini, L; Palleschi, S; De Milito, A; Coscia, C; Iessi, E; Logozzi, M; Molinari, A; Colone, M; Tatti, M; Sargiacomo, M; Fais, S				Parolini, Isabella; Federici, Cristina; Raggi, Carla; Lugini, Luana; Palleschi, Simonetta; De Milito, Angelo; Coscia, Carolina; Iessi, Elisabetta; Logozzi, Mariantonia; Molinari, Agnese; Colone, Marisa; Tatti, Massimo; Sargiacomo, Massimo; Fais, Stefano			Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAURDAN FLUORESCENCE; MEMBRANE-FUSION; PROTEOMIC ANALYSIS; INDUCE APOPTOSIS; PLASMA-MEMBRANE; MELANOMA-CELLS; T-LYMPHOCYTES; VESICLES; MICROVESICLES; CANCER	Exosomes secreted by normal and cancer cells carry and deliver a variety of molecules. To date, mechanisms referring to tumor exosome trafficking, including release and cell-cell transmission, have not been described. To gain insight into this, exosomes purified from metastatic melanoma cell medium were labeled with a lipid fluorescent probe, R18, and analyzed by spectrofluorometry and confocal microscopy. A low pH condition is a hallmark of tumor malignancy, potentially influencing exosome release and uptake by cancer cells. Using different pH conditions as a modifier of exosome traffic, we showed (i) an increased exosome release and uptake at low pH when compared with a buffered condition and (ii) exosome uptake by melanoma cells occurred by fusion. Membrane biophysical analysis, such as fluidity and lipid composition, indicated a high rigidity and sphingomyelin/ganglioside GM3 (N-acetylneuraminylgalactosylglucosylceramide) content in exosomes released at low pH. This was likely responsible for the increased fusion efficiency. Consistent with these results, pretreatment with proton pump inhibitors led to an inhibition of exosome uptake by melanoma cells. Fusion efficiency of tumor exosomes resulted in being higher in cells of metastatic origin than in those derived from primary tumors or normal cells. Furthermore, we found that caveolin-1, a protein involved in melanoma progression, is highly delivered through exosomes released in an acidic condition. The results of our study provide the evidence that exosomes may be used as a delivery system for paracrine diffusion of tumor malignancy, in turn supporting the importance of both exosomes and tumor pH as key targets for future anti-cancer strategies.	[Fais, Stefano] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Unit Antitumor Drugs, I-00161 Rome, Italy; [Coscia, Carolina; Tatti, Massimo] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Molinari, Agnese; Colone, Marisa] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Fais, S (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Unit Antitumor Drugs, Viale Regina Elena 299, I-00161 Rome, Italy.	stefano.fais@iss.it	COLONE, MARISA/E-9089-2015; Palleschi, Simonetta/G-8563-2011; Molinari, Agnese/E-7588-2015; tatti, Massimo/N-1382-2017; Fais, Stefano/J-8638-2016; Molinari, Agnese/AAC-2918-2021; Lugini, Luana/J-8672-2016; Federici, Cristina/O-4676-2016; Iessi, Elisabetta/O-2460-2017; parolini, Isabella/J-9955-2016	COLONE, MARISA/0000-0002-7522-7483; Palleschi, Simonetta/0000-0002-2180-0168; Molinari, Agnese/0000-0002-9592-5465; Fais, Stefano/0000-0001-9060-2766; Molinari, Agnese/0000-0002-9592-5465; Lugini, Luana/0000-0002-8778-2601; Federici, Cristina/0000-0001-6366-0231; Iessi, Elisabetta/0000-0001-7221-9173; parolini, Isabella/0000-0001-9863-1051; Raggi, Carla/0000-0002-1317-1541; De Milito, Angelo/0000-0003-2591-2914; Sargiacomo, Massimo/0000-0003-4040-706X	Italian Ministry for University and Research [RBNE03FMCJ-002]; Italy-to-China partnership; Chemores FP6 European; Italy-NIH partnership	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Italy-to-China partnership; Chemores FP6 European; Italy-NIH partnership	This work was supported in part by a grant from Fondo per gli Investimenti della Ricerca di Base (FIRB) year 2003 (RBNE03FMCJ-002) of the Italian Ministry for University and Research (to M.S. and I. P.), by an Italy-to-China partnership project, by the Chemores FP6 European Project, and by a Italy-NIH partnership project supported by the Italian Ministry of Health.	Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Bagatolli LA, 1998, BIOPHYS J, V75, P331, DOI 10.1016/S0006-3495(98)77517-4; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Cevc G, 1999, ADV DRUG DELIVER REV, V38, P207, DOI 10.1016/S0169-409X(99)00030-7; Chu VC, 2006, J VIROL, V80, P3180, DOI 10.1128/JVI.80.7.3180-3188.2006; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Felicetti F, 2009, INT J CANCER, V125, P1514, DOI 10.1002/ijc.24451; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Hakomori S, 2003, CURR OPIN HEMATOL, V10, P16, DOI 10.1097/00062752-200301000-00004; Harris FM, 2002, BBA-BIOMEMBRANES, V1565, P123, DOI 10.1016/S0005-2736(02)00514-X; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; LARSSON H, 1985, SCAND J GASTROENTERO, V20, P23, DOI 10.3109/00365528509095817; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Palleschi S, 1996, BBA-BIOMEMBRANES, V1279, P197, DOI 10.1016/0005-2736(95)00250-2; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Riteau B, 2003, HUM IMMUNOL, V64, P1064, DOI 10.1016/j.humimm.2003.08.344; Rogasevskaia T, 2006, J CELL SCI, V119, P2688, DOI 10.1242/jcs.03007; Sorice M, 1997, J LIPID RES, V38, P969; Taylor DD, 2002, GYNECOL ONCOL, V84, P443, DOI 10.1006/gyno.2001.6551; Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; VIDAL M, 1995, J BIOL CHEM, V270, P17823, DOI 10.1074/jbc.270.30.17823; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	42	931	965	24	203	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34211	34222		10.1074/jbc.M109.041152	http://dx.doi.org/10.1074/jbc.M109.041152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801663	Green Published, hybrid			2022-12-25	WOS:000272165200053
J	Shen, W; Gao, L; Balakrishnan, M; Bambara, RA				Shen, Wen; Gao, Lu; Balakrishnan, Mini; Bambara, Robert A.			A Recombination Hot Spot in HIV-1 Contains Guanosine Runs That Can Form a G-quartet Structure and Promote Strand Transfer in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COPY-CHOICE RECOMBINATION; MURINE SARCOMA-VIRUS; REVERSE-TRANSCRIPTASE; DNA-SYNTHESIS; RETROVIRAL RECOMBINATION; TELOMERIC DNA; GENOMIC RNA; INTERNAL REGIONS; G-QUADRUPLEXES	The co-packaged RNA genomes of human immunodeficiency virus-1 recombine at a high rate. Recombination can mix mutations to generate viruses that escape immune response. A cell-culture-based system was designed previously to map recombination events in a 459-bp region spanning the primer binding site through a portion of the gag protein coding region. Strikingly, a strong preferential site for recombination in vivo was identified within a 112-nucleotide-long region near the beginning of gag. Strand transfer assays in vitro revealed that three pause bands in the gag hot spot each corresponded to a run of guanosine (G) residues. Pausing of reverse transcriptase is known to promote recombination by strand transfer both in vivo and in vitro. To assess the significance of the G runs, we altered them by base substitutions. Disruption of the G runs eliminated both the associated pausing and strand transfer. Some G-rich sequences can develop G-quartet structures, which were first proposed to form in telomeric DNA. G-quartet structure formation is highly dependent on the presence of specific cations. Incubation in cations discouraging G-quartets altered gel mobility of the gag template consistent with breakdown of G-quartet structure. The same cations faded G-run pauses but did not affect pauses caused by hairpins, indicating that quartet structure causes pausing. Moreover, gel analysis with cations favoring G-quartet structure indicated no structure in mutated templates. Overall, results point to reverse transcriptase pausing at G runs that can form quartets as a unique feature of the gag recombination hot spot.	[Shen, Wen; Gao, Lu; Balakrishnan, Mini; Bambara, Robert A.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM049573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049573 ( to R.A.B.).	Aguiar RS, 2008, VIRUS RES, V134, P74, DOI 10.1016/j.virusres.2007.12.022; AWANG G, 1993, BIOCHEMISTRY-US, V32, P11453, DOI 10.1021/bi00093a024; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Berkhout B, 2004, AIDS, V18, P1861, DOI 10.1097/00002030-200409030-00022; Berkhout B, 2001, RNA, V7, P1097, DOI 10.1017/S1355838201002035; Bukrinskaya A, 2007, VIRUS RES, V124, P1, DOI 10.1016/j.virusres.2006.07.001; Chen JB, 2005, J VIROL, V79, P9337, DOI 10.1128/JVI.79.14.9337-9340.2005; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; DESTEFANO JJ, 1994, J BIOL CHEM, V269, P161; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P7423; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; DUESBERG PH, 1968, P NATL ACAD SCI USA, V60, P1511, DOI 10.1073/pnas.60.4.1511; Dykes C, 2004, VIROLOGY, V326, P262, DOI 10.1016/j.virol.2004.02.033; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Filler AG, 1997, AIDS RES HUM RETROV, V13, P291, DOI 10.1089/aid.1997.13.291; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Galetto R, 2006, J BIOL CHEM, V281, P2711, DOI 10.1074/jbc.M505457200; Galetto R, 2004, J BIOL CHEM, V279, P36625, DOI 10.1074/jbc.M405476200; Gao L, 2008, J BIOL CHEM, V283, P9196, DOI 10.1074/jbc.M710148200; Gatanaga H, 2002, J BIOL CHEM, V277, P5952, DOI 10.1074/jbc.M108005200; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; GUSCHLBAUER W, 1990, J BIOMOL STRUCT DYN, V8, P491, DOI 10.1080/07391102.1990.10507825; Halder K, 2005, NUCLEIC ACIDS RES, V33, P4466, DOI 10.1093/nar/gki750; Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537; Hanson MN, 2005, J MOL BIOL, V353, P772, DOI 10.1016/j.jmb.2005.08.065; Hantson Anke, 2005, Antiviral Chemistry & Chemotherapy, V16, P253; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; HUBER HE, 1989, J BIOL CHEM, V264, P4669; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; JI JP, 1992, BIOCHEMISTRY-US, V31, P954, DOI 10.1021/bi00119a002; JI JP, 1994, NUCLEIC ACIDS RES, V22, P47, DOI 10.1093/nar/22.1.47; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Lanciault C, 2006, J VIROL, V80, P2483, DOI 10.1128/JVI.80.5.2483-2494.2006; Lee R, 1998, BIOCHEMISTRY-US, V37, P900, DOI 10.1021/bi972197m; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Ly H, 1999, J VIROL, V73, P7255, DOI 10.1128/JVI.73.9.7255-7261.1999; Ly H, 2000, J VIROL, V74, P9937, DOI 10.1128/JVI.74.21.9937-9945.2000; Mani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004399; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Moumen A, 2003, J BIOL CHEM, V278, P15973, DOI 10.1074/jbc.M212306200; Moumen A, 2001, NUCLEIC ACIDS RES, V29, P3814, DOI 10.1093/nar/29.18.3814; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Multani AS, 2007, J CELL SCI, V120, P713, DOI 10.1242/jcs.03397; Negroni M, 2000, P NATL ACAD SCI USA, V97, P6385, DOI 10.1073/pnas.120520497; Operario DJ, 2006, J BIOL CHEM, V281, P32113, DOI 10.1074/jbc.M604665200; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Roda RH, 2002, J BIOL CHEM, V277, P46900, DOI 10.1074/jbc.M208638200; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Wooley DP, 1998, VIROLOGY, V243, P229, DOI 10.1006/viro.1998.9052; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; YONG WH, 1990, AIDS, V4, P199, DOI 10.1097/00002030-199003000-00004	70	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33883	33893		10.1074/jbc.M109.055368	http://dx.doi.org/10.1074/jbc.M109.055368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19822521	hybrid, Green Published			2022-12-25	WOS:000272165200021
J	Koshikawa, N; Hayashi, JI; Nakagawara, A; Takenaga, K				Koshikawa, Nobuko; Hayashi, Jun-Ichi; Nakagawara, Akira; Takenaga, Keizo			Reactive Oxygen Species-generating Mitochondrial DNA Mutation Up-regulates Hypoxia-inducible Factor-1 alpha Gene Transcription via Phosphatidylinositol 3-Kinase-Akt/Protein Kinase C/Histone Deacetylase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR 1-ALPHA GENE; EXPRESSION; CANCER; CELLS; ACTIVATION; INDUCTION; MECHANISM; PROMOTER; TARGET	Lewis lung carcinoma-derived high metastatic A11 cells constitutively overexpress hypoxia-inducible factor (HIF)-1 alpha mRNA compared with low metastatic P29 cells. Because A11 cells exclusively possess a G13997A mutation in the mitochondrial NADH dehydrogenase subunit 6 (ND6) gene, we addressed here a causal relationship between the ND6 mutation and the activation of HIF-1 alpha transcription, and we investigated the potential mechanism. Using trans-mitochondrial cybrids between A11 and P29 cells, we found that the ND6 mutation was directly involved in HIF-1 alpha mRNA overexpression. Stimulation of HIF-1 alpha transcription by the ND6 mutation was mediated by overproduction of reactive oxygen species (ROS) and subsequent activation of phosphatidylinositol 3-kinase (PI3K)-Akt and protein kinase C (PKC) signaling pathways. The up-regulation of HIF-1 alpha transcription was abolished by mithramycin A, an Sp1 inhibitor, but luciferase reporter and chromatin immunoprecipitation assays indicated that Sp1 was necessary but not sufficient for HIF-1 alpha mRNA overexpression in A11 cells. On the other hand, trichostatin A, a histone deacetylase (HDAC) inhibitor, markedly suppressed HIF-1 alpha transcription in A11 cells. In accordance with this, HDAC activity was high in A11 cells but low in P29 cells and in A11 cells treated with the ROS scavenger ebselene, the PI3K inhibitor LY294002, and the PKC inhibitor Ro31-8220. These results suggest that the ROS-generating ND6 mutation increases HIF-1 alpha transcription via the PI3K-Akt/PKC/HDAC pathway, leading to HIF-1 alpha protein accumulation in hypoxic tumor cells.	[Koshikawa, Nobuko; Takenaga, Keizo] Chiba Canc Ctr, Res Inst, Lab Canc Metastasis, Chuoh Ku, Chiba 2608717, Japan; [Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem & Innovat Canc Therapeut, Chuoh Ku, Chiba 2608717, Japan; [Hayashi, Jun-Ichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Takenaga, Keizo] Shimane Univ, Fac Med, Div Life Sci, Lab Tumor Biol, Izumo, Shimane 6938501, Japan	Chiba Cancer Center; Chiba Cancer Center; University of Tsukuba; Shimane University	Nakagawara, A (corresponding author), 666-2 Nitona,Chuoh Ku, Chiba 2608717, Japan.	akiranak@chiba-cc.jp; biokeizo@med.shimaneu-u.ac.jp			Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [21390317] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare ( to K. T.) and by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ( to N. K. and K. T.).	Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Das C, 2005, IUBMB LIFE, V57, P137, DOI 10.1080/15216540500090629; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Kim HY, 2007, EXP CELL RES, V313, P1866, DOI 10.1016/j.yexcr.2007.03.009; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Koshikawa N, 2006, ONCOGENE, V25, P917, DOI 10.1038/sj.onc.1209128; Koshikawa N, 2003, ONCOGENE, V22, P6717, DOI 10.1038/sj.onc.1206765; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Luo G, 1997, GENE EXPRESSION, V6, P287; Mayerhofer M, 2002, BLOOD, V100, P3767, DOI 10.1182/blood-2002-01-0109; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; Oh YT, 2008, NEUROSCI LETT, V431, P155, DOI 10.1016/j.neulet.2007.11.033; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069; Pouyssegur J, 2006, BIOL CHEM, V387, P1337, DOI 10.1515/BC.2006.167; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Saramaki OR, 2001, CANCER GENET CYTOGEN, V128, P31, DOI 10.1016/S0165-4608(01)00396-X; Secades P, 2009, GENE CHROMOSOME CANC, V48, P441, DOI 10.1002/gcc.20652; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yu ZT, 2002, J AM SOC NEPHROL, V13, P2009, DOI 10.1097/01.ASN.0000024253.59665.F1	32	109	117	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33185	33194		10.1074/jbc.M109.054221	http://dx.doi.org/10.1074/jbc.M109.054221			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801684	Green Published, hybrid			2022-12-25	WOS:000272028500023
J	Akiyama, H; Gotoh, A; Shin, RW; Koga, T; Ohashi, T; Sakamoto, W; Harada, A; Arai, H; Sawa, A; Uchida, C; Uchida, T				Akiyama, Hirotada; Gotoh, Aina; Shin, Ryong-Woon; Koga, Tomoe; Ohashi, Tsubasa; Sakamoto, Wataru; Harada, Akihiro; Arai, Hiroyuki; Sawa, Akira; Uchida, Chiyoko; Uchida, Takafumi			A Novel Role for hGas7b in Microtubular Maintenance POSSIBLE IMPLICATION IN TAU-ASSOCIATED PATHOLOGY IN ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 CELLS; PROTEIN; GAS7	Here, we report a novel role for hGas7b (human growth arrest specific protein 7b) in the regulation of microtubules. Using a bioinformatic approach, we studied the actin-binding protein hGas7b with a structural similarity to the WW domain of a peptidyl prolyl cis/trans isomerase, Pin1, that facilitates microtubule assembly. Thus, we have demonstrated that hGas7b binds Tau at the WW motif and that the hGas7b/Tau protein complex interacts with the microtubules, promoting tubulin polymerization. Tau, in turn, contributes to protein stability of hGas7b. Furthermore, we observed decreased levels of hGas7b in the brains from patients with Alzheimer disease. These results suggest an important role for hGas7b in microtubular maintenance and possible implication in Alzheimer disease.	[Akiyama, Hirotada; Gotoh, Aina; Koga, Tomoe; Ohashi, Tsubasa; Sakamoto, Wataru; Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Enzymol, Sendai, Miyagi 9818555, Japan; [Shin, Ryong-Woon] Tohoku Univ, Grad Sch Med, Dept Neuropathol, Sendai, Miyagi 9818555, Japan; [Arai, Hiroyuki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9818555, Japan; [Harada, Akihiro] Gunma Univ, Inst Mol & Cellular Regulat, Gunma 3718511, Japan; [Uchida, Chiyoko] Ibaraki Univ, Univ Hlth Ctr, Mito, Ibaraki 3108512, Japan; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Tohoku University; Tohoku University; Tohoku University; Gunma University; Ibaraki University; Johns Hopkins University; Johns Hopkins University	Uchida, T (corresponding author), 1-1 Amamiya, Sendai, Miyagi 9818555, Japan.	uchidat@biochem.tohoku.ac.jp		Uchida, Takafumi/0000-0003-3665-4906; Gotoh, Aina/0000-0002-0979-2265	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research on priority areas and a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Fujio K, 2007, NEUROREPORT, V18, P1049, DOI 10.1097/WNR.0b013e32818b2a0b; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; KARR TL, 1979, J BIOL CHEM, V254, P6107; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; Lortie K, 2005, BRAIN RES, V1036, P27, DOI 10.1016/j.brainres.2004.12.024; Lu PJ, 1999, NATURE, V399, P784; Murayama H, 1999, AM J PATHOL, V155, P877, DOI 10.1016/S0002-9440(10)65187-5; MURPHY DB, 1991, METHODS ENZYMOL, V196, P235; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Uchida T, 2009, J MOL BIOL, V391, P849, DOI 10.1016/j.jmb.2009.06.081	15	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32695	32699		10.1074/jbc.M109.035998	http://dx.doi.org/10.1074/jbc.M109.035998			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801671	Green Published, hybrid			2022-12-25	WOS:000272028400053
J	Ottolia, M; Nicoll, DA; Philipson, KD				Ottolia, Michela; Nicoll, Debora A.; Philipson, Kenneth D.			Roles of Two Ca2+-binding Domains in Regulation of the Cardiac Na+-Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; NA+/CA2+ EXCHANGER; MUTATIONAL ANALYSIS; CONFORMATIONAL-CHANGES; DYNAMIC PROPERTIES; CRYSTAL-STRUCTURE; CA2+ REGULATION; STEADY-STATE; NCX1; ISOFORMS	We expressed full-length Na+-Ca2+ exchangers (NCXs) with mutations in two Ca2+-binding domains (CBD1 and CBD2) to determine the roles of the CBDs in Ca2+-dependent regulation of NCX. CBD1 has four Ca2+-binding sites, and mutation of residues Asp(421) and Glu(451), which primarily coordinate Ca2+ at sites 1 and 2, had little effect on regulation of NCX by Ca2+. In contrast, mutations at residues Glu(385), Asp(446), Asp(447), and Asp(500), which coordinate Ca2+ at sites 3 and 4 of CBD1, resulted in a drastic decrease in the apparent affinity of peak exchange current for regulatory Ca2+. Another mutant, M7, with 7 key residues of CBD1 replaced, showed a further decrease in apparent Ca2+ affinity but retained regulation, confirming a contribution of CBD2 to Ca2+ regulation. Addition of the mutation K585E (located in CBD2) into the M7 background induced a marked increase in Ca2+ affinity for both steady-state and peak currents. Also, we have shown previously that the CBD2 mutations E516L and E683V have no Ca2+-dependent regulation. We now demonstrate that introduction of a positive charge at these locations rescues Ca2+-dependent regulation. Finally, our data demonstrate that deletion of the unstructured loops between beta-strands F and G of both CBDs does not alter the regulation of the exchanger by Ca2+, indicating that these segments are not important in regulation. Thus, CBD1 and CBD2 have distinct roles in Ca2+-dependent regulation of NCX. CBD1 determines the affinity of NCX for regulatory Ca2+, although CBD2 is also necessary for Ca2+-dependent regulation.	Univ Calif Los Angeles, Cardiovasc Res Labs, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Ottolia, M (corresponding author), Univ Calif Los Angeles, Cardiovasc Res Lab MRL 3 645, David Geffen Sch Med, Los Angeles, CA 90095 USA.	mottolia@mednet.ucla.edu			National Institutes of Health [HL49101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL49101.	Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Egger M, 1999, J MEMBRANE BIOL, V168, P107, DOI 10.1007/s002329900502; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilgemann DW, 1998, METHOD ENZYMOL, V293, P267; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Nicoll DA, 2002, ANN NY ACAD SCI, V976, P11; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Ottolia M, 2005, J BIOL CHEM, V280, P1061, DOI 10.1074/jbc.M411899200; Ottolia M, 2004, BIOPHYS J, V87, P899, DOI 10.1529/biophysj.104.043471; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Philipson KD, 2002, ANN NY ACAD SCI, V976, P1; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045; Xie Y, 2008, AM J PHYSIOL-CELL PH, V295, pC388, DOI 10.1152/ajpcell.00178.2008	22	58	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32735	32741		10.1074/jbc.M109.055434	http://dx.doi.org/10.1074/jbc.M109.055434			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801651	Green Published, hybrid			2022-12-25	WOS:000272028400058
J	Gilmore, S; Hofmann-Wellenhof, R; Muir, J; Soyer, HP				Gilmore, Stephen; Hofmann-Wellenhof, Rainer; Muir, Jim; Soyer, H. Peter			Lacunarity Analysis: A Promising Method for the Automated Assessment of Melanocytic Naevi and Melanoma	PLOS ONE			English	Article							PIGMENTED SKIN-LESIONS; ARTIFICIAL NEURAL-NETWORK; DIGITAL DERMOSCOPY ANALYSIS; IMAGE-ANALYSIS; EPILUMINESCENCE MICROSCOPY; DIAGNOSIS; COMPUTER; DIFFERENTIATION; PATTERN; SYSTEM	The early diagnosis of melanoma is critical to achieving reduced mortality and increased survival. Although clinical examination is currently the method of choice for melanocytic lesion assessment, there is a growing interest among clinicians regarding the potential diagnostic utility of computerised image analysis. Recognising that there exist significant shortcomings in currently available algorithms, we are motivated to investigate the utility of lacunarity, a simple statistical measure previously used in geology and other fields for the analysis of fractal and multi-scaled images, in the automated assessment of melanocytic naevi and melanoma. Digitised dermoscopic images of 111 benign melanocytic naevi, 99 dysplastic naevi and 102 melanomas were obtained over the period 2003 to 2008, and subject to lacunarity analysis. We found the lacunarity algorithm could accurately distinguish melanoma from benign melanocytic naevi or non-melanoma without introducing many of the limitations associated with other previously reported diagnostic algorithms. Lacunarity analysis suggests an ordering of irregularity in melanocytic lesions, and we suggest the clinical application of this ordering may have utility in the naked-eye dermoscopic diagnosis of early melanoma.			Gilmore, S (corresponding author), Univ Queensland, Sch Med, Princess Alexandra Hosp, Dermatol Res Ctr, Brisbane, Qld, Australia.	s.gilmore1@uq.edu.au	Muir, James B/ABI-2711-2020; Soyer, H. Peter/W-3791-2017; Soyer, H. Peter/E-6000-2010	Soyer, H. Peter/0000-0002-4770-561X; Soyer, H. Peter/0000-0002-4770-561X; Muir, James/0000-0003-3791-161X				ALLAIN C, 1991, PHYS REV A, V44, P3552, DOI 10.1103/PhysRevA.44.3552; Andreassi L, 1999, ARCH DERMATOL, V135, P1459, DOI 10.1001/archderm.135.12.1459; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Argenziano G, 2001, LANCET ONCOL, V2, P443, DOI 10.1016/S1470-2045(00)00422-8; Bauer P, 2000, MELANOMA RES, V10, P345, DOI 10.1097/00008390-200008000-00005; Benvenuto-Andrade C, 2007, ARCH DERMATOL, V143, P329, DOI 10.1001/archderm.143.3.329; Binder M, 1998, MELANOMA RES, V8, P261, DOI 10.1097/00008390-199806000-00009; BINDER M, 1994, BRIT J DERMATOL, V130, P460, DOI 10.1111/j.1365-2133.1994.tb03378.x; Blum A, 2004, BRIT J DERMATOL, V151, P1029, DOI 10.1111/j.1365-2133.2004.06210.x; CASCINELLI N, 1987, J AM ACAD DERMATOL, V16, P361, DOI 10.1016/S0190-9622(87)70050-4; Dougherty G, 2002, MED ENG PHYS, V24, P129, DOI 10.1016/S1350-4533(01)00106-0; Elbaum M, 2001, J AM ACAD DERMATOL, V44, P207, DOI 10.1067/mjd.2001.110395; Ernstoff MS, 2000, CLIN PLAST SURG, V27, P317; Fikrle T, 2007, J EUR ACAD DERMATOL, V21, P48, DOI 10.1111/j.1468-3083.2006.01864.x; GEFEN Y, 1983, PHYS REV LETT, V50, P145, DOI 10.1103/PhysRevLett.50.145; GREEN A, 1994, J AM ACAD DERMATOL, V31, P958, DOI 10.1016/S0190-9622(94)70264-0; GUTKOWITZKRUSIN D, 2007, COLOR ATLAS MELANOCY, P52; Hoffmann K, 2003, BRIT J DERMATOL, V149, P801, DOI 10.1046/j.1365-2133.2003.05547.x; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; LIN B, 1986, J PHYS A-MATH GEN, V19, pL49, DOI 10.1088/0305-4470/19/2/005; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Manousaki AG, 2006, INT J DERMATOL, V45, P402, DOI 10.1111/j.1365-4632.2006.02726.x; Manousaki AG, 2006, COMPUT BIOL MED, V36, P419, DOI 10.1016/j.compbiomed.2005.01.004; Menzies SW, 2005, ARCH DERMATOL, V141, P1388, DOI 10.1001/archderm.141.11.1388; Piantanelli A, 2005, MED BIOL ENG COMPUT, V43, P436, DOI 10.1007/BF02344723; Piccolo D, 2002, BRIT J DERMATOL, V147, P481, DOI 10.1046/j.1365-2133.2002.04978.x; Plotnick RE, 1996, PHYS REV E, V53, P5461, DOI 10.1103/PhysRevE.53.5461; Rubegni P, 2002, J INVEST DERMATOL, V119, P471, DOI 10.1046/j.1523-1747.2002.01835.x; Rubegni P, 2002, INT J CANCER, V101, P576, DOI 10.1002/ijc.10620; SCHINDEWOLF T, 1994, J AM ACAD DERMATOL, V31, P33, DOI 10.1016/S0190-9622(94)70132-6; Soyer HP, 2004, DERMATOLOGY, V208, P27, DOI 10.1159/000075042; Weinstock MA, 1999, AM J PREV MED, V17, P169, DOI 10.1016/S0749-3797(99)00077-X; Weishampel JF, 1998, INT J REMOTE SENS, V19, P1007, DOI 10.1080/014311698215847; Zalaudek I, 2007, ARCH DERMATOL, V143, P351, DOI 10.1001/archderm.143.3.351	34	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7449	10.1371/journal.pone.0007449	http://dx.doi.org/10.1371/journal.pone.0007449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823688	Green Published, gold			2022-12-25	WOS:000270808300020
J	Johnson, KJ; Griswold, IJ; O'Hare, T; Corbin, AS; Loriaux, M; Deininger, MW; Druker, BJ				Johnson, Kara J.; Griswold, Ian J.; O'Hare, Thomas; Corbin, Amie S.; Loriaux, Marc; Deininger, Michael W.; Druker, Brian J.			A BCR-ABL Mutant Lacking Direct Binding Sites for the GRB2, CBL and CRKL Adapter Proteins Fails to Induce Leukemia in Mice	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE-ACTIVITY; POSITIVE HUMAN LEUKEMIAS; PHILADELPHIA-CHROMOSOME; HEMATOPOIETIC-CELLS; SH2 DOMAIN; MYELOPROLIFERATIVE DISEASE; SIGNAL-TRANSDUCTION; TRANSFORMATION; ONCOGENE	The BCR-ABL tyrosine kinase is the defining feature of chronic myeloid leukemia (CML) and its kinase activity is required for induction of this disease. Current thinking holds that BCR-ABL forms a multi-protein complex that incorporates several substrates and adaptor proteins and is stabilized by multiple direct and indirect interactions. Signaling output from this highly redundant network leads to cellular transformation. Proteins known to be associated with BCR-ABL in this complex include: GRB2, c-CBL, p62(DOK), and CRKL. These proteins in turn, link BCR-ABL to various signaling pathways indicated in cellular transformation. In this study we show that a triple mutant of BCR-ABL with mutations of the direct binding sites for GRB2, CBL, p62(DOK) and CRKL, is defective for transformation of primary hematopoietic cells in vitro and in a murine CML model, while it retains the capacity to induce IL-3 independence in 32D cells. Compared to BCR-ABL, the triple mutant's ability to activate the MAP kinase and PI3-kinase pathways is severely compromised, while STAT5 phosphorylation is maintained, suggesting that the former are crucial for the transformation of primary cells, but dispensable for transformation of factor dependent cell lines. Our data suggest that inhibition of BCR-ABL-induced leukemia by disrupting protein interactions could be possible, but would require blocking of multiple sites.			Johnson, KJ (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA.	johnskar@ohsu.edu		Druker, Brian/0000-0001-8331-8206	NATIONAL CANCER INSTITUTE [R01CA065823] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA065823, R01 CA65823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhat A, 1997, J BIOL CHEM, V272, P16170, DOI 10.1074/jbc.272.26.16170; Bhat A, 1998, J BIOL CHEM, V273, P32360, DOI 10.1074/jbc.273.48.32360; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; CORTEZ D, 1995, MOL CELL BIOL, V15, P5531; Dai ZH, 2001, J BIOL CHEM, V276, P28954, DOI 10.1074/jbc.M101170200; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dinulescu DM, 2003, ONCOGENE, V22, P8852, DOI 10.1038/sj.onc.1206892; Gaston I, 2004, EXP HEMATOL, V32, P113, DOI 10.1016/j.exphem.2003.09.018; GISHIZKY ML, 1993, P NATL ACAD SCI USA, V90, P3755, DOI 10.1073/pnas.90.8.3755; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Gotoh A, 1997, Curr Opin Hematol, V4, P3; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; Heaney C, 1997, BLOOD, V89, P297, DOI 10.1182/blood.V89.1.297.297_297_306; ILARIA RL, 1995, BLOOD, V86, P3897, DOI 10.1182/blood.V86.10.3897.bloodjournal86103897; Kang JX, 2005, CARCINOGENESIS, V26, P1934, DOI 10.1093/carcin/bgi154; Kardinal C, 2001, BLOOD, V98, P1773, DOI 10.1182/blood.V98.6.1773; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; KOTANI H, 1994, HUM GENE THER, V5, P19, DOI 10.1089/hum.1994.5.1-19; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; LUGO TG, 1989, MOL CELL BIOL, V9, P1263, DOI 10.1128/MCB.9.3.1263; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; Million RP, 2002, BLOOD, V99, P4568, DOI 10.1182/blood-2001-12-0244; Million RP, 2000, BLOOD, V96, P664; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; ODA T, 1995, LEUKEMIA, V9, P295; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Raitano AB, 1997, BBA-REV CANCER, V1333, pF201, DOI 10.1016/S0304-419X(97)00023-1; Roumiantsev S, 2001, BLOOD, V97, P4, DOI 10.1182/blood.V97.1.4; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Sattler M, 1996, ONCOGENE, V12, P839; Sattler Martin, 1997, Cytokine and Growth Factor Reviews, V8, P63, DOI 10.1016/S1359-6101(96)00047-0; Sawyers CL, 1997, BAILLIERE CLIN HAEM, V10, P223, DOI 10.1016/S0950-3536(97)80004-2; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082; Senechal K, 1996, J BIOL CHEM, V271, P23255, DOI 10.1074/jbc.271.38.23255; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829	47	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7439	10.1371/journal.pone.0007439	http://dx.doi.org/10.1371/journal.pone.0007439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823681	gold, Green Submitted, Green Published			2022-12-25	WOS:000270808300015
J	Sumner, MD; Wotherspoon, SJ; Hindell, MA				Sumner, Michael D.; Wotherspoon, Simon J.; Hindell, Mark A.			Bayesian Estimation of Animal Movement from Archival and Satellite Tags	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; SURFACE TEMPERATURE; LOCATION ACCURACY; FORAGING ECOLOGY; GREY SEALS; GEOLOCATION; INFERENCE; MODEL; MIGRATIONS; SEABIRDS	The reliable estimation of animal location, and its associated error is fundamental to animal ecology. There are many existing techniques for handling location error, but these are often ad hoc or are used in isolation from each other. In this study we present a Bayesian framework for determining location that uses all the data available, is flexible to all tagging techniques, and provides location estimates with built-in measures of uncertainty. Bayesian methods allow the contributions of multiple data sources to be decomposed into manageable components. We illustrate with two examples for two different location methods: satellite tracking and light level geo-location. We show that many of the problems with uncertainty involved are reduced and quantified by our approach. This approach can use any available information, such as existing knowledge of the animal's potential range, light levels or direct location estimates, auxiliary data, and movement models. The approach provides a substantial contribution to the handling uncertainty in archival tag and satellite tracking data using readily available tools.			Sumner, MD (corresponding author), Univ Tasmania, Michael D Sumner Sch Math & Phys IASOS, Hobart, Tas, Australia.	mdsumner@utas.edu.au	Wotherspoon, Simon J/B-2390-2013; Hindell, Mark A/K-1131-2013; Hindell, Mark A/C-8368-2013	Wotherspoon, Simon J/0000-0002-6947-4445; Sumner, Michael/0000-0002-2471-7511; Hindell, Mark/0000-0002-7823-7185				Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Best NG, 1995, CODA CONVERGENCE DIA; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Bradshaw CJA, 2002, ICES J MAR SCI, V59, P770, DOI 10.1006/jmsc.2002.1246; Bradshaw Corey J.A., 2006, P889; Brothers NP, 1997, EMU, V97, P231; CROXALL J, 2004, RES GLOB PROC TRACK; DELONG RL, 1992, MAR MAMMAL SCI, V8, P155, DOI 10.1111/j.1748-7692.1992.tb00375.x; Dixon P, 1996, ECOL APPL, V6, P1034, DOI 10.2307/2269587; DOMEIER ML, 2005, FISHERY B, V108, P292; Dorazio RM, 2003, ECOL APPL, V13, P556, DOI 10.1890/1051-0761(2003)013[0556:BIADTA]2.0.CO;2; EKSTROM P, 2002, P INT SOC OPTICAL EN, V4815; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Ellison AM, 1996, ECOL APPL, V6, P1036, DOI 10.2307/2269588; Gelman A., 2004, BAYESIAN DATA ANAL; Gilks W.R., 1995, MARKOV CHAIN MONTE C, P1; Gunn JS, 2003, MAR FRESHWATER RES, V54, P515, DOI 10.1071/MF03022; Halpin PN, 2006, MAR ECOL PROG SER, V316, P239, DOI 10.3354/meps316239; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hill C., 2001, ELECT TAGGING TRACKI, P315, DOI DOI 10.1007/978-94-017-1402-0_17; Hill Roger D., 1994, P227; HINDELL MA, 1991, AUST J MAR FRESH RES, V42, P115; Hindell MA, 2003, J APPL ECOL, V40, P703, DOI 10.1046/j.1365-2664.2003.00832.x; Hunter J. R., 1986, DYNAMICS TUNA MOVEME; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Lake S, 2005, ECOGRAPHY, V28, P295, DOI 10.1111/j.0906-7590.2005.03949.x; Matthiopoulos J, 2005, J ANIM ECOL, V74, P716, DOI 10.1111/j.1365-2656.2005.00970.x; Matthiopoulos J, 2004, J APPL ECOL, V41, P476, DOI 10.1111/j.0021-8901.2004.00911.x; Matthiopoulos J, 2003, OIKOS, V102, P367, DOI 10.1034/j.1600-0706.2003.12528.x; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; MEEUS J, 1991, ASTRONOMICAL ALGORIT, V477; Nel DC, 2002, IBIS, V144, pE141, DOI 10.1046/j.1474-919X.2002.00092.x; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Ovaskainen O, 2008, ECOLOGY, V89, P542, DOI 10.1890/07-0443.1; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Roberts S, 2004, J THEOR BIOL, V227, P39, DOI 10.1016/j.jtbi.2003.07.002; Royer F, 2005, OIKOS, V109, P473, DOI 10.1111/j.0030-1299.2005.13777.x; *SERV ARG, 2004, US MAN COLL LOC SAT; Smith Paul, 1986, DETERMINING FISH MOV; Sumner MD, 2003, REMOTE SENS ENVIRON, V84, P161, DOI 10.1016/S0034-4257(02)00103-7; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Thompson D, 2003, MAR ECOL PROG SER, V260, P285, DOI 10.3354/meps260285; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; Turchin Peter, 1998; van den Hoff J, 2002, ANTARCT SCI, V14, P134, DOI 10.1017/S095410200200069X; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6; Wentz EA, 2003, INT J GEOGR INF SCI, V17, P623, DOI 10.1080/1365881031000135492; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; White NA, 2002, POLAR BIOL, V25, P629, DOI 10.1007/s00300-002-0385-8; Wintle BA, 2003, CONSERV BIOL, V17, P1579, DOI 10.1111/j.1523-1739.2003.00614.x; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; Xavier JC, 2004, FISH OCEANOGR, V13, P324, DOI 10.1111/j.1365-2419.2004.00298.x	57	113	119	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7324	10.1371/journal.pone.0007324	http://dx.doi.org/10.1371/journal.pone.0007324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823684	Green Published, gold, Green Accepted			2022-12-25	WOS:000270808300004
J	Singh, R; Lemire, J; Mailloux, RJ; Chenier, D; Hamel, R; Appanna, VD				Singh, Ranji; Lemire, Joseph; Mailloux, Ryan J.; Chenier, Daniel; Hamel, Robert; Appanna, Vasu D.			An ATP and Oxalate Generating Variant Tricarboxylic Acid Cycle Counters Aluminum Toxicity in Pseudomonas fluorescens	PLOS ONE			English	Article								Although the tricarboxylic acid (TCA) cycle is essential in almost all aerobic organisms, its precise modulation and integration in global cellular metabolism is not fully understood. Here, we report on an alternative TCA cycle uniquely aimed at generating ATP and oxalate, two metabolites critical for the survival of Pseudomonas fluorescens. The upregulation of isocitrate lyase (ICL) and acylating glyoxylate dehydrogenase (AGODH) led to the enhanced synthesis of oxalate, a dicarboxylic acid involved in the immobilization of aluminum (Al). The increased activity of succinyl-CoA synthetase (SCS) and oxalate CoA-transferase (OCT) in the Al-stressed cells afforded an effective route to ATP synthesis from oxalyl-CoA via substrate level phosphorylation. This modified TCA cycle with diminished efficacy in NADH production and decreased CO(2)-evolving capacity, orchestrates the synthesis of oxalate, NADPH, and ATP, ingredients pivotal to the survival of P. fluorescens in an Al environment. The channeling of succinyl-CoA towards ATP formation may be an important function of the TCA cycle during anaerobiosis, Fe starvation and O(2)-limited conditions.			Singh, R (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada.	vappanna@laurentian.ca		Appanna, Vasu/0000-0002-0138-5665; Mailloux, Ryan/0000-0003-3986-9830				ANDERSON S, 1992, FEBS LETT, V308, P94, DOI 10.1016/0014-5793(92)81059-U; Appanna VD, 2003, CURR MICROBIOL, V47, P521, DOI 10.1007/s00284-003-4100-y; Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; Baysse C, 2001, FEMS MICROBIOL LETT, V205, P57, DOI 10.1016/S0378-1097(01)00441-4; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bott M, 2007, TRENDS MICROBIOL, V15, P417, DOI 10.1016/j.tim.2007.08.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chenier D, 2008, APPL ENVIRON MICROB, V74, P3977, DOI 10.1128/AEM.02702-07; DIJKHUIZEN L, 1980, ARCH MICROBIOL, V124, P261, DOI 10.1007/BF00427736; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fraser ME, 2006, J BIOL CHEM, V281, P11058, DOI 10.1074/jbc.M511785200; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; GUCHHAIT RB, 1974, J BIOL CHEM, V249, P6646; Hamel R, 2003, BBA-GEN SUBJECTS, V1619, P70, DOI 10.1016/S0304-4165(02)00444-0; Hamel R, 2004, BIOCHEM BIOPH RES CO, V317, P1189, DOI 10.1016/j.bbrc.2004.03.157; Hugler M, 2005, J BACTERIOL, V187, P3020, DOI 10.1128/JB.187.9.3020-3027.2005; HUNGERER C, 1995, J BACTERIOL, V177, P1435, DOI 10.1128/jb.177.6.1435-1443.1995; Kern A, 2007, J BIOTECHNOL, V129, P6, DOI 10.1016/j.jbiotec.2006.11.021; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; KREBS A, 1974, CAN J BIOCHEM CELL B, V52, P594, DOI 10.1139/o74-086; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Mailloux RJ, 2008, ELECTROPHORESIS, V29, P1484, DOI 10.1002/elps.200700697; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Mailloux RJ, 2007, TOXICOL IN VITRO, V21, P16, DOI 10.1016/j.tiv.2006.07.013; Mailloux RJ, 2006, J BIOCHEM MOL TOXIC, V20, P198, DOI 10.1002/jbt.20137; Mailloux RJ, 2009, J BACTERIOL, V191, P3804, DOI 10.1128/JB.00046-09; Mailloux RJ, 2009, BIOCHIMIE, V91, P408, DOI 10.1016/j.biochi.2008.10.014; Mailloux RJ, 2006, ANAL BIOCHEM, V359, P210, DOI 10.1016/j.ab.2006.09.019; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Middaugh J, 2005, J BIOL CHEM, V280, P3159, DOI 10.1074/jbc.M411979200; Pandey AV, 1999, ANAL BIOCHEM, V268, P159, DOI 10.1006/abio.1998.2997; QUAYLE JR, 1961, BIOCHEM J, V78, P225, DOI 10.1042/bj0780225; Ricagno S, 2003, EMBO J, V22, P3210, DOI 10.1093/emboj/cdg333; Romanov V, 1999, ANAL BIOCHEM, V268, P49, DOI 10.1006/abio.1998.3033; Sadykov MR, 2008, J BACTERIOL, V190, P7621, DOI 10.1128/JB.00806-08; Schwimmer C, 2005, J BIOL CHEM, V280, P30751, DOI 10.1074/jbc.M501831200; Shoolingin-Jordan PM, 2003, BBA-PROTEINS PROTEOM, V1647, P361, DOI 10.1016/S1570-9639(03)00095-5; Singh R, 2005, EXTREMOPHILES, V9, P367, DOI 10.1007/s00792-005-0450-7; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; Ward RJ, 2001, J INORG BIOCHEM, V87, P9, DOI 10.1016/S0162-0134(01)00308-7; Williams AW, 1998, BIOCHEMISTRY-US, V37, P7096, DOI 10.1021/bi972562+	45	46	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7344	10.1371/journal.pone.0007344	http://dx.doi.org/10.1371/journal.pone.0007344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809498	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594000010
J	Reinicke, AT; Omilusik, KD; Basha, G; Jefferies, WA				Reinicke, Anna T.; Omilusik, Kyla D.; Basha, Genc; Jefferies, Wilfred A.			Dendritic Cell Cross-Priming Is Essential for Immune Responses to Listeria monocytogenes	PLOS ONE			English	Article								Cross-presentation is now recognized as a major mechanism for initiating CD8 T cell responses to virus and tumor antigens in vivo. It provides an elegant mechanism that allows relatively few Dendritic cells (DCs) to initiate primary immune responses while avoiding the consumptive nature of pathogenic infection. CD8 T cells play a major role in anti-bacterial immune responses; however, the contribution of cross-presentation for priming CD8 T cell responses to bacteria, in vivo, is not well established. Listeria monocytogenes (Listeria) is the causative agent of Listeriosis, an opportunistic food-borne bacterial infection that poses a significant public health risk. Here, we employ a transgenic mouse model in which cross-presentation is uniquely inactivated, to investigate cross-priming during primary Listeria infection. We show that cross-priming deficient mice are severely compromised in their ability to generate antigen-specific T cells to stimulate MHC I-restricted CTL responses following Listeria infection. The defect in generation of Listeria-elicited CD8 T cell responses is also apparent in vitro. However, in this setting, the endogenous route of processing Listeria-derived antigens is predominant. This reveals a new experimental dichotomy whereby functional sampling of Listeria-derived antigens in vivo but not in vitro is dependent on cross-presentation of exogenously derived antigen. Thus, under normal physiological circumstances, cross-presentation is demonstrated to play an essential role in priming CD8 T cell responses to bacteria.			Reinicke, AT (corresponding author), Univ British Columbia, Biomed Res Ctr, Michael Smith Labs, Dept Med Genet, 2222 Hlth Sci Mall, Vancouver, BC, Canada.	wilf@brc.ubc.ca		Omilusik, Kyla/0000-0003-3675-048X; Basha, Genc/0000-0003-0471-2892				Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; AlvarezDominguez C, 1997, J CELL SCI, V110, P731; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Basta S, 2003, VIRAL IMMUNOL, V16, P231, DOI 10.1089/088282403322396064; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; CHEERS C, 1978, INFECT IMMUN, V19, P755, DOI 10.1128/IAI.19.3.755-762.1978; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Gregory SH, 1997, INFECT IMMUN, V65, P5137, DOI 10.1128/IAI.65.12.5137-5141.1997; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Jiang J, 2003, J IMMUNOL, V171, P4352, DOI 10.4049/jimmunol.171.8.4352; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaufmann SHE, 2005, CURR OPIN IMMUNOL, V17, P79, DOI 10.1016/j.coi.2004.12.004; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; LADEL CH, 1994, J IMMUNOL, V153, P3116; Lenz LL, 2000, J EXP MED, V192, P1135, DOI 10.1084/jem.192.8.1135; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McElroy DS, 2009, MICROB PATHOGENESIS, V46, P214, DOI 10.1016/j.micpath.2009.01.003; MCGREGOR DD, 1970, NATURE, V228, P855, DOI 10.1038/228855a0; Merrick JC, 1997, AM J PATHOL, V151, P785; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; VILLANUEVA MS, 1995, J IMMUNOL, V155, P5227; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613	48	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7210	10.1371/journal.pone.0007210	http://dx.doi.org/10.1371/journal.pone.0007210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806187	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800001
J	Cederroth, CR; Nef, S				Cederroth, Christopher R.; Nef, Serge			Fetal Programming of Adult Glucose Homeostasis in Mice	PLOS ONE			English	Article								Background: Emerging evidence suggests that dietary soy and phytoestrogens can have beneficial effects on lipid and glucose metabolism. We have previously shown that male mice fed from conception to adulthood with a high soycontaining diet had reduced body weight, adiposity and a decrease in glucose intolerance, an early marker of insulin resistance and diabetes. Objectives: The purpose of this study was to identify the precise periods of exposure during which phytoestrogens and dietary soy improve lipid and glucose metabolism. Since intrauterine position (IUP) has been shown to alter sensitivity to endocrine disruptors, we also investigated whether the combination of IUP and fetal exposure to dietary phytoestrogens could potentially affect adult metabolic parameters. Methods: Male outbred mice (CD-1) were allowed ad libitum access to either a high soy-containing diet or a soy-free diet either during gestation, lactation or after weaning. Adiposity and bone mass density was assessed by dual x-ray absorptiometry. Glucose tolerance was assessed by a glucose tolerance test. Blood pressure was examined by the tail-cuff system. Results: Here we show that metabolic improvements are dependent on precise windows of exposure during life. The beneficial effects of dietary soy and phytoestrogens on adiposity were apparent only in animals fed post-natally, while the improvements in glucose tolerance are restricted to animals with fetal exposure to soy. Interestingly, we observed that IUP influenced adult glucose tolerance, but not adiposity. Similar IUP trends were observed for other estrogen-related metabolic parameters such as blood pressure and bone mass density. Conclusion: Our results suggest that IUP and fetal exposure to estrogenic environmental disrupting compounds, such as dietary phytoestrogens, could alter metabolic and cardiovascular parameters in adult individuals independently of adipose gain.			Cederroth, CR (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Serge.Nef@unige.ch	Nef, Serge/AAV-6445-2020; Cederroth, Christopher/B-9932-2011; Cederroth, Christopher R./AAO-9501-2020	Nef, Serge/0000-0001-5462-0676; Cederroth, Christopher/0000-0001-7267-5136				Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; BOKLAGE CE, 1985, AM J HUM GENET, V37, P591; Callewaert F, 2009, FASEB J, V23, P232, DOI 10.1096/fj.08-113456; Cederroth CR, 2008, DIABETES, V57, P1176, DOI 10.2337/db07-0630; Cederroth CR, 2008, CHIMIA, V62, P401, DOI 10.2533/chimia.2008.401; Cederroth CR, 2007, ENVIRON HEALTH PERSP, V115, P1467, DOI 10.1289/ehp.10413; Cederroth CR, 2009, MOL CELL ENDOCRINOL, V304, P30, DOI 10.1016/j.mce.2009.02.027; Cooper C, 1997, ANN RHEUM DIS, V56, P17, DOI 10.1136/ard.56.1.17; Cooper C, 2002, CALCIFIED TISSUE INT, V70, P391, DOI 10.1007/s00223-001-0044-z; COOPER C, 1995, J BONE MINER RES, V10, P940; Dempsey PJ, 1999, AM J HUM BIOL, V11, P577, DOI 10.1002/(SICI)1520-6300(199909/10)11:5<577::AID-AJHB1>3.0.CO;2-Y; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; GILL WB, 1979, J UROLOGY, V122, P36, DOI 10.1016/S0022-5347(17)56240-0; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; HENDERSON BE, 1988, BRIT J CANCER, V57, P216, DOI 10.1038/bjc.1988.46; HSIEH CC, 1992, AM J EPIDEMIOL, V136, P1321, DOI 10.1093/oxfordjournals.aje.a116444; Hwang CS, 2006, J STEROID BIOCHEM, V101, P246, DOI 10.1016/j.jsbmb.2006.06.020; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; Kaati G, 2006, PATIENT EDUC COUNS, V62, P95, DOI 10.1016/j.pec.2005.06.012; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lesage J, 2004, J ENDOCRINOL, V181, P291, DOI 10.1677/joe.0.1810291; Li SF, 1997, CANCER RES, V57, P4356; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Lin HY, 2005, DIABETES, V54, P1717, DOI 10.2337/diabetes.54.6.1717; Lummaa V, 2007, P NATL ACAD SCI USA, V104, P10915, DOI 10.1073/pnas.0605875104; MCFADDEN D, 1993, P NATL ACAD SCI USA, V90, P11900, DOI 10.1073/pnas.90.24.11900; McFadden D, 1996, HEARING RES, V97, P102, DOI 10.1016/0378-5955(96)00065-2; MILLER EM, 1995, OPTOMETRY VISION SCI, V72, P34, DOI 10.1097/00006324-199501000-00007; Miltenberger RJ, 1997, J NUTR, V127, pS1902, DOI 10.1093/jn/127.9.1902S; MONTANO MM, 1991, PHYSIOL BEHAV, V50, P323, DOI 10.1016/0031-9384(91)90073-W; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Newbold RR, 2007, MOL NUTR FOOD RES, V51, P912, DOI 10.1002/mnfr.200600259; Newbold RR, 2007, REPROD TOXICOL, V23, P290, DOI 10.1016/j.reprotox.2006.12.010; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; PANAGIOTOPOULOU K, 1990, CANCER CAUSE CONTROL, V1, P119, DOI 10.1007/BF00053162; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; RESNICK SM, 1993, BEHAV GENET, V23, P323, DOI 10.1007/BF01067432; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; SAAL FSV, 1980, SCIENCE, V208, P597, DOI 10.1126/science.7367881; SAAL FSV, 1992, PHYSIOL BEHAV, V52, P163, DOI 10.1016/0031-9384(92)90447-A; Saegusa H, 1999, METABOLISM, V48, P1584, DOI 10.1016/S0026-0495(99)90249-4; Seckl JR, 2001, MOL CELL ENDOCRINOL, V185, P61, DOI 10.1016/S0303-7207(01)00633-5; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; van Anders SM, 2006, HORM BEHAV, V49, P315, DOI 10.1016/j.yhbeh.2005.08.003; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; VOMSAAL FS, 1983, PHYSIOL BEHAV, V30, P675, DOI 10.1016/0031-9384(83)90162-2; VOMSAAL FS, 1978, BIOL REPROD, V19, P842, DOI 10.1095/biolreprod19.4.842; VOMSAAL FS, 1990, BIOL REPROD, V43, P751, DOI 10.1095/biolreprod43.5.751; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weber KS, 2001, J ENDOCRINOL, V170, P591, DOI 10.1677/joe.0.1700591	56	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7281	10.1371/journal.pone.0007281	http://dx.doi.org/10.1371/journal.pone.0007281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789640	Green Published, Green Submitted, gold			2022-12-25	WOS:000270354100027
J	Johnson, MK; Clark, TD; Njama-Meya, D; Rosenthal, PJ; Parikh, S				Johnson, Marla K.; Clark, Tamara D.; Njama-Meya, Denise; Rosenthal, Philip J.; Parikh, Sunil			Impact of the Method of G6PD Deficiency Assessment on Genetic Association Studies of Malaria Susceptibility	PLOS ONE			English	Article								Background: Clinical association studies have yielded varied results regarding the impact of glucose-6-phosphate dehydrogenase (G6PD) deficiency upon susceptibility to malaria. Analyses have been complicated by varied methods used to diagnose G6PD deficiency. Methodology/Prinicipal Findings: We compared the association between uncomplicated malaria incidence and G6PD deficiency in a cohort of 601 Ugandan children using two different diagnostic methods, enzyme activity and G6PD genotype (G202A, the predominant East African allele). Although roughly the same percentage of males were identified as deficient using enzyme activity (12%) and genotype (14%), nearly 30% of males who were enzymatically deficient were wildtype at G202A. The number of deficient females was three-fold higher with assessment by genotype (21%) compared to enzyme activity (7%). Heterozygous females accounted for the majority (46/54) of children with a mutant genotype but normal enzyme activity. G6PD deficiency, as determined by G6PD enzyme activity, conferred a 52% (relative risk [RR] 0.48, 95% CI 0.31-0.75) reduced risk of uncomplicated malaria in females. In contrast, when G6PD deficiency was defined based on genotype, the protective association for females was no longer seen (RR=0.99, 95% CI 0.70-1.39). Notably, restricting the analysis to those females who were both genotypically and enzymatically deficient, the association of deficiency and protection from uncomplicated malaria was again demonstrated in females, but not in males (RR=0.57, 95% CI 0.37-0.88 for females). Conclusions/Significance: This study underscores the impact that the method of identifying G6PD deficient individuals has upon association studies of G6PD deficiency and uncomplicated malaria. We found that G6PD-deficient females were significantly protected against uncomplicated malaria, but this protection was only seen when G6PD deficiency is described using enzyme activity. These observations may help to explain the discrepancy in some published association studies involving G6PD deficiency and uncomplicated malaria.			Johnson, MK (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA.	sparikh@medsfgh.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI052142, K23AI060681] Funding Source: NIH RePORTER; NIAID NIH HHS [AI060681, AI052142, U01 AI052142, K23 AI060681] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ainoon O., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P405; ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; BEUTLER E, 1989, BLOOD, V74, P2550; Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; Beutler E, 2001, BLOOD, V98, P2597, DOI 10.1182/blood.V98.9.2597; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; BIENZLE U, 1972, LANCET, V1, P107; BIENZLE U, 1979, AM J TROP MED HYG, V28, P619, DOI 10.4269/ajtmh.1979.28.619; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Davis JC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-18; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Drousiotou A, 2004, BLOOD CELL MOL DIS, V33, P25, DOI 10.1016/j.bcmd.2004.03.004; Enevold A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-61; Fanello CI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004031; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; Hirono A, 2002, BLOOD, V99, P1498, DOI 10.1182/blood.V99.4.1498; Lell B, 1999, CLIN INFECT DIS, V28, P794, DOI 10.1086/515193; Mason PJ, 2007, BLOOD REV, V21, P267, DOI 10.1016/j.blre.2007.05.002; Minucci A, 2009, IUBMB LIFE, V61, P27, DOI 10.1002/iub.137; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Parikh S, 2004, AM J TROP MED HYG, V71, P750, DOI 10.4269/ajtmh.2004.71.750; Reclos GJ, 2000, J MED SCREEN, V7, P46, DOI 10.1136/jms.7.1.46; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Samilchuk E, 2003, BLOOD CELL MOL DIS, V31, P201, DOI 10.1016/S1079-9796(03)00125-6; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; Tagarelli A, 2006, CLIN BIOCHEM, V39, P183, DOI 10.1016/j.clinbiochem.2005.10.015; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; TOWN M, 1992, HUM MOL GENET, V1, P171, DOI 10.1093/hmg/1.3.171; USANGA EA, 1985, NATURE, V313, P793, DOI 10.1038/313793a0; [No title captured]	39	52	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7246	10.1371/journal.pone.0007246	http://dx.doi.org/10.1371/journal.pone.0007246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789650	gold, Green Published, Green Submitted			2022-12-25	WOS:000270354100011
J	Wolff, EDS; Salisbury, SW; Horner, JR; Varricchio, DJ				Wolff, Ewan D. S.; Salisbury, Steven W.; Horner, John R.; Varricchio, David J.			Common Avian Infection Plagued the Tyrant Dinosaurs	PLOS ONE			English	Article							TRICHOMONAS-GALLINAE; CROCODILE; GOSHAWKS	Background: Tyrannosaurus rex and other tyrannosaurid fossils often display multiple, smooth-edged full-thickness erosive lesions on the mandible, either unilaterally or bilaterally. The cause of these lesions in the Tyrannosaurus rex specimen FMNH PR2081 (known informally by the name 'Sue') has previously been attributed to actinomycosis, a bacterial bone infection, or bite wounds from other tyrannosaurids. Methodology/Principal Findings: We conducted an extensive survey of tyrannosaurid specimens and identified ten individuals with full-thickness erosive lesions. These lesions were described, measured and photographed for comparison with one another. We also conducted an extensive survey of related archosaurs for similar lesions. We show here that these lesions are consistent with those caused by an avian parasitic infection called trichomonosis, which causes similar abnormalities on the mandible of modern birds, in particular raptors. Conclusions/ Significance: This finding represents the first evidence for the ancient evolutionary origin of an avian transmissible disease in non-avian theropod dinosaurs. It also provides a valuable insight into the palaeobiology of these now extinct animals. Based on the frequency with which these lesions occur, we hypothesize that tyrannosaurids were commonly infected by a Trichomonas gallinae-like protozoan. For tyrannosaurid populations, the only non-avian dinosaur group that show trichomonosis-type lesions, it is likely that the disease became endemic and spread as a result of antagonistic intraspecific behavior, consumption of prey infected by a Trichomonas gallinae-like protozoan and possibly even cannibalism. The severity of trichomonosis-related lesions in specimens such as Tyrannosaurus rex FMNH PR2081 and Tyrannosaurus rex MOR 980, strongly suggests that these animals died as a direct result of this disease, mostly likely through starvation.			Wolff, EDS (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.	ewolff@wisc.edu; s.salisbury@uq.edu.au	Salisbury, Steven W./A-7518-2011	Salisbury, Steven W./0000-0003-4097-8567; Wolff, Ewan/0000-0002-5726-4766				BAKER J, 1981, ORAL PATHOLOGY ANIMA, P135; BRAZAITIS P, 1981, J HERPETOL, V15, P360, DOI 10.2307/1563441; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Cooper J.E., 2002, BIRDS PREY HLTH DIS; COOPER JE, 1988, J WILDLIFE DIS, V24, P80, DOI 10.7589/0090-3558-24.1.80; COTT H. B., 1961, TRANS ZOOL SOC LONDON, V29, P211; ENSLEY PK, 1979, J AM VET MED ASSOC, V175, P978; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Harmon BG, 1998, POULTRY SCI, V77, P972, DOI 10.1093/ps/77.7.972; Heidenreich M, 1997, BIRDS PREY MED MANAG; Hibberd E. M. A., 1993, Mycologist, V7, P32, DOI 10.1016/S0269-915X(09)80625-3; Huchzermeyer F. W., 2003, CROCODILES BIOL HUSB, P337; Huchzermeyer FW, 2000, VET REC, V147, P515, DOI 10.1136/vr.147.18.515; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; JACOBSEN ER, 2007, INFECT DIS PATHOLOGY; Kalin J.A., 1936, Z F R MORPHOLOGIE OE, V32, P327; KEYMER IF, 1972, VET REC, V90, P579, DOI 10.1136/vr.90.21.579; Krone O, 2005, J WILDLIFE DIS, V41, P304, DOI 10.7589/0090-3558-41.2.304; LEBNINSKY NG, 1920, VERHANDLUNGEN NATURF, V31, P39; Levinee ND, 1941, AM J HYG, V33, P23, DOI 10.1093/oxfordjournals.aje.a118708; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Real J, 2000, J WILDLIFE DIS, V36, P64, DOI 10.7589/0090-3558-36.1.64; Rega Elizabeth A., 2001, Journal of Vertebrate Paleontology, V21, p92A; Saif Y., 2003, DIS POULTRY, V11th; SCHULTZ CWN, 1994, AM BIRD BNDR, V19, P56; STABLER RM, 1954, EXP PARASITOL, V3, P368, DOI 10.1016/0014-4894(54)90035-1; STABLER RM, 1969, PEREGRINE FALCON POP; STONE W B, 1969, Bulletin of the Wildlife Disease Association, V5, P147; Tanke D.H., 2006, HORNS BEAKS CERATOPS, P319; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; VARRICCHIO DJ, 1995, PALAEOGEOGR PALAEOCL, V114, P297, DOI 10.1016/0031-0182(94)00084-L; Webb G., 1989, CROCODILES AUSTR; WEBB GJW, 1977, AUST WILDLIFE RES, V4, P311; WEISBRODE SE, 2001, THOMPSONS SPECIALIZE, P502; WOLFF EDS, 2005, WILDL DIS ASS INT C	35	31	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7288	10.1371/journal.pone.0007288	http://dx.doi.org/10.1371/journal.pone.0007288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789646	Green Published, Green Submitted, gold			2022-12-25	WOS:000270354100032
J	Matter, AM; Hoot, SB; Anderson, PD; Neves, SS; Cheng, YQ				Matter, Andrea M.; Hoot, Sara B.; Anderson, Patrick D.; Neves, Susana S.; Cheng, Yi-Qiang			Valinomycin Biosynthetic Gene Cluster in Streptomyces: Conservation, Ecology and Evolution	PLOS ONE			English	Article								Many Streptomyces strains are known to produce valinomycin (VLM) antibiotic and the VLM biosynthetic gene cluster (vlm) has been characterized in two independent isolates. Here we report the phylogenetic relationships of these strains using both parsimony and likelihood methods, and discuss whether the vlm gene cluster shows evidence of horizontal transmission common in natural product biosynthetic genes. Eight Streptomyces strains from around the world were obtained and sequenced for three regions of the two large nonribosomal peptide synthetase genes (vlm1 and vlm2) involved in VLM biosynthesis. The DNA sequences representing the vlm gene cluster are highly conserved among all eight environmental strains. The geographic distribution pattern of these strains and the strict congruence between the trees of the two vlm genes and the housekeeping genes, 16S rDNA and trpB, suggest vertical transmission of the vlm gene cluster in Streptomyces with no evidence of horizontal gene transfer. We also explored the relationship of the sequence of vlm genes to that of the cereulide biosynthetic genes (ces) found in Bacillus cereus and found them highly divergent from each other at DNA level (genetic distance values >= 95.6%). It is possible that the vlm gene cluster and the ces gene cluster may share a relatively distant common ancestor but these two gene clusters have since evolved independently.			Matter, AM (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	ycheng@uwm.edu	Neves, Susana/B-8724-2008	Neves, Susana/0000-0001-8943-2624; Cheng, Eric/0000-0001-9336-2593				AGATA N, 1994, FEMS MICROBIOL LETT, V121, P31, DOI 10.1016/0378-1097(94)90141-4; Anderson AS, 2001, INT J SYST EVOL MICR, V51, P797, DOI 10.1099/00207713-51-3-797; Andersson MA, 1998, APPL ENVIRON MICROB, V64, P4767; Apetroaie C, 2005, ARCH MICROBIOL, V184, P141, DOI 10.1007/s00203-005-0032-1; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Brakhage AA, 2005, PHYTOCHEMISTRY, V66, P1200, DOI 10.1016/j.phytochem.2005.02.030; BROCKMANN H, 1955, CHEM BER-RECL, V88, P57, DOI 10.1002/cber.19550880111; Brown EW, 2001, ENVIRON MOL MUTAGEN, V38, P248, DOI 10.1002/em.1079; Cheng YQ, 2006, CHEMBIOCHEM, V7, P471, DOI 10.1002/cbic.200500425; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; Dixon N, 2007, NAT PROD REP, V24, P1288, DOI 10.1039/b616808f; Ehling-Schulz M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-20; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Gaschen B, 2001, BIOINFORMATICS, V17, P415, DOI 10.1093/bioinformatics/17.5.415; Haruo N, 1968, Google Patents, Patent No. [3365363, US3365363A]; HILLIS D, 1990, MOL SYSTEMATICS; Huddleston AS, 1997, APPL ENVIRON MICROB, V63, P1288, DOI 10.1128/AEM.63.4.1288-1297.1997; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kitching I. J., 1998, CLADISTICS THEORY PR; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Li W. H, 1997, MOL EVOLUTION; Liras P, 1998, Int Microbiol, V1, P271; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; MADDISON DR, 2001, MACCLADE 4 V 4 01; Magarvey NA, 2006, J AM CHEM SOC, V128, P10698, DOI 10.1021/ja0640187; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; Metsa-Ketela M, 2002, APPL ENVIRON MICROB, V68, P4472, DOI 10.1128/AEM.68.9.4472-4479.2002; Michel K.H., 1985, US Pat., Patent No. [4492650, 4,492,650]; Nylander J, 2004, MR MODELTEST V2 PROG; PAGE RDM, 1998, MOL EVOLUTION; PERKINS JB, 1990, J BACTERIOL, V172, P3108, DOI 10.1128/jb.172.6.3108-3116.1990; Pettit GR, 1999, BIOORGAN MED CHEM, V7, P895, DOI 10.1016/S0968-0896(99)00024-3; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; Ridley CP, 2008, P NATL ACAD SCI USA, V105, P4595, DOI 10.1073/pnas.0710107105; Rounge TB, 2007, APPL ENVIRON MICROB, V73, P7322, DOI 10.1128/AEM.01475-07; Ryoo IJ, 2006, BIOL PHARM BULL, V29, P817, DOI 10.1248/bpb.29.817; SWOFFORD DL, 2003, PAUP PHYLOGENETIC AN; TABER WA, 1957, CAN J MICROBIOL, V3, P953, DOI 10.1139/m57-106; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wiener P, 1998, MOL ECOL, V7, P1205, DOI 10.1046/j.1365-294x.1998.00450.x; Zwickl D., 2006, GARLI GENETIC ALGORI	48	37	37	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7194	10.1371/journal.pone.0007194	http://dx.doi.org/10.1371/journal.pone.0007194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787052	gold, Green Published, Green Submitted			2022-12-25	WOS:000270290100010
J	Lee, Y; Kim, SJ; Park, HD; Park, EH; Huang, SM; Jeon, SB; Kim, JM; Lim, DS; Koh, SS				Lee, Y.; Kim, S. J.; Park, H. D.; Park, E. H.; Huang, S. M.; Jeon, S. B.; Kim, J-M; Lim, D-S; Koh, S. S.			PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression	ONCOGENE			English	Article						PAUF; pancreatic cancer; metastasis; CXCR4; signaling	CHEMOKINE RECEPTOR CXCR4; EPIDERMAL-GROWTH-FACTOR; PROSTATE-CANCER; TUMOR-CELLS; MOUSE MODEL; BREAST; INVASION; CARCINOMA; MIGRATION; INCREASES	Pancreatic cancer is characterized by early metastatic spread, but the process of tumor cell dissemination is largely unknown. In this study we show that the soluble protein pancreatic adenocarcinoma upregulated factor (PAUF) has an important role in the metastasis and progression of the disease. Variations in the level of PAUF, either by overexpression or knockdown, resulted in altered migration, invasion and proliferation capacity of pancreatic cancer cells. Moreover, depletion of PAUF in metastatic cells dramatically abrogated the spread of the cells to distant organs in an orthotopic xenograft mouse model. PAUF elicited the activation of the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and AKT intracellular signaling cascades and consequently their downstream transcription factors in an autocrine manner. Genome-wide expression analysis revealed that C-X-C chemokine receptor type 4 (CXCR4) expression was induced by PAUF overexpression but was repressed by PAUF knockdown. The PAUF-mediated increase in cancer cell motility was attenuated by the CXCR4 inhibitor, AMD3100, or by anti-CXCR4 antibody. Furthermore, immunohistochemical analysis of pancreatic tumor tissues clearly showed a significant positive correlation between PAUF and CXCR4 expression. Collectively, these findings indicate that PAUF enhances the metastatic potential of pancreatic cancer cells, at least in part, by upregulating CXCR4 expression.	[Lee, Y.; Kim, S. J.; Park, E. H.; Koh, S. S.] Korea Res Inst Biosci & Biotechnol, Therapeut Antibody Res Ctr, Taejon 305806, South Korea; [Lee, Y.; Park, H. D.; Lim, D-S] Korea Adv Inst Sci & Technol, Natl Res Lab, Dept Biol Sci, Taejon 305701, South Korea; [Kim, S. J.; Koh, S. S.] Univ Sci & Technol, Sch Sci, Taejon, South Korea; [Park, H. D.; Jeon, S. B.] LG Life Sci Ltd, Taejon, South Korea; [Huang, S. M.; Kim, J-M] Chungnam Natl Univ, Dept Pathol, Canc Res Inst, Coll Med, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); LG Life Sciences Ltd; Chungnam National University	Koh, SS (corresponding author), Korea Res Inst Biosci & Biotechnol, Therapeut Antibody Res Ctr, 111 Gwahangno, Taejon 305806, South Korea.	daesiklim@kaist.ac.kr; sskoh@kribb.re.kr	Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555	Ministry of Education, Science and Technology, Korea	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the 21st Century Frontier Functional Human Genome Project of the Ministry of Education, Science and Technology, Korea. We thank CK Jung and MG Kang for statistical analysis, SH Kim for the luciferase reporter plasmids and HJ Hong for critiques of our work.	Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bachelder RE, 2002, CANCER RES, V62, P7203; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Benovic JL, 2004, CANCER CELL, V6, P429, DOI 10.1016/j.ccr.2004.10.017; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Gao RP, 2005, GASTROENTEROLOGY, V129, P1019, DOI 10.1053/j.gastro.2005.06.067; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Kim SA, 2009, CANCER SCI, V100, P828, DOI 10.1111/j.1349-7006.2009.01106.x; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; KORC M, 1992, J CLIN INVEST, V90, P1352, DOI 10.1172/JCI116001; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Marshall J, 2006, CANCER-AM CANCER SOC, V107, P1207, DOI 10.1002/cncr.22133; Mashino K, 2002, CANCER RES, V62, P2937; Matteucci E, 2005, EXP CELL RES, V310, P176, DOI 10.1016/j.yexcr.2005.07.008; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Okada Y, 2004, CLIN EXP METASTAS, V21, P285, DOI 10.1023/B:CLIN.0000046131.24625.54; Ozawa F, 2001, TERATOGEN CARCIN MUT, V21, P27, DOI 10.1002/1520-6866(2001)21:1<27::AID-TCM4>3.0.CO;2-9; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; SCHOUMACHER RA, 1990, P NATL ACAD SCI USA, V87, P4012, DOI 10.1073/pnas.87.10.4012; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Sung B, 2008, CANCER RES, V68, P8938, DOI 10.1158/0008-5472.CAN-08-2155; Taichman RS, 2002, CANCER RES, V62, P1832; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Wang Z, 2008, BRIT J CANCER, V99, P1695, DOI 10.1038/sj.bjc.6604745; Wehler T, 2006, ONCOL REP, V16, P1159; Zagzag D, 2005, CANCER RES, V65, P6178, DOI 10.1158/0008-5472.CAN-04-4406; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024	54	51	57	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					56	67		10.1038/onc.2009.298	http://dx.doi.org/10.1038/onc.2009.298			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19784070				2022-12-25	WOS:000273373500006
J	Germer, F; Zebger, I; Saggu, M; Lendzian, F; Schulz, R; Appel, J				Germer, Frauke; Zebger, Ingo; Saggu, Miguel; Lendzian, Friedhelm; Schulz, Ruediger; Appel, Jens			Overexpression, Isolation, and Spectroscopic Characterization of the Bidirectional [NiFe] Hydrogenase from Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RALSTONIA-EUTROPHA H16; DESULFOVIBRIO-GIGAS HYDROGENASE; RAY-STRUCTURE ANALYSIS; VULGARIS MIYAZAKI-F; ACTIVE-SITE; ALLOCHROMATIUM-VINOSUM; CRYSTAL-STRUCTURE; SP PCC-6803; SPECTROELECTROCHEMICAL CHARACTERIZATION; CHROMATIUM-VINOSUM	The bidirectional [NiFe] hydrogenase of the cyanobacterium Synechocystis sp. PCC 6803 was purified to apparent homogeneity by a single affinity chromatography step using a Synechocystis mutant with a Strep-tag II fused to the C terminus of HoxF. To increase the yield of purified enzyme and to test its overexpression capacity in Synechocystis the psbAII promoter was inserted upstream of the hoxE gene. In addition, the accessory genes (hypF, C, D, E, A, and B) from Nostoc sp. PCC 7120 were expressed under control of the psbAII promoter. The respective strains show higher hydrogenase activities compared with the wild type. For the first time a Fourier transform infrared (FTIR) spectroscopic characterization of a [NiFe] hydrogenase from an oxygenic phototroph is presented, revealing that two cyanides and one carbon monoxide coordinate the iron of the active site. At least four different redox states of the active site were detected during the reversible activation/inactivation. Although these states appear similar to those observed in standard [NiFe] hydrogenases, no paramagnetic nickel state could be detected in the fully oxidized and reduced forms. Electron paramagnetic resonance spectroscopy confirms the presence of several iron-sulfur clusters after reductive activation. One [4Fe4S](+) and at least one [2Fe2S](+) cluster could be identified. Catalytic amounts of NADH or NADPH are sufficient to activate the reaction of this enzyme with hydrogen.	[Appel, Jens] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Germer, Frauke; Schulz, Ruediger] Univ Kiel, Inst Bot, D-24118 Kiel, Germany; [Zebger, Ingo; Saggu, Miguel; Lendzian, Friedhelm] Tech Univ Berlin, Max Volmer Lab, D-10623 Berlin, Germany	Arizona State University; Arizona State University-Tempe; University of Kiel; Technical University of Berlin	Appel, J (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	jens.appel@asu.edu	Saggu, Miguel/B-1224-2009	Appel, Jens/0000-0002-0658-7899	Linde AG; foundation of the Universitat Kiel; state of Schleswig-Holstein; DFG; SFB 498	Linde AG; foundation of the Universitat Kiel; state of Schleswig-Holstein; DFG(German Research Foundation (DFG)); SFB 498	This work was supported by grants from Linde AG, the foundation of the Universitat Kiel and state of Schleswig-Holstein (to F. G.). We also acknowledge the DFG for financial support within the CoE "UniCat" (F. L.) and SFB 498 (I. Z., M. S., F. L.).	Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Appel J, 1996, BBA-PROTEIN STRUCT M, V1298, P141, DOI 10.1016/S0167-4838(96)00176-8; Appel J, 1998, J PHOTOCH PHOTOBIO B, V47, P1, DOI 10.1016/S1011-1344(98)00179-1; Armstrong FA, 2008, SCIENCE, V321, P498, DOI 10.1126/science.1161326; ASSO M, 1992, BIOCHIM BIOPHYS ACTA, V1122, P50, DOI 10.1016/0167-4838(92)90126-X; Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; COREMANS JMCC, 1992, BIOCHIM BIOPHYS ACTA, V1119, P157, DOI 10.1016/0167-4838(92)90386-R; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Cournac L, 2002, INT J HYDROGEN ENERG, V27, P1229, DOI 10.1016/S0360-3199(02)00105-2; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; deLacey AL, 1997, J AM CHEM SOC, V119, P7181, DOI 10.1021/ja963802w; DeLacey AL, 2002, J BIOL INORG CHEM, V7, P318, DOI 10.1007/s00775-001-0301-7; FERNANDEZ VM, 1985, BIOCHIM BIOPHYS ACTA, V832, P69, DOI 10.1016/0167-4838(85)90175-X; Fichtner C, 2006, BIOCHEMISTRY-US, V45, P9706, DOI 10.1021/bi0602462; Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; GUIGLIARELLI B, 1995, BIOCHEMISTRY-US, V34, P4781, DOI 10.1021/bi00014a036; Gutekunst K, 2005, MOL MICROBIOL, V58, P810, DOI 10.1111/j.1365-2958.2005.04867.x; Gutthann F, 2007, BBA-BIOENERGETICS, V1767, P161, DOI 10.1016/j.bbabio.2006.12.003; Happe RP, 2000, FEBS LETT, V466, P259, DOI 10.1016/S0014-5793(99)01799-8; Happe RP, 1997, NATURE, V385, P126, DOI 10.1038/385126a0; Higuchi Y, 1999, STRUCT FOLD DES, V7, P549, DOI 10.1016/S0969-2126(99)80071-9; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Hiromoto T, 2009, ANGEW CHEM INT EDIT, V48, P6457, DOI 10.1002/anie.200902695; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Huyett JE, 1997, J AM CHEM SOC, V119, P9291, DOI 10.1021/ja9700919; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Kurkin S, 2004, BIOCHEMISTRY-US, V43, P6820, DOI 10.1021/bi049854c; Lai CH, 1998, J AM CHEM SOC, V120, P10103, DOI 10.1021/ja982053a; Long MN, 2007, J BIOL INORG CHEM, V12, P62, DOI 10.1007/s00775-006-0162-1; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Ludwig M, 2006, J MOL EVOL, V63, P758, DOI 10.1007/s00239-006-0001-6; Mate Z, 1998, J BIOL CHEM, V273, P17439, DOI 10.1074/jbc.273.28.17439; MUKAI K, 1973, BIOCHIM BIOPHYS ACTA, V295, P49, DOI 10.1016/0005-2795(73)90072-X; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2002, J AM CHEM SOC, V124, P11628, DOI 10.1021/ja012645k; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; Sambrook J, 2001, MOL CLONING LAB MANU; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmitz O, 2002, BBA-BIOENERGETICS, V1554, P66, DOI 10.1016/S0005-2728(02)00214-1; SCHMITZ O, 1995, EUR J BIOCHEM, V233, P266, DOI 10.1111/j.1432-1033.1995.266_1.x; Schmitz O, 2001, MOL MICROBIOL, V41, P1409, DOI 10.1046/j.1365-2958.2001.02612.x; SCHNEIDER K, 1984, EUR J BIOCHEM, V142, P75, DOI 10.1111/j.1432-1033.1984.tb08252.x; Schroder O, 2007, J BIOL INORG CHEM, V12, P212, DOI 10.1007/s00775-006-0185-7; Schumann S, 2008, J BIOL CHEM, V283, P16602, DOI 10.1074/jbc.M709894200; Serebryakova LT, 1996, FEBS LETT, V383, P79, DOI 10.1016/0014-5793(96)00228-1; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; SURERUS KK, 1994, BIOCHEMISTRY-US, V33, P4980, DOI 10.1021/bi00182a029; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; van der Linden E, 2006, J BIOL INORG CHEM, V11, P247, DOI 10.1007/s00775-005-0075-4; Van der Linden E, 2004, J BIOL INORG CHEM, V9, P616, DOI 10.1007/s00775-004-0555-y; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; WANG R, 1971, PLANT PHYSIOL, V48, P108, DOI 10.1104/pp.48.1.108	65	48	61	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36462	36472		10.1074/jbc.M109.028795	http://dx.doi.org/10.1074/jbc.M109.028795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19801638	Green Published, hybrid			2022-12-25	WOS:000272970500048
J	Kirby, JM; Ahern, H; Roberts, AK; Kumar, V; Freeman, Z; Acharya, KR; Shone, CC				Kirby, Jonathan M.; Ahern, Helen; Roberts, April K.; Kumar, Vivek; Freeman, Zoe; Acharya, K. Ravi; Shone, Clifford C.			Cwp84, a Surface-associated Cysteine Protease, Plays a Role in the Maturation of the Surface Layer of Clostridium difficile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-LAYER; TOXIN-B; PROTEINS; GENOME; INFECTION; EPIDEMIC; HAMSTERS; SEQUENCE; DISEASE; STRAIN	Clostridium difficile is a major and growing problem as a hospital-associated infection that can cause severe, recurrent diarrhea. The mechanism by which the bacterium colonizes the gut during infection is poorly understood but undoubtedly involves protein components within the surface layer (S-layer), which play a role in adhesion. In C. difficile, the S-layer is composed of two principal components, the high and low molecular weight S-layer proteins, which are formed from the post-translational cleavage of a single precursor, SlpA. In the present study, we demonstrate that a recently characterized cysteine protease, Cwp84 plays a role in maturation of SlpA. Using a gene knockout approach, we show that inactivation of the Cwp84 gene in C. difficile 630 Delta Erm results in a bacterial phenotype in which only immature, single chain SlpA comprises the S-layer. The Cwp84 knock-out mutants (CD Delta Cwp84) displayed significantly different colony morphology compared with the wild-type strain and grew more slowly in liquid medium. SlpA extracted from CD Delta Cwp84 was readily cleaved into its mature subunits by trypsin treatment. Addition of trypsin to the growth medium also cleaved SlpA on CD Delta Cwp84 and increased the growth rate of the bacterium in a dose-dependent manner. Using the hamster model for C. difficile infection, CD Delta Cwp84 was found to be competent at causing disease with a similar pathology to the wild-type strain. The data show that whereas Cwp84 plays a role in the cleavage of SlpA, it is not an essential virulence factor and that bacteria expressing immature SlpA are able to cause disease.	[Kirby, Jonathan M.; Ahern, Helen; Roberts, April K.; Kumar, Vivek; Shone, Clifford C.] Hlth Protect Agcy, Res Dept, Salisbury SP4 0JQ, Wilts, England; [Kirby, Jonathan M.; Freeman, Zoe; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Health Protection Agency; University of Bath	Shone, CC (corresponding author), Hlth Protect Agcy, Res Dept, Salisbury SP4 0JQ, Wilts, England.	cliff.shone@hpa.org.uk	Roberts, April/AAD-7330-2019	Acharya, K. Ravi/0000-0002-3009-4058	Health Protection Agency studentship; United Kingdom Department of Health	Health Protection Agency studentship; United Kingdom Department of Health	This work was supported by a Health Protection Agency studentship ( to J. M. K.) and the United Kingdom Department of Health.	Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; Borriello SP, 1998, J ANTIMICROB CHEMOTH, V41, P13, DOI 10.1093/jac/41.suppl_3.13; Brazier JS, 2008, BRIT J BIOMED SCI, V65, P39, DOI 10.1080/09674845.2008.11732796; Calabi E, 2002, J BACTERIOL, V184, P3886, DOI 10.1128/JB.184.14.3886-3897.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; Cerquetti M, 2000, MICROB PATHOGENESIS, V28, P363, DOI 10.1006/mpat.2000.0356; Davis Ian J., 2005, P37; Deneve C, 2008, J MED MICROBIOL, V57, P732, DOI 10.1099/jmm.0.47676-0; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Janoir C, 2007, J BACTERIOL, V189, P7174, DOI 10.1128/JB.00578-07; Karjalainen T, 2002, J CLIN MICROBIOL, V40, P2452, DOI 10.1128/JCM.40.7.2452-2458.2002; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Navaneethan U, 2008, Minerva Gastroenterol Dietol, V54, P451; Ni Eidhin D, 2006, J MED MICROBIOL, V55, P69, DOI 10.1099/jmm.0.46204-0; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; ROBERTS AK, 1992, ACTA PAEDIATR, V81, P119, DOI 10.1111/j.1651-2227.1992.tb12186.x; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Savariau-Lacomme MP, 2003, J BACTERIOL, V185, P4461, DOI 10.1128/JB.185.15.4461-4470.2003; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179; Wright A, 2008, J MED MICROBIOL, V57, P750, DOI 10.1099/jmm.0.47532-0	32	83	87	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34666	34673		10.1074/jbc.M109.051177	http://dx.doi.org/10.1074/jbc.M109.051177			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19808679	Green Published, hybrid			2022-12-25	WOS:000272439600022
J	Das, B; Heimeier, RA; Buchholz, DR; Shi, YB				Das, Biswajit; Heimeier, Rachel A.; Buchholz, Daniel R.; Shi, Yun-Bo			Identification of Direct Thyroid Hormone Response Genes Reveals the Earliest Gene Regulation Programs during Frog Metamorphosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTORS; BETA-A GENE; XENOPUS-LAEVIS; MATRIX-METALLOPROTEINASE; TRANSCRIPTIONAL ACTIVATION; EXPRESSION PROGRAM; DUAL FUNCTIONS; IN-VIVO; STROMELYSIN-3; ELEMENT	Thyroid hormone (T3) is essential for normal development and organ function throughout vertebrates. Its effects are mainly mediated through transcriptional regulation by T3 receptor (TR). The identification and characterization of the immediate early, direct target genes are thus of critical importance in understanding the molecular pathways induced by T3. Unfortunately, this has been hampered by the difficulty to study gene regulation by T3 in uterus-enclosed mammalian embryos. Here we used Xenopus metamorphosis as a model for vertebrate postembryonic development to identify direct T3 response genes in vivo. We took advantage of the ability to easily induce metamorphosis with physiological levels of T3 and to carry out microarray analysis in Xenopus laevis and genome-wide sequence analysis in Xenopus tropicalis. This allowed us to identify 188 up-regulated and 249 down-regulated genes by T3 in the absence of new protein synthesis in whole animals. We further provide evidence to show that these genes contain functional TREs that are bound by TR in tadpoles and that their promoters are regulated by TR in vivo. More importantly, gene ontology analysis showed that the direct up-regulated genes are enriched in categories important for transcriptional regulation and protein degradation-dependent signaling processes but not DNA replication. Our findings thus revealed the existence of interesting pathways induced by T3 at the earliest step of metamorphosis.	[Das, Biswajit; Heimeier, Rachel A.; Shi, Yun-Bo] Eunice Kennedy Shriver NICHD, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, Program Cellular Regulat & Metab,NIH, Bethesda, MD 20892 USA; [Buchholz, Daniel R.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Ohio; University of Cincinnati	Shi, YB (corresponding author), NICHD, Lab Gene Regulat & Dev, Program Cellular Regulat & Metab, NIH, Bldg 18T,Rm 106, Rockville, MD 20852 USA.	shi@helix.nih.gov		Shi, Yun-Bo/0000-0002-6330-0639	National Institutes of Health Intramural Research Program of NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NICHD.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amano T, 2002, DEV DYNAM, V223, P526, DOI 10.1002/dvdy.10075; [Anonymous], 1989, STORY IODINE DEFICIE; Anselmo J, 2004, JAMA-J AM MED ASSOC, V292, P691, DOI 10.1001/jama.292.6.691; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; Buchholz DR, 2004, GENE EXPR PATTERNS, V4, P321, DOI 10.1016/j.modgep.2003.10.005; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Buchholz DR, 2005, J BIOL CHEM, V280, P41222, DOI 10.1074/jbc.M509593200; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; Cai LQ, 2007, DEV BIOL, V304, P260, DOI 10.1016/j.ydbio.2006.12.031; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; Davis PJ, 1996, THYROID, V6, P497, DOI 10.1089/thy.1996.6.497; de Escobar GA, 2007, PUBLIC HEALTH NUTR, V10, P1554, DOI 10.1017/S1368980007360928; de Escobar GM, 2004, BEST PRACT RES CL EN, V18, P225, DOI 10.1016/j.beem.2004.03.012; Denver RJ, 1997, J BIOL CHEM, V272, P8179, DOI 10.1074/jbc.272.13.8179; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Franklyn JA, 1996, TRENDS ENDOCRIN MET, V7, P50, DOI 10.1016/1043-2760(95)00227-8; FREAKE HC, 1995, ANNU REV NUTR, V15, P263, DOI 10.1146/annurev.nu.15.070195.001403; Fu LZ, 2006, J BIOL CHEM, V281, P16870, DOI 10.1074/jbc.M603041200; Fu LZ, 2005, J BIOL CHEM, V280, P27856, DOI 10.1074/jbc.M413275200; Fu LZ, 2002, MOL REPROD DEV, V62, P470, DOI 10.1002/mrd.10137; Furlow JD, 2002, ENDOCRINOLOGY, V143, P3295, DOI 10.1210/en.2002-220126; Gilbert L.I., 1996, METAMORPHOSIS POSTEM; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Havis E, 2003, EMBO REP, V4, P883, DOI 10.1038/sj.embor.embor908; Howdeshell KL, 2002, ENVIRON HEALTH PERSP, V110, P337, DOI 10.1289/ehp.02110s3337; Hsu JH, 1998, TRENDS ENDOCRIN MET, V9, P103, DOI 10.1016/S1043-2760(98)00026-5; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; Ishizuya-Oka A, 2001, CELL TISSUE RES, V303, P187, DOI 10.1007/s004410000291; IshizuyaOka A, 1997, DEV GENET, V20, P329, DOI 10.1002/(SICI)1520-6408(1997)20:4<329::AID-DVG4>3.0.CO;2-9; KANAMORI A, 1992, J BIOL CHEM, V267, P739; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Mathew S, 2009, J BIOL CHEM, V284, P18545, DOI 10.1074/jbc.M109.017723; Matsuda H, 2009, MOL CELL BIOL, V29, P745, DOI 10.1128/MCB.00827-08; PATTERTON D, 1995, DEV BIOL, V167, P252, DOI 10.1006/dbio.1995.1021; Paul BD, 2005, J BIOL CHEM, V280, P27165, DOI 10.1074/jbc.M503999200; Paul BD, 2005, MOL CELL BIOL, V25, P5712, DOI 10.1128/MCB.25.13.5712-5724.2005; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; Puzianowska-Kuznicka M, 1996, J BIOL CHEM, V271, P6273, DOI 10.1074/jbc.271.11.6273; Puzianowska-Kuznicka M, 1997, MOL CELL BIOL, V17, P4738, DOI 10.1128/MCB.17.8.4738; RANJAN M, 1994, J BIOL CHEM, V269, P24699; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ryu S, 2006, CELL CYCLE, V5, P1140, DOI 10.4161/cc.5.11.2779; Sachs LM, 2000, P NATL ACAD SCI USA, V97, P13138, DOI 10.1073/pnas.260141297; Sachs LM, 2000, COMP BIOCHEM PHYS B, V126, P199, DOI 10.1016/S0305-0491(00)00198-X; Sato Y, 2007, MECH DEVELOP, V124, P476, DOI 10.1016/j.mod.2007.03.006; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 1996, BIOESSAYS, V18, P391, DOI 10.1002/bies.950180509; SHI YB, 1994, DEV BIOL, V161, P48, DOI 10.1006/dbio.1994.1006; SHI YB, 1993, J BIOL CHEM, V268, P20312; SHI YB, 1996, METAMORPHOSIS POSTEM; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481; TATA JR, 1968, DEV BIOL, V18, P415, DOI 10.1016/0012-1606(68)90050-X; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Walsh LA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001000; Wang XD, 2008, ENDOCRINOLOGY, V149, P5610, DOI 10.1210/en.2008-0751; WANG Z, 1993, J BIOL CHEM, V268, P16270; WONG JM, 1995, J BIOL CHEM, V270, P18479, DOI 10.1074/jbc.270.31.18479; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Wong JM, 1998, J BIOL CHEM, V273, P14186, DOI 10.1074/jbc.273.23.14186; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	72	74	74	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34167	34178		10.1074/jbc.M109.066084	http://dx.doi.org/10.1074/jbc.M109.066084			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801647	hybrid, Green Published			2022-12-25	WOS:000272165200049
J	Frizzell, KM; Gamble, MJ; Berrocal, JG; Zhang, T; Krishnakumar, R; Cen, Y; Sauve, AA; Kraus, WL				Frizzell, Kristine M.; Gamble, Matthew J.; Berrocal, Jhoanna G.; Zhang, Tong; Krishnakumar, Raga; Cen, Yana; Sauve, Anthony A.; Kraus, W. Lee			Global Analysis of Transcriptional Regulation by Poly(ADP-ribose) Polymerase-1 and Poly(ADP-ribose) Glycohydrolase in MCF-7 Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; ADP-RIBOSE POLYMERASE; GENE-EXPRESSION; CHROMATIN-STRUCTURE; DNA-BINDING; P-VALUE; PARP-1; ACTIVATION; CLONING	Poly(ADP-ribose) polymerase-1 (PARP-1) and poly(ADP-ribose) glycohydrolase (PARG) are enzymes that modify target proteins by the addition and removal, respectively, of ADP-ribose polymers. Although a role for PARP-1 in gene regulation has been well established, the role of PARG is less clear. To investigate how PARP-1 and PARG coordinately regulate global patterns of gene expression, we used short hairpin RNAs to stably knock down PARP-1 or PARG in MCF-7 cells followed by expression microarray analyses. Correlation analyses showed that the majority of genes affected by the knockdown of one factor were similarly affected by the knockdown of the other factor. The most robustly regulated common genes were enriched for stress-response and metabolic functions. In chromatin immunoprecipitation assays, PARP-1 and PARG localized to the promoters of positively and negatively regulated target genes. The levels of chromatin-bound PARG at a given promoter generally correlated with the levels of PARP-1 across the subset of promoters tested. For about half of the genes tested, the binding of PARP-1 at the promoter was dependent on the binding of PARG. Experiments using stable re-expression of short hairpin RNA-resistant catalytic mutants showed that PARP-1 and PARG enzymatic activities are required for some, but not all, target genes. Collectively, our results indicate that PARP-1 and PARG, nuclear enzymes with opposing enzymatic activities, localize to target promoters and act in a similar, rather than antagonistic, manner to regulate gene expression.	[Frizzell, Kristine M.; Gamble, Matthew J.; Berrocal, Jhoanna G.; Zhang, Tong; Krishnakumar, Raga; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Frizzell, Kristine M.; Berrocal, Jhoanna G.; Krishnakumar, Raga; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Cen, Yana; Sauve, Anthony A.; Kraus, W. Lee] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 465 Biotechnol Bldg, Ithaca, NY 14853 USA.	wlk5@cornell.edu	Cen, Yana/F-4731-2014	Cen, Yana/0000-0001-6436-5744; Krishnakumar, Raga/0000-0002-2479-754X	National Institutes of Health [DK069710]; Endocrine Society; Cornell University Nanobiotechnology Center; National Science Foundation [ECS-9876771]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069710, R56DK069710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society; Cornell University Nanobiotechnology Center; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK069710 throughout the NIDDK ( to W. L. K.). This work was also supported by a grant from the Endocrine Society ( to W. L. K.) and the Cornell University Nanobiotechnology Center, a Science and Technology Centers Program of the National Science Foundation (Agreement Number ECS-9876771).	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Bonicalzi ME, 2003, BIOL CELL, V95, P635, DOI 10.1016/j.biolcel.2003.10.003; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; deSouza N, 2007, J CELL BIOL, V179, P923, DOI 10.1083/jcb.200708200; Dey BR, 1998, J BIOL CHEM, V273, P24095, DOI 10.1074/jbc.273.37.24095; Dow GS, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-4; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Gagne JP, 2009, J PROTEOME RES, V8, P1014, DOI 10.1021/pr800810n; Gao H, 2007, EXP CELL RES, V313, P984, DOI 10.1016/j.yexcr.2006.12.025; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Keil C, 2006, J BIOL CHEM, V281, P34394, DOI 10.1074/jbc.M606470200; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; KOTHS K, 1993, J BIOL CHEM, V268, P14245; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kun E, 2004, BIOCHEMISTRY-US, V43, P210, DOI 10.1021/bi0301791; Kun E, 2002, J BIOL CHEM, V277, P39066, DOI 10.1074/jbc.C200410200; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Li YN, 1996, HUM MOL GENET, V5, P1851, DOI 10.1093/hmg/5.12.1851; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Mabley JG, 2001, BRIT J PHARMACOL, V133, P909, DOI 10.1038/sj.bjp.0704156; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Mathieu J, 2008, ONCOGENE, V27, P3361, DOI 10.1038/sj.onc.1210997; Meisterernst M, 1997, P NATL ACAD SCI USA, V94, P2261, DOI 10.1073/pnas.94.6.2261; Meyer-Ficca ML, 2005, INT J BIOCHEM CELL B, V37, P920, DOI 10.1016/j.biocel.2004.09.011; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; Morrison C, 1997, NAT GENET, V17, P479, DOI 10.1038/ng1297-479; Murphy D, 2002, ADV PHYSIOL EDUC, V26, P256, DOI 10.1152/advan.00043.2002; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Oei SL, 2001, BIOCHEM BIOPH RES CO, V284, P450, DOI 10.1006/bbrc.2001.4985; OGATA N, 1981, J BIOL CHEM, V256, P4135; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Ohashi S, 2003, BIOCHEM BIOPH RES CO, V307, P915, DOI 10.1016/S0006-291X(03)01272-5; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Potaman VN, 2005, J MOL BIOL, V348, P609, DOI 10.1016/j.jmb.2005.03.010; Rapizzi E, 2004, MOL PHARMACOL, V66, P890, DOI 10.1124/mol.104.000968; Rolli V, 1997, BIOCHEMISTRY-US, V36, P12147, DOI 10.1021/bi971055p; Rolli V., 2000, DNA DAMAGE STRESS SI, P35; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shah RG, 2005, BIOCHEM BIOPH RES CO, V331, P167, DOI 10.1016/j.bbrc.2005.03.135; Shimokawa T, 1999, J BIOCHEM-TOKYO, V126, P748, DOI 10.1093/oxfordjournals.jbchem.a022512; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; St-Laurent JF, 2007, DNA REPAIR, V6, P329, DOI 10.1016/j.dnarep.2006.10.027; Tinari N, 2001, INT J CANCER, V91, P167, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1022>3.3.CO;2-Q; Tong WM, 2001, MOL CELL BIOL, V21, P4046, DOI 10.1128/MCB.21.12.4046-4054.2001; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2006, GENETICS, V172, P363, DOI 10.1534/genetics.105.049239; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Tulin A, 2003, CURR TOP DEV BIOL, V56, P55, DOI 10.1016/S0070-2153(03)01007-X; Wacker David A, 2007, Subcell Biochem, V41, P45; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; WATKINS D, 1989, AM J MED GENET, V34, P427, DOI 10.1002/ajmg.1320340320; YAMADA N, 1994, BIOCHEM J, V302, P781, DOI 10.1042/bj3020781; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zingarelli B, 2003, MOL MED, V9, P143, DOI 10.1007/BF03402179; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	87	94	100	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33926	33938		10.1074/jbc.M109.023879	http://dx.doi.org/10.1074/jbc.M109.023879			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19812418	Green Published, hybrid			2022-12-25	WOS:000272165200025
J	Han, YY; Eppinger, E; Schuster, IG; Weigand, LU; Liang, XL; Kremmer, E; Peschel, C; Krackhardt, AM				Han, Yanyan; Eppinger, Elfriede; Schuster, Ingrid G.; Weigand, Luise U.; Liang, Xiaoling; Kremmer, Elisabeth; Peschel, Christian; Krackhardt, Angela M.			Formin-like 1 (FMNL1) Is Regulated by N-terminal Myristoylation and Induces Polarized Membrane Blebbing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAPHANOUS-RELATED FORMIN; AUTOREGULATORY DOMAIN; ACTIN-FILAMENTS; CELL MOTILITY; MOUSE FORMIN; FRL-ALPHA; PROTEIN; MDIA1; RHO; IDENTIFICATION	The formin protein formin-like 1 (FMNL1) is highly restrictedly expressed in hematopoietic lineage-derived cells and has been previously identified as a tumor-associated antigen. However, function and regulation of FMNL1 are not well defined. We have identified a novel splice variant (FMNL1 gamma) containing an intron retention at the C terminus affecting the diaphanous autoinhibitory domain (DAD). FMNL1 gamma is specifically located at the cell membrane and cortex in diverse cell lines. Similar localization of FMNL1 was observed for a mutant lacking the DAD domain (FMNL1 Delta DAD), indicating that deregulation of autoinhibition is effective in FMNL1 gamma. Expression of both FMNL1 gamma and FMNL1 Delta DAD induces polarized nonapoptotic blebbing that is dependent on N-terminal myristoylation of FMNL1 but independent of Src and ROCK activity. Thus, our results describe N-myristoylation as a regulative mechanism of FMNL1 responsible for membrane trafficking potentially involved in a diversity of polarized processes of hematopoietic lineage-derived cells.	[Han, Yanyan; Eppinger, Elfriede; Schuster, Ingrid G.; Weigand, Luise U.; Liang, Xiaoling; Kremmer, Elisabeth; Krackhardt, Angela M.] Helmholtz Zentrum Munchen, Natl Res Ctr Environm & Hlth, Inst Mol Immunol, D-81377 Munich, Germany; [Peschel, Christian; Krackhardt, Angela M.] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich	Krackhardt, AM (corresponding author), Helmholtz Zentrum Munchen, Natl Res Ctr Environm & Hlth, Inst Mol Immunol, Marchioninistr 25, D-81377 Munich, Germany.	HTUangela.krackhardt@helmholtz-muenchen.deUTH		Liang, Xiaoling/0000-0002-0572-5188	Deutsche Forschungsgemeinschaft [KR2305/3-1]; Helmholtz Zentrum Munchen; Life Science Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Zentrum Munchen(Helmholtz Association); Life Science Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Grant KR2305/3-1, the Helmholtz Zentrum Munchen, and the Life Science Stiftung.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; PAIGE LA, 1990, BIOCHEMISTRY-US, V29, P10566, DOI 10.1021/bi00498a021; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schuster IG, 2007, BLOOD, V110, P2931, DOI 10.1182/blood-2006-11-058750; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 2004, EXP CELL RES, V301, P16, DOI 10.1016/j.yexcr.2004.08.020; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	33	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33409	33417		10.1074/jbc.M109.060699	http://dx.doi.org/10.1074/jbc.M109.060699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19815554	Green Published, hybrid			2022-12-25	WOS:000272028500047
J	Praporski, S; Ng, SM; Nguyen, AD; Corbin, CJ; Mechler, A; Zheng, J; Conley, AJ; Martin, LL				Praporski, Slavica; Ng, Su May; Nguyen, Ann D.; Corbin, C. Jo; Mechler, Adam; Zheng, Jie; Conley, Alan J.; Martin, Lisandra L.			Organization of Cytochrome P450 Enzymes Involved in Sex Steroid Synthesis PROTEIN-PROTEIN INTERACTIONS IN LIPID MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUARTZ-CRYSTAL MICROBALANCE; ATOMIC-FORCE MICROSCOPY; MOLECULE HEIGHT MEASUREMENTS; PHOSPHOLIPID-BILAYER DISKS; ESTROGEN SYNTHESIS; P450 REDUCTASE; AROMATASE CYTOCHROME-P450; MAMMALIAN AROMATASES; COMPLEX-FORMATION; ESCHERICHIA-COLI	Mounting evidence underscores the importance of protein-protein interactions in the functional regulation of drug-metabolizing P450s, but few studies have been conducted in membrane environments, and none have examined P450s catalyzing sex steroid synthesis. Here we report specific protein-protein interactions for full-length, human, wild type steroidogenic cytochrome P450 (P450, CYP) enzymes: 17 alpha-hydroxylase/17,20-lyase (P450c17, CYP17) and aromatase (P450arom, CYP19), as well as their electron donor NADPH-cytochrome P450 oxidoreductase (CPR). Fluorescence resonance energy transfer (FRET) 3 in live cells, coupled with quartz crystal microbalance (QCM), and atomic force microscopy (AFM) studies on phosphatidyl choline +/- cholesterol (mammalian) biomimetic membranes were used to investigate steroidogenic P450 interactions. The FRET results in living cells demonstrated that both P450c17 and P450arom homodimerize but do not heterodimerize, although they each heterodimerize with CPR. The lack of heteroassociation between P450c17 and P450arom was confirmed by QCM, wherein neither enzyme bound a membrane saturated with the other. In contrast, the CPR bound readily to either P450c17- or P450arom-saturated surfaces. Interestingly, N-terminally modified P450arom was stably incorporated and gave similar results to the wild type, although saturation was achieved with much less protein, suggesting that the putative transmembrane domain is not required for membrane association but for orientation. In fact, all of the proteins were remarkably stable in the membrane, such that high resolution AFM images were obtained, further supporting the formation of P450c17, P450arom, and CPR homodimers and oligomers in lipid bilayers. This unique combination of in vivo and in vitro studies has provided strong evidence for homodimerization and perhaps some higher order interactions for both P450c17 and P450arom.	[Nguyen, Ann D.; Corbin, C. Jo; Conley, Alan J.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Praporski, Slavica; Ng, Su May; Mechler, Adam; Martin, Lisandra L.] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; [Zheng, Jie] Univ Calif Davis, Sch Med, Dept Physiol, Davis, CA 95616 USA	University of California System; University of California Davis; Monash University; University of California System; University of California Davis	Conley, AJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	ajconley@ucdavis.edu; Lisa.Martin@sci.monash.edu.au	Martin, Lisandra L/E-4482-2010; Mechler, Adam/C-5777-2009; Praporski, Slavica/ABA-6323-2020	Martin, Lisandra L/0000-0003-0486-5813; Mechler, Adam/0000-0002-6428-6760; Conley, Alan/0000-0003-3798-7390; Praporski, Slavica/0000-0003-1891-759X	Australian Research Council; National Health & Medical Research Council; National Institutes of Health [HD-048797]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048797] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funds from the Australian Research Council (to L. L. M. and A. M.), the National Health & Medical Research Council (to L. L. M.), and National Institutes of Health Grant HD-048797 (to A.J.C.).	Asakura N, 2003, ANAL BIOCHEM, V314, P153, DOI 10.1016/S0003-2697(02)00642-5; Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Bayburt TH, 1998, J STRUCT BIOL, V123, P37, DOI 10.1006/jsbi.1998.4007; Bayburt TH, 2000, LANGMUIR, V16, P5993, DOI 10.1021/la991449c; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625; Civjan NR, 2003, BIOTECHNIQUES, V35, P556, DOI 10.2144/03353rr02; Conley A, 2001, REPRODUCTION, V121, P685, DOI 10.1530/rep.0.1210685; CONLEY AJ, 1990, BAILLIERE CLIN ENDOC, V4, P249, DOI 10.1016/S0950-351X(05)80050-3; Corbin CJ, 2003, MOL CELL ENDOCRINOL, V206, P147, DOI 10.1016/S0303-7207(02)00422-7; Corbin CJ, 2003, BIOL REPROD, V69, P390, DOI 10.1095/biolreprod.103.015578; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Denisov IG, 2009, PHARMACOL THERAPEUT, V124, P151, DOI 10.1016/j.pharmthera.2009.05.011; DICZFALUSY E, 1984, J STEROID BIOCHEM, V20, P945, DOI 10.1016/0022-4731(84)90002-5; ENGEL LL, 1973, HDB PHYSL, P467; Estavillo C, 2003, BIOPHYS CHEM, V104, P291, DOI 10.1016/S0301-4622(02)00383-6; Fleming BD, 2008, LANGMUIR, V24, P323, DOI 10.1021/la702511w; Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060; GRAHAMLORENCE S, 1995, PROTEIN SCI, V4, P1065, DOI 10.1002/pro.5560040605; GUENGERICH FP, 2003, 12 N AM ISSX M; GUT J, 1983, J BIOL CHEM, V258, P8588; HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51, DOI 10.1016/0303-7207(94)90278-X; Hlavica P, 2003, J INORG BIOCHEM, V96, P279, DOI 10.1016/S0162-0134(03)00152-1; Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501; Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Johnson DL, 2006, J MOL ENDOCRINOL, V36, P349, DOI 10.1677/jme.1.01971; Johnson DL, 2005, J AM CHEM SOC, V127, P2018, DOI 10.1021/ja045084g; Kagawa N, 2004, STEROIDS, V69, P235, DOI 10.1016/j.steroids.2004.01.002; Kaufman ED, 2007, LANGMUIR, V23, P6053, DOI 10.1021/la063725a; KAWATO S, 1982, J BIOL CHEM, V257, P7023; Kiselyova OI, 1999, ARCH BIOCHEM BIOPHYS, V371, P1, DOI 10.1006/abbi.1999.1412; Kuznetsov VY, 2004, PROTEOMICS, V4, P2390, DOI 10.1002/pmic.200300751; Mechler A, 2007, BIOPHYS J, V93, P3907, DOI 10.1529/biophysj.107.116525; Mechler A, 2009, BIOMATERIALS, V30, P682, DOI 10.1016/j.biomaterials.2008.10.016; Moran FM, 2002, ENDOCRINOLOGY, V143, P3361, DOI 10.1210/en.2002-220329; Muguruma H, 2006, J PHYS CHEM B, V110, P26033, DOI 10.1021/jp063755m; MYASOEDOVA KN, 1990, FEBS LETT, V275, P235, DOI 10.1016/0014-5793(90)81479-8; NAKAJIN S, 1981, J STEROID BIOCHEM, V14, P1249, DOI 10.1016/0022-4731(81)90328-9; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; Schenkman JB, 2001, ARCH BIOCHEM BIOPHYS, V385, P78, DOI 10.1006/abbi.2000.2140; Schuler G, 2006, REPRODUCTION, V131, P669, DOI 10.1530/rep.1.01033; Shen ZH, 2007, ANAL CHEM, V79, P1283, DOI 10.1021/ac061211a; Szczesna-Skorupa E, 2003, J BIOL CHEM, V278, P31269, DOI 10.1074/jbc.M301489200; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; TAMURA T, 1992, J ENDOCRINOL, V135, P589, DOI 10.1677/joe.0.1350589; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066	52	44	46	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33224	33232		10.1074/jbc.M109.006064	http://dx.doi.org/10.1074/jbc.M109.006064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19805543	hybrid, Green Published			2022-12-25	WOS:000272028500027
J	Tsiang, M; Jones, GS; Hung, M; Mukund, S; Han, B; Liu, XH; Babaoglu, K; Lansdon, E; Chen, X; Todd, J; Cai, T; Pagratis, N; Sakowicz, R; Geleziunas, R				Tsiang, Manuel; Jones, Gregg S.; Hung, Magdeleine; Mukund, Susmith; Han, Bin; Liu, Xiaohong; Babaoglu, Kerim; Lansdon, Eric; Chen, Xiaowu; Todd, Jacob; Cai, Terrence; Pagratis, Nikos; Sakowicz, Roman; Geleziunas, Romas			Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE; PROTEIN; DOMAIN; DNA; DIMERIZATION; INHIBITORS; IDENTIFICATION; INTERFACE; KINETICS; MUTANTS	The interaction between lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF) and human immunodeficiency virus type 1 (HIV-1) integrase (IN) is essential for HIV-1 replication. Homogeneous time-resolved fluorescence resonance energy transfer assays were developed to characterize HIV-1 integrase dimerization and the interaction between LEDGF and IN dimers. Using these assays in an equilibrium end point dose-response format with mathematical modeling, we determined the dissociation constants of IN dimers (K-dimer = 67.8 pM) and of LEDGF from IN dimers (K-d = 10.9 nM). When used in a kinetic format, the assays allowed the determination of the on-and off-rate constants for these same interactions. Integrase dimerization had a k(on) of 0.1247 nM(-1).min(-1) and a k(off) of 0.0080 min(-1) resulting in a K-dimer of 64.5 pM. LEDGF binding to IN dimers had a k(on) of 0.0285 nM(-1).min(-1) and a k(off) of 0.2340 min(-1) resulting in a K-d of 8.2 nM. These binding assays can also be used in an equilibrium end point competition format. In this format, the IN catalytic core domain produced a K-i of 15.2 nM while competing for integrase dimerization, confirming the very tight interaction of IN with itself. In the same format, LEDGF produced a K-i value of 35 nM when competing for LEDGF binding to IN dimers. In summary, this study describes a methodology combining homogeneous time-resolved fluorescence resonance energy transfer and mathematical modeling to derive the affinities between IN monomers and between LEDGF and IN dimers. This study revealed the significantly tighter nature of the IN-IN dimer compared with the IN-LEDGF interaction.	[Tsiang, Manuel; Jones, Gregg S.; Hung, Magdeleine; Mukund, Susmith; Han, Bin; Liu, Xiaohong; Babaoglu, Kerim; Lansdon, Eric; Chen, Xiaowu; Todd, Jacob; Cai, Terrence; Pagratis, Nikos; Sakowicz, Roman; Geleziunas, Romas] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Tsiang, M (corresponding author), Gilead Sci Inc, 333 Lakeside Dr, Foster City, CA 94404 USA.	MTsiang@gilead.com						Al-Mawsawi LQ, 2008, FEBS LETT, V582, P1425, DOI 10.1016/j.febslet.2008.02.076; Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127; Chen X, 2008, J MOL BIOL, V380, P504, DOI 10.1016/j.jmb.2008.04.054; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; COLEMAN RA, 1995, J BIOL CHEM, V270, P13842, DOI 10.1074/jbc.270.23.13842; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; DEBYSER Z, 2009, 16 C RETR OPP INF MO, P91; DIVITA G, 1993, FEBS LETT, V324, P153, DOI 10.1016/0014-5793(93)81383-B; DIVITA G, 1995, J MOL BIOL, V245, P508, DOI 10.1006/jmbi.1994.0042; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Hou Y, 2008, J BIOMOL SCREEN, V13, P406, DOI 10.1177/1087057108317060; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; Maertens G, 2005, FASEB J, V19, P1039, DOI 10.1096/fj.04-3373fje; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maroun RG, 2001, BIOCHEMISTRY-US, V40, P13840, DOI 10.1021/bi011328n; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Rahman S, 2007, VIROLOGY, V357, P79, DOI 10.1016/j.virol.2006.08.011; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Yu F, 2007, BIOCHEMISTRY-US, V46, P2899, DOI 10.1021/bi602387u; ZHANG ZY, 1991, J BIOL CHEM, V266, P15591	38	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33580	33599		10.1074/jbc.M109.040121	http://dx.doi.org/10.1074/jbc.M109.040121			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801648	Green Published, hybrid			2022-12-25	WOS:000272028500063
J	Cap, M; Vachova, L; Palkova, Z				Cap, Michal; Vachova, Libuse; Palkova, Zdena			Yeast Colony Survival Depends on Metabolic Adaptation and Cell Differentiation Rather Than on Stress Defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM SURVIVAL; SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; OXIDATIVE DAMAGE; LIFE-SPAN; CATALASE; AMMONIA; PROTEIN; OXYGEN	Enzymes scavenging reactive oxygen species (ROS) are important for cell protection during stress and aging. A deficiency in these enzymes leads to ROS imbalance, causing various disorders in many organisms, including yeast. In contrast to liquid cultures, where fitness of the yeast population depends on its ROS scavenging capability, the present study suggests that Saccharomyces cerevisiae cells growing in colonies capable of ammonia signaling use a broader protective strategy. Instead of maintaining high levels of antioxidant enzymes for ROS detoxification, colonies activate an alternative metabolism that prevents ROS production. Colonies of the strain deficient in cytosolic superoxide dismutase Sod1p thus developed the same way as wild type colonies. They produced comparable levels of ammonia and underwent similar developmental changes (expression of genes of alternative metabolism and center margin differentiation in ROS production, cell death occurrence, and activities of stress defense enzymes) and did not accumulate stress-resistant suppressants. An absence of cytosolic catalase Ctt1p, however, brought colonies developmental problems, which were even more prominent in the absence of mitochondrial Sod2p. sod2 Delta and ctt1 Delta colonies failed in ammonia production and sufficient activation of the alternative metabolism and were incapable of center margin differentiation, but they did not increase ROS levels. These new data indicate that colony disorders are not accompanied by ROS burst but could be a consequence of metabolic defects, which, however, could be elicited by imbalance in ROS produced in early developmental phases. Sod2p and homeostasis of ROS may participate in regulatory events leading to ammonia signaling.	[Palkova, Zdena] Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, CR-12844 Prague 2, Czech Republic; [Vachova, Libuse] ASCR, VVI, Inst Microbiol, Prague 14220 4, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Palkova, Z (corresponding author), Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Vinicna 5, CR-12844 Prague 2, Czech Republic.	zdenap@natur.cuni.cz	Cap, Michal/HGB-8892-2022; Vachova, Libuse/H-7620-2014; Čáp, Michal/Q-6496-2017; Palkova, Zdena/M-8692-2014	Vachova, Libuse/0000-0002-8143-6054; Palkova, Zdena/0000-0002-0864-8042; Cap, Michal/0000-0002-2327-371X	Grant Agency of the Czech Republic [525/05/0297, 204/08/0718]; Ministry of Education [LC531, MSM0021620858, AV0Z50200510]; Howard Hughes Medical Institute [55005623]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Grant Agency of the Czech Republic Grants 525/05/0297 and 204/08/0718; by Ministry of Education Grants LC531, MSM0021620858, and AV0Z50200510; and by Howard Hughes Medical Institute International Research Award 55005623 (to Z. P.).	BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bonatto D, 2007, FREE RADICAL BIO MED, V43, P557, DOI 10.1016/j.freeradbiomed.2007.05.013; Buhler M, 2009, EMBO J, V28, P2149, DOI 10.1038/emboj.2009.185; CLARE DA, 1984, ANAL BIOCHEM, V140, P532, DOI 10.1016/0003-2697(84)90204-5; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Eberhardt M.K., 2001, REACTIVE OXYGEN META, P303; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; Guaragnella N, 2008, FEBS LETT, V582, P210, DOI 10.1016/j.febslet.2007.12.007; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; KIM KW, 1988, J BIOL CHEM, V263, P4704; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Netto LES, 1996, J BIOL CHEM, V271, P15315, DOI 10.1074/jbc.271.26.15315; O'Brien KM, 2004, J BIOL CHEM, V279, P51817, DOI 10.1074/jbc.M405958200; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; Palkova Z, 2006, FEMS MICROBIOL REV, V30, P806, DOI 10.1111/j.1574-6976.2006.00034.x; Palkova Z, 2009, MOL MEMBR BIOL, V26, P228, DOI 10.1080/09687680902893130; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; Strain J, 1998, J BIOL CHEM, V273, P31138, DOI 10.1074/jbc.273.47.31138; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Vachova L, 2004, J BIOL CHEM, V279, P37973, DOI 10.1074/jbc.M404594200; Vachova L, 2009, ENVIRON MICROBIOL, V11, P494, DOI 10.1111/j.1462-2920.2008.01789.x; Van Zandyeke SM, 2002, MECH AGEING DEV, V123, P365, DOI 10.1016/S0047-6374(01)00382-7; Wawryn J, 1999, ACTA BIOCHIM POL, V46, P249, DOI 10.18388/abp.1999_4158; WESTERBEEKMARRES CAM, 1988, EUR J BIOCHEM, V174, P611, DOI 10.1111/j.1432-1033.1988.tb14142.x	29	38	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32572	32581		10.1074/jbc.M109.022871	http://dx.doi.org/10.1074/jbc.M109.022871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801643	Green Published, hybrid			2022-12-25	WOS:000272028400039
J	Eggers, CT; Schafer, JC; Goldenring, JR; Taylor, SS				Eggers, Christopher T.; Schafer, Jenny C.; Goldenring, James R.; Taylor, Susan S.			D-AKAP2 Interacts with Rab4 and Rab11 through Its RGS Domains and Regulates Transferrin Receptor Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; KINASE BINDING DOMAIN; A ANCHORING PROTEIN; CANINE KIDNEY-CELLS; STRUCTURAL BASIS; MYOCARDIAL-INFARCTION; GENE POLYMORPHISMS; COUPLING PROTEIN; MEMBRANE DOMAINS; EARLY ENDOSOMES	Dual-specific A-kinase-anchoring protein 2 (D-AKAP2/AKAP10), which interacts at its carboxyl terminus with protein kinase A and PDZ domain proteins, contains two tandem regulator of G-protein signaling (RGS) domains for which the binding partners have remained unknown. We show here that these RGS domains interact with Rab11 and GTP-bound Rab4, the first demonstration of RGS domains binding small GTPases. Rab4 and Rab11 help regulate membrane trafficking through the endocytic recycling pathways by recruiting effector proteins to specific membrane domains. Although D-AKAP2 is primarily cytosolic in HeLa cells, a fraction of the protein localizes to endosomes and can be recruited there to a greater extent by overexpression of Rab4 or Rab11. D-AKAP2 also regulates the morphology of the Rab11-containing compartment, with co-expression causing accumulation of both proteins on enlarged endosomes. Knockdown of D-AKAP2 by RNA interference caused a redistribution of both Rab11 and the constitutively recycling transferrin receptor to the periphery of cells. Knockdown also caused an increase in the rate of transferrin recycling, suggesting that D-AKAP2 promotes accumulation of recycling proteins in the Rab4/Rab11-positive endocytic recycling compartment.	[Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Schafer, Jenny C.; Goldenring, James R.] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37232 USA; [Schafer, Jenny C.; Goldenring, James R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Schafer, Jenny C.; Goldenring, James R.] Nashville Vet Affairs Med Ctr, Nashville, TN 37232 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Vanderbilt University; Vanderbilt University	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu			National Institutes of Health [DK054441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK070856, R01DK048370, P01DK054441, R01DK070856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK054441.	Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Deneka M, 2003, EMBO J, V22, P2645, DOI 10.1093/emboj/cdg257; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gisler SM, 2003, KIDNEY INT, V64, P1746, DOI 10.1046/j.1523-1755.2003.00267.x; Hamuro Y, 2002, J MOL BIOL, V321, P703, DOI 10.1016/S0022-2836(02)00419-9; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Kammerer S, 2003, P NATL ACAD SCI USA, V100, P4066, DOI 10.1073/pnas.2628028100; Lapierre LA, 2007, AM J PHYSIOL-GASTR L, V292, pG1249, DOI 10.1152/ajpgi.00505.2006; Lindsay AJ, 2004, FEBS LETT, V571, P86, DOI 10.1016/j.febslet.2004.06.068; Lindsay AJ, 2002, J BIOL CHEM, V277, P12190, DOI 10.1074/jbc.M108665200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nagelkerken B, 2000, BIOCHEM J, V346, P593, DOI 10.1042/0264-6021:3460593; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nishihama K, 2007, INT J MOL MED, V19, P129; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pagano A, 2004, MOL BIOL CELL, V15, P4990, DOI 10.1091/mbc.E04-04-0355; Peden AA, 2004, MOL BIOL CELL, V15, P3530, DOI 10.1091/mbc.E03-12-0918; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Tingley WG, 2007, P NATL ACAD SCI USA, V104, P8461, DOI 10.1073/pnas.0610393104; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Wang L, 2001, P NATL ACAD SCI USA, V98, P3220, DOI 10.1073/pnas.051633398; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Wirtenberger M, 2007, CARCINOGENESIS, V28, P423, DOI 10.1093/carcin/bgl164; Yoshida T, 2007, INT J MOL MED, V20, P581; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zheng B, 1999, TRENDS BIOCHEM SCI, V24, P411, DOI 10.1016/S0968-0004(99)01474-7; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832	42	51	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32869	32880		10.1074/jbc.M109.022582	http://dx.doi.org/10.1074/jbc.M109.022582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19797056	hybrid, Green Published			2022-12-25	WOS:000272028400071
J	Ding, XQ; Quiambao, AB; Fitzgerald, JB; Cooper, MJ; Conley, SM; Naash, MI				Ding, Xi-Qin; Quiambao, Alexander B.; Fitzgerald, J. Browning; Cooper, Mark J.; Conley, Shannon M.; Naash, Muna I.			Ocular Delivery of Compacted DNA-Nanoparticles Does Not Elicit Toxicity in the Mouse Retina	PLOS ONE			English	Article								Subretinal delivery of polyethylene glycol-substituted lysine peptide (CK30PEG)-compacted DNA nanoparticles results in efficient gene expression in retinal cells. This work evaluates the ocular safety of compacted DNA nanoparticles. CK30PEG-compacted nanoparticles containing an EGFP expression plasmid were subretinally injected in adult mice (1 mu l at 0.3, 1.0 and 3.0 mu g/mu l). Retinas were examined for signs of inflammation at 1, 2, 4 and 7 days post-injection. Neither infiltration of polymorphonuclear neutrophils or lymphocytes was detected in retinas. In addition, elevation of macrophage marker F4/80 or myeloid marker myeloperoxidase was not detected in the injected eyes. The chemokine KC mRNA increased 3-4 fold in eyes injected with either nanoparticles or saline at 1 day post-injection, but returned to control levels at 2 days post-injection. No elevation of KC protein was observed in these mice. The monocyte chemotactic protein-1, increased 3-4 fold at 1 day post-injection for both nanoparticle and saline injected eyes, but also returned to control levels at 2 days. No elevations of tumor necrosis factor alpha mRNA or protein were detected. These investigations show no signs of local inflammatory responses associated with subretinal injection of compacted DNA nanoparticles, indicating that the retina may be a suitable target for clinical nanoparticle-based interventions.			Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA.	xi-qin-ding@ouhsc.edu			NEI NIH HHS [EY018656, R21 EY017031, R01 EY018656, EY-017031, R01 EY018656-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R21EY017031, R01EY018656] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bennett J, 1996, NAT MED, V2, P649, DOI 10.1038/nm0696-649; Cai X, 2008, VISION RES, V48, P319, DOI 10.1016/j.visres.2007.07.012; Cai X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005290; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; Chintakuntlawar AV, 2007, INVEST OPHTH VIS SCI, V48, P781, DOI 10.1167/iovs.06-1036; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dai H, 2006, INT J NANOMED, V1, P507, DOI 10.2147/nano.2006.1.4.507; Davies M, 2006, MOL VIS, V12, P467; Dezawa M, 2002, MICRON, V33, P1, DOI 10.1016/S0968-4328(01)00002-6; Elner VM, 1997, EXP EYE RES, V65, P781, DOI 10.1006/exer.1997.0380; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761; Giese MJ, 1998, INVEST OPHTH VIS SCI, V39, P2785; Hantzschel N, 2007, LANGMUIR, V23, P10793, DOI 10.1021/la701691g; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; Heinecke JW, 1997, BIOFACTORS, V6, P145, DOI 10.1002/biof.5520060208; Holtkamp GM, 1999, CLIN EXP IMMUNOL, V118, P35; Jan E, 2008, ACS NANO, V2, P928, DOI 10.1021/nn7004393; JO N, 2003, INVEST OPHTHALMOL VI, V44; Jun AS, 2003, EYE, V17, P906, DOI 10.1038/sj.eye.6700565; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; Konstan MW, 2004, HUM GENE THER, V15, P1255, DOI 10.1089/hum.2004.15.1255; Kowalczyk TH, 2003, MOL THER, V7, pS375; Lee J, 2009, SMALL, V5, P1213, DOI 10.1002/smll.200801788; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Liaw J, 2001, GENE THER, V8, P999, DOI 10.1038/sj.gt.3301485; Limb GA, 1996, BRIT J OPHTHALMOL, V80, P168, DOI 10.1136/bjo.80.2.168; Limb GA, 2001, INVEST OPHTH VIS SCI, V42, P1586; Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Moyer AL, 2009, INVEST OPHTH VIS SCI, V50, P3783, DOI 10.1167/iovs.08-3051; Nakazawa T, 2006, MOL VIS, V12, P867; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Oshitari T, 2006, DIABETES, V55, P86, DOI 10.2337/diabetes.55.1.86; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Powers MR, 2005, CURR EYE RES, V30, P299, DOI 10.1080/02713680590923276; Ramadan RT, 2008, INVEST OPHTH VIS SCI, V49, P4482, DOI 10.1167/iovs.08-2085; Ramadan RT, 2006, CURR EYE RES, V31, P955, DOI 10.1080/02713680600976925; RAUSCH PG, 1978, NEW ENGL J MED, V298, P693, DOI 10.1056/NEJM197803302981301; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Uchida E, 2002, BIOL PHARM BULL, V25, P891, DOI 10.1248/bpb.25.891; Yoshida S, 2003, J LEUKOCYTE BIOL, V73, P137, DOI 10.1189/jlb.0302117; Yurek DM, 2009, MOL THER, V17, P641, DOI 10.1038/mt.2009.2; Ziady AG, 2003, MOL THER, V8, P936, DOI 10.1016/j.ymthe.2003.07.007; Ziady AG, 2003, MOL THER, V8, P948, DOI 10.1016/j.ymthe.2003.09.002	55	56	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7410	10.1371/journal.pone.0007410	http://dx.doi.org/10.1371/journal.pone.0007410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823583	Green Submitted, Green Published, gold			2022-12-25	WOS:000270728500011
J	Duan, ZF; Choy, E; Hornicek, FJ				Duan, Zhenfeng; Choy, Edwin; Hornicek, Francis J.			NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance	PLOS ONE			English	Article								Background: Multidrug resistance (MDR) is a major factor which contributes to the failure of cancer chemotherapy, and numerous efforts have been attempted to overcome MDR. To date, none of these attempts have yielded a tolerable and effective therapy to reverse MDR; thus, identification of new agents would be useful both clinically and scientifically. Methodology/Principal Findings: To identify small molecule compounds that can reverse chemoresistance, we developed a 96-well plate high-throughput cell-based screening assay in a paclitaxel resistant ovarian cancer cell line. Coincubating cells with a sublethal concentration of paclitaxel in combination with each of 2,000 small molecule compounds from the National Cancer Institute Diversity Set Library, we identified a previously uncharacterized molecule, NSC23925, that inhibits Pgp1 and reverses MDR1 (Pgp1) but does not inhibit MRP or BCRP-mediated MDR. The cytotoxic activity of NSC23925 was further evaluated using a panel of cancer cell lines expressing Pgp1, MRP, and BCRP. We found that at a concentration of >10 mu M NSC23925 moderately inhibits the proliferation of both sensitive and resistant cell lines with almost equal activity, but its inhibitory effect was not altered by co-incubation with the Pgp1 inhibitor, verapamil, suggesting that NSC23925 itself is not a substrate of Pgp1. Additionally, NSC23925 increases the intracellular accumulation of Pgp1 substrates: calcein AM, Rhodamine-123, paclitaxel, mitoxantrone, and doxorubicin. Interestingly, we further observed that, although NSC23925 directly inhibits the function of Pgp1 in a dose-dependent manner without altering the total expression level of Pgp1, NSC23925 actually stimulates ATPase activity of Pgp, a phenomenon seen in other Pgp inhibitors. Conclusions/Significance: The ability of NSC23925 to restore sensitivity to the cytotoxic effects of chemotherapy or to prevent resistance could significantly benefit cancer patients.			Duan, ZF (corresponding author), Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA.	zduan@partners.org		Duan, Zhenfeng/0000-0002-8543-083X; Choy, Edwin/0000-0001-9896-8084	NCI NIH HHS [R01 CA119617, R01-CA119617] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA119617] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed-Belkacem A, 2005, CANCER RES, V65, P4852, DOI 10.1158/0008-5472.CAN-04-1817; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Belpomme D, 2000, ANN ONCOL, V11, P1471, DOI 10.1023/A:1026556119020; Caldwell JS, 2007, ADV CANCER RES, V96, P145, DOI 10.1016/S0065-230X(06)96006-0; CARMICHAEL J, 1987, CANCER RES, V47, P936; Choi CH, 2004, BIOCHEM BIOPH RES CO, V320, P672, DOI 10.1016/j.bbrc.2004.06.020; Dai CL, 2007, CANCER CHEMOTH PHARM, V60, P741, DOI 10.1007/s00280-007-0420-0; Dantzig AH, 1996, CANCER RES, V56, P4171; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Duan ZF, 2005, CANCER CHEMOTH PHARM, V55, P277, DOI 10.1007/s00280-004-0878-y; Duan ZF, 1999, GENE, V229, P75, DOI 10.1016/S0378-1119(99)00042-6; Duan Z, 2007, MOL PHARMACOL, V72, P1137, DOI 10.1124/mol.107.038117; Duan ZF, 2009, CANCER CHEMOTH PHARM, V63, P1121, DOI 10.1007/s00280-008-0843-2; Ferry DR, 1996, EUR J CANCER, V32A, P1070, DOI 10.1016/0959-8049(96)00091-3; Garrigues A, 2002, ANAL BIOCHEM, V305, P106, DOI 10.1006/abio.2002.5650; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HAMADA H, 1988, CANCER RES, V48, P4926; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Iorns E, 2009, BIOCHEM J, V417, P361, DOI 10.1042/BJ20081682; Kaye SB, 2008, J CLIN ONCOL, V26, P2616, DOI 10.1200/JCO.2008.16.2123; Kitazaki T, 2005, LUNG CANCER, V49, P337, DOI 10.1016/j.lungcan.2005.03.035; Kolitz JE, 2004, J CLIN ONCOL, V22, P4290, DOI 10.1200/JCO.2004.11.106; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Lamendola DE, 2003, CANCER RES, V63, P2200; Litman T, 2003, J PHARMACOL EXP THER, V307, P846, DOI 10.1124/jpet.103.056960; Lourda M, 2007, INT J CANCER, V120, P611, DOI 10.1002/ijc.22327; Mellor HR, 2008, PHARMACOLOGY, V81, P275, DOI 10.1159/000115967; MILLWARD MJ, 1993, BRIT J CANCER, V67, P1031, DOI 10.1038/bjc.1993.189; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Scarborough GA, 2003, TRENDS BIOCHEM SCI, V28, P581, DOI 10.1016/j.tibs.2003.08.010; Scarborough GA, 2002, J BIOENERG BIOMEMBR, V34, P235, DOI 10.1023/A:1020211016696; Schwab D, 2003, J MED CHEM, V46, P1716, DOI 10.1021/jm021012t; Sikic BI, 1997, SEMIN HEMATOL, V34, P40; Sonneveld P, 2001, BRIT J HAEMATOL, V115, P895, DOI 10.1046/j.1365-2141.2001.03171.x; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TEBOEKHORST PAW, 1992, CANCER CHEMOTH PHARM, V30, P238, DOI 10.1007/BF00686322; TWENTYMAN PR, 1991, EUR J CANCER, V27, P1639, DOI 10.1016/0277-5379(91)90435-G; Ulukaya E, 2004, CHEMOTHERAPY, V50, P43, DOI 10.1159/000077285; Wang EJ, 2000, DRUG METAB DISPOS, V28, P522; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754; Zhu XM, 2005, ANTICANCER RES, V25, P1953	45	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7415	10.1371/journal.pone.0007415	http://dx.doi.org/10.1371/journal.pone.0007415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823672	gold, Green Published, Green Submitted			2022-12-25	WOS:000270728500014
J	Fleming-Waddell, JN; Olbricht, GR; Taxis, TM; White, JD; Vuocolo, T; Craig, BA; Tellam, RL; Neary, MK; Cockett, NE; Bidwell, CA				Fleming-Waddell, Jolena N.; Olbricht, Gayla R.; Taxis, Tasia M.; White, Jason D.; Vuocolo, Tony; Craig, Bruce A.; Tellam, Ross L.; Neary, Mike K.; Cockett, Noelle E.; Bidwell, Christopher A.			Effect of DLK1 and RTL1 but Not MEG3 or MEG8 on Muscle Gene Expression in Callipyge Lambs	PLOS ONE			English	Article							BETA-ADRENERGIC AGONIST; TUMOR-SUPPRESSOR PTEN; SKELETAL-MUSCLE; POLAR OVERDOMINANCE; E-BOX; PHENOTYPIC CHARACTERIZATION; PROTEINASE ACTIVITIES; NEGATIVE REGULATOR; TRANS-INTERACTION; FETAL ANTIGEN-1	Callipyge sheep exhibit extreme postnatal muscle hypertrophy in the loin and hindquarters as a result of a single nucleotide polymorphism (SNP) in the imprinted DLK1-DIO3 domain on ovine chromosome 18. The callipyge SNP up-regulates the expression of surrounding transcripts when inherited in cis without altering their allele-specific imprinting status. The callipyge phenotype exhibits polar overdominant inheritance since only paternal heterozygous animals have muscle hypertrophy. Two studies were conducted profiling gene expression in lamb muscles to determine the down-stream effects of over-expression of paternal allele-specific DLK1 and RTL1 as well as maternal allele-specific MEG3, RTL1AS and MEG8, using Affymetrix bovine expression arrays. A total of 375 transcripts were differentially expressed in callipyge muscle and 25 transcripts were subsequently validated by quantitative PCR. The muscle-specific expression patterns of most genes were similar to DLK1 and included genes that are transcriptional repressors or affect feedback mechanisms in beta-adrenergic and growth factor signaling pathways. One gene, phosphodiesterase 7A had an expression pattern similar to RTL1 expression indicating a biological activity for RTL1 in muscle. Only transcripts that localize to the DLK1-DIO3 domain were affected by inheritance of a maternal callipyge allele. Callipyge sheep are a unique model to study over expression of both paternal allele-specific genes and maternal allele-specific non-coding RNA with an accessible and nonlethal phenotype. This study has identified a number of genes that are regulated by DLK1 and RTL1 expression and exert control on postnatal skeletal muscle growth. The genes identified in this model are primary candidates for naturally regulating postnatal muscle growth in all meat animal species, and may serve as targets to ameliorate muscle atrophy conditions including myopathic diseases and age-related sarcopenia.			Fleming-Waddell, JN (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	cbidwell@purdue.edu	Craig, Bruce A/D-5797-2017; Tellam, Ross/T-2423-2019; White, Jason/AAF-8712-2020; Tellam, Ross/H-2798-2013; Vuocolo, Tony/H-7533-2013	Craig, Bruce A/0000-0001-9346-467X; White, Jason/0000-0002-0557-392X; Tellam, Ross/0000-0003-2353-1640; Vuocolo, Tony/0000-0002-5574-8126				Azmi S, 2004, J BIOL CHEM, V279, P52643, DOI 10.1074/jbc.M409188200; Bachmann E, 1996, J REPROD FERTIL, V107, P279; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidwell CA, 2001, ANIM GENET, V32, P248, DOI 10.1046/j.1365-2052.2001.00776.x; Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; Bloom TJ, 1996, P NATL ACAD SCI USA, V93, P14188, DOI 10.1073/pnas.93.24.14188; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Butler MP, 2004, J BIOL RHYTHM, V19, P126, DOI 10.1177/0748730403262870; Carpenter CE, 2000, CAN J ANIM SCI, V80, P511, DOI 10.4141/A00-009; Carpenter CE, 2000, CAN J ANIM SCI, V80, P297, DOI 10.4141/A99-115; Carpenter E, 1996, J ANIM SCI, V74, P388; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; Croteau S, 2003, MAMM GENOME, V14, P231, DOI 10.1007/s00335-002-2244-x; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; De Arcangelis V, 2003, MOL BIOL CELL, V14, P1392, DOI 10.1091/mbc.E02-03-0156; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duckett SK, 2000, J ANIM SCI, V78, P2836; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Enoksson S, 1998, DIABETOLOGIA, V41, P560, DOI 10.1007/s001250050947; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Freking BA, 1998, J ANIM SCI, V76, P2062; Freking BA, 1998, J ANIM SCI, V76, P2549; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Fujimoto K, 2007, INT J MOL MED, V19, P925; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1007/s002580050265; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Haberland M, 2007, MOL CELL BIOL, V27, P518, DOI 10.1128/MCB.01415-06; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Han P, 1997, J BIOL CHEM, V272, P16152, DOI 10.1074/jbc.272.26.16152; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Huang DW, 2008, BIOINFORMATION, V2, P428; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jackson SP, 1997, J ANIM SCI, V75, P125; Jackson SP, 1997, J ANIM SCI, V75, P133; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; JENSEN CH, 1993, HUM REPROD, V8, P635, DOI 10.1093/oxfordjournals.humrep.a138110; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Kijas JW, 2006, ANIM GENET, V37, P171, DOI 10.1111/j.1365-2052.2005.01399.x; Kim KS, 2004, MAMM GENOME, V15, P552, DOI 10.1007/s00335-004-2341-0; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Koohmaraie M, 1996, J ANIM SCI, V74, P70; KOOHMARAIE M, 1991, J ANIM SCI, V69, P4823, DOI 10.2527/1991.69124823x; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Li XP, 2008, ANIM GENET, V39, P189, DOI 10.1111/j.1365-2052.2007.01693.x; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Lynch C, 2003, CURR BIOL, V13, P1518, DOI 10.1016/S0960-9822(03)00618-3; Murphy SK, 2005, MAMM GENOME, V16, P171, DOI 10.1007/s00335-004-2421-1; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Noshiro M, 2004, GENES CELLS, V9, P317, DOI 10.1111/j.1356-9597.2004.00722.x; Nueda ML, 2007, J MOL BIOL, V367, P1270, DOI 10.1016/j.jmb.2006.10.020; Perkins AC, 2006, ANIM GENET, V37, P535, DOI 10.1111/j.1365-2052.2006.01518.x; Polineni P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-283; PRINGLE TD, 1993, J ANIM SCI, V71, P636, DOI 10.2527/1993.713636x; *R DCT, 2007, R LANG ENV STAT COMP; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Sato F, 2008, GENES CELLS, V13, P131, DOI 10.1111/j.1365-2443.2007.01153.x; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; SMAS CM, 1994, BIOCHEMISTRY-US, V33, P9257, DOI 10.1021/bi00197a029; Smit M, 2003, GENETICS, V163, P453; Smith TR, 2001, J ANIM SCI, V79, P781; Soderling SH, 1998, P NATL ACAD SCI USA, V95, P8991, DOI 10.1073/pnas.95.15.8991; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Vuocolo T, 2005, AUST J EXP AGR, V45, P879, DOI 10.1071/EA05049; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wermter AK, 2008, EUR J HUM GENET, V16, P1126, DOI 10.1038/ejhg.2008.64; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Yevtodiyenko A, 2006, DEV DYNAM, V235, P1115, DOI 10.1002/dvdy.20705; Yu M, 2007, MAMM GENOME, V18, P197, DOI 10.1007/s00335-007-9006-8	99	37	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7399	10.1371/journal.pone.0007399	http://dx.doi.org/10.1371/journal.pone.0007399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816583	gold, Green Published, Green Submitted			2022-12-25	WOS:000270594300015
J	Feng, YX; Wang, YM; Stock, O; Pfister, F; Tanimoto, N; Seeliger, MW; Hillebrands, JL; Hoffmann, S; Wolburg, H; Gretz, N; Hammes, HP				Feng, Yuxi; Wang, Yumei; Stock, Oliver; Pfister, Frederick; Tanimoto, Naoyuki; Seeliger, Mathias W.; Hillebrands, Jan-Luuk; Hoffmann, Sigrid; Wolburg, Hartwig; Gretz, Norbert; Hammes, Hans-Peter			Vasoregression Linked to Neuronal Damage in the Rat with Defect of Polycystin-2	PLOS ONE			English	Article								Background: Neuronal damage is correlated with vascular dysfunction in the diseased retina, but the underlying mechanisms remain controversial because of the lack of suitable models in which vasoregression related to neuronal damage initiates in the mature retinal vasculature. The aim of this study was to assess the temporal link between neuronal damage and vascular patency in a transgenic rat (TGR) with overexpression of a mutant cilia gene polycystin-2. Methods: Vasoregression, neuroglial changes and expression of neurotrophic factors were assessed in TGR and control rats in a time course. Determination of neuronal changes was performed by quantitative morphometry of paraffin-embedded vertical sections. Vascular cell composition and patency were assessed by quantitative retinal morphometry of digest preparations. Glial activation was assessed by western blot and immunofluorescence. Expression of neurotrophic factors was detected by quantitative PCR. Findings: At one month, number and thickness of the outer nuclear cell layers (ONL) in TGR rats were reduced by 31% (p<0.001) and 17% (p<0.05), respectively, compared to age-matched control rats. Furthermore, the reduction progressed from 1 to 7 months in TGR rats. Apoptosis was selectively detected in the photoreceptor in the ONL, starting after one month. Nevertheless, TGR and control rats showed normal responses in electroretinogram at one month. From the second month onwards, TGR retinas had significantly increased acellular capillaries (p<0.001), and a reduction of endothelial cells (p<0.01) and pericytes (p<0.01). Upregulation of GFAP was first detected in TGR retinas after 1 month in glial cells, in parallel with an increase of FGF2 (fourfold) and CNTF (60%), followed by upregulation of NGF (40%) at 3 months. Interpretation: Our data suggest that TGR is an appropriate animal model for vasoregression related to neuronal damage. Similarities to experimental diabetic retinopathy render this model suitable to understand general mechanisms of maturity-onset vasoregression.			Feng, YX (corresponding author), Univ Heidelberg, Dept Med 5, Med Fac Mannheim, D-6800 Mannheim, Germany.	hans-peter.hammes@med5.ma.uni-heidelberg.de	Hammes, Hans-Peter/S-3719-2019	Hillebrands, Jan-Luuk/0000-0003-3135-3274				Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; BLANKS JC, 1986, J COMP NEUROL, V254, P543, DOI 10.1002/cne.902540407; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chaum E, 2003, J CELL BIOCHEM, V88, P57, DOI 10.1002/jcb.10354; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; de Gooyer TE, 2006, INVEST OPHTH VIS SCI, V47, P5553, DOI 10.1167/iovs.06-0646; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; FALSINI B, 1989, DOC OPHTHALMOL, V73, P193, DOI 10.1007/BF00155037; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; HAMMES HP, 1995, MOL MED, V1, P527, DOI 10.1007/BF03401589; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hammes HP, 1998, DIABETES, V47, P401, DOI 10.2337/diabetes.47.3.401; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Hoffmann J, 2005, FASEB J, V19, P2035, DOI 10.1096/fj.04-2109fje; Holopigian K, 1997, INVEST OPHTH VIS SCI, V38, P2355; Joly S, 2007, INVEST OPHTH VIS SCI, V48, P2311, DOI 10.1167/iovs.06-1205; Kubota Y, 2008, J CLIN INVEST, V118, P2393, DOI 10.1172/JCI34882; Lambiase A, 1996, GRAEF ARCH CLIN EXP, V234, pS96, DOI 10.1007/BF02343055; Lenzi L, 2005, VISION RES, V45, P1491, DOI 10.1016/j.visres.2004.12.020; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; MASTRONARDE DN, 1984, J COMP NEUROL, V228, P598, DOI 10.1002/cne.902280410; Narendran N, 2004, AM J MED GENET A, V127A, P208, DOI 10.1002/ajmg.a.20673; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Palmowski AM, 1997, INVEST OPHTH VIS SCI, V38, P2586; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P4592, DOI 10.1167/iovs.04-0842; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; SAKAI H, 1995, OPHTHALMIC RES, V27, P57, DOI 10.1159/000267571; SEATON AD, 1994, INVEST OPHTH VIS SCI, V35, P162; SIDMAN RL, 1965, J HERED, V56, P23, DOI 10.1093/oxfordjournals.jhered.a107364; Vogel G, 2005, SCIENCE, V310, P216, DOI 10.1126/science.310.5746.216; Wang SM, 2000, INVEST OPHTH VIS SCI, V41, P537	36	54	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7328	10.1371/journal.pone.0007328	http://dx.doi.org/10.1371/journal.pone.0007328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806208	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800022
J	Wu, ZH; Wang, HW; Mu, WH; Ouyang, ZC; Nogales, E; Xing, JH				Wu, Zhanghan; Wang, Hong-Wei; Mu, Weihua; Ouyang, Zhongcan; Nogales, Eva; Xing, Jianhua			Simulations of Tubulin Sheet Polymers as Possible Structural Intermediates in Microtubule Assembly	PLOS ONE			English	Article							PROTEIN-PROTEIN ASSOCIATION; FORCE-VELOCITY RELATION; ELECTRON-MICROSCOPE; DYNAMICS; MODEL; POLYMERIZATION; FLUCTUATIONS; INSTABILITY; FIBRILS; LATTICE	The microtubule assembly process has been extensively studied, but the underlying molecular mechanism remains poorly understood. The structure of an artificially generated sheet polymer that alternates two types of lateral contacts and that directly converts into microtubules, has been proposed to correspond to the intermediate sheet structure observed during microtubule assembly. We have studied the self-assembly process of GMPCPP tubulins into sheet and microtubule structures using thermodynamic analysis and stochastic simulations. With the novel assumptions that tubulins can laterally interact in two different forms, and allosterically affect neighboring lateral interactions, we can explain existing experimental observations. At low temperature, the allosteric effect results in the observed sheet structure with alternating lateral interactions as the thermodynamically most stable form. At normal microtubule assembly temperature, our work indicates that a class of sheet structures resembling those observed at low temperature is transiently trapped as an intermediate during the assembly process. This work may shed light on the tubulin molecular interactions, and the role of sheet formation during microtubule assembly.			Wu, ZH (corresponding author), Virginia Polytech Inst & State Univ, Program Genet Bioinformat & Computat Biol, Blacksburg, VA 24061 USA.	xing@vt.edu	Xing, Jianhua/A-8101-2012; Mu, Weihua/AAG-6247-2020	Xing, Jianhua/0000-0002-3700-8765; Mu, Weihua/0000-0002-0338-7023				Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198; Alberts B, 2002, MOL BIOL CELL; AMOS LA, 1974, J CELL SCI, V14, P523; BAYLEY P, 1989, FEBS LETT, V259, P181, DOI 10.1016/0014-5793(89)81523-6; BERGEN LG, 1980, J CELL BIOL, V84, P141, DOI 10.1083/jcb.84.1.141; Brangwynne CP, 2007, P NATL ACAD SCI USA, V104, P16128, DOI 10.1073/pnas.0703094104; Buey RM, 2007, NAT CHEM BIOL, V3, P117, DOI 10.1038/nchembio853; BURTON PR, 1978, J CELL BIOL, V77, P120, DOI 10.1083/jcb.77.1.120; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; de Pablo PJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.098101; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; ERICKSON HP, 1989, J MOL BIOL, V206, P465, DOI 10.1016/0022-2836(89)90494-4; ERICKSON HP, 1974, J CELL BIOL, V60, P153, DOI 10.1083/jcb.60.1.153; ERICKSON HP, 1981, BIOPHYS J, V34, P293, DOI 10.1016/S0006-3495(81)84850-3; Fygenson DK, 2004, PROTEIN SCI, V13, P25, DOI 10.1110/ps.03225304; Gardner MK, 2006, CURR OPIN CELL BIOL, V18, P639, DOI 10.1016/j.ceb.2006.10.006; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; HILL TL, 1981, P NATL ACAD SCI-BIOL, V78, P5613, DOI 10.1073/pnas.78.9.5613; Howard J, 2001, MECH MOTOR PROTEINS; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KOREN R, 1976, BIOCHEMISTRY-US, V15, P1165, DOI 10.1021/bi00650a032; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; MARTIN SR, 1993, BIOPHYS J, V65, P578, DOI 10.1016/S0006-3495(93)81091-9; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; MILLER WH, 1980, J CHEM PHYS, V72, P99, DOI 10.1063/1.438959; Mogilner A, 1999, EUR BIOPHYS J BIOPHY, V28, P235, DOI 10.1007/s002490050204; Molodtsov MI, 2005, BIOPHYS J, V88, P3167, DOI 10.1529/biophysj.104.051789; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; O'Brien ET, 2008, P NATL ACAD SCI USA, V105, P19438, DOI 10.1073/pnas.0804865105; Odde DJ, 1999, J CELL SCI, V112, P3283; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Schaap IAT, 2006, BIOPHYS J, V91, P1521, DOI 10.1529/biophysj.105.077826; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Sept D, 2003, PROTEIN SCI, V12, P2257, DOI 10.1110/ps.03187503; Shin JH, 2003, J CELL BIOL, V162, P1183, DOI 10.1083/jcb.200304006; Sui HX, 2006, NATURE, V442, P475, DOI 10.1038/nature04816; SUMMERS K, 1979, J CELL BIOL, V83, P205, DOI 10.1083/jcb.83.1.205; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wang HW, 2005, CELL CYCLE, V4, P1157, DOI 10.4161/cc.4.9.2042; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Xu H, 2009, LANGMUIR, V25, P4115, DOI 10.1021/la802499n	49	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7291	10.1371/journal.pone.0007291	http://dx.doi.org/10.1371/journal.pone.0007291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19806219	gold, Green Published, Green Submitted			2022-12-25	WOS:000270593300008
J	Rodriguez, A; Luukkaala, T; Fleming, RE; Britton, RS; Bacon, BR; Parkkila, S				Rodriguez, Alejandra; Luukkaala, Tiina; Fleming, Robert E.; Britton, Robert S.; Bacon, Bruce R.; Parkkila, Seppo			Global Transcriptional Response to Hfe Deficiency and Dietary Iron Overload in Mouse Liver and Duodenum	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; HEPCIDIN EXPRESSION; PEPTIDE HEPCIDIN; TRANSPORTER; HEMOCHROMATOSIS; IDENTIFICATION; LIPOCALIN; PROTEINS	Iron is an essential trace element whose absorption is usually tightly regulated in the duodenum. HFE-related hereditary hemochromatosis (HH) is characterized by abnormally low expression of the iron-regulatory hormone, hepcidin, which results in increased iron absorption. The liver is crucial for iron homeostasis as it is the main production site of hepcidin. The aim of this study was to explore and compare the genome-wide transcriptome response to Hfe deficiency and dietary iron overload in murine liver and duodenum. Illumina (TM) arrays containing over 47,000 probes were used to study global transcriptional changes. Quantitative RT-PCR (Q-RT-PCR) was used to validate the microarray results. In the liver, the expression of 151 genes was altered in Hfe(-/-) mice while dietary iron overload changed the expression of 218 genes. There were 173 and 108 differentially expressed genes in the duodenum of Hfe(-/-) mice and mice with dietary iron overload, respectively. There was 93.5% concordance between the results obtained by microarray analysis and Q-RT-PCR. Overexpression of genes for acute phase reactants in the liver and a strong induction of digestive enzyme genes in the duodenum were characteristic of the Hfe-deficient genotype. In contrast, dietary iron overload caused a more pronounced change of gene expression responsive to oxidative stress. In conclusion, Hfe deficiency caused a previously unrecognized increase in gene expression of hepatic acute phase proteins and duodenal digestive enzymes.			Rodriguez, A (corresponding author), Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.	alejandra.rodriguez.martinez@uta.fi		Parkkila, Seppo/0000-0001-7323-8536; Luukkaala, Tiina/0000-0003-4636-9586	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041816] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66225, R01 HL066225] Funding Source: Medline; NIDDK NIH HHS [R01 DK041816, DK41816] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Abgueguen E, 2006, MAMM GENOME, V17, P430, DOI 10.1007/s00335-005-0122-z; Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Britton RS, 1996, SEMIN LIVER DIS, V16, P3, DOI 10.1055/s-2007-1007214; Brown KE, 2007, TOXICOL APPL PHARM, V223, P180, DOI 10.1016/j.taap.2007.05.011; Coppin H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r221; Damdinsuren B, 2005, INT J ONCOL, V26, P319; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming RE, 2005, SEMIN LIVER DIS, V25, P411, DOI 10.1055/s-2005-923313; Fleming RE, 1999, P NATL ACAD SCI USA, V96, P3143, DOI 10.1073/pnas.96.6.3143; Fleming RE, 2002, ANNU REV PHYSIOL, V64, P663, DOI 10.1146/annurev.physiol.64.081501.155838; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Ilyin G, 2003, FEBS LETT, V542, P22, DOI 10.1016/S0014-5793(03)00329-6; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Norton JD, 2000, J CELL SCI, V113, P3897; OWEN D, 1987, EMBO J, V6, P1287, DOI 10.1002/j.1460-2075.1987.tb02366.x; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Parkkila S, 2001, GASTROENTEROLOGY, V121, P1489, DOI 10.1053/gast.2001.29617; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Ramm GA, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P494; Rodriguez A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-379; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Trinder D, 2002, P NATL ACAD SCI USA, V99, P5622, DOI 10.1073/pnas.082112299; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2003, AM J PHYSIOL-RENAL, V285, pF9, DOI 10.1152/ajprenal.00008.2003; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492; Zoller H, 1999, LANCET, V353, P2120, DOI 10.1016/S0140-6736(98)11179-0; DAVID BIOINFORMATIC	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7212	10.1371/journal.pone.0007212	http://dx.doi.org/10.1371/journal.pone.0007212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787063	Green Published, Green Submitted, gold			2022-12-25	WOS:000270290100014
J	Capparelli, R; Romanelli, A; Iannaccone, M; Nocerino, N; Ripa, R; Pensato, S; Pedone, C; Iannelli, D				Capparelli, Rosanna; Romanelli, Alessandra; Iannaccone, Marco; Nocerino, Nunzia; Ripa, Raffaella; Pensato, Soccorsa; Pedone, Carlo; Iannelli, Domenico			Synergistic Antibacterial and Anti-Inflammatory Activity of Temporin A and Modified Temporin B In Vivo	PLOS ONE			English	Article								Temporins are antimicrobial peptides secreted by the granular glands of the European red frog (Rana temporaria). They are 10-14 amino acid long polypeptides active prevalently against gram positive bacteria. This study shows that a synthetic temporin B analogue (TB-YK), acquires the capacity to act in synergism with temporin A and to exert antimicrobial and anti-inflammatory activity in vivo against gram positive and gram negative bacteria. Administration of 3.4 mg/Kg of temporin A (TA)+1.6 mg/Kg TB-YK, given to individual mice concurrently with a lethal dose of bacteria (gram positive or negative), rescued 100% of the animals. More importantly, the same doses of temporins, administered one week after experimental infection with a sub lethal dose of bacteria, sterilized 100% of the animals within 3-6 days. Also, it is described an animal model based on the use of sub lethal doses of bacteria, which closely mimics bacterial infection in humans. The model offers the possibility to test in a preclinical setting the true potential of TA and TB-YK in combination as antimicrobial and anti-inflammatory agents.			Capparelli, R (corresponding author), Univ Naples Federico 2, Sch Biotechnol Sci, Dept Soil Plant Environm & Anim Prod Sci, Naples, Italy.	capparel@unina.it	Iannaccone, Marco/K-7559-2016; Capparelli, Rosanna/Q-3144-2017	Iannaccone, Marco/0000-0002-2283-6613; Capparelli, Rosanna/0000-0001-8614-6251; ROMANELLI, Alessandra/0000-0002-7609-4061				Ananias M, 2008, BRAZ J MED BIOL RES, V41, P877, DOI 10.1590/S0100-879X2008001000008; Becker K, 1998, J CLIN MICROBIOL, V36, P2548, DOI 10.1128/JCM.36.9.2548-2553.1998; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; BRADBURY AF, 1991, TRENDS BIOCHEM SCI, V16, P112, DOI 10.1016/0968-0004(91)90044-V; Bubert A, 1999, APPL ENVIRON MICROB, V65, P4688; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Carotenuto A, 2008, J MED CHEM, V51, P2354, DOI 10.1021/jm701604t; Cirioni O, 2005, J INFECT DIS, V192, P1613, DOI 10.1086/496888; Conlon JM, 2007, METHODS, V42, P349, DOI 10.1016/j.ymeth.2007.01.004; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; EDMAN P, 1950, ACTA CHEM SCAND, V283, P293; Feezor RJ, 2003, INFECT IMMUN, V71, P5803, DOI 10.1128/IAI.71.10.5803-5813.2003; Giacometti A, 2006, ANTIMICROB AGENTS CH, V50, P2478, DOI 10.1128/AAC.01553-05; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hong Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-178; Hujakka H, 2001, BIOORGAN MED CHEM, V9, P1601, DOI 10.1016/S0968-0896(01)00047-5; Lee J, 2009, BIOCHEM BIOPH RES CO, V379, P676, DOI 10.1016/j.bbrc.2008.12.030; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lu Y, 2006, PEPTIDES, V27, P3085, DOI 10.1016/j.peptides.2006.08.017; Mangoni ML, 2000, EUR J BIOCHEM, V267, P1447, DOI 10.1046/j.1432-1327.2000.01143.x; Oh H, 2000, ANTIMICROB AGENTS CH, V44, P68, DOI 10.1128/AAC.44.1.68-72.2000; Papagianni M, 2003, BIOTECHNOL ADV, V21, P465, DOI 10.1016/S0734-9750(03)00077-6; Rathinakumar R, 2009, J AM CHEM SOC, V131, P7609, DOI 10.1021/ja8093247; Rinaldi AC, 2002, BIOCHEM J, V368, P91, DOI 10.1042/BJ20020806; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Simmaco M, 1996, EUR J BIOCHEM, V242, P788, DOI 10.1111/j.1432-1033.1996.0788r.x; Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao HX, 2002, BIOCHEMISTRY-US, V41, P4425, DOI 10.1021/bi011929e	32	33	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7191	10.1371/journal.pone.0007191	http://dx.doi.org/10.1371/journal.pone.0007191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784377	Green Published, gold, Green Submitted			2022-12-25	WOS:000270290000008
J	Askham, JM; Platt, F; Chambers, PA; Snowden, H; Taylor, CF; Knowles, MA				Askham, J. M.; Platt, F.; Chambers, P. A.; Snowden, H.; Taylor, C. F.; Knowles, M. A.			AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K	ONCOGENE			English	Article						AKT1; mutation; bladder cancer	PLECKSTRIN HOMOLOGY DOMAIN; CELL CARCINOMA; PH DOMAIN; IN-VIVO; KINASE; PROTEIN; ACTIVATION; DOWNSTREAM; AKT/PKB; PATHWAY	The phosphatidylinositol-3-kinase (PI3 kinase)-AKT pathway is frequently activated in cancer. Recent reports have identified a transforming mutation of AKT1 in breast, colorectal, ovarian and lung cancers. We report here the occurrence of this mutation in bladder tumours. The AKT1 G49A (E17K) mutation was found in 2/44 (4.8%) bladder cancer cell lines and 5/184 (2.7%) bladder tumours. Cell lines expressing mutant AKT1 show constitutive AKT1 activation under conditions of growth factor withdrawal. We also detected a novel AKT1 mutation G145A (E49K). This mutation also enhances AKT activation and shows transforming activity in NIH3T3 cells, though activity is weaker than that of E17K. Enhanced activation of AKT1 when E17K and E49K mutations are in tandem suggests that they can co-operate.	[Askham, J. M.; Platt, F.; Knowles, M. A.] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Chambers, P. A.; Snowden, H.; Taylor, C. F.] St James Univ Hosp, Canc Res UK Genome Variat Lab, Leeds LS9 7TF, W Yorkshire, England	Cancer Research UK; Saint James's University Hospital; University of Leeds; Saint James's University Hospital	Knowles, MA (corresponding author), St James Univ Hosp, Canc Res UK Clin Ctr, Leeds Inst Mol Med, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	m.a.knowles@leeds.ac.uk	Chambers, Philip/AAK-8549-2020	Chambers, Philip/0000-0002-0926-717X; Knowles, Margaret/0000-0002-9363-8657	Cancer Research UK [C6228/A5433]	Cancer Research UK(Cancer Research UK)	This work was funded by a Programme grant from Cancer Research UK (C6228/A5433).	Aveyard JS, 1999, BRIT J CANCER, V80, P904, DOI 10.1038/sj.bjc.6690439; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Cairns P, 1998, ONCOGENE, V16, P3215, DOI 10.1038/sj.onc.1201855; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Cappellen D, 1997, ONCOGENE, V14, P3059, DOI 10.1038/sj.onc.1201154; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Knowles MA, 2003, CANCER RES, V63, P7652; Kumar R, 2005, CANCER RES, V65, P2511, DOI 10.1158/0008-5472.CAN-05-0189; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; PLATT FM, 2009, CLIN CAN RE IN PRESS; Pymar LS, 2008, HUM MOL GENET, V17, P2006, DOI 10.1093/hmg/ddn098; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Tokuda E, 2007, CANCER RES, V67, P9666, DOI 10.1158/0008-5472.CAN-07-1050; Wang DS, 2000, INT J CANCER, V88, P620, DOI 10.1002/1097-0215(20001115)88:4<620::AID-IJC16>3.0.CO;2-Z	27	83	84	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					150	155		10.1038/onc.2009.315	http://dx.doi.org/10.1038/onc.2009.315			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19802009				2022-12-25	WOS:000273373500014
J	Ballal, RD; Saha, T; Fan, SJ; Haddad, BR; Rosen, EM				Ballal, Rahul D.; Saha, Tapas; Fan, Saijun; Haddad, Bassam R.; Rosen, Eliot M.			BRCA1 Localization to the Telomere and Its Loss from the Telomere in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSCEPTIBILITY GENE BRCA1; BREAST-CANCER; CELL-LINES; CATALYTIC SUBUNIT; LENGTH CONTROL; COMPLEX; ASSOCIATION; INHIBITION; DISRUPTION; EXPRESSION	BRCA1, a tumor suppressor, participates in DNA damage signaling and repair. Previously, we showed that BRCA1 overexpression caused inhibition of telomerase activity and telomere shortening in breast and prostate cancer cells. We now report that BRCA1 knockdown causes increased telomerase reverse transcriptase expression, telomerase activity, and telomere length; but studies utilizing a combination of BRCA1 and telomerase reverse transcriptase small interfering RNAs suggest that BRCA1 also regulates telomere length independently of telomerase. Using telomeric chromatin immunoprecipitation assays, we detected BRCA1 at the telomere and demonstrated time-dependent loss of BRCA1 from the telomere following DNA damage. Further studies suggest that BRCA1 interacts with TRF1 and TRF2 in a DNA-dependent manner and that some of the nuclear BRCA1 colocalizes with TRF1/2. Our findings further suggest that Rad50 is required to localize BRCA1 at the telomere and that the association of BRCA1 with Rad50 does not require DNA. Finally, we found that BRCA1 regulates the length of the 3' G-rich overhang in a manner that is dependent upon Rad50. Our findings suggest that BRCA1 is recruited to the telomere in a Rad50-dependent manner and that BRCA1 may regulate telomere length and stability, in part through its presence at the telomere.	[Rosen, Eliot M.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Sch Med, Washington, DC 20057 USA; [Ballal, Rahul D.; Rosen, Eliot M.] Georgetown Univ, Sch Med, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA	Georgetown University; Georgetown University	Rosen, EM (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Sch Med, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	emr36@georgetown.edu			National Institutes of Health United States Public Health Service [RO1-CA80000, RO1-CA82599, RO1-CA104546]; American Federation for Aging Research; Cosmos Scholars Foundation; NATIONAL CANCER INSTITUTE [R01CA104546, R01CA080000, R01CA082599] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); American Federation for Aging Research; Cosmos Scholars Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants RO1-CA80000, RO1-CA82599, and RO1-CA104546 (to E.M.R.). This work was also supported by a predoctoral award from the American Federation for Aging Research (to R.D.B.) and the Cosmos Scholars Foundation Henry H. Work Science Award (to R.D.B.).	Al-Wahiby S, 2005, CYTOGENET GENOME RES, V109, P491, DOI 10.1159/000084208; ALLEY MC, 1988, CANCER RES, V48, P589; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Blackburn EH, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1196; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chai WH, 2006, EMBO REP, V7, P225, DOI 10.1038/sj.embor.7400600; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Fan SJ, 2001, ONCOGENE, V20, P4827, DOI 10.1038/sj.onc.1204666; Fan SJ, 1998, ONCOGENE, V16, P3069, DOI 10.1038/sj.onc.1202116; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; French JD, 2006, GENE CHROMOSOME CANC, V45, P277, DOI 10.1002/gcc.20290; Greider CW, 1999, CELL, V97, P419, DOI 10.1016/S0092-8674(00)80750-3; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Igbavboa U, 2003, J BIOL CHEM, V278, P17150, DOI 10.1074/jbc.M301150200; Jiang L, 2004, BIOL REPROD, V70, P1589, DOI 10.1095/biolreprod.103.022616; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Ma YX, 2006, MOL ENDOCRINOL, V20, P14, DOI 10.1210/me.2004-0488; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Rosen EM, 2006, CANCER LETT, V236, P175, DOI 10.1016/j.canlet.2005.04.037; Rosen EM, 2003, J CELL PHYSIOL, V196, P19, DOI 10.1002/jcp.10257; Staff S, 2003, CANCER RES, V63, P4978; Tahara H, 2005, NAT METHODS, V2, P829, DOI 10.1038/NMETH797; Wang X, 2007, CELL DEATH DIFFER, V14, P924, DOI 10.1038/sj.cdd.4402105; Weisberg TF, 1996, MOL CELL PROBE, V10, P139, DOI 10.1006/mcpr.1996.0019; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Wu GK, 2003, CANCER RES, V63, P2589; Wu Y, 2007, NAT STRUCT MOL BIOL, V14, P832, DOI 10.1038/nsmb1286; Xiong JB, 2003, MOL CELL BIOL, V23, P8668, DOI 10.1128/MCB.23.23.8668-8690.2003; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	40	45	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36083	36098		10.1074/jbc.M109.025825	http://dx.doi.org/10.1074/jbc.M109.025825			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19797051	Green Published, hybrid			2022-12-25	WOS:000272970500010
J	Beckham, SA; Boyd, SE; Reynolds, S; Willis, C; Johnstone, M; Mika, A; Simerska, P; Wijeyewickrema, LC; Smith, AI; Kemp, DJ; Pike, RN; Fischer, K				Beckham, Simone A.; Boyd, Sarah E.; Reynolds, Simone; Willis, Charlene; Johnstone, Masego; Mika, Angela; Simerska, Pavla; Wijeyewickrema, Lakshmi C.; Smith, A. Ian; Kemp, David J.; Pike, Robert N.; Fischer, Katja			Characterization of a Serine Protease Homologous to House Dust Mite Group 3 Allergens from the Scabies Mite Sarcoptes scabiei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-III ALLERGEN; DERMATOPHAGOIDES-PTERONYSSINUS; SUBSTRATE-SPECIFICITY; IN-VIVO; DISEASE; SKIN; RESISTANCE; BEHAVIOR; ENZYME; PHAGE	The scabies mite, Sarcoptes scabiei var. hominis, infests human skin, causing allergic reactions and facilitating bacterial infection by Streptococcus sp., with serious consequences such as rheumatic fever and rheumatic heart disease. To identify a possible drug target or vaccine candidate protein, we searched for homologues of the group 3 allergen of house dust mites, which we subsequently identified in a cDNA library. The native protein, designated Sar s 3, was shown to be present in the mite gut and excreted in fecal pellets into mite burrows within the upper epidermis. The substrate specificity of proteolytically active recombinant rSar s 3 was elucidated by screening a bacteriophage library. A preference for substrates containing a RS(G/A) sequence at the P1-P2' positions was revealed. A series of peptides synthesized as internally quenched fluorescent substrates validated the phage display data and high performance liquid chromatography/mass spectrometry analysis of the preferred cleaved substrate and confirmed the predicted cleavage site. Searches of the human proteome using sequence data from the phage display allowed the in silico prediction of putative physiological substrates. Among these were numerous epidermal proteins, with filaggrin being a particularly likely candidate substrate. We showed that recombinant rSar s 3 cleaves human filaggrin in vitro and obtained immunohistological evidence that the filaggrin protein is ingested by the mite. This is the first report elucidating the substrate specificity of Sar s 3 and its potential role in scabies mite biology.	[Beckham, Simone A.; Reynolds, Simone; Willis, Charlene; Johnstone, Masego; Mika, Angela; Kemp, David J.; Fischer, Katja] Queensland Inst Med Res, Div Infect Dis & Immunol, Herston, Qld 4029, Australia; [Boyd, Sarah E.] Monash Univ, Clayton Sch Informat Technol, Fac Informat Technol, Clayton, Vic 3800, Australia; [Beckham, Simone A.; Wijeyewickrema, Lakshmi C.; Smith, A. Ian; Pike, Robert N.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Fac Med, Clayton, Vic 3800, Australia; [Simerska, Pavla] Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia; [Reynolds, Simone] Univ Queensland, Sch Vet Sci, St Lucia, Qld 4072, Australia	QIMR Berghofer Medical Research Institute; Monash University; Monash University; University of Queensland; University of Queensland	Fischer, K (corresponding author), PO Royal Brisbane Hosp, Brisbane, Qld 4029, Australia.	Katja.Fischer@qimr.edu.au	Fischer, Katja/H-4989-2014; Willis, Charlene/U-1344-2017; Boyd, Sarah E/I-9047-2012; Wijeyewickrema, Lakshmi/A-9676-2015	Fischer, Katja/0000-0003-3408-3337; Wijeyewickrema, Lakshmi/0000-0001-6084-4887; , Simone/0000-0002-4902-2003; Smith, Ian/0000-0002-4143-2892; Pike, Robert/0000-0002-2083-0269; Boyd, Sarah/0000-0002-7264-8602	Australian National Health and Medical Research Council [496600]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Australian National Health and Medical Research Council fellowship and Program Grant 496600 (to D.J.K.).	BEYNON R, 2001, PROTEOLYTIC ENZYMES, P109; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; BROOK I, 1995, J CLIN MICROBIOL, V33, P2139, DOI 10.1128/JCM.33.8.2139-2140.1995; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; Currie B J, 2000, Australas J Dermatol, V41, P139, DOI 10.1046/j.1440-0960.2000.00417.x; Currie BJ, 2004, CLIN INFECT DIS, V39, pE8, DOI 10.1086/421776; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Fimiani M, 1997, J SUBMICR CYTOL PATH, V29, P105; HALL PK, 1978, BIOCHEM J, V173, P27, DOI 10.1042/bj1730027; Hanquier J, 2003, APPL ENVIRON MICROB, V69, P1108, DOI 10.1128/AEM.69.2.1108-1113.2003; Holt DC, 2003, J INVEST DERMATOL, V121, P1419, DOI 10.1046/j.1523-1747.2003.12621.x; Hwang SR, 2008, FEBS LETT, V582, P2527, DOI 10.1016/j.febslet.2008.06.017; JOHN RA, 2002, ENZYME ASSAYS, P75; Kerr FK, 2005, J BIOL CHEM, V280, P39510, DOI 10.1074/jbc.M506131200; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; MATTHEWS DJ, 1994, PROTEIN SCI, V3, P1197, DOI 10.1002/pro.5560030805; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; Mounsey KE, 2008, FUTURE MICROBIOL, V3, P57, DOI 10.2217/17460913.3.1.57; Nomura T, 2008, J INVEST DERMATOL, V128, P1436, DOI 10.1038/sj.jid.5701205; Perry DK, 1997, J BIOL CHEM, V272, P18530, DOI 10.1074/jbc.272.30.18530; Platts-Mills TAE, 1998, J ALLERGY CLIN IMMUN, V101, pS364, DOI 10.1016/S0091-6749(98)70221-0; Prins C, 2004, DERMATOLOGY, V208, P241, DOI 10.1159/000077310; Rapp CM, 2006, J MED ENTOMOL, V43, P539, DOI 10.1603/0022-2585(2006)43[539:POHIIT]2.0.CO;2; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Scott FL, 2008, J BIOL CHEM, V283, P19499, DOI 10.1074/jbc.M800331200; SMITH WA, 1994, CLIN EXP ALLERGY, V24, P220, DOI 10.1111/j.1365-2222.1994.tb00223.x; STEWART GA, 1992, IMMUNOLOGY, V75, P29; STEWART GA, 1994, ALLERGY, V49, P553, DOI 10.1111/j.1398-9995.1994.tb01128.x; Thomas WR, 1999, CLIN EXP ALLERGY, V29, P1583, DOI 10.1046/j.1365-2222.1999.00670.x; VANNESTE D, 1985, DERMATOLOGICA, V171, P343, DOI 10.1159/000249449; Walton SF, 2004, INT J PARASITOL, V34, P839, DOI 10.1016/j.ijpara.2004.04.002; Walton SF, 2007, CLIN MICROBIOL REV, V20, P268, DOI 10.1128/CMR.00042-06; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; Willis C, 2006, AM J TROP MED HYG, V75, P683, DOI 10.4269/ajtmh.2006.75.683	36	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34413	34422		10.1074/jbc.M109.061911	http://dx.doi.org/10.1074/jbc.M109.061911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19812030	Green Published, hybrid			2022-12-25	WOS:000272165200071
J	Bouvier, D; Spagnol, G; Chenavas, S; Kieken, F; Vitrac, H; Brownell, S; Kellezi, A; Forge, V; Sorgen, PL				Bouvier, Denis; Spagnol, Gaelle; Chenavas, Sylvie; Kieken, Fabien; Vitrac, Heidi; Brownell, Sarah; Kellezi, Admir; Forge, Vincent; Sorgen, Paul L.			Characterization of the Structure and Intermolecular Interactions between the Connexin40 and Connexin43 Carboxyl-terminal and Cytoplasmic Loop Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; DICHROISM SPECTROSCOPIC DATA; C-SRC; ZONULA OCCLUDENS-1; EXPRESSION RATIO; PH REGULATION; PROTEIN; CX43; CELLS; NMR	Gap junctions are intercellular channels that allow the passage of ions, small molecules, and second messengers that are essential for the coordination of cellular function. They are formed by two hemichannels, each constituted by the oligomerization of six connexins (Cx). Among the 21 different human Cx isoforms, studies have suggested that in the heart, Cx40 and Cx43 can oligomerize to form heteromeric hemichannels. The mechanism of heteromeric channel regulation has not been clearly defined. Tissue ischemia leads to intracellular acidification and closure of Cx43 and Cx40 homomeric channels. However, coexpression of Cx40 and Cx43 in Xenopus oocytes enhances the pH sensitivity of the channel. This phenomenon requires the carboxyl-terminal (CT) part of both connexins. In this study we used different biophysical methods to determine the structure of the Cx40CT and characterize the Cx40CT/Cx43CT interaction. Our results revealed that the Cx40CT is an intrinsically disordered protein similar to the Cx43CT and that the Cx40CT and Cx43CT can interact. Additionally, we have identified an interaction between the Cx40CT and the cytoplasmic loop of Cx40 as well as between the Cx40CT and the cytoplasmic loop of Cx43 ( and vice versa). Our studies support the "particle-receptor" model for pH gating of Cx40 and Cx43 gap junction channels and suggest that interactions between cytoplasmic regulatory domains (both homo- and hetero-connexin) could be important for the regulation of heteromeric channels.	[Bouvier, Denis; Spagnol, Gaelle; Chenavas, Sylvie; Kieken, Fabien; Brownell, Sarah; Sorgen, Paul L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Kellezi, Admir] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Vitrac, Heidi; Forge, Vincent] Commissariat Energie Atom, Lab Chim & Biol Metaux, UMR 5249, F-38054 Grenoble, France	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	psorgen@unmc.edu	Vitrac, Heidi/R-7117-2018	Vitrac, Heidi/0000-0002-8858-4914; Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health [GM072631, HL039707]; American Heart Association [0560050Z]; Nebraska Research Initiative [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL039707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Nebraska Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072631 and HL039707 (USPHS). This work was also supported by American Heart Association Grant 0560050Z, the Nebraska Research Initiative funding for the Nebraska Center for Structural Biology, and Eppley Cancer Center Support Grant P30CA036727.	Anumonwo JMB, 2001, CIRC RES, V88, P666, DOI 10.1161/hh0701.088833; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Bernstein SA, 2006, ADV CARDIOL, V42, P71, DOI 10.1159/000092563; Bouvier D, 2007, BIOMOL NMR ASSIGM, V1, P155, DOI 10.1007/s12104-007-9044-x; Bouvier D, 2008, CELL COMMUN ADHES, V15, P107, DOI 10.1080/15419060802014347; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Burt JM, 2001, AM J PHYSIOL-CELL PH, V280, pC500, DOI 10.1152/ajpcell.2001.280.3.C500; Cottrell GT, 2002, AM J PHYSIOL-CELL PH, V282, pC1469, DOI 10.1152/ajpcell.00484.2001; Cottrell GT, 2001, AM J PHYSIOL-CELL PH, V281, pC1559, DOI 10.1152/ajpcell.2001.281.5.C1559; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhein S, 2006, ADV CARDIOL, V42, P198, DOI 10.1159/000092570; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; EkVitorin JF, 1996, BIOPHYS J, V71, P1273, DOI 10.1016/S0006-3495(96)79328-1; Elenes S, 1999, J CARDIOVASC ELECTR, V10, P990, DOI 10.1111/j.1540-8167.1999.tb01270.x; Francis D, 1999, DEV GENET, V24, P123, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<123::AID-DVG12>3.0.CO;2-H; Gu H, 2000, CIRC RES, V86, pE98, DOI 10.1161/01.RES.86.10.e98; He DS, 1999, P NATL ACAD SCI USA, V96, P6495, DOI 10.1073/pnas.96.11.6495; Herve JC, 2006, ADV CARDIOL, V42, P107, DOI 10.1159/000092565; Hirst-Jensen BJ, 2007, J BIOL CHEM, V282, P5801, DOI 10.1074/jbc.M605233200; Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L; HOSSAIN MZ, 1994, J NEUROCHEM, V62, P2394; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kellezi A, 2008, PROTEIN EXPRES PURIF, V59, P215, DOI 10.1016/j.pep.2008.01.023; Koval M, 2006, TRENDS CELL BIOL, V16, P159, DOI 10.1016/j.tcb.2006.01.006; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Matesic D, 2003, CELL BIOL INT, V27, P89, DOI 10.1016/S1065-6995(02)00281-0; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Peters NS, 1997, CIRCULATION, V95, P988; Roger C, 2004, J PATHOL, V202, P241, DOI 10.1002/path.1509; Saffitz JE, 2000, CARDIOVASC RES, V45, P807, DOI 10.1016/S0008-6363(99)00421-6; Seki A, 2004, CIRC RES, V95, P22, DOI 10.1161/01.RES.0000140737.62245.c5; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sorgen PL, 2004, BIOPHYS J, V87, P574, DOI 10.1529/biophysj.103.039230; SPRAY DC, 1985, ANNU REV PHYSIOL, V47, P281, DOI 10.1146/annurev.ph.47.030185.001433; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Valiunas V, 2000, CIRC RES, V86, pE42, DOI 10.1161/01.RES.86.2.e42; Valiunas V, 2001, AM J PHYSIOL-HEART C, V281, pH1675, DOI 10.1152/ajpheart.2001.281.4.H1675; van Veen TAB, 2006, ADV CARDIOL, V42, P18, DOI 10.1159/000092560; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	50	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34257	34271		10.1074/jbc.M109.039594	http://dx.doi.org/10.1074/jbc.M109.039594			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808665	Green Published, hybrid			2022-12-25	WOS:000272165200057
J	Rostovtseva, TK; Boukari, H; Antignani, A; Shiu, B; Banerjee, S; Neutzner, A; Youle, RJ				Rostovtseva, Tatiana K.; Boukari, Hacene; Antignani, Antonella; Shiu, Brian; Banerjee, Soojay; Neutzner, Albert; Youle, Richard J.			Bax Activates Endophilin B1 Oligomerization and Lipid Membrane Vesiculation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; GIANT PHOSPHOLIPID-VESICLES; FLUCTUATION SPECTROSCOPY; PROTEIN FAMILY; DOMAIN; CURVATURE; MECHANISM; DYNAMICS; FISSION; BIF-1	Endophilins participate in membrane scission events that occur during endocytosis and intracellular organelle biogenesis through the combined activity of an N-terminal BAR domain that interacts with membranes and a C-terminal SH3 domain that mediates protein binding. Endophilin B1 (Endo B1) was identified to bind Bax, a Bcl-2 family member that promotes apoptosis, through yeast two-hybrid protein screens. Although Endo B1 does not bind Bax in healthy cells, during apoptosis, Endo B1 interacts transiently with Bax and promotes cytochrome c release from mitochondria. To explore the molecular mechanism of action of Endo B1, we have analyzed its interaction with Bax in cell-free systems. Purified recombinant Endo B1 in solution displays a Stokes radius indicating a tetrameric quarternary structure. However, when incubated with purified Bax, it assembles into oligomersmore than 4-fold greater in molecular weight. Although Endo B1 oligomerization is induced by Bax, Bax does not stably associate with the high molecular weight Endo B1 complex. Endo B1 oligomerization requires its C-terminal Src homology 3 domain and is not induced by Bcl-xL. Endo B1 combined with Bax reduces the size and changes the morphology of giant unilamellar vesicles by inducing massive vesiculation of liposomes. This activity of purified Bax protein to induce cell-free assembly of Endo B1 may reflect its activity in cells that regulates apoptosis and/or mitochondrial fusion.	[Antignani, Antonella; Shiu, Brian; Banerjee, Soojay; Youle, Richard J.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; Eunice Kennedy Shriver NICHD, Lab Phys & Struct Biol, Bethesda, MD 20892 USA; [Boukari, Hacene] Eunice Kennedy Shriver NICHD, Lab Integrat & Med Biophys, Program Phys Biol, Bethesda, MD 20892 USA; [Neutzner, Albert] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Basel	Youle, RJ (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, 35 Convent Dr,2C-917, Bethesda, MD 20892 USA.	youler@ninds.nih.gov	Neutzner, Albert/ABC-4368-2020	Neutzner, Albert/0000-0001-9254-5558	Eunice Kennedy Shriver NICHD; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002859] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Programs of the Eunice Kennedy Shriver NICHD (to T.K.R., H.B., and B.S.) and NINDS (to A.A., S.B., and R.J.Y.).	Angelova MI, 1999, EUR BIOPHYS J BIOPHY, V28, P142, DOI 10.1007/s002490050193; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Bagatolli LA, 2000, CHEM PHYS LIPIDS, V105, P135, DOI 10.1016/S0009-3084(00)00118-3; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Bernard AL, 2002, BBA-BIOMEMBRANES, V1567, P1, DOI 10.1016/S0005-2736(02)00617-X; BOROSKE E, 1981, BIOPHYS J, V34, P95, DOI 10.1016/S0006-3495(81)84839-4; Boukari H, 2003, BIOCHEMISTRY-US, V42, P1292, DOI 10.1021/bi026751q; Boukari H, 2008, METHOD CELL BIOL, V84, P659, DOI 10.1016/S0091-679X(07)84021-0; Chen Y, 1999, METHODS, V19, P234, DOI 10.1006/meth.1999.0854; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Roucou X, 2002, BIOCHEM J, V363, P547, DOI 10.1042/0264-6021:3630547; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Staneva G, 2005, CHEM PHYS LIPIDS, V136, P55, DOI 10.1016/j.chemphyslip.2005.03.007; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tamba Y, 2007, BIOPHYS J, V92, P3178, DOI 10.1529/biophysj.106.097105; Tanaka T, 2004, LANGMUIR, V20, P9526, DOI 10.1021/la049481g; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Webb WW, 2001, APPL OPTICS, V40, P3969, DOI 10.1364/AO.40.003969; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870	42	36	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34390	34399		10.1074/jbc.M109.021873	http://dx.doi.org/10.1074/jbc.M109.021873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19805544	Green Published, hybrid			2022-12-25	WOS:000272165200069
J	Polanska, UM; Duchesne, L; Harries, JC; Fernig, DG; Kinnunen, TK				Polanska, Urszula M.; Duchesne, Laurence; Harries, Janet C.; Fernig, David G.; Kinnunen, Tarja K.			N-Glycosylation Regulates Fibroblast Growth Factor Receptor/EGL-15 Activity in Caenorhabditis elegans in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FGF RECEPTOR; C-ELEGANS; SIGNALING PATHWAY; FACTOR FAMILY; MUTATIONS; LIGAND; ACTIVATION; ENCODES; DIFFERENTIATION; TRANSMEMBRANE	The regulation of cell function by fibroblast growth factors (FGFs) classically occurs through a dual receptor system of a tyrosine kinase receptor (FGFR) and a heparan sulfate proteoglycan co-receptor. Mutations in some consensus N-glycosylation sites in human FGFR result in skeletal disorders and craniosynostosis syndromes, and biophysical studies in vitro suggest that N-glycosylation of FGFR alters ligand and heparan sulfate binding properties. The evolutionarily conserved FGFR signaling system of Caenorhabditis elegans has been used to assess the role of N-glycosylation in the regulation of FGFR signaling in vivo. The C. elegans FGF receptor, EGL-15, is N-glycosylated in vivo, and genetic substitution of specific consensus N-glycosylation sites leads to defects in the maintenance of fluid homeostasis and differentiation of sex muscles, both of which are phenotypes previously associated with hyperactive EGL-15 signaling. These phenotypes are suppressed by hypoactive mutations in EGL-15 downstream signaling components or activating mutations in the phosphatidylinositol 3-kinase pathway, respectively. The results show that N-glycans negatively regulate FGFR activity in vivo supporting the notion that mutation of N-glycosylation sites in human FGFR may lead to inappropriate activation of the receptor.	[Polanska, Urszula M.; Duchesne, Laurence; Harries, Janet C.; Fernig, David G.; Kinnunen, Tarja K.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Liverpool	Kinnunen, TK (corresponding author), Univ Liverpool, Sch Biol Sci, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	T.K.Kinnunen@liverpool.ac.uk	Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293; Duchesne, Laurence/0000-0003-1985-6266; Kinnunen, Dr Tarja K/0000-0001-5630-2233	European Union Marie Curie Early Stage Training Programme; NorthWest Cancer Research Fund; Cancer and Polio Research Fund; Human Frontiers Science Programme; Medical Research Council; MRC [G0601549] Funding Source: UKRI; Medical Research Council [G0601549] Funding Source: researchfish	European Union Marie Curie Early Stage Training Programme(European Commission); NorthWest Cancer Research Fund; Cancer and Polio Research Fund; Human Frontiers Science Programme(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by European Union Marie Curie Early Stage Training Programme ( to U. M. P.), NorthWest Cancer Research Fund, Cancer and Polio Research Fund ( to D. G. F. and J. C. H.), Human Frontiers Science Programme ( to L. D.), and by the Medical Research Council ( to T. K.).	Altmann F, 2001, BIOCHIMIE, V83, P703, DOI 10.1016/S0300-9084(01)01297-4; Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Birnbaum D, 2005, DEV DYNAM, V232, P247, DOI 10.1002/dvdy.20219; Borland CZ, 2001, BIOESSAYS, V23, P1120, DOI 10.1002/bies.10007; BRENNER S, 1974, GENETICS, V77, P71; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; DEVORE DL, 1995, CELL, V83, P611, DOI 10.1016/0092-8674(95)90101-9; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Duchesne L, 2006, J BIOL CHEM, V281, P27178, DOI 10.1074/jbc.M601248200; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Goodman SJ, 2003, DEVELOPMENT, V130, P3757, DOI 10.1242/dev.00604; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Haslam SM, 2003, BIOCHIMIE, V85, P25, DOI 10.1016/S0300-9084(03)00041-5; Haslam SM, 2002, BIOCHEM SOC SYMP, V69, P117; Heuertz S, 2006, EUR J HUM GENET, V14, P1240, DOI 10.1038/sj.ejhg.5201700; Huang P, 2004, DEVELOPMENT, V131, P2595, DOI 10.1242/dev.01135; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Johnson D, 2008, PFLUG ARCH EUR J PHY, V456, P393, DOI 10.1007/s00424-007-0378-0; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Lee W, 2005, BIOCHEM BIOPH RES CO, V338, P1018, DOI 10.1016/j.bbrc.2005.10.041; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; Lo TW, 2008, DEV BIOL, V318, P268, DOI 10.1016/j.ydbio.2008.03.026; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Polanska UM, 2009, DEV DYNAM, V238, P277, DOI 10.1002/dvdy.21757; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Roubin R, 1999, ONCOGENE, V18, P6741, DOI 10.1038/sj.onc.1203074; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Sasson IE, 2004, DEVELOPMENT, V131, P5381, DOI 10.1242/dev.01423; Schachter H, 2002, BIOCHEM SOC SYMP, V69, P1; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; SODERQUIST AM, 1984, J BIOL CHEM, V259, P2586; Steinberger D, 1996, HUM MUTAT, V8, P386, DOI 10.1002/(SICI)1098-1004(1996)8:4<386::AID-HUMU18>3.3.CO;2-A; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Winterpacht A, 2000, PHYSIOL GENOMICS, V2, P9, DOI 10.1152/physiolgenomics.2000.2.1.9; Yu C, 2000, J NEUROIMMUNOL, V108, P2, DOI 10.1016/S0165-5728(99)00278-7; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	53	15	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33030	33039		10.1074/jbc.M109.058925	http://dx.doi.org/10.1074/jbc.M109.058925			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801543	Green Published, hybrid			2022-12-25	WOS:000272028500005
J	Sarhan, MF; Van Petegem, F; Ahern, CA				Sarhan, Maen F.; Van Petegem, Filip; Ahern, Christopher A.			A Double Tyrosine Motif in the Cardiac Sodium Channel Domain III-IV Linker Couples Calcium-dependent Calmodulin Binding to Inactivation Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; NA+ CHANNELS; MODULATION; KINASE; CA2+; EXCITABILITY; FACILITATION; DYSFUNCTION; ACTIVATION; UNDERLIE	Voltage-gated sodium channels maintain the electrical cadence and stability of neurons and muscle cells by selectively controlling the transmembrane passage of their namesake ion. The degree to which these channels contribute to cellular excitability can be managed therapeutically or fine-tuned by endogenous ligands. Intracellular calcium, for instance, modulates sodium channel inactivation, the process by which sodium conductance is negatively regulated. We explored the molecular basis for this effect by investigating the interaction between the ubiquitous calcium binding protein calmodulin (CaM) and the putative sodium channel inactivation gate composed of the cytosolic linker between homologous channel domains III and IV (DIII-IV). Experiments using isothermal titration calorimetry show that CaM binds to a novel double tyrosine motif in the center of the DIII-IV linker in a calcium- dependent manner, N-terminal to a region previously reported to be a CaM binding site. An alanine scan of aromatic residues in recombinant DIII-DIV linker peptides shows that whereas multiple side chains contribute to CaM binding, two tyrosines (Tyr(1494) and Tyr(1495)) play a crucial role in binding the CaM C-lobe. The functional relevance of these observations was then ascertained through electrophysiological measurement of sodium channel inactivation gating in the presence and absence of calcium. Experiments on patch-clamped transfected tsA201 cells show that only the Y1494A mutation of the five sites tested renders sodium channel steady-state inactivation insensitive to cytosolic calcium. The results demonstrate that calcium- dependent calmodulin binding to the sodium channel inactivation gate double tyrosine motif is required for calcium regulation of the cardiac sodium channel.	[Sarhan, Maen F.; Ahern, Christopher A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Sarhan, Maen F.; Ahern, Christopher A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Ahern, CA (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	cahern@interchange.ubc.ca	Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537; Ahern, Christopher/0000-0002-7975-2744	Canadian Institutes of Health Research [56858]; Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Supported by Canadian Institutes of Health Research Grant 56858, the Heart and Stroke Foundation of Canada, and the Michael Smith Foundation for Health Research.	Ahern CA, 2005, CIRC RES, V96, P991, DOI 10.1161/01.RES.0000166324.00524.dd; Bankston JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001258; Biswas S, 2009, CIRC RES, V104, P870, DOI 10.1161/CIRCRESAHA.108.193565; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; HORN R, 1981, NATURE, V291, P426, DOI 10.1038/291426a0; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; Kass Robert S, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS21, DOI 10.1111/j.1540-8167.2006.00381.x; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Maltsev VA, 2008, AM J PHYSIOL-HEART C, V294, pH1597, DOI 10.1152/ajpheart.00484.2007; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; Melillo G, 1996, CIRCULATION, V93, P1447, DOI 10.1161/01.CIR.93.7.1447; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; OLEARY ME, 1995, J GEN PHYSIOL, V106, P641, DOI 10.1085/jgp.106.4.641; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Viswanathan PC, 2004, TRENDS CARDIOVAS MED, V14, P28, DOI 10.1016/j.tcm.2003.10.001; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Young KA, 2005, J PHYSIOL-LONDON, V565, P349, DOI 10.1113/jphysiol.2004.081422	37	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33265	33274		10.1074/jbc.M109.052910	http://dx.doi.org/10.1074/jbc.M109.052910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808664	Green Published, hybrid			2022-12-25	WOS:000272028500031
J	Dierker, T; Dreier, R; Migone, M; Hamer, S; Grobe, K				Dierker, Tabea; Dreier, Rita; Migone, Manuel; Hamer, Sabine; Grobe, Kay			Heparan Sulfate and Transglutaminase Activity Are Required for the Formation of Covalently Cross-linked Hedgehog Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID BETA-A4 PEPTIDE; GLYPICAN DALLY-LIKE; UP-REGULATED GENES; SONIC-HEDGEHOG; TISSUE TRANSGLUTAMINASE; TERMINAL DIFFERENTIATION; CHONDROCYTE HYPERTROPHY; FACTOR-XIIIA; DISEASE; LINKING	Sonic hedgehog (Shh) signaling plays major roles in embryonic development and has also been associated with the progression of certain cancers. Here, Shh family members act directly as long range morphogens, and their ability to do so has been linked to the formation of freely diffusible multimers from the lipidated, cell-tethered monomer (ShhNp). In this work we demonstrate that the multimeric morphogen secreted from endogenous sources, such as mouse embryos and primary chick chondrocytes, consists of oligomeric substructures that are "undisruptable" by boiling, denaturants, and reducing agents. Undisruptable (UD) morphogen oligomers vary in molecular weight and possess elevated biological activity if compared with recombinant Sonic hedgehog (ShhN). However, ShhN can also undergo UD oligomerization via a heparan sulfate (HS)-dependent mechanism in vitro, and HS isolated from different sources differs in its ability to mediate UD oligomer formation. Moreover, site-directed mutagenesis of conserved ShhN glutamine residues abolishes UD oligomerization, and inhibitors directed against transglutaminase (TG) activity strongly decrease the amount of chondrocyte-secreted UD oligomers. These findings reveal an unsuspected ability of the N-terminal hedgehog (Hh) signaling domain to form biologically active, covalently crosslinked oligomers and a novel HS function in this TG-catalyzed process. We suggest that in hypertrophic chondrocytes, HS-assisted, TG-mediated Hh oligomerization modulates signaling via enhanced protein signaling activity.	[Dierker, Tabea; Migone, Manuel; Hamer, Sabine; Grobe, Kay] Univ Munster, Dept Gen Zool & Genet, D-48149 Munster, Germany; [Dierker, Tabea; Dreier, Rita; Migone, Manuel; Grobe, Kay] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	University of Munster; University of Munster	Grobe, K (corresponding author), Waldeyerstr 15, D-48149 Munster, Germany.	kgrobe@uni-muenster.de	Grobe, Kay/F-2399-2011	Dierker, Tabea/0000-0003-1991-2723	Deutsche Forschungsgemeinschaft (German Research Council) [SFB 492-B15, SFB 492-B18]	Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (German Research Council) Grants SFB 492-B15 (to K. G.) and SFB 492-B18 (to R. D.). The on-line version of this article (available at http://www.jbc.org) contains Supplements 1-5.	AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Feng J, 2004, DEVELOPMENT, V131, P4357, DOI 10.1242/dev.01301; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Gambetti S, 2005, BIOCHIMIE, V87, P551, DOI 10.1016/j.biochi.2005.01.012; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; GROENEN PJTA, 1994, EUR J BIOCHEM, V220, P795, DOI 10.1111/j.1432-1033.1994.tb18681.x; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Johnson K, 2001, AM J PATHOL, V159, P149, DOI 10.1016/S0002-9440(10)61682-3; Johnson KA, 2008, J CELL SCI, V121, P2256, DOI 10.1242/jcs.011262; Kim SY, 2002, NEUROCHEM INT, V40, P85, DOI 10.1016/S0197-0186(01)00064-X; Kirsch T, 2000, OSTEOARTHR CARTILAGE, V8, P294, DOI 10.1053/joca.1999.0304; Leteux C, 2001, J BIOL CHEM, V276, P12539, DOI 10.1074/jbc.M010291200; LORAND L, 1963, ARCH BIOCHEM BIOPHYS, V102, P171, DOI 10.1016/0003-9861(63)90168-1; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Murthy SNP, 1998, J NEUROCHEM, V71, P2607; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nurminskaya M, 1996, DEV DYNAM, V206, P260, DOI 10.1002/(SICI)1097-0177(199607)206:3<260::AID-AJA4>3.0.CO;2-G; Nurminskaya M, 1996, ANN NY ACAD SCI, V785, P309, DOI 10.1111/j.1749-6632.1996.tb56293.x; Pastor MT, 1999, FEBS LETT, V451, P231, DOI 10.1016/S0014-5793(99)00572-4; RASMUSSEN LK, 1994, FEBS LETT, V338, P161, DOI 10.1016/0014-5793(94)80356-0; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Rosenthal AK, 2003, OSTEOARTHR CARTILAGE, V11, P463, DOI 10.1016/S1063-4584(03)00074-8; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; WILLIAMS.HG, 1972, P NATL ACAD SCI USA, V69, P2322, DOI 10.1073/pnas.69.8.2322; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang FM, 2007, BIOCHEMISTRY-US, V46, P3933, DOI 10.1021/bi6025424	41	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32562	32571		10.1074/jbc.M109.044867	http://dx.doi.org/10.1074/jbc.M109.044867			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801637	hybrid, Green Published			2022-12-25	WOS:000272028400038
J	Waidmann, O; Pleli, T; Dvorak, K; Baehr, C; Mondorf, U; Plotz, G; Biondi, RM; Zeuzem, S; Piiper, A				Waidmann, Oliver; Pleli, Thomas; Dvorak, Karel; Baehr, Christina; Mondorf, Ulrich; Plotz, Guido; Biondi, Ricardo M.; Zeuzem, Stefan; Piiper, Albrecht			Inhibition of the Equilibrative Nucleoside Transporter 1 and Activation of A(2A) Adenosine Receptors by 8-(4-Chlorophenylthio)-modified cAMP Analogs and Their Hydrolytic Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; SIGNALING PATHWAYS; DOWN-REGULATION; PC12 CELLS; EPAC; APOPTOSIS	Cyclic AMP analogs containing hydrophobic modification of C-8 at the adenine ring such as 8-(4-chlorophenylthio)-cAMP (8-pCPT-cAMP) and 8-(4-chlorophenylthio)-2'-O-methyl-cAMP (8-pCPT-2'-O-methyl-cAMP) can penetrate membranes due to their high lipophilicity and directly activate intracellular cAMP effectors. Therefore, these cAMP analogs have been used in numerous studies, assuming that their effects reflect the consequences of direct activation of cAMP effectors. The present study provides evidence that 8-pCPT-modified cAMP analogs and their corresponding putative hydrolysis products (8-(4-chlorophenylthio)-adenosine (8-pCPT-ado) and 8-(4-chlorophenylthio)-2'-O-methyl-adenosine (8-pCPT-2'-O-methylado)) inhibit the equilibrative nucleoside transporter 1 (ENT1). In PC12 cells, in which nucleoside transport strongly depended on ENT1, 8- pCPT-ado, 8- pCPT-2'-O-methyl-ado, and, to a smaller extent, 8- pCPT-2'-O-methyl-cAMP caused an increase of protein kinase A substrate motif phosphorylation and antiapoptotic effect by an A(2A) adenosine receptor (A(2A)R)-dependent mechanism. In contrast, the effects of 8-pCPT-cAMP were mainly A(2A)R-independent. In HEK 293 showing little endogenous ENT1-dependent nucleoside transport, transfection of ENT1 conferred A(2A)R-dependent increase in protein kinase A substrate motif phosphorylation. Together, the data of the present study indicate that inhibition of ENT1 and activation of adenosine receptors have to be considered when interpreting the effects of 8-pCPT-substituted cAMP/adenosine analogs.	[Waidmann, Oliver; Pleli, Thomas; Dvorak, Karel; Baehr, Christina; Plotz, Guido; Biondi, Ricardo M.; Zeuzem, Stefan; Piiper, Albrecht] Univ Hosp Frankfurt, Dept Med, D-60590 Frankfurt, Germany; [Mondorf, Ulrich] Univ Hosp Frankfurt, Dept Med 3, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Piiper, A (corresponding author), Univ Hosp Frankfurt, Dept Med, D-60590 Frankfurt, Germany.	piiper@med.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Dvorak, Karel/AAD-8111-2020	Biondi, Ricardo/0000-0002-8873-7167; Plotz, Guido/0000-0001-5314-9739	Deutsche Forschungsgemeinschaft [Pi 258/7-4]; University of Saarland (HOMFOR); Wilhelm Sander foundation [2003.119.2]; Marie Christine Held and Erika Hecker foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Saarland (HOMFOR); Wilhelm Sander foundation; Marie Christine Held and Erika Hecker foundation	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Grant Pi 258/7-4) and in part by grants from the University of Saarland (HOMFOR), the Wilhelm Sander foundation (Grant 2003.119.2), and the Marie Christine Held and Erika Hecker foundation.	Arslan G, 1999, N-S ARCH PHARMACOL, V359, P28, DOI 10.1007/PL00005319; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; CAMPAGNE MMV, 1991, CANCER RES, V51, P1600; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Dremier S, 2007, ENDOCRINOLOGY, V148, P4612, DOI 10.1210/en.2007-0540; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dunwiddie TV, 2000, NEUROSCIENCE, V95, P81; Enyeart JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006088; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Haag S, 2008, N-S ARCH PHARMACOL, V378, P617, DOI 10.1007/s00210-008-0334-3; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Huang M, 2003, J PHARMACOL EXP THER, V304, P753, DOI 10.1124/jpet.102.044214; Huang M, 2002, J BIOL CHEM, V277, P28364, DOI 10.1074/jbc.C200321200; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; MARTINEK RG, 1963, CLIN CHEM, V9, P620; Mondorf UF, 2000, FEBS LETT, V472, P129, DOI 10.1016/S0014-5793(00)01433-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Noji T, 2002, J PHARMACOL EXP THER, V300, P200, DOI 10.1124/jpet.300.1.200; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; Piiper A, 2002, J BIOL CHEM, V277, P43623, DOI 10.1074/jbc.M203926200; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Ralevic V, 1998, PHARMACOL REV, V50, P413; van Noesel MM, 2002, CANCER RES, V62, P2157; VINTERMYR OK, 1995, ENDOCRINOLOGY, V136, P2513, DOI 10.1210/en.136.6.2513; Zimmerman EI, 2009, FEBS LETT, V583, P425, DOI 10.1016/j.febslet.2008.12.041	31	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32256	32263		10.1074/jbc.M109.056622	http://dx.doi.org/10.1074/jbc.M109.056622			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801629	hybrid, Green Published			2022-12-25	WOS:000272028400006
J	Shi, WF; Leong, M; Cho, E; Farrell, J; Chen, HC; Tian, J; Zhang, DZ				Shi, Wen-feng; Leong, Melanie; Cho, Ellen; Farrell, Joseph; Chen, Han-chun; Tian, Jun; Zhang, Dianzheng			Repressive Effects of Resveratrol on Androgen Receptor Transcriptional Activity	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; RED WINE; CHEMOPREVENTIVE AGENT; TRANS-RESVERATROL; LNCAP CELLS; EXPRESSION; GROWTH; MODULATION; APOPTOSIS; GRAPE	Background: The chemopreventive effects of resveratrol (RSV) on prostate cancer have been well established; the androgen receptor (AR) plays pivotal roles in prostatic tumorigenesis. However, the exact underlying molecular mechanisms about the effects of RSV on AR have not been fully elucidated. A model system is needed to determine whether and how RSV represses AR transcriptional activity. Methodology: The AR cDNA was first cloned into the retroviral vector pOZ-N and then integrated into the genome of AR-negative HeLa cells to generate the AR(+) cells. The constitutively expressed AR was characterized by monitoring hormone-stimulated nuclear translocation, DNA binding, and transcriptional activation, with the AR(-) cells serving as controls. AR(+) cells were treated with RSV, and both AR protein levels and AR transcriptional activity were measured simultaneously. Chromatin immunoprecipitation (ChIP) assays were used to detect the effects of RSV on the recruitment of AR to its cognate element (ARE). Results: AR in the AR (+) stable cell line functions in a manner similar to that of endogenously expressed AR. Using this model system we clearly demonstrated that RSV represses AR transcriptional activity independently of any effects on AR protein levels. However, neither the hormone-mediated nucleus translocation nor the AR/ARE interaction was affected by RSV treatment. Conclusion: We demonstrated unambiguously that RSV regulates AR target gene expression, at least in part, by repressing AR transcriptional activity. Repressive effects of RSV on AR activity result from mechanisms other than the affects of AR nuclear translocation or DNA binding.			Shi, WF (corresponding author), Shandong Univ, Dept Blood Purificat, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	dianzhengzh@pcom.edu		Chen, Han-chun/0000-0003-2528-3492				Agoulnik IU, 2008, ADV EXP MED BIOL, V617, P245, DOI 10.1007/978-0-387-69080-3_23; Agoulnik IU, 2006, J CELL BIOCHEM, V99, P362, DOI 10.1002/jcb.20811; Agoulnik IU, 2005, CANCER RES, V65, P7959, DOI 10.1158/0008-5472.CAN-04-3541; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Beck C, 2004, CURR GENE THER, V4, P457; Benitez DA, 2007, BRIT J CANCER, V96, P1595, DOI 10.1038/sj.bjc.6603755; Bertelli AAE, 1996, INT J CLIN PHARM RES, V16, P77; Bertelli AAE, 1998, DRUG EXP CLIN RES, V24, P51; Bertelli AAE, 1996, INT J TISSUE REACT, V18, P67; BOSTWICK DG, 1992, J CELL BIOCHEM, P10; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Careri M, 2003, J AGR FOOD CHEM, V51, P5226, DOI 10.1021/jf034149g; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Denis LJ, 2000, SEMIN SURG ONCOL, V18, P52, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<52::AID-SSU8>3.0.CO;2-6; DePrimo SE, 2001, HEMATOL ONCOL CLIN N, V15, P445, DOI 10.1016/S0889-8588(05)70225-2; Faus H, 2008, J CELL BIOCHEM, V104, P511, DOI 10.1002/jcb.21640; Fletterick RJ, 2005, BJU INT, V96, P2, DOI 10.1111/j.1464-410X.2005.05940.x; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Gao S, 2004, PROSTATE, V59, P214, DOI 10.1002/pros.10375; Harada N, 2007, J NUTR SCI VITAMINOL, V53, P556, DOI 10.3177/jnsv.53.556; Hsieh TC, 2000, ANTICANCER RES, V20, P225; Hsieh TC, 1999, EXP CELL RES, V249, P109, DOI 10.1006/excr.1999.4471; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jones SB, 2005, CANCER EPIDEM BIOMAR, V14, P596, DOI 10.1158/1055-9965.EPI-04-0398; Kageyama Y, 2007, RECENT PAT ANTI-CANC, V2, P203, DOI 10.2174/157489207782497172; Kong ANT, 2001, MUTAT RES-FUND MOL M, V480, P231, DOI 10.1016/S0027-5107(01)00182-8; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; Meeran SM, 2008, FRONT BIOSCI-LANDMRK, V13, P2191, DOI 10.2741/2834; Mitchell SH, 1999, CANCER RES, V59, P5892; Miyamoto H, 2005, MOL CARCINOGEN, V44, P1, DOI 10.1002/mc.20121; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; PARNES HL, 2004, J UROL 2, V171, P74; PARNES HL, 2004, J UROLOGY, V171, pS75; Parnes Howard L., 2004, Journal of Urology, V171, pS68, DOI 10.1097/01.ju.0000107220.64675.74; Ratan HL, 2002, UROL ONCOL, V7, P223, DOI 10.1016/S1078-1439(02)00194-1; Sartor O, 2002, UROLOGY, V60, P93; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schoonen WM, 2005, INT J CANCER, V113, P133, DOI 10.1002/ijc.20528; Seeni A, 2008, ASIAN PAC J CANCER P, V9, P7; Shih HM, 2007, BIOCHEM SOC T, V35, P1397, DOI 10.1042/BST0351397; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Wang TTY, 2008, CARCINOGENESIS, V29, P2001, DOI 10.1093/carcin/bgn131; Wang Y, 2002, J AGR FOOD CHEM, V50, P431, DOI 10.1021/jf010812u; WHITTEMORE AS, 1995, JNCI-J NATL CANCER I, V87, P652, DOI 10.1093/jnci/87.9.652; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; Yuan HQ, 2004, CANCER LETT, V213, P155, DOI 10.1016/j.canlet.2004.04.003; Zhang DZ, 2007, CELL RES, V17, P804, DOI 10.1038/cr.2007.72; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005	53	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7398	10.1371/journal.pone.0007398	http://dx.doi.org/10.1371/journal.pone.0007398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816598	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594300014
J	Fort, A; Cordaillat, M; Thollon, C; Salazar, G; Mechaly, I; Villeneuve, N; Vilaine, JP; Richard, S; Virsolvy, A				Fort, Aurelie; Cordaillat, Magali; Thollon, Catherine; Salazar, Guillermo; Mechaly, Ilana; Villeneuve, Nicole; Vilaine, Jean-Paul; Richard, Sylvain; Virsolvy, Anne			New Insights in the Contribution of Voltage-Gated Na-v Channels to Rat Aorta Contraction	PLOS ONE			English	Article								Background: Despite increasing evidence for the presence of voltage-gated Na+ channels (Na-v) isoforms and measurements of Na-v channel currents with the patch-clamp technique in arterial myocytes, no information is available to date as to whether or not Na-v channels play a functional role in arteries. The aim of the present work was to look for a physiological role of Na-v channels in the control of rat aortic contraction. Methodology/Principal Findings: Na-v channels were detected in the aortic media by Western blot analysis and double immunofluorescence labeling for Na-v channels and smooth muscle a-actin using specific antibodies. In parallel, using real time RT-PCR, we identified three Na-v transcripts: Na(v)1.2, Na(v)1.3, and Na(v)1.5. Only the Na(v)1.2 isoform was found in the intact media and in freshly isolated myocytes excluding contamination by other cell types. Using the specific Na-v channel agonist veratridine and antagonist tetrodotoxin (TTX), we unmasked a contribution of these channels in the response to the depolarizing agent KCl on rat aortic isometric tension recorded from endothelium-denuded aortic rings. Experimental conditions excluded a contribution of Na-v channels from the perivascular sympathetic nerve terminals. Addition of low concentrations of KCl (2-10 mM), which induced moderate membrane depolarization (e. g., from -55.9 +/- 1.4 mV to -45.9 +/- 1.2 mV at 10 mmol/L as measured with microelectrodes), triggered a contraction potentiated by veratridine (100 mu M) and blocked by TTX (1 mu M). KB-R7943, an inhibitor of the reverse mode of the Na+/Ca2+ exchanger, mimicked the effect of TTX and had no additive effect in presence of TTX. Conclusions/Significance: These results define a new role for Na-v channels in arterial physiology, and suggest that the TTX-sensitive Na(v)1.2 isoform, together with the Na+/Ca2+ exchanger, contributes to the contractile response of aortic myocytes at physiological range of membrane depolarization.			Fort, A (corresponding author), Univ Montpellier 1 & 2, INSERM, U637, Montpellier, France.	sylvain.richard@inserm.fr	Petit, Aurelie/O-1731-2018; Richard, Sylvain/C-9695-2016; VIRSOLVY, Anne/E-4964-2016	Petit, Aurelie/0000-0002-9069-9868; VIRSOLVY, Anne/0000-0002-5819-3306; Richard, Sylvain/0000-0001-9460-6705				Baluchnejadmojarad T, 2004, VASC PHARMACOL, V40, P301, DOI 10.1016/j.vph.2004.02.003; Barger G, 1910, J PHYSIOL-LONDON, V41, P19; Berra-Romani R, 2005, AM J PHYSIOL-HEART C, V289, pH137, DOI 10.1152/ajpheart.01156.2004; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Boccara G, 1999, CIRC RES, V85, P606, DOI 10.1161/01.RES.85.7.606; BODIN P, 1991, AM J PHYSIOL, V260, pC151, DOI 10.1152/ajpcell.1991.260.1.C151; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Catterall WA, 2003, PHARMACOL REV, V55, P575, DOI 10.1124/pr.55.4.7; Catterall WA, 1995, CARDIAC ELECTROPHYSI, P1; Choby C, 2000, PFLUG ARCH EUR J PHY, V440, P149, DOI 10.1007/s004240051032; Cordaillat M, 2007, AM J PHYSIOL-REG I, V292, pR1557, DOI 10.1152/ajpregu.00624.2006; Cox RH, 1998, J VASC RES, V35, P310, DOI 10.1159/000025600; DECKER N, 1984, N-S ARCH PHARMACOL, V326, P1, DOI 10.1007/BF00518771; DIGGES KG, 1983, EUR J PHARMACOL, V96, P95, DOI 10.1016/0014-2999(83)90533-2; Eatman D, 1998, EUR J PHARMACOL, V361, P207, DOI 10.1016/S0014-2999(98)00700-6; Fauaz G, 2000, BRIT J PHARMACOL, V131, P788, DOI 10.1038/sj.bjp.0703630; Hille B., 1992, IONIC CHANNELS EXCIT; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6; JAMES AF, 1995, AM J PHYSIOL-HEART C, V268, pH2358, DOI 10.1152/ajpheart.1995.268.6.H2358; Jo T, 2005, BIOCHEM BIOPH RES CO, V331, P1452, DOI 10.1016/j.bbrc.2005.04.062; Jo T, 2004, FEBS LETT, V567, P339, DOI 10.1016/j.febslet.2004.04.092; Krzemien DM, 2000, J COMP NEUROL, V420, P70; LEENEN FHH, 1992, J HYPERTENS, V10, P929; MACIA RA, 1984, N-S ARCH PHARMACOL, V325, P306, DOI 10.1007/BF00504373; Misra SN, 2008, EPILEPSIA, V49, P1535, DOI 10.1111/j.1528-1167.2008.01619.x; MURAMATSU I, 1987, BRIT J PHARMACOL, V91, P467, DOI 10.1111/j.1476-5381.1987.tb11238.x; Platoshyn O, 2005, PFLUG ARCH EUR J PHY, V451, P380, DOI 10.1007/s00424-005-1478-3; Quignard JF, 1997, CIRC RES, V80, P377, DOI 10.1161/01.res.0000435853.85322.af; Raina H, 2008, J PHYSIOL-LONDON, V586, P1669, DOI 10.1113/jphysiol.2007.150268; RICHARD S, 1992, BIOCHIM BIOPHYS ACTA, V1160, P95, DOI 10.1016/0167-4838(92)90042-C; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; SHINJOH M, 1991, EUR J PHARMACOL, V205, P199; SHINJOH M, 1992, JPN J PHARM S2, V58; Thollon C, 1999, CIRC RES, V84, P371, DOI 10.1161/01.RES.84.4.371; VANHEEL B, 1994, J PHYSIOL-LONDON, V475, P277, DOI 10.1113/jphysiol.1994.sp020068; Vasconcelos F, 2005, COMP BIOCHEM PHYS C, V141, P85, DOI 10.1016/j.cca.2005.05.012; Vassort G, 2001, PHYSIOL REV, V81, P767, DOI 10.1152/physrev.2001.81.2.767; Zhang XF, 1999, BRIT J PHARMACOL, V127, P1388, DOI 10.1038/sj.bjp.0702661	39	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7360	10.1371/journal.pone.0007360	http://dx.doi.org/10.1371/journal.pone.0007360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809503	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594000014
J	Garren, M; Raymundo, L; Guest, J; Harvell, CD; Azam, F				Garren, Melissa; Raymundo, Laurie; Guest, James; Harvell, C. Drew; Azam, Farooq			Resilience of Coral-Associated Bacterial Communities Exposed to Fish Farm Effluent	PLOS ONE			English	Article							BLACK BAND DISEASE; RIBOSOMAL-RNA SEQUENCES; MICROBIAL-POPULATIONS; DIVIDING CELLS; ECOLOGY; REEFS; DIVERSITY; FREQUENCY; IMPACTS; TISSUES	Background: The coral holobiont includes the coral animal, algal symbionts, and associated microbial community. These microbes help maintain the holobiont homeostasis; thus, sustaining robust mutualistic microbial communities is a fundamental part of long-term coral reef survival. Coastal pollution is one major threat to reefs, and intensive fish farming is a rapidly growing source of this pollution. Methodology & Principal Findings: We investigated the susceptibility and resilience of the bacterial communities associated with a common reef-building coral, Porites cylindrica, to coastal pollution by performing a clonally replicated transplantation experiment in Bolinao, Philippines adjacent to intensive fish farming. Ten fragments from each of four colonies (total of 40 fragments) were followed for 22 days across five sites: a well-flushed reference site (the original fragment source); two sites with low exposure to milkfish (Chanos chanos) aquaculture effluent; and two sites with high exposure. Elevated levels of dissolved organic carbon (DOC), chlorophyll a, total heterotrophic and autotrophic bacteria abundance, virus like particle (VLP) abundances, and culturable Vibrio abundance characterized the high effluent sites. Based on 16S rRNA clone libraries and denaturing gradient gel electrophoresis (DGGE) analysis, we observed rapid, dramatic changes in the coral-associated bacterial communities within five days of high effluent exposure. The community composition on fragments at these high effluent sites shifted towards known human and coral pathogens (i.e. Arcobacter, Fusobacterium, and Desulfovibrio) without the host corals showing signs of disease. The communities shifted back towards their original composition by day 22 without reduction in effluent levels. Significance: This study reveals fish farms as a likely source of pathogens with the potential to proliferate on corals and an unexpected short-term resilience of coral-associated bacterial communities to eutrophication pressure. These data highlight a need for improved aquaculture practices that can achieve both sustainable industry goals and long-term coral reef survival.			Garren, M (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	mgarren@ucsd.edu	Raymundo, Laurie/AAE-5230-2020; Guest, James/D-5179-2011; Bossier, Peter GM/A-8118-2008; Azam, Farooq/A-2306-2012	Guest, James/0000-0002-9714-9009; Bossier, Peter GM/0000-0002-6165-9111; 				Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BIDLE KD, 1995, APPL ENVIRON MICROB, V61, P944, DOI 10.1128/AEM.61.3.944-952.1995; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Garren M, 2008, ENVIRON MICROBIOL, V10, P2299, DOI 10.1111/j.1462-2920.2008.01654.x; Geffen Y, 2005, MAR BIOL, V146, P931, DOI 10.1007/s00227-004-1505-5; Gochfeld DJ, 2008, MAR ECOL PROG SER, V362, P119, DOI 10.3354/meps07418; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; HAGSTROM A, 1979, APPL ENVIRON MICROB, V37, P805; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Holmer M, 2002, MAR POLLUT BULL, V44, P685, DOI 10.1016/S0025-326X(02)00048-6; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Long RA, 2001, AQUAT MICROB ECOL, V26, P103, DOI 10.3354/ame026103; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Raymundo LJ, 2002, CORAL REEFS, V21, P260, DOI 10.1007/s00338-002-0237-6; Remily ER, 2006, MICROB ECOL, V51, P345, DOI 10.1007/s00248-006-9029-9; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rosenberg E, 2007, OCEANOGRAPHY, V20, P146, DOI 10.5670/oceanog.2007.60; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; RYPIEN KL, ENV MICROBI IN PRESS; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Torreton JP, 1996, MICROB ECOL, V32, P185; Viehman S, 2006, DIS AQUAT ORGAN, V69, P119, DOI 10.3354/dao069119; Villanueva RD, 2005, MAR POLLUT BULL, V51, P580, DOI 10.1016/j.marpolbul.2005.04.033; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57	45	84	84	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7319	10.1371/journal.pone.0007319	http://dx.doi.org/10.1371/journal.pone.0007319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806190	Green Submitted, Green Published, gold			2022-12-25	WOS:000270593800020
J	Dykxhoorn, DM; Wu, YC; Xie, HM; Yu, FY; Lal, A; Petrocca, F; Martinvalet, D; Song, E; Lim, B; Lieberman, J				Dykxhoorn, Derek M.; Wu, Yichao; Xie, Huangming; Yu, Fengyan; Lal, Ashish; Petrocca, Fabio; Martinvalet, Denis; Song, Erwei; Lim, Bing; Lieberman, Judy			miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases	PLOS ONE			English	Article								Background: The development of metastases involves the dissociation of cells from the primary tumor to penetrate the basement membrane, invade and then exit the vasculature to seed, and colonize distant tissues. The last step, establishment of macroscopic tumors at distant sites, is the least well understood. Four isogenic mouse breast cancer cell lines (67NR, 168FARN, 4TO7, and 4T1) that differ in their ability to metastasize when implanted into the mammary fat pad are used to model the steps of metastasis. Only 4T1 forms macroscopic lung and liver metastases. Because some miRNAs are dysregulated in cancer and affect cellular transformation, tumor formation, and metastasis, we examined whether changes in miRNA expression might explain the differences in metastasis of these cells. Methodology/Principal Findings: miRNA expression was analyzed by miRNA microarray and quantitative RT-PCR in isogenic mouse breast cancer cells with distinct metastatic capabilities. 4T1 cells that form macroscopic metastases had elevated expression of miR-200 family miRNAs compared to related cells that invade distant tissues, but are unable to colonize. Moreover, over-expressing miR-200 in 4TO7 cells enabled them to metastasize to lung and liver. These findings are surprising since the miR-200 family was previously shown to promote epithelial characteristics by inhibiting the transcriptional repressor Zeb2 and thereby enhancing E-cadherin expression. We confirmed these findings in these cells. The most metastatic 4T1 cells acquired epithelial properties (high expression of E-cadherin and cytokeratin-18) compared to the less metastatic cells. Conclusions/Significance: Expression of miR-200, which promotes a mesenchymal to epithelial cell transition (MET) by inhibiting Zeb2 expression, unexpectedly enhances macroscopic metastases in mouse breast cancer cell lines. These results suggest that for some tumors, tumor colonization at metastatic sites might be enhanced by MET. Therefore the epithelial nature of a tumor does not predict metastatic outcome.			Dykxhoorn, DM (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	ddykxhoorn@med.miami.edu; lieberman@idi.harvard.edu	Dykxhoorn, Derek M/D-1357-2015; Lieberman, Judy/A-2717-2015; Xie, Huangming/B-2260-2012					Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; BRACKEN CP, 2009, CELL MOL LIFE SCI; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chaffer CL, 2005, CLIN EXP METASTAS, V22, P115, DOI 10.1007/s10585-005-5141-3; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dykxhoorn DM, 2008, ADV EXP MED BIOL, V615, P299, DOI 10.1007/978-1-4020-6554-5_14; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gabbert HE, 1996, INT J CANCER, V69, P184, DOI 10.1002/(SICI)1097-0215(19960621)69:3<184::AID-IJC6>3.0.CO;2-W; GEBESHUBER CA, 2009, EMBO REP; Gonzalez MA, 1999, J PATHOL, V187, P523, DOI 10.1002/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO;2-3; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hashizume R, 1996, HISTOPATHOLOGY, V29, P139, DOI 10.1046/j.1365-2559.1996.d01-499.x; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kartenbeck J, 2005, EUR J CELL BIOL, V84, P417, DOI 10.1016/j.ejcb.2005.01.005; Kim SW, 2007, GENE CHROMOSOME CANC, V46, P1, DOI 10.1002/gcc.20384; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; LIPPONEN P, 1994, J PATHOL, V174, P101, DOI 10.1002/path.1711740206; Liu G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003592; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Parker C, 2001, BRIT J CANCER, V85, P1958, DOI 10.1054/bjoc.2001.2178; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; PETER ME, 2009, CELL CYCLE, V8; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; SHI SR, 1993, J HISTOCHEM CYTOCHEM, V41, P1599, DOI 10.1177/41.11.7691930; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wicha MS, 2006, CLIN CANCER RES, V12, P5606, DOI 10.1158/1078-0432.CCR-06-1537; WICKRAMASINGHE NS, 2009, NUCL ACIDS RES; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	60	247	259	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7181	10.1371/journal.pone.0007181	http://dx.doi.org/10.1371/journal.pone.0007181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787069	Green Published, gold, Green Submitted			2022-12-25	WOS:000270290100008
J	Borbone, E; Berlingieri, MT; De Bellis, F; Nebbioso, A; Chiappetta, G; Mai, A; Altucci, L; Fusco, A				Borbone, E.; Berlingieri, M. T.; De Bellis, F.; Nebbioso, A.; Chiappetta, G.; Mai, A.; Altucci, L.; Fusco, A.			Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation	ONCOGENE			English	Article						HDAC inhibitors; thyroid; carcinomas; apoptosis; TRAIL; proteasome	SUBEROYLANILIDE HYDROXAMIC ACID; REFRACTORY SOLID TUMORS; ACUTE MYELOID-LEUKEMIA; T-CELL LYMPHOMA; HDAC INHIBITORS; CLASS-II; ANTICANCER AGENT; PHASE-I; MALIGNANT PHENOTYPE; LIGAND TRAIL	Anaplastic thyroid carcinoma (ATC) is considered one of the most aggressive malignancies, having a poor prognosis and being refractory to conventional chemotherapy and radiotherapy. Alteration in histone deacetylase (HDAC) activity has been reported in cancer, thus encouraging the development of HDAC inhibitors, whose antitumor action has been shown in both solid and hematological malignancies. However, the molecular basis for their tumor selectivity is unknown. To find an innovative therapy for the treatment of ATCs, we studied the effects of deacetylase inhibitors on thyroid tumorigenesis models. We show that HDACs 1 and 2 are overexpressed in ATCs compared with normal cells or benign tumors and that HDAC inhibitors induce apoptosis selectively in the fully transformed thyroid cells. Our results indicate that these phenomena are mediated by a novel action of HDAC inhibitors that reduces tumor necrosis factor-related apoptosis-inducing ligand protein degradation by affecting the ubiquitin-dependent pathway. Indeed, the combined treatment with HDAC and proteasome inhibitors results in synergistic apoptosis. These results strongly encourage the preclinical application of the combination deacetylase-proteasome inhibitors for the treatment of ATC.	[Fusco, A.] IEOS, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Borbone, E.; Fusco, A.] NOGEC CEINGE, Naples, Italy; [De Bellis, F.; Nebbioso, A.; Altucci, L.] Univ Naples 2, Dipartimento Patol Gen, Naples, Italy; [Chiappetta, G.] Natl Canc Inst G Pascale, Funct Genom Unit, Dept Expt Oncol, Naples, Italy; [Mai, A.] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Universita della Campania Vanvitelli; IRCCS Fondazione Pascale; Fondazione Cenci Bolognetti; Sapienza University Rome	Fusco, A (corresponding author), IEOS, Dipartimento Biol & Patol Cellulare & Mol, Via S Pansini 5, I-80131 Naples, Italy.	lucia.altucci@unina2.it; alfusco@unina.it	Mai, Antonello/AAC-2144-2019; Altucci, Lucia/S-8031-2019; NEBBIOSO, ANGELA/GVS-1294-2022; NEBBIOSO, Angela/C-3566-2016	altucci, lucia/0000-0002-7312-5387; NEBBIOSO, Angela/0000-0001-5374-3527; Fusco, Alfredo/0000-0003-3332-5197; Mai, Antonello/0000-0001-9176-2382	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero dell Universita e della Ricerca Scientifica e Tecnologica (MIUR); EU [LSHC-CT2005-518417, HEALTH-F2-2007200620, HEALTH-F4-2007-200767, HEALTH-F4-2009221952]; NOGEC-Naples Oncogenomic Center	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero dell Universita e della Ricerca Scientifica e Tecnologica (MIUR); EU; NOGEC-Naples Oncogenomic Center	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC), and from the Ministero dell Universita e della Ricerca Scientifica e Tecnologica (MIUR); EU (LSHC-CT2005-518417; HEALTH-F2-2007200620; HEALTH-F4-2007-200767; HEALTH-F4-2009221952) and the NOGEC-Naples Oncogenomic Center. We thank Konstantina Vergadou for revising and editing the article, Mario Berardone for the artwork, and Pollice A for providing some plasmids.	Altucci L, 2005, INT J BIOCHEM CELL B, V37, P1752, DOI 10.1016/j.biocel.2005.04.019; Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Altucci L, 2009, INT J BIOCHEM CELL B, V41, P2, DOI 10.1016/j.biocel.2008.09.010; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Blumenschein GR, 2008, INVEST NEW DRUG, V26, P81, DOI 10.1007/s10637-007-9075-2; Bontempo P, 2007, INT J BIOCHEM CELL B, V39, P1902, DOI 10.1016/j.biocel.2007.05.010; Chiappetta G, 2008, EUR J CANCER, V44, P1015, DOI 10.1016/j.ejca.2008.02.039; Dai Y, 2008, CLIN CANCER RES, V14, P549, DOI 10.1158/1078-0432.CCR-07-1934; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Duvic M, 2007, DRUG TODAY, V43, P585, DOI 10.1358/dot.2007.43.9.1112980; Earel JK, 2006, CANCER RES, V66, P499, DOI 10.1158/0008-5472.CAN-05-3017; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Fiore L, 1997, J CLIN ENDOCR METAB, V82, P4094, DOI 10.1210/jc.82.12.4094; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Gore L, 2008, CLIN CANCER RES, V14, P4517, DOI 10.1158/1078-0432.CCR-07-1461; Hall MA, 2007, CANCER CELL, V12, P4, DOI 10.1016/j.ccr.2007.06.011; Hess-Stumpp H, 2007, INT J BIOCHEM CELL B, V39, P1388, DOI 10.1016/j.biocel.2007.02.009; Iervolino A, 2006, CANCER RES, V66, P6280, DOI 10.1158/0008-5472.CAN-06-0228; Inoue S, 2006, CANCER RES, V66, P6785, DOI 10.1158/0008-5472.CAN-05-4563; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kummar S, 2007, CLIN CANCER RES, V13, P5411, DOI 10.1158/1078-0432.CCR-07-0791; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; Macher-Goeppinger S, 2009, CLIN CANCER RES, V15, P650, DOI 10.1158/1078-0432.CCR-08-0284; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mai A, 2009, INT J BIOCHEM CELL B, V41, P199, DOI 10.1016/j.biocel.2008.08.020; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; Miller CP, 2009, BLOOD, V113, P4289, DOI 10.1182/blood-2008-08-174797; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mitsiades CS, 2005, CLIN CANCER RES, V11, P3958, DOI 10.1158/1078-0432.CCR-03-0776; Nappi TC, 2009, CANCER RES, V69, P1916, DOI 10.1158/0008-5472.CAN-08-1693; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; PORTELLA G, 1989, ONCOGENE, V4, P181; Saltman B, 2006, SURGERY, V140, P899, DOI 10.1016/j.surg.2006.07.027; Scognamiglio A, 2008, BBA-MOL CELL RES, V1783, P2030, DOI 10.1016/j.bbamcr.2008.07.007; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yu C, 2008, NEURO-ONCOLOGY, V10, P309, DOI 10.1215/15228517-2007-063	50	60	62	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					105	116		10.1038/onc.2009.306	http://dx.doi.org/10.1038/onc.2009.306			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19802013				2022-12-25	WOS:000273373500010
J	Pantoja-Uceda, D; Arolas, JL; Aviles, FX; Santoro, J; Ventura, S; Sommerhoff, CP				Pantoja-Uceda, David; Arolas, Joan L.; Aviles, Francesc X.; Santoro, Jorge; Ventura, Salvador; Sommerhoff, Christian P.			Deciphering the Structural Basis That Guides the Oxidative Folding of Leech-derived Tryptase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; TORSION ANGLE DYNAMICS; KAZAL-TYPE INHIBITOR; CARBOXYPEPTIDASE INHIBITOR; PROTEIN STRUCTURES; TRYPSIN-INHIBITOR; NMR; PROGRAM; PATHWAY; INTERMEDIATE	Protein folding mechanisms have remained elusive mainly because of the transient nature of intermediates. Leech-derived tryptase inhibitor (LDTI) is a Kazal-type serine proteinase inhibitor that is emerging as an attractive model for folding studies. It comprises 46 amino acid residues with three disulfide bonds, with one located inside a small triple-stranded antiparallel beta-sheet and with two involved in a cystine-stabilized alpha-helix, a motif that is widely distributed in bioactive peptides. Here, we analyzed the oxidative folding and reductive unfolding of LDTI by chromatographic and disulfide analyses of acid-trapped intermediates. It folds and unfolds, respectively, via sequential oxidation and reduction of the cysteine residues that give rise to a few 1- and 2-disulfide intermediates. Species containing two native disulfide bonds predominate during LDTI folding (IIa and IIc) and unfolding (IIa and IIb). Stop/go folding experiments demonstrate that only intermediate IIa is productive and oxidizes directly into the native form. The NMR structures of acid-trapped and further isolated IIa, IIb, and IIc reveal global folds similar to that of the native protein, including a native-like canonical inhibitory loop. Enzyme kinetics shows that both IIa and IIc are inhibitory-active, which may substantially reduce proteolysis of LDTI during its folding process. The results reported show that the kinetics of the folding reaction is modulated by the specific structural properties of the intermediates and together provide insights into the interdependence of conformational folding and the assembly of native disulfides during oxidative folding.	[Pantoja-Uceda, David; Arolas, Joan L.; Santoro, Jorge] CSIC, Inst Quim Fis Rocasolano, Dept Espectroscopia & Estructura Mol, E-28006 Madrid, Spain; [Aviles, Francesc X.; Ventura, Salvador] Univ Autonoma Barcelona, Fac Ciencies, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Aviles, Francesc X.; Ventura, Salvador] Univ Autonoma Barcelona, Fac Ciencies, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Sommerhoff, Christian P.] Univ Munich, Klinikumsstandort Innenstadt, Klin Chem & Klin Biochem Abt, D-80336 Munich, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Autonomous University of Barcelona; Autonomous University of Barcelona; University of Munich	Santoro, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Espectroscopia & Estructura Mol, Serrano 119, E-28006 Madrid, Spain.	jsantoro@iqfr.csic.es; salvador.ventura@uab.es	Ventura, Salvador/C-7021-2008; Avilés, Francesc Xavier/A-2664-2015; Ventura, Salvador/AAY-3170-2021; Aviles, Francesc Xavier/F-3482-2019; Pantoja-Uceda, David/J-8097-2014	Ventura, Salvador/0000-0002-9652-6351; Avilés, Francesc Xavier/0000-0002-1399-6789; Ventura, Salvador/0000-0002-9652-6351; Aviles, Francesc Xavier/0000-0002-1399-6789; Lopez Arolas, Joan/0000-0002-4198-5016; Pantoja-Uceda, David/0000-0003-4390-6972	Spanish Ministry for Science and Innovation [BIO2007-68046, BFU2005-01855]; Deutsche Forschungsgemeinschaft [SO 249/1-1]	Spanish Ministry for Science and Innovation(Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Spanish Ministry for Science and Innovation Grants BIO2007-68046 and BFU2005-01855 and Deutsche Forschungsgemeinschaft Grant SO 249/1-1.	Arolas JL, 2005, STRUCTURE, V13, P1193, DOI 10.1016/j.str.2005.05.008; Arolas JL, 2008, J BIOL CHEM, V283, P27110, DOI 10.1074/jbc.M803978200; Arolas JL, 2008, ANTIOXID REDOX SIGN, V10, P77, DOI 10.1089/ars.2007.1850; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; AUERSWALD EA, 1994, BIOL CHEM H-S, V375, P695, DOI 10.1515/bchm3.1994.375.10.695; Cemazar M, 2008, STRUCTURE, V16, P842, DOI 10.1016/j.str.2008.02.023; Chang JY, 2008, ANTIOXID REDOX SIGN, V10, P171, DOI 10.1089/ars.2007.1873; Chang JY, 2004, BIOCHEMISTRY-US, V43, P4522, DOI 10.1021/bi0360354; Creighton TE, 1997, BIOL CHEM, V378, P731; Darby N, 1995, Methods Mol Biol, V40, P219; DARBY NJ, 1995, J MOL BIOL, V249, P463, DOI 10.1006/jmbi.1995.0309; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiMarco S, 1997, STRUCTURE, V5, P1465; Gahl RF, 2009, BIOCHEMISTRY-US, V48, P2740, DOI 10.1021/bi802327j; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hemmi H, 2005, BIOCHEMISTRY-US, V44, P9626, DOI 10.1021/bi0472806; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI M, 1953, J BIOL CHEM, V204, P797; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MUHLHAHN P, 1994, FEBS LETT, V355, P290, DOI 10.1016/0014-5793(94)01225-3; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Narayan M, 2000, ACCOUNTS CHEM RES, V33, P805, DOI 10.1021/ar000063m; Pantoja-Uceda D, 2005, PROTEIN SCI, V14, P224, DOI 10.1110/ps.041138705; Pohlig G, 1996, EUR J BIOCHEM, V241, P619, DOI 10.1111/j.1432-1033.1996.00619.x; Schirra HJ, 1998, BIOCHEMISTRY-US, V37, P6263, DOI 10.1021/bi980136y; SEALOCK RW, 1973, BIOCHEMISTRY-US, V12, P3139, DOI 10.1021/bi00741a001; Sommerhoff CP, 2007, CURR PHARM DESIGN, V13, P313, DOI 10.2174/138161207779313579; SOMMERHOFF CP, 1994, BIOL CHEM H-S, V375, P685, DOI 10.1515/bchm3.1994.375.10.685; Sommerhoff CP, 2001, AM J RESP CRIT CARE, V164, pS52, DOI 10.1164/ajrccm.164.supplement_2.2106058; Stubbs MT, 1997, J BIOL CHEM, V272, P19931, DOI 10.1074/jbc.272.32.19931; Thannhauser TW, 1997, BIOCHEMISTRY-US, V36, P2154, DOI 10.1021/bi962340w; TSCHESCHE H, 1974, ANGEW CHEM INT EDIT, V13, P10, DOI 10.1002/anie.197400101; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Welker E, 2001, P NATL ACAD SCI USA, V98, P2312, DOI 10.1073/pnas.041615798; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC	45	14	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35612	35620		10.1074/jbc.M109.061077	http://dx.doi.org/10.1074/jbc.M109.061077			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19820233	Green Published, hybrid			2022-12-25	WOS:000272645600039
J	Fasanaro, P; Greco, S; Lorenzi, M; Pescatori, M; Brioschi, M; Kulshreshtha, R; Banfi, C; Stubbs, A; Calin, GA; Ivan, M; Capogrossi, MC; Martelli, F				Fasanaro, Pasquale; Greco, Simona; Lorenzi, Maria; Pescatori, Mario; Brioschi, Maura; Kulshreshtha, Ritu; Banfi, Cristina; Stubbs, Andrew; Calin, George A.; Ivan, Mircea; Capogrossi, Maurizio C.; Martelli, Fabio			An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' UNTRANSLATED REGIONS; MESSENGER-RNAS; GENE-EXPRESSION; BREAST-CANCER; BRUGADA-SYNDROME; IN-VIVO; MICRORNA TARGETS; HEART-FAILURE; MIRNAS; CELLS	miR-210 is a key player of cell response to hypoxia, modulating cell survival, VEGF-driven endothelial cell migration, and the ability of endothelial cells to form capillary-like structures. A crucial step in understanding microRNA (miRNA) function is the identification of their targets. However, only few miR-210 targets have been identified to date. Here, we describe an integrated strategy for large-scale identification of new miR-210 targets by combining transcriptomics and proteomics with bioinformatic approaches. To experimentally validate candidate targets, the RNA-induced silencing complex (RISC) loaded with miR-210 was purified by immunoprecipitation along with its mRNA targets. The complex was significantly enriched in mRNAs of 31 candidate targets, such as BDNF, GPD1L, ISCU, NCAM, and the non-coding RNA Xist. A subset of the newly identified targets was further confirmed by 3'-untranslated region (UTR) reporter assays, and hypoxia induced down-modulation of their expression was rescued blocking miR-210, providing support for the approach validity. In the case of 9 targets, such as PTPN1 and P4HB, miR-210 seed-pairing sequences localized in the coding sequence or in the 5'-UTR, in line with recent data extending miRNA targeting beyond the "classic" 3'-UTR recognition. Finally, Gene Ontology analysis of the targets highlights known miR-210 impact on cell cycle regulation and differentiation, and predicts a new role of this miRNA in RNA processing, DNA binding, development, membrane trafficking, and amino acid catabolism. Given the complexity of miRNA actions, we view such a multiprong approach as useful to adequately describe the multiple pathways regulated by miR-210 during physiopathological processes.	[Martelli, Fabio] IRCCS Ist Dermopat Immacolata, Lab Patol Vasc, I-00167 Rome, Italy; [Fasanaro, Pasquale; Greco, Simona] IRCCS Policlin San Donato, I-20097 San Donato Milanese, Italy; [Lorenzi, Maria] Ist Nazl Riposa & Cura Anziani, I-60121 Ancona, Italy; [Pescatori, Mario; Stubbs, Andrew] Erasmus MC, NL-3015 Rotterdam, Netherlands; [Brioschi, Maura; Banfi, Cristina] Ctr Cardiol Monzino IRCCS, I-20138 Milan, Italy; [Kulshreshtha, Ritu] Tufts Univ New England Med Ctr, Boston, MA 02111 USA; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ivan, Mircea] Indiana Univ, Indianapolis, IN 46202 USA	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Policlinico San Donato; IRCCS INRCA; Erasmus University Rotterdam; Erasmus MC; IRCCS Centro Cardiologico Monzino; Tufts Medical Center; University of Texas System; UTMD Anderson Cancer Center; Indiana University System; Indiana University-Purdue University Indianapolis	Martelli, F (corresponding author), IRCCS Ist Dermopat Immacolata, Lab Patol Vasc, I-00167 Rome, Italy.	f.martelli@idi.it	Calin, George/E-9390-2011; Banfi, Cristina/G-6362-2018; Brioschi, Marcos/AAA-7034-2022; Brioschi, Maura/G-5687-2018; greco, simona/J-5374-2016; Martelli, Fabio/AAL-3788-2020; greco, simona/AAD-3211-2021; Ivan, Mircea/A-8109-2012; Brioschi, Maura/AAB-4860-2019	Banfi, Cristina/0000-0003-3346-9879; Brioschi, Marcos/0000-0003-4822-8314; Brioschi, Maura/0000-0003-4706-4418; greco, simona/0000-0002-0275-7221; Martelli, Fabio/0000-0002-8624-7738; greco, simona/0000-0002-0275-7221; Brioschi, Maura/0000-0003-4706-4418; Calin, George/0000-0001-6704-5615; Ivan, Mircea/0000-0003-3424-6642	Ministero della Salute [RF06-conv.29/07-1, RF07-conv-85.1, RBLA035a4X-001, RF05-conv.66-1, RF07-55.1, RF07-strat]	Ministero della Salute(Ministry of Health, Italy)	This work was supported in part by Ministero della Salute Grants RF06-conv.29/07-1, RF07-conv-85.1, RBLA035a4X-001, RF05-conv.66-1, RF07-55.1, and RF07-strat.	Al-Shahrour F, 2008, NUCLEIC ACIDS RES, V36, pW341, DOI 10.1093/nar/gkn318; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benito B, 2008, PROG CARDIOVASC DIS, V51, P1, DOI 10.1016/j.pcad.2008.05.002; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Di Diego JM, 2005, J ELECTROCARDIOL, V38, P14, DOI 10.1016/j.jelectrocard.2005.06.003; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; GREITHER T, 2009, INT J CANC IN PRESS; Gross C, 2008, ONCOGENE, V27, P1333, DOI 10.1038/sj.onc.1210736; Hagele S, 2009, BIOCHEM J, V417, P235, DOI 10.1042/BJ20081353; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kataoka H, 2000, AM J CARDIOL, V86, P1056, DOI 10.1016/S0002-9149(00)01351-5; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIM HW, 2009, J BIOL CHEM IN PRESS; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kirino Y, 2008, RNA, V14, P2254, DOI 10.1261/rna.1133808; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; London B, 2007, CIRCULATION, V116, P2260, DOI 10.1161/CIRCULATIONAHA.107.703330; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; OMICHI C, 2009, INT J CARDI IN PRESS; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sirchia SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005559; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; TSAI NP, 2009, BIOCH J IN PRESS; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Van Norstrand DW, 2007, CIRCULATION, V116, P2253, DOI 10.1161/CIRCULATIONAHA.107.704627; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yoshida T, 2002, KIDNEY INT, V61, P1646, DOI 10.1046/j.1523-1755.2002.00341.x; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387; Zhdanov VP, 2009, MOL BIOSYST, V5, P638, DOI 10.1039/b808095j; Zhou X, 2009, GENETICA, V137, P159, DOI 10.1007/s10709-009-9378-7	64	230	238	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35134	35143		10.1074/jbc.M109.052779	http://dx.doi.org/10.1074/jbc.M109.052779			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826008	hybrid, Green Published			2022-12-25	WOS:000272439600067
J	Fuentealba, RA; Liu, Q; Kanekiyo, T; Zhang, J; Bu, GJ				Fuentealba, Rodrigo A.; Liu, Qiang; Kanekiyo, Takahisa; Zhang, Juan; Bu, Guojun			Low Density Lipoprotein Receptor-related Protein 1 Promotes Anti-apoptotic Signaling in Neurons by Activating Akt Survival Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCES TAU PHOSPHORYLATION; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; GROWTH-FACTOR; INSULIN-RECEPTOR; APOLIPOPROTEIN-E; CELL-DEATH; A-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION	The low density lipoprotein receptor-related protein 1 (LRP1) is a multi-ligand receptor abundantly expressed in neurons. Previous work has shown that brain LRP1 levels are decreased during aging and in Alzheimer disease. Although mounting evidence has demonstrated a role for LRP1 in the metabolism of apolipoprotein E/lipoprotein and amyloid-beta peptide, whether LRP1 also plays a direct role in neuronal survival is not clear. Here, we show that LRP1 expression is critical for the survival of primary neurons under stress conditions including trophic withdrawal, the presence of apoptosis inducers, or amyloid-beta-induced neurotoxicity. Using lentiviral short hairpin RNA to knock down endogenous LRP1 expression, we showed that a depletion of LRP1 leads to an activation of caspase-3 and increased neuronal apoptosis, an effect that was rescued by a caspase-3 inhibitor. A correlation between decreased Akt phosphorylation and the activation of caspase-3 was demonstrated in LRP1 knocked down neurons. Notably, LRP1 knockdown decreased insulin receptor levels in primary neurons, suggesting that decreased neuronal survival might be a consequence of an impaired insulin receptor signaling pathway. Correspondingly, both insulin receptor and phospho-Akt levels were decreased in LRP1 forebrain knock-out mice. These results demonstrate that LRP1 mediates anti-apoptotic function in neurons by regulating insulin receptor and the Akt survival pathway and suggest that restoring LRP1 expression in Alzheimer disease brain might be beneficial to inhibiting neurodegeneration.	[Bu, Guojun] Washington Univ, Sch Med, Dept Pediat, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Bu, GJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, Hope Ctr Neurol Disorders, 660 S Euclid Ave,Campus Box 8208, St Louis, MO 63110 USA.	bu@wustl.edu	Liu, Qiang/E-9245-2011	Fuentealba, Rodrigo/0000-0001-8724-091X	National Institutes of Health [R01 AG027924, R01 AG031784]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [R01AG035355, R01AG031784, R01AG027924, P01AG030128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG027924 and R01 AG031784. This work was also supported by a Zenith Fellows Award from the Alzheimer's Association (to G.B.).	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Brown MD, 1997, BRAIN RES, V747, P313, DOI 10.1016/S0006-8993(96)01321-2; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; BU GJ, 1994, J BIOL CHEM, V269, P18521; Bu GJ, 2001, INT REV CYTOL, V209, P79; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; CARPENTIER JL, 1989, DIABETOLOGIA, V32, P627; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gauthier A, 2003, J BIOL CHEM, V278, P11945, DOI 10.1074/jbc.M212989200; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Ko KWS, 2001, BIOCHEMISTRY-US, V40, P752, DOI 10.1021/bi001797+; LaFerla FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; LeBlanc Andrea C., 2005, Current Alzheimer Research, V2, P389, DOI 10.2174/156720505774330573; Lesne S, 2005, J BIOL CHEM, V280, P24941, DOI 10.1074/jbc.M413495200; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Magrane J, 2005, J NEUROSCI, V25, P10960, DOI 10.1523/JNEUROSCI.1723-05.2005; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Narita M, 1997, J NEUROCHEM, V68, P587; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pei JJ, 2003, ACTA NEUROPATHOL, V105, P381, DOI 10.1007/s00401-002-0657-y; Rickle A, 2004, NEUROREPORT, V15, P955, DOI 10.1097/00001756-200404290-00005; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rohn TT, 2001, AM J PATHOL, V158, P189, DOI 10.1016/S0002-9440(10)63957-0; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; SHEARMAN MS, 1995, J NEUROCHEM, V65, P218, DOI 10.1046/j.1471-4159.1995.65010218.x; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tamaki C, 2007, MOL PHARMACOL, V72, P850, DOI 10.1124/mol.107.036913; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; TOOYAMA I, 1995, BRAIN RES, V691, P235, DOI 10.1016/0006-8993(95)00735-9; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Van Uden E, 2002, J NEUROSCI, V22, P9298; Wei WL, 2002, J BIOL CHEM, V277, P17649, DOI 10.1074/jbc.M111704200; Weihl CC, 1999, J NEUROSCI, V19, P5360; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; WOLF BB, 1992, AM J PATHOL, V141, P37; Yamada K, 2008, J BIOL CHEM, V283, P34554, DOI 10.1074/jbc.M801487200; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	65	76	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34045	34053		10.1074/jbc.M109.021030	http://dx.doi.org/10.1074/jbc.M109.021030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815552	Green Published, hybrid			2022-12-25	WOS:000272165200037
J	Kwon, MC; Koo, BK; Kim, YY; Lee, SH; Kim, NS; Kim, JH; Kong, YY				Kwon, Min-chul; Koo, Bon-Kyoung; Kim, Yoon-Young; Lee, Sang-Hee; Kim, Nam-Shik; Kim, Jae-Hwan; Kong, Young-Yun			Essential Role of CR6-interacting Factor 1 (Crif1) in E74-like Factor 3 (ELF3)-mediated Intestinal Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; STEM-CELLS; CANCER; DIFFERENTIATION; PROTEINS; RECEPTOR; IDENTIFICATION; EXPRESSION; STAT3	Although terminal differentiation of intestinal epithelium is essential for the efficient digestion and absorption of nutrients, little is known about the molecular mechanisms underlying this process. Recent studies have shown that Elf3 (E74-like factor 3), a member of the ETS transcription factor family, has an essential role in the terminal differentiation of absorptive enterocytes and mucus-secreting goblet cells. Here, we demonstrated that Crif1 (CR6-interacting factor 1) functions as transcriptional coactivator of Elf3 in intestinal epithelium differentiation. The intestinal epithelium-specific Crif1-deficient mice died soon after birth and displayed severe alterations of tissue architecture in the small intestine, including poor microvillus formation and abnormal differentiation of absorptive enterocytes. Strikingly, these phenotypes are largely similar to that of Elf3-deficient mice, suggesting that Elf3 signaling in the intestinal epithelium depends on the Crif1 expression. We dissected this relationship further and found that Crif1 indeed interacted with Elf3 through its ETS DNA binding domain and enhanced the transcriptional activity of Elf3 by regulating the DNA binding activity. Knockdown of Crif1 by RNA interference conversely attenuated the transcriptional activity of Elf3. Consistently, the expression level of Tgf-beta RII (transforming growth factor beta type II receptor), a critical target gene of Elf3, was dramatically reduced in the Crif1-deficient mice. Our results reveal that Crif1 is a novel and essential transcriptional coactivator of Elf3 for the terminal differentiation of absorptive enterocytes.	[Kwon, Min-chul; Koo, Bon-Kyoung; Kong, Young-Yun] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul 151747, South Korea; [Kwon, Min-chul; Koo, Bon-Kyoung; Kim, Yoon-Young; Kim, Nam-Shik] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea; [Lee, Sang-Hee] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon 305333, South Korea; [Kim, Jae-Hwan] Pochon CHA Univ, Grad Sch Life Sci & Biotechnol, CHA Stem Cell Inst, Seoul 135907, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Korea Basic Science Institute (KBSI); Pochon Cha University	Kong, YY (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, San 56-1, Seoul 151747, South Korea.	ykong@snu.ac.kr	Koo, Bon-Kyoung/V-5219-2017	Koo, Bon-Kyoung/0000-0002-4134-8033	Center for Biological Modulators of the 21C Frontier RD Program [CBM32-A2300-01-00-01]; Korea Science and Engineering Foundation [2009-0062800]; Ministry of Science and Technology of Korea [FG06-42-1]; National Research Foundation of Korea [2009-0079371]	Center for Biological Modulators of the 21C Frontier RD Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Science and Technology of Korea(Ministry of Science & Technology (MOST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Center for Biological Modulators of the 21C Frontier R&D Program Grant CBM32-A2300-01-00-01, Korea Science and Engineering Foundation Grant 2009-0062800, 21C Frontier Functional Human Genome Project Grant FG06-42-1 from the Ministry of Science and Technology of Korea, and Basic Science Research Program Grant 2009-0079371 through the National Research Foundation of Korea.	Alonzi T, 2004, CYTOKINE, V26, P45, DOI 10.1016/j.cyto.2003.12.002; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; Choi SG, 1998, J BIOL CHEM, V273, P110, DOI 10.1074/jbc.273.1.110; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Do HJ, 2006, FEBS LETT, V580, P1865, DOI 10.1016/j.febslet.2006.02.049; Flentjar N, 2007, GASTROENTEROLOGY, V132, P1410, DOI 10.1053/j.gastro.2007.02.054; Gornemann J, 2002, VIROLOGY, V303, P69, DOI 10.1006/viro.2002.1670; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Katz JP, 2002, DEVELOPMENT, V129, P2619; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Kim JH, 2002, J BIOL CHEM, V277, P17520, DOI 10.1074/jbc.M110434200; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Park KC, 2005, MOL ENDOCRINOL, V19, P12, DOI 10.1210/me.2004-0107; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Schedin PJ, 2004, ONCOGENE, V23, P1766, DOI 10.1038/sj.onc.1207391; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Suh JH, 2008, MOL ENDOCRINOL, V22, P33, DOI 10.1210/me.2007-0194; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	34	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33634	33641		10.1074/jbc.M109.059840	http://dx.doi.org/10.1074/jbc.M109.059840			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801644	Green Published, hybrid			2022-12-25	WOS:000272028500067
J	Wang, PS; Wang, J; Xiao, ZC; Pallen, CJ				Wang, Pei-Shan; Wang, Jing; Xiao, Zhi-Cheng; Pallen, Catherine J.			Protein-tyrosine Phosphatase alpha Acts as an Upstream Regulator of Fyn Signaling to Promote Oligodendrocyte Differentiation and Myelination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CILIARY NEUROTROPHIC FACTOR; SRC FAMILY KINASES; CNS MYELINATION; MORPHOLOGICAL-DIFFERENTIATION; PROCESS OUTGROWTH; PROGENITOR CELLS; PRECURSOR CELLS; RPTP-ALPHA; PTP-ALPHA	The tyrosine kinase Fyn plays a key role in oligodendrocyte differentiation and myelination in the central nervous system, but the molecules responsible for regulating Fyn activation in these processes remain poorly defined. Here we show that receptor-like protein-tyrosine phosphatase alpha (PTP alpha) is an important positive regulator of Fyn activation and signaling that is required for the differentiation of oligodendrocyte progenitor cells (OPCs). PTP alpha is expressed in OPCs and is up-regulated during differentiation. We used two model systems to investigate the role of PTP alpha in OPC differentiation: the rat CG4 cell line where PTP alpha expression was silenced by small interfering RNA, and oligosphere-derived primary OPCs isolated from wild-type and PTP alpha-null mouse embryos. In both cell systems, the ablation of PTP alpha inhibited differentiation and morphological changes that accompany this process. Although Fyn was activated upon induction of differentiation, the level of activation was severely reduced in cells lacking PTP alpha, as was the activation of Fyn effector molecules focal adhesion kinase, Rac1, and Cdc42, and inactivation of Rho. Interestingly, another downstream effector of Fyn, p190RhoGAP, which is responsible for Rho inactivation during differentiation, was not affected by PTP alpha ablation. In vivo studies revealed defective myelination in the PTP alpha(-/-) mouse brain. Together, our findings demonstrate that PTP alpha is a critical regulator of Fyn activation and of specific Fyn signaling events during differentiation, and is essential for promoting OPC differentiation and central nervous system myelination.	[Wang, Pei-Shan; Pallen, Catherine J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Wang, Jing; Pallen, Catherine J.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 4H4, Canada; [Wang, Pei-Shan; Wang, Jing; Pallen, Catherine J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Xiao, Zhi-Cheng] Kunming Med Coll, Inst Mol & Clin Med, Kunming 650031, Peoples R China; [Xiao, Zhi-Cheng] GlaxoSmithKline Inc, R&D China, Shanghai 201203, Peoples R China	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia; Kunming Medical University; GlaxoSmithKline	Pallen, CJ (corresponding author), 3102-950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	cpallen@interchange.ubc.ca	xiao, zhicheng/A-1529-2011	Pallen, Catherine/0000-0002-3576-5295; xiao, zhicheng/0000-0001-5172-762X	Canadian Institutes of Health Research [MOP-62759]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-62759.	AvellanaAdalid V, 1996, J NEUROSCI RES, V45, P558, DOI 10.1002/(SICI)1097-4547(19960901)45:5<558::AID-JNR6>3.0.CO;2-B; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Biffiger K, 2000, J NEUROSCI, V20, P7430; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; BRAUNINGER A, 1992, GENE, V110, P205, DOI 10.1016/0378-1119(92)90649-A; BRYANT SS, 1995, J BIOL CHEM, V270, P17947, DOI 10.1074/jbc.270.30.17947; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Cui QL, 2005, J BIOL CHEM, V280, P8918, DOI 10.1074/jbc.M414267200; Deng WB, 2003, NEUROTOXICOLOGY, V24, P161, DOI 10.1016/S0161-813X(02)00196-1; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; FANARRAGA ML, 1995, GLIA, V15, P95, DOI 10.1002/glia.440150202; Forrest AD, 2009, J NEUROSCI RES, V87, P3456, DOI 10.1002/jnr.22022; Granot-Attas S, 2004, EXP CELL RES, V294, P236, DOI 10.1016/j.yexcr.2003.11.003; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Hoshina N, 2007, GENES CELLS, V12, P1245, DOI 10.1111/j.1365-2443.2007.01130.x; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Massa PT, 2004, J NEUROSCI RES, V77, P15, DOI 10.1002/jnr.20155; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; MAYER M, 1994, DEVELOPMENT, V120, P143; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Nakahara J, 2003, DEV CELL, V4, P841, DOI 10.1016/S1534-5807(03)00155-2; Nakahara J, 2005, NEUROSCI LETT, V379, P116, DOI 10.1016/j.neulet.2004.12.066; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Pedraza CE, 2008, GLIA, V56, P1339, DOI 10.1002/glia.20702; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; Ranjan M, 1996, MOL CELL NEUROSCI, V7, P404, DOI 10.1006/mcne.1996.0029; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Samayawardhena LA, 2008, J BIOL CHEM, V283, P29175, DOI 10.1074/jbc.M804077200; Sperber BR, 2001, J NEUROSCI RES, V63, P303, DOI 10.1002/1097-4547(20010215)63:4<303::AID-JNR1024>3.0.CO;2-A; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Taniguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P151, DOI 10.1016/S0006-291X(03)00923-9; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Umemori H, 1999, J NEUROSCI, V19, P1393; Vitry S, 1999, J NEUROSCI RES, V58, P735; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Zawadzka M, 2007, CURR OPIN NEUROL, V20, P294, DOI 10.1097/WCO.0b013e32813aee7f; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zhang SC, 1998, J NEUROCYTOL, V27, P475, DOI 10.1023/A:1006953023845; Zhang SC, 1998, J NEUROSCI RES, V54, P181, DOI 10.1002/(SICI)1097-4547(19981015)54:2<181::AID-JNR6>3.0.CO;2-A	62	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33692	33702		10.1074/jbc.M109.061770	http://dx.doi.org/10.1074/jbc.M109.061770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19812040	Green Published, hybrid			2022-12-25	WOS:000272028500073
J	Keller, A; Leidinger, P; Lange, J; Borries, A; Schroers, H; Scheffler, M; Lenhof, HP; Ruprecht, K; Meese, E				Keller, Andreas; Leidinger, Petra; Lange, Julia; Borries, Anne; Schroers, Hannah; Scheffler, Matthias; Lenhof, Hans-Peter; Ruprecht, Klemens; Meese, Eckart			Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls	PLOS ONE			English	Article							CANCER; BIOMARKERS; CELLS	Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system, which is heterogenous with respect to clinical manifestations and response to therapy. Identification of biomarkers appears desirable for an improved diagnosis of MS as well as for monitoring of disease activity and treatment response. MicroRNAs (miRNAs) are short non-coding RNAs, which have been shown to have the potential to serve as biomarkers for different human diseases, most notably cancer. Here, we analyzed the expression profiles of 866 human miRNAs. In detail, we investigated the miRNA expression in blood cells of 20 patients with relapsing-remitting MS (RRMS) and 19 healthy controls using a human miRNA microarray and the Geniom Real Time Analyzer (GRTA) platform. We identified 165 miRNAs that were significantly up- or downregulated in patients with RRMS as compared to healthy controls. The best single miRNA marker, hsa-miR-145, allowed discriminating MS from controls with a specificity of 89.5%, a sensitivity of 90.0%, and an accuracy of 89.7%. A set of 48 miRNAs that was evaluated by radial basis function kernel support vector machines and 10-fold cross validation yielded a specificity of 95%, a sensitivity of 97.6%, and an accuracy of 96.3%. While 43 of the 165 miRNAs deregulated in patients with MS have previously been related to other human diseases, the remaining 122 miRNAs are so far exclusively associated with MS. The implications of our study are twofold. The miRNA expression profiles in blood cells may serve as a biomarker for MS, and deregulation of miRNA expression may play a role in the pathogenesis of MS.			Keller, A (corresponding author), Febit Biomed Gmbh, Heidelberg, Germany.	andreas.keller@febit.de	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895				Bielekova B, 2004, BRAIN, V127, P1463, DOI 10.1093/brain/awh176; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; SCHAFER A, 2009, INT J CANC; Vorwerk S, 2008, NEW BIOTECHNOL, V25, P142, DOI 10.1016/j.nbt.2008.08.005; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0	19	280	311	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7440	10.1371/journal.pone.0007440	http://dx.doi.org/10.1371/journal.pone.0007440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823682	gold, Green Submitted, Green Published			2022-12-25	WOS:000270808300016
J	Le Naour, F; Bralet, MP; Debois, D; Sandt, C; Guettier, C; Dumas, P; Brunelle, A; Laprevote, O				Le Naour, Francois; Bralet, Marie-Pierre; Debois, Delphine; Sandt, Christophe; Guettier, Catherine; Dumas, Paul; Brunelle, Alain; Laprevote, Olivier			Chemical Imaging on Liver Steatosis Using Synchrotron Infrared and ToF-SIMS Microspectroscopies	PLOS ONE			English	Article								Fatty liver or steatosis is a frequent histopathological change. It is a precursor for steatohepatitis that may progress to cirrhosis and in some cases to hepatocellular carcinoma. In this study we addressed the in situ composition and distribution of biochemical compounds on tissue sections of steatotic liver using both synchrotron FTIR (Fourier transform infrared) and ToF-SIMS (time of flight secondary ion mass spectrometry) microspectroscopies. FTIR is a vibrational spectroscopy that allows investigating the global biochemical composition and ToF-SIMS lead to identify molecular species in particular lipids. Synchrotron FTIR microspectroscopy demonstrated that bands linked to lipid contribution such as -CH(3) and -CH(2) as well as esters were highly intense in steatotic vesicles. Moreover, a careful analysis of the -CH(2) symmetric and anti- symmetric stretching modes revealed a slight downward shift in spectra recorded inside steatotic vesicles when compared to spectra recorded outside, suggesting a different lipid environment inside the steatotic vesicles. ToF-SIMS analysis of such steatotic vesicles disclosed a selective enrichment in cholesterol as well as in diacylglycerol (DAG) species carrying long alkyl chains. Indeed, DAG C36 species were selectively localized inside the steatotic vesicles whereas DAG C30 species were detected mostly outside. Furthermore, FTIR detected a signal corresponding to olefin (C = C, 3000- 3060 cm(-1)) and revealed a selective localization of unsaturated lipids inside the steatotic vesicles. ToF-SIMS analysis definitely demonstrated that DAG species C30, C32, C34 and C36 carrying at least one unsaturated alkyl chain were selectively concentrated into the steatotic vesicles. On the other hand, investigations performed on the non-steatotic part of the fatty livers have revealed important changes when compared to the normal liver. Although the non-steatotic regions of fatty livers exhibited normal histological aspect, IR spectra demonstrated an increase in the lipid content and ToF-SIMS detected small lipid droplets corresponding most likely to the first steps of lipid accretion.			Le Naour, F (corresponding author), INSERM, U602, Villejuif, France.	francois.le-naour@inserm.fr	Sandt, Christophe/ABE-6818-2020; Sandt, Christophe/M-9806-2014; Brunelle, Alain/L-3889-2013; Soleil, SMIS/I-3166-2014	Sandt, Christophe/0000-0002-6432-2004; Sandt, Christophe/0000-0002-6432-2004; Brunelle, Alain/0000-0001-6526-6481; 				Albano E, 2005, ALIMENT PHARM THER, V22, P71, DOI 10.1111/j.1365-2036.2005.02601.x; Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004; Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8; Brunelle A, 2005, J MASS SPECTROM, V40, P985, DOI 10.1002/jms.902; Brunelle A, 2007, CURR PHARM DESIGN, V13, P3335, DOI 10.2174/138161207782360618; Brunelle A, 2009, ANAL BIOANAL CHEM, V393, P31, DOI 10.1007/s00216-008-2367-3; Debois D, 2009, ANAL CHEM, V81, P2823, DOI 10.1021/ac900045m; Diem M, 2000, BIOPOLYMERS, V57, P282, DOI 10.1002/1097-0282(2000)57:5<282::AID-BIP50>3.0.CO;2-R; Dreissig I, 2009, SPECTROCHIM ACTA A, V71, P2069, DOI 10.1016/j.saa.2008.08.008; Dumas P, 2003, VIB SPECTROSC, V32, P3, DOI 10.1016/S0924-2031(03)00043-2; Dumas P, 2007, TRENDS BIOTECHNOL, V25, P40, DOI 10.1016/j.tibtech.2006.11.002; Ginsberg HN, 2006, CELL METAB, V4, P179, DOI 10.1016/j.cmet.2006.08.010; Goldberg IJ, 2006, GASTROENTEROLOGY, V130, P1343, DOI 10.1053/j.gastro.2006.02.040; Jackson M, 1998, CELL MOL BIOL, V44, P89; Liu KZ, 2006, BBA-BIOMEMBRANES, V1758, P960, DOI 10.1016/j.bbamem.2006.05.006; Miller LM, 2006, BBA-BIOMEMBRANES, V1758, P846, DOI 10.1016/j.bbamem.2006.04.010; Nagata Kiyoshi, 2007, Journal of Toxicological Sciences, V32, P453, DOI 10.2131/jts.32.453; Oleszczuk A, 2007, EXP TOXICOL PATHOL, V59, P205, DOI 10.1016/j.etp.2007.05.009; Tahallah N, 2008, J LIPID RES, V49, P438, DOI 10.1194/jlr.M700421-JLR200; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077	20	65	67	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7408	10.1371/journal.pone.0007408	http://dx.doi.org/10.1371/journal.pone.0007408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823674	gold, Green Published, Green Submitted			2022-12-25	WOS:000270728500009
J	Wayengera, M				Wayengera, Misaki			Searching for New Clues about the Molecular Cause of Endomyocardial Fibrosis by Way of In Silico Proteomics and Analytical Chemistry	PLOS ONE			English	Article								Background: Endomyocardial Fibrosis (EMF) -is a chronic inflammatory disease of the heart with related pathology to that of late stage Chaga's disease. Indeed, both diseases are thought to result from auto-immune responses against myocardial tissue. As is the case that molecular mimicry between the acidic termini of Trypanosoma cruzi ribosomal P0, P1 and P2 beta (or simply TcP0, TcP1, and TcP2 beta) proteins and myocardial tissue causes Chaga's disease, excessive exposure to certain infections, toxins including cassava ones, allergy and malnutrition has been suggested as the possible cause for EMF. Recent studies have defined the proteomic characteristics of the T. cruzi ribosomal P protein-C-termini involved in mediating auto-immunity against Beta1-adrenergic receptors of the heart in Chaga's disease. This study aimed to investigate the similarity of C-termini of TcP0/TcP2 beta to sequences and molecules of several plants, microbial, viral and chemical elements-most prior thought to be possible causative agents for EMF. Methods and Principal Findings: Comparative Sequence alignments and phylogeny using the BLAST-P tool at the Swiss Institute of Biotechnology (SIB) revealed homologs of C-termini of TcP0 and TcP2b among related proteins from several eukaryotes including the animals (Homo sapiens, C. elegans, D. melanogaster), plants (Arabidopsis thaliana, Zea mays, Glycina Max, Oryza sativa, Rhizopus oryzae) and protozoa (P. falciparum, T. gondii, Leishmania spp). The chemical formulae of the two T. cruzi ribosomal protein C-terminal peptides were found to be C(61)H(83)N(13)O(26)S(1)and C(64)H(87)N(13)O(28)S(1) respectively by Protparam. Both peptides are heavily negatively charged. Constitutively, both auto-antigens predominantly contain Asparagine (D), Glycine (G) and Phenylamine (F), with a balanced Leucine (L) and Methionine (M) percent composition of 7.7%. The afore going composition, found to be non-homologous to all molecules of chemical species in the databases searched, suggests the possible role of a metabolic pathway in the pathogenesis of EMF if aligned with our "molecular mimicry'' hypothesis. Conclusions: Our findings provide a "window'' to suggest that cross reactivity of antibodies against C-terminal sequences of several animal, plant and protozoal ribosomal P proteins with heart tissue may mediate EMF in a similar manner as C-termini of T. cruzi do for Chaga's disease.			Wayengera, M (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Pathol,Div Mol Pathol, Kampala, Uganda.	wmisaki@yahoo.com		Wayengera, Misaki/0000-0001-7239-8079				Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andy JJ, 1998, ACTA TROP, V69, P127, DOI 10.1016/S0001-706X(97)00125-3; Bassett DE, 1997, NAT GENET, V15, P339, DOI 10.1038/ng0497-339; BEISEL WR, 1995, AM J CLIN NUTR, V62, P813, DOI 10.1093/ajcn/62.4.813; Boehme SA, 2004, J IMMUNOL, V173, P3599, DOI 10.4049/jimmunol.173.6.3599; Bukhman G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000097; Byarugaba W, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-14; CONNOR DH, 1967, AM HEART J, V74, P687, DOI 10.1016/0002-8703(67)90509-1; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; CRAWFORD MA, 1962, LANCET, V1, P352; DAVIES JNP, 1948, E AFR MED J, V25, P10; EDGE J, 1946, LANCET, V248, P675; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Freers J, 1996, LANCET, V347, P197, DOI 10.1016/S0140-6736(96)90383-9; Gagou ME, 2000, NUCLEIC ACIDS RES, V28, P736, DOI 10.1093/nar/28.3.736; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grela P, 2008, J MOL EVOL, V67, P154, DOI 10.1007/s00239-008-9132-2; HASLER P, 1991, J BIOL CHEM, V266, P13815; Iglezias SD, 2008, VIRCHOWS ARCH, V453, P233, DOI 10.1007/s00428-008-0652-3; LEWIS CE, 1958, P SOC EXP BIOL MED, V99, P523; Martin Osvaldo A, 2009, PMC Biophys, V2, P4, DOI 10.1186/1757-5036-2-4; Mocumbi AO, 2008, NEW ENGL J MED, V359, P43, DOI 10.1056/NEJMoa0708629; Ntusi Ntobeko B A, 2009, Expert Rev Cardiovasc Ther, V7, P169, DOI 10.1586/14779072.7.2.169; OJO GO, 1970, BRIT HEART J, V32, P671; OSAMU G, 2008, NUCLEIC ACIDS RES, V36, P2630; PARRY EHO, 1965, Q J MED, V34, P383; Rutakingirwa M, 1999, TROP MED INT HEALTH, V4, P229, DOI 10.1046/j.1365-3156.1999.43376.x; SCHIJMAN AG, 1992, IMMUNOL LETT, V33, P15, DOI 10.1016/0165-2478(92)90087-5; SCHIJMAN AG, 1992, NUCLEIC ACIDS RES, V20, P2894, DOI 10.1093/nar/20.11.2894; SCHIJMAN AG, 1990, NUCLEIC ACIDS RES, V18, P3399, DOI 10.1093/nar/18.11.3399; Sepulveda P, 2000, INFECT IMMUN, V68, P5114, DOI 10.1128/IAI.68.9.5114-5119.2000; Sivasankaran S, 2009, HEART, V95, P9, DOI 10.1136/hrt.2008.148437; SKEIKY YAW, 1992, J EXP MED, V176, P201, DOI 10.1084/jem.176.1.201; Spry C J, 1985, Heart Vessels Suppl, V1, P240, DOI 10.1007/BF02072402; Turan AA, 2008, AM J FOREN MED PATH, V29, P354, DOI 10.1097/PAF.0b013e3181859fe3; WAYENGERA M, 2008, SCI RES ESSAYS, V3, P125; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830	39	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7420	10.1371/journal.pone.0007420	http://dx.doi.org/10.1371/journal.pone.0007420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823676	Green Published, Green Submitted, gold			2022-12-25	WOS:000270728500018
J	Lao, NT; Maloney, AP; Atkins, JF; Kavanagh, TA				Lao, Nga T.; Maloney, Alan P.; Atkins, John F.; Kavanagh, Tony A.			Versatile Dual Reporter Gene Systems for Investigating Stop Codon Readthrough in Plants	PLOS ONE			English	Article								Background: Translation is most often terminated when a ribosome encounters the first in-frame stop codon (UAA, UAG or UGA) in an mRNA. However, many viruses (and some cellular mRNAs) contain "stop" codons that cause a proportion of ribosomes to terminate and others to incorporate an amino acid and continue to synthesize a "readthrough", or C-terminally extended, protein. This dynamic redefinition of codon meaning is dependent on specific sequence context. Methodology: We describe two versatile dual reporter systems which facilitate investigation of stop codon readthrough in vivo in intact plants, and identification of the amino acid incorporated at the decoded stop codon. The first is based on the reporter enzymes NAN and GUS for which sensitive fluorogenic and histochemical substrates are available; the second on GST and GFP. Conclusions: We show that the NAN-GUS system can be used for direct in planta measurements of readthrough efficiency following transient expression of reporter constructs in leaves, and moreover, that the system is sufficiently sensitive to permit measurement of readthrough in stably transformed plants. We further show that the GST-GFP system can be used to affinity purify readthrough products for mass spectrometric analysis and provide the first definitive evidence that tyrosine alone is specified in vivo by a 'leaky' UAG codon, and tyrosine and tryptophan, respectively, at decoded UAA, and UGA codons in the Tobacco mosaic virus (TMV) readthrough context.			Lao, NT (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Plant Mol Genet Lab, Dublin, Ireland.	tkvanagh@mail.tcd.ie		Atkins, John/0000-0001-7933-0165	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079523] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079523, GM079523] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; BEIER H, 1984, EMBO J, V3, P351, DOI 10.1002/j.1460-2075.1984.tb01810.x; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; BERGSTROM DE, 1995, GENETICS, V139, P1331; BRAULT V, 1995, EMBO J, V14, P650, DOI 10.1002/j.1460-2075.1995.tb07043.x; Brown CM, 1996, J VIROL, V70, P5884, DOI 10.1128/JVI.70.9.5884-5892.1996; Cardno TS, 2009, RNA, V15, P1614, DOI 10.1261/rna.1586709; Cazzonelli CI, 2005, TRANSGENIC RES, V14, P941, DOI 10.1007/s11248-005-2539-2; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Fabret C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-22; FENG YX, 1992, J VIROL, V66, P5127, DOI 10.1128/JVI.66.8.5127-5132.1992; Grentzmann G, 1998, RNA, V4, P479; Grimm M, 1998, PLANT MOL BIOL, V38, P689, DOI 10.1023/A:1006068303683; Herr AJ, 2004, J BIOL CHEM, V279, P11081, DOI 10.1074/jbc.M311491200; Hirosawa-Takamori M, 2009, FASEB J, V23, P107, DOI 10.1096/fj.08-116640; ISHIKAWA M, 1986, NUCLEIC ACIDS RES, V14, P8291, DOI 10.1093/nar/14.21.8291; ISHIKAWA M, 1991, J VIROL, V65, P861, DOI 10.1128/JVI.65.2.861-868.1991; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kirby J, 2002, PLANT J, V32, P391, DOI 10.1046/j.1365-313X.2002.01422.x; Lewandowski DJ, 2000, VIROLOGY, V271, P90, DOI 10.1006/viro.2000.0313; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Liu QP, 2004, BIOSYSTEMS, V77, P33, DOI 10.1016/j.biosystems.2004.03.005; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; NAMY O, 2009, RECODING EXPANSION D; Ohtsubo H, 1999, GENES GENET SYST, V74, P83, DOI 10.1266/ggs.74.83; PELHAM HRB, 1978, NATURE, V272, P469, DOI 10.1038/272469a0; Robinson DN, 1997, DEVELOPMENT, V124, P1405; Salas-Marco J, 2004, MOL CELL BIOL, V24, P7769, DOI 10.1128/MCB.24.17.7769-7778.2004; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; SKUZESKI JM, 1990, PLANT MOL BIOL, V15, P65, DOI 10.1007/BF00017725; SKUZESKI JM, 1991, J MOL BIOL, V218, P365, DOI 10.1016/0022-2836(91)90718-L; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; STANSFIELD I, 1994, CURR GENET, V25, P385, DOI 10.1007/BF00351776; Steneberg P, 1998, GENE DEV, V12, P956, DOI 10.1101/gad.12.7.956; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; Tate WP, 1996, BIOCHIMIE, V78, P945, DOI 10.1016/S0300-9084(97)86716-8; Urban C, 1996, NUCLEIC ACIDS RES, V24, P3424, DOI 10.1093/nar/24.17.3424; VALLE RPC, 1987, EMBO J, V6, P3049, DOI 10.1002/j.1460-2075.1987.tb02611.x; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; ZERFASS K, 1992, NUCLEIC ACIDS RES, V20, P5911, DOI 10.1093/nar/20.22.5911; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	45	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7354	10.1371/journal.pone.0007354	http://dx.doi.org/10.1371/journal.pone.0007354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816579	gold, Green Published, Green Submitted			2022-12-25	WOS:000270594300005
J	Sakamoto, KQ; Takahashi, A; Iwata, T; Trathan, PN				Sakamoto, Kentaro Q.; Takahashi, Akinori; Iwata, Takashi; Trathan, Philip N.			From the Eye of the Albatrosses: A Bird-Borne Camera Shows an Association between Albatrosses and a Killer Whale in the Southern Ocean	PLOS ONE			English	Article								Albatrosses fly many hundreds of kilometers across the open ocean to find and feed upon their prey. Despite the growing number of studies concerning their foraging behaviour, relatively little is known about how albatrosses actually locate their prey. Here, we present our results from the first deployments of a combined animal-borne camera and depth data logger on free-ranging black-browed albatrosses (Thalassarche melanophrys). The still images recorded from these cameras showed that some albatrosses actively followed a killer whale (Orcinus orca), possibly to feed on food scraps left by this diving predator. The camera images together with the depth profiles showed that the birds dived only occasionally, but that they actively dived when other birds or the killer whale were present. This association with diving predators or other birds may partially explain how albatrosses find their prey more efficiently in the apparently 'featureless' ocean, with a minimal requirement for energetically costly diving or landing activities.	[Sakamoto, Kentaro Q.] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Takahashi, Akinori; Iwata, Takashi] Natl Inst Polar Res, Dept Polar Sci, Grad Univ Adv Studies, Tachikawa, Tokyo, Japan; [Trathan, Philip N.] NERC, British Antarctic Survey, Cambridge, England	Hokkaido University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Sakamoto, KQ (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	atak@nipr.ac.jp	Sakamoto, Kentaro/N-7424-2019; Sakamoto, Kentaro/A-4843-2012	Sakamoto, Kentaro/0000-0002-8499-799X; Sakamoto, Kentaro/0000-0002-8499-799X	NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anderson EM, 2008, MAR ECOL PROG SER, V360, P291, DOI 10.3354/meps07359; Au D.W., 1988, P174; Bluff LA, 2008, BIOL LETTERS, V4, P319, DOI 10.1098/rsbl.2008.0075; Brooke M, 2004, ALBATROSSES PETRELS; Cherel Y, 2000, MAR ECOL PROG SER, V207, P183, DOI 10.3354/meps207183; CROXALL JP, 1994, ANTARCT SCI, V6, P155, DOI 10.1017/S0954102094000246; Croxall JP, 1999, MAR ECOL PROG SER, V177, P115, DOI 10.3354/meps177115; EVANS PGH, 1982, MAMMAL REV, V12, P187, DOI 10.1111/j.1365-2907.1982.tb00015.x; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; GON O, 1990, FISHES SO OCEAN; Grunbaum D, 2003, ECOLOGY, V84, P3265, DOI 10.1890/01-4098; Hedd A, 1997, IBIS, V139, P452, DOI 10.1111/j.1474-919X.1997.tb04658.x; Hodges C. L., 1994, Marine Ornithology, V22, P205; Huin N, 1997, ANTARCT SCI, V9, P243, DOI 10.1017/S0954102097000321; Huin N, 2000, IBIS, V142, P550, DOI 10.1111/j.1474-919X.2000.tb04456.x; Kock KH, 2006, POLAR BIOL, V29, P379, DOI 10.1007/s00300-005-0067-4; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Nevitt G, 2004, J EXP BIOL, V207, P3537, DOI 10.1242/jeb.01198; Nevitt GA, 2008, P NATL ACAD SCI USA, V105, P4576, DOI 10.1073/pnas.0709047105; Pierotti R., 1988, P31; PRINCE PA, 1994, ANTARCT SCI, V6, P353, DOI 10.1017/S0954102094000532; RIDOUX V, 1987, CAN J ZOOL, V65, P2113, DOI 10.1139/z87-324; Rutz C, 2007, SCIENCE, V318, P765, DOI 10.1126/science.1146788; SAFINA C, 2002, EYE ALBATROSSES; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Silverman ED, 2004, MAR ECOL PROG SER, V277, P25, DOI 10.3354/meps277025; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Xavier JC, 2003, IBIS, V145, P593, DOI 10.1046/j.1474-919X.2003.00196.x	29	39	40	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7322	10.1371/journal.pone.0007322	http://dx.doi.org/10.1371/journal.pone.0007322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809497	Green Published, Green Accepted, gold			2022-12-25	WOS:000270594000006
J	Shortreed, KE; Krause, MP; Huang, JH; Dhanani, D; Moradi, J; Ceddia, RB; Hawke, TJ				Shortreed, Karin E.; Krause, Matthew P.; Huang, Julianna H.; Dhanani, Dili; Moradi, Jasmin; Ceddia, Rolando B.; Hawke, Thomas J.			Muscle-Specific Adaptations, Impaired Oxidative Capacity and Maintenance of Contractile Function Characterize Diet-Induced Obese Mouse Skeletal Muscle	PLOS ONE			English	Article								Background: The effects of diet-induced obesity on skeletal muscle function are largely unknown, particularly as it relates to changes in oxidative metabolism and morphology. Principal Findings: Compared to control fed mice, mice fed a high fat diet (HFD; 60% kcal: fat) for 8 weeks displayed increased body mass and insulin resistance without overt fasting hyperglycemia (i.e. pre-diabetic). Histological analysis revealed a greater oxidative potential in the HFD gastrocnemius/plantaris (increased IIA, reduced IIB fiber-type percentages) and soleus (increased I, IIA cross-sectional areas) muscles, but no change in fiber type percentages in tibialis anterior muscles compared to controls. Intramyocellular lipid levels were significantly increased relative to control in HFD gastrocnemius/plantaris, but were similar to control values in the HFD soleus. Using a novel, single muscle fiber approach, impairments in complete palmitate and glucose oxidation (72.8 +/- 6.6% and 61.8 +/- 9.1% of control, respectively; p<0.05) with HFD were detected. These reductions were consistent with measures made using intact extensor digitorum longus and soleus muscles. Compared to controls, no difference in succinate dehydrogenase or citrate synthase enzyme activities were observed between groups in any muscle studied, however, short-chain fatty acyl CoA dehydrogenase (SCHAD) activity was elevated in the HFD soleus, but not tibialis anterior muscles. Despite these morphological and metabolic alterations, no significant difference in peak tetanic force or low-frequency fatigue rates were observed between groups. Conclusions: These findings indicate that HFD induces early adaptive responses that occur in a muscle-specific pattern, but are insufficient to prevent impairments in oxidative metabolism with continued high-fat feeding. Moreover, the morphological and metabolic changes which occur with 8 weeks of HFD do not significantly impact muscle contractile properties.			Shortreed, KE (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	hawke@mcmaster.ca		Hawke, Thomas/0000-0003-4974-4820				Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386; Ceddia RB, 2004, J PHYSIOL-LONDON, V555, P409, DOI 10.1113/jphysiol.2003.056291; Ceddia RB, 1999, INT J OBESITY, V23, P75, DOI 10.1038/sj.ijo.0800762; Chanseaume E, 2006, J NUTR, V136, P2194, DOI 10.1093/jn/136.8.2194; de Wilde J, 2008, PHYSIOL GENOMICS, V32, P360, DOI 10.1152/physiolgenomics.00219.2007; FARKAS GA, 1994, J APPL PHYSIOL, V77, P2250, DOI 10.1152/jappl.1994.77.5.2250; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Hawke TJ, 2003, J BIOL CHEM, V278, P4015, DOI 10.1074/jbc.M209200200; Kemp JG, 2009, INT J OBESITY, V33, P831, DOI 10.1038/ijo.2009.100; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krause MP, 2008, AM J PHYSIOL-CELL PH, V295, pC203, DOI 10.1152/ajpcell.00030.2008; Krause MP, 2009, J APPL PHYSIOL, V106, P1650, DOI 10.1152/japplphysiol.91565.2008; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Lionetti L, 2007, INT J OBESITY, V31, P1596, DOI 10.1038/sj.ijo.0803636; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Pimenta AS, 2008, J CELL PHYSIOL, V217, P478, DOI 10.1002/jcp.21520; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Silveira LR, 2008, J CELL PHYSIOL, V217, P1, DOI 10.1002/jcp.21514; Smith AC, 2007, AM J PHYSIOL-ENDOC M, V293, pE172, DOI 10.1152/ajpendo.00677.2006; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033	29	86	89	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7293	10.1371/journal.pone.0007293	http://dx.doi.org/10.1371/journal.pone.0007293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806198	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800008
J	Armengol, L; Villatoro, S; Gonzalez, JR; Pantano, L; Garcia-Aragones, M; Rabionet, R; Caceres, M; Estivill, X				Armengol, Lluis; Villatoro, Sergi; Gonzalez, Juan R.; Pantano, Lorena; Garcia-Aragones, Manel; Rabionet, Raquel; Caceres, Mario; Estivill, Xavier			Identification of Copy Number Variants Defining Genomic Differences among Major Human Groups	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; HAPTOGLOBIN-RELATED PROTEIN; TRYPANOSOME LYTIC FACTOR; EVALUATION SEE PROJECT; SICKLE-CELL MUTATION; FACTOR-V-LEIDEN; S-GLOBIN GENE; MACULAR DEGENERATION; STRUCTURAL VARIATION; HIGH-RESOLUTION	Background: Understanding the genetic contribution to phenotype variation of human groups is necessary to elucidate differences in disease predisposition and response to pharmaceutical treatments in different human populations. Methodology/Principal Findings: We have investigated the genome-wide profile of structural variation on pooled samples from the three populations studied in the HapMap project by comparative genome hybridization (CGH) in different array platforms. We have identified and experimentally validated 33 genomic loci that show significant copy number differences from one population to the other. Interestingly, we found an enrichment of genes related to environment adaptation (immune response, lipid metabolism and extracellular space) within these regions and the study of expression data revealed that more than half of the copy number variants (CNVs) translate into gene-expression differences among populations, suggesting that they could have functional consequences. In addition, the identification of single nucleotide polymorphisms (SNPs) that are in linkage disequilibrium with the copy number alleles allowed us to detect evidences of population differentiation and recent selection at the nucleotide variation level. Conclusions: Overall, our results provide a comprehensive view of relevant copy number changes that might play a role in phenotypic differences among major human populations, and generate a list of interesting candidates for future studies.			Armengol, L (corresponding author), UPF, CRG, Genes & Dis Program, Genet Causes Dis Grp, Barcelona, Catalonia, Spain.	xavier.estivill@crg.es	Estivill, Xavier/A-3125-2013; rabionet, raquel/A-7407-2009; Rabionet, Raquel/C-8379-2009; Gonzalez, Juan R/B-7860-2018; Cáceres, Mario/A-6379-2009; Estivill, Xavier/E-2957-2012	Estivill, Xavier/0000-0002-0723-2256; rabionet, raquel/0000-0001-5006-8140; Rabionet, Raquel/0000-0001-5006-8140; Gonzalez, Juan R/0000-0003-3267-2146; Cáceres, Mario/0000-0002-7736-3251; Villatoro, Sergio/0000-0001-6940-2866				ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; Armengol L, 2008, CYTOGENET GENOME RES, V123, P108, DOI 10.1159/000184698; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brazier L, 1999, ATHEROSCLEROSIS, V144, P323, DOI 10.1016/S0021-9150(98)00333-5; Bressler SB, 2008, ARCH OPHTHALMOL-CHIC, V126, P241, DOI 10.1001/archophthalmol.2007.53; Buckley PG, 2002, HUM MOL GENET, V11, P3221, DOI 10.1093/hmg/11.25.3221; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; CELIK T, 2008, NUTR METAB CARDIOVAS; Chang MA, 2008, INVEST OPHTH VIS SCI, V49, P2395, DOI 10.1167/iovs.07-1584; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Daar AS, 2005, NAT REV GENET, V6, P241, DOI 10.1038/nrg1559; de Stahl TD, 2008, HUM MUTAT, V29, P398, DOI 10.1002/humu.20659; Drain J, 2001, J BIOL CHEM, V276, P30254, DOI 10.1074/jbc.M010198200; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Estivill X, 1997, HUM MUTAT, V10, P135, DOI 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.3.CO;2-P; EXCOFFIER L, 1992, GENETICS, V131, P479; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GAETA G, 2007, NUTR METAB CARDIOVAS; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Gonzalez JR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-261; Good P, 2000, PERMUTATION TESTS PR; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hahmann HW, 1999, ATHEROSCLEROSIS, V144, P221, DOI 10.1016/S0021-9150(99)00057-X; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HAPMAP CI, 2005, NATURE, V437, P1299; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hurles ME, 2008, TRENDS GENET, V24, P238, DOI 10.1016/j.tig.2008.03.001; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Krafsur ES, 2003, TRENDS PARASITOL, V19, P162, DOI 10.1016/S1471-4922(03)00034-5; KULOZIK AE, 1986, AM J HUM GENET, V39, P239; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAPOUMEROULIE C, 1992, HUM GENET, V89, P333; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; LOZANO J, UNPUB; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; NAGEL RL, 1985, NEW ENGL J MED, V312, P880, DOI 10.1056/NEJM198504043121403; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Ogorelkova M, 1999, HUM MOL GENET, V8, P2087, DOI 10.1093/hmg/8.11.2087; Ogorelkova M, 2001, HUM MOL GENET, V10, P815, DOI 10.1093/hmg/10.8.815; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Pantano L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-573; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Shen MC, 1997, THROMB RES, V87, P377, DOI 10.1016/S0049-3848(97)00141-2; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Spencer KL, 2008, HUM MOL GENET, V17, P971, DOI 10.1093/hmg/ddm369; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; VATSIS KP, 1991, P NATL ACAD SCI USA, V88, P6333, DOI 10.1073/pnas.88.14.6333; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; White SJ, 2007, CYTOGENET GENOME RES, V118, P19, DOI 10.1159/000106437; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhang XZ, 2007, HUM GENET, V120, P681, DOI 10.1007/s00439-006-0253-7; 1994, HUM MUTAT, V4, P167	103	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7230	10.1371/journal.pone.0007230	http://dx.doi.org/10.1371/journal.pone.0007230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789632	gold, Green Published			2022-12-25	WOS:000270354100004
J	Debeb, BG; Galat, V; Epple-Farmer, J; Iannaccone, S; Woodward, WA; Bader, M; Iannaccone, P; Binas, B				Debeb, Bisrat G.; Galat, Vasiliy; Epple-Farmer, Jessica; Iannaccone, Steve; Woodward, Wendy A.; Bader, Michael; Iannaccone, Philip; Binas, Bert			Isolation of Oct4-Expressing Extraembryonic Endoderm Precursor Cell Lines	PLOS ONE			English	Article								Background: The extraembryonic endoderm (ExEn) defines the yolk sac, a set of membranes that provide essential support for mammalian embryos. Recent findings suggest that the committed ExEn precursor is present already in the embryonic Inner Cell Mass (ICM) as a group of cells that intermingles with the closely related epiblast precursor. All ICM cells contain Oct4, a key transcription factor that is first expressed at the morula stage. In vitro, the epiblast precursor is most closely represented by the well-characterized embryonic stem (ES) cell lines that maintain the expression of Oct4, but analogous ExEn precursor cell lines are not known and it is unclear if they would express Oct4. Methodology/Principal Findings: Here we report the isolation and characterization of permanently proliferating Oct4-expressing rat cell lines ("XEN-P cell lines''), which closely resemble the ExEn precursor. We isolated the XEN-P cell lines from blastocysts and characterized them by plating and gene expression assays as well as by injection into embryos. Like ES cells, the XEN-P cells express Oct4 and SSEA1 at high levels and their growth is stimulated by leukemia inhibitory factor, but instead of the epiblast determinant Nanog, they express the ExEn determinants Gata6 and Gata4. Further, they lack markers characteristic of the more differentiated primitive/visceral and parietal ExEn stages, but exclusively differentiate into these stages in vitro and contribute to them in vivo. Conclusions/Significance: Our findings (i) suggest strongly that the ExEn precursor is a self-renewable entity, (ii) indicate that active Oct4 gene expression (transcription plus translation) is part of its molecular identity, and (iii) provide an in vitro model of early ExEn differentiation.			Debeb, BG (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA.	bbinas@hanyang.ac.kr	Bader, Michael/K-2124-2013; Woodward, Wendy/AAX-6593-2020	Bader, Michael/0000-0003-4780-4164; Woodward, Wendy/0000-0002-7935-739X; Galat, Vasiliy/0000-0003-3612-098X				Baron MH, 2003, EXP HEMATOL, V31, P1160, DOI 10.1016/j.exphem.2003.08.019; Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burton GJ, 2001, PLACENTA, V22, pS70, DOI 10.1053/plac.2001.0639; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; CHAZAUD C, 2006, DEV CELL, V615, P24; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; DEBEB BG, 2007, MOL BIOL CELL S, V18, pA212; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; EPPLEFARMER J, 2009, CELL TRANSPLANT 0429; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; GALAT V, 2009, STEM CELLS DEV  0529; GARDNER RL, 1983, INT REV EXP PATHOL, V63, P133; GARDNER RL, 1985, PHILOS T R SOC LON B, V163, P78; Gerbe F, 2008, DEV BIOL, V313, P594, DOI 10.1016/j.ydbio.2007.10.048; Iannaccone PM, 2002, TRANSGENIC ANIMAL TE, P235; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Li CL, 2009, CELL RES, V19, P173, DOI 10.1038/cr.2008.301; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagy A., 2002, MANIPULATING MOUSE E; Nath AK, 2004, DEVELOPMENT, V131, P2485, DOI 10.1242/dev.01131; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; NICHOLS J, 2009, DEVELOPMENT 200 0826; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Notarianni E, 2001, PLACENTA, V22, P111, DOI 10.1053/plac.2000.0592; OVITT CE, 1998, MOL HUM REPROD, V1021, P31; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Sambrook J, 2001, MOL CLONING LAB MANU; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; Shimosato D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-80; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; STEWART MH, 2006, NAT METHODS, V807, P15; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013	58	39	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7216	10.1371/journal.pone.0007216	http://dx.doi.org/10.1371/journal.pone.0007216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784378	Green Published, gold			2022-12-25	WOS:000270290000016
J	Hernandez, H; Makarova, OV; Makarov, EM; Morgner, N; Muto, Y; Krummel, DP; Robinson, CV				Hernandez, Helena; Makarova, Olga V.; Makarov, Evgeny M.; Morgner, Nina; Muto, Yutaka; Krummel, Daniel Pomeranz; Robinson, Carol V.			Isoforms of U1-70k Control Subunit Dynamics in the Human Spliceosomal U1 snRNP	PLOS ONE			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; PRE-MESSENGER-RNA; SM PROTEINS D1; MASS-SPECTROMETRY; ARGININE RESIDUES; DOMAIN; PHOSPHORYLATION; COMPLEXES; 70K; RECONSTITUTION	Most human protein-encoding genes contain multiple exons that are spliced together, frequently in alternative arrangements, by the spliceosome. It is established that U1 snRNP is an essential component of the spliceosome, in human consisting of RNA and ten proteins, several of which are post-translationally modified and exist as multiple isoforms. Unresolved and challenging to investigate are the effects of these post translational modifications on the dynamics, interactions and stability of the particle. Using mass spectrometry we investigate the composition and dynamics of the native human U1 snRNP and compare native and recombinant complexes to isolate the effects of various subunits and isoforms on the overall stability. Our data reveal differential incorporation of four protein isoforms and dynamic interactions of subunits U1-A, U1-C and Sm-B/B'. Results also show that unstructured post-translationally modified C-terminal tails are responsible for the dynamics of Sm-B/B' and U1-C and that their interactions with the Sm core are controlled by binding to different U1-70k isoforms and their phosphorylation status in vivo. These results therefore provide the important functional link between proteomics and structure as well as insight into the dynamic quaternary structure of the native U1 snRNP important for its function.			Hernandez, H (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cvr24@cam.ac.uk	Morgner, Nina/O-7021-2018; Morgner, Nina/I-7975-2012	Morgner, Nina/0000-0002-1872-490X; robinson, carol/0000-0001-7829-5505; Makarov, Evgeny/0000-0003-2543-9637	MRC [MC_U105184330] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C004272/1] Funding Source: Medline; Medical Research Council [MC_U105184330] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; BRANLANT C, 1980, NUCLEIC ACIDS RES, V8, P4143, DOI 10.1093/nar/8.18.4143; Cao WH, 1998, J BIOL CHEM, V273, P20629, DOI 10.1074/jbc.273.32.20629; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; CHU JL, 1991, GENE, V97, P311; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dieker J, 2008, CELL DEATH DIFFER, V15, P793, DOI 10.1038/sj.cdd.4402312; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donmez G, 2007, MOL CELL, V25, P399, DOI 10.1016/j.molcel.2006.12.019; FISCHER U, 1993, EMBO J, V12, P573, DOI 10.1002/j.1460-2075.1993.tb05689.x; HAMM J, 1990, CELL, V62, P569, DOI 10.1016/0092-8674(90)90021-6; Hanson CL, 2003, J BIOL CHEM, V278, P1259, DOI 10.1074/jbc.M208966200; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Hochleitner EO, 2005, J BIOL CHEM, V280, P2536, DOI 10.1074/jbc.M409587200; Hof D, 2005, AUTOIMMUN REV, V4, P380, DOI 10.1016/j.autrev.2005.02.003; Jurchen JC, 2003, J AM CHEM SOC, V125, P2817, DOI 10.1021/ja0211508; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kaltashov IA, 2008, J AM SOC MASS SPECTR, V19, P1239, DOI 10.1016/j.jasms.2008.05.018; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; McConnell TS, 2003, RNA, V9, P193, DOI 10.1261/rna.2136103; Mckay AR, 2006, J AM CHEM SOC, V128, P11433, DOI 10.1021/ja061468q; Miranda TB, 2004, BIOCHEM BIOPH RES CO, V323, P382, DOI 10.1016/j.bbrc.2004.08.107; Mouaikel J, 2003, EMBO REP, V4, P616, DOI 10.1038/sj.embor.embor863; Muto Y, 2004, J MOL BIOL, V341, P185, DOI 10.1016/j.jmb.2004.04.078; Muto Y, 2001, Nucleic Acids Res Suppl, P275; NELISSEN RLH, 1994, EMBO J, V13, P4113, DOI 10.1002/j.1460-2075.1994.tb06729.x; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Patel SB, 2008, NUCLEIC ACIDS RES, V36, P6482, DOI 10.1093/nar/gkn658; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; SCHMAUSS C, 1992, J BIOL CHEM, V267, P8521; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; SPRITZ RA, 1987, NUCLEIC ACIDS RES, V15, P10373, DOI 10.1093/nar/15.24.10373; Stark H, 2006, ANNU REV BIOPH BIOM, V35, P435, DOI 10.1146/annurev.biophys.35.040405.101953; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; TAZI J, 1993, NATURE, V363, P283, DOI 10.1038/363283a0; Uetrecht C, 2008, P NATL ACAD SCI USA, V105, P9216, DOI 10.1073/pnas.0800406105; VANDAM A, 1989, EMBO J, V8, P3853, DOI 10.1002/j.1460-2075.1989.tb08563.x; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Will CL, 1996, NUCLEIC ACIDS RES, V24, P4614, DOI 10.1093/nar/24.23.4614; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	58	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7202	10.1371/journal.pone.0007202	http://dx.doi.org/10.1371/journal.pone.0007202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784376	Green Published, gold, Green Submitted			2022-12-25	WOS:000270290000011
J	Zwaenepoel, K; Goris, J; Erneux, C; Parker, PJ; Janssens, V				Zwaenepoel, Karen; Goris, Jozef; Erneux, Christophe; Parker, Peter J.; Janssens, Veerle			Protein phosphatase 2A PR130/B ''alpha 1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling	FASEB JOURNAL			English	Article						receptor tyrosine kinase; c-Cbl; Akt/protein kinase B; extracellular signal-regulated kinase	PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; DOWN-REGULATION; TYROSINE PHOSPHORYLATION; REGULATORY SUBUNIT; LIPID PHOSPHATASE; B''/PR72 SUBUNIT; GENE IEX-1; IN-VIVO; SHIP2; IDENTIFICATION	To elucidate novel cell biological functions of specific protein phosphatase 2A (PP2A) holoenzymes, we identified and biochemically characterized a complex between the Src homology 2 (SH2) domain-containing inositol polyphosphate 5-phosphatase 2 (SHIP2) and a PP2A holoenzyme comprising PR130/B ''alpha 1 as a regulatory subunit (PP2A(T130)) in several mammalian cell lines. PR130/B ''alpha 1 and SHIP2 partially colocalize in untreated HeLa cells, and both translocate to the cell membrane on epidermal growth factor (EGF) stimulation. Concomitantly, a transient EGF-dependent interaction of PR130/B ''alpha 1 with the EGF receptor (EGFR) was observed, whereas the SHIP2-PR130 interaction remained constitutive. As previously reported for SHIP2, RNA interference-mediated knockdown of PR130 in COS-7 cells resulted in increased EGF-induced proteasome-dependent EGFR degradation, and an increased interaction of EGFR with the E3 ligase c-Cbl. In concordance with faster EGFR clearance or desensitization, intrinsic EGFR kinase activity (phospho-Tyr-1068) and downstream protein kinase B and extracellular signal-regulated kinase/mitogen-activated protein kinase pathways were more rapidly inactivated in PR130-knockdown cells. Notably, these effects could be rescued by reintroduction of RNA interference-resistant Myc-PR130, excluding any off-target effect. These data highlight a novel biological role of the PP2A(T130) holoenzyme in EGF signaling through interaction with EGFR and the phosphatidylinositol (3,4,5)-trisphosphate 5-phosphatase SHIP2. This interaction may be of clinical relevance as dysfunction of EGF-mediated signaling has been linked to various human cancers.-Zwaenepoel, K., Goris, J., Erneux, C., Parker, P. J., Janssens, V. Protein phosphatase 2A PR130/B ''alpha 1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling. FASEB J. 24, 538-547 (2010). www.fasebj.org	[Zwaenepoel, Karen; Goris, Jozef; Janssens, Veerle] Katholieke Univ Leuven, Fac Med, Dept Mol Cell Biol, Prot Phosphorylat & Prote Lab, Louvain, Belgium; [Erneux, Christophe] Free Univ Brussels, Sch Med, Inst Interdisciplinary Res, Brussels, Belgium; [Parker, Peter J.] London Res Inst Canc Res UK, Prot Phosphorylat Lab, London, England; [Parker, Peter J.] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	KU Leuven; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of London; Institute of Cancer Research - UK; University of London; King's College London	Janssens, V (corresponding author), Gasthuisberg O&NI, Fac Med, Dept Mol Cell Biol, Prot Phosphorylat & Prote Lab, Herestr 49,Box 901, B-3000 Louvain, Belgium.	veerle.janssens@med.kuleuven.be	Janssens, Veerle/I-7059-2016; Parker, Peter j/D-5192-2013	Janssens, Veerle/0000-0002-6772-8448; parker, peter/0000-0002-6218-2933	Geconcerteerde OnderzoeksActies of the Flemish government; Interuniversitary Attraction Poles of the Belgian Science Policy [P6/28]; National Fund for scientific research; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen	Geconcerteerde OnderzoeksActies of the Flemish government; Interuniversitary Attraction Poles of the Belgian Science Policy; National Fund for scientific research; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO)	We acknowledge the Cell Imaging Core (Katholieke Universiteit Leuven) for the use of microscope facilities, Dr. S. Dilworth (Imperial College, London, UK) for providing antibodies, and Dr. N. Totty (Protein Analysis Laboratory, London Research Institute-Cancer Research UK, London, UK) for mass spectroscopic analyses. This work was supported by grants from the Geconcerteerde OnderzoeksActies of the Flemish government (to V.J. and J.G.), the Interuniversitary Attraction Poles of the Belgian Science Policy P6/28 (to J.G. and C. E.), the National Fund for scientific research (to C. E.), and the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (to V.J. and J.G.).	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Artemenko Y, 2007, J CELL PHYSIOL, V211, P598, DOI 10.1002/jcp.20965; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; Creyghton MP, 2006, P NATL ACAD SCI USA, V103, P5397, DOI 10.1073/pnas.0507237103; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Davis AJ, 2008, J BIOL CHEM, V283, P16104, DOI 10.1074/jbc.M710313200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Grempler R, 2007, FEBS LETT, V581, P5885, DOI 10.1016/j.febslet.2007.11.066; HEISERMANN GJ, 1990, J BIOL CHEM, V265, P12820; HENDRIX P, 1993, J BIOL CHEM, V268, P15267; HERNANDEZSOTOMAYOR SMT, 1991, J BIOL CHEM, V266, P21281; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Hudelist G, 2006, PROTEOMICS, V6, P1989, DOI 10.1002/pmic.200500129; Ishihara H, 1999, BIOCHEM BIOPH RES CO, V260, P265, DOI 10.1006/bbrc.1999.0888; Janssens V, 2003, J BIOL CHEM, V278, P10697, DOI 10.1074/jbc.M211717200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Koch A, 2005, ONCOGENE, V24, P3436, DOI 10.1038/sj.onc.1208558; Kono Y, 2002, GENES CELLS, V7, P821, DOI 10.1046/j.1365-2443.2002.00562.x; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; KUPPUSWAMY D, 1993, J BIOL CHEM, V268, P19134; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Lubert EJ, 2001, J BIOL CHEM, V276, P38582, DOI 10.1074/jbc.M106906200; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paternotte N, 2005, FEBS J, V272, P6052, DOI 10.1111/j.1742-4658.2005.04996.x; Pesesse X, 1998, FEBS LETT, V437, P301, DOI 10.1016/S0014-5793(98)01255-1; Pesesse X, 1997, BIOCHEM BIOPH RES CO, V239, P697, DOI 10.1006/bbrc.1997.7538; Pesesse X, 2001, J BIOL CHEM, V276, P28348, DOI 10.1074/jbc.M103537200; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Prasad NK, 2008, CARCINOGENESIS, V29, P25, DOI 10.1093/carcin/bgm213; Prasad NK, 2005, J BIOL CHEM, V280, P13129, DOI 10.1074/jbc.M410289200; Raaijmakers JH, 2007, CELL SIGNAL, V19, P1249, DOI 10.1016/j.cellsig.2006.12.015; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Schiebel K, 2000, CYTOGENET CELL GENET, V91, P224, DOI 10.1159/000056849; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stevens I, 2003, EUR J BIOCHEM, V270, P376, DOI 10.1046/j.1432-1033.2003.03398.x; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Vandenbroere I, 2003, BIOCHEM BIOPH RES CO, V300, P494, DOI 10.1016/S0006-291X(02)02894-2; Wang YJ, 2004, J IMMUNOL, V173, P6820, DOI 10.4049/jimmunol.173.11.6820; WELSH JB, 1991, J CELL BIOL, V114, P533, DOI 10.1083/jcb.114.3.533; Xie JW, 2008, FEBS LETT, V582, P3011, DOI 10.1016/j.febslet.2008.07.048; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang J, 2007, CELL SIGNAL, V19, P2194, DOI 10.1016/j.cellsig.2007.06.022; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200; Zwaenepoel K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-393	55	38	40	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					538	547		10.1096/fj.09-140228	http://dx.doi.org/10.1096/fj.09-140228			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19825976				2022-12-25	WOS:000274045000021
J	Shiota, M; Yokomizo, A; Tada, Y; Inokuchi, J; Kashiwagi, E; Masubuchi, D; Eto, M; Uchiumi, T; Naito, S				Shiota, M.; Yokomizo, A.; Tada, Y.; Inokuchi, J.; Kashiwagi, E.; Masubuchi, D.; Eto, M.; Uchiumi, T.; Naito, S.			Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression	ONCOGENE			English	Article						AR; CRPC; oxidative stress; prostate cancer; ROS; Twist1	ANTIOXIDANT ENZYMES; EXPRESSION; DAMAGE; GENE; MUTATIONS; RADIATION; PROTEIN; AGE	There are few successful therapies for castration-resistant prostate cancer (CRPC). Recently, CRPC has been thought to result from augmented androgen/androgen receptor (AR) signaling pathway, for most of which AR overexpression has been observed. In this study, Twist1, a member of basic helix-loop-helix transcription factors as well as AR was upregulated in response to hydrogen peroxide, and the response to which was abolished by an addition of N-acetyl-L-cysteine and Twist1 knockdown. In addition, castration-resistant LNCaP derivatives and hydrogen peroxide-resistant LNCaP derivatives exhibited a similar phenotype to each other. Then, both castration and AR knockdown increased intracellular reactive oxygen species level. Moreover, Twist1 was shown to regulate AR expression through binding to E-boxes in AR promoter region. Silencing of Twist1 suppressed cell growth of AR-expressing LNCaP cells as well as castration-resistant LNCaP derivatives by inducing cell-cycle arrest at G1 phase and cellular apoptosis. These findings indicated that castration-induced oxidative stress may promote AR overexpression through Twist1 overexpression, which could result in a gain of castration resistance. Modulation of castration-induced oxidative stress or Twist1/AR signaling might be a useful strategy for developing a novel therapeutics in prostate cancer, even in CRPC, which remains dependent on AR signaling by overexpressing AR. Oncogene (2010) 29, 237-250; doi:10.1038/onc.2009.322; published online 5 October 2009	[Shiota, M.; Yokomizo, A.; Tada, Y.; Inokuchi, J.; Kashiwagi, E.; Masubuchi, D.; Naito, S.] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, Fukuoka 8128252, Japan; [Uchiumi, T.] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka 8128252, Japan; [Eto, M.] Kumamoto Univ, Grad Sch Med, Dept Urol, Kumamoto, Japan	Kyushu University; Kyushu University; Kumamoto University	Yokomizo, A (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128252, Japan.	yokoa@uro.med.kyushu-u.ac.jp	Shiota, Masaki/Q-9387-2019; Inokuchi, Junichi/AAO-3297-2020	Inokuchi, Junichi/0000-0002-6791-905X; Shiota, Masaki/0000-0002-3306-4858	Ministry of Health, Labor and Welfare, Japan [016]; Japanese Urological Association, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Urological Association, Japan	This work was supported in part by Health Sciences Research Grants for Clinical Research for evidence-based medicine and grants-in-aid for Cancer Research (016), from the Ministry of Health, Labor and Welfare, Japan, Young Researcher Promotion Grant from the Japanese Urological Association, Japan. We are grateful to Dr Chawnshang Chang for providing the pCMV-AR plasmid. We would like to thank Dr Dongchon Kang (Kyushu University, Fukuoka, Japan) for helping with quantitative real-time PCR and flow cytometry, and Noriko Hakoda, Hitomi Matoba and Seiko Kamori for their technical assistances.	Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; BILLIS A, 1996, J UROL PATHOL, V5, P1; Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9; Castanon I, 2001, DEVELOPMENT, V128, P3145; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Debes JD, 2002, CANCER LETT, V187, P1, DOI 10.1016/S0304-3835(02)00413-5; Ghatak S, 1996, BIOCHEM BIOPH RES CO, V222, P362, DOI 10.1006/bbrc.1996.0749; Gregory CW, 1998, CANCER RES, V58, P5718; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Hakimian P, 2008, BJU INT, V102, P1509, DOI 10.1111/j.1464-410X.2008.07933.x; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hsing AW, 2001, EPIDEMIOL REV, V23, P3, DOI 10.1093/oxfordjournals.epirev.a000792; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lee DK, 2003, J CLIN ENDOCR METAB, V88, P4043, DOI 10.1210/jc.2003-030261; Linja MJ, 2001, CANCER RES, V61, P3550; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Mitsiades N, 2008, SEMIN ONCOL, V35, P569, DOI 10.1053/j.seminoncol.2008.08.002; Oberley TD, 2000, PROSTATE, V44, P144, DOI 10.1002/1097-0045(20000701)44:2<144::AID-PROS7>3.0.CO;2-G; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Pang ST, 2002, ENDOCRINOLOGY, V143, P4897, DOI 10.1210/en.2002-220327; Patel BJ, 2000, J UROLOGY, V164, P1420, DOI 10.1016/S0022-5347(05)67210-2; Pathak S, 2008, CANCER LETT, V261, P74, DOI 10.1016/j.canlet.2007.11.015; Pinthus JH, 2007, NEOPLASIA, V9, P68, DOI 10.1593/neo.06739; Reddy GPV, 2006, J CELL BIOCHEM, V98, P1408, DOI 10.1002/jcb.20927; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Sakr WA, 1996, EUR UROL, V30, P138; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Stasinopoulos IA, 2005, J BIOL CHEM, V280, P2294, DOI 10.1074/jbc.M411018200; Tam NNC, 2003, AM J PATHOL, V163, P2513, DOI 10.1016/S0002-9440(10)63606-1; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; Tso CL, 2000, CANCER J, V6, P220; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; van Doorn R, 2004, CANCER RES, V64, P5578, DOI 10.1158/0008-5472.CAN-04-1253; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008	45	98	99	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2010	29	2					237	250		10.1038/onc.2009.322	http://dx.doi.org/10.1038/onc.2009.322			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19802001				2022-12-25	WOS:000273650000007
J	van Amerongen, R; Nawijn, MC; Lambooij, JP; Proost, N; Jonkers, J; Berns, A				van Amerongen, R.; Nawijn, M. C.; Lambooij, J-P; Proost, N.; Jonkers, J.; Berns, A.			Frat oncoproteins act at the crossroad of canonical and noncanonical Wnt-signaling pathways	ONCOGENE			English	Article						Frat; Gsk3-binding protein; lymphoma-genesis; Diversin; Wnt-signal transduction; planar cell polarity	KINASE-I-EPSILON; CELL POLARITY; PLANAR POLARITY; BETA-CATENIN; AXIN; ACTIVATION; BINDING; LEADS; OVEREXPRESSION; PROTOONCOGENE	Wnt-signal transduction is critical for development and tissue homeostasis in a wide range of animal species and is frequently deregulated in human cancers. Members of the Frat/GBP family of glycogen synthase kinase 3 beta (Gsk3b)binding oncoproteins are recognized as potent activators of the Wnt/beta-catenin pathway in vertebrates. Here, we reveal a novel, Gsk3b-independent function of Frat converging on the activation of JNK and AP-1. Both these have been used as readouts for the noncanonical Frizzled/PCP pathway, which controls polarized cell movements and the establishment of tissue polarity. We find that Frat synergizes with Diversin, the mammalian homolog of the Drosophila PCP protein diego, in the activation of JNK/AP-1 signaling. Importantly, Frat mutants deficient for binding to Gsk3b retain oncogenic activity in vivo, suggesting that Wnt/beta-catenin-independent events contribute to Frat-induced malignant transformation. The observed activities of Frat are reminiscent of the dual function of Dishevelled in the Wnt/beta-catenin and Frizzled/PCP pathways and suggest that Frat may also function to bridge canonical and noncanonical Wnt pathways.	[van Amerongen, R.; Nawijn, M. C.; Lambooij, J-P; Proost, N.; Berns, A.] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [van Amerongen, R.; Nawijn, M. C.; Lambooij, J-P; Proost, N.; Berns, A.] Ctr Biomed Genet, Amsterdam, Netherlands; [Jonkers, J.] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Berns, A.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.berns@nki.nl	van Amerongen, Renee/G-2945-2017; van Amerongen, Renee/N-6645-2019; Jonkers, Jos/AAG-3246-2019	van Amerongen, Renee/0000-0002-8808-2092; van Amerongen, Renee/0000-0002-8808-2092; Jonkers, Jos/0000-0002-9264-9792; Nawijn, Martijn/0000-0003-3372-6521	Centre of Biomedical Genetics (CBG)	Centre of Biomedical Genetics (CBG)	We thank Dr Walter Birchmeier, Dr Hans Clevers, Dr Gerald Crabtree, Dr Trevor Dale, Dr Jolita Hendriksen, Dr Rob Michalides, and Dr Rob Wolthuis for providing constructs and reagents and Dr Ping Chen for advice on cochlear dissections. We thank Fina van de Ahe, Sjaak Greven, Loes Rijswijk, and Maaike Voetel for tail vein injections, Hanneke van de Gulden for generating the Frat1<SUP>IAQA</SUP> mutant, and Dr Joaquim Calbo-Angrill for reading of an early version of the manuscript. This work received financial support from the Centre of Biomedical Genetics (CBG).	Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fanto M, 2004, J CELL SCI, V117, P527, DOI 10.1242/jcs.00973; Ferkey DM, 2002, J BIOL CHEM, V277, P16147, DOI 10.1074/jbc.M112363200; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Jonkers J, 1997, EMBO J, V16, P441, DOI 10.1093/emboj/16.3.441; Jonkers J, 1999, MECH DEVELOP, V88, P183, DOI 10.1016/S0925-4773(99)00187-2; Jonkers J, 1999, ONCOGENE, V18, P5982, DOI 10.1038/sj.onc.1202995; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Moeller H, 2006, P NATL ACAD SCI USA, V103, P15900, DOI 10.1073/pnas.0603808103; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Saitoh T, 2001, INT J ONCOL, V19, P311; Sakanaka C, 2000, RECENT PROG HORM RES, V55, P225; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041; THEISEN H, 1994, DEVELOPMENT, V120, P347; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; van Amerongen R, 2005, CELL CYCLE, V4, pE89; van Amerongen R, 2005, GENE DEV, V19, P425, DOI 10.1101/gad.326705; van Amerongen R, 2004, J BIOL CHEM, V279, P26967, DOI 10.1074/jbc.M400439200; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang Y, 2006, BRIT J CANCER, V94, P686, DOI 10.1038/sj.bjc.6602988; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wang YH, 2008, INT J CANCER, V123, P561, DOI 10.1002/ijc.23600; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	47	32	32	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					93	104		10.1038/onc.2009.310	http://dx.doi.org/10.1038/onc.2009.310			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19802005				2022-12-25	WOS:000273373500009
J	Acharya, M; Lingenfelter, DJ; Huang, LJ; Gage, PJ; Walter, MA				Acharya, Moulinath; Lingenfelter, David J.; Huang, LiJia; Gage, Philip J.; Walter, Michael A.			Human PRKC Apoptosis WT1 Regulator Is a Novel PITX2-interacting Protein That Regulates PITX2 Transcriptional Activity in Ocular Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXENFELD-RIEGER MALFORMATIONS; AMYLOID-BETA; FACTOR GENE; PAR-4; MUTATIONS; FOXC1; HINDLIMB; ISOFORMS; CLONING; KINASE	Mutations in the homeobox transcription factor PITX2 result in Axenfeld-Rieger syndrome (ARS), which is associated with anterior segment dysgenesis and an increased risk of glaucoma. To understand the pathogenesis of the defects resulting from PITX2 mutations, it is essential to know the normal functions of PITX2 and its interaction with the network of proteins in the eye. Yeast two-hybrid screening was performed using a cDNA library from a human trabecular meshwork primary cell line to detect novel PITX2-interacting proteins and study their role in ARS pathogenesis. After screening of similar to 1 x 10(6) clones, one putative interacting protein was identified named PRKC apoptosis WT1 regulator (PAWR). This interaction was further confirmed by retransformation assay in yeast cells as well as co-immunoprecipitation in ocular cells and nickel pulldown assay in vitro. PAWR is reportedly a proapoptotic protein capable of selectively inducing apoptosis primarily in cancer cells. Our analysis indicates that the homeodomain and the adjacent inhibitory domain in PITX2 interact with the C-terminal leucine zipper domain of PAWR. Endogenous PAWR and PITX2 were found to be located in the nucleus of ocular cells and to co-localize in the mesenchyme of the iridocorneal angle of the developing mouse eye, consistent with a role in the development of the anterior segment of the eye. PAWR was also found to inhibit PITX2 transcriptional activity in ocular cells. These data suggest PAWR is a novel PITX2-interacting protein that regulates PITX2 activity in ocular cells. This information sheds new light in understanding ARS and associated glaucoma pathogenesis.	[Acharya, Moulinath; Huang, LiJia; Walter, Michael A.] Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; [Walter, Michael A.] Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2H7, Canada; [Lingenfelter, David J.; Gage, Philip J.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Alberta; University of Alberta; University of Michigan System; University of Michigan	Walter, MA (corresponding author), Univ Alberta, Dept Med Genet, 8-32 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	mwalter@ualberta.ca		Acharya, Moulinath/0000-0001-8013-7426; Gage, Philip/0000-0001-5536-6702	Canadian Institute of Health Research [CIHRMOP77782]; National Institutes of Health [EY014126, EY007003]; NATIONAL EYE INSTITUTE [P30EY007003, R01EY014126, F31EY007003] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by Operating Grant CIHRMOP77782 from the Canadian Institute of Health Research (to M. A. W.). This work was also supported by National Institutes of Health Grants EY014126 and EY007003 from the NEI (to P. J. G.).	ACHARYA M, 2010, ENCY EYE IN PRESS; Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Arakawa H, 1998, P NATL ACAD SCI USA, V95, P4573, DOI 10.1073/pnas.95.8.4573; Axenfeld TH, 1920, KLIN MONATSBL AUGENH, V65, P381; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Cunningham ET, 1998, ARCH OPHTHALMOL-CHIC, V116, P78, DOI 10.1001/archopht.116.1.78; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; Doward W, 1999, J MED GENET, V36, P152; El-Guendy N, 2003, EXP CELL RES, V283, P51, DOI 10.1016/S0014-4827(02)00016-2; Footz T, 2009, INVEST OPHTH VIS SCI, V50, P2599, DOI 10.1167/iovs.08-3251; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gage PJ, 1997, HUM MOL GENET, V6, P457, DOI 10.1093/hmg/6.3.457; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; Guo Q, 2004, J BIOL CHEM, V279, P4596, DOI 10.1074/jbc.M309811200; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hjalt Tord A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010082; Huang LJ, 2008, INVEST OPHTH VIS SCI, V49, P5243, DOI 10.1167/iovs.07-1625; Johnstone RW, 1998, GENOMICS, V53, P241, DOI 10.1006/geno.1998.5494; Johnstone RW, 1996, MOL CELL BIOL, V16, P6945; Kogel D, 1998, ONCOGENE, V17, P2645, DOI 10.1038/sj.onc.1202204; Kozlowski K, 2000, HUM MOL GENET, V9, P2131, DOI 10.1093/hmg/9.14.2131; Kulak SC, 1998, HUM MOL GENET, V7, P1113, DOI 10.1093/hmg/7.7.1113; Lines MA, 2004, INVEST OPHTH VIS SCI, V45, P828, DOI 10.1167/iovs.03-0309; Lines MA, 2002, HUM MOL GENET, V11, P1177, DOI 10.1093/hmg/11.10.1177; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Ranganathan P, 2005, ANN NY ACAD SCI, V1059, P76, DOI 10.1196/annals.1339.046; RIEGER H, 1935, GRAEFE ARCH OPHTHALM, V133, P602; Roussigne M, 2003, ONCOGENE, V22, P2432, DOI 10.1038/sj.onc.1206271; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; SELLS SF, 1994, CELL GROWTH DIFFER, V5, P457; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shields M B, 1983, Trans Am Ophthalmol Soc, V81, P736; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Xie J, 2005, J BIOL CHEM, V280, P13824, DOI 10.1074/jbc.M411933200	39	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34829	34838		10.1074/jbc.M109.006684	http://dx.doi.org/10.1074/jbc.M109.006684			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801652	Green Published, hybrid			2022-12-25	WOS:000272439600038
J	Cameron, PH; Chevet, E; Pluquet, O; Thomas, DY; Bergeron, JJM				Cameron, Pamela H.; Chevet, Eric; Pluquet, Olivier; Thomas, David Y.; Bergeron, John J. M.			Calnexin Phosphorylation Attenuates the Release of Partially Misfolded alpha 1-Antitrypsin to the Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; IN-VIVO; GLYCOPROTEIN; ALPHA(1)-ANTITRYPSIN; SIGNAL; PHOSPHOPROTEOME; ASSOCIATION; CELLS	Calnexin is a type I integral membrane phosphoprotein resident of the endoplasmic reticulum. Its intraluminal domain has been deduced to function as a lectin chaperone coordinating the timing of folding of newly synthesized N-linked glycoproteins of the secretory pathway. Its C-terminal cytosolic oriented extension has an ERK1 phosphorylation site at Ser(563) affecting calnexin association with the translocon. Here we find an additional function for calnexin phosphorylation at Ser563 in endoplasmic reticulum quality control. A low dose of the mis-folding agent L-azetidine 2-carboxylic acid slows glycoprotein maturation and diminishes the extent and rate of secretion of newly synthesized secretory alpha 1-antitrypsin. Under these conditions the phosphorylation of calnexin is enhanced at Ser563. Inhibition of this phosphorylation by the MEK1 inhibitor PD98059 enhanced the extent and rate of alpha 1-antitrypsin secretion comparable with that achieved by inhibiting alpha-mannosidase activity with kifunensine. This is the first report in which the phosphorylation of calnexin is linked to the efficiency of secretion of a cargo glycoprotein.	[Cameron, Pamela H.; Thomas, David Y.; Bergeron, John J. M.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Thomas, David Y.] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B2, Canada; [Chevet, Eric; Pluquet, Olivier] Univ Bordeaux 2, INSERM, U889, F-33076 Bordeaux, France	McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Bergeron, JJM (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada.	john.bergeron@mcgill.ca	Bergeron, John/AAW-1893-2021; chevet, eric/E-4992-2016; Thomas, David/M-7661-2017	chevet, eric/0000-0001-5855-4522; Thomas, David/0000-0002-8854-762X	Canadian Institutes of Health Research; Avenir Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Avenir Program	This work was supported by grants from the Canadian Institutes of Health Research ( to D.Y.T. and J. J. M. B.) and from the Avenir Program ( to E. C.).	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabral CM, 2002, MOL BIOL CELL, V13, P2639, DOI 10.1091/mbc.E02-02-0068; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Kim JE, 2005, J PROTEOME RES, V4, P1339, DOI 10.1021/pr050048h; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Nguyen DT, 2004, MOL BIOL CELL, V15, P4248, DOI 10.1091/mbc.E03-11-0851; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6; Wong HN, 1998, J BIOL CHEM, V273, P17227, DOI 10.1074/jbc.273.27.17227; Yang F, 2006, J PROTEOME RES, V5, P1252, DOI 10.1021/pr060028v	29	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34570	34579		10.1074/jbc.M109.053165	http://dx.doi.org/10.1074/jbc.M109.053165			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19815548	Green Published, hybrid			2022-12-25	WOS:000272439600012
J	Lin, JC; Tarn, WY				Lin, Jung-Chun; Tarn, Woan-Yuh			RNA-binding Motif Protein 4 Translocates to Cytoplasmic Granules and Suppresses Translation via Argonaute2 during Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MICRORNAS; MODULATION; REGULATOR; PATHWAY; RBM4	The RNA-binding motif protein 4 (RBM4) plays multiple roles in mRNA metabolism, including translation control. RBM4 suppresses cap-dependent translation but activates internal ribosome entry site-mediated translation. Because of its high expression level in muscle and heart, we investigated the function of RBM4 in myoblast cells. Here, we demonstrate that RBM4 is phosphorylated and translocates to the cytoplasm in mouse C2C12 cells upon cell differentiation. Notably, RBM4 is transiently deposited into cytoplasmic granules containing microtubule assembly factors as well as poly(A)(+) RNAs. Moreover, RBM4 colocalizes with the components of micro-ribonucleoproteins, including the Argonaute2 (Ago2) protein, during muscle cell differentiation. RBM4 interacts directly with Ago2 and may recruit Ago2 to suppress translation of target mRNAs. Furthermore, RBM4 selectively associates with muscle cell-specific microRNAs and potentiates their translation repression activity by promoting micro-ribonucleoprotein association with target mRNAs. Altogether, our results suggest that RBM4 translocates to the cytoplasm and participates in translation suppression during muscle cell differentiation.	[Lin, Jung-Chun; Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan	Tarn, WY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	wtarn@ibms.sinica.edu.tw	Tarn, Woan-Yuh/N-8464-2018		National Science Council [NSC 96-2628-B001-013]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council Grant NSC 96-2628-B001-013.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hammell CM, 2008, RNA BIOL, V5, P123, DOI 10.4161/rna.5.3.6570; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; JACKSON RJ, 2007, SCI STKE, V367, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Li C, 2003, MOL CELL BIOL, V23, P7363, DOI 10.1128/MCB.23.20.7363-7376.2003; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Srsen V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-28; TARN WY, 1995, P NATL ACAD SCI USA, V92, P2504, DOI 10.1073/pnas.92.7.2504; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007	21	29	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34658	34665		10.1074/jbc.M109.032946	http://dx.doi.org/10.1074/jbc.M109.032946			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801630	Green Published, hybrid			2022-12-25	WOS:000272439600021
J	Herget, M; Kreissig, N; Kolbe, C; Scholz, C; Tampe, R; Abele, R				Herget, Meike; Kreissig, Nina; Kolbe, Christian; Schoelz, Christian; Tampe, Robert; Abele, Rupert			Purification and Reconstitution of the Antigen Transport Complex TAP A PREREQUISITE FOR DETERMINATION OF PEPTIDE STOICHIOMETRY AND ATP HYDROLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ABC TRANSPORTER; PROCESSING TAP; DISTINCT FUNCTIONS; BINDING; MECHANISM; PROTEINS; MACHINERY; TRANSLOCATION; TRANSMISSION	The transporter associated with antigen processing (TAP) is an essential machine of the adaptive immune system that translocates antigenic peptides from the cytosol into the endoplasmic reticulum lumen for loading of major histocompatibility class I molecules. To examine this ABC transport complex in mechanistic detail, we have established, after extensive screening and optimization, the solubilization, purification, and reconstitution for TAP to preserve its function in each step. This allowed us to determine the substrate-binding stoichiometry of the TAP complex by fluorescence cross-correlation spectroscopy. In addition, the TAP complex shows strict coupling between peptide binding and ATP hydrolysis, revealing no basal ATPase activity in the absence of peptides. These results represent an optimal starting point for detailed mechanistic studies of the transport cycle of TAP by single molecule experiments to analyze single steps of peptide translocation and the stoichiometry between peptide transport and ATP hydrolysis.	[Herget, Meike; Kreissig, Nina; Kolbe, Christian; Schoelz, Christian; Tampe, Robert; Abele, Rupert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de; abele@em.uni-frankfurt.de	Schölz, Christian/K-2855-2014; Tampé, Robert/H-2953-2015; Schölz, Christian/F-1261-2010	Schölz, Christian/0000-0002-1633-2072; Tampé, Robert/0000-0002-0403-2160; 	German Research Foundation [SFB 807, AB149/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grant SFB 807 ( to R. T.) and Grant AB149/1-1 ( to R. A.).	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Aisenbrey C, 2006, J BIOL CHEM, V281, P30365, DOI 10.1074/jbc.M603000200; Bamber L, 2006, P NATL ACAD SCI USA, V103, P16224, DOI 10.1073/pnas.0607640103; Cantor RS, 1997, J PHYS CHEM B, V101, P1723, DOI 10.1021/jp963911x; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Doeven MK, 2004, J BIOL CHEM, V279, P32301, DOI 10.1074/jbc.M404343200; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Groothuis TAM, 2005, IMMUNOL REV, V207, P60, DOI 10.1111/j.0105-2896.2005.00305.x; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Karttunen JT, 2001, P NATL ACAD SCI USA, V98, P7431, DOI 10.1073/pnas.121180198; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Lapinski PE, 2001, J BIOL CHEM, V276, P7526, DOI 10.1074/jbc.M009448200; Loman A, 2008, CHEM PHYS LETT, V459, P18, DOI 10.1016/j.cplett.2008.05.018; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Neumann L, 2002, J MOL BIOL, V324, P965, DOI 10.1016/S0022-2836(02)01148-8; Neumann L, 1999, J MOL BIOL, V294, P1203, DOI 10.1006/jmbi.1999.3329; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Nitsche JM, 2004, BIOPHYS J, V86, P2058, DOI 10.1016/S0006-3495(04)74267-8; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Saveanu L, 2001, J BIOL CHEM, V276, P22107, DOI 10.1074/jbc.M011221200; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Scholz C, 2005, J BIOENERG BIOMEMBR, V37, P509, DOI 10.1007/s10863-005-9500-1; Sherman E, 2008, BIOPHYS J, V94, P4819, DOI 10.1529/biophysj.107.120220; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhao CG, 2008, J BIOL CHEM, V283, P17083, DOI 10.1074/jbc.M801794200	39	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33740	33749		10.1074/jbc.M109.047779	http://dx.doi.org/10.1074/jbc.M109.047779			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808685	hybrid, Green Published			2022-12-25	WOS:000272165200004
J	Machida, YJ; Machida, Y; Vashisht, AA; Wohlschlegel, JA; Dutta, A				Machida, Yuichi J.; Machida, Yuka; Vashisht, Ajay A.; Wohlschlegel, James A.; Dutta, Anindya			The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; BRCA1-ASSOCIATED PROTEIN-1; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY; UBIQUITIN HYDROLASE; ACTIVATION DOMAIN; RNA INTERFERENCE; ASSOCIATION; COMPLEX; CYCLE	The deubiquitinating enzyme BRCA1-associated protein 1 (BAP1) possesses growth inhibitory activity and functions as a tumor suppressor. In this study we report that BAP1 also plays positive roles in cell proliferation. BAP1 depletion by RNAi inhibits cell proliferation as does overexpression of a dominant negative mutant of BAP1. Mass spectrometry analyses of copurified proteins revealed that BAP1 is associated with factors involved in chromatin modulation and transcriptional regulation. We show that the interaction with host cell factor-1 (HCF-1), a cell-cycle regulator composed of HCF-1N and HCF-1C, is critical for the BAP1-mediated growth regulation. We found that HCF-1N is modified with Lys-48-linked polyubiquitin chains on its Kelch domain. The HCF-1 binding motif of BAP1 is required for interaction with HCF-1N and mediates deubiquitination of HCF-1N by BAP1. The importance of the BAP1-HCF-1 interaction is underscored by the fact that growth suppression by the dominant negative BAP1 mutant is entirely dependent on the HCF-1 binding motif. These results suggest that BAP1 regulates cell proliferation by deubiquitinating HCF-1.	[Machida, Yuichi J.; Machida, Yuka] Mayo Clin, Mayo Coll Med, Div Oncol Res, Rochester, MN 55905 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Machida, Yuichi J.; Machida, Yuka; Dutta, Anindya] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22901 USA	Mayo Clinic; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Virginia	Machida, YJ (corresponding author), 200 1st St Sw, Rochester, MN 55905 USA.	machida.yuichi@mayo.edu	Machida, Yuichi/AAO-3533-2021	Machida, Yuichi/0000-0003-1414-0568; Dutta, Anindya/0000-0002-4319-0073	National Institutes of Health [R01 CA60499]; Minnesota Partnership for Biotechnology and Medical Genomics; UCLA Jonsson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics; UCLA Jonsson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA60499 (to A. D.). This work was also supported by the Minnesota Partnership for Biotechnology and Medical Genomics (to Y. J. M.) and the UCLA Jonsson Cancer Center (to J. A. W.).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; BUCHHAGEN DL, 1994, INT J CANCER, V57, P473, DOI 10.1002/ijc.2910570406; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Luciano RL, 2000, P NATL ACAD SCI USA, V97, P10757, DOI 10.1073/pnas.190062797; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Luciano RL, 2002, P NATL ACAD SCI USA, V99, P13403, DOI 10.1073/pnas.202200399; Machida YJ, 2006, MOL BIOL CELL, V17, P4837, DOI 10.1091/mbc.E06-04-0340; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403	52	188	198	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34179	34188		10.1074/jbc.M109.046755	http://dx.doi.org/10.1074/jbc.M109.046755			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815555	Green Published, hybrid			2022-12-25	WOS:000272165200050
J	Kale, S; Jordan, F				Kale, Sachin; Jordan, Frank			Conformational Ensemble Modulates Cooperativity in the Rate-determining Catalytic Step in the E1 Component of the Escherichia coli Pyruvate Dehydrogenase Multienzyme Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-CENTER COMMUNICATION; REDUCTIVE ACETYLATION; REACTION INTERMEDIATE; DEPENDENT ENZYMES; SUBUNIT INTERFACE; THIAMINE ENZYMES; PLAUSIBLE MODEL; SITES; BINDING; SUBSTRATE	Cooperativity is extensively used by enzymes, particularly those acting at key metabolic branch points, to "fine tune" catalysis. Thus, cooperativity and enzyme catalysis are intimately linked, yet their linkage is poorly understood. Here we show that negative cooperativity in the rate-determining step in the E1 component of the Escherichia coli pyruvate dehydrogenase multienzyme complex is an outcome of redistribution of a "rate-promoting" conformational pre-equilibrium. An array of biophysical and biochemical studies indicates that non-catalytic but conserved residues directly regulate the redistribution. Furthermore, factors such as ligands and temperature, individually or in concert, also strongly influence the redistribution. As a consequence, these factors also exert their influence on catalysis by profoundly influencing the pre-equilibrium facilitated dynamics of communication between multienzyme components. Our observations suggest a mode of cooperativity in the E1 component that is consistent with the dynamical hypothesis shown to satisfactorily explain cooperativity in many well studied enzymes. The results point to the likely existence of multiple modes of communication between subunits when the entire class of thiamin diphosphate-dependent enzymes is considered.	[Kale, Sachin; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	frjordan@rutgers.edu			National Institutes of Health [GM 50380]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM 50380.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Fersht A., 1998, STRUCTURE MECH PROTE, P147; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Jones DD, 2001, J MOL BIOL, V305, P49, DOI 10.1006/jmbi.2000.4257; Jordan F, 2005, ACCOUNTS CHEM RES, V38, P755, DOI 10.1021/ar040244e; Jordan F, 2004, SCIENCE, V306, P818, DOI 10.1126/science.1105457; Kale S, 2008, P NATL ACAD SCI USA, V105, P1158, DOI 10.1073/pnas.0709328105; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; Kolodziej AF, 1996, BIOCHEMISTRY-US, V35, P14782, DOI 10.1021/bi961481v; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kovina MV, 1998, FEBS LETT, V440, P81, DOI 10.1016/S0014-5793(98)01423-9; Kumar S, 2000, PROTEIN SCI, V9, P10; Li J, 2004, J BIOL CHEM, V279, P32968, DOI 10.1074/jbc.M403611200; Li J, 2007, J BIOL CHEM, V282, P11904, DOI 10.1074/jbc.M610843200; MASSEY V, 1966, J BIOL CHEM, V241, P2347; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nakai T, 2004, J MOL BIOL, V337, P1011, DOI 10.1016/j.jmb.2004.02.011; Nemeria N, 2005, J BIOL CHEM, V280, P21473, DOI 10.1074/jbc.M502691200; Nemeria N, 2002, BIOCHEMISTRY-US, V41, P15459, DOI 10.1021/bi0205909; Nemeria N, 1998, BIOCHEMISTRY-US, V37, P911, DOI 10.1021/bi9722251; Nemeria N, 2001, J BIOL CHEM, V276, P45969, DOI 10.1074/jbc.M104116200; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Park YH, 2004, BIOCHEMISTRY-US, V43, P14037, DOI 10.1021/bi049027b; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; SCRUTTON NS, 1992, SCIENCE, V258, P1140, DOI 10.1126/science.1439821; Seifert F, 2006, BIOCHEMISTRY-US, V45, P12775, DOI 10.1021/bi061582l; Sergienko EA, 2000, BIOCHEMISTRY-US, V39, P13862, DOI 10.1021/bi001214w; Sergienko EA, 2002, BIOCHEMISTRY-US, V41, P3952, DOI 10.1021/bi011860a; Stetefeld J, 2006, P NATL ACAD SCI USA, V103, P13688, DOI 10.1073/pnas.0600306103; SUNDSTROM M, 1992, FEBS LETT, V313, P229, DOI 10.1016/0014-5793(92)81197-T; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Truhlar DG, 2001, P NATL ACAD SCI USA, V98, P848, DOI 10.1073/pnas.98.3.848; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wynn RM, 2004, STRUCTURE, V12, P2185, DOI 10.1016/j.str.2004.09.013; Yi JZ, 1996, J BIOL CHEM, V271, P33192, DOI 10.1074/jbc.271.52.33192	44	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33122	33129		10.1074/jbc.M109.065508	http://dx.doi.org/10.1074/jbc.M109.065508			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801660	Green Published, hybrid			2022-12-25	WOS:000272028500016
J	Khazaei, MR; Puschel, AW				Khazaei, Mohammad R.; Pueschel, Andreas W.			Phosphorylation of the Par Polarity Complex Protein Par3 at Serine 962 Is Mediated by Aurora A and Regulates Its Function in Neuronal Polarity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE SMURF2; MAMMALIAN-CELLS; SELF-RENEWAL; ESTABLISHMENT; ACTIVATION; APKC; LOCALIZATION; MECHANISMS; MATURATION; GSK-3-BETA	The Aurora kinases are a family of serine/threonine protein kinases that perform important functions during the cell cycle. Recently, it was shown that Drosophila Aurora A also regulates the asymmetric localization of Numb to the basal and the partitioning-defective (Par) complex to the apical cortex of neuroblasts by phosphorylating Par6. Here, we show that Aurora A is required for neuronal polarity. Suppression of Aurora A by RNA interference results in the loss of neuronal polarity. Aurora A interacts directly with the atypical protein kinase C binding domain of Par3 and phosphorylates it at serine 962. The phosphorylation of Par3 at serine 962 contributes to its function in the establishment of neuronal polarity.	[Khazaei, Mohammad R.; Pueschel, Andreas W.] Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, D-48149 Munster, Germany	University of Munster	Puschel, AW (corresponding author), Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, Schlosspl 5, D-48149 Munster, Germany.	apuschel@uni-muenster.de			Deutsche Forschungsgemeinschaft [SFB 629, GRK 1050]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 629 and GRK 1050 (to A. W. P.).	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Mandell JW, 1996, J NEUROSCI, V16, P5727; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Schwamborn JC, 2006, METHOD ENZYMOL, V406, P715, DOI 10.1016/S0076-6879(06)06056-3; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang YG, 2006, EMBO J, V25, P5058, DOI 10.1038/sj.emboj.7601384; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368	41	32	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33571	33579		10.1074/jbc.M109.055897	http://dx.doi.org/10.1074/jbc.M109.055897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19812038	Green Published, hybrid			2022-12-25	WOS:000272028500062
J	Oakley, FD; Smith, RL; Engelhardt, JF				Oakley, Fredrick D.; Smith, Rachel L.; Engelhardt, John F.			Lipid Rafts and Caveolin-1 Coordinate Interleukin-1 beta (IL-1 beta)-dependent Activation of NF kappa B by Controlling Endocytosis of Nox2 and IL-1 beta Receptor 1 from the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGOCYTE NADPH OXIDASE; SMOOTH-MUSCLE-CELLS; SIGNALING PATHWAYS; TYPE-1 RECEPTOR; VAV PROTEINS; MICRODOMAINS; RAC1; TRAFFICKING; DOMAIN; CHOLESTEROL	Recent evidence suggests that signaling by the proinflammatory cytokine interleukin-1 beta (IL-1 beta) is dependent on reactive oxygen species derived from NADPH oxidase. Redox signaling in response to IL-1 beta is known to require endocytosis of its cognate receptor (IL-1R1) following ligand binding and the formation of redox-active signaling endosomes that contain Nox2 (also called redoxosomes). The consequent generation of reactive oxygen species by redoxosomes is responsible for the downstream recruitment of IL-1R1 effectors (IRAK, TRAF6, and I kappa B kinase kinases) and ultimately for activation of the transcription factor NF kappa B. Despite this knowledge of the signaling events that occur downstream of redoxosome formation, an understanding of the mechanisms that coordinate the genesis of redoxosomes following IL-1 beta stimulation has been lacking. Here, we demonstrate that lipid rafts play an important role in this process. We show that Nox2 and IL-1R1 localize to plasma membrane lipid rafts in the unstimulated state and that IL-1 beta signals caveolin-1-dependent endocytosis of both proteins into the redoxosome. We also show that inhibiting lipid raft-mediated endocytosis prevents NF kappa B activation. Finally, we demonstrate that Vav1, a Rac1 guanine exchange factor and activator of Nox2, is recruited to lipid rafts following IL-1 beta stimulation and that it is required for NF kappa B activation. Our results fill in an important mechanistic gap in the understanding of early IL-1R1 and Nox2 signaling events that control NF kappa B activation, a redox-dependent process important in inflammation.	[Oakley, Fredrick D.; Smith, Rachel L.; Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Oakley, Fredrick D.; Engelhardt, John F.] Univ Iowa, Carver Coll Med, Med Scientist Training Program, Iowa City, IA 52242 USA; [Engelhardt, John F.] Univ Iowa, Carver Coll Med, Ctr Gene Therapy, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Engelhardt, JF (corresponding author), Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Rm 1-111 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu		Engelhardt, John/0000-0003-2389-9277	National Institutes of Health [R01 DK067928, R01 DK051315]; NIDDK [R01 DK051315]; NIEHS [F30 ES015950]; Center for Gene Therapy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067928, R01DK051315, P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES015950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Gene Therapy(Ohio State University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK067928 and R01 DK051315 from NIDDK and Grant F30 ES015950 from NIEHS. This work was also supported by the University of Iowa Gene Transfer Vector Core, which is funded through the Center for Gene Therapy (National Institutes of Health Grant P30 DK54759), and by the Roy J. Carver Chair in Molecular Medicine.	ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Arnalich F, 2000, INFECT IMMUN, V68, P1942, DOI 10.1128/IAI.68.4.1942-1945.2000; BORISH L, 1992, J IMMUNOL, V149, P3078; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Charvet C, 2002, J BIOL CHEM, V277, P15376, DOI 10.1074/jbc.M111627200; Chen YK, 2005, BRIT J ORAL MAX SURG, V43, P185, DOI 10.1016/j.bjoms.2004.02.026; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Fan HK, 2006, FRONT BIOSCI-LANDMRK, V11, P2264, DOI 10.2741/1969; Han C H, 2000, J Vet Sci, V1, P19; Han CH, 2001, J BIOCHEM-TOKYO, V129, P513, DOI 10.1093/oxfordjournals.jbchem.a002885; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hebeis B, 2005, BLOOD, V106, P635, DOI 10.1182/blood-2004-10-3919; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kreuzer J, 2002, FASEB J, V16, P38, DOI 10.1096/fj.01-1036fje; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; LeClerc PC, 2002, ENDOCRINOLOGY, V143, P4702, DOI 10.1210/en.2002-220679; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2009, ANTIOXID REDOX SIGN, V11, P1249, DOI 10.1089/ARS.2008.2407; Lin HW, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-15; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Roepstorff K, 2008, J BIOL CHEM, V283, P7983, DOI 10.1074/jbc.M708281200; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; Shao DM, 2003, FEBS LETT, V550, P101, DOI 10.1016/S0014-5793(03)00845-7; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Smith RM, 1998, CELL SIGNAL, V10, P355, DOI 10.1016/S0898-6568(97)00170-8; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sverdlov M, 2007, J CELL MOL MED, V11, P1239, DOI 10.1111/j.1582-4934.2007.00127.x; Teixeira A, 1999, J NEUROCHEM, V72, P120, DOI 10.1046/j.1471-4159.1999.0720120.x; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; von Bernuth H, 2005, CLIN INFECT DIS, V41, pS436, DOI 10.1086/431994; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; WILSON CA, 1990, J IMMUNOL, V144, P3784; Yamada J, 2003, EXP EYE RES, V76, P161, DOI 10.1016/S0014-4835(02)00293-2; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62; Zuo L, 2005, ARTERIOSCL THROM VAS, V25, P1824, DOI 10.1161/01.ATV.0000175295.09607.18	53	89	90	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33255	33264		10.1074/jbc.M109.042127	http://dx.doi.org/10.1074/jbc.M109.042127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801678	hybrid, Green Published			2022-12-25	WOS:000272028500030
J	Diani, L; Colombelli, C; Nachimuthu, BT; Donnianni, R; Plevani, P; Muzi-Falconi, M; Pellicioli, A				Diani, Laura; Colombelli, Claudia; Nachimuthu, Benjamin Tamilselvan; Donnianni, Roberto; Plevani, Paolo; Muzi-Falconi, Marco; Pellicioli, Achille			Saccharomyces CDK1 Phosphorylates Rad53 Kinase in Metaphase, Influencing Cellular Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT ACTIVATION; PROTEIN-INTERACTION; BUDDING YEAST; DNA-DAMAGE; CEREVISIAE; GROWTH; DOMAIN; PHASE; CYCLE	Rad53 is an essential protein kinase governing DNA damage and replication stress checkpoints in budding yeast. It also appears to be involved in cellular morphogenesis processes. Mass spectrometry analyses revealed that Rad53 is phosphorylated at multiple SQ/TQ and at SP/TP residues, which are typical consensus sites for phosphatidylinositol 3-kinase-related kinases and CDKs, respectively. Here we show that Clb-CDK1 phosphorylates Rad53 at Ser(774) in metaphase. This phosphorylation event does not influence the DNA damage and replication checkpoint roles of Rad53, and it is independent of the spindle assembly checkpoint network. Moreover, the Ser-to-Asp mutation, mimicking a constitutive phosphorylation state at site 774, causes sensitivity to calcofluor, supporting a functional linkage between Rad53 and cellular morphogenesis.	[Diani, Laura; Colombelli, Claudia; Nachimuthu, Benjamin Tamilselvan; Donnianni, Roberto; Plevani, Paolo; Muzi-Falconi, Marco; Pellicioli, Achille] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy	University of Milan	Pellicioli, A (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Via Celoria 26, I-20133 Milan, Italy.	achille.pellicioli@unimi.it	Nachimuthu, Benjamin Tamilselvan/AAE-6473-2019; Muzi-Falconi, Marco/A-6035-2012; Pellicioli, Achille/B-8765-2017	Muzi-Falconi, Marco/0000-0001-7046-6090; Pellicioli, Achille/0000-0002-1528-9009; PLEVANI, PAOLO/0000-0003-1869-2626	Associazione Italiana Ricerca sul Cancro; Fondazione Cariplo; European Union; Ministero dell'Istruzione; dell'Universita' d della Ricerca	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); European Union(European Commission); Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita' d della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from Associazione Italiana Ricerca sul Cancro, Fondazione Cariplo, the European Union FP6 Integrated Project DNA Repair, and Ministero dell'Istruzione, dell'Universita' d della Ricerca (to A. P., M. M.- F., and P. P.).	Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Clemenson C, 2006, MOL CELL BIOL, V26, P9149, DOI 10.1128/MCB.00310-06; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Enserink JM, 2006, J CELL BIOL, V175, P729, DOI 10.1083/jcb.200605080; Enserink JM, 2009, J CELL BIOL, V185, P423, DOI 10.1083/jcb.200811083; Fay DS, 1997, CURR GENET, V31, P97, DOI 10.1007/s002940050181; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; Hammet A, 2003, IUBMB LIFE, V55, P23, DOI 10.1080/1521654031000070636; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Lim HH, 1998, CURR BIOL, V8, P231, DOI 10.1016/S0960-9822(98)70088-0; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pellicioli A, 2005, CURR BIOL, V15, pR769, DOI 10.1016/j.cub.2005.08.057; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; STRACKER TH, 2009, DNA REPAIR AMST; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; ZHENG P, 1993, MOL CELL BIOL, V13, P5829, DOI 10.1128/MCB.13.9.5829	25	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32627	32634		10.1074/jbc.M109.048157	http://dx.doi.org/10.1074/jbc.M109.048157			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801655	hybrid, Green Published			2022-12-25	WOS:000272028400045
J	Masson, O; Chavey, C; Dray, C; Meulle, A; Daviaud, D; Quilliot, D; Muller, C; Valet, P; Liaudet-Coopman, E				Masson, Olivier; Chavey, Carine; Dray, Cedric; Meulle, Aline; Daviaud, Danielle; Quilliot, Didier; Muller, Catherine; Valet, Philippe; Liaudet-Coopman, Emmanuelle			LRP1 Receptor Controls Adipogenesis and Is Up-Regulated In Human and Mouse Obese Adipose Tissue	PLOS ONE			English	Article								The cell surface low-density lipoprotein receptor-related protein 1, LRP1, plays a major role in lipid metabolism. The question that remains open concerns the function of LRP1 in adipogenesis. Here, we show that LRP1 is highly expressed in murine preadipocytes as well as in primary culture of human adipocytes. Moreover, LRP1 remains abundantly synthesised during mouse and human adipocyte differentiation. We demonstrate that LRP1 silencing in 3T3F442A murine preadipocytes significantly inhibits the expression of PPAR gamma, HSL and aP2 adipocyte differentiation markers after adipogenesis induction, and leads to lipid-depleted cells. We further show that the absence of lipids in LRP1-silenced preadipocytes is not caused by lipolysis induction. In addition, we provide the first evidences that LRP1 is significantly up-regulated in obese C57BI6/J mouse adipocytes and obese human adipose tissues. Interestingly, silencing of LRP1 in fully-differentiated adipocytes also reduces cellular lipid level and is associated with an increase of basal lipolysis. However, the ability of mature adipocytes to induce lipolysis is independent of LRP1 expression. Altogether, our findings highlight the dual role of LRP1 in the control of adipogenesis and lipid homeostasis, and suggest that LRP1 may be an important therapeutic target in obesity.			Masson, O (corresponding author), Univ Montpellier 1, INSERM, IRCM,U896, CRLC Val Aurelle Paul Lamarque, Montpellier, France.	e.liaudet@valdorel.fnclcc.fr	Meulle, Aline/M-6370-2014; MULLER, Catherine/M-2185-2018; Liaudet-Coopman, Emmanuelle/N-4744-2017; Valet, Philippe/N-7472-2017; MULLER, Catherine/E-2060-2011; Quillot, Didier/ABB-5326-2021; dray, cedric/N-7440-2017	Liaudet-Coopman, Emmanuelle/0000-0001-9313-9690; Valet, Philippe/0000-0001-6520-7393; DRAY, Cedric/0000-0002-4712-791X; Chavey, Carine/0000-0002-5267-5638				BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Bour S, 2007, BIOCHIMIE, V89, P916, DOI 10.1016/j.biochi.2007.02.013; CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; CHAPPELL DA, 1994, J BIOL CHEM, V269, P18001; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; DESCAMPS O, 1993, J BIOL CHEM, V268, P974; Fears CY, 2005, CANCER RES, V65, P9338, DOI 10.1158/0008-5472.CAN-05-1560; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Gauthier A, 2003, J BIOL CHEM, V278, P11945, DOI 10.1074/jbc.M212989200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Heeren J, 2002, J MOL MED-JMM, V80, P576, DOI 10.1007/s00109-002-0351-5; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; JI ZS, 1993, J BIOL CHEM, V268, P10160; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P9307, DOI 10.1074/jbc.270.16.9307; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; NYKJAER A, 1993, J BIOL CHEM, V268, P15048; Prawitt J, 2008, EXP CELL RES, V314, P814, DOI 10.1016/j.yexcr.2007.11.011; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vassiliou G, 2001, J BIOL CHEM, V276, P48823, DOI 10.1074/jbc.M103954200; VIGNON F, 1986, ENDOCRINOLOGY, V118, P1537, DOI 10.1210/endo-118-4-1537; WILLNOW TE, 1994, J CELL SCI, V107, P719; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; Yue LL, 2004, J BIOL CHEM, V279, P47626, DOI 10.1074/jbc.M408461200; Zhang HY, 2004, J BIOL CHEM, V279, P2221, DOI 10.1074/jbc.M310679200; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	34	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7422	10.1371/journal.pone.0007422	http://dx.doi.org/10.1371/journal.pone.0007422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823686	Green Published, gold, Green Submitted			2022-12-25	WOS:000270728500020
J	Ropert-Coudert, Y; Brooks, L; Yamamoto, M; Kato, A				Ropert-Coudert, Yan; Brooks, Lisa; Yamamoto, Maki; Kato, Akiko			ECG Response of Koalas to Tourists Proximity: A Preliminary Study	PLOS ONE			English	Article								Koalas operate on a tight energy budget and, thus, may not always display behavioral avoidance reaction when placed in a stressful condition. We investigated the physiological response of captive koalas Phascolarctos cinereus in a conservation centre to the presence of tourists walking through their habitat. We compared, using animal-attached data-recorders, the electrocardiogram activity of female koalas in contact with tourists and in a human-free area. One of the koalas in the tourist zone presented elevated heart rate values and variability throughout the recording period. The remaining female in the exhibit area showed a higher field resting heart rates during the daytime than that in the isolated area. In the evening, heart rate profiles changed drastically and both the koalas in the exhibit and in the tourist-free zones displayed similar field resting heart rates, which were lower than those during the day. In parallel, the autonomic nervous systems of these two individuals evolved from sympathetic-dominant during the day to parasympathetic-dominant in the evening. Our results report ECG of free-living koalas for the first time. Although they are preliminary due to the difficulty of having sufficient samples of animals of the same sex and age, our results stress out the importance of studies investigating the physiological reaction of animals to tourists.	[Ropert-Coudert, Yan] Inst Pluridisciplinaire Hubert Curien, UMR7178, Strasbourg, France; [Brooks, Lisa] Phillip Isl Nat Pk, Koala Conservat Ctr, Cowes, Vic, Australia; [Yamamoto, Maki] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata, Japan; [Kato, Akiko] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Nagaoka University of Technology; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Ropert-Coudert, Y (corresponding author), Inst Pluridisciplinaire Hubert Curien, UMR7178, Strasbourg, France.	yan.ropert-coudert@c-strasbourg.fr	Kato, Akiko/W-2447-2019	Kato, Akiko/0000-0002-8947-3634				Accorsi PA, 2008, GEN COMP ENDOCR, V155, P398, DOI 10.1016/j.ygcen.2007.07.002; BLANSHARD W, 1994, WILDLIFE, P547; Culik B., 1990, P177; De Villiers M, 2006, POLAR BIOL, V29, P717, DOI 10.1007/s00300-006-0137-2; Eckert R, 1978, ANIMAL PHYSL; FISHER LA, 1983, REGUL PEPTIDES, V5, P153, DOI 10.1016/0167-0115(83)90123-4; Froget G, 2002, J EXP BIOL, V205, P2511; Handasyde, 1999, KOALA NATURAL HIST C; Hume I.D., 1999, MARSUPIAL NUTR; JACKSON SM, 2003, AUSTR MAMMALS BIOL C, P163; KINNEAR JE, 1967, NATURE, V215, P1501, DOI 10.1038/2151501a0; Krockenberger AK, 2007, FUNCT ECOL, V21, P748, DOI 10.1111/j.1365-2435.2007.01279.x; Kuwahara M, 1999, LAB ANIM SCI, V49, P202; Kuwahara M, 1996, J AUTONOM NERV SYST, V60, P43, DOI 10.1016/0165-1838(96)00028-8; McPhee JM, 2003, J EXP BIOL, V206, P1941, DOI 10.1242/jeb.00369; NAGY KA, 1985, AUST J ZOOL, V33, P655, DOI 10.1071/ZO9850655; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Ropert-Coudert Y, 2006, MAR ECOL PROG SER, V328, P275, DOI 10.3354/meps328275; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Ward S, 2002, J EXP BIOL, V205, P3347; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; YAMAMOTO M, 2001, THESIS GRADUATE U AD	24	12	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7378	10.1371/journal.pone.0007378	http://dx.doi.org/10.1371/journal.pone.0007378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823679	gold, Green Submitted, Green Published			2022-12-25	WOS:000270728500004
J	Sears, DD; Miles, PD; Chapman, J; Ofrecio, JM; Almazan, F; Thapar, D; Miller, YI				Sears, Dorothy D.; Miles, Philip D.; Chapman, Justin; Ofrecio, Jachelle M.; Almazan, Felicidad; Thapar, Divya; Miller, Yury I.			12/15-Lipoxygenase Is Required for the Early Onset of High Fat Diet-Induced Adipose Tissue Inflammation and Insulin Resistance in Mice	PLOS ONE			English	Article								Background: Recent understanding that insulin resistance is an inflammatory condition necessitates searching for genes that regulate inflammation in insulin sensitive tissues. 12/15-lipoxygenase (12/15LO) regulates the expression of proinflammatory cytokines and chemokines and is implicated in the early development of diet-induced atherosclerosis. Thus, we tested the hypothesis that 12/15LO is involved in the onset of high fat diet (HFD)-induced insulin resistance. Methodology/Principal Findings: Cells over-expressing 12/15LO secreted two potent chemokines, MCP-1 and osteopontin, implicated in the development of insulin resistance. We assessed adipose tissue inflammation and whole body insulin resistance in wild type (WT) and 12/15LO knockout (KO) mice after 2-4 weeks on HFD. In adipose tissue from WT mice, HFD resulted in recruitment of CD11b(+), F4/80(+) macrophages and elevated protein levels of the inflammatory markers IL-1 beta, IL-6, IL-10, IL-12, IFNc, Cxcl1 and TNF alpha. Remarkably, adipose tissue from HFD-fed 12/15LO KO mice was not infiltrated by macrophages and did not display any increase in the inflammatory markers compared to adipose tissue from normal chow-fed mice. WT mice developed severe whole body (hepatic and skeletal muscle) insulin resistance after HFD, as measured by hyperinsulinemic euglycemic clamp. In contrast, 12/15LO KO mice exhibited no HFD-induced change in insulin-stimulated glucose disposal rate or hepatic glucose output during clamp studies. Insulin-stimulated Akt phosphorylation in muscle tissue from HFD-fed mice was significantly greater in 12/15LO KO mice than in WT mice. Conclusions: These results demonstrate that 12/15LO mediates early stages of adipose tissue inflammation and whole body insulin resistance induced by high fat feeding.			Sears, DD (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	dsears@ucsd.edu	Sears, Dorothy D/AHE-5524-2022	Sears, Dorothy D/0000-0002-9260-3540	NHLBI NIH HHS [R01 HL081862, R01HL081862] Funding Source: Medline; NIDDK NIH HHS [K01-DK62025, K01 DK062025] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK062025] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENZ DJ, 1995, J BIOL CHEM, V270, P5191, DOI 10.1074/jbc.270.10.5191; Bolick DT, 2006, ARTERIOSCL THROM VAS, V26, P1260, DOI 10.1161/01.ATV.0000217909.09198.d6; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Browse J, 2005, VITAM HORM, V72, P431, DOI 10.1016/S0083-6729(05)72012-4; CHAKRABARTI SK, 2009, 12 15 LIPOXYGENASE P; Chen M, 2005, DIABETOLOGIA, V48, P486, DOI 10.1007/s00125-005-1673-y; Cyrus T, 2001, CIRCULATION, V103, P2277; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Delker C, 2006, PLANT BIOLOGY, V8, P297, DOI 10.1055/s-2006-923935; Dwarakanath RS, 2008, J VASC RES, V45, P132, DOI 10.1159/000109966; Dwarakanath RS, 2004, J MOL CELL CARDIOL, V36, P585, DOI 10.1016/j.yjmcc.2004.02.007; EZAKI M, 1995, J LIPID RES, V36, P1996; Hatley ME, 2003, J BIOL CHEM, V278, P25369, DOI 10.1074/jbc.M301175200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Li SL, 2006, DIABETES, V55, P2611, DOI 10.2337/db06-0164; Li SL, 2005, J LIPID RES, V46, P220, DOI 10.1194/jlr.M400328-JLR200; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Natarajan R, 1997, HYPERTENSION, V30, P873, DOI 10.1161/01.HYP.30.4.873; NATARAJAN R, 1993, P NATL ACAD SCI USA, V90, P4947, DOI 10.1073/pnas.90.11.4947; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; Natarajan R, 2001, ARTERIOSCL THROM VAS, V21, P1408, DOI 10.1161/hq0901.095278; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Patricia MK, 2001, CIRC RES, V88, P659, DOI 10.1161/hh0701.088838; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; Scheidegger KJ, 1997, J BIOL CHEM, V272, P21609, DOI 10.1074/jbc.272.34.21609; Spanbroek R, 2001, P NATL ACAD SCI USA, V98, P5152, DOI 10.1073/pnas.091076998; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen YH, 2008, AM J PHYSIOL-HEART C, V294, pH1933, DOI 10.1152/ajpheart.00260.2007; Wen YS, 2007, ENDOCRINOLOGY, V148, P1313, DOI 10.1210/en.2006-0665; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003	47	104	107	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7250	10.1371/journal.pone.0007250	http://dx.doi.org/10.1371/journal.pone.0007250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787041	gold, Green Published, Green Submitted			2022-12-25	WOS:000270290100023
J	Murayama, K; Nakayama, S; Kato-Murayama, M; Akasaka, R; Ohbayashi, N; Kamewari-Hayami, Y; Terada, T; Shirouzu, M; Tsurumi, T; Yokoyama, S				Murayama, Kazutaka; Nakayama, Sanae; Kato-Murayama, Miyuki; Akasaka, Ryogo; Ohbayashi, Naomi; Kamewari-Hayami, Yuki; Terada, Takaho; Shirouzu, Mikako; Tsurumi, Tatsuya; Yokoyama, Shigeyuki			Crystal Structure of Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; ACCESSORY PROTEIN; SLIDING CLAMP; C-TERMINUS; FUNCTIONAL INTERACTION; BINDING ACTIVITY; REPLICATION; UL42; PURIFICATION; SPECIFICITY	The DNA polymerase processivity factor of the Epstein-Barr virus, BMRF1, associates with the polymerase catalytic subunit, BALF5, to enhance the polymerase processivity and exonuclease activities of the holoenzyme. In this study, the crystal structure of C-terminally truncated BMRF1 (BMRF1-Delta C) was solved in an oligomeric state. The molecular structure of BMRF1-Delta C shares structural similarity with other processivity factors, such as herpes simplex virus UL42, cytomegalovirus UL44, and human proliferating cell nuclear antigen. However, the oligomerization architectures of these proteins range from a monomer to a trimer. PAGE and mutational analyses indicated that BMRF1-Delta C, like UL44, forms a C-shaped head-to-head dimer. DNA binding assays suggested that basic amino acid residues on the concave surface of the C-shaped dimer play an important role in interactions with DNA. The C95E mutant, which disrupts dimer formation, lacked DNA binding activity, indicating that dimer formation is required for DNA binding. These characteristics are similar to those of another dimeric viral processivity factor, UL44. Although the R87E and H141F mutants of BMRF1-Delta C exhibited dramatically reduced polymerase processivity, they were still able to bind DNA and to dimerize. These amino acid residues are located near the dimer interface, suggesting that BMRF1-Delta C associates with the catalytic subunit BALF5 around the dimer interface. Consequently, the monomeric form of BMRF1-Delta C probably binds to BALF5, because the steric consequences would prevent the maintenance of the dimeric form. A distinctive feature of BMRF1-Delta C is that the dimeric and monomeric forms might be utilized for the DNA binding and replication processes, respectively.	[Nakayama, Sanae; Tsurumi, Tatsuya] Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, Nagoya, Aichi 4648681, Japan; Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Measurements & Diagnost, Sendai, Miyagi 9808575, Japan; [Murayama, Kazutaka; Kato-Murayama, Miyuki; Akasaka, Ryogo; Ohbayashi, Naomi; Kamewari-Hayami, Yuki; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN, Syst Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan	Aichi Cancer Center; Tohoku University; RIKEN; University of Tokyo	Tsurumi, T (corresponding author), Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338	Special Coordination Funds for Promoting Science and Technology; RIKEN; Ministry of Education, Culture, Sports, Science, and Technology	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Special Coordination Funds for Promoting Science and Technology and the RIKEN Structure Genomics/Proteomics Initiative in the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science, and Technology.	Appleton BA, 2006, J BIOL CHEM, V281, P5224, DOI 10.1074/jbc.M506900200; Appleton BA, 2004, MOL CELL, V15, P233, DOI 10.1016/j.molcel.2004.06.018; Argiriadi MA, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bruck I, 2001, GENOME BIOL, V2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chen XL, 2004, J BIOL CHEM, V279, P28375, DOI 10.1074/jbc.M400032200; CHOW CS, 1995, J VIROL, V69, P6965, DOI 10.1128/JVI.69.11.6965-6971.1995; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIGARD P, 1993, J VIROL, V67, P398, DOI 10.1128/JVI.67.1.398-406.1993; FIXMAN ED, 1995, J VIROL, V69, P2998, DOI 10.1128/JVI.69.5.2998-3006.1995; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kigawa Takanori, 2002, Journal of Structural and Functional Genomics, V2, P29, DOI 10.1023/A:1013203532303; Komazin-Meredith G, 2008, STRUCTURE, V16, P1214, DOI 10.1016/j.str.2008.05.008; Komazin-Meredith G, 2008, J BIOL CHEM, V283, P6154, DOI 10.1074/jbc.M708691200; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Loregian A, 2004, J VIROL, V78, P158, DOI 10.1128/JVI.78.1.158-167.2004; Loregian A, 2007, NUCLEIC ACIDS RES, V35, P4779, DOI 10.1093/nar/gkm506; Makhov AM, 2004, J BIOL CHEM, V279, P40358, DOI 10.1074/jbc.M408733200; Matsumiya S, 2003, PROTEIN SCI, V12, P823, DOI 10.1110/ps.0234503; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Randell JCW, 2005, J VIROL, V79, P12025, DOI 10.1128/JVI.79.18.12025-12034.2005; Randell JCW, 2004, J MOL BIOL, V335, P409, DOI 10.1016/j.jmb.2003.10.064; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Tsurumi T, 1996, VIROLOGY, V222, P352, DOI 10.1006/viro.1996.0432; TSURUMI T, 1993, J VIROL, V67, P1681, DOI 10.1128/JVI.67.3.1681-1687.1993; TSURUMI T, 1991, BIOCHEM J, V280, P703, DOI 10.1042/bj2800703; TSURUMI T, 1994, J VIROL, V68, P3354, DOI 10.1128/JVI.68.5.3354-3363.1994; TSURUMI T, 1993, J VIROL, V67, P7648, DOI 10.1128/JVI.67.12.7648-7653.1993; TSURUMI T, 1991, VIROLOGY, V182, P376, DOI 10.1016/0042-6822(91)90685-5; Tsurumi T, 2001, CURR TOP MICROBIOL, V258, P65; VILLANI G, 1981, J BIOL CHEM, V256, P8202; Weisshart K, 1999, J VIROL, V73, P55, DOI 10.1128/JVI.73.1.55-66.1999; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	48	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35896	35905		10.1074/jbc.M109.051581	http://dx.doi.org/10.1074/jbc.M109.051581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19801550	hybrid, Green Published			2022-12-25	WOS:000272645600065
J	Hall, EH; Daugherty, AE; Choi, CK; Horwitz, AF; Brautigan, DL				Hall, Emily H.; Daugherty, Abbi E.; Choi, Colin K.; Horwitz, Alan F.; Brautigan, David L.			Tensin1 Requires Protein Phosphatase-1 alpha in Addition to RhoGAP DLC-1 to Control Cell Polarization, Migration, and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; FOCAL ADHESIONS; MATRIX ADHESIONS; TUMOR-SUPPRESSOR; LIVER; DROSOPHILA; DYNAMICS; INTEGRIN; DOMAIN; SWITCH	Tensin is a family of multidomain scaffold proteins that bind the cytoplasmic tail of beta-integrins and localize to adhesions that anchor stress fibers in cells. Tensin expression is suppressed in cancer, especially metastatic cancer. The N-terminal domain of tensin1 associates with protein phosphatase-1 alpha (PP1 alpha) and mediates PP1 alpha localization to adhesions. Here, we show F302A mutation in aKVXF motif of tensin1 abrogates binding to PP1 alpha. The SH2 domain in tensin family member c-ten requires R474 to bind a RhoGAP called DLC-1 (deleted in liver cancer). We mutated the corresponding residue in tensin1, R1488A, and showed this reduces association with DLC-1. Unexpectedly, tensin1 F302A also had reduced association with DLC-1. Expression of tensin1 F302A or R1488A showed similar dominant phenotypes, with reduced cell polarization, lowered MLC20 phosphorylation and reduced levels of RhoA(GTP) compared with cells expressing tensin1 WT. However, migration and invasion of metastatic MDA MB 231 breast cancer cells were differentially affected by tensin1 mutated at F302A or R1488A. Cancer cells stably expressing F302A tensin1 showed increased migration and invasion compared with cells stably expressing either R1488A tensin1 or WT tensin1. This suggests that PP1 alpha bound to tensin1 has additional effects in reducing migration and invasion that are not mediated through DLC-1. Our results show the importance of PP1 alpha binding to tensin1 for the regulation of cell polarization, migration, and invasion.	[Hall, Emily H.; Daugherty, Abbi E.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Hall, Emily H.; Daugherty, Abbi E.; Brautigan, David L.] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Choi, Colin K.] Univ Virginia, Sch Med, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Horwitz, Alan F.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Brautigan, DL (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, POB 800577, Charlottesville, VA 22908 USA.	db8g@virginia.edu			National Institutes of Health [CA40042, GM23244, T32 CA009109]; NATIONAL CANCER INSTITUTE [P01CA040042, T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023244, R37GM023244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA40042, GM23244, and T32 CA009109.	Chen HY, 2000, BIOCHEM J, V351, P403, DOI 10.1042/0264-6021:3510403; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Eto M, 2007, J BIOL CHEM, V282, P17806, DOI 10.1074/jbc.M700944200; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hers I, 2006, J BIOL CHEM, V281, P4762, DOI 10.1074/jbc.M511008200; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Lo SH, 1997, J CELL BIOL, V136, P1349, DOI 10.1083/jcb.136.6.1349; Mouneimne G, 2007, DEV CELL, V13, P317, DOI 10.1016/j.devcel.2007.08.010; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Pylayeva Y, 2007, NAT CELL BIOL, V9, P877, DOI 10.1038/ncb0807-877; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 1999, J CELL SCI, V112, P1655	26	39	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34713	34722		10.1074/jbc.M109.059592	http://dx.doi.org/10.1074/jbc.M109.059592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826001	Green Published, hybrid			2022-12-25	WOS:000272439600027
J	Bando, M; Katou, Y; Komata, M; Tanaka, H; Itoh, T; Sutani, T; Shirahige, K				Bando, Masashige; Katou, Yuki; Komata, Makiko; Tanaka, Hirokazu; Itoh, Takehiko; Sutani, Takashi; Shirahige, Katsuhiko			Csm3, Tof1, and Mrc1 Form a Heterotrimeric Mediator Complex That Associates with DNA Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC DNA; PROGRESSION; HELICASE; STRESS; RAD53; MCM; COMPONENTS; RESPONSES	Mrc1(mediator of replication checkpoint), Tof1 (topoisomerase I interacting factor), and Csm3 (chromosome segregation in meiosis) are checkpoint-mediator proteins that function during DNA replication and activate the effector kinase Rad53. We reported previously that Mrc1 and Tof1 are constituents of the replication machinery and that both proteins are required for the proper arrest and stabilization of replication forks in the presence of hydroxyurea. In our current study, we show that Csm3 is a component of moving replication forks and that both Tof1 and Csm3 are specifically required for the association of Mrc1 with these structures. In contrast, the deletion of mrc1 did not affect the association of Tof1 and Csm3 with the replication fork complex. In agreement with previous observations in yeast cells, the results of a baculovirus coexpression system showed that these three proteins interact directly with each other to form a mediator complex in the absence of replication forks.	[Bando, Masashige; Katou, Yuki; Komata, Makiko; Tanaka, Hirokazu; Itoh, Takehiko; Sutani, Takashi; Shirahige, Katsuhiko] Tokyo Inst Technol, Dept Biol Sci, Lab Chromosome Struct & Funct, Grad Sch Biosci & Biotechnol,Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Shirahige, K (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Lab Chromosome Struct & Funct, Grad Sch Biosci & Biotechnol,Midori Ku, B-20,4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	kshirahi@bio.titech.ac.jp	Itoh, Takehiko/E-8873-2014	Itoh, Takehiko/0000-0002-6113-557X; Shirahige, Katsuhiko/0000-0002-7862-1144; Sutani, Takashi/0000-0002-9959-9513	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported in part by Grants-in-aid on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. To whom correspondence should be addressed. Tel.: 81-45-924-5812; Fax: 81-45-924-5814; E-mail: kshirahi@bio.titech.ac.jp.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Foss EJ, 2001, GENETICS, V157, P567; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gottifredi V, 2005, SEMIN CELL DEV BIOL, V16, P355, DOI 10.1016/j.semcdb.2005.02.011; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Hori Y, 1996, MOL BIOL CELL, V7, P409, DOI 10.1091/mbc.7.3.409; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Komata M, 2009, MOL CELL BIOL, V29, P5008, DOI 10.1128/MCB.01934-08; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004	30	98	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34355	34365		10.1074/jbc.M109.065730	http://dx.doi.org/10.1074/jbc.M109.065730			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19819872	Green Published, hybrid			2022-12-25	WOS:000272165200065
J	Kim, SC; Kang, L; Nagaraj, S; Blancaflor, EB; Mysore, KS; Chapman, KD				Kim, Sang-Chul; Kang, Li; Nagaraj, Satish; Blancaflor, Elison B.; Mysore, Kirankumar S.; Chapman, Kent D.			Mutations in Arabidopsis Fatty Acid Amide Hydrolase Reveal That Catalytic Activity Influences Growth but Not Sensitivity to Abscisic Acid or Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACYLETHANOLAMINES; SIGNATURE FAMILY; ANANDAMIDE AMIDOHYDROLASE; ENDOCANNABINOID SYSTEM; THALIANA SEEDLINGS; ENZYME; LIPIDS; PLANTS; 2-ARACHIDONOYLGLYCEROL; IDENTIFICATION	Fatty acid amide hydrolase (FAAH) terminates the endocannabinoid signaling pathway that regulates numerous neurobehavioral processes in animals by hydrolyzing N-acylethanolamines (NAEs). Recently, an Arabidopsis FAAH homologue (AtFAAH) was identified, and several studies, especially those using AtFAAH overexpressing and knock-out lines, have suggested an in vivo role for FAAH in the catabolism of NAEs in plants. We previously reported that overexpression of AtFAAH in Arabidopsis resulted in accelerated seedling growth, and in seedlings that were insensitive to exogenous NAEs but hypersensitive to abscisic acid (ABA) and hypersusceptible to nonhost pathogens. Here we show that whereas the enhanced growth and NAE tolerance of the AtFAAH overexpressing seedlings depend on the catalytic activity of AtFAAH, hypersensitivity to ABA and hypersusceptibility to nonhost pathogens are independent of its enzymatic activity. Five amino acids known to be critical for rat FAAH activity are also conserved in AtFAAH (Lys-205, Ser-281, Ser-282, Ser-305, and Arg-307). Site-directed mutation of each of these conserved residues in AtFAAH abolished its hydrolytic activity when expressed in Escherichia coli, supporting a common catalytic mechanism in animal and plant FAAH enzymes. Overexpression of these inactive AtFAAH mutants in Arabidopsis showed no growth enhancement and no NAE tolerance, but still rendered the seedlings hypersensitive to ABA and hypersusceptible to nonhost pathogens to a degree similar to the overexpression of the native AtFAAH. Taken together, our findings suggest that the AtFAAH influences plant growth and interacts with ABA signaling and plant defense through distinctly different mechanisms.	[Kang, Li; Nagaraj, Satish; Blancaflor, Elison B.; Mysore, Kirankumar S.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; [Kim, Sang-Chul; Blancaflor, Elison B.; Chapman, Kent D.] Univ N Texas, Ctr Plant Lipid Res, Dept Biol Sci, Denton, TX 76203 USA	Noble Research Institute; University of North Texas System; University of North Texas Denton	Mysore, KS (corresponding author), 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	ksmysore@noble.org; chapman@unt.edu	Mysore, Kirankumar/AAG-7112-2020	Mysore, Kirankumar/0000-0002-9805-5741; Chapman, Kent/0000-0003-0489-3072; Blancaflor, Elison/0000-0001-6115-9670	Samuel Roberts Noble Foundation; United States Department of Energy Office of Science (BES) [DE-FG02-05ER15647]	Samuel Roberts Noble Foundation; United States Department of Energy Office of Science (BES)(United States Department of Energy (DOE))	This work was supported by the Samuel Roberts Noble Foundation and a grant from the United States Department of Energy Office of Science (BES) agreement number DE-FG02-05ER15647 (to E. B. B. and K. D. C.).	Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Cai G, 2005, FEMS MICROBIOL LETT, V249, P15, DOI 10.1016/j.femsle.2005.05.038; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; Chapman KD, 1998, PLANT PHYSIOL, V116, P1163, DOI 10.1104/pp.116.3.1163; Chebrou H, 1996, BBA-PROTEIN STRUCT M, V1298, P285, DOI 10.1016/S0167-4838(96)00145-8; Clement AB, 2003, J NEUROSCI, V23, P3916; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Fezza Filomena, 2008, V49, P101, DOI 10.1007/978-1-4020-8831-5_4; Fowler CJ, 2006, FUND CLIN PHARMACOL, V20, P549, DOI 10.1111/j.1472-8206.2006.00442.x; Fowler CJ, 2001, BIOCHEM PHARMACOL, V62, P517, DOI 10.1016/S0006-2952(01)00712-2; Gertsch J, 2008, PLANTA MED, V74, P638, DOI 10.1055/s-2008-1034302; Ghafouri N, 2004, BRIT J PHARMACOL, V143, P774, DOI 10.1038/sj.bjp.0705948; Gopalakrishna KN, 2004, BIOCHEMISTRY-US, V43, P7725, DOI 10.1021/bi049907q; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; Labahn J, 2002, J MOL BIOL, V322, P1053, DOI 10.1016/S0022-2836(02)00886-0; Labar G, 2007, CHEM BIODIVERS, V4, P1882, DOI 10.1002/cbdv.200790157; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Maurelli S, 1995, FEBS LETT, V377, P82, DOI 10.1016/0014-5793(95)01311-3; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; McKinney MK, 2003, J BIOL CHEM, V278, P37393, DOI 10.1074/jbc.M303922200; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Patricelli MP, 2000, J BIOL CHEM, V275, P19177, DOI 10.1074/jbc.M001607200; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P14125, DOI 10.1021/bi991876p; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P9804, DOI 10.1021/bi990637z; SCHMID PC, 1985, J BIOL CHEM, V260, P4145; Shrestha R, 2003, J BIOL CHEM, V278, P34990, DOI 10.1074/jbc.M305613200; Shrestha R, 2002, PLANT PHYSIOL, V130, P391, DOI 10.1104/pp.004689; Shrestha R, 2006, BBA-MOL CELL BIOL L, V1761, P324, DOI 10.1016/j.bbalip.2006.03.004; Teaster ND, 2007, PLANT CELL, V19, P2454, DOI 10.1105/tpc.106.048702; UEDA N, 1995, J BIOL CHEM, V270, P23823, DOI 10.1074/jbc.270.40.23823; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103; Yates ML, 2007, FASEB J, V21, pA1177	40	18	20	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34065	34074		10.1074/jbc.M109.059022	http://dx.doi.org/10.1074/jbc.M109.059022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801664	Green Published, hybrid			2022-12-25	WOS:000272165200039
J	Ge, CX; Xiao, GZ; Jiang, D; Yang, Q; Hatch, NE; Roca, H; Franceschi, RT				Ge, Chunxi; Xiao, Guozhi; Jiang, Di; Yang, Qian; Hatch, Nan E.; Roca, Hernan; Franceschi, Renny T.			Identification and Functional Characterization of ERK/MAPK Phosphorylation Sites in the Runx2 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; MYELOID-LEUKEMIA GENE; GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; CELL-DIFFERENTIATION; MAMMALIAN-CELLS; ASCORBIC-ACID; IN-VITRO; KINASE; EXPRESSION	The Runx2 transcription factor is required for commitment of mesenchymal cells to bone lineages and is a major regulator of osteoblast-specific gene expression. Runx2 is subject to a number of post-transcriptional controls including selective proteolysis and phosphorylation. We previously reported that Runx2 is phosphorylated and activated by the ERK/MAPK pathway (Xiao, G., Jiang, D., Thomas, P., Benson, M. D., Guan, K., Karsenty, G., and Franceschi, R. T. (2000) J. Biol. Chem. 275, 4453-4459). In this study, we used a combination of in vitro and in vivo phosphorylation analysis, mass spectroscopy, and functional assays to identify two sites at Ser(301) and Ser(319) within the proline/serine/threonine domain of Runx2 that are required for this regulation. These sites are phosphorylated by activated ERK1 in vitro and in cell culture. In addition to confirming ERK-dependent phosphorylation at Ser(319), mass spectroscopy identified two other ERK-phosphorylated sites at Ser(43) and Ser(510). Furthermore, introduction of S301A, S319A mutations rendered Runx2 resistant to MAPK-dependent activation and reduced its ability to stimulate osteoblast-specific gene expression and differentiation after transfection into Runx2-null calvarial cells and mesenchymal cells. In contrast, S301E, S319E Runx2 mutants had enhanced transcriptional activity that was minimally dependent on MAPK signaling, consistent with the addition of a negative charge mimicking serine phosphorylation. These results emphasize the important role played by Runx2 phosphorylation in the control of osteoblast gene expression and provide a mechanism to explain how physiological signals acting on bone through the ERK/MAPK pathway can stimulate osteoblast-specific gene expression.	[Franceschi, Renny T.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Franceschi, Renny T.] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; [Xiao, Guozhi] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15240 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Franceschi, RT (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, 1101 N Univ Ave, Ann Arbor, MI 48109 USA.	rennyf@umich.edu	Hatch, Nan/ABC-9177-2020; Hatch, Nan/AAQ-8465-2020	Hatch, Nan/0000-0002-2632-0841	National Institutes of Health; Department of Defense [W81XWH-07-1-0160];  [DE11723];  [DE12211];  [DK072230]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011723, R01DE012211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); ; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Runx2 phosphorylation and skeletal maturation. Furthermore, Grants DE11723 and DE12211 (to R. T. F.) and Grant DK072230 and Department of Defense Grant W81XWH-07-1-0160 (to G. X.).	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Bae JS, 2007, J CELL BIOCHEM, V100, P434, DOI 10.1002/jcb.21039; Barnes GL, 2004, CANCER RES, V64, P4506, DOI 10.1158/0008-5472.CAN-03-3851; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Kousteni S, 2003, J CLIN INVEST, V111, P1651, DOI 10.1172/JCI200317261; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; LI Y, 2009, J BONE MINE IN PRESS; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Moalli MR, 2001, J APPL PHYSIOL, V91, P912, DOI 10.1152/jappl.2001.91.2.912; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Takeuchi Y, 1996, J BIOL CHEM, V271, P3938; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Tou LQ, 2003, MOL CELL ENDOCRINOL, V205, P121, DOI 10.1016/S0303-7207(03)00151-5; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zayzafoon M, 2004, J BIOL CHEM, V279, P3662, DOI 10.1074/jbc.M308158200; Zetser A, 2001, DEV BIOL, V240, P168, DOI 10.1006/dbio.2001.0465; Zhang YH, 2004, J BIOL CHEM, V279, P53116, DOI 10.1074/jbc.M405502200; ZHENG CF, 1993, J BIOL CHEM, V268, P23933; Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633; Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200	64	170	173	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32533	32543		10.1074/jbc.M109.040980	http://dx.doi.org/10.1074/jbc.M109.040980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801668	Green Published, hybrid			2022-12-25	WOS:000272028400035
J	Kurki, I; Peromaa, T; Hyvarinen, A; Saarinen, J				Kurki, Ilmari; Peromaa, Tarja; Hyvarinen, Aapo; Saarinen, Jussi			Visual Features Underlying Perceived Brightness as Revealed by Classification Images	PLOS ONE			English	Article							LETTER IDENTIFICATION; RECEPTIVE-FIELDS; PERCEPTION; CONTRAST; MODEL; LIGHTNESS	Along with physical luminance, the perceived brightness is known to depend on the spatial structure of the stimulus. Often it is assumed that neural computation of the brightness is based on the analysis of luminance borders of the stimulus. However, this has not been tested directly. We introduce a new variant of the psychophysical reverse-correlation or classification image method to estimate and localize the physical features of the stimuli which correlate with the perceived brightness, using a brightness-matching task. We derive classification images for the illusory Craik-O'Brien-Cornsweet stimulus and a "real'' uniform step stimulus. For both stimuli, classification images reveal a positive peak at the stimulus border, along with a negative peak at the background, but are flat at the center of the stimulus, suggesting that brightness is determined solely by the border information. Features in the perceptually completed area in the Craik-O'Brien-Cornsweet do not contribute to its brightness, nor could we see low-frequency boosting, which has been offered as an explanation for the illusion. Tuning of the classification image profiles changes remarkably little with stimulus size. This supports the idea that only certain spatial scales are used for computing the brightness of a surface.			Kurki, I (corresponding author), Univ Helsinki, Dept Psychol, Fabianinkatu 28, SF-00100 Helsinki, Finland.	ilmari.kurki@helsinki.fi		Peromaa, Tarja/0000-0001-6290-111X; Hyvarinen, Aapo/0000-0002-5806-4432				AREND LE, 1993, PERCEPT PSYCHOPHYS, V54, P446, DOI 10.3758/BF03211767; AREND LE, 1993, PERCEPT PSYCHOPHYS, V54, P457, DOI 10.3758/BF03211768; BEARD B, 1998, SPIE P, P79; BURR DC, 1987, VISION RES, V27, P1903, DOI 10.1016/0042-6989(87)90056-3; CAMPBELL FW, 1965, J PHYSIOL-LONDON, V181, P576, DOI 10.1113/jphysiol.1965.sp007784; Dakin SC, 2003, P ROY SOC B-BIOL SCI, V270, P2341, DOI 10.1098/rspb.2003.2528; Eckstein MP, 2002, J VISION, V2, pI, DOI 10.1167/2.1.i; Efron B., 1994, INTRO BOOTSTRAP; Gold JM, 2000, CURR BIOL, V10, P663, DOI 10.1016/S0960-9822(00)00523-6; Graham N.V.S, 1989, VISUAL PATTERN ANAL; GROSSBERG S, 1988, PERCEPT PSYCHOPHYS, V43, P241, DOI 10.3758/BF03207869; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kontsevich LL, 2004, VISION RES, V44, P1493, DOI 10.1016/j.visres.2003.11.027; Majaj NJ, 2002, VISION RES, V42, P1165, DOI 10.1016/S0042-6989(02)00045-7; Mangini MC, 2004, COGNITIVE SCI, V28, P209, DOI 10.1016/j.cogsci.2003.11.004; MORRONE MC, 1988, PROC R SOC SER B-BIO, V235, P221, DOI 10.1098/rspb.1988.0073; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Pelli DG, 1999, SCIENCE, V285, P844, DOI 10.1126/science.285.5429.844; Perna A, 2007, VISION RES, V47, P1282, DOI 10.1016/j.visres.2007.01.011; Peromaa TL, 2004, VISION RES, V44, P1919, DOI 10.1016/j.visres.2004.03.005; PESSOA L, 1995, VISION RES, V35, P2201, DOI 10.1016/0042-6989(94)00313-0; Salmela VR, 2005, J OPT SOC AM A, V22, P2239, DOI 10.1364/JOSAA.22.002239; Shimozaki SS, 2005, J VISION, V5, P45, DOI 10.1167/5.1.5; SOLOMON JA, 1994, NATURE, V369, P395, DOI 10.1038/369395a0; Tjan BS, 2006, J VISION, V6, P387, DOI 10.1167/6.4.8; WHITTLE P, 1994, LIGHTNESS BRIGHTNESS, P111; Whittle P., 1994, BRIGHTNESS LIGHTNESS, P35	27	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7432	10.1371/journal.pone.0007432	http://dx.doi.org/10.1371/journal.pone.0007432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823590	gold, Green Published, Green Submitted			2022-12-25	WOS:000270808300010
J	Chan, ACH; Borts, RH; Hoffmann, E				Chan, Andrew Chi-Ho; Borts, Rhona H.; Hoffmann, Eva			Temperature-Dependent Modulation of Chromosome Segregation in msh4 Mutants of Budding Yeast	PLOS ONE			English	Article								Background: In many organisms, homologous chromosomes rely upon recombination-mediated linkages, termed crossovers, to promote their accurate segregation at meiosis I. In budding yeast, the evolutionarily conserved mismatch-repair paralogues, Msh4 and Msh5, promote crossover formation in conjunction with several other proteins, collectively termed the Synapsis Initiation Complex (SIC) proteins or 'ZMM's (Zip1-Zip2-Zip3-Zip4-Spo16, Msh4-Msh5, Mer3). zmm mutants show decreased levels of crossovers and increased chromosome missegregation, which is thought to cause decreased spore viability. Principal Findings: In contrast to other ZMM mutants, msh4 and msh5 mutants show improved spore viability and chromosome segregation in response to elevated temperature (23 degrees C versus 33 degrees C). Crossover frequencies in the population of viable spores in msh4 and msh5 mutants are similar at both temperatures, suggesting that temperature-mediated chromosome segregation does not occur by increasing crossover frequencies. Furthermore, meiotic progression defects at elevated temperature do not select for a subpopulation of cells with improved segregation. Instead, another ZMM protein, Zip1, is important for the temperature-dependent improvement in spore viability. Conclusions: Our data demonstrate interactions between genetic (zmm status) and environmental factors in determining chromosome segregation.			Chan, ACH (corresponding author), Univ Sussex, MRC, Genome Damage & Stabil Ctr, Falmer, England.	eh58@sussex.ac.uk	hoffmann, eva/AAM-6594-2020	hoffmann, eva/0000-0002-2588-0652	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Chambers SR, 1996, MOL CELL BIOL, V16, P6110; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; DAWSON DS, 1986, SCIENCE, V234, P713, DOI 10.1126/science.3535068; Hoffmann ER, 2004, CYTOGENET GENOME RES, V107, P232, DOI 10.1159/000080601; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Lacefield S, 2007, NAT GENET, V39, P1273, DOI 10.1038/ng2120; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; LOIDL J, 1994, P NATL ACAD SCI USA, V91, P331, DOI 10.1073/pnas.91.1.331; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Novak JE, 2001, GENETICS, V158, P1013; OBLOMOVA G, 2000, NATURE, V407, P703; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Peoples-Holst TL, 2005, GENE DEV, V19, P863, DOI 10.1101/gad.1293605; PERKINS DD, 1949, GENETICS, V34, P607; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; RESNICK MA, 1989, P NATL ACAD SCI USA, V86, P2276, DOI 10.1073/pnas.86.7.2276; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; SCHWACHA A, 1995, CELL, V83, P738; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; WOLF KW, 1994, BIOESSAYS, V16, P107, DOI 10.1002/bies.950160207	34	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7284	10.1371/journal.pone.0007284	http://dx.doi.org/10.1371/journal.pone.0007284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816584	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000270594300002
J	Chattopadhyay, S; Bhattacharyya, S; Saha, B; Chakraborty, J; Mohanty, S; Hossain, DMS; Banerjee, S; Das, K; Sa, G; Das, T				Chattopadhyay, Sreya; Bhattacharyya, Sankar; Saha, Baisakhi; Chakraborty, Juni; Mohanty, Suchismita; Hossain, Dewan Md. Sakib; Banerjee, Shuvomoy; Das, Kaushik; Sa, Gaurisankar; Das, Tanya			Tumor-Shed PGE(2) Impairs IL2R gamma c-Signaling to Inhibit CD4(+) T Cell Survival: Regulation by Theaflavins	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; BLACK TEA; PROSTAGLANDIN E-2; ELEVATING AGENTS; CUTTING EDGE; EXPRESSION; RECEPTOR; APOPTOSIS; LYMPHOCYTES	Background: Many tumors are associated with decreased cellular immunity and elevated levels of prostaglandin E2 (PGE2), a known inhibitor of CD4+ T cell activation and inducer of type-2 cytokine bias. However, the role of this immunomodulator in the survival of T helper cells remained unclear. Since CD4+ T cells play critical roles in cell-mediated immunity, detail knowledge of the effect tumor-derived PGE2 might have on CD4+ T cell survival and the underlying mechanism may, therefore, help to overcome the overall immune deviation in cancer. Methodology/Principal Findings: By culturing purified human peripheral CD4+ T cells or Jurkat cells with spent media of theaflavin- or celecoxib-pre-treated MCF-7 cells, we show that tumor-shed PGE2 severely impairs interleukin 2 receptor cc (IL2R gamma c)-mediated survival signaling in CD4+ T cells. Indeed, tumor-shed PGE2 down-regulates IL2R gamma c expression, reduces phosphorylation as well as activation of Janus kinase 3 (Jak-3)/signal transducer and activator of transcription 5 (Stat-5) and decreases Bcl-2/Bax ratio thereby leading to activation of intrinsic apoptotic pathway. Constitutively active Stat-5A (Stat5A1*6) over-expression efficiently elevates Bcl-2 levels in CD4+ T cells and protects them from tumor-induced death while dominant-negative Stat-5A over-expression fails to do so, indicating the importance of Stat-5A-signaling in CD4+ T cell survival. Further support towards the involvement of PGE2 comes from the results that (a) purified synthetic PGE2 induces CD4+ T cell apoptosis, and (b) when knocked out by small interfering RNA, cyclooxygenase-2 (Cox-2)-defective tumor cells fail to initiate death. Interestingly, the entire phenomena could be reverted back by theaflavins that restore cytokine-dependent IL2Rcc/Jak-3/Stat-5A signaling in CD4+ T cells thereby protecting them from tumor-shed PGE2-induced apoptosis. Conclusions/Significance: These data strongly suggest that tumor-shed PGE2 is an important factor leading to CD4+ T cell apoptosis during cancer and raise the possibility that theaflavins may have the potential as an effective immunorestorer in cancer-bearer.			Chattopadhyay, S (corresponding author), Bose Inst, Div Mol Med, P-1-12 CIT Scheme VIIM, Kolkata, India.	tanya@bic.boseinst.ernet.in	Bhattacharyya, Sankar/AAK-2204-2020; Bhattacharyya, Sankar/GZH-3091-2022; Banerjee, Shuvomoy/AAZ-2479-2021	Bhattacharyya, Sankar/0000-0002-3235-4220; Banerjee, Shuvomoy/0000-0002-6936-1950				ALAVA MA, 1992, BIOCHEM J, V284, P189, DOI 10.1042/bj2840189; Alves NL, 2007, IMMUNOL LETT, V108, P113, DOI 10.1016/j.imlet.2006.11.006; ANASTASSIOU ED, 1992, J IMMUNOL, V148, P2845; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Baird AM, 1998, J LEUKOCYTE BIOL, V63, P669, DOI 10.1002/jlb.63.6.669; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bhattacharyya A, 2005, INT J CANCER, V117, P308, DOI 10.1002/ijc.21075; Bhattacharyya S, 2007, J BIOL CHEM, V282, P15954, DOI 10.1074/jbc.M608189200; Bhattacharyya S, 2007, CANCER RES, V67, P362, DOI 10.1158/0008-5472.CAN-06-2583; CAYEUX SJ, 1993, BONE MARROW TRANSPL, V12, P603; Chemnitz JM, 2006, CANCER RES, V66, P1114, DOI 10.1158/0008-5472.CAN-05-3252; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Das T, 2008, J IMMUNOL, V180, P4687, DOI 10.4049/jimmunol.180.7.4687; Das T, 2008, CANCER RES, V68, P2014, DOI 10.1158/0008-5472.CAN-07-6037; Dreger H, 2008, EXP BIOL MED, V233, P427, DOI 10.3181/0710-RM-292; Finke J, 1999, IMMUNOL TODAY, V20, P158, DOI 10.1016/S0167-5699(98)01435-2; GOEDEGEBUURE PS, 1995, IMMUNOL RES, V14, P119, DOI 10.1007/BF02918172; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; GOODWIN JS, 1977, J EXP MED, V146, P1719, DOI 10.1084/jem.146.6.1719; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HILKENS CMU, 1995, EUR J IMMUNOL, V25, P59, DOI 10.1002/eji.1830250112; Huang H, 2007, IMMUNOLOGY, V120, P148, DOI 10.1111/j.1365-2567.2006.02452.x; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kolenko V, 1999, BLOOD, V93, P2308, DOI 10.1182/blood.V93.7.2308.407k16_2308_2318; Kolenko V, 1997, J IMMUNOL, V159, P3057; Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x; Li CQ, 2008, PROTEIN SCI, V17, P1624, DOI 10.1110/ps.036145.108; Luczaj W, 2005, PREV MED, V40, P910, DOI 10.1016/j.ypmed.2004.10.014; Mandal D, 2006, INT IMMUNOPHARMACOL, V6, P433, DOI 10.1016/j.intimp.2005.09.005; Mandal D, 2007, NUTR CANCER, V58, P213, DOI 10.1080/01635580701328503; Marzo AL, 1999, CANCER RES, V59, P1071; Mastino A, 1992, Dev Immunol, V2, P263, DOI 10.1155/1992/80863; Micallef MJ, 1997, CANCER IMMUNOL IMMUN, V43, P361, DOI 10.1007/s002620050345; MINAKUCHI R, 1990, J IMMUNOL, V145, P2616; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; Oakes SA, 1996, IMMUNITY, V5, P605, DOI 10.1016/S1074-7613(00)80274-5; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; PASSWELL J, 1983, CLIN EXP IMMUNOL, V51, P61; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Prasad S, 2007, LIFE SCI, V81, P1323, DOI 10.1016/j.lfs.2007.07.033; Rabinowich H, 1998, J CLIN INVEST, V101, P2579, DOI 10.1172/JCI1518; Reichert TE, 1998, J IMMUNOTHER, V21, P295, DOI 10.1097/00002371-199807000-00007; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; Saas P, 1997, J CLIN INVEST, V99, P1173, DOI 10.1172/JCI119273; SAIAGH S, 1994, INT J IMMUNOPHARMACO, V16, P775, DOI 10.1016/0192-0561(94)90098-1; Saito T, 2000, CLIN CANCER RES, V6, P1351; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Shreedhar V, 1999, IMMUNITY, V11, P625, DOI 10.1016/S1074-7613(00)80137-5; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Spierings DCJ, 2006, EUR J IMMUNOL, V36, P1707, DOI 10.1002/eji.200635929; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Thomis DC, 1997, J EXP MED, V185, P197, DOI 10.1084/jem.185.2.197; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Vermeer MA, 2008, J AGR FOOD CHEM, V56, P12031, DOI 10.1021/jf8022035; Wang JCE, 2003, J IMMUNOL, V171, P6339, DOI 10.4049/jimmunol.171.12.6339; Watanabe S, 2003, J IMMUNOL, V171, P5828, DOI 10.4049/jimmunol.171.11.5828; Webb LMC, 2005, J IMMUNOL, V175, P2783, DOI 10.4049/jimmunol.175.5.2783; Wen RR, 2001, MOL CELL BIOL, V21, P678, DOI 10.1128/MCB.21.2.678-689.2001; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Yang CS, 2005, EXP LUNG RES, V31, P135, DOI 10.1080/01902140490495525; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yang L, 2003, J CLIN INVEST, V111, P727, DOI 10.1172/JCI200316492; Zhang Q, 1996, P NATL ACAD SCI USA, V93, P9148, DOI 10.1073/pnas.93.17.9148	67	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7382	10.1371/journal.pone.0007382	http://dx.doi.org/10.1371/journal.pone.0007382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812686	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594200008
J	Biebl, A; Muendlein, A; Kazakbaeva, Z; Heuberger, S; Sonderegger, G; Drexel, H; Lau, S; Nickel, R; Kabesch, M; Simma, B				Biebl, Ariane; Muendlein, Axel; Kazakbaeva, Zhyrgal; Heuberger, Sigrid; Sonderegger, Gudrun; Drexel, Heinz; Lau, Susanne; Nickel, Renate; Kabesch, Michael; Simma, Burkhard			CD14 C-159T and Toll-Like Receptor 4 Asp299Gly Polymorphisms in Surviving Meningococcal Disease Patients	PLOS ONE			English	Article							SOLUBLE CD14; SUSCEPTIBILITY; MUTATIONS; PROMOTER; BINDING; INFECTION; SEVERITY; RISK; GENE	Background: Carriage of Neisseria meningitidis occurs approximately in 10% of the population, onset of invasive meningococcal disease (IMD) cannot be predicted and differs between ages. It remains unclear, which host factors determine invasion of the bloodstream by the bacteria. Innate immunity has a very important role in the first recognition of invading pathogens. The functional single nucleotide polymorphisms (SNPs) CD14 C-159T and toll-like receptor 4 (TLR4) Asp299Gly have been associated with the risk of gram-negative infections. However, their role in development of IMD still remains unclear. Our aim was to investigate the influence of CD14 C-159T and TLR4 Asp299Gly polymorphisms on the risk of IMD. Methodology/Principal Findings: It was a retrospective case control study. Surviving Austrian meningococcal disease patients were enrolled by sending buccal swabs for DNA analysis. 185 cases with a proven meningococcal infection and 770 healthy controls were enrolled. In surviving meningococcal disease patients DNA analysis of CD14 C-159T and TLR 4 Asp299Gly polymorphisms was performed, as they are part of the innate immune response to bacterial determinants. CD14 C-159T and TLR4 Asp299Gly SNPs were not significantly associated with the presence of IMD when compared to healthy controls. The odds ratio for CD14 C-159T SNP was 1.14 (95% confidence interval (CI) 0.91-1.43; p = 0.266). In TLR4 Asp 299 Gly SNP the odds ratio was 0.78 (CI 0.47-1.43; p = 0.359). Conclusion/Significance: We could not observe a significant influence of CD14 C-159T and TLR4 Asp299Gly polymorphisms on the risk of developing IMD in surviving meningococcal disease patients. To our knowledge, this is the first study investigating the influence of the CD14 C-159T SNP on the susceptibility to IMD.			Biebl, A (corresponding author), Univ Teaching Hosp, Dept Pediat, Feldkirch, Austria.	ariane.biebl@gespag.at	Muendlein, Axel/AAS-5313-2021; Kabesch, Michael/AAB-5701-2020; Kabesch, Michael/GZM-1583-2022	Muendlein, Axel/0000-0002-5582-4125				*ACIP, 2005, MMWR-MORBID MORTAL W, V7, P1; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bunker-Wiersma HE, 2008, PEDIATR CRIT CARE ME, V9, P517, DOI 10.1097/PCC.0b013e318184985b; Burgmann H, 1996, CLIN IMMUNOL IMMUNOP, V80, P307, DOI 10.1006/clin.1996.0128; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Emonts M, 2003, LANCET INFECT DIS, V3, P565, DOI 10.1016/S1473-3099(03)00740-0; Faber J, 2006, PEDIATR INFECT DIS J, V25, P80, DOI 10.1097/01.inf.0000195595.22547.fe; Gardner P, 2006, NEW ENGL J MED, V355, P1466, DOI 10.1056/NEJMcp063561; Hubacek JA, 1999, CIRCULATION, V99, P3218, DOI 10.1161/01.CIR.99.25.3218; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Jessen KM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-108; LABETA MO, 1993, EUR J IMMUNOL, V23, P2144, DOI 10.1002/eji.1830230915; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Read RC, 2001, J INFECT DIS, V184, P640, DOI 10.1086/322798; Read RC, 2009, CRIT CARE MED, V37, P1237, DOI 10.1097/CCM.0b013e31819c39bc; Rupp J, 2004, GENES IMMUN, V5, P435, DOI 10.1038/sj.gene.6364112; Sengler C, 2003, CLIN EXP ALLERGY, V33, P166, DOI 10.1046/j.1365-2222.2003.01549.x; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Sutherland AM, 2005, CRIT CARE MED, V33, P638, DOI [10.1097/01.CCM.0000156242.44356.C5, 10.1097/01.ccm.0000156242.44356.c5]; Trotter CL, 2006, EPIDEMIOL INFECT, V134, P556, DOI 10.1017/S0950268805005339; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	23	19	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7374	10.1371/journal.pone.0007374	http://dx.doi.org/10.1371/journal.pone.0007374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809507	Green Submitted, Green Published, gold			2022-12-25	WOS:000270594000021
J	Li, GR; Sun, HY; Chen, JB; Zhou, Y; Tse, HF; Lau, CP				Li, Gui-Rong; Sun, Hai-Ying; Chen, Jing-Bo; Zhou, Yuan; Tse, Hung-Fat; Lau, Chu-Pak			Characterization of Multiple Ion Channels in Cultured Human Cardiac Fibroblasts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN ATRIAL; CHLORIDE CHANNELS; SODIUM CURRENT; ACTION-POTENTIALS; SINOATRIAL NODE; K+ CURRENTS; POTASSIUM CHANNELS; TRANSIENT OUTWARD; MYOCYTES	Background: Although fibroblast-to-myocyte electrical coupling is experimentally suggested, electrophysiology of cardiac fibroblasts is not as well established as contractile cardiac myocytes. The present study was therefore designed to characterize ion channels in cultured human cardiac fibroblasts. Methods and Findings: A whole-cell patch voltage clamp technique and RT-PCR were employed to determine ion channels expression and their molecular identities. We found that multiple ion channels were heterogeneously expressed in human cardiac fibroblasts. These include a big conductance Ca2+-activated K+ current (BKCa) in most (88%) human cardiac fibroblasts, a delayed rectifier K+ current (IKDR) and a transient outward K+ current (I-to) in a small population (15 and 14%, respectively) of cells, an inwardly-rectifying K+ current (I-Kir) in 24% of cells, and a chloride current (I-Cl) in 7% of cells under isotonic conditions. In addition, two types of voltage-gated Na+ currents (I-Na) with distinct properties were present in most (61%) human cardiac fibroblasts. One was a slowly inactivated current with a persistent component, sensitive to tetrodotoxin (TTX) inhibition (I-Na.TTX, IC50 = 7.8 nM), the other was a rapidly inactivated current, relatively resistant to TTX (I-Na.TTXR, IC50 = 1.8 mu M). RT-PCR revealed the molecular identities (mRNAs) of these ion channels in human cardiac fibroblasts, including KCa.1.1 (responsible for BKCa), Kv1.5, Kv1.6 (responsible for IKDR), Kv4.2, Kv4.3 (responsible for I-to), Kir2.1, Kir2.3 (for I-Kir), Clnc3 (for I-Cl), NaV1.2, NaV1.3, NaV1.6, NaV1.7 (for I-Na.TTX), and NaV1.5 (for I-Na.TTXR). Conclusions: These results provide the first information that multiple ion channels are present in cultured human cardiac fibroblasts, and suggest the potential contribution of these ion channels to fibroblast-myocytes electrical coupling.			Li, GR (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China.	grli@hkucc.hku.hk	Tse, Hung-Fat/C-4426-2009; Li, Gui-Rong/C-4341-2009; , 李贵荣（沧海一粟）/AAZ-4335-2020	Tse, Hung-Fat/0000-0002-9578-7808; , 李贵荣（沧海一粟）/0000-0002-9437-2280				Baumgarten CM, 2003, PROG BIOPHYS MOL BIO, V82, P25, DOI 10.1016/S0079-6107(03)00003-8; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Camelliti P, 2005, MICROSC MICROANAL, V11, P249, DOI [10.1017/S1431927605050506, 10.1017/S143927605050506]; Camelliti P, 2004, CARDIOVASC RES, V62, P415, DOI 10.1016/j.cardiores.2004.01.027; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Camelliti P, 2006, ADV CARDIOL, V42, P132, DOI 10.1159/000092566; Chilton L, 2005, AM J PHYSIOL-HEART C, V288, pH2931, DOI 10.1152/ajpheart.01220.2004; Coiret G, 2007, MOL PHARMACOL, V71, P843, DOI 10.1124/mol.106.028290; Du XL, 2004, J GEN PHYSIOL, V123, P427, DOI 10.1085/jgp.200409013; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Feng JL, 1996, AM J PHYSIOL-HEART C, V270, pH1676, DOI 10.1152/ajpheart.1996.270.5.H1676; Flack EC, 2006, J MOL CELL CARDIOL, V40, P474, DOI 10.1016/j.yjmcc.2006.01.019; FURUKAWA T, 1995, J MOL CELL CARDIOL, V27, P831, DOI 10.1016/0022-2828(95)90090-X; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Gao Z, 2005, BRIT J PHARMACOL, V144, P595, DOI 10.1038/sj.bjp.0706113; Gao Z, 2007, J MOL CELL CARDIOL, V42, P98, DOI 10.1016/j.yjmcc.2006.10.002; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hammarstrom AKM, 1999, J PHYSIOL-LONDON, V520, P451, DOI 10.1111/j.1469-7793.1999.t01-1-00451.x; Hu H, 2009, J CELL PHYSIOL, V218, P427, DOI 10.1002/jcp.21617; Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096; Kohl P, 2003, CIRC RES, V93, P381, DOI 10.1161/01.RES.0000091364.90121.0C; KOHL P, 1994, EXP PHYSIOL, V79, P943, DOI 10.1113/expphysiol.1994.sp003819; Kohl P, 2007, HEART RHYTHM, V4, P233, DOI 10.1016/j.hrthm.2006.10.014; Kuhlmann CRW, 2005, ACTA PHYSIOL SCAND, V183, P161, DOI 10.1111/j.1365-201X.2004.01378.x; Lei M, 2007, CARDIOVASC RES, V74, P356, DOI 10.1016/j.cardiores.2007.01.009; LI GR, 1995, AM J PHYSIOL-HEART C, V269, pH463, DOI 10.1152/ajpheart.1995.269.2.H463; Li GR, 2005, STEM CELLS, V23, P371, DOI 10.1634/stemcells.2004-0213; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Li GR, 1998, AM J PHYSIOL-CELL PH, V274, pC577, DOI 10.1152/ajpcell.1998.274.3.C577; Li GR, 1999, AM J PHYSIOL-HEART C, V276, pH98, DOI 10.1152/ajpheart.1999.276.1.H98; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Li GR, 1996, AM J PHYSIOL-CELL PH, V270, pC500; Li GR, 2006, STEM CELLS, V24, P1519, DOI 10.1634/stemcells.2005-0307; Liu H, 2007, J MOL CELL CARDIOL, V42, P760, DOI 10.1016/j.yjmcc.2006.10.013; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Nilius B, 2001, J PHYSIOL-LONDON, V532, P581, DOI 10.1111/j.1469-7793.2001.0581e.x; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; ROOK MB, 1992, AM J PHYSIOL, V263, pC959, DOI 10.1152/ajpcell.1992.263.5.C959; Rose RA, 2007, J PHYSIOL-LONDON, V580, P255, DOI 10.1113/jphysiol.2006.120832; Sachse FB, 2008, ANN BIOMED ENG, V36, P41, DOI 10.1007/s10439-007-9405-8; SAKAKIBARA Y, 1992, CIRC RES, V71, P535, DOI 10.1161/01.RES.71.3.535; Shibukawa Y, 2005, BIOPHYS J, V88, P3924, DOI 10.1529/biophysj.104.054429; Shirihai O, 1998, J CELL PHYSIOL, V177, P197; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Wang GL, 2002, CIRC RES, V91, pE28, DOI 10.1161/01.RES.0000042062.69653.E4; Wang YJ, 2006, J MEMBRANE BIOL, V213, P175, DOI 10.1007/s00232-007-0027-8; Wu WKK, 2006, J CELL PHYSIOL, V207, P437, DOI 10.1002/jcp.20576	51	94	96	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7307	10.1371/journal.pone.0007307	http://dx.doi.org/10.1371/journal.pone.0007307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806193	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800015
J	Jaiswal, S; Pearson, T; Friberg, H; Shultz, LD; Greiner, DL; Rothman, AL; Mathew, A				Jaiswal, Smita; Pearson, Todd; Friberg, Heather; Shultz, Leonard D.; Greiner, Dale L.; Rothman, Alan L.; Mathew, Anuja			Dengue Virus Infection and Virus-Specific HLA-A2 Restricted Immune Responses in Humanized NOD-scid IL2r gamma(null) Mice	PLOS ONE			English	Article								Background: The lack of a suitable animal model to study viral and immunological mechanisms of human dengue disease has been a deterrent to dengue research. Methodology/Principal Findings: We sought to establish an animal model for dengue virus (DENV) infection and immunity using non-obese diabetic/severe combined immunodeficiency interleukin-2 receptor gamma-chain knockout (NOD-scid IL2r gamma(null)) mice engrafted with human hematopoietic stem cells. Human CD45(+) cells in the bone marrow of engrafted mice were susceptible to in vitro infection using low passage clinical and established strains of DENV. Engrafted mice were infected with DENV type 2 by different routes and at multiple time points post infection, we detected DENV antigen and RNA in the sera, bone marrow, spleen and liver of infected engrafted mice. Anti-dengue IgM antibodies directed against the envelope protein of DENV peaked in the sera of mice at 1 week post infection. Human T cells that developed following engraftment of HLA-A2 transgenic NOD-scid IL2r gamma(null) mice with HLA-A2(+) human cord blood hematopoietic stem cells, were able to secrete IFN-gamma, IL-2 and TNF-alpha in response to stimulation with three previously identified A2 restricted dengue peptides NS4b 2353((111-119)), NS4b 2423((181-189)), and NS4a 2148((56-64)). Conclusions/Significance: This is the first study to demonstrate infection of human cells and functional DENV-specific T cell responses in DENV-infected humanized mice. Overall, these mice should be a valuable tool to study the role of prior immunity on subsequent DENV infections.			Jaiswal, S (corresponding author), Univ Massachusetts, Sch Med, Ctr Infect Dis & Vaccine Res, Worcester, MA 01605 USA.	anuja.mathew@umassmed.edu	Mathew, Anuja/V-6711-2019	Mathew, Anuja/0000-0002-6752-009X; Rothman, Alan/0000-0002-4064-6848	NCI NIH HHS [CA34196, P30 CA034196] Funding Source: Medline; NIAID NIH HHS [U19 AI057319] Funding Source: Medline; NIDDK NIH HHS [DK52530] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052530] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887; Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539; Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817; Bente DA, 2005, J VIROL, V79, P13797, DOI 10.1128/JVI.79.21.13797-13799.2005; Bray M, 1998, J VIROL, V72, P1647, DOI 10.1128/JVI.72.2.1647-1651.1998; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; ECKELS KH, 1994, AM J TROP MED HYG, V50, P472, DOI 10.4269/ajtmh.1994.50.472; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; HALSTEAD SB, 1973, J INFECT DIS, V128, P7, DOI 10.1093/infdis/128.1.7; Ishikawa F, 2002, EXP HEMATOL, V30, P488, DOI 10.1016/S0301-472X(02)00784-1; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jarchum I, 2007, DIABETES, V56, P2551, DOI 10.2337/db07-0332; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; KURANE I, 1990, ARCH VIROL, V110, P91, DOI 10.1007/BF01310705; KURANE I, 1994, ARCH VIROL, P59; Kurane I, 1998, VIROLOGY, V240, P169, DOI 10.1006/viro.1997.8925; Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; MOTA J, 2009, J VIROL; Pearson T, 2008, CURR TOP MICROBIOL, V324, P25; Sanchez V, 2006, FEMS IMMUNOL MED MIC, V46, P113, DOI 10.1111/j.1574-695X.2005.00008.x; Shresta S, 2005, J IMMUNOL, V175, P3946, DOI 10.4049/jimmunol.175.6.3946; Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Takaki T, 2006, J IMMUNOL, V176, P3257, DOI 10.4049/jimmunol.176.5.3257; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Woodland RT, 2006, SEMIN IMMUNOL, V18, P318, DOI 10.1016/j.smim.2006.06.001; WOODLAND RT, 2007, BLOOD; WU SJL, 1995, AM J TROP MED HYG, V52, P468, DOI 10.4269/ajtmh.1995.52.468	46	102	106	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7251	10.1371/journal.pone.0007251	http://dx.doi.org/10.1371/journal.pone.0007251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802382	gold, Green Published, Green Submitted			2022-12-25	WOS:000270593600003
J	Maisonneuve, E; Ducret, A; Khoueiry, P; Lignon, S; Longhi, S; Talla, E; Dukan, S				Maisonneuve, Etienne; Ducret, Adrien; Khoueiry, Pierre; Lignon, Sabrina; Longhi, Sonia; Talla, Emmanuel; Dukan, Sam			Rules Governing Selective Protein Carbonylation	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUTAMINE-SYNTHETASE; CATALYZED OXIDATION; DISORDERED REGIONS; COG DATABASE; WEB SERVER; PREDICTION; DAMAGE; SEQUENCE; SITES	Background: Carbonyl derivatives are mainly formed by direct metal-catalysed oxidation (MCO) attacks on the amino-acid side chains of proline, arginine, lysine and threonine residues. For reasons unknown, only some proteins are prone to carbonylation. Methodology/Principal Findings: We used mass spectrometry analysis to identify carbonylated sites in: BSA that had undergone in vitro MCO, and 23 carbonylated proteins in Escherichia coli. The presence of a carbonylated site rendered the neighbouring carbonylatable site more prone to carbonylation. Most carbonylated sites were present within hot spots of carbonylation. These observations led us to suggest rules for identifying sites more prone to carbonylation. We used these rules to design an in silico model (available at http://www.lcb.cnrs-mrs.fr/CSPD/), allowing an effective and accurate prediction of sites and of proteins more prone to carbonylation in the E. coli proteome. Conclusions/Significance: We observed that proteins evolve to either selectively maintain or lose predicted hot spots of carbonylation depending on their biological function. As our predictive model also allows efficient detection of carbonylated proteins in Bacillus subtilis, we believe that our model may be extended to direct MCO attacks in all organisms.			Maisonneuve, E (corresponding author), Aix Marseille Univ, CNRS, Chim Bacterienne Lab, UPR 9043, 31 Chemin Joseph Aiguier, Marseille, France.	talla@ifr88.cnrs-mrs.fr; sdukan@ifr88.cnrs-mrs.fr	Khoueiry, Pierre/F-2130-2017; LONGHI, Sonia/M-5305-2014	Khoueiry, Pierre/0000-0001-7643-3310; LONGHI, Sonia/0000-0002-6829-6771; TALLA, Emmanuel/0000-0002-7775-8296; maisonneuve, Etienne/0000-0003-3451-1223				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; BOURHIS J, 2007, CURRENT PRO IN PRESS; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Chandonia JM, 1999, PROTEINS, V35, P293; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Desnues B, 2003, EMBO REP, V4, P400, DOI 10.1038/sj.embor.embor799; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fredriksson A, 2006, MOL MICROBIOL, V59, P350, DOI 10.1111/j.1365-2958.2005.04947.x; Galzitskaya OV, 2006, BIOINFORMATICS, V22, P2948, DOI 10.1093/bioinformatics/btl504; Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Lee S, 2006, J PROTEOME RES, V5, P539, DOI 10.1021/pr050299q; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; LEVINE RL, 1983, J BIOL CHEM, V258, P1823; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liu JF, 2003, NUCLEIC ACIDS RES, V31, P3833, DOI 10.1093/nar/gkg515; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Mirzaei H, 2006, ANAL CHEM, V78, P770, DOI 10.1021/ac0514220; Mirzaei H, 2005, ANAL CHEM, V77, P2386, DOI 10.1021/ac0484373; Mirzaei H, 2006, J PROTEOME RES, V5, P2159, DOI 10.1021/pr060021d; Mostertz J, 2003, MOL GENET GENOMICS, V269, P640, DOI 10.1007/s00438-003-0877-4; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; OBRADOVIC Z, 2005, PROTEINS; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Temple A, 2006, J AM SOC MASS SPECTR, V17, P1172, DOI 10.1016/j.jasms.2006.04.030; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534	49	95	97	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7269	10.1371/journal.pone.0007269	http://dx.doi.org/10.1371/journal.pone.0007269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802390	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593600004
J	Tang, KH; Feng, XY; Tang, YJJ; Blankenship, RE				Tang, Kuo-Hsiang; Feng, Xueyang; Tang, Yinjie J.; Blankenship, Robert E.			Carbohydrate Metabolism and Carbon Fixation in Roseobacter denitrificans OCh114	PLOS ONE			English	Article								The Roseobacter clade of aerobic marine proteobacteria, which compose 10-25% of the total marine bacterial community, has been reported to fix CO2, although it has not been determined what pathway is involved. In this study, we report the first metabolic studies on carbohydrate utilization, CO2 assimilation, and amino acid biosynthesis in the phototrophic Roseobacter clade bacterium Roseobacter denitrificans OCh114. We develop a new minimal medium containing defined carbon source(s), in which the requirements of yeast extract reported previously for the growth of R. denitrificans can be replaced by vitamin B-12 (cyanocobalamin). Tracer experiments were carried out in R. denitrificans grown in a newly developed minimal medium containing isotopically labeled pyruvate, glucose or bicarbonate as a single carbon source or in combination. Through measurements of C-13-isotopomer labeling patterns in protein-derived amino acids, gene expression profiles, and enzymatic activity assays, we report that: (1) R. denitrificans uses the anaplerotic pathways mainly via the malic enzyme to fix 10-15% of protein carbon from CO2; (2) R. denitrificans employs the Entner-Doudoroff (ED) pathway for carbohydrate metabolism and the non-oxidative pentose phosphate pathway for the biosynthesis of histidine, ATP, and coenzymes; (3) the Embden-Meyerhof-Parnas (EMP, glycolysis) pathway is not active and the enzymatic activity of 6-phosphofructokinase (PFK) cannot be detected in R. denitrificans; and (4) isoleucine can be synthesized from both threonine-dependent (20% total flux) and citramalate-dependent (80% total flux) pathways using pyruvate as the sole carbon source.			Tang, KH (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	blankenship@wustl.edu	Feng, Xueyang/G-1295-2015; Tang, Yinjie/AAI-5584-2020	Feng, Xueyang/0000-0003-4426-5732				Allard J, 2001, P NATL ACAD SCI USA, V98, P3679, DOI 10.1073/pnas.071380898; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Biebl H, 2005, INT J SYST EVOL MICR, V55, P2377, DOI 10.1099/ijs.0.63832-0; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; CONRAD R, 1977, J GEN MICROBIOL, V101, P277, DOI 10.1099/00221287-101-2-277; CONRAD R, 1977, ARCH MICROBIOL, V112, P39, DOI 10.1007/BF00446652; ENTNER N, 1952, J BIOL CHEM, V196, P853; Griffiths JS, 2002, BIOORGAN MED CHEM, V10, P545, DOI 10.1016/S0968-0896(01)00307-8; Guillouet S, 1999, APPL ENVIRON MICROB, V65, P3100; HATFIELD GW, 1970, J BIOL CHEM, V245, P1742; Holmes DE, 2004, INT J SYST EVOL MICR, V54, P1591, DOI 10.1099/ijs.0.02958-0; Howell DM, 1999, J BACTERIOL, V181, P331, DOI 10.1128/JB.181.1.331-333.1999; KISHIMOTO N, 1995, FEMS MICROBIOL ECOL, V16, P291, DOI 10.1016/0168-6496(95)00003-S; Koblizek M, 2003, ARCH MICROBIOL, V180, P327, DOI 10.1007/s00203-003-0596-6; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Kortluke C, 1997, J BACTERIOL, V179, P5247, DOI 10.1128/jb.179.17.5247-5258.1997; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Lin H, 2005, APPL MICROBIOL BIOT, V67, P515, DOI 10.1007/s00253-004-1789-x; MELOCHE HP, 1964, J BIOL CHEM, V239, P3511; MELOCHE HP, 1964, J BIOL CHEM, V239, P3505; MEYER CR, 1988, PLANT PHYSIOL, V86, P325, DOI 10.1104/pp.86.2.325; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Motter AE, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.1; Mukhopadhyay B, 1998, J BIOL CHEM, V273, P5155, DOI 10.1074/jbc.273.9.5155; Pavlekovic M, 2009, J MICROBIOL METH, V78, P119, DOI 10.1016/j.mimet.2009.04.003; Pingitore F, 2007, ANAL CHEM, V79, P2483, DOI 10.1021/ac061906b; RAY TB, 1976, PLANT PHYSIOL, V58, P603, DOI 10.1104/pp.58.5.603; Risso C, 2008, J BACTERIOL, V190, P2266, DOI 10.1128/JB.01841-07; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; SHIBA T, 1991, SYST APPL MICROBIOL, V14, P140, DOI 10.1016/S0723-2020(11)80292-4; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; SHIBA T, 1986, MICROBIOL SCI, V3, P376; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; Tang KH, 2009, J BACTERIOL, V191, P3580, DOI 10.1128/JB.00110-09; Tang Y, 2007, J BACTERIOL, V189, P940, DOI 10.1128/JB.00948-06; Tang YJ, 2009, BIOTECHNOL BIOENG, V102, P1377, DOI 10.1002/bit.22181; THOMPSON JS, 1968, ANAL BIOCHEM, V24, P197, DOI 10.1016/0003-2697(68)90170-X; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wahl SA, 2004, BIOTECHNOL BIOENG, V85, P259, DOI 10.1002/bit.10909; Xu H, 2004, J BACTERIOL, V186, P5400, DOI 10.1128/JB.186.16.5400-5409.2004; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998	49	53	54	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e7233	10.1371/journal.pone.0007233	http://dx.doi.org/10.1371/journal.pone.0007233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794911	gold, Green Published, Green Submitted			2022-12-25	WOS:000270354200001
J	Fujita, K; Seike, T; Yutsudo, N; Ohno, M; Yamada, H; Yamaguchi, H; Sakumi, K; Yamakawa, Y; Kido, MA; Takaki, A; Katafuchi, T; Tanaka, Y; Nakabeppu, Y; Noda, M				Fujita, Kyota; Seike, Toshihiro; Yutsudo, Noriko; Ohno, Mizuki; Yamada, Hidetaka; Yamaguchi, Hiroo; Sakumi, Kunihiko; Yamakawa, Yukiko; Kido, Mizuho A.; Takaki, Atsushi; Katafuchi, Toshihiko; Tanaka, Yoshinori; Nakabeppu, Yusaku; Noda, Mami			Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease	PLOS ONE			English	Article								It has been shown that molecular hydrogen (H(2)) acts as a therapeutic antioxidant and suppresses brain injury by buffering the effects of oxidative stress. Chronic oxidative stress causes neurodegenerative diseases such as Parkinson's disease (PD). Here, we show that drinking H(2)-containing water significantly reduced the loss of dopaminergic neurons in PD model mice using both acute and chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The concentration-dependency of H(2) showed that H(2) as low as 0.08 ppm had almost the same effect as saturated H(2) water (1.5 ppm). MPTP-induced accumulation of cellular 8-oxoguanine (8-oxoG), a marker of DNA damage, and 4-hydroxynonenal (4-HNE), a marker of lipid peroxidation were significantly decreased in the nigro-striatal dopaminergic pathway in mice drinking H(2)-containing water, whereas production of superoxide (O(2)center dot(-)) detected by intravascular injection of dihydroethidium (DHE) was not reduced significantly. Our results indicated that low concentration of H(2) in drinking water can reduce oxidative stress in the brain. Thus, drinking H(2)-containing water may be useful in daily life to prevent or minimize the risk of life style-related oxidative stress and neurodegeneration.			Fujita, K (corresponding author), Kyushu Univ, Lab Pathophysiol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan.	noda@phar.kyushu-u.ac.jp	Noda, Mami/AAC-3949-2020; TANAKA, YOSHINORI/GNO-9581-2022; Nakabeppu, Yusaku/A-8902-2011; Sakumi, Kunihiko/G-4808-2011	TANAKA, YOSHINORI/0000-0003-1123-127X; Nakabeppu, Yusaku/0000-0002-6739-242X; 				Awasthi YC, 2008, FREE RADICAL BIO MED, V45, P111, DOI 10.1016/j.freeradbiomed.2008.04.007; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Betarbet R, 1997, J NEUROSCI, V17, P6761; Cai JM, 2008, NEUROSCI LETT, V441, P167, DOI 10.1016/j.neulet.2008.05.077; Chiba Y, 2005, J GERONTOL A-BIOL, V60, P1087, DOI 10.1093/gerona/60.9.1087; CRABBE JC, 1982, BEHAV BRAIN RES, V4, P289, DOI 10.1016/0166-4328(82)90006-7; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Drukarch B, 2001, EXPERT OPIN INV DRUG, V10, P1855, DOI 10.1517/13543784.10.10.1855; DU XY, 1995, BRAIN RES, V680, P229, DOI 10.1016/0006-8993(95)00215-C; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; GRIMA B, 1987, NATURE, V326, P707, DOI 10.1038/326707a0; GUTTERIDGE JMC, 1992, ANN NEUROL, V32, pS16, DOI 10.1002/ana.410320705; HASEGAWA E, 1990, BIOCHEM BIOPH RES CO, V170, P1049, DOI 10.1016/0006-291X(90)90498-C; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Kajitani K, 2009, CELL DEATH DIFFER, V16, P417, DOI 10.1038/cdd.2008.162; KATAFUCHI T, 1985, BRAIN RES, V359, P1, DOI 10.1016/0006-8993(85)91406-4; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kikuchi H, 2002, ACTA NEUROPATHOL, V103, P408, DOI 10.1007/s00401-001-0480-x; Klivenyi P, 1998, NEUROBIOL DIS, V5, P253, DOI 10.1006/nbdi.1998.0191; Langston J.W., 2002, PARKINSONS DIS DIAGN; Liang LP, 2007, J NEUROSCI, V27, P4326, DOI 10.1523/JNEUROSCI.0019-07.2007; Liberatore GT, 1999, NAT MED, V5, P1403; Lotharius J, 2000, J BIOL CHEM, V275, P38581, DOI 10.1074/jbc.M005385200; Mallajosyula JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001616; Meredith GE, 1999, EUR J NEUROSCI, V11, P3585, DOI 10.1046/j.1460-9568.1999.00774.x; Mitsumoto Y, 1998, BIOCHEM BIOPH RES CO, V248, P660, DOI 10.1006/bbrc.1998.8986; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; NICKLAS WJ, 1987, LIFE SCI, V40, P721, DOI 10.1016/0024-3205(87)90299-2; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Ohashi S, 2006, NEUROSCI LETT, V401, P183, DOI 10.1016/j.neulet.2006.03.017; Ohno M, 2009, METHODS MOL BIOL, V554, P199, DOI 10.1007/978-1-59745-521-3_13; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; OOBOSHI H, 1993, EUR J PHARMACOL, V233, P165, DOI 10.1016/0014-2999(93)90363-M; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802; Sakumi K, 2003, CANCER RES, V63, P902; Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Selley ML, 1998, FREE RADICAL BIO MED, V25, P169, DOI 10.1016/S0891-5849(98)00021-5; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Shimura-Miura H, 1999, ANN NEUROL, V46, P920, DOI 10.1002/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R; Song DD, 2000, J NEUROSCI, V20, P5102; Stadler K, 2008, FREE RADICAL BIO MED, V45, P866, DOI 10.1016/j.freeradbiomed.2008.06.023; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Yamaguchi H, 2006, CELL DEATH DIFFER, V13, P551, DOI 10.1038/sj.cdd.4401788; Yanagihara T, 2005, BIOSCI BIOTECH BIOCH, V69, P1985, DOI 10.1271/bbb.69.1985; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	69	144	161	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7247	10.1371/journal.pone.0007247	http://dx.doi.org/10.1371/journal.pone.0007247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789628	Green Published, gold			2022-12-25	WOS:000270354100012
J	Colombo, L; Zevin, J				Colombo, Lucia; Zevin, Jason			Stress Priming in Reading and the Selective Modulation of Lexical and Sub-Lexical Pathways	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; STRATEGIC CONTROL; NAMING TASK; DUAL-ROUTE; ALOUD; CONSISTENCY; ASSIGNMENT; REGULARITY; FREQUENCY; MODELS	Four experiments employed a priming methodology to investigate different mechanisms of stress assignment and how they are modulated by lexical and sub-lexical mechanisms in reading aloud in Italian. Lexical stress is unpredictable in Italian, and requires lexical look-up. The most frequent stress pattern (Dominant) is on the penultimate syllable [laVOro (work)], while stress on the antepenultimate syllable [MAcchina (car)] is relatively less frequent (non-Dominant). Word and pseudoword naming responses primed by words with non-dominant stress - which require whole-word knowledge to be read correctly - were compared to those primed by nonwords. Percentage of errors to words and percentage of dominant stress responses to nonwords were measured. In Experiments 1 and 2 stress errors increased for non-dominant stress words primed by nonwords, as compared to when they were primed by words. The results could be attributed to greater activation of sub-lexical codes, and an associated tendency to assign the dominant stress pattern by default in the nonword prime condition. Alternatively, they may have been the consequence of prosodic priming, inducing more errors on trials in which the stress pattern of primes and targets was not congruent. The two interpretations were investigated in Experiments 3 and 4. The results overall suggested a limited role of the default metrical pattern in word pronunciation, and showed clear effect of prosodic priming, but only when the sub-lexical mechanism prevailed.			Colombo, L (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	lucia.colombo@unipd.it; jdz2001@med.cornell.edu	Colombo, Lucia/B-7605-2008; Zevin, Jason/AAG-3266-2021	Zevin, Jason/0000-0001-8929-5914; COLOMBO, LUCIA/0000-0002-2564-7578				Burani C, 2004, BRAIN LANG, V90, P318, DOI 10.1016/S0093-934X(03)00444-9; BUTTERWORTH B, 1992, COGNITION, V42, P261, DOI 10.1016/0010-0277(92)90045-J; Colombo L, 2000, CORTEX, V36, P703, DOI 10.1016/S0010-9452(08)70547-1; Colombo L, 2004, NEUROPSYCHOLOGIA, V42, P1192, DOI 10.1016/j.neuropsychologia.2004.02.004; COLOMBO L, 1992, J EXP PSYCHOL HUMAN, V18, P987, DOI 10.1037/0096-1523.18.4.987; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Cortese MJ, 2000, MEM COGNITION, V28, P1269, DOI 10.3758/BF03211827; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Desain P, 2003, PERCEPTION, V32, P341, DOI 10.1068/p3370; Gonnerman LM, 2007, J EXP PSYCHOL GEN, V136, P323, DOI 10.1037/0096-3445.136.2.323; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Kello CT, 2000, J EXP PSYCHOL LEARN, V26, P719, DOI 10.1037/0278-7393.26.3.719; LEVELT W, 1995, COGNITION COGNITION, P301; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lupker SJ, 1997, J EXP PSYCHOL LEARN, V23, P570, DOI 10.1037/0278-7393.23.3.570; MICELI G, 1993, COGNITIVE NEUROPSYCH, V10, P273, DOI 10.1080/02643299308253465; MONAGHAN P, 2008, P 30 ANN C COGN SCI; MONSELL S, 1989, J EXP PSYCHOL GEN, V118, P43, DOI 10.1037/0096-3445.118.1.43; Plaut DC, 1999, CARN S COGN, P381; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Protopapas A, 2006, J RES READ, V29, P418, DOI 10.1111/j.1467-9817.2006.00316.x; Rastle K, 2000, J MEM LANG, V42, P342, DOI 10.1006/jmla.1999.2687; Rastle K, 2002, J EXP PSYCHOL HUMAN, V28, P307, DOI 10.1037//0096-1523.28.2.307; Roelofs A, 1998, J EXP PSYCHOL LEARN, V24, P922, DOI 10.1037/0278-7393.24.4.922; Schiller NO, 2004, BRAIN LANG, V90, P231, DOI 10.1016/S0093-934X(03)00436-X; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Tabossi P., 1992, ORTHOGRAPHY PHONOLOG, P319; TILLMANN B, 2002, ADV CONSCIOUSNESS RE, P231; TREIMAN R, 1995, J EXP PSYCHOL GEN, V124, P107, DOI 10.1037/0096-3445.124.2.107; YANG J, 2006, P 28 ANN C COGN SCI; YANG JF, P 13 ANN C IN PRESS; Zevin JD, 2000, J EXP PSYCHOL LEARN, V26, P121, DOI 10.1037/0278-7393.26.1.121; Zevin JD, 2006, J MEM LANG, V54, P145, DOI 10.1016/j.jml.2005.08.002	34	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7219	10.1371/journal.pone.0007219	http://dx.doi.org/10.1371/journal.pone.0007219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	500HR	19787062	gold, Green Published, Green Submitted			2022-12-25	WOS:000270290100018
J	Inoue, J; Misawa, A; Tanaka, Y; Ichinose, S; Sugino, Y; Hosoi, H; Sugimoto, T; Imoto, I; Inazawa, J				Inoue, Jun; Misawa, Akiko; Tanaka, Yukichi; Ichinose, Shizuko; Sugino, Yuriko; Hosoi, Hajime; Sugimoto, Tohru; Imoto, Issei; Inazawa, Johji			Lysosomal-Associated Protein Multispanning Transmembrane 5 Gene (LAPTM5) Is Associated with Spontaneous Regression of Neuroblastomas	PLOS ONE			English	Article								Background: Neuroblastoma (NB) is the most frequently occurring solid tumor in children, and shows heterogeneous clinical behavior. Favorable tumors, which are usually detected by mass screening based on increased levels of catecholamines in urine, regress spontaneously via programmed cell death (PCD) or mature through differentiation into benign ganglioneuroma (GN). In contrast, advanced-type NB tumors often grow aggressively, despite intensive chemotherapy. Understanding the molecular mechanisms of PCD during spontaneous regression in favorable NB tumors, as well as identifying genes with a pro-death role, is a matter of urgency for developing novel approaches to the treatment of advanced-type NB tumors. Principal Findings: We found that the expression of lysosomal associated protein multispanning transmembrane 5 (LAPTM5) was usually down-regulated due to DNA methylation in an NB cell-specific manner, but up-regulated in degenerating NB cells within locally regressing areas of favorable tumors detected by mass-screening. Experiments in vitro showed that not only a restoration of its expression but also the accumulation of LAPTM5 protein, was required to induce non-apoptotic cell death with autophagic vacuoles and lysosomal destabilization with lysosomal-membrane permeabilization (LMP) in a caspase-independent manner. While autophagy is a membrane-trafficking pathway to degrade the proteins in lysosomes, the LAPTM5-mediated lysosomal destabilization with LMP leads to an interruption of autophagic flux, resulting in the accumulation of immature autophagic vacuoles, p62/SQSTM1, and ubiqitinated proteins as substrates of autophagic degradation. In addition, ubiquitin-positive inclusion bodies appeared in degenerating NB cells. Conclusions: We propose a novel molecular mechanism for PCD with the accumulation of autophagic vacuoles due to LAPTM5-mediated lysosomal destabilization. LAPTM5-induced cell death is lysosomal cell death with impaired autophagy, not cell death by autophagy, so-called autophagic cell death. Thus LAPTM5-mediated PCD is closely associated with the spontaneous regression of NBs and opens new avenues for exploring innovative clinical interventions for this tumor.			Inoue, J (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan.	johinaz.cgen@mri.tmd.ac.jp	Imoto, Issei/AAD-5799-2020; imoto, Issei/D-8065-2012					Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; Cortese R, 2008, INT J BIOCHEM CELL B, V40, P1494, DOI 10.1016/j.biocel.2007.11.018; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Fritsch P, 2004, PEDIATR BLOOD CANCER, V43, P679, DOI 10.1002/pbc.20126; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Gonzalgo ML, 2007, NAT PROTOC, V2, P1931, DOI 10.1038/nprot.2007.271; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Hoehner JC, 1997, BRIT J CANCER, V75, P1185, DOI 10.1038/bjc.1997.203; Ichimiya S, 2001, MED PEDIATR ONCOL, V36, P42, DOI 10.1002/1096-911X(20010101)36:1<42::AID-MPO1011>3.0.CO;2-K; IKEDA H, 1995, J PEDIATR SURG, V30, P805, DOI 10.1016/0022-3468(95)90752-1; Inazawa J, 2004, CANCER SCI, V95, P559, DOI 10.1111/j.1349-7006.2004.tb02486.x; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Kitanaka C, 2002, J NATL CANCER I, V94, P358; Kodet R, 1998, Cesk Patol, V34, P123; Koizumi H, 2006, AM J SURG PATHOL, V30, P249, DOI 10.1097/01.pas.0000184805.60908.37; KOIZUMI H, 1995, VIRCHOWS ARCH, V427, P167; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; MARIS JM, 1995, CANCER RES, V55, P4664; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Misawa A, 2005, CANCER RES, V65, P10233, DOI 10.1158/0008-5472.CAN-05-1073; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Oue T, 2005, J PEDIATR SURG, V40, P359, DOI 10.1016/j.jpedsurg.2004.10.062; Oue T, 1996, J PEDIATR SURG, V31, P251, DOI 10.1016/S0022-3468(96)90009-3; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; PRITCHARD J, 1994, LANCET, V344, P869, DOI 10.1016/S0140-6736(94)92834-7; Reynolds CP, 2002, J NATL CANCER I, V94, P319; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; Sugino Y, 2007, ONCOGENE, V26, P7401, DOI 10.1038/sj.onc.1210550; Tanaka K, 2007, ONCOGENE, V26, P6456, DOI 10.1038/sj.onc.1210459; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; Tonini GP, 1997, J NEURO-ONCOL, V31, P209; Toyota M, 1999, CANCER RES, V59, P2307; Yamamoto K, 1998, J CLIN ONCOL, V16, P1265, DOI 10.1200/JCO.1998.16.4.1265; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599	47	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7099	10.1371/journal.pone.0007099	http://dx.doi.org/10.1371/journal.pone.0007099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787053	Green Published, Green Submitted, gold			2022-12-25	WOS:000270290100003
J	Acin-Perez, R; Hoyos, B; Zhao, F; Vinogradov, V; Fischman, DA; Harris, RA; Leitges, M; Wongsiriroj, N; Blaner, WS; Manfredi, G; Hammerling, U				Acin-Perez, Rebeca; Hoyos, Beatrice; Zhao, Feng; Vinogradov, Valerie; Fischman, Donald A.; Harris, Robert A.; Leitges, Michael; Wongsiriroj, Nuttaporn; Blaner, William S.; Manfredi, Giovanni; Hammerling, Ulrich			Control of oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial energy homoeostasis	FASEB JOURNAL			English	Article						intermediary metabolism; pyruvate dehydrogenase complex; respiration; retinoid metabolism; signal transduction	PROTEIN-KINASE-C; RETRO-RETINOIDS; MOLECULAR-BASIS; CELL-GROWTH; ACTIVATION; ANHYDRORETINOL; DELTA; ABSORPTION; BIOLOGY; STRESS	The physiology of two metabolites of vitamin A is understood in substantial detail: retinaldehyde functions as the universal chromophore in the vertebrate and invertebrate eye; retinoic acid regulates a set of vertebrate transcription factors, the retinoic acid receptor superfamily. The third member of this retinoid triumvirate is retinol. While functioning as the precursor of retinaldehyde and retinoic acid, a growing body of evidence suggests a far more fundamental role for retinol in signal transduction. Here we show that retinol is essential for the metabolic fitness of mitochondria. When cells were deprived of retinol, respiration and ATP synthesis defaulted to basal levels. They recovered to significantly higher energy output as soon as retinol was restored to physiological concentration, without the need for metabolic conversion to other retinoids. Retinol emerged as an essential cofactor of protein kinase C delta (PKC delta), without which this enzyme failed to be activated in mitochondria. Furthermore, retinol needed to physically bind PKC delta, because mutation of the retinol binding site rendered PKC delta unresponsive to Rol, while retaining responsiveness to phorbol ester. The PKC delta/retinol complex signaled the pyruvate dehydrogenase complex for enhanced flux of pyruvate into the Krebs cycle. The baseline response was reduced in vitamin A-deficient lecithin: retinol acyl transferase-knockout mice, but this was corrected within 3 h by intraperitoneal injection of vitamin A; this suggests that vitamin A is physiologically important. These results illuminate a hitherto unsuspected role of vitamin A in mitochondrial bioenergetics of mammals, acting as a nutritional sensor. As such, retinol is of fundamental importance for energy homeostasis. The data provide a mechanistic explanation to the nearly 100-yr-old question of why vitamin A deficiency causes so many pathologies that are independent of retinoic acid action.-Acin-Perez, T., Hoyos, B., Zhao, F., Vinogradov, V., Fischman, D. A., Harris, R. A., Leitges, M., Wongsiriroj, N., Blaner, W. S., Manfredi, G., Hammerling, U. Control of oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial energy homoeostasis. FASEB J. 24, 627-636 (2010). www.fasebj.org	[Hoyos, Beatrice; Zhao, Feng; Vinogradov, Valerie; Hammerling, Ulrich] Sloan Kettering Inst Canc Res, Program Immunol, New York, NY 10065 USA; [Acin-Perez, Rebeca; Manfredi, Giovanni] Weill Cornell Med Sch, Dept Neurol & Neurobiol, New York, NY USA; [Fischman, Donald A.] Weill Cornell Med Sch, Dept Cell & Dev Biol, New York, NY USA; [Harris, Robert A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Wongsiriroj, Nuttaporn] Graz Univ, Inst Mol Biosci, Graz, Austria; [Blaner, William S.] Columbia Univ, Coll Phys & Surg, Dept Human Nutr, New York, NY USA; [Blaner, William S.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Indiana University System; Indiana University-Purdue University Indianapolis; University of Oslo; University of Graz; Columbia University; Columbia University	Hammerling, U (corresponding author), Sloan Kettering Inst Canc Res, Program Immunol, 1275 York Ave, New York, NY 10065 USA.	u-hammerling@ski.mskcc.org	Acin-Perez, Rebeca/H-6160-2015; Acin-Perez, Rebeca/AAU-4913-2020; Leitges, Michael/AAN-1953-2021	Acin-Perez, Rebeca/0000-0001-9553-8337; Acin-Perez, Rebeca/0000-0001-9553-8337; Leitges, Michael/0000-0003-4203-6995	National Institutes of Health [DK069384, CA089362, DK079221, K02NS047306]; NATIONAL CANCER INSTITUTE [R01CA089362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS047306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Anatoli Starkov and Gregg Duester for helpful discussions and Ouathek Ouerfelli and Alice Cao for their expertise in analytical chemistry. This work was supported by grants from the National Institutes of Health: DK069384 (to U. H.); CA089362 (to U. H.); DK079221 (to W. S. B.); and K02NS047306 (to G. M.). R. A.-P. thanks the Spanish Ministry of Education for a Fulbright fellowship.	Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; BUCK J, 1990, J EXP MED, V171, P1613, DOI 10.1084/jem.171.5.1613; BUCK J, 1991, SCIENCE, V254, P1654, DOI 10.1126/science.1749937; BUCK J, 1993, J EXP MED, V178, P675, DOI 10.1084/jem.178.2.675; Chen YQ, 1999, CANCER RES, V59, P3985; Chiu HJ, 2008, FASEB J, V22, P3878, DOI 10.1096/fj.08-112375; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; EPPINGER TM, 1993, J EXP MED, V178, P1995, DOI 10.1084/jem.178.6.1995; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Galter D, 2003, EUR J BIOCHEM, V270, P1316, DOI 10.1046/j.1432-1033.2003.03502.x; GARBE A, 1992, J EXP MED, V176, P109, DOI 10.1084/jem.176.1.109; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Hoyos B, 2005, J BIOL CHEM, V280, P6872, DOI 10.1074/jbc.M412695200; Hoyos B, 2002, J BIOL CHEM, V277, P23949, DOI 10.1074/jbc.M110750200; Hoyos B, 2000, J EXP MED, V192, P835, DOI 10.1084/jem.192.6.835; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Imam A, 2001, FASEB J, V15, P28; Kang HW, 2007, MOL CELL ENDOCRINOL, V271, P18, DOI 10.1016/j.mce.2007.03.002; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Kim HJ, 2006, ONCOGENE, V25, P2785, DOI 10.1038/sj.onc.1209303; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Korichneva I, 2003, J PHARMACOL EXP THER, V305, P426, DOI 10.1124/jpet.103.048900; Korichneva I, 1999, J CELL SCI, V112, P2521; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Livera G, 2002, REPRODUCTION, V124, P173, DOI 10.1530/rep.0.1240173; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Mao GE, 2000, TOXICOL APPL PHARM, V163, P38, DOI 10.1006/taap.1999.8828; McCollum EV, 1913, J BIOL CHEM, V15, P167; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; OConnell MJ, 1996, J EXP MED, V184, P549, DOI 10.1084/jem.184.2.549; Osborne TB, 1913, J BIOL CHEM, V15, P311; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; PINTON P, 2004, J CELL BIOL, P1; Ross A. Catharine, 1994, P521; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	48	61	63	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					627	636		10.1096/fj.09-142281	http://dx.doi.org/10.1096/fj.09-142281			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19812372	Green Published			2022-12-25	WOS:000274045000030
J	Mata, J				Mata, Juan			Genome-wide mapping of myosin protein-RNA networks suggests the existence of specialized protein production sites	FASEB JOURNAL			English	Article						RIp-chip; fission yeast; posttranscriptional control	FISSION YEAST; MESSENGER-RNAS; ACTIN CYTOSKELETON; ARP2/3 COMPLEX; I MYOSINS; RIP-CHIP; IDENTIFICATION; TRANSPORT; FAMILY; RNG3P	Motor proteins can organize posttranscriptional processes by transporting ribonucleoprotein complexes to specific locations. To investigate a possible role of myosin proteins in gene expression control, I have identified mRNAs associated with five myosin heavy chains in the fission yeast Schizosaccharomyces pombe, by purifying the proteins and identifying bound transcripts using DNA microarrays. Each myosin coimmunoprecipitated with 5-13 different mRNAs (similar to 0.1-0.2% of all genes), including those encoding four different myosin heavy chains. Moreover, one of the myosins (Myo1) interacted with mRNAs encoding components of the cortical actin cytoskeleton. These interactions were not observed in control immunoprecipitates. A myosin-specific chaperone (Rng3) that interacts cotranslationally with myosin mRNAs was essential for the association between myosin proteins and transcripts but not between Myo1 and other mRNAs. Finally, proteins encoded by the Myo1-associated mRNAs immunoprecipitated each other's transcripts, but not myosin mRNAs. These interactions suggest the existence of two distinct myosin-containing ribonucleoprotein complexes: those containing myosin mRNAs and those associated with Myo1. They are distinguished by their mRNA composition, requirement for the Rng3 chaperone and the presence of nonmyosin cytoskeletal proteins. I propose that these complexes represent specialized sites for the production of myosin proteins and the assembly of cytoskeletal components, respectively.-Mata, J. Genome-wide mapping of myosin protein-RNA networks suggests the existence of specialized protein production sites. FASEB J. 24, 479-484 (2010). www.fasebj.org	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Mata, J (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	jm593@cam.ac.uk		Mata, Juan/0000-0002-5514-3653	Medical Research Council New Investigator Award [G0501168]; Medical Research Council [G0501168] Funding Source: researchfish; MRC [G0501168] Funding Source: UKRI	Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The author thanks Jurg Bahler for support throughout this project. The author also thanks Jurg Bahler, Samuel Marguerat, and Maria Amorim for comments on the manuscript, and Stephen Watt for help with microarray experiments. Kathy Gould (Vanderbilt University Medical Center, Nashville, TN, USA) provided the rng3-65 mutant. This work was supported by a Medical Research Council New Investigator Award (G0501168) to J.M.	Amorim MJ, 2009, EMBO REP, V10, P186, DOI 10.1038/embor.2008.228; Barker SL, 2007, MOL BIOL CELL, V18, P2893, DOI 10.1091/mbc.E07-05-0436; Baroni Timothy E., 2008, V419, P93, DOI 10.1007/978-1-59745-033-1_6; Carnahan RH, 2003, J CELL BIOL, V162, P851, DOI 10.1083/jcb.200305012; Chang L, 2006, J CELL BIOL, V172, P747, DOI 10.1083/jcb.200511033; Chang W, 2008, RNA, V14, P491, DOI 10.1261/rna.665008; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Gachet Y, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P225; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Mishra M, 2005, EUKARYOT CELL, V4, P567, DOI 10.1128/EC.4.3.567-576.2005; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Wong KCY, 2000, J CELL SCI, V113, P2421	26	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					479	484		10.1096/fj.09-140335	http://dx.doi.org/10.1096/fj.09-140335			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19805578				2022-12-25	WOS:000274045000015
J	Pereira, RMS; Teixeira, KLD; Barreto-De-Souza, V; Calegari-Silva, TC; De-Melo, LDB; Soares, DC; Bou-Habib, DC; Silva, AM; Saraiva, EM; Lopes, UG				Pereira, Renata M. S.; Dias Teixeira, Karina Luiza; Barreto-de-Souza, Victor; Calegari-Silva, Teresa Cristina; De-Melo, Luiz D. B.; Soares, Deivid C.; Bou-Habib, Dumith C.; Silva, Aristobolo M.; Saraiva, Elvira M.; Lopes, Ulisses G.			Novel role for the double-stranded RNA-activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania	FASEB JOURNAL			English	Article						IL-10; Leishmania amazonensis; NF-kappa B; nitric oxide	NF-KAPPA-B; ARGINASE-I INDUCTION; NITRIC-OXIDE; MURINE MACROPHAGES; MAJOR INFECTION; INNATE IMMUNITY; L-ARGININE; INTERFERON; INTERLEUKIN-10; EXPRESSION	The evolution of Leishmania infection depends on the balance between microbicidal and suppressor macrophage functions. Double-stranded RNA (dsRNA)-activated protein kinase R (PKR), a classic antiviral protein, is able to regulate a number of signaling pathways and macrophage functions. We investigated the possible role of PKR in the modulation of Leishmania infection. Our data demonstrated that Leishmania amazonensis infection led to PKR activation and increased PKR levels. Consistently, in macrophages from PKR knockout 129Sv/Ev mice and RAW-264.7 cells stably expressing a dominant-negative (DN) construct of PKR (DN-PKR), L. amazonensis infection was strongly reduced. The treatment of infected macrophages with the synthetic double-stranded RNA poly(I: C), a potent PKR inductor, increased L. amazonensis intracellular proliferation. This effect was reversed by 2-aminopurine (2-AP), a pharmacological inhibitor of PKR, as well as by the expression of DN-PKR. NO release induced by dsRNA treatment was inhibited by L. amazonensis through NF-kappa B modulation. PKR activation induced by dsRNA also resulted in IL-10 production, whose neutralization with specific antibody completely abrogated L. amazonensis proliferation. Our data demonstrated a new role of PKR in protozoan parasitic infection through IL-10 modulation.-Pereira, R. M. S., Teixeira, K. L. D., Barreto-deSouza, V. Calegari-Silva, T. C., De-Melo, D. B., Soares, D. C., Bou-Habib, D. C., Silva, A. M., Saraiva, E. M., Lopes, U. G. Novel role for the double-stranded RNA-activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania. FASEB J. 24, 617-626 (2010). www.fasebj.org	[Pereira, Renata M. S.; Dias Teixeira, Karina Luiza; Calegari-Silva, Teresa Cristina; De-Melo, Luiz D. B.; Lopes, Ulisses G.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Mol Parasitol Lab, Inst Biofis Carlos Chagas Filho, BR-21949902 Rio De Janeiro, Brazil; [Soares, Deivid C.; Saraiva, Elvira M.] Univ Fed Rio de Janeiro, Lab Imunobiol Leishmanioses, Inst Microbiol Paulo Goes, BR-21949902 Rio De Janeiro, Brazil; [Barreto-de-Souza, Victor; Bou-Habib, Dumith C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisas Timo, Rio De Janeiro, Brazil; [Silva, Aristobolo M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Lopes, UG (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Mol Parasitol Lab, Inst Biofis Carlos Chagas Filho, Av Carlos Chagas Filho S-N, BR-21949902 Rio De Janeiro, Brazil.	lopesu@biof.ufrj.br	Silva, Victor/AAL-3189-2021; Lopes, Ulisses Gazos/T-6634-2019; Dias Teixeira, Karina/J-4918-2017; Lopes, Ulisses/N-4416-2013; Silva, Aristóbolo/AAA-2239-2021; Pereira, Renata/V-6194-2019; Bou-Habib, Dumith/GPP-1624-2022; Silva, Aristobolo/CAF-4874-2022; Saraiva, Elvira M/L-2864-2017	Dias Teixeira, Karina/0000-0002-6115-6768; Silva, Aristóbolo/0000-0001-7473-7433; Bou-Habib, Dumith/0000-0003-0552-9045; Saraiva, Elvira M/0000-0002-6388-5286; Barreto S B Silva, Victor/0000-0002-7413-0735; Pereira, Renata/0000-0002-7719-8356; De Melo, Luiz Dione Barbosa/0000-0003-2445-9943; Calegari Silva, Teresa Cristina/0000-0002-1656-3460	Fundacao Carlos Chagas Filho de Amparo; Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao Carlos Chagas Filho de Amparo; Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank Professor Marcela Lopes for revising the manuscript. We also thank Paulo Cordeiro for his technical expertise, Judy Grevan for editing the text in English, and the Hemotherapy Service of the Hospital Clementino Fraga Filho (Federal University of Rio de Janeiro) for providing buffy coats. This work was supported by the Brazilian research funding agencies Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Barreto-De-Souza V, 2006, J INFECT DIS, V194, P846, DOI 10.1086/506618; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bogdan C, 1999, PARASITOL TODAY, V15, P22, DOI 10.1016/S0169-4758(98)01362-3; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Calegari-Silva TC, 2009, IMMUNOL LETT, V127, P19, DOI 10.1016/j.imlet.2009.08.009; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Chakrabarti A, 2008, J BIOL CHEM, V283, P25132, DOI 10.1074/jbc.M804770200; Chatelain R, 1999, PARASITE IMMUNOL, V21, P211, DOI 10.1046/j.1365-3024.1999.00224.x; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Danelli MGM, 2009, PHYTOCHEMISTRY, V70, P608, DOI 10.1016/j.phytochem.2009.03.009; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; de Almeida MC, 2003, MEM I OSWALDO CRUZ, V98, P861, DOI 10.1590/S0074-02762003000700001; Domingo-Gil E, 2008, J VIROL, V82, P254, DOI 10.1128/JVI.01384-07; EVANS TG, 1993, J IMMUNOL, V151, P907; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; GREEN SJ, 1990, IMMUNOL LETT, V25, P15, DOI 10.1016/0165-2478(90)90083-3; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; GUSELLA GL, 1995, J IMMUNOL, V154, P345; Iniesta V, 2005, INFECT IMMUN, V73, P6085, DOI 10.1128/IAI.73.9.6085-6090.2005; Iniesta V, 2002, PARASITE IMMUNOL, V24, P113, DOI 10.1046/j.1365-3024.2002.00444.x; Iniesta V, 2001, J EXP MED, V193, P777, DOI 10.1084/jem.193.6.777; Jones DE, 2002, INFECT IMMUN, V70, P2151, DOI 10.1128/IAI.70.4.2151-2158.2002; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Munder M, 1999, J IMMUNOL, V163, P3771; Murray HW, 2003, J INFECT DIS, V188, P458, DOI 10.1086/376510; Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458; Padigel UM, 2003, J IMMUNOL, V171, P3705, DOI 10.4049/jimmunol.171.7.3705; Qi H, 2004, INFECT IMMUN, V72, P988, DOI 10.1128/IAI.72.2.988-995.2004; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Taylor DR, 1996, MOL CELL BIOL, V16, P6295; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; Ward SV, 2002, VIROLOGY, V296, P136, DOI 10.1006/viro.2002.1356; *WHO TROP DIS RES, 2009, LEISHM BURD DIS; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yeung MC, 1996, P NATL ACAD SCI USA, V93, P12451, DOI 10.1073/pnas.93.22.12451; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	48	42	43	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					617	626		10.1096/fj.09-140053	http://dx.doi.org/10.1096/fj.09-140053			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19812373	Bronze			2022-12-25	WOS:000274045000029
J	Dean, JL; McClendon, AK; Stengel, KR; Knudsen, ES				Dean, J. L.; McClendon, A. K.; Stengel, K. R.; Knudsen, E. S.			Modeling the effect of the RB tumor suppressor on disease progression: dependence on oncogene network and cellular context	ONCOGENE			English	Article						retinoblastoma tumor suppressor (RB); Ras; c-Myc; chemotherapeutics; cell cycle checkpoints	PRB-DEFICIENT EPIDERMIS; CYCLE CONTROL; RETINOBLASTOMA PROTEIN; C-MYC; SKIN CARCINOGENESIS; INDUCED APOPTOSIS; RAS; CANCER; P53; FIBROBLASTS	The retinoblastoma tumor suppressor, RB, is a key regulator of cellular proliferation that is functionally inactivated at high frequency in human cancer. Although RB has been extensively studied with regard to tumor etiology, loss of tumor-suppressor function often occurs relatively late in tumor progression. Therefore, inactivation of RB could have a profound impact on the behavior of tumors driven by discrete oncogenes. Here, collaboration between Ras or c-Myc deregulation and RB functional state was investigated in a model of conditional genetic deletion to decipher the effects related to disease progression. These studies showed that RB loss had a robust impact on mitogen dependence, anchorage dependence and overall survival, which was significantly modified by oncogene activation. Specifically, RB deficiency predisposed c-Myc-expressing cells to cell death and reduced overall tumorigenic proliferation. In contrast, RB deficiency exacerbated the tumorigenic behavior of Ras-transformed cells in both the model system and human tumor cell lines. As these tumors exhibited highly aggressive behavior, the possibility of exploiting the intrinsic sensitivity to cell death with RB loss was evaluated. Particularly, although Ras-transformed, RB-deficient cells bypassed the G1-checkpoint elicited by pharmacological activation of the p53 pathway, they were also highly sensitized to cell death. Altogether, these data suggest that the impact of RB deletion is dependent on the oncogene milieu, and can directly contribute to transformed phenotypes and response to therapeutic intervention.	[Dean, J. L.; McClendon, A. K.; Knudsen, E. S.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Dean, J. L.; McClendon, A. K.; Knudsen, E. S.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Stengel, K. R.] Univ Cincinnati, Coll Med, Dept Cell & Canc Biol, Cincinnati, OH USA	Jefferson University; Jefferson University; University System of Ohio; University of Cincinnati	Knudsen, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, BLSB Room 1002,233 S 10th St, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org		Stengel, Kristy/0000-0002-8330-5744				Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Alkarain A, 2004, BREAST CANCER RES, V6, P13, DOI 10.1186/bcr722; Berkovich E, 2001, J BIOL CHEM, V276, P42851, DOI 10.1074/jbc.M103596200; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; BOS JL, 1989, CANCER RES, V49, P4682; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Crespo P, 2000, CELL MOL LIFE SCI, V57, P1613, DOI 10.1007/PL00000645; DeGregori J, 2006, MOL CELL BIOL, V26, P1165, DOI 10.1128/MCB.26.4.1165-1169.2006; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FILMUS J, 1994, ONCOGENE, V9, P3627; Groth A, 2000, J BIOL CHEM, V275, P27473; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Kharitonova MA, 2007, CELL BIOL INT, V31, P220, DOI 10.1016/j.cellbi.2006.10.008; Kitagawa M, 2008, ONCOGENE, V27, P5303, DOI 10.1038/onc.2008.164; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Lara MF, 2008, MOL CARCINOGEN, V47, P105, DOI 10.1002/mc.20367; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; Leung JY, 2008, ONCOGENE, V27, P4172, DOI 10.1038/onc.2008.55; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; MacPherson D, 2007, EMBO J, V26, P784, DOI 10.1038/sj.emboj.7601515; Mallette FA, 2004, ONCOGENE, V23, P91, DOI 10.1038/sj.onc.1206886; Marino S, 2000, GENE DEV, V14, P994; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Markey MP, 2002, CANCER RES, V62, P6587; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Miyamoto H, 1996, J UROLOGY, V155, P1444, DOI 10.1016/S0022-5347(01)66304-3; MORGENBESSER SD, 1994, NATURE, V371, P72, DOI 10.1038/371072a0; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Rogoff HA, 2004, CELL CYCLE, V3, P845; Ruiz S, 2005, CANCER RES, V65, P9678, DOI 10.1158/0008-5472.CAN-05-1853; Santos M, 2008, MOL CARCINOGEN, V47, P815, DOI 10.1002/mc.20426; Seeley SL, 2007, CANCER LETT, V245, P205, DOI 10.1016/j.canlet.2006.01.028; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Stengel KR, 2008, CELL CYCLE, V7, DOI 10.4161/cc.7.8.5737; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; WANG JYJ, 1994, ADV CANCER RES, V64, P25, DOI 10.1016/S0065-230X(08)60834-9; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006; Zagorski WA, 2007, CANCER RES, V67, P8264, DOI 10.1158/0008-5472.CAN-06-4753; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	54	13	13	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					68	80		10.1038/onc.2009.313	http://dx.doi.org/10.1038/onc.2009.313			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19802012				2022-12-25	WOS:000273373500007
J	Mizwicki, MT; Bula, CM; Mahinthichaichan, P; Henry, HL; Ishizuka, S; Norman, AW				Mizwicki, Mathew T.; Bula, Craig M.; Mahinthichaichan, Paween; Henry, Helen L.; Ishizuka, Seiichi; Norman, Anthony W.			On the Mechanism Underlying (23S)-25-Dehydro-1 alpha(OH)-vitamin D-3-26,23-lactone Antagonism of hVDRwt Gene Activation and Its Switch to a Superagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; CONFORMATIONAL ENSEMBLE MODEL; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; CRYSTAL-STRUCTURES; NUCLEAR RECEPTOR; STRUCTURAL BASIS; PAGETS-DISEASE; LIGAND; VDR; ANALOGS	(23S)-25-Dehydro-1 alpha(OH)-vitamin D-3-26,23-lactone (MK) is an antagonist of the 1 alpha,25(OH)(2)-vitamin D-3 (1,25D)/human nuclear vitamin D receptor (hVDR) transcription initiation complex, where the activation helix (i.e. helix-12) is closed. To study the mode of antagonism of MK an hVDR mutant library was designed to alter the free molecular volume in the region of the hVDR ligand binding pocket occupied by the ligand side-chain atoms (i.e. proximal to helix-12). The 1,25D-hVDR structure-function studies demonstrate that 1) van der Waals contacts between helix-12 residues Leu-414 and Val-418 and 1,25D enhance the stability of the closed helix-12 conformer and 2) removal of the side-chain H-bonds to His-305(F) and/or His-397(F) have no effect on 1,25D transactivation, even though they reduce the binding affinity of 1,25D. The MK structure-function results demonstrate that the His-305, Leu-404, Leu-414, and Val-418 mutations, which increase the free volume of the hVDR ligand binding pocket, significantly enhance MK antagonist potency. Surprisingly, the H305F and H305F/H397F mutations turn MK into a VDR superagonist (EC50 similar to 0.05 nM) but do not concomitantly alter MK binding affinity. Molecular modeling studies demonstrate that MK antagonism stems from its side chain energetically preferring a pose in the VDR ligand binding pocket where its terminal C26-methylene atom is far removed from helix-12. MK superagonism results from an energetically favored increase in interaction between Leu-404/Val-418 and C26, resulting in an increase in the stability and population of the closed, helix-12 conformer. Finally, the results/model generated, coupled with application of a VDR ensemble allosterics model, provide an understanding for the species specificity of MK.	[Mizwicki, Mathew T.; Bula, Craig M.; Mahinthichaichan, Paween; Henry, Helen L.; Norman, Anthony W.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Ishizuka, Seiichi] Teijin Inst Biomed Res, Dept Bone & Calcium Metab, Tokyo 1918512, Japan	University of California System; University of California Riverside	Mizwicki, MT (corresponding author), Univ Calif Riverside, Dept Biochem, 5470 Boyce Hall, Riverside, CA 92521 USA.	mathew.mizwicki@ucr.edu		Mahinthichaichan, Paween/0000-0002-2216-4482				Barletta F, 2002, MOL ENDOCRINOL, V16, P301, DOI 10.1210/me.16.2.301; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bula CM, 2000, MOL ENDOCRINOL, V14, P1788, DOI 10.1210/me.14.11.1788; Bula CM, 2005, ENDOCRINOLOGY, V146, P5581, DOI 10.1210/en.2005-0806; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; Choi MW, 2001, BIOORGAN MED CHEM, V9, P1721, DOI 10.1016/S0968-0896(01)00060-8; Ciesielski F, 2004, J STEROID BIOCHEM, V89-90, P55, DOI 10.1016/j.jsbmb.2004.03.109; Egea PF, 2000, FEBS LETT, V476, P62, DOI 10.1016/S0014-5793(00)01672-0; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Ishizuka S, 2005, ENDOCRINOLOGY, V146, P2023, DOI 10.1210/en.2004-1140; Ishizuka S, 2001, STEROIDS, V66, P227, DOI 10.1016/S0039-128X(00)00146-X; Kurihara N, 2004, J STEROID BIOCHEM, V89-90, P321, DOI 10.1016/j.jsbmb.2004.03.023; Miura D, 1999, FEBS LETT, V460, P297, DOI 10.1016/S0014-5793(99)01347-2; Miura D, 1999, J BIOL CHEM, V274, P16392, DOI 10.1074/jbc.274.23.16392; Mizwicki MT, 2007, J STEROID BIOCHEM, V103, P243, DOI 10.1016/j.jsbmb.2006.12.004; Mizwicki MT, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275re4; Mizwicki MT, 2004, P NATL ACAD SCI USA, V101, P12876, DOI 10.1073/pnas.0403606101; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; Ochiai E, 2005, MOL ENDOCRINOL, V19, P1147, DOI 10.1210/me.2004-0234; PELEG S, 1995, J BIOL CHEM, V270, P10551, DOI 10.1074/jbc.270.18.10551; PELEG S, 1994, VITAMIN D, P237; Perakyla M, 2004, CHEM BIOL, V11, P1147, DOI 10.1016/j.chembiol.2004.05.023; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Siu-Caldera ML, 1999, J STEROID BIOCHEM, V71, P111, DOI 10.1016/S0960-0760(99)00130-2; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; Takenouchi K, 2004, J STEROID BIOCHEM, V89-90, P31, DOI 10.1016/j.jsbmb.2004.03.046; Tocchini-Valentini G, 2004, J MED CHEM, V47, P1956, DOI 10.1021/jm0310582; Tocchini-Valentini G, 2001, P NATL ACAD SCI USA, V98, P5491, DOI 10.1073/pnas.091018698; Toell A, 2001, MOL PHARMACOL, V59, P1478, DOI 10.1124/mol.59.6.1478; Vaisanen S, 2002, MOL PHARMACOL, V62, P788, DOI 10.1124/mol.62.4.788; WECKSLER WR, 1979, ANAL BIOCHEM, V92, P314, DOI 10.1016/0003-2697(79)90664-X; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528	33	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36292	36301		10.1074/jbc.M109.042069	http://dx.doi.org/10.1074/jbc.M109.042069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19801650	hybrid, Green Published			2022-12-25	WOS:000272970500031
J	Franz, H; Mosch, K; Soeroes, S; Urlaub, H; Fischle, W				Franz, Henriette; Mosch, Kerstin; Soeroes, Szabolcs; Urlaub, Henning; Fischle, Wolfgang			Multimerization and H3K9me3 Binding Are Required for CDYL1b Heterochromatin Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE LYSINE METHYLATION; STRUCTURAL BASIS; CHROMATIN FIBER; GENE FAMILY; PROTEINS; CHROMODOMAIN; H3; NUCLEOSOME; METHYLTRANSFERASES; HYDRATASE	Proteins containing defined recognition modules mediate readout and translation of histone modifications. These factors are thought to initiate downstream signaling events regulating chromatin structure and function. We identified CDYL1 as an interaction partner of histone H3 trimethylated on lysine 9 (H3K9me3). CDYL1 belongs to a family of chromodomain factors found in vertebrates. We show that three different splicing variants of CDYL1, a, b, and c, are differentially expressed in various tissues with CDYL1b being the most abundant variant. Although all three splicing variants share a common C-terminal enoyl-CoA hydratase-like domain, only CDYL1b contains a functional chromodomain implicated in H3K9me3 binding. A splicing event introducing an N-terminal extension right at the beginning of the chromodomain of CDYL1a inactivates its chromodomain. CDYL1c does not contain a chromodomain at all. Although CDYL1b displays binding affinity to methyl-lysine residues in different sequence context similar to chromodomains in other chromatin factors, we demonstrate that the CDYL1b chromodomain/H3K9me3 interaction is necessary but not sufficient for association of the factor with heterochromatin. Indeed, multimerization of the protein via the enoyl-CoA hydratase-like domain is essential for H3K9me3 chromatin binding in vitro and heterochromatin localization in vivo. In agreement, overexpression of CDYL1c that can multimerize, but does not interact with H3K9me3 can displace CDYL1b from heterochromatin. Our results imply that multimeric binding to H3K9me3 by CDYL1b homomeric complexes is essential for efficient chromatin targeting. We suggest that similar multivalent binding stably anchors other histone modification binding factors on their target chromatin regions.	[Franz, Henriette; Mosch, Kerstin; Soeroes, Szabolcs; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Fischle, W (corresponding author), Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany.	wfischl@gwdg.de		Franz, Henriette/0000-0001-9358-7442	Max Planck Society; European Union [FP6]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	This work was supported in whole or in part by the Max Planck Society and the European Union FP6, Network of Excellence, "The Epigenome."	Bhowmick BK, 2006, GENET MOL RES, V5, P696; Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; Dorus S, 2003, HUM MOL GENET, V12, P1643, DOI 10.1093/hmg/ddg185; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim JJP, 2002, CURR OPIN STRUC BIOL, V12, P721, DOI 10.1016/S0959-440X(02)00390-1; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Lachner M, 2004, COLD SPRING HARB SYM, V69, P209, DOI 10.1101/sqb.2004.69.209; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 2002, P NATL ACAD SCI USA, V99, P8707, DOI 10.1073/pnas.082248899; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Lakowski B, 2006, J MOL NEUROSCI, V29, P227, DOI 10.1385/JMN:29:3:227; Leuba SH, 1999, METH MOL B, V119, P143; Li X, 2007, TRENDS GENET, V23, P427, DOI 10.1016/j.tig.2007.06.001; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Mateos-Langerak J, 2007, MOL BIOL CELL, V18, P1464, DOI 10.1091/mbc.E06-01-0025; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; PALOSAARI PM, 1991, J BIOL CHEM, V266, P10750; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Wu H, 2009, PROTEINS, V76, P1054, DOI 10.1002/prot.22472	52	40	42	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35049	35059		10.1074/jbc.M109.052332	http://dx.doi.org/10.1074/jbc.M109.052332			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19808672	Green Published, hybrid			2022-12-25	WOS:000272439600059
J	Ikeda, Y; DeMartino, GN; Brown, MS; Lee, JN; Goldstein, JL; Ye, J				Ikeda, Yukio; DeMartino, George N.; Brown, Michael S.; Lee, Joon No; Goldstein, Joseph L.; Ye, Jin			Regulated Endoplasmic Reticulum-associated Degradation of a Polytopic Protein p97 RECRUITS PROTEASOMES TO Insig-1 BEFORE EXTRACTION FROM MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME-ASSOCIATED PROTEINS; CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; HAMSTER OVARY CELLS; 26S PROTEASOME; INSIG-1; CHOLESTEROL; MEMBRANE; SREBPS; REDUCTASE	Polytopic membrane proteins subjected to endoplasmic reticulum (ER)-associated degradation are extracted from membranes and targeted to proteasomes for destruction. The extraction mechanism is poorly understood. One polytopic ER protein subjected to ER-associated degradation is Insig-1, a negative regulator of cholesterol synthesis. Insig-1 is rapidly degraded by proteasomes when cells are depleted of cholesterol, and its degradation is inhibited when sterols accumulate in cells. Insig-2, a functional homologue of Insig-1, is degraded slowly, and its degradation is not regulated by sterols. Here, we report that a single amino acid substitution in Insig-2, Insig-2(L210A), causes Insig-2 to be degraded in an accelerated and sterol-regulated manner similar to Insig-1. In seeking an explanation for the accelerated degradation, we found that proteasomes bind to wild type Insig-1 and mutant Insig-2(L210A) but not to wild type Insig-2, whereas the proteins are still embedded in cell membranes. This binding depends on at least two factors, ubiquitination of Insig and association with the ATPase p97/VCP complex. These data suggest that p97 recruits proteasomes to polytopic ER proteins even before they are extracted from membranes.	[Ikeda, Yukio; Brown, Michael S.; Lee, Joon No; Goldstein, Joseph L.; Ye, Jin] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu			National Institutes of Health [2PO1HL20948, RO1DK46181]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 2PO1HL20948 and RO1DK46181. This work was also supported by the Perot Family Foundation.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1978, J BIOL CHEM, V253, P1121; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee JN, 2006, P NATL ACAD SCI USA, V103, P4958, DOI 10.1073/pnas.0600422103; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	40	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34889	34900		10.1074/jbc.M109.044875	http://dx.doi.org/10.1074/jbc.M109.044875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19815544	Green Published, hybrid			2022-12-25	WOS:000272439600044
J	De Arcangelis, V; Liu, R; Soto, D; Xiang, Y				De Arcangelis, Vania; Liu, Ruijie; Soto, Dagoberto; Xiang, Yang			Differential Association of Phosphodiesterase 4D Isoforms with beta(2)-Adrenoceptor in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; RECEPTOR; CAMP; PHOSPHORYLATION; CONTRACTION; MODULATION; HEART; PDE4	cAMP and protein kinase A (PKA) activation represents a key signaling mechanism upon beta-adrenergic stimulation under stress. Both beta(1)- and beta(2)-adrenoreceptor (ARs) subtypes induce cAMP accumulation, yet play distinct roles in cardiac contraction and myocyte apoptosis. Differences in controlling cAMP/PKA activities through the assembly of complexes between the receptors and cAMP-specific phosphodiesterases contribute to the distinct biological outcomes. Here, we demonstrate that beta(2)ARs form signaling complexes with a set of PDE4D isoforms expressed in cardiac myocytes. PDE4D9 and PDE4D8 bind to the beta(2)AR at resting conditions; however, agonist stimulation induces dissociation of PDE4D9 from the receptor but recruitment of PDE4D8 to the receptor. Agonist stimulation also induces recruitment of PDE4D5 to the beta(2)AR. Moreover, the receptor-associated PDE4D isoforms play distinct roles in controlling cAMP activities and regulating the PKA phosphorylation of the receptor and myocyte contraction rate responses. Knockdown of PDE4D9 with short hairpin RNA enhances the beta(2)AR-induced cAMP signaling, whereas knockdown of PDE4D8 only slightly prolongs the receptor-induced cAMP signaling in myocytes. Inhibition of PDE4D9 and PDE4D5 enhances the base-line levels of contraction rates, whereas inhibition of PDE4D9 and PDE4D8 enhances the maximal contraction rate increases upon activation of beta(2)AR. Our data underscore the complex regulation of intracellular cAMP by beta(2)AR-associated phosphodiesterase enzymes to enforce the specificity of the receptor signaling for physiological responses.	[Xiang, Yang] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Xiang, Yang] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Xiang, Y (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 523 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.	kevinyx@illinois.edu	Soto, Dagoberto I/N-6817-2014	Soto, Dagoberto I/0000-0002-7350-1530; liu, ruijie/0000-0002-2468-0579	National Institutes of Health [HL082846]; American Heart Association [0635331N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL082846 ( to Y.X.). This work was also supported by American Heart Association 0635331N ( to Y.X.).	Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Richter W, 2005, BIOCHEM J, V388, P803, DOI 10.1042/BJ20050030; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiao RP, 2006, TRENDS PHARMACOL SCI, V27, P330, DOI 10.1016/j.tips.2006.04.009; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhou YY, 1997, AM J PHYSIOL-HEART C, V273, pH1611, DOI 10.1152/ajpheart.1997.273.3.H1611; Zhu WZ, 2005, CIRC RES, V97, P244, DOI 10.1161/01.RES.0000176764.38934.86	18	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33824	33832		10.1074/jbc.M109.020388	http://dx.doi.org/10.1074/jbc.M109.020388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801680	hybrid, Green Published			2022-12-25	WOS:000272165200014
J	Zhao, J; Connorton, JM; Guo, YQ; Li, XK; Shigaki, T; Hirschi, KD; Pittman, JK				Zhao, Jian; Connorton, James M.; Guo, YingQing; Li, Xiangkai; Shigaki, Toshiro; Hirschi, Kendal D.; Pittman, Jon K.			Functional Studies of Split Arabidopsis Ca2+/H+ Exchangers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; PROTEIN-PROTEIN INTERACTIONS; SACCHAROMYCES-CEREVISIAE; SUCROSE TRANSPORTERS; H+/CA2+ ANTIPORTER; ABC TRANSPORTER; CROSS-TALK; CAX1; YEAST; IDENTIFICATION	In plants, high capacity tonoplast cation/H+ antiport is mediated in part by a family of cation exchanger (CAX) transporters. Functional association between CAX1 and CAX3 has previously been shown. In this study we further examine the interactions between CAX protein domains through the use of nonfunctional halves of CAX transporters. We demonstrate that a protein coding for an N-terminal half of an activated variant of CAX1(sCAX1) can associate with the C-terminal half of either CAX1 or CAX3 to form a functional transporter that may exhibit unique transport properties. Using yeast split ubiquitin, in planta bimolecular fluorescence complementation, and gel shift experiments, we demonstrate a physical interaction among the half proteins. Moreover, the half-proteins both independently localized to the same yeast endomembrane. Co-expressing variants of N- and C-terminal halves of CAX1 and CAX3 in yeast suggested that the N-terminal region mediates Ca2+ transport, whereas the C-terminal half defines salt tolerance phenotypes. Furthermore, in yeast assays, auto-inhibited CAX1 could be differentially activated by CAX split proteins. The N-terminal half of CAX1 when co-expressed with CAX1 activated Ca2+ transport, whereas co-expressing C-terminal halves of CAX variants with CAX1 conferred salt tolerance but no apparent Ca2+ transport. These findings demonstrate plasticity through hetero-CAX complex formation as well as a novel means to engineer CAX transport.	[Zhao, Jian; Guo, YingQing; Li, Xiangkai; Shigaki, Toshiro; Hirschi, Kendal D.] Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA; [Connorton, James M.; Pittman, Jon K.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Hirschi, Kendal D.] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX 77845 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); University of Manchester; Texas A&M University System; Texas A&M University College Station	Hirschi, KD (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, 1100 Bates St,Suite 9018,Campus Mail Stop BCM 320, Houston, TX 77030 USA.	kendalh@bcm.edu	hirschi, kendal/GNP-0351-2022; Zhao, Jian/Q-8591-2019; li, xiang/GWM-6319-2022	Zhao, Jian/0000-0002-4416-7334; Pittman, Jon/0000-0001-7197-1494; Connorton, James/0000-0002-9379-5599; Guo, Yingqing/0000-0002-9527-6119	United States Department of Agriculture/Agricultural Research Service [58-6250-6001]; National Science Foundation [90344350]; United States Department of Agriculture Cooperative State Research, Education, & Extension Service [2005-34402-17121]; Designing Foods for Health grant; Biotechnology and Biological Sciences Research Council [BB/B502152/1]	United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture Cooperative State Research, Education, & Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Designing Foods for Health grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the United States Department of Agriculture/Agricultural Research Service under Cooperative Agreement 58-6250-6001, National Science Foundation Grant 90344350, United States Department of Agriculture Cooperative State Research, Education, & Extension Service Grant 2005-34402-17121, a Designing Foods for Health grant (to K. D. H.), and by Biotechnology and Biological Sciences Research Council Grant BB/B502152/1 (to J. K. P.).	Amtmann A, 2009, NEW PHYTOL, V181, P35, DOI 10.1111/j.1469-8137.2008.02666.x; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Cheng NH, 2005, PLANT PHYSIOL, V138, P2048, DOI 10.1104/pp.105.061218; Cheng NH, 2003, J BIOL CHEM, V278, P6503, DOI 10.1074/jbc.M210883200; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Hirschi KD, 2004, PLANT PHYSIOL, V136, P2438, DOI 10.1104/pp.104.046490; Hull G, 1996, PLANT SCI, V120, P153, DOI 10.1016/S0168-9452(96)04496-2; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Liang F, 1997, P NATL ACAD SCI USA, V94, P8579, DOI 10.1073/pnas.94.16.8579; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; Marty F, 1999, PLANT CELL, V11, P587, DOI 10.1105/tpc.11.4.587; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Mitsui K, 2005, BBA-BIOMEMBRANES, V1720, P125, DOI 10.1016/j.bbamem.2005.11.005; Nathan DF, 1999, P NATL ACAD SCI USA, V96, P1409, DOI 10.1073/pnas.96.4.1409; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Ottolia M, 2001, J BIOL CHEM, V276, P19603, DOI 10.1074/jbc.M101489200; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pittman JK, 2002, PLANT PHYSIOL, V130, P1054, DOI 10.1104/pp.008193; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Reinders A, 2002, PLANT CELL, V14, P1567, DOI 10.1105/tpc.002428; Reinders A, 2002, STRUCTURE, V10, P763, DOI 10.1016/S0969-2126(02)00773-6; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schulz B, 2004, SCIENCE, V306, P622, DOI 10.1126/science.1105227; SCHUMAKER KS, 1986, J BIOL CHEM, V261, P2172; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2006, PLANT BIOLOGY, V8, P419, DOI 10.1055/s-2006-923950; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; Shigaki T, 2003, J BIOL CHEM, V278, P6610, DOI 10.1074/jbc.M209952200; Shigaki T, 2001, J BIOL CHEM, V276, P43152, DOI 10.1074/jbc.M106637200; Shigaki T, 2001, ANAL BIOCHEM, V298, P118, DOI 10.1006/abio.2001.5341; Shigaki T, 2000, GENE, V257, P291, DOI 10.1016/S0378-1119(00)00390-5; Sze H, 2000, ANNU REV PLANT PHYS, V51, P433, DOI 10.1146/annurev.arplant.51.1.433; Ueoka-Nakanishi H, 2000, EUR J BIOCHEM, V267, P3090, DOI 10.1046/j.1432-1033.2000.01343.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Zhao J, 2008, PLANTA, V227, P659, DOI 10.1007/s00425-007-0648-2; Zhao J, 2009, J BIOL CHEM, V284, P4605, DOI 10.1074/jbc.M804462200; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	44	38	42	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34075	34083		10.1074/jbc.M109.070235	http://dx.doi.org/10.1074/jbc.M109.070235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19819871	Green Published, hybrid			2022-12-25	WOS:000272165200040
J	Ferrera, L; Caputo, A; Ubby, I; Bussani, E; Zegarra-Moran, O; Ravazzolo, R; Pagani, F; Galietta, LJV				Ferrera, Loretta; Caputo, Antonella; Ubby, Ifeoma; Bussani, Erica; Zegarra-Moran, Olga; Ravazzolo, Roberto; Pagani, Franco; Galietta, Luis J. V.			Regulation of TMEM16A Chloride Channel Properties by Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CA2+-ACTIVATED CL-CURRENTS; COLLECTING DUCT CELLS; SMOOTH-MUSCLE-CELLS; INOSITOL 3,4,5,6-TETRAKISPHOSPHATE; BINDING-PROTEIN; CALCIUM; CONDUCTANCE; ACTIVATION; MECHANISM	Expression of TMEM16A protein is associated with the activity of Ca2+-activated Cl- channels. TMEM16A primary transcript undergoes alternative splicing. thus resulting in the generation of multiple isoforms. We have determined the pattern of splicing and assessed the functional properties of the corresponding TMEM16A variants. We found three alternative exons, 6b, 13, and 15, coding for segments of 22, 4, and 26 amino acids, respectively, which are differently spliced in human organs. By patch clamp experiments on transfected cells, we found that skipping of exon 6b changes the Ca2+ sensitivity by nearly 4-fold, resulting in Cl- currents requiring lower Ca2+ concentrations to be activated. At the membrane potential of 80 mV, the apparent half-effective concentration decreases from 350 to 90 nM when the segment corresponding to exon 6b is excluded. Skipping of exon 13 instead strongly reduces the characteristic time-dependent activation observed for Ca2+-activated Cl- channels at positive membrane potentials. This effect was also obtained by deleting only the second pair of amino acids corresponding to exon 13. Alternative splicing appears as an important mechanism to regulate the voltage and Ca2+ dependence of the TMEM16A-dependent Cl- channels in a tissue-specific manner.	[Ferrera, Loretta; Caputo, Antonella; Zegarra-Moran, Olga; Ravazzolo, Roberto; Galietta, Luis J. V.] Ist Giannina Gaslini, Genet Mol Lab, I-16147 Genoa, Italy; [Ubby, Ifeoma; Bussani, Erica; Pagani, Franco] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Ravazzolo, Roberto] Univ Genoa, Dept Pediat, I-16132 Genoa, Italy; [Ravazzolo, Roberto] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Genoa; University of Genoa	Galietta, LJV (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, Largo G Gaslini 5, I-16147 Genoa, Italy.	galietta@unige.it	Galietta, Luis JV/HCG-8692-2022; Pillay, Nischalan/F-9536-2012; Ferrera, Loretta/AAA-7641-2020; Ferrera, Loretta/AGJ-3063-2022	Ferrera, Loretta/0000-0003-0528-1158; Galietta, Luis/0000-0001-8686-3461; Pagani, Franco/0000-0002-2678-3459	National Institutes of Health [P30 DK072517]; Cystic Fibrosis Foundation; Fondazione Italiana per la Ricerca sulla Fibrosi Cistica; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Fondazione Italiana per la Ricerca sulla Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P30 DK072517 and by the Cystic Fibrosis Foundation (to L.J.V.G) and the Fondazione Italiana per la Ricerca sulla Fibrosi Cistica (to L.J.V.G. and F.P.).	Angermann JE, 2006, J GEN PHYSIOL, V128, P73, DOI 10.1085/jgp.200609507; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Boese SH, 2004, AM J PHYSIOL-RENAL, V286, pF682, DOI 10.1152/ajprenal.00123.2003; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; EVANS MG, 1986, J PHYSIOL-LONDON, V378, P437, DOI 10.1113/jphysiol.1986.sp016229; Fededa JP, 2005, MOL CELL, V19, P393, DOI 10.1016/j.molcel.2005.06.035; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; GomezHernandez JM, 1997, J PHYSIOL-LONDON, V502, P569, DOI 10.1111/j.1469-7793.1997.569bj.x; Greenwood IA, 2001, J PHYSIOL-LONDON, V534, P395, DOI 10.1111/j.1469-7793.2001.00395.x; Hallani M, 1998, J MEMBRANE BIOL, V161, P163, DOI 10.1007/s002329900323; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Ho MWY, 2001, J BIOL CHEM, V276, P18673, DOI 10.1074/jbc.M101128200; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kaneko H, 2006, J GEN PHYSIOL, V127, P737, DOI 10.1085/jgp.200609497; Kidd JF, 2000, ANNU REV PHYSIOL, V62, P493, DOI 10.1146/annurev.physiol.62.1.493; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Nilius B, 1997, J PHYSIOL-LONDON, V498, P381, DOI 10.1113/jphysiol.1997.sp021865; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Qu ZQ, 2003, AM J PHYSIOL-RENAL, V285, pF326, DOI 10.1152/ajprenal.00034.2003; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SCOTT RH, 1995, PHARMACOL THERAPEUT, V66, P535, DOI 10.1016/0163-7258(95)00018-C; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; TALEB O, 1988, PFLUG ARCH EUR J PHY, V412, P641, DOI 10.1007/BF00583766; Tarran R, 2002, J GEN PHYSIOL, V120, P407, DOI 10.1085/jgp.20028599; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang YX, 1997, P NATL ACAD SCI USA, V94, P14918, DOI 10.1073/pnas.94.26.14918; Xie WW, 1996, J BIOL CHEM, V271, P14092, DOI 10.1074/jbc.271.24.14092; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	35	170	178	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33360	33368		10.1074/jbc.M109.046607	http://dx.doi.org/10.1074/jbc.M109.046607			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19819874	hybrid, Green Published			2022-12-25	WOS:000272028500041
J	Jimenez, N; Vilches, S; Lacasta, A; Regue, M; Merino, S; Tomas, JM				Jimenez, Natalia; Vilches, Silvia; Lacasta, Anna; Regue, Miguel; Merino, Susana; Tomas, Juan M.			A Bifunctional Enzyme in a Single Gene Catalyzes the Incorporation of GlcN into the Aeromonas Core Lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-MANNO-HEPTOSE; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; 3-DEOXY-D-MANNO-OCTULOSONIC ACID; SALMONICIDA LIPOPOLYSACCHARIDE; HYDROPHILA STRAINS; LIPID-A; BIOSYNTHESIS; VIRULENCE; SEQUENCE	The core lipopolysaccharide (LPS) of Aeromonas hydrophila AH-3 and Aeromonas salmonicida A450 is characterized by the presence of the pentasaccharide alpha-D-GlcN-(1 -> 7)-L-alpha-D-Hep-(1 -> 2)-L-alpha-D-Hep-(1 -> 3)-L- alpha-D-Hep-(1 -> 5)-alpha-Kdo. Previously it has been suggested that the WahA protein is involved in the incorporation of GlcN residue to outer core LPS. The WahA protein contains two domains: a glycosyltransferase and a carbohydrate esterase. In this work we demonstrate that the independent expression of the WahA glycosyltransferase domain catalyzes the incorporation of GlcNAc from UDP-GlcNAc to the outer core LPS. Independent expression of the carbohydrate esterase domain leads to the deacetylation of the GlcNAc residue to GlcN. Thus, the WahA is the first described bifunctional glycosyltransferase enzyme involved in the biosynthesis of core LPS. By contrast in Enterobacteriaceae containing GlcN in their outer core LPS the two reactions are performed by two different enzymes.	[Jimenez, Natalia; Vilches, Silvia; Lacasta, Anna; Merino, Susana; Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, E-08071 Barcelona, Spain; [Regue, Miguel] Univ Barcelona, Fac Farm, Dept Microbiol & Parasitol Sanitarias, E-08028 Barcelona, Spain	University of Barcelona; University of Barcelona	Tomas, JM (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Diagonal 645, E-08071 Barcelona, Spain.	jtomas@ub.edu	Tomas, Juan M/L-1398-2015; Merino, Susana/D-4342-2014; Lacasta, Anna/P-2278-2017	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259; Jimenez, Natalia/0000-0002-7057-0426; Lacasta, Anna/0000-0001-8381-9844	Ministerio de Educacion, Ciencia y Deporte; Ministerio de Sanidad, Spain; Generalitat de Catalunya	Ministerio de Educacion, Ciencia y Deporte(Spanish Government); Ministerio de Sanidad, Spain(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by Plan Nacional de I + D and Fondo de Investigaciones Sanitarias grants from Ministerio de Educacion, Ciencia y Deporte, and Ministerio de Sanidad, Spain and the Generalitat de Catalunya ( Centre de Referencia en Biotecnologia).	Aguilar A, 1997, INFECT IMMUN, V65, P1245, DOI 10.1128/IAI.65.4.1245-1250.1997; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; BURKE V, 1984, APPL ENVIRON MICROB, V48, P361, DOI 10.1128/AEM.48.2.361-366.1984; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; James CL, 2002, BIOCHEMISTRY-US, V41, P3720, DOI 10.1021/bi015909o; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Jimenez N, 2009, J BACTERIOL, V191, P2228, DOI 10.1128/JB.01395-08; Knirel YA, 2004, CARBOHYD RES, V339, P787, DOI 10.1016/j.carres.2003.12.008; Knirel YA, 1997, EUR J BIOCHEM, V247, P402, DOI 10.1111/j.1432-1033.1997.00402.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; McArthur F, 2005, J BACTERIOL, V187, P5292, DOI 10.1128/JB.187.15.5292-5300.2005; Merino S, 1996, FEMS MICROBIOL LETT, V139, P97, DOI 10.1016/0378-1097(96)00068-7; MERINO S, 1992, INFECT IMMUN, V60, P4343, DOI 10.1128/IAI.60.10.4343-4349.1992; MERINO S, 1991, J GEN MICROBIOL, V137, P1583, DOI 10.1099/00221287-137-7-1583; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; Regue M, 2005, J BIOL CHEM, V280, P36648, DOI 10.1074/jbc.M506278200; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Rubires X, 1997, J BACTERIOL, V179, P7581, DOI 10.1128/jb.179.23.7581-7586.1997; SCOTT M, 1968, J GEN MICROBIOL, V50, P321, DOI 10.1099/00221287-50-2-321; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornley JP, 1997, REV MED MICROBIOL, V8, P61; Valvano MA, 2000, J BACTERIOL, V182, P488, DOI 10.1128/JB.182.2.488-497.2000; Valvano MA, 2002, MICROBIOL-SGM, V148, P1979, DOI 10.1099/00221287-148-7-1979; VINOGRADOV EV, 1995, EUR J BIOCHEM, V233, P152, DOI 10.1111/j.1432-1033.1995.152_1.x; Wang Z, 2006, CARBOHYD RES, V341, P109, DOI 10.1016/j.carres.2005.10.017; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	38	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					32995	33005		10.1074/jbc.M109.038828	http://dx.doi.org/10.1074/jbc.M109.038828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19805547	hybrid, Green Published			2022-12-25	WOS:000272028500002
J	Kronenberg, D; Vadon-Le Goff, S; Bourhis, JM; Font, B; Eichenberger, D; Hulmes, DJS; Moali, C				Kronenberg, Daniel; Vadon-Le Goff, Sandrine; Bourhis, Jean-Marie; Font, Bernard; Eichenberger, Denise; Hulmes, David J. S.; Moali, Catherine			Strong Cooperativity and Loose Geometry between CUB Domains Are the Basis for Procollagen C-Proteinase Enhancer Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEIN-1; BINDING; METALLOPROTEINASES; GLYCOPROTEIN; INHIBITORS; INSIGHTS; ROLES	Procollagen C-proteinase enhancers (PCPE-1 and -2) specifically activate bone morphogenetic protein-1 (BMP-1) and other members of the tolloid proteinase family during C-terminal processing of fibrillar collagen precursors. PCPEs consist of two CUB domains (CUB1 and CUB2) and one NTR domain separated by one short and one long linker. It was previously shown that PCPEs can strongly interact with procollagen molecules, but the exact mechanism by which they enhance BMP-1 activity remains largely unknown. Here, we used a series of deletion mutants of PCPE-1 and two chimeric constructs with repetitions of the same CUB domain to study the role of each domain and linker. Out of all the forms tested, only those containing both CUB1 and CUB2 were capable of enhancing BMP-1 activity and binding to a mini-procollagen substrate with nanomolar affinity. Both these properties were lost by individual CUB domains, which had dissociation constants at least three orders of magnitude higher. In addition, none of the constructs tested could inhibit PCPE activity, although CUB2CUB2NTR was found to modulate BMP-1 activity through direct complex formation with the enzyme, resulting in a decreased rate of substrate processing. Finally, increasing the length of the short linker between CUB1 and CUB2 was without detrimental effect on both activity and substrate binding. These data support the conclusion that CUB1 and CUB2 bind to the procollagen substrate in a cooperative manner, involving the short linker that provides a flexible tether linking the two binding regions.	[Kronenberg, Daniel; Vadon-Le Goff, Sandrine; Bourhis, Jean-Marie; Font, Bernard; Eichenberger, Denise; Hulmes, David J. S.; Moali, Catherine] Univ Lyon, CNRS, UMR 5086, Inst Biol & Chim Prot,Biosci Gerland Lyon Sud IFR, F-69367 Lyon 7, France; [Kronenberg, Daniel] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, D-55128 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Johannes Gutenberg University of Mainz	Moali, C (corresponding author), Univ Lyon, CNRS, UMR 5086, Inst Biol & Chim Prot,Biosci Gerland Lyon Sud IFR, 7 Passage Vercors, F-69367 Lyon 7, France.	c.moali@ibcp.fr	le goff, sandrine/AAE-1990-2019; Kronenberg, Daniel/ABA-9255-2020	Kronenberg, Daniel/0000-0001-6807-7328; Hulmes, David/0000-0002-0651-1317; vadon-le goff, sandrine/0000-0002-4582-2273; MOALI, Catherine/0000-0003-2479-4290	Region Rhone-Alpes; European Commission [NMP2-CT-2003-504017]; Agence Nationale de la Recherche; CNRS; Universite Claude Bernard Lyon 1	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1	This work was supported by the Region Rhone-Alpes, the European Commission (contract NMP2-CT-2003-504017), the Agence Nationale de la Recherche, the CNRS, and the Universite Claude Bernard Lyon 1.	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Appleton BA, 2007, EMBO J, V26, P4902, DOI 10.1038/sj.emboj.7601906; BAICI A, 1981, EUR J BIOCHEM, V119, P9, DOI 10.1111/j.1432-1033.1981.tb05570.x; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Bradford D, 2009, INT J BIOCHEM CELL B, V41, P487, DOI 10.1016/j.biocel.2008.03.014; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Hulmes D. J. S., 2008, P15, DOI 10.1007/978-0-387-73906-9_2; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Liepinsh E, 2003, J BIOL CHEM, V278, P25982, DOI 10.1074/jbc.M302734200; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; MOALI C, 2009, EUR J DERMA IN PRESS, V19; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200	24	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33437	33446		10.1074/jbc.M109.046128	http://dx.doi.org/10.1074/jbc.M109.046128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801683	Green Published, hybrid			2022-12-25	WOS:000272028500050
J	Lee, Y; Ha, J; Kim, HJ; Kim, YS; Chang, EJ; Song, WJ; Kim, HH				Lee, Youngkyun; Ha, Jeongim; Kim, Hyung Joon; Kim, Yeun-Soo; Chang, Eun-Ju; Song, Woo-Joo; Kim, Hong-Hee			Negative Feedback Inhibition of NFATc1 by DYRK1A Regulates Bone Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; DOWN-SYNDROME; DUAL-SPECIFICITY; TRANSGENIC MICE; OSTEOCLAST DIFFERENTIATION; MENTAL-RETARDATION; RECEPTOR ACTIVATOR; FUNCTIONAL-LINK; PROTEIN-KINASES; YOUNG MEN	DYRK1A is a serine/threonine kinase that has been linked to mental retardation associated with Down syndrome. In the present report, we describe a previously unknown role for DYRK1A in bone homeostasis. The protein expression of DYRK1A increased during osteoclast differentiation. In vitro studies in osteoclasts revealed that DYRK1A inhibited osteoclastogenesis. Whereas DYRK1A phosphorylated and inhibited the osteoclastogenic transcription factor NFATc1, forced expression of NFATc1 induced DYRK1A expression, suggesting a negative feedback loop. Transgenic mice overexpressing DYRK1A by the extent of the increased gene dosage in Down syndrome exhibited significantly reduced bone mass despite the decreased osteoclastogenesis, which is reminiscent of osteoporotic bone phenotype in Down syndrome patients. In these mice, attenuated osteoblast differentiation and function in the presence of extra DYRK1A overrode the effect of impaired osteoclastogenesis. However, impeded osteoclastogenesis in DYRK1A transgenic mice was proven to be beneficial in protecting bone loss induced by inflammation or estrogen deficiency. These results provide novel insight into the role for DYRK1A in bone homeostasis as well as in bone destructive diseases, in which modulation of DYRK1A might be used as a strategy to treat unregulated bone resorption.	[Kim, Yeun-Soo; Song, Woo-Joo] Inje Univ, Inst Brain Sci & Technol, Grad Program Neurosci, Pusan 614735, South Korea; [Lee, Youngkyun; Ha, Jeongim; Kim, Hyung Joon; Chang, Eun-Ju; Kim, Hong-Hee] Seoul Natl Univ, Dept Cell & Dev Biol, BK21 Program, Seoul 110749, South Korea; [Lee, Youngkyun; Ha, Jeongim; Kim, Hyung Joon; Chang, Eun-Ju; Kim, Hong-Hee] Seoul Natl Univ, DRI, Seoul 110749, South Korea	Inje University; Seoul National University (SNU); Seoul National University (SNU)	Song, WJ (corresponding author), Inje Univ, Inst Brain Sci & Technol, Grad Program Neurosci, Kaegum 2 Dong, Pusan 614735, South Korea.	wjsong@inje.ac.kr; hhbkim@snu.ac.kr	Kim, Hyung-Joon/ABD-3143-2020; Kim, Hyung Joon/D-6123-2012; Lee, Youngkyun/D-2667-2011	Kim, Hyung-Joon/0000-0002-2962-9553; 	Korea Science and Engineering Foundation [R01-2007-000-11910-0]; Korea Research Foundation [KRF-2008-314-E00180, KRF-2008-313-E00439]; Korean Government; 21C Frontier Functional Proteomics Project [FPR08B1-170]; Science Research Center [2009-0063269]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); 21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); Science Research Center	This work was supported by Korea Science and Engineering Foundation Grant R01-2007-000-11910-0 (to W.-J.S.), Korea Research Foundation Grants KRF-2008-314-E00180 (to W.-J.S.) and KRF-2008-313-E00439 (to Y.L.) funded by the Korean Government, and 21C Frontier Functional Proteomics Project Grant FPR08B1-170 and Science Research Center Grant 2009-0063269 (to H.-H. K.).	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Angelopoulou N, 2000, CALCIFIED TISSUE INT, V66, P176, DOI 10.1007/s002230010035; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Baptista F, 2005, OSTEOPOROSIS INT, V16, P380, DOI 10.1007/s00198-004-1687-1; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Center J, 1998, AM J MENT RETARD, V103, P19, DOI 10.1352/0895-8017(1998)103<0019:PWMRHA>2.0.CO;2; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Grimwood JS, 2000, HISTOPATHOLOGY, V36, P279; Guijarro M, 2008, J INTELL DISABIL RES, V52, P182, DOI 10.1111/j.1365-2788.2007.00992.x; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Lee Y, 2008, BLOOD, V111, P885, DOI 10.1182/blood-2007-03-082941; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Sakadamis A, 2002, EUR J OBSTET GYN R B, V100, P208, DOI 10.1016/S0301-2115(01)00478-X; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Sumarsono SH, 1996, NATURE, V379, P534, DOI 10.1038/379534a0; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006	37	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33343	33351		10.1074/jbc.M109.042234	http://dx.doi.org/10.1074/jbc.M109.042234			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801542	Green Published, hybrid			2022-12-25	WOS:000272028500039
J	Zou, YX; Mi, J; Cui, JP; Lu, DF; Zhang, XY; Guo, CH; Gao, GM; Liu, QJ; Chen, BX; Shao, CS; Gong, YQ				Zou, Yongxin; Mi, Jun; Cui, Jinpeng; Lu, Defen; Zhang, Xiyu; Guo, Chenhong; Gao, Guimin; Liu, Qiji; Chen, Bingxi; Shao, Changshun; Gong, Yaoqin			Characterization of Nuclear Localization Signal in the N Terminus of CUL4B and Its Essential Role in Cyclin E Degradation and Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; UBIQUITIN LIGASE COMPLEX; CHROMOSOME INSTABILITY; IMPORTIN-ALPHA; HUMAN HOMOLOG; DNA-DAMAGE; S-PHASE; PROTEIN; TARGETS; CDT1	CUL4A and CUL4B, which are derived from the same ancestor, CUL4, encode scaffold proteins that organize cullin-RING ubiquitin ligase (E3) complexes. Recent genetic studies have shown that germ line mutation in CUL4B can cause mental retardation, short stature, and other abnormalities in humans. CUL4A was observed to be overexpressed in breast and hepatocellular cancers, although no germ line mutation in human CUL4A has been reported. Although CUL4A has been known to be involved in a number of cellular processes, including DNA repair and cell cycle regulation, little is known about whether CUL4B has similar functions. In this report, we tested the functional importance of CUL4B in cell proliferation and characterized the nuclear localization signal (NLS) that is essential for its function. We found that RNA interference silencing of CUL4B led to an inhibition of cell proliferation and a prolonged S phase, due to the overaccumulation of cyclin E, a substrate targeted by CUL4B for ubiquitination. We showed that, unlike CUL4A and other cullins that carry their NLS in their C termini, NLS in CUL4B is located in its N terminus, between amino acid 37 and 40, KKRK. This NLS could bind to importin alpha 1, alpha 3, and alpha 5. NLS-deleted CUL4B was distributed in cytoplasm and failed to promote cell proliferation. Therefore, the nuclear localization of CUL4B mediated by NLS is critical for its normal function in cell proliferation.	[Zou, Yongxin; Mi, Jun; Cui, Jinpeng; Lu, Defen; Zhang, Xiyu; Guo, Chenhong; Gao, Guimin; Liu, Qiji; Chen, Bingxi; Shao, Changshun; Gong, Yaoqin] Shandong Univ, Sch Med, Inst Mol Med & Genet, Minist Educ,Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China; [Shao, Changshun] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Shandong University; Rutgers State University New Brunswick	Shao, CS (corresponding author), Shandong Univ, Sch Med, Inst Mol Med & Genet, Minist Educ,Key Lab Expt Teratol, 44 Wen Hua Xi Lu, Jinan 250012, Shandong, Peoples R China.	shao@biology.rutgers.edu; yxg8@sdu.edu.cn	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342	National Science Foundation Research [30830065]; National Basic Research Program of China [2007CB512001]; National High-tech Research and Development Program of China [2006AA02A406]	National Science Foundation Research(National Science Foundation (NSF)); National Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Science Foundation Research Grant 30830065, National Basic Research Program of China grant 2007CB512001, and National High-tech Research and Development Program of China Grant 2006AA02A406.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Chen LC, 1998, CANCER RES, V58, P3677; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grundt K, 2007, BBA-MOL CELL RES, V1773, P1398, DOI 10.1016/j.bbamcr.2007.05.013; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kopanja D, 2009, ONCOGENE, V28, P2456, DOI 10.1038/onc.2009.86; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Li KY, 2003, CANCER RES, V63, P3593; Lischka P, 2003, J VIROL, V77, P3734, DOI 10.1128/JVI.77.6.3734-3748.2003; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Liu ZJ, 2009, MUTAT RES-FUND MOL M, V662, P75, DOI 10.1016/j.mrfmmm.2008.12.009; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nag A, 2004, CANCER RES, V64, P8152, DOI 10.1158/0008-5472.CAN-04-2598; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Schindl M, 2007, ANTICANCER RES, V27, P949; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Simone C, 2002, J CLIN PATHOL-MOL PA, V55, P200, DOI 10.1136/mp.55.3.200; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Waning DL, 2008, BLOOD, V112, P320, DOI 10.1182/blood-2007-11-126300; Xia Y, 2008, BIOCHEM BIOPH RES CO, V368, P438, DOI 10.1016/j.bbrc.2008.01.111; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	49	85	89	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33320	33332		10.1074/jbc.M109.050427	http://dx.doi.org/10.1074/jbc.M109.050427			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801544	hybrid, Green Published			2022-12-25	WOS:000272028500037
J	Marin, M; Heinz, DW; Pieper, DH; Klink, BU				Marin, Macarena; Heinz, Dirk W.; Pieper, Dietmar H.; Klink, Bjoern U.			Crystal Structure and Catalytic Mechanism of 4-Methylmuconolactone Methylisomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIED 3-OXOADIPATE PATHWAY; SP STRAIN MT1; GENE-CLUSTER; PROTEIN; PSEUDOMONAS; 4-METHYLCATECHOL; PURIFICATION; DEGRADATION; REFINEMENT; METABOLISM	When methyl-substituted aromatic compounds are degraded via ortho (intradiol)-cleavage of 4-methylcatechol, the dead-end metabolite 4-methylmuconolactone (4-ML) is formed. Degradation of 4-ML has only been described in few bacterial species, including Pseudomonas reinekei MT1. The isomerization of 4-ML to 3-methylmuconolactone (3-ML) is the first step required for the mineralization of 4-ML and is catalyzed by an enzyme termed 4-methylmuconolactone methylisomerase (MLMI). We identified the gene encoding MLMI in P. reinekei MT1 and solved the crystal structures of MLMI in complex with 3-ML at 1.4-angstrom resolution, with 4-ML at 1.9-angstrom resolution and with a MES buffer molecule at 1.45-angstrom resolution. MLMI exhibits a ferredoxin-like fold and assembles as a tight functional homodimeric complex. We were able to assign the active site clefts of MLMI from P. reinekei MT1 and of the homologous MLMI from Cupriavidus necator JMP134, which has previously been crystallized in a structural genomics project. Kinetic and structural analysis of wild-type MLMI and variants created by site-directed mutagenesis indicate Tyr-39 and His-26 to be the most probable catalytic residues. The previously proposed involvement of Cys-67 in covalent catalysis can now be excluded. Residue His-52 was found to be important for substrate affinity, with only marginal effect on catalytic activity. Based on these results, a novel catalytic mechanism for the isomerization of 4-ML to 3-ML by MLMI, involving a bislactonic intermediate, is proposed. This broadens the knowledge about the diverse group of proteins exhibiting a ferredoxin-like fold.	Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; [Heinz, Dirk W.; Klink, Bjoern U.] Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research		dpi@helmholtz-hzi.de	Marin, Macarena/H-8742-2013	Marin, Macarena/0000-0002-6966-2446	Deutsche Forschungsgemeinschaft-International Research	Deutsche Forschungsgemeinschaft-International Research(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft-International Research Training Group 653.	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCE NC, 1989, BIOCHEM J, V262, P303, DOI 10.1042/bj2620303; CAIN RB, 1989, J CHEM SOC PERK T 1, P202, DOI 10.1039/p19890000202; Camara B, 2007, J BACTERIOL, V189, P1664, DOI 10.1128/JB.01192-06; CATELANI D, 1971, BIOCHEM J, V121, P89, DOI 10.1042/bj1210089; CHARI RVJ, 1987, J AM CHEM SOC, V109, P5520, DOI 10.1021/ja00252a035; Dgany O, 2004, J BIOL CHEM, V279, P51516, DOI 10.1074/jbc.M409952200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erb RW, 1998, GENE, V206, P53, DOI 10.1016/S0378-1119(97)00565-9; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; KNACKMUSS HJ, 1976, EUR J APPL MICROBIOL, V2, P267, DOI 10.1007/BF01278610; Lytle BL, 2004, J BIOMOL NMR, V28, P397, DOI 10.1023/B:JNMR.0000015385.54050.19; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikodem P, 2003, J BACTERIOL, V185, P6790, DOI 10.1128/JB.185.23.6790-6800.2003; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PIEPER DH, 1990, BIOCHEM J, V271, P529, DOI 10.1042/bj2710529; Russell RB, 1998, J MOL BIOL, V282, P903, DOI 10.1006/jmbi.1998.2043; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	24	5	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32709	32716		10.1074/jbc.M109.024604	http://dx.doi.org/10.1074/jbc.M109.024604			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801657	hybrid, Green Published			2022-12-25	WOS:000272028400055
J	Stomel, JM; Wilson, JW; Leon, MA; Stafford, P; Chaput, JC				Stomel, Joshua M.; Wilson, James W.; Leon, Megan A.; Stafford, Phillip; Chaput, John C.			A Man-Made ATP-Binding Protein Evolved Independent of Nature Causes Abnormal Growth in Bacterial Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI; DIVISION; DNA; EXPRESSION; INSIGHTS; REGULON; FOLD	Recent advances in de novo protein evolution have made it possible to create synthetic proteins from unbiased libraries that fold into stable tertiary structures with predefined functions. However, it is not known whether such proteins will be functional when expressed inside living cells or how a host organism would respond to an encounter with a non-biological protein. Here, we examine the physiology and morphology of Escherichia coli cells engineered to express a synthetic ATP-binding protein evolved entirely from non-biological origins. We show that this man-made protein disrupts the normal energetic balance of the cell by altering the levels of intracellular ATP. This disruption cascades into a series of events that ultimately limit reproductive competency by inhibiting cell division. We now describe a detailed investigation into the synthetic biology of this man-made protein in a living bacterial organism, and the effect that this protein has on normal cell physiology.			Stomel, JM (corresponding author), Arizona State Univ, Ctr BioOpt Nanotechnol, Tempe, AZ 85287 USA.	john.chaput@asu.edu		Stafford, Phillip/0000-0001-7989-9036				Arends SJR, 2004, J BACTERIOL, V186, P880, DOI 10.1128/JB.186.3.880-884.2004; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Benner SA, 2004, SCIENCE, V306, P625, DOI 10.1126/science.1101104; Brakmann S, 2001, CHEMBIOCHEM, V2, P865, DOI 10.1002/1439-7633(20011203)2:12<865::AID-CBIC865>3.0.CO;2-6; Chaput JC, 2004, CHEM BIOL, V11, P865, DOI 10.1016/j.chembiol.2004.04.006; Chaput JC, 2008, EXPERT OPIN BIOL TH, V8, P1087, DOI 10.1517/14712598.8.8.1087 ; Chen GZ, 2003, CAN J MICROBIOL, V49, P733, DOI 10.1139/W03-096; Chung HJ, 2000, LETT APPL MICROBIOL, V31, P416, DOI 10.1046/j.1472-765X.2000.00840.x; Delaney JC, 2003, P NATL ACAD SCI USA, V100, P4469, DOI 10.1073/pnas.0837277100; DHAR PK, 2009, J BIOL ENG, V3, P1; Elbeik T, 2004, J CLIN MICROBIOL, V42, P3120, DOI 10.1128/JCM.42.7.3120-3127.2004; Elbeik T, 2004, J CLIN MICROBIOL, V42, P563, DOI 10.1128/JCM.42.2.563-569.2004; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Filipovska A, 2008, ACS CHEM BIOL, V3, P51, DOI 10.1021/cb700185e; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Harry E., 2006, INT REV CYTOL, V253, P27; Henry AA, 2003, CURR OPIN CHEM BIOL, V7, P727, DOI 10.1016/j.cbpa.2003.10.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Leonard E, 2008, TRENDS BIOTECHNOL, V26, P674, DOI 10.1016/j.tibtech.2008.08.003; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Mansy SS, 2007, J MOL BIOL, V371, P501, DOI 10.1016/j.jmb.2007.05.062; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Pruss BM, 1996, J BACTERIOL, V178, P668; Pryciak PM, 2009, CHEM BIOL, V16, P249, DOI 10.1016/j.chembiol.2009.01.011; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Sismour AM, 2004, NUCLEIC ACIDS RES, V32, P728, DOI 10.1093/nar/gkh241; Smith MD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000467; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Watkins JL, 2008, CHEMBIOCHEM, V9, P1361, DOI 10.1002/cbic.200800147; Wei YN, 2003, P NATL ACAD SCI USA, V100, P13270, DOI 10.1073/pnas.1835644100; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	48	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7385	10.1371/journal.pone.0007385	http://dx.doi.org/10.1371/journal.pone.0007385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812699	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594200010
J	Sun, Y; Liou, B; Quinn, B; Ran, HM; Xu, YH; Grabowski, GA				Sun, Ying; Liou, Benjamin; Quinn, Brian; Ran, Huimin; Xu, You-Hai; Grabowski, Gregory A.			In Vivo and Ex Vivo Evaluation of L-Type Calcium Channel Blockers on Acid beta-Glucosidase in Gaucher Disease Mouse Models	PLOS ONE			English	Article							SAPOSIN-C; DILTIAZEM; MICE; GLUCOCEREBROSIDASE; FIBROBLASTS; MUTATIONS; PHENOTYPE; REGISTRY; THERAPY; PLACE	Gaucher disease is a lysosomal storage disease caused by mutations in acid beta-glucosidase (GCase) leading to defective hydrolysis and accumulation of its substrates. Two L-type calcium channel (LTCC) blockers-verapamil and diltiazem-have been reported to modulate endoplasmic reticulum (ER) folding, trafficking, and activity of GCase in human Gaucher disease fibroblasts. Similarly, these LTCC blockers were tested with cultured skin fibroblasts from homozygous point-mutated GCase mice (V394L, D409H, D409V, and N370S) with the effect of enhancing of GCase activity. Correspondingly, diltiazem increased GCase protein and facilitated GCase trafficking to the lysosomes of these cells. The in vivo effects of diltiazem on GCase were evaluated in mice homozygous wild-type (WT), V394L and D409H. In D409H homozygotes diltiazem (10 mg/kg/d via drinking water or 50-200 mg/kg/d intraperitoneally) had minor effects on increasing GCase activity in brain and liver (1.2-fold). Diltiazem treatment (10 mg/kg/d) had essentially no effect on WT and V394L GCase protein or activity levels (, 1.2-fold) in liver. These results show that LTCC blockers had the ex vivo effects of increasing GCase activity and protein in the mouse fibroblasts, but these effects did not translate into similar changes in vivo even at very high drug doses.			Sun, Y (corresponding author), Univ Cincinnati, Med Ctr, Coll Med, Cincinnati Childrens Hosp,Div Human Genet, Cincinnati, OH 45267 USA.	ying.sun@cchmc.org			NIDDK NIH HHS [R01 NS/DK36729, R01 NS/DK36681, R01 DK036729] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Biala G, 2003, POL J PHARMACOL, V55, P327; Butters TD, 2005, GLYCOBIOLOGY, V15, pR43, DOI 10.1093/glycob/cwi076; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; Eder C, 1998, AM J PHYSIOL-CELL PH, V275, pC327, DOI 10.1152/ajpcell.1998.275.2.C327; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; EYAL N, 1990, GENE, V96, P277, DOI 10.1016/0378-1119(90)90264-R; Flynn JT, 2000, PEDIATR NEPHROL, V15, P302, DOI 10.1007/s004670000480; Grabowski GA, 2006, METABOLIC MOL BASES; Kornhaber GJ, 2008, CHEMBIOCHEM, V9, P2643, DOI 10.1002/cbic.200800249; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; Luszczki JJ, 2007, PHARMACOL REP, V59, P672; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; NAITO K, 1986, ARZNEIMITTEL-FORSCH, V36-1, P25; Nunia V, 2007, J ENVIRON PATHOL TOX, V26, P185, DOI 10.1615/JEnvironPatholToxicolOncol.v26.i3.30; PasmanikChor M, 1996, BIOCHEM MOL MED, V59, P125, DOI 10.1006/bmme.1996.0077; Rigat B, 2009, MOL GENET METAB, V96, P225, DOI 10.1016/j.ymgme.2008.12.008; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Sinclair GB, 2007, MOL GENET METAB, V90, P148, DOI 10.1016/j.ymgme.2006.09.008; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Sun Y, 2003, J BIOL CHEM, V278, P31918, DOI 10.1074/jbc.M302752200; Sun Y, 2007, HUM MOL GENET, V16, P957, DOI 10.1093/hmg/ddm040; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TSUJI A, 1988, J BIOCHEM-TOKYO, V104, P276, DOI 10.1093/oxfordjournals.jbchem.a122457; Weinreb NJ, 2005, AM J HEMATOL, V80, P223, DOI 10.1002/ajh.20504; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Westermann D, 2006, EUR J HEART FAIL, V8, P115, DOI 10.1016/j.ejheart.2005.07.012; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	31	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7320	10.1371/journal.pone.0007320	http://dx.doi.org/10.1371/journal.pone.0007320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809509	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594000005
J	Franz, CK; Quach, ET; Krudy, CA; Federici, T; Kliem, MA; Snyder, BR; Raore, B; Boulis, NM				Franz, Colin K.; Quach, Eric T.; Krudy, Christina A.; Federici, Thais; Kliem, Michele A.; Snyder, Brooke R.; Raore, Bethwei; Boulis, Nicholas M.			A Conditioning Lesion Provides Selective Protection in a Rat Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article								Background: Amyotrophic Lateral Sclerosis (ALS) is neurodegenerative disease characterized by muscle weakness and atrophy due to progressive motoneuron loss. The death of motoneuron is preceded by the failure of neuromuscular junctions (NMJs) and axonal retraction. Thus, to develop an effective ALS therapy you must simultaneously preserve motoneuron somas, motor axons and NMJs. A conditioning lesion has the potential to accomplish this since it has been shown to enhance neuronal survival and recovery from trauma in a variety of contexts. Methodology/Principal Findings: To test the effects of a conditioning lesion in a model of familial ALS we administered a tibial nerve crush injury to presymptomatic fALS(G93A) rats. We examined its effects on motor function, motoneuron somas, motor axons, and NMJs. Our experiments revealed a novel paradigm for the conditioning lesion effect. Specifically we found that the motor functional decline in fALS(G93A) rats that received a conditioning lesion was delayed and less severe. These improvements in motor function corresponded to greater motoneuron survival, reduced motor axonopathy, and enhanced NMJ maintenance at disease end-stage. Furthermore, the increased NMJ maintenance was selective for muscle compartments innervated by the most resilient (slow) motoneuron subtypes, but was absent in muscle compartments innervated by the most vulnerable (fast fatigable) motoneuron subtypes. Conclusions/Significance: These findings support the development of strategies aimed at mimicking the conditioning lesion effect to treat ALS as well as underlined the importance of considering the heterogeneity of motoneuron sub-types when evaluating prospective ALS therapeutics.			Franz, CK (corresponding author), Univ Calgary, Fac Med, Calgary, AB, Canada.	nboulis@emory.edu	Franz, Colin/A-2513-2012	Franz, Colin K./0000-0003-4546-8638				Armon C, 2007, J NEUROL SCI, V262, P45, DOI 10.1016/j.jns.2007.06.021; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beck M, 2001, AMYOTROPH LATERAL SC, V2, pS55, DOI 10.1080/146608201300079454; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chong MS, 1996, J COMP NEUROL, V370, P97, DOI 10.1002/(SICI)1096-9861(19960617)370:1<97::AID-CNE9>3.0.CO;2-G; Dal Bello-Haas V, 2007, NEUROLOGY, V68, P2003, DOI 10.1212/01.wnl.0000264418.92308.a4; DENGLER R, 1990, MUSCLE NERVE, V13, P545, DOI 10.1002/mus.880130612; Drory VE, 2001, J NEUROL SCI, V191, P133, DOI 10.1016/S0022-510X(01)00610-4; EDSTROM L, 1986, MUSCLE NERVE, V9, P104, DOI 10.1002/mus.880090203; Federici T, 2006, MUSCLE NERVE, V33, P302, DOI 10.1002/mus.20439; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; FORMAN DS, 1980, BRAIN RES, V182, P180, DOI 10.1016/0006-8993(80)90842-2; Franz CK, 2009, NEUROBIOL DIS, V33, P473, DOI 10.1016/j.nbd.2008.12.003; Frey D, 2000, J NEUROSCI, V20, P2534; Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3; Gould TW, 2007, NEUROSCI BIOBEHAV R, V31, P1073, DOI 10.1016/j.neubiorev.2007.04.015; Gould TW, 2009, NEUROSCIENTIST, V15, P105, DOI 10.1177/1073858408324787; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; HENNEMAN E, 1981, HDB PHYSL NERVOUS SY, P345; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Ikeda K, 2005, J NEUROSCI RES, V82, P63, DOI 10.1002/jnr.20621; JENQ CB, 1988, BRAIN RES, V457, P63, DOI 10.1016/0006-8993(88)90057-1; Kaspar BK, 2005, ANN NEUROL, V57, P649, DOI 10.1002/ana.20451; Kernell D., 2006, MOTONEURONE ITS MUSC; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Kirkinezos IG, 2003, ANN NEUROL, V53, P804, DOI 10.1002/ana.10597; Kong JM, 1998, J NEUROSCI, V18, P3241; Kong JM, 1999, J COMP NEUROL, V412, P373, DOI 10.1002/(SICI)1096-9861(19990920)412:2<373::AID-CNE13>3.0.CO;2-N; Lambrechts D, 2007, TRENDS NEUROSCI, V30, P536, DOI 10.1016/j.tins.2007.07.002; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P201, DOI 10.1001/archneur.55.2.201; Mariotti R, 2002, NEUROSCIENCE, V115, P331, DOI 10.1016/S0306-4522(02)00448-7; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; MCQUARRIE IG, 1973, ARCH NEUROL-CHICAGO, V29, P53, DOI 10.1001/archneur.1973.00490250071008; MCQUARRIE IG, 1985, J COMP NEUROL, V231, P239, DOI 10.1002/cne.902310211; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Nguyen MD, 2000, P NATL ACAD SCI USA, V97, P12306, DOI 10.1073/pnas.97.22.12306; NIETOSAMPEDRO M, 1987, ANN NY ACAD SCI, V495, P108, DOI 10.1111/j.1749-6632.1987.tb23670.x; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; PETTE D, 1992, REV PHYSIOL BIOCH P, V120, P115, DOI 10.1007/BFb0036123; Pinto AC, 1999, J NEUROL SCI, V169, P69, DOI 10.1016/S0022-510X(99)00218-X; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Sakuma K, 2001, BRAIN RES, V907, P1, DOI 10.1016/S0006-8993(01)02288-0; Scarmeas N, 2002, NEUROLOGY, V59, P773, DOI 10.1212/WNL.59.5.773; Sharp PS, 2005, NEUROSCIENCE, V130, P897, DOI 10.1016/j.neuroscience.2004.09.069; Simon M, 2003, EUR J NEUROSCI, V18, P2460, DOI 10.1046/j.1460-9568.2003.02978.x; Simon M, 2002, NEUROSCI LETT, V320, P9, DOI 10.1016/S0304-3940(02)00007-1; Simon M, 2000, EUR J NEUROSCI, V12, P863, DOI 10.1046/j.1460-9568.2000.00975.x; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; Sterne GD, 1997, J CELL BIOL, V139, P709, DOI 10.1083/jcb.139.3.709; Strickland D, 1996, ACTA NEUROL SCAND, V94, P45, DOI 10.1111/j.1600-0404.1996.tb00038.x; ULFHAKE B, 1982, BRAIN RES, V251, P201, DOI 10.1016/0006-8993(82)90738-7; Veldink JH, 2005, NEUROLOGY, V64, P241, DOI 10.1212/01.WNL.0000149513.82332.5C; Veldink JH, 2003, NEUROMUSCULAR DISORD, V13, P737, DOI 10.1016/S0960-8966(03)00104-4	57	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7357	10.1371/journal.pone.0007357	http://dx.doi.org/10.1371/journal.pone.0007357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806196	Green Submitted, gold, Green Published			2022-12-25	WOS:000270593800030
J	Gong, YX; Yao, E; Shen, RL; Goel, A; Arcila, M; Teruya-Feldstein, J; Zakowski, MF; Frankel, S; Peifer, M; Thomas, RK; Ladanyi, M; Pao, W				Gong, Yixuan; Yao, Evelyn; Shen, Ronglai; Goel, Aviva; Arcila, Maria; Teruya-Feldstein, Julie; Zakowski, Maureen F.; Frankel, Stanley; Peifer, Martin; Thomas, Roman K.; Ladanyi, Marc; Pao, William			High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507)	PLOS ONE			English	Article								Background: The IGF receptor type 1 (IGF-1R) pathway is frequently deregulated in human tumors and has become a target of interest for anti-cancer therapy. Methodology/Principal Findings: We used a panel of 22 non-small cell lung cancer (NSCLC) cell lines to investigate predictive biomarkers of response to R1507, a fully-humanized anti-IGF-1R monoclonal antibody (Ab; Roche). 5 lines were moderately sensitive (25-50% growth inhibition) to R1507 alone. While levels of phospho-IGF-1R did not correlate with drug sensitivity, 4 out of 5 sensitive lines displayed high levels of total IGF-1R versus 1 out of 17 resistant lines (p = 0.003, Fisher's Exact). Sensitive lines also harbored higher copy numbers of IGF-1R as assessed by independent SNP array analysis. Addition of erlotinib or paclitaxel to R1507 led to further growth inhibition in sensitive but not resistant lines. In one EGFR mutant lung adenocarcinoma cell line (11-18), R1507 and erlotinib co-treatment induced apoptosis, whereas treatment with either drug alone induced only cell cycle arrest. Apoptosis was mediated, in part, by the survival-related AKT pathway. Additionally, immunohistochemical (IHC) staining of total IGF-1R with an anti-total IGF-1R Ab (G11; Ventana) was performed on tissue microarrays (TMAs) containing 270 independent NSCLC tumor samples. Staining intensity was scored on a scale of 0 to 3+. 39.3% of tumors showed medium to high IGF-1R IHC staining (scores of 2+ or 3+, respectively), while 16.7% had scores of 3+. Conclusions/Significance: In NSCLC cell lines, high levels of total IGF-1R are associated with moderate sensitivity to R1507. These results suggest a possible enrichment strategy for clinical trials with anti-IGF-1R therapy.			Gong, YX (corresponding author), Mem Sloan Kettering Canc Ctr, Pao Lab, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	william.pao@vanderbilt.edu	Ladanyi, Marc/AAG-8585-2019; Arcila, Maria/ABE-2235-2021	Peifer, Martin/0000-0002-5243-5503; Beckmann, Aviva/0000-0002-5739-5512; Beckmann, Aviva/0000-0001-6099-6135	NATIONAL CANCER INSTITUTE [P01CA129243, K08CA097980, R01CA121210] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA129243, R01 CA121210, K08 CA097980] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Derrane M, 1998, J NATL CANCER I, V90, P1770, DOI 10.1093/jnci/90.23.1770; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Karp DD, 2007, J CLIN ONCOL, V25; Karp DD, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.8015; London SJ, 2002, JNCI-J NATL CANCER I, V94, P749, DOI 10.1093/jnci/94.10.749; Ludovini V, 2009, ANN ONCOL, V20, P842, DOI 10.1093/annonc/mdn727; Merrick DT, 2007, J CLIN ONCOL, V25; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Paz K, 2008, COMB CHEM HIGH T SCR, V11, P62, DOI 10.2174/138620708783398313; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Travis WD, 1999, HISTOLOGICAL TYPING; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yee D, 2006, BRIT J CANCER, V94, P465, DOI 10.1038/sj.bjc.6602963; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151	22	111	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7273	10.1371/journal.pone.0007273	http://dx.doi.org/10.1371/journal.pone.0007273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806209	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800006
J	Roos, AK; Eriksson, F; Timmons, JA; Gerhardt, J; Nyman, U; Gudmundsdotter, L; Brave, A; Wahren, B; Pisa, P				Roos, Anna-Karin; Eriksson, Fredrik; Timmons, James A.; Gerhardt, Josefine; Nyman, Ulrika; Gudmundsdotter, Lindvi; Brave, Andreas; Wahren, Britta; Pisa, Pavel			Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; GENE-EXPRESSION; PLASMID DNA; SKELETAL-MUSCLE; IMMUNE-RESPONSES; VACCINE DELIVERY; INTRAMUSCULAR INJECTION; FIREFLY LUCIFERASE; NAKED DNA; IMMUNOGENICITY	Background: Electrical pulses have been used to enhance uptake of molecules into living cells for decades. This technique, often referred to as electroporation, has become an increasingly popular method to enhance in vivo DNA delivery for both gene therapy applications as well as for delivery of vaccines against both infectious diseases and cancer. In vivo electrovaccination (gene delivery followed by electroporation) is currently being investigated in several clinical trials, including DNA delivery to healthy volunteers. However, the mode of action at molecular level is not yet fully understood. Methodology/Principal Findings: This study investigates intradermal DNA electrovaccination in detail and describes the effects on expression of the vaccine antigen, plasmid persistence and the local tissue environment. Gene profiling of the vaccination site showed that the combination of DNA and electroporation induced a significant up-regulation of proinflammatory genes. In vivo imaging of luciferase activity after electrovaccination demonstrated a rapid onset (minutes) and a long duration (months) of transgene expression. However, when the more immunogenic prostate specific antigen (PSA) was co-administered, PSA-specific T cells were induced and concurrently the luciferase expression became undetectable. Electroporation did not affect the long-term persistence of the PSA-expressing plasmid. Conclusions/Significance: This study provides important insights to how DNA delivery by intradermal electrovaccination affects the local immunological responses of the skin, transgene expression and clearance of the plasmid. As the described vaccination approach is currently being evaluated in clinical trials, the data provided will be of high significance.			Roos, AK (corresponding author), Karolinska Inst, Sci Pk, Solna, Sweden.	roos.anki@gmail.com	Timmons, James A/J-4698-2014; Timmons, James A/M-6350-2019; Nyman, Ulrika/D-3708-2013	Timmons, James A/0000-0002-2255-1220; Timmons, James A/0000-0002-2255-1220; Eriksson, Fredrik/0000-0001-9548-3276				Ahlen G, 2007, J IMMUNOL, V179, P4741, DOI 10.4049/jimmunol.179.7.4741; Babiuk S, 2004, J BIOTECHNOL, V110, P1, DOI 10.1016/j.jbiotec.2004.01.015; Babiuk S, 2003, MOL THER, V8, P992, DOI 10.1016/j.ymthe.2003.09.008; Babiuk S, 2002, VACCINE, V20, P3399, DOI 10.1016/S0264-410X(02)00269-4; Barouch DH, 2004, IMMUNOL REV, V202, P266, DOI 10.1111/j.0105-2896.2004.00200.x; Bergman PJ, 2003, CLIN CANCER RES, V9, P1284; Bins AD, 2005, NAT MED, V11, P899, DOI 10.1038/nm1264; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Chen Z, 2002, BIOCHEM BIOPH RES CO, V290, P66, DOI 10.1006/bbrc.2001.6147; Chiarella P, 2008, EXPERT OPIN BIOL TH, V8, P1645, DOI 10.1517/14712598.8.11.1645 ; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Doh SG, 1997, GENE THER, V4, P648, DOI 10.1038/sj.gt.3300460; Drabick JJ, 2001, MOL THER, V3, P249, DOI 10.1006/mthe.2000.0257; Dupuis M, 2000, J IMMUNOL, V165, P2850, DOI 10.4049/jimmunol.165.5.2850; Durieux AC, 2004, J GENE MED, V6, P809, DOI 10.1002/jgm.534; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Greenland JR, 2007, J IMMUNOL, V178, P5652, DOI 10.4049/jimmunol.178.9.5652; Greenland JR, 2007, VACCINE, V25, P3731, DOI 10.1016/j.vaccine.2007.01.120; Gronevik E, 2005, J GENE MED, V7, P1246, DOI 10.1002/jgm.760; Guevara-Patino JA, 2003, ADV CANCER RES, V90, P157, DOI 10.1016/S0065-230X(03)90005-4; Hakamata Y, 2006, TRANSPLANTATION, V81, P1179, DOI 10.1097/01.tp.0000203137.06587.4a; Hirao LA, 2008, VACCINE, V26, P440, DOI 10.1016/j.vaccine.2007.10.041; Hooper JW, 2007, VACCINE, V25, P1814, DOI 10.1016/j.vaccine.2006.11.017; Jeon YH, 2006, VACCINE, V24, P3057, DOI 10.1016/j.vaccine.2006.01.033; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Luxembourg A, 2007, EXPERT OPIN BIOL TH, V7, P1647, DOI 10.1517/14712598.7.11.1647; Maruyama H, 2001, GENE THER, V8, P1808, DOI 10.1038/sj.gt.3301604; Medi BM, 2005, INT J PHARMACEUT, V294, P53, DOI 10.1016/j.ijpharm.2004.12.014; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Prud'homme GJ, 2006, CURR GENE THER, V6, P243, DOI 10.2174/156652306776359504; Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326; Rizzuto G, 1999, P NATL ACAD SCI USA, V96, P6417, DOI 10.1073/pnas.96.11.6417; Roos AK, 2006, MOL THER, V13, P320, DOI 10.1016/j.ymthe.2005.08.005; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; SCHIRRMACHER V, 2008, 2 INT C CANC VACC AD; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Tollefsen S, 2003, SCAND J IMMUNOL, V57, P229, DOI 10.1046/j.1365-3083.2003.01218.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007; Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; Zhang L, 2002, BBA-GEN SUBJECTS, V1572, P1, DOI 10.1016/S0304-4165(02)00270-2; Zhu DL, 2002, CURR OPIN MOL THER, V4, P41	48	112	118	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7226	10.1371/journal.pone.0007226	http://dx.doi.org/10.1371/journal.pone.0007226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789652	gold, Green Published, Green Submitted			2022-12-25	WOS:000270354100002
J	Deng, MQ; Li, R				Deng, Manqi; Li, Rong			Sperm Chromatin-Induced Ectopic Polar Body Extrusion in Mouse Eggs after ICSI and Delayed Egg Activation	PLOS ONE			English	Article								Meiotic chromosomes in an oocyte are not only a maternal genome carrier but also provide a positional signal to induce cortical polarization and define asymmetric meiotic division of the oocyte, resulting in polar body extrusion and haploidization of the maternal genome. The meiotic chromosomes play dual function in determination of meiosis: 1) organizing a bipolar spindle formation and 2) inducing cortical polarization and assembly of a distinct cortical cytoskeleton structure in the overlying cortex for polar body extrusion. At fertilization, a sperm brings exogenous paternal chromatin into the egg, which induces ectopic cortical polarization at the sperm entry site and leads to a cone formation, known as fertilization cone. Here we show that the sperm chromatin-induced fertilization cone formation is an abortive polar body extrusion due to lack of spindle induction by the sperm chromatin during fertilization. If experimentally manipulating the fertilization process to allow sperm chromatin to induce both cortical polarization and spindle formation, the fertilization cone can be converted into polar body extrusion. This suggests that sperm chromatin is also able to induce polar body extrusion, like its maternal counterpart. The usually observed cone formation instead of ectopic polar body extrusion induced by sperm chromatin during fertilization is due to special sperm chromatin compaction which restrains it from rapid spindle induction and therefore provides a protective mechanism to prevent a possible paternal genome loss during ectopic polar body extrusion.			Deng, MQ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Obstet & Gynecol & Reprod Biol, Boston, MA 02115 USA.	Mdeng3@BICS.BWH.Harvard.edu; RLI@stowers-institute.org						Arney KL, 2001, INT J DEV BIOL, V45, P533; BALHORN R, 1982, J CELL BIOL, V93, P298, DOI 10.1083/jcb.93.2.298; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Bringmann H, 2005, CELL CYCLE, V4, P1709, DOI 10.4161/cc.4.12.2215; Calvin H. I, 1971, Journal Reprod Fertil, VNo. 13, P65; Cao LG, 1996, MOL BIOL CELL, V7, P225, DOI 10.1091/mbc.7.2.225; Caron C, 2005, PROG MOLEC, V38, P65; Cho C, 2003, BIOL REPROD, V69, P211, DOI 10.1095/biolreprod.102.015115; CHOURROUT D, 1982, REPROD NUTR DEV, V22, P713, DOI 10.1051/rnd:19820601; Churikov D, 2004, CYTOGENET GENOME RES, V105, P203, DOI 10.1159/000078190; CLARKE HJ, 1986, J CELL BIOL, V102, P1039, DOI 10.1083/jcb.102.3.1039; CROZET N, 1988, GAMETE RES, V19, P291, DOI 10.1002/mrd.1120190308; Dadoune JP, 2003, MICROSC RES TECHNIQ, V61, P56, DOI 10.1002/jemt.10317; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Deng MQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005249; Deng MQ, 2005, DEV BIOL, V278, P358, DOI 10.1016/j.ydbio.2004.11.013; Deng MQ, 2003, DEV BIOL, V257, P166, DOI 10.1016/S0012-1606(03)00045-9; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Duncan FE, 2005, DEV BIOL, V280, P38, DOI 10.1016/j.ydbio.2004.12.034; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Hales KG, 1999, CURR OPIN CELL BIOL, V11, P717, DOI 10.1016/S0955-0674(99)00042-3; HARROUK W, 1993, CHROMOSOMA, V102, P279, DOI 10.1007/BF00352402; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hogan B., 1986, Manipulating the mouse embryo. A laboratory manual.; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Jones KT, 2005, REPRODUCTION, V130, P813, DOI 10.1530/rep.1.00710; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Kimura Y, 1998, BIOL REPROD, V58, P1407, DOI 10.1095/biolreprod58.6.1407; Kishigami S, 2006, NAT PROTOC, V1, P125, DOI 10.1038/nprot.2006.21; Laberge RM, 2005, ARCH ANDROLOGY, V51, P125, DOI 10.1080/014850190518134; Lawrence Y, 1997, DEVELOPMENT, V124, P233; LONGO FJ, 1978, DEV BIOL, V67, P249, DOI 10.1016/0012-1606(78)90197-5; LONGO FJ, 1988, INT REV CYTOL, V113, P233; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; MARO B, 1984, J EMBRYOL EXP MORPH, V81, P211; Matson S, 2006, BIOL REPROD, V74, P169, DOI 10.1095/biolreprod.105.046409; Morris ID, 2002, HUM REPROD, V17, P990, DOI 10.1093/humrep/17.4.990; Ogura A, 1998, P NATL ACAD SCI USA, V95, P5611, DOI 10.1073/pnas.95.10.5611; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; Sasagawa I, 1998, BIOL REPROD, V58, P248, DOI 10.1095/biolreprod58.1.248; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Simerly C, 1998, MOL BIOL CELL, V9, P2509, DOI 10.1091/mbc.9.9.2509; Tarozzi N, 2007, REPROD BIOMED ONLINE, V14, P746, DOI 10.1016/S1472-6483(10)60678-5; Terada Y, 2000, MOL REPROD DEV, V56, P89, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;89::AID-MRD11&gt;3.0.CO;2-I; Tesarik J, 1996, HUM REPROD, V11, P780; TILNEY LG, 1980, J CELL BIOL, V87, P771, DOI 10.1083/jcb.87.3.771; Tomashov-Matar R, 2005, REPRODUCTION, V130, P467, DOI 10.1530/rep.1.00746; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; Vinot S, 2004, CURR BIOL, V14, P520, DOI 10.1016/j.cub.2004.02.061; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; Ward WS, 2000, ZYGOTE, V8, P51, DOI 10.1017/S0967199400000824; WARD WS, 1991, BIOL REPROD, V44, P569, DOI 10.1095/biolreprod44.4.569; WARD WS, 1994, J CELL BIOCHEM, V55, P77, DOI 10.1002/jcb.240550109; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; YOSHIDA N, 2006, DEV BIOL; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019; 2008, FERTIL STERIL, V90, pS199	67	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7171	10.1371/journal.pone.0007171	http://dx.doi.org/10.1371/journal.pone.0007171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19787051	Green Submitted, Green Published, gold			2022-12-25	WOS:000270290100006
J	Du, YCN; Klimstra, DS; Varmus, H				Du, Yi-Chieh Nancy; Klimstra, David S.; Varmus, Harold			Activation of PyMT in beta Cells Induces Irreversible Hyperplasia, but Oncogene-Dependent Acinar Cell Carcinomas When Activated in Pancreatic Progenitors	PLOS ONE			English	Article							SOMATIC MOUSE MODEL; IN-VIVO; MICE; EXPRESSION; APOPTOSIS; ANTIGEN; BIOLOGY; GROWTH; CANCER; PDX-1	It is unclear whether the cellular origin of various forms of pancreatic cancer involves transformation or transdifferentiation of different target cells or whether tumors arise from common precursors, with tumor types determined by the specific genetic alterations. Previous studies suggested that pancreatic ductal carcinomas might be induced by polyoma middle T antigen (PyMT) expressed in non-ductal cells. To ask whether PyMT transforms and transdifferentiates endocrine cells toward exocrine tumor phenotypes, we generated transgenic mice that carry tetracycline-inducible PyMT and a linked luciferase reporter. Induction of PyMT in beta cells causes beta-cell hyperplastic lesions that do not progress to malignant neoplasms. When PyMT is de-induced, beta cell proliferation and growth cease; however, regression does not occur, suggesting that continued production of PyMT is not required to maintain the viable expanded beta cell population. In contrast, induction of PyMT in early pancreatic progenitor cells under the control of Pdx1 produces acinar cell carcinomas and beta-cell hyperplasia. The survival of acinar tumor cells is dependent on continued expression of PyMT. Our findings indicate that PyMT can induce exocrine tumors from pancreatic progenitor cells, but cells in the beta cell lineage are not transdifferentiated toward exocrine cell types by PyMT; instead, they undergo oncogene-dependent hyperplastic growth, but do not require PyMT for survival.			Du, YCN (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, New York, NY 10021 USA.	duy@mskcc.org			NCI NIH HHS [P30 CA08748, P30-CA 08748, P01 CA94060, R24 CA083084, P30 CA008748, P01 CA094060, U01 CA105492, 5U01CA105492, R24 CA83084] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA105492, P30CA008748, P01CA094060, R24CA083084] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berkovich I, 2001, DIABETES, V50, P2260, DOI 10.2337/diabetes.50.10.2260; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; GITTES GK, 1992, P NATL ACAD SCI USA, V89, P1128, DOI 10.1073/pnas.89.3.1128; Gottlieb KA, 2001, MICROBIOL MOL BIOL R, V65, P288, DOI 10.1128/MMBR.65.2.288-318.2001; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Klimstra DS, 2007, MODERN PATHOL, V20, pS94, DOI 10.1038/modpathol.3800686; KLIMSTRA DS, 1992, AM J SURG PATHOL, V16, P815, DOI 10.1097/00000478-199209000-00001; Lewis BC, 2005, MOL CELL BIOL, V25, P1228, DOI 10.1128/MCB.25.4.1228-1237.2005; Lewis BC, 2003, GENE DEV, V17, P3127, DOI 10.1101/gad.1140403; LUDLOW JW, 1993, FASEB J, V7, P866, DOI 10.1096/fasebj.7.10.8344486; Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645; Naik P, 1996, GENE DEV, V10, P2105, DOI 10.1101/gad.10.17.2105; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; PASSMAN RS, 1994, J CLIN INVEST, V94, P2421, DOI 10.1172/JCI117609; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Shih DQ, 2002, P NATL ACAD SCI USA, V99, P3818, DOI 10.1073/pnas.062605899; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Varmus H, 2005, COLD SH Q B, V70, P1, DOI 10.1101/sqb.2005.70.039; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2008, CANCER RES, V68, P3086; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; YOSHIDA T, 1994, AM J PATHOL, V145, P671; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6932	10.1371/journal.pone.0006932	http://dx.doi.org/10.1371/journal.pone.0006932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19812721	gold, Green Published, Green Submitted			2022-12-25	WOS:000269622300015
J	Pope, AJ; Karrupiah, K; Kearns, PN; Xia, Y; Cardounel, AJ				Pope, Arthur J.; Karrupiah, Kanchana; Kearns, Patrick N.; Xia, Yong; Cardounel, Arturo J.			Role of Dimethylarginine Dimethylaminohydrolases in the Regulation of Endothelial Nitric Oxide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY-DISEASE; ASYMMETRIC DIMETHYLARGININE; ENDOGENOUS METHYLARGININES; MEDIATED INHIBITION; ARGININE ADMA; DYSFUNCTION; OVEREXPRESSION; EXPRESSION; SYNTHASE; PATHWAY	Reduced NO is a hallmark of endothelial dysfunction, and among the mechanisms for impaired NO synthesis is the accumulation of the endogenous nitric-oxide synthase inhibitor asymmetric dimethylarginine (ADMA). Free ADMA is actively metabolized by the intracellular enzyme dimethylarginine dimethylaminohydrolase (DDAH), which catalyzes the conversion of ADMA to citrulline. Decreased DDAH expression/activity is evident in disease states associated with endothelial dysfunction and is believed to be the mechanism responsible for increased methylarginines and sub-sequent ADMA-mediated endothelial nitric-oxide synthase impairment. Two isoforms of DDAH have been identified; however, it is presently unclear which is responsible for endothelial ADMA metabolism and NO regulation. The current study investigated the effects of both DDAH-1 and DDAH-2 in the regulation of methylarginines and endothelial NO generation. Results demonstrated that overexpression of DDAH-1 and DDAH-2 increased endothelial NO by 24 and 18%,respectively. Moreover, small interfering RNA-mediated down-regulation of DDAH-1 and DDAH-2 reduced NO bioavailability by 27 and 57%, respectively. The reduction in NO production following DDAH-1 gene silencing was associated with a 48% reduction in L-Arg/ADMA and was partially restored with L-Arg supplementation. In contrast, L-Arg/ADMA was unchanged in the DDAH-2-silenced cells, and L-Arg supplementation had no effect on NO. These results clearly demonstrate that DDAH-1 and DDAH-2 manifest their effects through different mechanisms, the former of which is largely ADMA-dependent and the latter ADMA-independent. Overall, the present study demonstrates an important regulatory role for DDAH in the maintenance of endothelial function and identifies this pathway as a potential target for treating diseases associated with decreased NO bioavailability.	[Cardounel, Arturo J.] Univ Florida, Dept Physiol & Funct Genom, Coll Med, Gainesville, FL 32607 USA; [Xia, Yong] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	State University System of Florida; University of Florida; University System of Ohio; Ohio State University	Cardounel, AJ (corresponding author), Univ Florida, Dept Physiol & Funct Genom, Coll Med, 1600 SW Archer Rd,M552, Gainesville, FL 32607 USA.	cardounel.1@ufl.edu			National Institutes of Health [HL081734, F31H90027]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081734 and F31H90027.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Birdsey GM, 2000, ACTA PHYSIOL SCAND, V168, P73; Boger GI, 2007, J AM COLL CARDIOL, V49, P2274, DOI 10.1016/j.jacc.2007.02.051; Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173; Boger RH, 2000, ARTERIOSCL THROM VAS, V20, P1557, DOI 10.1161/01.ATV.20.6.1557; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; Cooke JP, 2000, ARTERIOSCL THROM VAS, V20, P2032, DOI 10.1161/01.ATV.20.9.2032; Dayal S, 2008, AM J PHYSIOL-HEART C, V295, pH816, DOI 10.1152/ajpheart.01348.2007; Dayoub H, 2008, STROKE, V39, P180, DOI 10.1161/STROKEAHA.107.490631; Forbes SP, 2008, BIOCHEMISTRY-US, V47, P1819, DOI 10.1021/bi701659n; GRAY GA, 2009, ACTA HISTOC IN PRESS; GRIFFITH TM, 1984, NATURE, V308, P645, DOI 10.1038/308645a0; Hong L, 2007, J BIOL CHEM, V282, P34684, DOI 10.1074/jbc.M707231200; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Jacobi J, 2005, CIRCULATION, V111, P1431, DOI 10.1161/01.CIR.0000158487.80483.09; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Maas R, 2007, CRIT CARE MED, V35, P1876, DOI 10.1097/01.CCM.0000277038.11630.71; Maas R, 2007, CLIN CHEM, V53, P693, DOI 10.1373/clinchem.2006.081893; Maas R, 2007, ATHEROSCLEROSIS, V191, P211, DOI 10.1016/j.atherosclerosis.2006.03.024; Onozato ML, 2008, DIABETES, V57, P172, DOI 10.2337/db06-1772; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pope AJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1679, DOI 10.1152/ajpcell.00224.2007; Potena L, 2008, TRANSPLANTATION, V85, P827, DOI 10.1097/TP.0b013e318166a3a4; Schulze F, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.005; Simon A, 2003, CIRC RES, V93, P813, DOI 10.1161/01.RES.0000097761.19223.0D; Smith CL, 2003, BIOCHEM BIOPH RES CO, V308, P984, DOI 10.1016/S0006-291X(03)01507-9; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Sydow K, 2008, ARTERIOSCL THROM VAS, V28, P692, DOI 10.1161/ATVBAHA.108.162073; Tanaka M, 2005, CIRCULATION, V112, P1549, DOI 10.1161/CIRCULATIONAHA.105.537670; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Vallance P, 2005, J AM SOC NEPHROL, V16, P2254, DOI 10.1681/ASN.2005050539; Volti GL, 2008, ANESTHESIOLOGY, V109, P1054, DOI 10.1097/ALN.0b013e31818d8a77; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212; Zakrzewicz Dariusz, 2009, BMC Pulm Med, V9, P5, DOI 10.1186/1471-2466-9-5; Zoccali C, 2007, NEPHROL DIAL TRANSPL, V22, P801, DOI 10.1093/ndt/gfl719	43	66	68	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35338	35347		10.1074/jbc.M109.037036	http://dx.doi.org/10.1074/jbc.M109.037036			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19820234	Green Published, hybrid			2022-12-25	WOS:000272645600010
J	Tomar, A; George, SP; Mathew, S; Khurana, S				Tomar, Alok; George, Sundeep P.; Mathew, Sijo; Khurana, Seema			Differential Effects of Lysophosphatidic Acid and Phosphatidylinositol 4,5-Bisphosphate on Actin Dynamics by Direct Association with the Actin-binding Protein Villin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL MIGRATION; PHOSPHOLIPASE C-GAMMA(1); PHOSPHATIDIC-ACID; PPAR-GAMMA; GELSOLIN; LPA; LYSOPHOSPHOLIPIDS; IDENTIFICATION; ACTIVATION; MOTILITY	We have previously reported that the epithelial cell-specific actin-binding protein villin directly associates with phosphatidylinositol 4,5-bisphosphate (PIP2) through three binding sites that overlap with actin-binding sites in villin. As a result, association of villin with PIP2 inhibits actin depolymerization and enhances actin cross-linking by villin. In this study, we demonstrate that these three PIP2-binding sites also bind the more hydrophilic phospholipid, lysophosphatidic acid (LPA) but with a higher affinity than PIP2 (dissociation constant (K-d) of 22 mu M versus 39.5 mu M for PIP2). More interestingly, unlike PIP2, the association of villin with LPA inhibits all actin regulatory functions of villin. In addition, unlike PIP2, LPA dramatically stimulates the tyrosine phosphorylation of villin by c-Src kinase. These studies suggest that in cells, selective interaction of villin with either PIP2 or LPA could have dramatically different outcomes on actin reorganization as well as phospholipid-regulated cell signaling. These studies provide a novel regulatory mechanism for phospholipid-induced changes in the microfilament structure and cell function and suggest that LPA could be an intracellular regulator of the actin cytoskeleton.	[Tomar, Alok; George, Sundeep P.; Mathew, Sijo; Khurana, Seema] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Khurana, S (corresponding author), Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Nash 402,894 Union Ave, Memphis, TN 38163 USA.	skhurana@utmem.edu		Khurana, Seema/0000-0002-6884-810X	NIDDK [DK-65006, DK-54755, DK-81408]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054755, R01DK065006, R01DK081408] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-65006, DK-54755, and DK-81408 (to S. K.) through the NIDDK.	AHMED S, 1993, J BIOL CHEM, V268, P10709; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Chemin J, 2005, J BIOL CHEM, V280, P4415, DOI 10.1074/jbc.M408246200; CHETTIBI S, 1994, FEMS IMMUNOL MED MIC, V8, P271, DOI 10.1016/0928-8244(94)90059-0; DeCorte V, 1997, FEBS LETT, V401, P191, DOI 10.1016/S0014-5793(96)01471-8; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Kalari S, 2009, AM J PHYSIOL-LUNG C, V296, pL328, DOI 10.1152/ajplung.90431.2008; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Kumar N, 2004, J BIOL CHEM, V279, P24915, DOI 10.1074/jbc.C400110200; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; LAUENER R, 1995, BIOCHEM BIOPH RES CO, V215, P8, DOI 10.1006/bbrc.1995.2427; Louvard RAD, 2003, MOL BIOL CELL, V14, P4641, DOI 10.1091/mbc.E03-02-0091; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Meerschaert K, 1998, EMBO J, V17, P5923, DOI 10.1093/emboj/17.20.5923; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mintzer E, 2006, BBA-BIOMEMBRANES, V1758, P85, DOI 10.1016/j.bbamem.2005.12.009; Murph M, 2006, CLIN CANCER RES, V12, P6598, DOI 10.1158/1078-0432.CCR-06-1721; Nam JO, 2005, CANCER RES, V65, P4153, DOI 10.1158/0008-5472.CAN-04-2705; Niggli V, 2006, ADV MOL CEL, V37, P221, DOI 10.1016/S1569-2558(06)37011-7; Panebra A, 2001, AM J PHYSIOL-CELL PH, V281, pC1046, DOI 10.1152/ajpcell.2001.281.3.C1046; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Sando JJ, 1996, BIOCHEM J, V317, P583, DOI 10.1042/bj3170583; Sengupta S, 2004, SEMIN CELL DEV BIOL, V15, P503, DOI 10.1016/j.semcdb.2004.05.003; Tomar A, 2004, MOL BIOL CELL, V15, P4807, DOI 10.1091/mbc.E04-05-0431; Tomar A, 2006, J BIOL CHEM, V281, P31972, DOI 10.1074/jbc.M604323200; Wang YH, 2007, AM J PHYSIOL-CELL PH, V292, pC1775, DOI 10.1152/ajpcell.00420.2006; Waters CM, 2006, BIOCHEM J, V398, P55, DOI 10.1042/BJ20060155; WATSON SP, 1985, BIOCHEM J, V232, P61, DOI 10.1042/bj2320061	34	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35278	35282		10.1074/jbc.C109.060830	http://dx.doi.org/10.1074/jbc.C109.060830			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19808673	Green Published, hybrid			2022-12-25	WOS:000272645600003
J	Rosen, D; Lewis, AM; Mizote, A; Thomas, JM; Aley, PK; Vasudevan, SR; Parkesh, R; Galione, A; Izumi, M; Ganesan, A; Churchill, GC				Rosen, Daniel; Lewis, Alexander M.; Mizote, Akiko; Thomas, Justyn M.; Aley, Parvinder K.; Vasudevan, Sridhar R.; Parkesh, Raman; Galione, Antony; Izumi, Minoru; Ganesan, A.; Churchill, Grant C.			Analogues of the Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Antagonist Ned-19 Indicate Two Binding Sites on the NAADP Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE; MOBILIZES CALCIUM; INACTIVATION; COORDINATION; METABOLITE; ORGANELLES; CHANNEL; CELLS; CA-2+	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a Ca2+-releasing messenger. Biological data suggest that its receptor has two binding sites: one high-affinity locking site and one low-affinity opening site. To directly address the presence and function of these putative binding sites, we synthesized and tested analogues of the NAADP antagonist Ned-19. Ned-19 itself inhibits both NAADP-mediated Ca2+ release and NAADP binding. A fluorometry bioassay was used to assess NAADP-mediated Ca2+ release, whereas a radioreceptor assay was used to assess binding to the NAAD Preceptor (only at the high-affinity site). In Ned-20, the fluorine is para rather than ortho as in Ned-19. Ned-20 does not inhibit NAADP-mediated Ca2+ release but inhibits NAADP binding. Conversely, Ned-19.4 (a methyl ester of Ned-19) inhibits NAADP-mediated Ca2+ release but cannot inhibit NAADP binding. Furthermore, Ned-20 prevents the self-desensitization response characteristic of NAADP in sea urchin eggs, confirming that this response is mediated by a high-affinity allosteric site to which NAADP binds in the radioreceptor assay. Collectively, these data provide the first direct evidence for two binding sites (one high-and one low affinity) on the NAADP receptor.	[Rosen, Daniel; Lewis, Alexander M.; Thomas, Justyn M.; Aley, Parvinder K.; Vasudevan, Sridhar R.; Parkesh, Raman; Galione, Antony; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Ganesan, A.] Univ Southampton, Dept Chem, Southampton SO17 1BJ, Hants, England; [Mizote, Akiko; Izumi, Minoru] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	University of Oxford; University of Southampton; Okayama University	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	grant.churchill@pharm.ox.ac.uk	Ganesan, A/F-6698-2011; Galione, Antony/E-5884-2011; Vasudevan, Sridhar/B-1841-2015	Vasudevan, Sridhar/0000-0003-0516-2984; Ganesan, A/0000-0003-4862-7999; Aley, Parvinder/0000-0002-0749-8329; Galione, Antony/0000-0002-4132-7646	Biotechnology and Biological Sciences Research Council [BB/G008523/1]; BBSRC [BB/G008523/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/G008523/1.	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Billington RA, 2000, BIOCHEM BIOPH RES CO, V276, P112, DOI 10.1006/bbrc.2000.3444; Billington RA, 2005, CELL CALCIUM, V37, P81, DOI 10.1016/j.ceca.2004.06.009; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Churamani D, 2006, BIOCHEM J, V397, P313, DOI 10.1042/BJ20060179; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; DARGIE PJ, 1990, CELL REGUL, V1, P279, DOI 10.1091/mbc.1.3.279; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Galione A, 2004, BRIT J PHARMACOL, V142, P1203, DOI 10.1038/sj.bjp.0705888; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Galione A, 2005, CELL CALCIUM, V38, P273, DOI 10.1016/j.ceca.2005.06.031; Genazzani AA, 1997, J BIOL CHEM, V272, P7669, DOI 10.1074/jbc.272.12.7669; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; Kenakin T, 2003, TRENDS PHARMACOL SCI, V24, P346, DOI 10.1016/S0165-6147(03)00167-6; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lewis AM, 2007, ANAL BIOCHEM, V371, P26, DOI 10.1016/j.ab.2007.08.030; MORGAN AJ, 2006, CALCIUM SIGNALING, P265; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	40	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34930	34934		10.1074/jbc.M109.016519	http://dx.doi.org/10.1074/jbc.M109.016519			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19826006	Green Published, hybrid			2022-12-25	WOS:000272439600048
J	Song, XZ; Lasanajak, Y; Olson, LJ; Boonen, M; Dahms, NM; Kornfeld, S; Cummings, RD; Smith, DF				Song, Xuezheng; Lasanajak, Yi; Olson, Linda J.; Boonen, Marielle; Dahms, Nancy M.; Kornfeld, Stuart; Cummings, Richard D.; Smith, David F.			Glycan Microarray Analysis of P-type Lectins Reveals Distinct Phosphomannose Glycan Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; ACETYLGLUCOSAMINELYSOSOMAL-ENZYME N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; ALPHA-N-ACETYLGLUCOSAMINIDASE; RICINUS-COMMUNIS AGGLUTININ; PANCREATIC RIBONUCLEASE-B; LYSOSOMAL-ENZYMES; CARBOHYDRATE-RECOGNITION; CONCANAVALIN-A; STRUCTURAL DETERMINANTS; LIGAND INTERACTIONS	The specificity of the cation-independent and -dependent mannose 6-phosphate receptors (CI-MPR and CD-MPR) for high mannose-type N-glycans of defined structure containing zero, one, or two Man-P-GlcNAc phosphodiester or Man-6-P phosphomonoester residues was determined by analysis on a phosphorylated glycan microarray. Amine-activated glycans were covalently printed on N-hydroxysuccinimide-activated glass slides and interrogated with different concentrations of recombinant CD-MPR or soluble CI-MPR. Neither receptor bound to non-phosphorylated glycans. The CD-MPR bound weakly or undetectably to the phosphodiester derivatives, but strongly to the phosphomonoester-containing glycans with the exception of a single Man7GlcNAc2-R isomer that contained a single Man-6-P residue. By contrast, the CI-MPR bound with high affinity to glycans containing either phospho-mono- or -diesters although, like the CD-MPR, it differentially recognized isomers of phosphorylated Man7GlcNAc2-R. This differential recognition of phosphorylated glycans by the CI- and CD-MPRs has implications for understanding the biosynthesis and targeting of lysosomal hydrolases.	[Smith, David F.] Emory Univ, Dept Biochem, Sch Med, O Wayne Rollins Res Ctr, Atlanta, GA 30322 USA; [Olson, Linda J.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Boonen, Marielle; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Emory University; Medical College of Wisconsin; Washington University (WUSTL)	Smith, DF (corresponding author), Emory Univ, Dept Biochem, Sch Med, O Wayne Rollins Res Ctr, 1510 Clifton Rd,Rm 4035, Atlanta, GA 30322 USA.	dfsmith@emory.edu			National Institutes of Health [R01DK42667, CA08759, GM085448]; NATIONAL CANCER INSTITUTE [R37CA008759, R01CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK42667 (to N.M.D.), CA08759 (to S.K.), and GM085448 (to D.F.S.).	BAENZIGER JU, 1979, J BIOL CHEM, V254, P2400; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Bao M, 1996, J BIOL CHEM, V271, P31446, DOI 10.1074/jbc.271.49.31446; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bohnsack RN, 2009, J BIOL CHEM, V284, P35215, DOI 10.1074/jbc.M109.056184; Boonen M, 2009, MOL BIOL CELL, V20, P4381, DOI 10.1091/mbc.E09-05-0398; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; BRENCKLE R, 1980, ARCH BIOCHEM BIOPHYS, V201, P160, DOI 10.1016/0003-9861(80)90499-3; BREWER CF, 1986, J BIOL CHEM, V261, P7306; Chavez CA, 2007, BIOCHEMISTRY-US, V46, P12604, DOI 10.1021/bi7011806; Dahms NM, 2008, GLYCOBIOLOGY, V18, P664, DOI 10.1093/glycob/cwn061; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; DORLAND L, 1981, J BIOL CHEM, V256, P7708; Feizi T, 2003, CURR OPIN STRUC BIOL, V13, P637, DOI 10.1016/j.sbi.2003.09.002; Gary-Bobo M, 2007, CURR MED CHEM, V14, P2945, DOI 10.2174/092986707782794005; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; GORDON JA, 1972, FEBS LETT, V24, P193, DOI 10.1016/0014-5793(72)80765-8; Hancock MK, 2002, J BIOL CHEM, V277, P47205, DOI 10.1074/jbc.M208534200; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Kornfeld R, 1998, J BIOL CHEM, V273, P23203, DOI 10.1074/jbc.273.36.23203; Kornfeld R, 1999, J BIOL CHEM, V274, P32778, DOI 10.1074/jbc.274.46.32778; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LIANG CJ, 1980, J BIOCHEM-TOKYO, V88, P51; Liang PH, 2008, CURR OPIN CHEM BIOL, V12, P86, DOI 10.1016/j.cbpa.2008.01.031; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; NARASIMHAN S, 1986, CARBOHYD RES, V149, P65, DOI 10.1016/S0008-6215(00)90370-7; NATOWICZ M, 1982, J BIOL CHEM, V257, P4412; Olson LJ, 2004, J BIOL CHEM, V279, P34000, DOI 10.1074/jbc.M404588200; PLUMMER TH, 1968, J BIOL CHEM, V243, P5158; PLUMMER TH, 1964, J BIOL CHEM, V239, P2530; Prien JM, 2009, J AM SOC MASS SPECTR, V20, P539, DOI 10.1016/j.jasms.2008.11.012; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Reddy ST, 2004, J BIOL CHEM, V279, P38658, DOI 10.1074/jbc.M407474200; REITMAN ML, 1981, J BIOL CHEM, V256, P4275; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; Schimanski LM, 2009, BLOOD CELL MOL DIS, V43, P180, DOI 10.1016/j.bcmd.2009.03.010; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; STEIN M, 1987, EMBO J, V6, P2677, DOI 10.1002/j.1460-2075.1987.tb02559.x; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Sun GJ, 2005, GLYCOBIOLOGY, V15, P1136, DOI 10.1093/glycob/cwi098; TABAS I, 1980, J BIOL CHEM, V255, P6633; TONG PY, 1989, J BIOL CHEM, V264, P7962; TONG PY, 1989, J BIOL CHEM, V264, P7970; VARKI A, 1983, J BIOL CHEM, V258, P2808; VARKI A, 1980, J BIOL CHEM, V255, P847; von Figura K, 1991, Curr Opin Cell Biol, V3, P642, DOI 10.1016/0955-0674(91)90035-W; Wang DN, 2003, PROTEOMICS, V3, P2167, DOI 10.1002/pmic.200300601; Zhao KW, 1997, J BIOL CHEM, V272, P22758, DOI 10.1074/jbc.272.36.22758	52	51	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35201	35214		10.1074/jbc.M109.056119	http://dx.doi.org/10.1074/jbc.M109.056119			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19801653	Green Published, hybrid			2022-12-25	WOS:000272439600073
J	Li, Y; Trojer, P; Xu, CF; Cheung, P; Kuo, A; Drury, WJ; Qiao, Q; Neubert, TA; Xu, RM; Gozani, O; Reinberg, D				Li, Yan; Trojer, Patrick; Xu, Chong-Feng; Cheung, Peggie; Kuo, Alex; Drury, William J., III; Qiao, Qi; Neubert, Thomas A.; Xu, Rui-Ming; Gozani, Or; Reinberg, Danny			The Target of the NSD Family of Histone Lysine Methyltransferases Depends on the Nature of the Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; WOLF-HIRSCHHORN-SYNDROME; NUCLEOSOME CORE PARTICLE; SYNDROME CRITICAL REGION; ACUTE MYELOID-LEUKEMIA; DOMAIN-CONTAINING GENE; H3K36 METHYLATION; MULTIPLE-MYELOMA; TRANSCRIPTIONAL ELONGATION; RECOMBINANT HISTONES	The NSD (nuclear receptor SET domain-containing) family of histone lysine methyltransferases is a critical participant in chromatin integrity as evidenced by the number of human diseases associated with the aberrant expression of its family members. Yet, the specific targets of these enzymes are not clear, with marked discrepancies being reported in the literature. We demonstrate that NSD2 can exhibit disparate target preferences based on the nature of the substrate provided. The NSD2 complex purified from human cells and recombinant NSD2 both exhibit specific targeting of histone H3 lysine 36 (H3K36) when provided with nucleosome substrates, but histone H4 lysine 44 is the primary target in the case of octamer substrates, irrespective of the histones being native or recombinant. This disparity is negated when NSD2 is presented with octamer targets in conjunction with short single- or double-stranded DNA. Although the octamers cannot form nucleosomes, the target is nonetheless nucleosome-specific as is the product, dimethylated H3K36. This study clarifies in part the previous discrepancies reported with respect to NSD targets. We propose that DNA acts as an allosteric effector of NSD2 such that H3K36 becomes the preferred target.	[Drury, William J., III; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Reinberg, Danny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Xu, Chong-Feng; Neubert, Thomas A.; Xu, Rui-Ming] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Xu, Chong-Feng; Neubert, Thomas A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Cheung, Peggie; Kuo, Alex; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Xu, Rui-Ming] Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; Stanford University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Reinberg, D (corresponding author), 522 1st Ave,2nd Floor,Rm 211, New York, NY 10016 USA.	reinbd01@nyumc.org	Kuo, Alex/AAL-2845-2020; Gozani, Or P/I-6157-2013; xu, rui/GRX-5734-2022	Gozani, Or/0000-0002-1365-4463; Reinberg, Danny/0000-0003-4288-2016	National Institutes of Health [4R37GM037120-24, S10 RR017990, P30 NS050276, P30CA016087, GM063716]; Howard Hughes Medical Institute; Basic Research Program of China [2009CB825501]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063716, R37GM037120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Basic Research Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 4R37GM037120-24 (to D.R.), S10 RR017990, P30 NS050276, and P30CA016087 (to T.A.N.) and GM063716 (to R.M.X.). This work was also supported by a grant from the Howard Hughes Medical Institute (to D.R.) and Basic Research Program of China Grant 2009CB825501 (to R.M.X.).	Angrand PO, 2001, GENOMICS, V74, P79, DOI 10.1006/geno.2001.6524; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Bender LB, 2006, DEVELOPMENT, V133, P3907, DOI 10.1242/dev.02584; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Dilworth FJ, 1999, P NATL ACAD SCI USA, V96, P1995, DOI 10.1073/pnas.96.5.1995; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Kang HB, 2009, FEBS LETT, V583, P1880, DOI 10.1016/j.febslet.2009.05.038; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kim SM, 2006, BIOCHEM BIOPH RES CO, V345, P318, DOI 10.1016/j.bbrc.2006.04.095; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Todoerti K, 2005, BRIT J HAEMATOL, V131, P214, DOI 10.1111/j.1365-2141.2005.05741.x; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang X, 2001, J BIOL CHEM, V276, P40417, DOI 10.1074/jbc.M104765200; Wright TJ, 1997, HUM MOL GENET, V6, P317, DOI 10.1093/hmg/6.2.317; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang LW, 2004, INT J MASS SPECTROM, V234, P213, DOI 10.1016/j.ijms.2004.02.012	44	196	206	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34283	34295		10.1074/jbc.M109.034462	http://dx.doi.org/10.1074/jbc.M109.034462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808676	hybrid, Green Published			2022-12-25	WOS:000272165200059
J	Tuli, A; Sharma, M; Capek, HL; Naslavsky, N; Caplan, S; Solheim, JC				Tuli, Amit; Sharma, Mahak; Capek, Haley L.; Naslavsky, Naava; Caplan, Steve; Solheim, Joyce C.			Mechanism for Amyloid Precursor-like Protein 2 Enhancement of Major Histocompatibility Complex Class I Molecule Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SORTING SIGNALS; COATED PITS; ENDOCYTOSIS; PEPTIDE; EXPRESSION; CLATHRIN; APP; TRAFFICKING; ANTIGENS; APLP2	Earlier studies have demonstrated interaction of the murine major histocompatibility complex (MHC) class I molecule K-d with amyloid precursor-like protein 2 (APLP2), a ubiquitously expressed member of the amyloid precursor protein family. Our current findings indicate that APLP2 is internalized in a clathrin-dependent manner, as shown by utilization of inhibitors of the clathrin pathway. Furthermore, we demonstrated that APLP2 and K-d bind at the cell surface and are internalized together. The APLP2 cytoplasmic tail contains two overlapping consensus motifs for binding to the adaptor protein-2 complex, and mutation of a tyrosine shared by both motifs severely impaired APLP2 internalization and ability to promote K-d endocytosis. Upon increased expression of wild type APLP2, K-d molecules were predominantly directed to the lysosomes rather than recycled to the plasma membrane. These findings suggest a model in which APLP2 binds K-d at the plasma membrane, facilitates uptake of K-d in a clathrin-dependent manner, and routes the endocytosed K-d to the lysosomal degradation pathway. Thus, APLP2 has a multistep trafficking function that influences the expression of major histocompatibility complex class I molecules at the plasma membrane.	[Tuli, Amit; Capek, Haley L.; Solheim, Joyce C.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Tuli, Amit; Sharma, Mahak; Naslavsky, Naava; Caplan, Steve; Solheim, Joyce C.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Solheim, Joyce C.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Solheim, JC (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	jsolheim@unmc.edu		Sharma, Mahak/0000-0002-4117-4790; Tuli, Amit/0000-0001-5476-4127	National Institutes of Health [GM57428, GM74876]; Nebraska Cancer and Smoking Disease Research; Eppley Cancer Center Pediatric Cancer Research; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074876, R01GM057428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Cancer and Smoking Disease Research; Eppley Cancer Center Pediatric Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57428 (to J.C.S.) and GM74876 (to S.C.), a Nebraska Cancer and Smoking Disease Research Program grant, and an Eppley Cancer Center Pediatric Cancer Research grant (to J.C.S.).	Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Boll W, 2002, TRAFFIC, V3, P590, DOI 10.1034/j.1600-0854.2002.30808.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cappai R, 1999, FEBS LETT, V442, P95, DOI 10.1016/S0014-5793(98)01635-4; CAPPS GG, 1989, J CELL BIOL, V108, P1317, DOI 10.1083/jcb.108.4.1317; Chiu I, 1999, P NATL ACAD SCI USA, V96, P13944, DOI 10.1073/pnas.96.24.13944; Covell DG, 2003, MOL CANCER THER, V2, P317; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DASGUPTA JD, 1988, J IMMUNOL, V141, P2577; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; FEUERBACH D, 1993, EMBO J, V12, P3153, DOI 10.1002/j.1460-2075.1993.tb05984.x; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Guo J, 1998, INVEST OPHTH VIS SCI, V39, P292; HAASS C, 1993, J BIOL CHEM, V268, P3021; Harris MR, 2001, INT IMMUNOL, V13, P1275, DOI 10.1093/intimm/13.10.1275; HOCHMAN JH, 1991, J IMMUNOL, V146, P1862; HUET C, 1980, CELL, V21, P429, DOI 10.1016/0092-8674(80)90479-1; JACOBSEN JS, 1994, J BIOL CHEM, V269, P8376; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Lai A, 1998, J BIOL CHEM, V273, P3732, DOI 10.1074/jbc.273.6.3732; Li XF, 1999, J BIOL CHEM, V274, P27249, DOI 10.1074/jbc.274.38.27249; LO ACY, 1995, J BIOL CHEM, V270, P12641, DOI 10.1074/jbc.270.21.12641; Lybarger L, 2001, J IMMUNOL, V167, P2097, DOI 10.4049/jimmunol.167.4.2097; MACHY P, 1982, P NATL ACAD SCI-BIOL, V79, P4148, DOI 10.1073/pnas.79.13.4148; MACHY P, 1987, NATURE, V328, P724, DOI 10.1038/328724a0; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Morris CR, 2003, J BIOL CHEM, V278, P12618, DOI 10.1074/jbc.M208203200; Myers NB, 2000, J IMMUNOL, V165, P5656, DOI 10.4049/jimmunol.165.10.5656; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; OZATO K, 1983, P NATL ACAD SCI-BIOL, V80, P2040, DOI 10.1073/pnas.80.7.2040; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rassoulzadegan M, 1998, EMBO J, V17, P4647, DOI 10.1093/emboj/17.16.4647; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Santos SG, 2006, J IMMUNOL, V176, P2942, DOI 10.4049/jimmunol.176.5.2942; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Sester M, 2000, J BIOL CHEM, V275, P3645, DOI 10.1074/jbc.275.5.3645; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SMITH JD, 1993, J EXP MED, V178, P2035, DOI 10.1084/jem.178.6.2035; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; THINAKARAN G, 1995, J NEUROSCI, V15, P6314; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; TSE DB, 1984, J EXP MED, V159, P193, DOI 10.1084/jem.159.1.193; Tuli A, 2008, IMMUNOGENETICS, V60, P303, DOI 10.1007/s00251-008-0296-0; Tuli A, 2008, J IMMUNOL, V181, P1978, DOI 10.4049/jimmunol.181.3.1978; Tuli A, 2009, CANCER IMMUNOL IMMUN, V58, P1419, DOI 10.1007/s00262-009-0657-z; Turnquist HR, 2000, METH MOL B, V156, P165; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wolfe MS, 2007, J CELL SCI, V120, P3157, DOI 10.1242/jcs.03481; Yu YYL, 1999, INT IMMUNOL, V11, P1897, DOI 10.1093/intimm/11.12.1897; Zhao XH, 2001, J CELL SCI, V114, P353; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	59	19	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34296	34307		10.1074/jbc.M109.039727	http://dx.doi.org/10.1074/jbc.M109.039727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808674	hybrid, Green Published			2022-12-25	WOS:000272165200060
J	Lee, JW; Park, E; Jeong, MS; Jeon, YJ; Eom, SH; Seol, JH; Chung, CH				Lee, Jung Wook; Park, Eunyong; Jeong, Min Sun; Jeon, Young Joo; Eom, Soo Hyun; Seol, Jae Hong; Chung, Chin Ha			HslVU ATP-dependent Protease Utilizes Maximally Six among Twelve Threonine Active Sites during Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HOMOLOG; CRYSTAL-STRUCTURE; 20S PROTEASOME; HSLUV PROTEASE; COMPLEX; CELL; MECHANISM; HSIU; HYDROLYSIS; ACTIVATION	HslVU is a bacterial ATP-dependent protease distantly related to eukaryotic proteasomes consisting of hexameric HslU ATPase and dodecameric HslV protease. As a homolog of the 20 S proteasome beta-subunits, HslV also uses the N-terminal threonine as the active site residue. However, unlike the proteasome that has only 6 active sites among the 14 beta-subunits, HslV has 12 active sites that could potentially contribute to proteolytic activity. Here, by using a series of HslV dodecamers containing different numbers of active sites, we demonstrate that like the proteasome, HslV with only similar to 6 active sites is sufficient to support full catalytic activity. However, a further reduction of the number of active sites leads to a proportional decrease in activity. Using proteasome inhibitors, we also demonstrate that substrate-mediated stabilization of the HslV-HslU interaction remains unchanged until the number of the active sites is decreased to similar to 6 but is gradually compromised upon further reduction. These results with a mathematical model suggest HslVU utilizes no more than 6 active sites at any given time, presumably because of the action of HslU. These results also suggest that each ATP-bound HslU subunit activates one HslV subunit and that substrate bound to the HslV active site stimulates the HslU ATPase activity by stabilizing the HslV-HslU interaction. We propose this mechanism plays an important role in supporting complete degradation of substrates while preventing wasteful ATP hydrolysis in the resting state by controlling the interaction between HslV and HslU through the catalytic engagement of the proteolytic active sites.	[Lee, Jung Wook; Park, Eunyong; Jeong, Min Sun; Jeon, Young Joo; Seol, Jae Hong; Chung, Chin Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Eom, Soo Hyun] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea	Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST)	Chung, CH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	chchung@snu.ac.kr		Jeon, Young Joo/0000-0003-1004-5336	Korean Research Foundation [KRF-2005-084-C00025]; Korea Science and Engineering Foundation [M10533010001-05-N3301]	Korean Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korean Research Foundation Grant KRF-2005-084-C00025 and Korea Science and Engineering Foundation Grant M10533010001-05-N3301.	Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; BROWN BM, 1993, BIOCHEMISTRY-US, V32, P1354, DOI 10.1021/bi00056a022; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; CREAMER LK, 1981, ARCH BIOCHEM BIOPHYS, V211, P689, DOI 10.1016/0003-9861(81)90505-1; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Huang HC, 1997, J BIOL CHEM, V272, P21364, DOI 10.1074/jbc.272.34.21364; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Ishikawa T, 2000, NATURE, V408, P667, DOI 10.1038/35047165; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; KOZAK M, 1983, MICROBIOL REV, V47, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maupin-Furlow JA, 2001, ADV APPL MICROBIOL, V50, P279, DOI 10.1016/S0065-2164(01)50008-8; MILLA ME, 1995, BIOCHEMISTRY-US, V34, P3344, DOI 10.1021/bi00010a025; Neuwald AF, 1999, GENOME RES, V9, P27; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Park E, 2008, J BIOL CHEM, V283, P33258, DOI 10.1074/jbc.M805411200; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; REDDY P, 1985, P NATL ACAD SCI USA, V82, P5656, DOI 10.1073/pnas.82.17.5656; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; RUBIN DM, 1995, CURR BIOL, V5, P854, DOI 10.1016/S0960-9822(95)00172-2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Seemuller E, 1996, NATURE, V382, P468, DOI 10.1038/382468a0; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Seong IS, 2002, J BIOL CHEM, V277, P25976, DOI 10.1074/jbc.M202793200; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Yoo SJ, 1997, FEBS LETT, V412, P57, DOI 10.1016/S0014-5793(97)00742-4; Yoo SJ, 1997, BIOCHEM BIOPH RES CO, V238, P581, DOI 10.1006/bbrc.1997.7341; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035	42	10	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33475	33484		10.1074/jbc.M109.045807	http://dx.doi.org/10.1074/jbc.M109.045807			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801685	hybrid, Green Published			2022-12-25	WOS:000272028500054
J	Oberholzer, AE; Schneider, P; Siebold, C; Baumann, U; Erni, B				Oberholzer, Anselm E.; Schneider, Philipp; Siebold, Christian; Baumann, Ulrich; Erni, Bernhard			Crystal Structure of Enzyme I of the Phosphoenolpyruvate Sugar Phosphotransferase System in the Dephosphorylated State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE PHOSPHATE DIKINASE; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; ACETATE KINASE; BACTERIAL PHOSPHOENOLPYRUVATE; CARBOHYDRATE TRANSPORTERS; PHOSPHOCARRIER PROTEIN; LACTOCOCCUS-LACTIS; DIFFRACTION DATA	The bacterial phosphoenolpyruvate (PEP) sugar phosphotransferase system mediates sugar uptake and controls the carbon metabolism in response to carbohydrate availability. Enzyme I (EI), the first component of the phosphotransferase system, consists of an N-terminal protein binding domain (EIN) and a C-terminal PEP binding domain (EIC). EI transfers phosphate from PEP by double displacement via a histidine residue on EIN to the general phosphoryl carrier protein HPr. Here we report the 2.4 angstrom crystal structure of the homodimeric EI from Staphylococcus aureus. EIN consists of the helical hairpin HPr binding subdomain and the phosphorylatable beta alpha phospho-histidine (P-His) domain. EIC folds into an (beta alpha)(8) barrel. The dimer interface of EIC buries 1833 angstrom(2) of accessible surface per monomer and contains two Ca2+ binding sites per dimer. The structures of the S. aureus and Escherichia coli EI domains (Teplyakov, A., Lim, K., Zhu, P. P., Kapadia, G., Chen, C. C., Schwartz, J., Howard, A., Reddy, P. T., Peterkofsky, A., and Herzberg, O. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 16218-16223) are very similar. The orientation of the domains relative to each other, however, is different. In the present structure the P-His domain is docked to the HPr binding domain in an orientation appropriate for in-line transfer of the phosphate to the active site histidine of the acceptor HPr. In the E. coli structure the phospho-His of the P-His domain projects into the PEP binding site of EIC. In the S. aureus structure the crystallographic temperature factors are lower for the HPr binding domain in contact with the P-His domain and higher for EIC. In the E. coli structure it is the reverse.	[Oberholzer, Anselm E.; Schneider, Philipp; Siebold, Christian; Baumann, Ulrich; Erni, Bernhard] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Baumann, U (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	ulrich.baumann@ibc.unibe.ch; erni@ibc.unibe.ch	Baumann, Ulrich/B-1220-2013	Siebold, Christian/0000-0002-6635-3621	Swiss National Science Foundation [3100A0-105247]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation Grant 3100A0-105247.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOX DK, 1986, J BIOL CHEM, V261, P3487; FOX DK, 1986, J BIOL CHEM, V261, P3498; Garcia-Alles LF, 2003, BIOCHEMISTRY-US, V42, P4744, DOI 10.1021/bi034007f; Garcia-Alles LF, 2002, J BIOL CHEM, V277, P6934, DOI 10.1074/jbc.M110067200; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Ginsburg A, 2002, ARCH BIOCHEM BIOPHYS, V397, P273, DOI 10.1006/abbi.2001.2603; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gorrell A, 2005, J BIOL CHEM, V280, P10731, DOI 10.1074/jbc.M412118200; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Herzberg O, 2002, BIOCHEMISTRY-US, V41, P780, DOI 10.1021/bi011799+; Hesterkamp Thomas, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P309; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; LICALSI C, 1991, J BIOL CHEM, V266, P19519; Lim K, 2007, BIOCHEMISTRY-US, V46, P14845, DOI 10.1021/bi701848w; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Marquez JA, 2006, J BIOL CHEM, V281, P32508, DOI 10.1074/jbc.M513721200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Oberholzer AE, 2005, J MOL BIOL, V346, P521, DOI 10.1016/j.jmb.2004.11.077; Patel HV, 2006, J BIOL CHEM, V281, P17579, DOI 10.1074/jbc.M508966200; Patel HV, 2006, J BIOL CHEM, V281, P17570, DOI 10.1074/jbc.M508965200; Peterkofsky A, 2001, J MOL MICROB BIOTECH, V3, P347; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Saier MH, 2005, BIOCHEM SOC T, V33, P220, DOI 10.1042/BST0330220; Seok YJ, 1996, P NATL ACAD SCI USA, V93, P347, DOI 10.1073/pnas.93.1.347; Seok YJ, 1996, BIOCHEMISTRY-US, V35, P236, DOI 10.1021/bi952052k; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; SIEBOLD C, 2002, THESIS U BERN; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Suh JY, 2006, J BIOL CHEM, V281, P8939, DOI 10.1074/jbc.M513466200; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Wei M, 2000, J BIOL CHEM, V275, P41156, DOI 10.1074/jbc.M006149200; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; XU Y, 1995, BIOCHEMISTRY-US, V34, P2181, DOI 10.1021/bi00007a011; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Zurbriggen A, 2008, J BIOL CHEM, V283, P35789, DOI 10.1074/jbc.M804893200	47	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33169	33176		10.1074/jbc.M109.057612	http://dx.doi.org/10.1074/jbc.M109.057612			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801641	Green Published, hybrid			2022-12-25	WOS:000272028500021
J	Paumet, F; Wesolowski, J; Garcia-Diaz, A; Delevoye, C; Aulner, N; Shuman, HA; Subtil, A; Rothman, JE				Paumet, Fabienne; Wesolowski, Jordan; Garcia-Diaz, Alejandro; Delevoye, Cedric; Aulner, Nathalie; Shuman, Howard A.; Subtil, Agathe; Rothman, James E.			Intracellular Bacteria Encode Inhibitory SNARE-Like Proteins	PLOS ONE			English	Article								Pathogens use diverse molecular machines to penetrate host cells and manipulate intracellular vesicular trafficking. Viruses employ glycoproteins, functionally and structurally similar to the SNARE proteins, to induce eukaryotic membrane fusion. Intracellular pathogens, on the other hand, need to block fusion of their infectious phagosomes with various endocytic compartments to escape from the degradative pathway. The molecular details concerning the mechanisms underlying this process are lacking. Using both an in vitro liposome fusion assay and a cellular assay, we showed that SNARE-like bacterial proteins block membrane fusion in eukaryotic cells by directly inhibiting SNARE-mediated membrane fusion. More specifically, we showed that IncA and icmG/DotF, two SNARE-like proteins respectively expressed by Chlamydia and Legionella, inhibit the endocytic SNARE machinery. Furthermore, we identified that the SNARE-like motif present in these bacterial proteins encodes the inhibitory function. This finding suggests that SNARE-like motifs are capable of specifically manipulating membrane fusion in a wide variety of biological environments. Ultimately, this motif may have been selected during evolution because it is an efficient structural motif for modifying eukaryotic membrane fusion and thus contribute to pathogen survival.			Paumet, F (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	fabienne.paumet@jefferson.edu	; Subtil, Agathe/C-7464-2017	Delevoye, Cedric/0000-0002-3835-6649; Subtil, Agathe/0000-0002-7481-4846; Paumet, Fabienne/0000-0003-4466-6966; Wesolowski, Jordan/0000-0002-4439-385X	NIAID NIH HHS [AI064481, AI23549, R01 AI064481, R01 AI023549, R01 AI073486] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023549, R01AI073486, R01AI064481] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barocchi MA, 2005, NAT REV MICROBIOL, V3, P349, DOI 10.1038/nrmicro1131; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Dautry-Varsat A, 2004, TRAFFIC, V5, P561, DOI 10.1111/j.1398-9219.2004.00207.x; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Duclos S, 2000, CELL MICROBIOL, V2, P365, DOI 10.1046/j.1462-5822.2000.00066.x; EISSENBERG LG, 1983, INFECT IMMUN, V40, P741, DOI 10.1128/IAI.40.2.741-751.1983; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fields KA, 2002, INFECT IMMUN, V70, P3816, DOI 10.1128/IAI.70.7.3816-3823.2002; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Geisler WM, 2001, J INFECT DIS, V184, P879, DOI 10.1086/323340; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Hackstadt T, 2000, TRAFFIC, V1, P93, DOI 10.1034/j.1600-0854.2000.010201.x; Hashim S, 2000, J BIOL CHEM, V275, P16281, DOI 10.1074/jbc.275.21.16281; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Lutz-Wohlgroth L, 2006, J VET MED A, V53, P185, DOI 10.1111/j.1439-0442.2006.00819.x; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Morozova I, 2004, PLASMID, V51, P127, DOI 10.1016/j.plasmid.2003.12.004; Mullock BM, 2000, MOL BIOL CELL, V11, P3137, DOI 10.1091/mbc.11.9.3137; Nakamura N, 2000, J BIOL CHEM, V275, P6523, DOI 10.1074/jbc.275.9.6523; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Oh YK, 1996, INFECT IMMUN, V64, P319, DOI 10.1128/IAI.64.1.319-325.1996; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Paumet F, 2005, J BIOL CHEM, V280, P21137, DOI 10.1074/jbc.M500841200; Paumet F, 2004, P NATL ACAD SCI USA, V101, P3376, DOI 10.1073/pnas.0400271101; Paumet F, 2001, J CELL BIOL, V155, P961, DOI 10.1083/jcb.200104092; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; Roa M, 1997, J IMMUNOL, V159, P2815; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Rockey DD, 2002, MICROBIOL-SGM, V148, P2497, DOI 10.1099/00221287-148-8-2497; Rockey DD, 1997, MOL MICROBIOL, V24, P217, DOI 10.1046/j.1365-2958.1997.3371700.x; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Sagi-Eisenberg R, 2007, IMMUNOL REV, V217, P292, DOI 10.1111/j.1600-065X.2007.00516.x; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; SCHWARTZ LB, 1979, J IMMUNOL, V123, P1445; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Sollner TH, 2004, CURR OPIN CELL BIOL, V16, P429, DOI 10.1016/j.ceb.2004.06.015; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Varlamov O, 2004, J CELL BIOL, V164, P79, DOI 10.1083/jcb.200307066; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Wu M, 2007, J CELL SCI, V120, P3147, DOI 10.1242/jcs.007260; Xia MS, 2005, J INFECT DIS, V192, P1229, DOI 10.1086/444394	51	64	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7375	10.1371/journal.pone.0007375	http://dx.doi.org/10.1371/journal.pone.0007375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823575	Green Published, gold			2022-12-25	WOS:000270728500003
J	Stone, GW; Barzee, S; Snarsky, V; Santucci, C; Tran, B; Langer, R; Zugates, GT; Anderson, DG; Kornbluth, RS				Stone, Geoffrey W.; Barzee, Suzanne; Snarsky, Victoria; Santucci, Camila; Tran, Brian; Langer, Robert; Zugates, Gregory T.; Anderson, Daniel G.; Kornbluth, Richard S.			Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma	PLOS ONE			English	Article								Stimulation of CD40 or Toll-Like Receptors (TLR) has potential for tumor immunotherapy. Combinations of CD40 and TLR stimulation can be synergistic, resulting in even stronger dendritic cell (DC) and CD8+ T cell responses. To evaluate such combinations, established B16F10 melanoma tumors were injected every other day X 5 with plasmid DNA encoding a multimeric, soluble form of CD40L (pSP-D-CD40L) either alone or combined with an agonist for TLR1/2 (Pam(3)CSK(4)), TLR2/6 (FSL-1 and MALP2), TLR3 (polyinosinic-polycytidylic acid, poly(I:C)), TLR4 (monophosphoryl lipid A, MPL), TLR7 (imiquimod), or TLR9 (Class B CpG phosphorothioate oligodeoxynucleotide, CpG). When used by itself, pSP-D-CD40L slowed tumor growth and prolonged survival, but did not lead to cure. Of the TLR agonists, CpG and poly(I:C) also slowed tumor growth, and the combination of these two TLR agonists was more effective than either agent alone. The triple combination of intratumoral pSP-D-CD40L + CpG + poly(I:C) markedly slowed tumor growth and prolonged survival. This treatment was associated with a reduction in intratumoral CD11c+ dendritic cells and an influx of CD8+ T cells. Since intratumoral injection of plasmid DNA does not lead to efficient transgene expression, pSP-D-CD40L was also tested with cationic polymers that form DNA-containing nanoparticles which lead to enhanced intratumoral gene expression. Intratumoral injections of pSP-D-CD40L-containing nanoparticles formed from polyethylenimine (PEI) or C32 (a novel biodegradable poly(B-amino esters) polymer) in combination with CpG + poly(I:C) had dramatic antitumor effects and frequently cured mice of B16F10 tumors. These data confirm and extend previous reports that CD40 and TLR agonists are synergistic and demonstrate that this combination of immunostimulants can significantly suppress tumor growth in mice. In addition, the enhanced effectiveness of nanoparticle formulations of DNA encoding immunostimulatory molecules such as multimeric, soluble CD40L supports the further study of this technology for tumor immunotherapy.			Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.	rkornbluth@ucsd.edu		Kornbluth, Richard/0000-0002-0218-2026	NATIONAL CANCER INSTITUTE [R01CA132091, U54CA119349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073240, P30AI036214, T32AI007384, K22AI068489, R21AI078834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA119349, R01CA132091, R01 CA132091, U54CA119349] Funding Source: Medline; NIAID NIH HHS [R21AI078834, T32 AI007384, T32AI007384, P30AI036214, K22AI068489, 5R21AI073240, P30 AI036214, R21 AI078834, R21 AI073240, K22 AI068489] Funding Source: Medline; NIBIB NIH HHS [R37 EB000244, R37EB000244] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Ahonen CL, 2008, BLOOD, V111, P3116, DOI 10.1182/blood-2007-09-114371; Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101; Barr TA, 2003, IMMUNOLOGY, V109, P87, DOI 10.1046/j.1365-2567.2003.01634.x; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Broomfield SA, 2009, J IMMUNOL, V182, P5217, DOI 10.4049/jimmunol.0803826; Buhtoiarov IN, 2007, IMMUNOLOGY, V120, P412, DOI 10.1111/j.1365-2567.2006.02517.x; COTTEN M, 1994, GENE THER, V1, P239; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; Currie AJ, 2008, J IMMUNOL, V180, P1535, DOI 10.4049/jimmunol.180.3.1535; de Herve MGD, 2005, BLOOD, V106, P2806, DOI 10.1182/blood-2004-12-4678; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; FIDLER IJ, 1975, CANCER RES, V35, P218; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; Finkelstein SE, 2004, J LEUKOCYTE BIOL, V76, P333, DOI 10.1189/jlb.0304120; Fuse S, 2009, J IMMUNOL, V182, P4244, DOI 10.4049/jimmunol.0802041; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Greenland JR, 2005, MOL THER, V12, P164, DOI 10.1016/j.ymthe.2005.01.021; GUARDA G, 2009, NATURE; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Hanks BA, 2005, NAT MED, V11, P130, DOI 10.1038/nm1183; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; Hiura T, 2005, J IMMUNOL, V175, P5058, DOI 10.4049/jimmunol.175.8.5058; Hodge JW, 2003, CLIN CANCER RES, V9, P1837; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kikuchi T, 2000, CANCER RES, V60, P6391; Kochenderfer JN, 2007, EXP BIOL MED, V232, P1128, DOI 10.3181/0702-MR-42; Kornbluth RS, 1998, P NATL ACAD SCI USA, V95, P5205, DOI 10.1073/pnas.95.9.5205; Kornbluth RS, 2002, J HEMATOTH STEM CELL, V11, P787, DOI 10.1089/152581602760404595; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lapteva N, 2007, CANCER RES, V67, P10528, DOI 10.1158/0008-5472.CAN-07-0833; LEVY HB, 1969, P NATL ACAD SCI USA, V62, P357, DOI 10.1073/pnas.62.2.357; Liu K, 2005, J EXP MED, V202, P1507, DOI 10.1084/jem.20050956; Marzo AL, 1999, J IMMUNOL, V162, P5838; McCutcheon B, 2005, AM SURGEON, V71, P662; McWilliams JA, 2006, J IMMUNOL, V177, P155, DOI 10.4049/jimmunol.177.1.155; Meunier MC, 2005, NAT MED, V11, P1222, DOI 10.1038/nm1311; Moodycliffe AM, 2000, J EXP MED, V191, P2011, DOI 10.1084/jem.191.11.2011; Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Okano F, 2005, J IMMUNOL, V174, P2645, DOI 10.4049/jimmunol.174.5.2645; Perona-Wright G, 2009, J IMMUNOL, V182, P2808, DOI 10.4049/jimmunol.0803553; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Powell AM, 2004, CLIN EXP DERMATOL, V29, P15, DOI 10.1111/j.1365-2230.2004.01452.x; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Roman M, 1997, NAT MED, V3, P849, DOI 10.1038/nm0897-849; Scarlett UK, 2009, CANCER RES, V69, P7329, DOI 10.1158/0008-5472.CAN-09-0835; Schreurs MWJ, 2000, CANCER RES, V60, P6995; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Seliger B, 2001, CANCER RES, V61, P1095; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; Sparwasser T, 1999, J IMMUNOL, V162, P2368; Stone GW, 2006, CLIN VACCINE IMMUNOL, V13, P1223, DOI 10.1128/CVI.00198-06; Stone GW, 2009, J THORAC ONCOL, V4, P802, DOI 10.1097/JTO.0b013e3181a8634d; Stone GW, 2006, J VIROL, V80, P1762, DOI 10.1128/JVI.80.4.1762-1772.2006; Stumbles PA, 2004, J IMMUNOL, V173, P5923, DOI 10.4049/jimmunol.173.10.5923; Tamada K, 2006, CANCER IMMUNOL IMMUN, V55, P355, DOI 10.1007/s00262-005-0081-y; Thomas M, 2002, P NATL ACAD SCI USA, V99, P14640, DOI 10.1073/pnas.192581499; Thomsen LL, 2004, VACCINE, V22, P1799, DOI 10.1016/j.vaccine.2003.09.052; Toso JF, 2002, J IMMUNOL METHODS, V259, P181, DOI 10.1016/S0022-1759(01)00513-0; Turner JG, 2001, J IMMUNOL, V166, P89, DOI 10.4049/jimmunol.166.1.89; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; van Mierlo GJD, 2002, P NATL ACAD SCI USA, V99, P5561, DOI 10.1073/pnas.082107699; van Mierlo GJD, 2004, J IMMUNOL, V173, P6753, DOI 10.4049/jimmunol.173.11.6753; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Vicari AP, 2002, SEMIN CANCER BIOL, V12, P33, DOI 10.1006/scbi.2001.0400; Vonderheide RH, 2001, J CLIN ONCOL, V19, P3280, DOI 10.1200/JCO.2001.19.13.3280; Vonderheide RH, 2007, J CLIN ONCOL, V25, P876, DOI 10.1200/JCO.2006.08.3311; Walsh P, 2000, HUM GENE THER, V11, P1355, DOI 10.1089/10430340050032447; Wells JW, 2008, J IMMUNOL, V181, P3422, DOI 10.4049/jimmunol.181.5.3422; Welters MJP, 2007, VACCINE, V25, P1379, DOI 10.1016/j.vaccine.2006.10.049; Whitmore MM, 2004, CANCER RES, V64, P5850, DOI 10.1158/0008-5472.CAN-04-0063; Wierda WG, 2000, BLOOD, V96, P2917; Xiang R, 2001, J IMMUNOL, V167, P4560, DOI 10.4049/jimmunol.167.8.4560; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059; Zhang LX, 2003, P NATL ACAD SCI USA, V100, P15101, DOI 10.1073/pnas.2135379100; Zheng RX, 2008, CANCER RES, V68, P4045, DOI 10.1158/0008-5472.CAN-07-6669; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105	90	53	63	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7334	10.1371/journal.pone.0007334	http://dx.doi.org/10.1371/journal.pone.0007334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812695	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594200002
J	McGregor, SJ; Busa, MA; Yaggie, JA; Bollt, EM				McGregor, Stephen J.; Busa, Michael A.; Yaggie, James A.; Bollt, Erik M.			High Resolution MEMS Accelerometers to Estimate VO2 and Compare Running Mechanics between Highly Trained Inter-Collegiate and Untrained Runners	PLOS ONE			English	Article								Background: The purposes of this study were to determine the validity and reliability of high resolution accelerometers (HRA) relative to VO2 and speed, and compare putative differences in HRA signal between trained (T) and untrained (UT) runners during treadmill locomotion. Methodology: Runners performed 2 incremental VO2max trials while wearing HRA. RMS of high frequency signal from three axes (VT, ML, AP) and the Euclidean resultant (RES) were compared to VO2 to determine validity and reliability. Additionally, axial rms relative to speed, and ratio of axial accelerations to RES were compared between T and UT to determine if differences in running mechanics could be identified between the two groups. Principal Findings: Regression of RES was strongly related to VO2, but T was different than UT (r = 0.96 vs 0.92; p <.001) for walking and running. During walking, only the ratio of ML and AP to RES were different between groups. For running, nearly all acceleration parameters were lower for T than UT, the exception being ratio of VT to RES, which was higher in T than UT. All of these differences during running were despite higher VO2, O-2 cost, and lower RER in T vs UT, which resulted in no significant difference in energy expenditure between groups. Conclusions/Signficance: These results indicate that HRA can accurately and reliably estimate VO2 during treadmill locomotion, but differences exist between T and UT that should be considered when estimating energy expenditure. Differences in running mechanics between T and UT were identified, yet the importance of these differences remains to be determined.			McGregor, SJ (corresponding author), Eastern Michigan Univ, Appl Physiol Lab, Ypsilanti, MI 48197 USA.	smcgregor@emich.edu						Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Banister E W, 1980, Can J Appl Sport Sci, V5, P170; Billat VL, 2006, J PHYSIOL SCI, V56, P103, DOI 10.2170/physiolsci.R2028; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; CAVAGNA G, 1961, J APPL PHYSIOL, V16, P191, DOI 10.1152/jappl.1961.16.1.191; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; COUTTS AJ, 2008, J SCI MED SPORT; DANIELS J, 1992, MED SCI SPORT EXER, V24, P483; DANIELS JT, 1985, MED SCI SPORT EXER, V17, P332; Foster C, 2005, MED SCI SPORT EXER, V37, P670, DOI 10.1249/01.MSS.0000158183.64465.BF; Foster C, 2007, SPORTS MED, V37, P316, DOI 10.2165/00007256-200737040-00011; Fudge BW, 2007, MED SCI SPORT EXER, V39, P192, DOI 10.1249/01.mss.0000235884.71487.21; Georgoulis Anastasios D, 2006, J Clin Monit Comput, V20, P11, DOI 10.1007/s10877-006-1032-7; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Kurz MJ, 2007, J BIOMECH ENG-T ASME, V129, P216, DOI 10.1115/1.2486008; Kurz MJ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-30; Lambert EV, 2005, BRIT J SPORT MED, V39, P52, DOI 10.1136/bjsm.2003.011247; Lucia A, 2006, APPL PHYSIOL NUTR ME, V31, P530, DOI 10.1139/H06-029; MARTIN PE, 1992, MED SCI SPORT EXER, V24, P467; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; MCGREGOR SJ, 2007, MED SCI SPORTS EXERC, V39, pS35; MCGREGOR SJ, 2008, J STRENGTH IN PRESS; McGregor SJ, 2009, CHAOS, V19, DOI 10.1063/1.3147423; Messier SP, 2008, MED SCI SPORT EXER, V40, P1873, DOI 10.1249/MSS.0b013e31817ed272; Miller DJ, 2006, J BIOMECH, V39, P2873, DOI 10.1016/j.jbiomech.2005.10.019; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P328, DOI 10.1016/S0268-0033(98)00090-4; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; Moraiti C, 2007, KNEE SURG SPORT TR A, V15, P1406, DOI 10.1007/s00167-007-0373-1; MORGAN DW, 1995, MED SCI SPORT EXER, V27, P404; MORTON RH, 1990, J APPL PHYSIOL, V69, P1171, DOI 10.1152/jappl.1990.69.3.1171; Slawinski JS, 2004, MED SCI SPORT EXER, V36, P1440, DOI 10.1249/01.MSS.0000135785.68760.96; Stagno KM, 2007, J SPORT SCI, V25, P629, DOI 10.1080/02640410600811817; Terrier Philippe, 2005, J Neuroeng Rehabil, V2, P28, DOI 10.1186/1743-0003-2-28; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2007, MED SCI SPORT EXER, V39, P1501, DOI 10.1097/mss.0b013e318150d42e; Trost SG, 2006, MED SCI SPORT EXER, V38, P380, DOI 10.1249/01.mss.0000183848.25845.e0; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de; WILLIAMS KR, 1987, J APPL PHYSIOL, V63, P1236, DOI 10.1152/jappl.1987.63.3.1236	42	61	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7355	10.1371/journal.pone.0007355	http://dx.doi.org/10.1371/journal.pone.0007355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806216	Green Published, gold, Green Submitted			2022-12-25	WOS:000270593800029
J	Halder, S; Murakami, M; Verma, SC; Kumar, P; Yi, FM; Robertson, ES				Halder, Sabyasachi; Murakami, Masanao; Verma, Subhash C.; Kumar, Pankaj; Yi, Fuming; Robertson, Erle S.			Early Events Associated with Infection of Epstein-Barr Virus Infection of Primary B-Cells	PLOS ONE			English	Article								Epstein Barr virus (EBV) is closely associated with the development of a vast number of human cancers. To develop a system for monitoring early cellular and viral events associated with EBV infection a self-recombining BAC containing 172-kb of the Epstein Barr virus genome BAC-EBV designated as MD1 BAC (Chen et al., 2005, J. Virology) was used to introduce an expression cassette of green fluorescent protein (GFP) by homologous recombination, and the resultant BAC clone, BAC-GFP-EBV was transfected into the HEK 293T epithelial cell line. The resulting recombinant GFP EBV was induced to produce progeny virus by chemical inducer from the stable HEK 293T BAC GFP EBV cell line and the virus was used to immortalize human primary B-cell as monitored by green fluorescence and outgrowth of the primary B cells. The infection, B-cell activation and cell proliferation due to GFP EBV was monitored by the expression of the B-cell surface antigens CD5, CD10, CD19, CD23, CD39, CD40, CD44 and the intercellular proliferation marker Ki-67 using Flow cytometry. The results show a dramatic increase in Ki-67 which continues to increase by 6-7 days post-infection. Likewise, CD40 signals showed a gradual increase, whereas CD23 signals were increased by 6-12 hours, maximally by 3 days and then decreased. Monitoring the viral gene expression pattern showed an early burst of lytic gene expression. This up-regulation of lytic gene expression prior to latent genes during early infection strongly suggests that EBV infects primary B-cell with an initial burst of lytic gene expression and the resulting progeny virus is competent for infecting new primary B-cells. This process may be critical for establishment of latency prior to cellular transformation. The newly infected primary B-cells can be further analyzed for investigating B cell activation due to EBV infection.			Halder, S (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	erle@mail.med.upenn.edu			NATIONAL CANCER INSTITUTE [R01CA137894, R01CA108461, K99CA126182] Funding Source: NIH RePORTER; NCI NIH HHS [1R01CA137894-01, K99 CA126182-02, K99 CA126182, 5R01CA108461-05, R01 CA108461, R01 CA137894] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; ALFIERI C, 1991, VIROLOGY, V181, P595, DOI 10.1016/0042-6822(91)90893-G; Baumforth KRN, 1999, J CLIN PATHOL-MOL PA, V52, P307; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; BROOKS LA, 1993, J VIROL, V67, P3182, DOI 10.1128/JVI.67.6.3182-3190.1993; Brune W, 2000, TRENDS GENET, V16, P254, DOI 10.1016/S0168-9525(00)02015-1; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen A, 2005, J VIROL, V79, P4506, DOI 10.1128/JVI.79.7.4506-4509.2005; CLARK EA, 1991, ANNU REV IMMUNOL, V97, P127; COLBY BM, 1980, J VIROL, V34, P560, DOI 10.1128/JVI.34.2.560-568.1980; CORDIERBUSSAT M, 1993, INT J CANCER, V53, P153, DOI 10.1002/ijc.2910530128; DALENS M, 1975, INT J CANCER, V16, P1008, DOI 10.1002/ijc.2910160614; DATTA AK, 1980, P NATL ACAD SCI-BIOL, V77, P5163, DOI 10.1073/pnas.77.9.5163; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; FARREL PJ, 2005, EPSTEIN BARR VIRUS G; FARRELL PJ, 1989, EMBO J, V8, P127, DOI 10.1002/j.1460-2075.1989.tb03356.x; FLEMINGTON E, 1990, J VIROL, V64, P4549, DOI 10.1128/JVI.64.9.4549-4552.1990; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; Gagro A, 2000, IMMUNOLOGY, V101, P201, DOI 10.1046/j.1365-2567.2000.00098.x; Gerdes J, 1984, Hematol Oncol, V2, P365; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; GONG M, 1987, J VIROL, V61, P499, DOI 10.1128/JVI.61.2.499-508.1987; HENLE W, 1967, SCIENCE, V157, P1064, DOI 10.1126/science.157.3792.1064; Herrold RE, 1996, J VIROL, V70, P2049, DOI 10.1128/JVI.70.3.2049-2054.1996; Hochberg D, 2004, P NATL ACAD SCI USA, V101, P239, DOI 10.1073/pnas.2237267100; Imadome KI, 2009, MICROBES INFECT, V11, P429, DOI 10.1016/j.micinf.2009.01.007; Imadome KI, 2003, P NATL ACAD SCI USA, V100, P7836, DOI 10.1073/pnas.1231363100; ISHII Y, 1972, J RETICULOENDOTH SOC, V11, P383; JONES JF, 1988, NEW ENGL J MED, V318, P733, DOI 10.1056/NEJM198803243181203; Kanda T, 2004, J VIROL, V78, P7004, DOI 10.1128/JVI.78.13.7004-7015.2004; Kaplan D, 2001, P NATL ACAD SCI USA, V98, P13850, DOI 10.1073/pnas.241509398; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; KEMPKES B, 1995, P NATL ACAD SCI USA, V92, P5875, DOI 10.1073/pnas.92.13.5875; KENNEY S, 1989, J VIROL, V63, P1729, DOI 10.1128/JVI.63.4.1729-1736.1989; KIEFF E, 2001, FIELDS VIROLOGY, P2511; KIEFF E, 1996, FIELDS VIROLOGY, P2443; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KINTNER C, 1981, NATURE, V294, P458, DOI 10.1038/294458a0; Klein E, 1999, IMMUNOL LETT, V68, P147, DOI 10.1016/S0165-2478(99)00044-9; Kobayashi I, 1999, J PATHOL, V189, P34, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;34::AID-PATH391&gt;3.0.CO;2-4; KRYWORUCKHO M, 1995, IMMUNOLOGY, V86, P41; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Lan K, 2007, CURR PROTOC MICROBIO, DOI DOI 10.1002/9780471729259.MCL4E02S6; LEWIN N, 1987, INT J CANCER, V39, P472, DOI 10.1002/ijc.2910390411; LIN JC, 1991, J VIROL, V65, P2728, DOI 10.1128/JVI.65.5.2728-2731.1991; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANN KP, 1985, J VIROL, V55, P710, DOI 10.1128/JVI.55.3.710-720.1985; MAUNDERS MJ, 1994, J GEN VIROL, V75, P769, DOI 10.1099/0022-1317-75-4-769; MILLER RA, 1984, J IMMUNOL, V133, P3408; MOCARSKI ES, 1980, CELL, V22, P243, DOI 10.1016/0092-8674(80)90172-5; NADLER LM, 1983, J IMMUNOL, V131, P244; NEMEROW GR, 1985, J VIROL, V55, P347, DOI 10.1128/JVI.55.2.347-351.1985; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; PEARSON GR, 1978, J VIROL, V28, P344, DOI 10.1128/JVI.28.1.344-351.1978; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; POST LE, 1981, CELL, V25, P227, DOI 10.1016/0092-8674(81)90247-6; RICKINSON AB, 1974, INT J CANCER, V14, P704, DOI 10.1002/ijc.2910140603; RICKINSON AB, 1977, INT J CANCER, V19, P775, DOI 10.1002/ijc.2910190606; RING CJA, 1994, J GEN VIROL, V75, P1, DOI 10.1099/0022-1317-75-1-1; ROSS W, 1995, J CLIN PATHOL-CL MOL, V48, pM113; SCHAEFFER HJ, 1978, NATURE, V272, P583, DOI 10.1038/272583a0; SIXBEY JW, 1987, J GEN VIROL, V68, P805, DOI 10.1099/0022-1317-68-3-805; SMILEY JR, 1980, NATURE, V285, P333, DOI 10.1038/285333a0; Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497; Speck P, 1999, ARCH VIROL, V144, P1123, DOI 10.1007/s007050050574; Takada K, 2001, CURR TOP MICROBIOL, V258, P141; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; THORLEYLAWSON DA, 1985, J IMMUNOL, V134, P3007; TOMKINSON B, 1993, J VIROL, V67, P2014, DOI 10.1128/JVI.67.4.2014-2025.1993; UCKUN FM, 1988, BLOOD, V71, P13; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330, DOI 10.1016/S0952-7915(97)80078-7; Verma SC, 2007, CELL HOST MICROBE, V2, P106, DOI 10.1016/j.chom.2007.07.002; WANG D, 1988, J VIROL, V62, P4173, DOI 10.1128/JVI.62.11.4173-4184.1988; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; WOLF H, 1993, INTERVIROLOGY, V35, P26, DOI 10.1159/000150293; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006	80	71	74	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7214	10.1371/journal.pone.0007214	http://dx.doi.org/10.1371/journal.pone.0007214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19784370	Green Published, gold, Green Submitted			2022-12-25	WOS:000270290000015
J	Sowalsky, AG; Alt-Holland, A; Shamis, Y; Garlick, JA; Feig, LA				Sowalsky, A. G.; Alt-Holland, A.; Shamis, Y.; Garlick, J. A.; Feig, L. A.			RalA suppresses early stages of Ras-induced squamous cell carcinoma progression	ONCOGENE			English	Article						Ral; Ras; squamous cell carcinoma; E-cadherin; tumor progression	EXOCYST COMPLEX; CANCER; GTPASES; RAIA; SKIN; ACTIVATION; EXPRESSION; GROWTH; IDENTIFICATION; PROLIFERATION	Ras proteins activate Raf and PI-3 kinases, as well as exchange factors for RalA and RalB GTPases. Many previous studies have reported that the Ral-signaling cascade contributes positively to Ras-mediated oncogenesis. Here, using a bioengineered tissue model of early steps in Ras-induced human squamous cell carcinoma of the skin, we found the opposite. Conversion of Ras-expressing keratinocytes from a premalignant to malignant state induced by decreasing E-cadherin function was associated with and required an approximately two to threefold decrease in RalA expression. Moreover, direct knockdown of RalA to a similar degree by shRNA expression in these cells reduced E-cadherin levels and also induced progression to a malignant phenotype. Knockdown of the Ral effector, Exo84, mimicked the effects of decreasing RalA levels in these engineered tissues. These phenomena can be explained by our finding that the stability of E-cadherin in Ras-expressing keratinocytes depends upon this RalA signaling cascade. These results imply that an important component of the early stages in squamous carcinoma progression may be a modest decrease in RalA gene expression that magnifies the effects of decreased E-cadherin expression by promoting its degradation.	[Sowalsky, A. G.; Feig, L. A.] Tufts Univ, Dept Biochem, Sch Med, Boston, MA 02111 USA; [Sowalsky, A. G.; Shamis, Y.; Feig, L. A.] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Boston, MA 02111 USA; [Alt-Holland, A.] Tufts Univ, Dept Endodont, Sch Dent Med, Boston, MA 02111 USA; [Garlick, J. A.] Tufts Univ, Dept Oral & Maxillofacial Pathol, Sch Dent Med, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Tufts University	Feig, LA (corresponding author), Tufts Univ, Dept Biochem, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	larry.feig@tufts.edu	Sowalsky, Adam/K-1485-2013	Sowalsky, Adam/0000-0003-2760-1853	NIGMS; NIDCR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047717, R56GM047717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083324] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank MW Carlson, Y Szwec-Levin, S Ezell, T DesRochers and S Dong for excellent technical assistance. This work was supported by grants to LAF from NIGMS and to JAG from NIDCR. We thank N Fusenig for HaCaT cells and their derivatives and F Watt for the H-2K<SUP>d</SUP>-Ecad vectors.	BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Carlson Mark W, 2008, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1909s41; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dlugosz A, 2002, J INVEST DERM SYMP P, V7, P17, DOI 10.1046/j.1523-1747.2002.19631.x; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; FENWICK R, 2009, BIOCHEMISTRY; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Garlick JA, 2007, ADV BIOCHEM ENG BIOT, V103, P207; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Greenberg S, 2004, METH MOL B, V289, P425; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kudo Y, 2003, ORAL ONCOL, V39, P515, DOI 10.1016/S1368-8375(03)00015-0; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Margulis A, 2004, METH MOL B, V289, P61; Margulis A, 2005, CANCER RES, V65, P1783, DOI 10.1158/0008-5472.CAN-04-3399; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Panner A, 2006, MOL CELL BIOL, V26, P7345, DOI 10.1128/MCB.00126-06; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; Polzin A, 2002, MOL CELL BIOL, V22, P1714, DOI 10.1128/MCB.22.6.1714-1722.2002; Pons M, 2006, Clin Transl Oncol, V8, P466, DOI 10.1007/s12094-006-0046-4; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Singhal SS, 2005, BIOCHEM PHARMACOL, V70, P481, DOI 10.1016/j.bcp.2005.05.005; Smith SC, 2007, CLIN CANCER RES, V13, P3803, DOI 10.1158/1078-0432.CCR-06-2419; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Sugita S, 2008, ACTA PHYSIOL, V192, P185, DOI 10.1111/j.1748-1716.2007.01803.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Zhu AJ, 1996, J CELL SCI, V109, P3013	47	16	17	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					45	55		10.1038/onc.2009.307	http://dx.doi.org/10.1038/onc.2009.307			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19802010	Green Accepted			2022-12-25	WOS:000273373500005
J	Das, K; Bandwar, RP; White, KL; Feng, JY; Sarafianos, SG; Tuske, S; Tu, XY; Clark, AD; Boyer, PL; Hou, XR; Gaffney, BL; Jones, RA; Miller, MD; Hughes, SH; Arnold, E				Das, Kalyan; Bandwar, Rajiv P.; White, Kirsten L.; Feng, Joy Y.; Sarafianos, Stefan G.; Tuske, Steven; Tu, Xiongying; Clark, Arthur D., Jr.; Boyer, Paul L.; Hou, Xiaorong; Gaffney, Barbara L.; Jones, Roger A.; Miller, Michael D.; Hughes, Stephen H.; Arnold, Eddy			Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; THYMIDINE ANALOG MUTATIONS; IN-VITRO SELECTION; MOLECULAR-MECHANISMS; PRIMER UNBLOCKING; NUCLEOSIDE ANALOG; COMBINATION THERAPY; DRUG-RESISTANCE; AZT RESISTANCE; DNA	K65R is a primary reverse transcriptase (RT) mutation selected in human immunodeficiency virus type 1-infected patients taking antiretroviral regimens containing tenofovir disoproxil fumarate or other nucleoside analog RT drugs. We determined the crystal structures of K65R mutant RT crosslinked to double-stranded DNA and in complexes with tenofovir diphosphate (TFV-DP) or dATP. The crystals permit substitution of TFV-DP with dATP at the dNTP-binding site. The guanidinium planes of the arginines K65R and Arg72 were stacked to form a molecular platform that restricts the conformational adaptability of both of the residues, which explains the negative effects of the K65R mutation on nucleotide incorporation and on excision. Furthermore, the guanidinium planes of K65R and Arg72 were stacked in two different rotameric conformations in TFV-DP- and dATP-bound structures that may help explain how K65R RT discriminates the drug from substrates. These K65R-mediated effects on RT structure and function help us to visualize the complex interaction with other key nucleotide RT drug resistance mutations, such as M184V, L74V, and thymidine analog resistance mutations.	[Das, Kalyan; Bandwar, Rajiv P.; Sarafianos, Stefan G.; Tuske, Steven; Tu, Xiongying; Clark, Arthur D., Jr.; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Das, Kalyan; Bandwar, Rajiv P.; Sarafianos, Stefan G.; Tuske, Steven; Tu, Xiongying; Clark, Arthur D., Jr.; Hou, Xiaorong; Gaffney, Barbara L.; Jones, Roger A.; Arnold, Eddy] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [White, Kirsten L.; Feng, Joy Y.; Miller, Michael D.] Gilead Sci Inc, Foster City, CA 94404 USA; [Boyer, Paul L.; Hughes, Stephen H.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Gilead Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Arnold, E (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	arnold@cabm.rutgers.edu	Tu, Xiongying/H-7983-2012; Das, Kalyan/B-2967-2018; Das, Kalyan/O-9224-2019; Jones, Roger A./GRY-0637-2022	Das, Kalyan/0000-0002-8897-324X; Das, Kalyan/0000-0002-8897-324X; Bandwar, Rajiv/0000-0002-8081-8958; Sarafianos, Stefan G/0000-0002-5840-154X; Jones, Roger A./0000-0002-6835-6615	National Institutes of Health [AI 27690]; NCI; Center for Cancer Research; NIGMS;  [P01 GM066671]; NATIONAL CANCER INSTITUTE [ZIABC010481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027690, R01AI027690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health MERIT Award AI 27690 and Grant P01 GM066671 (to E.A.) for support of RT structural studies and by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research, and NIGMS (to S.H.H.).	Arnold E, 1996, Drug Des Discov, V13, P29; Bazmi HZ, 2000, ANTIMICROB AGENTS CH, V44, P1783, DOI 10.1128/AAC.44.7.1783-1788.2000; Boyer PL, 2002, J VIROL, V76, P9143, DOI 10.1128/JVI.76.18.9143-9151.2002; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Catucci M, 1999, J ACQ IMMUN DEF SYND, V21, P203, DOI 10.1097/00126334-199907010-00004; Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08; Das K, 2007, J MOL BIOL, V365, P77, DOI 10.1016/j.jmb.2006.08.097; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Deval J, 2004, J BIOL CHEM, V279, P509, DOI 10.1074/jbc.M308806200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARAJ A, 1994, ANTIMICROB AGENTS CH, V38, P2300, DOI 10.1128/AAC.38.10.2300; Feng JY, 1999, FASEB J, V13, P1511, DOI 10.1096/fasebj.13.12.1511; Feng JY, 1999, BIOCHEMISTRY-US, V38, P55, DOI 10.1021/bi982340r; Garforth SJ, 2007, J MOL BIOL, V365, P38, DOI 10.1016/j.jmb.2006.09.057; GU ZX, 1995, P NATL ACAD SCI USA, V92, P2760, DOI 10.1073/pnas.92.7.2760; Harrigan PR, 2000, J INFECT DIS, V181, P912, DOI 10.1086/315317; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Kagan RM, 2007, ANTIVIR RES, V75, P210, DOI 10.1016/j.antiviral.2007.03.006; KATI WM, 1992, J BIOL CHEM, V267, P25988; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Mas A, 2000, EMBO J, V19, P5752, DOI 10.1093/emboj/19.21.5752; Mason PE, 2003, P NATL ACAD SCI USA, V100, P4557, DOI 10.1073/pnas.0735920100; Masquelier B, 1999, ANTIVIR THER, V4, P69; McColl DJ, 2008, ANTIVIR THER, V13, P189; Meyer PR, 2003, J VIROL, V77, P3871, DOI 10.1128/JVI.77.6.3871-3877.2003; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; Parikh UM, 2007, AIDS, V21, P1405, DOI 10.1097/QAD.0b013e3281ac229b; Parikh UM, 2006, J VIROL, V80, P4971, DOI 10.1128/JVI.80.10.4971-4977.2006; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Radzio J, 2005, PROTEIN SCI, V14, P1929, DOI 10.1110/ps.051445605; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Selmi B, 2001, J BIOL CHEM, V276, P48466, DOI 10.1074/jbc.M107003200; Shahs FS, 2000, J BIOL CHEM, V275, P27037; Sharma PL, 2004, VIROLOGY, V321, P222, DOI 10.1016/j.virol.2003.11.013; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Svarovskaia ES, 2008, JAIDS-J ACQ IMM DEF, V48, P428, DOI 10.1097/QAI.0b013e31817bbe93; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Whitcomb JM, 2003, J INFECT DIS, V188, P992, DOI 10.1086/378281; White KL, 2006, ANTIVIR THER, V11, P155; White KL, 2005, AIDS, V19, P1751, DOI 10.1097/01.aids.0000189851.21441.f1; White KL, 2004, ANTIMICROB AGENTS CH, V48, P992, DOI 10.1128/AAC.48.3.992-1003.2004; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; Winters MA, 1997, ANTIMICROB AGENTS CH, V41, P757, DOI 10.1128/AAC.41.4.757	54	67	68	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35092	35100		10.1074/jbc.M109.022525	http://dx.doi.org/10.1074/jbc.M109.022525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19812032	hybrid, Green Published			2022-12-25	WOS:000272439600063
J	daCosta, CJB; Medaglia, SA; Lavigne, N; Wang, SZ; Carswell, CL; Baenziger, JE				daCosta, Corrie J. B.; Medaglia, Sarah A.; Lavigne, Nadine; Wang, Shuzhi; Carswell, Casey L.; Baenziger, John E.			Anionic Lipids Allosterically Modulate Multiple Nicotinic Acetylcholine Receptor Conformational Equilibria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFRARED DIFFERENCE SPECTROSCOPY; PHOSPHATIDIC-ACID; PROTEIN INTERACTIONS; RECONSTITUTED MEMBRANES; SPONTANEOUS CURVATURE; TORPEDO-CALIFORNICA; AGONIST BINDING; ION-CHANNEL; CHOLESTEROL; LIGAND	Anionic lipids influence the ability of the nicotinic acetylcholine receptor to gate open in response to neurotransmitter binding, but the underlying mechanisms are poorly understood. We show here that anionic lipids with relatively small headgroups, and thus the greatest ability to influence lipid packing/bilayer physical properties, are the most effective at stabilizing an agonist-activatable receptor. The differing abilities of anionic lipids to stabilize an activatable receptor stem from differing abilities to preferentially favor resting over both uncoupled and desensitized conformations. Anionic lipids thus modulate multiple acetylcholine receptor conformational equilibria. Our data suggest that both lipids and membrane physical properties act as classic allosteric modulators influencing function by interacting with and thus preferentially stabilizing different native acetylcholine receptor conformational states.	[daCosta, Corrie J. B.; Medaglia, Sarah A.; Lavigne, Nadine; Wang, Shuzhi; Carswell, Casey L.; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Baenziger, JE (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	John.Baenziger@uottawa.ca		Baenziger, John/0000-0002-2888-5328	Canadian Institutes of Health Research; Canadian Institutes of Health Research Canadian Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Canadian Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to J.E.B.) and a Canadian Institutes of Health Research Canadian Graduate Scholarship (to C.J.B.D.).	Alley SH, 2008, CHEM PHYS LIPIDS, V154, P64, DOI 10.1016/j.chemphyslip.2008.03.007; Baenziger JE, 1999, BIOCHEMISTRY-US, V38, P4905, DOI 10.1021/bi990181l; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; BAENZIGER JE, 1992, BIOPHYS J, V61, P983, DOI 10.1016/S0006-3495(92)81905-7; BAENZIGER JE, 1993, BIOCHEMISTRY-US, V32, P5448, DOI 10.1021/bi00071a022; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; BHUSHAN A, 1993, BIOPHYS J, V64, P716, DOI 10.1016/S0006-3495(93)81431-0; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; BOYD ND, 1980, BIOCHEMISTRY-US, V19, P5344, DOI 10.1021/bi00564a031; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; CRIADO M, 1984, BIOCHIM BIOPHYS ACTA, V798, P374, DOI 10.1016/0304-4165(84)90112-0; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2004, J BIOL CHEM, V279, P14967, DOI 10.1074/jbc.M310037200; daCosta CJB, 2003, ACTA CRYSTALLOGR D, V59, P77, DOI 10.1107/S0907444902019236; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; Dickey A, 2008, BIOPHYS J, V95, P2636, DOI 10.1529/biophysj.107.128074; ELLENA JF, 1983, BIOCHEMISTRY-US, V22, P5523, DOI 10.1021/bi00293a012; Elmore DE, 2006, FEBS LETT, V580, P144, DOI 10.1016/j.febslet.2005.11.064; Engel AG, 2002, MOL NEUROBIOL, V26, P347, DOI 10.1385/MN:26:2-3:347; FERNANDEZBALLESTER G, 1994, BIOCHEMISTRY-US, V33, P4065, DOI 10.1021/bi00179a035; FONG TM, 1987, BIOCHEMISTRY-US, V26, P3871, DOI 10.1021/bi00387a020; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HEIDMANN T, 1979, EUR J BIOCHEM, V94, P281, DOI 10.1111/j.1432-1033.1979.tb12894.x; HERZ JM, 1987, J BIOL CHEM, V262, P7238; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Mantipragada SB, 2003, BIOCHEMISTRY-US, V42, P9167, DOI 10.1021/bi034485q; Marchand S, 2002, J NEUROSCI, V22, P8891; MCCARTHY MP, 1992, J BIOL CHEM, V267, P7655; METHOT N, 1995, BIOCHEMISTRY-US, V34, P15142, DOI 10.1021/bi00046a021; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Reid SE, 1996, SPECTROCHIM ACTA A, V52, P1347, DOI 10.1016/0584-8539(96)01718-7; Ryan SE, 2002, J BIOL CHEM, V277, P10420, DOI 10.1074/jbc.M107412200; Ryan SE, 1996, J BIOL CHEM, V271, P24590, DOI 10.1074/jbc.271.40.24590; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; SUNSHINE C, 1992, BIOCHIM BIOPHYS ACTA, V1108, P240, DOI 10.1016/0005-2736(92)90031-G; SUNSHINE C, 1994, BBA-BIOMEMBRANES, V1191, P59, DOI 10.1016/0005-2736(94)90233-X; Vance D., 1996, BIOCH LIPIDS LIPOPRO, V31, P1	45	44	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33841	33849		10.1074/jbc.M109.048280	http://dx.doi.org/10.1074/jbc.M109.048280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19815550	Green Published, hybrid			2022-12-25	WOS:000272165200016
J	Oosterveer, MH; Grefhorst, A; van Dijk, TH; Havinga, R; Staels, B; Kuipers, F; Groen, AK; Reijngoud, DJ				Oosterveer, Maaike H.; Grefhorst, Aldo; van Dijk, Theo H.; Havinga, Rick; Staels, Bart; Kuipers, Folkert; Groen, Albert K.; Reijngoud, Dirk-Jan			Fenofibrate Simultaneously Induces Hepatic Fatty Acid Oxidation, Synthesis, and Elongation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-ALPHA; PPAR-ALPHA; GENE-EXPRESSION; LIVER-DISEASE; IN-VIVO; ADAPTIVE RESPONSE; FASTING RESPONSE; METABOLISM; DEFICIENCY; RAT	A growing body of evidence indicates that peroxisome proliferator-activated receptor alpha (PPAR alpha) not merely serves as a transcriptional regulator of fatty acid catabolism but also exerts a much broader role in hepatic lipid metabolism. We determined adaptations in hepatic lipid metabolism and related aspects of carbohydrate metabolism upon treatment of C57Bl/6 mice with the PPAR alpha agonist fenofibrate. Stable isotope procedures were applied to assess hepatic fatty acid synthesis, fatty acid elongation, and carbohydrate metabolism. Fenofibrate treatment strongly induced hepatic de novo lipogenesis and chain elongation (+/- 300, 150, and 600% for C16:0, C18:0, and C18:1 synthesis, respectively) in parallel with an increased expression of lipogenic genes. The lipogenic induction in fenofibrate-treated mice was found to depend on sterol regulatory element-binding protein 1c (SREBP-1c) but not carbohydrate response element-binding protein (ChREBP). Fenofibrate treatment resulted in a reduced contribution of glycolysis to acetylCoA production, whereas the cycling of glucose 6-phosphate through the pentose phosphate pathway presumably was enhanced. Altogether, our data indicate that beta-oxidation and lipogenesis are induced simultaneously upon fenofibrate treatment. These observations may reflect a physiological mechanism by which PPAR beta and SREBP-1c collectively ensure proper handling of fatty acids to protect the liver against cytotoxic damage.	[Oosterveer, Maaike H.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab,Dept Pediat, NL-9700 RB Groningen, Netherlands; [van Dijk, Theo H.; Kuipers, Folkert; Groen, Albert K.; Reijngoud, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, NL-9700 RB Groningen, Netherlands; [Staels, Bart] Univ Lille Nord France, Inst Pasteur Lille, INSERM, U545, F-59019 Lille, France	University of Groningen; University of Groningen; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Oosterveer, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab,Dept Pediat, POB 30-001, NL-9700 RB Groningen, Netherlands.	M.H.Oosterveer@med.umcg.nl	Staels, Bart/N-9497-2016; oosterveer, maaike h/C-3374-2013	Staels, Bart/0000-0002-3784-1503; Reijngoud, Dirk-Jan/0000-0003-1157-4491; Kuipers, Folkert/0000-0003-2518-737X	Dutch Diabetes Foundation [2002.00.041]; EU [018734]	Dutch Diabetes Foundation; EU(European Commission)	This work was supported by Dutch Diabetes Foundation Grant 2002.00.041 and by EU Grant Hepadip 018734.	Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CASTELEIN H, 1994, J BIOL CHEM, V269, P26754; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Cheung C, 2004, CANCER RES, V64, P3849, DOI 10.1158/0008-5472.CAN-04-0322; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Derks TGJ, 2008, HEPATOLOGY, V47, P1032, DOI 10.1002/hep.22101; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Gueraud F, 1999, J LIPID RES, V40, P152; Hebbachi AM, 2008, J BIOL CHEM, V283, P4866, DOI 10.1074/jbc.M709471200; HOHORST HJ, 1970, METHODEN ENZYMATISCH, P1200; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Inoue I, 1998, LIFE SCI, V63, P135, DOI 10.1016/S0024-3205(98)00249-5; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; KEPPLER D, 1970, METHODEN ENZYMATISCH, P1089; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Knight BL, 2005, BIOCHEM J, V389, P413, DOI 10.1042/BJ20041896; Konig B, 2009, EUR J PHARMACOL, V605, P23, DOI 10.1016/j.ejphar.2009.01.009; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Martin PGP, 2007, HEPATOLOGY, V45, P767, DOI 10.1002/hep.21510; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; MUSKIET FAJ, 1983, J CHROMATOGR, V278, P231, DOI 10.1016/S0378-4347(00)84782-9; Ogata M, 2009, ATHEROSCLEROSIS, V205, P413, DOI 10.1016/j.atherosclerosis.2009.01.008; Oosterveer MH, 2008, J BIOL CHEM, V283, P25437, DOI 10.1074/jbc.M801922200; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Reszko AE, 2004, J BIOL CHEM, V279, P19574, DOI 10.1074/jbc.M400162200; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Schrauwen P, 2004, P NUTR SOC, V63, P287, DOI 10.1079/PNS2003336; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Spolarics Z, 1998, J LEUKOCYTE BIOL, V63, P534, DOI 10.1002/jlb.63.5.534; Sriram G, 2008, MOL GENET METAB, V93, P145, DOI 10.1016/j.ymgme.2007.09.008; Staels B, 2008, NAT CLIN PRACT CARD, V5, P542, DOI 10.1038/ncpcardio1278; Stienstra R, 2007, ENDOCRINOLOGY, V148, P2753, DOI 10.1210/en.2007-0014; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; van der Veen JN, 2007, J LIPID RES, V48, P337, DOI 10.1194/jlr.M600170-JLR200; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; Wong DA, 2004, J BIOL CHEM, V279, P41302, DOI 10.1074/jbc.M406766200; Xu J, 2004, ENDOCRINOLOGY, V145, P1087, DOI 10.1210/en.2003-1173; Yeon JE, 2004, J GASTROEN HEPATOL, V19, P799, DOI 10.1111/j.1440-1746.2004.03349.x	55	114	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34036	34044		10.1074/jbc.M109.051052	http://dx.doi.org/10.1074/jbc.M109.051052			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19801551	Green Published, hybrid			2022-12-25	WOS:000272165200036
J	Agrawal, S; van Dooren, GG; Beatty, WL; Striepen, B				Agrawal, Swati; van Dooren, Giel G.; Beatty, Wandy L.; Striepen, Boris			Genetic Evidence that an Endosymbiont-derived Endoplasmic Reticulum-associated Protein Degradation (ERAD) System Functions in Import of Apicoplast Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; APICOMPLEXAN PARASITES; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; ENCODED PROTEINS; DRUG TARGET; COMPLEX; TRANSLOCATION; EVOLUTION; TRANSPORT	Most apicomplexan parasites harbor a relict chloroplast, the apicoplast, that is critical for their survival. Whereas the apicoplast maintains a small genome, the bulk of its proteins are nuclear encoded and imported into the organelle. Several models have been proposed to explain how proteins might cross the four membranes that surround the apicoplast; however, experimental data discriminating these models are largely missing. Here we present genetic evidence that apicoplast protein import depends on elements derived from the ER-associated protein degradation (ERAD) system of the endosymbiont. We identified two sets of ERAD components in Toxoplasma gondii, one associated with the ER and cytoplasm and one localized to the membranes of the apicoplast. We engineered a conditional null mutant in apicoplast Der1, the putative pore of the apicoplast ERAD complex, and found that loss of Der1(Ap) results in loss of apicoplast protein import and subsequent death of the parasite.	[Agrawal, Swati; Striepen, Boris] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [van Dooren, Giel G.; Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Beatty, Wandy L.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Washington University (WUSTL)	Striepen, B (corresponding author), 500 W Brooks Dr, Athens, GA 30602 USA.	striepen@cb.uga.edu	van Dooren, Giel G/A-8896-2012	van Dooren, Giel G/0000-0003-2455-9821; Striepen, Boris/0000-0002-7426-432X; Agrawal, Swati/0000-0001-6295-6954	National Institutes of Health [AI64671]; American Heart Association; Australian National Health and Medical Research Council [400489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI64671 (to B. S.).; Supported by a predoctoral fellowship from the American Heart Association.; Recipient of a C. J. Martin Overseas Fellowship (400489) from the Australian National Health and Medical Research Council. Current address: Plant Cell Biology Research Centre, School of Botany, University of Melbourne, Parkville, Vic, Australia.	Brossier F, 2008, EUKARYOT CELL, V7, P664, DOI 10.1128/EC.00331-07; Brydges SD, 2008, BIOL CELL, V100, P253, DOI 10.1042/BC20070076; Carey KL, 2000, MOL BIOCHEM PARASIT, V105, P25, DOI 10.1016/S0166-6851(99)00160-7; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; DeRocher A, 2005, J CELL SCI, V118, P565, DOI 10.1242/jcs.01627; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Hager KM, 1999, J CELL SCI, V112, P2631; Hempel F, 2009, MOL BIOL EVOL, V26, P1781, DOI 10.1093/molbev/msp079; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Karnataki A, 2007, MOL MICROBIOL, V63, P1653, DOI 10.1111/j.1365-2958.2007.05619.x; Keeling PJ, 2009, J EUKARYOT MICROBIOL, V56, P1, DOI 10.1111/j.1550-7408.2008.00371.x; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Meissner M, 2002, J CELL SCI, V115, P563; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Poteete AR, 2006, BIOTECHNIQUES, V41, P261, DOI 10.2144/000112242; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Thomsen-Zieger N, 2003, FEBS LETT, V547, P80, DOI 10.1016/S0014-5793(03)00673-2; Tonkin CJ, 2008, TRAFFIC, V9, P166, DOI 10.1111/j.1600-0854.2007.00660.x; Tonkin CJ, 2006, MOL MICROBIOL, V61, P614, DOI 10.1111/j.1365-2958.2006.05244.x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	46	138	138	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33683	33691		10.1074/jbc.M109.044024	http://dx.doi.org/10.1074/jbc.M109.044024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19808683	hybrid, Green Published			2022-12-25	WOS:000272028500072
J	Hawse, WF; Wolberger, C				Hawse, William F.; Wolberger, Cynthia			Structure-based Mechanism of ADP-ribosylation by Sirtuins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIR2 PROTEIN; DEACETYLASE ACTIVITY; SIR2-LIKE PROTEINS; TRYPANOSOMA-BRUCEI; RIBOSYLTRANSFERASE; ACETYLATION; FAMILY; YEAST; GENE; CRYSTALLOGRAPHY	Sirtuins comprise a family of enzymes found in all organisms, where they play a role in diverse processes including transcriptional silencing, aging, regulation of transcription, and metabolism. The predominant reaction catalyzed by these enzymes is NAD(+)-dependent lysine deacetylation, although some sirtuins exhibit a weaker ADP-ribosyltransferase activity. Although the Sir2 deacetylation mechanism is well established, much less is known about the Sir2 ADP-ribosylation reaction. We have studied the ADP-ribosylation activity of a bacterial sirtuin, Sir2Tm, and show that acetylated peptides containing arginine or lysine 2 residues C-terminal to the acetyl lysine, the +2 position, are preferentially ADP-ribosylated at the +2 residue. A structure of Sir2Tm bound to the acetylated +2 arginine peptide shows how this arginine could enter the active site and react with a deacetylation reaction intermediate to yield an ADP-ribosylated peptide. The new biochemical and structural studies presented here provide mechanistic insights into the Sir2 ADP-ribosylation reaction and will aid in identifying substrates of this reaction.	[Hawse, William F.; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Wolberger, C (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		Wolberger, Cynthia/0000-0001-8578-2969	National Science Foundation [MCB-0615815]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0615815.	Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kowieski TM, 2008, J BIOL CHEM, V283, P5317, DOI 10.1074/jbc.M707613200; LENO GH, 1990, FEBS LETT, V276, P29, DOI 10.1016/0014-5793(90)80499-9; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 2002, METHOD ENZYMOL, V353, P282; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tsang AW, 1998, J BIOL CHEM, V273, P31788, DOI 10.1074/jbc.273.48.31788	35	46	47	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33654	33661		10.1074/jbc.M109.024521	http://dx.doi.org/10.1074/jbc.M109.024521			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801667	Green Published, hybrid			2022-12-25	WOS:000272028500069
J	Kim, J; Hannibal, L; Gherasim, C; Jacobsen, DW; Banerjee, R				Kim, Jihoe; Hannibal, Luciana; Gherasim, Carmen; Jacobsen, Donald W.; Banerjee, Ruma			A Human Vitamin B-12 Trafficking Protein Uses Glutathione Transferase Activity for Processing Alkylcobalamins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COA MUTASE; GENETIC COMPLEMENTATION; HUMAN-FIBROBLASTS; COBALAMIN; HYDROXOCOBALAMIN; METHYLCOBALAMIN; HOMOCYSTINURIA; IDENTIFICATION; METABOLISM; ACIDEMIA	Pathways for tailoring and processing vitamins into active cofactor forms exist in mammals that are unable to synthesize these cofactors de novo. A prerequisite for intracellular tailoring of alkylcobalamins entering from the circulation is removal of the alkyl group to generate an intermediate that can subsequently be converted into the active cofactor forms. MMACHC, a cytosolic cobalamin trafficking chaperone, has been shown recently to catalyze a reductive decyanation reaction when it encounters cyanocobalamin. In this study, we demonstrate that this versatile protein catalyzes an entirely different chemical reaction with alkylcobalamins using the thiolate of glutathione for nucleophilic displacement to generate cob( I) alamin and the corresponding glutathione thioether. Biologically relevant thiols, e. g. cysteine and homocysteine, cannot substitute for glutathione. The catalytic turnover numbers for the dealkylation of methylcobalamin and 5'-deoxyadenosylcobalamin by MMACHC are 11.7 +/- 0.2 and 0.174 +/- 0.006 h(-1) at 20 degrees C, respectively. This glutathione transferase activity of MMACHC is reminiscent of the methyltransferase chemistry catalyzed by the vitamin B-12-dependent methionine synthase and is impaired in the cblC group of inborn errors of cobalamin disorders.	[Kim, Jihoe; Gherasim, Carmen; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Hannibal, Luciana; Jacobsen, Donald W.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Hannibal, Luciana; Jacobsen, Donald W.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Jacobsen, Donald W.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Cleveland Clinic Foundation	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Hannibal, Luciana/AAY-7689-2021	Hannibal, Luciana/0000-0002-0911-5758	National Institutes of Health [DK45776, HL71907]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK45776 (to R.B.) and HL71907 (to D.W.J.).	AMAGASAKI T, 1990, BLOOD, V76, P1380; Andersson HC, 1998, J PEDIATR-US, V132, P121, DOI 10.1016/S0022-3476(98)70496-2; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Babbitt PC, 2000, P NATL ACAD SCI USA, V97, P10298, DOI 10.1073/pnas.97.19.10298; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; BARTHOLOMEW DW, 1988, J PEDIATR-US, V112, P32, DOI 10.1016/S0022-3476(88)80114-8; CHU RC, 1993, METABOLISM, V42, P315, DOI 10.1016/0026-0495(93)90080-8; GIMSING P, 1983, ANAL BIOCHEM, V129, P296, DOI 10.1016/0003-2697(83)90553-5; GRAVEL RA, 1975, P NATL ACAD SCI USA, V72, P3181, DOI 10.1073/pnas.72.8.3181; Gupta Y, 2008, CRIT REV THER DRUG, V25, P347, DOI 10.1615/CritRevTherDrugCarrierSyst.v25.i4.20; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; HOGENKAMP HPC, 1987, BIOCHEMISTRY-US, V26, P4723, DOI 10.1021/bi00389a019; HOGENKAMP HPC, 1985, BIOCHEMISTRY-US, V24, P6428, DOI 10.1021/bi00344a018; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; KOLHOUSE JF, 1977, P NATL ACAD SCI USA, V74, P921, DOI 10.1073/pnas.74.3.921; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; MARTIN BD, 1992, J AM CHEM SOC, V114, P585, DOI 10.1021/ja00028a027; Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051; MELLMAN I, 1979, J BIOL CHEM, V254, P1847; MELLMAN IS, 1977, P NATL ACAD SCI USA, V74, P916, DOI 10.1073/pnas.74.3.916; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Padovani D, 2006, BIOCHEMISTRY-US, V45, P2951, DOI 10.1021/bi051742d; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Rosenblatt D. S., 2001, METABOLIC MOL BASES, V8th, P3897; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; WILLARD HF, 1978, AM J HUM GENET, V30, P1	30	84	87	5	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33418	33424		10.1074/jbc.M109.057877	http://dx.doi.org/10.1074/jbc.M109.057877			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801555	hybrid, Green Published			2022-12-25	WOS:000272028500048
J	Noorwez, SM; Sama, RRK; Kaushal, S				Noorwez, Syed M.; Sama, Reddy Ranjith K.; Kaushal, Shalesh			Calnexin Improves the Folding Efficiency of Mutant Rhodopsin in the Presence of Pharmacological Chaperone 11-cis-Retinal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MOLECULAR CHAPERONES; CELL-SURFACE; WILD-TYPE; EXPRESSION; RECEPTOR; PROTEIN; DISEASES	The lectin chaperone calnexin (Cnx) is important for quality control of glycoproteins, and the chances of correct folding of a protein increase the longer the protein interacts with Cnx. Mutations in glycoproteins increase their association with Cnx, and these mutant proteins are retained in the endoplasmic reticulum. However, until now, the increased interaction with Cnx was not known to increase the folding of mutant glycoproteins. Because many human diseases result from glycoprotein misfolding, a Cnx-assisted folding of mutant glycoproteins could be beneficial. Mutations of rhodopsin, the glycoprotein pigment of rod photoreceptors, cause misfolding resulting in retinitis pigmentosa. Despite the critical role of Cnx in glycoprotein folding, surprisingly little is known about its interaction with rhodopsin or whether this interaction could be modulated to increase the folding of mutant rhodopsin. Here, we demonstrate that Cnx preferentially associates with misfolded mutant opsins associated with retinitis pigmentosa. Furthermore, the overexpression of Cnx leads to an increased accumulation of misfolded P23H opsin but not the correctly folded protein. Finally, we demonstrate that increased levels of Cnx in the presence of the pharmacological chaperone 11-cis-retinal increase the folding efficiency and result in an increase in correct folding of mutant rhodopsin. These results demonstrate that misfolded rather than correctly folded rhodopsin is a substrate for Cnx and that the interaction between Cnx and mutant, misfolded rhodopsin, can be targeted to increase the yield of folded mutant protein.	[Noorwez, Syed M.; Sama, Reddy Ranjith K.; Kaushal, Shalesh] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester		shalesh.kaushal@umassmemorial.org			Research to Prevent Blindness; Charlie Mack Overstreet Retinal Diseases Fund	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Charlie Mack Overstreet Retinal Diseases Fund	This work was supported by Research to Prevent Blindness (unrestricted grant) and Charlie Mack Overstreet Retinal Diseases Fund.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bradley CA, 2008, J BIOL CHEM, V283, P22043, DOI 10.1074/jbc.M801708200; Brothers SP, 2006, J MOL ENDOCRINOL, V37, P479, DOI 10.1677/jme.1.02142; Butz JA, 2003, BIOTECHNOL BIOENG, V84, P292, DOI 10.1002/bit.10771; Deretic D, 2006, VISION RES, V46, P4427, DOI 10.1016/j.visres.2006.07.028; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Esapa CT, 2005, HUM MOL GENET, V14, P295, DOI 10.1093/hmg/ddi026; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Higgins MK, 2003, BBA-BIOMEMBRANES, V1610, P124, DOI 10.1016/S0005-2736(02)00715-0; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Katanosaka K, 1998, FEBS LETT, V424, P149, DOI 10.1016/S0014-5793(98)00160-4; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kim PS, 2008, MOL ENDOCRINOL, V22, P477, DOI 10.1210/me.2007-0183; Klabunde J, 2007, FEMS YEAST RES, V7, P1168, DOI 10.1111/j.1567-1364.2007.00271.x; Kosmaoglou M, 2008, MOL VIS, V14, P2466; Krebs MP, 2009, INVEST OPHTH VIS SCI, V50, P2956, DOI 10.1167/iovs.08-3116; LE AQ, 1994, J BIOL CHEM, V269, P7514; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Morello JP, 2001, BIOCHEMISTRY-US, V40, P6766, DOI 10.1021/bi002699r; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Noorwez SM, 2008, INVEST OPHTH VIS SCI, V49, P3224, DOI 10.1167/iovs.07-1539; Okada T, 2001, CURR OPIN STRUC BIOL, V11, P420, DOI 10.1016/S0959-440X(00)00227-X; Okiyoneda T, 2008, BBA-MOL CELL RES, V1783, P1585, DOI 10.1016/j.bbamcr.2008.04.002; Paulsson K, 2003, BBA-MOL CELL RES, V1641, P1, DOI 10.1016/S0167-4889(03)00048-X; Prasad SA, 1998, EUR J IMMUNOL, V28, P907, DOI 10.1002/(SICI)1521-4141(199803)28:03<907::AID-IMMU907>3.3.CO;2-W; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Saliba RS, 2002, J CELL SCI, V115, P2907; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532	40	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33333	33342		10.1074/jbc.M109.043364	http://dx.doi.org/10.1074/jbc.M109.043364			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801547	Green Published, hybrid			2022-12-25	WOS:000272028500038
J	Boily-Larouche, G; Iscache, AL; Zijenah, LS; Humphrey, JH; Mouland, AJ; Ward, BJ; Roger, M				Boily-Larouche, Genevieve; Iscache, Anne-Laure; Zijenah, Lynn S.; Humphrey, Jean H.; Mouland, Andrew J.; Ward, Brian J.; Roger, Michel			Functional Genetic Variants in DC-SIGNR Are Associated with Mother-to-Child Transmission of HIV-1	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; VERTICAL TRANSMISSION; EXPRESSION; INFECTION; ADHESION; CCR5; POLYMORPHISMS; DIVERSITY; INFANTS; ANTIGEN	Background: Mother-to-child transmission (MTCT) is the main cause of HIV-1 infection in children worldwide. Given that the C-type lectin receptor, dendritic cell-specific ICAM-grabbing non-integrin-related (DC-SIGNR, also known as CD209L or liver/lymph node-specific ICAM-grabbing non-integrin (L-SIGN)), can interact with pathogens including HIV-1 and is expressed at the maternal-fetal interface, we hypothesized that it could influence MTCT of HIV-1. Methods and Findings: To investigate the potential role of DC-SIGNR in MTCT of HIV-1, we carried out a genetic association study of DC-SIGNR in a well-characterized cohort of 197 HIV-infected mothers and their infants recruited in Harare, Zimbabwe. Infants harbouring two copies of DC-SIGNR H1 and/or H3 haplotypes (H1-H1, H1-H3, H3-H3) had a 3.6-fold increased risk of in utero (IU) (P = 0.013) HIV-1 infection and a 5.7-fold increased risk of intrapartum (IP) (P = 0.025) HIV-1 infection after adjusting for a number of maternal factors. The implicated H1 and H3 haplotypes share two single nucleotide polymorphisms (SNPs) in promoter region (p-198A) and intron 2 (int2-180A) that were associated with increased risk of both IU (P = 0.045 and P = 0.003, respectively) and IP (P = 0.025, for int2-180A) HIV-1 infection. The promoter variant reduced transcriptional activity in vitro. In homozygous H1 infants bearing both the p-198A and int2-180A mutations, we observed a 4-fold decrease in the level of placental DC-SIGNR transcripts, disproportionately affecting the expression of membrane-bound isoforms compared to infant noncarriers (P = 0.011). Conclusion: These results suggest that DC-SIGNR plays a crucial role in MTCT of HIV-1 and that impaired placental DC-SIGNR expression increases risk of transmission.			Boily-Larouche, G (corresponding author), CHU Montreal, Ctr Rech, Immunogenet Lab, Montreal, PQ, Canada.	michel.roger.chum@ssss.gouv.qc.ca						Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Boily-Larouche G, 2007, HUM IMMUNOL, V68, P523, DOI 10.1016/j.humimm.2007.02.002; Boniotto M, 2000, GENES IMMUN, V1, P346, DOI 10.1038/sj.gene.6363685; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; D Kanmogne G, 2007, J CEREBR BLOOD F MET, V27, P123, DOI 10.1038/sj.jcbfm.9600330; Humphrey JH, 2006, J INFECT DIS, V193, P960; Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6; Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a; Kwiek JJ, 2008, J INFECT DIS, V197, P1378, DOI 10.1086/587646; Kwiek JJ, 2006, PLOS MED, V3, P70, DOI 10.1371/journal.pmed.0030010; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Liu HL, 2005, EUR J HUM GENET, V13, P707, DOI 10.1038/sj.ejhg.5201409; Luzuriaga Katherine, 2007, Curr Infect Dis Rep, V9, P511, DOI 10.1007/s11908-007-0076-2; Mangano A, 2008, J INFECT DIS, V198, P694, DOI 10.1086/590498; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Mukhtar M, 2002, VIROLOGY, V297, P78, DOI 10.1006/viro.2002.1376; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; Pedersen BR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000838; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Singh KK, 2003, J INFECT DIS, V188, P1461, DOI 10.1086/379038; SINGH KK, 2009, PEDIAT RES; Singh KK, 2008, JAIDS-J ACQ IMM DEF, V49, P259, DOI 10.1097/QAI.0b013e318186eaa4; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Soilleux EJ, 2002, HUM PATHOL, V33, P652, DOI 10.1053/hupa.2002.124036; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Yang B, 2009, MICROVASC RES, V77, P212, DOI 10.1016/j.mvr.2008.11.003; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142	32	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7211	10.1371/journal.pone.0007211	http://dx.doi.org/10.1371/journal.pone.0007211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809496	Green Published, Green Submitted, gold			2022-12-25	WOS:000270594000001
J	Salama, SA; Kamel, MW; Botting, S; Salih, SM; Borahay, MA; Hamed, AA; Kilic, GS; Saeed, M; Williams, MY; Diaz-Arrastia, CR				Salama, Salama A.; Kamel, Marwa W.; Botting, Shaleen; Salih, Sana M.; Borahay, Mostafa A.; Hamed, Ahmed A.; Kilic, Gokhan S.; Saeed, Muhammad; Williams, Marian Y.; Diaz-Arrastia, Concepcion R.			Catechol-O-Methyltransferase Expression and 2-Methoxyestradiol Affect Microtubule Dynamics and Modify Steroid Receptor Signaling in Leiomyoma Cells	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; HUMAN UTERINE LEIOMYOMA; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; AROMATASE EXPRESSION; MENSTRUAL-CYCLE; FIBROIDS; GROWTH; COMPLEX; GENE	Context: Development of optimal medicinal treatments of uterine leiomyomas represents a significant challenge. 2-Methoxyestradiol (2ME) is an endogenous estrogen metabolite formed by sequential action of CYP450s and catechol-O-methyltransferase (COMT). Our previous study demonstrated that 2ME is a potent antiproliferative, proapoptotic, antiangiogenic, and collagen synthesis inhibitor in human leiomyomas cells (huLM). Objectives: Our objectives were to investigate whether COMT expression, by the virtue of 2ME formation, affects the growth of huLM, and to explore the cellular and molecular mechanisms whereby COMT expression or treatment with 2ME affect these cells. Results: Our data demonstrated that E-2-induced proliferation was less pronounced in cells over-expressing COMT or treated with 2ME (500 nM). This effect on cell proliferation was associated with microtubules stabilization and diminution of estrogen receptor alpha (ER alpha) and progesterone receptor (PR) transcriptional activities, due to shifts in their subcellular localization and sequestration in the cytoplasm. In addition, COMT over expression or treatment with 2ME reduced the expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and the basal level as well as TNF-alpha-induced aromatase (CYP19) expression. Conclusions: COMT over expression or treatment with 2ME stabilize microtubules, ameliorates E-2-induced proliferation, inhibits ER alpha and PR signaling, and reduces HIF-1 alpha and CYP19 expression in human uterine leiomyoma cells. Thus, microtubules are a candidate target for treatment of uterine leiomyomas. In addition, the naturally occurring microtubule-targeting agent 2ME represents a potential new therapeutic for uterine leiomyomas.			Salama, SA (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Houston, TX 77030 USA.	salama@bcm.tmc.edu	Borahay, Mostafa/AAJ-6582-2020	Borahay, Mostafa/0000-0002-0554-132X; Williams-Brown, Marian/0000-0001-5034-5152; theiler, shaleen/0000-0002-6881-6319; Kilic, Gokhan/0000-0002-7926-7458				Al-Hendy A, 2004, AM J OBSTET GYNECOL, V191, P1621, DOI 10.1016/j.ajog.2004.04.022; Azuma K, 2004, FEBS LETT, V577, P339, DOI 10.1016/j.febslet.2004.10.025; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P736, DOI 10.1210/jc.78.3.736; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P3964, DOI 10.1073/pnas.91.9.3964; Ding L, 2004, J CLIN ENDOCR METAB, V89, P5549, DOI 10.1210/jc.2004-0161; Edwards RD, 2007, NEW ENGL J MED, V356, P360; Englund K, 1998, J CLIN ENDOCR METAB, V83, P4092, DOI 10.1210/jc.83.11.4092; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Farquhar CM, 2002, OBSTET GYNECOL, V99, P229, DOI 10.1016/S0029-7844(01)01723-9; Hassan MH, 2007, J CLIN ENDOCR METAB, V92, P3949, DOI 10.1210/jc.2007-0823; Hoekstra AV, 2009, J CLIN ENDOCR METAB, V94, P1768, DOI 10.1210/jc.2008-2093; Hwu YM, 2008, FERTIL STERIL, V89, P468, DOI 10.1016/j.fertnstert.2007.02.031; Imir AG, 2007, J CLIN ENDOCR METAB, V92, P1979, DOI 10.1210/jc.2006-2482; Ishikawa H, 2009, J CLIN ENDOCR METAB, V94, P1752, DOI 10.1210/jc.2008-2327; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; LaVallee TM, 2008, MOL CANCER THER, V7, P1472, DOI 10.1158/1535-7163.MCT-08-0107; Lee SJ, 2009, MOL ENDOCRINOL, V23, P620, DOI 10.1210/me.2007-0477; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Manavathi B, 2006, P NATL ACAD SCI USA, V103, P15981, DOI 10.1073/pnas.0607445103; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Nisolle M, 1999, HUM REPROD, V14, P2844, DOI 10.1093/humrep/14.11.2844; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Purohit A, 1999, BIOCHEM BIOPH RES CO, V261, P214, DOI 10.1006/bbrc.1999.1010; Reiter-Funk CK, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-16; Salama SA, 2008, INT J CANCER, V123, P1246, DOI 10.1002/ijc.23653; Salama SA, 2006, J SOC GYNECOL INVEST, V13, P542, DOI 10.1016/j.jsgi.2006.09.003; Salama SA, 2009, J CLIN ENDOCR METAB, V94, P285, DOI 10.1210/jc.2008-1389; Shrum CK, 2009, P NATL ACAD SCI USA, V106, P2647, DOI 10.1073/pnas.0806677106; Sourla A, 1996, CANCER RES, V56, P3123; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Sumitani H, 2000, ENDOCRINOLOGY, V141, P3852, DOI 10.1210/en.141.10.3852; Vrzal R, 2008, EUR J PHARMACOL, V581, P244, DOI 10.1016/j.ejphar.2007.11.059; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Yu LD, 2008, MOL MED, V14, P264, DOI 10.2119/2007-00101.Yu	38	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7356	10.1371/journal.pone.0007356	http://dx.doi.org/10.1371/journal.pone.0007356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809499	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594000012
J	Jarve, M; Zhivotovsky, LA; Rootsi, S; Help, H; Rogaev, EI; Khusnutdinova, EK; Kivisild, T; Sanchez, JJ				Jarve, Mari; Zhivotovsky, Lev A.; Rootsi, Siiri; Help, Hela; Rogaev, Evgeny I.; Khusnutdinova, Elza K.; Kivisild, Toomas; Sanchez, Juan J.			Decreased Rate of Evolution in Y Chromosome STR Loci of Increased Size of the Repeat Unit	PLOS ONE			English	Article							GENETIC LEGACY; MUTATION-RATE; EUROPE; POPULATIONS; MARKERS; SPREAD	Background: Polymorphic Y chromosome short tandem repeats (STRs) have been widely used in population genetic and evolutionary studies. Compared to di-, tri-, and tetranucleotide repeats, STRs with longer repeat units occur more rarely and are far less commonly used. Principal Findings: In order to study the evolutionary dynamics of STRs according to repeat unit size, we analysed variation at 24 Y chromosome repeat loci: 1 tri-, 14 tetra-, 7 penta-, and 2 hexanucleotide loci. According to our results, penta- and hexanucleotide repeats have approximately two times lower repeat variance and diversity than tri- and tetranucleotide repeats, indicating that their mutation rate is about half of that of tri- and tetranucleotide repeats. Thus, STR markers with longer repeat units are more robust in distinguishing Y chromosome haplogroups and, in some cases, phylogenetic splits within established haplogroups. Conclusions: Our findings suggest that Y chromosome STRs of increased repeat unit size have a lower rate of evolution, which has significant relevance in population genetic and evolutionary studies.			Jarve, M (corresponding author), Univ Tartu, Dept Evolutionary Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	mari.jarve@ut.ee	Kivisild, Toomas/P-5889-2017; Khusnutdinova, Elza Kamilevna/A-4810-2013; Rogaev, Evgeny/AAN-7662-2020; Zhivotovsky, Lev A/A-1351-2012	Kivisild, Toomas/0000-0002-6297-7808; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; 				de Knijff P, 2000, AM J HUM GENET, V67, P1055; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Ge JY, 2009, FORENSIC SCI INT-GEN, V3, P179, DOI 10.1016/j.fsigen.2009.01.007; Goedbloed M, 2009, INT J LEGAL MED, V123, P471, DOI 10.1007/s00414-009-0342-y; Hanson Erin K., 2006, Legal Medicine, V8, P110, DOI 10.1016/j.legalmed.2005.10.001; Hanson EK, 2006, J FORENSIC SCI, V51, P1298, DOI 10.1111/j.1556-4029.2006.00263.x; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M, 2004, AM J HUM GENET, V74, P1183, DOI 10.1086/421531; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Nei M., 1987, MOL EVOLUTIONARY GEN; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Schlecht J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000093; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; XUE Y, 2009, CURR BIOL; Xue YL, 2005, AM J HUM GENET, V77, P1112, DOI 10.1086/498583; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2000, MOL BIOL EVOL, V17, P757, DOI 10.1093/oxfordjournals.molbev.a026354; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	27	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7276	10.1371/journal.pone.0007276	http://dx.doi.org/10.1371/journal.pone.0007276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789645	Green Published, gold, Green Submitted			2022-12-25	WOS:000270354100024
J	Mo, JR; Mathur, A; Angagaw, M; Zhao, SX; Wang, YX; Gargano, D; DiBacco, A; Bachman, ES				Mo, Jan-Rung; Mathur, Anjili; Angagaw, Minilik; Zhao, Shuxia; Wang, Yuxun; Gargano, Diana; DiBacco, Alessandra; Bachman, Eric S.			Splenectomy Normalizes Hematocrit in Murine Polycythemia Vera	PLOS ONE			English	Article								Splenic enlargement (splenomegaly) develops in numerous disease states, although a specific pathogenic role for the spleen has rarely been described. In polycythemia vera (PV), an activating mutation in Janus kinase 2 (JAK2(V617)) induces splenomegaly and an increase in hematocrit. Splenectomy is sparingly performed in patients with PV, however, due to surgical complications. Thus, the role of the spleen in the pathogenesis of human PV remains unknown. We specifically tested the role of the spleen in the pathogenesis of PV by performing either sham (SH) or splenectomy (SPL) surgeries in a murine model of JAK2(V617F)-driven PV. Compared to SH-operated mice, which rapidly develop high hematocrits after JAK2(V617F) transplantation, SPL mice completely fail to develop this phenotype. Disease burden (JAK2(V617)) is equivalent in the bone marrow of SH and SPL mice, however, and both groups develop fibrosis and osteosclerosis. If SPL is performed after PV is established, hematocrit rapidly declines to normal even though myelofibrosis and osteosclerosis again develop independently in the bone marrow. In contrast, SPL only blunts hematocrit elevation in secondary, erythropoietin-induced polycythemia. We conclude that the spleen is required for an elevated hematocrit in murine, JAK2(V617F)-driven PV, and propose that this phenotype of PV may require a specific interaction between mutant cells and the spleen.			Mo, JR (corresponding author), Merck Res Labs, Dept Oncol Pharmacol, Lab Anim Res & Pharmacol, Boston, MA USA.	eric.bachman@bmc.org		Wang, Yuxun/0000-0002-4252-6102				Agool A, 2006, J NUCL MED, V47, P1592; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Cadili A, 2008, AM J MED, V121, P371, DOI 10.1016/j.amjmed.2008.02.014; Cunningham SC, 2004, AM J SURG, V188, P94, DOI 10.1016/j.amjsurg.2003.11.040; DEHAAN G, 1994, BLOOD, V84, P4157, DOI 10.1182/blood.V84.12.4157.bloodjournal84124157; Gilbert HS, 2003, SEMIN HEMATOL, V40, P26, DOI 10.1053/shem.2003.50031; Hsieh PP, 2007, MODERN PATHOL, V20, P929, DOI 10.1038/modpathol.3800826; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Larsen TS, 2007, EUR J HAEMATOL, V79, P508, DOI 10.1111/j.1600-0609.2007.00960.x; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Mathur A, 2009, BIOCHEM PHARMACOL, V78, P382, DOI 10.1016/j.bcp.2009.04.025; MCDONALD TP, 1992, BLOOD, V80, P352; Mesa RA, 2000, BLOOD REV, V14, P121, DOI 10.1054/blre.2000.0132; Messinezy M, 1997, BRIT J HAEMATOL, V98, P103, DOI 10.1046/j.1365-2141.1997.1552969.x; MORGAN KJ, 2008, ANNU REV MED, V59, P371; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; RAFF RF, 1993, EXP HEMATOL, V21, P385; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Tefferi A, 2003, MAYO CLIN PROC, V78, P174, DOI 10.4065/78.2.174; WASSERMAN LR, 1963, NEW ENGL J MED, V269, P1226, DOI 10.1056/NEJM196312052692302; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200; 1984, CANCER, V54, P333	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7286	10.1371/journal.pone.0007286	http://dx.doi.org/10.1371/journal.pone.0007286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789710	Green Submitted, Green Published, gold			2022-12-25	WOS:000270354100031
J	Durazo, A; Shaw, BF; Chattopadhyay, M; Faull, KF; Nersissian, AM; Valentine, JS; Whitelegge, JP				Durazo, Armando; Shaw, Bryan F.; Chattopadhyay, Madhuri; Faull, Kym F.; Nersissian, Aram M.; Valentine, Joan Selverstone; Whitelegge, Julian P.			Metal-free Superoxide Dismutase-1 and Three Different Amyotrophic Lateral Sclerosis Variants Share a Similar Partially Unfolded beta-Barrel at Physiological Temperature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDE HYDROGEN-EXCHANGE; PANCREATIC TRYPSIN-INHIBITOR; MOLECULAR-WEIGHT COMPLEXES; NUCLEAR MAGNETIC-RESONANCE; MASS-SPECTROMETRY; CU,ZN-SUPEROXIDE DISMUTASE; PROTON-EXCHANGE; PROTEIN; MUTATIONS; DISEASE	The structure and unfolding of metal-free (apo) human wildtype SOD1 and three pathogenic variants of SOD1 (A4V, G93R, and H48Q) that cause familial amyotrophic lateral sclerosis have been studied with amide hydrogen/deuterium exchange and mass spectrometry. The results indicate that a significant proportion of each of these proteins exists in solution in a conformation in which some strands of the beta-barrel (i.e. beta 2) are well protected from exchange at physiological temperature (37 degrees C), whereas other strands (i.e. beta 3 and beta 4) appear to be unprotected from hydrogen/deuterium exchange. Moreover, the thermal unfolding of these proteins does not result in the uniform incorporation of deuterium throughout the polypeptide but involves the local unfolding of different residues at different temperatures. Some regions of the proteins (i.e. the "Greek key" loop, residues 104-116) unfold at a significantly higher temperature than other regions (i.e. beta 3 and beta 4, residues 21-53). Together, these results show that human wild-type apo-SOD1 and variants have a partially unfolded beta-barrel at physiological temperature and unfold non-cooperatively.	[Durazo, Armando; Chattopadhyay, Madhuri; Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Faull, Kym F.; Whitelegge, Julian P.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Shaw, Bryan F.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Nersissian, Aram M.] Occidental Coll, Dept Chem, Los Angeles, CA 90041 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Occidental College	Whitelegge, JP (corresponding author), Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, NPI Semel Inst, POB 42,760 Westwood Plaza, Los Angeles, CA 90024 USA.	jpw@chem.ucla.edu	Shaw, Bryan/A-7001-2008		National Institutes of Health [NS-049134, DK46828, GM28222]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-049134, DK46828, and GM28222.	Anderson JS, 2008, BIOCHEMISTRY-US, V47, P6178, DOI 10.1021/bi800284y; Anderson JS, 2006, BIOPHYS J, V91, pL93, DOI 10.1529/biophysj.106.094219; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Assfalg M, 2003, J MOL BIOL, V330, P145, DOI 10.1016/S0022-2836(03)00533-3; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Bieler S, 2004, CURR DRUG TARGETS, V5, P553; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; KRISHNA NR, 1979, BIOPHYS J, V26, P345, DOI 10.1016/S0006-3495(79)85258-3; KRISHNA NR, 1980, BIOPOLYMERS, V19, P2003, DOI 10.1002/bip.1980.360191106; Lee VMY, 2002, NEUROBIOL AGING, V23, P1039, DOI 10.1016/S0197-4580(02)00121-5; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; WAGNER G, 1979, J MOL BIOL, V134, P75, DOI 10.1016/0022-2836(79)90414-5; WAGNER G, 1978, NATURE, V275, P247, DOI 10.1038/275247a0; WAGNER G, 1982, J MOL BIOL, V160, P343, DOI 10.1016/0022-2836(82)90180-2; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Zhang ZQ, 1996, BIOCHEMISTRY-US, V35, P779, DOI 10.1021/bi952227q	32	35	35	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34382	34389		10.1074/jbc.M109.052076	http://dx.doi.org/10.1074/jbc.M109.052076			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19805550	Green Published, hybrid			2022-12-25	WOS:000272165200068
J	Sharda, S; Koay, MST; Kim, YJ; Engelhard, M; Gartner, W				Sharda, Shivani; Koay, Melissa S. T.; Kim, Young-Jun; Engelhard, Martin; Gaertner, Wolfgang			A Non-hydrolyzable ATP Derivative Generates a Stable Complex in a Light-inducible Two-component System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; FILAMENTOUS CYANOBACTERIUM; PHYTOCHROME; CHROMOPHORE; BACTERIOPHYTOCHROME; DIMERIZATION; BILIVERDIN; PROTEINS; REVEALS	Isothermal calorimetry (ITC) measurements yielded the binding constants during complex formation of light-inducible histidine kinases (HK) and their cognate CheY-type response regulators (RR). HK-RR interactions represent the core function of the bacterial two-component system, which is also present in many bacterial phytochromes. Here, we have studied the recombinant forms of phytochromes CphA and CphB from the cyanobacterium Tolypothrix PCC7601 and their cognate RRs RcpA and RcpB. The interaction between the two reaction partners (HK and RR) was studied in the presence and absence of ATP. A complex formation was observable in the presence of ATP, but specific interactions were only found when a non-hydrolyzable ATP derivative was added to the mixture. Also, the incubation of the HK domain alone (expressed as a recombinant protein) with the RR did not yield specific interactions, indicating that the HK domain is only active as a component of the full-length phytochrome. Considering also previous studies on the same proteins (Hubschmann, T., Jorissen, H. J. M. M., Borner, T., Gartner, W., and de Marsac, N. (2001) Eur. J. Biochem. 268, 3383-3389) we now conclude that the HK domains of these phytochromes are active only when the chromophore domain is in its Pr form. The formerly documented phosphate transfer between the HK domain and the RR takes place via a transiently formed protein-protein complex, which becomes detectable by ITC in the presence of a non-hydrolyzable ATP derivative. This finding is of interest also in relation to the function of some (blue light-sensitive) photoreceptors that carry the HK domain and the RR fused together in one single protein.	[Kim, Young-Jun; Engelhard, Martin] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Sharda, Shivani; Koay, Melissa S. T.; Gaertner, Wolfgang] Max Planck Inst Bioinorgan Chem, D-45413 Mulheim, Germany	Max Planck Society; Max Planck Society	Engelhard, M (corresponding author), Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany.	martin.engelhard@mpi-dortmund.mpg.de; gaertner@mpi-muelheim.mpg.de	Sharda, Shivani/ABI-5086-2020; Koay, Melissa/E-9915-2012	Sharda, Shivani/0000-0002-8838-0823; Gartner, Wolfgang/0000-0002-6898-7011	Helmholtz-Society [VIBS VH-VI-157]; International Max Planck Research School Chemical Biology	Helmholtz-Society(Helmholtz Association); International Max Planck Research School Chemical Biology	This work was supported in part by the Helmholtz-Society (VIBS VH-VI-157, to M. E. and W. G.) and the International Max Planck Research School Chemical Biology (to Y. J. K.).	Benda C, 2004, BIOPHYS J, V87, P476, DOI 10.1529/biophysj.103.033696; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Cao Z, 2008, BIOPHYS J, V94, P897, DOI 10.1529/biophysj.107.108977; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Evans K, 2006, J MOL BIOL, V364, P655, DOI 10.1016/j.jmb.2006.09.045; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Hubschmann T, 2001, EUR J BIOCHEM, V268, P3383, DOI 10.1046/j.1432-1327.2001.02229.x; Hubschmann T, 2001, EUR J BIOCHEM, V268, P2055, DOI 10.1046/j.1432-1327.2001.02083.x; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Jorissen HJMM, 2002, EUR J BIOCHEM, V269, P2662, DOI 10.1046/j.1432-1033.2002.02928.x; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Otto H, 2003, BIOPHYS J, V84, p291A; Pathak GP, 2009, ENVIRON MICROBIOL, V11, P2388, DOI 10.1111/j.1462-2920.2009.01967.x; Quest B, 2004, EUR J BIOCHEM, V271, P1117, DOI 10.1111/j.1432-1033.2004.04015.x; Quest B, 2007, FEBS J, V274, P2088, DOI 10.1111/j.1742-4658.2007.05751.x; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	19	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33999	34004		10.1074/jbc.M109.017772	http://dx.doi.org/10.1074/jbc.M109.017772			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19808667	Green Published, hybrid			2022-12-25	WOS:000272165200032
J	Wendt, MK; Smith, JA; Schiemann, WP				Wendt, Michael K.; Smith, Jason A.; Schiemann, William P.			p130Cas Is Required for Mammary Tumor Growth and Transforming Growth Factor-beta-mediated Metastasis through Regulation of Smad2/3 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER PROGRESSION; TGF-BETA; CELL-PROLIFERATION; GLAND DEVELOPMENT; TUMORIGENESIS; RECEPTOR; MODEL; MECHANISMS; RESISTANCE	During breast cancer progression, transforming growth factor-beta (TGF-beta) switches from tumor suppressor to a prometastatic molecule. Several recent studies suggest that this conversion in TGF-beta function depends upon fundamental changes in the TGF-beta signaling system. We show here that these changes in TGF-beta signaling are concomitant with aberrant expression of the focal adhesion protein, p130Cas. Indeed, elevating expression of either the full-length (FL) or just the carboxyl terminus (CT) of p130Cas in mammary epithelial cells (MECs) diminished the ability of TGF-beta 1 to activate Smad2/3, but increased its coupling to p38 MAPK. This shift in TGF-beta signaling evoked (i) resistance to TGF-beta-induced growth arrest, and (ii) acinar filling upon three-dimensional organotypic cultures of p130Cas-FL or -CT expressing MECs. Furthermore, rendering metastatic MECs deficient in p130Cas enhanced TGF-beta-stimulated Smad2/3 activity, which restored TGF-beta-induced growth inhibition both in vitro and in mammary tumors produced in mice. Additionally, whereas elevating T beta R-II expression in metastatic MECs had no affect on their phosphorylation of Smad2/3, this event markedly enhanced their activation of p38 MAPK, leading to increased MEC invasion and metastasis. Importantly, depleting p130Cas expression in T beta R-II-expressing metastatic MECs significantly increased their activation of Smad2/3, which (i) reestablished the physiologic balance between canonical and noncanonical TGF-beta signaling, and (ii) reversed cellular invasion and early mammary tumor cell dissemination stimulated by TGF-beta. Collectively, our findings identify p130Cas as a molecular rheostat that regulatesthedelicatebalancebetweencanonicalandnoncanonical TGF-beta signaling, a balance that is critical to maintaining the tumor suppressor function of TGF-beta during breast cancer progression.	[Wendt, Michael K.; Smith, Jason A.; Schiemann, William P.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Schiemann, WP (corresponding author), Univ Colorado Denver, Anschutz Med Campus,RC1 S Tower,Rm L18-6110,1280, Aurora, CO 80045 USA.	Bill.Schiemann@ucdenver.edu		Wendt, Mike/0000-0002-3665-7413	National Institutes of Health [CA129359]; Komen Foundation [BCTR0706967]; Department of Defense [BC084651]; American Cancer Society [PF-09-120-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA129359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129359, Komen Foundation Grant BCTR0706967, Department of Defense Grant BC084651 (to W. P. S.), and American Cancer Society Grant PF-09-120-01-CSM (to M. K. W.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Benson JR, 2004, LANCET ONCOL, V5, P229, DOI 10.1016/S1470-2045(04)01426-3; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Chen RH, 1997, CELL GROWTH DIFFER, V8, P821; Dawson PJ, 1996, AM J PATHOL, V148, P313; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Geiger B, 2006, CELL, V127, P879, DOI 10.1016/j.cell.2006.11.020; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Ingman WV, 2008, BIOL REPROD, V79, P711, DOI 10.1095/biolreprod.107.067272; Jin W, 2007, ONCOGENE, V26, P7684, DOI 10.1038/sj.onc.1210571; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim W, 2008, MOL BIOL CELL, V19, P2135, DOI 10.1091/mbc.E07-10-0991; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Neil JR, 2008, CARCINOGENESIS, V29, P2227, DOI 10.1093/carcin/bgn202; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Schiemann WP, 2007, EXPERT REV ANTICANC, V7, P609, DOI 10.1586/14737140.7.5.609; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; SILBERSTEIN GB, 1987, SCIENCE, V237, P291, DOI 10.1126/science.3474783; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Ta HQ, 2008, CANCER RES, V68, P8796, DOI 10.1158/0008-5472.CAN-08-2426; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; van der Flier S, 2000, INT J CANCER, V89, P465, DOI 10.1002/1097-0215(20000920)89:5<465::AID-IJC11>3.0.CO;2-O; Wakefield LM, 2001, J MAMMARY GLAND BIOL, V6, P67, DOI 10.1023/A:1009568532177; Weaver VM, 1996, BIOCHEM CELL BIOL, V74, P833, DOI 10.1139/o96-089; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoshida BA, 2000, JNCI-J NATL CANCER I, V92, P1717, DOI 10.1093/jnci/92.21.1717	44	48	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34145	34156		10.1074/jbc.M109.023614	http://dx.doi.org/10.1074/jbc.M109.023614			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19822523	Green Published, hybrid			2022-12-25	WOS:000272165200047
J	Long, X; Tharp, DL; Georger, MA; Slivano, OJ; Lee, MY; Wamhoff, BR; Bowles, DK; Miano, JM				Long, Xiaochun; Tharp, Darla L.; Georger, Mary A.; Slivano, Orazio J.; Lee, Monica Y.; Wamhoff, Brian R.; Bowles, Douglas K.; Miano, Joseph M.			The Smooth Muscle Cell-restricted KCNMB1 Ion Channel Subunit Is a Direct Transcriptional Target of Serum Response Factor and Myocardin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNEL; GENE-EXPRESSION; MAXIK CHANNEL; LARGE-CONDUCTANCE; PHENOTYPIC MODULATION; FORCED EXPRESSION; BETA-1 SUBUNIT; CALPONIN GENE; UP-REGULATION	Large conductance calcium-activated potassium (MaxiK) channels play a pivotal role in maintaining normal arterial tone by regulating the excitation-contraction coupling process. MaxiK channels comprise alpha and beta subunits encoded by Kcnma and the cell-restricted Kcnmb genes, respectively. Although the functionality of MaxiK channel subunits has been well studied, the molecular regulation of their transcription and modulation in smooth muscle cells (SMCs) is incomplete. Using several model systems, we demonstrate down-regulation of Kcnmb1 mRNA upon SMC phenotypic modulation in vitro and in vivo. As part of a broad effort to define all functional CArG elements in the genome (i.e. the CArGome), we discovered two conserved CArG boxes located in the proximal promoter and first intron of the human KCNMB1 gene. Gel shift and chromatin immunoprecipitation assays confirmed serum response factor (SRF) binding to both CArG elements. A luciferase assay showed myocardin (MYOCD)-mediated transactivation of the KCNMB1 promoter in a CArG element-dependent manner. In vivo analysis of the human KCNMB1 promoter disclosed activity in embryonic heart and aortic SMCs; mutation of both conserved CArG elements completely abolished in vivo promoter activity. Forced expression of MYOCD increased Kcnmb1 expression in a variety of rodent and human non-SMC lines with no effect on expression of the Kcnma1 subunit. Conversely, knockdown of Srf resulted in decreases of endogenous Kcnmb1. Functional studies demonstrated MYOCD-induced, iberiotoxin-sensitive potassium currents in porcine coronary SMCs. These results reveal the first ion channel subunit as a direct target of SRF-MYOCD transactivation, providing further insight into the role of MYOCD as a master regulator of the SMC contractile phenotype.	[Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Tharp, Darla L.; Bowles, Douglas K.] Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA; [Lee, Monica Y.; Wamhoff, Brian R.] Univ Virginia, Dept Med, Div Cardiovasc, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	University of Rochester; University of Missouri System; University of Missouri Columbia; University of Virginia	Miano, JM (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Box CVRI,601 Elmwood Ave, Rochester, NY 14642 USA.	j.m.miano@rochester.edu	; Miano, Joseph/L-5634-2018	Bowles, Doug/0000-0003-2043-7368; Miano, Joseph/0000-0001-7522-3207; Long, Xiaochun/0000-0001-9714-0023	National Institutes of Health [HL62572, HL091168, HL52490, HL079934, HL081682]; American Heart Association [0535002N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL062572, K02HL079934, R01HL081682, P01HL052490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62572 and HL091168 (to J. M. M.), HL52490 and HL079934 (to D. K. B.), and HL081682 (to B. R. W.). This work was also supported by American Heart Association Scientist Development Grant 0535002N (to B. R. W.).	Amberg GC, 2003, J CLIN INVEST, V112, P717, DOI 10.1172/JC1200318684; Baker DL, 1998, NUCLEIC ACIDS RES, V26, P1092, DOI 10.1093/nar/26.4.1092; Barlow CA, 2006, J PHYSIOL-LONDON, V570, P59, DOI 10.1113/jphysiol.2005.098426; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; CAMPBELL GR, 1985, EXP MOL PATHOL, V42, P139, DOI 10.1016/0014-4800(85)90023-1; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chang WM, 2000, J BIOL CHEM, V275, P3991, DOI 10.1074/jbc.275.6.3991; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dhulipala PDK, 1999, BBA-GENE STRUCT EXPR, V1444, P254, DOI 10.1016/S0167-4781(98)00276-0; Fan QI, 2002, BBA-GENE STRUCT EXPR, V1577, P401, DOI 10.1016/S0167-4781(02)00441-4; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Gollasch M, 1998, FASEB J, V12, P593, DOI 10.1096/fasebj.12.7.593; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kraner SD, 1999, J BIOL CHEM, V274, P8129, DOI 10.1074/jbc.274.12.8129; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Kundu P, 2007, J BIOL CHEM, V282, P27478, DOI 10.1074/jbc.M704777200; Kuratomi S, 2009, CARDIOVASC RES, V83, P682, DOI 10.1093/cvr/cvp171; Larsson E, 2008, MOL GENET GENOMICS, V280, P127, DOI 10.1007/s00438-008-0349-y; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Mack CP, 1999, CIRC RES, V84, P852; McGahon Mary K, 2007, Channels (Austin), V1, P141; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2004, CIRC RES, V95, P340, DOI 10.1161/01.RES.0000140893.16465.2d; Miano JM, 2001, MAMM GENOME, V12, P187, DOI 10.1007/s003350010266; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Nishimaru K, 2004, J PHYSIOL-LONDON, V559, P849, DOI 10.1113/jphysiol.2004.068676; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Quignard JF, 2001, CARDIOVASC RES, V49, P177, DOI 10.1016/S0008-6363(00)00210-8; Rene C, 2005, NUCLEIC ACIDS RES, V33, P5271, DOI 10.1093/nar/gki837; Saada N, 2003, BIOCHEM BIOPH RES CO, V302, P23, DOI 10.1016/S0006-291X(03)00097-4; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tanaka Y, 2004, J PHARMACOL SCI, V94, P339, DOI 10.1254/jphs.94.339; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Thorneloe KS, 2005, CAN J PHYSIOL PHARM, V83, P215, DOI 10.1139/Y05-016; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Woodman L, 2008, J IMMUNOL, V181, P5001, DOI 10.4049/jimmunol.181.7.5001; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Zhang XY, 2009, GENE, V438, P33, DOI 10.1016/j.gene.2009.03.001; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200	69	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33671	33682		10.1074/jbc.M109.050419	http://dx.doi.org/10.1074/jbc.M109.050419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19801679	Green Published, hybrid			2022-12-25	WOS:000272028500071
J	Araki, K; Shimura, T; Yajima, T; Tsutsumi, S; Suzuki, H; Okada, K; Kobayashi, T; Raz, A; Kuwano, H				Araki, Kenichiro; Shimura, Tatsuo; Yajima, Toshiki; Tsutsumi, Soichi; Suzuki, Hideki; Okada, Kohji; Kobayashi, Tsutomu; Raz, Avraham; Kuwano, Hiroyuki			Phosphoglucose Isomerase/Autocrine Motility Factor Promotes Melanoma Cell Migration through ERK Activation Dependent on Autocrine Production of Interleukin-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; MESSENGER-RNA EXPRESSION; PROTEIN-KINASE; GENE-EXPRESSION; DOWN-REGULATION; CANCER CELLS; NUDE-MICE; IN-VITRO; IL-8; INDUCTION	It is well known that phosphoglucose isomerase/autocrine motility factor (AMF) promotes cell migration in an autocrine manner in various tumor cells. However, it remains unclear whether certain cytokines modulate the effects of AMF on tumor cell migration. Because interleukin (IL)-8, a proinflammatory cytokine, is produced by melanoma cells and has been correlated with melanoma migration, the migratory ability of melanoma cells induced by AMF may also involve induction of IL-8 expression. In the present study, we assessed whether AMF promotes melanoma cell migration through autocrine production of IL-8. We found that AMF stimulation increased IL-8 production through up-regulation of IL-8 mRNA transcription, especially in biologically early stage melanoma cells. AMF-induced migration of these cells was inhibited by a specific neutralizing antibody against IL-8. The IL-8 production induced by AMF was mediated by the ERK1/2 pathways. These findings suggest that melanoma migration induced by AMF is mediated by autocrine production of IL-8 as a novel downstream modulator of the AMF signaling pathway.	[Araki, Kenichiro; Shimura, Tatsuo; Yajima, Toshiki; Tsutsumi, Soichi; Suzuki, Hideki; Okada, Kohji; Kobayashi, Tsutomu; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, Gunma, Japan; [Raz, Avraham] Wayne State Univ, Karmanos Canc Inst, Dept Tumor Progress & Metastasis, Detroit, MI 48201 USA	Gunma University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Araki, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, 3-39-22 Showa Machi, Gunma, Japan.	karaki@showa.gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); NATIONAL CANCER INSTITUTE [R01CA051714] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and the Support Program for Improving Graduate School Education from MEXT.	Abdel-Malak NA, 2008, BLOOD, V111, P4145, DOI 10.1182/blood-2007-08-110338; ACHARI A, 1981, PHILOS T ROY SOC B, V293, P145, DOI 10.1098/rstb.1981.0068; Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; COLOMBO MP, 1992, MELANOMA RES, V2, P181, DOI 10.1097/00008390-199209000-00006; DEFORGE LE, 1993, J BIOL CHEM, V268, P25568; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; Funasaka T, 2002, INT J CANCER, V101, P217, DOI 10.1002/ijc.10617; Funasaka T, 2007, CANCER RES, V67, P4236, DOI 10.1158/0008-5472.CAN-06-3935; Furuya M, 2004, J PATHOL, V203, P551, DOI 10.1002/path.1543; Haga A, 2003, INT J CANCER, V107, P707, DOI 10.1002/ijc.11449; Haga A, 2000, BBA-PROTEIN STRUCT M, V1480, P235, DOI 10.1016/S0167-4838(00)00075-3; HERLYN M, 1985, CANCER RES, V45, P5670; Hobbie S, 1997, J IMMUNOL, V159, P5550; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; JUHASZ I, 1993, AM J PATHOL, V143, P528; KASAHARA T, 1991, IMMUNOLOGY, V74, P60; KOHN EC, 1990, BIOCHEM BIOPH RES CO, V166, P757, DOI 10.1016/0006-291X(90)90874-M; LIOTTA LA, 1986, P NATL ACAD SCI USA, V83, P3302, DOI 10.1073/pnas.83.10.3302; LUSCINSKAS FW, 1992, J IMMUNOL, V149, P2163; Neudauer CL, 2003, EXP CELL RES, V286, P128, DOI 10.1016/S0014-4827(03)00049-1; Norgauer J, 1996, J IMMUNOL, V156, P1132; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Satyamoorthy K, 2002, CELL GROWTH DIFFER, V13, P87; SCHADENDORF D, 1993, J IMMUNOL, V151, P2667; Schaider H, 2003, INT J CANCER, V103, P335, DOI 10.1002/ijc.10775; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Shimoda K, 1998, HEPATOLOGY, V28, P108, DOI 10.1002/hep.510280116; SILLETTI S, 1991, CANCER RES, V51, P3507; SINGH RK, 1994, CANCER RES, V54, P3242; Sonoda Y, 1997, J BIOL CHEM, V272, P15366, DOI 10.1074/jbc.272.24.15366; STRACKE ML, 1989, J BIOL CHEM, V264, P21544; STRACKE ML, 1988, BIOCHEM BIOPH RES CO, V153, P1076, DOI 10.1016/S0006-291X(88)81338-X; Tikhonov I, 2001, CLIN EXP IMMUNOL, V125, P414, DOI 10.1046/j.1365-2249.2001.01626.x; Timar J, 1996, CANCER RES, V56, P1902; Tsutsumi S, 2004, CLIN CANCER RES, V10, P7775, DOI 10.1158/1078-0432.CCR-04-1015; Tsutsumi S, 2003, J BIOL CHEM, V278, P32165, DOI 10.1074/jbc.M304537200; Tsutsumi S, 2002, CANCER RES, V62, P4484; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; VERSCHRAEGEN CF, 1991, ANTICANCER RES, V11, P529; WANG JM, 1990, BIOCHEM BIOPH RES CO, V169, P165, DOI 10.1016/0006-291X(90)91449-3; Watanabe H, 1996, CANCER RES, V56, P2960; Wigmore SJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE720, DOI 10.1152/ajpendo.1997.273.4.E720	44	21	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32305	32311		10.1074/jbc.M109.008250	http://dx.doi.org/10.1074/jbc.M109.008250			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19801670	Green Published, hybrid			2022-12-25	WOS:000272028400012
J	Jagannathan, I; Ichikawa, HT; Kruger, T; Fay, PJ				Jagannathan, Indu; Ichikawa, H. Travis; Kruger, Tricia; Fay, Philip J.			Identification of Residues in the 558-Loop of Factor VIIIa A2 Subunit That Interact with Factor IXa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	22nd Congress of the International-Society-on-Thrombosis-and-Haemostasis	JUL 11-17, 2009	Boston, MA	Int Soc Thrombosis & Haemostasis			PORCINE FACTOR-VIII; ACTIVATED PROTEIN-C; A1/A3-C1-C2 DIMER; FACTOR XASE; FACTOR-X; BINDING-SITE; RECONSTITUTION; PROTEOLYSIS; A2-SUBUNIT; CLEAVAGE	Factor VIIIa is comprised of A1, A2, and A3C1C2 subunits. Several lines of evidence have identified the A2 558-loop as interacting with factor IXa. The contributions of individual residues within this region to inter-protein affinity and cofactor activity were assessed following alanine scanning mutagenesis of residues 555-571 that border or are contained within the loop. Variants were expressed as isolated A2 domains in Sf9 cells using a baculovirus construct and purified to >90%. Two reconstitution assays were employed to determine affinity and activity parameters. The first assay reconstituted factor Xase using varying concentrations of A2 mutant and fixed levels of A1/A3C1C2 dimer purified from wild type (WT), baby hamster kidney cell-expressed factor VIII, factor IXa, and phospholipid vesicles to determine the inter-molecular K-d for A2. The second assay determined the K-d for A2 in factor VIIIa by reconstituting various A2 and fixed levels of A1/A3C1C2. Parameter values were determined by factor Xa generation assays. WT A2 expressed in insect cells yielded similar K-d and k(cat) values following reconstitution as WT A2 purified from baby hamster kidney cell-expressed factor VIII. All A2 variants exhibited modest if any increases in K-d values for factor VIIIa assembly. However, variants S558A, V559A, D560A, G563A, and I566A showed >9-fold increases in K-d for factor Xase assembly, implicating these residues in stabilizing A2 association with factor IXa. Furthermore, variants Y555A, V559A, D560A, G563A, I566A, and D569A showed >80% reduction in k(cat) for factor Xa generation. These results identify residues in the 558-loop critical to interaction with factor IXa in Xase.	[Fay, Philip J.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	Philip_Fay@urmc.rochester.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076213, R01HL038199] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38199, R01 HL076213, HL76213, R01 HL038199] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bajaj SP, 2001, J BIOL CHEM, V276, P16302, DOI 10.1074/jbc.M011680200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DUFFY EJ, 1992, J BIOL CHEM, V267, P7821; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; Fay PJ, 2005, BLOOD REV, V19, P15, DOI 10.1016/j.blre.2004.02.003; FAY PJ, 1994, J BIOL CHEM, V269, P20522; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Jenkins PV, 2004, BIOCHEMISTRY-US, V43, P5094, DOI 10.1021/bi036289p; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; LAMPHEAR BJ, 1992, J BIOL CHEM, V267, P3725; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1984, BLOOD, V63, P1303; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; MUTUCUMARANA VP, 1992, J BIOL CHEM, V267, P17012; Newell JL, 2009, J BIOL CHEM, V284, P11080, DOI 10.1074/jbc.M900234200; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; REGAN LM, 1994, J BIOL CHEM, V269, P9445; Sarafanov AG, 2006, BIOCHEMISTRY-US, V45, P1829, DOI 10.1021/bi0520380; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0	30	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32248	32255		10.1074/jbc.M109.050781	http://dx.doi.org/10.1074/jbc.M109.050781			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	522VR	19801661	Green Published, hybrid			2022-12-25	WOS:000272028400005
J	Jimenez, RH; Boylan, JM; Lee, JS; Francesconi, M; Castellani, G; Sanders, JA; Gruppuso, PA				Jimenez, Rosa H.; Boylan, Joan M.; Lee, Ju-Seog; Francesconi, Mirko; Castellani, Gastone; Sanders, Jennifer A.; Gruppuso, Philip A.			Rapamycin Response in Tumorigenic and Non-Tumorigenic Hepatic Cell Lines	PLOS ONE			English	Article							RAT-LIVER; HEPATOCELLULAR CANCER; MTOR; GROWTH; TRANSCRIPTION; TARGET; PHOSPHORYLATION; PROLIFERATION; TRANSLATION; DOWNSTREAM	Background: The mTOR inhibitor rapamycin has anti-tumor activity across a variety of human cancers, including hepatocellular carcinoma. However, resistance to its growth inhibitory effects is common. We hypothesized that hepatic cell lines with varying rapamycin responsiveness would show common characteristics accounting for resistance to the drug. Methodology/Principal Findings: We profiled a total of 13 cell lines for rapamycin-induced growth inhibition. The non-tumorigenic rat liver epithelial cell line WB-F344 was highly sensitive while the tumorigenic WB311 cell line, originally derived from the WB-F344 line, was highly resistant. The other 11 cell lines showed a wide range of sensitivities. Rapamycin induced inhibition of cyclin E-dependent kinase activity in some cell lines, but the ability to do so did not correlate with sensitivity. Inhibition of cyclin E-dependent kinase activity was related to incorporation of p27(Kip1) into cyclin E-containing complexes in some but not all cell lines. Similarly, sensitivity of global protein synthesis to rapamycin did not correlate with its anti-proliferative effect. However, rapamycin potently inhibited phosphorylation of two key substrates, ribosomal protein S6 and 4E-BP1, in all cases, indicating that the locus of rapamycin resistance was downstream from inhibition of mTOR Complex 1. Microarray analysis did not disclose a unifying mechanism for rapamycin resistance, although the glycolytic pathway was downregulated in all four cell lines studied. Conclusions/Significance: We conclude that the mechanisms of rapamycin resistance in hepatic cells involve alterations of signaling downstream from mTOR and that the mechanisms are highly heterogeneous, thus predicting that maintaining or promoting sensitivity will be highly challenging.			Jimenez, RH (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA.	Philip_Gruppuso@brown.edu	francesconi, mirko/O-8080-2015; Castellani, Gastone c/L-3333-2017; Lee, Ju-Seog/X-1786-2018	francesconi, mirko/0000-0002-8702-0877; Castellani, Gastone c/0000-0003-4892-925X; Lee, Ju-Seog/0000-0002-5666-9753; Sanders, Jennifer/0000-0002-4714-5114	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD024455] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035831] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER; NCRR NIH HHS [P20RR017695, P20 RR017695] Funding Source: Medline; NICHD NIH HHS [R01HD24455, R01 HD024455, R01HD35831, R01 HD035831, F31 HD041893] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Anand P, 2006, J NUTR, V136, P27, DOI 10.1093/jn/136.1.27; Baba HA, 2009, LIVER INT, V29, P399, DOI 10.1111/j.1478-3231.2008.01798.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boylan JM, 2005, BIOCHEM BIOPH RES CO, V330, P722, DOI 10.1016/j.bbrc.2005.03.042; Boylan JM, 2001, J BIOL CHEM, V276, P44457, DOI 10.1074/jbc.M103457200; Campbell WA, 2000, J BIOL CHEM, V275, P5347, DOI 10.1074/jbc.275.8.5347; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; CURRAN TR, 1993, EXP CELL RES, V209, P53, DOI 10.1006/excr.1993.1284; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Francesconi M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S9; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gruppuso PA, 2005, PEDIATR RES, V57, P185, DOI 10.1203/01.PDR.0000151646.55587.0F; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heuer M, 2009, TRANSPL P, V41, P359, DOI 10.1016/j.transproceed.2008.10.090; Hixson DC, 2000, EXP MOL PATHOL, V68, P152, DOI 10.1006/exmp.2000.2302; HIXSON DC, 1985, CANCER RES, V45, P3742; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang YP, 2001, J BIOL CHEM, V276, P10943, DOI 10.1074/jbc.M007758200; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; LEE LW, 1989, AM J PATHOL, V135, P63; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; PANASYUK G, 2009, J BIOL CHEM; PITOT H. C., 1964, NAT CANCER INST MONOGR, V13, P229; Riemenschneider MJ, 2006, CANCER RES, V66, P5618, DOI 10.1158/0008-5472.CAN-06-0364; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarsour EH, 2005, J BIOL CHEM, V280, P18033, DOI 10.1074/jbc.M501939200; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Treiber G, 2009, EXPERT REV ANTICANC, V9, P247, DOI 10.1586/14737140.9.2.247; TSAO MS, 1985, CANCER RES, V45, P5139; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang W, 2009, DIGEST DIS SCI, V54, P2128, DOI 10.1007/s10620-008-0605-3; Wang Z, 2009, J CANCER RES CLIN, V135, P715, DOI 10.1007/s00432-008-0506-z; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; ZHOU L, 2009, MED ONCOL	48	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7373	10.1371/journal.pone.0007373	http://dx.doi.org/10.1371/journal.pone.0007373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816606	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594300007
J	Das, H; George, JC; Joseph, M; Das, M; Abdulhameed, N; Blitz, A; Khan, M; Sakthivel, R; Mao, HQ; Hoit, BD; Kuppusamy, P; Pompili, VJ				Das, Hiranmoy; George, Jon C.; Joseph, Matthew; Das, Manjusri; Abdulhameed, Nasreen; Blitz, Anna; Khan, Mahmood; Sakthivel, Ramasamy; Mao, Hai-Quan; Hoit, Brian D.; Kuppusamy, Periannan; Pompili, Vincent J.			Stem Cell Therapy with Overexpressed VEGF and PDGF Genes Improves Cardiac Function in a Rat Infarct Model	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; REDUCED NEOVASCULARIZATION CAPACITY; CORONARY-ARTERY; ISCHEMIC-HEART; GROWTH-FACTOR; BLOOD; ANGIOGENESIS; TRANSPLANTATION; EXPANSION; CONTRIBUTES	Background: Therapeutic potential was evaluated in a rat model of myocardial infarction using nanofiber-expanded human cord blood derived hematopoietic stem cells (CD133+/CD34+) genetically modified with VEGF plus PDGF genes (VIP). Methods and Findings: Myocardial function was monitored every two weeks up to six weeks after therapy. Echocardiography revealed time dependent improvement of left ventricular function evaluated by M-mode, fractional shortening, anterior wall tissue velocity, wall motion score index, strain and strain rate in animals treated with VEGF plus PDGF overexpressed stem cells (VIP) compared to nanofiber expanded cells (Exp), freshly isolated cells (FCB) or media control (Media). Improvement observed was as follows: VIP. Exp. FCB. media. Similar trend was noticed in the exercise capacity of rats on a treadmill. These findings correlated with significantly increased neovascularization in ischemic tissue and markedly reduced infarct area in animals in the VIP group. Stem cells in addition to their usual homing sites such as lung, spleen, bone marrow and liver, also migrated to sites of myocardial ischemia. The improvement of cardiac function correlated with expression of heart tissue connexin 43, a gap junctional protein, and heart tissue angiogenesis related protein molecules like VEGF, pNOS3, NOS2 and GSK3. There was no evidence of upregulation in the molecules of oncogenic potential in genetically modified or other stem cell therapy groups. Conclusion: Regenerative therapy using nanofiber-expanded hematopoietic stem cells with overexpression of VEGF and PDGF has a favorable impact on the improvement of rat myocardial function accompanied by upregulation of tissue connexin 43 and pro-angiogenic molecules after infarction.			Das, H (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	hiranmoy.das@osumc.edu	Das, Hiranmoy/R-7452-2019	Khan, Mahmood/0000-0003-3430-374X; Das, Hiranmoy/0000-0002-3343-0096; Mao, Hai-Quan/0000-0002-4262-9988	NIAMS NIH HHS [K01 AR054114] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054114] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bartunek J, 2005, CIRCULATION, V112, pI178, DOI 10.1161/CIRCULATIONAHA.104.522292; Brown JA, 2008, CLIN IMMUNOL, V127, P286, DOI 10.1016/j.clim.2008.02.008; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Das H, 2004, J IMMUNOL, V172, P6578, DOI 10.4049/jimmunol.172.11.6578; Das H, 2009, CELL TRANSPLANT, V18, P305, DOI 10.3727/096368909788534870; Erbs S, 2005, CIRC RES, V97, P756, DOI 10.1161/01.RES.0000185811.71306.8b; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Feigenbaum H, 1993, Int J Card Imaging, V9 Suppl 2, P55, DOI 10.1007/BF01143180; Giordano FJ, 1996, NAT MED, V2, P534, DOI 10.1038/nm0596-534; Gluckman, 1997, Oncologist, V2, P340; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; Hao XJ, 2004, BIOCHEM BIOPH RES CO, V322, P292, DOI 10.1016/j.bbrc.2004.07.101; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; HOCHMAN JS, 1987, CIRCULATION, V75, P299, DOI 10.1161/01.CIR.75.1.299; Ibukiyama C, 1996, JPN HEART J, V37, P285; Kalka C, 2000, CIRC RES, V86, P1198, DOI 10.1161/01.RES.86.12.1198; Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483; Kawamoto A, 2001, CIRCULATION, V103, P634; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kinnunen K, 2006, ACTA PHYSIOL, V187, P447, DOI 10.1111/j.1748-1716.2006.01588.x; Kobayashi T, 2000, J SURG RES, V89, P189, DOI 10.1006/jsre.2000.5828; KRAUSGRILL B, 2009, CELL TRANSP IN PRESS; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038; Leor J, 2006, STEM CELLS, V24, P772, DOI 10.1634/stemcells.2005-0212; Li ML, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-5; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Morgan EE, 2004, AM J PHYSIOL-HEART C, V287, pH2049, DOI 10.1152/ajpheart.00393.2004; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Reffelmann T, 2009, J AM COLL CARDIOL, V53, P305, DOI 10.1016/j.jacc.2008.10.018; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Singh S, 2009, CLIN CARDIOL, V32, P176, DOI 10.1002/clc.20470; Stamm C, 2004, THORAC CARDIOV SURG, V52, P127, DOI 10.1055/s-2004-817978; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Symes JF, 1999, ANN THORAC SURG, V68, P830, DOI 10.1016/S0003-4975(99)00807-3; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Tse W, 2008, CURR OPIN HEMATOL, V15, P279, DOI 10.1097/MOH.0b013e328304ae2c; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Vale PR, 2000, CIRCULATION, V102, P965, DOI 10.1161/01.CIR.102.9.965; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; WHITE HD, 1994, CIRCULATION, V89, P61, DOI 10.1161/01.CIR.89.1.61; Wu KH, 2009, J CELL BIOCHEM, V107, P926, DOI 10.1002/jcb.22193	50	80	87	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7325	10.1371/journal.pone.0007325	http://dx.doi.org/10.1371/journal.pone.0007325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809493	Green Published, gold, Green Submitted			2022-12-25	WOS:000270594000007
J	Lindfors, E; Gopalacharyulu, PV; Halperin, E; Oresic, M				Lindfors, Erno; Gopalacharyulu, Peddinti V.; Halperin, Eran; Oresic, Matej			Detection of Molecular Paths Associated with Insulitis and Type 1 Diabetes in Non-Obese Diabetic Mouse	PLOS ONE			English	Article								Recent clinical evidence suggests important role of lipid and amino acid metabolism in early pre-autoimmune stages of type 1 diabetes pathogenesis. We study the molecular paths associated with the incidence of insulitis and type 1 diabetes in the Non-Obese Diabetic (NOD) mouse model using available gene expression data from the pancreatic tissue from young prediabetic mice. We apply a graph-theoretic approach by using a modified color coding algorithm to detect optimal molecular paths associated with specific phenotypes in an integrated biological network encompassing heterogeneous interaction data types. In agreement with our recent clinical findings, we identified a path downregulated in early insulitis involving dihydroxyacetone phosphate acyltransferase (DHAPAT), a key regulator of ether phospholipid synthesis. The pathway involving serine/threonine-protein phosphatase (PP2A), an upstream regulator of lipid metabolism and insulin secretion, was found upregulated in early insulitis. Our findings provide further evidence for an important role of lipid metabolism in early stages of type 1 diabetes pathogenesis, as well as suggest that such dysregulation of lipids and related increased oxidative stress can be tracked to beta cells.			Lindfors, E (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	matej.oresic@vtt.fi	Peddinti, Gopal/G-4872-2016; Oresic, Matej/K-7673-2016; Oresic, Matej/AAV-3978-2020	Peddinti, Gopal/0000-0002-8767-968X; Oresic, Matej/0000-0002-2856-9165; 				Achenbach P, 2005, DIABETES, V54, pS25, DOI 10.2337/diabetes.54.suppl_2.S25; ALON N, 1995, J ASSOC COMPUT MACH, V42, P844, DOI 10.1145/210332.210337; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; BARRETT T, 2008, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKN1764; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Crispin JC, 2008, TRENDS IMMUNOL, V29, P110, DOI 10.1016/j.it.2007.12.003; Ewens KG, 2002, DIABETES, V51, P3318, DOI 10.2337/diabetes.51.11.3318; Futschik ME, 2007, BIOINFORMATICS, V23, P605, DOI 10.1093/bioinformatics/btl683; Gopalacharyulu PV, 2008, INT J DATA MIN BIOIN, V2, P54, DOI 10.1504/IJDMB.2008.016756; Gopalacharyulu PV, 2005, BIOINFORMATICS, V21, pI177, DOI 10.1093/bioinformatics/bti1015; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Hulbert EM, 2007, NUCLEIC ACIDS RES, V35, pD742, DOI 10.1093/nar/gkl933; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krull M, 2006, NUCLEIC ACIDS RES, V34, pD546, DOI 10.1093/nar/gkj107; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lee TC, 1998, BBA-LIPID LIPID MET, V1394, P129, DOI 10.1016/S0005-2760(98)00107-6; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lubert EJ, 2001, J BIOL CHEM, V276, P38582, DOI 10.1074/jbc.M106906200; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Notkins AL, 2001, J CLIN INVEST, V108, P1247, DOI 10.1172/JCI200114257; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; PARAMESWARA VK, 2005, JOP, V8, P303; Puigserver P, 2006, NAT MED, V12, P38, DOI 10.1038/nm0106-38; R Core Team, 2022, R LANG ENV STAT COMP; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scott J, 2006, J COMPUT BIOL, V13, P133, DOI 10.1089/cmb.2006.13.133; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Vukkadapu SS, 2005, PHYSIOL GENOMICS, V21, P201, DOI 10.1152/physiolgenomics.00173.2004; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769; Zoeller RA, 2002, AM J PHYSIOL-HEART C, V283, pH671, DOI 10.1152/ajpheart.00524.2001	41	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7323	10.1371/journal.pone.0007323	http://dx.doi.org/10.1371/journal.pone.0007323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798418	Green Published, gold			2022-12-25	WOS:000270593300014
J	Harris, S; Kaplan, JT; Curiel, A; Bookheimer, SY; Iacoboni, M; Cohen, MS				Harris, Sam; Kaplan, Jonas T.; Curiel, Ashley; Bookheimer, Susan Y.; Iacoboni, Marco; Cohen, Mark S.			The Neural Correlates of Religious and Nonreligious Belief	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CORTICAL MIDLINE STRUCTURES; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; PRELIMINARY SPECT; BRAIN-FUNCTION; SELF; FMRI; MEDITATION; OPTIMIZATION	Background: While religious faith remains one of the most significant features of human life, little is known about its relationship to ordinary belief at the level of the brain. Nor is it known whether religious believers and nonbelievers differ in how they evaluate statements of fact. Our lab previously has used functional neuroimaging to study belief as a general mode of cognition [1], and others have looked specifically at religious belief [2]. However, no research has compared these two states of mind directly. Methodology/Principal Findings: We used functional magnetic resonance imaging (fMRI) to measure signal changes in the brains of thirty subjects-fifteen committed Christians and fifteen nonbelievers-as they evaluated the truth and falsity of religious and nonreligious propositions. For both groups, and in both categories of stimuli, belief (judgments of "true'' vs judgments of "false'') was associated with greater signal in the ventromedial prefrontal cortex, an area important for self-representation [3,4,5,6], emotional associations [7], reward [8,9,10], and goal-driven behavior [11]. This region showed greater signal whether subjects believed statements about God, the Virgin Birth, etc. or statements about ordinary facts. A comparison of both stimulus categories suggests that religious thinking is more associated with brain regions that govern emotion, self-representation, and cognitive conflict, while thinking about ordinary facts is more reliant upon memory retrieval networks. Conclusions/Significance: While religious and nonreligious thinking differentially engage broad regions of the frontal, parietal, and medial temporal lobes, the difference between belief and disbelief appears to be content-independent. Our study compares religious thinking with ordinary cognition and, as such, constitutes a step toward developing a neuropsychology of religion. However, these findings may also further our understanding of how the brain accepts statements of all kinds to be valid descriptions of the world.			Harris, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.	mscohen@ucla.edu	Cohen, Mark S/C-6610-2011	Cohen, Mark S/0000-0001-6731-4053; Bookheimer, Susan/0000-0002-3417-5891	NCRR NIH HHS [P41 RR013642, RR00865, M01 RR000865, RR13642, C06 RR012169] Funding Source: Medline; NIDA NIH HHS [R90 DA023422] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642, C06RR012169, M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R90DA023422] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anastasi MW, 2008, J ALTERN COMPLEM MED, V14, P163, DOI 10.1089/acm.2007.0675; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Azari NP, 2001, EUR J NEUROSCI, V13, P1649, DOI 10.1046/j.0953-816x.2001.01527.x; Barrett JL, 2000, TRENDS COGN SCI, V4, P29, DOI 10.1016/S1364-6613(99)01419-9; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BLOOM P, 2004, DESCARTES BABY SCI C, pR15; Borg J, 2003, AM J PSYCHIAT, V160, P1965, DOI 10.1176/appi.ajp.160.11.1965; Boyer P, 2003, TRENDS COGN SCI, V7, P119, DOI 10.1016/S1364-6613(03)00031-7; Boyer P, 2001, RELIG EXPLAINED EVOL; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; BROOKS M, 2009, BORN BELIEVERS YOUR; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; D'Argembeau A, 2008, SOC COGN AFFECT NEUR, V3, P244, DOI 10.1093/scan/nsn020; DENNETT DC, 2006, BREAKING SPELL RELIG, pR14; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; DURKHEIM E, 2001, ELEMENTARY FORMS REL, pR41; Evans EM, 2001, COGNITIVE PSYCHOL, V42, P217, DOI 10.1006/cogp.2001.0749; Freud S., 1975, FUTURE ILLUSION; Freud Sigmund, 1994, CIVILIZ ITS DISCONT; Harris S, 2008, ANN NEUROL, V63, P141, DOI 10.1002/ana.21301; HOOD BM, 2009, SUPERSENSE WE BELIEV; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Inzlicht M, 2009, PSYCHOL SCI, V20, P385, DOI 10.1111/j.1467-9280.2009.02305.x; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MARX K, 1971, CRITIQUE HEGELS PHIL; Matsumoto K, 2004, CURR OPIN NEUROBIOL, V14, P178, DOI 10.1016/j.conb.2004.03.005; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Newberg A, 2003, PERCEPT MOTOR SKILL, V97, P625, DOI 10.2466/PMS.97.6.625-630; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg AB, 2006, PSYCHIAT RES-NEUROIM, V148, P67, DOI 10.1016/j.pscychresns.2006.07.001; NORRIS P, 2004, SACRED SECULAR RELIG, pR15; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Previc FH, 2006, CONSCIOUS COGN, V15, P500, DOI 10.1016/j.concog.2005.09.009; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Schjodt U, 2008, NEUROSCI LETT, V443, P165, DOI 10.1016/j.neulet.2008.07.068; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Weber Max., 1993, SOCIOL RELIG; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zuckerman P., 2008, SOC GOD	60	76	78	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e0007272	10.1371/journal.pone.0007272	http://dx.doi.org/10.1371/journal.pone.0007272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501BP	19794914	Green Published, gold			2022-12-25	WOS:000270354200005
J	Wang, YF; Chen, ZL; Qiao, F; Ying, TY; Yuan, J; Zhong, ZJ; Zhou, L; Du, XY; Wang, ZJ; Zhao, J; Dong, SC; Jia, LL; Yuan, XT; Yang, RF; Sun, YS; Huang, LY				Wang, Yufei; Chen, Zeliang; Qiao, Feng; Ying, Tianyi; Yuan, Jing; Zhong, Zhijun; Zhou, Lei; Du, Xinying; Wang, Zhoujia; Zhao, Jin; Dong, Shicun; Jia, Leili; Yuan, Xitong; Yang, Ruifu; Sun, Yansong; Huang, Liuyu			Comparative Proteomics Analyses Reveal the virB of B-melitensis Affects Expression of Intracellular Survival Related Proteins	PLOS ONE			English	Article							HIGH-TEMPERATURE-REQUIREMENT; OUTER-MEMBRANE PROTEIN; BRUCELLA-ABORTUS; ESCHERICHIA-COLI; TRIGGER FACTOR; HEAT-SHOCK; IN-VIVO; HTRA; SUIS; IDENTIFICATION	Backgound: Brucella melitensis is a facultative, intracellular, pathogenic bacterium that replicates within macrophages. The type IV secretion system encoded by the virB operon (virB) is involved in Brucella intracellular survival. However, the underlying molecular mechanisms, especially the target proteins affected by the virB, remain largely unclear. Methodology/Principal Findings: In order to define the proteins affected by virB, the proteomes of wild-type and the virB mutant were compared under in vitro conditions where virB was highly activated. The differentially expressed proteins were identified by MALDI-TOF-MS. Forty-four down-regulated and eighteen up-regulated proteins which exhibited a 2-fold or greater change were identified. These proteins included those involved in amino acid transport and metabolism, lipid metabolism, energy production, cell membrane biogenesis, translation, post-translational modifications and protein turnover, as well as unknown proteins. Interestingly, several important virulence related proteins involved in intracellular survival, including VjbR, DnaK, HtrA, Omp25, and GntR, were down-regulated in the virB mutant. Transcription analysis of virB and vjbR at different growth phase showed that virB positively affect transcription of vjbR in a growth phase dependent manner. Quantitative RT-PCR showed that transcription of these genes was also affected by virB during macrophage cell infection, consistent with the observed decreased survival of the virB mutant in macrophage. Conclusions/Significance: These data indicated that the virB operon may control the intracellular survival of Brucella by affecting the expression of relevant proteins.			Wang, YF (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	Zeliangchen@yahoo.com; Huangly@nic.bmi.ac.cn		Qian, Pei-Yuan/0000-0003-4074-9078; wang, yong/0000-0003-3595-3867				Billard E, 2005, INFECT IMMUN, V73, P8418, DOI 10.1128/IAI.73.12.8418-8424.2005; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; CLOECKAERT A, 1992, J GEN MICROBIOL, V138, P1543, DOI 10.1099/00221287-138-7-1543; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Edmonds MD, 2002, RES VET SCI, V72, P235, DOI 10.1053/rvsc.2002.0555; Edmonds MD, 2002, VET MICROBIOL, V88, P205, DOI 10.1016/S0378-1135(02)00110-4; Edmonds MD, 2001, AM J VET RES, V62, P1461, DOI 10.2460/ajvr.2001.62.1461; ELZER PH, 1994, INFECT IMMUN, V62, P4135, DOI 10.1128/IAI.62.10.4135-4139.1994; ELZER PH, 1995, PLASMID, V33, P51, DOI 10.1006/plas.1995.1006; Elzer PH, 1996, INFECT IMMUN, V64, P4838, DOI 10.1128/IAI.64.11.4838-4841.1996; GEISOW MJ, 1981, J CELL BIOL, V89, P645, DOI 10.1083/jcb.89.3.645; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; Jubier-Maurin V, 2001, INFECT IMMUN, V69, P4823, DOI 10.1128/IAI.69.8.4823-4830.2001; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Kohler S, 1996, MOL MICROBIOL, V20, P701, DOI 10.1111/j.1365-2958.1996.tb02510.x; Kohler S, 2002, INFECT IMMUN, V70, P1631, DOI 10.1128/IAI.70.3.1631-1634.2002; Kulakov YK, 1997, RES MICROBIOL, V148, P145, DOI 10.1016/S0923-2508(97)87645-0; Laskowska E, 1996, MOL MICROBIOL, V22, P555, DOI 10.1046/j.1365-2958.1996.1231493.x; Li SR, 1996, INFECT IMMUN, V64, P2088, DOI 10.1128/IAI.64.6.2088-2094.1996; LIN JS, 1995, INFECT IMMUN, V63, P1409, DOI 10.1128/IAI.63.4.1409-1414.1995; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda H, 1996, BIOL CHEM H-S, V377, P217; Nijskens C, 2008, MICROB PATHOGENESIS, V45, P134, DOI 10.1016/j.micpath.2008.04.005; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Phillips RW, 1997, RES VET SCI, V63, P165, DOI 10.1016/S0034-5288(97)90012-6; PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Taminiau B, 2002, INFECT IMMUN, V70, P3004, DOI 10.1128/IAI.70.6.3004-3011.2002; Teixeira-Gomes AP, 2000, INFECT IMMUN, V68, P2954, DOI 10.1128/IAI.68.5.2954-2961.2000; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Yamamoto T, 1996, INFECT IMMUN, V64, P2980, DOI 10.1128/IAI.64.8.2980-2987.1996; Yang XH, 2007, VACCINE, V25, P2261, DOI 10.1016/j.vaccine.2006.12.004	40	243	259	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5368	10.1371/journal.pone.0005368	http://dx.doi.org/10.1371/journal.pone.0005368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401764	gold, Green Published, Green Submitted			2022-12-25	WOS:000265601100011
